# Copyright (c) 1966-2020 Johns Hopkins University. Use of this file adheres to the terms specified at https://omim.org/help/agreement.
# Generated: 2020-12-19
# IMPORTANT - Please switch to using genemap2.txt, this file (genemap.txt) will be removed August 1st, 2020.
# See end of file for additional documentation on specific fields
# Sort	Month	Day	Year	Cyto Location	Gene Symbols	Confidence (deprecated)	Gene Name	MIM Number	Mapping Method (deprecated)	Comments	Phenotypes	Mouse Gene Symbol
1.1	5	13	13	1pter-p36.13	CTRCT8, CCV		Cataract, congenital, Volkmann type	115665		linked to Rh in Scottish family	Cataract 8, multiple types (2)	
1.2	9	25	01	1p36.23	ENO1, PPH, MPB1		Enolase-1, alpha	172430			Enolase deficiency (1)	4(Eno1)
1.3	12	22	87	1pter-p36	ERPL1, HLM2		Endogenous retroviral pol gene-like sequence 1 (oncogene HLM2)	131190				
1.4	4	14	11	1p36.11	HMGCL		3-hydroxy-3-methylglutaryl-Coenzyme A lyase	613898			HMG-CoA lyase deficiency, 246450 (3)	4(Hmgcl)
1.5	4	30	15	1p36.33	AGRN, CMS8		Agrin	103320			Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3)	4(Agrn)
1.6	12	14	20	1p36.33	GNB1, MRD42, MDS		Guanine nucleotide-binding protein, beta polypeptide-1	139380			Mental retardation, autosomal dominant 42, 616973 (3); Leukemia, acute lymphoblastic, somatic, 613065 (3); Myelodysplastic syndrome, somatic, 614286 (3)	4(Gnb1)
1.7	10	2	07	1p35.2	SDC3, SYND3, SDCN		Syndecan 3	186357			{Obesity, association with}, 601665 (3)	4(Synd3)
1.8	8	28	98	1pter-p22.1	SAI1, MTS1, TFS1		Suppression of anchorage independence-1 (malignant transformation suppression-1)	154280				4(Tfs1)
1.9	05	27	20	1p36.33	ATAD3A, HAYOS, PHRINL		ATPase family, AAA domain-containing, member 3A	612316			Harel-Yoon syndrome, 617183 (3); Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal, 618810 (3)	4(Atad3)
1.10	10	6	08	1p36.33	ATAD3B, TOB3, KIAA1273		ATPase family, AAA domain-containing, member 3B	612317				
1.11	11	29	16	1p36.33	ATAD3C		ATPase family, AAA domain-containing, member 3C	617227				
1.12	04	13	20	1p36.33	C1DUPp36.33, DUP1p36.33		Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster	618815			Chromosome 1p36.33 duplication syndrome, ATAD3 gene cluster (4)	
1.13	5	6	13	1p36.33	C1orf86, FAAP20		Chromosome 1 open reading frame 86	615183				
1.14	7	3	06	1p36.33	CALML6, CAGLP		Calmodulin-like 6	610171				
1.15	9	30	10	1p36.33	CCNL2		Cyclin L2	613482				4(Ccnl2)
1.16	3	23	14	1p36.33	CPSF3L, INTS11, RC68		Cleavage and polyadenylation-specific factor 3-like	611354				
1.17	10	13	15	1p36.33	FAM132A, C1QDC2, C1QTNF12		Family with sequence similarity 132, member A	616593				
1.18	11	1	13	1p36.33	GLTPD1, CPTP		Glycolipid transfer protein domain-containing protein 1	615467				
1.19	12	19	14	1p36.33	ISG15, G1P2, IFI15, IMD38		ISG15 ubiquitin-like modifier	147571			Immunodeficiency 38, 616126 (3)	
1.20	3	23	09	1p36.33	MIR200A, MIRN200A		Micro RNA 200A	612090				
1.21	3	23	09	1p36.33	MIR200B, MIRN200B		Micro RNA 200B	612091				
1.22	3	23	09	1p36.33	MIR429, MIRN429		Micro RNA 429	612094				
1.23	1	9	17	1p36.33	MXRA8, ASP3		Matrix remodeling-associated protein 8	617293				4(Mxra8)
1.24	12	02	20	1p36.33	NOC2L, NIR		NOC2-like nucleolar-associated transcriptional repressor	610770				
1.25	8	18	14	1p36.33	PERM1, C1orf170		PPARGC1-and ESRR-induced regulator, muscle, 1	615921				
1.26	1	21	16	1p36.33	SAMD11, MRS		Sterile alpha motif domain-containing protein 11	616765				
1.27	10	10	11	1p36.33	SDF4, CAB45		Stromal cell-derived factor 4	614282				
1.28	9	21	17	1p36.33	SSU72		Ssu72, S. cerevisiae, homolof of	617680				4(Ssu72)
1.29	4	24	01	1p36.33	TAS1R3, T1R3		Taste receptor type 1, member 3	605865				4(Tas1r3)
1.30	12	2	14	1p36.33	TMEM240, C1orf70, SCA21		Transmembrane protein 240	616101			Spinocerebellar ataxia 21, 607454 (3)	
1.31	10	27	89	1p36.23	CA6		Carbonic anhydrase VI	114780				
1.32	2	18	08	1p36.33	NADK		NAD kinase	611616				
1.33	08	21	19	1p36.23	PER3, FASPS3		Period circadian regulator 3	603427		mutation identified in 1 FASPS3 family	?Advanced sleep phase syndrome, familial, 3, 616882 (3)	
1.34	7	18	06	1p36.32	ACTRT2, ARPT2, ARPM2		Actin-related protein T2	608535				
1.35	5	21	07	1p36.32	AJAP1, SHREW1		Adherens junction-associated protein 1	610972				
1.36	05	01	20	1p36.32	ARHGEF16		RHO guanine nucleotide exchange factor 16	618871				
1.37	2	2	16	1p36.32	CEP104, GLYBP, KIAA0562, JBTS25		Centrosomal protein, 104kD	616690			Joubert syndrome 25, 616781 (3)	
1.38	08	21	19	1p36.33	MIB2		Mindbomb E3 ubiquitin protein ligase 2	611141				
1.39	4	8	13	1p36.32	MIR551A		Micro RNA 551A	615148				
1.40	09	06	18	1p36.32	MMEL1, NEPII, NEP2, NL1, SEP		Membrane metalloendopeptidase-like 1	618104				
1.41	10	25	12	1p36.32	PEX10, NALD, PBD6A, PBD6B		Peroxisome biogenesis factor 10	602859			Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3); Peroxisome biogenesis disorder 6B, 614871 (3)	
1.42	7	9	09	1p36.32	PLCH2, PLCL4		Phospholipase C, eta-2	612836				
1.43	8	27	15	1p36.32	TPRG1L, FAM79A		Tumor protein p63 regulated 1-like	611460				
1.44	4	8	03	1p36.32-p36.13	DYT13		Dystonia 13, torsion	607671			Dystonia 13, torsion (2)	
1.45	4	16	11	1p36.32-p35.3	KONDS		Kondoh syndrome (mental retardation, microcephaly, growth retardation, joint contractures, and facial dysmorphism)	606242		linked to rs966321 and rs1441834	Kondoh syndrome (2)	
1.46	10	5	11	1p36.31	GPR153		G protein-coupled receptor 153	614269				4(Gpr153)
1.47	09	19	19	1p36.31	HES2		Hes family bHLH transcription factor 2	609970				
1.48	09	19	19	1p36.31	HES3		Hes family bHLH transcription factor 3	609971				
1.49	09	19	19	1p36.33	HES4		Hes family bHLH transcription factor 4	608060				
1.50	09	19	19	1p36.32	HES5		Hes family bHLH transcription factor 5	607348				
1.51	3	12	15	1p36.31	KLHL21, KIAA0469		Kelch-like 21	616262				
1.52	4	27	16	1p36.31	RNF207, C1orf188		RING finger protein 207	616923				
1.53	1	20	09	1p36.31	THAP3		THAP domain-containing protein 3	612532				
1.54	11	4	93	1p36.31	RPL22, EAP		Ribosomal protein L22	180474		fused with AML1 in t(3;21)		
1.55	9	18	12	1p36.31	DNAJC11		DNAJ/HSP40 homolog, subfamily C, member 11	614827				
1.56	1	5	12	1p36.31-p36.13	DFNB96		Deafness, autosomal recessive 96	614414		between rs3817914 and rs477558	Deafness, autosomal recessive 96 (2)	
1.57	8	18	12	1p36.33	AURKAIP1, AKIP, AIP		Aurora kinase A-interacting protein 1	609183				
1.58	04	27	20	1p36.33	B3GALT6, SEMDJL1, EDSSPD2, ALGAZ		UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6	615291			Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3); Ehlers-Danlos syndrome, spondylodysplastic type, 2, 615349 (3); Al-Gazali syndrome, 609465 (3)	4(B3galt6)
1.59	1	27	11	1p36.33	CDK11B, CDC2L1, P58, CDK11		Cyclin-dependent kinase 11B	176873				
1.60	1	27	11	1p36.33	CDK11A, CDC2L2		Cyclin-dependent kinase 11A	116951				
1.61	8	4	99	1p36.32	DFFB, CAD, DFF2		DNA fragmentation factor, 40kD, beta subunit	601883				
1.62	9	11	12	1p36.33	GABRD, GEFSP5, EIG10, EJM7		Gamma-aminobutyric acid (GABA) A receptor, delta	137163			{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3); {Epilepsy, idiopathic generalized, 10}, 613060 (3); {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)	
1.63	12	24	08	1p36.32	MEGF6, EGFL3		Multiple epidermal growth factor-like domains 6	604266				
1.64	6	15	99	1p36.33	TNFRSF18, AITR, GITR		Tumor necrosis factor receptor superfamily, member 18	603905				
1.65	3	30	99	1p36.31	KCNAB2, KCNA2B		Potassium voltage-gated channel, shaker-related subfamily, beta member 2	601142				
1.66	11	1	99	1p36.33	MMP23A, MMP21, MIFR		Matrix metalloproteinase 23A	603320				
1.67	11	1	99	1p36.33	MMP23B, MMP22		Matrix metalloproteinase 23B	603321				
1.68	1	12	11	1p36.22	MTHFR		Methylenetetrahydrofolate reductase	607093			Homocystinuria due to MTHFR deficiency, 236250 (3); {Schizophrenia, susceptibility to}, 181500 (3); {Vascular disease, susceptibility to} (3); {Neural tube defects, susceptibility to}, 601634 (3); {Thromboembolism, susceptibility to}, 188050 (3)	4(Mthfr)
1.69	9	9	13	1p36.32	PRDM16, MEL1, LVNC8, CMD1LL		PR domain-containing protein 16	605557			Left ventricular noncompaction 8, 615373 (3); Cardiomyopathy, dilated, 1LL, 615373 (3)	
1.70	8	9	99	1p36.3	PTPRZ2		Protein-tyrosine phosphatase, receptor-type, zeta-2	604008				
1.71	1	20	98	1p36.13	RNU1A, RNU1		RNA, U1A small nuclear	180680		?same as A12M2		3(Rnu1b1)
1.72	08	21	19	1p36.33-p36.32	SKI, SGS		SKI proto-oncogene	164780		formerly mapped to 1q22-q24	Shprintzen-Goldberg syndrome, 182212 (3)	
1.73	12	23	02	1p36.31	TNFRSF25, TNFRSF12, DR3, LARD		Tumor necrosis factor receptor superfamily, member 25	603366				
1.74	9	28	10	1p36.22	UBE4B, UFD2A, KIAA0684		Ubiquitination factor E4B	613565				
1.75	4	6	13	1p36.22	UBIAD1, TERE1, SCCD		UbiA prenyltransferase domain-containing protein 1	611632			Corneal dystrophy, Schnyder type, 121800 (3)	
1.76	3	20	08	1p36.33	VWA1, WARP		von Willebrand factor A domain-containing protein 1	611901				
1.77	6	20	01	1p36.32	WDR8		WD repeat-containing protein 8	606040				
1.78	11	22	13	1p36.31	ZBTB48, HKR3		Zinc finger- and BTB domain-containing protein 48	165270				
1.79	2	6	94	1p36.12	HTR1D		5-hydroxytryptamine (serotonin) receptor-1D	182133				4(Htr1d)
1.80	6	10	98	1p36.22	DFFA, DFF1		DNA fragmentation factor, 45kD, alpha subunit	601882				
1.81	3	10	11	1p36.22	MASP2		Mannan-binding lectin serine protease 2	605102			MASP2 deficiency, 613791 (3)	
1.82	12	22	17	1p36.22	PLOD1, LH1, LLH, EDSKCL1		Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase)	153454			Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3)	4(Plod)
1.83	08	24	20	1p36.33	SCNN1D		Sodium channel epithelial 1, subunit delta	601328				
1.84	12	18	98	1p36.22	TNFRSF1B, TNFR2, TNFBR		Tumor necrosis factor receptor superfamily, member 1B	191191				4(Tnfr1)
1.85	12	14	98	1p36.32	TNFRSF14, HVEM, TR2		Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)	602746				
1.86	1	11	07	1p36.21	CASP9, APAF3		Caspase 9, apoptosis-related cysteine protease	602234				
1.87	10	25	19	1p36.31	ESPN, USH1M		Espin	606351		mutation identified in 1 USH1M family	Deafness, autosomal recessive 36, 609006 (3); Deafness, neurosensory, without vestibular involvement, autosomal dominant, 609006 (3); ?Usher syndrome, type 1M, 618632 (3)	4(espn)
1.88	2	28	08	1p36.33	MRPL20		Mitochondrial ribosomal protein L20	611833				
1.89	2	17	11	1p36.12	C1QA		Complement component 1, q subcomponent, A chain	120550			C1q deficiency, 613652 (3)	
1.90	2	17	11	1p36.12	C1QB		Complement component 1, q subcomponent, B chain	120570			C1q deficiency, 613652 (3)	(C1qb)
1.91	2	17	11	1p36.12	C1QC, C1QG		Complement component 1, q subcomponent, C chain	120575			C1q deficiency, 613652 (3)	
1.92	07	13	20	1p36.13	FBXO42, FBX42, KIAA1332		F-box protein 42	609109				4(Fbox42)
1.93	07	13	20	1p36.22	FBXO6, FBX6, FBG2		F-box protein 6	605647				4(Fbxo6)
1.94	1	8	07	1p36.13	HSPB7, CVHSP		Heat-shock 27kD protein 7	610692				
1.95	7	18	14	1p36.23	UTS2		Urotensin II	604097				
1.96	07	26	19	1p36.22	ANGPTL7, CDT6		Angiopoietin-like 7	618517				
1.97	12	30	04	1p36.22	APITD1		Apoptosis-inducing, TAF9-like domain 1	609130				
1.98	7	17	09	1p36.22	CTNNBIP1, ICAT		Catenin, beta-interacting protein 1	607758				
1.99	01	21	20	1p36.22	DRAXIN, C1orf187		Dorsal inhibitory axon guidance protein	612682				
1.100	7	27	09	1p36.22	EXOSC10, PMSCL2		Exosome component 10	605960				
1.101	5	24	13	1p36.22	LZIC		Leucine zipper and CTNNBIP1 domains-containing protein	610458				
1.102	11	05	18	1p36.22	MIIP, IIP45		Migration and invasion inhibitory protein	608772				
1.103	9	25	12	1p36.22	NMNAT1, NMNAT, PNAT1, LCA9		Nicotinamide nucleotide adenylyltransferase 1	608700			Leber congenital amaurosis 9, 608553 (3)	
1.104	03	31	20	1p36.22	DISP3, PTCHD2, KIAA1337		Dispatched RND transporter family, member 3	611251				
1.105	2	28	07	1p36.22	SLC25A33		Solute carrier family 25 (mitochondrial carrier), member 33	610816				4(Slc25A33)
1.106	12	18	07	1p36.22	SPSB, SSB1		SPRY domain- and SOCS box-containing 1	611657				
1.107	9	22	08	1p36.22	CASZ1, SRG		Castor zinc finger protein 1	609895				4(Srg)
1.108	08	21	19	1p36.22-p36.21	VPS13D, SCAR4		Vacuolar protein sorting 13 homolog D	608877			Spinocerebellar ataxia, autosomal recessive 4, 607317 (3)	4(Vps13d)
1.109	3	5	18	1p36.21	AGMAT, AUH		Agmatinase	617887				
1.110	2	11	08	1p36.21	CTRC, CLCR		Chymotrypsin	601405			{Pancreatitis, chronic, susceptibility to}, 167800 (3)	
1.111	7	20	15	1p36.21	EFHD2, SWS1		EF-hand domain family, member D2	616450				
1.112	07	13	20	1p36.22	FBXO44, FBX44, FBX6A, FBG3		F-box protein 44	609111				4(Fbxo44)
1.113	2	28	06	1p36.21	GBD2		Gallbladder disease 2	609918		between D1S1597 and D1S47	Gallbladder disease 2 (2)	
1.114	01	30	19	1p36.21	KAZN		Kazrin, periplakin-interacting protein	618301				4(Kazn)
1.115	5	6	13	1p36.21	LRRC38		Leucine-rich repeat-containing protein 38	615212				
1.116	12	10	13	1p36.21	PDPN, TI1A, T1A2, GP36, OTS8, AGGRUS		Podoplanin	608863				
1.117	7	8	16	1p36.21	PLEKHM2, SKIP, KIAA0842		Pleckstrin homology domain-containing protein, family M, member 2	609613				
1.118	3	12	07	1p36.21	SLC25A34		Solute carrier family 25, member 34	610817				4(Slc25A34)
1.119	10	10	19	1p36.21	CELA2A, ELA2A, AOMS4		Chymotrypsin-like elastase family, member 2A	609443			Abdominal obesity-metabolic syndrome 4, 618620 (3)	
1.120	9	2	12	1p36.21	CELA2B, ELA2B		Chymotrypsin-like elastase family, member 2B	609444				
1.121	3	31	15	1p36.22	KIF1B, CMT2A, CMT2A1, NBLST1		Kinesin family member 1B	605995		mutation identified in 1 CMT2A1 family	?Charcot-Marie-Tooth disease, type 2A1, 118210 (3); Pheochromocytoma, 171300 (3); {Neuroblastoma, susceptibility to, 1}, 256700 (3)	4(Kif1b)
1.122	8	30	16	1p36.22	MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B		Mitofusin 2	608507			Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3); Hereditary motor and sensory neuropathy VIA, 601152 (3); Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3)	
1.123	4	20	17	1p36.22	MTOR, FRAP1, SKS		Mechanistic target of rapamycin	601231			Smith-Kingsmore syndrome, 616638 (3); Focal cortical dysplasia, type II, somatic, 607341 (3)	
1.124	7	8	09	1p36.13	NBPF1, KIAA1693		Neuroblastoma breakpoint family, member 1	610501		pseudogenes on 3 and 5		
1.125	9	15	11	1p36.12	NBPF3		Neuroblastoma breakpoint family, member 3	612992				
1.126	4	29	14	1p36.22	NPPA, PND, ANP, ATFB6, ATRST2		Natriuretic peptide precursor A	108780			Atrial fibrillation, familial, 6, 612201 (3); Atrial standstill 2, 615745 (3)	4(Pnd)
1.127	5	9	95	1p36.22	NPPB, BNP		Natriuretic peptide precursor B	600295				4(Nppb)
1.128	10	25	12	1p36.22	PEX14, PBD13A		Peroxisome biogenesis factor 14	601791			Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3)	
1.129	5	23	14	1p36.22	PIK3CD, APDS, IMD14		Phosphatidylinositol 3-kinase, catalytic, 110kD, delta	602839			Immunodeficiency 14, 615513 (3)	
1.130	3	12	08	1p36.2	SCZD12		Schizophrenia 12	608543		max lod at D1S1612	{Schizophrenia 12}, 181500 (2)	
1.131	8	4	99	1p36.23	SLC2A5, GLUT5		Solute carrier family 2 (facilitated glucose transporter), member 5	138230				
1.132	10	11	06	1p36.23	SLC2A7, GLUT7		Solute carrier family 2 (facilitated glucose transporter), member 7	610371				
1.133	10	5	10	1p36.22	TARDBP, TDP43, ALS10		TAR DNA-binding protein	605078		pseudogenes on 2, 6, 8, 13, 20	Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3); Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)	4(Tardbp)
1.134	4	10	90	1p36.22	PGD		6-phosphogluconate dehydrogenase	172200				4(Pgd)
1.135	07	13	20	1p36.13	PAX7, RMS2, MYOSCO		Paired box gene 7	167410		fused with FKHR in rhabdomyosarcoma	Rhabdomyosarcoma 2, alveolar, 268220 (3); Myopathy, congenital, progressive, with scoliosis, 618578 (3)	4(Pax7)
1.136	3	24	88	1p35.3	FGR, SRC2		Oncogene FGR	164940		same as SRC2		4(Fgr)
1.137	9	22	97	1p36.2-p36.1	GLC3B		Glaucoma 3, primary infantile, B	600975			Glaucoma 3, primary infantile, B (2)	
1.138	6	17	16	1p36.23	RERE, NEDBEH		RE repeats-encoding gene	605226			Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3)	
1.139	6	28	17	1p36.23	SLC45A1, DNB5, IDDNPF		Solute carrier family 45, member 1	605763			Intellectual developmental disorder with neuropsychiatric features, 617532 (3)	
1.140	10	3	11	1p36.13	ZBTB17, ZNF151, MIZ1		Zinc finger- and BTB domain-containing protein 17	604084				
1.141	1	1	95	1p36.12	CDA		Cytidine deaminase	123920				
1.142	2	19	08	1p35.3	EPB41, EL1		Erythrocyte surface protein band 4.1	130500			Elliptocytosis-1, 611804 (3)	4(Elp1)
1.143	5	14	18	1p36.11	RHCE, RHNA		Rhesus system C and E polypeptides	111700		?order: C-E-D	[Blood group, Rhesus] (3); Rh-null disease, amorph type, 617970 (3)	
1.144	5	25	05	1p36.11	RHD		Rhesus system D polypeptide	111680			[Rh-negative blood type] (3)	
1.145	5	23	12	1p36.13	AKR7A2, AKR7, AFAR		Aldo-keto reductase family 7, member A2	603418		pseudogenes on Xq25 and 1p12		
1.146	8	8	13	1p36.13	AKR7A3, AFAR2		Aldo-keto reductase family 7, member A3	608477				
1.147	8	8	13	1p36.13	AKR7A4, AFAR3		Aldo-keto reductase family 7, member A4	608478				
1.148	12	22	08	1p36.13	ARHGEF10L, GRINCHGEF, KIAA1626		RHO guanine nucleotide exchange factor 10-like protein	612494				
1.149	12	22	08	1p36.13	ARHGEF19, WGEF		RHO guanine nucleotide exchange factor 19	612496				4(Arhgef19)
1.150	10	13	15	1p36.12	ASAP3, UPLC1, CENTB6, DDEFL1, ACAP4		ARF GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 3	616594				
1.151	3	30	16	1p36.13	EMC1, KIAA0090, CAVIPMR		Endoplasmic reticulum membrane protein complex, subunit 1	616846			Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3)	
1.152	7	17	09	1p36.21	FBLP1, MIGFILIN		Filamin-binding LIM protein 1	607747				
1.153	02	22	19	1p36.13	MICOS10, MINOS1, MIO10, MIC10		Mitochondrial contact site and cristae organizing system, 10kD subunit	616574				
1.154	2	18	08	1p36.13	NECAP2		NECAP endocytosis-associated protein 2	611624				
1.155	1	28	08	1p36.13	OTUD3, KIAA0459		OTU domain-containing protein 3	611758				
1.156	1	16	07	1p36.13	PADI1		Peptidylarginine deiminase, type I	607934				
1.157	1	16	07	1p36.13	PADI2		Peptidylarginine deiminase, type II	607935				
1.158	12	22	16	1p36.13	PADI3, UHS1		Peptidylarginine deiminase, type III	606755			Uncombable hair syndrome, 191480 (3)	
1.159	1	16	07	1p36.13	PADI4, PADI5, PAD		Peptidylarginine deiminase, type IV	605347			{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
1.160	12	6	16	1p36.13	PADI6, PREMBL2		Peptidylarginine deiminase, type VI	610363			Preimplantation embryonic lethality 2, 617234 (3)	
1.161	8	21	12	1p36.13	PQLC2		PQ loop repeat-containing protein 2	614760				
1.162	10	25	16	1p36.13	RNF186		Ring finger protein 186	617163				
1.163	1	25	18	1p13.3	SLC25A24, SCAMC1		Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24	608744			Fontaine progeroid syndrome, 612289 (3)	2(Slc25a24)
1.164	09	19	19	1p36.21-p36.13	SPEN, MINT, SHARP, HIAA0929		Spen family transcriptional repressor	613484				
1.165	12	01	20	1p36.13	TRG-CCC1-1, TRNAG1, TRG1		tRNA glycine 1 (anticodon CCC) 1-1	189911				
1.166	7	22	14	1p36.13	UBR4, ZUBR1, RBAF600, KIAA1307		Ubiquitin protein ligase E3 component n-recognin 4	609890				
1.167	09	27	20	1q21.2	APH1A		APH1 homolog A, gamma secretase subunit	607629				
1.168	1	11	95	1p36.12	ID3		Inhibitor of DNA binding 3, dominant negative, helix-loop-helix protein	600277				
1.169	10	24	97	1p36.13	D1S1733E, DAN		Differential-screening-selected gene aberrant in neuroblastoma	600613		aberrant in some neuroblastomas		4(D4H1S1733E)
1.170	1	29	16	1p36.11	MAN1C1		Mannosidase, alpha, class 1C, member 1	616772				
1.171	1	3	05	1p36.13-p34.3	ANIB3		Aneurysm, intracranial berry, 3	609122			Aneurysm, intracranial berry, 3 (2)	
1.172	10	24	14	1p36.13-p34.3	EA8		Episodic ataxia, type 8	616055		between rs2743201 and rs215791	Episodic ataxia, type 8 (2)	
1.173	8	23	09	1p36.12	B6QTL1		Vitamin B6 plasma level QTL 1	612957		associated with rs4654748	{Vitamin B6 plasma level QTL 1} (2)	
1.174	1	9	13	1p36.12	CAMK2N1		Calcium/calmodulin-dependent protein kinase II inhibitor 1	614986				
1.175	12	05	19	1p36.12	CELA3A		Chymotrypsin-like elastase 3A	618693		proximal to CELA3B		
1.176	12	05	19	1p36.12	CELA3B		Chymotrypsin-like elastase 3A	618694		distal to CELA3A		
1.177	8	18	14	1p36.12	EIF4G3, EIF4GII		Eukaryotic translation initiation factor 4-gamma, 3	603929				
1.178	7	17	09	1p36.12	EPHA8, EEK, HEK3		Ephrin receptor EphA8 (eph- and elk-related kinase)	176945				
1.179	11	3	14	1p36.12	HP1BP3, HP1BP74		Heterochromatin protein 1-binding protein 3	616072				
1.180	3	3	16	1p36.12	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF		Lysine-specific demethylase 1A	609132			Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	
1.181	7	20	12	1p36.12	KIF17, KIAA1405		Kinesin family member 17	605037				
1.182	4	27	09	1p36.12	MUL1, MULAN, C1orf166		Mitochondrial ubiquitin ligase activator of NFKB1	612037				
1.183	3	1	01	1p36.12	PLA2G2D, SPLASH		Phospholipase A2, group IID	605630				4(Pla2g2d)
1.184	5	25	13	1p36.12	TCEA3		Transcription elongation factor A, 3	604128				
1.185	2	2	16	1p36.12	UBXN10		UBX domain protein 10	616783				
1.186	4	5	11	1p36.12-p35.1	BFIS4, BFIC4		Seizures, benign familial infantile, 4	612627		between D1S2864 and D1S2830	Seizures, benign familial infantile, 4 (2)	
1.187	03	25	20	1p36.1-p35.3	AHDC1, XIGIS, MRD25		AT-hook DNA-binding motif-containing protein 1	615790			Xia-Gibbs syndrome, 615829 (3)	
1.188	7	20	12	1p36.11	CD52, CDW52		CD52 molecule	114280				
1.189	05	29	20	1p36.11	CEP85, CCDC21		Centrosomal protein, 85kD	618898				
1.190	7	2	18	1p36.11	CLIC4, MTCLIC		Chloride intracellular channel 4	606536				
1.191	2	25	15	1p36.11	CNKSR1, CNK1		Connector enhancer of KSR 1	603272				
1.192	6	22	14	1p36.13	CROCC, ROOTLETIN, KIAA0445		Ciliary rootlet coiled-coil protein	615776				
1.193	1	23	18	1p36.11	DHDDS, HDS, RP59, DEDSM		Dehydrodolichyl diphosphate synthase	608172		mutation identified in 1 CDG1BB patient	Retinitis pigmentosa 59, 613861 (3); Developmental delay and seizures with or without movement abnormalities, 617836 (3); ?Congenital disorder of glycosylation, type 1bb, 613861 (3)	
1.194	4	6	11	1p36.11	FCN3, HAKA1		Ficolin 3	604973			Immunodeficiency due to ficolin 3 deficiency, 613860 (3)	
1.195	5	19	17	1p36.11	GPATCH3		G-patch domain-containing protein 3	617486				
1.196	3	11	14	1p36.11	GRHL3, SOM, TFCP2L4, VWS2		Grainyhead-like 3	608317			Van der Woude syndrome 2, 606713 (3)	
1.197	10	7	02	1p36.12	HNRPR, HNRNPR		Heterogeneous nuclear ribonucleoprotein R	607201				
1.198	2	11	13	1p36.11	IFNLR1, IL28RA		Interferon, lambda receptor 1	607404				
1.199	09	11	19	1p36.11	LIN28A		lin-28 homolog A	611043				4(Lin28)
1.200	12	30	14	1p36.11	LYPLA2, APT2		Lysophospholipase II	616143				
1.201	2	8	12	1p36.11	MAP3K6, MAPKKK6, ASK2		Mitogen-activated protein kinase kinase kinase 6	604468				
1.202	2	23	16	1p36.11	MYOM3		Myomesin 3	616832				4(Myom3)
1.203	09	19	19	1p36.11	NUDC		Nuclear distribution C, dynein complex regulator	610325				
1.204	4	29	14	1p36.11	PAFAH2		Platelet-activating factor acetylhydrolase 2	602344				
1.205	7	17	09	1p36.11	PAQR7, MPRA, PGLP		Progestin and ADIPOQ receptor family, member 7	607779				
1.206	8	20	12	1p36.11	PIGV, HPMRS1		Phosphatidylinositol glycan, class V	610274			Hyperphosphatasia with mental retardation syndrome 1, 239300 (3)	
1.207	02	19	20	1p36.11	PITHD1, C1orf128		PITH domain containing 1	618784				
1.208	3	11	08	1p36.11	PNRC2		Proline-rich nuclear receptor coactivator 2	611882				
1.209	7	19	12	1p36.11	SFN		Stratifin	601290				
1.210	3	7	14	1p36.11	SH3BGRL3		SH3 domain-binding glutamic acid-rich protein-like protein 3	615679				
1.211	1	17	13	1p36.11	SLC30A2, ZNT2, TNZD		Solute carrier family 30 (zinc transporter), member 2	609617			Zinc deficiency, transient neonatal, 608118 (3)	4(Slc30a2)
1.212	7	27	09	1p36.11	SRRM1, SRM160		Serine/arginine repetitive matrix 1 (ser/arg-related nuclear matrix protein, 160kD)	605975				
1.213	7	18	14	1p36.11	STPG1, MAPO2, C1orf201		Sperm-tail PG-rich repeat-containing protein 1	615826				4(Stpg1)
1.214	09	19	19	1p36.11	SYF2, P29		SYF2 pre-mRNA splicing factor	607090				
1.215	2	14	08	1p36.11	SYTL1, SLP1, JFC1		Synaptotagmin-like protein 1	608042				
1.216	10	22	20	1p36.11	TENT5B, FAM46		Terminal nucleotidyltransferase 5B	619069				
1.217	6	22	14	1p36.11	TMEM50A, SMP1		Transmembrane protein 50A	605348		between RHD and RHCE		
1.218	5	24	13	1p36.11	TMEM57, FLJ10747		Transmembrane protein 57	610301				4(Tmem57)
1.219	2	10	14	1p36.11	TRIM63, RNF28, SMRZ, MURF1		Tripartite motif containing 63	606131				
1.220	2	19	16	1p36.11	TRNP1		TMF1-regulated nuclear protein 1	616824				
1.221	5	29	15	1p36.11	UBXN11, SOC		UBX domain protein 11	609151				
1.222	12	22	15	1p36.11	ZNF593, ZT86		Zinc finger protein 593	616698				
1.223	1	29	16	1p36.11	ZNF683, HOBIT		Zinc finger protein 683	616775				
1.224	11	13	17	1p36.11	WASF2, WAVE2, SCAR2		WAS protein family member 2	605875		?pseudogene on Xp11.21		
1.225	8	28	97	1p36.13	CAPZB, CAPPB		Capping protein (actin filament) muscle Z-line, beta	601572				
1.226	1	8	16	1p36.12	CDC42, TKS		Cell division cycle 42 (GTP-binding protein, 25kD)	116952			Takenouchi-Kosaki syndrome, 616737 (3)	4(cdc42)
1.227	1	1	95	1p35.3	CHC1, RCC1		Regulator of chromosome condensation	179710				4(Chc1)
1.228	5	25	14	1p36.12	DDOST, OST, OST48, CDG1R		Dolichyl-diphosphooligosaccharide-protein glycosyltransferase	602202		mutation (cmpd het) identified in 1 CDG1R patient	?Congenital disorder of glycosylation, type Ir, 614507 (3)	
1.229	7	16	09	1p36.21	DHRS3, RETSDR1		Short-chain dehydrogenase/reductase family, member 3	612830				
1.230	11	17	16	1p36.12	ECE1		Endothelin converting enzyme 1	600423		mutation identified in 1 HCAD patient	?Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3); {Hypertension, essential, susceptibility to}, 145500 (3)	
1.231	5	6	13	1p36.13	EPHA2, ECK, CTPP1, CTPA, ARCC2, CTRCT6		Ephrin receptor EphA2	176946			Cataract 6, multiple types, 116600 (3)	
1.232	4	11	97	1p36.11	EXTL1		Exostosin-like 1	601738				
1.233	8	28	02	1p36.11	HMGN2, HMG17		High-mobility group nucleosomal binding protein 2	163910				
1.234	4	1	01	1p36.12	HSPG2, PLC, SJS, SJA, SJS1		Heparan sulfate proteoglycan of basement membrane (perlecan)	142461			Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	4(Plc)
1.235	2	28	03	1p36.11	MDS2		Myelodysplasia syndrome gene 2	607305		fused with ETV6 in myelodysplastic syndrome		
1.236	3	6	01	1p36.11	NR0B2, SHP		Nuclear receptor subfamily 0, group B, member 2	604630			Obesity, mild, early-onset, 601665 (3)	
1.237	11	3	98	1p35.3	RNU17A, RNE1		RNA, U17a small nucleolar	180645		in IVS1 of CHC1		
1.238	11	3	98	1p35.3	RNU17B		RNA, U17b small nucleolar	603239				
1.239	12	15	99	1p35.3	RNU17D, U17HG		RNA, U17d small nucleolar	603238				
1.240	8	30	09	1p36.11	RPS6KA1, RSK1		Ribosomal protein S6 kinase, 90kD, 1	601684				
1.241	2	20	98	1p36.21	RSC1A1, RS1		Regulatory solute carrier protein, family 1, member 1	601966				
1.242	12	19	11	1p36.11	SRSF10, FUSIP1, TASR, TASR1, TASR2		Splicine factor, serine/arginine-rich, 10	605221		pseudogenes on chr. 9, 12, 20		
1.243	2	15	96	1p36.11	TCEB3		Transcription elongation factor B (SIII), polypeptide 3 (110kD, elongin A)	600786				
1.244	9	2	09	1q21.1	TRNAN1, TRN1, TRN		tRNA asparagine	189880				
1.245	06	14	19	1p36.12	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB, BDPLT22		eph tyrosine kinase 3 (ephrin receptor EphB2)	600997		mutation identified in 1 BDPLT22 family	{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3); ?Bleeding disorder, platelet-type, 22, 618462 (3)	4(Ephb2)
1.246	4	23	96	1p36.1-p35	MEMO1		Methylation modifier for class I HLA	601201				
1.247	10	22	95	1p36.13	MFAP2, MAGP, MAGP1		Microfibrillar-associated protein-2	156790				4(Mfap2)
1.248	2	26	95	1p36.12	RAP1GA1		RAP1, GTPase activating protein 1	600278				
1.249	2	4	09	1p36.11	RPL11, DBA7		Ribosomal protein L11	604175			Diamond-Blackfan anemia 7, 612562 (3)	
1.250	01	17	19	1p36.13	SDHB, SDH2, SDHIP, PGL4		Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)	185470		1 of 2 polypeptides	Paragangliomas 4, 115310 (3); Pheochromocytoma, 171300 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3)	
1.251	09	18	20	1p36.11	SLC9A1, NHE1, APNH, LIKNS		Solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter, Na+/H+, amiloride sensitive)	107310			Lichtenstein-Knorr syndrome, 616291 (3)	4(Apnh, Nhe1)
1.252	7	17	01	1p36.11	STMN1, LAP18, SMN		Stathmin	151442				4(Lap18)
1.253	1	1	95	1p36.11	GPR3		G protein-coupled receptor-3	600241				
1.254	3	17	94	1p35.3	OPRD1		Opioid receptor, delta-1	165195				4(Nbor, Oprd1)
1.255	8	12	09	1p36.12	ALPL, HOPS, TNSALP		Alkaline phosphatase, liver/bone/kidney	171760			Hypophosphatasia, infantile, 241500 (3); Hypophosphatasia, childhood, 241510 (3); Odontohypophosphatasia, 146300 (3); Hypophosphatasia, adult, 146300 (3)	4(Akp2)
1.256	3	17	06	1p36.31	ACOT7, BACH, LACH		Acyl-CoA thioesterase 7	602587				
1.257	2	15	06	1p36	AD7CNTP		Alzheimer disease neuronal thread protein	607413				
1.258	1	25	99	1p36.13	ALDH4A1, ALDH4, P5CDH		Aldehyde dehydrogenase 4 family, member A1 (delta-1-pyrroline 5-carboxylate dehydrogenase)	606811			Hyperprolinemia, type II, 239510 (3)	
1.259	11	7	08	1p36	ALPQTL2		Alkaline phosphatase, plasma level of, QTL 2	612367		linkage with rs1780324	{Alkaline phosphatase, plasma level of, QTL 2} (2)	
1.260	1	11	17	1p36.13	ATP13A2, PARK9, KRPPD, SPG78		ATPase 13A2	610513		mutation identified in 1 family with CLN12	Kufor-Rakeb syndrome, 606693 (3); Spastic paraplegia 78, autosomal recessive, 617225 (3)	4(Atp13a2)
1.261	10	6	09	1p36	BCC1		Basal cell carcinoma, susceptibility to, 1	605462		associated with rs7538876	{Basal cell carcinoma, susceptibility to, 1} (2)	
1.262	5	14	02	1p36	BMND3		Bone mineral density QTL 3	606928		?another locus at 3p21	[Bone mineral density QTL 3] (2)	
1.263	8	31	12	1p36.31-p36.23	CAMTA1, KIAA0833, CANPMR		Calmodulin-binding transcription activator 1	611501			Cerebellar ataxia, nonprogressive, with mental retardation, 614756 (3)	
1.264	2	20	07	1p36.31	CHD5		Chromodomain helicase DNA-binding protein 5	610771				4(Chd5)
1.265	6	19	98	1p36.22	CLCN6		Chloride channel 6	602726				
1.266	11	3	09	1p36.13	CLCNKA		Chloride channel, kidney, A	602024		11kb from CLCNKB; simultaneous mutation in CLCNKA and CLCNKB	Bartter syndrome, type 4b, digenic, 613090 (3)	
1.267	8	24	04	1p36.13	CLCNKB		Chloride channel, kidney, B	602023		unequal crossingover with CLCNKA	Bartter syndrome, type 3, 607364 (3); Bartter syndrome, type 4b, digenic, 613090 (3)	
1.268	3	3	15	1p36.22	CLSTN1, KIAA0911		Calsyntenin 1	611321				4(Clstn1)
1.269	1	4	93	1p36	CMM, MLM, DNS		Cutaneous malignant melanoma/dysplastic nevus	155600		some linkage studies negative; see 9p	{Melanoma, cutaneous malignant, 1} (2)	
1.270	12	30	09	1p36.11	CNR2, CB2, CX5		Cannabinoid receptor 2	605051				
1.271	08	21	19	1p36.33	DVL1, DRS2		Dishevelled segment polarity protein 1	601365			Robinow syndrome, autosomal dominant 2, 616331 (3)	
1.272	2	01	01	1p36.22	CORT		Cortistatin	602784				4(Cort)
1.273	1	20	09	1p36	DEL1p36, C1DELp36		Chromosome 1p36 deletion syndrome	607872		contiguous gene deletion syndrome	Chromosome 1p36 deletion syndrome (4)	
1.274	3	13	06	1p36.23	DJ1, PARK7		Oncogene DJ-1	602533			Parkinson disease 7, autosomal recessive early-onset, 606324 (3)	
1.275	2	23	95	1p36.12	E2F2		E2F transcription factor 2	600426				
1.276	09	19	19	1p35.3	EYA3		EYA transcriptional coactivator and phosphatase 3	601655				4(Eya3)
1.277	07	13	20	1p36.22	FBXO2, FBX2, FBG1, NFB42		F-box protein 2	607112				4(Fbxo2)
1.278	5	29	12	1p36.22	H6PD, GDH, G6PDH, CORTRD1		Hexose-6-phosphate dehydrogenase	138090		digenic triallelic mutations with HSD11B1	Cortisone reductase deficiency 1, 604931 (3)	
1.279	6	9	09	1p36	IBD7		Inflammatory bowel disease 7	605225		associated with rs6426833	{Inflammatory bowel disease 7} (2)	
1.280	4	17	01	1p36.31	ICMT		Isoprenylcysteine carboxylmethyltransferase	605851				
1.281	2	7	17	1p36.11	KDF1, C1orf172, ECTD12		Keratinocyte differentiation factor 1	616758		mutation identified in 1 ECTD12 family	?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type, 617337 (3)	4(Kdf1)
1.282	4	2	01	1p36.12	LUZP1		Leucine zipper protein 1	601422				4(Luzp)
1.283	08	21	19	1p36.22	MAD2L2, MAD2B, FANCV		Mitotic arrest-deficient 2 like 2	604094		mutation identified in 1 FANCV patient; pseudogene on 14q21-q23	?Fanconi anemia, complementation group V, 617243 (3)	
1.284	9	16	03	1p36.23	MIG6, RALT		Mitogen-inducible gene 6	608069				
1.285	3	23	09	1p36.22	MIR34A, MIRN34A		Micro RNA 34A	611172				
1.286	2	23	09	1p36	MS4		Multiple sclerosis, susceptibility to, 4	612596		associated with rs10492972	{Multiple sclerosis, susceptibility to, 4} (2)	
1.287	7	22	11	1p36	MYP14		Myopia 14	610320		between D1S552 and D1S1622	Myopia 14 (2)	
1.288	12	30	02	1p36.31	NPHP4, SLSN4		Nephrocystin 4	607215			Nephronophthisis 4, 606966 (3); Senior-Loken syndrome 4, 606996 (3)	
1.289	7	9	06	1p36.32	PANK4		Pantothenate kinase 4	606162				
1.290	6	1	04	1p36.12	PINK1, PARK6		PTEN-induced putative kinase 1	608309			Parkinson disease 6, early onset, 605909 (3)	
1.291	02	08	19	1p36.13	PLA2G2E		Secretory phospholipase A2, group IIE	618320				
1.292	4	24	18	1p36.31	PLEKHG5, KIAA0720, DSMA4, CMTRIC		Pleckstrin homology domain- and RhoGEF domain-containing protein G5	611101			Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3); Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3)	
1.293	9	28	96	1p36.21	PRDM2, RIZ		PR domain-containing protein 2 (retinoblastoma protein-binding zinc-finger protein RIZ)	601196				4(Riz)
1.294	7	09	06	1p36.33	PRKCZ, PKC2		Protein kinase C, zeta form	176982				
1.295	11	29	99	1p36.11	RUNX3, CBFA3, PEBP2A3, AML2		Runt-related transcription factor 3	600210				4(Aml2, Cbfa3)
1.296	6	4	13	1p36.32	SMIM1, VEL		Small integral membrane protein 1	615242			[Blood group, Vel system], 615264 (3)	
1.297	2	12	03	1p36.31	TAS1R1, T1R1		Taste receptor type 1, member 1	606225				4(T1r1)
1.298	2	12	03	1p36.13	TAS1R2, T1R2		Taste receptor type 1, member 2	606226				4(T1r2)
1.299	1	15	14	1p36.33	TNFRSF4, TXGP1L, OX40, ACT35, IMD16		Tumor necrosis factor receptor superfamily, member 4	600315		mutation identified in 1 IMD16 family	?Immunodeficiency 16, 615593 (3)	4(Ox40)
1.300	12	18	98	1p36.22	TNFRSF8, CD30, D1S166E		Tumor necrosis factor receptor superfamily, member 8 (CD30 antigen; Ki-1 antigen)	153243				4(Cd30)
1.301	12	18	98	1p36.23	TNFRSF9, ILA, CD137		Tumor necrosis factor receptor superfamily, member 9 (interleukin-activated receptor; Ly63, mouse, homolog of)	602250				(Cd157)
1.302	11	13	18	1p36.32	TP73		p53-related protein	601990		imprinted		
1.303	12	01	20	1p36.13	TRE-TTC3-1, TRNAE1, TRNE, TRE		tRNA glutamic acid (anticodon TTC) 3-1	180640				
1.304	4	21	17	1p36.12	USP48, USP31		Ubiquitin-specific peptidase 48	617445				
1.305	7	9	06	1p36.23	VAMP3		Vesicle-associated membrane protein 3	603657				
1.306	6	27	08	1p36.12	ZBTB40, KIAA0478		Zinc finger- and BTB domain-containing protein 40	612106				
1.307	06	25	19	1p36	ZBTB40IT1		ZBTB40 intronic transcript 1, noncoding	618485				
1.308	1	2	08	1p36.12	ZNF436, KIAA1710		Zinc finger protein 436	611703				
1.309	5	29	02	1p36.11	GALE		UDP galactose-4-epimerase	606953			Galactose epimerase deficiency, 230350 (3)	
1.310	3	12	96	1p36.13	HTR6		5-hydroxytryptamine (serotonin) receptor-6	601109				
1.311	06	19	19	1p36.11	LDLRAP1, ARH, FHCB2, FHCB1, FHCL4		Low density lipoprotein receptor adaptor protein 1	605747			Hypercholesterolemia, familial, 4, 603813 (3)	
1.312	11	18	16	1p36.11	SELENON, SEPN1, SELN, RSMD1, CFTD		Selenoprotein N	606210			Muscular dystrophy, rigid spine, 1, 602771 (3); Myopathy, congenital, with fiber-type disproportion, 255310 (3)	
1.313	11	1	04	1p36-p34	DYX8		Dyslexia, susceptibility to, 8	608995		between D1S552 and D1S1622	{Dyslexia, susceptibility to, 8} (2)	
1.314	12	23	14	1p36.13	PLA2G5, FRFB		Phospholipase A2, group V	601192			[Fleck retina, familial benign], 228980 (3)	4(Pla2g5)
1.315	5	4	00	1p34.3	PABPC4, PABP4, IPABP, APP1		Polyadenylate-binding protein, cytoplasmic, 4	603407				
1.316	12	3	91	1p36.22	SRM, SPS1		Spermidine synthase-1	182891		?pseudogene on 3p14-q21		
1.317	4	29	16	1p36.11	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2		AT rich interactive domain 1A, SWI-like	603024			Coffin-Siris syndrome 2, 614607 (3)	
1.318	1	15	13	1p35.3	ATP1F1, IF1		ATPase inhibitory factor 1	614981				
1.319	3	28	11	1p36.11	CATSPER4		Cation channel, sperm-associated, 4	609121				4(Catsper4)
1.320	1	27	04	1p35.1	CSMD2, KIAA1884		Cub and Sushi multiple domains 2	608398				
1.321	7	17	09	1p35.3	GMEB1		Glucocorticoid modulatory element-binding protein 1	604409				
1.322	1	9	17	1p35.3	MECR, NRBF1, DYTOABG		Mitochondrial trans-2-enoyl-CoA reductase	608205			Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, 617282 (3)	
1.323	11	7	08	1p35.3	MED18		Mediator complex subunit 18	612384				
1.324	2	21	07	1p36.11	PDIK1L		PDLIM1-interacting kinase 1-like	610785				
1.325	7	16	12	1p35.3	PHACTR4		Phosphatase and actin regulator 4	608726				
1.326	2	1	11	1p35.3	PTPRU, GLEPP1, PTPU2		Protein tyrosine phosphatase, receptor type, U	602454				
1.327	5	13	03	1p35.3	SEST2, HI95		Sestrin 2	607767				9(Sest2)
1.328	10	25	17	1p35.3	SMPDL3B, ASML3B		Sphingolyelin phosphodiesterase, acid-like, 3B	617737				
1.329	12	19	11	1p35.3	SRSF4, SFRS4, SRp75		Splicing factor, serine/arginine-rich, 4	601940				
1.330	7	2	18	1p35.3	STX12, STX13		Syntaxin 12	606892				
1.331	9	22	08	1p35.3	TAF12		TAF12 RNA polymerase II, TATA box-binding protein-associated factor, 20kD	600773				
1.332	1	30	18	1p35.3	THEMIS2, C1orf38, ICB1		Thymocyte selection-associated protein family, member 2	617856				
1.333	12	18	14	1p34.3	MEAF6, C1orf149, EAF6		MYST/ESA1-associated factor 6	611001				
1.334	11	09	18	1p34.3	ADPRHL2, ARH3, CONDSIAS		ADP-ribosylhydrolase-like 2	610624			Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, 618170 (3)	
1.335	1	9	13	1p34.3	ZC3H12A, MCPIP, MCPIP1		Zinc finger CCCH domain-containing protein 12A	610562				
1.336	8	8	13	1p35.2	HCRTR1, OX1R		Hypocretin receptor 1	602392				
1.337	7	16	09	1p35.2	NKAIN1		Na+/K+ transporting ATPase-interacting 1	612871				4(Nkain1)
1.338	08	21	19	1p35.2	PUM1, KIAA0099, SCA47		Pumilio RNA binding family member 1	607204			Spinocerebellar ataxia 47, 617931 (3)	
1.339	4	2	12	1p35.2	SERINC2		Serine incorporator 2	614549				
1.340	7	27	09	1p35.2	SNRNP40, SPF38, PRPF8BP		Small nuclear ribonucleoprotein 40kDa (U5)	607797				
1.341	09	28	20	1p35.2	SPOCD1		SPOC domain-containing protein 1	619038				
1.342	11	3	14	1p35.2	TINAGL1, TINAGRP		Tubulointerstitial nephritis antigen-like protein 1	616064				
1.343	9	24	08	1p36.11	RCAN3, DSCR1L2, MCIP3		Regulator of calcineurin 3	605860				4(Dscr1l2)
1.344	6	12	17	1p35.1	BSDC1		BSD domain-containing protein 1	617518				
1.345	11	23	11	1p35.2	CCDC28B, MGC1203		Coiled-coil domain-containing protein 28B	610162			{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	
1.346	8	29	02	1p34.3	DNALI1, P28		Dynein, axonemal, light intermediate polypeptide 1	602135				
1.347	3	20	08	1p35.1	FNDC5, FRCP2		Fibronectin type III domain-containing protein 5	611906				4(Fndc5)
1.348	2	18	96	1p34.3	GJA4, CX37		Gap junction protein, alpha-4, 37kD (connexin 37)	121012				(Gja4)
1.349	6	13	17	1p34.3	GJB3, CX31, DFNA2B, EKVP1		Gap junction protein, beta-3	603324		same YAC as GJA4	Erythrokeratodermia variabilis et progressiva 1, 133200 (3); Deafness, autosomal dominant 2B, 612644 (3); Deafness, autosomal recessive (3); Deafness, autosomal dominant, with peripheral neuropathy (3); Deafness, digenic, GJB2/GJB3, 220290 (3)	
1.350	6	13	17	1p34.3	GJB4, CX30.3, EKVP2		Gap junction protein, beta-4	605425			Erythrokeratodermia variabilis et progressiva 2, 617524 (3)	
1.351	11	29	00	1p34.3	GJB5, CX31.1		Gap junction protein, beta-5	604493				
1.352	1	3	17	1p35.1	HMGB4		High mobility group box 4	617285				4(Hmgb4)
1.353	3	26	07	1p35.1	IBRDC3, NKLAM		IBR domain-containing protein 3	610872				
1.354	5	26	13	1p35.2	KPNA6		Karyopherin alpha-6	610563				
1.355	1	14	16	1p35.1	TRIM62, DEAR1		Tripartite motif-containing protein 62	616755				
1.356	01	20	20	1p35.1	ZBTB8A, BOZF1		Zinc finger- and BTB domain-containing protein 8A	618742				
1.357	7	17	14	1p35.1	ZBTB8OS, ARCH		Zinc finger- and BTB domain-containing protein 8, opposite strand	615891				
1.358	4	2	16	1p35.1	ZSCAN20, ZNF31, KOX29		Zinc finger- and SCAN domain-containing protein 20	611315				
1.359	9	1	16	1p35.2	ADGRB2, BAI2		Adhesion G protein-coupled receptor B2	602683				
1.360	5	3	18	1p35	C1DELp35, DEL1p35		Chromosome 1p35 deletion syndrome	617930		SRO 1.03 Mb containing 23 genes	Chromosome 1p35 deletion syndrome (4)	
1.361	8	21	91	1p35	EBVS1		Epstein-Barr virus integration site	132850				
1.362	3	21	93	1p35.3	G1P3, IFI616		Interferon, alpha-inducible protein (clone IFI-6-16)	147572				
1.363	5	26	98	1p35.2	MATN1, CRTM, CMP		Matrilin 1, cartilage matrix protein	115437				
1.364	02	12	19	1p36.13	PLA2G2A, PLA2B, PLA2L, MOM1		Phospholipase A2, group IIA, platelets, synovial fluid	172411		germline mutation identified in 1 CRC patient	{?Colorectal cancer, susceptibility to}, 114500 (3)	4(Pla2g2a)
1.365	7	27	09	1p35.3	PPP1R8, NIPP1, ARD1		Protein phosphatase-1, regulatory subunit-8	602636				
1.366	3	1	01	1p35.2	PTP4A2, PTP4A, PRL2, HH13		Protein tyrosine phosphatase, type 4A, 2	601584				
1.367	4	7	94	1p35.3	RPA2		Replication protein A2, 32kD	179836				
1.368	11	22	16	1p36.12	WNT4, SERKAL		Wingless-type MMTV integration site family, member 4	603490		mutation identified in 1 SERKAL family	?SERKAL syndrome, 611812 (3); Mullerian aplasia and hyperandrogenism, 158330 (3)	4(Wnt4)
1.369	08	21	19	1p35.1	YARS1, YARS, CMTDIC, TYRRS, YTS, YRS		Tyrosyl-tRNA synthetase 1	603623			Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	
1.370	8	26	15	1p35.3	YTHDF2		YTH N6-methyladenosine RNA-binding protein 2	610640		fused with AML1 in t(1;21)		
1.371	7	11	16	1p34.3	CSF3R, GCSFR, SCN7		Colony-stimulating factor-3 receptor (granulocyte)	138971			Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3)	
1.372	5	22	14	1p35.2	LCK, IMD22		Lymphocyte-specific protein tyrosine kinase	153390		LCK/TCRB fusion in leukemia; mutation identified in 1 IMD22 patient	?Immunodeficiency 22, 615758 (3)	4(Lck)
1.373	9	29	96	1p35.3	PTAFR		Platelet-activating factor receptor	173393				
1.374	6	8	15	1p35.1	HPCA, DYT2		Hippocalcin, 23kD, Ca2+-binding protein	142622			Dystonia 2, torsion, autosomal recessive, 224500 (3)	
1.375	4	23	08	1p34.3	MRPS15		Mitochondrial ribosomal protein S15	611979				
1.376	5	11	16	1p34.3	AGO1, EIF2C1, GERP95, EIF2C		Argonaute 1, RISC catalytic component	606228				
1.377	7	1	02	1p34.2	CITED4		CBP/P300-interacting transactivator, with glu/asp-rich carboxy terminal domain, 4	606815				
1.378	6	27	08	1p34.3	EIF2C3, AGO3		Eukaryotic translation initiation factor 2C, subunit 3 (argonaute 3)	607355				4(Ago3)
1.379	7	23	03	1p34.3	EIF2C4, AGO4, KIAA1567		Eukaryotic translation initiation factor 2C, 4 (argonaute 4)	607356				4(Eif2c4)
1.380	8	18	98	1p34.2	GUCA2A, GUCA2		Guanylate cyclase activator 2A (guanylin 2, intestinal, heat-stable)	139392				4(Guca2)
1.381	1	22	07	1p35.1	TSSK3, STK22C, STK22D		Testis-specific serine/threonine kinase 3	607660				4(Stk22d)
1.382	1	30	12	1p34.2	EBNA1BP2, EBP2		EBNA1-binding protein 2	614443				
1.383	4	17	13	1p34.3	AKIRIN1		Akirin 1	615164				
1.384	9	10	12	1p34.3	C1orf109		Chromosome 1 open reading frame 109	614799				
1.385	3	24	06	1p34.3	CDCA8		Cell division cycle-associated protein 8	609977		possible pseudogene on chr.7		
1.386	9	10	07	1p34.3	EPHA10		Ephrin receptor EphA10	611123				
1.387	2	28	06	1p34.3	GBD3		Gallbladder disease 3	609919		new D2S255	Gallbladder disease 3 (2)	
1.388	4	1	08	1p34.3	GJA9, CX59		Gap junction protein, alpha-9	611923				
1.389	5	16	05	1p34.3	GNL2, NGP1		Guanine nucleotide-binding protein-like 2	609365				
1.390	06	15	20	1p34.2	HEYL		HES-related bHLH transcription factor with YRPW motif-like protein	609034				
1.391	7	7	13	1p34.3	KIAA0319L, KIAA1837		KIAA0319-like	613535				
1.392	4	6	18	1p34.3	LSM10		Lsm10, U7 small nuclear RNA-associated protein	617909				
1.393	01	07	20	1p34.2	MYCL, LMYC		MYCL protooncogene, bHLH transcription factor	164850				4(Lmyc1)
1.394	2	16	04	1p34.3	NCDN, KIAA0607		Neurochondrin	608458				
1.395	09	19	19	1p34.3	RSPO1, FLJ40906		R-spondin 1	609595			Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3); Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)	
1.396	3	11	08	1p35.1	S100PBP, S100PBPR		S100P-binding protein	611889				
1.397	4	10	14	1p34.3	SF3A3, SF3A60, SAP61, PRP9		Splicing factor 3A, subunit 3	605596				
1.398	6	12	17	1p34.3	SNIP1, PMRED		SMAD nuclear interacting protein 1	608241			Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3)	
1.399	6	30	05	1p34.3	STK40, SHIK		Serine/threonine protein kinase 40	609437				
1.400	7	2	18	1p34.3	TEKT2, TEKTB1		Tektin 2	608953				
1.401	1	18	12	1p34.3	TFAP2E		Transcription factor AP2-epsilon	614428				
1.402	7	13	15	1p34.3	THRAP3, TRAP150		Thyroid hormone receptor-associated protein 3	603809				
1.403	5	21	07	1p34.3	TRAPPC3, BET3		Trafficking protein particle complex, subunit 3	610955				
1.404	6	30	05	1p34.3	UTP11L, CGI94		UTP11-like protein	609440				
1.405	8	27	15	1p34.3	ZMYM4, ZNF262, KIAA0425		Zinc finger, MYM-type 4	613568				
1.406	09	19	19	1p34.3	CLSPN		Claspin	605434				
1.407	1	23	08	1p35.1	SYNC1		Syncoilin 1	611750				
1.408	5	25	13	1p35.1	AZIN2, ODC1L, KIAA1945		Antizyme inhibitor 2	608353				
1.409	5	26	13	1p34.2	NT5C1A, CN1A, CNI, CN1		5'-nucleotidase, cytosolic, IA	610525				
1.410	2	25	10	1p34.3	COL8A2, FECD1, PPCD2		Collagen VIII, alpha-2 polypeptide	120252			Corneal dystrophy, Fuchs endothelial, 1, 136800 (3); Corneal dystrophy, posterior polymorphous 2, 609140 (3)	
1.411	01	31	20	1p34.1	MUTYH, MYH		mutY DNA glycosylase	604933			Adenomas, multiple colorectal, 608456 (3); Gastric cancer, somatic, 613659 (3)	
1.412	11	12	12	1p34.2	BMP8B, OP2		Bone morphogenetic protein-8b (osteogenic protein 2)	602284				4(Bmp8)
1.413	09	26	19	1p34.2	EXO5, C1orf176		Exonuclease 5	618601				
1.414	12	22	17	1p34.2	CAP1		Cyclase-associated actin cytoskeleton regulatory protein 1	617801				
1.415	11	30	06	1p34.2	CLDN19, HOMG5		Claudin 19	610036			Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)	4(Cldn19)
1.416	7	13	17	1p34.2	COL9A2, EDM2, STL5		Collagen IX, alpha-2 polypeptide	120260		mutation identified in1 STL5 family	Epiphyseal dysplasia, multiple, 2, 600204 (3); ?Stickler syndrome, type V, 614284 (3)	4(Col9a2)
1.417	08	09	19	1p34.2	ELOVL1, SSC1, IKSHD		Elongation of very long chain fatty acids-like 1	611813			Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies, 618527 (3)	
1.418	10	12	14	1p34.2	FOXJ3, KIAA1041		Forkhead box J3	616035				
1.419	12	17	20	1p34.2	HYI		Hydroxypyruvate isomerase	619128				
1.420	2	25	15	1p34.2	MED8		Mediator complex subunit 8	607956				
1.421	10	30	20	1p34.2	MFSD2A, NEDMISBA		Major facilitator superfamily domain-containing protein 2A	614397			Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain abnormalities, 616486 (3)	
1.422	4	8	13	1p34.2	MIR30C1		Micro RNA 30C-1	615151				
1.423	11	20	20	1p34.2	MIR30E, MIR30E*		Micro RNA 30E	619105				
1.424	8	19	04	1p34.3	NOR1		Oxidored-nitro domain-containing protein 1	608854				
1.425	5	24	13	1p34.2	OXCT2, FLJ0030		3-oxoacid CoA transferase 2	610289				
1.426	7	27	09	1p34.1	PIK3R3		Phosphatidylinositol 3-kinase, regulatory, 3	606076				
1.427	8	8	13	1p34.2	PPIE, CYP33		Peptidyl-prolyl isomerase E	602435				
1.428	2	20	98	1p34.3	PSMB2		Proteasome subunit, beta type, 2	602175				
1.429	12	17	15	1p34.2	SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN		Solute carrier family 2 (facilitated glucose transporter), member 1	138140		probably in 1p33	GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3); GLUT1 deficiency syndrome 2, childhood onset, 612126 (3); {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3); Dystonia 9, 601042 (3); Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	
1.430	4	22	16	1p34.2	SMAP2, SMAP1L		Small ADP-ribosylation factor GTPase-activating protein 2	616916				
1.431	09	09	19	1p34.2	SVBP, CCDC23, NEDAHM		Small vasohibin-binding protein	617853			Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly, 618569 (3)	
1.432	10	23	20	1p34.2	SZT2, KIAA0467, DEE18		SZT2 subunit of KICSTOR complex	615463			Developmental and epileptic encephalopathy 18, 615476 (3)	
1.433	2	16	18	1p34.2	TRIT1, IPT, COXPD35		tRNA isopentenyltransferase 1	617840			Combined oxidative phosphorylation deficiency 35, 617873 (3)	
1.434	12	11	12	1p34.2	WDR65		WD repeat-containing protein 65	614259				1(Wdr65)
1.435	9	24	08	1p34.3	YRDC, IRIP		YRDC domain-containing protein	612276				4(Yrdc)
1.436	4	24	18	1p34.2	ZFP69, ZNF642		Zinc finger protein 69	617939				4(Zfp69)
1.437	09	19	19	1p34.2	CDC20		Cell division cycle 20	603618		pseudogene on 9q13-q21		
1.438	6	15	99	1p34.3	NDUFS5		NADH-ubiquinone oxidoreductase subunit S5	603847				
1.439	5	7	03	1p32.3	OSBPL9, ORP9		Oxysterol-binding protein-like protein 9	606737				
1.440	11	27	18	1p34.1	ARTN		Artemin	603886				
1.441	7	17	14	1p34.2	CTPS1, CTPS, IMD24		Cytidine 5'-triphosphate synthetase 1	123860			Immunodeficiency 24, 615897 (3)	
1.442	2	25	15	1p34.1	DNMAP1, DMAP1		DNMT1-associated protein 1	605077				
1.443	5	31	05	1p34.1	EIF2B3		Eukaryotic translation initiation factor 2B, subunit 3	606273			Leukoencephalopathy with vanishing white matter, 603896 (3)	
1.444	10	3	07	1p35.2	EIF3I, EIF3S2, TRIP1		Eukaryotic translation initiation factor 3, subunit I	603911		pseudogene on 7q32		
1.445	9	9	08	1p34.2	FOXO6		Forkhead box O6	611457				4(Foxo6)
1.446	2	24	97	1p35.2-p35.1	HDAC1, RPD3L1		Histone deacetylase-1	601241				
1.447	10	25	19	1p34.1	HECTD3		HECT domain-containing E3 ugiquitin protein ligase 3	618638				
1.448	10	02	20	1p34.1	HPDL, NEDSWMA, SPG83		4-hydroxyphenylpyruvate dioxygenase-like	618994			Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3); Spastic paraplegia 83, autosomal recessive, 619027 (3)	
1.449	9	7	12	1p34.1	IPO13, IMP13, KIAA0724, RANBP13		Importin 13	610411				
1.450	5	29	12	1p34.2-p34.1	KDM4A, JMJD2A, JHDM3A, KIAA0677		Lysine-specific demethylase 4A	609764				
1.451	8	24	04	1p34.1	KIF2C, KNSL6, MCAK		Kinesin family, member 2C	604538				
1.452	12	30	14	1p34.1	LURAP1, LRAP35A		Leucine-rich adaptor protein 1	616129				
1.453	9	24	08	1p34.1	MAST2, MAST205, KIAA0807		Microtubule-associated serine/threonine kinase 2	612257				
1.454	10	31	19	1p34.1	MMACHC		Metabolism of cobalamin associated C	609831			Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)	
1.455	9	16	12	1p34.1	NASP		Nuclear autoantigenic sperm protein	603185				
1.456	3	6	18	1p34.1	PRDX1, PRXI, PAGA, NKEFA		Peroxiredoxin 1	176763		pseudogene PAGB on 9p22	Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3)	
1.457	2	1	11	1p34.1	PLK3, CNK, PRK		Polo-like kinase 3	602913		previously assigned to 8p21 by FISH		
1.458	4	13	98	1p34.3	POU3F1		POU domain, class 3, transcription factor-1	602479				4(Pou3f1)
1.459	5	17	04	1p34.2	PPIH		Peptidyl-prolyl isomerase H	606095				
1.460	2	23	08	1p34.2	RIMS3, NIM3, KIAA0137		Protein regulating synaptic membrane exocytosis 3	611600				
1.461	12	30	14	1p34.1	RNF220		RING finger protein 220	616136				
1.462	10	23	20	1p34.1	ST3GAL3, SIAT6, ST3GALII, MRT12, DEE15		ST3 beta-galactoside alpha-2,3-sialyltransferase 3	606494		mutation identified in 1 DEE15 family	Mental retardation, autosomal recessive 12, 611090 (3); ?Developmental and epileptic encephalopathy 15, 615006 (3)	
1.463	1	4	08	1p34.1	TCTEX1D4		TCTEX1 domain-containing 4	611713				
1.464	4	20	17	1p34.1	TOE1, PCH7		Target of EGR1	613931			Pontocerebellar hypoplasia, type 7, 614969 (3)	
1.465	12	21	09	1p34.1	TSPAN1, NET1		Tetraspanin 1	613170				
1.466	3	31	11	1p33	UQCRH		Ubiquinol-cytochrome c reductase hinge protein	613844		pseudogene on 1p36		
1.467	10	25	19	1p34.1	KLF717, ZLF393		Kruppel-like factor 17	609602				4(Znf393)
1.468	01	31	20	1p34-p33	LRRC41, MUF1		Leucine-rich repeat-containing protein 41	618753				
1.469	8	4	97	1p34.1-p32	PTOS1		Ptosis, congenital 1, autosomal dominant	178300			Ptosis, hereditary congenital, 1 (2)	
1.470	2	1	95	1p34.1	RPS8		Ribosomal protein S8	600357				
1.471	8	24	09	1p35.1	AK2		Adenylate kinase-2, mitochondrial	103020			Reticular dysgenesis, 267500 (3)	4(Ak2)
1.472	3	21	93	1p35.2	COL16A1		Collagen XVI, alpha-1 polypeptide	120326				
1.473	02	26	19	1p34.1	DPH2, DPH2L2		Diphthamide biosynthesis protein 2	603456				
1.474	6	6	91	1p34.2	EDN2		Endothelin-2	131241		vasoactive intestinal contractor (VIC) = mouse and rat equivalent		
1.475	09	19	19	1p33-p32	ELAVL4, HUD, PNEM		ELAV-like RNA binding protein 4 (Hu antigen D)	168360				4(Hud)
1.476	12	28	05	1p34.2	ERMAP, SC, RD		Erythroblast membrane-associated protein	609017			[Blood group, Scianna system], 111750 (3); [Blood group, Radin], 111620 (3)	4(Ermap)
1.477	6	22	99	1p34.3	FHL3, SLIM2		Four-and-a-half LIM domains-3	602790				
1.478	9	18	08	1p36.11	FUCA1		Fucosidase, alpha-L- 1, tissue	612280		8cM distal to RH; pseudogene on 2q31-q32	Fucosidosis, 230000 (3)	4(Fuca)
1.479	2	4	02	1p34.2	HIVEP3, KRC		Human immunodeficiency virus type 1 enhancer-binding protein 3	606649				
1.480	10	9	94	1p34.3	INPP5B		Inositol polyphosphate-5-phosphatase, 75kD	147264				4(Inpp5b)
1.481	3	6	09	1p34.2	KCNQ4, DFNA2A		Potassium voltage-gated channel, KQT-like subfamily, member 4	603537			Deafness, autosomal dominant 2A, 600101 (3)	
1.482	11	13	96	1p35.2	LAPTM5		Lysosomal-associated multispanning membrane protein-5	601476				
1.483	10	09	07	1p32.3	LRP8, APOER2, MCI1		Low density lipoprotein receptor-related protein 8 (Apolipoprotein E receptor 2)	602600			{Myocardial infarction, susceptibility to}, 608446 (3)	
1.484	6	7	10	1p35.1	MARCKSL1, MLP, MRP		MARCKS-like protein 1	602940				4(Mlp)
1.485	09	27	20	1p34.2	MPL, TPOR, MPLV, THCYT2		MPL protooncogene, thrombopoietin receptor	159530			Thrombocytopenia, congenital amegakaryocytic, 604498 (3); Thrombocythemia 2, 601977 (3); Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)	
1.486	2	3	15	1p34.2	P3H1, LEPRE1, GROS1, OI8		Prolyl 3-hydroxylase 1	610339			Osteogenesis imperfecta, type VIII, 610915 (3)	
1.487	5	19	06	1p35.2	PEF1		Peflin	610033				
1.488	3	6	08	1p34.3	RRAGC, RAGC		RAS-related GTP-binding protein C	608267				
1.489	09	19	19	1p34.2	SCMH1		Scm polycomb group protein homolog 1	616396				4(Scmh1)
1.490	8	31	01	1p34.3	SFPQ, PSF		Splicing factor, proline- and glutamine-rich	605199		fusion gene with TFE3 in RCC		
1.491	11	19	10	1p34.1	UROD		Uroporphyrinogen decarboxylase	613521			Porphyria cutanea tarda, 176100 (3); Porphyria, hepatoerythropoietic, 176100 (3)	4(Urod)
1.492	2	23	12	1p34.2	YBX1, NSEP1, YB1, DBPB		Y box binding protein 1 (major histocompatibility complex, class II, Y box-binding protein I)	154030				
1.493	6	23	05	1p34.2	ZMPSTE24, FACE1, STE24, MADB		Zinc metalloproteinase STE24	606480			Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3); Restrictive dermopathy, lethal, 275210 (3)	
1.494	10	9	94	1p34.3	GRIK3, GLUR7		Glutamate receptor, ionotropic, kainate 3	138243				
1.495	5	29	98	1p34.2	GUCA2B, UGN		Guanylate cyclase activator 2B (uroguanylin)	601271				4(Guca1b)
1.496	09	19	19	1p32.3	MAGOH		Mago homolog, exon junction complex subunit	602603				4(Magoh)
1.497	09	27	18	1p34.1	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15		Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase	606822			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3); Retinitis pigmentosa 76, 617123 (3)	
1.498	1	1	95	1p34.2	TIE, JTK14, TIE1		Tyrosine kinase with immunoglobulin and epidermal growth factor homology domains	600222				
1.499	5	28	98	1p33	FOXD2, FKHL17, FREAC9		Forkhead box D2	602211				
1.500	8	31	10	1p34-p32	MACST		Macrostomia	613545		max lod at D1S2797	Macrostomia (2)	
1.501	9	11	91	1p33	CYP4B1		Cytochrome P450, subfamily IVB, polypeptide 1	124075				4(Cyp4a)
1.502	11	4	91	1p31.3	DDIT1, GADD45		DNA damage-inducible transcript-1	126335				
1.503	7	28	15	1p33	AGBL4, CCP6		ATP/GTP-binding protein-like 4	616476				
1.504	1	11	07	1p33	CYP4A11		Cytochrome P450, subfamily IVA, polypeptide 11	601310				
1.505	8	2	13	1p33	CYP4A22		Cytochrome P450, family 4, subfamily A, polypeptide 22	615341				
1.506	1	9	13	1p33	CYP4X1, CYPIVX1		Cytochrome P450, family 4, subfamily X, polypeptide 1	614999				
1.507	07	16	20	1p33	CYP4Z1		Cytochrome P450, family 4, subfamily Z, member 1	618953				
1.508	07	16	20	1p33	CYP4Z2P		Cytochrome P450, family 4, subfamily Z, member 2, pseudogene	618954				
1.509	5	28	15	1p33	DMBX1, OTX3		Diencephalon/mesencephalon homeobox 1	607410				
1.510	11	19	13	1p33	FAAH		Fatty acid amide hydrolase	602935			{Drug addiction, susceptibility to}, 606581 (3)	4(Faah)
1.511	03	29	19	1p33	FAAHP1, FAAHOUT, LINC00505		Fatty acid amide hydrolase pseudogene 1	618375				
1.512	3	18	11	1p32.3	FAF1, HFAF1		Fas-associated factor 1	604460				
1.513	10	13	09	1p33	KNCN, KINO, L5		Kinocilin	611455				4(Kncn)
1.514	7	17	09	1p33	MKNK1, MNK1		Mitogen-activated protein kinase-interacting serine/threonine kinase 1	606724				
1.515	11	3	94	1p34.3	MTF1		Metal-regulatory transcription factor 1	600172				
1.516	5	30	17	1p33	NSUN4		NOP2/SUN RNA methyltransferase family, member 4	615394				
1.517	4	6	11	1p33	OFC13		Orofacial cleft 13	613857		associated with rs3827730	Orofacial cleft 13 (2)	
1.518	12	14	16	1p33	PDZK1IP1, MAP17		PDZK1-interacting protein 1	607178		near SLC in human, mouse, chicken, zebrafish		
1.519	6	23	15	1p33	SKINTL, SKINTP		SKINT1-like pseudogene	616392				
1.520	1	20	17	1p34.1	SLC6A9, GLYT1, GCENSG		Solute carrier family 6 (neurotransmitter transporter, glycine), member 9	601019			Glycine encephalopathy with normal serum glycine, 617301 (3)	4(Slc6a9)
1.521	5	3	11	1p33	SPATA6, SRF1, HASH		Spermatogenesis-associated protein 6	613947				
1.522	12	27	13	1p33	STIL, SIL, MCPH7		SCL/TAL1-interrupting locus	181590		within about 250kb of SCL	Microcephaly 7, primary, autosomal recessive, 612703 (3)	
1.523	12	10	12	1p33	TRABD2B, TIKI2		TRAB domain-containing protein 2B	614913				
1.524	9	8	06	1p34.1	BEST4, VMD2L2		Bestrophin 4	607336				
1.525	9	10	12	1p32.3	DMRTA2		Doublesex- and MAB3-related transcription factor A2	614804				
1.526	5	4	09	1p33-p32	BMND14		Bone mineral density quantitative trait locus 14	612728		associated with rs17131547	[Bone mineral density QTL 14] (2)	
1.527	12	6	01	1p34.3	MYCBP		MYC-binding protein	606535				
1.528	5	2	01	1p34.1	AKR1A1, ALR		Aldo-keto reductase family 1, member A1 (aldehyde reductase)	103830				
1.529	8	9	99	1p34.1	B4GALT2		Beta-1,4-galactosyltransferase 2	604013				
1.530	6	15	99	1p32.3	DIO1, TXDI1		Deiodinase, iodothyronine, type I	147892				4(Dio1)
1.531	9	22	95	1p22.1	TGFBR3		Transforming growth factor, beta receptor III (betaglycan, 300kD)	600742				
1.532	07	14	20	1p34.2	RIMKLA, NAAGS2		Ribosomal modification protein RimK-like family, member A	618949				
1.533	10	31	01	1p32.3	DHCR24, KIAA0018		24-dehydrocholesterol reductase	606418			Desmosterolosis, 602398 (3)	
1.534	1	27	11	1p33-p31.1	FWS		Forsythe-Wakeling syndrome	613606		between rs2354462 and rs718883	Forsythe-Wakeling syndrome (2)	
1.535	3	17	94	1p35.2	FABP3		Fatty acid-binding protein 3, muscle	134651				4(Fabph1)
1.536	3	24	06	1p32.3	ACOT11, THEA, BFIT, BFIT1, BFIT2, KIAA0707		Acyl-CoA thioesterase 11	606803				4(Thea)
1.537	11	19	13	1p34.1	ATP6V0B, ATP6F		ATPase, H+ transporting, V0 subunit b	603717				4(Atp6v0b)
1.538	12	24	08	1q32.3	BATF3		Basic leucine zipper transcription factor, ATF-like, 3	612470				
1.539	4	6	18	1p32.3	LEXM, C1orf177, LEM		Lymphocyte expansion molecule	616446				
1.540	04	19	19	1p32.3	COA7, RESA1, SELRC1, C1orf163, SCAN3		Cytochrome C oxidase assembly factor	615623			Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3, 618387 (3)	
1.541	8	19	13	1p32.3	GLIS1		Glis family zinc finger protein 1	610378				4(Glis1)
1.542	06	19	19	1p32.3	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1, FHCL3		Proprotein convertase, subtilisin/kexin-type, 9	607786			Hypercholesterolemia, familial, 3, 603776 (3); {Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	
1.543	5	17	04	1p32.3	PODN		Podocan	608661				
1.544	09	19	19	1p32.3	PRPF38A, PRP38A		Pre-mRNA processing factor 38A	617031				
1.545	7	3	06	1p32.3	TMEM48, NDC1		Transmembrane protein 48	610115				
1.546	8	18	16	1p32.3	TMEM59, DCF1		Transmembrane protein 59	617084				
1.547	6	30	05	1p32.3	TXNDC12, TLP19, ERP18		Thioredoxin domain-containing protein 12	609448				
1.548	5	13	09	1p32.3	USP24, KIAA1057		Ubiquitin-specific protease 24	610569				
1.549	6	12	17	1p32.3	YIPF1		YIP1 domain family, member 1	617521				
1.550	11	11	14	1p32.3	ZFYVE9, MADHIP, SARA		Zinc finger, FYVE domain containing 9	603755				
1.551	11	22	19	1p32.3	ZYG11A		ZYG11 family, member A, cell cycle regulator	618675				
1.552	11	22	19	1p32.3	ZYG11B		ZYG11 family, member B, cell cycle regulator	618673				
1.553	9	10	12	1p32.3	DMRTB1		Doublesex- and MAB3-related transcription factor B1	614805				
1.554	06	17	19	1p32.2	FYB2, ARAP, C1orf168		FYN-binding protein 2	618478				
1.555	7	2	98	1p32.3	NRD1		Nardilysin (N-arginine dibasic convertase)	602651				
1.556	12	01	20	1p32.3	PARS2, DEE75		Prolyl-tRNA synthetase 2	612036			Developmental and epileptic encephalopathy 75, 618437 (3)	
1.557	10	26	17	1p32.2	PLPP3, PPAP2B		Phospholipid phosphatase 3	607125				
1.558	8	18	16	1p32.2-p32.1	OMA1, MPRP1		OMA1 zinc metallopeptidase	617081				
1.559	04	27	20	1p32.1	C1orf87, CREF		Chromosome 1 open reading frame 87	618860				
1.560	7	7	15	1p32.1	FGGY, FLJ10986		FGGY carbohydrate kinase domain-containing protein	611370				
1.561	09	19	19	1p32.1	HOOK1, HK1		Hook microtubule tethering protein 1	607820				4(Hook1)
1.562	3	5	08	1p32.3	MRPL37		Mitochondrial ribosomal protein L37	611843				
1.563	09	26	18	1p32.1	MYSM1, 2ADUB, KIAA1915, BMFS4		MYB-like, SWIRM, and MPN domains-containing protein 1	612176			Bone marrow failure syndrome 4, 618116 (3)	
1.564	08	21	19	1p31.3	DNAJC6, DJC6, KIAA0473, PARK19		DNAJ heat shock protein family (Hsp40) member C6	608375			Parkinson disease 19a, juvenile-onset, 615528 (3); Parkinson disease 19b, early-onset, 615528 (3)	
1.565	6	18	99	1p31.3	USP1		Ubiquitin-specific protease 1	603478				
1.566	4	14	11	1p32.2	C8A		Complement component-8, alpha polypeptide	120950			C8 deficiency, type I, 613790 (3)	
1.567	3	10	11	1p32.2	C8B		Complement component-8, beta polypeptide	120960			C8 deficiency, type II, 613789 (3)	4(C8b)
1.568	10	6	08	1p32.3	CDCP2		Cub domain-containing protein 2	612320		?associated with PARK10		
1.569	6	18	99	1p32.3	CDKN2C, INK4C		Cyclin-dependent kinase inhibitor 2C	603369				
1.570	12	31	16	1p32.3	CPT2, IIAE4		Carnitine palmitoyltransferase II	600650		formerly at 1p13	CPT II deficiency, myopathic, stress-induced, 255110 (3); CPT II deficiency, infantile, 600649 (3); CPT II deficiency, lethal neonatal, 608836 (3); {Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)	
1.571	11	13	94	1p32.3	EPS15		Epidermal growth factor receptor pathway substrate-15	600051				
1.572	2	15	17	1p33	FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11		Forkhead box E3	601094			Anterior segment dysgenesis 2, multiple subtypes, 610256 (3); Cataract 34, multiple types, 612968 (3); {Aortic aneurysm, familial thoracic 11, susceptibility to}, 617349 (3)	
1.573	6	22	14	1p32.3	GPX7, NPGPX		Glutathione peroxidase 7	615784				
1.574	5	24	13	1p35.2	KHDRBS1, SAM68		KH domain-containing, RNA-binding, signal transduction-associated protein 1	602489				
1.575	1	30	01	1p34.2	NFYC, CBFC		Nuclear transcription factor Y, gamma	605344				4(Nfyc)
1.576	08	21	19	1p32.3	ORC1, ORC1L		Origin recognition complex, subunit 1	601902			Meier-Gorlin syndrome 1, 224690 (3)	
1.577	4	10	15	1p32	PARK10, AAOPD		Parkinson disease 10	606852		max lod at D1S2652; ?associated with CDCP2	{Parkinson disease 10} (2)	
1.578	1	5	12	1p34.2	PPT1, CLN1		Palmitoyl-protein thioesterase 1	600722			Ceroid lipofuscinosis, neuronal, 1, 256730 (3)	
1.579	3	1	06	1p34.1	PRNPIP, PINT1		Prion protein-interacting protein	609917				
1.580	08	21	19	1p34.1	PTCH2		Patched 2	603673			Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3); Basal cell nevus syndrome, 109400 (3)	4(Ptch2)
1.581	9	10	14	1p34.2	PTPRF, LAR, BNAH2		Protein tyrosine phosphatase, receptor type, f polypeptide	179590		mutation identified in 1 BNAH2 family	?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3)	4(Ptprf)
1.582	08	21	19	1p34.1	RAD54L, HR54, HRAD54		RAD54 like	603615			{Breast cancer, invasive ductal}, 114480 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3); Adenocarcinoma, colonic, somatic (3)	
1.583	1	26	93	1p34.2	RLF		Rearranged L-myc fusion sequence	180610		<800kb from MYCL1		
1.584	5	1	17	1p32.3	SCP2		Sterol carrier protein-2	184755		mutation identified in 1 LKDMN patient	?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3)	4(Scp2)
1.585	9	3	10	1p32	STQTL23		Stature quantitative trait locus 23	613548		linked to rs628667	{Stature QTL 23} (2)	
1.586	6	10	02	1p32.1	TACSTD2, TROP2, M1S1		Tumor-associated calcium signal transducer 2	137290			Corneal dystrophy, gelatinous drop-like, 204870 (3)	
1.587	8	27	15	1p33	TAL1, TCL5, SCL		T-cell acute lymphocytic leukemia-1	187040		proximal to MYCL1	Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	4(Scl)
1.588	5	25	13	1p34.1	TESK2		Testis-specific protein kinase 2	604746				
1.589	2	12	08	1p33	CMPK1, CMPK, UMPK, UMK, CMK		Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic	191710				
1.590	08	21	19	1p32.2-p32.1	DAB1, SCA37		DAB adaptor protein 1	603448			Spinocerebellar ataxia 37, 615945 (3)	4(Dab1)
1.591	09	19	19	1p32.1	JUN		Jun proto-oncogene, AP-1 transcription factor subunit	165160				4(Jun)
1.592	02	14	19	1p34.3	MACF1, ACF7, KIAA1251, LIS9		Microtubule-actin cross-linking factor 1	608271			Lissencephaly 9 with complex brainstem malformation, 618325 (3)	4(Macf1)
1.593	4	11	11	1p31.1	NEXN, NELIN, CMD1CC, CMH20		Nexilin F-actin binding protein	613121			Cardiomyopathy, dilated, 1CC, 613122 (3); Cardiomyopathy, hypertrophic, 20, 613876 (3)	
1.594	9	13	89	1p32.3	RAB3B		Brain antigen RAB3B	179510				
1.595	2	17	09	1p32.3	RNF11		Ring finger protein 11	612598				
1.596	1	22	09	1p31.3	SLC35D1, UGTREL7, KIAA0260, SHNKND		Solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1	610804			Schneckenbecken dysplasia, 269250 (3)	
1.597	8	8	91	1p21.2	VCAM1		Vascular cell adhesion molecule-1	192225				3(Vcam1)
1.598	3	21	93	1p34.1	IPP		Intracisternal A particle-promoted polypeptide	147485				4(Ipp)
1.599	09	09	19	1p31.3	AK4, AK3		Adenylate kinase 4	103030				4(Ak3)
1.600	09	19	19	1p31.3	ATG4C, APG4C		Autophagy related 4C cysteine peptidase	611339				
1.601	8	3	12	1p31.3	DIRAS3, ARHI		DIRAS family, GTP-binding RAS-like protein 3	605193				
1.602	10	23	20	1p31.3	DOCK7, KIAA1771, DEE23		Dedicator of cytokinesis 7	615730			Developmental and epileptic encephalopathy 23, 615859 (3)	4(Dock7)
1.603	8	28	17	1p31.3	EFCAB7, KIAA1799		EF-hand calcium-binding domain-containing protein 7	617632				
1.604	9	23	13	1p31.3	GNG12		Guanine nucleotide-binding protein, gamma 12	615405				6(Gng12)
1.605	9	23	13	1p31.3	GNG12AS1		GNG12 antisense RNA 1	615406				
1.606	1	12	11	1p31.3	IL23R, IBD17		Interleukin 23 receptor	607562			{Inflammatory bowel disease 17, protection against}, 612261 (3); {Psoriasis, protection against}, 605606 (3)	
1.607	07	28	18	1p31.3	PATJ, INADL		PALS1-associated tight junction protein	603199				
1.608	7	17	09	1p31.3	ITGB3BP, NRIF3		Integrin, beta-3, binding protein of	605494				
1.609	09	01	20	1p31.3	JAK1, AIIDE		Janus kinase 1 (a protein-tyrosine kinase)	147795		related gene on 9p24	Autoinflammation, immune dysregulation, and eosinophilia, 618999 (3)	4(Jak1)
1.610	5	4	12	1p31.3	KANK4		KN motif- and ankyrin repeat domain-containing protein 4	614612				
1.611	3	8	16	1p31.3	MEIR1, KIAA1610		Mesoderm induction-early response protein 1	616848				
1.612	3	23	09	1p31.3	MIR101-1, MIRN101-1		Micro RNA 101-1	612511		another locus, MIRN101-2, on 9p24		
1.613	3	14	13	1p31.3	OPHLC, C1DUPp31.3, DUP1p31.3		Omphalocele due to duplication of 1p31.3	164750		duplication of 710kb at 1p31.3	Omphalocele due to duplication of 1p31.3 (4)	
1.614	09	19	19	1p31.3	RAVER2, KIAA1579		Ribonucleoprotein, PTB binding 2	609953				
1.615	8	31	17	1p31.3	ROR1, NTRKR1		Receptor tyrosine kinase-like orphan receptor 1	602336		mutation identified in 1 DFNB108 family	?Deafness, autosomal recessive 108, 617654 (3)	
1.616	7	14	14	1p31.3	SERBP1, PAIRBP1		Serpine1 mRNA-binding protein 1	607378				
1.617	8	20	08	1p31.3	SGIP1		SH3-domain GRB2-like (endophilin)-interacting protein 1	611540				
1.618	12	5	02	1p32.3	SSBP3		Single-stranded DNA-binding protein 3	607390				
1.619	8	19	13	1p31.3	TM2D1, BBP		TM2 domain-containing protein 1	610080				
1.620	5	6	03	1p32.3	TTC4		Tetratricopeptide repeat domain 4	606753		pseudogene on 7p14-p13		
1.621	5	26	13	1p31.1	TYW3		tRNA-wybutosine-synthesizing protein 3, S. cerevisiae, homolog of	611245				
1.622	9	23	13	1p31.3	WLS, GPR177, EVI		WNTless, Drosophila, homolog of	611514				
1.623	7	2	98	1p32.1	CYP2J2		Cytochrome P450, subfamily IIJ (arachidonic acid epoxygenase), polypeptide 2	601258				4(Cyp2j2)
1.624	10	30	17	1p31.3	NFIA, BRMUTD		Nuclear factor I/A	600727			Brain malformations with or without urinary tract defects, 613735 (3)	4(Nfia)
1.625	11	13	12	1p31.3-p31.1	POROK5, DSAP3		Porokeratosis 5, disseminated superficial actinic	612293		between D1S438 and D1S464	Porokeratosis 5, disseminated superficial actinic (2)	
1.626	4	24	08	1p31.3	DEPDC1		DEP domain-containing 1	612002				
1.627	6	9	98	1p31.3	IL12RB2		Interleukin 12 receptor, beta-2	601642				
1.628	9	10	09	1p31.2	PBC3		Biliary cirrhosis, primary, 3	613008		associated with rs3790567	{Biliary cirrhosis, primary, 3} (2)	
1.629	6	15	95	1p31.1	PTGER3, EP3		Prostaglandin E receptor 3, EP3 subtype	176806				3(Ptger3)
1.630	6	30	15	1p31.1	ADGRL2, LPHN2, LPHH1, CIRL2, CL2, KIAA0786		Adhesion G protein-coupled receptor L2	607018				
1.631	6	30	15	1p31.1	ADGRL4, ETL, ELTD1		Adhesion G protein-coupled receptor L4	616419				3(Adgrl4)
1.632	4	5	13	1p31.1	ANKRD13C		Ankyrin repeat domain-containing protein 13C	615125				
1.633	08	13	20	1p31.1	CTH		Cystathionine gamma-lyase	607657		previously assigned to chr.16	Cystathioninuria, 219500 (3)	
1.634	4	2	16	1p31.1	DNAJB4, HLJ1		DNAJ/HSP40 homolog, subfamily B, member 4	611327				
1.635	1	29	16	1p31.1	FAM73A, MIGA1		Miga, Drosophila, homolog of, 1	616773				
1.636	5	25	13	1p31.1	FPGT, GFPP		Fucose-1-phosphate guanylyltransferase	603609				
1.637	6	1	09	1p31.1	FUBP1, FUBP, FBP		Far upstream element-binding protein 1	603444				
1.638	11	09	20	1p31.1	GIPC2		GIPC PDZ domain-containing family, member 2	619089				
1.639	5	25	13	1p31.1	HHLA3		Human endogenous retrovirus-H long terminal repeat-associating 3	604372				
1.640	6	11	11	1p31.1	IFI44L		Interferon-induced protein 44-like	613975				
1.641	3	14	07	1p31.1	IFI44, P44		Interferon-induced protein 44	610468				
1.642	12	3	07	1p31.1	LHX8		LIM homeobox 8	604425				
1.643	1	30	12	1p31.1	LRRC7, DENSIN, KIAA1365		Leucine-rich repeat-containing protein 7	614453				
1.644	5	9	18	1p31.1	LRRIQ3, LRRC44		Leucine rich repeats- and IQ motif-containing protein 3	617957				
1.645	12	21	09	1p31.1	NEGR1, KILON		Neuronal growth regulator 1	613173				
1.646	03	29	19	1p31.1	NEXAS1		NEXN antisense RNA 1	618370				
1.647	05	18	20	1p31.1	PIGK, GPI8, NEDHCAS		Phosphatidylinositol glycan, class K	605087			Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures, 618879 (3)	
1.648	4	18	11	1p31.1	PRKACB		Protein kinase, cAMP-dependent, catalytic, beta	176892				
1.649	6	16	95	1p31.1	PTGFR		Prostaglandin F receptor (FP)	600563				3(Ptgfr)
1.650	12	19	11	1p31.1	SRSF11, SFRS11		Splicing factor, serine/arginine-rich, 11	602010				
1.651	8	19	13	1p31.1	ST6GALNAC3, SIAT7C		ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	610133				
1.652	7	8	09	1p31.1	ST6GALNAC5, SIAT7E		ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6 sialyltransferase 5	610134				
1.653	11	09	18	1p31.1	TNNI3K, CCDD		TNNI3-interacting kinase	613932			Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3)	
1.654	03	16	20	1p31.1	TTLL7		Tubulin tyrosine ligase-like family, member 7	618813				
1.655	4	8	13	1p31.1	USP33, VDU1		Ubiquitin-specific protease 33	615146				
1.656	11	1	01	1p31.3	INSL5		Insulin-like 5	606413				
1.657	6	27	08	1p22.3	LPAR3, EDG7, LPA3		Lysophosphatidic acid receptor 3	605106				3(Edg7)
1.658	4	27	12	1p31.1-p21.1	SPG29		Spastic paraplegia 29, autosomal dominant	609727		max lod at D1S2865	Spastic paraplegia 29, autosomal dominant (2)	
1.659	6	26	02	1p31.1	ACADM, MCAD		Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain	607008			Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)	3(Acadm)
1.660	1	12	07	1p31.1	AK5		Adenylate kinase 5	608009				
1.661	5	8	97	1p31	AIR		Acute insulin response	601676			Acute insulin response (2)	
1.662	11	19	11	1p31.3	FOXD3, AIS1, VAMAS2		Forkhead box D3	611539			{Autoimmune disease, susceptibility to, 1}, 607836 (3)	4(Foxd3)
1.663	1	7	11	1p31.3	ANGPTL3, ANGPT5, FHBL2		Angiopoietin-like 3	604774			Hypobetalipoproteinemia, familial, 2, 605019 (3)	4(Angptl3, hypl)
1.664	4	17	07	1p31	ASRT4		Asthma-related traits, susceptibility to, 4	610906		max lod at D1S2890	{Asthma-related traits, susceptibility to, 4} (2)	
1.665	11	3	09	1p32.3	BSND		Barttin	606412			Bartter syndrome, type 4a, 602522 (3); Sensorineural deafness with mild renal dysfunction, 602522 (3)	
1.666	11	6	98	1q22	CLK2		CDC-like kinase 2	602989		near GDLD and PRKAA2; conflicting assignment 1q21		
1.667	6	20	91	1p21.2	DBT, BCATE2		Dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex)	248610		pseudogene on 3q24	Maple syrup urine disease, type II, 248600 (3)	
1.668	12	11	12	1p31.3	LEPR, OBR, LEPRD		Leptin receptor	601007			Obesity, morbid, due to leptin receptor deficiency, 614963 (3)	4(Lepr)
1.669	9	7	10	1p31.3	LEPROT, OBRGRP		Leptin receptor overlapping transcript	613461		transcribed in same direction as LEPR		
1.670	09	19	19	1p31.1	MSH4		mutS homolog 4	602105				
1.671	7	17	14	1p31	OFC14		Orofacial cleft 14	615892			Orofacial cleft 14 (2)	
1.672	3	26	02	1p31	PAOD1		Peripheral arterial occlusive disease 1	606787			Peripheral arterial occlusive disease 1 (2)	
1.673	10	9	94	1p31.3	PDE4B, DPDE4		Phosphodiesterase-4B, cAMP-specific (dunce-like phosphodiesterase E4)	600127				4(Pde4b)
1.674	6	3	14	1p31.3	PGM1, GSD14, CDG1T		Phosphoglucomutase-1	171900		distal to ACADM; formerly 1p22.1	Congenital disorder of glycosylation, type It, 614921 (3)	4(Pgm2)
1.675	3	9	98	1p31.1	PIN1L		Peptidyl-prolyl cis/trans isomerase, NIMA-interacting-like	602051		?transcribed pseudogene		
1.676	8	17	98	1p32.2	PRKAA2, AMPK		Protein kinase, AMP-activated, alpha-2 catalytic subunit	600497				
1.677	2	12	01	1p31.1	RABGGTB		Rab geranylgeranyltransferase, beta subunit	179080				3(Rabggtb)
1.678	12	11	19	1p31.3	RPE65, RP20, LCA2		RPE65 retinoid isomerohydrolase	180069			Leber congenital amaurosis 2, 204100 (3); Retinitis pigmentosa 20, 613794 (3); Retinitis pigmentosa 87 with choroidal involvement, 618697 (3)	3(Rpe65)
1.679	11	18	16	1p22.3	SELENOF, SEP15		Selenoprotein F	606254				
1.680	1	11	95	1p31.1	CRYZ		Crystallin, zeta (quinone reductase)	123691				
1.681	8	12	01	1p31-p21	AVSD1, AVCD		Atrioventricular septal defect, susceptibility to, 1	606215			{Atrioventricular septal defect, susceptibility to, 1} (2)	
1.682	08	21	19	1p31.3	ALG6, CDG1C		ALG6 alpha-1,3-glucosyltransferase	604566			Congenital disorder of glycosylation, type Ic, 603147 (3)	
1.683	3	11	16	1p22.3	CLCA1, CACC1		Chloride channel accessory 1	603906				
1.684	3	11	16	1p22.3	CLCA2		Chloride channel accessory 2	604003				
1.685	10	01	20	1p22.3	CLCA3		Chloride channel accessory 3	604337				
1.686	3	11	16	1p22.3	CLCA4, CACC2		Chloride channel accessory 4	616857				3(Clca4)
1.687	5	19	06	1p22.3	COL24A1		Collagen, type XXIV, alpha-1	610025				
1.688	01	26	00	1p22.3	CYR61, IGFBP10		Cysteine-rich angiogenic inducer, 61 (insulin-like growth factor-binding protein-10)	602369				3(Igfbp10)
1.689	3	11	09	1p31.1-p22.3	DNASE2B, DLAD		Deoxyribonuclease II beta	608057				
1.690	1	30	01	1p22.3	LMO4		LIM domain only 4	603129				3(Lmo4)
1.691	11	11	14	1p22.2	BARHL2		BARH-like 2	605212				
1.692	8	28	09	1p22.3	MCOLN3		Mucolipin 3	607400				3(Mcoln3)
1.693	5	9	18	1p22.3	WDR63		WD repeat-containing protein 63	617968				
1.694	1	28	08	1p22.2	CCBL2, KAT3		Cysteine conjugate beta-lyase 2	610656				3(Kat3)
1.695	08	21	19	1p22.2	HFM1, MER3, POF9		Helicase for meiosis 1	615684			Premature ovarian failure 9, 615724 (3)	
1.696	12	23	08	1p22.2	GBP1		Guanylate binding protein 1, interferon-inducible, 67kD	600411				3(Gbp1)
1.697	12	24	08	1p22.2	GBP2		Guanylate-binding protein 2, interferon-inducible	600412				
1.698	12	24	08	1p22.2	GBP3		Guanylate-binding protein 3	600413				
1.699	12	24	08	1p22.2	GBP4		Guanylate-binding protein 4	612466				
1.700	12	24	08	1p22.2	GBP5		Guanylate-binding protein 5	611467				
1.701	12	24	08	1p22.2	GBP6		Guanylate-binding protein 6	612467				
1.702	12	24	08	1p22.2	GBP7		Guanylate-binding protein 7	612468				
1.703	7	22	09	1p22.2	LRRC8B, TALRRP, KIAA0231		Leucine-rich repeat-containing protein 8B	612888				5(Lrrc8b)
1.704	7	22	09	1p22.2	LRRC8C, FAD158, AD158		Leucine-rich repeat-containing protein 8C	612889				5(Lrrc8c)
1.705	7	22	09	1p22.2	LRRC8D, LRRC5		Leucine-rich repeat-containing protein 8D	612890				5(Lrrc8d)
1.706	11	30	06	1p22.2	PKN2, PRKCL2, PRK2, PAK2		Protein kinase N2	602549				
1.707	7	18	14	1p22.2	GTF2B, TFIIB, TF2B		General transcription factor IIb	189963				
1.708	4	27	12	1p22.2	ZNF326, ZIRD		Zinc finger protein 326	614601				
1.709	8	25	11	1p22.2	ZNF644, MYP21		Zinc finger protein 644	614159			Myopia 21, autosomal dominant, 614167 (3)	
1.710	7	21	14	1p22.1	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2		ATP-binding transporter, retina-specific	601691			Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3); Cone-rod dystrophy 3, 604116 (3); {Macular degeneration, age-related, 2}, 153800 (3); Fundus flavimaculatus, 248200 (3); Retinal dystrophy, early-onset severe, 248200 (3)	
1.711	1	14	07	1p22.1	ARHGAP29, PARG1		RHO GTPase-activating protein 29	610496				
1.712	7	18	14	1p22.1	BCAR3, SH2D3B, NSP2		Breast cancer antiestrogen resistance 3	604704				
1.713	8	30	17	1p22.1	BRDT, SPGF21		Bromodomain, testis-specific	602144		mutation identified in 1 SPGF21 patient	?Spermatogenic failure 21, 617644 (3)	
1.714	07	28	20	1p22.1	C1orf146, SPO16, SCRE		Chromosome 1 open reading frame 146	618968				5(C1orf146)
1.715	5	23	13	1p22.1	DNTTIP2, ERBP, FCF2		DNTT-interacting protein 2	611199				
1.716	11	13	96	1p22.1	DR1		Down-regulator of transcription 1, TBP-binding (negative cofactor 2)	601482				
1.717	3	27	17	1p22.1	EPHX4, ABHD7		Epoxide hydrolase 4	617401				
1.718	4	2	12	1p22.1	FAM69A		Family with sequence similarity 69, member A	614542				
1.719	9	16	12	1p22.1	FNBP1L, TOCA1, C1orf39		Formin binding protein 1-like	608848				
1.720	11	2	11	1p22.1	GCLM, GLCLR		Glutamate-cysteine ligase, modifier subunit	601176			{Myocardial infarction, susceptibility to}, 608446 (3)	3(Glclr)
1.721	4	24	18	1p22.1	KIAA1107, APACHE		KIAA1107 gene	617945				5(Kiaa1107)
1.722	3	22	06	1p22.1	MTF2, PCL2, M96		Metal-regulatory transcription factor 2	609882				
1.723	10	13	09	1p22.1	RPAP2, C1orf82		RNA polymerase II-associated protein 2	611476				
1.724	2	3	09	1p22.1	RPL5, DBA6		Ribosomal protein L5	603634			Diamond-Blackfan anemia 6, 612561 (3)	
1.725	11	27	18	1p22.1	SNORD21, RNU21		Small nucleolar RNA, C/D box 21	603635				
1.726	3	25	16	1p22.1	TMED5		Transmembrane p24 trafficking protein 5	616876				
1.727	6	7	16	1p31.1	ZRANB2, ZNF265, ZIS		Zinc finger RANBP2-type domain-containing protein 2	604347				
1.728	10	20	15	1p22.3	BCL10, IMD37		B-cell leukemia/lymphoma 10	603517		mutation identified in 1 IMD37 patient	Lymphoma, MALT, somatic, 137245 (3); {Lymphoma, follicular, somatic}, 605027 (3); {Male germ cell tumor, somatic}, 273300 (3); {Sezary syndrome, somatic} (3); {Mesothelioma, somatic}, 156240 (3); ?Immunodeficiency 37, 616098 (3)	
1.729	08	23	19	1p22.2-p22.1	CDC7, CDC7L1		Cell division cycle 7	603311				5(Cdc7l1)
1.730	11	2	04	1p22	CMM4		Melanoma, cutaneous malignant, 4	608035		between D1S430 and D1S2664	{Melanoma, cutaneous malignant, 4} (2)	
1.731	12	5	95	1p22.3	CTBS, CTB		Chitobiase, di-N-acetyl-	600873				
1.732	9	9	08	1p13.2	CSDE1, D1S155E, UNR		Cold-shock domain-containing E1, RNA-binding	191510		130bp 5' to NRAS		
1.733	11	6	00	1p22.3	DDAH1		Dimethylarginine dimethylaminohydrolase-1	604743				
1.734	5	19	09	1p21.3	DPYD, DPD		Dihydropyrimidine dehydrogenase	612779			Dihydropyrimidine dehydrogenase deficiency, 274270 (3); 5-fluorouracil toxicity, 274270 (3)	
1.735	12	24	08	1p22.1	EVI5, NB4S		Ecotropic viral integration site 5	602942				
1.736	02	10	20	1p22.1	GFI1, ZNF163, SCN2		Growth factor independent 1	600871		mutation identified in 1 NICINA patient	Neutropenia, severe congenital 2, autosomal dominant, 613107 (3); ?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)	5(Gfi1)
1.737	12	5	95	1p22.3	GNG5		Guanine nucleotide-binding protein (G protein), gamma 5	600874				
1.738	7	17	09	1p22.3	HS2ST1		Heparan sulfate 2-O-sulfotransferase 1	604844				
1.739	2	14	13	1p22	KAZA2		Kala-azar, susceptibility to, 2	611381			{Kala-azar, susceptibility to, 2} (2)	
1.740	8	28	09	1p22.3	MCOLN2		Mucolipin 2	607399		incorrectly assigned to chr.3		3(Mcoln2)
1.741	10	25	11	1p21.3	MIR137, MIRN137		Micro RNA 137	614304				
1.742	7	1	05	1p13.1	TRIM45		Tripartite motif-containing protein 45	609318				
1.743	1	4	93	1p22	UOX		Urate oxidase, pseudogene	191540		nonsense mutations responsible for absence of enzyme in man and hominoid primates	[Urate oxidase deficiency] (1)	
1.744	3	27	15	1p21.3	ABCD3, PXMP1, PMP70, CBAS5		ATP-binding cassette, subfamily D, member 3 (peroxisomal membrane protein 1, 70kD)	170995		mutation identified in 1 CBAS5 family	?Bile acid synthesis defect, congenital, 5, 616278 (3)	3(Pmp70)
1.745	2	20	98	1p21.3	CNN3		Calponin 3, acidic	602374				
1.746	10	7	88	1p21.3	F3, TFA		Coagulation factor III	134390				
1.747	4	22	02	1p22.1	GLML, GVM, VMGLOM		Glomulin	601749			Glomuvenous malformations, 138000 (3)	
1.748	10	05	20	1p21.3	ALG14, CMS15, IDDEBF, MEPCA		ALG14 UDP-N-acetylglucosaminyltransferase subunit	612866		mutation identified in 1 CMSWTA family	?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3); Intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies, 619031 (3); Myopathy, epilepsy, and progressive cerebral atrophy, 619036 (3)	
1.749	7	17	14	1p21.3	RWDD3, RSUME		RWD domain-containing protein 3	615875				
1.750	1	9	17	1p21.3-p21.2	PLPPR4, LPPR4, PRG1, KIAA0455		Phospholipid phosphatase-related protein 4	607813				
1.751	1	9	17	1p21.3	PLPPR5, LPPR5, PAP2D, PAP2		Phospholipid phosphatase-related protein 5	617287				3(Plppr5)
1.752	4	21	17	1q21.3	S100A16, AAG13		S100 calcium-binding protein A16	617437				3(S100a16)
1.753	12	10	12	1p21.3	SNX7		Sorting nexin 7	614904				
1.754	5	11	07	1p13.2	CHIA, TSA1902, CHIT2		Chitinase, acidic	606080				
1.755	02	26	19	1p21.2	DPH5, HSPC143		Diphthamide biosynthesis protein 5	611075				
1.756	12	7	07	1p21.2	FRRS1, SDR2		Ferric chelate reductase 1	611578				
1.757	5	11	16	1p21.2	GPR88, STRG, COCPMR		G protein-coupled receptor 88	607468		mutation identified in 1 COCPMR family	?Chorea, childhood-onset, with psychomotor retardation, 616939 (3)	
1.758	3	20	14	1p21.2	PALMD, PALML		Palmdelphin	610182				3(Palmd)
1.759	5	26	13	1p21.2	RTCD1, RPC		RNA terminal phosphate cyclase domain-containing protein 1	611286				
1.760	10	13	17	1p21.2	SASS6, SAS6, MCPH14		SAS-6 centriolar assembly protein	609321		mutation identified in 1 MCPH14 family	?Microcephaly 14, primary, autosomal recessive, 616402 (3)	
1.761	2	25	08	1p21.2	SLC30A7, ZNT7		Solute carrier family 30 (zinc transporter), member 7	611149				3(Slc30a7)
1.762	11	01	18	1p21.1	RNPC3, SNRNP65, KIAA1839, IGHD5		RNA-binding region-containing protein 3	618016		mutation identified in 1 IGHD5 family	?Growth hormone deficiency, isolated, type V, 618160 (3)	
1.763	6	13	07	1p21.1-p13.3	MRT4		Mental retardation, autosomal recessive, 4	611107		between D2S429 and D1S187	Mental retardation, autosomal recessive, 4 (2)	
1.764	07	13	20	1p13.2	DDX20		DEAD-box helicase 20	606168				
1.765	7	16	14	1p21.1-q21.3	HYPT5, MUHH2		Hypotrichosis 5	612841		max lod at D1S2881	Hypotrichosis 5 (2)	
1.766	3	26	07	1p21.2	AGL, GDE		Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme)	610860			Glycogen storage disease IIIa, 232400 (3); Glycogen storage disease IIIb, 232400 (3)	
1.767	10	23	87	1p21.1	AMY1A		Amylase, salivary, alpha-1A	104700		multiple amylase genes		3(Amy1)
1.768	10	31	91	1p21.1	AMY1B		Amylase, salivary, alpha-1B	104701				
1.769	11	4	91	1p21.1	AMY1C		Amylase, salivary, alpha-1C	104702				
1.770	9	14	88	1p21.1	AMY2A		Amylase, pancreatic, alpha-2A	104650				3(Amy2)
1.771	6	4	90	1p21.1	AMY2B		Amylase, pancreatic, alpha-2B	104660		distal to NGFB		
1.772	08	12	19	1p21.1	COL11A1, STL2, DFNA37		Collagen XI, alpha-1 polypeptide	120280		mutation identified in 1 DFNA37 family	Stickler syndrome, type II, 604841 (3); Marshall syndrome, 154780 (3); {Lumbar disc herniation, susceptibility to}, 603932 (3); Fibrochondrogenesis 1, 228520 (3); ?Deafness, autosomal dominant 37, 618533 (3)	3(Col11a1)
1.773	12	22	00	1p13.3	CELSR2, EGFL2, MEGF3		Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 2)	604265				
1.774	08	21	19	1p21.2	CDC14A, DFNB32		Cell division cycle 14A	603504			Deafness, autosomal recessive 32, with or without immotile sperm, 608653 (3)	
1.775	7	18	12	1q21.1	FAM72D		Family with sequence similarity 72, member D	614712				
1.776	4	6	15	1p13.2	MAGI3, KIAA1634		Membrane-associated guanylate kinase, WW and PDZ domains-containing, 3	615943				3(Magi3)
1.777	11	11	14	1p21.1	OLFM3, NOE3		Olfactomedin 3	607567				3(Olfm3)
1.778	7	27	09	1p13.3	PROK1, PK1, PRK1, EGVEGF		Prokineticin 1	606233				
1.779	2	16	04	1p21.3	PTBP2, NPTB		Polypyrimidine tract-binding protein 2	608449				
1.780	9	18	08	1p21.2	S1PR1, EDG1, S1P1		Sphingosine-1-phosphate receptor 1	601974				
1.781	12	3	01	1p21.2	SLC35A3, AMRS		Solute carrier family 35 (UDP-GlcNAc transporter), member 3	605632		mutation identified in 1 family	?Arthrogryposis, mental retardation, and seizures, 615553 (3)	
1.782	5	23	06	1p21	STQTL7		Stature quantitative trait locus 7	609822		max lod at D1S1631	{Stature QTL 7} (2)	
1.783	8	9	01	1p13.2	BCAS2, DAM1		Breast carcinoma amplified sequence 2	605783				
1.784	11	4	93	1p13.3	CD53, MOX44		CD53 antigen	151525				3(Cd53)
1.785	1	9	95	1p13.3	KCNA3		Potassium voltage-gated channel, shaker-related subfamily, member 3	176263		mapped probably in error to chr.13		
1.786	3	30	00	1p21-p13.3	WS2B		Waardenburg syndrome, type 2B	600193			Waardenburg syndrome, type 2B (2)	
1.787	5	9	95	1p13.2	ADORA3		Adenosine A3 receptor	600445				3(Adora3)
1.788	11	3	09	1p13.3	ALX3, FND1		Aristaless-like homeobox 3	606014			Frontonasal dysplasia 1, 136760 (3)	
1.789	11	9	13	1p13.2	AMPD1, MMDD		Adenosine monophosphate deaminase-1, muscle	102770			Myopathy due to myoadenylate deaminase deficiency, 615511 (3)	3(Ampd1)
1.790	10	27	97	1p13.3	CSF1, MCSF		Colony-stimulating factor-1 (macrophage)	120420		incorrectly assigned to chr.5		3(Csfm)
1.791	8	26	15	1p13.3	AHCYL1, DCAL, IRBIT		Adenosylhomocysteine-like 1	607826				
1.792	3	12	14	1p13.3	AMIGO1, ALI2, KIAA1163		Adhesion molecule with Ig-like domain 1	615689				
1.793	6	3	14	1p13.3	AMPD2, SPG63, PCH9		Adenosine monophosphate deaminase-2, isoform L	102771		mutation identified in 1 SPG63 family	?Spastic paraplegia 63, 615686 (3); Pontocerebellar hypoplasia, type 9, 615809 (3)	3(Ampd2)
1.794	11	27	19	1p13.3	C10orf194		Chromosome 1 open reading frame 194	618682				
1.795	1	13	16	1p13.3	CEPT1		Choline/ethanolamine phosphotransferase 1	616751				
1.796	5	25	13	1p13.2	CHI3L2, YKL39		Chitinase 3-like 2	601526				
1.797	07	14	20	1p13.3	CLCC1, MCLC, RP32		Chloride channel CLIC-like 1	617539			Retinitis pigmentosa 32, 609913 (3)	
1.798	7	17	09	1p13.3	CYMP		Chymosin pseudogene	118943				
1.799	3	14	13	1p13.3-p13.2	DENND2D		DENN/MADD domain-containing protein 2D	615111				
1.800	03	31	20	1p13.3	EPS8L3, EPS8R3, HYPT5		EPS8-like protein 3	614989		mutation identified in 1 HYPT5 family	?Hypotrichosis 5, 612841 (3)	3(Eps8l3)
1.801	7	17	09	1p13.3	GPR61		G protein-coupled receptor 61	606916				
1.802	9	12	93	1p13.3	GSTM1		Glutathione S-transferase M1	138350				
1.803	9	12	93	1p13.3	GSTM2, GST4		Glutathione S-transferase M2, muscle	138380				
1.804	9	12	93	1p13.3	GSTM3, GST5		Glutathione S-transferase M3, brain	138390				
1.805	11	4	93	1p13.3	GSTM4		Glutathione S-transferase M4	138333				
1.806	07	17	20	1p13.3	HENMT1, C1orf59, HEN1		HEN methyltransferase 1	612178				
1.807	10	23	20	1p13.3	KCNA2, DEE32		Potassium channel, voltage-gated, Shaker-related subfamily, member 2	176262			Developmental and epileptic encephalopathy 32, 616366 (3)	12(Kcna2)
1.808	2	7	17	1p13.3	KCNC4		Potassium voltage-gated channel, Shaw-related subfamily, member 4	176265				
1.809	5	24	13	1p13.3	KIAA1324, EIG121		KIAA1324 gene	611298				
1.810	8	28	09	1p13.3	GSTM5		Glutathione S-transferase M5	138385		pseudogene on chr.3		
1.811	7	31	15	1p13.3	DRAM2, TMEM77, CORD21		Damage-regulated autophagy modulator 2	613360			Cone-rod dystrophy 21, 616502 (3)	
1.812	8	19	13	1p13.3	MIR197		Micro rNA 197	611189				
1.813	9	12	08	1p13.3	NTNG1, LMNT1, KIAA0976		Netrin G1	608818				
1.814	3	6	08	1p13.3	PRMT6		Protein arginine N-methyltransferase 6	608274				
1.815	7	10	93	1p13.2	RAP1A, KREV1		RAS-related protein RAP1A	179520		pseudogene on 14q24.3		
1.816	3	23	15	1p13.3	SLC6A17, NTT4, MRT48		Solute carrier family 6 (neurotransmitter transporter), member 17	610299			Mental retardation, autosomal recessive 48, 616269 (3)	
1.817	11	27	18	1p13.3	SLC16A4, MCT5		Solute carrier family 16 (monocarboxylic acid transporter) member 4	603878				
1.818	1	31	11	1p13.3	SORT1, NT3, LDLCQ6		Sortilin	602458			[Low density lipoprotein cholesterol level QTL6], 613589 (3)	
1.819	3	23	18	1p13.3	STRIP1, FAR11A, FAM40A		Striatin-interacting protein 1	617918				
1.820	4	20	17	1p13.3	TAF13, TAF2K, MRT60		TAF13 RNA polymerase II, TATA box-binding protein-associated factor, 18kD	600774			Mental retardation, autosomal recessive 60, 617432 (3)	
1.821	9	10	07	1p13.3	UBL4B		Ubiquitin-like 4B	611127				3(Ubl4b)
1.822	12	4	09	1p13.3	VAV3		Vav3 oncogene	605541				
1.823	4	10	14	1p13.3	WDR47, NEMITIN, KIAA0893		WD repeat-containing protein 47	615734				
1.824	6	3	15	1p13.2	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9		Potassium voltage-gated channel, Shal-related subfamily, member 3	605411			Spinocerebellar ataxia 19, 607346 (3); Brugada syndrome 9, 616399 (3)	
1.825	12	28	08	1p13.2	DCLRE1B, SNM1B, APOLLO		DNA cross-link repair protein 1B	609683				
1.826	10	11	17	1p12	WARS2, NEMMLAS		Tryptophanyl-tRNA synthetase 2	604733			Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, 617710 (3)	
1.827	4	15	08	1p13.1	CASQ2		Calsequestrin, fast-twitch, skeletal muscle-2	114251			Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)	
1.828	4	27	12	1p13.2	AP4B1, SPG47, CPSQ5		Adaptor-related protein complex 4, beta-1 subunit	607245			Spastic paraplegia 47, autosomal recessive, 614066 (3)	
1.829	07	17	20	1p13.2	ATP5PB, ATP5F1		ATP synthase peripheral stalk membrane, subunit B	603270				
1.830	9	21	11	1p13.2	C1orf88, PIFO		Chromosome 1 open reading frame 88 (pitchfork, mouse, homolog of)	614234				
1.831	7	17	09	1p13.2	CAPZA1, CAPPA1		Capping protein, muscle Z-line, alpha-1	601580				3(Capza1)
1.832	3	14	13	1p13.2	CTTNBP2NL		CTTNBP2 N terminus-like protein	615100				
1.833	5	30	17	1p13.2	FAM19A3, TAFA3		Family with sequence similarity 19, member A3, CC motif chemokine-like	617497				
1.834	10	23	15	1p13.3	LAMTOR5, HBXIP, XIP		Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 5	608521				
1.835	1	31	07	1p13.2	MOV10, KIAA1631		Moloney leukemia virus 10, mouse, homolog of	610742				
1.836	3	9	17	1p13.2	NR1H5P, FXRB		Nuclear receptor subfamily 1, group H, member 5, pseudogene	617386				
1.837	1	4	16	1p13.2	NRAS, ALPS4, NS6, CMNS, NCMS		NRAS protooncogene, GTPase	164790		cen-CD2-NGFB-NRAS	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Noonan syndrome 6, 613224 (3); Epidermal nevus, somatic, 162900 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Colorectal cancer, somatic, 114500 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Neurocutaneous melanosis, somatic, 249400 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	3(Nras)
1.838	5	25	13	1p13.2	OVGP1		Oviductal glycoprotein 1	603578				
1.839	3	22	06	1p13.2	PPM1J, PP2CZ, PPP2CZ		Protein phosphatase, magnesium-dependent, 1J	609957				
1.840	8	3	12	1p13.2	RHOC, ARHC, ARH9, RHOH9		RAS homolog gene family, member C (oncogene RHO H9)	165380		incorrectly assigned to chr.5		
1.841	7	18	14	1p13.2	RSBN1, ROSBIN		Round spermatid basic protein 1	615858				
1.842	12	18	07	1p13.2	SIKE		Suppressor of IKK-epsilon	611656				
1.843	7	27	09	1p13.2	SYT6		Synaptotagmin 6	607718				
1.844	12	2	09	1p13.2	TSPAN2, NET3		Tetraspanin 2	613133				
1.845	1	17	08	1p13.2	WDR77, MEP50		WD repeat-containing protein 77	611734				
1.846	11	24	14	1p13.2	SLC16A1, MCT1, HHF7, MCT1D		Solute carrier family 16 (monocarboxylic acid transporters), member 1	600682			Erythrocyte lactate transporter defect, 245340 (3); Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3); Monocarboxylate transporter 1 deficiency, 616095 (3)	
1.847	02	08	19	1p13.1	ATP1A1, CMT2DD, HOMGSMR2		ATPase, Na+K+ transporting, alpha-1 polypeptide	182310			Charcot-Marie-Tooth disease, axonal, type 2DD, 618036 (3); Hypomagnesemia, seizures, and mental retardation 2, 618314 (3)	3(Atp1a1)
1.848	02	08	19	1p13.1	ATP1A1AS1		ATP1A1 antisense RNA 1	618305				
1.849	11	20	95	1p13.1	CD2		CD2 antigen (p50), sheep red blood cell receptor	186990				3(Ly37)
1.850	7	13	12	1p13.3	GPSM2, LGN, PINS, DFNB82, CMCS		G protein signaling modulator 2	609245			Chudley-McCullough syndrome, 604213 (3)	
1.851	4	30	93	1p12	HSD3B1		Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 1 (placental, peripheral)	109715				3(Hsd3b1)
1.852	4	6	16	1p12	HSD3B2		Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 2 (adrenal, gonadal)	613890			Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3)	3(Hsd3b2)
1.853	4	15	98	1p13.3	KCNA10		Potassium voltage-gated channel, shaker-related subfamily, member 10	602420				
1.854	8	19	13	1p13.2	OLFML3, OLF44		Olfactomedin-like 3	610088				
1.855	11	24	14	1p13.2	NGF, NGFB, HSAN5		Nerve growth factor, beta	162030		same 310kb fragment as TSHB; order: cen-CD2-CD58-ATP1A1-NGF-TSHB-NRAS-tel	Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	3(Ngfb)
1.856	12	2	09	1p13.3	PSRC1, DDA3		Proline/serine-rich coiled-coil protein 1	613126				3(Psrc1)
1.857	3	6	08	1p13.1	SLC22A15, FLIPT1		Solute carrier family 22 (organic cation transporter), member 15	608275				
1.858	10	2	12	1p13.1	TTF2		Transcription termination factor, RNA polymerase II	604718				
1.859	3	29	06	1p13-p12	VCTN1, B7H4, B7X, B7S1		V-set domain containing T cell activation inhibitor 1	608162				3(B7h4)
1.860	11	15	18	1p34.2	PPCS, CMD2C		Phosphopantothenoylcysteine synthetase	609853			Cardiomyopathy, dilated, 2C, 618189 (3)	
1.861	3	20	06	1p12	REG4		Regenerating islet-derived family, member 4	609846				
1.862	6	30	98	1p13.1	PTGFRN, FPRP		Prostaglandin F2 receptor negative regulator	601204				
1.863	10	12	90	1p13.1	CD58, LFA3		CD58 antigen (lymphocyte function-associated antigen 3)	153420		?same as MSK1; gene cloned		
1.864	6	4	12	1p13.3	GNAI3, ARCND1		Guanine nucleotide-binding protein (G-protein), alpha-inhibiting activity polypeptide-3	139370			Auriculocondylar syndrome 1, 602483 (3)	3(Gnai3)
1.865	4	6	11	1p13.3	GNAT2, ACHM4		Guanine nucleotide-binding protein (G-protein), alpha-transducing (transducin) activity polypeptide-2	139340			Achromatopsia 4, 613856 (3)	3(Gnat2)
1.866	7	17	09	1p12	HAO2, HAOX2		Hydroxyacid oxidase 2	605176				
1.867	2	5	15	1p13.1	IGSF3, LCDD		Immunoglobulin superfamily, member 3	603491		mutation identified in 1 LCDD family	?Lacrimal duct defect, 149700 (3)	
1.868	3	15	13	1p13.2	LRIG2, LIG2, KIAA0806, UFS2		Leucine-rich repeats- and immunoglobulin-like domains-containing protein 2	608869			Urofacial syndrome 2, 615112 (3)	3(Lrig2)
1.869	2	2	01	1p12	MAN1A2		Mannosidase, alpha, class 1A, member 2	604345				3(Man1a2)
1.870	9	10	98	1p13.3	PSMA5, PSC5		Proteasome component 5	176844				
1.871	5	25	00	1p13.2	PHTF1		Putative homeodomain transcription factor 1	604950				
1.872	3	27	09	1p13.2	PTPN22, PEP, PTPN8, LYP		Protein tyrosine phosphatase, nonreceptor-type 22	600716			{Diabetes, type 1, susceptibility to}, 222100 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3); {Systemic lupus erythematosus susceptibility to}, 152700 (3)	
1.873	6	28	01	1p13.3	RBM15, SPEN, OTT		One-twenty two protein (RNA binding motif protein 15; Spen, Drosophila, homolog of)	606077			Megakaryoblastic leukemia, acute (2)	
1.874	08	21	19	1p13.3	SARS1, SARS, SERS, NEDMAS		Seryl-tRNA synthetase 1	607529		mutation identified in 1 NEDMAS family	?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3)	
1.875	8	28	17	1p13.2	ST7L, ST7R		Suppressor of tumorigenicity 7-like protein	617640				
1.876	6	9	98	1p13.2	SYCP1, SCP1		Synaptonemal complex protein-1	602162				
1.877	12	24	08	1p12	TBX15		T-box 15	604127			Cousin syndrome, 260660 (3)	3(Tbx15)
1.878	8	14	15	1p13.2	TRIM33, TIF1G, RFG7, PTC7		Tripartite motif-containing protein 33	605769		fused with RET to form PTC7		
1.879	9	4	08	1p13.2	TSHB, CHNG4		Thyroid-stimulating hormone, beta polypeptide	188540		centromeric to NGFB	Hypothyroidism, congenital, nongoitrous 4, 275100 (3)	3(Tshb)
1.880	7	24	15	1p13.1	VANGL1, STBM2		Vang-like 1	610132			Caudal regression syndrome, 600145 (3); {Neural tube defects, susceptibility to}, 182940 (3)	
1.881	5	23	00	1p13	VUR		Vesicoureteral reflux	193000			Vesicoureteral reflux (2)	
1.882	11	01	18	1p13.2	WNT2B, WNT13, XWNT2		Wingless-type MMTV integration site family, member 2B	601968			Diarrhea 9, 618168 (3)	
1.883	5	9	01	1p12	HMGCS2		3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2, mitochondrial	600234			HMG-CoA synthase-2 deficiency, 605911 (3)	
1.884	5	4	00	1p12	WDR3		WD repeat-containing protein 3	604737				
1.885	09	26	19	1p12	ADAM30		ADAM metallopeptidase domain 30	604779				
1.886	09	29	20	1p11.2	FCGR1B, CD34		Fc fragment of IgG receptor Ib	601502				
1.887	03	29	19	1p12	GDAP2, SCAR27		Ganglioside-induced differentiation-associated protein 2	618128			Spinocerebellar ataxia, autosomal recessive 27, 618369 (3)	
1.888	8	2	13	1p13.3	LRIF1, RIF1		Ligand-dependent nuclear receptor-interacting factor 1	615354				
1.889	9	21	11	1p13.3	NBPF4		Neuroblastoma breakpoint family, member 4	613994				
1.890	09	29	20	1p13.3	NBPF5P		NBPF member 5, pseudogene	613995				
1.891	9	21	11	1p13.3	NBPF6		Neuroblastoma breakpoint family, member 6	613996				
1.892	9	21	11	1p12	NBPF7		Neuroblastoma breakpoint family, member 7	613997				
1.893	08	21	19	1p12	NOTCH2, AGS2, HJCYS		Notch receptor 2	600275			Alagille syndrome 2, 610205 (3); Hajdu-Cheney syndrome, 102500 (3)	3(Notch2)
1.894	07	19	18	1p12	NOTCH2NLR		NOTCH2 N-terminal-like-related, pseudogene	618026				
1.895	10	12	14	1p12	PHGDH, NLS1, PHGDHD		Phosphoglycerate dehydrogenase	606879			Phosphoglycerate dehydrogenase deficiency, 601815 (3); Neu-Laxova syndrome 1, 256520 (3)	
1.896	10	07	19	1p12	SEC22B, SEC22L1		SEC22 homolog B, vesicle trafficking protein	604029				
1.897	9	24	15	1p12	SPAG17, PF6		Sperm-associated antigen 17	616554				
1.898	7	18	12	1p11.2	SRGAP2C		SLIT-ROBO Rho GTPase-activating protein 2C	614704				
1.899	5	9	18	1p12	TENT5C, FAM46C		Terminal nucleotidyltransferase 5C	613952				
1.900	3	6	98	1p21.2	EXTL2		Exostosin-like 2	602411				3(Extl2)
1.901	1	9	95	1p13.1	NHLH2, HEN2		Nescient helix loop helix 2	162361				3(Nscl2)
1.902	7	18	12	1p11.2	FAM72B		Family with sequence similarity 72, member B	614711				
1.903	10	15	02	1p11	MNRI		Meningioma, radiation-induced	606190			Meningioma, radiation-induced (2)	
1.904	5	4	12	1p	ANON1		Anorexia nervosa, susceptibility to, 1	606788			{Anorexia nervosa, susceptibility to, 1} (2)	
1.905	2	5	01	1p	PSORS7		Psoriasis susceptibility 7	605606			{Psoriasis susceptibility 7} (2)	
1.906	1	2	91	1q44	ADSS		Adenylosuccinate synthetase (Ade(-)H-complementing)	103060				13(Nid)
1.907	11	14	91	1q23.3	HSPA6		Heat-shock 70kD protein-6 (HSP70B')	140555				
1.908	8	28	97	1q	LRE2		LINE retrotransposable element-2	151628		inserted in DMD gene		
1.909	2	2	16	1q22	PMF1		Polyamine-modulated factor 1	609176				
1.910	4	19	12	1q21.1	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1		RNA-binding motif protein 8A	605313		pseudogene on chr.14	Thrombocytopenia-absent radius syndrome, 274000 (3)	
1.911	4	17	01	1q21.3	TMOD4		Tropomodulin 4, muscle	605834				3(Tmod4)
1.912	08	26	20	1q22	DPM3, MDDGC15, MDDGB15		Dolichyl-phosphate mannosyltransferase 3	605951		mutation identified in 1 MDDGB15 patient	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15, 612937 (3); ?Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 15, 618992 (3)	
1.913	7	20	09	1q12-q21.3	GNRHR2		Gonadotropin-releasing hormone receptor 2	612875		?processed pseudogene		
1.914	6	3	94	1q21.3	S100A9, CAGB, CFAG		S100 calcium-binding protein A9 (calgranulin B)	123886				3(Cagb)
1.915	9	13	89	1q12-q22	TRNL		tRNA asparagine-like	189890				
1.916	9	12	93	1q24.2	DPT		Dermatopontin	125597				
1.917	11	9	95	1q22	MEF2D		MADS box transcription enhancer factor 2, polypeptide D (myocyte enhancer factor 2D)	600663				3(Mef2d)
1.918	1	16	01	1q12-q24	CORD8		Cone-rod dystrophy 8	605549			Cone-rod dystrophy 8 (2)	
1.919	02	13	19	1q23.3	DDR2, NTRKR3, TKT, WRCN		Discoidin domain receptor family, member 2	191311			Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3); Warburg-Cinotti syndrome, 618175 (3)	
1.920	4	6	15	1q21.2	ACP6, LPAP, ACPL1		Acid phosphatase 6, lysophosphatide	611471				
1.921	8	30	07	1q21	AD13		Alzheimer disease-13	611152		max lod D1S498	{Alzheimer disease-13} (2)	
1.922	9	12	13	1q21.2	ADAMTSL4, TSRC1, ECTOL2		ADAMTS-like 4	610113			Ectopia lentis, isolated, autosomal recessive, 225100 (3); Ectopia lentis et pupillae, 225200 (3)	3(Adamtsl4)
1.923	6	18	99	1q21.3	ANXA9, ANX31		Annexin A9 (annexin XXXI)	603319				
1.924	8	27	15	1q21.3	ARNT		Aryl hydrocarbon receptor nuclear translocator	126110				3(Arnt)
1.925	5	26	98	1q21.2	BCL9		B-cell CLL/lymphoma-9	602597				
1.926	5	11	00	1q21.2	CA14		Carbonic anhydrase XIV	604832				
1.927	2	24	15	1q23.2	CASQ1, VMCQA		Calsequestrin, fast-twitch, skeletal muscle-1	114250			Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3)	
1.928	8	2	13	1q21.3	CELF3, TNRC4, BRUNOL1		CUGbp- and ELAV-like family, member 3	612678				
1.929	9	28	09	1q21.1	CHD1L, ALC1		Chromodomain helicase DNA-binding protein 1-like	613039				
1.930	9	9	02	1q21.3	CHRNB2, EFNL3		Cholinergic receptor, nicotinic, beta polypeptide-2	118507		linked to AMY in mouse	Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	3(Acrb2)
1.931	11	28	01	1q21.3	CTMP		C-terminal modulator protein	606388				
1.932	9	2	96	1q21.3	CTSK		Cathepsin K	601105			Pycnodysostosis, 265800 (3)	
1.933	6	3	94	1q21.3	CTSS		Cathepsin S	116845				3(Ctss)
1.934	6	9	98	1q22	DAP3		Death associated protein 3	602074				
1.935	3	25	13	1q21.2	ECM1, URBWD		Extracellular matrix protein-1	602201			Urbach-Wiethe disease, 247100 (3)	
1.936	09	29	20	1q21.1	FCGR1C, CD64		Fc fragment of IgG receptor Ic, pseudogene	601503				
1.937	4	18	08	1q21.3	FLG, ATOD2		Filaggrin	135940			Ichthyosis vulgaris, 146700 (3); {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	3(flg)
1.938	2	17	12	1q22	GBA		Glucosidase, acid beta	606463		pseudogene GBAP ~16kb 3' to GBA	Gaucher disease, type I, 230800 (3); Gaucher disease, type II, 230900 (3); Gaucher disease, type III, 231000 (3); Gaucher disease, type IIIC, 231005 (3); Gaucher disease, perinatal lethal, 608013 (3); {Parkinson disease, late-onset, susceptibility to}, 168600 (3); {Lewy body dementia, susceptibility to}, 127750 (3)	3(Gba)
1.939	8	28	97	1q22	GENEY		Gene Y	600986				3(GeneY)
1.940	12	11	07	1q23.1	HDGF		Hepatoma-derived growth factor	600339		previously assigned to Chr.X		
1.941	3	11	03	1q21.2	HIST2H2AA, H2AFO, H2A		Histone 2, H2aa	142720				
1.942	1	14	13	1q21.2	HIST2H2AB, H2AB		Histone gene cluster 2, H2A histone family, member B	615014				
1.943	3	12	03	1q21.2	HIST2H3C, H3F2		Histone 2, H3c	142780				
1.944	9	13	89	1q21.2	H4FN, H4F2		H4 histone, family 2	142750		100-200 histone genes; some on chromosome 6 and 12, as well as perhaps 7		
1.945	1	15	04	1q21.1	HJV, HFE2A		Hemojuvelin	608374		between D1S442 and D1S2347	Hemochromatosis, type 2A, 602390 (3)	
1.946	4	30	01	1q23.1	IRTA1		Immunoglobulin superfamily receptor translocation-associated gene 1	605876		fused with IGHA1 in multiple myeloma		
1.947	4	30	01	1q23.1	IRTA2		Immunoglobulin superfamily receptor translocation-associated gene 2	605877				
1.948	11	4	93	1q21.3	IVL		Involucrin	147360				
1.949	3	10	00	1q21.3	JTB, PAR		Jumping translocation breakpoint	604671				
1.950	3	4	10	1q21.3	KPRP		Keratinocyte proline-rich protein	613260				
1.951	2	17	09	1q21.3	LCE1A, LEP1		Late cornified envelope protein 1A	612603				3(Lce1a)
1.952	2	17	09	1q21.3	LCE1B, LEP2		Late cornified envelope protein 1B	612604				3(Lce1b)
1.953	2	17	09	1q21.3	LCE1C, LEP3		Late cornified envelope 1C	612605				3(Lce1c)
1.954	2	17	09	1q21.3	LCE1D, LEP4		Late cornified envelope protein 1D	612606				3(Lce1d)
1.955	2	17	09	1q21.3	LCE1E		Late cornified envelope protein 1E	612607				3(Lce1e)
1.956	2	17	09	1q21.3	LCE1F, LEP6		Late cornified envelope protein 1F	612608				3(Lce1f)
1.957	2	18	09	1q21.3	LCE2A, LEP9		Late cornified envelope protein 2A	612609				3(Lce2a)
1.958	2	18	09	1q21.3	LCE2B, LEP10, XP5		Late cornified envelope protein 2B	612610				3(Lce2b)
1.959	2	18	09	1q21.3	LCE2C, LEP11		Late cornified envelope protein 2C	612611				3(Lce2c)
1.960	2	18	09	1q21.3	LCE2D, LEP12		Late cornified envelope protein 2D	612612				3(Lce2d)
1.961	2	23	09	1q21.3	LCE3A, LEP13		Late cornified envelope protein 3A	612613				3(Lce3a)
1.962	2	23	09	1q21.3	LCE3B, LEP14		Late cornified envelope protein 3B	612614				3(Lce3b)
1.963	2	23	09	1q21.3	LCE3C, LEP15		Late cornified envelope protein 3C	612615				3(Lce3c)
1.964	2	23	09	1q21.3	LCE3D, LEP16		Late cornified envelope protein 3D	612616		within intron 2 of LCE3C		3(Lce3d)
1.965	2	23	09	1q21.3	LCE3E, LEP17		Late cornified envelope protein 3E	612617				3(Lce3e)
1.966	2	23	09	1q21.3	LCE4A, LEP8		Late cornified envelope protein 4A	612618				3(Lce4a)
1.967	2	23	09	1q21.3	LCE5A, LEP18		Late cornified envelope protein 5A	612619				3(Lce5a)
1.968	8	20	07	1q21.3	LELP1		Late cornified envelope-like proline-rich 1	611042				
1.969	10	7	10	1q21.3	LOR		Loricrin	152445			Vohwinkel syndrome with ichthyosis, 604117 (3)	3(lor)
1.970	7	4	95	1q21.2	MCL1		Myeloid cell leukemia sequence 1 (BCL2-related)	159552				3(Mcl1)
1.971	5	23	16	1q21.3	MLLT11, AF1Q		Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 11	604684				
1.972	2	26	08	1q21.3	MRPL9		Mitochondrial ribosomal protein L9	611824				
1.973	4	24	08	1q21.2	MRPS21		Mitochondrial ribosomal protein S21	611984		9 pseudogenes		
1.974	8	3	99	1q22	MTX1, MTXN		Metaxin 1	600605		between GBA and TSP3		3(Mtxn)
1.975	11	01	19	1q22	MUC1, PUM, MCKD1		Mucin 1, cell surface associated	158340		5cM proximal to SPTA1	Medullary cystic kidney disease 1, 174000 (3)	3(Muc1)
1.976	11	24	16	1q22	NAXE, APOA1BP, AIBP, PEBEL		NAD(P)HX epimerase	608862			Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 617186 (3)	
1.977	12	13	00	1q21.1	PDZK1		PDZ domain-containing 1	603831				
1.978	10	29	03	1q21.3	PGRPIA		Peptidoglycan recognition protein, intermediate, alpha	608197				
1.979	10	29	03	1q21.3	PGRPIB		Peptidoglycan recognition protein, intermediate, beta	608198				
1.980	7	2	01	1q21.1	PIAS3		Protein inhibitor of activated STAT3	605987				
1.981	1	14	09	1q22	PKLR, PK1		Pyruvate kinase, liver and RBC type	609712			Pyruvate kinase deficiency, 266200 (3); Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)	3(Pk1)
1.982	10	21	96	1q23.1	PRCC, RCCP1		Papillary renal cell carcinoma, translocation-associated	179755		t(X;1)(p11;q21); fuses with TFE3 in RCCP	Renal cell carcinoma, papillary, 605074 (3)	
1.983	7	19	18	1q21.3	PSMB4, PRAAS3		Proteasome subunit, beta type, 4	602177		mutation identified in 1 PRAAS3 patient and 1 digenic family	?Proteasome-associated autoinflammatory syndrome 3 and digenic forms, 617591 (3)	
1.984	4	16	03	1q21	PSORS4		Psoriasis susceptibility 4	603935			{Psoriasis susceptibility 4} (2)	
1.985	2	14	01	1q21	PTCPRN, PRN1		Papillary thyroid carcinoma with papillary renal neoplasia	605642			Thyroid carcinoma, papillary, with papillary renal neoplasia (2)	
1.986	10	17	00	1q21	RFH1, AORF		Renal failure, progressive, with hypertension	161900			Nephropathy-hypertension (2)	
1.987	10	28	15	1q21.3	RORC, RORG, RZRG, IMD42		RAR-related orphan receptor C	602943			Immunodeficiency 42, 616622 (3)	3(Rorc)
1.988	3	28	17	1q21.3	RPS27, MPS1, DBA17		Ribosomal protein S27	603702		mutation identified in 1 DBA17 patient	?Diamond-Blackfan anemia 17, 617409 (3)	
1.989	11	17	94	1q21.3	S100A1		S100 protein, alpha polypeptide	176940				
1.990	3	4	10	1q21.3	RPTN		Repetin	613259				3(Rptn)
1.991	11	17	94	1q21.3	S100A2, S100L		S100 calcium-binding protein A2	176993				
1.992	11	17	94	1q21.3	S100A3, S100E		S100 calcium-binding protein A3	176992				
1.993	11	17	94	1q21.3	S100A4, CAPL		S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)	114210				3(Capl)
1.994	11	17	94	1q21.3	S100A5, S100D		S100 calcium-binding protein A5	176991				
1.995	11	17	94	1q21.3	S100A6, CACY		S100 calcium-binding protein A6 (calcyclin)	114110				3(Cacy)
1.996	2	9	95	1q21.3	S100A7		S100 calcium-binding protein A7	600353				
1.997	11	26	02	1q21.3	S100A8, CAGA, CFAG		S100 calcium-binding protein A8 (calgranulin A)	123885		over-expressed in 1q21-linked psoriasis		3(Caga)
1.998	7	11	94	1q21.3	S100A10, CAL1L		S100 calcium-binding protein A10 (annexin II ligand, calpactin I, light polypeptide (p11))	114085		on chr.3 in mouse		
1.999	10	14	98	1q21.3	S100A11		S100 calcium-binding protein A11	603114				
1.1000	10	14	98	1q21.3	S100A12, CAAF1, CGRP		S100 calcium-binding protein A12	603112		between S100A8 and S100A9		
1.1001	3	9	98	1q21.3	S100A13		S100 calcium-binding protein A13	601989				
1.1002	1	11	07	1q21.3	S100A14, BCMP84		S100 Calcium-binding protein A14	607986				
1.1003	5	13	02	1q22	SCAMP3, PROPIN1		Secretory carrier membrane protein 3	606913				
1.1004	9	9	11	1q23.3	SDHC, PGL3		Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD	602413			Paragangliomas 3, 605373 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Gastrointestinal stromal tumor, 606764 (3)	
1.1005	1	4	00	1q21.3	SETDB1		SET domain protein, bifurcated, 1	604396				
1.1006	3	10	00	1q23.1	SH2D2A, TSAD		SH2 domain protein 2A	604514				
1.1007	6	16	95	1q21.3	SHC1		SHC (Src homology 2 domain-containing) transforming protein-1	600560				
1.1008	10	4	02	1q23.2	SLAMF8, BLAME		SLAM family, member 8	606620				
1.1009	2	15	02	1q21.3	SLC39A1, ZIRTL		Solute carrier family 39 (zinc transporter), member 3 (zinc/iron-regulated transporter-like)	604740		REc		3(Zirtl)
1.1010	3	23	06	1q21.3	SMCP, MCSP, MCS		Sperm mitochondria-associated cysteine-rich protein	601148				
1.1011	5	19	15	1q21.3	SPRR4		Small proline-rich protein 4	616363				
1.1012	3	11	09	1q23.1	SPTA1, EL2, SPH3, HS3, HPP		Spectrin, alpha, erythrocytic-1	182860		17cM proximal to FY	Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3); Spherocytosis, type 3, 270970 (3)	1(Spna1)
1.1013	7	4	95	1q22	THBS3, TSP3		Thrombospondin 3	188062				3(Thbs3)
1.1014	6	16	99	1q21.3	TUFT1		Tuftelin 1	600087		?mutant in amelogenesis imperfecta		
1.1015	1	7	02	1q21.1	TXNIP, VDUP1		Thioredoxin-interacting protein	606599				3(Txnip)
1.1016	6	5	08	1q22	UBQLN4, A1U, C1orf6		Ubiquitin 4	605440				
1.1017	2	25	08	1q21.3	VPS72, CFL1, YL1		Vacuolar protein sorting 72, yeast, homolog of	600607				
1.1018	6	17	17	1q22	ARHGEF2, GEFH1, KIAA0651, NEDMHM		RHO guanine nucleotide exchange factor 2	607560		mutation identified in 1 NEDMHM family	?Neurodevelopmental disorder with midbrain and hindbrain malformations, 617523 (3)	
1.1019	8	25	04	1q21-q22	ASPG3		Asperger syndrome, susceptibility to, 3	608781		max lod at D1S484	{Asperger syndrome susceptibility 3} (2)	
1.1020	5	11	00	1q23.3	DUSP1, YVH1		Dual-specificity phosphatase 12	604835				
1.1021	11	5	97	1q22	EFNA1, EPLG1, TNFAIP4		eph-related receptor tyrosine kinase ligand 1 (tumor necrosis factor, alpha-induced protein 4)	191164				3(Epl1)
1.1022	11	5	97	1q21.3	EFNA3, EPLG3		eph-related receptor tyrosine kinase ligand 3 (ephrin A3)	601381				3(Epl3)
1.1023	11	5	97	1q21.3	EFNA4, EPLG4		eph-related receptor tyrosine kinase ligand 4 (ephrin-A4)	601380				3(Epl4)
1.1024	2	28	08	1q23.1	MRPL24		Mitochondrial ribosomal protein L24	611836				
1.1025	1	11	07	1q23.3	NIT1		Nitrilase 1	604618				1(Nit1)
1.1026	4	18	94	1q21.3	NPR1, ANPRA		Natriuretic peptide receptor A/guanylate cyclase A	108960				
1.1027	01	23	20	1q23.1	NTRK1, TRKA		Neurotrophic tyrosine kinase, receptor, type 1	191315		TRK = chimera of TPM3 and NTRK1	Insensitivity to pain, congenital, with anhidrosis, 256800 (3)	
1.1028	10	14	18	1q21.3	SELENBP1, SP56, EHMTO		Selenium-binding protein 1	604188			Extraoral halitosis due to MTO deficiency, 618148 (3)	
1.1029	7	10	93	1q21.3	SPRR1A		Small proline-rich protein 1A	182265				
1.1030	7	10	93	1q21.3	SPRR1B		Small proline-rich protein 1B	182266				
1.1031	7	10	93	1q21.3	SPRR2A		Small proline-rich protein 2A	182267		about 7 SPRR2 genes		
1.1032	7	10	93	1q21.3	SPRR2B		Small proline-rich protein 2B	182268				
1.1033	7	10	93	1q21-q22	SPRR2C		Small proline-rich protein 2C	182269		prob. pseudogene		
1.1034	7	10	93	1q21.3	SPRR3		Small proline-rich protein 3	182271				
1.1035	08	21	19	1q21.2	VPS45, VPS45A, SCN5		Vacuolar protein sorting 45 homolog	610035			Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3)	
1.1036	09	26	19	1q23.3	ADAMTS4		ADAM metallopeptidase with thrombospondin type 1 motif 4 (aggrecanase 1)	603876				
1.1037	4	30	91	1q23.2	APCS, SAP		Amyloid P component, serum	104770		probably close to CRP	{?Amyloidosis, secondary, susceptibility to} (1)	1(Sap)
1.1038	2	20	03	1q23.3	APOA2		Apolipoprotein A-II	107670			Apolipoprotein A-II deficiency (3); {Hypercholesterolemia, familial, modifier of}, 143890 (3)	1(Apoa2)
1.1039	1	23	18	1q23.2	ATP1A2, FHM2, MHP2		ATPase, Na+K+ transporting, alpha-2 polypeptide	182340			Migraine, familial hemiplegic, 2, 602481 (3); Alternating hemiplegia of childhood 1, 104290 (3); Migraine, familial basilar, 602481 (3)	1(Atpa3)
1.1040	1	17	03	1q21-q23	BMND2		Bone mineral density QTL 2	605833			[Bone mineral density QTL 2] (2)	
1.1041	3	21	93	1q23.1	CD1A		Thymocyte antigen CD1A	188370		genes A, B, C, D in cluster		3(Ly38)
1.1042	3	21	93	1q23.1	CD1B		Thymocyte antigen CD1B	188360				
1.1043	3	21	93	1q23.1	CD1C		Thymocyte antigen CD1C	188340				
1.1044	3	21	93	1q23.1	CD1D		Thymocyte antigen CD1D	188410				3(Cd1d)
1.1045	10	9	94	1q23.1	CD1E		Thymocyte antigen CD1E	188411				
1.1046	7	2	98	1q23.1	CD5L		CD5 antigen-like (scavenger receptor cysteine rich family)	602592				
1.1047	5	1	91	1q23.2	CRP		C-reactive protein	123260				1(Crp)
1.1048	1	27	04	1q21-q23	DFNA49		Deafness, autosomal dominant 49	608372		max lod at D1S3784 and D1S3786	Deafness, autosomal dominant 49 (2)	
1.1049	9	8	11	1q21-q23	ERVK-7, HERV-KIII, HERV-K102		Endogenous retrovirus group K, member 7	614013				
1.1050	12	5	95	1q23.1	ETV3, PE1		ets variant gene 3	164873				
1.1051	09	29	20	1q23.3	FCGR2A, IGFR2, CD32		Fc fragment of IgG receptor IIa	146790		FCG2 and FCG3 within 250kb	{Lupus nephritis, susceptibility to}, 152700 (3); {Malaria, severe, susceptibility to}, 611162 (3); {Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3)	1(Ly17, Cd32)
1.1052	3	11	03	1q21.2	HIST2H2BE, H2B		Histone 2, H2be	601831				
1.1053	3	11	03	1q21.2	HIST2H2AC, H2AFQ		Histone 2, H2ac	602797				
1.1054	10	24	00	1q23.1	INSRR, IRR		Insulin receptor-related receptor	147671				
1.1055	3	23	09	1q23.1	PYHIN1, IFIX		Pyrin and Hin domain family, member 1	612677				
1.1056	12	21	09	1q21-q23	SLEB14		Systemic lupus erythematosus, susceptibility to, 14	613145		associated with rs3093061	{Systemic lupus erythematosus, susceptibility to, 14} (2)	
1.1057	12	5	95	1q22	SSR2		Signal sequence receptor, beta	600867				
1.1058	08	21	19	1q23.2	VANGL2, LTAP		VANGL planar cell polarity protein 2	600533			Neural tube defects, 182940 (3)	1(Lp)
1.1059	5	4	00	1q23.2	TAGLN2		Transgelin 2	604634				1(Tagln2)
1.1060	2	28	03	1q23.2	ATP1A4, ATP1AL2		ATPase, Na+/K+ transporting, alpha-4 polypeptide	607321				1(Atp1a4)
1.1061	3	15	11	1p11.2	C1orf152, COAS3		Chromosome 1 open reading frame 152	608609				
1.1062	11	11	14	1q21.1	CD160, BY55		CD160 antigen	604463				
1.1063	12	17	08	1q21.1	DEL1q21, C1DELq21		Chromosome 1q21.1 deletion syndrome	612474		contiguous gene deletion syndrome	Chromosome 1q21.1 deletion syndrome (4)	
1.1064	12	17	08	1q21.1	DUP1q21, C1DUPq21		Chromosome 1q21.1 duplication syndrome	612475		contiguous gene duplication syndrome	Chromosome 1q21.1 duplication syndrome (4)	
1.1065	3	9	00	1q21.1	FMO5		Flavin-containing monooxygenase 5	603957				
1.1066	5	3	13	1q21.2	GJA8, CX50, CTRCT1, CZP1, CAE1		Gap junction membrane channel protein alpha-8 (connexin 50)	600897			Cataract 1, multiple types, 116200 (3)	3(Gja8)
1.1067	7	16	09	1q21.1	GPR89A		G protein-coupled receptor 89A	612821				
1.1068	7	16	09	1q21.2	GPR89B, GPHR		G protein-coupled receptor 89B	612806				
1.1069	09	11	19	1q21.1	HYDIN2, KIAA1864		HYDIN axonemal central pair apparatus protein 2	610813		duplicated copy 16q22.2		
1.1070	5	25	13	1q21.1	ITGA10		Integrin, alpha-10	604042				
1.1071	9	22	09	1q21.1	NBLST6		Neuroblastoma, susceptibility to, 6	613017		?contiguous gene deletion or duplication disease	{Neuroblastoma, susceptibility to, 6} (2)	
1.1072	9	21	11	1q21.1	NBPF10		Neuroblastoma breakpoint family, member 10	614000				
1.1073	9	21	11	1q21.2	NBPF11		Neuroblastoma breakpoint family, member 11	614001				
1.1074	9	21	11	1q21.1	NBPF12, COAS1, KIAA1245		Neuroblastoma breakpoint family, member 12	608607				
1.1075	9	21	11	1p11.2	NBPF8		Neuroblastoma breakpoint family, member 8	613998				
1.1076	9	21	11	1q21.2	NBPF9		Neuroblastoma breakpoint family, member 9	613999				
1.1077	9	21	11	1q21.2	NBPF14		Neuroblastoma breakpoint, member 14	614003				
1.1078	2	5	07	1q21.1	NBPF15, MGC8902		Neuroblastoma breakpoint family, member 15	610414		contains 6 copies of DUF1220 domain		
1.1079	9	21	11	1q21.1	NBPF16		Neuroblastoma breakpoint family, member 16	614005				
1.1080	9	21	11	1q21.2	NBPF19		Neuroblastoma breakpoint family, member 19	614006				
1.1081	9	21	11	1q21.1	NBPF20		Neuroblastoma breakpoint family, member 20	614007				
1.1082	6	24	15	1q21.1	NBPF17P, NBPF23		Neuroblastoma breakpoint family, member 17, pseudogene	612970				
1.1083	6	22	18	1q21.1	NOTCH2NLA		NOTCH2 N-terminal-like protein A	618023				
1.1084	7	18	18	1q21.2	NOTCH2NLB		NOTCH2 N-terminal-like protein B	618024				
1.1085	05	04	20	1q21.2	NOTCH2NLC, NIID, ETM6		NOTCH2 N-terminal-like protein C	618025			Neuronal intranuclear inclusion disease, 603472 (3); Tremor, hereditary essential, 6, 618866 (3)	
1.1086	1	20	99	1q23.2	PEA15, HMAT1, PED		Phosphoprotein enriched in astrocytes, 15kD	603434				
1.1087	11	11	20	1q21.1	PEX11B, PEX14B		Peroxisome biogenesis 11B	603867			Peroxisome biogenesis disorder 14B, 614920 (3)	
1.1088	3	15	11	1q21.2	PDE4DIP, MMGL, KIAA0454, KIAA0477		Phosphodiesterase 4D-interacting protein	608117				
1.1089	4	26	17	1q21.1	POLR3C, RPC62, RPC3		Polymerase III, RNA, subunit C	617454				
1.1090	4	27	17	1q21.1	POLR3GL		Polymerase III, RNA, subunit G-like	617457				
1.1091	3	15	11	1q21.1	PPIAL4A, COAS2		Peptidylprolyl isomerase A (cyclophilin A)-like 4A	608608				
1.1092	11	11	14	1q21.1	PRKAB2		Protein kinase, AMP-activated, noncatalytic, beta-2	602741				
1.1093	7	18	12	1q21.1	SRGAP2B		SLIT-ROBO Rho GTPase-activating protein 2B	614703				
1.1094	7	18	12	1q21.1	SRGAP2D		SLIT-ROBO Rho GTPase-activating protein 2D	614705				
1.1095	8	1	12	1q21.1	UAQTL6		Uric acid concentration, serum, quantitative trait locus 6	614747		associated with C/T variant at chr1_142697422	[Uric acid concentration, serum, QTL6] (2)	
1.1096	7	13	98	1q21.3	PIK4CB		Phosphatidylinositol 4-kinase, catalytic, beta polypeptide	602758				
1.1097	10	23	02	1q21.3	RFX5		Regulatory factor X, 5 (influences HLA class II expression)	601863			Bare lymphocyte syndrome, type II, complementation group C, 209920 (3); Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)	
1.1098	08	23	19	1q21.2	BOLA1		bolA family member 1	613181				
1.1099	6	22	14	1q21.2	CIART, CHRONO, GM129		Circadian-associated repressor of transcription	615782				
1.1100	7	17	09	1q21.3	ENSA		Endosulfine, alpha	603061				
1.1101	11	24	14	1q21.2	FALEC, FAL1		Focally amplified long noncoding RNA in epithelial cancer	616092				
1.1102	3	9	16	1q21.1	FAM72C		Family with sequence similarity 72, member C	616853				
1.1103	4	16	14	1q21.2	GJA5, CX40, ATFB11		Gap junction protein, alpha-5, 40kD (connexin 40)	121013			Atrial fibrillation, familial, 11, 614049 (3); Atrial standstill, digenic (GJA5/SCN5A), 108770 (3)	3(Gja5)
1.1104	9	2	08	1q21.3	GOLPH3L, GPP34R		Golgi phosphoprotein 3-like	612208				
1.1105	08	21	19	1q21.2	PRPF3, HPRP3, RP18		Pre-mRNA processing factor 3	607301			Retinitis pigmentosa 18, 601414 (3)	
1.1106	9	25	18	1q22	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS		Lamin A/C	150330			Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, type 2, 151660 (3); Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3); Muscular dystrophy, congenital, 613205 (3); Mandibuloacral dysplasia, 248370 (3); Hutchinson-Gilford progeria, 176670 (3); Restrictive dermopathy, lethal, 275210 (3); Heart-hand syndrome, Slovenian type, 610140 (3); Malouf syndrome, 212112 (3)	3(Lmna)
1.1107	1	23	08	1q21.2	OTUD7B, CEZANNE		OTU domain-containing protein 7B	611748				
1.1108	6	2	15	1q21.2	PLEKHO1, CKIP1		Pleckstrin homology domain-containing protein, family O, member 1	608335				
1.1109	6	5	12	1q21.2	SF3B4, SF3B49, SAP49, AFD1		Splicing factor 3B, subunit 4	605593			Acrofacial dysostosis 1, Nager type, 154400 (3)	
1.1110	07	16	20	1q22	SMG5, EST1B, KIAA1089		SMG5 nonsense-mediated nRNA decay factor	610962				
1.1111	6	22	12	1q21.2	SV2A, SV2		Synaptic vesicle glycoprotein 2A	185860				
1.1112	8	5	14	1q21.2	TARS2, COXPD21		Threonyl-tRNA synthetase 2	612805		mutation identified in one COXPD21 family	?Combined oxidative phosphorylation deficiency 21, 615918 (3)	
1.1113	2	26	16	1q21.3	ZNF687, KIAA1441, PDB6		Zinc finger protein 687	610568		fused with AML1 in t(1;21)	Paget disease of bone 6, 616833 (3)	
1.1114	11	4	04	1q23.3	F11R, JAM1		F11 receptor (junctional adhesion molecule 1)	605721				
1.1115	09	29	20	1q21.2	FCGR1A, IGFR1, CD64		Fc fragment of IgG receptor Ia	146760			[IgG receptor I, phagocytic, familial deficiency of] (3)	3(Fcgr1)
1.1116	6	30	08	1q21.3	TNFAIP8L2, TIPE2		Tumor necrosis factor-alpha-induced protein 8-like 2	612112				3(Tnfaip8l2)
1.1117	6	28	17	1q23.2	CADM3, IGSF4B, TSLL1, NECL1, SYNCAM3		Cell adhesion molecule 3	609743				1(Igsf4b)
1.1118	12	21	09	1q23.1	FCRL1, FCRH1		Fc receptor-like protein 1	606508				
1.1119	11	27	01	1q23.1	FCRH3		Fc receptor-like protein 3	606510				
1.1120	11	27	01	1q23.1	SPAP1, SPAP1A, SPAP1B, SPAP1C		SH2 domain-containing phosphatase anchor protein 1	606509				
1.1121	09	26	19	1q21.3	ADAM15, MDC15		ADAM metallopeptidase domain 15	605548				
1.1122	1	14	13	1q21.3	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6		Adenosine deaminase, RNA-specific	146920			Dyschromatosis symmetrica hereditaria, 127400 (3); Aicardi-Goutieres syndrome 6, 615010 (3)	3(Adar)
1.1123	9	27	17	1q21.3	AQP10		Aquaporin 10	606578				
1.1124	9	22	08	1q21.3	ATP8B2, ATPID		ATPase, class I, type 8B, member 2	605867				
1.1125	7	20	12	1q21.3	BNIPL, BNIPS, BNIPL1, BNIPL2		BCL2/adenovirus E1B 19kD protein-interacting protein 2-like	611275				
1.1126	4	20	17	1q21.3	C1orf43, NS5ATP4, NICE3		Chromosome 1 open reading frame 43	617428				
1.1127	4	19	12	1q21.3	CERS2, LASS2		Ceramide synthase 2	606920				
1.1128	9	2	11	1q21.3	CHTOP, C10orf77, SRAG, FOP		Chromatin target of PRMT1	614206				
1.1129	1	13	11	1q21.3	CKS1B, CKS1		CDC28 protein kinase 1B	116900		previously to 8q21 by FISH		
1.1130	8	4	97	1q23.1	CRABP2, RBP6		Cellular retinoic acid-binding protein-2	180231				
1.1131	6	20	07	1q21.3	CREB3L4, CREB4, AIBZIP		cAMP responsive element binding protein 3-like 4	607138				
1.1132	4	20	17	1q21.3	CRCT1, NICE1, C1orf42		Cysteine-rich c-terminal 1	617426				
1.1133	10	27	08	1q21.3	CRTC2, TORC2		CREB-regulated transcription coactivator 2	608972				
1.1134	09	11	19	1q21.3	FLAD1, FADS, LSMFLAD		Flavin adenine dinucleotide synthetase 1	610595			Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3)	
1.1135	08	10	18	1q21.3	FLG2, IFPS, PSS6		Filaggrin family, member 2	616284			Peeling skin syndrome 6, 618084 (3)	
1.1136	6	7	11	1q21.3	HAX1, SCN3		HCLS1-associated protein X1	605998			Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)	
1.1137	1	18	06	1q21.3	HORMAD1, NOHMA		HORMA domain-containing 1	609824				3(Nohma)
1.1138	2	16	10	1q21.3	HRM2		Hair morphology 2 (curly hair)	139450		associated with rs11803731	Hair, curly (2)	
1.1139	4	10	15	1q21.3	HRNR		Hornerin	616293				3(Hrnr)
1.1140	07	21	20	1q21.3	IL6R, IL6RQ, IL6QTL, HIES5		Interleukin-6 receptor	147880		IL6R-like gene on chr.9	[Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3); [Interleukin 6, serum level of, QTL], 614752 (3); Hyper-IgE recurrent infection syndrome 5, autosomal recessive, 618944 (3)	
1.1141	3	23	14	1q21.3	INTS3, INT3, SOSSA		Integrator complex subunit 3	611347				
1.1142	11	11	19	1q21.3	KCNN3, SK3, SKCA3, ZLS3		Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 3	602983			Zimmermann-Laband syndrome 3, 618658 (3)	
1.1143	9	16	12	1q21.3	LINGO4, LRRN6D		Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 4	609794				
1.1144	04	30	19	1q21.3	MINDY1, FAM63A		MINDY lysine-48 deubiquitinase 1	618407				
1.1145	5	25	13	1q21.3	OAZ3, AZ3		Ornithine decarboxylase antizyme 3	605138				
1.1146	03	19	20	1q21.3	PBXIP1, HPIP		PBX homeobox-interacting protein 1	618819				
1.1147	11	13	15	1q21.3	PMVK, PMK, POROK1		Phosphomevalonate kinase	607622			Porokeratosis 1, multiple types, 175800 (3)	
1.1148	1	13	16	1q21.3	POGZ, KIAA0461, MRD37, WHSUS		POGO transposable element with ZNF domain	614787			White-Sutton syndrome, 616364 (3)	
1.1149	5	25	17	1q21.3	PRUNE1, DRES17, NMIHBA		Prune exopolyphosphatase 1	617413			Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, 617481 (3)	
1.1150	7	27	09	1q21.3	PYGO2		Pygopus, Drosophila, homolog of, 2	606903				
1.1151	2	1	11	1q21.3	RAB13		RAB13, member RAS oncogene family	602672		previously assigned to 12q13 by in situ hybridization		
1.1152	7	2	02	1q22	RHBG		Rhesus blood group, B glycoprotein	607079				3(Rhbg)
1.1153	7	18	12	1q21.2	RPRD2		Regulation of nuclear pre-mRNA domain-containing 2	614695				
1.1154	10	2	12	1q21.3	PSMD4, S5A, RPN10		Proteasome 26S subunit, non-ATPase, 4	601648				3(Psmd4)
1.1155	4	20	17	1q21.3	S100A7A, S100A15, NICE2		S100 calcium-binding protein A7A	617427				
1.1156	8	19	09	1q21.3	SCNM1, MGC3180		Sodium channel modifier 1	608095				
1.1157	4	21	15	1q21.3	SEMA6C, KIAA1869		Semaphorin 6C	609294				16(Sema6c)
1.1158	2	25	15	1q21.3	SHE		SH2 domain-containing protein E	610482				
1.1159	7	27	09	1q21.3	SLC27A3, FATP3		Solute carrier family 27 (fatty acid transporter), member 3	604193				
1.1160	8	21	08	1q21.3	SNX27, MRT1		Sorting nexin 27	611541				
1.1161	8	2	17	1q21.3	SPRR2D		Small proline-rich protein 2D	617587				
1.1162	8	2	17	1q21.3	SPRR2E		Small proline-rich protein 2E	617588				
1.1163	7	27	17	1q21.3	SPRR2F		Small proline-rich protein 2F	617589				
1.1164	7	27	17	1q21.3	SPRR2G		Small proline-rich protein 2G	617590				
1.1165	12	23	16	1q21.3	TCHH, THH, THL, TRHY, UHS3		Trichohyalin	190370		mutation identified in 1 UHS3 patient	?Uncombable hair syndrome 3, 617252 (3)	
1.1166	3	7	14	1q21.3	THEM5, ACOT15		Thioesterase superfamily member 5	615653				3(Them5)
1.1167	7	20	15	1q21.3	UBAP2L, NICE4		Ubiquitin-associated protein 2-like	616472				
1.1168	4	20	17	1q21.3	UBE2Q1, GTAP, NICE5		Ubiquitin-conjugating enzyme E2Q family member 1	617429				
1.1169	9	20	14	1q21.3	ZBTB7B, ZFP67, CKROX, THPOK		Zinc finger- and BTB domain-containing protein 7B	607646				
1.1170	3	21	93	1q23.3	CD48, BCM1, BLAST1		CD48 antigen (B-cell membrane protein)	109530				1(Bcm1)
1.1171	4	27	09	1q23.3	ITLN1, INTL, LFR, HL1		Intelectin 1	609873				
1.1172	4	27	09	1q23.3	ITLN2, HL2		Intelectin 2	609874				
1.1173	9	11	95	1q23.3	LY9		T-lymphocyte surface antigen Ly-9	600684		within 410kb of CD48		1(Ly9)
1.1174	10	4	05	1q21.2	ANP32E, LANPL		Acidic leucine-rich nuclear phosphoprotein 32 family, member E	609611				
1.1175	08	21	19	1q22	ASH1L, KIAA1420, ASH1, MRD52		ASH1-like histone lysine methyltransferase	607999			Mental retardation, autosomal dominant 52, 617796 (3)	
1.1176	01	24	20	1q22	C1orf61, CROC4		Chromosome 1 open reading frame 61	618747				
1.1177	3	3	95	1q23.1	IFI16		Interferon, gamma-inducible protein 16	147586				
1.1178	3	8	00	1q23.1-q23.2	AIM2		Absent in melanoma 2	604578				
1.1179	2	12	09	1q23.3	CD244, NAIL, NKR2B4, SLAMF4		CD244 antigen	605554			{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
1.1180	09	29	20	1q23.3	FCGR2B, CD32		Fc fragment of IgG receptor Ia	604590			{Systemic lupus erythematosus, susceptibility to}, 152700 (3); {Malaria, resistance to}, 611162 (3)	
1.1181	11	13	15	1q22	FDPS, FPS, POROK9		Farnesyl diphosphate synthase	134629			Porokeratosis 9, multiple types, 616631 (3)	
1.1182	8	19	13	1q22	GON4L, KIAA1606		GON4-like protein	610393				
1.1183	3	24	06	1q22	HCN3, KIAA1535		Hyperpolarization-activated cyclic nucleotide-gated potassium channel 3	609973				
1.1184	09	27	20	1q22	KRTCAP2, KCP2		Keratinocyte-associated protein 2	619029				
1.1185	12	4	02	1q21.3	LENEP, LEP503		Lens epithelial protein	607377				
1.1186	7	15	13	1q22	LAMTOR2, MAPBPIP, p14		Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2	610389			Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)	
1.1187	8	20	07	1q22	MEX3A		Mex-3, C. elegans, homolog of, A	611007				
1.1188	3	23	09	1q22	MIR9-1, MIRN9-1		Micro RNA 9-1	611186				
1.1189	3	3	95	1q23.1	MNDA		Myeloid cell nuclear differentiation antigen	159553				
1.1190	11	28	18	1q23.3	MPZ, CMT1B, CMTDID, DSS, CHN2		Myelin protein zero	159440			Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas disease, 145900 (3); Hypomyelinating neuropathy, congenital, 2, 618184 (3); Charcot-Marie-Tooth disease, type 2J, 607736 (3); Roussy-Levy syndrome, 180800 (3); Charcot-Marie-Tooth disease, type 2I, 607677 (3); Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	1(Mpp)
1.1191	9	22	17	1q22	MSTO1, MMYAT		Misato 1, mitochondrial distribution and morphology regulator	617619			Myopathy, mitochondrial, and ataxia, 617675 (3)	
1.1192	7	12	94	1q23.2	NHLH1, HEN1		Nescient helix loop helix 1	162360		closely linked to Sap in mouse		1(Nscl)
1.1193	4	19	12	1q22	PAQR6		Progestin and ADIPOQ receptor family, member 6	614579				
1.1194	9	12	96	1q23.3	PPOX		Protoporphyrinogen oxidase	600923			Porphyria variegata, 176200 (3)	
1.1195	10	25	12	1q23.2	PEX19, PXF, HK33, D1S2223E, PBD12A		Peroxisome biogenesis factor 19 (peroxisomal farnesylated protein)	600279			Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	
1.1196	7	29	09	1q22	RAB25, RAB11C		Ras-associated protein RAB25	612942				
1.1197	8	7	13	1q22	RIT1, RIT, ROC1, NS8		Ric-like protein without CAAX motif 1	609591			Noonan syndrome 8, 615355 (3)	3(Rit)
1.1198	1	26	17	1q22	RUSC1, NESCA		RUN domain- and SH3 domain-containing protein 1	617318				
1.1199	5	30	17	1q22	RXFP4, RLN3R2, GPR100, GPCR142		Relaxin/insulin-like family peptide receptor 4	609043				3(Gpr100)
1.1200	11	30	06	1q22	SEMA4A, SEMB, RP35, CORD10		Semaphorin 4A	607292			Retinitis pigmentosa 35, 610282 (3); Cone-rod dystrophy 10, 610283 (3)	
1.1201	9	2	08	1q23.3	SH2D1B, EAT2		SH2 domain-containing 1B	608510				
1.1202	3	12	07	1q22	SLC25A44		Solute carrier family 25, member 44	610824				3(Slc25a44)
1.1203	1	21	11	1q22	SLC50A1, RAG1AP1		Solute carrier family 50 (sugar transporter), member 1	613683				
1.1204	4	17	13	1q21.3	SNAPIN, SNAPAP, BLOC1S7, BLOS7		SNAP-associated protein	607007				
1.1205	7	16	02	1q23.3	USP21, USP23		Ubiquitin-specific protease 21	604729				
1.1206	2	15	17	1q22	YY1AP1, YAP, HCCA2, GRNG		YY1 associated protein 1	607860			Grange syndrome, 602531 (3)	
1.1207	6	23	98	1q24.1	ALDH9A1, ALDH9, E3		Aldehyde dehydrogenase 9 family, member A1	602733				
1.1208	8	13	15	1q23.3	ATF6, ACHM7		Activating transcription factor-6	605537			Achromatopsia 7, 616517 (3)	
1.1209	8	5	14	1q24.2	CD247, CD3Z, TCRZ, IMD25		CD247 antigen	186780		mutation identified in one IMD25 patient	?Immunodeficiency 25, 610163 (3)	1(T3z, Cd3z)
1.1210	3	17	06	1q23.2	IGSF9, KIAA1355		Immunoglobulin superfamily, member 9	609738				1(Igsf9)
1.1211	02	12	20	1q23.3	LMX1A, LMX1, DFNA7		LIM homeo box transcription factor-1, alpha	600298			Deafness, autosomal dominant 7, 601412 (3)	
1.1212	2	8	11	1q23.2	NCSTN		Nicastrin	605254			Acne inversa, familial, 1, 142690 (3)	
1.1213	5	9	95	1q24.2	OTF1, OCT1		Octamer-binding transcription factor-1	164175				1(Otf1)
1.1214	5	2	94	1q23.3	RXRG		Retinoid X receptor, gamma	180247				1(Rxrg)
1.1215	8	24	04	1q23.3	SLAMF1, SLAM, CDW150, CD150		SLAM family, member 1	603492				
1.1216	8	2	13	1q21.3	TPM3, NEM1, CFTD, CAPM1		Tropomyosin 3	191030		TRK = chimera of TPM3 and NTRK1; NEM1 to 1q21-q23 by Fd	Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3); CAP myopathy 1, 609284 (3); Myopathy, congenital, with fiber-type disproportion, 255310 (3)	1(Tpm3)
1.1217	7	11	17	1q23.3	USF1, HYPLIP1		Upstream transcription factor 1	191523			{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)	1(Usf1)
1.1218	7	1	05	1q24.1	UCK2, TSA903		Uridine/cytidine kinase 2	609329				
1.1219	3	22	06	1q23.2	CCDC19, NESG1		Coiled-coil domain-containing 19	605152				
1.1220	4	19	01	1q21.3	PIP5K1A		Phosphatidylinositol-4-phosphate 5-kinase, type I, alpha	603275				
1.1221	2	2	07	1q24.2	ATP1B1		ATPase, Na+K+ transporting, beta-1 polypeptide	182330			[Blood pressure regulation QTL], 145500 (2)	1(Atp1b1)
1.1222	8	9	99	1q23.3	B4GALT3		Beta-1,4-galactosyltransferase 3	604014				
1.1223	6	8	01	1q23	BDET		Bleeding disorder, east Texas type	605913			Bleeding disorder, east Texas type (2)	
1.1224	1	23	90	1q23	D1S61, D1S111, MS336		Minisatellite 33.6	157560				
1.1225	7	13	99	1q22	CCT3, TRIC5		Chaperonin-containing TCP1, subunit 3, gamma (TCP1 (t-complex-1) ring complex, polypeptide 5)	600114				3(Tric5)
1.1226	03	19	19	1q23.2	DUSP23, DUSP25, LDP3, VHZ		Dual-specificity phosphatase 23	618361				
1.1227	5	4	12	1q24.2	F5, THPH2, RPRGL1		Coagulation factor V (proaccelerin, labile factor)	612309		Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment	Factor V deficiency, 227400 (3); {Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Budd-Chiari syndrome}, 600880 (3); Thrombophilia due to activated protein C resistance, 188055 (3); {Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)	1(Cf5)
1.1228	11	11	14	1q24.3	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B		Fas ligand (TNF superfamily, member 6)	134638			Autoimmune lymphoproliferative syndrome, type IB, 601859 (3); {Lung cancer, susceptibility to}, 211980 (3)	1(Fas1)
1.1229	7	10	91	1q23.2	FCER1A		Fc IgE receptor, alpha polypeptide	147140				1(Fcer1a)
1.1230	8	11	91	1q23.3	FCER1G		Fc fragment of IgE, high affinity I, receptor for, gamma polypeptide	147139		probably on 1q close to CD32		1(Fcer1a)
1.1231	09	29	20	1q23.3	FCGR2C, CD32C		Fc fragment of IgG receptor IIc	612169		?pseudogene		
1.1232	09	29	20	1q23.3	FCGR3A, CD16, IGFR3, IMD20		Fc fragment of IgG receptor IIIa	146740		FCGR2A and FCGR3A within 250kb antigen	Immunodeficiency 20, 615707 (3)	
1.1233	09	29	20	1q23.3	FCGR3B		Fc fragment of IgG receptor IIIb	610665				
1.1234	7	12	02	1q23.3	FREB		Fc receptor homolog expressed in B cells	606891				
1.1235	3	8	00	1q24.1	MGST3		Glutatione S-transferase, microsomal, 3	604564				
1.1236	2	2	07	1q23.3	RGS5		Regulator of G protein signaling-5	603276			[Blood pressure regulation QTL], 145500 (2)	
1.1237	12	13	18	1q23.3	NDUFS2, MC1DN6		NADH-ubiquinone oxidoreductase core subunit S2	602985			Mitochondrial complex I deficiency, nuclear type 6, 618228 (3)	
1.1238	2	6	08	1q23.3	NUF2, NUF2R, CDCA1		NUF2, S. cerevisiae, homolog of	611772				
1.1239	8	28	17	1q23.3	PBX1, CAKUHED		Pre-B cell leukemia transcription factor-1	176310		pseudogene PBXP1 on chr.3	Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, 617641 (3)	1(Pbx)
1.1240	6	15	99	1q25.1	TNFSF18, AITRL, GITRL		Tumor necrosis factor ligand superfamily, member 18	603898				
1.1241	8	30	02	1q24.2	XCL1, SCYC1, SCM1, LTN, LPTN		Chemokine, C motif, ligand 1 (lymphotactin)	600250				1(Lptn)
1.1242	8	30	02	1q24.2	XCL2, SCYC2, SCM1B		Chemokine, C motif, ligand 2	604828				
1.1243	2	4	02	1q23.3	SLAMF7, CRACC, CS1		SLAM family, member 7	606625				
1.1244	4	17	01	1q24.2	TBX19		T-box 19	604614			Adrenocorticotropic hormone deficiency, 201400 (3)	
1.1245	7	1	15	1q23.2	COPA, AILJK		Coatomer protein complex, subunit alpha	601924			{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3)	
1.1246	4	30	93	1q24.3	FMO1		Flavin-containing monooxygenase 1, fetal liver	136130				
1.1247	6	4	08	1q24.3	FMO2		Flavin-containing monooxygenase 2, pulmonary	603955		probably cluster of FMO genes at 1q23-q25		
1.1248	10	26	97	1q24.3	FMO3, TMAU		Flavin-containing monooxygenase 3	136132			Trimethylaminuria, 602079 (3)	
1.1249	6	4	08	1q24.3	FMO4		Flavin-containing monooxygenase 2, adult liver	136131				
1.1250	04	15	19	1q25.1	MRPS14, COXPD38		Mitochondrial ribosomal protein S14	611978		mutation identified in 1 COXPD38 patient	?Combined oxidative phosphorylation deficiency 38, 618378 (3)	
1.1251	12	22	17	1q24.3	PIGC, GPI2, GPIBD16, MRT62		Phosphatidylinositol glycan, class C	601730			Glycosylphosphatidylinositol biosynthesis defect 16, 617816 (3)	
1.1252	3	20	18	1q24.2	SELE, ELAM1		Selectin E (endothelial leukocyte adhesion molecule-1)	131210				1(Elam)
1.1253	7	14	11	1q24.2	SELL, LYAM1, LAM1, LNHR		Selectin L (lymphocyte adhesion molecule 1)	153240				1(Lnhr)
1.1254	7	31	17	1q24.2	SELP, GRMP		Selectin P (granulocyte membrane protein, 140kD; antigen CD62)	173610		in same 300kb segment as LYAM1, ELAM1		1(Grmp)
1.1255	3	1	12	1q25.1	SERPINC1, AT3, AT3D, THPH7		Antithrombin III	107300		~17cM distal to FY	Thrombophilia due to antithrombin III deficiency, 613118 (3)	1(At3)
1.1256	12	22	16	1q23.1	BCAN		Brevican	600347				
1.1257	10	22	20	1q21.3	GATAD2B, KIAA1150, p68, GANDS		GATA zinc finger domain-containing protein 2B	614998			GAND syndrome, 615074 (3)	
1.1258	1	30	02	1q23.2	IGSF8, PGRL, CD81P3		Immunoglobulin superfamily, member 8	606644				
1.1259	4	15	08	1q23.1	ISG20L2		Interferon-stimulated exonuclease gene 20-kD-like 2	611930				
1.1260	04	08	20	1q23.1	KIRREL1, NEPH1		Kirre-like nephrin family adhesion molecule 1	607428				
1.1261	8	18	04	1q23.3	KIS		Kinase-interacting stathmin	608849				
1.1262	11	11	14	1q23.1	NES		Nestin	600915				
1.1263	12	10	13	1q23.3	NR1I3, CAR, MB67		Nuclear receptor subfamily 1, group I, member 3	603881				
1.1264	8	3	12	1q23.1	PEAR1		Platelet endothelial aggregation receptor 1	610278				
1.1265	8	24	04	1q23.2-q23.3	SLAMF6, NTBA		SLAM family, member 6	606446				
1.1266	11	19	13	1q22	TMEM79, MATT		Transmembrane protein 79	615531				3(Tmem79)
1.1267	3	27	17	1q23.2	ACKR1, DARC, FY, GPD, WBCQ1		Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines)	613665		by A, 1q22-q23	[Blood group, Duffy system], 110700 (3); {Malaria, vivax, protection against}, 611162 (3); [White blood cell count QTL], 611862 (3)	1(Fy, Darc)
1.1268	7	18	14	1q23.2	DCAF8, WDR42A, GAN2		DDB1- and CUL4-associated factor 8	615820		mutation identified in 1 GAN2 family	?Giant axonal neuropathy 2, autosomal dominant, 610100 (3)	
1.1269	7	7	14	1q23.2	KCNJ9, GIRK3		Potassium inwardly-rectifying channel, subfamily J, member 9	600932				
1.1270	9	1	11	1q23.2	KCNJ10, SESAME		Potassium inwardly-rectifying channel, subfamily J, member 10	602208			SESAME syndrome, 612780 (3); Enlarged vestibular aqueduct, digenic, 600791 (3)	1(Kcnj10)
1.1271	8	23	06	1q23.2	PIGM		Phosphatidylinositol glycan, class M	610273			Glycosylphosphatidylinositol deficiency, 610293 (3)	
1.1272	2	23	08	1q24.2	TIPRL, TIP41, TIP		TIP41-like protein	611807				
1.1273	10	3	11	1q23.3	ARHGAP30		RHO GTPase-activating protein 30	614264				
1.1274	9	26	17	1q23.3	CD84, SLAMF5		CD84 antigen	604513				
1.1275	12	3	14	1q23.3	CFAP126, FLTP		Cilia- and flagella-associated protein 126	616119				
1.1276	1	11	07	1q23.3	DEDD, DEFT		Death effector domain-containing protein	606841				
1.1277	12	6	16	1q23.3	FCRLB, FCRL2, FREB2, FCRY		Fc receptor-like protein B	609251				
1.1278	12	5	03	1q25.1	GAS5		Growth arrest-specific 5	608280				
1.1279	2	10	11	1q23.3	HSD17B7		17-beta-hydroxysteroid dehydrogenase VII	606756				
1.1280	10	09	20	1q23.3	HSPA7		Heat-shock protein family A (Hsp70) member 7, pseudogene	140556				
1.1281	3	18	17	1q23.3	KLHDC9, KARCA1		Kelch domain-containing protein 9	617375				
1.1282	6	28	17	1q23.3	NECTIN 4, PVRL4, PRR4, EDSS1		Nectin 4	609607			Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)	
1.1283	1	1	10	1q23.3	NOS1AP, CAPON, KIAA0464		Nitric oxide synthase 1 (neuronal) adaptor protein	605551				
1.1284	9	9	10	1q23.3	PFDN2		Prefoldin 2	613466				
1.1285	2	21	10	1q23.3	QTV		QT interval, variation in	610141		associated with rs12143842	[QT interval, variation in] (2)	
1.1286	5	5	09	1q23.3	RGS4		Regulator of G protein signaling 4	602516				
1.1287	2	13	12	1q24.2	SLC19A2, THTR1, TRMA, THMD1		Solute carrier family 19 (thiamine transporter), member 2	603941			Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	
1.1288	12	15	16	1q23.3	SPATA46		Spermatogenesis-associated protein 46	617257				
1.1289	10	12	14	1q23.3	TSTD1, KAT		Thiosulfate sulfurtransferase (rhodanese)-like domain-containing protein 1	616041				
1.1290	5	25	13	1q23.3	UAP1, SPAG2		ADP-N-acetylglucosamine pyrophosphorylase 1	602862				
1.1291	08	07	18	1q23.3	UFC1, NEDSG		Ubiquitin-fold modifier-conjugating enzyme 1	610554			Neurodevelopmental disorder with spasticity and poor growth, 618076 (3)	
1.1292	10	25	19	1p32.3	TUT4, ZCCHC11, KIAA0191		Terminal uridylyl transferase 4	613692				
1.1293	4	9	15	1q24.2	ADCY10, SAC, HCA2		Adenylyl cyclase 10, soluble	605205			{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)	
1.1294	11	30	00	1q24	DFNM1		Deafness, nonsyndromic, modifier 1	605429			{Deafness, nonsyndromic, modifier 1} (2)	
1.1295	3	9	00	1q25.1	GPR52		G protein-coupled receptor 52	604106				
1.1296	8	31	17	1q24.2	MPZL1, PZR		Myelin protein zero-like 1	604376				
1.1297	09	12	19	1q24.2	NME7, MN23H7		NME/NM23 family, member 7	613465				
1.1298	7	28	11	1q24.2	PRRX1, PMX1, PHOX1, AGOTC		Paired-related homeobox gene 1	167420			Agnathia-otocephaly complex, 202650 (3)	1(Pmx)
1.1299	5	26	13	1q24.2	RCSD1, CAPZIP		RCSD domain-containing protein 1	610579				
1.1300	3	2	98	1q25.1	TNR		Tenascin R (restrictin, janusin)	601995				4(Tnr)
1.1301	09	27	18	1q25.2	TOR1AIP1, LAP1, LAP1B, LGMD2Y		Torsin A-interacting protein 1	614512		mutation identified in 1 MRRSDC family	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures, 617072 (3)	
1.1302	3	29	12	1q25.2	TOR1AIP2, LULL1		Torsin A-interacting protein 2	614513				
1.1303	9	19	13	1q25.2	QSOX1		Quiescin Q6 sulfhydryl oxidase 1	603120				
1.1304	03	09	20	1q25.2	ABL2, ABLL, ARG		ABL protooncogene 2, nonreceptor tyrosine kinase	164690		fused with ETV6 in AML		1(Abll)
1.1305	8	10	05	1q25.3-q31.1	HMCN1, FBLN6, FIBL6, ARMD1		Hemicentin (fibulin 6)	608548			{Macular degeneration, age-related, 1}, 603075 (3)	
1.1306	1	23	01	1q31.1	PRG4, CACP, MSF, SZP, HAPO		Proteoglycan 4 (megakaryocyte stimulating factor; hemangiopoietin)	604283			Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	1(Prg4)
1.1307	8	28	01	1q25.1	SIP		SIAH1-interacting protein	606186				
1.1308	5	12	09	1q24.1	TADA1L, STAF42		Transcriptional adaptor 1-like	612763				
1.1309	5	13	02	1q24.3	VAMP24		Vesicle-associated membrane protein 4	606909				
1.1310	9	27	17	1q24.1	GPA33		Glycoprotein A33	602171				
1.1311	8	10	18	1q24.1	ILDR2		Immunoglobulin-like domain-containing receptor 2	618081				1(Ldlr2)
1.1312	5	6	13	1q24.1	LRRC52		Leucine-rich repeat-containing protein 52	615218				
1.1313	9	10	09	1q24.1	MAEL		Maelstrom, Drosophila, homolog of	611368				
1.1314	1	29	08	1q25.1-q25.2	RFWD2, COP1		Ring finger- and WD repeat domain-containing protein 2	608067		pseudogenes on chr. 3, 9, 18		
1.1315	6	3	14	1q24.1	TMCO1, CFSMR		Transmembrane and coiled-coil domains protein 1	614123			Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3)	
1.1316	7	19	18	1q24.2	CREG1		Cellular repressor of E1A-stimulated genes 1	618055				
1.1317	3	27	12	1q24.2	DCAF6, IQWD1, NRIP		DDB1 and CUL4 associated factor 6	610494				
1.1318	4	15	11	1q24.2	GORAB, SCYL1BP1, NTKLBP1, GO		Golgin, RAB6-interacting	607983			Geroderma osteodysplasticum, 231070 (3)	
1.1319	9	24	08	1q24.2	GPR161		G protein-coupled receptor 161	612250				
1.1320	7	17	09	1q24.2	KIFAP3, SMAP		Kinesin-associated protein 3	601836				
1.1321	6	4	13	1q24.2	METTL18, C1orf156		Methyltransferase-like 18	615255				
1.1322	10	25	19	1q24.2	MPC2, BRP44		Mitochondrial pyruvate carrier 2	614737				
1.1323	4	6	15	1q24.2	SCYL3, PACE1		SCY1-like 3, S. cerevisiae, homolog of	608192				
1.1324	1	17	08	1q25.2	C1orf76, NDSP		Neuroblastoma-derived secretory protein	611727				
1.1325	7	18	12	1q24.3	DNM3, KIAA0820		Dynamin 3	611445				
1.1326	10	10	18	1q24.3	EEF1AKNMT, METTL13, FEAT, KIAA0859, DFNB26M		EEF1A lysine and N-terminal methyltransferase	617987		mutation identified in 1 family	?{Deafness, autosomal recessive 26, modifier of}, 605429 (3)	
1.1327	3	23	09	1q24.3	MIR199A2, MIRN199A2		Micro RNA 199A2	610720				
1.1328	3	23	09	1q24.3	MIR214, MIRN214		Micro RNA 214	610721				
1.1329	7	18	11	1q24.3	MIR3120		Micro RNA 3120	614722		in intron 13 of DNM3 in sense orientation		
1.1330	3	18	17	1q24.3	PRRC2C, KIAA1096		Proline-rich coiled-coil protein 3C	617373				
1.1331	10	24	12	1q24.3	MYOC, TIGR, GLC1A, JOAG, GPOA		Myocilin (trabecular meshwork-induced glucocorticoid response protein)	601652			Glaucoma 1A, primary open angle, 137750 (3)	1(Tigr)
1.1332	8	30	07	1q25	AD14		Alzheimer disease 14	611154		max lod at D1S218	{Alzheimer disease-14} (2)	
1.1333	7	13	09	1q25.2	ASTN1, ASTN		Astrotactin 1	600904				1(Astn)
1.1334	4	6	18	1q25.3	TRMT1L, C1orf25, TRM1L		tRNA methyltransferase 1-like	611673				
1.1335	07	13	20	1q25.3	DHX9, DDX9, NDHII		DExH-box helicase 9	603115				1(Ddx9)
1.1336	8	21	07	1q25.2	FAM20B		Family with sequence similarity 20, member B	611063				
1.1337	10	2	09	1q25.2	LHX4, CPHD4		LIM homeo box gene 4	602146		fused to IGH in ALL	Pituitary hormone deficiency, combined, 4, 262700 (3)	
1.1338	11	16	20	1q25.3	NCF2		Neutrophil cytosolic factor-2, 65kD	608515			Chronic granulomatous disease 2, autosomal recessive, 233710 (3)	1(Ncf2)
1.1339	9	7	07	1q25.3	NPL, C1orf13, C112		N-acetylneuraminate pyruvate lyase	611412				
1.1340	5	3	07	1q25	PDON2		Periodontitis, aggressive, 2	608526		between D1S196 and D1S533	Periodontitis, aggressive, 2 (2)	
1.1341	03	29	19	1q31.1	PLA2G4A, PLA2G4, GURDP		Phospholipase A2, group IVA, cytosolic	600522			Gastrointestinal ulceration, recurrent, with dysfunctional platelets, 618372 (3)	
1.1342	8	20	07	1q25.3	RGSL1		Regulator of G protein signaling-like 1	611012				
1.1343	8	2	07	1q25	RGSL2		Regulator of G protein signaling-like 2	611013		related to AD linked to 1q25		
1.1344	1	24	02	1q25.3	RNASEL, RNS4, PRCA1, HPC1		Ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)	180435			Prostate cancer 1, 601518 (3)	
1.1345	07	16	20	1q25.3	SMG7, EST1C, KIAA0250		SMG7 nonsense-mediated mRNA decay factor	610964				
1.1346	3	12	96	1q25.2	SOAT1, STAT, ACAT		Sterol O-acyltransferase 1 (acyl-Coenzyme A: cholesterol acyltransferase 1)	102642				
1.1347	4	18	05	1q25.1	TNFSF4, GP34, OX4OL		Tumor necrosis factor ligand superfamily, member 4	603594			{Myocardial infarction, susceptibility to}, 608446 (3)	1(Tnfsf4)
1.1348	1	1	95	1q31.1	TPR		Tumor potentiating region (translocated promoter region)	189940		fused with MET in chemically induced tumor		
1.1349	08	21	19	1q25.3	TSEN15, SEN15, C1orf19, PCH2F		tRNA splicing endonuclease, subunit 15	608756			Pontocerebellar hypoplasia, type 2F, 617026 (3)	
1.1350	3	8	91	1q22	BGLAP		Bone gamma-carboxyglutamic acid protein	112260				3(Bglap)
1.1351	12	01	20	1q25.3	CACNA1E, CACNL1A6, DEE69		Calcium channel, voltage-dependent, alpha 1E subunit	601013			Developmental and epileptic encephalopathy 69, 618285 (3)	
1.1352	08	21	19	1q31.2	CDC73, HRPT2, C1orf28		Cell division cycle 73	607393			Hyperparathyroidism-jaw tumor syndrome, 145001 (3); Hyperparathyroidism, familial primary, 145000 (3); Parathyroid adenoma with cystic changes, 145001 (3); Parathyroid carcinoma, 608266 (3)	
1.1353	2	21	02	1q25.3	LAMC2, LAMNB2, LAMB2T		Laminin, gamma-2 (nicein, 100kD; kalinin, 105kD; BM600, 100kD)	150292			Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	
1.1354	10	25	10	1q25.2	PDCN, NPHS2, SRN1		Podocin	604766		modifies phenotype of NPHS1 mutations to FSGS	Nephrotic syndrome, type 2, 600995 (3)	
1.1355	6	19	98	1q25.3	RGS16		Regulator of G protein signaling-16	602514				
1.1356	3	31	03	1q25.2	TOR3A, ADIR		Torsin family 3, member A (ATP-dependent interferon-responsive protein)	607555				
1.1357	12	16	93	1q31.1	PDC		Phosducin, pineal gland	171490				1(Pdc)
1.1358	7	10	92	1q32.1	ATP2B4, ATP2B2, PMCA4		ATPase, Ca++ transporting, plasma membrane, 4	108732				
1.1359	12	19	19	1q25.1	ANKRD45		Ankyrin repeat domain-containing protein 45	618712				
1.1360	10	8	07	1q25.1	CENPL		Centromeric protein L	611503				
1.1361	6	14	07	1q25.1	DARS2, ASPRS. LBSL		Aspartyl-tRNA synthetase 2	610956			Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3)	
1.1362	12	17	15	1q25.1	KIAA0040		KIAA0040 gene	616696				
1.1363	9	21	17	1q25.1	KLHL20, KLEIP, KLHLX		Kelch-like 20	617679				
1.1364	7	17	09	1q25.1	PRDX6		Peroxiredoxin 6	602316				
1.1365	10	23	20	1q25.1	RC3H1, KIAA2025, IMDSHY		Roquin	609424		mutation identified in 1 IMDSHY patient	?Immune dysregulation and systemic hyperinflammation syndrome, 618998 (3)	
1.1366	5	3	17	1q25.1	TNN		Tenascin N	617472				
1.1367	6	9	15	1q25.3	XPR1, SYG1, IBGC6		Xenotropic and polytropic retrovirus receptor	605237			Basal ganglia calcification, idiopathic, 6, 616413 (3)	1(Xpr1)
1.1368	2	20	98	1q32.1	LAD1		Ladinin	602314				1(Lad1)
1.1369	11	27	18	1q25.2	ANGPTL1		Angiopoietin-like 1	603874				
1.1370	2	15	18	1q25.2	CEP350, CAP350, KIAA0480		Centrosomal protein 350	617870				
1.1371	12	22	17	1q25.2	RALGPS2, FLJ10244		RAL guanine nucleotide exchange factor with PH domain and SH3 domain-binding motif 2	617819				
1.1372	8	3	12	1q25.2	RASAL2, NGAP		Ras protein activator-like 2	606136				
1.1373	10	07	19	1q25.2	SEC16B, LZTR2, RGPR, SEC16S		SEC16 homolog B, endoplasmic reticulum export factor	612855				
1.1374	10	31	17	1q25.2	TDRD5, TUDOR3		Tudor domain-containing protein 5	617748				
1.1375	5	13	15	1q25.2-q25.3	ACBD6		Acyl-CoA-binding domain-containing protein 6	616352				
1.1376	12	27	13	1q25.2-q25.3	LINC-COX2		Long intergenic noncoding RNA COX2	615492				
1.1377	1	1	95	1q31.1	PTGS2		Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)	600262				
1.1378	1	16	07	1q25.3	APOBEC4		Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 4	609908				
1.1379	11	11	14	1q25.3	ARPC5, ARC16		Actin-related protein 2/3 complex, subunit 5	604227				
1.1380	11	21	18	1q25.3	COLGALT2, GLT25D2, KIAA0584		Collagen beta(1-0)galactosyltransferase 2	617533				
1.1381	11	05	18	1q25.3	EDEM3, C1orf22		Endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 3	610214				
1.1382	7	17	09	1q25.3	IER5		Immediate-early response gene 5	607177				
1.1383	07	31	20	1q25.3	IVNS1ABP, NS1BP, ND1, IMD70		Influenza virus NS1A protein-binding protein	609209			Immunodeficiency 70, 618969 (3)	
1.1384	8	17	98	1q25.3	MR1, HLALS		Major histocompatibility complex, class I-related	600764				
1.1385	9	11	12	1q25.3	NMNAT2, PNAT2, KIAA0479		Nicotinamide nucleotide adenylyltransferase 2	608701				
1.1386	7	27	09	1q25.3	RGL1, RGL		Ral guanine nucleotide dissociation stimulator-like 1	605667				
1.1387	11	2	04	1q25.3	RNF2, RING2, RING1B, HIPI3, DING, BAP1		RING finger protein 2	608985				
1.1388	8	1	16	1q25.3	STX6		Syntaxin 6	603944				
1.1389	4	19	06	1q25.3	VDAC4		Voltage-dependent anion channel 4	610030				
1.1390	7	31	08	1q31.3	ASPM, MCPH5		Abnormal spindle-like, microcephaly-associated	605481			Microcephaly 5, primary, autosomal recessive, 608716 (3)	
1.1391	5	23	00	1q31.2	B3GALT2, GLCT2		UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 2	603018				
1.1392	12	13	00	1q31	BOS2		Branchiootic syndrome 2	120502			Branchiootic syndrome 2 (2)	
1.1393	5	12	09	1q31	CELIAC7		Celiac disease, susceptibility to, 7	612005		associated with rs2816316	{Celiac disease, susceptibility to, 7} (2)	
1.1394	1	24	93	1q32.1	CTSE		Cathepsin E	116890		closely linked to REN		
1.1395	3	29	06	1q25.3	GLUL, GLNS		Glutamate-ammonia ligase (glutamine synthase)	138290		pseudogene on chr.9	Glutamine deficiency, congenital, 610015 (3)	
1.1396	3	30	18	1q32.1	KIF14, KIAA0042, MKS12, MCPH20		Kinesin family member 14	611279		mutation identified in 1 MKS12 family	?Meckel syndrome 12, 616258 (3); Microcephaly 20, primary, autosomal recessive, 617914 (3)	1(Kif14)
1.1397	10	29	96	1q31.2	RGS2, G0S8		G0 to G1 switch regulatory 8, 24kD	600861				
1.1398	10	15	09	1q25.3	LAMC1, LAMB2		Laminin, gamma-1 (formerly LAMB2)	150290		at least 3 genes, ?linked		1(Lamb2)
1.1399	3	21	07	1q32.3	LQK1		LQK1 protein	610864				
1.1400	1	24	03	1q31	MGR6, FHM3		Migraine, several forms	607516			{Migraine with or without aura, susceptibility to, 6} (2); {Migraine, familial hemiplegic, 4} (2)	
1.1401	2	6	08	1q32.1	NAV1, POMFIL3, KIAA1151		Neuron navigator 1	611628				
1.1402	8	17	98	1q32.1	PFKFB2		Fructose-2,6-bisphosphatase, cardiac isozyme	171835				
1.1403	6	27	02	1q32.1	PHLDA3, TIH1		Pleckstrin homology-like domain, family A, member 3	607054				1(Phlda3)
1.1404	10	15	09	1q31	PVOP1		Pelvic organ prolapse, susceptibility to, 1	176780		associated with rs10911193	{Pelvic organ prolapse, susceptibility to, 1} (2)	
1.1405	6	11	97	1q31.2	RGS1, IER1, IR20		Regulator of G-protein signaling 1	600323				
1.1406	6	23	15	1q32.1	UBE2T, HSPC150, FANCT		Ubiquitin-conjugating enzyme E2T	610538			Fanconi anemia, complementation group T, 616435 (3)	
1.1407	3	8	07	1q31.2	TROVE2, RO60, SSA2		TROVE domain family, member 2	600063				
1.1408	4	17	13	1q32.1	CDK18, PCTK3		Cyclin-dependent kinase 18	169190				
1.1409	7	27	11	1q32.1	CHIT, CHITD		Chitotriosidase	600031			[Chitotriosidase deficiency], 614122 (3)	
1.1410	1	1	12	1q32.1	IL10, CSIF, GVHDS		Interleukin-10	124092			{HIV-1, susceptibility to}, 609423 (3); {Graft-versus-host disease, protection against}, 614395 (3); {Rheumatoid arthritis, progression of}, 180300 (3)	
1.1411	7	17	09	1q32.1	KIF21B, KIAA0449		Kinesin family member 21B	608322				1(Kif21b)
1.1412	6	26	01	1q31.3	LHX9		LIM homeo box gene 9	606066				1(Lhx9)
1.1413	7	22	09	1q31.3-q32.1	PTPRC, CD45, LCA		Protein tyrosine phosphatase, receptor type, c polypeptide	151460			{Hepatitis C virus, susceptibility to}, 609532 (3); Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)	1(Ly5)
1.1414	3	8	07	1q32.1	SLC41A1		Solute carrier family 41, member 1	610801				1(Slc41a1)
1.1415	7	22	09	1q31.3	CFHR1, FHR1, HFL1, CFHL1		Complement factor H-related 1	134371			{Macular degeneration, age-related, reduced risk of}, 603075 (3); {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	
1.1416	7	22	09	1q31.3	CFHR2, FHR2, HFL3, CFHL2		Complement factor H-related 2	600889		in same 165kb YAC as F13B		
1.1417	7	22	09	1q31.3	CFHR3, FHR3, HLF4, CFHL3		Complement factor H-related 3	605336			{Macular degeneration, age-related, reduced risk of}, 603075 (3); {Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	
1.1418	7	22	09	1q31.3	CFHR4, FHR4, CFHL4		Complement factor H-related 4	605337				
1.1419	07	26	19	1q31.3	CRB1, RP12, LCA8		Crumbs cell polarity complex component 1	604210			Retinitis pigmentosa-12, 600105 (3); Leber congenital amaurosis 8, 613835 (3); Pigmented paravenous chorioretinal atrophy, 172870 (3)	
1.1420	3	21	93	1q31.3	F13B		Coagulation factor XIII, B polypeptide	134580			Factor XIIIB deficiency, 613235 (3)	1(F13b)
1.1421	12	3	90	1q32.1	MYOG, MYF4		Myogenic factor-4; myogenin	159980				1(Myog)
1.1422	6	4	97	1q31-q42	PHA2A, PHA2		Pseudohypoaldosteronism type IIA	145260			Pseudohypoaldosteronism, type IIA (2)	
1.1423	7	14	11	1q32.1	PIGR		Polymeric immunoglobulin receptor	173880				
1.1424	1	20	11	1q42.13	PSEN2, AD4, STM2, CMD1V		Presenilin 2	600759			Alzheimer disease-4, 606889 (3); Cardiomyopathy, dilated, 1V, 613697 (3)	
1.1425	04	15	19	1q31.1	BRINP3, FAM5C		Bone morphogenetic protein/retionoic acid-inducible neural-specific protein 3	618390				
1.1426	01	04	19	1q31.1	ODR4, C1orf27		Odorant response abnormal 4, C. elegans, homolog of	609335				
1.1427	8	31	17	1q31.1	PACERR, PTGS2AS1		PTGS2 antisense NFKB1 complex-mediated expression regulator RNA, noncoding	617650				
1.1428	12	30	05	1q31.1	PSNP2		Supranuclear palsy, progressive, 2	609454		between D1S238 and D1S2823	Supranuclear palsy, progressive, 2 (2)	
1.1429	12	18	08	1q31.2	RGS21		Regulator of G protein signaling 21	612407				1(Rgs1)
1.1430	7	25	18	1q31.3	ATP6V1G3		ATPase, H+ transporting, V1 subunit G3	618071				
1.1431	4	4	02	1q31.2	GLRX2, GRX2		Glutaredoxin 2	606820				
1.1432	3	15	10	1q31.3	DENND1B, FAM31B, C1orf18		DENN/MADD domain-containing 1B	613292				
1.1433	12	21	10	1q32.3	FLVCR1, AXPC1, PCARP		Feline leukemia virus subgroup C receptor 1	609144			Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)	
1.1434	11	05	20	1q31.3	KCNT2, SLICK, DEE57		Potassium channel, subfamily T, member 2	610044		mutation identified in 1 DEE57 patient	?Developmental and epileptic encephalopathy 57, 617771 (3)	
1.1435	5	11	09	1q32.1	MIR181A1, MIR213, MIRN181A1		Micro RNA 181A1	612742				
1.1436	5	11	09	1q32.1	MIR181B1, MIRN181B1		Micro RNA 181B1	612744				
1.1437	4	15	02	1q31.3	NEK7		Never-in-mitosis gene A-related kinase 7	606848				
1.1438	7	5	90	1q32.1	TNNI1		Troponin-I, skeletal, slow	191042				1(Tnni1)
1.1439	4	16	14	1q31.3-q32.1	NYS7		Nystagmus 7, congenital, autosomal dominant	614826		between D1S218 and D1S2655	Nystagmus 7, congenital, autosomal dominant (2)	
1.1440	8	17	98	1q32.1	AVPR1B, AVPR3		Arginine vasopressin receptor-1B	600264				
1.1441	5	9	97	1q32.1	BTG2, PC3		B-cell translocation gene 2 (pheochromocytoma cell-3)	601597				
1.1442	7	9	90	1q32.2	C4BPA		Complement component 4-binding protein, alpha polypeptide	120830		same RE fragment as C4BPB		1(C4bp)
1.1443	7	9	90	1q32.1	C4BPB		Complement component 4-binding protein, beta polypeptide	120831				
1.1444	03	31	20	1q32.1	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1, MHS5		Calcium channel, voltage-dependent, L type, alpha 1S subunit	114208			Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant hyperthermia susceptibility 5}, 601887 (3); {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3); {Malignant hyperthermia, susceptibility to, 5}, 601887 (3)	1(Cchl1a3, mdg)
1.1445	3	11	92	1q32.2	CD34		CD34 antigen	142230				1(Cd34)
1.1446	8	11	17	1q32.2	CD55, DAF, CROM, CHAPLE		CD55 antigen (blood group Cromer)	125240			[Blood group Cromer], 613793 (3); Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy, 226300 (3)	
1.1447	6	6	16	1q31.3	CFH, HF1, HUS, ARMD4, AHUS1		Complement factor H	134370			{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3); Complement factor H deficiency, 609814 (3); {Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3)	1(Cfh)
1.1448	12	21	12	1q31.3	CFHR5, CFHL5, FHR5, CFHR5D		Complement factor H-related 5	608593			Nephropathy due to CFHR5 deficiency, 614809 (3)	
1.1449	03	09	20	1q32.2	CR1, C3BR		Complement component (3b/4b) receptor-1	120620			[Blood group, Knops system], 607486 (3); {Malaria, severe, resistance to}, 611162 (3)	
1.1450	4	30	01	1q32.2	CR1L		Complement component receptor 1-like	605886				
1.1451	7	6	12	1q32.2	CR2, C3DR, SLEB9, CVID7		Complement component (3d/Epstein-Barr virus) receptor-2	120650			{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3); Immunodeficiency, common variable, 7, 614699 (3)	1(Cr2)
1.1452	5	12	99	1q32.1	CSRP1, CSRP		Cysteine and glycine-rich protein-1	123876				3(Csrp)
1.1453	3	20	09	1q32.1	CYB5BR1, NQO3A2, B5R.1		Cytochrome b5 reductase 1	608341				
1.1454	11	13	98	1q32.1	ELF3, ESX		E74-like factor 3 (ETS domain transcription factor, serine box, epithelial-specific)	602191				
1.1455	1	1	95	1q32.1	ELK4, SAP1		ELK4, ETS-domain protein (SRF accessory protein 1)	600246				1(Elk4)
1.1456	7	18	12	1q32.1	FAM72A, LMPIP, UGENE		Family with sequence similarity 72, member A	614710				
1.1457	9	8	11	1q32	GFND1		Glomerulopathy with fibronectin deposits 1	137950		max lod at D1S2782	Glomerulopathy with fibronectin deposits 1 (2)	
1.1458	12	03	20	1q32.2	HHAT, MART2, SKI1, NNMS		Hedgehog acyltransferase	605743			Nivelon-Nivelon-Mabille syndrome, 600092 (3)	
1.1459	2	28	01	1q32.1	IL19		Interleukin 19	605687				
1.1460	2	7	01	1q32.1	IL20		Interleukin 20	605619				1(Il20)
1.1461	6	27	01	1q32.1	IL24, ST16, MDA7		Interleukin 24 (suppression of tumorigenicity 16)	604136				
1.1462	09	24	20	1q32.2	MIR29B2		Micro RNA 29B2	619035				
1.1463	09	11	18	1q32.1	KDM5B, JARID1B, PUT1, PLU1, RBBP2H1A, MRT65		Lysine-specific demethylase 5B	605393			Mental retardation, autosomal recessive 65, 618109 (3)	
1.1464	10	23	14	1q32.1	KISS1, HH13		KISS1 metastasis suppressor	603286		mutation identified in 1 HH13 family	?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3)	
1.1465	2	12	15	1q32.2	LAMB3, AI1A		Laminin, beta-3 (nicein, 125kD; kalinin, 140kD; BM600, 125kD)	150310			Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Amelogenesis imperfecta, type IA, 104530 (3)	
1.1466	2	4	02	1q32.1	LGR6		Leucine-rich repeat-containing G protein-coupled receptor-6	606653				
1.1467	11	11	14	1q32.1	LMOD1, SMLMOD, 1D		Leiomodin 1	602715				
1.1468	8	17	09	1q32.2	MCP, CD46, AHUS2		Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen)	120920			{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3)	
1.1469	04	22	20	1q32.1	MDM4, BMFS6		MDM4 regulator of p53	602704		mutation identified in 1 BMFS6 family	?Bone marrow failure syndrome 6, 618849 (3)	1(Mdm4)
1.1470	5	29	12	1q32.1	NUAK2, SNARK		NUAK family, SNF1-like kinase, 2	608131				
1.1471	2	2	10	1q32	PARK16		Parkinson disease 16	613164		associated with rs823128	{Parkinson disease 16} (2)	
1.1472	3	25	15	1q32	PFHB2		Progressive familial heart block, type II	140400		between D1S70 and D1S505	Progressive familial heart block, type II (2)	
1.1473	7	14	98	1q32.1	PIK3C2B		Phosphatidylinositol 3-kinase, class 2, beta polypeptide	602838				
1.1474	02	14	20	1q32.1	PKP1, EDSFS		Plakophilin-1	601975			Ectodermal dysplasia/skin fragility syndrome, 604536 (3)	
1.1475	10	15	97	1q32.1	PRELP		Proline arginine-rich end leucine-rich repeat protein	601914				
1.1476	01	04	19	1q32-q41	PTPN14, PEZ, CATLPH		Protein tyrosine phosphatase, nonreceptor-type, 14	603155			Choanal atresia and lymphedema, 613611 (3)	
1.1477	3	9	00	1q32.1	RAB7L1		RAB7-like 1	603949				
1.1478	12	18	95	1q32.1	RBBP5, RBQ3		Retinoblastoma-binding protein-5	600697				
1.1479	11	3	09	1q32.1	REN, HNFJ2		Renin	179820		~24cM distal to AT3	[Hyperproreninemia] (3); Renal tubular dysgenesis, 267430 (3); Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)	1(Ren1)
1.1480	2	14	13	1q32.1	SNRPE, HYPT11		Small nuclear ribonucleoprotein polypeptide E	128260			Hypotrichosis 11, 615059 (3)	
1.1481	5	4	00	1q32.1	SOX13, ICA12		SRY-box 13	604748				
1.1482	04	27	20	1q32.1	TIMM17A, TIM17A		Translocase of inner mitochondrial membrane 17A	605057				
1.1483	7	26	10	1q32.1	TNNT2, CMH2, CMD1D, RCM3, LVNC6		Troponin-T2, cardiac	191045			Cardiomyopathy, hypertrophic, 2, 115195 (3); Cardiomyopathy, dilated, 1D, 601494 (3); Cardiomyopathy, familial restrictive, 3, 612422 (3); Left ventricular noncompaction 6, 601494 (3)	
1.1484	2	18	98	1q32.3	TRAF5		TNF receptor-associated factor 5	602356				1(Traf5)
1.1485	12	21	06	1q31.2	UCHL5, UCH37		Ubiquitin carboxyl-terminal hydrolase L5	610667				
1.1486	1	9	13	1q32.2	CAMK1G, CLICK3		Calcium/calmodulin-dependent protein kinase IG	614994				
1.1487	3	15	16	1q41	CENPF, CILD31, STROMS		Centromere autoantigen F, 400kD	600236			Stromme syndrome, 243605 (3)	1(Cenpf)
1.1488	1	30	12	1q32.2	G0S2		G0/G1 switch gene 2	614447				
1.1489	5	29	12	1q32.2	HSD11B1, HSD11, HSD11L, CORTRD2		Hydroxysteroid, 11-beta, dehydrogenase 1	600713		digenic triallelic mutations with H6PD	Cortisone reductase deficiency 2, 614662 (3)	
1.1490	12	21	12	1q32.2	IRF6, VWS, LPS, PIT, PPS1, OFC6		Interferon regulatory factor 6	607199		OFC6 in enhancer 5' of IRF6	van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome 1, 119500 (3); {Orofacial cleft 6}, 608864 (3)	
1.1491	7	9	15	1q32.2	KCNH1, EAG, TMBTS, ZLS1		Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of)	603305			Temple-Baraitser syndrome, 611816 (3); Zimmermann-Laband syndrome 1, 135500 (3)	
1.1492	1	20	99	1q32.1	RABIF, RASGFR3, MSS4		Rab-interacting factor (Ras-specific guanine-releasing factor-3; mammalian suppressor of SEC4)	603417				
1.1493	4	25	12	1q32.1	ADIPOR1, CGI45		Adiponectin receptor 1	607945				1(Adipor1)
1.1494	5	18	95	1q32.1	ADORA1, RDC7		Adenosine A1 receptor	102775				
1.1495	12	03	20	1q32.1	ARL8A, GIE2		ADP ribosylation factor-like GTPase 8A	616597				
1.1496	11	1	13	1q32.1	BLACAT1, LINC00912		Bladder cancer-associated transcript 1, noncoding	615480				
1.1497	08	26	19	1q32.1	BMNCR		Bone marrow associated noncoding RNA	618553				
1.1498	07	31	20	1q32.1	RHEX, C1orf186, RHEX		Regulator of hemoglobinization and erythroid cell expansion	616088				
1.1499	3	24	11	1q32.1	CAMSAP1L, CAMSAP2, KIAA1078		Calmodulin-regulated spectrin-associated protein 1-like 1	613775				
1.1500	4	23	08	1q32.1	CHI3L1, GP39, YKL40, ASRT7		Chitinase 3-like 1 (cartilage glycoprotein-39)	601525			{Schizophrenia, susceptibility to}, 181500 (3); {Asthma-related traits, susceptibility to, 7}, 611960 (3)	
1.1501	9	9	13	1q32.1	CNTN2, TAX, TAX1, FAME5		Contactin 2 (transiently-expressed axonal glycoprotein)	190197		1 family identified with mutation	?Epilepsy, myoclonic, familial adult, 5, 615400 (3)	
1.1502	07	13	20	1q32.1	DDX59, OFD5		DEAD-box helicase 59	615464			Orofaciodigital syndrome V, 174300 (3)	
1.1503	1	27	18	1q32.1	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23		Dual serine/threonine and tyrosine protein kinase	612666			Congenital anomalies of kidney and urinary tract 1, 610805 (3); Spastic paraplegia 23, 270750 (3)	
1.1504	1	24	10	1q32.1	EIF2D, HCA56		Eukaryotic translation initiation factor 2D	613709				1(Eif2d)
1.1505	3	20	06	1q32.1	ETNK2, EKI2		Ethanolamine kinase 2	609859				1(Etnk2)
1.1506	1	1	95	1q32.1	FMOD		Fibromodulin	600245				
1.1507	2	20	98	1q32.1	GPR25		G protein-coupled receptor-25	602174				
1.1508	8	15	17	1q32.1	GPR37L1, ETBRLP2		G protein-coupled receptor 37-like 1	617630				
1.1509	2	12	09	1q32.1	IBD23		Inflammatory bowel disease 23	612381		associated with rs3024505	{Inflammatory bowel disease 23} (2)	
1.1510	1	26	17	1q32.1	IGFN1, EEF1A2BP1		Immunoglobulin-like and fibronectin type III domains-containing protein 1	617309				
1.1511	06	23	20	1q32.1	IKBKE		Inhibitor of nuclear factor kappa-B kinase, subunit epsilon	605048				
1.1512	08	07	18	1q32.1	INAVA, C1orf106, IBD29		Innate immunity activator	618051			{Inflammatory bowel disease 29}, 618077 (3)	
1.1513	3	29	12	1q32.1	KLHDC8A		Kelch domain-containing protein 8A	614503				
1.1514	3	30	12	1q32.1	KLHL12, DKIR		Kelch-like 12	614522				
1.1515	2	25	15	1q32.1	LEMD1		LEM domain-containing protein 1	610480				
1.1516	09	06	18	1q32.1	LRRN2, GAC1, LRANK1		Leucine-rich repeat protein, neuronal, 2	605492				
1.1517	12	10	13	1q32.1	MAPKAPK2, MK2		Mitogen-activated protein kinase-activated protein kinase 2	602006				
1.1518	7	22	16	1q32.1	MIR1231		Micro RNA 1231	617040				
1.1519	11	4	93	1q32.1	MYBPH		Myosin-binding protein H	160795				
1.1520	03	19	19	1q32.1	NFASC, KIAA0756, NEDCPMD		Neurofascin	609145			Neurodevelopmental disorder with central and peripheral motor dysfunction, 618356 (3)	
1.1521	1	28	00	1q32.1	NR5A2, FTF, HB1F		Nuclear receptor subfamily 5, group A, member 2 (fetoprotein transcription factor)	604453				
1.1522	3	20	08	1q32.1	NUCKS1, NUCKS		Nuclear casein kinase and cyclin-dependent kinase substrate 1	611912				1(Nucks1)
1.1523	7	27	09	1q32.1	PEPP3, KIAA0969		Phosphatidylinositol 3-phosphate-binding PH domain protein 3	607771				
1.1524	9	22	16	1q32.1	PM20D1		Peptidase M20 domain-containing protein 1	617124				
1.1525	8	20	01	1q32.1	PPP1R12B, MYPT2		Protein phosphatase 1, regulatory subunit 12B (myosin phosphatase target subunit 2)	603768				
1.1526	2	16	16	1q32.1	PPP1R15B, CREP, MSSGM2		Protein phosphatase 1, regulatory subunit 15B	613257			Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3)	
1.1527	8	16	12	1q32.1	PPFIA4		Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha 4	603145				
1.1528	11	27	94	1q32.1	PTPN7		Protein tyrosine phosphatase, nonreceptor-type, 7	176889				
1.1529	1	17	06	1q32.1	SLC45A3, PRST, PCANAP6, IPCA6		Solute carrier family 45, member 3 (prostein)	605097				
1.1530	4	30	15	1q32.1	SYT2, CMS7, MYSPC		Synaptotagmin-2	600104			Myasthenic syndrome, congenital, 7, presynaptic, 616040 (3)	1(Syt2)
1.1531	4	2	03	1q32.1	RASSF5, NORE1		Ras association (RalGDS/AF-6) domain family 5 (Nore1, mouse, homolog of)	607020				1(Nore1)
1.1532	2	2	17	1q32.1	SHISA4, C1orf40, TMEM58		Shisa family, member 4	617326				
1.1533	8	8	13	1q32.1	SLC26A9		Solute carrier family 26 (sulfate transporter), member 9	608481				
1.1534	3	14	07	1q32.1	SRGAP2, KIAA0456		Slit-robo GTPase-activating protein, rho, 2	606524				
1.1535	12	02	20	1q32.1	YOD1, OTUD2, DUBA8		YOD1 deubiquitinase	612023				
1.1536	12	15	10	1q32.1	ZBED6		Zinc finger BED domain-containing protein 6	613512		in intron 1 of ZC3H11A		
1.1537	12	15	10	1q32.1	ZC3H11A, KIAA0663		Zinc finger CCCH domain-containing protein 11A	613513				
1.1538	12	19	19	1q32.1	ZNF281, ZBP99, GZP1		Zinc finger ptoein 281	618703				
1.1539	10	07	20	1q32.3	DTL, RAMP, DCAF2, CDT2		Denticleless E3 ubiquitin protein ligase homolog	610617				
1.1540	6	10	98	1q32.1	RNPEP		Arginyl aminopeptidase (aminopeptidase B)	602675				
1.1541	10	23	87	1q42.13	GUK1		Guanylate kinase-1	139270				
1.1542	10	23	87	1q32.1-q42	GUK2		Guanylate kinase-2	139280		genetic independence of GUK1 and GUK2 unproved		
1.1543	2	3	05	1q32.1	DYRK3		Dual-specificity tyrosine phosphorylation-regulated kinase 3	603497				1(Dyrk3)
1.1544	9	7	10	1q32.1	FAIM3, TOSO, FCMR		Fas apoptotic inhibitory molecule 3	606015				
1.1545	3	23	09	1q32.2	MIR29C, MIRN29C		Micro RNA 29C	610784				
1.1546	12	21	09	1q32.2	MIR205, MIRN205		Micro RNA 205	613147				
1.1547	7	27	09	1q32.2	PLXNA2, OCT, PLXN2		Plexin A2 (OCT transmembrane protein)	601054				
1.1548	12	17	07	1q32.1	SARG, C1orf116		Specifically androgen-regulated gene	611680				
1.1549	7	25	18	1q32.2	SYT14, SCAR11		Synaptotagmin 14	610949		mutation identified in 1 SCAR11 family	?Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)	
1.1550	07	13	20	1q32.3	PROX1		Prospero homeo box 1	601546				(Prox1)
1.1551	12	27	13	1q32.3	NEK2, RP67		Never in mitosis gene a-related kinase 2	604043		pseudogenes on chr. 2, 14, and 22; mutation identified in 1 family	?Retinitis pigmentosa 67, 615565 (3)	
1.1552	5	25	10	1q32.3	ATF3		Activating transcription factor 3	603148				
1.1553	1	30	01	1q32.1	FCAMR		Fc fragment of IgA and IgM, receptor for	605484				1(Fcamr)
1.1554	3	24	14	1q32.3	INTS7, INT7		Integrator complex subunit 7	611350				
1.1555	3	4	08	1q32.3	NENF, CIR2		Neuron-derived neurotrophic factor	611874				
1.1556	05	14	19	1q32.3	PACC1, TMEM206		Proton-activated chloride channel 1	618427				
1.1557	08	21	19	1q32.3	RD3, LCA12, C1orf36		Retinal degeneration 3, GUCY2D regulator	180040			Leber congenital amaurosis 12, 610612 (3)	1(rd3)
1.1558	6	12	17	1q32.3	RPS6KC1, RPK118		Ribosomal protein S6 kinase C1	617517				
1.1559	2	25	08	1q32.3	SLC30A1, ZNT1		Solute carrier family 30 (zinc transporter), member 1	609521				
1.1560	2	25	15	1q32.3	VASH2		Vasohibin 2	610471				
1.1561	7	22	11	1q32.2	TRAF3IP3, T3JAM		TRAF3-interacting protein 3	608255				1(T3jam)
1.1562	10	30	08	1q41	AIDA		Axin interactor, dorsalization-associated	612375				
1.1563	7	18	14	1q41	BPNT1		3'(2'),5'-bisphosphate nucleotidase 1	604053				
1.1564	02	14	20	1q41	CAPN8		Calpain 8	618777				
1.1565	9	16	12	1q41	DUSP10, MKP5		Dual-specificity phosphatase 10	608867				
1.1566	8	24	98	1q41	ESRRG		Estrogen-related receptor, gamma	602969				
1.1567	3	26	16	1q41	GPATCH2, GPATC2		G-patch domain-containing protein 2	616836				
1.1568	5	30	03	1q42.12	H3F3A, H3F3		H3 histone, family 3A	601128				
1.1569	12	26	14	1q41	IARS2, CAGSSS		Isoleucyl-tRNA synthetase 2	612801		mutation identified in 1 CAGSSS family	?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3)	
1.1570	12	29	06	1q32.3	SMYD2		SET and MYND domain-containing protein 2	610663				
1.1571	11	16	98	1q41	KCNK2, TREK		Potassium channel, subfamily K, member 2	603219				
1.1572	3	4	10	1q41	KCTD3		Potassium channel tetramerization domain-containing protein 3	613272				
1.1573	6	1	12	1q32.3	LINC00538, YIYA		Long intergenic noncoding RNA 538	614635				
1.1574	9	21	15	1q41	LYPLAL1		Lysophospholipase-like 1	616548				
1.1575	7	17	09	1q41	MARK1, KIAA1477		MAP/microtubule affinity-regulating kinase 1	606511				
1.1576	3	23	09	1q41	MIR194-1, MIRN194-1		Micro RNA 194-1	610940				
1.1577	3	23	09	1q41	MIR215, MIRN215		Micro RNA 215	610943				
1.1578	7	27	11	1q41	MOSC1, MARC1		Molybdenum cofactor sulfurase C-terminal domain-containing protein 1	614126				
1.1579	7	27	11	1q41	MOSC2, MARC2		Molybdenum cofactor sulfurase C-terminal domain-containing protein 2	614127				
1.1580	2	2	16	1q32.3	NSL1, DC8, C1orf48		NSL1, MIS12 kinetochore complex component	609174				
1.1581	6	4	97	1q32.3	PPP2R5A		Protein phosphatase-2, regulatory subunit B (B56), alpha isoform	601643				
1.1582	9	17	11	1q41	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2		RAB3 GTPase-activating protein (noncatalytic) subunit 2	609275			Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)	
1.1583	4	26	12	1q41	RMD1		Rippling muscle disease 1	600332			Rippling muscle disease-1 (2)	
1.1584	8	19	13	1q41	RRP15		Ribosomal RNA-processing 15, S. cerevisiae, homolog of	611193				
1.1585	7	11	16	1q41	SLC30A10, ZNT10, HMNDYT1		Solute carrier family 30 (zinc transporter), member 10	611146			Hypermanganesemia with dystonia 1, 613280 (3)	
1.1586	5	23	07	1q41	SPATA17, MSRG11		Spermatogenesis-associated protein 17	611032				1(Spata17)
1.1587	7	18	14	1q41	SUSD4		Sushi domain-containing protein 4	615827				
1.1588	9	14	12	1q41	TGFB2, LDS4		Transforming growth factor, beta-2	190220			Loeys-Dietz syndrome 4, 614816 (3)	1(Tgfb2)
1.1589	12	5	13	1q41	TLR5, TIL3, SLEB1, MELIOS		Toll-like receptor-5	603031			{Legionnaire disease, susceptibility to}, 608556 (3); {Systemic lupus erythematosus, resistance to}, 601744 (3); {Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3); {Melioidosis, susceptibility to}, 615557 (3)	
1.1590	3	25	16	1q32.1	TMEM9, TMEM9A, DERM4		Transmembrane protein 9	616877				
1.1591	12	8	00	1q42.2	TSNAX, TRAX		Translin-associated factor X	602964				8(Tsnax)
1.1592	1	27	04	1q41	USH2A, RP39		Usherin	608400			Usher syndrome, type 2A, 276901 (3); Retinitis pigmentosa 39, 613809 (3)	1(Ush2a)
1.1593	12	21	09	1q41-q42	AUTS11		Autism, susceptibility to, 11	610836		associated with rs12740310, rs3737296, and rs12310279	{Autism susceptibility 11} (2)	
1.1594	9	22	08	1q41	CAPN2		Calpain, large polypeptide L2	114230				
1.1595	5	22	07	1q42.13	CDC42BPA, PK428, MRCKA		CDC42-binding protein kinase alpha	603412				
1.1596	1	31	11	1q41-q42	DEL1q41q42, C1DELq41q42		Chromosome 1q41-q42 deletion syndrome	612530		contiguous gene deletion of 1.7Mb	Chromosome 1q41-q42 deletion syndrome (4)	
1.1597	5	3	18	1q41	EPRS, PARS, HLD15		Glutamyl-prolyl-tRNA synthetase	138295			Leukodystrophy, hypomyelinating, 15, 617951 (3)	1(Eprs)
1.1598	05	20	20	1q42.13	GALNT2, CDG2T		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2	602274			Congenital disorder of glycosylation, type IIt, 618885 (3)	
1.1599	3	21	93	1q41	HLX1		H.20-like homeobox 1	142995				1(Hlx1)
1.1600	4	16	98	1q42.11	NVL		Nuclear valosin-containing protein-like	602426				
1.1601	10	16	92	1q42.12	ITPKB		Inositol 1,4,5-trisphosphate 3-kinase B	147522				
1.1602	1	7	14	1q41-q44	OTSC10		Otosclerosis 10	615589			Otosclerosis 10 (2)	
1.1603	1	29	01	1q42.13	ABCB10, MTABC2		ATP-binding cassette, subfamily B, member 10	605454		pseudogene on 15q13-q14		
1.1604	11	14	18	1q42.13	ARF1, PVNH8		ADP-ribosylation factor-1	103180			Periventricular nodular heterotopia 8, 618185 (3)	
1.1605	10	6	09	1q42	BCC2		Basal cell carcinoma, susceptibility to, 2	613058		associated with rs801114	{Basal cell carcinoma, susceptibility to, 2} (2)	
1.1606	7	17	09	1q42.2	CAPN9		Calpain 9	606401				
1.1607	03	31	20	1q41	DISP1, DISPA		Dispatched RND transporter family, member 1	607502				
1.1608	2	21	06	1q42.12	DNAH14, HL18		Dynein, axonemal, heavy chain 14	603341				
1.1609	12	16	05	1q42	EA3		Episodic ataxia, type 3	606554		max lod at D1S235	Episodic ataxia, type 3 (2)	
1.1610	1	11	16	1q42.2	GNPAT, DHAPAT, RCDP2		Glyceronephosphate O-acyltransferase	602744			Rhizomelic chondrodysplasia punctata, type 2, 222765 (3)	
1.1611	1	14	13	1q42.13	HIST3H2A		Histone gene cluster 3, H2A histone	615015				
1.1612	1	31	13	1q42.13	HIST3H2BB, H2Bb		Histone gene cluster 3, H2B histone family, member B	615046				
1.1613	3	11	03	1q42.13	HIST3H3, H3FT, H3T		Histone 3, H3	602820				
1.1614	8	8	91	1q42	HRES1		HTLV-1 related endogenous sequence	143025				
1.1615	4	10	00	1q42	MDC1B		Muscular dystrophy, congenital, 1B	604801			Muscular dystrophy, congenital, 1B (2)	
1.1616	9	7	10	1q41	MIA3, TANGO1, TANGO, KIAA0268		Melanoma inhibitory activity family, member 3	613455				
1.1617	10	14	19	1q42.2	MAP3K21, MLK4, KIAA1804		Mitogen-activated protein kinase kinase kinase 21	614793				
1.1618	11	19	13	1q42.12	PARP1, ADPRT, PPOL, PARP		Poly(ADP-ribose) polymerase 1	173870		?processed pseudogenes on chr.13 and 14		
1.1619	6	8	89	1q42	PEPC		Peptidase C	170000		1q25, 1q32 = conflicting localizations		1(Pep3)
1.1620	4	4	07	1q42.13	RHOU, WRCH1		Ras homolog gene family, member U	606366				
1.1621	7	20	01	1q42.13	RNF16		RING finger protein-16	606123				11(Rnf16)
1.1622	2	1	01	1q41	TAF1A, RAFI48, SL1		TATA box-binding protein-associated factor 1A	604903				
1.1623	5	26	13	1q42.2	TRIM67		Tripartite motif-containing protein 67	610584				
1.1624	2	17	15	1q42.13	WNT3A		Wingless-type MMTV integration site family, member 3A	606359				
1.1625	10	10	01	1q42.13	WNT14		Wingless-type MMTV integration site family, member 14	602863				
1.1626	11	08	19	1q43	ACTN2, CMD1AA, CMH23, MYOCOZ, MPD6		Actinin, alpha-2	102573			Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3); Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3); Myopathy, congenital with structured cores and Z-line abnormalities, 618654 (3); Myopathy, distal, 6, adult onset, 618655 (3)	13(Actn2)
1.1627	10	4	05	1q42.2	AGT, SERPINA8		Angiotensinogen	106150			{Hypertension, essential, susceptibility to}, 145500 (3); {Preeclampsia, susceptibility to} (3); Renal tubular dysgenesis, 267430 (3)	8(Agt)
1.1628	09	30	19	1q42.2	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH		egl-9 family hypoxia inducible factor 1	606425			Erythrocytosis, familial, 3, 609820 (3); [Hemoglobin, high altitude adaptation], 609070 (3)	
1.1629	7	17	01	1q43	EXO1, HEX1		Exonuclease 1, S. cerevisiae, homolog of	606063				
1.1630	7	1	97	1q42.2	KCNK1, TWIK1		Potassium channel, subfamily K, member 1	601745				
1.1631	4	18	05	1q43	LGALS8, PCTA1		Lectin, galactoside-binding, soluble, 8	606099				
1.1632	10	12	90	1q42.13	RAB4A, RAB4		Ras-associated protein RAB4A	179511				1(Rab4a)
1.1633	12	5	16	1q42.3	TBCE, KCS, KCS1, HRD, PEAMO		Tubulin-specific chaperone E	604934			Kenny-Caffey syndrome, type 1, 244460 (3); Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3); Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3)	
1.1634	5	4	00	1q42.3	TM7SF1		Transmembrane 7 superfamily, member 1	604658				
1.1635	7	17	09	1q42.12	ACBD3, GOCAP1, GOLPH1, GCP60		Acyl-Coenzyme A binding domain containing 3	606809				
1.1636	3	11	16	1q42.13	ACTA1, ASMA, NEM3, CFTD1, SHPM		Actin, alpha-1, skeletal muscle	102610		mutation identified in 1 SHPM family	Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3); Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3); Myopathy, actin, congenital, with cores, 161800 (3); Myopathy, congenital, with fiber-type disproportion 1, 255310 (3); ?Myopathy, scapulohumeroperoneal, 616852 (3)	8(Actsk1)
1.1637	8	18	17	1q42.2	DISC1, SCZD9		Disrupted in schizophrenia 1	605210			{Schizophrenia 9, susceptibility to}, 604906 (3)	8(Disc1)
1.1638	9	20	01	1q42.2	DISC2		Disrupted in schizophrenia 2	606271		noncoding antisense RAN	Schizophrenia, 181500 (2)	
1.1639	5	18	18	1q42.12	LEFTY2, EBAF, TGFB4, LEFTA, LEFTYA		Left-right determination factor 2	601877				1(lefty2)
1.1640	9	20	17	1q42.12	EPHX1		Epoxide hydroxylase 1, microsomal xenobiotic	132810		mutation identified in 1 FHCA patient	?Hypercholanemia, familial, 607748 (3)	1(Eph1)
1.1641	8	16	11	1q43	FH, HLRCC, MCUL1, FMRD		Fumarate hydratase	136850			Fumarase deficiency, 606812 (3); Leiomyomatosis and renal cell cancer, 150800 (3)	
1.1642	6	22	18	1q42.12	LBR, PHA, PHASK		Lamin B receptor	600024			Pelger-Huet anomaly, 169400 (3); Greenberg skeletal dysplasia, 215140 (3); ?Reynolds syndrome, 613471 (3); Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3)	
1.1643	4	21	99	1q42.12	LEFTB, LEFTY1		Left-right determination, factor B	603037				1(lefty1)
1.1644	3	20	06	1q42.12	MIXL1, MIXL, MIX		MIX1 homeobox-like protein 1	609852				1(Mixl1)
1.1645	6	4	98	1q41	TP53BP2, ASPP2		Tumor protein p53-binding protein-2	602143				
1.1646	12	28	08	1q42.3	ARID4B, SAP180, RBP1L1, RBBP1L1, BRCAA1		AT-rich interactive domain-containing protein 4B	609696				
1.1647	7	20	06	1q43	RYR2, VTSIP, ARVD2, ARVC2		Ryanodine receptor-2 (cardiac)	180902			Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3); Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	13(Ryr2)
1.1648	5	16	17	1q42.11	CNIH4, CNIH2		Cornichon family AMPA receptor auxiliary protein 4	617483				
1.1649	04	30	19	1q42.11	DEGS1, DES1, MLD, HLD18		Delta(4)-desaturase, sphingolipid, 1	615843			Leukodystrophy, hypomyelinating, 18, 618404 (3)	
1.1650	10	15	91	1q42.11-q42.13	RN5S1@		RNA, 5S cluster 1	180420		25-30% at 1q31 (RN5S3@)		
1.1651	07	13	20	1q42.11	FBXO28, FBX28, KIAA0483		F-box protein 28	609100				1(Fbxo28)
1.1652	12	6	16	1q42.12	LIN9		Lin9, C. elegans, homolog of	609375				
1.1653	12	09	19	1q42.12	TMEM63A, KIAA0792, HLD19		Transmembrane protein 63A	618685			Leukodystrophy, hypomyelinating, 19, transient infantile, 618688 (3)	
1.1654	8	18	14	1q42.12	SRP9, ALURBP		Signal recognition particle, 9-kD	600707				
1.1655	1	20	16	1q42.13	CCSAP, CSAP, C1orf96		Centriole-, cilia-, and spindle-associated protein	616762				
1.1656	6	13	12	1q42.12	ENAH, ENA, MENA, NDPP1		Enabled, Drosophila, homolog of	609061				1(Enah)
1.1657	12	19	18	1q42.13	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3		Gap junction protein, gamma-2 (47kD)	608803			Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic paraplegia 44, autosomal recessive, 613206 (3); Lymphatic malformation 3, 613480 (3)	
1.1658	09	19	19	1q42.13	IBA57, C1orf69, MMDS3, SPG74		Iron-sulfur cluster assembly factor IBA57	615316			Multiple mitochondrial dysfunctions syndrome 3, 615330 (3); ?Spastic paraplegia 74, autosomal recessive, 616451 (3)	
1.1659	3	11	08	1q42.13	MRPL55		Mitochondrial ribosomal protein L55	611859				
1.1660	03	15	19	1q42.13	NUP133, NPHS18, GAMOS8		Nucleoporin, 133kD	607613		mutation identified in 1 GAMOS8 family	Nephrotic syndrome, type 18, 618177 (3); ?Galloway-Mowat syndrome 8, 618349 (3)	
1.1661	2	4	16	1q42.13	PGBD5		Piggybac transposable element-derived 5	616791				
1.1662	6	19	15	1q42.12	PYCR2, HLD10		Pyrroline-5-carboxylate reductase 2	616406			Leukodystrophy, hypomyelinating, 10, 616420 (3)	
1.1663	2	22	11	1q42.13	RNF186, RACO1		Ring finger protein 187	613754				
1.1664	1	31	15	1q42.13	TRIM11		Tripartite motif-containing protein 11	607868				
1.1665	8	15	17	1q42.11-q42.12	WDR26, SKDEAS		WD repeat-containing protein 26	617424			Skraban-Deardorff syndrome, 617616 (3)	
1.1666	12	30	14	1q42.13	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4		AARF domain-containing kinase 3	606980			Coenzyme Q10 deficiency, primary, 4, 612016 (3)	
1.1667	10	23	20	1q42.2	ARV1, DEE38		ARV1 homolog, fatty acid homeostasis modulator	611647			Developmental and epileptic encephalopathy 38, 617020 (3)	
1.1668	10	23	20	1q42.2	COA6, C1orf31, MC4DN13		Cytochrome c oxidase assembly factor 6	614772			Mitochondrial complex IV deficiency, nuclear type 13, 616501 (3)	
1.1669	3	27	17	1q42.2	COG2, LDLC, CDG2Q		Component of oligomeric golgi complex 2	606974		mutation identified in 1 CDG2Q patient	?Congenital disorder of glycosylation, type IIq, 617395 (3)	
1.1670	11	04	20	1q42.2	EXOC8, EXO84, SEC84, NEDMISB		Exocyst complex component 8	615283		mutation identified in 1 NEDMISB family	?Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy, 619076 (3)	
1.1671	08	23	19	1q42.2	MAP10, KIAA1383, MTR120		Microtubule-associated protein 10	618551				
1.1672	01	29	20	1q42.2	PCNX2, KIAA0435		Pecanex 2	617656				8(Pcnx2)
1.1673	2	19	08	1q42.2	SIPA1L2, KIAA1389		SIPA1-like protein 2	611609				
1.1674	2	4	15	1q42.2	SPRTN, DVC1, C1orf124, RJALS		SprT-like N-terminal domain protein	616086			Ruijs-Aalfs syndrome, 616200 (3)	
1.1675	10	10	14	1q42-q43	EDARADD, ED3, EDA3, ECTD11B, ECTD11A		EDAR-associated death domain	606603			Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3); Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	13(Edaradd)
1.1676	02	12	19	1q42.2-q43	PCAP		Predisposing for prostate cancer	602759			{Prostate cancer, susceptibility to} (2)	
1.1677	1	5	07	1q42.2-q43	SHFL1, SHFLD		Split-hand/foot malformation with long bone deficiency 1	119100		between rs1124110 and rs535043	Split-hand/foot malformation with long bone deficiency 1 (2)	
1.1678	10	7	13	1q42.3	ERO1LB		Endoplasmic reticulum oxidoreduction 1-like beta	615437				13(Ero1l)
1.1679	4	23	13	1q42.3	B3GALNT2, MGC39558, MDDGA11		Beta-1,3-N-acetylgalactosaminyltransferase 2	610194			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3)	
1.1680	5	25	13	1q42.3	GNG4		Guanine nucleotide-binding protein, gamma 4	604388				
1.1681	11	13	17	1q42.3	IRF2BP2, CVID14		Interferon regulatory factor 2-binding protein 2	615332		mutation identified in 1 CVID14 family	?Immunodeficiency, common variable, 14, 617765 (3)	
1.1682	1	30	15	1q42.3	LYST, CHS1		Lysosomal trafficking regulator	606897			Chediak-Higashi syndrome, 214500 (3)	13(Lyst, bg)
1.1683	9	18	08	1q42.2	TARBP1, TRP185		TAR RNA-binding protein 1	605052				
1.1684	09	17	20	1q42.3	TOMM20, MAS20, KIAA0016		Translocase of outer mitochondrial membrane 20	601848				
1.1685	3	23	14	1q43	BECN2, BECN1L1		Beclin 2	615687				1(Becn2)
1.1686	2	21	02	1q43	CHML, REP2		Choroideremia-like	118825				
1.1687	08	04	20	1q43	CHRM3, PBS, EGBRS		Cholinergic receptor, muscarinic, 3	118494			Prune belly syndrome, 100100 (3)	
1.1688	2	4	15	1q43	FMN2, MRT47		Formin 2	606373			Mental retardation, autosomal recessive 47, 616193 (3)	1(Fmn2)
1.1689	5	28	02	1q42.3	GGPS1, GGPPS1		Geranylgeranyl diphosphate synthase 1	606982				
1.1690	12	27	16	1q43	GREM2, PRDC, STHAG9		Gremlin 2 homolog, cystine knot superfamily	608832			Tooth agenesis, selective, 9, 617275 (3)	
1.1691	2	21	02	1q43	KMO		Kynurenine 3-monooxygenase	603538				
1.1692	7	12	13	1q43	MTR, HMAG		5-methyltetrahydrofolate-homocysteine methyltransferase 1	156570			Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3); {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	13(Mtr)
1.1693	6	8	89	1q42.3	NID		Nidogen	131390				
1.1694	2	18	02	1q43	OPN3, ECPN		Opsin 3	606695				
1.1695	4	20	11	1q43	RGS7		Regulator of G protein signaling 7	602517				1(Rgs7)
1.1696	12	15	10	1q43	ZP4, ZPB		Zona pellucida glycoprotein 4	613514				
1.1697	12	4	08	1q43-q44	DFNB45		Deafness, autosomal recessive 45	612433		between D1S547 and D1S2836	Deafness, autosomal recessive 45 (2)	
1.1698	10	16	14	1q43-q44	SDCCAG8, CCCAP, SLSN7, BBS16		Serologically defined colon cancer antigen 8	613524			Senior-Loken syndrome 7, 613615 (3); Bardet-Biedl syndrome 16, 615993 (3)	
1.1699	3	15	07	1q44	AHCTF1, ELYS		AT hook containing transcription factor 1	610853				
1.1700	11	27	19	1q43-q44	AKT3, PKBG, MPPH2		AKT serine/threonine kinase 3	611223			Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3)	1(Akt3)
1.1701	6	12	17	1q44	CATSPERE, C10orf101		Cation channel, sprem-associated, auxiliary subunit epsilon	617510				
1.1702	9	21	09	1q43	CEP170, KIAA0470		Centrosomal protein, 170kD	613023				
1.1703	9	7	10	1q44	CNST		Consortin	613439				
1.1704	10	23	20	1q44	COX20, FAM36A, MC4DN11		Cytochrome c oxidase assembly factor COX20	614698			Mitochondrial complex IV deficiency, nuclear type 11, 619054 (3)	
1.1705	7	20	12	1q44	DESI2, PPPDE1		Desumoylating isopeptidase 2	614638				
1.1706	11	05	20	1q44	HNRNPU, HNRPU, SAFA, DEE54		Heterogeneous nuclear ribonucleoprotein U	602869			Developmental and epileptic encephalopathy 54, 617391 (3)	
1.1707	9	8	11	1q44	KIF26B		Kinesin family member 26B	614026				
1.1708	8	10	16	1q44	LYPD8		LY6/PLAUR domain-containing protein 8	617067				
1.1709	6	14	18	1q44	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH		NLR family, pyrin domain containing 3	606416			Familial cold inflammatory syndrome 1, 120100 (3); Muckle-Wells syndrome, 191900 (3); CINCA syndrome, 607115 (3); Deafness, autosomal dominant 34, with or without inflammation, 617772 (3); Keratoendothelitis fugax hereditaria, 148200 (3)	
1.1710	07	17	19	1q44	OR2M7		Olfactory receptor, family 2, subfamily M, member 7	618509				
1.1711	1	5	16	1q44	OR2W3		Olfactory receptor family 2 subfamily W member 3	616729				
1.1712	12	17	07	1q44	OR13G1		Olfactory receptor, family 13, subfamily G, member 1	611677				
1.1713	07	26	19	1q44	OR14I1		Olfactory receptor, family 14, subfamily I, member 1	618516				
1.1714	6	27	14	1q44	SMYD3		SET and MYND domain-containing protein 3	608783				
1.1715	11	11	14	1q44	TFB2M		Transcription factor B2, mitochondrial	607055				
1.1716	3	23	93	1q44	ZNF124		Zinc finger protein-124 (HZF-16)	194631				
1.1717	5	12	15	1q44	ZNF695, SBZF3		Zinc finger protein 695	616348				
1.1718	4	20	17	1q44	ZBTB18, ZNF238, RP58, MRD22		Zinc finger and BTB domain containing 18	608433			Mental retardation, autosomal dominant 22, 612337 (3)	
1.1719	11	10	17	1q44	ZNF692, AREBP		Zinc finger protein 692	617758				
1.1720	4	19	11	1q44	ZNF496, NIZP1, ZFP496		Zinc finger protein 496	613911				11(Znf496)
1.1721	11	3	11	Chr.1	SPGF2, ASG		Spermatogenic failure 2	108420		inversion of chromosome 1	Spermatogenic failure 2 (2)	
2.1	7	22	13	2pter-p24	CTRCT29		Cataract 29, coralliform	115800		between D2S297 and D2S2269	Cataract 29, coralliform (2)	
2.2	6	14	10	2p25.3	ADI1, SIPL		Acireductone dioxygenase 1	613400				
2.3	5	4	12	2p25.3	COLEC11, CLK1, 3MC2		Collectin 11	612502			3MC syndrome 2, 265050 (3)	
2.4	4	2	16	2p25.3	FAM110C		Family with sequence similarity 110, member C	611395				
2.5	09	19	19	2p25.3	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA, ASGD7		Peroxidasin	605158			Anterior segment dysgenesis 7, with sclerocornea, 269400 (3)	
2.6	1	26	17	2p25.3	SH3YL1		SH3 domain- and SYLF domain-containing protein 1	617314				
2.7	2	19	10	2p25.3	TMEM18		Transmembrane protein 18	613220				
2.8	9	21	17	2p25.3	TRAPPC12, TTC15, PEBAS		Trafficking protein particle complex, subunit 12	614139			Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, 617669 (3)	
2.9	2	12	08	2p25.2	CMPK2		Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial	611787				
2.10	7	11	17	2p25.3	EIPR1, TSSC1		EARP complex and GARP complex interacting protein 1	608998				12(Tssc1)
2.11	8	27	09	2p25.1	ITGB1BP1, ICAP1, ICAP1A, ICAP1B		Integrin cytoplasmic domain-associated protein 1 beta	607153				
2.12	12	28	08	2p25.2	RSAD2, VIPERIN		Radical S-adenosyl methionine domain containing 2	607810				
2.13	7	25	18	2p25.1	ATP6V1C2		ATPase, H+ transporting, V1 subunit C2	618070				
2.14	12	23	05	2p25.1	GRHL1, LBP32, MGR		Grainyhead-like 1	609786				
2.15	1	22	08	2p25.1	GREB1		GREB1 protein	611736				
2.16	7	17	09	2p25.1	HPCAL1		Hippocalcin-like 1	600207				
2.17	1	11	17	2p25.1	KIDINS220, ARMS, SINO		Kinase D-interacting substrate, 220kD	615759			Spastic paraplegia, intellectual disability, nystagmus, and obesity, 617296 (3)	
2.18	10	13	09	2p25.1	MBOAT2, LPCAT4		Membrane-bound O-acyltransferase domain-containing 2	611949				
2.19	2	4	15	2p25.1	NOL10, PQBP5		Nucleolar protein 10	616197				
2.20	8	6	13	2p25.1	NTSR2		Neurotensin receptor 2	605538				
2.21	6	12	12	2p25.1	TYHAQ		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta isoform	609009		pseudogene on chr.22		
2.22	3	14	06	2p25.1-p24.3	DFNB47		Deafness, neurosensory, autosomal recessive 47	609946		max lod at D2S1400 and D2S262	Deafness, neurosensory, autosomal recessive 47 (2)	
2.23	8	23	16	2p21	DYNC2LI1, D2LIC, LIC3, SRTD15		Dynein, cytoplasmic 2, light intermediate chain 1	617083			Short-rib thoracic dysplasia 15 with polydactyly, 617088 (3)	
2.24	7	7	89	2p25.3	ACP1		Acid phosphatase 1, soluble	171500				12(Acp1)
2.25	09	26	19	2p25.1	ADAM17, TACE, NISBD1		ADAM metallopeptidase domain 17	603639		mutation identified in 1 NISBD1 family	?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3)	12(Tace)
2.26	12	18	08	2p25	ALLC		Allantoicase	612396		nonfunctional in humans		
2.27	12	23	19	2p25.1	CYS1		Cystin 1	618713				12(Cys1)
2.28	1	15	96	2p25.1	ID2		Inhibitor of DNA binding 2, dominant negative	600386				
2.29	8	27	09	2p23.3	ITSN2, SH3D1B, SWAP, KIAA1256		Intersectin 2	604464				
2.30	5	21	99	2p25.1	KCNF1, KH1		Potassium voltage-gated channel, subfamily F, member 1	603787				
2.31	2	13	14	2p25.1	KLF11, TIEG2, FKLF1, FKLF, MODY7		Kruppel-like factor 11	603301			Maturity-onset diabetes of the young, type VII, 610508 (3)	12(Klf11)
2.32	10	30	20	2p25.1	ODC1, NEDBA		Ornithine decarboxylase-1	165640		pseudogene ODCP on 7q31-qter	Neurodevelopmental disorder with alopecia and brain abnormalities, 619075 (3)	12(Odc)
2.33	10	11	05	2p25	PEE2		Preeclampsia/eclampsia 2	609402			Preeclampsia/eclampsia 2 (2)	
2.34	7	29	15	2p25.3	RNASEH1, PEOB2		Ribonuclease H1	604123		pseudogenes on chr. 17 and chr.1	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3)	12(Rnaseh1)
2.35	2	4	09	2p25.3	RPS7, DBA8		Ribosomal protein S7	603658			Diamond-Blackfan anemia 8, 612563 (3)	
2.36	07	13	20	2p25.2	SOX11, MRD27, CSS9		SRY-box 11	600898			Coffin-Siris syndrome 9, 615866 (3)	
2.37	2	1	01	2p25.1	RAF1B, RAFI63, SL1		TATA box-binding protein-associated factor 1B	604904				
2.38	7	11	11	2p23.3	SAP14, SF3B14, P14		Spliceosome-associated protein, 14kD	607835				
2.39	11	05	18	2p25.3	SNTG2, SYN5		Syntrophin, gamma-2	608715				
2.40	11	12	20	2p23.3	SUPT7L, SUPT7H, SPT7l, KIAA0764, STAF65G		SPTY7-like, STAGA complex subunit gamma	612762				
2.41	9	29	09	2p25.3	TPO, TPX, TDH2A		Thyroid peroxidase	606765			Thyroid dyshormonogenesis 2A, 274500 (3)	12(Tpo)
2.42	11	22	17	2p25-p22	ETM2, ETM		Tremor, hereditary essential, 2	602134		max lod at D2S272	Essential tremor, hereditary, 2 (2)	
2.43	6	10	03	2p25-p24	HYT3		Hypertension, essential, susceptibility to, 3	607329			{Hypertension, essential, susceptibility to, 3}, 145500 (2)	
2.44	8	22	07	2p25.1	PDIA6, ERP5		Protein disulfide isomerase, family A, member 6	611099				
2.45	4	10	90	2p25.1	RRM2		Ribonucleotide reductase, M2 polypeptide	180390		pseudogenes on 1p, 1q, Xp		12(Rrm2)
2.46	7	27	09	2p25-p12	PPKP3		Keratoderma, palmoplantar, punctate type III	101850		max lod at ACP1 and IGKC	?Keratoderma, palmoplantar, punctate type 3 (2)	
2.47	4	6	15	2p24.3	FAM84A, NSE1		Family with sequence similarity 84, member A	611234				
2.48	12	30	14	2p24.3	GACAT3, LINC01458		Gastric cancer-associated transcript 3, noncoding	616132				
2.49	9	20	14	2p24.3	MYCNUT		MYCN upstream transcript, noncoding	615968				
2.50	09	13	19	2p24.3	TRIB2, TRB2		Tribbles pseudokinase 2	609462				
2.51	12	24	08	2p24.2	GEN1		GEN1, Drosophila, homolog of	612449				
2.52	8	29	08	2p24.2	MSGN1		Mesogenin 1	612209				
2.53	5	24	13	2p24.2	NT5C1B, CN1B, AIRP		5'-nucleotidase, cytosolic, Ib	610526				
2.54	2	9	16	2p24.2	RDH14, SDR7C4, PAN2		Retinol dehydrogenase 14	616796				
2.55	10	4	05	2p24.2	SMC6L1, SMC6		Structural maintenance of chromosomes 6-like 1	609387				
2.56	5	19	06	2p24.1	HS1BP3, FLJ14249, ETM2		HS1-binding protein 3	609359				
2.57	1	17	18	2p24.1	LDAH, C2orf43		Lipid droplet associated hydrolase	613570				
2.58	7	21	11	2p24.3	MYCN, NMYC, ODED, MODED		Oncogene NMYC	164840		proximal to APOB	Feingold syndrome 1, 164280 (3)	12(Nmyc1)
2.59	8	27	09	2p24.3	MYCNOS, NCYM		Oncogene NCYM, opposite strand	605374				
2.60	8	3	12	2p24.1	RHOB, ARHB, ARH6, RHOH6		RAS homolog gene family, member B (oncogene RHO H6)	165370				
2.61	6	29	94	2p24.1	SDC1		Syndecan 1	186355		close to NMYC in mouse		12(Synd1)
2.62	2	11	14	2p24.1	WDR35, NAOFEN, KIAA1336, CED2, SRTD7		WD repeat-containing protein 35	613602			Cranioectodermal dysplasia 2, 613610 (3); Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	
2.63	10	12	16	2p23.3	ZNF513, RP58		Zinc finger protein 513	613598		mutation identified in 1 RP58 family	?Retinitis pigmentosa 58, 613617 (3)	
2.64	8	2	13	2p24.1-p23.3	ATAD2B, KIAA1240		ATPase family, AAA domain-containing, member 2B	615347				
2.65	06	19	19	2p24.1	APOB, FLDB, LDLCQ4, FCHL2		Apolipoprotein B (including Ag(x) antigen)	107730		1 gene for liver apo-B100 and gut apo-B48; Ag linked	Hypobetalipoproteinemia, 615558 (3); Hypercholesterolemia, familial, 2, 144010 (3)	12(Apob)
2.66	3	8	07	2p24-p22	CLQTL2		Cholesterol level quantitative trait locus 2	610760		max lod at D2S1360	[Cholesterol level QTL 2] (2)	
2.67	5	24	01	2p25.1	DDEF2, PAP		Development- and differentiation-enhancing factor 2	603817				
2.68	07	13	20	2p24.3	DDX1		DEAD-box helicase 1	601257				
2.69	1	3	06	2p24	GEFSP4		Generalized epilepsy with febrile seizures plus, type 4	609800		max lod at D2S305	Epilepsy, generalized, with febrile seizures plus, type 4 (2)	
2.70	6	15	99	2p24.2	KCNS3, KV9.3		Potassium voltate-gated channel, delayed-rectifier, subfamily S, member 3	603888				
2.71	2	23	05	2p24	KTCN4		Keratoconus 4	609271		between D2S305 and D2S2373	Keratoconus 4 (2)	
2.72	9	1	15	2p25.3	MYT1L, KIAA1106, MRD39		Myelin transcription factor 1-like	613084			Mental retardation, autosomal dominant 39, 616521 (3)	12(Myt1l)
2.73	9	7	04	2p24.1	ODD, OSR1		ODD-skipped, Drosophila, homolog of	608891				
2.74	3	9	00	2p25.1	ROCK2		RHO-associated coiled-coil-containing protein kinase 2	604002				
2.75	12	23	19	2p11.2	CHMP3, VPS24, NEDF		Charged multivesicular body protein 3	610052				
2.76	7	17	01	2p24.1	GDF7		Growth/differentiation factor 7	604651				
2.77	10	05	20	2p24.1	MATN3, EDM5, HOA, OS2, SEMDBCD		Matrilin 3	602109		mutation identified in 1 SEMDM family	Epiphyseal dysplasia, multiple, 5, 607078 (3); {Osteoarthritis susceptibility 2}, 140600 (3); ?Spondyloepimetaphyseal dysplasia, Borochowitz Cormier-Daire type, 608728 (3)	12(Matn3)
2.78	7	29	15	2p24.3	NBAS, NAG, SOPH, ILFS2		Neuroblastoma-amplified sequence	608025			Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3); Infantile liver failure syndrome 2, 616483 (3)	
2.79	10	13	05	2p23.3	TCF23		Transcription factor 23	609635				5(Tcf23)
2.80	2	27	18	2p23.3	ADCY3, BMIQ19		Adenylate cyclase-3	600291			{Obesity, susceptibility to, BMIQ19}, 617885 (3)	
2.81	6	3	98	2p23.3	CENPA		Centromere protein A, 17kD	117139				5(Cenpa)
2.82	8	29	08	2p23.3	ABHD1, LABH1		Abhydrolase domain-containing 1	612195				5(Abhd1)
2.83	7	11	16	2p23.3	AGBL5, CCP5, RP75		AATP/GTP-binding protein-like 5	615900			Retinitis pigmentosa 75, 617023 (3)	
2.84	01	08	20	2p23.3	ASXL2, KIAA1685, SHAPNS		ASXL transcriptional regulator 2	612991			Shashi-Pena syndrome, 617190 (3)	
2.85	2	25	15	2p23.3	C2orf44, WDCP		WD repeat- and coiled-coil-containing protein	616234				
2.86	10	08	07	2p23.3	CENPO		Centromeric protein O	611504				
2.87	7	14	14	2p23.3	CGREF1, CGR11		Cell growth regulator with EF-hand domain 1	606137				
2.88	4	24	18	2p23.3	CIB4, KIP4		Calcium- and integrin-binding protein 4	610646				
2.89	5	23	11	2p23.3	DNAJC5G		DNAJ/HSP40 homolog, subfamily C, member 5, gamma	613946				
2.90	8	17	10	2p23.3	DNAJC27, RBJ		DNAJ/HSP40 homolog, subfamily, C, member 27	613527				
2.91	1	27	04	2p23.3	DPYSL5, CRMP5, CRAM		Dihydropyrimidinase-like 5	608383				5(Dpysl5)
2.92	09	19	19	2p23.3	DRC1, CCDC164, C2orf39, CILD21		Dynein regulatory complex, subunit 1	615288			Ciliary dyskinesia, primary, 21, 615294 (3)	
2.93	2	9	16	2p23.3	EFR3B, KIAA0953		Efr3, S. cerevisiae, homolog of, B	616797				
2.94	10	29	03	2p23.3	EIF2B4		Eukaryotic translation initiation factor 2B, subunit 4	606687			Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
2.95	8	27	09	2p23.3	FKBP1B, PKBP1L		FK506-binding protein 1B	600620				
2.96	3	20	08	2p23.3	FNDC4, FRCP1		Fibronectin type III domain-containing protein 4	611905				5(Fndc4)
2.97	08	12	19	2p23.3	IFT172, SLB, KIAA1179, SRTD10, RP71		Intraflagellar transport 172	607386			Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3); Retinitis pigmentosa 71, 616394 (3)	
2.98	06	29	20	2p23.3	OST4		Oligosaccharyltransferase complex, noncatalytic subunit 4	618932				
2.99	1	7	09	2p23.3	POMC, OBAIRH		Proopiomelanocortin (adrenocorticotropin/beta-lipotropin)	176830			Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3); {Obesity, early-onset, susceptibility to}, 601665 (3)	12(Pomc1)
2.100	10	12	14	2p23.3	PPM1G, PP2CG		Protein phosphatase, magnesium/manganese-dependent, 1G	605119				
2.101	2	9	17	2p23.3	PRTHD1, C2orf79		Peptidyl-tRNA hydrolase domain-containing 1	617342				
2.102	3	31	09	2p23.3	RAB10		Ras-associated protein	612672				
2.103	02	14	20	2p23.3	SELENOI, SELI, SPG81		Selenoprotein I	607915			Spastic paraplegia 81, autosomal recessive, 618768 (3)	
2.104	08	06	20	2p23.3	SLC5A6, SMVT, NERIB		Solute carrier family 5 (sodium dependent vitamin transporter), member 6	604024			Neurodegeneration, infantile-onset, biotin-responsive, 618973 (3)	
2.105	2	25	08	2p23.3	SLC30A3, ZNT3		Solute carrier family 30 (zinc transporter), member 3	602878				5(Slc30a3)
2.106	08	12	20	2p23.3	SNX17		Sorting nexin 17	605963				
2.107	4	6	15	2p23.3	TMEM214		Transmembrane protein 214	615301				
2.108	8	3	12	2p23.3	TP53I3, PIG3		Tumor protein p53-inducible protein 3	605171				
2.109	8	13	15	2p23.3	TRIM54, RNF30, MURF3		Tripartite motif containing 54	606474				
2.110	10	13	09	2p23.3	XAB1, MBDIN		XPA-binding protein	611479				
2.111	8	27	09	2p23.3	EMILIN1, EMILIN		Elastin microfibril interfacer 1	130660				
2.112	11	1	10	2p23.3	GCKR, GKRP, FGQTL5		Glucokinase (hexokinase 4) regulatory protein	600842			[Fasting plasma glucose level QTL 5], 613463 (3)	
2.113	6	23	11	2p23.3	KHK		Ketohexokinase (fructokinase)	614058			[Fructosuria], 229800 (3)	
2.114	8	27	09	2p23.3	SLC4A1AP		Solute carrier family 4 (anion exchanger), member 1, adaptor protein	602655				
2.115	8	27	01	2p23.3	MAPRE3, EB3, RP3, EBF3		Microtubule-associated protein, RP/EB family, member 3	605788				
2.116	3	14	06	2p23.3-p22.3	GINGF3, HGF3, GGF3		Fibromatosis, gingival, 3	609955		between D2S2221 and D2S1788	Fibromatosis, gingival, 3 (2)	
2.117	10	13	13	2p23.2	BRE, BRCC4, BRCC45		Brain and reproductive organ-expressed protein	610497				
2.118	8	31	11	2p23.2	FOSL2		FOS-like antigen-2	601575				
2.119	1	27	04	2p23.1	GALNT14		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14	608225				
2.120	01	30	19	2p23.2	PCARE, C2orf71, RP54		Photoreceptor cilium actin regulator	613425			Retinitis pigmentosa 54, 613428 (3)	
2.121	6	16	06	2p23.2	PLB1, PLB, FLJ30866		Phospholipase B1	610179				
2.122	9	10	07	2p23.2	RBKS		Ribokinase	611132				
2.123	9	8	11	2p23.2	SPDYA, SPY1, RINGOA		Speedy, xenopus, homolog of, A	614029				
2.124	2	4	15	2p23.2	WDR43, UTP5, KIAA0007		WD repeat-containing protein 43	616195				
2.125	11	05	18	2p23.1	CAPN13, FLJ23523		Calpain 13	610228				
2.126	11	05	18	2p23.1	CAPN14		Calpain 14	610229				
2.127	1	31	08	2p23.1	LBH		Limb bud and heart development, mouse, homolog of	611763				
2.128	9	28	11	2p23.1	LCLAT1, ALCAT1, AGPAT8		Lysocardiolipin acyltransferase 1	614241				17(Lclat1)
2.129	6	1	18	2p23.3	GAREM2		GRB2-associated regulator of MAPK1, subtype 2	617999				
2.130	12	28	08	2p23.1	YPEL5		Yippee-like 5	609726				17(Ypel5)
2.131	9	24	08	2q32.1	DNAJC10, ERDJ5, JPDI		DNAJ/HSP40 homolog, subfamily C, member 10	607987				
2.132	9	22	09	2p23.2-p23.1	ALK, NBLST3		Anaplastic lymphoma kinase (Ki-1)	105590			{Neuroblastoma, susceptibility to, 3}, 613014 (3)	17(Alk)
2.133	01	03	20	2p23.3	DNMT3A, TBRS, HESJAS		DNA methyltransferase 3A	602769			Tatton-Brown-Rahman syndrome, 615879 (3); Acute myeloid leukemia, somatic, 601626 (3); Heyn-Sproul-Jackson syndrome, 618724 (3)	
2.134	07	17	20	2p23.3	HADHA, MTPA		Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit	600890			LCHAD deficiency, 609016 (3); Mitochondrial trifunctional protein deficiency, 609015 (3); HELLP syndrome, maternal, of pregnancy, 609016 (3); Fatty liver, acute, of pregnancy, 609016 (3)	
2.135	3	19	08	2p23.3	HADHB		Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase /enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit	143450			Trifunctional protein deficiency, 609015 (3)	
2.136	8	2	13	2p23.3	KCNK3, TASK, PPH4		Potassium channel, subfamily K, member 3	603220			Pulmonary hypertension, primary, 4, 615344 (3)	5(Kcnk3)
2.137	11	20	98	2p23.3	KIF3C		Kinesin family member 3C	602845				12(Kif3c)
2.138	1	30	18	2p23.3	MFSD2B		Major facilitator superfamily domain-containing protein 2B	617845				
2.139	12	29	99	2p23.3	NCOA1, SRC1		Nuclear receptor coactivator 1	602691				
2.140	6	18	01	2p23.3	NRBP		Nuclear receptor-binding protein	606010				
2.141	5	31	17	2p23.2	PPP1CB, NSLH2		Protein phosphatase-1, catalytic subunit, beta isoform	600590			Noonan syndrome-like disorder with loose anagen hair 2, 617506 (3)	12(Ppp1cb)
2.142	11	28	01	2p23.3	PREB		Prolactin regulatory element-binding protein	606395				5(Preb)
2.143	10	21	02	2p23.1	SRD5A2		Steroid-5-alpha-reductase, alpha polypeptide-2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha-2)	607306			Pseudovaginal perineoscrotal hypospadias, 264600 (3)	
2.144	8	17	99	2p23.3	DTNB		Dystrobrevin, beta	602415				12(Dtnb)
2.145	8	4	09	2p23.3	OTOF, DFNB9, NSRD9, AUNB1		Otoferlin	603681		symbolized DFNB6 by authors	Deafness, autosomal recessive 9, 601071 (3); Auditory neuropathy, autosomal recessive, 1, 601071 (3)	
2.146	8	17	98	2p22.1	SLC8A1, NCX1		Solute carrier family 8, member 1 (sodium-calcium exchanger-1)	182305				
2.147	7	27	16	2p23.1	XDH, XAN1		Xanthine dehydrogenase (xanthine oxidase)	607633			Xanthinuria, type I, 278300 (3)	17(Xd)
2.148	09	04	19	2p23.3	MPV17, MTDPS6, CMT2EE		Mitochondrial inner membrane protein MPV17	137960			Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3); Charcot-Marie-Tooth disease, axonal, type 2EE, 618400 (3)	5(Mpv17)
2.149	3	18	08	2p23.3	UCN, UROC		Urocortin	600945				
2.150	12	03	20	2p22.2-p22.1	ATL2, ARL3IP2		Atlastin GTPase 2	609368				
2.151	6	9	08	2p22.3	DPY30		DPY30, C. elegans, homolog of	612032				
2.152	7	23	15	2p22.3	MIR558		Micro RNA 558	616473		BIRC6 is host gene		
2.153	12	4	14	2p22.3	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4		NLR family, caspase recruitment domain-containing 4	606831		mutation identified in 1 FCAS4 family	Autoinflammation with infantile enterocolitis, 616050 (3); ?Familial cold autoinflammatory syndrome 4, 616115 (3)	
2.154	10	11	16	2p22.2	SULT6B1		Sulfotransferase family 6B, member 1	617152				
2.155	6	17	17	2p22.3	YIPF4		Yip1 domain family, member 4	617534				
2.156	4	26	10	2p22.3-p21	CANDF1, CMCT		Candidiasis, familial, 1	114580		between D2S367 and D2S2240	Candidiasis, familial, 1, autosomal dominant (2)	
2.157	7	16	09	2p22.2	CEBPZ, CBF, NOC1		CCAAT/enhancer-binding protein, zeta	612828				
2.158	9	23	08	2p22.2	FAM82A1, FAM82A, RMD2		Family with sequence similarity 82, member A1	611872				
2.159	7	18	14	2p22.2	FEZ2		Fasciculation and elongation protein zeta 2	604826				
2.160	1	30	18	2p22.2	MACOM		Macrophthalmia, colobomatous, with microcornea	602499			Macrophthalmia, colobomatous, with microcornea (4)	
2.161	8	1	14	2p22.2	NDUFAF7, MIDA		NADH-ubiquinone oxidoreductase complex assembly factor 7	615898				
2.162	8	27	09	2p22.2	QPCT, QC		Glutaminyl-peptide cyclotransferase	607065				
2.163	9	18	17	2p22.2	VIT, VIT1		Vitrin	617693				
2.164	9	20	14	2p22.1	GEMIN6		GEM-associated protein 6	607006				
2.165	3	31	15	2p22.1	MAP4K3, GLK		Mitogen-activated protein kinase kinase kinase kinase 3	604921				
2.166	9	17	11	2p22.1-p21	HNFJ3		Hyperuricemic nephropathy, familial juvenile, 3	614227		between rs372139 and rs896986	Hyperuricemic nephropathy, familial juvenile, 3 (2)	
2.167	5	26	13	2p22.1	HNRNPLL, HNRPLL, SRRF		Heterogeneous nuclear ribonucleoprotein L-like	611208				
2.168	3	24	14	2p23.2	MRPL33		Mitochondrial ribosomal protein L33	610059				
2.169	8	21	12	2p22.2	STRN		Striatin, calmodulin-binding protein	614765				
2.170	1	7	09	2p22.3	BIRC6, KIAA1289		Baculoviral IAP repeat-containing protein-6	605638				
2.171	8	28	01	2p22.2	CRIM1		Cysteine-rich motor neuron protein 1	606189				
2.172	1	26	17	2p22.2	CYP1B1, GLC3A, ASGD6		Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1	601771			Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3); Anterior segment dysgenesis 6, multiple subtypes, 617315 (3)	
2.173	1	2	03	2p21	EML4, ROPP120		Echinoderm microtubule associated protein like-4	607442				
2.174	2	12	08	2p22.3	MEMO1, MEMO, C2orf4		Mediator of cell motility 1	611786				
2.175	11	24	20	2p21-p16	MSH2, COCA1, FCC1, HNPCC1, MMRCS2		mutS homolog 2	609309			Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3); Muir-Torre syndrome, 158320 (3); Mismatch repair cancer syndrome 2, 619096 (3)	
2.176	8	27	09	2p24.1	PUM2, KIAA0235		Pumilio, Drosophila, homolog of, 2	607205				
2.177	12	19	11	2p22.1	SRSF7, SFRS7		Splicing factor, arginine/serine-rich 7, 35kD	600572				
2.178	2	25	08	2p22.3	SLC30A6, ZNT6		Solute carrier family 30 (zinc transporter), member 6	611148				17(Slc30a6)
2.179	08	22	19	2p22.1	SOS1, GINGF, GF1, HGF, NS4		SOS Ras/Rac guanine nucleotide exchange factor 1	182530		mutation identified in 1 GINGF1 family	?Fibromatosis, gingival, 1, 135300 (3); Noonan syndrome 4, 610733 (3)	17(Sos1)
2.180	4	27	12	2p22.3	SPAST, SPG4		Spastin	604277			Spastic paraplegia 4, autosomal dominant, 182601 (3)	
2.181	1	28	08	2p22.1	THUMPD2, C2orf8		THUMP domain-containing 2	611751				
2.182	7	12	92	2p16.3	HTLF		Human T-cell leukemia virus enhancer factor	143089				
2.183	05	15	20	2p22.1	GALM, GLAT, GALAC4		Galactose mutarotase	137030			Galactosemia IV, 618881 (3)	
2.184	11	19	19	2p21	ABCG5, STSL2		ATP-binding cassette, subfamily G, member 5	605459			Sitosterolemia 2, 618666 (3)	
2.185	11	19	19	2p21	ABCG8, GBD4, STSL1		ATP-binding cassette, subfamily G, member 8	605460			Sitosterolemia 1, 210250 (3); {Gallbladder disease 4}, 611465 (3)	
2.186	3	2	17	2p21	ATP6V1E2, ATP6E1		ATPase, H+ transporting, V1 subunit E1	617385				
2.187	11	05	20	2p23.3	CAD, CDG1Z, DEE50		CAD trifunctional protein of pyrimidine biosynthesis	114010			Developmental and epileptic encephalopathy 50, 616457 (3)	
2.188	3	13	15	2p21	CALM2, LQT15		Calmodulin-2	114182			Long QT syndrome 15, 616249 (3)	
2.189	6	4	13	2p21	CAMKMT, C2orf34		Calmodulin lysine N-methyltransferase	609559				
2.190	8	27	09	2p22.2	CDC42EP3, CEP3, BORG2		CDC42 effector protein 3	606133				
2.191	8	27	09	2p21	COX7A2L, COX7RP, EB1		Cytochrome c oxidase subunit VIIA, polypeptide 2-like	605771				
2.192	5	22	14	2p21	CRIPT, SSMDF		Cystine-rich PDZ binding protein	604594			Short stature with microcephaly and distinctive facies, 615789 (3)	
2.193	4	21	10	2p21	DEL2p21, C2DELp21		Homozygous 2p21 deletion syndrome	606407		contiguous gene syndrome disrupting SLC3A1 and PREPL genes	Hypotonia-cystinuria syndrome (4)	
2.194	5	2	01	2p23.1	EHD3		EH domain-containing 3	605891				
2.195	06	05	20	2p22.2	EIF2AK2, PRKR, LEUDEN		Eurkaryotic translation initiation factor 2-alpha kinase 2	176871			Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome, 618877 (3)	17(Prkr)
2.196	12	19	11	2p21	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8		Epithelial cellular adhesion molecule	185535		previously assigned to 4q	Diarrhea 5, with tufting enteropathy, congenital, 613217 (3); Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	
2.197	08	17	18	2p16.3	FBXO11, FBX11, VIT1, PRMT9, IDDFBA		F-box only protein 11	607871		?2p16	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3)	17(Fbxo11)
2.198	9	21	17	2p21	HAAO, VCRL1		3-hydroxyanthranilate 3,4-dioxygenase	604521			Vertebral, cardiac, renal, and limb defects syndrome 1, 617660 (3)	
2.199	8	27	09	2p21	KCNG3, KV6.3		Potassium voltage-gated channel, subfamily G, member 3	606767				
2.200	10	7	08	2p21	LEPQTL1, LSL		Leptin serum levels quantitative trait locus 1	601694			[Leptin serum levels QTL1] (2)	
2.201	4	9	09	2p16.3	LHCGR, LHR, LCGR		Luteinizing hormone/choriogonadotropin receptor	152790			Precocious puberty, male, 176410 (3); Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3); Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3); Luteinizing hormone resistance, female, 238320 (3); Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)	
2.202	1	22	09	2p25.1	LPIN1		Lipin 1	605518		related to LSL	Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)	12(Lpin1)
2.203	10	23	20	2p21	LRPPRC, LRP130, LSFC, MC4DN5		Leucine-rich PPR motif-containing protein	607544			Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian), 220111 (3)	
2.204	04	13	20	2p21	PKDCC, VLK, SGK493, RLSDF		Protein kinase domain-containing, cytoplasmic	614150			Rhizomelic limb shortening with dysmorphic features, 618821 (3)	
2.205	4	30	09	2p21	PLEKHH2		Pleckstrin homology domain-containing protein, family H, member 2	612723				
2.206	10	19	01	2p21	PPM1B		Protein phosphatase, magnesium-dependent, 1, beta isoform	603770		formerly PP2CB		
2.207	07	28	18	2p21	PREPL, KIAA0436, CMS22		Prolyl endopeptidase-like	609557			Myasthenic syndrome, congenital, 22, 616224 (3)	
2.208	8	4	99	2p21	PRKCE, PKCE		Protein kinase C, epsilon	176975				
2.209	7	1	02	2p22.2	PRKCN		Protein kinase C, nu	607077				
2.210	8	3	12	2p21	RHOQ, ARHQ, TC10		Ras-homolog gene family, member Q	605857				
2.211	08	12	19	2p21	SIX3, HPE2		SIX homeobox 3	603714			Holoprosencephaly 2, 157170 (3); Schizencephaly, 269160 (3)	17(Six3)
2.212	7	12	02	2p21	SOCS5, CIS6, KIAA0671		Suppressor of cytokine signaling 5	607094		also signals at 3p22		
2.213	5	1	91	2p16.2	SPTBN1		Spectrin, beta, nonerythrocytic-1 (beta-fodrin)	182790				
2.214	2	18	08	2p21	THADA, KIAA1767		Thyroid adenoma-associated gene	611800				
2.215	5	19	15	2p21	TTC7A, TTC7, KIAA1140, MINAT, GIDID		Tetratricopeptide repeat domain 7A	609332			Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	17(Ttc7a)
2.216	6	10	08	2p21	ZFP36L2, ERF2, TIS11D		Zinc finger protein 36-like 2	612053		incorrectly mapped to 6p21.3		
2.217	1	27	11	2p21	MCFD2, F5F8D2		Multiple coagulation factor deficiency protein 2	607788			Factor V and factor VIII, combined deficiency of, 613625 (3)	
2.218	2	11	08	2p21	EPAS1, MOP2, HIF2A, ECYT4		Endothelial PAS domain protein 1	603349			Erythrocytosis, familial, 4, 611783 (3)	
2.219	1	4	11	2p16.3	FSHR, ODG1		Follicle stimulating hormone receptor	136435			Ovarian dysgenesis 1, 233300 (3); Ovarian response to FSH stimulation, 276400 (3); Ovarian hyperstimulation syndrome, 608115 (3)	
2.220	2	4	96	2p21	PIGF		Phosphatidylinositol glycan, class F	600153		pseudogene on 5		17(Pigf)
2.221	8	25	04	2p21-p13	SCA25		Spinocerebellar ataxia 25	608703			Spinocerebellar ataxia 25 (2)	
2.222	3	7	14	2p21-p12	DFNA58		Deafness, autosomal dominant 58	615654		between D2S2259 and D2S2114	Deafness, autosomal dominant 58 (2)	
2.223	9	9	10	2p16.3	GTF2A1L, ALF		General transcription factor IIA, 1-like	605358				
2.224	11	19	11	2p16.3	NRXN1, PTHSL2, SCZD17		Neurexin 1	600565			Pitt-Hopkins-like syndrome 2, 614325 (3); {Schizophrenia, susceptibility to, 17}, 614332 (3)	
2.225	10	26	18	2p16.3	PPP1R21, CCDC128, KLRAQ1		Protein phosphatase 1, regulatory subunit 21	618159				
2.226	4	21	10	2p21	SLC3A1, ATR1, D2H, NBAT		Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters), member 1	104614			Cystinuria, 220100 (3)	
2.227	10	4	12	2p16.3	STON1, STN1, SBLF, SALF		Stonin 1	605357				
2.228	2	16	18	2p16.2	ASB3		Ankyrin repeat-containing SOCS box protein 3	605760				11(Asb3)
2.229	4	21	17	2p16.2	CHAC2		ChaC, E. coli, homolog of, 2	617446				
2.230	1	26	12	2p16.2	ERLEC1, C2orf30		Erlectin (endoplasmic reticulum lectin 1)	611229				
2.231	4	28	10	2p16.2	ACYP2, ACYP		Acylphosphatase 2, muscle type	102595				
2.232	8	27	09	2p16.2	PSME4, PA200, KIAA0077		Proteasome activator subunit 4	607705				
2.233	8	31	16	2p16.1	BCL11A, CTIP1, EVI9, KIAA1809, DILOS		B-cell CLL/lymphoma 11A	606557			Dias-Logan syndrome, 617101 (3)	
2.234	6	1	17	2p16.1	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHOL		Coiled-coil domain-containing protein 88A	609736		mutation identified in 1 PEHOL family	?PEHO syndrome-like, 617507 (3)	11(Ape)
2.235	9	8	14	2p16.1	HBFQTL5		Fetal hemoglobin quantitative trait locus 5	142335		associated with rs11886868	[Fetal hemoglobin QTL5] (2)	
2.236	3	23	09	2p16.1	MIR216, MIRN216		Micro RNA 216	610944				
2.237	3	14	13	2p16.1	MIR217		Micro RNA 217	615096				
2.238	3	17	16	2p16.1	PAPOLG		Poly(A) polymerase, gamma	616865				
2.239	9	30	03	2p16.1	PHF9, FANCL		PHD finger protein 9	608111			Fanconi anemia, complementation group L, 614083 (3)	
2.240	11	29	12	2p16.1	PNPT1, OLD35, COXPD13, DFNB70		Polyribonucleotide nucleotidyltransferase 1	610316			Combined oxidative phosphorylation deficiency 13, 614932 (3); Deafness, autosomal recessive 70, 614934 (3)	
2.241	2	5	16	2p16.1	PPP4R3B, PP4R3B, SMEK2, KIAA1387		Protein phosphatase 4, regulatory subunit 3, beta	610352				
2.242	3	17	16	2p16-p15	PUS10, DOBI		Pseudouridylate synthase 10	612787				
2.243	3	31	16	2p16.1	RPS27A, UBA80, HUBCEP80, CEP80, UBCEP1		Ribosomal protein S27a	191343				
2.244	1	20	09	2p16.1-p15	DEL2p16.1-p15, C2DELp161-p15		Chromosome 2p16.1-p15 deletion syndrome	612513		contiguous gene deletion syndrome	Chromosome 2p16.1-p15 deletion syndrome (4)	
2.245	4	19	06	2p16	ASRT3		Asthma-related traits, susceptibility to, 3	609958		max lod at rs2063871	{Asthma-related traits, susceptibility to, 3} (2)	
2.246	9	7	00	2p16	CNC2		Carney complex, type II	605244			Carney complex, type II (2)	
2.247	6	2	99	2p16.1	EFEMP1, FBNL, DHRD		EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like)	601548			Doyne honeycomb degeneration of retina, 126600 (3)	
2.248	2	21	02	2p16.2	GPR75		G protein-coupled receptor 75	606704				
2.249	11	24	20	2p16.3	MSH6, GTBP, HNPCC5, MMRCS3		mutS homolog 6	600678		0.5 Mb from MSH2	Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3); Mismatch repair cancer syndrome 3, 619097 (3); {Endometrial cancer, familial}, 608089 (3)	
2.250	10	23	20	2p15	MDH1, DEE88		Malate dehydrogenase, soluble	154200		proximal to APOB; mutation identified in 1 DEE88 family	?Developmental and epileptic encephalopathy 88, 618959 (3)	11(Mor2)
2.251	9	3	10	2p16	STQTL24		Stature quantitative trait locus 24	613549		linked to rs1520446	{Stature QTL 24} (2)	
2.252	5	11	98	2p15	XPO1, CRM1		Exportin-1 (required for chromosome region maintenance)	602559				
2.253	11	29	99	2p16-p15	DYX3		Dyslexia, susceptibility to, 3	604254			{Dyslexia, susceptibility to, 3} (2)	
2.254	7	1	11	2p16-p15	GLC1H		Glaucoma 1, open angle, H	611276		between D2S123 AND D2S2165	Glaucoma 1, open angle, H (2)	
2.255	4	28	97	2p14	PPP3R1, CALNB1		Protein phosphatase-3 (formerly 2B), regulatory subunit B (19kD), alpha isoform (calcineurin B, type I)	601302				
2.256	08	12	19	2p21	SIX2		SIX homeobox 2	604994				17(Six2)
2.257	5	29	98	2p16.1	VRK2		Vaccinia-related kinase-2	602169				
2.258	6	16	99	2p16.1	MTIF2		Mitochondrial translational initiation factor 2	603766				
2.259	11	3	05	2p15	COMMD1, MURR1		Copper metabolism Murr1 domain-containing 1	607238				
2.260	6	26	13	2p15	B3GNT2, B3GNT1, B3GNT		Beta-1,3-N-acetylglucosyaminyltransferase 2	605581				
2.261	5	26	05	2p15	CCT4, CCTD, SRB		Chaperonin containing T-complex polypeptide 1, subunit 4	605142				11(mf)
2.262	4	23	08	2p15	EHBP1, KIAA0903, HPC12		EH domain-binding protein 1	609922			{Prostate cancer, hereditary, 12}, 611868 (3)	
2.263	10	27	10	2p15	FAM161A, RP28		Family with sequence similarity 161, member A	613596			Retinitis pigmentosa 28, 606068 (3)	
2.264	10	25	12	2p15	PEX13, ZWS, NALD, PBD11A, PBD11B		Peroxisome biogenesis factor 13 (peroxin 13)	601789			Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3); Peroxisome biogenesis disorder 11B, 614885 (3)	
2.265	12	17	12	2p15	TMEM17		Transmembrane protein 17	614950				
2.266	7	1	13	2p15	USP34, KIAA0570		Ubiquitin-specific protease 34	615295				
2.267	09	27	20	2p15	WDPCP, C2orf86, BBS15, CHDTHP		WD repeat-containing planar cell polarity effector	613580		mutation identified in 1 BBS15 family	?Bardet-Biedl syndrome 15, 615992 (3); Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3)	
2.268	12	29	09	2p14	ETAA1, ETAA16		Ewing tumor-associated antigen 1	613196				
2.269	12	18	19	2p13.3	NFU1, HIRIP, MMDS1		NFU1 iron-sulfur cluster scaffold	608100			Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)	
2.270	11	11	14	2p14	ACTR2, ARP2		Actin-related protein 2	604221				
2.271	5	23	07	2p13.3	AFPL, C2orf13		Aprataxin- and PNK-like factor	611035				
2.272	4	8	16	2p14	CEP68, KIAA0582		Centrosomal protein, 68kD	616889				
2.273	08	15	19	2p14	CNRIP1, CRIP1		Cannabinoid receptor-interacting protein 1	618538				
2.274	4	6	18	2p14	LGALSL		Galectin-like protein	617902				
2.275	12	19	19	2p14	PNO1		Partner of NOB1	618710				
2.276	4	1	96	2p14	RAB1, RAB1A		RAB1, member RAS oncogene family	179508				11(Rab1)
2.277	1	25	18	2p14	SERTAD2, TRIPBR2, KIAA0127		SERTA domain-containing protein 2	617851				
2.278	11	25	15	2p14	SLC1A4, SATT, ASCT1, SPATCCM		Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4	600229			Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3)	
2.279	10	11	07	2p14	SPRED2		Sprouty-related EVH1 domain-containing protein 2	609292				11(Spred2)
2.280	10	03	19	2p15-p14	VPS54, VPS54L, WR		VPS54 subunit of GARP complex	614633				14(Vps54)
2.281	7	3	06	2p14-p13.3	HRPT3		Hyperparathyroidism 3	610071		between D2S2368 and D2S358	Hyperparathyroidism 3 (2)	
2.282	12	17	95	2p13.3	ADD2		Adducin-2, beta	102681				6(Add2)
2.283	08	12	19	2p13.2	EMX1		Empty spiracles homeobox 1	600034		close to VAX2		6(Dmx1)
2.284	08	26	19	2p14	MEIS1		Meis homeobox 1	601739				11(Meis1)
2.285	7	20	09	2p14-p13	RLS7		Restless legs syndrome, susceptibility to, 7	612853		associated with rs2300478	{Restless legs syndrome 7} (2)	
2.286	11	29	00	2p16.1	RTN4, NOGO		Neurite outgrowth inhibitor (reticulon 4)	604475				
2.287	10	23	20	2p15	UGP2, UGPP2, DEE83		Uridyl diphosphate glucose pyrophosphorylase-2	191760			Developmental and epileptic encephalopathy 83, 618744 (3)	
2.288	4	15	09	2p13.2	SPR		Sepiapterin reductase	182125			Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3)	1(Spr)
2.289	11	29	01	2q21.3	CCNT2		Cyclin T2	603862				
2.290	6	23	15	2p13.3	AAK1, KIAA1048		Adaptor protein 2-associated kinase 1	616405				
2.291	6	27	16	2p13.3	ANKRD53		Ankyrin repeat domain-containing protein 53	617009				
2.292	3	3	16	2p13.3	BMP10		Bone morphogenetic protein 10	608748				
2.293	3	20	15	2p13.3	FAM136A		Family with sequence similarity 136, member A	616275				
2.294	6	27	05	2p13.3	GKN1, CA11		Gastrokine 1	606402				
2.295	09	13	19	2p13.3	GKN2, GDDR		Gastrokine 2	618589				
2.296	10	18	19	2p13.3	GMCL1, SPATA29, BTBD13		Germ cell-less 1, spermatogenesis-associated	618627				
2.297	8	27	02	2p13.1	LOXL3		Lysyl oxidase-like 3	607163				
2.298	1	6	09	2p13.3	MCEE		Methylmalonyl-CoA epimerase	608419			Methylmalonyl-CoA epimerase deficiency, 251120 (3)	
2.299	8	27	09	2p13.3	NAGK, GNK		N-acetylglucosamine kinase	606828				
2.300	8	20	07	2p13.3	PAIP2B		Polyadenylate-binding protein-interacting protein 2B	611018				
2.301	9	2	12	2p14	PELI1		Pellino, Drosophila, homolog of, 1	614797				
2.302	5	22	07	2p13.3	PCYOX1, PCL1, KIAA0908		Prenylcysteine oxidase 1	610995				
2.303	9	7	12	2p13.3	PROKR1, PKR1, GPR73		Prokineticin receptor 1	607122				
2.304	5	25	13	2p13.3	SNRPG		Small nuclear ribonucleoprotein polypeptide G	603542				
2.305	08	30	19	2p13.3	TEX261		Testis-expressed gene 261	618562				
2.306	09	27	18	2p13.2	DYSF, LGMDR2, MMD1		Dysferlin	603009			Muscular dystrophy, limb-girdle, autosomal recessive 2, 253601 (3); Myopathy, distal, with anterior tibial onset, 606768 (3); Miyoshi muscular dystrophy 1, 254130 (3)	6(Dysf)
2.307	4	18	12	2p13.2	CYP26B1, CYP26A2, P450RAI2, RHFCA		Cytochrome P450, subfamily XXVIB, polypeptide 1	605207			Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	
2.308	9	9	08	2p13.2	FBXO41, FBX41, KIAA1940		F-box only protein 41	609108				6(Fbxo41)
2.309	04	19	19	2p13.2	EXOC6B, SEC15B, KIAA0919, SEMDJL3		Exocyst complex component 6B	607880			Spondyloepimetaphyseal dysplasia with joint laxity, type 3, 618395 (3)	
2.310	12	01	20	2p13.2	SMYD5		SET and MYND domain-containing protein 5	619114				
2.311	11	19	11	2p13.2	ZNF638, NP220		Zinc finger protein 638	614349				
2.312	6	3	14	2p13.1	ACTG2, ACTA3, VSCM		Actin, gamma-2, smooth muscle, enteric	102545			Visceral myopathy, 155310 (3)	
2.313	9	15	17	2p13.3	ANTXR1, TEM8, ATR, GAPO		Anthrax toxin receptor 1	606410		mutation identified in 1 HCI patient	GAPO syndrome, 230740 (3); {?Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	
2.314	08	26	20	2p13.3	ASPRV1, SASP, TAPS, MUNO, ADLI		Aspartic peptidase, retroviral-like 1	611765			Ichthyosis, lamellar, autosomal dominant, 146750 (3)	
2.315	08	23	19	2p13.1	BOLA3, MMDS2		bolA family member 3	613183			Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3)	
2.316	8	27	09	2p13.1	DUSP11, PIR1		Dual specificity phosphatase-11, RNA/RNP complex-interacting	603092				
2.317	11	21	20	2p13.1	M1AP, SPATA37, C2orf65, SPGF48		Meiosis 1-associated protein	619098			Spermatogenic failure 48, 619108 (3)	6(M1ap)
2.318	4	23	13	2p13.1	MOGS, GCS1, CDG2B		Mannosyl-oligosaccharide glucosidase	601336			Congenital disorder of glycosylation, type IIb, 606056 (3)	
2.319	11	05	18	2p13.1	PCGF1, NSPC1		Polycomb group RING finger protein 1	610231				6(Pcgf1)
2.320	9	12	13	2p13.1	STAMBP, AMSH, MICCAP		STAM binding protein	606247			Microcephaly-capillary malformation syndrome, 614261 (3)	
2.321	03	05	20	2p13.1	TET3, KIAA0401, BEFAHRS		TET oncogene family, member 3	613555			Beck-Fahrner syndrome, 618798 (3)	
2.322	10	31	17	2p13.1	TPRKB, GAMOS5		TP53RK-binding protein	608680			Galloway-Mowat syndrome 5, 617731 (3)	
2.323	2	26	02	2p13.1	NAT8, TSC510		N-acetyltransferase 8	606716				
2.324	5	25	13	2p13.1	NAT8B, CML2		N-acetyltransferase 8B	608190				
2.325	7	17	02	2p13.1	TLX2, HOX11L1		T-cell leukemia, homeobox 2	604240				
2.326	10	31	19	2p13.1	ALMS1, ALSS, KIAA0328		ALMS1 centrosome and basal body associated protein	606844			Alstrom syndrome, 203800 (3)	
2.327	2	9	92	2p13.3	ANXA4, ANX4		Annexin A4 (placental anticoagulant protein II)	106491				6(Anx4)
2.328	11	30	06	2p13.3	ARHGAP25, KAIA0053		RHO GTPase-activating protein 25	610587				
2.329	6	16	99	2p13.1	AUP1		Ancient ubiquitous protein 1	602434				6(Aup1)
2.330	12	26	13	2p13.2	CCT7		Chaperonin containing T-complex polypeptide 1, subunit 7	605140				
2.331	3	7	14	2p13.3	CD207, LANGERIN, CLEC4K		CD207 antigen	604862		mutation identified in 1 patient	[?Birbeck granule deficiency], 613393 (3)	6(Langerin)
2.332	02	19	20	2p13.1	DCTN1, HMN7B		Dynactin 1	601143			Neuronopathy, distal hereditary motor, type VIIB, 607641 (3); {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3); Perry syndrome, 168605 (3)	
2.333	8	17	16	2p13.1	DGUOK, DGK, MTDPS3, PEOB4, NCPH		Deoxyguanosine kinase, mitochondrial	601465			Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, 617070 (3); Portal hypertension, noncirrhotic, 617068 (3)	
2.334	12	15	98	2p13.1	DOK1		Downstream of tyrosine kinase 1	602919				6(Dok1)
2.335	8	24	92	2p13.2	EGR4, NGFIC		Early growth response-4	128992				6(Egr4)
2.336	4	30	15	2p13.3	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1		Glutamine-fructose-6-phosphate transaminase	138292			Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	
2.337	7	9	15	2p13.1	INO80B, PAPA1, HMGA1L4		INO80 complex, subunit B	616456				
2.338	8	27	02	2p13.1	LBX2		Lady bird-like homeo box 2	607164				6(Lbx2)
2.339	11	27	94	2p13.3	MAD		MAD protein (MAX-binding protein)	600021				
2.340	8	20	98	2p13	OFC2		Orofacial cleft 2	602966		?relation to TGFA	Orofacial cleft 2 (2)	
2.341	11	6	94	2p15	OTX1		Orthodenticle, Drosophila, homolog of, 1	600036				
2.342	10	28	99	2p13	PEE1, PREG1		Preeclampsia/eclampsia 1	189800		?distinct loci at 2p25 and 9p13	Preeclampsia/eclampsia 1 (2)	
2.343	4	23	98	2p13.1	RTKN		Rhotekin	602288				6(Rtkn)
2.344	4	10	15	2p13	PARK3		Parkinson disease 3	602404			{Parkinson disease 3} (2)	
2.345	6	28	99	2p13.1	SEMAW		Semaphorin W	603706				6(Semawa)
2.346	12	27	13	2p13.2	SFXN5		Sideroflexin 5	615572				
2.347	5	6	03	2p13.1	SLC4A5, NBC4		Solute carrier family 4, sodium bicarbonate cotransporter, member 5	606757				
2.348	7	10	93	2p13.3	TGFA		Transforming growth factor, alpha	190170				6(Tgfa)
2.349	4	17	13	2p13.3	TIA1, WDM		TIA1 cytotoxic granule-associated RNA-binding protein	603518			Welander distal myopathy, 604454 (3)	
2.350	12	31	99	2p13.3	VAX2		Ventral anterior homeo box 2	604295				6(Vax2)
2.351	6	3	02	2p14	C1D, SUNCOR		Nuclear DNA-binding protein C1D	606997		pseudogene on chr.10		
2.352	3	9	98	2p13.3	PCBP1		Poly(rC)-binding protein-1	601209				
2.353	8	27	09	2p13.2	RAB11RIP5, RIP11, KIAA0857		Rab11 family-interacting protein 5	605536				
2.354	07	31	20	2p16.1	REL		REL protooncogene, NF-kappa-B subunit	164910				11(Rel)
2.355	7	22	13	2p12	CTRCT27, CCNP		Cataract 27, nuclear progressive	607304		near D2S2333	Cataract 27, nuclear progressive (2)	
2.356	5	27	05	2p11.2	CD8A		CD8 antigen, alpha polypeptide (p32)	186910		distal to IGK	CD8 deficiency, familial, 608957 (3)	6(Ly2)
2.357	9	12	93	2p11.2	CD8B1, CD8B		CD8 antigen, beta polypeptide 1 (p37)	186730		pseudogene, CD8B2, on 2q12		6(Ly3)
2.358	1	6	11	2p12	DFNA43		Deafness, autosomal dominant 43	608394		max lod at D2S139	Deafness, autosomal dominant 43 (2)	
2.359	8	14	00	2p11.2	EIF2AK3, PEK, PERK, WRS		Eukaryotic translation initiation factor 2-alpha kinase 3	604032			Wolcott-Rallison syndrome, 226980 (3)	
2.360	08	19	20	2p12	EVA1A, TMEM166, FAM176A		EVA1 homolog A, regulator of programmed cell death	618990				
2.361	09	12	19	2p13.3	FIGLA, POF6		Folliculogenesis specific bHLH transcription factor	608697			Premature ovarian failure 6, 612310 (3)	
2.362	3	13	07	2p11.2	GGCX, VKCFD1		Gamma-glutamyl carboxylase	137167			Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3); Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)	
2.363	4	11	97	2p12	HK2		Hexokinase-2, muscle	601125		no recombination with TGFA		
2.364	7	24	15	2p11.2	IGKC, IGKCD		Immunoglobulin kappa constant region	147200			Kappa light chain deficiency, 614102 (3)	6(Igkc)
2.365	4	15	08	2p12	IGKJ@		Immunoglobulin kappa light chain joining gene cluster	146970		5 genes		
2.366	4	15	08	2p12	IGKV@		Immunoglobulin kappa light chain variable gene cluster	146980		25+ genes in 4 classes; orphon gene 1.5Mb telomeric of IGKC		6(Igkv)
2.367	6	18	91	2p11.2	IGKDEL		Immunoglobulin kappa polypeptide deleting element	146780				6(Igkrs)
2.368	2	5	16	1p36.12	PLA2G2F		Phospholipase A2, group IIf	616793				4(Pla2g2f)
2.369	3	26	07	2p12	LRRTM1		Leucine-rich repeat transmembrane protein 1	610867				6(Lrrtm1)
2.370	3	26	07	2p12	LRRTM4		Leucine-rich repeat transmembrane protein 4	610870				6(Lrrtm4)
2.371	3	5	08	2p13.1	MRPL53		Mitochondrial ribosomal protein L53	611857		pseudogene on 1		
2.372	3	17	94	2p12	PAP		Pancreatitis-associated protein	167805				
2.373	10	7	02	2p12	POLE4		Polymerase, DNA, epsilon-4	607269				
2.374	12	19	16	2p13.1	HTRA2, OMI, PARK13, PRSS25, MGCA8		HTRA serine peptidase 2	606441			{Parkinson disease 13}, 610297 (3); 3-methylglutaconic aciduria, type VIII, 617248 (3)	
2.375	3	14	96	2p12	REG1A, PSPS1, REG		Regenerating islet-derived 1 alpha (pancreatic stone protein, pancreatic thread protein)	167770				12(Reg1)
2.376	2	28	06	2p12	REG3G, PAP1B		Regenerating islet-derived 3-gamma	609933				
2.377	10	4	93	2p12	REGL, PSPS2		Regenerating islet-derived, rat, homolog-like (pancreatic stone protein-like; pancreatic thread protein-like)	167771				?3(Reg2)
2.378	5	28	02	2p13.1	WBP1		WW domain-binding protein 1	606961				
2.379	2	1	11	2p12-p11.2	DEL2p12p11.2, C2DELp12p11.2		Chromosome 2p12-p11.2 deletion syndrome	613564		contiguous gene deletion syndrome	Chromosome 2p12-p11.2 deletion syndrome (4)	
2.380	5	21	07	2p11.2	SFTPB, SFTB3, SMDP1		Pulmonary surfactant-associated protein B, 18kD	178640			Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)	6(Sftp3)
2.381	5	13	02	2p11.2	VAMP8		Vesicle-associated membrane protein 8	603177				6(Vamp8)
2.382	11	09	18	2p12	CTNNA2, CAPR, CTNR, CDCBM9		Catenin, alpha-2 (cadherin-associated protein, related)	114025			Cortical dysplasia, complex, with other brain malformations 9, 618174 (3)	6(Capr)
2.383	1	31	00	2p11.2	GNLY, D2S69E, TLA519		Granulysin (T-lymphocyte activation gene 519)	188855				
2.384	3	5	03	2p12-q22	HSR		Hand skill, relative	139900			[Handedness] (2)	
2.385	5	2	94	2p22.3	LTBP1		Latent transforming growth factor beta binding protein 1	150390				
2.386	9	29	13	2p11.2	ELMOD3, RBED1, DFNB88		ELMO/CED12 domain-containing protein 3	615427		one family identified with mutation	?Deafness, autosomal recessive 88, 615429 (3)	
2.387	07	26	19	2p11.2	C2orf68, HCRCN81		Chromosome 2 open reading frame 68	618519				
2.388	2	21	06	2p11.2	DNAH6, HL2		Dynein, axonemal, heavy chain 6	603336				
2.389	10	21	08	2p11.2	FOXI3		Forkhead box I3	612351				
2.390	2	20	09	2p11.2	IMMT, HMP		Inner membrane protein, mitochondrial (mitofilin)	600378		pseudogene on chr.21		
2.391	7	18	12	2p11.2	KCMF1, DEBT91, FIGC		Potassium channel modulatory factor 1	614719				
2.392	10	24	11	2p11.2	KDM3A, JMJD1A, JHDM2A, TSGA, KIAA0742		Lysine-specific demethylase 3A	611512				
2.393	8	4	97	2p11.2	MAT2A, MATA2, SAMS2		Methionine adenosyltransferase II, alpha	601468				
2.394	3	5	08	2p11.2	MRPL35		Mitochondrial ribosomal protein L35	611841		pseudogenes on 6, 10, and X		
2.395	5	19	15	2p11.2	PARTICL		Promoter of MAT2A antisense radiation-induced circulating long noncoding RNA	616350		overlaps promoter of MAT2A on opposite strand		
2.396	7	9	15	2p11.2	POLR1A, RPA194, AFDCIN		Polymerase I, RNA, subunit A	616404			Acrofacial dysostosis, Cincinnati type, 616462 (3)	
2.397	10	22	20	2p11.2	PTCD3, COXPD51		Pentatricopeptide repeat domain-containing protein 3	614918		mutation identified in 1 COXPD51 patient	?Combined oxidative phosphorylation deficiency 51, 619057 (3)	
2.398	1	21	15	2p11.2	REEP1, C2orf23, SPG31, HMN5B		Receptor expression-enhancing protein 1	609139		mutation identified in 1 HMN5B family	Spastic paraplegia 31, autosomal dominant, 610250 (3); ?Neuronopathy, distal hereditary motor, type VB, 614751 (3)	
2.399	7	27	17	2p11.2	RETSAT		Retinol saturase	617597				
2.400	4	23	09	2p11.2	RGPD1, RGP1		RANBP2-like and GRIP domain-containing protein 1	612704				
2.401	4	23	09	2p11.2	RGPD2, RGP2		RANBP2-like and GRIP domain-containing protein 2	612705				
2.402	07	28	20	2p11.2	RMND5A, RMD5, GID2		Required for meiotic nuclear division 5 homolog A	618964				
2.403	12	22	08	2p11.2	RNF181		Ring finger protein 181	612490				
2.404	06	21	19	2p11.2	RPIA, RPI, RPIAD		Ribose 5-phosphate isomerase A	180430			Ribose 5-phosphate isomerase deficiency, 608611 (3)	
2.405	9	16	16	2p11.2	SIAT9, ST3GALV, SPDRS		Sialyltransferase 9	604402			Salt and pepper developmental regression syndrome, 609056 (3)	
2.406	12	13	17	2p11.2	SMYD1, BOP, ZMYND18		SET and MYND domain-containing protein 1	606846				
2.407	12	27	10	2p11.2	SUCLG1, SUCLA1, MTDPS9		Succinate-CoA ligase, alpha subunit	611224			Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)	
2.408	6	13	12	2p11.2	TCF7L1		Transcription factor 7-like 1	604652				
2.409	3	4	10	2p11.2	TGOLN2, TGN46, TGN38		Trans-golgi network protein 2, 46kD	603062				
2.410	8	19	13	2p11.2	THNSL2, THS2		Threonine synthase-like 2	611261				
2.411	1	14	16	2p11.2	TMEM150A, TMEM150		Transmembrane protein 150A	616757				
2.412	3	7	14	2p11.2	TMSB10		Thymosin, beta-10	188399				
2.413	12	10	12	2p11.2	TRABD2A, TIKI1		TRAB domain-containing protein 2A	614912				
2.414	2	23	08	2p11.2	USP39, SAD1		Ubiquitin-specific protease 39	611594				
2.415	8	27	09	2p11.2	VAMP5		Vesicle-associated membrane protein 5 (myobrevin)	607029				
2.416	6	24	99	2p11.2	ZFP103, KF1		Zinc finger protein 103, mouse, homolog of	602507				
2.417	9	19	00	2p12	C2orf3, TCF9, GCF		GC factor	189901				
2.418	1	30	07	2q11.2	ANKRD23, DARP		Ankyrin repeat domain-containing protein 23	610736				
2.419	2	28	08	2p12	MRPL19, MRPL15, KIAA0104		Mitochondrial ribosomal protein L19	611832				
2.420	4	23	08	2q11.1	MRPS5		Mitochondrial ribosomal protein S5	611972				
2.421	1	25	88	2p11.2	FABP1		Fatty acid-binding protein, liver	134650				6(Fabpl)
2.422	11	23	16	2q11.2	NEURL3, LINCR		Neuralized E3 ubiquitin protein ligase 3	617206				
2.423	7	15	04	2p12	TACR1, TAC1R, NK1R		Tachykinin receptor 1 (substance P receptor; neurokinin-1 receptor)	162323				
2.424	9	2	08	2p11.2	PLGLB1, PLGL, PRGB		Plasminogen-like B1	173340				
2.425	9	20	00	2p14	PLEK		Pleckstrin	173570				11(Plek)
2.426	12	4	95	2p24.2	VSNL1		Visinin-like 1	600817				
2.427	08	28	20	2p13.3	ATP6V1B1, ATP6B1, VPP3, DRTA2		ATPase, H+ transporting, lysosomal, 56/58kD, V1 subunit B, isoform 1	192132			Distal renal tubular acidosis 2 with progressive sensorineural hearing loss, 267300 (3)	8(Atp6b1)
2.428	3	8	91	2q11.2	COX5B		Cytochrome c oxidase, subunit Vb	123866		7 pseudogenes on 4, 6, 7, 11, 12, 13, and 22		
2.429	2	14	02	2cen-q13	GLC1B		Glaucoma 1, open angle, B (adult-onset)	606689			Glaucoma 1B, primary open angle, adult onset (2)	
2.430	10	23	87	2q14.2	INHBB		Inhibin, beta-2	147390				1(Inhbb)
2.431	10	23	87	2q11.1	MAL		T-lymphocyte maturation-associated protein	188860				
2.432	12	19	90	2q14.2	RALB		RAS-like protein B	179551				
2.433	1	1	95	2p11.2	CAPG		Capping protein (actin filament), gelsolin-like	153615				
2.434	2	28	06	2q	COPD		Pulmonary disease, chronic obstructive, severe early-onset	606963		?SERPINE2	Pulmonary disease, chronic obstructive, severe early-onset (2)	
2.435	10	7	98	2q11.2	CNGA3, CNG3, ACHM2		Cyclic nucleotide-gated channel, alpha-3	600053			Achromatopsia 2, 216900 (3)	
2.436	10	15	98	2q11.2	DUSP2, PAC1		Dual-specificity phosphatase-2	603068				
2.437	7	26	10	2q11.2	TMEM127		Transmembrane protein 127	613403			{Pheochromocytoma, susceptibility to}, 171300 (3)	
2.438	4	25	08	2q11-q12	CELIAC8		Celiac disease, susceptibility to, 8	612006		associated with rs917997 and rs13015714	{Celiac disease, susceptibility to, 8} (2)	
2.439	12	17	12	2q13	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B		Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of)	604095			Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3); Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3); [Hair morphology 1, hair thickness], 612630 (3)	
2.440	10	3	11	2q13	RANBP2, NUP358, ANE1, IIAE3		RAN-binding protein 2	601181			{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)	10(Ranbp2)
2.441	3	20	08	2q11-q14	NNO3		Nanophthalmos 3	611897		max lod at D2S2265	Nanophthalmos 3 (2)	
2.442	8	17	98	2q14.1	SLC20A1, GLVR1		Solute carrier family 20, phosphate transporter, member 1 (Gibbon ape leukemia virus receptor-1)	137570				2(Slc20a1)
2.443	9	9	10	2q11.1	KCNIP3, KCHIP3, CSEN, DREAM		Potassium channel-interacting protein 3	604662				
2.444	10	25	16	2q11.1	PROM2, PROML2		Prominin 2	617160				2(Prom2)
2.445	1	30	01	2q11.2	ACTR1B, ARP1B, CTRN2		Actin-related protein 1B	605144				
2.446	4	23	98	2q12.3	SULT1C1		Sulfotransferase 1C1	602385				
2.447	11	14	19	2q11.2	ADRA2B, ADRA2L1		Adrenergic, alpha-2B-, receptor	104260				
2.448	12	7	07	2q11.2	ARID5A, MRF1		AT-rich interactive domain-containing protein 5A	611583				
2.449	5	17	18	2q11.2	NCAPH, CAPH, BRRN1, MCPH23		Non-SMC condensin I complex subunit H	602332		mutation identified in 1 MCPH23 patient	?Microcephaly 23, primary, autosomal recessive, 617985 (3)	
2.450	10	23	20	2q11.2	COA5, C2orf64, PET191, MC4DN9		Cytochrome c oxidase assembly factor 5	613920		mutation identified in 1 MC4DN9 family	?Mitochondrial complex IV, deficiency, nuclear type 9, 616500 (3)	
2.451	8	27	09	2q11.2	CHST10, HNK1ST		Carbohydrate sulfotransferase 10	606376				
2.452	8	31	12	2q11.2	CIAO1, WDR39		WD repeat-containing protein CIAO1	604333				
2.453	8	31	09	2q11.2	CNNM3, ACDP3		Cyclin M3	607804		previously assigned to 2p12-p11.2		
2.454	8	31	09	2q11.2	CNNM4, ACDP4		Cyclin M4	607805			Jalili syndrome, 217080 (3)	1(Cnnm4)
2.455	08	14	19	2q11.2	CREG2		Cellular repressor of E1A-stimulated genes 2	618540				
2.456	9	30	09	2q24.1	CYTIP, PSCDBP, HE		Cytohesin 1 interacting protein	604448				
2.457	6	23	15	2q11.2	GPAT2		Glycerol-3-phosphate acyltransferase 2, mitochondrial	616431				
2.458	2	9	00	2q12.1	IL1RL1		Interleukin 1 receptor-like 1	601203				
2.459	10	24	00	2q11.2	INPP4A, INPP4		Inositol polyphosphate-4-phosphatase, type I, 107kD	600916				
2.460	10	25	17	2q11.2	KANSL3, NSL3, KIAA1310		Kat8 regulatory NSL complex, subunit 3	617742				
2.461	4	4	16	2q11.2	LMAN2L, VIPL, MRT52		LMAN2-like protein	609552		mutation identified in 1 MRT52 family	?Mental retardation, autosomal recessive, 52, 616887 (3)	
2.462	4	30	15	2q11.2	LIPT1, LIPT1D		Lipoyltransferase 1	610284			Lipoyltransferase 1 deficiency, 616299 (3)	
2.463	9	21	15	2q11.2	LYG2, LYSG2		Lysozyme G-like 2	616547				
2.464	2	25	15	2q11.2	MAP4K4, HGK, NIK, KIAA0687		Mitogen-activated protein kinase kinase kinase kinase 4	604666				
2.465	2	28	08	2q11.2	MRPL30, MRPL28		Mitochondrial ribosomal protein L30	611838				
2.466	12	17	07	2q11.2	PDCL3, PHLP3, VIAF		Phosducin-like 3	611678				
2.467	02	20	20	2q11.2	REV1L, REV1		REV1 DNA directed polymerase	606134				
2.468	4	21	17	2q11.2	RPL31		Ribosomal protein L31	617415				
2.469	1	1	96	2q12.1	SLC9A2		Solute carrier family 9 (sodium/hydrogen exchanger), member 2	600530				1(Slc9a2)
2.470	2	19	10	2q11.2	SNRNP200, ASCC3L1, KIAA0788, RP33		Small nuclear ribonucleoprotein 200kD (U5)	601664			Retinitis pigmentosa 33, 610359 (3)	
2.471	11	14	19	2q11.2	STARD7, GTT1, FAME2		START domain-containing protein 4	616712			Epilepsy, familial adult myoclonic, 2, 607876 (3)	
2.472	1	27	04	2q12.3	SULT1C2		Sulfotransferase family 1C, member 2	608357				
2.473	3	7	14	2q11.2	TMEM131, KIAA0257, CC28		Transmembrane protein 131	615659				
2.474	5	9	18	2q11.2	TSGA10, SPGF26		Testis-specific protein 10	607166		mutation identified in 1 SPGF26	?Spermatogenic failure 26, 617961 (3)	
2.475	2	4	09	2q11.2	TXNDC9, PHLP3		Thioredoxin domain-containing protein 9	612564				
2.476	12	22	17	2q11.2	UNC50, UNCL, GMH1		Unc50 inner nuclear membrane RNA-binding protein	617826				
2.477	5	23	16	2q11.2	VWA3B, SCAR22		von Willebrand factor A domain-containing protein 3B	614884		mutation identified in 1 SCAR22 family	?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3)	
2.478	3	1	01	2q11.1	ZNF2		Zinc finger protein-2	194500				
2.479	5	5	00	2q12.1	GPR45		G protein-coupled receptor 45	604838				
2.480	10	17	96	2q11.2	LAF4		Lymphoid nuclear protein related to AF4	601464				1(Laf4)
2.481	2	19	04	2q12.3	ST6GALII, KIAA1877		Beta-galactoside alpha-2,6-sialyltransferase II	608472				
2.482	3	1	00	2q12.1	IL18R1, IL1RRP		Interleukin 18 receptor 1	604494				
2.483	3	10	00	2q12.1	IL18RAP, ACPL		Interleukin 18 receptor accessory protein	604509				
2.484	8	17	98	2q11.2-q12.1	IL1R1, IL1RA		Interleukin-1 receptor, type I	147810				1(Il1r)
2.485	2	9	00	2q12.1	IL1RL2, IL1RRP2		Interleukin 1 receptor-like 2	604512				
2.486	3	8	00	2q11.2	MGAT4A		Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A	604623				
2.487	5	12	00	2q12.2	NCK2		NCK adaptor protein 2	604930				
2.488	12	23	05	2q12.2	UXS1, UGD		UDP-glucuronate decarboxylase 1	609749				
2.489	6	30	16	2q11.2	ZAP70, SRK, ADMIO2, IMD48		Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase)	176947			Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3); Immunodeficiency 48, 269840 (3)	1(Zap70)
2.490	7	9	06	2q14.2	MARCO		Macrophage receptor with collagenous structure	604870				1(Marco)
2.491	6	23	98	2q12.2	FHL2, DRAL		Four and a half LIM domains-2 (Down-regulated in rhabdomyosarcoma LIM protein)	602633				
2.492	9	28	00	2q12-q14	IGKV1OR2-108, IGO1		Immunoglobulin orphon (transposed element) 1	147185				
2.493	8	27	01	2q14.1	PAX8		Paired box homeotic gene-8	167415			Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)	2(Pax8)
2.494	1	5	93	2q14.2	DBI		Diazepam-binding inhibitor	125950		?on 6q21-qter		
2.495	12	21	98	2q11.2	IL1R2, IL1RB		Interleukin-1 receptor, type II	147811				1(Il1rb)
2.496	9	10	07	2q37.1	SNORD82, RNU82		Small nucleolar RNA, C/D box, 82	611133				
2.497	2	26	95	2q37.1	NCL		Nucleolin	164035				
2.498	9	1	11	2q14.1	IL37, IL1F7, FIL1Z, IL1H4, IL1RP1		Interleukin 37	605510				
2.499	12	11	18	2q12.1	LINC01159, LINC-BRN1B		Long intergenic noncoding RNA 1159	618208				1(Linc01159)
2.500	8	17	16	2q12.1	LNC13		Long noncoding RNA 13	617071				
2.501	4	23	08	2q12.1	MRPS9		Mitochondrial ribosomal protein S9	611975				
2.502	11	02	18	2q12.1	PANTR1, LINC01158		POU3F3-adjacent noncoding transcript 1	618169				
2.503	10	03	19	2q12.1	POU3F3, SNIBFIS		POU domain, class 3, transcription factor-3	602480			Snijders Blok-Fisher syndrome, 618604 (3)	1(Pou3f3)
2.504	4	30	09	2q12.1	SLC9A4, NHE4		Solute carrier family 9 (sodium/hydrogen exchanger), member 4	600531				1(Slc9a4)
2.505	8	27	09	2q12.1-q12.2	TGFBRAP1, TRAP1		Transforming growth factor-beta receptor-associated protein 1	606237				
2.506	9	2	08	2q12.2	PLGLA, PRGA		Plasminogen-like A	612212				
2.507	10	11	16	2q12.3	SULT1C3		Sulfotransferase family 1C, member 3	617151				
2.508	4	23	09	2q12.3	GCC2, GCC185, KIAA0336		GRIP and coiled-coil domains-containing protein 2	612711				
2.509	08	22	19	2q12.3	LIMS1, PINCH1		LIM and senescent cell antigen-like domains 1	602567				
2.510	10	11	16	2q12.3	SLC5A7, CHT1, HMN7A, CMS20		Solute carrier family 5 (choline transporter), member 7	608761			Neuronopathy, distal hereditary motor, type VIIA, 158580 (3); Myasthenic syndrome, congenital, 20, presynaptic, 617143 (3)	
2.511	4	23	09	2q12.2	RGPD3, RGP3		RANBP2-like and GRIP domain-containing protein 3	612706				
2.512	4	23	09	2q12.3	RGPD4, RGP4		RANBP2-like and GRIP domain-containing protein 4	612707				
2.513	4	23	09	2q13	RGPD5, RGP5, BS63		RANBP2-like and GRIP domain-containing protein 5	612708				
2.514	4	23	09	2q13	RGPD6, RGP6		RANBP2-like and GRIP domain-containing protein 6	612709				
2.515	4	23	09	2q12.3-q13	RGPD7, RGP7		RANBP2-like and GRIP domain-containing protein 7	612710				
2.516	4	23	09	2q14.1	RGPD8, RGP8, RANBP2L1		RANBP2-like and GRIP domain-containing protein 8	602752				
2.517	3	6	08	2q14.1	DPP10, DPRP3, KIAA1492		Dipeptidyl peptidase X	608209				
2.518	10	18	19	2q13	ANAPC1, APC1		Anaphase-promoting complex, subunit 1	608473			Rothmund-Thomson syndrome, type 1, 618625 (3)	
2.519	10	11	16	2q13	BCL2L11, BIM		BCL2-like 11	603827				
2.520	1	12	15	2q14.1	CKAP2L, RADMIS		Cytoskeleton-associated protein 2-like	616174			Filippi syndrome, 272440 (3)	
2.521	3	31	03	2q13	COMA		Cogan-type congenital oculomotor apraxia	257550		independent gene or feature of nephronophthisis	Oculomotor apraxia, congenital, Cogan-type (2)	
2.522	3	17	08	2q13-q14	FBLN7, TM14		Fibulin 7	611551				
2.523	10	15	97	2q13	MALL, BENE		mal, T-cell differentiation protein-like	602022				
2.524	9	1	11	2q14.1	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14		Interleukin 36 receptor antagonist	605507			Psoriasis 14, pustular, 614204 (3)	
2.525	9	1	11	2q14.1	IL36A, IL1F6, FIL1E		Interleukin 36, alpha	605509				
2.526	9	1	11	2q14.1	IL36B, IL1F8, IL1H2, FIL1H		Interleukin 36, beta	605508				
2.527	9	1	11	2q14.1	IL36G, IL1F9, IL1H1, IL1RP2		Interleukin 36, gamma	605542				
2.528	7	12	17	2q13	MIR4435-2HG, MORRBID		MIR4435-2 host gene (long noncoding RNA MORRBID)	617144				
2.529	6	16	99	2q11.2	NPAS2, MOP4		Neuronal PAS domain protein 2	603347				1(Npas2)
2.530	6	16	04	2q13	NPHP1, NPH1, SLSN1, JBTS4		Nephrocystin	607100			Nephronophthisis 1, juvenile, 256100 (3); Senior-Loken syndrome-1, 266900 (3); Joubert syndrome 4, 609583 (3)	
2.531	1	30	12	2q14.1	PSD4, EFA6B, TIC		Pleckstrin and Sec7 domains-containing protein 4	614442				
2.532	11	27	00	2q14.1	RABL2A		RAB-like 2A	605412				
2.533	1	22	08	2q13	SEPT10		Septin 10	611737		pseudogene on 8q22.1-q12		
2.534	06	29	20	2q13	SH3RF3, POSH2		SH3 domain-containing RING finger protein 3	618933				
2.535	11	23	16	2q13	TMEM87B		Transmembrane protein 87B	617203				
2.536	12	4	03	2q14.1	TTL		Tubulin-tyrosine ligase	608291				2(Ttl)
2.537	3	1	12	2q14.3	PROC, PC, THPH3, THPH4		Protein C (inactivator of coagulation factors Va and VIIIa)	612283			Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3); Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)	
2.538	8	21	07	2q14.1	CBWD2		Cobalamin synthetase W domain-containing protein 2	611079				
2.539	8	21	07	2q14.1	FOXD4L1		Forkhead box D4-like 1	611084				
2.540	3	22	93	2q14.2	EN1		Engrailed-1	131290				1(En1)
2.541	11	7	17	2q14.3	BIN1, AMPHL, CNM2		Box-dependent MYC-interacting protein-1 (amphiphysin-like)	601248			Centronuclear myopathy 2, 255200 (3)	18(Bin1)
2.542	09	12	19	2q13	BUB1		BUB1 mitotic checkpoint serine/threonine kinase	602452			Colorectal cancer with chromosomal instability, somatic, 114500 (3)	2(Bub1)
2.543	8	27	09	2q14.2-q14.3	CLASP1, KIAA0622		CLIP-associated protein 1	605852				
2.544	5	26	13	2q14.3	CNTNAP5, CASPR5		Contactin-associated protein-like 5	610519				
2.545	1	17	08	2q14.2	EPB41L5, KIAA1548		Erythrocyte membrane protein band 4.1-like 5	611730				
2.546	12	10	14	2q14.2	GLI2, HPE9, CJS		GLI-Kruppel family member GLI2 (oncogene GLI2)	165230			Holoprosencephaly 9, 610829 (3); Culler-Jones syndrome, 615849 (3)	
2.547	6	11	98	2q14.1	IL1A		Interleukin-1, alpha	147760		within 430kb of IL1B, IL1RN		2(Il1a)
2.548	5	27	05	2q14.1	IL1B		Interleukin-1, beta	147720		within 430kb of IL1RN, IL1A	{Gastric cancer risk after H. pylori infection}, 137215 (3)	2(Il1b)
2.549	7	1	13	2q14.1	IL1F10, IL1HY2		Interleukin 1 family, member 10	615296				
2.550	12	23	05	2q14.2	TFCP2L1, CRTR1, LBP9		Transcription factor CP2-like 1	609785				
2.551	6	9	08	2p14	WDR92, LOC116143, MONAD		WD repeat-containing protein 92	610729				
2.552	11	14	14	2q14.3	GYPC, GE, GPC		Glycophorin C	110750			{Malaria, resistance to}, 611162 (3); [Blood group, Gerbich], 616089 (3)	
2.553	03	09	20	2q14-q21	LCO		Liver cancer oncogene	165320				
2.554	2	10	95	2q14-q21	VIS1, HIS1		Viral integration site 1	164755				2(His1)
2.555	11	9	99	2q14-q22	CMD1H		Cardiomyopathy, dilated, 1H	604288			Cardiomyopathy, dilated, 1H (2)	
2.556	4	22	10	2q14.1	ACTR3, ARP3		Actin-related protein 3	604222				
2.557	12	24	08	2q14.1	BMIQ13		Body mass index quantitative trait locus 13	612459		associated with rs7566605	[Body mass index QTL13] (2)	
2.558	6	17	16	2q14.1	CHCHD5, MIC14		Coiled coil-helix-coiled coil-helix domain-containing protein 5	616978				
2.559	12	4	08	2q14.1-q14.2	INSIG2		Insulin-induced gene 2	608660				
2.560	11	8	95	2q14.2	SCTR		Secretin receptor	182098				
2.561	4	6	11	2q13	MERTK, RP38		Mer tyrosine kinase protooncogene	604705			Retinitis pigmentosa 38, 613862 (3)	
2.562	07	13	20	2q14.1	DDX18		DEAD-box helicase 18	606355				
2.563	07	06	20	2q14.1	POLR1B, TCS4		Polymerase I, RNA, subunit B	602000			Treacher-Collins syndrome 4, 618939 (3)	
2.564	10	23	20	2q12.2	ECRG4, C2orf40		ECRG4 augurin precursor	611752				
2.565	11	19	11	2q14.2	C1QL2, CTRP10, C1QTNF10		Complement component 1, q subcomponent-like 2	614330				
2.566	12	19	19	2q14.2	CFAP221, PCDP1		Cilia- and flagella-associated protein 221	618704				
2.567	10	1	17	2q14.2	PTPN4, PTPMEG1		Protein-tyrosine phosphatase, nonreceptor-type, 4	176878				
2.568	7	9	09	2q14.1	IL1RN, MVCD4, DIRA		Interleukin-1 receptor antagonist	147679			{Gastric cancer risk after H. pylori infection}, 137215 (3); {Microvascular complications of diabetes 4}, 612628 (3); Interleukin 1 receptor antagonist deficiency, 612852 (3)	
2.569	09	17	20	2q14.2	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN, LWS		RNA, U4ATAC small nuclear	601428			Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3); Roifman syndrome, 616651 (3); Lowry-Wood syndrome, 226960 (3)	
2.570	08	23	19	2q14.2	STEAP3, TSAP6, AHMIO2		STEAP3 metalloreductase	609671		mutation identified in 1 AHMIO2 family	?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3)	1(Steap3)
2.571	04	02	20	2q14.2	TMEM37		Transmembrane protein 37	618831				
2.572	09	27	18	2q14.3	LIMS2, PINCH2, MDRCMTT		LIM and senescent cell antigen-like domains 2	607908		mutation identified in 1 LGMD2W family	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue, 616827 (3)	
2.573	6	27	14	2q14.3	MAP3K2, MEKK2		Mitogen-activated protein kinase kinase kinase 2	609487				
2.574	3	6	18	2q14.3	NIFK, MKI67IP, NOPP34		Nucleolar protein interacting with the FHA domain of MKI67	611970				
2.575	9	27	17	2q14.3	POLR2D		Polymerase II, RNA, subunit D	606017				
2.576	12	28	08	2q14.3	SAP130		Sin3A-associated protein, 130kD	609697				
2.577	8	27	09	2q14.3	UGGT1, HUGT1		UDP-glucose glycoprotein glucosyltransferase 1	605897				
2.578	8	10	18	2q14.3	WDR33, WDC146		WD repeat-containing protein 33	618082				
2.579	4	27	12	2q14.3-q21.3	DYT21		Dystonia 21	614588			Dystonia 21 (2)	
2.580	4	16	03	2q22.1	CXCR4, D2S201E, NPY3R, WHIMS		Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3)	162643			WHIM syndrome, 193670 (3); Myelokathexis, isolated (3)	
2.581	6	2	15	2q14.3	ERCC3, XPB, TTD2		Excision-repair cross-complementing rodent repair deficiency, complementation group 3	133510			Xeroderma pigmentosum, group B, 610651 (3); Trichothiodystrophy 2, photosensitive, 616390 (3)	
2.582	10	15	98	2q14.3	GPR17		G protein-coupled receptor-17	603071				
2.583	10	17	12	2q14.3	HS6ST1, HS6ST, HH15		Heparan sulfate 6-O-sulfotransferase 1	604846			{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3)	
2.584	1	23	09	2q21.3	LCT, LAC, LPH		Lactase (lactase-phlorizin hydrolase)	603202			Lactase deficiency, congenital, 223000 (3)	
2.585	2	5	09	2q21.3	MCM6		Minichromosome maintenance deficient (mis5, S. pombe) 6	601806		mutations in introns 9 and 13	Lactase persistence/nonpersistence, 223100 (3)	
2.586	7	1	97	2q21.2-q21.3	MGAT5		Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl- glucosaminyltransferase	601774				
2.587	3	23	09	2q21.3	MIR128-1, MIRN128-1, MIR128A		Micro RNA 128-1	611774				
2.588	9	1	15	2q21	NMTC3		Nonmedullary thyroid carcinoma 3	606240			{Thyroid carcinoma, nonmedullary, 3} (2)	
2.589	11	20	98	2q21.2	GPR39		G protein-coupled receptor-39	602886				
2.590	08	24	20	2q24.3	SCN7A, SCN6A		Sodium voltage-gated channel, alpha subnit 7	182392				
2.591	9	23	08	2q21.1	ADHD5		Attention deficit-hyperactivity disorder, susceptibility to, 5	612311		max lod at rs985162	{Attention deficit-hyperactivity disorder, susceptibility to, 5} (2)	
2.592	11	16	15	2q21.1	CFC1, CRYPTIC, HTX2		Cryptic protein	605194			Heterotaxy, visceral, 2, autosomal, 605376 (3)	
2.593	9	7	10	2q21.1	FAM128A, MOZART2A		Family with sequence similarity 128, member A	613449				
2.594	9	7	10	2q21.1	FAM128B, MOZART2B		Family with sequence similarity 128, member B	613450				
2.595	9	2	09	2q21.1	IMP4, BXDC4		Imp4, S. cerevisiae, homolog of	612981				
2.596	12	27	01	2q14.3	MYO7B		Myosin VIIb	606541				18(Myo7b)
2.597	05	31	19	2q21.1	PLEKHB2, EVT2		Pleckstrin homology domain-containing protein, family B, member 2	618452				
2.598	6	7	10	2q21.1	POTEE, POTE2		POTE ankyrin domain family, member E	608914		5 POTE2 genes within 2Mb segment		
2.599	8	18	12	2q21.1	POTEKP, ACT, ACTBL3, POTEK, FKSG30		POTE ankyrin domain family, member K, pseudogene	611266				
2.600	8	27	09	2q21.1	PTPN18, BDP1		Protein-tyrosine phosphatase, nonreceptor-type, 18	606587				
2.601	3	2	01	2q14.3	TSN		Translin	600575				
2.602	7	22	09	2q21.1	RAB6C, WTH3		Ras-associated protein RAB6C	612909				
2.603	10	17	19	2q21.1	SMPD4, NSMASE3, KIAA1418, NEDMABA		Sphingomyelin phosphodiesterase 4, neutral membrane	610457			Neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies, 618622 (3)	
2.604	4	6	18	2q21.1	TUBA3D, KTCN9		Tubulin, alpha-3D	617878			Keratoconus 9, 617928 (3)	
2.605	12	4	03	2q21.1-q22	CHDS2		Coronary heart disease, susceptibility to, 2	608316			{Coronary heart disease, susceptibility to, 2} (2)	
2.606	2	26	16	2q21.1	CCDC115, CCP1, CDG2O		Coiled-coil domain-containing protein 115	613734			Congenital disorder of glycosylation, type IIo, 616828 (3)	1(Ccdc115)
2.607	5	24	13	2q21.2	LYPD1, PHTS		LY6/PLAUR domain-containing protein 1	610450				
2.608	3	14	13	2q21.2	NCKAP5, NAP5		NCK-associated protein 5	608789				
2.609	08	21	19	2q21.3	DARS1, DARS, HBSL		Aspartyl tRNA synthetase 1	603084			Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3)	
2.610	3	22	06	2q21.3	RAB3GAP1, WARBM1, P130		RAB3 GTPase-activating protein, catalytic subunit	602536			Warburg micro syndrome 1, 600118 (3)	
2.611	08	11	20	2q21.3	TMEM163, SV31		Transmembrane protein 163	618978		REc		
2.612	5	19	16	2q21.3	ZRANB3		Zinc finger RANBP2-type domain-containing protein 3	615655				
2.613	5	29	15	2q21.3	UBXN4, UBXD2, KIAA2042, ERASIN		UBX domain protein 4	611216				
2.614	6	30	08	2q21.1	ARHGEF4, ASEF		RHO guanine nucleotide exchange factor 4	605216				
2.615	7	3	06	2q22.3	GTDC1		Glycosyltransferase-like domain containing 1	610165				
2.616	1	13	16	2q22.1	HNMT, MRT51		Histamine N-methyltransferase	605238			{Asthma, susceptibility to}, 600807 (3); Mental retardation, autosomal recessive 51, 616739 (3)	
2.617	6	4	98	2q23.3	NEB, NEM2		Nebulin	161650			Nemaline myopathy 2, autosomal recessive, 256030 (3)	2(Neb)
2.618	4	19	07	2q22.3	ZEB2, ZFHX1B, SMADIP1, SIP1		Zinc finger E box-binding homeobox 2	605802			Mowat-Wilson syndrome, 235730 (3)	
2.619	11	21	02	2p16.3	KCNK12, THIK2		Potassium channel, subfamily K, member 12	607366				
2.620	4	6	11	2q23.3	CACNB4, EJM6, EA5, EIG9		Calcium channel, voltage-dependent, beta 4 subunit	601949			{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3); {Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3); Episodic ataxia, type 5, 613855 (3)	2(Cacnb4)
2.621	11	16	10	2q24.1	NR4A2, NURR1, NOT, TINUR		Nuclear receptor subfamily 4, group A, member 2	601828				2(Nurr1)
2.622	12	23	19	2q23.1	ORC4, ORC4L		Origin recognition complex, subunit 4	603056			Meier-Gorlin syndrome 2, 613800 (3)	
2.623	8	27	09	2q24.3	GRB14		Growth factor receptor-bound protein 14	601524				
2.624	5	2	08	2q22-q24	MAFD5		Major affective disorder 5	611535			{Major affective disorder 5} (2)	
2.625	7	18	14	2q22.1	NXPH2, NPH2		Neuroxophilin 2	604635				
2.626	9	21	17	2q22.2	KYNU, KYNUU, VCRL2		Kynureninase	605197		mutation identified in 1 KYNUU family	?Hydroxykynureninuria, 236800 (3); Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3)	
2.627	1	24	09	2q22.3-q23.1	ACVR2A, ACVR2		Activin A receptor, type IIA	102581				
2.628	5	26	13	2q22.2-q22.3	ARHGAP15, BM046		Rho GTPase-activating protein 15	610578				
2.629	3	27	12	2q31.1	DCAF17, C20orf37		DDB1- and CUL4-associated factor 17	612515			Woodhouse-Sakati syndrome, 241080 (3)	
2.630	1	1	95	2q24.2	DPP4, CD26, ADCP2		Dipeptidylpeptidase IV (CD26; adenosine deaminase complexing protein-2)	102720				
2.631	8	18	98	2q24.2	FAP, FAPA		Fibroblast activation protein, alpha subunit	600403				
2.632	8	1	08	2q23.3	RPRM		Reprimo	612171				
2.633	5	2	06	2q24.1	ACVR1, ACVRLK2, ALK2, FOP		Activin A receptor, type I	102576			Fibrodysplasia ossificans progressiva, 135100 (3)	
2.634	2	28	01	2q24.2	BAZ2B		Bromodomain adjacent to zinc finger domain, 2B	605683				
2.635	5	25	00	2q24.2	PLA2R1, PLA2R		Phospholipase A2 receptor 1	604939				
2.636	12	03	20	2q23.3	ARL5A		ADP ribosylation factor-like GTPase 5A	608960				
2.637	10	23	20	2q24.3	SCN2A, SCN2A1, BFIC3, DEE11, BFIS3, BFNIS, EA9		Sodium voltage-gated channel, alpha subunit 2	182390		4 related genes on chr.2	Seizures, benign familial infantile, 3, 607745 (3); Developmental and epileptic encephalopathy 11, 613721 (3); Episodic ataxia, type 9, 618924 (3)	2(Scn2a)
2.638	1	17	01	2q24.2	SLC4A10		Solute carrier family 4 (sodium bicarbonate cotransporter-like), member 10	605556				
2.639	8	9	99	2q23-q24.3	DFNA16		Deafness, autosomal dominant 16	603964			Deafness, autosomal dominant 16 (2)	
2.640	4	6	01	2q23-q31	DFNB27		Deafness, autosomal recessive 27	605818			Deafness, autosomal recessive 27 (2)	
2.641	11	29	99	2q24.1	PKP4		Plakophilin-4	604276				
2.642	8	20	07	2q23.1	EPC2		Enhancer of polycomb, Drosophila, homolog of, 2	611000				
2.643	8	1	14	2q23.1-q23.2	KIF5C, NKHC2, CDCBM2		Kinesin family member 5C	604593			Cortical dysplasia, complex, with other brain malformations 2, 615282 (3)	
2.644	10	15	07	2q23.1	MBD5, KIAA1461, MRD1		Methyl-CpG-binding domain protein 5	611472			Mental retardation, autosomal dominant 1, 156200 (3)	
2.645	4	20	10	2q23.2	LYPD6		LY6/PLAUR domain-containing protein 6	613359				
2.646	4	8	08	2q23.2	C2orf25, MMADHC		Chromosome 2 open reading frame 25	611935			Homocystinuria, cblD type, variant 1, 277410 (3); Methylmalonic aciduria, cblD type, variant 2, 277410 (3); Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)	
2.647	12	03	20	2q23.3	ARL6IP6, AIP6		ADP ribosylation factor-like GTPase 6 interacting protein 6	616495				
2.648	3	31	15	2q23.3	FMNL2, KIAA1902		Formin-like 2	616285				
2.649	6	29	99	2q23.3	NMI		NMYC interactor	603525		previously assigned to 22q13.3		
2.650	09	19	19	2q23.3	PRPF40A, HYPA, FNBP3, FBP11		Pre-mRNA processing factor 40A	612941				
2.651	8	3	12	2q23.3	RND3, RHOE, ARHE		RHO family GTPase 3	602924				
2.652	7	9	06	2q23.3	STAM2		Signal-transducing adaptor molecule 2	606244				
2.653	8	27	09	2q23.3	TNFAIP6		Tumor necrosis factor, alpha-induced protein-6	600410				
2.654	1	20	09	2q31.1	ABCB11, BSEP, SPGP, PFIC2, BRIC2		ATP-binding cassette, subfamily B, member 11 (bile salt export pump)	603201			Cholestasis, progressive familial intrahepatic 2, 601847 (3); Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	
2.655	9	22	08	2q24.2	CD302, DCL1, KIAA0022		CD302 antigen	612246				
2.656	8	19	13	2q24.3	COBLL1, COBLR1, KIAA0977		COBL-like protein 1	610318				2(Cobll1)
2.657	4	7	15	2q24.2	IFIH1, MDA5, AGS7, SGMRT1		Interferon induced with helicase C domain 1	606951			Aicardi-Goutieres syndrome 7, 615846 (3); Singleton-Merten syndrome 1, 182250 (3)	
2.658	10	23	20	2q24.3	SCN1A, GEFSP2, SMEI, FEB3A, DEE6, DRVT, FHM3		Sodium voltage-gated channel, alpha subunit 1	182389			Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3); Migraine, familial hemiplegic, 3, 609634 (3); Febrile seizures, familial, 3A, 604403 (3); Dravet syndrome, 607208 (3)	2(Scn1a)
2.659	12	01	20	2q24.3	SCN3A, FFEVF4, DEE62		Sodium voltage-gated channel, alpha subunit 3	182391			Epilepsy, familial focal, with variable foci 4, 617935 (3); Developmental and epileptic encephalopathy 62, 617938 (3)	2(Scn3a)
2.660	08	24	20	2q24.3	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D		Sodium voltage-gated channel, alpha subunit 9	603415			Erythermalgia, primary, 133020 (3); Paroxysmal extreme pain disorder, 167400 (3); Insensitivity to pain, congenital, 243000 (3); Febrile seizures, familial, 3B, 613863 (3); Generalized epilepsy with febrile seizures plus, type 7, 613863 (3); Small fiber neuropathy, 133020 (3); Neuropathy, hereditary sensory and autonomic, type IID, 243000 (3)	
2.661	10	23	20	2q31.1	SLC25A12, ARALAR, DEE39		Solute carrier family 25 (mitochondrial carrier, Aralar), member 12	603667			Developmental and epileptic encephalopathy 39, 612949 (3)	
2.662	11	17	10	2q24.3	GALNT3, HHS, HFTC1		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3	601756			Tumoral calcinosis, hyperphosphatemic, familial, 1, 211900 (3)	
2.663	8	21	07	2q31.1	LRP2, DBS		Low density lipoprotein-related protein 2	600073			Donnai-Barrow syndrome, 222448 (3)	
2.664	4	30	15	2q31.1	CHRNA1, ACHRD, CMS1B, CMS1A		Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle	100690			Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3); Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	2(Acra)
2.665	7	8	10	2q24-q32	FGQTL1		Fasting plasma glucose level QTL 1	612108		associated with rs560887	[Fasting plasma glucose level QTL 1] (2)	
2.666	7	8	10	2q31.1	G6PC2, IGRP		Glucose-6-phosphatase, catalytic, 2	608058				2(Igrp)
2.667	6	15	99	2q24-q32	MMDK, MDK		Mesomelic dysplasia, Kantaputra type	156232			Mesomelic dysplasia, Kantaputra type (2)	
2.668	1	11	95	2q37.1	NPPC		Natriuretic peptide precursor C	600296				1(Nppc)
2.669	4	22	10	2q24.1	ACVR1C, ALK7		Activin A receptor, type IC	608981				
2.670	8	19	13	2q24.1	ERMN, JN, KIAA1189		Ermin	610072				
2.671	1	27	04	2q23.3-q24.1	GALNT13, KIAA1918		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13	608369				
2.672	09	02	20	2q24.1	GPD2		Glycerol-3-phosphate dehydrogenase 2 (mitochondrial)	138430		pseudogene on 19	{Type 2 diabetes mellitus, susceptibility to}, 125853 (3)	
2.673	12	2	96	2q24.1	KCNJ3, GIRK1		Potassium inwardly-rectifying channel, subfamily J, member 3	601534				
2.674	04	07	20	2p24.1	LAPTM4A		Lysosome-associated protein, transmembrane 4, alpha	618837				
2.675	5	8	09	2q24.1	SYNSTH		Synesthesia	612759		max lod at D2S142	Synesthesia (2)	
2.676	2	9	17	2q24.1	UPP2		Uridine phosphorylase 2	617340				
2.677	4	22	10	2q24.1-q31.1	INTLQ2		Intelligence quantitative trait locus 3	610295			{Intelligence QTL3} (2)	
2.678	4	6	13	2q24.1	GALNT5, GALNACT5		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5	615129				
2.679	8	27	09	2q24.2	GCA		Grancalcin	607030				
2.680	2	12	15	2q24.2	ITGB6, AI1H		Integrin, beta-6	147558			Amelogenesis imperfecta, type IH, 616221 (3)	
2.681	3	6	08	2q24.2	KCNH7, ERG3, HERG3, Kv11.3		Potassium channel, voltage-gated, subfamily H, member 7	608169				
2.682	6	7	10	2q24.2	MARCH7		Membrane-associated RING-CH finger protein 7	613334				
2.683	8	27	09	2q24.2	PSMD14, POH1, PAD1		Proteasome 26S subunit, non-ATPase, 14	607173				
2.684	3	29	16	2q24.2	RBMS1, MSSP, SCR2		RNA-binding motif protein, single strand-interacting, 1	602310				
2.685	4	2	16	2q24.2	TANC1, KIAA1728		Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 1	611397				
2.686	3	18	13	2q24.2	TANK, ITRAF		TRAF family member-associated NF-Kappa-B activator	603893				
2.687	12	19	18	2q24.2	TBR1, IDDAS		T-box, brain, 1	604616			Intellectual developmental disorder with autism and speech delay, 606053 (3)	2(Tbr1)
2.688	11	11	14	2q24.3	B3GALT1		UDP-GAL:beta-GlcNAc beta-1,3-galactosyltransferase, polypeptide 1	603093				
2.689	8	2	13	2q24.3	CERS6, LASS6		Ceramide synthase 6	615336				
2.690	12	23	05	2q24.3	CMYA3, XIRP2		Cardiomyopathy-associated protein 3	609778				
2.691	2	18	09	2q24.3	IDDM19		Diabetes mellitus, insulin-dependent, 19	610155		associated with rs1990760	{Diabetes mellitus, insulin-dependent, 19} (2)	
2.692	8	26	15	2q24.3	SLC38A11		Solute carrier family 38 (amino acid transporter), member 11	616526				
2.693	8	27	09	2q24.3	STK39, SPAK		Serine/threonine protein kinase 39	607648				
2.694	2	11	14	2q24.3	TTC21B, THM1, NPHP12, SRTD4, ATD4		Tetratricopeptide repeat domain 21B	612014			Nephronophthisis 12, 613820 (3); Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	
2.695	1	11	16	2q31.2	AGPS, ADHAPS, RCDP3		Alkylglycerone-phosphate synthase	603051			Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	2(Agps)
2.696	10	16	14	2q31.1	BBS5		BBS gene 5	603650			Bardet-Biedl syndrome 5, 615983 (3)	
2.697	10	12	14	2q31.2	CCDC141, CAMDI		Coiled-coil domain-containing protein 141	616031				
2.698	4	21	16	2q31.1	CDCA7, JPO1, ICF3		Cell division cycle-associated 7	609937			Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3)	
2.699	12	18	20	2q31.1	GAD1, SCP, CPSQ1, DEE89		Glutamate decarboxylase-1, brain, 67kD	605363		mutation identified in 1 CPSQ1 family	?Cerebral palsy, spastic quadriplegic, 1, 603513 (3); Developmental and epileptic encephalopathy 89, 619124 (3)	2(Gad1)
2.700	12	9	98	2q31	IDDM7		Insulin-dependent diabetes mellitus-7	600321			{Diabetes mellitus, insulin-dependent, 7} (2)	
2.701	1	24	01	2q32.1	ITGAV, VNRA		Integrin, alpha-V (vitronectin receptor, alpha polypeptide)	193210				
2.702	08	17	18	2q31.1	LNPK, KIAA1715, NEDEHCC		Lunapark	610236			Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, 618090 (3)	2(Lnp)
2.703	3	23	09	2q31.1	MIR10B, MIRN10B		Micro RNA 10B	611576				
2.704	1	7	02	2q33.1	MPP4, DLG6		Membrane protein, palmitoylated 4	606575				
2.705	10	30	17	2q31.2	NFE2L2, NRF2, IMDDHH		Nuclear factor, erythroid-derived 2-like 2	600492			Immunodeficiency, developmental delay, and hypohomocysteinemia, 617744 (3)	
2.706	10	28	08	2q31	PNKD2		Paroxysmal nonkinesigenic dyskinesia 2	611147		between D2S2188 and D2S364	Paroxysmal nonkinesigenic dyskinesia 2 (2)	
2.707	12	9	09	2q31	SHFM5		Split-hand/foot malformation 5	606708		between EVX2 and D2S294	Split-hand/foot malformation 5 (2)	
2.708	7	1	97	2q31.1	SP3		Sp3 transcription factor	601804				
2.709	04	16	19	2q31.2	TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY		Titin	188840			Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy, dilated, 1G, 604145 (3); Tibial muscular dystrophy, tardive, 600334 (3); Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3); Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3); Salih myopathy, 611705 (3)	2(Ttn)
2.710	02	12	20	2q32.1	CALCRL, CGRPR, CRLR, LMPHM8		Calcitonin receptor-like	114190		mutation identified in 1 LMPHM8 family	?Lymphatic malformation 8, 618773 (3)	
2.711	1	4	93	2q31.1	EVX2		Even-skipped homeo box-2	142991		13kb 5' to HOX4I		2(Evx2)
2.712	2	26	93	2q31.1	HOXD3, HOX4A		Homeo box-D3	142980				2(Hox4.1)
2.713	4	1	14	2q31.1	HOXD4, HOX4B		Homeo box-D4	142981				2(Hox4.2)
2.714	2	26	93	2q31.1	HOXD9, HOX4C		Homeo box-D9	142982				2(Hox4.3)
2.715	7	19	04	2q31.1	HOXD10, HOX4D		Homeo box-D10	142984			Vertical talus, congenital, 192950 (3); Charcot-Marie-Tooth disease, foot deformity of, 192950 (3)	2(Hox4.4)
2.716	2	26	93	2q31.1	HOXD8, HOX4E		Homeo box-D8	142985				2(Hox4.5)
2.717	2	26	93	2q31.1	HOXD11, HOX4F		Homeo box-D11	142986				2(Hox4.6)
2.718	2	26	93	2q31.1	HOXD1, HOX4G		Homeo box-D1	142987				2(Hox4.7)
2.719	2	26	93	2q31.1	HOXD12, HOX4H		Homeo box-D12	142988		upstream from HOX4A-G		2(Hox4.8)
2.720	5	9	16	2q31.1	HOXD13, HOX4I, SPD1, BDSD		Homeo box-D13	142989		mutation identified in 1 BDSD family	Synpolydactyly 1, 186000 (3); Brachydactyly, type E, 113300 (3); Brachydactyly, type D, 113200 (3); Syndactyly, type V, 186300 (3); ?Brachydactyly-syndactyly syndrome, 610713 (3)	2(Hox4.9)
2.721	7	16	92	2q31.3	ITGA4, CD49D		Integrin, alpha-4 (antigen CD49D, alpha-4 subunit of VLA-4 receptor)	192975				
2.722	9	23	08	2q31.1	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2		Chimerin 1 (GTPase-activating protein, rho, 2)	118423			Duane retraction syndrome 2, 604356 (3)	
2.723	12	30	92	2q32.1	TFPI, LACI		Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)	152310				
2.724	4	15	09	2q32.1	FRZB, FRZB1, SRFP3, OS1		Frizzled-related protein	605083			{Osteoarthritis susceptibility 1}, 165720 (3)	
2.725	08	21	19	2q32.2	PMS1, PMSL1, HNPCC3		PMS1 homolog 1, mismatch repair system component	600258				
2.726	9	22	08	2q31.1	ATP5G3		ATP synthase, mitochondrial, C subunit-3	602736				
2.727	9	10	12	2q31.1	CIR1		CBF1-interacting corepressor	605228				
2.728	8	18	08	2q31.1	DHRS9, RDHTBE		Short-chain dehydrogenase/reductase family, member 9	612131				
2.729	1	5	11	2q31.1	DUP2q31.1, C2DUPq31.1		Chromosome 2q31.1 duplication syndrome	613681		duplication of 9 HOXD genes and MTX2	Chromosome 2q31.1 duplication syndrome (4)	
2.730	07	02	19	2q31.1	DYNC1I2, DNCI2, IC2, NEDMIBA		Dynein, cytoplasmic-1, intermediate chain-2	603331			Neurodevelopmental disorder with microcephaly and structural brain anomalies, 618492 (3)	2(Dnci2)
2.731	12	11	18	2q31.1	HAGLR, MDGT		HOXD antisense growth-associated long noncoding RNA	618209				2(Haglr)
2.732	1	10	09	2q31.1	ITGA6		Integrin, alpha-6	147556			Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)	
2.733	4	10	14	2q31.1	KLHL41, KBTBD10, SARCOSIN, NEM9		Kelch-like family member 41	607701			Nemaline myopathy 9, 615731 (3)	
2.734	8	3	12	2q31.1	METAP1D, MAP1D		Methionyl aminopeptidase type 1D (mitochondrial)	610267				
2.735	11	22	19	2q31.1	METTL5, HSPC133, MRT72		Methyltransferase-like 5	618628			Intellectual developmental disorder, autosomal recessive 72, 618665 (3)	
2.736	06	03	20	2q31.1	METTL8, TIP		Methyltransferase-like 8	609525				2(Mettl8)
2.737	12	16	20	2q31.1	MTX2, MDPS		Metaxin 2	608555			Mandibuloacral dysplasia progeroid syndrome, 619127 (3)	
2.738	3	3	03	2q24.3	NOSTRIN		Nitric oxide synthase trafficker	607496				
2.739	8	30	11	2q31.1	OLA1, GTBP9		OBG-like ATPase 1	611175				
2.740	9	9	13	2q31.1	PDK1		Pyruvate dehydrogenase kinase, isoenzyme 1	602524				
2.741	8	27	09	2q31.1	PPIG		Peptidyl-prolyl isomerase G (cyclophilin G)	606093				
2.742	12	17	12	2q31.1	SCRN3, SES3		Secernin 3	614967				
2.743	12	6	16	2q31.1	SP5		Transcription factor Sp5	609391				2(Sp5)
2.744	7	14	14	2q24.3	SPC25, SPBC25		SPC25, NDC80 kinetochore complex component	609395				
2.745	11	11	19	2q31.1	SSB, LARP3		Small RNA-binding exonuclease protection factor La	109090				
2.746	3	31	11	2q31.1	UBR3		Ubiquitin protein ligase E3 component N-recognin 3	613831				3(Ubr3)
2.747	08	14	20	2q31.1	WIPF1, WASPIP, WIP, WAS2		WAS/WASL-interacting protein family, member 1	602357			Wiskott-Aldrich syndrome 2, 614493 (3)	
2.748	11	7	17	2q31.1	ZAK, MLTK, MRK, SFMMP, CNM6		Leucine zipper- and sterile alpha motif-containing kinase	609479			Split-foot malformation with mesoaxial polydactyly, 616890 (3); Centronuclear myopathy 6 with fiber-type disproportion, 617760 (3)	
2.749	4	24	06	2q31.1	MYO3B		Myosin IIIB	610040				
2.750	11	11	14	2q31.2	FKBP7, FKBP23		FK506-binding protein 7	607062				
2.751	2	1	11	2q31.2	HNRPA3, D10S102, FBRNP		Heterogeneous nuclear ribonucleoprotein A3	605372				
2.752	3	8	07	2q31.2	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2		Phosphodiesterase 11A	604961			Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	
2.753	3	18	08	2q31.2	PLEKHA3, FAPP1		Pleckstrin homology domain-containing protein, family A, member 3	607774				
2.754	12	30	19	2q31.2	PJVK, DFNB59		Pejvakin	610219			Deafness, autosomal recessive 59, 610220 (3)	
2.755	10	4	16	2q31.2	RBM45		RNA binding motif protein 45	608888				
2.756	10	27	08	2q31.2-q31.3	ZNF385B, ZFN533		Zinc finger protein 385B	612344				
2.757	10	27	08	2q31.2	DEL2q31		Chromosome 2q31.2 deletion syndrome	612345		contiguous gene deletion syndrome	Chromosome 2q31.2 deletion syndrome (4)	
2.758	11	4	98	2q31.1	HAT1		Histone acetyltransferase-1	603053				
2.759	2	27	13	2q31.3	CERKL, RP26		Ceramide kinase-like	608381			Retinitis pigmentosa 26, 608380 (3)	
2.760	09	19	19	2q31.3	CWC22, KIAA1604, NCM		CWC22 spliceosome-associated protein homolog	615186				
2.761	6	17	17	2q31.1	FASTKD1, KIAA1800		Fast kinase domains 1	617529				
2.762	2	21	12	2q31.3	MIR1258		Micro RNA 1258	614488		on opposite strand from ZNF385B		
2.763	12	13	18	2q33.1	NDUFB3, MC1DN25		NADH-ubiquinone oxidoreductase subunit B3	603839		pseudogenes on chr. 1, 9, and 14	Mitochondrial complex I deficiency, nuclear type 25, 618246 (3)	
2.764	6	24	08	2q31.2	PRKRA, PACT, RAX, DYT16		Protein kinase, interferon-inducible double-stranded RNA-dependent activator	603424			Dystonia 16, 612067 (3)	
2.765	12	27	13	2q31.3	SCHLAP1, PCAT114, LINC00913		SWI/SNF complex antagonist associated with prostate cancer 1, noncoding	615568				
2.766	8	8	13	2q31.3	SSFA2, CS1		Sperm-specific antigen 2	118990				
2.767	1	16	14	2q31.3-q32.1	DA10		Arthrogryposis, distal, type 10	187370		max lod at D2S364	Arthrogryposis, distal, type 10 (2)	
2.768	11	7	01	2q31.1	ATF2, CREB2		Activating transcription factor 2	123811				
2.769	1	8	95	2q31.1	DLX1		Distal-less homeo box-1	600029				
2.770	1	8	95	2q31.1	DLX2, TES1		Distal-less homeo box-2	126255				2(Dlx2)
2.771	1	15	96	2q32.2	INPP1		Inositol polyphosphate-1-phosphatase	147263				1(Inpp1)
2.772	08	24	20	2q33.3	KLF7, UKLF		Kruppel-like factor 7	604865				1(Klf7)
2.773	8	27	09	2q32.3	MYO1B		Myosin IB	606537				
2.774	09	02	20	2q31.3	NEUROD1, T2D		Neurogenic differentiation 1	601724			{Type 2 diabetes mellitus, susceptibility to}, 125853 (3); Maturity-onset diabetes of the young 6, 606394 (3)	2(Neurod)
2.775	11	30	00	2q32.3	PCGEM1		Prostate-specific gene PCGEM1	605443				
2.776	3	17	03	2q32.2	SLC40A1, SLC11A3, FPN1, IREG1, HFE4		Solute carrier family 40 (iron-regulated transporter), member 1	604653			Hemochromatosis, type 4, 606069 (3)	1(Slc11a3)
2.777	9	22	17	2q32.3	CAVIN2, SDPR, SDR		Caveolae-associated protein 2	606728				
2.778	5	29	01	2q32.3	TMEFF2, HPP1, TR		Transmembrane protein with EGF-like and 2 follistatin-like domains 2	605734				
2.779	1	11	89	2q34	RPE		Ribulose 5-phosphate 3-epimerase	180480				
2.780	12	01	20	2q32.2	GLS, GLS1, DEE71, CASGID, GDPAG		Glutaminase	138280		mutation identified in 1 CASGID patient	Developmental and epileptic encephalopathy 71, 618328 (3); ?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development, 618339 (3); Global developmental delay, progressive ataxia, and elevated glutamine, 618412 (3)	1(Gls)
2.781	10	22	18	2q32.1	FSIP2, SPGF34		Fibrous sheath-interacting protein 2	615796			Spermatogenic failure 34, 618153 (3)	
2.782	12	5	03	2q32.1	NUP35, NP44		Nucleoporin, 35kD	608140				
2.783	5	7	03	2q31.2	OSBPL6, ORP6		Oxysterol-binding protein-like protein 6	606734				
2.784	8	30	09	2q32.1	PDE1A		Phosphodiesterase-1A	171890				
2.785	2	21	10	2q31.3-q32.1	PPP1R1C, IPP5		Protein phosphatase 1, regulatory subunit 1C	613240				
2.786	9	10	09	2q32.1	SCZD14		Schizophrenia 14	612361		associated with rs1344706	{Schizophrenia, susceptibility to, 14} (2)	
2.787	10	19	99	2q31.3	UBE2E3, UBCH9		Ubiquitin-conjugating enzyme E2E 3	604151				
2.788	9	23	08	2q32.1	ZNF804A, C2orf10		Zinc finger protein 804A	612282				
2.789	5	11	00	2q32.1	NCKAP1, NAP1		NCK-associated protein 1	604891				
2.790	10	27	97	2q32.1-q32.3	ARVD4		Arrhythmogenic right ventricular dysplasia 4	602087			Arrhythmogenic right ventricular dysplasia 4 (2)	
2.791	05	07	19	2q34	MYL1, MYOFTA		Myosin, light polypeptide-1, alkali, skeletal, fast	160780			Myopathy, congenital, with fast-twitch (type II) fiber atrophy, 618414 (3)	1(Mylt)
2.792	3	15	13	2q32.2	C2orf88, SMAKAP		Small membrane protein kinase A-anchoring protein	615117				
2.793	03	07	19	2q32.2	COL3A1, EDSVASC, PMGEDSV		Collagen III, alpha-1 polypeptide	120180		in same 35kb segment as COL5A2	Ehlers-Danlos syndrome, vascular type, 130050 (3); Polymicrogyria with or without vascular-type EDS, 618343 (3)	1(Col3a1)
2.794	12	22	17	2q32.2	COL5A2, EDSCL2		Collagen V, alpha-2 polypeptide	120190		very close to COL3A1	Ehlers-Danlos syndrome, classic type, 2, 130010 (3)	
2.795	12	23	05	2q32.2	FLJ25415		FLJ25415 gene	609803				
2.796	8	13	11	2q32.2	GDF8, MSTN, MSLHP		Growth differentiation factor-8 (myostatin)	601788			Muscle hypertrophy, 614160 (3)	1(Cmpt, Gdf8)
2.797	1	8	07	2q32.2	HIBCH		3-hydroxyisobutyryl-CoA hydrolase	610690			3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)	
2.798	9	29	10	2q32.2	MFSD6, MMR2		Major facilitator superfamily domain-containing protein 6	613476				
2.799	8	26	15	2q32.2	NEMP2, TMEM194B		Nuclear envelope integral membrane protein 2	616497				
2.800	4	7	10	2q32.2	ORMDL1		ORM1-like protein 1	610073		pseudogene on 10p14		
2.801	1	29	07	2q33.1	SUMO1, UBL1, SMT3, OFC10		Small ubiquitin-like modifier 1	601912		mutation identified in 1 OFC10 patient	?Orofacial cleft 10, 613705 (3)	1(Sumo1)
2.802	10	07	20	2q32.2	STAT1, CANDF7, IMD31A, IMD31B, IMD31C		Signal transducer and activator of transcription-1	600555			Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3); Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3); Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant, 614162 (3)	1(Stat1)
2.803	7	18	12	2q32.2-q32.3	STAT4, SLEB11		Signal transducer and activator of transcription-4	600558			{Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3)	1(Stat4)
2.804	2	3	06	2q32.1-q32.2	GULP1, CED6		PTB domain-containing engulfment adaptor protein 1	608165				
2.805	12	22	16	2q32.3	HECW2, NEDL2, KIAA1301, NDHSAL		HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 2	617245			Neurodevelopmental disorder with hypotonia, seizures, and absent language, 617268 (3)	
2.806	6	26	08	2q32.3	OBFC2A, SSB2		Oligonucleotide/oligosaccharide-binding fold-containing protein 2A	612103				
2.807	5	4	12	2q32.3	STK17B, DRAK2		Serine/threonine protein kinase 17b	604727				
2.808	4	23	98	2q32.2	NAB1		NGFI-A-binding protein, ERG1-binding protein	600800				1(Nab1)
2.809	7	10	08	2q33.3	CREB1		cAMP-response element-binding protein-1	123810		fusion gene with EWSR1	Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)	1(Creb1)
2.810	09	26	19	2q33.3	ADAM23, MDC3		ADAM metallopeptidase domain 23	603710				
2.811	02	21	20	2q33.1	ALS2, ALSJ, PLSJ, IAHSP		Alsin Rho guanine nucleotide exchange factor ALS2	606352			Amyotrophic lateral sclerosis 2, juvenile, 205100 (3); Primary lateral sclerosis, juvenile, 606353 (3); Spastic paralysis, infantile onset ascending, 607225 (3)	
2.812	2	27	03	2q33.2	ALS2CR8, CARF		Amyotrophic lateral sclerosis 2 chromosome region, candidate 8 (calcium response factor)	607586				
2.813	7	14	98	2q33.1	AOX1		Aldehyde oxidase-1	602841				
2.814	11	02	20	2q35	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1		BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone	603647			Mitochondrial complex III deficiency, nuclear type 1, 124000 (3); Bjornstad syndrome, 262000 (3); GRACILE syndrome, 603358 (3)	
2.815	2	13	14	2q33.1-q33.2	BMPR2, PPH1, POVD1		Bone morphogenetic receptor, type II	600799			Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3); Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3); Pulmonary venoocclusive disease 1, 265450 (3)	
2.816	7	26	10	2q33.1	BOLL, BOULE		BOL-like (Boule, Drosophila, homolog of)	606165				1(Boule)
2.817	11	18	14	2q33.1	CASP8, MCH5, ALPS2B		Caspase 8, apoptosis-related cysteine protease	601763		mutation identified in 1 ALPS2B family	?Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3); Hepatocellular carcinoma, somatic, 114550 (3); {Breast cancer, protection against}, 114480 (3); {Lung cancer, protection against}, 211980 (3)	1(Casp8)
2.818	12	7	07	2q33.1	CFLAR, FLIP, CASPER, FLAME1, CASH		CASP8- and FADD-like apoptosis regulator	603599				
2.819	8	16	99	2q33.1	CLK1, CLK, STY		CDC-like kinase 1	601951				
2.820	7	24	15	2q33.2	CTLA4, IDDM12, CELIAC3, ALPS5		Cytotoxic T-lymphocyte-associated serine esterase-4	123890			{Hashimoto thyroiditis}, 140300 (3); {Systemic lupus erythematosus, susceptibility to}, 152700 (3); {Diabetes mellitus, insulin-dependent, 12}, 601388 (3); {Celiac disease, susceptibility to, 3}, 609755 (3); Autoimmune lymphoproliferative syndrome, type V, 616100 (3)	1(Ctla4)
2.821	11	6	01	2q32.2	DIRC1		Disrupted in renal cancer 1	606423				
2.822	09	12	19	2q33.1	FZD7		Frizzled class receptor 7	603410				
2.823	1	30	01	2q33.2	ICOS, AILIM, CVID1		Inducible costimulator	604558			Immunodeficiency, common variable, 1, 607594 (3)	
2.824	4	19	01	2q33.1	NIF3L1		Ngg1 interacting factor 3, S. pombe, homolog of, like 1	605778				1(Nif3l1)
2.825	12	23	19	2q33.1	ORC2, ORC2L		Origin recognition complex, subunit 2	601182				
2.826	2	18	02	2q33.1	PLDL1, PLCE, PLCL		Phospholipase C-like 1	600597				
2.827	7	14	14	2q33.1	PPIL3		Peptidyl-prolyl isomerase-like 3	615811				
2.828	10	21	96	2q34	PTHR2		Parathyroid hormone receptor 2	601469				
2.829	12	11	18	2q33.1	RFTN2		Lipid raft linking protein 2	618215				
2.830	2	28	07	2q33	RLS4		Restless legs syndrome, susceptibility to, 4	610439		between D2S311 and D2S317	{Restless legs syndrome 4} (2)	
2.831	5	27	14	2q33.1	SATB2, KIAA1034, GLSS		Special AT-rich sequence-binding protein 2	608148			Glass syndrome, 612313 (3)	
2.832	7	21	15	2q33.1	CASP10, MCH4, ALPS2		Caspase 10, apoptosis-related cysteine protease	601762			Autoimmune lymphoproliferative syndrome, type II, 603909 (3); Lymphoma, non-Hodgkin, somatic, 605027 (3); Gastric cancer, somatic, 613659 (3)	
2.833	8	24	92	2q33.2	CD28		CD28 antigen (Tp44)	186760				1(Cd28)
2.834	4	30	15	2q37.1	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C		Cholinergic receptor, nicotinic, delta polypeptide	100720		mutation identified in 1 CMS3A patient and 1 CMS3C family	?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3); Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3); ?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	1(Acrd)
2.835	4	22	15	2q37.1	CHRNG, ACHRG		Cholinergic receptor, nicotinic, gamma polypeptide	100730		tightly linked to CHRND by RE	Escobar syndrome, 265000 (3); Multiple pterygium syndrome, lethal type, 253290 (3)	1(Acrg)
2.836	5	14	04	2q33.3	EEF1B2, EEF1B1		Eukaryotic translation elongation factor-1, beta-2	600655		pseudogene on chr.15		
2.837	12	5	91	2q35	IGFBP2		Insulin-like growth factor-binding protein-2, 36kD	146731				1(Igfbp2)
2.838	1	5	06	2q33.2	NBEAL1, ALS2CR17		Neurobeachin-like 1	609816				
2.839	12	13	18	2q33.3	NDUFS1, MC1DN5		NADH-ubiquinone oxidoreductase core subunit S1	157655			Mitochondrial complex I deficiency, nuclear type 5, 618226 (3)	
2.840	5	19	09	2q33.1	STRADB, ILPIP, ALS2CR2		STE20-related kinase adaptor beta	607333		pseudogenes on chromosomes 1 and 9		
2.841	2	28	06	2q33.1	TRAK2, GRIF1, ALS2CR3, KIAA0549, OIP98		Gamma-aminobutyric acid receptor-interacting factor 1	607334				
2.842	4	4	00	2q33.3	CRYGA, CRYG1		Crystallin, gamma A	123660				1(Cryg1)
2.843	9	12	13	2q33.3	CRYGB, CRYG2, CTRCT39		Crystallin, gamma B	123670			Cataract 39, multiple types, autosomal dominant, 615188 (3)	1(Len2)
2.844	5	3	13	2q33.3	CRYGC, CRYG3, CTRCT2, CCL		Crystallin, gamma C	123680			Cataract 2, multiple types, 604307 (3)	
2.845	5	3	13	2q33.3	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC		Crystallin, gamma D	123690			Cataract 4, multiple types, 115700 (3)	1(Crygd, Lop2)
2.846	1	29	04	2q35	IHH, BDA1		Indian hedgehog	600726			Acrocapitofemoral dysplasia, 607778 (3); Brachydactyly, type A1, 112500 (3)	
2.847	2	28	06	2q36.1	PI7, PN1, SERPINE2		Protease inhibitor 7 (protease nexin I)	177010		near MYL1; ?COPD susceptibility		
2.848	10	10	11	2q33-q36	EJM9		Epilepsy, juvenile myoclonic, susceptibility to, 9	614280		max lod at D2S2248	{Epilepsy, juvenile myoclonic, susceptibility to, 9} (2)	
2.849	10	26	99	2q35	IGFBP5, IBP5		Insulin-like growth factor-binding protein 5	146734				1(Igfbp5)
2.850	1	4	93	2q35	INHA		Inhibin, alpha	147380		proximal to PAX3		1(Inha)
2.851	8	29	02	2q36.3	CCL20, SCYA20, MIP3A, LARC		Chemokine, C-C motif, ligand 20	601960				
2.852	8	18	98	2q35	CYP27A1, CYP27, CTX		Cytochrome P450, subfamily XXVIIA, polypeptide 1 (sterol 27-hydroxylase)	606530			Cerebrotendinous xanthomatosis, 213700 (3)	1(Cyp27)
2.853	2	18	09	2q33.1	ANIB9		Aneurysm, intracranial berry, 9	612586		associated with rs700651	{Aneurysm, intracranial berry, 9} (2)	
2.854	12	30	14	2q33.1	CDK15, PFTAIRE2, ALS2CR7		Cyclin-dependent kinase 15	616147				
2.855	3	24	14	2q32.3	DNAH7, KIAA0944		Dynein, axonemal, heavy chain 7	610061				
2.856	1	30	15	2q33.1	FTCDNL1, FONG		Formiminotransferase cyclodeaminase N-terminal like	614308				
2.857	7	18	14	2q33.1	GTF3C3, TFIIIC102		General transcription factor 3C, polypeptide 3	604888				
2.858	4	27	12	2q33.1	HSPD1, SPG13, HSP60, HLD4		Heat-shock 60kD protein 1	118190			Spastic paraplegia 13, autosomal dominant, 605280 (3); Leukodystrophy, hypomyelinating, 4, 612233 (3)	
2.859	9	4	02	2q33.1	HSPE1, HSP10		Heat-shock 10kD protein	600141				
2.860	12	22	16	2q33.1	MAIP1, C2orf47		Matrix AAA peptidase-interacting protein 1	617267				
2.861	6	23	15	2q33.1	MARS2, SPAX3, COXPD25		Methionyl-tRNA synthetase 2	609728		mutation identified in 1 COXPD25 family	Spastic ataxia 3, autosomal recessive, 611390 (3); ?Combined oxidative phosphorylation deficiency 25, 616430 (3)	
2.862	8	30	17	2q33.1	MOB4, MOBKL3, PREI3, MOB1, MOB3		MOB family, member 4	609361				
2.863	1	8	16	2q33.1	NOP58, NOP5		Nop58, S. cerevisiae, homolog of	616742				
2.864	2	25	16	2q33.1	PGAP1, MRT42		Post-GPI attachment to proteins 1	611655			Mental retardation, autosomal recessive 42, 615802 (3)	
2.865	10	26	11	2q33.1	SF3B1, SF3B155, SAP155, MDS		Splicing factor 3B, subunit 1	605590			Myelodysplastic syndrome, somatic, 614286 (3)	1(Sf3b1)
2.866	12	4	08	2q33.1	SGOL2, SGO2, TRIPIN		Shugoshin-like 2	612425				
2.867	4	15	11	2q33.1	SPATS2L, SGNP		Spermatogenesis-associated serine-rich protein 2-like	613817				
2.868	7	2	18	2q33.2	ABI2, AIP1		ABL interactor 2	606442				
2.869	1	18	12	2q33.1	TMEM237, ALS2CR4, JBTS14		Transmembrane protein 237	614423			Joubert syndrome 14, 614424 (3)	
2.870	10	28	15	2q33.2	WDR12		WD repeat-containing protein 12	616620				1(Wdr12)
2.871	07	17	19	2q33.3	DYTN		Dystrotelin	618510				1(Dytn)
2.872	04	30	20	2q33.3	FASTKD2, KIAA0971, COXPD44		FAST kinase domains 2	612322			Combined oxidative phosphorylation deficiency 44, 618855 (3)	
2.873	09	12	19	2q33.3	FZD5		Frizzled class receptor 5	601723				1(Mfz5)
2.874	2	6	07	2q33.3	GPR1		G protein-coupled receptor-1	600239		conflicting assignment to 15q21.6		
2.875	8	28	17	2q33.3	GPR1AS		GPR1 antisense RNA	617636				
2.876	6	4	13	2q33.3	METTL21A, FAM119A		Methyltransferase-like 21A	615257				
2.877	08	11	20	2q33.3	MYOSLID		Myocardin-induced smooth muscle long noncoding RNA, inducer of differentiation	618976		overlaps with 3 other lncRNAs in the opposite direction		
2.878	4	15	09	2q33.3	OS4, GOA1		Osteoarthritis susceptibility 4	610839		max lod at D2S2358	{Osteoarthritis susceptibility 4} (2)	
2.879	1	14	13	2q34	IDH1		Isocitrate dehydrogenase, soluble	147700			{Glioma, susceptibility to, somatic}, 137800 (3)	1(Idh1)
2.880	8	1	16	2q33.3	ZDBF2, KIAA1571		Zinc finger DBF domain-containing protein 2	617059				
2.881	1	18	13	2q35	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2		ATP-binding cassette, subfamily A, member 12	607800			Ichthyosis, congenital, autosomal recessive 4A, 601277 (3); Ichthyosis, congenital, autosomal recessive 4B (harlequin), 242500 (3)	1(Abca12)
2.882	11	22	13	2q33.3	C2orf80, GONDA1		Chromosome 2 open reading frame 80	615536				
2.883	8	24	04	2q35	CTDSP1, NLIIF, SCP1		C-terminal domain of RNA polymerase II polypeptide A, small phosphatase of, 1	605323				
2.884	11	19	13	2q34	ERBB4, HER4, ALS19		Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4	600543			Amyotrophic lateral sclerosis 19, 615515 (3)	
2.885	03	09	20	2q35	FN1, FN, LETS, FNZ, GFND2, SMDCF		Fibronectin-1	135600			Glomerulopathy with fibronectin deposits 2, 601894 (3); Spondylometaphyseal dysplasia, corner fracture type, 184255 (3)	1(Fn1)
2.886	8	24	12	2q34	KANSL1L, C2orf67, MSL1V2		KAT8 regulatory NSL complex subunit 1-like	613833				
2.887	9	5	01	2q34	LANCL1, GPR69A		LanC-like 1 (G protein-coupled receptor 69A)	604155				
2.888	12	9	98	2q34	IDDM13		Insulin-dependent diabetes mellitus-13	601318			{Diabetes mellitus, insulin-dependent, 13} (2)	
2.889	2	23	12	2q34	IKZF2, ANF1A2, HELIOS		Ikaros family zinc finger 2	606234				
2.890	5	25	00	2q33.3	NRP2, VEGF1265R2, NPN2		Neuropilin 2	602070				
2.891	8	1	08	2q34	SPAG16, PF20		Sperm-associated antigen 16	612173				1(Spag16)
2.892	1	10	89	2q34	TCL4		T-cell leukemia/lymphoma-4	186860			Leukemia/lymphoma, T-cell (2)	
2.893	4	27	11	2q34	ACADL, LCAD		Acyl-Coenzyme A dehydrogenase, long chain	609576				1(Acadl)
2.894	9	18	08	2q36.1	ACSL3, FACL3, ACS3		Acyl-CoA synthetase long-chain family member 3	602371				
2.895	10	4	05	2q35	BARD1		BRCA1-associated RING domain 1	601593			{Breast cancer, susceptibility to}, 114480 (3)	
2.896	10	23	87	2q34	MAP2		Microtubule-associated protein-2	157130				
2.897	12	11	02	2q34-q35	SLEN2		Systemic lupus erythematosus with nephritis, susceptibility to, 2	607966			{Systemic lupus erythematosus with nephritis, susceptibility to, 2} (2)	
2.898	8	7	14	2q35	CRYBA2, CTRCT42		Crystallin, beta A2	600836		mutation identified in 1 CTRCT42 family	?Cataract 42, 115900 (3)	1(cryba2)
2.899	4	19	16	2q34-q36	DUP2q35, C2DUPq35, SDTY1, SD1		Chromosome 2q35 duplication syndrome (syndactyly, type I)	185900			Syndactyly, type 1, with or without craniosynostosis (4)	
2.900	1	24	02	2q35	SMARCAL1, HARP, SIOD		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A-like	606622			Schimke immunoosseous dysplasia, 242900 (3)	1(Smarcal1)
2.901	1	16	07	2q37.3	AQP12A, AQPX2, AQP12		Aquaporin 12A	609789				
2.902	5	25	13	2q35	AAMP		Angio-associated migratory cell protein	603488				
2.903	6	27	17	2q35	ANKZF1, ZNF744		Ankyrin repeat- and zinc finger domain-containing 1	617541				
2.904	2	1	11	2q35	ARPC2, ARC34		Actin-related protein 2/3 complex, subunit 2	604224				
2.905	09	19	19	2q35	ATG9A, APG9L1		Autophagy related 9A	612204				
2.906	6	7	04	2q35	ATIC, PURH, AICAR		5-aminoimidazole-4-carboxyamide ribonucleotide formyltransferase/IMP cyclohydrolase	601731			AICA-ribosiduria due to ATIC deficiency, 608688 (3)	
2.907	12	02	19	2q35	CFAP65, CCDC108, SPGF40		Cilia- and flagella-associated protein 65	614270			Spermatogenic failure 40, 618664 (3)	
2.908	1	24	01	2q35	CDK5R2, NCK5AI		Cyclin-dependent kinase 5, regulatory subunit 2	603764				
2.909	06	20	19	2q34	CPS1, PHN		Carbamoyl-phosphate synthetase 1, mitochondrial	608307		urea cycle enzyme	Carbamoylphosphate synthetase I deficiency, 237300 (3); {Pulmonary hypertension, neonatal, susceptibility to}, 615371 (3)	1(Cps)
2.910	7	8	11	2q35	CXCR1, IL8RA		Chemokine, CXC motif, receptor 1	146929			{AIDS, slow progression to}, 609423 (3)	
2.911	2	8	11	2q35	CXCR2, IL8RB, IL8R2		Chemokine, CXC motif, receptor 2	146928				1(Il8r2)
2.912	09	01	20	2q35	DES, CMD1I, MFM1, SCPNK		Desmin	125660			Myopathy, myofibrillar, 1, 601419 (3); Cardiomyopathy, dilated, 1I, 604765 (3); Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	1(Des)
2.913	7	11	16	2q35	DNAJB2, HSJ1, HSPF3, DSMA5		DnaJ, E. coli, homolog of, subfamily B, member 2 (heat-shock protein, DNAJ-like 1)	604139			Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3)	
2.914	3	23	14	2q35	DNPEP, ASPEP, DAP		Aspartyl aminopeptidase	611367				
2.915	11	19	13	2q35	GMPPA, AAMR		GDP-mannose pyrophosphorylase A	615495			Alacrima, achalasia, and mental retardation syndrome, 615510 (3)	
2.916	6	2	06	2q35	GPBAR1, BG37		G protein-coupled bile acid receptor 1	610147				
2.917	6	7	10	2q35	MARCH4, RNF174, KIAA1399		Membrane-associated RING-CH finger protein 4	608208				
2.918	3	23	09	2q35	MIR26B, MIRN26B		Micro RNA 26B	612152				
2.919	3	23	09	2q35	MIR375, MIRN375		Micro RNA 375	611173				
2.920	02	28	20	2q35	PNKD, R1, TAHCCP2, KIPP1184, BRP17, FPD1, PDC, DYT8		PNKD metallo-beta-lactamase domain-containing protein	609023			Paroxysmal nonkinesigenic dyskinesia 1, 118800 (3)	
2.921	1	2	08	2q35	MREG, DSU		Melanoregulin	609207				1(Dsu)
2.922	2	10	04	2q35	MTBS1		Mycobacterium tuberculosis, susceptibility to infection by	607949			{Tuberculosis, susceptibility to} (2)	
2.923	9	22	09	2q35	NBLST5		Neuroblastoma, susceptibility to, 5	613016		associated with rs6435862, rs3768716	{Neuroblastoma, susceptibility to, 5} (2)	
2.924	1	14	09	2q35	NHEJ1, XLF		Nonhomologous end-joining factor 1	611290			Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)	
2.925	8	24	09	2q35	OBSL1, KIAA0657, 3M2		Obscurin-like 1	610991			3-M syndrome 2, 612921 (3)	
2.926	8	27	09	2q35	PECR, TERP		Peroxisomal trans-2-enoyl-CoA reductase	605843				
2.927	1	28	10	2q34	PIKFYVE, PIP5K3		Phosphatidylinositol kinase, FYVE-finger containing	609414			Corneal fleck dystrophy, 121850 (3)	
2.928	09	18	20	2q35	PRKAG3, SMGMQTL		Protein kinase, AMP-activated, noncatalytic, gamma 3	604976			[Skeletal muscle glycogen content and metabolism QTL], 619030 (3)	
2.929	5	4	09	2q35	RESP18		Regulated endocrine-specific protein 18	612721				
2.930	9	22	14	2q35	RNF25, AO7		Ring finger protein 25	616014				
2.931	3	29	10	2q35	RPL37A		Ribosomal protein L37A	613314				
2.932	8	27	08	2q35	RQCD1, RCD1, CNOT9		Required for cell differentiation 1, S. pombe, homolog of	612054				
2.933	12	21	09	2q35	NRAMP1, NRAMP, SLC11A1		Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1	600266		within 220 kb of VIL1	{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3); {Buruli ulcer, susceptibility to}, 610446 (3)	1(Nramp)
2.934	9	19	14	2q35	SPEG, APEG1, CNM5		SPEG complex locus	615950			Centronuclear myopathy 5, 615959 (3)	
2.935	3	25	03	2q35	STK36, FU, KIAA1278		Serine/threonine protein kinase 36	607652				
2.936	8	19	13	2q35	TMBIM1, RECS1		Transmembrane BAX inhibitor motif-containing protein 1	610364				
2.937	7	5	15	2q35	TUBA4A, TUBA1, ALS22		Tubulin, alpha-4A	191110			Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia, 616208 (3)	1(Tuba4a)
2.938	09	11	19	2q34	UNC80, C2orf21, KIAA1843		Unc-80 homolog, NALCN channel complex subunit	612636			Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3)	
2.939	5	5	00	2q35	WNT6		Wingless-type MMTV integration site family, member 6	604663				1(Wnt6)
2.940	7	22	11	2q35	WNT10A, SSPS, STHAG4, OODD		Wingless-type MMTV integration site family, member 10A	606268			Odontoonychodermal dysplasia, 257980 (3); Schopf-Schulz-Passarge syndrome, 224750 (3); Tooth agenesis, selective, 4, 150400 (3)	
2.941	6	6	94	2q35	XRCC5		X-ray repair, complementing defective, repair in Chinese hamster cells-5	194364		included in YAC contig spanning 2q33-q34		1(Xrcc5)
2.942	9	29	10	2q35	ZFAND2B, AIRAPL		Zinc finger AN1 domain-containing protein 2B	613474				
2.943	05	14	19	2q35	ZNF142, NEDISHM		Zinc finger protein-142	604083			Neurodevelopmental disorder with impaired speech and hyperkinetic movements, 618425 (3)	
2.944	1	22	08	2q35	ACCN4, ASIC4, BNAC4		Cation channel, amiloride-sensitive, neuronal, 4	606715				
2.945	5	22	03	2q36.1	KCNE4, MIRP3		Potassium channel, voltage-gated, ISK-related subfamily, member 4	607775				
2.946	1	11	05	2q35-q36	PSHK2		Pseudohyperkalemia, familial, 2, due to red cell leak	609153		max lod at D2S1338	Pseudohyperkalemia, familial, 2, due to red cell leak (2)	
2.947	2	3	99	2q36.1	SCG2, CHGC		Secretogranin II (chromogranin C)	118930				1(Scg2)
2.948	6	4	90	2q35	TNP1		Transition protein-1	190231				1(Tp1)
2.949	2	18	08	2q35	TNS1, TNS		Tensin 1	600076				1(Tns)
2.950	11	13	18	2q35	VIL1		Villin-1	193040				1(Vil)
2.951	6	4	97	2q35	PTPRN, IA2		Protein tyrosine phosphatase, receptor type N (islet cell antigen 2)	601773				1(Ptprn)
2.952	3	5	95	2q37.3	GPC1		Glypican 1	600395				
2.953	2	25	16	2q35	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2		ATP-binding cassette, subfamily B, member 6	605452			Microphthalmia, isolated, with coloboma 7, 614497 (3); [Blood group, Langereis system], 111600 (3); Dyschromatosis universalis hereditaria 3, 615402 (3); Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	
2.954	4	20	04	2q36	ACRPV		Acropectorovertebral dysplasia (F syndrome)	102510			Acropectorovertebral dysplasia (2)	
2.955	7	18	14	2q36.3	AGFG1, HRB, RIP, RAB		ADP-ribosylation factor GTPase-activating protein with FG repeats 1	600862				
2.956	09	09	20	2q36.1	FARSB, FARSLB, RILDBC1		Phenylalanine-tRNA synthetase-like, beta subunit	609690			Rajab interstitial lung disease with brain calcifications 1, 613658 (3)	
2.957	8	27	09	2q35	FEV		Fifth Ewing sarcoma variant	607150		fused with EWS in tumors		
2.958	5	23	11	2q36	IGAN2		IgA nephropathy, susceptibility to, 2	613944		between D2S1323 and D2S362	{IgA nephropathy, susceptibility to, 2} (2)	
2.959	09	02	20	2q36.3	IRS1		Insulin receptor substrate-1	147545			{Type 2 diabetes mellitus, susceptibility to}, 125853 (3); {Coronary artery disease, susceptibility to} (3)	1(Irs1)
2.960	9	9	13	2q36.1	MRPL44, COXPD16		Mitochondrial ribosomal protein L44	611849		Mutation identified in 1 family	?Combined oxidative phosphorylation deficiency 16, 615395 (3)	
2.961	10	9	94	2q35	SLC2C, AE3		Anion exchanger 3, neuronal	106195				1(Ae3)
2.962	12	18	07	2q36.3	SPHKAP, SKIP, KIAA1678		SPHK1 interactor, AKAP domain containing	611646				
2.963	9	12	02	2q35	STK11IP, KIAA1898, LIP1		Serine/threonine kinase 11 interacting protein	607172				
2.964	11	22	99	2q37.3	AGXT, SPAT		Alanine-glyoxylate aminotransferase, liver-specific peroxisomal	604285			Hyperoxaluria, primary, type 1, 259900 (3)	
2.965	01	31	19	2q36.3	COL4A3, ATS2, ATS3		Collagen IV, alpha-3 polypeptide (Goodpasture antigen)	120070		noncollagenous domain = Goodpasture antigen	Alport syndrome 2, autosomal recessive, 203780 (3); Hematuria, benign familial, 141200 (3); Alport syndrome 3, autosomal dominant, 104200 (3)	
2.966	01	31	19	2q36.3	COL4A4, ATS2, BFH		Collagen IV, alpha-4 polypeptide	120131		head-to-head with COL4A4 in same YAC	Alport syndrome 2, autosomal recessive, 203780 (3); Hematuria, familial benign, 141200 (3)	
2.967	2	8	13	2q37.1	ECEL1, XCE, DA5D		Endothelin-converting enzyme-like 1	605896			Arthrogryposis, distal, type 5D, 615065 (3)	
2.968	2	18	98	2q37.2	GBX2		Gastrulation brain homeobox 2	601135				1(Gbx2)
2.969	03	09	20	2q24.2	GCG		Glucagon	138030				2(Gcg)
2.970	8	15	97	2q37.1	INPP5D, SHIP		Inositol polyphosphate-5-phosphatase, 145kD	601582				1(Inpp5d)
2.971	4	7	14	2q37.1	PDE6D, JBTS22		Phosphodiesterase 6D, cGMP-specific, rod, delta	602676		mutation identified in 1 JBTS22 family	?Joubert syndrome 22, 615665 (3)	1(Pde6d)
2.972	8	27	09	2q37.1	PTMA, TMSA		Prothymosin, alpha (gene sequence 28)	188390				
2.973	2	14	01	2q37.3	RAMP1		Receptor activity-modifying protein 1	605153				1(Ramp1)
2.974	12	1	14	2q36.1	AP1S3, PSORS15		Adaptor-related protein complex 1, sigma-3 subunit	615781			{Psoriasis 15, pustular, susceptibility to}, 616106 (3)	
2.975	4	14	10	2q35	CHPF, CSS2		Chondroitin polymerizing factor	610405				
2.976	9	27	17	2q36.1	EPHA4, HEK8, TYRO1		Ephrin receptor EphA4	602188				
2.977	8	3	12	2q36.1	MOGAT1, MGAT1, DGAT2L1		Monoacylglycerol O-acyltransferase 1	610268				
2.978	2	23	12	2q36.1	PAX3, WS1, HUP2, CDHS, WS3		Paired box homeotic gene-3	606597			Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type 3, 148820 (3); Craniofacial-deafness-hand syndrome, 122880 (3); Rhabdomyosarcoma 2, alveolar, 268220 (3)	1(Sp)
2.979	7	16	09	2q36.1	SGPP2, SPP2		Sphingosine-1-phosphate phosphatase 2	612827				
2.980	8	10	18	2q36.1	WDFY1, FENS1		WD repeat-and FYVE domain-containing protein 1	618080				
2.981	2	21	10	2q36.1-q36.3	SPDA3		Spondyloarthropathy, susceptibility to, 3	613238		max lod at D2S2228	{Spondyloarthropathy, susceptibility to, 3} (2)	
2.982	04	30	19	2q36.2	FAM124B		Family with sequence similarity 124, member B	618403				
2.983	10	13	09	2q36.2	DOCK10, KIAA0694, ZIZ3		Dedicator of cytokinesis 10	611518				
2.984	2	27	12	2q36.2	CUL3, PHA2E		Cullin 3	603136			Pseudohypoaldosteronism, type IIE, 614496 (3)	
2.985	8	25	16	2q36.3	MFF, C2orf33, EMPF2		Mitochondrial fission factor	614785			Encephalopathy due to defective mitochondrial and peroxisomal fission 2, 617086 (3)	
2.986	12	10	13	2q36.3	NYPA2, KIAA1486		Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 2	615478				
2.987	8	17	09	2q36.3	PID1, NYGGF4		Phosphotyrosine interaction domain-containing 1	612930				
2.988	6	12	17	2q36.3	RHBDD1, RRP4, RHBDL4		Rhomboid domain-containing 1	617515				
2.989	2	13	12	2q36.3	SLC19A3, THMD2, BBGD		Solute carrier family 19 (folate transporter), member 3	606152			Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)	1(Slc19a3)
2.990	10	15	13	2q36.3	TM4SF20, SLI5		Transmembrane 4 L6 family, member 20	615404			{Specific language impairment 5}, 615432 (3)	
2.991	11	7	17	2q36.3	TRIP12, MRD49		Thyroid hormone receptor interactor 12	604506			Mental retardation, autosomal dominant 49, 617752 (3)	
2.992	3	14	96	2q37.1	HTR2B		5-hydroxytryptamine (serotonin) receptor-2B	601122				
2.993	4	12	92	2q37.1	ALPP		Alkaline phosphatase, placental (Regan isozyme)	171800				4(Akp2)
2.994	4	12	92	2q37.1	ALPPL2		Alkaline phosphatase, placental-like 2	171810				
2.995	9	22	08	2q37.3	ASB1		Ankyrin repeat-containing SOCS box protein 1	605758				1(Asb1)
2.996	10	14	15	2q37	BDMR, C2DELq37, DEL2q37		Chromosome 2q37 deletion syndrome	600430			Chromosome 2q37 deletion syndrome (4)	
2.997	7	20	15	2q37.3	COL6A3, DYT27, BTHLM1, UCMD1		Collagen VI, alpha-3 polypeptide	120250		close to CRBP1	Bethlem myopathy 1, 158810 (3); Ullrich congenital muscular dystrophy 1, 254090 (3); Dystonia 27, 616411 (3)	1(Col6a3)
2.998	8	11	15	2q37.3	ACKR3, CXCR7, CMKOR1, GPR159, RDC1		Atypical chemokine receptor 3	610376				
2.999	4	29	03	2q36.3	DNER		Delta-and notch-like egf-related receptor	607299				
2.1000	3	9	00	2q37.1	GPR55		G protein-coupled receptor 55	604107				
2.1001	12	29	99	2q37.3	HDLBP, VGL		High-density lipoprotein-binding protein	142695				
2.1002	9	1	05	2q37.1	ITM2C, BRI3		Integral membrane protein 2C	609554				
2.1003	8	25	11	2q37.1	KCNJ13, SVD, LCA16		Potassium inwardly-rectifying channel, subfamily J, member 13	603208			Snowflake vitreoretinal degeneration, 193230 (3); Leber congenital amaurosis 16, 614186 (3)	
2.1004	04	17	20	2q37.3	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9		Kinesin family member 1A	601255		incorrectly assigned to chr.9	Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy, hereditary sensory, type IIC, 614213 (3); NESCAV syndrome, 614255 (3); Spastic paraplegia 30, autosomal dominant, 610357 (3)	
2.1005	5	31	05	2q37.3	MLPH		Melanophilin	606526			Griscelli syndrome, type 3, 609227 (3)	1(Mlph)
2.1006	1	8	01	2q37.1	NEU2, SIAL2		Neuraminidase 2	605528				
2.1007	7	17	01	2q37.1	NGEF		Neuronal guanine nucleotide exchange factor	605991				1(Ngef)
2.1008	10	1	07	2q37.3	SEPT2, NEDD5, DIFF6		Septin 2	601506				
2.1009	3	26	02	2q37.1	TRPM8, TRPP8		Transient receptor potential cation channel, subfamily M, member 8	606678				
2.1010	6	7	10	2q37.1	UGT1A1, UGT1, GNT1, BILIQTL1		UDP glycosyltransferase 1 family, polypeptide A1	191740			Crigler-Najjar syndrome, type I, 218800 (3); [Gilbert syndrome], 143500 (3); Crigler-Najjar syndrome, type II, 606785 (3); Hyperbilirubinemia, familial transient neonatal, 237900 (3); [Bilirubin, serum level of, QTL1], 601816 (3)	1(Ugt1)
2.1011	11	1	01	2q37.1	UGT1A3, UGT1C		UDP-glycosyltransferase 1 family, polypeptide A3	606428				
2.1012	11	1	01	2q37.1	UGT1A4, UGT1D		UDP-glycosyltransferase 1 family, polypeptide A4	606429				
2.1013	11	1	01	2q37.1	UGT1A5		UDP-glycosyltransferase 1 family, polypeptide A5	606430				
2.1014	11	1	01	2q37.1	UGT1A8		UDP-glycosyltransferase 1 family, polypeptide A8	606433				
2.1015	11	1	01	2q37.1	UGT1A6		UDP-glycosyltransferase 1 family, polypeptide A6	606431				
2.1016	11	1	01	2q37.1	UGT1A7		UDP-glycosyltransferase 1 family, polypeptide A7	606432				
2.1017	11	1	01	2q37.1	UGT1A9		UDP-glycosyltransferase 1 family, polypeptide A9	606434				
2.1018	11	1	01	2q37.1	UGT1A10		UDP-glycosyltransferase 1 family, polypeptide A10	606435				
2.1019	6	10	98	2q37.1	SPP2		Secreted phosphoprotein-2, 24kD	602637				
2.1020	6	22	01	2q37.1	ALPI		Alkaline phosphatase, intestinal	171740		close to ALPP; proximal to PAX3		1(Akp3)
2.1021	12	03	20	2q37.1	ARL4C, ARL7		ADP ribosylation factor-like GTPase 4C	604787				
2.1022	8	15	17	2q37.1	ARMC9, KIAA1868, JBTS30		Armadillo repeat-containing protein 9	617612			Joubert syndrome 30, 617622 (3)	
2.1023	09	19	19	2q37.1	ATG16L1, APG16L, IBD10		Autophagy related 16 like 1	610767			{Inflammatory bowel disease (Crohn disease) 10}, 611081 (3)	
2.1024	7	22	13	2q37.1	B3GNT7		Beta-1,3-N-acetylglucosaminyltransferase 7	615313				
2.1025	8	1	08	2q37.1	CAB39		Calcium-binding protein 39	612174				
2.1026	9	22	14	2q37.1	COPS7B		COP9 signalosome, subunit 7B	616010				
2.1027	1	9	07	2q37.1	DGKD		Diacylglycerol kinase, delta, 130kD	601826				
2.1028	2	18	08	2q37.1	EFHD1		EF-hand domain family, member D1	611617				
2.1029	2	21	06	2q37.1	EIF4E2, EIF4EL3, 4EHP		Eukaryotic translation initiation factor 4E family, member 2	605895				
2.1030	9	9	08	2q36.3	FBXO36, FBX36		F-box only protein 36	609105				1(Fbxo36)
2.1031	4	10	15	2q37.1	GIGYF2, KIAA0642, PARK11		GRB10-interacting GYF protein 2	612003			{Parkinson disease 11}, 607688 (3)	1(Gigyf2)
2.1032	3	23	09	2q37.1	HJURP		Holliday junction recognition protein	612667				
2.1033	3	23	06	2q37.1	MYP12		Myopia 12	609995		max lod at D2S2344	Myopia 12 (2)	
2.1034	5	19	06	2q37.1	NMUR1, GPR66, FM3		Neuromedin U receptor 1	604153				
2.1035	4	15	11	2q37.1	PRSS56, MCOP6		Protease, serine, 56	613858			Microphthalmia, isolated 6, 613517 (3)	
2.1036	1	22	18	2q37.1	PSMD1		Proteasome 26S subunit, non-ATPase, 1	617842				
2.1037	01	04	19	2q37.1	RNU20		RNA, U20 small nucleolar	604012				
2.1038	2	25	14	2q37.1	SCARNA5		Small Cajal body-specific RNA 5	615640		within intron 9 of ATG16L1		
2.1039	2	25	14	2q37.1	SCARNA6		Small Cajal body-specific RNA 6	615641		within intron 12 of ATG16L1		
2.1040	7	7	05	2q37.1	SP100		Nuclear antigen SP100	604585				
2.1041	10	11	06	2q37.1	SP110, IFI41, IFI75, VODI		SP110 nuclear body protein (interferon-induced protein 41, 30kD; interferon-induced protein 75, 52kD)	604457			Hepatic venoocclusive disease with immunodeficiency, 235550 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
2.1042	4	23	09	2q37.1	SAG, RP47		S-antigen; retina and pineal gland (arrestin)	181031			Oguchi disease-1, 258100 (3); Retinitis pigmentosa 47, 613758 (3)	1(Sag)
2.1043	10	26	17	2q37.1	SP140L		Nuclear body protein SP140-like	617747				
2.1044	9	7	10	2q37.1	STQTL21		Stature quantitative trait locus 21	613440		associated with rs6717918	{Stature QTL 21} (2)	
2.1045	9	10	09	2q37.1	TIGD1		TIGGER transposable element-derived gene 1	612972				
2.1046	5	24	13	2q37.1	USP40		Ubiquitin-specific protease 40	610570				
2.1047	2	5	01	2q37.2	SH3BP4, BOG25		SH3 domain-binding protein 4	605611				
2.1048	7	20	01	2q37.1-q37.3	HPE6		Holoprosencephaly 6	605934			Holoprosencephaly 6 (2)	
2.1049	11	05	18	2q37.2	AGAP1, CENTG2, KIAA1099		Arf GTPase-activating protein with GTPase domain, ankyrin repeat, and pleckstrin homology domain 1	608651				
2.1050	09	19	19	2q37.1	DIS3L2, PRLMNS		DIS3 like exosome 3'-5' exoribonuclease 2	614184			Perlman syndrome, 267000 (3)	
2.1051	10	13	15	2q37.3	HDAC4, HDACA		Histone deacetylase 4	605314				
2.1052	09	19	19	2q37.3	ATG4B, APG4B, KIAA0943		Autophagy related 4B cysteine peptidase	611338				
2.1053	9	27	17	2q37.3	BOK, BCL2L9		BCL2-related ovarian killer	605404				
2.1054	4	17	09	2q37.3	CAPN10, NIDDM1		Calpain-10	605286			{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)	
2.1055	9	22	14	2q37.3	COPS8, CSN8		COP9 signalosome, subunit 8	616011				1(Csn8)
2.1056	10	23	08	2q37.3	D2HGDH, D2HGD		D-2-hydroxyglutarate dehydrogenase	609186			D-2-hydroxyglutaric aciduria, 600721 (3)	
2.1057	5	25	13	2q37.3	DTYMK, TYMK, CDC8		Deoxythymidylate kinase	188345				
2.1058	2	15	18	2q37.3	ERFE, FAM132B, CTRP15		Erythroferrone	615099				1(Fam132b)
2.1059	8	2	17	2q37.3	FARP2, FRG, FIR		FERM, ARHGEF, and pleckstrin domain-containing protein 2	617586				
2.1060	2	7	07	2q37.3	GAL3ST2, GP3ST		Galactose-3-O-sulfotransferase 2	608237				
2.1061	6	19	98	2q37.3	GPR35		G protein-coupled receptor-35	602646				
2.1062	09	19	19	2q37.3	HES6		Hes family bHLH transcription factor 6	610331				
2.1063	06	11	20	2q37.3	ILKAP, PP2CD		ILK-associated serine/threonine phosphatase	618909				
2.1064	3	15	04	2q37.3	ING5		Inhibitor of growth-5	608525				
2.1065	7	1	11	2q37.3	LRRFIP1, GCF2, TRIP, FLAP1		Leucine-rich repeat in FLII-interacting protein 1	603256				
2.1066	5	6	13	2q37.3	MIR149		Micro RNA 149	615209				
2.1067	1	13	15	2q37.3	MTERF4, MTERFD2		Mitochondrial transcription termination factor 4	615393				
2.1068	12	13	18	2q37.3	NDUFA10, MC1DN22		NADH-ubiquinone oxidoreductase subunit A10	603835			Mitochondrial complex I deficiency, nuclear type 22, 618243 (3)	
2.1069	5	25	13	2q37.3	NEU4		Neuraminidase 4	608527				1(Neu4)
2.1070	6	12	03	2q37.3	OTOSP		Otospiralin	607877				
2.1071	3	3	03	2q37.3	PASK, KIAA0135		Pas domain-containing serine-threonine kinase	607505				
2.1072	1	6	11	2q37.3	PDCD1, SLEB2		Programmed cell death 1	600244			{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3); {Multiple sclerosis, disease progression, modifier of}, 126200 (3)	
2.1073	08	21	19	2q37.3	PER2, FASPS1, KIAA0347		Period circadian regulator 2	603426		mutation identified in 1 FASPS1 family	?Advanced sleep phase syndrome, familial, 1, 604348 (3)	
2.1074	8	20	98	2q37.3	PPP1R7, SDS22		Protein phosphatase 1, regulatory subunit 7	602877				
2.1075	9	27	17	2q37.3	PRLH, PRRP		Prolactin-releasing hormone	602663				
2.1076	10	28	09	2q37.3	RAB17		Ras-associated protein	602206				
2.1077	9	28	00	2q37.3	RNPEPL1		Arginyl aminopeptidase-like 1 (aminopeptidase B-like)	605287				
2.1078	8	21	07	2q37.3	SCLY, SCL		Selenocysteine lyase	611056				
2.1079	11	18	15	2q37.3	SNED1, SNEP		SUSHI, NIDOGEN, and EGF-like domains protein 1	616634				1(Sned1)
2.1080	9	20	14	2q37.3	STK25, SOK1, YSK1		Serine/threonine protein kinase 25	602255				
2.1081	1	20	09	2q37.3	THAP4		THAP domain-containing protein 4	612533				
2.1082	1	2	08	2q37.3	TMEM16G, PCANAP5, IPCA5, DTMPP, NGEP		Transmembrane protein 16G	605096				
2.1083	11	4	15	2q37.3	TRAF3IP1, MIPT3, SLSN9		TNF receptor-associated factor 3-interacting protein 1	607380			Senior-Loken syndrome 9, 616629 (3)	
2.1084	10	11	17	2q37.3	UBE2F, NCE2		Ubiquitin-conjugating enzyme E2F	617700				
2.1085	8	11	15	2q37.3	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS		Twist, Drosophila, homolog of, 2 (dermis-expressed protein 1, mouse, homolog of)	607556			Focal facial dermal dysplasia 3, Setleis type, 227260 (3); Barber-Say syndrome, 209885 (3); Ablepharon-macrostomia syndrome, 200110 (3)	
2.1086	4	6	00	Chr.2	TSE2		Transsuppressor of expression 2	601136				
3.1	3	10	11	3pter-p25	DEL3pterp25, C3DELpterp25		3p- syndrome (chromosome 3pter-p25 deletion syndrome)	613792		contiguous gene deletion syndrome	3p- syndrome (4)	
3.2	12	22	89	3p22.1	CCK		Cholecystokinin	118440				9(Cck)
3.3	3	10	11	3p22.2	CX3CR1, GPR13, V28		Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13)	601470			{Rapid progression to AIDS from HIV1 infection}, 609423 (3); {Coronary artery disease, resistance to}, 607339 (3); {Macular degeneration, age-related, 12}, 613784 (3)	
3.4	3	17	05	3p26.2	CRBN, MRT2		Cereblon	609262		between D3S3525 and D3S1560	Mental retardation, autosomal recessive 2, 607417 (3)	
3.5	12	17	07	3p26.1	EGO		Eosinophil granule ontogeny	611662				
3.6	1	8	01	3p25.3	OGG1		8-hydroxyguanine DNA glycosylase	601982			Renal cell carcinoma, clear cell, somatic, 144700 (3)	6(Ogg1)
3.7	3	5	95	3p25.3	OXTR		Oxytocin receptor	167055		3p25 by others; within 7-10kb of CAV3		
3.8	12	03	20	3p26.1	ARL8B, GIE1		ADP ribosylation factor-like GTPase 8B	616596				
3.9	2	28	03	3p26.3	CHL1, CALL, L1CAM2		CHL1, mouse, homolog of (L1 cell adhesion molecule 2)	607416				6(Chl1)
3.10	4	3	03	3p26.1	EDEM, KIAA0212		ER degradation-enhancing alpha-mannosidase-like protein	607673				
3.11	10	30	20	3p26.1	GRM7, MGLUR7, NEDSHBA		Glutamate receptor, metabotropic, 7	604101			Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities, 618922 (3)	
3.12	6	10	16	3p26.1	ITPR1, SCA15, SCA16, SCA29		Inositol 1,4,5-triphosphate receptor, type 1	147265			Spinocerebellar ataxia 15, 606658 (3); Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3); Gillespie syndrome, 206700 (3)	6(Itpr1)
3.13	5	12	17	3p25.3	SSUH2, C3orf32, FLS485		Ssu2, C. elegans, homolog of	617479				
3.14	8	24	09	3p26.1-p25.1	ARHI2		Age-related hearing impairment 2	612976		associated with rs11928865, rs779701, and rs779706	{Age-related hearing impairment 2} (2)	
3.15	9	30	10	3p26.1	BHLHE40, HLHB2, STRA13, DEC1		Basic helix-loop-helix family, member E40	604256				
3.16	5	30	00	3p12.3	CNTN3, PANG		Contactin 3 (plasmocytoma-associated neuronal glycoprotein)	601325				6(Pang)
3.17	02	12	19	3p26	HPC5		Prostate cancer, hereditary, 5	609299		between D3S1270 and D3S4559	{Prostate cancer, hereditary, 5} (2)	
3.18	3	8	04	3p26	IBD9		Inflammatory bowel disease 9	608448			{Inflammatory bowel disease 9} (2)	
3.19	3	20	06	3p26.1	SETMAR, METNASE		SET and Mariner transposase domains-containing protein	609834				
3.20	5	23	06	3p26	STQTL5		Stature quantitative trait locus 5	608982		max lod between D3S1297 and D3S1304	{Stature QTL 5} (2)	
3.21	10	29	03	3p26.1	SUMF1, FGE		Sulfatase-modifying factor-1	607939			Multiple sulfatase deficiency, 272200 (3)	6(Sumf1)
3.22	5	25	05	3p25.3	ATP2B2, PMCA2		ATPase, Ca++ transporting, plasma membrane, 2	108733			{Deafness, autosomal recessive 12, modifier of}, 601386 (3)	
3.23	2	9	17	3p25.3	BRPF1, BR140, IDDDFP		Bromodomain- and PHD finger-containing protein 1, 140kD	602410			Intellectual developmental disorder with dysmorphic facies and ptosis, 617333 (3)	
3.24	6	9	08	3p26.3-p26.2	CNTN4		Contactin 4	607280				
3.25	10	17	02	3p26.3	CNTN6, NB3		Contactin 6	607220				
3.26	2	20	03	3p25.3	GHRL		Ghrelin	605353			{Obesity, susceptibility to}, 601665 (3)	
3.27	10	31	19	3p25.3	VHL		von Hippel-Lindau tumor suppressor	608537			von Hippel-Lindau syndrome, 193300 (3); Renal cell carcinoma, somatic, 144700 (3); Pheochromocytoma, 171300 (3); Hemangioblastoma, cerebellar, somatic (3); Erythrocytosis, familial, 2, 263400 (3)	
3.28	9	12	08	3p26-p24.2	MYMY1, MYMY		Moyamoya disease	252350		max lod at D3S3050	Moyamoya disease (2)	
3.29	6	7	94	3p26.2	IL5RA		Interleukin-5 receptor, alpha	147851				6(Il5r)
3.30	5	11	00	3p25.3	LMCD1		LIM and cysteine-rich domains 1	604859				6(Lmcd1)
3.31	11	11	14	3p25.3	ARPC4, ARC20		Actin-related protein 2/3 complex, subunit 4	604226				
3.32	09	19	19	3p25.3	ATG7, APG7L, GSA7		Autophagy related 7	608760				
3.33	2	25	14	3p25.3	BRK1, C3orf10, HSPC300		BRICK1, SCAR/WAVE actin-nucleating complex subunit	611183				
3.34	8	28	09	3p25.3	CAMK1, CAMKI		Calcium/calmodulin-dependent protein kinase I	604998				
3.35	4	24	03	3p25.3	CRELD1, AVSD2		Cysteine-rich protein with EGF-like domains 1	607170			{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3); Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)	6(Creld1)
3.36	3	14	01	3p25.3	FANCD2, FANCD, FACD, FAD		Fanconi anemia, complementation group D2	613984			Fanconi anemia, complementation group D2, 227646 (3)	
3.37	05	24	19	3p25.3	GHRLOS		Ghrelin opposite strand, noncoding	618445				
3.38	1	9	13	3p25.3	IL17RE		Interleukin 17 receptor E	614995				
3.39	4	6	10	3p25.3	IRAK2		Interleukin 1 receptor-associated kinase 2	603304				
3.40	09	19	19	3p25.3	JAGN1, SCN6		Jagunal homolog 1	616012			Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3)	6(Jagn1)
3.41	8	22	07	3p25.3	MTMR14, C3orf29, HJUMPY		Myotubularin-related protein 14	611089			{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)	
3.42	11	21	20	3p25.3	PRRT3AS1		PRRT3 antisense RNA 1, noncoding	619106				
3.43	11	10	17	3p25.3	RPUSD3		RNA pseudouridylate synthase domain-containing protein 3	617759				
3.44	4	29	14	3p25.3	SETD5, KIAA1757		SET domain-containing protein 5	615743			Mental retardation, autosomal dominant 23, 615761 (3)	
3.45	2	2	10	3p25.3	SLC6A11, GAT3, GAT4		Solute carrier family 6 (neurotransmitter transporter, GABA), member 11	607952				
3.46	4	26	10	3p25.3	TADA3, TADA3L, ADA3		Transcriptional adaptor 3	602945				
3.47	7	6	15	3p25.3	IL17RC, IL17RL, CANDF9		Interleukin 17 receptor C	610925			Candidiasis, familial, 9, 616445 (3)	
3.48	12	01	20	3p22.1	TRAK1, OIP106, KIAA1042, DEE68		Trafficking protein, kinesin-binding 1	608112			Developmental and epileptic encephalopathy 68, 618201 (3)	9(hyrt)
3.49	5	7	03	3p23	OSBPL10, ORP10		Oxysterol-binding protein-like protein 10	606738				
3.50	2	25	15	3p25.2	CAND2, TIP120B, KIAA0667		Cullin-associated neddylation -dissociated 2	610403				
3.51	12	09	19	3p25.2-p25.1	IQSEC1, KIAA0763, IDDSSBA		IQ motif- and Sec7 domain-containing protein 1	610166			Intellectual developmental disorder with short stature and behavioral abnormalities, 618687 (3)	
3.52	12	17	12	3p25.2	TAMM41, RAM41, C3orf31		Translocator assembly and maintenance, mitochondrial, S. cerevisiae, homolog of	614948				
3.53	4	15	03	3p25.2-p25.1	UVM2		Melanoma, uveal, susceptibility to, 2	606661			{Melanoma, uveal, susceptibility to, 2} (2)	
3.54	11	29	04	3p25.1	BTD		Biotinidase	609019			Biotinidase deficiency, 253260 (3)	
3.55	02	19	19	3p25.3	CAV3, LQT9, MPDT, RMD2		Caveolin-3	601253		within 7-10kb of OXTR	Rippling muscle disease 2, 606072 (3); Creatine phosphokinase, elevated serum, 123320 (3); Myopathy, distal, Tateyama type, 614321 (3); Cardiomyopathy, familial hypertrophic, 192600 (3); Long QT syndrome 9, 611818 (3)	
3.56	5	23	13	3p25.3	CIDEC, FSP27, CIDE3, FPLD5		Cell death-inducing DFFA-like effector C	612120		1 patient identified with mutation	?Lipodystrophy, familial partial, type 5, 615238 (3)	
3.57	4	30	15	3p25.1	COLQ, EAD, CMS5		Collagenic tail of endplate acetylcholinesterase	603033			Myasthenic syndrome, congenital, 5, 603034 (3)	
3.58	5	24	13	3p25.3	LHFPL4		LHFP-like protein 4	610240				
3.59	2	2	04	3p25.2	MKRN2		Makorin 2	608426				6(Mkrn2)
3.60	10	05	20	3p25.1	MRPS25, COXPD50		Mitochondrial ribosomal protein S25	611987		mutation identified in 1 COXPD50 patient	?Combined oxidative phosphorylation deficiency 50, 619025 (3)	
3.61	10	21	99	3p25.1	NR2C2, TR4, TAK1		Nuclear receptor subfamily 2, group C, member 2	601426				
3.62	3	27	09	3p25.2	PPARG, PPARG1, PPARG2, CIMT1, GLM1		Peroxisome proliferator activated receptor, gamma	601487		PPARG1, PPARG2 from same gene	Obesity, severe, 601665 (3); [Obesity, resistance to] (3); Insulin resistance, severe, digenic, 604367 (3); Lipodystrophy, familial partial, type 3, 604367 (3); Carotid intimal medial thickness 1, 609338 (3); {Diabetes, type 2}, 125853 (3)	
3.63	8	3	14	3p25.2	RAF1, CRAF, NS5, CMD1NN		Oncogene RAF1	164760			Noonan syndrome 5, 611553 (3); LEOPARD syndrome 2, 611554 (3); Cardiomyopathy, dilated, 1NN, 615916 (3)	6(Raf1)
3.64	10	28	02	3p25.3	SRGAP3, KIAA0411, MEGAP		Slit-robo GTPase-activating protein, rho, 3	606525				
3.65	11	2	04	3p25.2	SYN2		Synapsin II	600755			{Schizophrenia, susceptibility to}, 181500 (3)	6(Syn2)
3.66	10	3	02	3p25.2	TIMP4		Tissue inhibitor of metalloproteinase 4	601915				6(Timp4)
3.67	3	27	13	3p25.1	TMEM43, ARVD5, ARVC5, EDMD7		Transmembrane protein 43	612048			Arrhythmogenic right ventricular dysplasia 5, 604400 (3); Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3)	
3.68	12	09	19	3p25.3-p25.2	VGLL4, KIAA0121		Vestigial-like family member 4	618692				
3.69	7	18	06	3p25.1	WNT7A		Wingless-type MMTV integration site family, member 7A	601570			Ulna and fibula, absence of, with severe limb deficiency, 276820 (3); Fuhrmann syndrome, 228930 (3)	
3.70	08	07	20	3p25.1	XPC, XPCC		XPC complex subunit, DNA damage recognition and repair factor	613208			Xeroderma pigmentosum, group C, 278720 (3)	6(Xpc)
3.71	10	5	11	3p24.3	PLCL2, KIAA1092		Phospholipase C-like 2	614276				
3.72	08	21	19	3p25.3	RAD18		RAD18 E3 ubiquitin protein ligase	605256				
3.73	09	20	19	3p25.3	SEC13, SEC13L1, D3S1231E, SEC13R		SEC13 homolog, nuclear pore and COPII coat complex component	600152				6(Sec13n)
3.74	10	9	94	3p25.1	FBLN2		Fibulin-2	135821				6(Fbln2)
3.75	6	19	15	3p25.3	SLC6A1, GABATR, MAE		Solute carrier family 6 (neurotransmitter transporter, GABA), member 1	137165			Myoclonic-atonic epilepsy, 616421 (3)	
3.76	5	27	05	3p25-p22	OVCAS1		Ovarian cancer, susceptibility to, 1	607893		between D3S1597 and D3S3611	{Ovarian cancer, susceptibility to} (2)	
3.77	3	5	95	3p25.1	SLC6A6, TAUT		Solute carrier family 6 (neurotransmitter transporter, taurine), member 6	186854				6(Slc6a6)
3.78	9	10	07	3p25.1	ANKRD28, PITK, KIAA0379		Ankyrin repeat domain-containing protein 28	611122				
3.79	2	18	16	3p25.1	CCDC174, HSPC212, IHPM		Coiled-coil domain-containing protein 174	616735			Hypotonia, infantile, with psychomotor retardation, 616816 (3)	
3.80	8	21	07	3p25.1	CHDH4, MIA40		Coiled-coil-helix-coiled-coil-helix domain-containing protein 4	611077				
3.81	12	4	03	3p25.1	EAF1		ELL-associated factor 1	608315				
3.82	8	31	12	3p25.1	FGD5		FYVE, RhoGEF, and PH domain-containing protein 5	614788				
3.83	4	6	13	3p25.1	GALNT15, GALNACT15		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15	615131				
3.84	6	22	14	3p25.1	HACL1, HPCL2		2-hydroxyacyl-CoA lyase 1	604300				
3.85	06	03	20	3p25.1	METTL6		Methyltransferase-like 6	618903				
3.86	8	28	09	3p25.1	NUP210, GP210, KIAA0906		Nucleoporin, 210kD	607703				
3.87	11	19	10	3p25.1	SH3BP5, SAB		SH3 domain-binding protein 5	605612		previously mapped to 1q431		14(Sh3bp5)
3.88	6	2	16	3p26.2	TRNT1, SIFD, RPEM		tRNA nucleotidyltransferase, CCA-adding, 1	612907		pseudogenes on chromosomes 1 and 22	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3); Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3)	
3.89	11	21	02	3p25.1	LSM3		LSM3 protein	607283				
3.90	7	8	16	3p25.1	RBSN,  ZFYVE20		Rabenosyn 5	609511				
3.91	08	21	19	3p25.2	TSEN2, SEN2, PCH2B		tRNA splicing endonuclease, subunit 2	608753			Pontocerebellar hypoplasia type 2B, 612389 (3)	
3.92	8	20	10	3p25.1-p23	LGMD1H		Muscular dystrophy, limb-girdle, type 1H	613530		between D3S1263 and D3S1277	Muscular dystrophy, limb-girdle, type 1H (2)	
3.93	12	09	19	3p25.1	COL6A4P1, DVWA, DIVA, LOC344875		Collagen, type VI, alpha 4, pseudogene 1	612397				
3.94	02	26	19	3p25.1	DPH3, KTI11, ZCSL2, DELGIP1		Diphthamide biosynthesis protein 3	608959				
3.95	4	15	09	3p24.3	OS6		Osteoarthritis susceptibility 6	612401		associated with rs11718863 and rs7639618	{Osteoarthritis susceptibility 6} (2)	
3.96	12	11	18	3p24.3	RFTN1, KIAA0084		Lipid raft linking protein 1	618210				
3.97	2	4	15	3p24.3	SGOL1, SGO, SGO1, CAID		Shugoshin-like 1	609168			Chronic atrial and intestinal dysrhythmia, 616201 (3)	
3.98	4	29	14	3p24.3	TBC1D5, KIAA0210		TBC1 domain family, member 5	615740				
3.99	9	4	08	3p24.2	THRB, ERBA2, THR1, PRTH		Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2)	190160			Thyroid hormone resistance, 188570 (3); Thyroid hormone resistance, autosomal recessive, 274300 (3); Thyroid hormone resistance, selective pituitary, 145650 (3)	
3.100	8	3	12	3p24.2	UBE2E1, UBCH6		Ubiquitin-conjugating enzyme E2E 1	602916				
3.101	10	2	12	3p24.2	NR1D2, RVR, BD73		Nuclear receptor subfamily 1, group D, member 2	602304				
3.102	8	31	06	3p24.2	OXSM, KS		3-oxoacyl-ACP synthase, mitochondrial	610324				14(Oxsm)
3.103	12	27	13	3p24.2	RPL15, DBA12		Ribosomal protein L15	604174		mutation identified in 1 family	?Diamond-Blackfan anemia 12, 615550 (3)	
3.104	3	5	98	3p24.3	UBE2E2		Ubiquitin-conjugating enzyme E2E 2 (homologous to yeast UBC4/5)	602163				
3.105	1	2	08	3p24.2-p23	FEB9		Febrile seizures, familial, 9	611634		between D3S3727 and D3S3567	Febrile seizures, familial, 9 (2)	
3.106	03	02	20	3p24.1	AZI2, AZ2, NAP1, TILP		5-azacytidine-induced protein 2	609916				
3.107	1	28	14	3p24-p23	GADL1		Glutamate decarboxylase-like 1	615601				
3.108	7	11	17	3p24.1	TGFBR2, HNPCC6, AAT3, MFS2, LDS2		Transforming growth factor, beta receptor II, 70-80kD	190182			Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3); Esophageal cancer, somatic, 133239 (3); Loeys-Dietz syndrome 2, 610168 (3)	9(Tgbfr2)
3.109	12	22	00	3p21.31	CELSR3, EGFL1, MEGF2		Cadherin EGF LAG seven-pass G-type receptor 3 (epidermal growth factor-like 1)	604264				
3.110	8	20	15	3p24	ATOD9		Dermatitis, atopic, 9	613519		max lod at D3S1768	{Dermatitis, atopic, susceptibility to, 9} (2)	
3.111	12	30	98	3p24.3	CAF		CREBBP-associated factor	602303				17(Caf)
3.112	11	28	01	3p25.1	CAPN7, PALBH		Calpain 7	606400				
3.113	10	17	00	3p22.3	CCR4, CKR4, CMKBR4		Chemokine (C-C) receptor-4	604836				
3.114	4	17	13	3p24.1	CMC1, C3orf68		Cytochrome C oxidase assembly mitochondrial protein 1, S. cerevisiae, homolog of	615166				
3.115	4	15	03	3p24.3	DAZL, DAZH, SPGYLA		Deleted in azoospermia-like	601486		?founding member of DAZ gene family	{Spermatogenic failure, susceptibility to} (3)	
3.116	08	24	20	3p24.1	LRRC3B, LRP15		Leucine-rich repeat-containing protein 3B	618996				
3.117	02	24	20	3p24.1	NEK10, CILD44		NIMA-related kinase 10	618726			Ciliary dyskinesia, primary, 44, 618781 (3)	
3.118	6	9	15	3p24.2	NGLY1, PNG1, CDDG, CDG1V		N-glycanase 1	610661			Congenital disorder of deglycosylation, 615273 (3)	
3.119	11	19	13	3p24.2	RARB, HAP, MCOPS12		Retinoic acid receptor, beta polypeptide	180220		= HAP = HBV-activated protein	Microphthalmia, syndromic 12, 615524 (3)	14(Rarb)
3.120	1	30	01	3p24.2	TOP2B		Topoisomerase (DNA) II, beta, 180kD	126431				
3.121	8	27	01	3p24.1	RBMS3		RNA-binding motif protein, single strand-interacting, 3	605786				
3.122	9	22	03	3p24-p22	HSN1B		Hereditary sensory neuropathy, type IB	608088		max lod at D3S2338	Neuropathy, hereditary sensory, type IB (2)	
3.123	8	18	98	3p24.3	RAB5A, RAB5		RAS-associated protein RAB5A	179512				
3.124	4	23	98	3p22.3-p22.2	STAC		SRC homology three (SH3) and cysteine-rich domain	602317				9(Stac)
3.125	3	14	06	3p24-p21	ASPG4		Asperger syndrome, susceptibility to, 4	609954		max lod at D3S2432	{Asperger syndrome susceptibility 4} (2)	
3.126	6	9	98	3p24.3	SATB1		Special AT-rich sequence binding protein-1	602075				
3.127	1	14	14	3p23	STT3B, SIMP, CDG1X		STT3B, subunit of the oligosaccharyltransferase complex (catalytic)	608605		mutation identified in 1 family	?Congenital disorder of glycosylation, type Ix, 615597 (3)	
3.128	12	23	05	3p22.3	UBP1, LBP1A, LBP1B		Upstream binding protein 1	609784				
3.129	8	4	09	3p22.2	ACAA1		Acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiolase)	604054				
3.130	1	17	08	3p21.31	CDCP1, SIMA135		CUB domain-containing protein 1	611735				
3.131	1	11	89	3p23-p21	SCLC1		Small-cell cancer of lung	182280		centromeric to ERBA2	Small-cell cancer of lung (2)	
3.132	6	16	99	3p21.31	SMARCC1, BAF155		SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily C, member 1	601732				
3.133	6	28	02	3p21.31	TDGF1		Teratocarcinoma-derived growth factor-1	187395			Forebrain defects (3)	9(Tdgf1)
3.134	04	18	19	3p22.3	ARPP21, RCS		Cyclic AMP-regulated phosphoprotein, 21kD	605488				
3.135	8	28	09	3p22.3	CLASP2		CLIP-associated protein 2	605853				
3.136	12	5	11	3p22.3	CMTM6, CKLFSF6		CKLF-like marvel transmembrane domain-containing 6	607889				9(Cklfsf6)
3.137	12	5	11	3p22.3	CMTM7, CKLFSF7		CKLF-like marvel transmembrane domain-containing 7	607890				9(Cklfsf7)
3.138	12	5	11	3p22.3	CMTM8, CKLFSF8		CKLF-like marvel transmembrane domain-containing 8	607891				9(Cklfsf8)
3.139	12	21	09	3p22.2	DCLK3, DCK3, CLR		Doublecortin-like kinase 3	613167				9(Dclk2)
3.140	7	17	14	3p22.3	DYNC1LI1, LIC1		Dynein, cytoplasmic 1, light intermediate chain 1	615890				
3.141	8	28	09	3p22.3	FBXL2, FBL2		F-box and leucine-rich repeat protein 2	605652				
3.142	2	11	08	3p22.3	GPD1L, KIAA0089		Glycerol-3-phosphate dehydrogenase 1-like	611778			Brugada syndrome 2, 611777 (3)	
3.143	9	16	03	3p22.3	PDCD6IP, AIP1, ALIX, KIAA1375		Programmed cell death 6-interacting protein	608074				
3.144	11	22	19	3p22.3	TRIM71, LIN41, HYDCC1		Tripartite motif-containing protein 71	618570			Hydrocephalus, congenital communicating, 1, 618667 (3)	
3.145	12	23	05	3p22.2	CMYA1, XIN		Cardiomyopathy-associated protein 1	609777				
3.146	2	2	14	3p22.2	DDH2		Developmental dysplasia of the hip 2	615612		between rs4481097 and rs4626072	Developmental dysplasia of the hip 2 (2)	
3.147	9	8	11	3p22.2	LRRFIP2		Leucine-rich repeat in FLII-interacting protein 2	614043				
3.148	3	23	09	3p22.2	MIR26A, MIRN26A1		Micro RNA 26A1	612151				
3.149	9	24	09	3p22.2	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2		Sodium channel, voltage-gated, type V, alpha polypeptide	600163			Long QT syndrome 3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart block, progressive, type IA, 113900 (3); Heart block, nonprogressive, 113900 (3); Ventricular fibrillation, familial, 1, 603829 (3); Sick sinus syndrome 1, 608567 (3); Cardiomyopathy, dilated, 1E, 601154 (3); {Sudden infant death syndrome, susceptibility to}, 272120 (3); Atrial fibrillation, familial, 10, 614022 (3)	
3.150	08	24	20	3p22.2	SCN10A, FEPS2		Sodium voltage-gated channel, alpha subunit 10	604427			Episodic pain syndrome, familial, 2, 615551 (3)	
3.151	08	24	20	3p22.2	SCN11A, HSAN7, FEPS3		Sodium voltage-gated channel, alpha subunit 11	604385			Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3); Episodic pain syndrome, familial, 3, 615552 (3)	9(Scn11a)
3.152	01	04	19	3p22.2	SLC22A13, ORCTL3, OCTL1		Solute carrier family 22 (organic anion/urate transporter), member 13	604047				
3.153	01	04	19	3p22.2	SLC22A14, ORCTL4, OCTL2		Solute carrier family 22, member 14	604048				
3.154	8	25	11	3p22.1-p21.3	ANO10, TMEM16K, SCAR10		Anoctamin 10	613726			Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)	
3.155	04	01	19	3p22.1	CTNNB1, NEDSDV, EVR7		Catenin (cadherin-associated protein), beta 1, 88kD	116806			Neurodevelopmental disorder with spastic diplegia and visual defects, 615075 (3); Pilomatricoma, somatic, 132600 (3); Ovarian cancer, somatic, 167000 (3); Hepatocellular carcinoma, somatic, 114550 (3); Medulloblastoma, somatic, 155255 (3); Exudative vitreoretinopathy 7, 617572 (3); Colorectal cancer, somatic, 114500 (3)	9(Catnb)
3.156	2	25	15	3p22.2	EPM2AIP1, KIAA0766		EPM2A-interacting protein 1	607911				9(Epm2aip1)
3.157	10	25	16	3p22.1	HHATL, MBOAT3, C3orf3, KIAA1173		Hedgehog acyltransferase-like protein	608116				
3.158	10	14	19	3p22.1	HIGD1A, HIG1, RCF1A		HIG1 hypoxia-inducivle domain family, member 1A	618623				
3.159	8	2	13	3p22.1	KLHL40, SYRP, KBTBD5, NEM8		Kelch-like 40	615340			Nemaline myopathy 8, autosomal recessive, 615348 (3)	
3.160	2	21	14	3p22.1	NKTR		Natural tumor-killer recognition sequence	161565		mouse gene close to Cck		9(Nktr)
3.161	10	14	18	3p22.1	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8, MDDGC8		Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 2	614828			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8, 618135 (3)	
3.162	4	21	17	3p22.1	RPL14		Ribosomal protein L14	617414				
3.163	10	07	19	3p22.1	SEC22C		SEC22 homolog C, vesicle trafficking protein	604028				
3.164	3	17	16	3p22.1	SLC25A38, SIDBA2		Solute carrier family 25, member 38	610819			Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3)	9(Slc25a38)
3.165	6	22	12	3p22.1	SNORA62, RNU108, RNE2		Small nucleolar RNA, H/ACA box, 62	180646				
3.166	6	27	16	3p22.1	ULK4, FAM7C1		Unc51-like kinase 4	617010				9(Ulk4)
3.167	8	25	11	3p21.31	NBEAL2, KIAA0540, GPS, BDPLT4		Neurobeachin-like 2	614169			Gray platelet syndrome, 139090 (3)	
3.168	11	28	01	3p22.2	AXUD1		Axin1 upregulated	606458				
3.169	9	9	08	3p22.1	CCR8, CMKBR8, CMKBRL2, CKRL1		Chemokine (C-C) receptor 8	601834				
3.170	10	6	11	3p22.3	CRTAP, CASP, OI7		Cartilage-associated protein	605497			Osteogenesis imperfecta, type VII, 610682 (3)	9(Crtap)
3.171	10	4	12	3p22	HHV8S		Human herpesvirus 8, susceptibility to	614836			{Human herpesvirus 8, susceptibility to} (2)	
3.172	3	23	09	3p22.3	MIR128-2, MIR128B, MIRN128-2		Micro RNA 128-2	611769				
3.173	1	29	01	3p24.1	SLC4A7, NBC2, NBC3		Solute carrier family 4, sodium bicarbonate cotransporter, member 7	603353				
3.174	5	9	95	3p22.1	VIPR1		Vasoactive intestinal peptide receptor 1	192321		incorrectly assigned to 2q37		9(Vipr1)
3.175	7	8	95	3p21.31	TGM4		Transglutaminase-4, prostate	600585				
3.176	11	13	07	3p22.2	ACVR2B, ACTRIIB, HTX4		Activin A receptor, type IIB	602730			Heterotaxy, visceral, 4, autosomal, 613751 (3)	
3.177	2	19	02	3p22.1	CYP8B1, CYP12		Cytochrome P450, subfamily VIIIB, polypeptide 1	602172				9(Cyp8b1)
3.178	02	11	19	3p22.2	DLEC1, DLC1		Deleted in lung and esophageal cancer 1	604050				
3.179	8	9	99	3p22.2	GOLGA4		Golgi autoantigen, golgin subfamily a, 4	602509				
3.180	2	22	11	3p22.2	EXOG, ENDOGL1, ENGL		Endo/exonuclease, ENDOG-like	604051				
3.181	06	25	20	3p22.2	MYD88, MYD88D, IMD68		MYD88 innate immune signal transduction adaptor	602170			Immunodeficiency 68, 612260 (3); Macroglobulinemia, Waldenstrom, somatic, 153600 (3)	9(Myd88)
3.182	8	9	99	3p22.2	OSR1		Oxidative stress-responsive 1	604046				
3.183	8	25	11	3p22.2	PLCD1, NDNC3		Phospholipase C, delta-1	602142			Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)	
3.184	8	5	97	3p21.31	TNA		Tetranectin (plasminogen-binding protein)	187520				
3.185	8	9	99	3p22.2	XYLB		Xylulokinase, H. influenzae, homolog of	604049				
3.186	05	08	19	3p21.31	PTH1R, PTHR1, PTHR, PFE, EKNS		Parathyroid hormone 1 receptor	168468			Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3); Chondrodysplasia, Blomstrand type, 215045 (3); Eiken syndrome, 600002 (3); Failure of tooth eruption, primary, 125350 (3)	
3.187	2	28	03	3p22.1	MOBP		Myelin-associated oligodendrocyte basic protein	600948				9(Mobp)
3.188	1	30	01	3p21.31	PFKFB4		6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4	605320				
3.189	6	18	90	3p21.31	ZNF35, HF10		Zinc finger protein-35 (HF.10)	194533				
3.190	2	2	11	3p22.3	GLB1, MPS4B		Galactosidase, beta-1	611458		3p14.2-p11 excluded	GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II, 230600 (3); GM1-gangliosidosis, type III, 230650 (3); Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	9(Bgl)
3.191	8	28	09	3p22.2	GORASP1, GOLPH5, GRASP65, P65		Golgi reassembly stacking protein 1, 65kD	606867				
3.192	5	12	09	3p22.1	LYZL4		Lysozyme-like 4	612750				
3.193	10	5	17	3p21.31	TOPAZ1, C3orf77		Testis- and ovary-specific PAZ domain protein 1	614412				9(Topaz1)
3.194	7	31	08	3p22.2	WDR48, KIAA1449		WD repeat-containing protein 48	612167				
3.195	2	14	08	3p22.1	MYRIP, SLAC2C		Myosin VIIA- and RAB-interacting protein	611790				
3.196	6	7	10	3p21.32	MIR138-1, MIRN138-1		Micro RNA 138-1	613394				
3.197	12	18	08	3p21.31	ALS2CL		ALS2 C-terminal-like protein	612402				9(Als2cl)
3.198	3	14	14	3p21.31	AMIGO3, ALI3		Adhesion molecule with Ig-like domain 3	615691				
3.199	3	9	00	3p21.31	BSN, ZNF231		Bassoon, mouse, homolog of	604020				
3.200	1	9	13	3p21.31	CAMKV, 1G5		CAM kinase-like vesicle-associated	614993				9(Camkv)
3.201	09	12	19	3p21.31	CCDC51, MITOK		Coiled-coil domain-containing protein 51	618585				
3.202	7	2	18	3p21.31	CSPG5, NGC		Chondroitin sulfate proteoglycan 5	606775				
3.203	10	23	20	3p21.31	DALRD3, DEE86		DALR anticodon-binding domain-containing protein 3	618904		mutation identified in 1 DEE86 family	?Developmental and epileptic encephalopathy 86, 618910 (3)	
3.204	07	13	20	3p21.31	DHX30, DDX30, RETCOR, KIAA0890, NEDMIAL		DExH-box helicase 30	616423			Neurodevelopmental disorder with severe motor impairment and absent language, 617804 (3)	
3.205	3	7	13	3p21.31	ELP6, TMEM103, C3orf75		Elongator acetyltransferase complex, subunit 6	615020				
3.206	6	1	12	3p21.31	EXOSC7, RRP42		Exosome component 7	606488				
3.207	09	27	18	3p21.31	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19		GDP-mannose pyrophosphorylase B	615320			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3)	
3.208	8	28	09	3p21.31	IHPK1, IP6K1, KIAA0263		Inositol hexaphosphate kinase 1	606991				
3.209	2	25	15	3p21.31	KIF9		Kinesin family member 9	607910				
3.210	7	13	17	3p21.31	KIF15, KLP2, KNSL7		Kinesin family, member 15	617569				
3.211	11	24	14	3p21.31	KLHDC8B, CHL		Kelch domain-containing protein 8B	613169			{Hodgkin lymphoma, susceptibility to}, 236000 (3)	
3.212	4	25	08	3p21.31	LTF		Lactotransferrin	150210				9(Ltf)
3.213	3	29	13	3p21.31	MIR191		Micro RNA 191	615150				
3.214	11	23	16	3p21.31	MIR4271		Micro RNA 4271	617176				
3.215	8	27	15	3p21.31	MON1A, SAND1		Mon1, S. cerevisiae, homolog of, A	611464				6(Mon1a)
3.216	12	13	18	3p21.31	NDUFAF3, MC1DN18		NADH-ubiquinone oxidoreductase complex assembly factor 3	612911			Mitochondrial complex I deficiency, nuclear type 18, 618240 (3)	
3.217	09	16	19	3p21.31	P4HTM, PH4, HIDEA		Prolyl 4-hydroxylase, transmembrane	614584			Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities, 618493 (3)	
3.218	02	12	19	3p21.31	PLXNB1, SEP		Plexin B1	601053				
3.219	2	25	15	3p21.31	PRSS50		Protease, serine, 50	607950				
3.220	5	17	18	3p21.31	QRICH1, VERBRAS		Glutamine-rich protein 1	617387			Ververi-Brady syndrome, 617982 (3)	
3.221	2	24	12	3p21.31	RNF123, KPC1		Ring finger protein 123	614472				
3.222	10	30	06	3p21.31	SCAP		SREBP cleavage-activating protein	601510				
3.223	11	17	16	3p21.1	SELENOK, SELK, HSPC030		Selenoprotein K	607916				
3.224	1	19	11	3p21.31	SLC25A20, CACT, CAC		Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (carnitine-acylcarnitine translocase)	613698		pseudogene on 6p12	Carnitine-acylcarnitine translocase deficiency, 212138 (3)	
3.225	7	14	14	3p21.31	TMA7, HSPC016		Translation machinery-associated 7, S. cerevisiae, homolog of	615808				
3.226	2	5	16	3p21.31	TRAIP, TRIP, RNF206, SCKL9		TRAF-interacting protein	605958			Seckel syndrome 9, 616777 (3)	
3.227	6	16	99	3p21.31	USP4, UNP		Ubiquitin-specific protease-4	603486				9(Unp)
3.228	2	24	12	3p21.31	USP19, KIAA0891		Ubiquitin-specific protease 19	614471				
3.229	2	1	11	3p21.31	WDR6		WD repeat-containing protein 6	606031		previously assigned to 15q21 by FISH		
3.230	1	5	06	3p21.31	ZD1		Zygodactyly 1	609815		max lod at D3S2409	Zygodactyly 1 (2)	
3.231	10	11	16	3p21.31	ZDHHC3, DHHC3, GODZ		Zinc finger DHHC domain-containing protein 3	617150				
3.232	02	06	20	3p21.2	ABHD14A, DORZ1		Abhydrolase domain-containing protein 14A	618771				
3.233	8	11	15	3p22.1	ACKR2, CCBP2, CMKBR9, D6, CCR9, CCR10		Atypical chemokine receptor 2	602648				
3.234	11	19	11	3p21.1	BAP1, TPDS		BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	603089			Tumor predisposition syndrome, 614327 (3)	
3.235	07	24	19	3p21.31	CACNA2D2, KIAA0558, CASVDD		Calcium channel, voltage-dependent, alpha-2/delta subunit 2	607082			Cerebellar atrophy with seizures and variable developmental delay, 618501 (3)	
3.236	3	2	98	3p21.31	CAMP, FALL39		Cathelicidin antimicrobial peptide	600474				
3.237	12	19	11	3p21.2	CISH, BACTS2		Cytokine inducible SH2-containing protein	602441			{Tuberculosis, susceptibility to}, 607948 (3); {Malaria, susceptibility to}, 611162 (3); {Bacteremia, susceptibility to}, 614383 (3)	9(Cish)
3.238	9	9	08	3p21.31	CCR3, CKR3, CMKBR3		Chemokine (C-C) receptor 3	601268				
3.239	9	9	08	3p21.31	CCR9		Chemokine, CC motif, receptor 9	604738				
3.240	12	2	14	3p21.31	COL7A1, NDNC8		Collagen VII, alpha-1 polypeptide	120120			Epidermolysis bullosa dystrophica, AD, 131750 (3); Epidermolysis bullosa dystrophica, AR, 226600 (3); Epidermolysis bullosa, pretibial, 131850 (3); EBD, Bart type, 132000 (3); EBD, localisata variant (3); Transient bullous of the newborn, 131705 (3); Epidermolysis bullosa pruriginosa, 604129 (3); Toenail dystrophy, isolated, 607523 (3); EBD inversa, 226600 (3)	
3.241	4	26	08	3p21.31	CYB561D2, 101F6		Cytochrome b-561 domain containing 2	607068				
3.242	7	24	17	3p21.1	DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37		Dynein, axonemal, heavy chain-1	603332		mutation identified in 1 CILD37 family	Spermatogenic failure 18, 617576 (3); ?Ciliary dyskinesia, primary, 37, 617577 (3)	14(Dnah1)
3.243	9	28	00	3p22.1	ENTPD3, CD39L3		Ectonucleoside triphosphate diphosphohydrolase 3	603161				
3.244	8	6	13	3p21.31	FYCO1, CATC2, CTRCT18		FYVE and coiled-coil domain containing 1	607182			Cataract 18, autosomal recessive, 610019 (3)	
3.245	8	25	11	3p21.31	GPX1, GPXD		Glutathione peroxidase-1	138320		?pseudogene on 3p11-p12	Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)	
3.246	6	16	99	3p21.31	HYAL2, LUCA2		Hyaluronoglucosaminidase 2	603551				9(Hyal2)
3.247	8	31	99	3p21.31	HYAL3, LUCA3		Hyaluronoglucosaminidase 3	604038				
3.248	9	9	08	3p21.3	IBD12		Inflammatory bowel disease 12	612241			{Inflammatory bowel disease 12} (2)	
3.249	9	28	98	3p21.31	IFRD2		Interferon-related developmental regulator-2	602725				
3.250	3	9	00	3p22.2	ITGA9		Integrin, alpha-9	603963				
3.251	7	22	16	3p21.31	LARS2, PRLTS4, HLASA		Leucyl-tRNA synthetase, mitochondrial	604544		mutation identified in 1 HLASA patient	Perrault syndrome 4, 615300 (3); ?Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3)	
3.252	2	22	00	3p21.31	LIMD1		LIM domain-containing protein 1	604543				9(Limd1)
3.253	9	11	02	3p21.31	LRRC2		Leucine-rich repeat-containing 2	607180				
3.254	10	16	14	3p21.31	LZTFL1, BBS17		Leucine zipper transcription factor-like 1	606568			Bardet-Biedl syndrome 17, 615994 (3)	9(Lztfl1)
3.255	9	16	16	3p21.2	MAPKAP3, 3PK, MDPT3		Mitogen-activated protein kinase-activated protein kinase-3	602130		mutation identified in 1 MDPT3 family	?Macular dystrophy, patterned, 3, 617111 (3)	
3.256	12	28	08	3q21.3	MGLL, MGL, HUK5		Monoglyceride lipase	609699				6(Mgll)
3.257	11	24	20	3p22.2	MLH1, COCA2, HNPCC2, MMRCS1		DNA mismatch repair protein MLH1	120436			Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Mismatch repair cancer syndrome 1, 276300 (3); Muir-Torre syndrome, 158320 (3)	
3.258	09	12	19	3p21.31	NME6		NME/NM23 nucleoside diphosphate kinase 6	608294				
3.259	8	22	16	3p21.31	MST1R, RON, NPCA3		Macrophage stimulating 1 receptor (c-met-related tyrosine kinase)	600168			{Nasopharyngeal carcinoma, susceptibility to, 3}, 617075 (3)	
3.260	02	06	20	3p21.31	NAA80, FUS2		N-alpha-acetyltransferase 80, NatH catalytic subunit	607073				
3.261	10	25	19	3p21.31	NPRL2, FFEVF2		NPR2-like protein, GATOR1 complex subunit	607072			Epilepsy, familial focal, with variable foci 2, 617116 (3)	
3.262	05	28	20	3p21.31	PTPN23, KIAA1471, HDPTP, NEDBASS		Protein-tyrosine phosphatase, nonreceptor-type, 23	606584			Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, 618890 (3)	
3.263	02	11	19	3p21.31	RASSF1		RAS association domain family protein 1	605082		epigenetically inactivated		
3.264	01	29	20	3p21.31	RHOA, ARHA, ARH12, RHOH12, EDFAOB		Ras homolog gene family, member A (oncogene RHO H12)	165390			Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic, 618727 (3)	
3.265	4	29	02	3p21.31	RMB5, LUCA15		RNA-binding motif protein 5	606884				
3.266	4	29	02	3p21.31	RBM6, DEF3		RNA-binding motif protein 6	606886				9(Rbm6)
3.267	10	12	14	3p22.1	RPSA, LAMR1, LAMBR, ICAS		Ribosomal protein SA	150370			Asplenia, isolated congenital, 271400 (3)	9(Lamr1)
3.268	4	30	09	3p21.31	RTP3, TMEM7		Receptor-transporting protein 3	607181				
3.269	1	14	02	3p21.31	SACM1L, SAC1, KIAA0851		SAC1 suppressor of actin mutations 1-like	606569				
3.270	3	15	96	3p21.31	SEMA3F, SEMA4		Semaphorin III/F	601124				
3.271	7	8	96	3p21.31	SEMA5		Semaphorin A(V)	601281				
3.272	2	2	17	3p21.31	SHISA5, SCOTIN		Shisa family, member 5	607290		pseudogene on Xq13.1-q13.3		
3.273	4	20	10	3p21.31	SLC6A20, XT3		X transporter protein 3	605616			Hyperglycinuria, 138500 (3); Iminoglycinuria, digenic, 242600 (3)	9(Xt3)
3.274	5	2	06	3p21.31	SLC26A6		Solute carrier family 26 (anion transporter), member 6	610068				
3.275	6	27	02	3p21.31	SLC38A3, SN1, G17		Solute carrier family 38, member 3	604437				
3.276	12	27	01	3p21.2	TLR9		Toll-like receptor 9	605474				
3.277	11	11	14	3p21.31	TMEM115, PL6		Transmembrane protein 115	607069				
3.278	3	9	98	3p21.3	TRR		Transfer RNA arginine	601994				
3.279	05	14	19	3p22.2	TTC21A, STI2, SPGF37		Tetratricopeptide repeat domain-containing protein 21A	611430			Spermatogenic failure 37, 618429 (3)	
3.280	3	18	08	3p21.31	UCN2, SRP, UR		Urocortin II	605902				
3.281	4	4	05	3p21.31	FUS1		FUS1 gene	607052				
3.282	2	28	94	3p21.31	UQCRC1		Ubiquinol-cytochrome c reductase core protein I	191328		close upstream of COL7A1		
3.283	10	15	13	3p21.31	ZMYND10, BLU		Zinc finger MYND domain-containing protein 10	607070			Ciliary dyskinesia, primary, 22, 615444 (3)	
3.284	6	1	07	3p21.31	ATRIP		ATR-interacting protein	606605				
3.285	3	8	00	3p24.1	EOMES, TBR2		Eomesodermin, Xenopus laevis, homolog of	604615		?translocation separating regulatory element from promoter		9(Tbr2)
3.286	2	11	15	3p21.31	HYAL1, MPS9		Hyaluronoglucosaminidase 1	607071		mutation identified in 1 MPS9 patient	?Mucopolysaccharidosis type IX, 601492 (3)	9(Hyal1)
3.287	6	16	99	3p21.31	PRKAR2A		Protein kinase, cAMP-dependent, regulatory, type II, alpha	176910				
3.288	2	23	16	3p21.31	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS		SET domain-containing protein 2	612778			Luscan-Lumish syndrome, 616831 (3)	
3.289	7	14	09	3p21.31	TREX1, AGS1, CRV, HERNS		3' repair exonuclease 1	606609			Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3); Chilblain lupus, 610448 (3); Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3); {Systemic lupus erythematosus, susceptibility to}, 152700 (3)	
3.290	4	19	06	3p21.2	PARP3, ADPRTL3		Poly(ADP-ribose) polymerase 3	607726				9(Adprtl3)
3.291	8	28	02	3p21.31	XCR1, CCXCR1, GPR5		Chemokine, C motif, receptor 1 (G protein-coupled receptor-5)	600552				
3.292	2	22	10	3p21.1	TNNC1, CMD1Z, CMH13		Troponin-C1, slow	191040			Cardiomyopathy, dilated, 1Z, 611879 (3); Cardiomyopathy, hypertrophic, 13, 613243 (3)	7(Tnnc1)
3.293	12	19	16	3p21.2	DCAF1, RIP, VPRBP, KIAA0800		DDB1- and CUL4-associated factor 1	617259				
3.294	10	03	19	3p21.31	HEMK1, MTQ1, MPRMC		HemK methyltransferase family, member 1	618609				
3.295	6	1	18	3p21.31	IMPDH2, IMPD2		Inosine-5'-monophosphate dehydrogenase, type II	146691			[IMPDH2 enzyme activity, variation in], 617995 (3)	
3.296	9	23	13	3p21.2	PCBP4, MGC10		Poly(rC)-binding protein 4	608503				9(Pcbp4)
3.297	09	19	19	3p21.2	POC1A, PIX2, SOFT		POC1 centriolar protein A	614783			Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3)	
3.298	3	14	06	3p21.2	PPM1M, PP2CE		Protein phosphatase 1M (protein phosphatase 2C, eta isoform)	608979				
3.299	6	21	01	3p21.31	AMT, NKH, GCE		Aminomethyltransferase (glycine cleavage system protein T)	238310			Glycine encephalopathy, 605899 (3)	
3.300	4	8	02	3p21.2	GRM2, MGLUR2		Glutamate receptor, metabotropic, 2	604099				
3.301	10	2	09	3p14.3	HESX1, RPX, CPHD5		Homeo box gene expressed in ES cells	601802			Septooptic dysplasia, 182230 (3); Pituitary hormone deficiency, combined, 5, 182230 (3); Growth hormone deficiency with pituitary anomalies, 182230 (3)	14(Hesx1)
3.302	10	6	92	3p21.1	ITIH1		Inter-alpha (globulin) inhibitor, H1 polypeptide	147270				14(Intin1)
3.303	10	6	92	3p21.1	ITIH3		Inter-alpha (globulin) inhibitor, H3 polypeptide	146650				14(Intin3)
3.304	2	7	06	3p14.3	SPATA12, SRG5		Spermatogenesis-associated protein 12	609869				
3.305	6	19	98	3p14.3	SLAP		Sarcolemmal-associated protein	602701				
3.306	06	19	19	3p21.1	ITIH4, PK120, ITIHL1		Inter-alpha (globulin) inhibitor, H4 polypeptide	600564				14(Itih4)
3.307	2	24	06	3p21.2	ACY1, ACY1D		Aminoacylase-1	104620			Aminoacylase 1 deficiency, 609924 (3)	9(Acy)
3.308	7	8	95	3p21.2	ALAS1		Aminolevulinate, delta-, synthase-1	125290				
3.309	7	16	09	3p21.2	ARMET, ARP		Arginine-rich protein, mutated in early stage tumors	601916				
3.310	11	1	13	3p21.1	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA		Calcium channel, voltage-dependent, L type, alpha 1D subunit	114206			Sinoatrial node dysfunction and deafness, 614896 (3); Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	14(Cch1a2)
3.311	11	28	01	3p21.1-p14.3	CACNA2D3		Calcium channel, voltage-dependent, alpha-2/delta subunit 3	606399				
3.312	8	28	09	3p14.2	CADPS, CAPS		Ca(2+)-dependent activator protein for secretion	604667				
3.313	12	02	20	3p21.1	DCP1A, SMIF		Decapping mRNA 1A	607010				
3.314	2	21	06	3p14.3	DNAH12, DNAHC3, HL19		Dynein, heavy chain-5	603340				
3.315	4	26	10	3p14.3-p14.2	FAM107A, DRR1, TU3A		Family with sequence similarity 107, member A (downregulated in renal cell carcinoma 1)	608295				
3.316	4	19	05	3p21.1	GNL3, NS, E2IG3		Guanine nucleotide-binding protein-like 3	608011				
3.317	5	13	02	3p21.2	GPR62		G protein-coupled receptor 62	606917				
3.318	04	23	19	3p21.1	GLT8D1		Glycosyltransferase 8 domain-containing protein 1	618399				
3.319	1	29	01	3p21.1	IL17RB, IL17BR, IL17RH1		Interleukin 17, receptor B	605458				
3.320	10	13	09	3p21.2	MIRLET7G, LET7G, MIRNLET7G		Micro RNA Let7G	612102				
3.321	11	23	16	3p21.1	MUSTN1, MUSTANG		Musculoskeletal embryonic nuclear protein 1	617195				
3.322	5	24	02	3p21.1	NEK4, STK2, NRK2		NIMA (never in mitosis gene a)-related kinase 4 (serine/threonine protein kinase-2)	601959				
3.323	11	22	13	3p21.1	NISCH, IRAS, KIAA0975		Nischarin	615507				
3.324	9	28	12	3p13	PROK2, PK2, BV8, HH4		Prokineticin 2	607002			Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3)	6(Prok2)
3.325	2	17	09	3p21.2	RBM15B, OTT3, HUMAGCGB		RNA-binding motif protein 15B	612602				
3.326	08	21	19	3p21.1	RFT1, CDG1N		RFT1 homolog	611908			Congenital disorder of glycosylation, type In, 612015 (3)	
3.327	9	9	13	3p21.1	SFMBT1, RU1		SCM-like protein with 4 MBT domains 1	607319				
3.328	04	24	20	3p21.1	SPCS1, SPC12		Signal peptidase complex, subunit 1	610358				
3.329	11	23	16	3p21.1	TMEM110, STIMATE		Transmembrane protein 110	617189				
3.330	08	07	20	3p21.2	TWF2, PTK9L, A6RP		Twinfilin actin-binding protein 2	607433				
3.331	9	9	10	3p21.2	WDR82, TMEM113		WD repeat-containing protein 82	611059				
3.332	8	11	15	3p14.3	APPL1, APPL, MODY14		Adaptor protein containing PH domain, PTB domain, and leucine zipper motif 1	604299			{Maturity-onset diabetes of the young, type 14}, 616511 (3)	
3.333	1	18	12	3p14.3	DNASE1L3, SLEB16		Deoxyribonuclease I-like 3	602244			Systemic lupus erythematosus 16, 614420 (3)	
3.334	05	08	20	3p21.33	ABHD5, CGI58, IECN2, NCIE2		Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase	604780			Chanarin-Dorfman syndrome, 275630 (3)	
3.335	6	7	94	3p21.31	APEH, D3S48E		N-acylaminoacyl-peptide hydrolase	102645				
3.336	8	28	09	3p21.31	ARIH2, ARI2, TRIAD1		Ariadne, Drosophila, homolog of, 2	605615				
3.337	11	4	93	3p21.31	CDC25A		Cell division cycle 25A	116947				
3.338	5	28	08	3p21	CELIAC9		Celiac disease, susceptibility to, 9	612007		associated with rs6441961	{Celiac disease, susceptibility to, 9} (2)	
3.339	9	9	08	3p21.31	CCR1, CMKBR1, CKR1, HM145		Chemokine (C-C) receptor 1	601159				9(Cmkbr1)
3.340	9	8	08	3p21.31	CCR2, CMKBR2		Chemokine (C-C) receptor 2	601267			{HIV infection, susceptibility/resistance to} (3)	
3.341	1	27	04	3p21.31	CCRL2		Chemokine, CC motif, receptor-like protein 2	608379				
3.342	1	13	09	3p21.31	CCR5, CMKBR5, CCCKR5, IDDM22		Chemokine (C-C) receptor 5	601373			{HIV infection, susceptibility/resistance to} (3); {West nile virus, susceptibility to}, 610379 (3); {Hepatitis C virus, resistance to}, 609532 (3); {Diabetes mellitus, insulin-dependent, 22}, 612522 (3)	
3.343	9	9	08	3p21.31	CXCR6, STRL33, BONZO		Chemokine, CXC motif, receptor 6	605163				
3.344	09	27	18	3p21.31	DAG1, DAG, MDDGC9, MDDGA9, LGMDR16		Dystrophin-associated glycoprotein-1	128239			Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3); Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3)	9(Dag1)
3.345	11	20	98	3p21.2	DUSP7, MKPX, PYST2		Dual-specificity phosphatase-7	602749				9(Dusp7)
3.346	9	9	08	3p21.31	FBXW12, FBW12, FBXO35, FBXO12		F-box and WD40 domain protein 12	609075				
3.347	4	15	11	3p21.2	GLYCTK, GLYCTK1		Glycerate kinase	610516			D-glyceric aciduria, 220120 (3)	
3.348	01	13	20	3p21.31	GNAI2, GNAI2B, GIP		Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2	139360		on 12p13-p12, GNAI2L	Pituitary adenoma, ACTH-secreting, somatic (3); Ventricular tachycardia, idiopathic, 192605 (3)	9(Gnai2)
3.349	2	8	18	3p21.31	GNAT1, CSNBAD3, CSNB1G		Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1	139330			Night blindness, congenital stationary, autosomal dominant 3, 610444 (3); Night blindness, congenital stationary, type 1G, 616389 (3)	9(Gnat1)
3.350	1	25	11	3p21	HSCR6		Hirschsprung disease, susceptibility to, 6	606874			{Hirschsprung disease, susceptibility to, 6} (2)	
3.351	9	30	02	3p21.31	IHPK2, IP6K2		Inositol hexaphosphate kinase 2	606992				
3.352	9	6	11	3p21.31	LAMB2, LAMS, NPHS5		Laminin, beta-2 (laminin S)	150325			Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3); Pierson syndrome, 609049 (3)	
3.353	5	9	97	3p21.31	MAP4		Microtubule-associated protein 4	157132				9(Map4)
3.354	8	27	92	3p21.31	MST1, HGFL		Macrophage-stimulating-1 (hepatocyte growth factor-like)	142408				9(Hgfl)
3.355	7	16	09	3p21.31	NCKIPSD, AF3P21, SPIN90		NCK-interacting protein with SH3 domain	606671				
3.356	10	13	09	3p21.31	NICN1		Nicolin 1	611516		processed pseudogene on X		9(Nicn1)
3.357	08	26	19	3p21.1	PBRM1, PB1, BAF180		Polybromo 1	606083				
3.358	4	15	11	3p21	PSC		Cholangitis, primary sclerosing	613806			Cholangitis, primary sclerosing (2)	
3.359	08	21	19	3p21.31	QARS1, QARS, GLNRS, MSCCA		Glutaminyl-tRNA synthetase 1	603727			Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3)	
3.360	5	12	09	3p22.1	SNRK, KIAA0096		SNF-related kinase	612760				
3.361	1	11	07	3p22.1	SS18L2		SS18-like gene 2	606473				
3.362	03	19	19	3p21.31	ZNF197, ZNF20, VHLAK		Zinc finger protein 197	618359				
3.363	12	17	15	3p21.31	ZNF589, SZF1		Zinc finger protein 589	616702				
3.364	12	7	95	3p21.31	TCTA		T-cell leukemia translocation altered gene	600690				
3.365	12	11	02	3p21.31	TMIE, DFNB6		Transmembrane inner ear-expressed gene	607237			Deafness, autosomal recessive 6, 600971 (3)	?9(sr)
3.366	1	6	14	3p21.31	UBE7, UBE1L		Ubiquitin-activating enzyme-7	191325				
3.367	1	30	01	3p13	GPR27, SREB1		G protein-coupled receptor 27	605187				
3.368	11	8	94	3p25.3	HRH1		Histamine receptor, subclass H1	600167				6(Hrh1)
3.369	8	25	11	3p14.3	WNT5A		Wingless-type MMTV integration site family, member 5A	164975			Robinow syndrome, autosomal dominant 1, 180700 (3)	
3.370	3	14	96	3p14.1	TMF1		TATA element modulatory factor 1	601126				
3.371	6	30	08	3p14.3	ARHGEF3, XPLN		RHO guanine nucleotide exchange factor 3	612115				
3.372	3	11	09	3p21-p13	MPVQTL2		Mean platelet volume quantitative trait locus 2	612574		associated with rs12485738	[Mean platelet volume QTL2] (2)	
3.373	12	22	14	3q22.3	A4GNT		Alpha-1,4-N-acetylglucosaminyltransferase	616709				
3.374	05	08	20	3p14.3	ADHB6		Abhydrolase domain-containing protein 6, acylglycerol lipase	616966				
3.375	2	27	17	3p14.3	ACOX2, BRCACOX, CBAS6		Acyl-Coenzyme A oxidase 2, branched chain	601641			Bile acid synthesis defect, congenital, 6, 617308 (3)	
3.376	12	15	16	3p14.3	ERC2, CAST, KIAA0378		ELKS/RAB6-interacting/CAST family, member 2	617250				
3.377	7	29	15	3p14.3	FAM208A, RAP140, C3orf63, KIAA1105		Family with sequence similarity 208, member A	616493				
3.378	1	31	12	3p14.3	FLNB, SCT, AOI, LRS1		Filamin B	603381			Spondylocarpotarsal synostosis syndrome, 272460 (3); Larsen syndrome, 150250 (3); Atelosteogenesis, type I, 108720 (3); Atelosteogenesis, type III, 108721 (3); Boomerang dysplasia, 112310 (3)	
3.379	12	19	19	3p14.3	ESRG, HESRG		Embryonic stem cell-related protein	611473				
3.380	02	24	20	3p14.3	KCTD6, KCASH3		Potassium channel tetramerization domain-containing protein 6	618791				
3.381	3	17	08	3p14.3	PXK, MONAKA		PXK domain-containing serine/threonine kinase	611450				
3.382	9	23	13	3p14.3	RPP14		Ribonuclease P, 14kD subunit	606112				
3.383	2	12	16	3p14.1	SLC25A26, SAMC, COXPD28		Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26	611037			Combined oxidative phosphorylation deficiency 28, 616794 (3)	
3.384	7	22	16	3p21.1	TKT, SDDHD		Transketolase	606781			Short stature, developmental delay, and congenital heart defects, 617044 (3)	
3.385	09	26	19	3p14.1	ADAMTS9		ADAM metallopeptidase with thrombospondin type 1 motif 9	605421				
3.386	6	11	13	3p14.3	IL17RD, SEF, HH18		Interleukin 17, receptor D (Sef, zebrafish, homolog of)	606807			Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3)	
3.387	5	28	13	3p14.2	FAM3D		Family with sequence similarity 3, member D	608619				
3.388	8	5	02	3p14.2	FRA3B, FHIT		Fragile histidine triad gene	601153		deleted in RCC		14(Fhit, Fra14A2)
3.389	3	22	93	3p14.2	PTPRG, PTPG		Protein tyrosine phosphatase, receptor type, gamma polypeptide	176886				
3.390	6	1	09	3p14.2	FEZF2, ZNF312, FEZL, TOF		FEZ family zinc finger 2	607414				
3.391	1	11	18	3p14.2	SNTN, S100AL, S100A1L		Sentan, cilia apical structural protein	617832				
3.392	1	22	04	3p14.3	ARF4, ARF2		ADP-ribosylation factor 4	601177				
3.393	2	15	12	3p14.1	ATXN7, SCA7, OPCA3		Ataxin 7	607640			Spinocerebellar ataxia 7, 164500 (3)	
3.394	2	15	12	3p14.1	ATXN7AS1, SCAANT1		ATXN7 antisense noncoding transcript 1	614481				
3.395	7	12	13	3p14.1	EOGT, EOGT1, C3orf64, AOS4		EGF domain-specific O-linked N-acetylglucosamine transferase	614789			Adams-Oliver syndrome 4, 615297 (3)	
3.396	5	30	17	3p14.1	FAM19A1, TAFA1		Family with sequence similarity 19, member A1, CC motif chemokine-like	617495				
3.397	5	30	17	3p14.1	FAM19A4, TAFA4		Family with sequence similarity 19, member A4, CC motif chemokine-like	617498				
3.398	4	24	15	3p13	FOXP1, QRF1		Forkhead box P1	605515			Mental retardation with language impairment and with or without autistic features, 613670 (3)	
3.399	4	26	17	3p14.1	FRMD4B, GRSP1, KIAA1013		FERM domain-containing protein 4B	617467				
3.400	10	23	15	3p14.1	KBTBD8, TAKRP, KIAA1842		KELCH repeat- and BTB/POZ domain-containing protein 8	616607				
3.401	1	5	15	3p14.1	LMOD3, NEM10		Leiomodin 3	616112			Nemaline myopathy 10, 616165 (3)	
3.402	3	3	09	3p14.1	MAGI1, BAIAP1, WWP3, TNRC19		Membrane-associated guanylate kinase, WW and PDZ domains-containing, 1	602625				
3.403	1	30	18	3p14.1	PSMD6, KIAA0107		Proteasome 26S subunit, non-ATPase, 6	617857				
3.404	5	25	13	3p14.1	SUCLG2		Succinate-CoA ligase, GDP-forming, beta subunit	603922				
3.405	4	23	08	3p14.1	THOC7, NIF3L1BP1		THO complex, subunit 7	611965				
3.406	11	27	18	3p14.1	UBE1C, UBA3		Ubiquitin-activating enzyme E1C	603172				
3.407	4	23	07	3p14.1-q12.3	HYT7		Hypertension, essential, susceptibility to, 7	610948			{Hypertension, essential, susceptibility to, 7} (2)	
3.408	1	26	17	3p13	MITF, WS2A, CMM8, COMMAD		Microphthalmia-associated transcription factor	156845			Waardenburg syndrome, type 2A, 193510 (3); Waardenburg syndrome/ocular albinism, digenic, 103470 (3); Tietz albinism-deafness syndrome, 103500 (3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3); COMMAD syndrome, 617306 (3)	6(mi)
3.409	12	03	20	3p14.1	ARL6IP5		ADP ribosylation factor-like GTPase 6 interacting protein 5	605709				
3.410	01	25	19	3p21.2	DOCK3, NEDIDHA		Dedicator of cytokinesis 3	603123			Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia, 618292 (3)	
3.411	2	21	06	3p13	EIF4E3		Eukaryotic translation initiation factor 4E family, member 3	609896				
3.412	2	25	09	3p14.1	LRIG1, LIG1		Leucine-rich repeats- and immunoglobulin-like domains-containing protein 1	608868				6(Lrig1)
3.413	3	25	16	3p14.1	PRICKLE2		Prickle-like 2	608501				
3.414	3	3	10	3p13	EBLN2		Endogenous Borna-like N element-containing protein 2	613250				
3.415	4	20	04	3p14-q13	KTCN3		Keratoconus 3	608586			Keratoconus 3 (2)	
3.416	6	14	18	3q13.31	ATP6V1A, HO68, ARCL2D, IECEE3		ATPase, H+ transporting, V1 subunit A	607027			Cutis laxa, autosomal recessive, type IID, 617403 (3); Epileptic encephalopathy, infantile or early childhood, 3, 618012 (3)	
3.417	3	29	10	3p13	GXYLT2, GLT8D4		Glucoside xylosyltransferase 2	613322				
3.418	12	28	08	3p13	PDZRN3, KIAA1095		PDZ domain-containing ring finger protein 3	609729				
3.419	4	7	11	3p13	PPP4R2, PP4R2		Protein phosphatase 4, regulatory subunit 2	613822				
3.420	8	30	09	3p13	RYBP, YEAF1		Ring1- and YY1-binding protein	607535				
3.421	4	6	16	3p13	SAMMSON, LINC01212		Survival-associated mitochondrial melanoma-specific oncogenic noncoding RNA	616895				
3.422	12	14	10	3p13	SHQ1		Shq1, S. cerevisiae, homolog of	613663				
3.423	7	22	11	3p14.3	PDHB, PDHBD		Pyruvate dehydrogenase, E1 beta polypeptide	179060			Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)	
3.424	09	09	19	3p12.3	ROBO2, SAX3, KIAA1568		Roundabout guidance receptor 2	602431			Vesicoureteral reflux 2, 610878 (3)	16(Robo2)
3.425	04	30	19	3p12.3	ZNF717, OB1		Zinc finger protein 717	618405				
3.426	6	28	17	3p12.1	CADM2, IGSF4D, SYNCAM2, NECL3		Cell adhesion molecule 2	609938				16(Igsf4d)
3.427	9	21	12	3p12.2	GBE1, GSD4, APBD		Glycogen branching enzyme	607839			Glycogen storage disease IV, 232500 (3); Polyglucosan body disease, adult form, 263570 (3)	
3.428	8	4	98	3p11.2-p11.1	HTR1F, HTR1EL, MR77		5-hydroxytryptamine receptor 1F	182134				
3.429	09	09	19	3p12.3	ROBO1, DUTT1, SAX3		Roundabout guidance receptor 1	602430				
3.430	1	24	04	3p11.1	CGGBP1		CGG triplet repeat binding protein 1	603363				
3.431	12	03	20	3q11.2	ARL6, BBS3, RP55		ADP ribosylation factor-like GTPase 6	608845			Bardet-Biedl syndrome 3, 600151 (3); {Bardet-Biedl syndrome 1, modifier of}, 209900 (3); Retinitis pigmentosa 55, 613575 (3)	
3.432	4	30	02	3p12-q13	DYX5		Dyslexia, susceptibility to, 5	606896		?same locus as SSD	{Dyslexia, susceptibility to, 5} (2)	
3.433	08	12	19	3q13.12-q13.13	IFT57, ESRRBL1, HIPPI, OFD18		Intraflagellar transport 57 (HIP1 protein interactor)	606621		mutation identified in 1 OFD18 family	?Orofaciodigital syndrome XVIII, 617927 (3)	
3.434	2	10	04	3p12-q13	SSD		Speech-sound disorder	608445		?same locus as DYX5	{Speech-sound disorder} (2)	
3.435	1	25	11	3p12-q13.2	PBC1		Biliary cirrhosis, primary, 1	109720		associated with rs6441286	Biliary cirrhosis, primary, 1 (2)	
3.436	5	3	93	3q25.33	IL12A		Interleukin-12A (natural killer cell stimulatory factor-1, cytotoxic lymphocyte maturation factor-1, p35)	161560				
3.437	7	11	93	3q13.31	ZNF80		Zinc finger protein-80 (pT17)	194553				
3.438	12	23	19	3p11.2	CHMP2B, DMT1, VPS2B, ALS17		Charged multivesicular body protein 2B	609512			Dementia, familial, nonspecific, 600795 (3); Amyotrophic lateral sclerosis 17, 614696 (3)	
3.439	8	18	98	3p11.1	EPHA3, ETK1, HEK		Ephrin receptor EphA3 (human embryo kinase 1)	179611				
3.440	10	2	09	3p11.2	POU1F1, PIT1, CPHD1		POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1)	173110			Pituitary hormone deficiency, combined, 1, 613038 (3)	16(Pit1,dw)
3.441	9	11	02	3p	CRCL		Creatinine clearance QTL	607135		in African Americans	Creatinine clearance QTL (2)	
3.442	8	25	04	3p21.31	MYL3, CMH8		Myosin, light polypeptide-3, alkali; ventricular, skeletal, slow	160790			Cardiomyopathy, hypertrophic, 8, 608751 (3)	9(Mylc)
3.443	11	24	14	3p21.1	PRKCD, CVID9, ALPS3		Protein kinase C, delta	176977		mutation identified in 1 family	Autoimmune lymphoproliferative syndrome, type III, 615559 (3)	14(Pkcd)
3.444	9	8	11	3cen-q13	ERVK-5, HERV-KII		Endogenous retrovirus group K, member 5	614012				
3.445	9	18	00	3q13.33	COX17		Cytochrome c oxidase assembly protein COX17	604813		pseudogene on chr. 13?		
3.446	10	20	99	3q12.3	RPL24		Ribosomal protein L24	604180				
3.447	5	1	91	3q21.3	RPN1		Ribophorin I	180470				6(Rpn1)
3.448	10	7	14	3q12.2	TFG, HMSNP, SPG57		TRK-fused gene	602498		fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 family	Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3); ?Spastic paraplegia 57, autosomal recessive, 615658 (3)	
3.449	12	04	20	3q11.1-q11.2	ARL13B, ARL2L1, JBTS8		ADP ribosylation factor-like GTPase 13B	608922			Joubert syndrome 8, 612291 (3)	
3.450	10	13	15	3q11.2	DHFRL1		Dihydrofolate reductase-like 1	616588				
3.451	5	25	13	3q11.2	EPHA6, HEK12, EHK2		Ephrin receptor EphA6	600066				
3.452	11	22	19	3q11.2	GABRR3		Gamma-aminobutyric acid receptor, RHO-3	618668				
3.453	12	30	14	3q12.3	IMPG2, IPM200, RP56, VMD5		Interphotoreceptor matrix proteoglycan 2	607056			Retinitis pigmentosa 56, 613581 (3); Macular dystrophy, vitelliform, 5, 616152 (3)	
3.454	09	17	20	3q11.2	NSUN3, COXPD48		NOP2/SUN RNA methyltransferase family, member 3	617491			Combined oxidative phosphorylation deficiency 48, 619012 (3)	
3.455	3	1	12	3q11.1	PROS1, THPH5, THPH6		Protein S, alpha	176880		pseudogene PROSP contiguous on chr.3	Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3); Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)	
3.456	4	1	96	3q11.2	GPR15		G protein-coupled receptor-15	601166				
3.457	3	16	10	3q11.2-q13.12	CAMPD1		Camptodactyly 1	114200		between D3S2465 and D3S3044	Camptodactyly 1 (2)	
3.458	05	22	20	3q11.2	CPOX, HARPO		Coproporphyrinogen oxidase	612732			Coproporphyria, 121300 (3); Harderoporphyria, 618892 (3)	
3.459	9	27	01	3q12.2	TARSH		Target of Nesh-SH3	606279				
3.460	8	20	07	3q12.1	TMEM30C, CDC50C		Transmembrane protein 30C	611030				
3.461	11	28	88	3q13.2	MOX2		MRC OX-2 antigen	155970				
3.462	7	11	91	3q12.1	COL8A1		Collagen VIII, alpha-1 polypeptide	120251				
3.463	2	21	13	3q12.1	DCBLD2, ESDN		Discoidin, CUB, and LCCL domain-containing protein 2	608698				
3.464	9	2	09	3q12.1	FILIP1L		Filamin A-interacting protein 1-like	612993				
3.465	6	10	08	3q11.2	MINA, MINA53, MDIG		MYC-induced nuclear antigen	612049				
3.466	8	30	09	3q12.1	ST3GAL6, ST3GALVI		ST3 beta-galactoside alpha-2,3-sialyltransferase 6	607156				
3.467	10	1	17	3q12.1-q12.2	TBC1D23, PCH11		TBC1 domain family, member 23	617687			Pontocerebellar hypoplasia, type 11, 617695 (3)	
3.468	7	17	14	3q12.3	CEP97		Centrosomal protein, 97kD	615864				
3.469	9	1	16	3q12.2	ADGRG7, GPR128		Adhesion G protein-coupled receptor G7	612307				
3.470	1	29	16	3q12.2	NIT2		Nitrilase family member 2	616769				
3.471	4	27	16	3q12.2	TMEM45A, DERP7, DNAPTP4		Transmembrane protein 45A	616928				
3.472	08	11	20	3q12.2	TOMM70		Translocase of outer mitochondrial membrane 70	606081				
3.473	8	19	13	3q21.3	CHST13, C4ST3		Carbohydrate sulfotransferase 13	610124				
3.474	06	03	20	3q12.3	NFKBIZ, INAP, MAIL, IKBZ		Nuclear factor kappa-B inhibitor, zeta	608004				16(Inap)
3.475	5	6	13	3q12.3	PCNP		PEST-containing nuclear protein	615210				
3.476	7	9	09	3q12.3	SENP7, KIAA1707		Sentrin-specific protease family, member 7	612846				
3.477	09	11	19	3q12.3	TRMT10C, RG9MTD1, MRPP1, COXPD30		tRNA methyltransferase 10C, mitochondrial RNase P subunit	615423			Combined oxidative phosphorylation deficiency 30, 616974 (3)	
3.478	04	15	19	3q12.3	ZBTB11, MRT69		Zinc finger- and BTB domain-containing protein 11	618181			Intellectual developmental disorder, autosomal recessive 69, 618383 (3)	
3.479	8	18	14	3q12.3	ZPLD1		Zona pellucida-like domain-containing protein 1	615915				
3.480	11	27	19	3q13	CHDS5		Coronary heart disease, susceptibility to, 5	608901			{Coronary heart disease, susceptibility to, 5} (2)	
3.481	8	28	09	3q13.31	GAP43		Neuron growth-associated protein 43	162060				16(Gap43)
3.482	5	22	03	3q13.2	GCET2, HGAL		Germinal center-expressed transcript 2	607792				
3.483	10	18	10	3q13.33	GOLGB1, GCP372		Golgi autoantigen, golgin subfamily B, 1	602500				
3.484	9	29	96	3q13.33	HCLS1		Hematopoietic cell-specific Lyn substrate 1	601306				
3.485	11	27	19	3q21.1-q21.2	KALRN, HAPIP, DUO		Kalirin	604605				
3.486	4	14	05	3q27.1	MAGEF1		Melanoma antigen, family F, 1	609267				
3.487	1	28	00	3q13.13	MORC1		MORC family CW-type zinc finger 1 (microrchidia, mouse, homolog of)	603205				16(Morc)
3.488	6	28	17	3q13.13	NECTIN3, PVRL3, PRR3		Nectin 3	607147				
3.489	5	25	00	3q13.13	TRAT1, TRIM		T-cell receptor-associated transmembrane adaptor 1	604962				
3.490	4	16	11	3q21.2	UMPS, OPRT		Uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase)	613891			Orotic aciduria, 258900 (3)	
3.491	1	3	02	3q13.33	NR1I2, PXR, SXR, PARq		Nuclear receptor subfamily 1, group I, member 2	603065				
3.492	1	13	09	3q13.2	CD200R1, MOX2R, OX2R		CD200 receptor 1	607546				
3.493	12	13	00	3q13.13	GUCA1C, GCAP3		Guanylate cyclase activator 1C	605128				
3.494	11	25	96	3q13.1	MHS4		Malignant hyperthermia susceptibility 4	600467			{Malignant hyperthermia susceptibility 4} (2)	
3.495	12	10	15	3q13.11	CBLB		CAS-BR-M murine ecotropic retroviral transforming sequence B	604491				
3.496	2	19	97	3q13.11	ALCAM		Activated leukocyte cell adhesion molecule	601662				
3.497	3	24	06	3p12.1	VGLL3, VGL3		Vestigial-like 3	609980				
3.498	1	14	00	3q13.12	CD47, MER6, IAP		CD47 antigen (Rh-related antigen; integrin-associated protein)	601028				
3.499	10	28	15	3q13.12	DUBR, DUM, LINC0883		DPPA2 upstream-binding RNA, noncoding	616619				16(Dubr)
3.500	8	25	11	3q13.1-q13.2	CD96, TACTILE		CD96 antigen	606037			C syndrome, 211750 (3)	
3.501	5	17	18	3q13.13	CIP2A, KIAA1524, p90		Cell proliferation-regulating inhibitor of protein phosphatase 2A	610643				
3.502	1	30	12	3q13.13	DPPA2, PESCRG1, ECAT15-2		Developmental pluripotency-associated gene 2	614445				16(Dppa2)
3.503	7	27	11	3q13.13	DPPA4		Developmental pluripotency-associated gene 4	614125				
3.504	7	13	17	3q13.13	DZIP3, KIAA0675		DAZ-interacting zinc finger protein 3	608672				
3.505	5	25	13	3q13.13	HHLA2		Human endogenous retrovirus-H long terminal repeat-associating 2	604371				
3.506	3	1	06	3q13.13	MYH15		Myosin, heavy chain 15	609929				
3.507	7	14	14	3q13.13	RETNLB, RELMB, FIZZ2		Resistin-like protein, beta	605645				
3.508	01	31	20	3q13.2	ABHD10		Abhydrolase domain-containing protein 10, depalmitoylase	618756				
3.509	11	05	18	3q13.2	BOC		Brother of CDON	608708				
3.510	2	25	15	3q13.2	BTLA		B- and T-lymphocyte attenuator	607925				
3.511	4	23	08	3q13.2	C3orf52, TTMP		Chromosome 3 open reading frame 52	611956				
3.512	02	27	20	3q13.2	CCDS80, URB, SSG1		Coiled-coil domain-containing protein 80	608298				16(Urb)
3.513	7	24	17	3q13.2	CFAP44, WDR52, SPGF20		Cilia- and flagella-associated protein 44	617559		mutation identified in 1 SPGF20 patient	?Spermatogenic failure 20, 617593 (3)	
3.514	02	06	20	3q13.31	NAA50, NAT13, NAT5, SAN		N-alpha-acetyltransferase 50, NatE catalytic subunit	610834				
3.515	04	27	20	3q13.2	NEPRO, C3orf17, ANXD3		Nucleolus and neural progenitor protein	617089			Anauxetic dysplasia 3, 618853 (3)	
3.516	5	24	13	3q13.2	PHLDB2		Pleckstrin homology-like domain, family B, member 2	610298				
3.517	7	1	16	3q13.2	PLCXD1		Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 2	617015				
3.518	7	2	18	3q13.2	SIDT1		SID1 transmembrane family, member 1	606816				
3.519	4	30	09	3q13.2	SLC9A10		Solute carrier family 9, member 10	612738				
3.520	11	3	11	3q13.2	SPICE1, CCDC52		Spindle- and centriole-associated protein 1	613447				
3.521	9	9	13	3q13.2	TAGLN3, NP24, NP22		Transgelin 3	607953				
3.522	7	11	17	3q13.2	USF3		Upstream transcription factor family, member 3	617568				
3.523	5	28	13	3q13.13	ZBED2		Zinc finger BED domain-containing protein 2	615246				
3.524	9	16	14	3q13.31	ZBTB20, ZNF288, DPZF, PRIMS		Zinc finger and BTB-domain containing 20	606025			Primrose syndrome, 259050 (3)	
3.525	2	28	03	3q13.33	PLA1A, PSPLA1		Phosphatidylserine-specific phospholipase A1-alpha	607460				16(Pla1a)
3.526	6	7	12	3q13.2-q13.33	STUT3		Stuttering, familial persistent, 3	614655		max lod at D3S1310	Stuttering, familial persistent, 3 (2)	
3.527	8	31	12	3q21.1	ADCY5, FDFM		Adenylate cyclase-5	600293			Dyskinesia, familial, with facial myokymia, 606703 (3)	16(Adcy5)
3.528	11	3	98	3q13.31	LSAMP, LAMP		Limbic system-associated membrane protein	603241				16(Lsamp)
3.529	5	4	12	3q13.32-q13.33	ARHGAP31, CDGAP, KIAA1204, AOS1		Rho GTPase-activating protein 31	610911			Adams-Oliver syndrome 1, 100300 (3)	
3.530	7	9	07	3q13.33	ARGFX		Arginine-fifty homeobox	611164		pseudogenes on 5q23.2 and 17q11.2		
3.531	8	9	99	3q13.32	B4GALT4		Beta-1,4-galactosyltransferase 4	604015				
3.532	11	22	17	3q13.31	DRD3, ETM1, FET1		Dopamine receptor D3	126451			{Schizophrenia, susceptibility to}, 181500 (3); {Essential tremor, hereditary, 1}, 190300 (3)	
3.533	5	3	13	3q13.33	FSTL1, FRP, MIR198		Follistatin-like 1	605547		FSTL1 mRNA can encode a protein or produce an micoRNA		
3.534	5	25	00	3q13.33	GSK3B		Glycogen synthase kinase 3-beta	605004				
3.535	8	27	08	3q21.2	MUC13		Mucin 13, cell surface-associated	612181				
3.536	5	4	00	3q13.33	POLQ		Polymerase, DNA, theta	604419				
3.537	10	15	09	3q13.33	POPDC2, POP2		Popeye domain-containing protein 2	605823				
3.538	11	27	19	3q13.33	RABL3, PNCA5		RAB, member of RAS oncogene family-like 3	618542		mutation identified in 1 PNCA5 family	{?Pancreatic cancer, susceptibility to, 5}, 618680 (3)	
3.539	5	26	05	3q13.33	STXBP5L, LLGL4		Syntaxin-binding protein 5-like	609381				
3.540	7	13	09	3q13.31	TIGIT		T-cell immunoreceptor with immunoglobulin and ITIM domains	612859				
3.541	4	15	11	3q22.1	TRH		Thyrotropin-releasing hormone	613879			Thyrotropin-releasing hormone deficiency, 275120 (1)	6(Trh)
3.542	4	23	98	3q13.32	UPK1B		Uroplakin 1B	602380				
3.543	9	29	13	3q13.31	DEL3q13.31, C13DELq13.31		Chromosome 3q13.31 deletion syndrome	615433			Chromosome 3q13.31 deletion syndrome (4)	
3.544	10	24	14	3q13.31	TUSC7, LSAMPAS3, LOC285194		Tumor suppressor candidate 7, noncoding	616057				
3.545	2	2	17	3q13.31	ZDHHC23, NIDD		Zinc finger DHHC-type containing 23	617334				
3.546	6	13	12	3q13.33	ADPRH		ADP-ribosylarginine hydrolase	603081				
3.547	09	22	20	3q13.33	CFAP91, MAATS1, AAT1, C3orf15		Cilia and flagella associated protein 91	609910				
3.548	11	11	14	3q13.33	EAF2		ELL-associated factor 2	607659				
3.549	4	19	12	3q13.33	GPR156, GABABL		G protein-coupled receptor 156	610464				
3.550	8	8	13	3q13.33	GTF2E1, TF2E1		General transcription factor IIE, polypeptide 1	189962				
3.551	4	29	14	3q13.33	HGD, AKU		Homogentisate 1,2-dioxygenase (homogentisate oxidase)	607474			Alkaptonuria, 203500 (3)	16(aku)
3.552	1	18	18	3q13.33	IQCB1, NPHP5, KIAA0036		IQ motif-containing protein B1	609237			Senior-Loken syndrome 5, 609254 (3)	
3.553	5	25	13	3q13.33	NDUFB4		NADH-ubiquinone oxidoreductase subunit B4	603840				
3.554	09	27	18	3q13.33	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMDR21		Protein O-glucosyltransferase 1	615618		mutation identified in 1 LGMDR21 family	Dowling-Degos disease 4, 615696 (3); ?Muscular dystrophy, limb-girdle, autosomal recessive 21, 617232 (3)	
3.555	10	2	12	3q13.33	SLC15A2, PEPT2		Solute carrier family 15 (H+/peptide transporter), member 2	602339				
3.556	12	13	18	3q13.33	TIMMDC1, C3orf1, MC1DN31		Translocase of inner mitochondrial membrane domain-containing protein 1	615534			Mitochondrial complex I deficiency, nuclear type 31, 618251 (3)	
3.557	12	4	03	3q21.3	ABTB1, BPOZ		Ankyrin repeat and BTB/POZ domain containing 1	608308				
3.558	4	1	01	3q21	ATOD1		Dermatitis, atopic, 1	603165		max lod at D3S3606	{Dermatitis, atopic, susceptibility to, 1} (2)	
3.559	12	9	95	3q13.33	CD80, CD28LG, LAB7		CD80 antigen (CD28 antigen ligand 1, B7-1 antigen)	112203				3(Cd80)
3.560	3	2	98	3q13.33	CD86, CD28LG2, LAB72		CD86 antigen (CD28 antigen ligand 2, B7-2 antigen)	601020				16(Cd86)
3.561	10	23	15	3q22.1	COL6A4P2		Collagen, type VI, alpha-4, pseudogene 2	616612				9(Col6a4)
3.562	10	23	15	3q22.1	COL6A5, COL29A1		Collagen, type VI, alpha-5	611916				
3.563	10	24	15	3q22.1	COL6A6		Collagen, type VI, alpha-6	616613				9(Col6a6)
3.564	1	13	16	3q21.1	CSTA, STFA, STF1, AREI, PSS4		Cystatin A (stefin A)	184600			Peeling skin syndrome 4, 607936 (3)	16(Stf1)
3.565	01	13	20	3q21.1	DTX3L, BBAP		Deltex E3 ubiquitin liase 3L	613143		head-to-head with PARP9		
3.566	09	30	19	3q21	FGQTL6, BWQTL3		Fasting plasma glucose level QTL 6; Birth weight QTL 3	613460		associated with rs11708067 and rs11708067	[Fasting plasma glucose level QTL 6] (2); [Birth weight QTL 3] (2)	
3.567	12	19	05	3q21.3	GP9		Glycoprotein IX, platelet	173515			Bernard-Soulier syndrome, type C, 231200 (3)	
3.568	4	10	14	3q21.3	GATA2, DCML, MONOMAC, IMD21		GATA-binding protein-2	137295			Immunodeficiency 21, 614172 (3); Emberger syndrome, 614038 (3); {Myelodysplastic syndrome, susceptibility to}, 614286 (3); {Leukemia, acute myeloid, susceptibility to}, 601626 (3)	6(Gata2)
3.569	6	5	12	3q21.3-q22.1	IFT122, WDR10, CED1		Intraflagellar transport 122	606045			Cranioectodermal dysplasia 1, 218330 (3)	
3.570	2	14	01	3q21.1	KPNA1, RCH2, SRP1		Karyopherin, alpha-1	600686				
3.571	9	16	16	3q22.2	KY, MFM7		Kyphoscoliosis peptidase	605739			Myopathy, myofibrillar, 7, 617114 (3)	9(ky)
3.572	12	18	18	3q21.3	LINC01565		Long intergenic noncoding RNA 1565	618259				
3.573	6	2	16	3q21.3	MCM2, CDCL1, DFNA70		Minichromosome maintenance deficient, S. cerevisiae, 2, homolog of (mitotin)	116945		mutation identified in 1 DFNA70 family	?Deafness, autosomal dominant 70, 616968 (3)	
3.574	11	08	19	3q21.1	MYLK, MLCK, AAT7, MMIHS		Myosin-light-polypeptide kinase	600922		pseudogene on 3p13	Aortic aneurysm, familial thoracic 7, 613780 (3); Megacystis-microcolon-intestinal hypoperistalsis syndrome, 249210 (3)	
3.575	10	26	98	3q22.3	NCK		Non-catalytic region of tyrosine kinase	600508				
3.576	6	10	08	3q21.1	PARP9, BAL1, BAL		Poly(ADP-ribose) polymerase 9	612065				
3.577	6	24	08	3q21.1	PARP15, BAL3		Poly(ADP-ribose) polymerase 15	612066				
3.578	12	14	99	3q21	PSORS5		Psoriasis susceptibility 5	604316			{Psoriasis susceptibility 5} (2)	
3.579	3	3	03	3q21.3	RAB7, CMT2B, PSN		Ras-associated protein RAB7	602298			Charcot-Marie-Tooth disease, type 2B, 600882 (3)	9(Rab7)
3.580	6	16	99	3q21.3	RUVBL1, NMP238, TIP49		RUVB, E. coli, homolog-like 1	603449				
3.581	1	24	12	3q22.1-q22.2	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2		Solute carrier organic anion transporter family, member 2A1	601460			Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	
3.582	9	1	11	3q22.1	TF, TFQTL1		Transferrin	190000			Atransferrinemia, 209300 (3)	9(Trf)
3.583	2	22	07	3q21.3	TXNRD3, TRXR3, TR2		Thioredoxin reductase 3	606235				
3.584	12	22	16	3q21.2	ZNF148, ZFP148, GDACCF		Zinc finger protein-148	601897			Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, 617260 (3)	
3.585	12	27	01	3q21.3	KLF15, KKLF		Kruppel-like factor 15	606465				
3.586	11	2	99	3q21.3	MBD4, MED1		Methyl-CpG-binding domain protein 4	603574				6(Mdb4)
3.587	12	13	06	3q21-q22	HCFP1, MBS2		Facial paresis, hereditary congenital, 1	601471			Facial paresis, hereditary congenital, 1 (2)	
3.588	12	23	05	3q22.1	NEK11		Never in mitosis gene A-related kinase 11	609779				
3.589	6	21	01	3q22.3	PCCB		Propionyl Coenzyme A carboxylase, beta polypeptide	232050		pccB complementation group	Propionicacidemia, 606054 (3)	
3.590	12	22	89	3q23	RBP1, CRBP1		Retinol-binding protein-1, cellular	180260		close to CRBP2		9(Crbp)
3.591	10	4	93	3q22.1	ACPP		Acid phosphatase, prostate	171790				
3.592	11	5	97	3q22.2	EPHB1, EPHT2, NET		eph tyrosine kinase 2 (ephrin receptor EphB1)	600600				
3.593	5	29	12	3q23	GRK7, GPRK7		G protein-coupled receptor kinase 7	606987				
3.594	12	29	99	3q22.1	ATP2C1, BCPM, HHD		ATPase, Ca(2+)-sequestering	604384			Hailey-Hailey disease, 169600 (3)	
3.595	6	4	97	3q21-q24	GLC1C		Glaucoma 1, open angle, C	601682			Glaucoma 1C, primary open angle (2)	
3.596	6	27	02	3q23	PCOLCE2		Procollagen C-endopeptidase enhancer-2	607064				
3.597	1	31	13	3q22.1	RHO, RP4, OPN2, CSNBAD1		Rhodopsin (opsin 2)	180380			Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3); Night blindness, congenital stationary, autosomal dominant 1, 610445 (3); Retinitis punctata albescens, 136880 (3)	6(Rho)
3.598	5	19	15	3q24	AGTR1, AGTR1A, AT2R1		Angiotensin receptor 1	106165			{Hypertension, essential}, 145500 (3); Renal tubular dysgenesis, 267430 (3)	
3.599	5	24	12	3q22.1	BFSP2, CP49, CP47, CTRCT12		Beaded filament structural protein 2 (cytoskeletal protein, 49 kD)	603212			Cataract 12, multiple types, 611597 (3)	
3.600	8	25	11	3q25.1	CLRN1, USH3A, USH3, RP61		Clarin 1	606397		frequent in Finland; ?digenic interaction with MYO7A	Usher syndrome, type 3A, 276902 (3); Retinitis pigmentosa 61, 614180 (3)	3(Ush3)
3.601	05	05	20	3q25.1	MED12L, NOPAR, KIAA1635, NIZIDS		Mediator complex subunit 12-like	611318			Nizon-Isidor syndrome, 618872 (3)	
3.602	2	3	99	3q25.1	TM4SF1, M3S1, TAAL6		Transmembrane-4 superfamily, member 1	191155				
3.603	9	8	11	3q21-q25.2	ERVK-4, HERV-KI		Endogenous retrovirus group K, member 4	614011				
3.604	8	22	16	3q25.2	MME, CD10, CALLA, NEP, CMT2T, SCA43		Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen)	120520		mutation identified in 1 SCA43 family	Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3); ?Spinocerebellar ataxia 43, 617018 (3)	9(Mme)
3.605	1	1	95	3q27.3	SIAT1		Sialyltransferase-1 (beta-galactoside alpha-2,6-sialyltransferase)	109675				
3.606	4	6	18	3q26.2	TERC, TRC3, TR, DKCA1, PFBMFT2		Telomerase RNA component	602322			Dyskeratosis congenita, autosomal dominant 1, 127550 (3); {Aplastic anemia}, 614743 (3); {Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3)	3(Terc)
3.607	10	15	97	3q27.1	EPHB3, ETK2		EPH-like tyrosine kinase-2	601839				
3.608	12	2	99	3q21.3	PLXNA1, NOVP, NOV, PLXN1		Plexin A1 (NOV transmembrane protein)	601055				
3.609	12	22	87	3q23	RBP2, CRBP2		Retinol-binding protein-2, cellular	180280		close to CRBP1		9(Crbp2)
3.610	10	22	18	3q13.3-q21.1	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1		Calcium-sensing receptor	601199		15cM from RHO	Hypocalciuric hypercalcemia, type I, 145980 (3); Hyperparathyroidism, neonatal, 239200 (3); Hypocalcemia, autosomal dominant, 601198 (3); Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3); {Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3)	16(Gprc2a)
3.611	10	11	16	3q21.1	CCDC14		Coiled-coil domain-containing protein 14	617147				
3.612	09	06	18	3q21.1	FAM162A, ,C3orf28, E2IG5		Family with sequence similiarity 162, member A	608017				
3.613	9	9	08	3q13.33	FBXO40, FBX40, KIAA1195		F-box only protein 40	609107				16(Fbxo40)
3.614	3	28	11	3q13.33	ILDR1, DFNB42		Immunoglobulin-like domain-containing receptor 1	609739			Deafness, autosomal recessive 42, 609646 (3)	
3.615	11	01	07	3q21.2	OSBPL11, ORP11		Oxysterol-binding protein-like protein 11	606739		previously assigned to chr.8		
3.616	4	19	06	3q21.1	PARP14, KIAA1268		Poly(ADP-ribose) polymerase 14	610028				
3.617	5	11	16	3q21.1	PDIA5, PDIR		Protein disulfide isomerase, family A, member 5	616942				
3.618	8	18	14	3q21.1	PTPLB, HACD2		Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member B	615939				
3.619	1	28	08	3q21.1	ROPN1, ODF6		Rhophilin-associated tail protein 1	611757				
3.620	10	07	19	3q21.1	SEC22A, SEC22L2		SEC22 homolog A, vesicle trafficking protein	612442				
3.621	03	09	20	3q21.1	SLC49A4, DIRC2, RCC4		Solute carrier family 48, member 4	602773		t(2;3)(q35;q21) in renal cell carcinoma		
3.622	9	6	11	3q21.2	HEG1, KIAA1237		Heart of glass, zebrafish, homolog of, 1	614182				
3.623	7	14	14	3q21.2	ITGB5		Integrin, beta-5	147561				
3.624	8	26	15	3p14.3	PDE12		Phosphodiesterase 12	616519				
3.625	3	8	07	3q21.2-q21.3	SLC41A3		Solute carrier family 41, member 3	610803				
3.626	8	30	09	3q21.2	SNX4		Sorting nexin 4	605931				
3.627	1	27	11	3q21.3	ALDH1L1, FTHFD		Aldehyde dehydrogenase 1 family, member L1	600249				
3.628	2	13	14	3q21.3	CHCHD6, CHCM1		Coiled-coil-helix-coiled-coil-helix domain-containing protein 6	615634				
3.629	7	19	18	3q21.3	CNBP, ZNF9, CNBP1, DM2, PROMM		CCHC-type zinc finger nucleic acid-binding protein	116955			Myotonic dystrophy 2, 602668 (3)	
3.630	11	19	13	3q21.3	COPG1		Coatomer protein complex, subunit gamma-1	615525				
3.631	6	21	13	3q21.3	DNAJB8, DJ6		DNAJ/HSP40 homolog, subfamily B, member 8	611337				
3.632	9	9	13	3q21.3	EEFSEC, SELB, EFSEC		Eukaryotic elongation factor, selenocysteine-tRNA-specific	607695				
3.633	11	11	14	3q21.3	H1FX, H1X		H1 histone family, member X	602785				
3.634	12	23	19	3q21.3	HMCES		5-hydroxymethylcytosine-binding protein, embryonic stem cell-specific	618288				
3.635	5	12	09	3q21.3	ISY1, KIAA1160		ISY1 splicing factor, S. cerevisiae, homolog of	612764				
3.636	10	29	15	3q21.3	PODXL2, EG		Podocalyxin-like 2	616627				
3.637	01	04	19	3q21.3	SEC61A1, SEC61, HNFJ4		SEC61 translocon, alpha-1 subunit	609213			Hyperuricemic nephropathy, familial juvenile, 4, 617056 (3)	
3.638	5	12	15	3q21.3	UROC1, UROCD		Urocanase domain-containing protein 1	613012		mutation identified in 1 UROCD patient	?Urocanase deficiency, 276880 (3)	
3.639	5	22	14	3q21.3	ZXDC		ZCD family zinc finger protein C	615746				
3.640	6	4	98	3q25.1	AADAC, DAC		Arylacetamide deacetylase (esterase)	600338				
3.641	8	11	15	3q22.1	ACKR4, CCRL1, PPR1		Atypical chemokine receptor 4	606065				
3.642	6	19	01	3q22	DFNA18		Deafness, autosomal dominant 18	606012			Deafness, autosomal dominant 18 (2)	
3.643	6	20	17	3q22.3	FAIM		Fax apoptotic inhibitory molecule	617535				
3.644	9	9	10	3q22.1	NPHP3, NPH3, RHPD1, MKS7		Nephrocystin 3	608002			Nephronophthisis 3, 604387 (3); Renal-hepatic-pancreatic dysplasia 1, 208540 (3); Meckel syndrome 7, 267010 (3)	
3.645	7	22	16	3q22	PARK21		Parkinson disease 21	616361		conflicting mapping on 20pter-p12	Parkinson disease 21 (2)	
3.646	8	28	09	3q22.1	PLXND1		Plexin D1	604282				
3.647	3	31	15	3q22.2-q22.3	PP2R3A, PR72, PR130		Protein phosphatase 2, regulatory subunit B'', alpha	604944				
3.648	9	4	02	3q22	SLSN3		Senior-Loken syndrome 3	606995		?allelic with NPHP3	Senior-Loken syndrome 3 (2)	
3.649	11	05	20	3q22.1	UBA5, UBE1DC1, DEE44, SCAR24		Ubiquitin-like modifier activating enzyme 5	610552		mutation identified in 1 SCAR24 family	Developmental and epileptic encephalopathy 44, 617132 (3); ?Spinocerebellar ataxia, autosomal recessive 24, 617133 (3)	
3.650	4	13	98	3q23	ATP1B3		ATPase, Na+/K+ transporting, beta 3 polypeptide	601867				9(Atp1b3)
3.651	1	21	97	3q23	RASA2, GAP1M		RAS p21 protein activator 2	601589				
3.652	8	30	07	3q22-q24	AD15		Alzheimer disease 15	611155		max lod at D3S1579	{Alzheimer disease-15} (2)	
3.653	02	21	20	3q23	ATR, FRP1, SCKL1, FCTCS		ATR serine/threonine kinase	601215		mutation identified in 1 FCTCS family	Seckel syndrome 1, 210600 (3); ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3)	
3.654	4	20	11	3q22-q24	DWS, C3DELq22q24, DEL3q22q24		Dandy-Walker syndrome	220200		ZIC1 and ZIC4 good candidate genes	Dandy-Walker syndrome (4)	
3.655	6	12	07	3q22-q24	OTSC5		Otosclerosis 5	608787		max lod at D3S1569	Otosclerosis 5 (2)	
3.656	8	9	99	3q23	RNF7, ROC2, SAG		RING finger protein-7 (regulator of cullins 2; sensitive to apoptosis gene)	603863				
3.657	4	23	98	3q23	TRPC1, TRP1		Transient receptor potential channel 1	602343		also called Htrp-1		
3.658	5	4	00	3q22-q25	PABPL1		Polyadenylate-binding protein-like 1	173865				
3.659	10	18	11	3q22.1	ACAD11		Acyl-CoA dehydrogenase family, member 11	614288				
3.660	5	25	13	3q22.1	CPNE4, CPN4		Copine IV	604208				
3.661	02	24	20	3q22.1	CDV3, H41		CDV3, mouse, homolog of	618789				
3.662	7	13	16	3q22.1	DNAJC13, RME8, KIAA0678		DNAJ/HSP40 homolog, subfamily C, member 13	614334				
3.663	4	27	12	3q22.1	MRPL3, MRL3, COXPD9		Mitochondrial ribosomal protein L3	607118			Combined oxidative phosphorylation deficiency 9, 614582 (3)	
3.664	3	18	17	3q22.1	NUDT16		Nudix hydrolase 16	617381				
3.665	9	27	17	3q22.1	PIK3R4		Phosphatidylinositol 3-kinase, regulatory subunit 4	602610				
3.666	7	18	14	3q22.1	RAB6B		Ras-associated protein RAB6B	615852				
3.667	3	29	16	3q22.1	SRPRB, APMCF1		Signal recognition particle receptor, beta subunit	616883				
3.668	1	4	16	3q22.1	TMCC1, KIAA0779		Transmembrane and coiled-coil domain family 1	616242				
3.669	2	24	17	3q22.1	TMEM108, RTLN, KIAA1690		Transmembrane protein 108	617361				
3.670	8	30	09	3q22.1	TOPBP1, KIAA0259		DNA topoisomerase II-binding protein 1	607760				
3.671	5	29	12	3q22.2	AMOTL2, KIAA0989		Angiomotin-like 2	614658				
3.672	2	23	12	3q22.2	ANAPC13, APC13, SWM1		Anaphase-promoting complex, subunit 13	614484				
3.673	3	7	14	3q22.2	CEP63, SCKL6		Centrosomal protein, 63kD	614724		mutation identified in 1 family	?Seckel syndrome 6, 614728 (3)	
3.674	10	2	12	3q22.2	RYK, RYK1		RYK receptor-like tyrosine kinase	600524				9(Ryk1)
3.675	07	26	19	3q22.3	ARMC8		Armadillo repeat-containing protein 8	618521				
3.676	10	25	11	3q22.3	CEP70		Centrosomal protein, 70kD	614310				
3.677	9	20	14	3q22.3	DBR1		Debranching enzyme 1, S. cerevisiae, homolog of	607024				
3.678	8	7	17	3q22.3	DZIP1L, DZIP2, PKD5		DAZ-interacting zinc finger protein 1-like	617570			Polycystic kidney disease 5, 617610 (3)	9(Dzip1l)
3.679	12	11	15	3q22.3	ESYT3, FAM62C		Extended synaptotagmin-like protein 3	616692				
3.680	07	17	19	3q22.3	MRAS, RRAS3, NS11		Muscle Ras viral oncogene homolog	608435			Noonan syndrome 11, 618499 (3)	
3.681	09	23	19	3q22.3	MSL2, KIAA1585		MSL complex subunit 2	614802				
3.682	09	12	19	3q22.3	NME9, NXL2, TXNDC6		NME/NM23 family, member 9	618584				
3.683	9	9	08	3q22.3	PIK3CB, PI3KCB		Phosphatidylinositol 3-kinase, catalytic, beta	602925				
3.684	12	15	17	3q22.3	SLC35G2, TMEM22		Solute carrier family 35, member G2	617812				
3.685	8	31	17	3q22.3	STAG1, MRD47		Stromal antigen 1	604358			Mental retardation, autosomal dominant 47, 617635 (3)	
3.686	08	24	20	3q23	BPESC1		Blepharophimosis, ptosis, and epicanthus inversus candidate gene 1	618995				
3.687	3	3	15	3q23	CLSTN2		Calsyntenin 2	611323				
3.688	12	8	17	3q23	COPB2, MCPH19		Coatomer protein complex, subunit beta-2	606990		mutation identified in 1 MCPH19 family	?Microcephaly 19, primary, autosomal recessive, 617800 (3)	
3.689	11	2	04	3q22.3	FOXL2, BPES, BPES1, PFRK, POF3		Forkhead transcription factor FOXL2	605597			Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3); Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3); Premature ovarian failure 3, 608996 (3)	
3.690	09	26	18	3q23	MRPS22, C3orf5, COXPD5, ODG7		Mitochondrial ribosomal protein S22	605810			Combined oxidative phosphorylation deficiency 5, 611719 (3); Ovarian dysgenesis 7, 618117 (3)	
3.691	8	29	07	3q23	NMNAT3, PNAT3		Nicotinamide nucleotide adenylyltransferase 3	608702				
3.692	4	19	12	3q23	PAQR9		Progestin and ADIPOQ receptor family, member 9	614580				
3.693	02	21	20	3q23	PLS1, DFNA76		Plastin-1	602734			Deafness, autosomal dominant 76, 618787 (3)	
3.694	10	19	99	3q24	PLSCR1, MMTRA1B		Phospholipid scramblase 1	604170				
3.695	3	10	03	3q24	PLSCR2		Phospholipid scramblase 2	607610				
3.696	3	10	03	3q24	PLSCR4		Phospholipid scramblase 4	607612				
3.697	12	30	14	3q23	SLC25A36, PNC2		Solute carrier family 25 (mitochondrial carrier, pyrimidine nucleotide transporter), member 36	616149				
3.698	6	5	00	3q22.3	SOX14		SRY-box 14	604747				
3.699	12	18	07	3q23	SPSB4, SSB4		SPRY domain- and SOCS box-containing 4	611660				
3.700	2	17	09	3q23	STQTL10		Stature quantitative trait locus 10	612221		associated with rs6440003	{Stature QTL 10} (2)	
3.701	3	5	98	3q23	TFDP2, DP2		Transcription factor Dp-2 (E2F dimerization partner 2)	602160				
3.702	1	24	18	3q23	U2SURP, SR140, KIAA0332		U2 small nuclear ribonucleoprotein-associated SURP domain-containing protein	617849				
3.703	2	17	09	3q23	ZBTB38		Zinc finger- and BTB domain-containing protein 38	612218				
3.704	6	4	02	3q24-q25	CP		Ceruloplasmin	117700		~15cM from TF	[Hypoceruloplasminemia, hereditary], 604290 (3); Cerebellar ataxia, 604290 (3); Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)	9(Cp)
3.705	2	13	15	3q24	PLOD2, LH2, TLH, BRKS2		Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2	601865			Bruck syndrome 2, 609220 (3)	9(Plod2)
3.706	8	29	08	3q24	C3orf58, DIA1		Chromosome 3 open reading frame 58	612200				
3.707	6	2	06	3q24	CHST2		Carbohydrate sulfotransferase-2 (GlcNAc-6-O-sulfotransferase; N-acetylglucosamine-6-O-sulfotransferase)	603798		mapped by FISH to 7q31		
3.708	8	28	09	3q24	CPA3		Carboxypeptidase A3, mast cell	114851				
3.709	7	18	14	3q24	CPB1, PCPB, PASP		Carboxypeptidase B1, tissue	114852				
3.710	8	28	15	3q25.31	GMPS		Guanine monophosphate synthetase	600358		fusion gene with MLL in AML		
3.711	11	28	01	3q25.1	GPR87		G protein-coupled receptor 87	606379				
3.712	06	26	20	3q24	HPS3		HPS3 biogenesis of lysosomal organelles complex 2 subunit 1	606118			Hermansky-Pudlak syndrome 3, 614072 (3)	3(Hps3)
3.713	08	06	19	3q25.1	P2RY13, GPR86		Purinergic receptor P2Y13	606380				
3.714	12	27	13	3q24	SLC9A9, AUTS16		Solute carrier family 9 (sodium/hydrogen exchanger), member A9	608396		mutation identified in 1 family	{?Autism susceptibility 16}, 613410 (3)	
3.715	11	18	16	3q25.1	SELENOT, SELT		Selenoprotein T	607912				
3.716	7	17	12	3q25.1	WWTR1, TAZ		WW domain-containing transcription regulator 1	607392				
3.717	3	5	18	3q24	ZIC4		Zic family, member 4	608948				9(Zic4)
3.718	01	14	20	3q24	ZIC1, CRS6, BAIDCS		Zic family, member 1	600470		mutation identified in 1 CRS6 family	?Craniosynostosis 6, 616602 (3); Structural brain anomalies with impaired intellectual development and craniosynostosis, 618736 (3)	9(Zic1)
3.719	9	15	11	3q25.1	P2RY12, P2Y12, BDPLT8		Purinergic receptor P2Y, G protein-coupled, 12	600515			Bleeding disorder, platelet-type, 8, 609821 (3)	
3.720	9	9	08	3q25.31-q25.32	VEPH1, MELT, KIAA1692		Ventricular zone-expressed PH domain-containing protein, zebrafish, homolog of, 1	609594				
3.721	2	5	14	3q24	GYG1, GSD15		Glycogenin 1	603942		mutation identified in 1 GSD15 patient	?Glycogen storage disease XV, 613507 (3); Polyglucosan body myopathy 2, 616199 (3)	
3.722	4	21	16	3q25.1	SUCNR1, GPR91		Succinate receptor 1	606381				
3.723	3	8	07	3q24-q26	HDLCQ5		High density lipoprotein cholesterol level QTL 5	610761		max lod at D3S3053	[High density lipoprotein cholesterol level QTL 5] (2)	
3.724	1	30	02	3q24-q26	UVM1		Melanoma, uveal, susceptibility to, 1	606660			{Melanoma, uveal, susceptibility to, 1} (2)	
3.725	2	3	13	3q26.1	B3GALT3, GLCT3, GLOB		UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3	603094			[Blood group, globoside system], 615021 (3); [Blood group, P1PK system, P(k) phenotype], 111400 (3)	
3.726	2	6	08	3q25.32	IQCJ		IQ motif-containing protein J	611622				
3.727	12	27	01	3q25.1-q25.2	MBNL1, KIAA0428, EXP		Muscleblind-like protein	606516				
3.728	6	23	98	3q25.2	P2RY1, P2Y1		Purinergic receptor P2Y, G-protein coupled, 1	601167				
3.729	5	5	98	3q25.32	PTX3		Pentraxin-3	602492				
3.730	5	28	98	3q25.1	SIAH2		Seven in absentia, Drosophila, homolog of, 2	602213				
3.731	8	30	09	3q25.1	TM4SF4, ILTMP		Transmembrane 4 superfamily, member 4	606567				
3.732	5	28	08	3q25-q26	CELIAC10		Celiac disease, susceptibility to, 10	612008		associated with rs17810546	{Celiac disease, susceptibility to, 10} (2)	
3.733	4	10	14	3q25-q26	ETL6		Epilepsy, familial temporal lobe, 6	615697		between D3S1584 and D3S3520	Epilepsy, familial temporal lobe, 6 (2)	
3.734	8	12	98	3q25.32	SHOX2, SHOT, OG12		Short stature homeo box 2	602504				3(Og12)
3.735	2	3	06	3q26.1	SI		Sucrase-isomaltase	609845			Sucrase-isomaltase deficiency, congenital, 222900 (3)	3(Sis)
3.736	8	18	04	3q23	XRN1, SEP1		Exoribonuclease 1	607994				
3.737	6	7	04	3q25-q27	ASPG1		Asperger syndrome, susceptibility to, 1	608638		max lod with D3S3037	{Asperger syndrome susceptibility 1} (2)	
3.738	5	16	07	3q25-q27	AUTS8		Autism, susceptibility to, 8	607373			{Autism susceptibility 8} (2)	
3.739	8	27	01	3q26.2	EIF5A2		Eukaryotic translation initiation factor 5A2	605782				
3.740	5	31	05	3q27.1	MCCC1, MCCA		3-Methylcrotonyl-CoA carboxylase 1	609010			3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)	
3.741	8	26	04	3q26.2	PRKCI		Protein kinase C, iota	600539		pseudogene on X		3(Prkci)
3.742	12	22	15	3q25.1	COMMD2		COMM domain-containing protein 2	616699				
3.743	3	19	09	3q25.1	EIF2A		Eukaryotic translation initiation factor 2A	609234				
3.744	06	25	20	3q25.1	GPR171		G protein-coupled receptor 171	618925				
3.745	3	18	17	3q25.1	IGSF10		Immunoglobulin superfamily, member 10	617351				
3.746	03	09	20	3q25.32	MLF1		Myeloid leukemia factor-1	601402				
3.747	8	19	13	3q25.1	P2RY14, BPR105, KIAA0001		Purinergic receptor P2Y, G protein-coupled, 14	610116				
3.748	12	01	20	3q25.1	RNF13, DEE73		RING finger protein 13	609247			Developmental and epileptic encephalopathy 73, 618379 (3)	
3.749	9	21	17	3q25.1	SERP1, RAMP4		Stress-associated endoplasmic reticulum protein 1	617674				
3.750	3	23	14	3q25.1	TMEM183B, C1orf37DUP		Transmembrane protein 183B	611365				
3.751	10	25	17	3q25.1	TSC22D2, KIAA0669		TSC22 domain family, member 2	617724				3(Tsc22d2)
3.752	2	20	97	3q25.1	PFN2, PFL, D3S1319E		Profilin-2	176590		mapped previously to chr.1		
3.753	11	16	98	3q24	SMARCA3, SNF2L3, HIP116		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3	603257				
3.754	6	27	17	3q25.2	ARHGEF26, SGEF		Rho guanine nucleotide exchange factor 26	617552				
3.755	07	13	20	3q25.2	DHX36, G4R1, RHAU, KIAA1488		DEAH-box helicase 36	612767				
3.756	4	8	16	3q25.2	DWORF, LOC100507537		Dwarf open reading frame	616891				
3.757	8	8	13	3q25.2	RAP2B		Ras-related protein 2B	179541				
3.758	8	16	10	3q25.3	BWQTL2		Birth weight quantitative trait locus 2	613459		associated with rs900400	[Birth weight QTL 2] (2)	
3.759	4	7	05	3q25.32	LXN, ECI, TCI		Latexin	609305				3(Lxn)
3.760	8	30	09	3q25.32	RARRES1, TIG1		Retinoic acid receptor responder 1	605090				
3.761	5	5	10	3q25.31	CCNL1, ANIA6A		Cyclin L1	613384				
3.762	8	27	15	3q25.31	LEKR1		Leucine-, glutamate-, and lysine-rich protein 1	613536				
3.763	7	9	09	3q25.31	PLCH1, PLCL3, KIAA1069		Phospholipase C, eta-1	612835				
3.764	4	27	12	3q25.31	SLC33A1, ACATN, AT1, SPG42, CCHLND		Solute carrier family 33 (acetyl-CoA transporter), member 1	603690			Spastic paraplegia 42, autosomal dominant, 612539 (3); Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	3(Acatn)
3.765	6	13	12	3q25.31	SSR3, TRAPG		Signal sequence receptor, gamma	606213				
3.766	12	17	08	3q25.31	TIPARP		TCDD-inducible poly(ADP-ribose) polymerase	612480				
3.767	10	15	13	3q25.32	GFM1, EFG1, GFM, COXPD1		Mitochondrial elongation factor G1	606639			Combined oxidative phosphorylation deficiency 1, 609060 (3)	
3.768	04	30	19	3q25.32	RSRC1, SRRP53, MRT70		Arginine/serine-rich coiled-coil protein 1	613352			Intellectual developmental disorder, autosomal recessive 70, 618402 (3)	
3.769	12	04	20	3q25.33	ARL14, ARF7		ADP ribosylation factor-like GTPase 14	614439				
3.770	08	12	19	3q25.33	IFT80, KIAA1374, WDR56, SRTD2, ATD2		Intraflagellar transport 80	611177			Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	
3.771	2	25	14	3q25.33	SCARNA7		Small Cajal body-specific RNA 7	615644				
3.772	12	13	18	3q21.3	ACAD9, MC1DN20		Acyl-CoA dehydrogenase family, member 9	611103			Mitochondrial complex I deficiency, nuclear type 20, 611126 (3)	
3.773	5	15	08	3q26	AGA1, MPB		Alopecia, androgenetic, 1	109200			Alopecia, androgenetic, 1 (2)	
3.774	8	10	18	3q27.1	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2		Chloride channel-2	600570			{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3); {Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3); {Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3); Leukoencephalopathy with ataxia, 615651 (3); Hyperaldosteronism, familial, type II, 605635 (3)	
3.775	3	20	08	3q26.31	FNDC3B, FAD104		Fibronectin domain III-containing protein 3B	611909				3(Fndc3b)
3.776	10	9	94	3q26	MDS1		Myelodysplasia syndrome-1	600049		cen--EVI1--MDS1--EAP--tel	Myelodysplasia syndrome-1 (3)	
3.777	1	8	16	3q26.2	MECOM, EVI1, RUSAT2		MDS1 and EVS1 complex locus	165215			Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3)	3(Evi1)
3.778	4	13	05	3q26	MYP8		Myopia 8	609257			Myopia 8 (2)	
3.779	8	3	12	3q28	OSTN		Osteocrin	610280				16(Ostn)
3.780	8	23	17	3q26.31	PLD1, CVDD		Phospholipase D1, phosphatidylcholine-specific	602382			Cardiac valvular defect, developmental, 212093 (3)	3(Pld1)
3.781	10	7	99	3q26.1	SERPINI1, PI12		Protease inhibitor 12	602445			Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)	
3.782	12	28	08	3q26.1	SLITRK3, KIAA0848		SLIT- and NTRK-like family, member 3	609679				3(Slitrk3)
3.783	6	16	99	3q26.31	TNFSF10, TRAIL, APO2L		Tumor necrosis factor ligand superfamily, member 10	603598				
3.784	1	24	01	3q25.33	CAPC		Chromosome-associated protein C	605575				
3.785	11	4	98	3q25.31	KCNAB1, KCNA1B		Potassium voltage-gated channel, shaker-related subfamily, beta member 1	601141				3(Kcna1b)
3.786	2	1	11	3q25.33	KPNA4, QIP1		Karyopherin alpha-4	602970				
3.787	8	20	07	3q26.1	NMD3		NMD3, S. cerevisiae, homolog of	611021				
3.788	1	25	05	3q26.1	PDCD10, TFAR15, CCM3		Programmed cell death 10	609118			Cerebral cavernous malformations 3, 603285 (3)	
3.789	4	8	08	3q25.3-q26.1	PPM1L, PP2CE		Protein phosphatase 1-like	611931				
3.790	9	7	12	3q26.1	SPTSSB, C3orf57, SSSPTB, ADMP		Serine palmitoyltransferase, small subunit B	610412				
3.791	12	30	14	3q25.33	TRIM59, RNF104, MRF1, IFT80L		Tripartite motif-containing protein 59	616148				3(Trim59)
3.792	4	25	18	3q26.1	BCHE, CHE1, BCHED		Butyrylcholinesterase	177400		distal to CP, TF	{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}, 617936 (3); Butyrylcholinesterase deficiency, 617936 (3)	
3.793	6	13	95	3q26.31	ECT2		Epithelial cell transforming sequence 2 oncogene	600586				3(Ect2)
3.794	2	5	01	3q26.1	SERPIN12, PI14, MEPI		Protease inhibitor 14	605587				
3.795	8	7	01	3q26.1-q26.3	MNG3		Multinodular goiter-3	606082			Goiter, multinodular, 3 (2)	
3.796	12	5	13	3q26.2	SLC2A2, GLUT2		Solute carrier family 2 (facilitated glucose transporter), member 2	138160			{Diabetes mellitus, noninsulin-dependent}, 125853 (3); Fanconi-Bickel syndrome, 227810 (3)	
3.797	7	11	11	3q26.2	ARPM1		Actin-related protein M1	608534				
3.798	8	28	09	3q26.2	GOLIM4, GOLPH4, GPP130		Golgi integral membrane protein 4	606805				
3.799	09	25	20	3q26.2	LRRC34		Leucine-rich repeat-containing protein 34	619037				
3.800	9	12	13	3q26.2	MYNN		Myoneurin	606042				
3.801	10	07	19	3q26.2	SEC62, TLOC1, HTP1		SEC62 homolog, preprotein translocation factor	602173				
3.802	5	29	13	3q26.2	SKIL, SNO		SKI-like	165340				
3.803	4	3	14	3q26.2	SLC7A14, KIAA1613, RP68		Solute carrier family 7, member 14	615720			Retinitis pigmentosa 68, 615725 (3)	
3.804	7	18	14	3q26.2	TRV-AAC1-1, TRNAV24		Transfer RNA valine (AAC) 1-1	615310				
3.805	1	26	01	3q26.2	CLDN11, OTM, OSP		Claudin 11 (oligodendrocyte transmembrane protein)	601326				
3.806	6	16	99	3q26.33	USP13, ISOT3		Ubiquitin-specific protease-13	603591				
3.807	7	15	16	3q26.2-q26.3	TNIK, KIAA0551, MRT54		TRAF2-and NCK-interacting kinase	610005			Mental retardation, autosomal recessive 54, 617028 (3)	
3.808	11	26	12	3q26.2-q26.31	APMR2		Alopecia-mental retardation syndrome 2	610422		between D3S1564 and D3S2427	Alopecia-mental retardation syndrome 2 (2)	
3.809	3	19	09	3q26.2-q26.33	FEB10		Febrile seizures, familial, 10	612637		between D3S3656 and D3S1232	Febrile seizures, familial, 10 (2)	
3.810	8	21	07	3q26.33	PEX5L, PEX5R, PXR2B		Peroxisome biogenesis factor 5-like	611058				
3.811	03	06	20	3q27.2	TRA2B, SFRS10		Transformer 2 beta homolog	602719				
3.812	5	1	91	3q29	APOD		Apolipoprotein D	107740				16(Apod)
3.813	8	20	07	3q26.33	ACTL6A, BAF53, BAF53A		Actin-like 6A	604958				
3.814	3	15	11	3q26.33	CCDC39		Coiled-coil domain-containing protein 39	613798			Ciliary dyskinesia, primary, 14, 613807 (3)	
3.815	11	27	18	3q26.33	NDUFB5		NADH-ubiquinone oxidoreductase subunit B5	603841				
3.816	4	30	15	3q26.33	SOX2OT, NCRNA00043		SOX2 overlapping transcript, noncoding	616338				
3.817	4	21	10	3q26.33	DCUN1D1, RP42		DCN1 domain-containing protein 1	605905		previously mapped to 6q16		
3.818	7	3	06	3q26.33	DNAJC19, TIM14		DnaJ (Hsp40) homolog, subfamily C, member 19 (translocase of inner mitochondrial membrane 14, yeast, homolog of)	608977			3-methylglutaconic aciduria, type V, 610198 (3)	
3.819	5	6	13	3q26.33	GNB4, CMTD1F		Guanine nucleotide-binding protein, beta-4	610863			Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3)	
3.820	2	13	15	3q26.31	GHSR, GHDP		Growth hormone secretagogue receptor	601898			Growth hormone deficiency, isolated partial, 615925 (3)	
3.821	3	5	08	3q26.33	MRPL47		Mitochondrial ribosomal protein L47	611852				
3.822	8	19	04	3q26.31	NAALADL2		N-acetylated alpha-linked acidic dipeptidase-like 2	608806		?involved in Cornelia de Lange syndrome		
3.823	2	21	10	3q26.31	NCEH1, NCEH, KIAA1363		Neutral cholesterol ester hydrolase 1	613234				
3.824	05	14	20	3q26.31	NLGN1		Neuroligin 1	600568			{Autism, susceptibility to, 20}, 618830 (3)	
3.825	10	09	18	3q26.32	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO		Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide	171834			Ovarian cancer, somatic, 167000 (3); Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic, 114500 (3); Gastric cancer, somatic, 613659 (3); Hepatocellular carcinoma, somatic, 114550 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); CLOVE syndrome, somatic, 612918 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3); CLAPO syndrome, somatic, 613089 (3); Macrodactyly, somatic, 155500 (3)	
3.826	4	30	15	3q26.31	SPATA16, SPGF6		Spermatogenesis-associated protein 16	609856		mutation identified in 1 SPGF6 family	?Spermatogenic failure 6, 102530 (3)	
3.827	4	30	01	3q27.1	DCLAMP		Lysosome-associated membrane glycoprotein, dendritic cell-specific	605883				
3.828	1	22	07	3q26.33	SOX2, MCOPS3		SRY (sex determining region Y)-box 2	184429			Microphthalmia, syndromic 3, 206900 (3); Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)	
3.829	3	9	12	3q27.1	THPO, MGDF, MPLLG, TPO, THCYT1		Thrombopoietin (megakaryocyte growth and development factor)	600044			Thrombocythemia 1, 187950 (3)	16(Thpo)
3.830	11	13	01	3q26.32	WIG1		Wildtype p53-induced gene	606452				
3.831	1	29	01	3q26.32	KCNMB3		Potassium large conductance calcium-activated channel, subfamily M, beta member 3	605222				
3.832	11	26	12	3q26.3-q27.3	APMR1		Alopecia-mental retardation syndrome 1	203650		max lod at D3S3583	Alopecia-mental retardation syndrome 1 (2)	
3.833	5	24	13	3q29	ATP13A3, AFURS1		ATPase 13A3	610232				
3.834	11	11	14	3q26.32	KCNMB2		Potassium channel, calcium-activated, large conductance, subfamily M, beta member 2	605214				
3.835	5	11	16	3q26.32	TBL1XR1, TBLR1, IRA1, C21, MRD41		Transducin-beta-like 1 receptor 1	608628			Mental retardation, autosomal dominant 41 , 616944 (3); Pierpont syndrome, 602342 (3)	
3.836	9	20	00	3q27.1	ABCC5, MRP5, MOATC		ATP-binding cassette, subfamily C, member 5	605251				
3.837	2	17	09	3q27.3	ADIPOQ, APM1, GBP28, ADIPQTL1		Adipocyte-, C1q-, and collagen domain-containing	605441			Adiponectin deficiency, 612556 (3)	16(Apm1)
3.838	1	25	18	3q27.3	AHSG, APMR1		Alpha-2HS-glycoprotein	138680		mutation identified in 1 APMR1 family	?Alopecia-mental retardation syndrome 1, 203650 (3)	
3.839	01	03	20	3q27.1	ALG3, NOT56L, CDGS4, CDG1D		ALG3 alpha-1,3-mannosyltransferase	608750			Congenital disorder of glycosylation, type Id, 601110 (3)	
3.840	9	9	14	3q27	AOMS1, SYNX		Abdominal obesity-metabolic syndrome QTL1	605552		epistatic gene on 17p12	Abdominal obesity-metabolic syndrome 1 (2)	
3.841	8	28	09	3q26.33	ATP11B, ATPIR		ATPase, class VI, type 11B	605869				
3.842	4	3	01	3q27.3	BCL6		B-cell CLL/lymphoma-6	109565			Lymphoma, B-cell (2)	16(Bcl6)
3.843	6	16	99	3q27.1	CHRD		Chordin	603475		near THPO, CLCN2, EIF4G1		16(Chrd)
3.844	6	13	07	3q28	CLDN16, PCLN1, HOMG3		Claudin 16 (paracellin 1)	603959			Hypomagnesemia 3, renal, 248250 (3)	
3.845	8	6	13	3q27.3	CRYGS, CRYG8, CTRCT20		Crystallin, gamma S	123730			Cataract 20, multiple types, 116100 (3)	
3.846	4	8	16	3q27.1	DVL3, DRS3		Dishevelled 3 (homologous to Drosophila dsh)	601368			Robinow syndrome, autosomal dominant 3, 616894 (3)	
3.847	1	28	14	3q27.2	EHHADH, PBFE, LBFP, FRTS3		Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase	607037		mutation identified in 1 family	?Fanconi renotubular syndrome 3, 615605 (3)	
3.848	10	29	03	3q27.1	EIF2B5, LVWM, CACH, CLE		Eukaryotic translation initiation factor 2B, subunit 5	603945			Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
3.849	4	10	15	3q27.1	EIF4G1, EIF4G, PARK18		Eukaryotic translation initiation factor 4 gamma, 1	600495		amplified in squamous cell lung cancer	{Parkinson disease 18}, 614251 (3)	
3.850	7	5	01	3q27.3	FETUB		Fetuin B	605954				
3.851	03	09	20	3q27.3	HRG, THPH11		Histidine-rich glycoprotein	142640			Thrombophilia due to HRG deficiency, 613116 (3)	
3.852	7	3	06	3q27.1	HTR3C		5-hydroxytryptamine receptor 3C	610121				
3.853	7	3	06	3q27.1	HTR3D		5-hydroxytryptamine receptor 3, subunit D	610122				
3.854	7	3	06	3q27.1	HTR3E		5-hydroxytryptamine receptor 3, subunit E	610123				
3.855	10	28	08	3q27.3	KNG1, KNG		Kininogen 1	612358			[Kininogen deficiency], 228960 (3); [High molecular weight kininogen deficiency], 228960 (3)	
3.856	11	30	06	3q27.1	MAPO6D1, SL21		MAP6 domain-containing protein 1	610593				
3.857	1	19	07	3q27.2	MAP3K13, LZK		Mitogen-activated protein kinase kinase kinase 13 (leucine zipper-bearing kinase)	604915				
3.858	5	22	07	3q27.1	PARL		Presenilin-associated rhomboid-like protein	607858				
3.859	3	5	95	3q27.3	RFC4		Replication factor C4, 37kD (activator 1, 37kD)	102577				
3.860	2	28	03	3q27.3	RPL39L		Ribosomal protein L39-like	607547				
3.861	7	1	05	3q27.3	RTP4		Receptor-transporting protein 4	609350				
3.862	1	19	07	3q27.2	SENP2, SMT3IP2, AXAM2, KIAA1331		Sentrin-specific protease family, member 2	608261				
3.863	10	23	18	3q28	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8		Tumor protein p63 (tumor protein p73-like)	603273			Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3); Split-hand/foot malformation 4, 605289 (3); Hay-Wells syndrome, 106260 (3); ADULT syndrome, 103285 (3); Limb-mammary syndrome, 603543 (3); Rapp-Hodgkin syndrome, 129400 (3); Orofacial cleft 8, 618149 (3)	16(Trp63)
3.864	6	16	99	3q27.2-q27.3	DGKG, DAGK3		Diacylglycerol kinase, gamma, 90-kD	601854				
3.865	7	16	14	3q27.2	LIPH, LAH2, ARWH2, HYPT7		Lipase H	607365			Hypotrichosis 7, 604379 (3); Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	
3.866	10	10	14	3q27.3	MASP1, CRARF, 3MC1		Mannan-binding lectin serine protease-1 (C4/C2 activating component of Ra-reactive factor)	600521			3MC syndrome 1, 257920 (3)	16(Crarf)
3.867	9	7	00	3q27-q28	SPG14		Spastic paraplegia 14, autosomal recessive	605229			Spastic paraplegia 14, autosomal recessive (2)	
3.868	07	28	20	3q27.1	ABCF3		ATP-binding cassette, subfamily F, member 3	618967				
3.869	8	19	13	3q27.1	B3GNT5		Beta-1,3-N-acetylglucosaminyltransferase 5	615333				
3.870	10	10	14	3q27.1	CAMK2N2, CAMKIIN		Calcium/calmodulin-dependent protein kinase II inhibitor 2	608721				
3.871	2	25	14	3q27.1	ECE2, KIAA0604		Endothelin-converting enzyme 2	610145				
3.872	1	13	17	3q27.1	KLHL24, KRIP6, EBSSH		Kelch-like 24	611295			Epidermolysis bullosa simplex, generalized, with scarring and hair loss, 617294 (3)	
3.873	8	28	09	3q27.1	MIR1224, MIRN1224		Micro RNA 1224	611620				
3.874	8	28	09	3q27.1	PSMD2, S2, TRAP2		Proteasome 26S subunit, non-APTase, 2	606223				
3.875	12	09	19	3q27.1	YEATS2, KIAA1197, FAME4		YEATS domain-containing protein 2	613373		mutation identifed in 1 FAME4 family	?Epilepsy, myoclonic, familial adult, 4, 615127 (3)	
3.876	03	25	19	3q27.2	VPS8		VPS8, corvet complex subunit	618366				
3.877	7	25	18	3q27.3	DNAJB11, HEDJ, DJ9, ABBP2, PKD6		DNAJ/HSP40 homolog, subfamily B, member 11	611341			Polycystic kidney disease 6 with or without polycystic liver disease, 618061 (3)	
3.878	9	7	11	3q27.1	KLHL6, FLJ00029		Kelch-like 6	614214				
3.879	7	14	14	3q27.3	RTP1		Receptor-transporting protein 1	609137				
3.880	7	14	14	3q27.3	RTP2		Receptor-transporting protein 2	609138				
3.881	5	3	11	3q27.3	SNORA63, RNU107, RNE3		Small nucleolar RNA, H/ACA box, 63	180647				
3.882	4	2	16	3q27.3	SNORA81		Small nucleolar RNA, H/ACA box, 81	611334		in intron 3 of EIF2A		
3.883	09	18	19	3q27.1	AP2M1, CLAPM1, MRD60		Adaptor-related protein complex 2, mu 1 subunit	601024			Intellectual developmental disorder 60 with seizures, 618587 (3)	
3.884	8	20	15	3q28	CCDC50, C3orf6, DFNA44		Coiled-coil domain-containing protein 50	611051		mutation identified in 1 DFNA44 family	?Deafness, autosomal dominant 44, 607453 (3)	
3.885	5	28	08	3q28	CELIAC11		Celiac disease, susceptibility to, 11	612009		associated with rs1464510	{Celiac disease, susceptibility to, 11} (2)	
3.886	8	28	09	3q27.3	EIF4A2		Eukaryotic translation initiation factor-4A, isoform 2	601102		previously 18p11.2 by FISH		16(Eif4a2)
3.887	1	26	97	3q27.2	ETV5, ERM		ets variant gene 5 (ets-related molecule)	601600				
3.888	11	05	20	3q28-q29	FGF12, FHF1, DEE47		Fibroblast growth factor-12	601513			Developmental and epileptic encephalopathy 47, 617166 (3)	16(Fhf1)
3.889	03	25	20	3q26.33	FXR1, MYORIBF, MYOPMIL		FMR1 autosomal homolog 1	600819		mutation identified in 1 MYORIBF family and 1 MYOPMIL family	?Myopathy, congenital, with respiratory insufficiency and bone fractures, 618822 (3); ?Myopathy, congenital proximal, with minicore lesions, 618823 (3)	
3.890	1	30	12	3q28	GMNC, GEMC1		Geminin coiled-coil domain-containing protein	614448				
3.891	8	6	07	3q27.2	IGF2BP2, IMP2		Insulin-like growth factor 2 mRNA-binding protein 2	608289			{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	
3.892	11	4	98	3q28	IL1RAP		Interleukin 1 receptor accessory protein	602626				
3.893	9	2	11	3q28	LNCR5		Lung cancer susceptibility 5	614210		associated with rs4488809	{Lung cancer susceptibility 5} (2)	
3.894	10	1	95	3q27-q28	LPP		Lipoma-preferred-partner gene	600700		fused with HMGIC in lipoma; fused with MLL in leukemia	Lipoma (3); Leukemia, acute myeloid, 601626 (3)	
3.895	3	23	09	3q28	MIR28, MIRN28		Micro RNA 28	612154				
3.896	6	19	01	3q27.1	POLR2H, RPB8		Polymerase II, RNA, subunit H	606023				
3.897	3	25	14	3q28	PYDC2, POP2		Pyrin domain-containing protein 2	615701				
3.898	10	23	87	3q27.3	SST		Somatostatin	182450				16(Smst)
3.899	8	27	12	3q28	TMEM207		Transmembrane protein 207	614786				
3.900	10	10	18	3q28	UTS2B, URP		Urotensin 2B	618134				
3.901	7	19	06	3q28	CLDN1, SEMP1, ILVASC		Claudin 1	603718			Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)	
3.902	09	19	19	3q29	HES1, HRY		Hes family bHLH transcription factor 1	139605				
3.903	06	16	20	3q29	OPA1, NTG, NPG, BERHS, MTDPS14		OPA1 mitochondrial dynamin-like GTPase	605290		mutation identified in 1 MTDPS14 family	Optic atrophy 1, 165500 (3); {Glaucoma, normal tension, susceptibility to}, 606657 (3); Optic atrophy plus syndrome, 125250 (3); Behr syndrome, 210000 (3); ?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3)	?16(Bst)
3.904	2	25	15	3q29	ATP13A4		ATPase 13A4	609556				
3.905	1	24	13	3q29	BDH1, BDH		3-hydroxybutyrate dehydrogenase 1	603063				
3.906	8	28	09	3q29	CENTB2, KIAA0041, ACAP2		Centaurin, beta-2	607766				
3.907	3	23	14	3q29	CEP19, C3orf34, MOSPGF		Centrosomal protein, 19kD	615586		mutation identified in 1 family	Morbid obesity and spermatogenic failure, 615703 (3)	
3.908	8	22	05	3q29	CPN2		Carboxypeptidase N, polypeptide 2, 83-KD	603104		conflicting assignment to chr.8		16(Cpn2)
3.909	11	22	19	3q29	DHHC19		Zinc finger DHHC domain-containing palmitoyltransferase 19	618671				
3.910	09	09	19	3q29	DLG1		Discs large MAGUK scaffold protein 1	601014		deleted in 3q29 microdeletion syndrome		16(Dlgh1)
3.911	9	9	08	3q29	FBXO45, FBX45		F-box only protein 45	609112				16(Fbxo45)
3.912	5	2	16	3q29	FYTTD1, UIF		Forty-two-three domain-containing protein 1	616933				
3.913	8	8	13	3q29	GP5		Glycoprotein V, platelet	173511				
3.914	12	17	08	3q29	IQCG		IQ motif-containing protein G	612477				
3.915	7	14	14	3q29	LMLN		Leishmanolysin-like	609380				
3.916	11	24	20	3q29	LSG1		Large 60S subunit nuclear export GTPase 1	610780				
3.917	10	23	87	3q29	MFI2, MAP97		Melanoma-associated antigen p97	155750				
3.918	4	15	08	3q29	DEL3q29, MICRODEL3q29		Chromosome 3q29 microdeletion syndrome	609425		contiguous gene deletion syndrome	Chromosome 3q29 microdeletion syndrome (4)	
3.919	5	24	13	3q29	MUC20		Mucin 20, cell surface-associated	610360				
3.920	4	15	08	3q29	DUP3q29, MICRODUP3q29		Chromosome 3q29 microduplication syndrome	611936		contiguous gene duplication syndrome	Chromosome 3q29 microduplication syndrome (4)	
3.921	3	30	12	3q29	MIR570		Micro RNA 570	614538				
3.922	8	8	91	3q29	MUC4		Mucin 4, tracheobronchial	158372				
3.923	10	28	15	3q29	NCBP2, CBP20, NIP1		Nuclear CAP-binding protein 2	605133				
3.924	05	15	20	3q29	NRROS, LRRC33, SENEBAC		Negative regulator of oxygen species	615322			Seizures, early-onset, with neurodegeneration and brain calcification, 618875 (3)	
3.925	6	25	08	3q29	OSTA		Organic solute transporter, alpha	612084				16(Osta)
3.926	2	3	15	3q28	P3H2, LEPREL1, MCVD		Prolyl 3-hydroxylase 2	610341			Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)	16(Leprel1)
3.927	6	22	05	3q29	PAK2, PAK65		p21-activated kinase 2	605022		deleted in 3q29 microdeletion syndrome		
3.928	3	6	14	3q29	PCYT1A, CTPCT, PCYT1, SMDCRD		Phosphate cytidylyltransferase 1, choline, alpha isoform	123695			Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3)	16(Ctpct)
3.929	9	9	10	3q29	PIGX		Phosphatidylinositol glycan, class X	610276				
3.930	12	17	07	3q29	PIGZ, SMP3		Phosphatidylinositol glycan, class Z	611671				
3.931	10	07	19	3q29	PLAAT1, HRASLS		Phospholipase A and acetyltransferase 1	606487				
3.932	5	8	97	3q29	PPP1R2, IPP2		Protein phosphatase-1, regulatory (inhibitor) subunit 2	601792		pseudogenes on chr. 5 and 6		
3.933	08	09	19	3q29	RNF168, RIDL		RING finger protein 168	612688			RIDDLE syndrome, 611943 (3)	
3.934	09	11	20	3q29	RUBCN, RUBICON, KIAA0226, SCAR15		RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein	613516			Spinocerebellar ataxia, autosomal recessive 15, 615705 (3)	
3.935	7	9	09	3q29	SENP5		Sentrin-specific protease family, member 5	612845				
3.936	3	27	17	3q29	TCTEX1D2, SRTD17		TCTEX1 domain-containing protein 2	617353			Short-rib thoracic dysplasia 17 with or without polydactyly, 617405 (3)	
3.937	1	8	16	3q29	TFRC, TFR, CD71, IMD46		Transferrin receptor	190010			Immunodeficiency 46, 616740 (3)	16(Trfr)
3.938	8	28	09	3q29	TNK2, ACK, ACK1		Tyrosine kinase, non-receptor, 2	606994				
3.939	6	19	15	3q29	UBXN7, KIAA0794		UBX domain protein 7	616379				
3.940	3	14	13	3q29	WDR53		WD repeat-containing protein 53	615110				
3.941	4	2	12	3q29	XXYLT1, C3orf21		Xyloside xylosyltransferase 1	614552				
3.942	5	28	98	3p21.2	RPL29, HIP		Ribosomal protein L29	601832				9(Rpl29)
3.943	1	13	09	3q29	RPL35A, DBA5		Ribosomal protein L35A	180468		previous assignment to chr.18 in error	Diamond-Blackfan anemia 5, 612528 (3)	
4.1	1	7	02	4p16.3	ADD1		Adducin-1, alpha	102680			{Hypertension, essential, salt-sensitive}, 145500 (3)	5(Add1)
4.2	9	8	11	4p16.3	ATP5I, ATP5K		ATP synthase, H+ transporting, mitochondrial FO complex, subunit E	601519				5(Atp5k)
4.3	7	20	12	4p16.3	C4orf48		chromosome 4 open reading frame 48	614690				
4.4	12	01	20	4p16.3	CPLX1, CPX1, DEE63		Complexin 1	605032			Developmental and epileptic encephalopathy 63, 617976 (3)	
4.5	12	10	13	4p16.3	CRIPAK, FLJ3443		Cysteine-rich inhibitor of PAK1	610203				
4.6	10	31	19	4p16.3	NSG1, D4S234E, D4S234		Neuronal vesicle trafficking associated 1	607645				
4.7	10	15	98	4p16.3	DGKQ, DAGK4		Diacylglycerol kinase, theta, 110kD	601207				5(Dagk4)
4.8	12	5	16	4p16.3	FAM53A, DNTNP		Family with sequence similarity 53, member A	617229				
4.9	10	11	06	4p16.3	FGFR3, ACH		Fibroblast growth factor receptor-3	134934			Achondroplasia, 100800 (3); Hypochondroplasia, 146000 (3); Thanatophoric dysplasia, type I, 187600 (3); Crouzon syndrome with acanthosis nigricans, 612247 (3); Muenke syndrome, 602849 (3); Bladder cancer, somatic, 109800 (3); Colorectal cancer, somatic, 114500 (3); Cervical cancer, somatic, 603956 (3); LADD syndrome, 149730 (3); CATSHL syndrome, 610474 (3); Nevus, epidermal, somatic, 162900 (3); Thanatophoric dysplasia, type II, 187601 (3); Spermatocytic seminoma, somatic, 273300 (3); SADDAN, 616482 (3)	5(Fgfr3)
4.10	5	29	12	4p16.3	GRK4, GPRK2L, GPRK4		G protein-coupled receptor kinase 4	137026				5(Gprk2l)
4.11	11	1	10	4p16.3	HAUS3, DGT3, C4orf15		HAUS augmin-like complex, subunit 3	613430				
4.12	4	20	17	4p16.3	HTT, HD, IT15, LOMARS		Huntingtin	613004		distal to D4S10	Huntington disease, 143100 (3); Lopes-Maciel-Rodan syndrome, 617435 (3)	5(Hdh)
4.13	10	29	03	4p16.3	IDUA, IDA		Iduronidase, alpha-L-	252800			Mucopolysaccharidosis Ih, 607014 (3); Mucopolysaccharidosis Is, 607016 (3); Mucopolysaccharidosis Ih/s, 607015 (3)	5(Idua)
4.14	2	1	00	4p16.3	LETM1		Leucine zipper/EF-hand-containing transmembrane protein 1	604407				
4.15	9	30	13	4p16.3	LRPAP1, A2MRAP, MYP23		Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1)	104225			Myopia 23, autosomal recessive, 615431 (3)	
4.16	9	22	17	4p16.3	LYAR		Ly1 antibody-reactive protein, mouse, homolog of	617684				1(Lyar)
4.17	8	30	09	4p16.3	MAEA, EMP		Macrophage erythroblast attacher	606801				
4.18	11	30	11	4p16.3	MDCMP		Muscular dystrophy, congenital, merosin-positive	609456		max lod at D4S432	Muscular dystrophy, congenital, merosin-positive (2)	
4.19	3	22	93	4p16.3	MYL5		Myosin, light polypeptide-5, regulatory	160782				
4.20	1	29	14	4p16.3	NAT8L, CML3, NACED		N-acetyltransferase 8-like	610647		mutation identified in 1 patient	?N-acetylaspartate deficiency, 614063 (3)	
4.21	10	31	19	4p16.3	NELFA, WHSC2		Negative elongation factor complex member A	606026				
4.22	2	16	18	4p16.3	NKX1-1, SAX2		NK1 homeobox 1	617869				
4.23	4	20	17	4p16.3	NSD2, WHSC1, MMSET		Nuclear receptor-binding SET domain protein 2	602952				
4.24	7	13	09	4p16.3	NOP14, NOL14, RES425		Nop14, S. cerevisiae, homolog of	611526				
4.25	6	27	17	4p16.3	PCGF3, RNF3, RNF3A		Polycomb group RING finger protein 3	617543				
4.26	12	22	09	4p16.3	PDE6B, PDEB, RP40, CSNBAD2		Phosphodiesterase-6B, cGMP-specific, rod, beta	180072			Night blindness, congenital stationary, autosomal dominant 2, 163500 (3); Retinitis pigmentosa-40, 613801 (3)	5(Pdeb, rd)
4.27	5	2	16	4p16.3	PIGG, GPI7, MRT53		Phosphatidylinositol glycan anchor biosynthesis class G protein	616918			Mental retardation, autosomal recessive 53, 616917 (3)	
4.28	11	20	98	4p16.3	RNF4		RING finger protein-4	602850				
4.29	6	9	08	4p16.3	RNF212, ZHP3		Ring finger protein 212	612041			Recombination rate QTL 1, 612042 (3)	
4.30	5	30	01	4p16.3	SH3BP2, CRPM		SH3-domain binding protein 2	602104			Cherubism, 118400 (3)	
4.31	3	27	01	4p16.3	SLBP, HBP		Histone stem-loop binding protein	602422				
4.32	7	1	16	4p16.3	SLC26A1, SAT1, CAON		Solute carrier family 26 (sulfate transporter), member 1	610130		mutation identified in 1 CAON patient	?Nephrolithiasis, calcium oxalate, 167030 (3)	
4.33	5	11	01	4p16.3	SPON2		Spondin 2	605918				
4.34	5	5	15	4p16.3	TACC3		Transforming, acidic, coiled-coil-containing protein 3	605303				5(Tacc3)
4.35	5	22	07	4p16.3	TETRAN, TPO1		Tetracycline transporter-like protein	610977				
4.36	9	22	14	4p16.3	TMEM129		Transmembrane protein 129	615975				
4.37	11	24	15	4p16.3	TMEM175		Transmembrane protein 175	616660				
4.38	12	29	06	4p16.3	TNIP2, ABIN2, FLIP1		TNFAIP3-interacting protein 2	610669				
4.39	5	26	12	4p16.3	UVSSA, KIAA1530, UVSS3		UV-stimulated scaffold protein A	614632			UV-sensitive syndrome 3, 614640 (3)	
4.40	6	10	10	4p16.3	WHS		Wolf-Hirschhorn syndrome	194190		contiguous gene syndrome; critical region 200kb region 1.9Mb from telomere	Wolf-Hirschhorn syndrome (4)	
4.41	2	25	15	4p16.3	ZBTB49, ZNF509		Zinc finger- and BTB domain-containing protein 49	616238				
4.42	5	13	13	4p16.3	ZNF141, D4S90, PAPA6		Zinc finger protein-141 (clone pHZ-44)	194648		1 family identified with mutation	?Polydactyly, postaxial, type A6, 615226 (3)	
4.43	1	18	12	4p16.2	CYTL1, C17		Cytokine-like protein 1	607930				
4.44	04	10	20	4p16.3	DOK7, C4orf25, CMS10, FADS3		Downstream of tyrosine kinase 7	610285		mutation identified in 1 FADS3 family	Myasthenic syndrome, congenital, 10, 254300 (3); Fetal akinesia deformation sequence 3, 618389 (3)	
4.45	5	23	13	4p16.1	JAKMIP1, JAMIP1, MARLIN1		Janus kinase and microtubule-interacting protein 1	611195				
4.46	6	12	14	4p16.3	OTOP1		Otopetrin 1	607806				5(Otop1)
4.47	4	17	07	4p16.3	POLN		Polymerase, DNA, nu	610887				5(Poln)
4.48	7	16	13	4p16.3	RGS12		Regulator of G protein signaling 12	602512				5(Rgs12)
4.49	2	23	09	4p16.3	ADRA2C, ADRA2L2		Adrenergic, alpha-2C-, receptor	104250		linked to D4S10	{Congestive heart failure and beta-blocker response, modifier of} (3)	
4.50	1	5	12	4p16.1	AFAP1, AFAP, AFAP110		Actin filament-associated protein 1	608252				
4.51	4	17	13	4p16.1	BLOC1S4, BLOS4, CNO		Biogenesis of lysosome-related organelles complex 1, subunit 4	605695				5(cno)
4.52	1	11	16	4p15.33	BOD1L1, FAM44A		BOD1-like protein 1	616746				
4.53	7	17	14	4p16.1	CLNK, MIST		Cytokine-dependent hematopoietic cell linker	611434				
4.54	6	19	12	4p16.1	CPZ		Carboxypeptidase Z	603105				
4.55	8	30	09	4p16.1	GPR78		G protein-coupled receptor 78	606921				
4.56	6	27	08	4p16.1	HMX1, H6		Homeo box (H6 family) 1	142992			Oculoauricular syndrome, 612109 (3)	5(Hmx1)
4.57	1	16	07	4p16.1	HTRA3, PRSP		HTRA serine peptidase 3	608785				
4.58	05	29	20	4p16.1	MAN2B2		Mannosidase, alpha, class 2B, member 2	618899				
4.59	4	21	16	4p16.1	MRFAP1, PAM14, PGR1`		MORF4 family- associated protein 1	616905				
4.60	08	21	19	4p16.2	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3		MSH homeobox 1	142983			Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3); Orofacial cleft 5, 608874 (3); Ectodermal dysplasia 3, Witkop type, 189500 (3)	5(Hox7)
4.61	4	13	10	4p15.33	NKX3-2, BAPX1, SMMD		Bagpipe homeo box, Drosophila, homolog of	602183			Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)	5(Bapx1)
4.62	01	13	20	4p16.1	SORCS2, KIAA1329		Sortilin-related VPS10 domain-containing receptor 2	606284				
4.63	4	26	10	4p16.1	TADA2B, ADA2B		Transcriptional adaptor 2B	608790				
4.64	10	11	12	4p16.1	TBC1D14, KIAA1322		TBC1 domain family, member 14	614855				
4.65	09	11	19	4p16.1	TRMT44, METTL19		tRNA methyltransferase 44 homolog	614309				
4.66	7	21	15	4p16.1	USP17L9P, USP17		Ubiquitin-specific protease 17-like family member 9, pseudogene	607011				
4.67	07	29	20	4p16.1	WDR1, PFITS		WD repeat-containing protein 1	604734			Periodic fever, immunodeficiency, and thrombocytopenia syndrome, 150550 (3)	
4.68	1	14	14	4p16.1	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41		Wolframin	606201		mutation identified in 1 CTRCT41 family	Wolfram syndrome 1, 222300 (3); Deafness, autosomal dominant 6/14/38, 600965 (3); Wolfram-like syndrome, autosomal dominant, 614296 (3); {Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3); ?Cataract 41, 116400 (3)	
4.69	10	25	17	4p16.1	ZNF518B, KIAA1729		Zinc finger protein 518B	617734				
4.70	4	8	98	4p16.2	CRMP1, DPYSL1, DRP1		Collapsin response mediator protein-1	602462				
4.71	5	18	18	4p16.1	DRD5, DRD1B, DRD1L2		Dopamine receptor D5	126453		pseudogenes on 2p11 and 1q21	{Blepharospasm, primary benign}, 606798 (3); {Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)	5(Drd5)
4.72	1	24	09	4p16.1	ABLIM2, KIAA1808		Actin-binding LIM protein family, member 2	612544				5(Ablim2)
4.73	7	8	95	4p16	CRSA, CRS3		Craniosynostosis, Adelaide type	600593			Craniosynostosis, Adelaide type (2)	
4.74	3	27	18	4p16.3	CTBP1, HADDTS		C-terminal binding protein 1	602618			Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3)	
4.75	10	31	19	4p16.2	EVC		EvC ciliary complex subunit 1	604831		mutation identified in 1 WAD patient	Ellis-van Creveld syndrome, 225500 (3); ?Weyers acrofacial dysostosis, 193530 (3)	
4.76	4	26	01	4p16.3	FGFRL1		Fibroblast growth factor receptor-like 1	605830				
4.77	3	9	98	4p16.3	GAK		Cyclin G associated kinase	602052				
4.78	08	19	19	4p16.1	GRPEL1, HMGE		GrpE-like 1, mitochondrial	606173				
4.79	5	4	00	4p16.3	HGFAC, HGFA		Hepatocyte growth factor activator	604552				
4.80	5	7	03	4p15.32	KSP37		Killer-specific secretory protein, 37kD	607713				
4.81	10	31	19	4p16.2	EVC2, LBN, WAD		EvC ciliary complex subunit 2 (limbin)	607261			Ellis-van Creveld syndrome, 225500 (3); Weyers acrofacial dysostosis, 193530 (3)	5(Lbn)
4.82	1	13	09	4p16	PLSA1, PLSA		Primary lateral sclerosis, adult, 1	611637		max lod at D4S2936	Primary lateral sclerosis, adult, 1 (2)	
4.83	7	2	01	4p16.1	PPP2R2C, PR52		Protein phosphatase 2A, regulatory subunit B, gamma isoform	605997				
4.84	7	8	95	4p16.1	S100P		S100 calcium-binding protein P	600614				
4.85	9	6	11	4p16.3	ZFYVE28, LST2, KIAA1643		Zinc finger FYVE domain-containing protein 28	614176				
4.86	1	24	09	4p16.1	SLC2A9, GLUT9, UAQTL2		Solute carrier family 2 (facilitated glucose transporter), member 9	606142			{Uric acid concentration, serum, QTL 2}, 612076 (3); Hypouricemia, renal, 2, 612076 (3)	
4.87	12	21	00	4p16-p15.2	SLEB3		Systemic lupus erythematosus, susceptibility to, 3	605480			{Systemic lupus erythematosus, susceptibility to, 3} (2)	
4.88	11	13	18	4p16-p15	MNDEC		Microtia with nasolacrimal duct imperforation and eye coloboma	611863		copy number variant (CNV) association	Microtia with nasolacrimal duct imperforation and eye coloboma (4)	
4.89	4	27	12	4p16-p15	SPG38		Spastic paraplegia 38, autosomal dominant	612335		between D4S432 and D4S1599	Spastic paraplegia 38, autosomal dominant (2)	
4.90	4	22	10	4p16-q34	INTLQ1		Intelligence quantitative trait locus 1	603783		associated with D4S2943, MSX1, and D4S1607	{Intelligence QTL1} (2)	
4.91	8	30	09	4p15.32	FBXL5, FBL5		F-box and leucine-rich repeat protein 5	605655				
4.92	7	18	14	4p15.33	HS3ST1, 3OST, 3OST1		Heparan sulfate (glucosamine)3-O-sulfotransferase 1	603244				
4.93	9	9	13	4p15.33	RAB28, CORD18		Ras-associated protein 28	612994			Cone-rod dystrophy 18, 615374 (3)	
4.94	1	13	11	4p15.32	BST1		Bone marrow stromal cell antigen 1	600387		previously assigned to 14q32.3		
4.95	08	17	20	4p15.32	CLRN2		Clarin 2	618988				5(Clrn2)
4.96	5	24	13	4p15.32	MED28, EG1, MAGICIN		Mediator complex subunit 28	610311				
4.97	4	8	16	4p15.32	TAPT1, CMVFR, OCLSBG		Transmembrane anterior posterior transformation 1	612758			Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3)	5(Tapt1)
4.98	1	13	09	4p15.2	GBA3, CBGL1		Glucosidase, beta, acid 3	606619				
4.99	1	29	16	4p15.31	MIR218-1		Micro RNA 218-1	616770		within intron of SLIT2		5(Mir218-1)
4.100	4	15	09	4p15.32	QDPR, DHPR		Quinoid dihydropteridine reductase	612676			Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)	5(Qdpr)
4.101	10	14	19	4p15.2	SLC34A2, PULAM		Solute carrier family 34 (sodium/phosphate cotransporter), member 2	604217			Pulmonary alveolar microlithiasis, 265100 (3)	
4.102	1	12	99	4p16.1	ACOX3		Acyl-coenzyme A oxidase 3, pristanoyl	603402				
4.103	12	01	20	4p15.32	CC2D2A, KIAA1345, MKS6, COACH2		Coiled-coil and C2 domains-containing protein 2A	612013			Joubert syndrome 9, 612285 (3); Meckel syndrome 6, 612284 (3); COACH syndrome 2, 619111 (3)	
4.104	07	13	20	4p15.2	DHX15, DDX15, DBP1, HRH2		DEAH-box helicase 15	603403				
4.105	8	30	09	4p15.32	FGFBP1, FGFBP, HBP17		Fibroblast growth factor-binding protein 1	607737				
4.106	11	13	01	4p15.3	HDL3, HLN2		Huntington disease-like 3	604802			Huntington disease-like 3 (2)	
4.107	10	29	03	4p15.3-p15.2	KCNIP4, KCHIP4		Kv channel-interacting protein 4	608182				
4.108	8	30	09	4p15.31	NCAPG, CAPG		Non-SMC condensin I complex subunit G	606280				
4.109	2	17	09	4p15.31	LCORL, MLR1		Ligand-dependent nuclear receptor corepressor-like protein	611799				
4.110	3	23	09	4p15.32	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4		Prominin 1	604365			Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657 (3); Stargardt disease 4, 603786 (3); Macular dystrophy, retinal, 2, 608051 (3)	
4.111	2	17	09	4p15.3	STQTL13		Stature quantitative trait locus 13	612226		associated with rs16896068	{Stature QTL 13} (2)	
4.112	12	1	03	4p15.2	SOD3		Superoxide dismutase-3, extracellular	185490			[Superoxide dismutase, elevated extracellular] (3)	
4.113	8	30	09	4p15.2	ANAPC4, APC4		Anaphase-promoting complex, subunit 4	606947				
4.114	9	1	16	4p15.2	ADGRA3, GPR125		Adhesion G protein-coupled receptor A3	612303				
4.115	12	4	03	4p15.2	LGI2, KIAA1916		Leucine-rich gene, glioma-inactivated, 2	608301				
4.116	6	27	08	4p15.2	PI4K2B		Phosphatidylinositol 4-kinase, type 2, beta	612101				
4.117	9	10	12	4p15.2	RBPJ, RBPSUH, IGKJRB1, AOS3		Recombination signal-binding protein 1 for kappa J region	147183		pseudogenes at 9q13, 9p13, and 3q25	Adams-Oliver syndrome 3, 614814 (3)	5(Rbpsuh)
4.118	3	28	11	4p15.2	SEPSECS, SLA, LP, PCH2D		O-phosphoserine tRNA-selenocysteine tRNA synthase	613009			Pontocerebellar hypoplasia type 2D, 613811 (3)	
4.119	4	26	17	4p15.2	SMIM20, MITRAC7, C4orf52		Small integral membrane protein 20	617465				
4.120	09	12	19	4p15.31	SLIT2		SLIT guidance ligand 2	603746				
4.121	2	14	08	4p15.2	ZCCHC4		Zinc finger CCHC domain-containing protein 4	611792				
4.122	6	15	99	4p15.2	CCKAR		Cholecystokinin A receptor	118444				5(Cckar)
4.123	3	27	09	4p15.2	PPARGC1A, PPARGC1		Peroxisome proliferator-activated receptor-gamma, coactivator 1, alpha	604517				
4.124	3	12	07	4p15.2	STIM2, KIAA1482		Stromal interaction molecule 2	610841				5(Stim2)
4.125	10	23	20	4p14	UGDH, UDPGDH, DEE84		UDP-glucose dehydrogenase	603370			Developmental and epileptic encephalopathy 84, 618792 (3)	5(Udgh)
4.126	9	9	03	4p14	KLHL5		Kelch-like 5	608064				
4.127	4	23	08	4p15.1-q12	NPC1, NPCA1		Nasopharyngeal carcinoma 1	607107		?associated with acyl-CoA thioesterase 7-like	{Nasopharyngeal carcinoma 1} (2)	
4.128	5	22	03	4p14	CHRNA9		Cholinergic receptor, neuronal nicotinic, alpha polypeptide 9	605116				
4.129	3	20	06	4p14	TBC1D1, KIAA1108		TBC1 domain family, member 1	609850				5(Tbc1d1)
4.130	5	9	95	4p15.32	CD38		CD38 antigen (p45); ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase	107270				
4.131	10	7	02	4p15	EPPS		Epilepsy, partial, with pericentral spikes	607221			Epilepsy, partial, with pericentral spikes (2)	
4.132	2	4	99	4p15.32	LDB2, CLIM1		LIM domain-binding factor-2	603450				
4.133	11	20	98	4p15.1	PCDH7, BHPCDH		Protocadherin-7	602988				
4.134	10	08	08	4p15-p14	BMIQ7		Body mass index quantitative trait locus 7	608410			{Obesity, susceptibility to, BMIQ7} (2)	
4.135	4	14	05	4p14-p13	APBB2, FE65L1		Amyloid beta A4 precursor protein-binding, family B, member 2 (Fe65-like 1)	602710				
4.136	8	30	09	4p14	ARAP2, CENTD1, KIAA0580		ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	606645				
4.137	6	16	16	4p14	DTHD1		Death domain-containing protein 1	616979				
4.138	11	20	98	4p14	HIP2		Huntingtin-interacting protein-2	602846				
4.139	9	10	07	4p14	KLB, BKL		Klotho, beta	611135				
4.140	12	6	16	4p14	KLF3, BKLF		Kruppel-like factor 3	609392				
4.141	3	20	16	4p14	LIAS, PDHLD, HGCLAS		Lipoic acid synthase	607031			Hyperglycinemia, lactic acidosis, and seizures, 614462 (3)	
4.142	12	10	13	4p14	MIR574, MIR574-3p		Micro RNA 574	615469				
4.143	5	30	17	4p14	NSUN7		NOP2/SUN RNA methyltransferase family, member 7	617185				
4.144	11	24	20	4p14	PDS5A, KIAA0648, SCC112		PDS5 cohesin-associated factor A	613200				
4.145	11	17	20	4p14	RBM7		RNA-binding motif protein 47	619104				
4.146	5	26	13	4p14	RELL1		Relt-like 1	611212				
4.147	2	21	10	4p14	TLR1, TIL. LPRS5		Toll-like receptor-1	601194			{Leprosy, protection against}, 613223 (3); {Leprosy, susceptibility to, 5}, 613223 (3)	
4.148	8	30	09	4p14	TLR6		Toll-like receptor 6	605403				5(Tlr6)
4.149	7	2	18	4p14	TLR10		Toll-like receptor 10	606270				
4.150	2	15	17	4p13	UCHL1, PARK5, SPG79, NDGOA		Ubiquitin C-terminal esterase L1	191342		mutation identified in 1 PARK5 family	{?Parkinson disease 5, susceptibility to}, 613643 (3); Spastic paraplegia 79, autosomal recessive, 615491 (3)	
4.151	1	9	13	4p14	UCH1LAS		Ubiquitin carboxyl-terminal esterase L1, antisense	614991				
4.152	04	19	19	4p14	RFC1, RECC1, CANVAS		Replication factor C1, 145kD (activator 1, 145kD)	102579			Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome, 614575 (3)	5(Rfc1)
4.153	4	23	08	4p14	LOC344967		Acyl-CoA thioesterase 7-like	611963		?associated with nasopharyngeal carcinoma		
4.154	4	10	15	4p14	WDR19, SRTD5, ATD5, NPHP13, CED4		WD repeat-containing protein 19	608151		mutation identified in 1 CED4 family and 1 SRTD5 family	Nephronophthisis 13, 614377 (3); ?Cranioectodermal dysplasia 4, 614378 (3); ?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3); Senior-Loken syndrome 8, 616307 (3)	
4.155	5	16	95	4p12	GABRA4		Gamma-aminobutyric acid (GABA) A receptor, alpha-4	137141		cluster with GABRA2, B1, G1; ?involved in autism		7(Gabra4)
4.156	10	23	87	4p14	PGM2		Phosphoglucomutase-2	172000				5(Pgm1)
4.157	1	30	91	4q21.21	BMP3		Bone morphogenetic protein-3	112263				5(Bmp3)
4.158	8	21	92	4p12	GABRG1		Gamma-aminobutyric acid (GABA) A receptor, gamma-1	137166				
4.159	2	19	10	4p12	GNPDA2, GNP2		Glucosamine-6-phosphate deaminase 2	613222				
4.160	2	25	10	4p13	GRXCR1		Glutaredoxin, cysteine-rich, 1	613283			Deafness, autosomal recessive 25, 613285 (3)	5(Grxcr1)
4.161	05	24	19	4p13	KCTD8		Potassium channel tetramerization domain-containing protein 8	618442				
4.162	10	30	17	4p13	LIMCH1, LMO7B		LIM and calponin homology domains-containing protein 1	617750				
4.163	02	08	19	4p14	RHOH, ARHH, TTF		Ras homolog gene family, member H	602037		mutation identified in 1 EV4 family	{?Epidermodysplasia verruciformis, susceptibility to, 4}, 618307 (3)	
4.164	6	15	99	4p14	RPL9		Ribosomal protein L9	603686		pseudogene on Xpter-p21		
4.165	2	2	17	4p13	SHISA3		Shisa family, member 3	617325				
4.166	8	8	17	4p13	SLC30A9, C4orf1, HUEL, BILAPES		Solute carrier family 30 (zinc transporter), member 9	604604		mutation identified in 1 BILAPES family	?Birk-Landau-Perez syndrome, 617595 (3)	
4.167	07	24	19	4p13	TMEM33		Transmembrane protein 33	618515				
4.168	12	01	20	4p12	GABRA2, DEE78		Gamma-aminobutyric acid (GABA) A receptor, alpha-2	137140			{Alcohol dependence, susceptibility to}, 103780 (3); Developmental and epileptic encephalopathy 78, 618557 (3)	5(Gabra2)
4.169	11	05	20	4p12	GABRB1, DEE45		Gamma-aminobutyric acid (GABA) A receptor, beta-1	137190			Developmental and epileptic encephalopathy 45, 617153 (3)	5(Gabrb1)
4.170	1	6	09	4p13-q21	NRCLP2		Narcolepsy 2	605841		max lod at D4S2987	Narcolepsy 2 (2)	
4.171	11	20	15	4p12	COMMD8		COMM domain-containing protein 8	616656				
4.172	4	27	12	4p12	CORIN, CRN, TMPRSS10, ATC2, PEE5		Corin, serine peptidase	605236			Preeclampsia/eclampsia 5, 614595 (3)	
4.173	4	21	10	4p12	COX7B2		Cytochrome C oxidase subunit VIIb2	609811				
4.174	11	05	20	4p12	GUF1, EF4, DEE40		GUF1 homolog, GTPase	617064		mutation identified in 1 DEE40 family	?Developmental and epileptic encephalopathy 40, 617065 (3)	
4.175	1	31	18	4p13	PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS		Paired mesoderm homeo box 2B	603851			Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3); {Neuroblastoma, susceptibility to, 2}, 613013 (3); Neuroblastoma with Hirschsprung disease, 613013 (3)	
4.176	10	22	99	4p14	PTTG2		Pituitary tumor-transforming gene 2	604231				
4.177	12	13	95	4p12-p11	TEC		tec protein tyrosine kinase	600583				
4.178	10	12	94	4p12	TXK, BTKL		TXK tyrosine kinase	600058				5(Txk)
4.179	3	10	11	4p12	CNGA1, CNCG1, RP49		Cyclic nucleotide gated channel, alpha 1	123825			Retinitis pigmentosa 49, 613756 (3)	5(Cncg)
4.180	08	29	19	4p11	CWH43, PGAP2IP		Cell wall biogenesis protein 43 C-terminal homolog	618561				
4.181	2	25	15	4p11	SLAIN2, KIAA1458		SLAIN motif family, member 2	610492				5(Slain2)
4.182	09	04	19	4p11	SLC10A4		Solute carrier family 10 (sodium/bile acid cotransporter family), member 4	618563				
4.183	8	31	09	4p11	ZAR1		Zygote arrest 1	607520				5(Zar1)
4.184	10	23	87	4p15.32	PEPS		Peptidase S	170250				5(Pep7)
4.185	6	16	99	4p	MHW1		Mental health wellness 1	603663		at D4S2949	{Mental health wellness-1} (2)	
4.186	6	16	99	4q	MHW2		Mental health wellness 2	603664		at D4S397	{Mental health wellness-2} (2)	
4.187	10	8	96	4q	PSORS3		Psoriasis susceptibility 3	601454			{Psoriasis susceptibility 3} (2)	
4.188	9	20	00	4q25	RRH		Rhodopsin homolog, retinal pigment epithelium-derived (peropsin)	605224				3(Rrh)
4.189	2	28	07	4q	WM2		Macroglobulinemia, Waldenstrom, susceptibility to, 2	610430		between D4S2910 and D4S1539	{Macroglobulinemia, Waldenstrom, susceptibility to, 2} (2)	
4.190	12	17	07	4q12	PDCL2		Phosducin-like 2	611676				5(Pdcl2)
4.191	5	5	00	4q12	CHIC2, BTL		Cysteine-rich hydrophobic domain 2 (Brx-like gene translocated in leukemia)	604332			{Leukemia, acute myeloid}, 601626 (3)	
4.192	8	30	09	4q12	HOPX, HOP		HOP homeobox	607275				
4.193	7	15	09	4q12	SPATA18, SPETEX1		Spermatogenesis-associated protein 18	612814				
4.194	10	12	94	4q13.3	AFM, ALBA, ALB2		Afamin	104145		10kb 3' of AFP		
4.195	9	20	14	4q13.3	AFP, HPAFP, AFPD		Alpha-fetoprotein	104150		order: 5'-ALB-3'--5'-AFP-3'	[Hereditary persistence of alpha-fetoprotein], 615970 (3); Alpha-fetoprotein deficiency, 615969 (3)	5(Afp)
4.196	9	10	14	4q13.3	ALB, ANALBA, FDAH		Albumin	103600		linked to GC	Analbuminemia, 616000 (3); [Dysalbuminemic hyperthyroxinemia], 615999 (3)	5(Alb1)
4.197	10	23	87	4q13.3	STATH		Statherin	184470				
4.198	12	5	11	4q12	AASDH, ACSF4		Aminoadipate-semialdehyde dehydrogenase	614365				
4.199	12	04	20	4q12	ARL9		ADP ribosylation factor-like GTPase 9	612405				
4.200	5	3	17	4q12	CEP135, KIAA0635, MCPH8		Centrosomal protein, 135kD	611423			Microcephaly 8, primary, autosomal recessive, 614673 (3)	
4.201	8	27	01	4q12	CLOCK		Circadian locomotor output cycles kaput	601851				5(Clock)
4.202	6	1	12	4q12	DANCR, ANCR, KIAA0114		Differentiation-antagonizing noncoding RNA	614625				
4.203	9	9	09	4q12	DCUN1D4, KIAA0276		DCN1 domain-containing protein 4	612977				
4.204	7	7	09	4q12	EXOC1, SEC3		Exocyst complex component 1	607879				
4.205	04	02	19	1p33	PAINQTL1		Pain sensitivity quantitative trait locus 1	618377		deletion identified in 1 PAINQTL1 family	?Pain sensitivity QTL1 (4)	
4.206	5	28	03	4q12	FIP1L1		Fip1-like 1	607686		fused to PDGFRA in hypereosinophilic syndrome		
4.207	9	4	14	4q13.3	GC, DBP		Group-specific component (vitamin D-binding protein)	139200		4q13-q21.1 by in situ hybridization		5(Gc)
4.208	09	29	20	4q13.2	GCOM2, GRINL1B		GRINL1B complex locus 2	608311				
4.209	10	30	19	4q12	GSX2, GSH2, DMJDS2		GS homeobox 2	616253			Diencephalic-mesencephalic junction dysplasia syndrome 2, 618646 (3)	
4.210	9	14	11	4q12	IGFBP7, MAC25, RAMSVPS		Insulin-like growth factor-binding protein-7	602867			Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)	
4.211	12	28	08	4q12	LNX1, LNX, PDZRN2		Ligand of numb protein X1	609732				
4.212	6	1	12	4q12	MIR4449		Micro RNA 4449	614627				
4.213	7	18	06	4q12	MYP9		Myopia 9	609258			Myopia 9 (2)	
4.214	09	27	18	4q12	SGCB, LGMDR4		Sarcoglycan, beta (43kD dystrophin-associated glycoprotein)	600900			Muscular dystrophy, limb-girdle, autosomal recessive 4, 604286 (3)	
4.215	12	24	08	4q12	KDR		Kinase insert domain receptor	191306		?mutant in TAPVR1	Hemangioma, capillary infantile, somatic, 602089 (3); {Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	
4.216	07	16	19	4q12	KIT, PBT, MASTC		Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene	164920		same 700bp segment as PDGFRA	Piebaldism, 172800 (3); Gastrointestinal stromal tumor, familial, 606764 (3); Leukemia, acute myeloid, somatic, 601626 (3); Germ cell tumors, somatic, 273300 (3); Mastocytosis, cutaneous, 154800 (3); Mastocytosis, systemic, somatic, 154800 (3)	5(Kit; W)
4.217	12	12	12	4q12	NOA1, C4orf14		Nitric oxide-associated protein 1	614919				
4.218	6	16	94	4q12	PAICS, AIRC		Phosphoribosylaminoimidazole carboxylase	172439		bifunctional enzyme; ade-D; 625bp from PPAT		
4.219	07	16	19	4q12	PDGFRA		Platelet-derived growth factor receptor, alpha polypeptide	173490		same 700bp segment as KIT; fused to BCR or FIP1L1	Gastrointestinal stromal tumor/GIST-plus syndrome, somatic or familial, 175510 (3); Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)	5(Pdgfra)
4.220	5	2	94	4q12	POL2RB		Polymerase (RNA) II (DNA directed) polypeptide B, 140kD	180661				
4.221	6	16	94	4q12	PPAT, GPAT		Phosphoribosylpyrophosphate amidotransferase	172450				
4.222	12	18	08	4q12	RASL11B		RAS-like, family 11, member B	612404				
4.223	11	12	19	4q12	REST, NRSF, WT6, GINGF5, HGF5, DFNA27		RE1-silencing transcription factor	600571		mutation identified in one DFNA27 family	{Wilms tumor 6, susceptibility to}, 616806 (3); Fibromatosis, gingival, 5, 617626 (3); ?Deafness, autosomal dominant 27, 612431 (3)	
4.224	6	1	12	4q12	SNORA26		Small nucleolar RNA, H/ACA box, 26	614626				
4.225	08	22	18	4q12	SPINK2, SPGF29		Serine protease inhibitor, Kazal-type, 2	605753		mutation identified in 1 SPGF29 family	?Spermatogenic failure 29, 618091 (3)	
4.226	1	5	12	4q12	SRD5A3, SRD5A2L, CDG1Q, KRIZI		Steroid 5-alpha-reductase 3	611715			Congenital disorder of glycosylation, type Iq, 612379 (3); Kahrizi syndrome, 612713 (3)	
4.227	4	10	14	4q12	SRP72, BMFS1		Signal recognition particle, 72kD	602122			Bone marrow failure syndrome 1, 614675 (3)	
4.228	1	22	07	4q12	TAPVR1		Total anomalous pulmonary venous return 1	106700		between D4S1630 and D4S3019; ?mutation in KDR	Total anomalous pulmonary venous return (2)	
4.229	7	18	12	4q12	TMEM165, FT27, CDG2K		Transmembrane protein 165	614726			Congenital disorder of glycosylation, type IIk, 614727 (3)	
4.230	7	9	09	4q12	USP46		Ubiquitin-specific peptidase 46	612849				
4.231	8	28	02	4q13.3	CXCL1, GRO1, MGSA		Chemokine, C-X-C, ligand 1 (GRO1 oncogene; melanoma growth stimulating activity, alpha)	155730		apparently cluster of 3 GRO genes		5(Mgsa)
4.232	8	29	02	4q13.3	CXCL2, GRO2, MIP2A		Chemokine, C-X-C motif, ligand 2 (GRO2 oncogene)	139110				5(Mip2a)
4.233	8	29	02	4q13.3	CXCL3, GRO3, MIP2B		Chemokine, C-X-C motif, ligand 3 (GRO3 oncogene)	139111				5(Mip2b)
4.234	8	30	02	4q13.3	CXCL5, SCYB5, ENA78		Chemokine, C-X-C motif, ligand 5 (epithelial-derived neutrophil-activating peptide 78)	600324				
4.235	8	30	02	4q13.3	CXCL6, SCYB6, GCP2		Chemokine, C-X-C motif, ligand 6 (granulocyte chemotactic protein-2)	138965				
4.236	4	30	97	4q13.3	IL8		Interleukin-8	146930				
4.237	10	6	92	4q13.3	PF4		Platelet factor 4	173460		6kb from PF4V1		
4.238	10	6	92	4q13.3	PF4V1		Platelet factor 4, variant 1 (PF4-like)	173461		same region as PF4 and IP10		
4.239	8	25	11	4q13.3	PPBP, CXCL7, SCYB7, CTAP3, TGB		Pro-platelet basic protein	121010		less than 7kb from PF4		
4.240	09	29	20	4q13.3	PPBPP1, PPBPL1, TGB2		Pro-platelet basic protein pseudogene 1	188035				
4.241	11	19	11	4q12-q13.1	MRT31		Mental retardation, autosomal recessive 31	614329		between rs11944876 and rs6551838	Mental retardation, autosomal recessive 31 (2)	
4.242	3	13	06	4q12-q13.2	DFNB55		Deafness, autosomal recessive 55	609952		max lod at D4S2638	Deafness, autosomal recessive 55 (2)	
4.243	8	18	98	4q13.2	CENPC1, CENPC		Centromere autoantigen C1	117141		?pseudogene on chr.12		5(Cenpc)
4.244	3	30	12	4q21.21	RASGEF1B, GPIG4		RASGEF domain family, member 1B	614532				
4.245	3	13	06	4q13.1-q13.2	EPHA5, TYRO4, HEK7		Ephrin receptor EphA5	600004				
4.246	7	9	06	4q13.3	GRSF1		G-rich RNA sequence-binding factor 1	604851				
4.247	3	29	90	4q13.3	HTN1		Histatin-1	142701		3 genes in a 15kb segment		
4.248	6	16	97	4q13.3	HTN3, HTN2, HIS2		Histatin-3	142702				
4.249	12	13	00	4q13.3	UGT2A1		Uridine diphosphate glycosyltransferase 2 family, member A1	604716				
4.250	6	2	15	4q13.2	UGT2A3		Uridine diphosphate glucuronosyltransferase 2 family, member A3	616382				5(Ugt2a3)
4.251	6	23	98	4q13.3	UGT2B4, UGT2B11		UDP-glucuronyltransferase, family 2, beta-4	600067		cluster in order B7--B4--B15 in 195kb		5(Ugt2b4)
4.252	6	23	98	4q13.2	UGT2B7, UGT2B9		UDP-glucuronyltransferase, family 2, beta-7	600068				
4.253	6	23	98	4q13.2	UGT2B15, UGT2B8		UDP-glucuronyltransferase, family 2, beta-15	600069				
4.254	5	25	13	4q13.2	UGT2B17, BMND12		UDP-glucuronyltransferase, family 2, beta-17	601903			{Bone mineral density QTL 12, osteoporosis}, 612560 (3)	
4.255	11	19	11	4q13-q21	AIS4, VAMAS5		Autoimmune disease, susceptibility to, 4	609400		between D4S392 and D4S3042	{Autoimmune disease, susceptibility to, 4} (2)	
4.256	6	8	89	4q13.3	AREG		Amphiregulin	104640				5(Areg)
4.257	10	1	95	4q13.3	BTC		Betacellulin	600345		tightly linked to Areg in mouse		5(Btc)
4.258	6	2	15	4q13.3	CSN3, CNS10, CSNK		Casein, kappa	601695				
4.259	10	5	06	4q13.3	MUC7		Mucin 7, salivary	158375			{Asthma, protection against}, 600807 (3)	
4.260	9	22	11	4q21.1	SCARB2, CD36L2, LIMPII, AMRF, EPM4		Scavenger receptor class B, member 2	602257			Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	
4.261	6	30	15	4q13.1	ADGRL3, LPHN3, CIRL3, CL3, LEC3, KIAA0768		Adhesion G protein-coupled receptor L3	616417				
4.262	6	13	18	4q31.21	GAB1, DFNB26		Grb2-associated binding protein 1	604439		mutation identified in 1 family	?Deafness, autosomal recessive 26, 605428 (3)	8(Gab1)
4.263	11	20	95	4q13.3	STE, EST		Sulfotransferase, estrogen-preferring	600043				5(Ste)
4.264	12	15	16	4q13.1	TECRL, TERL, SRD5A2L2, GPSN2L, CPVT3		Trans-2,3-enoyl-CoA reductase-like protein	617242			Ventricular tachycardia, catecholaminergic polymorphic, 3, 614021 (3)	
4.265	5	5	98	4q21.21	PRKG2, PRKGR2		Protein kinase, cGMP-dependent, type II	601591				
4.266	5	2	07	4q13.2	SYT14L, SYTDEP, CHR415SYT		Synaptotagmin 14-like protein	610892				
4.267	11	11	14	4q13.2	STAP1, BRDG1		Signal transducing adaptor family member 1	604298				
4.268	1	9	08	4q13.2	TMPRSS11A, ECRG1		Transmembrane protease, serine 11A	611704				
4.269	8	18	14	4q13.2	UGT2B10		Uridine diphosphate glycosyltransferase 2 family, member B10	600070				
4.270	4	4	05	4q13.2	UGT2B28		Uridine diphosphate glycosyltransferase 2 family, member B28	606497				
4.271	6	19	12	4q13.2	UGT2B11		Uridine diphosphate glycosyltransferase 2 family, member B11	603064				
4.272	1	3	17	4q13.2	YTHDC1, KIAA1966		TYH domain-containing protein 1	617283				
4.273	11	6	14	4q13.2-q21.3	ETL3, FMTLE		Epilepsy, familial temporal lobe, 3	611630		max lod at D4S1517	Epilepsy, familial temporal lobe, 3 (2)	
4.274	8	4	17	4q13.3	AMTN, AI3B		Amelotin	610912		mutation identified in 1 AI3B family	?Amelogenesis imperfecta, type IIIB, 617607 (3)	5(Amtn)
4.275	9	20	14	4q13.3	ANKRD17, GTAR		Ankyrin repeat domain-containing protein 17	615929				
4.276	9	27	17	4q13.3	EREG		Epiregulin	602061				
4.277	9	8	11	4q13.3	MTHFD2L		Methylenetetrahydrofolate dehydrogenase 2-like, NADP(+)-dependent	614047				
4.278	03	19	19	4q13.3	NPFFR2, GPR74, NPFF2, NPGPR		Neuropeptide FF receptor 2	607449				
4.279	2	15	14	4q13.3	ODAM, APIN		Odontogenic ameloblast-associated protein	614843				
4.280	9	22	17	4q13.3	PARM1, CIPAR1		Prostate androgen-regulated mucin-like protein 1	617688				
4.281	11	15	17	4q13.3	PPBPP2, PPBPL2		Pro-platelet basic protein pseudogene 2	611591				
4.282	7	14	14	4q13.3	PROL1, PRL1, BPLP		Proline-rich lacrimal protein 1	608936				
4.283	2	18	09	4q13.3	RASSF6		Ras association domain family, member 6	612620				
4.284	8	19	13	4q13.3	RUFY3, SINGAR1, RIPX		FUN and FYVE domains-containing protein 3	611194				
4.285	02	26	19	4q13.3	SMR3A, PBI		Submaxillary gland androgen-regulated protein 3A	618340				
4.286	2	23	08	4q13.3	SMR3B, SMR1B, PRL3, PBII		Submaxillary gland androgen-regulated protein 3, mouse, homolog of, B	611593				
4.287	8	8	13	4q13.3	SULT1B1, ST1B2		Sulfotransferase family 1B, member 1	608436				
4.288	8	19	13	4q13.2	TMPRSS11E, DESC1		Transmembrane protease, serine 11E	610399				5(Tmprss11e)
4.289	9	12	93	4q13.3	DCK		Deoxycytidine kinase	125450				
4.290	09	26	19	4q13.3	ADAMTS3, HKLLS3		ADAM metallopeptidase with thrombospondin type 1 motif, 3	605011			Hennekam lymphangiectasia-lymphedema syndrome 3, 618154 (3)	
4.291	7	16	09	4q21.3-q22.1	AFF1, MLLT2, AF4		AF4/FMR2 family, member 1	159557		fuses with ALL1		5(Af4)
4.292	3	23	15	4q13.3	AMBN, AI1F		Ameloblastin	601259		mutation identified in 1 AI1F family	Amelogenesis imperfecta, type IF, 616270 (3)	5(Ambn)
4.293	1	18	13	4q21.21	ANTXR2, CMG2, HFS		Anthrax toxin receptor 2	608041			Hyaline fibromatosis syndrome, 228600 (3)	
4.294	6	6	91	4q21.21	ANXA3, ANX3		Annexin A3 (lipocortin III)	106490				
4.295	11	30	06	4q21.2-q21.3	ARHGAP24, RCGAP72, FILGAP		RHO GTPase-activating protein 24	610586				
4.296	12	15	10	4q21	DEL4q21, C4DELq21		Chromosome 4q21 deletion syndrome	613509		contiguous gene deletion if at least 30 genes	Chromosome 4q21 deletion syndrome (4)	
4.297	6	15	99	4q21.23	CDS1		CDP-diacylglycerol synthase 1	603548				
4.298	8	29	02	4q21.1	CXCL9, MIG, SCYB9		Chemokine, C-X-C motif, ligand 9	601704		close to INP10		
4.299	8	29	02	4q21.1	CXCL10, INP10		Chemokine, C-X-C motif, ligand 10 (interferon-inducible cytokine IP-10)	147310		?involved in monocytic leukemia with t(4;11)(q21;q23)		
4.300	8	30	02	4q21.1	CXCL13, SCYB13, BCA1, BLC		Chemokine, C-X-C motif, ligand 13	605149				
4.301	1	23	09	4q22.1	DMP1, ARHR, ARHP		Dentin matrix acidic phosphoprotein	600980			Hypophosphatemic rickets, AR, 241520 (3)	
4.302	8	4	09	4q13.3	ENAM, AIH2, AI1C		Enamelin	606585			Amelogenesis imperfecta, type IB, 104500 (3); Amelogenesis imperfecta, type IC, 204650 (3)	
4.303	12	23	19	4q13.3	EPGN, EPG		Epithelial mitogen	618717				
4.304	8	3	14	4q21.21	FGF5, TCMGLY		Fibroblast growth factor-5	165190			Trichomegaly, 190330 (3)	5(Fgf5)
4.305	9	13	17	4q21.21	FRAS1, FRASRS1		FRAS1 gene	607830			Fraser syndrome 1, 219000 (3)	5(bl, Fras1)
4.306	7	16	09	4q22.1	HSD17B11, RETSDR2, PAN1B		17-beta-hydroxysteroid dehydrogenase XI	612831				
4.307	3	30	00	4q13.3	IGJ		Immunoglobulin J polypeptide, linker protein for	147790				5(Igj)
4.308	11	11	14	4q21.22	PLAC8		Placenta-specific gene 8	607515				5(Plac8)
4.309	11	2	99	4q13.3	SLC4A4, NBC1, KNBC		Solute carrier family 4, sodium bicarbonate cotransporter, member 4	603345			Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	
4.310	1	18	11	4q22.1	SNCA, NACP, PARK1, PARK4		Synuclein, alpha (non A4 component of amyloid precursor)	163890			Parkinson disease 4, 605543 (3); Dementia, Lewy body, 127750 (3); Parkinson disease 1, 168601 (3)	
4.311	2	18	08	4q13.3	UTP3, CRL1, CRLZ1		UTP3, S. crevisiae, homolog of	611614				5(Utp3)
4.312	6	12	17	4q21.23	WDFY3, ALFY, BCHS, MCPH18		WD repeat- and FYVE domain-containing protein 3	617485		mutation identified in 1 MCPH18 family	?Microcephaly 18, primary, autosomal dominant, 617520 (3)	
4.313	09	19	19	4q21.23	COQ2, COQ10D1, MSA1		Coenzyme Q2, polyprenyltransferase	609825			Coenzyme Q10 deficiency, primary, 1, 607426 (3); {Multiple system atrophy, susceptibility to}, 146500 (3)	
4.314	9	22	09	4q22.3	HPGDS, PGDS		Prostaglandin D2 synthase, hematopoietic	602598				3(Pgds)
4.315	8	29	08	4q22.1	NAP1L5, DRLM		Nucleosome assembly protein 1-like 5	612203				
4.316	6	12	17	4q21-q23	PFM3		Parietal foramina 3	609566		maximum lod between D4S2986 and D4S421	Parietal foramina 3 (2)	
4.317	11	3	09	4q22.1	PKD2		Polycystin-2	173910			Polycystic kidney disease 2, 613095 (3)	5(Pkd2)
4.318	09	11	19	4q22.3	UNC5C, UNC5H3		unc-5 netrin receptor C	603610				3(Unc5c)
4.319	9	9	90	4q23	ADH5, FDH		Alcohol dehydrogenase (class III), chi polypeptide	103710				
4.320	3	14	13	4q23	EIF4E, EIF4EL1, AUTS19		Eukaryotic translation initiation factor 4E	133440		pseudogene on 20	{Autism, susceptibility to, 19}, 615091 (3)	
4.321	9	12	93	4q21-q25	FECB		Fecundity gene, Boorla, of sheep, homolog of	134720		sheep chr.6		
4.322	2	18	96	4q22.1	IBSP		Integrin-binding sialoprotein (bone sialoprotein II)	147563				5(Ibsp)
4.323	2	4	00	4q23	RAP1GDS1		RAP1, GTP-GDP dissociation stimulator 1	179502		fusion partner with NUP98 in ALL	Lymphocytic leukemia, acute T-cell (3)	
4.324	1	27	97	4q22.1	SPP1, OPN		Secreted phosphoprotein-1 (osteopontin, bone sialoprotein)	166490				5(Spp1)
4.325	8	25	04	4q21-q31	OFC4		Orofacial cleft 4	608371			Orofacial cleft 4 (2)	
4.326	7	27	12	4q21.1	ART3		ADP-ribosyltransferase 3	603086				
4.327	02	18	20	4q21.1	CCNI		Cyclin I	618783				
4.328	02	06	20	16q21	DRC7, CCDC135, CFAP50, C16orf50		Dynein regulatory complex subunit 7	618769				
4.329	10	5	17	4q21.1	ODAPH, C4orf26		Odontogenesis-associated phosphoprotein	614829			Amelogenesis imperfecta, type IIA4, 614832 (3)	
4.330	7	20	12	4q21.1	CCNG2		Cyclin G2	603203				
4.331	5	25	13	4q21.1	CDKL2, KKIAMRE, P56		Cyclin-dependent kinase-like 2	603442				
4.332	7	25	18	4q21.1	CNOT6L, CCR4B		CCR4-NOT transcription complex, subunit 6-like	618069				
4.333	5	24	13	4q13.3	COX18		Cytochrome c oxidase assembly protein COX18	610428				
4.334	8	3	97	4q13.3	CSN1		Casein, alpha	115450				
4.335	8	3	97	4q13.3	CSN2		Casein, beta	115460				5(Csn2)
4.336	5	7	01	4q22.1	MEPE		Matrix, extracellular, phosphoglycoprotein	605912				
4.337	2	26	08	4q21.1	MRPL1		Mitochondrial ribosomal protein L1	611821				
4.338	12	26	13	4q21.1	NAAA, ASAHL		N-acylethanolamine acid amidase	607469				
4.339	8	30	09	4q21.1	NUP54		Nucleoporin, 54kD	607607				
4.340	10	15	13	4q21.21	PCAT4, GDEP		Prostate cancer-associated transcript 4	609717				
4.341	8	30	09	4q21.1	PPEF2		Protein phosphatase, EF hand calcium-binding domain-2	602256				
4.342	11	11	14	4q21.1	RCHY1, ZNF363, PIRH2, ARNIP		Ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase	607680				
4.343	11	09	20	4q21.22	SCD4, ACOD4, DFNA79		Stearoyl-CoA desaturase 4	608370		mutation identified in 1 DFNA79 family	?Deafness, autosomal dominant 79, 619086 (3)	
4.344	7	20	09	4q21.1	SEPT11		Septin 11	612887				
4.345	4	18	07	4q21.1	SHROOM3, SHRM, KIAA1481		Shroom family member 3	604570				
4.346	1	20	09	4q21.1	THAP6		THAP domain-containing protein 6	612535				
4.347	7	20	12	4q21.1	USO1, TAP, p115		USO1 vesicle docking protein, S. cerevisiae, homolog of	603344				
4.348	12	1	98	4q21.22	HNRPD, AUF1, AUF1A		Heterogeneous nuclear ribonucleoprotein D	601324				3(Hnrpd)
4.349	8	30	02	4q21.1	CXCL11, SCYB11, IP9, SCYB9B		Chemokine, C-X-C motif, ligand 11	604852				5(Scyb11)
4.350	2	10	14	4q21.23	FAM175A, CCDC98, ABRAXAS, ABRA1		Family with sequence similarity 175, member A	611143				
4.351	9	28	12	4q13.2	GNRHR, LHRHR, HH7		Gonadotropin-releasing hormone receptor	138850		placed at 4q12 or 4q13 by some	Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3)	5(Gnrhr)
4.352	4	19	01	4q32.3	KLHL2, MAYVEN		Kelch-like 2	605774				8(Klhl2)
4.353	9	1	16	4q21.23	NKX6-1, NKX6A		NK6, Drosophila, homolog of, 1	602563				
4.354	8	31	17	4q21.21	BMP2K, BIKE		BMP2-inducible kinase	617648				
4.355	4	19	12	4q21.21	PAQR3, RKTG		Progestin and ADIPOQ receptor family, member 3	614577				
4.356	11	17	15	4q21.21	PRDM8, EPM10		PR domain-containing protein 8	616639		mutation identified in 1 EPM10 family	?Epilepsy, progressive myoclonic, 10, 616640 (3)	
4.357	09	27	18	4q21.22	HNRNPDL, HNRPDL, JKTBP, LGMDD3		Heterogeneous nuclear ribonucleoprotein D-like protein	607137			Muscular dystrophy, limb-girdle, autosomal dominant 3, 609115 (3)	
4.358	9	22	14	4q21.22	COPS4, CSN4		COP9 signalosome, subunit 4	616008				
4.359	4	20	10	4q21.22	LIN54		Lin54, C. elegans, homolog of	613367				
4.360	11	07	19	4q21.22	SEC31A, SEC31L1, KIAA0905, NEDSOSB		SEC31 homolog A, COPII coat complex component	610257		mutation identified in 1 NEDSOSB family	?Neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies, 618651 (3)	
4.361	1	20	09	4q21.22	THAP9		THAP domain-containing protein 9	612537				
4.362	1	9	17	4q21.22	TMEM150C, TTN3		Transmembrane protein 150C	617292				
4.363	9	21	11	4q21.23	AGPAT9, GPAT3, MAG1		1-acylglycerol-3-phosphate O-acyltransferase 9	610958				
4.364	3	30	12	4q21.23	HELQ, HEL308		Helicase, POLQ-like	606769				5(Hel308)
4.365	4	24	08	4q21.23	MRPS18C, MRPS18-1		Mitochondrial ribosomal protein S18C	611983		6 pseudogenes		
4.366	4	27	00	4q21.23	HPSE, HSE1, HPA		Heparanase	604724				
4.367	1	22	97	4q21.3	PTPN13		Protein tyrosine phosphatase, nonreceptor-type, 13 (APO-1/CD95 (Fas)-associated phosphatase)	600267		633bp upstream of JNK3		5(Ptpn13)
4.368	6	21	05	4q22.1	DSPP, DPP, DGI1, DFNA39, DTDP2		Dentin sialophosphoprotein	125485			Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3); Dentinogenesis imperfecta, Shields type III, 125500 (3); Dentin dysplasia, type II, 125420 (3)	
4.369	9	23	13	4q21.3	MAPK10, PRKM10, JNK3		Mitogen-activated protein kinase 10	602897				
4.370	4	20	10	4q21.3	SLC10A6, SOAT		Solute carrier family 10 (sodium/bile acid cotransporter family), member 6	613366				
4.371	3	29	12	4q22.1	ABCG2, BCRP, ABCP, UAQTL1, GOUT1		ATP-binding cassette, subfamily G, member 2	603756			[Junior blood group system], 614490 (3); [Uric acid concentration, serum, QTL1], 138900 (3)	6(Abcp)
4.372	8	26	02	4q23	ADH1A, ADH1		Alcohol dehydrogenase IA (class I), alpha polypeptide	103700				
4.373	6	5	18	4q23	ADH1B, ADH2		Alcohol dehydrogenase IB (class I), beta polypeptide	103720			{Alcohol dependence, protection against}, 103780 (3); {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}, 103780 (3)	
4.374	11	14	10	4q23	ADH1C, ADH3		Alcohol dehydrogenase IC (class I), gamma polypeptide	103730			{Alcohol dependence, protection against}, 103780 (3); {Parkinson disease, susceptibility to}, 168600 (3)	3(Adh3)
4.375	11	6	89	4q23	ADH4		Alcohol dehydrogenase (class II), pi polypeptide	103740				
4.376	8	28	97	4q22.2	ATOH1, ATH1		Atonal, Drosophila, homolog of, 1	601461				
4.377	8	9	01	4q22.3	ENH		Enigma-like LIM domain protein	605904				
4.378	1	30	15	4q22.1-q22.2	GRID2, SCAR18		Glutamate receptor, ionotropic, delta-2	602368			Spinocerebellar ataxia, autosomal recessive 18, 616204 (3)	6(Grid2)
4.379	10	27	08	4q22	MUSQTL1		Musical aptitude quantitative trait locus 1	612343		near D4S423 and D4S2460	[Musical aptitude QTL 1] (2)	
4.380	1	2	91	4q22.3	PDHA2		Pyruvate dehydrogenase, E1-alpha polypeptide, testis specific form	179061				19(Pdhal)
4.381	12	29	15	4q24	SLC39A8, BIGM103, CDG2N		Solute carrier family 39 (zinc transporter), member 8	608732			Congenital disorder of glycosylation, type IIn, 616721 (3)	
4.382	03	19	19	4q22.3	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS, HRZ		SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1	612761			Adermatoglyphia, 136000 (3); Basan syndrome, 129200 (3); Huriez syndrome, 181600 (3)	
4.383	7	26	15	4q24	BANK1, FLJ20706, BANK		B-cell scaffold protein with ankyrin repeats 1	610292				
4.384	12	18	07	4q24	CXXC4, IDAX		CXXC finger protein 4	611645				
4.385	03	06	19	4q23	MTTP		Microsomal triglyceride transfer protein, 88kD	157147			Abetalipoproteinemia, 200100 (3); {Metabolic syndrome, protection against}, 605552 (3)	3(Mtp)
4.386	10	8	07	4q24	CISD2, WFS2, ZCD2, ERIS		CDGSH iron sulfur domain protein 2	611507			Wolfram syndrome 2, 604928 (3)	
4.387	8	9	05	4q24	MANBA, MANB1		Mannosidase, beta A, lysosomal	609489		linked in mouse to Adl-3	Mannosidosis, beta, 248510 (3)	3(Bmn)
4.388	3	17	06	4q25	HADHSC, SCHAD, HHF4		L-3-hydroxyacyl-CoA dehydrogenase, short chain	601609			3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3); Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)	
4.389	3	23	06	4q22-q27	MYP11		Myopia 11	609994		max lod at D4S1564	Myopia 11 (2)	
4.390	8	20	15	4q22.1	ATOD8		Dermatitis, atopic, 8	613518			{Dermatitis, atopic, susceptibility to, 8} (2)	
4.391	06	29	20	4q22.1	CCSER1, FAM190A		Coiled-coil serine-rich protein 1	618934				
4.392	3	16	10	4q22.1	FAM13A, FAM13A1, KIAA0914		Family with sequence similarity 13, member A	613299		overlaps with FAM13AOS		
4.393	3	16	10	4q22.1	FAM13AOS, FAM13A1OS		FAM13A opposite strand	613300		overlaps with FAM13A		
4.394	11	11	14	2q24.3	FIGN		Fidgetin	605295				2(Fign)
4.395	5	26	13	4q22.1	GPRIN3, GRIN3		G protein-regulated inducer of neurite outgrowth 3	611241				
4.396	11	11	14	4q22.1	HERC3		HECT domain and RCC1-like domain 3	605200				
4.397	8	18	08	4q22.1	HSD17B13, SCDR9		17-beta-hydroxysteroid dehydrogenase XIII	612127				
4.398	4	23	08	4q22.1	KLHL8, KIAA1378		Kelch-like 8	611967				
4.399	9	26	17	4q22.1	MMRN1, ECM		Multimerin 1	601456				
4.400	1	12	16	4q22.1	PIGY, HPMRS6		Phosphatidylinositol glycan, class Y	610662			Hyperphosphatasia with mental retardation syndrome 6, 616809 (3)	
4.401	7	20	15	4q22.1	PPM1K, PP2CM, PTMP, MSUDMV		Protein phosphatase, PP2C domain-containing, 1K	611065		mutation identified in 1 MSUDMV family	?Maple syrup urine disease, mild variant, 615135 (3)	
4.402	9	10	09	4q22.1	TIGD2		TIGGER transposable element-derived gene 2	612973				
4.403	3	10	05	4q22.1	HERC5, CEB1		HECT domain and RCC1-like domain 5	608242				
4.404	5	25	17	4q23	DNAJB14		DNAJ/HSP40 homolog, subfamily B, member 14	617487				
4.405	7	18	12	4q23	LAMTOR3, MP1, MAPBP		Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 3	603296				
4.406	2	21	18	4q23	C4orf54, LOC285556, FOPV		Chromosome 4 open reading frame 54	617881				
4.407	4	6	15	4q23	METAP1, KIAA0094		Methionyl aminopeptidase 1	610151				
4.408	09	11	19	4q23	TRMT10A, RG9MTD2, MSSGM1		tRNA methyltransferase 10A	616013			Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3)	
4.409	12	21	09	4q23	TSPAN5, NET4		Tetraspanin 5	613136				
4.410	8	26	02	4q23	ADH6		Alcohol dehydrogenase 6 (aldehyde reductase)	103735				
4.411	12	19	96	4q23	ADH7		Alcohol dehydrogenase-7	600086				
4.412	3	8	16	4q22.3	BMPR1B, ALK6, AMDD, BDA2, BDA1D		Bone morphogenetic protein receptor, type IB	603248			Brachydactyly, type A2, 112600 (3); Acromesomelic dysplasia, Demirhan type, 609441 (3); Brachydactyly, type A1, D, 616849 (3)	
4.413	05	19	20	4q24	NFKB1, CVID12		Nuclear factor kappa-B, subunit 1 (p105, p50)	164011			Immunodeficiency, common variable, 12, 616576 (3)	
4.414	7	9	06	4q25	LEF1		Lymphoid enhancer-binding factor-1	153245			Sebaceous tumors, somatic (3)	3(Lef1)
4.415	2	16	11	4q24	AIMP1, SCYE1, EMAP2, EMAPII, HLD3		ARS-interacting multifunctional protein 1	603605			Leukodystrophy, hypomyelinating, 3, 260600 (3)	
4.416	8	18	14	4q24	GSTCD		Glutathione S-transferase C-terminal domain-containing protein	615912				
4.417	4	7	94	4q23	H2AZ		H2AZ histone	142763				
4.418	3	24	14	4q24	INTS12, INT12		Integrator complex subunit 12	611355				
4.419	4	4	02	4q24	MGR1, MA		Migraine with or without aura, susceptibility to, 1	157300			{Migraine with or without aura, susceptibility to, 1} (2)	
4.420	2	12	08	4q24	NHEDC2, NHA2		NA+/H+ exchanger domain-containing protein 2	611789				3(Nhedc1)
4.421	10	13	09	4q24	NHEDC1		Na+/H+ exchanger domain-containing protein 1	611527				
4.422	5	24	13	4q24	NPNT, POEM		Nephronectin	610306				
4.423	10	8	13	4q24	OCA5		Albinism, oculocutaneous, type V	615312		max lod at D4S961	Albinism, oculocutaneous, type V (2)	
4.424	6	11	02	4q25	PAPSS1, ATPSK1		3'-phosphoadenosine 5'-phosphosulfate synthase 1 (ATP sulfurylase/APS kinase-1)	603262				3(Atpsk1)
4.425	4	21	16	4q24	TBCK, IHPRF3		TBC1 domain-containing kinase	616899			Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3)	
4.426	10	26	11	4q24	TET2, KIAA1546, MDS		TET oncogene family, member 2	612839			Myelodysplastic syndrome, somatic, 614286 (3)	
4.427	8	1	16	4q24	UBE2D3, UBCH5C		Ubiquitin-conjugating enzyme E2D 3	602963				
4.428	11	3	14	4q24	CENPE, MCPH13		Centromere autoantigen E, 312kD	117143		mutation identified in 1 MCPH13 family	?Microcephaly 13, primary, autosomal recessive, 616051 (3)	
4.429	8	30	09	4q24	DDIT4L, REDD2		DNA damage-inducible transcript 4-like	607730				
4.430	01	02	19	4q24	PPP3CA, PPP2B, CALNA, CNA1, IECEE1, ACCIID		Protein phosphatase 3, catalytic subunit, alpha isoform (calcineurin A alpha)	114105			Epileptic encephalopathy, infantile or early childhood, 1, 617711 (3); Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development, 618265 (3)	
4.431	4	14	10	4q24-q28	HWE2		Epilepsy, hot water, 2	613340		between D4S1572 and D4S2277	Epilepsy, hot water, 2 (2)	
4.432	7	20	12	4q25	AGXT2L1		Alanine-glyoxylate aminotransferase 2-like 1	614682				
4.433	12	01	20	4q25	ALPK1, LAK, KIAA1527, ROSAH		Alpha-kinase 1	607347			ROSAH syndrome, 614979 (3)	
4.434	10	08	07	4q25	ATFB5		Atrial fibrillation, familial, 5	611494		association with rs2200733 and rs10033464	{Atrial fibrillation, familial, 5} (2)	
4.435	3	15	07	4q25	C4orf16, GBAR, 2C18		Gamma-1 adaptin brefeldin-A resistance protein	610851				
4.436	10	15	13	4q25	CFI, FI, AHUS3, ARMD13		Complement factor I	217030		40kb distal to EGF	Complement factor I deficiency, 610984 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3); {Macular degeneration, age-related, 13, susceptibility to}, 615439 (3)	
4.437	2	12	15	4q25	COL25A1, CLAC, CFEOM5		Collagen, type XXV, alpha-1 polypeptide	610004			Fibrosis of extraocular muscles, congenital, 5, 616219 (3)	
4.438	1	28	13	4q25	CYP2U1, SPG56		Cytochrome P450, family 2, subfamily U, polypeptide 1	610670			Spastic paraplegia 56, autosomal recessive, 615030 (3)	
4.439	03	02	20	4q25	DKK2		Dickkopf WNT signaling pathway inhibitor 2	605415				
4.440	1	9	08	4q25	EGF, URG, HOMG4		Epidermal growth factor (urogastrone)	131530		linked to ADH3; cen-ADH3-EGF-IL2-qter	Hypomagnesemia 4, renal, 611718 (3)	3(Egf)
4.441	11	5	97	4q25	ENPEP		Glutamyl aminopeptidase (aminopeptidase A)	138297				
4.442	8	20	08	4q25	ELOVL6, LCE, FACE		Elongation of very long chain fatty acids-like 6	611546				
4.443	4	27	09	4q25	NOLA1, GAR1		Nucleolar protein family A, member 1	606468				
4.444	10	30	19	4q25	LARP7, PIP7S, ALAZS		La ribonucleoprotein 7, transcriptional regulator	612026			Alazami syndrome, 615071 (3)	
4.445	7	23	09	4q25	LGV1		Longevity 1, QTL	152430		maximum lod at D4S1564	[Longevity 1] (2)	
4.446	1	31	13	4q25	LRIT3, FIGLER4, CSNB1F		Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 3	615004			Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3)	
4.447	11	19	13	4q25	MIR297		Micro RNA 297	615520				
4.448	4	27	12	4q25	MIR302A		Micro RNA 302A	614596				
4.449	4	27	12	4q25	MIR302B		Micro RNA 302B	614597				
4.450	4	27	12	4q25	MIR302C		Micro RNA 302C	614598				
4.451	4	27	12	4q25	MIR302D		Micro RNA 302D	614599				
4.452	4	27	12	4q25	MIR367		Micro RNA 367	614600				
4.453	6	21	12	4q25	NEUROG2, NGN2, ATOH4		Neurogenin 2	606624				
4.454	09	15	20	4q25	OSTC		Oligosaccharyltransferase complex, noncatalytic subunit	619023				
4.455	1	3	17	4q25	PANCR		PITX2 adjacent noncoding RNA	617286				
4.456	11	23	16	4q24	PPA2, SCFI, SCFAI		Pyrophosphatase, inorganic, 2	609988		mutation identified in 1 SCFAI family	Sudden cardiac failure, infantile, 617222 (3); ?Sudden cardiac failure, alcohol-induced, 617223 (3)	
4.457	3	20	16	4q25	RPL34		Ribosomal protein L34	616862				
4.458	3	13	15	4q25	SEC24B		SEC24-related gene family, member B	607184				
4.459	06	27	19	4q25	SGMS2, SMS2, CDL		Sphingomyelin synthase 2	611574			Calvarial doughnut lesions with bone fragility with or without spondylometaphyseal dysplasia, 126550 (3)	
4.460	9	28	12	4q24	TACR3, NK3R, HH11		Tachykinin receptor 3	162332			Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3)	
4.461	6	4	97	4q25	CASP6, MCH2		Caspase 6, apoptosis-related cysteine protease	601532				
4.462	10	1	17	4q25	TIFA, T2BP		TRAF-interacting protein with forkhead-associated domain	609028				
4.463	12	18	07	4q25	PLA2G12A, GXII, ROSSY		Phospholipase A2, Group XIIA	611652				
4.464	1	29	13	4q26	NDST4		N-deacetylase/N-sulfotransferase 4	615039				
4.465	1	27	17	4q25	PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4		Paired-like homeodomain transcription factor-2	601542			Axenfeld-Rieger syndrome, type 1, 180500 (3); Ring dermoid of cornea, 180550 (3); Anterior segment dysgenesis 4, 137600 (3)	
4.466	2	21	06	4q26	PRSS12, BSSP3, MRT1		Protease, serine, 12	606709			Mental retardation, autosomal recessive 1, 249500 (3)	
4.467	9	12	08	4q25-q26	ANK2, LQT4		Ankyrin-2, nonerythrocytic	106410			Long QT syndrome 4, 600919 (3); Cardiac arrhythmia, ankyrin-B-related, 600919 (3)	
4.468	8	27	01	4q23	DAPP1, BAM32		Dual adaptor of phosphotyrosine and 3-phosphoinositides 1	605768				
4.469	7	5	92	4q28.1	FGF2, FGFB		Fibroblast growth factor-2 (basic)	134920		many alternate names		3(Fgf2)
4.470	4	2	16	4q13.2	UBA6, UBE1L2		Ubiquitin activating enzyme 6	611361				
4.471	2	28	03	4q21.1	GENEX3414		Genethonin 1	607406				
4.472	5	19	06	4q26	ARSJ		Arylsulfatase J	610010				
4.473	8	30	09	4q26	CAMK2D		Calcium/calmodulin-dependent protein kinase II-delta	607708				
4.474	8	7	15	4q26	METTL14, KIAA1627		Methyltransferase-like 14	616504				
4.475	01	04	19	4q26	NDST3		N-deacetylase/N-sulfotransferase 3	603950				
4.476	11	24	98	4q26	PDE5A		Phosphodiesterase 5A	603310				
4.477	5	22	03	4q28.2	PGRMC2		Progesterone receptor membrane component 2	607735				
4.478	4	7	15	4q26	SEC24D, KIAA0755, CLCRP2		SEC24-related gene family, member D	607186			Cole-Carpenter syndrome 2, 616294 (3)	
4.479	6	12	17	4q26	TRAM1L1		Translocation-associated membrane protein 1-like 1	617505				
4.480	1	22	13	4q26	UGT8, CGT		UDP glycosyltransferase 8 (cerebroside synthase)	601291				
4.481	4	20	17	4q26	USP53, KIAA1350		Ubiquitin-specific peptidase 53	617431				
4.482	3	29	18	4q27	IL2		Interleukin-2	147680				3(Il2)
4.483	5	22	14	4q27	IL21, CVID11		Interleukin 21	605384		mutation identified in 1 CVID11 patient	?Immunodeficiency, common variable, 11, 615767 (3)	3(Il21)
4.484	3	28	11	4q26	MYOZ2, CMH16		Myozenin 2	605602			Cardiomyopathy, hypertrophic, 16, 613838 (3)	
4.485	5	4	12	4q27	ANXA5, ENX2, RPRGL3		Annexin A5 (endonexin II)	131230			{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)	3(Anx5)
4.486	7	27	11	4q27	ADAD1, TENR		Adenosine deaminase domain-containing protein 1, testis-specific	614130				
4.487	10	16	14	4q27	BBS7		BBS7 gene	607590			Bardet-Biedl syndrome 7, 615984 (3)	
4.488	1	7	06	4q27	BBS12, FLJ35630, C4orf24		BBS12 gene	610683		1Mb centromeric to BBS	Bardet-Biedl syndrome 12, 615989 (3)	
4.489	8	24	92	4q27	CCNA, CCN1		Cyclin A	123835				3(Cyca)
4.490	2	23	08	4q27	CELIAC6, AIS5		Celiac disease, susceptibility to, 6	611598			{Celiac disease, susceptibility to, 6} (2); {Autoimmune disease, susceptibility to, 5} (2)	
4.491	7	25	18	4q27	EXOSC9, PMSCL1, PCH1D		Exosome component 9	606180			Pontocerebellar hypoplasia, type 1D, 618065 (3)	
4.492	2	18	09	4q27	IDDM23		Diabetes mellitus, insulin-dependent, 23	612622		associated with rs6534347	{Diabetes mellitus, insulin-dependent, 23} (2)	
4.493	1	11	18	4q27	KIAA1109, ALKKUCS		KIAA1109 gene	611565			Alkuraya-Kucinskas syndrome, 617822 (3)	
4.494	6	19	98	4q27	MAD2L1		Mitotic arrest deficient, yeast, homolog-like 1	601467		previously mapped to 5q23-q31		
4.495	04	07	20	4q27	NDNF, C4orf31, NORD, HH25		Neuron-derived neurotrophic factor	616506			Hypogonadotropic hypogonadism 25 with anosmia, 618841 (3)	
4.496	8	25	11	4q27	PRDM5, BCS2		PR domain-containing protein 5	614161			Brittle cornea syndrome 2, 614170 (3)	
4.497	7	2	18	4q27	QRFPR, GPR103		Pyroglutamylated RFamide peptide receptor	606925				
4.498	6	17	15	4q27	TRPC3, TRP3, SCA41		Transient receptor potential cation channel, subfamily C, member 3	602345		mutation identified in one SCA41 patient	?Spinocerebellar ataxia 41, 616410 (3)	
4.499	1	12	15	4q28.1	PLK4, STK18, SAK, MCCRP2		Polo-like kinase 4 (serine/threonine protein kinase-18)	605031			Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3)	13(Sak)
4.500	10	4	16	4q27-q28.2	MRT29		Mental retardation, autosomal recessive 29	614333		between rs10518325 and rs10518608	Mental retardation, autosomal recessive 29 (2)	
4.501	9	19	14	4q31.3	FGA		Fibrinogen, alpha polypeptide	134820			Dysfibrinogenemia, congenital, 616004 (3); Hypodysfibrinogenemia, congenital, 616004 (3); Amyloidosis, familial visceral, 105200 (3); Afibrinogenemia, congenital, 202400 (3)	
4.502	9	19	14	4q31.3	FGB		Fibrinogen, beta polypeptide	134830		4q31 by A; proximal to GYPB/GYPA	Dysfibrinogenemia, congenital, 616004 (3); Afibrinogenemia, congenital, 202400 (3); Hypofibrinogenemia, congenital, 202400 (3)	
4.503	9	30	14	4q32.1	FGG		Fibrinogen, gamma polypeptide	134850		linked to MN	Dysfibrinogenemia, congenital, 616004 (3); Hypofibrinogenemia, congenital, 202400 (3); Afibrinogenemia, congenital, 202400 (3); Hypodysfibrinogenemia, 616004 (3)	3(Fgg)
4.504	11	02	20	4q28.1	HSPA4L, APG1		Heat-shock protein family A (HSP70) member 4-like protein	619077				
4.505	09	11	19	4q28.1	INTU, KIAA1284, PDZK6, SRTD20, OFD17		Inturned planar cell polarity protein	610621		mutation identified in 1 SRTD20 patient and 1 OFD17 patient	?Short-rib thoracic dysplasia 20 with polydactyly, 617925 (3); ?Orofaciodigital syndrome XVII, 617926 (3)	
4.506	01	14	20	4q31.21	SMAD1, MADH1, MADR1, BSP1		SMAD family member 1	601595				
4.507	12	21	87	4q26	FABP2		Fatty acid-binding protein, intestinal	134640				3(Fabpi)
4.508	3	30	18	4q31.21	GYPB, SS		Glycophorin B	617923			[Blood group, Ss], 111740 (3); {Malaria, resistance to}, 611162 (3)	
4.509	4	30	91	4q31.21	GYPE, GPE		Glycophorin E	138590		tandem: 5'-GYPA-GYPB-GYPE-3'; ?4q31.1		
4.510	3	2	98	4q31.1	MGST2, GST2		Microsomal glutathione S-transferase 2	601733				
4.511	10	23	87	4q28-q31	SF		Stoltzfus blood group	111800		~25cM from MNSs	[Blood group, Stoltzfus system] (2)	
4.512	2	17	09	4q31.21	HHIP, HIP		Hedgehog-interacting protein	606178				8(Hip)
4.513	09	19	19	4q28.1	FAT4, VMLDS2, HKLLS2		FAT atypical cadherin 4	612411			Van Maldergem syndrome 2, 615546 (3); Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3)	
4.514	7	2	18	4q28.1	NUDT6, ASFGF2		Nudix hydrolase 6	606261				
4.515	3	8	07	4q28.1	SLC25A31, ANT4, AAC4		Solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 31	610796				
4.516	9	30	15	4q28.1	SPATA5, SPAF, EHLMRS		Spermatogenesis-associated protein 5	613940			Epilepsy, hearing loss, and mental retardation syndrome, 616577 (3)	
4.517	09	19	19	4q28.1	SPRY1		Sprouty RTK signaling antagonist 1	602465				
4.518	1	8	15	4q28.2	MFSD8, MGC33302, CLN7, CCMD		Major facilitator superfamily domain-containing protein 8	611124			Ceroid lipofuscinosis, neuronal, 7, 610951 (3); Macular dystrophy with central cone involvement, 616170 (3)	
4.519	5	26	13	4q28.2	PHF17, JADE1		PHD finger protein 17	610514				
4.520	5	26	13	4q28.2	SCLT1, CAP1A		Sodium channel and clathrin linker 1	611399				
4.521	3	30	18	4q31.21	GYPA, MN, GPA		Glycophorin A	617922			[Blood group, MNSs system], 111300 (3); {Malaria, resistance to}, 611162 (3)	
4.522	6	4	99	4q31.1	NDUFC1		NADH-ubiquinone oxidoreductase subunit C1	603844				
4.523	11	2	04	4q31.1	MAML3, MAM2, KIAA1816		Mastermind-like 3	608991				
4.524	12	5	03	4q28.3	PCDH10, KIAA1400		Protocadherin 10	608286				
4.525	2	25	15	4q28.3	SLC7A11, XCT		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 11	607933				
4.526	10	5	10	4q31	AAA2		Aortic aneurysm, familial abdominal 2	609782		max lod at D4S1644	Aortic aneurysm, familial abdominal 2 (2)	
4.527	11	1	99	4q31.21	ABCE1, RNASELI, RNS4I		ATP-binding cassette, subfamily E, member 1 (ribonuclease L inhibitor)	601213				
4.528	8	28	02	4q34.1	HMGB2, HMG2		High-mobility group box 2 (high-mobility group (nonhistone chromosomal) protein 2)	163906				
4.529	6	13	95	4q31.21	IL15		Interleukin-15	600554				
4.530	4	8	10	4q32.1	LRAT, LCA14		Lecithin retinol acyltransferase	604863			Retinal dystrophy, early-onset severe, 613341 (3); Leber congenital amaurosis 14, 613341 (3); Retinitis pigmentosa, juvenile, 613341 (3)	
4.531	2	20	97	4q32.1	NPY2R		Neuropeptide Y receptor Y2	162642				3(Npy2r)
4.532	12	5	03	4q28.3	PCDH18, KIAA1562		Protocadherin 18	608287				
4.533	5	5	09	4q31	STQTL12		Stature quantitative trait locus 12	612224		associated with rs6854783	{Stature QTL 12} (2)	
4.534	04	30	19	4q31.1	UCP1		Uncoupling protein 1 (mitochondrial, proton carrier)	113730				8(Ucp)
4.535	2	18	98	4q32.2	NPY5R		Neuropeptide Y receptor Y5	602001				8(Npy5r)
4.536	10	11	17	4q32.1	TDO2, TPH2, TRPO, HYPTRP		Tryptophan oxygenase	191070		mutation identified in 1 HYPTRP patient	[?Hypertryptophanemia], 600627 (3)	
4.537	3	22	06	4q31-q34	PAND3		Panic disorder 3	609985		max lod at D4S413	Panic disorder 3 (2)	
4.538	7	21	03	4q31-q34	PSORS9		Psoriasis susceptibility 9	607857		max lod at D4S1597	{Psoriasis susceptibility 9} (2)	
4.539	9	9	08	4q31.1	CCRN4L, CCR4L, CCR4		Carbon catabolite repression 4-like	608468				3(Ccrn4l)
4.540	8	25	16	4q31.1	CLGN		Calmegin	601858				
4.541	3	11	09	4q31.1	ELMOD2		ELMO domain-containing protein 2	610196				
4.542	1	29	01	4q34.1	GALNT7		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7	605005				
4.543	3	10	09	4q31.1	LOC152586		LOC152586 gene	610310				
4.544	12	5	17	4q31.1	NAA15, NARG1, NATH, MRD50		N-alpha-acetyltransferase 15, NatA auxiliary subunit	608000			Mental retardation, autosomal dominant 50, 617787 (3)	
4.545	7	7	00	4q31.23	NR3C2, MLR, MCR		Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor; aldosterone receptor)	600983			Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3); Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	
4.546	5	3	13	4q31.1	RAB33B, SMC2		Ras-associated protein RAB33B	605950			Smith-McCort dysplasia 2, 615222 (3)	
4.547	6	30	15	4q31.1	SETD7, SET7, KIAA1717		SET domain-containing protein 7	606594				
4.548	3	11	03	4q31.21	MMAA		MMAA gene	607481			Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)	
4.549	1	12	99	4q31.21	SMARCA5, SNF2H		SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 5	603375				
4.550	9	1	05	4q31.21	ZNF330, NOA36		Zinc finger protein 330	609550				
4.551	1	6	09	4q31.23	ARHGAP10, GRAF2, PSGAP		RHO GTPase-activating protein 10	609746				
4.552	2	28	94	4q31.22	BRN3B		Brn3b POU domain transcription factor	113725				
4.553	5	19	15	4q31.22-q31.23	EDNRA, MFDA		Endothelin receptor type A	131243			{Migraine, resistance to}, 157300 (3); Mandibulofacial dysostosis with alopecia, 616367 (3)	
4.554	10	1	09	4q31.21	FREM3		FRAS1-related extracellular matrix protein 3	608946				
4.555	8	30	09	4q31.22	LSM6		LSM6 protein	607286				
4.556	1	22	08	4q31.21	OTUD4, KIAA1046, HIN1		OTD domain-containing protein 4	611744				
4.557	03	19	19	4q31.22	SLC10A7, SSASKS		Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	611459			Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis, 618363 (3)	
4.558	6	15	99	4q31.3	RPS3A		Ribosomal protein S3a	180478				
4.559	8	24	09	4q31.3	PLRG1, PRL1		Pleiotropic regulator 1	605961				
4.560	2	17	11	4q31.21	ANAPC10, DOC1, APC10		Anaphase-promoting complex, subunit 10	613745				8(Anapc10)
4.561	6	28	18	4q31.21	TBC1D9, KIAA0882		TBC1 domain family member 9	618035				
4.562	4	26	11	4q31.23	TMEM184C, TMEM34		Transmembrane protein 184C	613937				
4.563	02	12	19	4q31.21	USP38		Ubiquitin-specific protease 38	618322				
4.564	5	9	18	4q31.21-q31.22	ZNF827		Zinc finger protein 827	617962				
4.565	01	24	20	4q31.22	TTC29, SPGF42		Tetratricopeptide repeat domain-containing protein 29	618735			Spermatogenic failure 42, 618745 (3)	
4.566	12	21	09	4q31.2-q31.3	DCLK2, DCK2, CLIK2, CL2		Doublecortin-like kinase 2	613166				3(Dclk2)
4.567	12	9	14	4q31.23	PRMT9, PRMT10		Protein arginine methyltransferase 9	616125				
4.568	10	13	09	4q31.3	DCHS2, CDHJ, PCDHJ		Dachsous, Drosophila, homolog of, 2	612486				3(Dchs2)
4.569	9	9	08	4q31.3	FBXW7, AGO, CDC4		F-box and WD40 domain protein 7	606278				
4.570	04	13	20	4q31.3	GATB, PET112, COXPD41		Glutamyl-tRNA amidotransferase, subunit B	603645		mutation identified in 1 COXPD41 family	?Combined oxidative phosphorylation deficiency 41, 618838 (3)	
4.571	6	13	18	4q32.1	GLRB, HKPX2		Glycine receptor, beta subunit	138492			Hyperekplexia 2, 614619 (3)	3(Glrb)
4.572	1	4	16	4q31.3	KIAA0922, TMEM131L		KIAA0922 gene	616243				
4.573	7	6	12	4q31.3	LRBA, LBA, CDC4L, CVID8		Lipopolysaccharide-responsive, beige-like anchor protein	606453			Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3)	
4.574	09	09	19	4q31.3	MAB21L2, MCSKS14		mab-21 like 2	604357			Microphthalmia/coloboma and skeletal dysplasia syndrome, 615877 (3)	
4.575	8	27	15	4q31.3	MND1		Meiotic nuclear division 1, S. cerevisiae, homolog of	611422				
4.576	2	11	98	4q32.1	PPID		Peptidylprolyl isomerase D (cyclophilin D)	601753				
4.577	10	19	99	4q31.3	SFRP2, SARP1		Secreted frizzled-related protein 2	604157				3(Sfrp2)
4.578	12	13	06	4q31.3	SH3D19, EBP		SH3 domain protein 19	608674		fused with AML1 in t(4;21)		
4.579	11	11	14	4q31.3	SNORD73A, RNU73		Small nucleolar RNA, C/D box 73A	603568				
4.580	7	7	15	4q31.3	TRIM2, KIAA0517, CMT2R		Tripartite motif-containing protein 2	614141			Charcot-Marie-Tooth disease, type 2R, 615490 (3)	
4.581	12	17	15	4q32.1	ASIC5, HINAC		Acid-sensing ion channel family member 5	616693				3(Asic5)
4.582	6	10	94	4q32.2	NPY1R		Neuropeptide Y receptor	162641				8(Npy1r)
4.583	12	18	07	4q31.3-q32.3	HSCR9		Hirschsprung disease, susceptibility to, 9	611644		between D4S3049 and D4S1566	{Hirschsprung disease, susceptibility to, 9} (2)	
4.584	4	22	09	4q32.1	ASAP		Aster-associated protein	610070				
4.585	4	29	14	4q32.1	GUCY1A3, GUC1A3, GUCSA3, MYMY6		Guanylate cyclase 1, soluble, alpha 3	139396			Moyamoya 6 with achalasia, 615750 (3)	
4.586	8	18	98	4q32.1	GUCY1B3, GUC1B3, GUCSB3		Guanylate cyclase 1, soluble, beta 3	139397				
4.587	2	16	04	4q32.1	PDGFC		Platelet-derived growth factor C	608452				
4.588	8	18	15	4q32.1	RXFP1, LGR7		Relaxin/insulin-like family peptide receptor 1	606654				
4.589	4	5	13	4q31.3	TLR2, TIL4		Toll-like receptor-2	603028			{Leprosy, susceptibility to}, 246300 (3); {Colorectal cancer, susceptibility to}, 114500 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
4.590	2	21	10	4q34.3	AGA		Aspartylglucosaminidase	613228			Aspartylglucosaminuria, 208400 (3)	8(Aga)
4.591	11	30	06	4p15.32	CPEB2		Cytoplasmic polyadenylation element-binding protein 2	610605				5(Cpeb2)
4.592	06	25	20	4q32.1	GRIA2, GLUR2, NEDLIB		Glutamate receptor, ionotropic, AMPA 2	138247			Neurodevelopmental disorder with language impairment and behavioral abnormalities, 618917 (3)	3(Glur2)
4.593	10	15	09	4q32.3	TLL1, TLL, ASD6		Tolloid-like 1	606742			Atrial septal defect 6, 613087 (3)	8(Tll1)
4.594	7	31	08	4q32-q34	RP29		Retinitis pigmentosa 29	612165		maximum lod at D4S415	Retinitis pigmentosa 29 (2)	
4.595	2	25	16	4q32.3	MSMO1, SC4MOL, ERG25, MCCPD		Methylsterol monooxygenase 1	607545			Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3)	
4.596	8	25	03	4q32.1	ETFDH, MADD		Electron transfer flavoprotein:ubiquinone oxidoreductase	231675			Glutaric acidemia IIC, 231680 (3)	3(Etfdh)
4.597	2	5	15	4q32.1	C4orf46, RCDG1		Chromosome 4 open reading frame 46	616210				
4.598	10	2	12	4q32.1	CTSO		Cathepsin O	600550				
4.599	5	19	09	4q32.1	FNIP2, FNIPL, KIAA1450		Folliculin-interacting protein 2	612768				
4.600	8	1	18	4q32.1	RAPGEF2, NRAPGEP, RAGEF, KIAA0313		Rap guanine nucleotide exchange factor 2	609530		mutation identified in 1 FAME7 patient	?Epilepsy, familial adult myoclonic, 7, 618075 (3)	
4.601	1	27	11	4q32.1-q32.2	TRIP4q32.1q32.2, C4TRIPq32.1q32.2		Chromosome 4q32.1-q32.2 triplication syndrome	613603			Chromosome 4q32.1-q32.2 triplication syndrome (4)	
4.602	1	28	08	4q33	AADAT, KAT2		Alpha-aminoadipate aminotransferase	611754				8(Aadat)
4.603	2	16	18	4q32.2	NAF1		Nuclear assembly factor 1 ribonucleoprotein	617868				8(Naf1)
4.604	6	7	10	4q32.2-q32.3	MARCH1		Membrane-associated RING-CH finger protein 1	613331				
4.605	8	30	09	4q32.3	ANP32C, PP32R1		Acidic leucine-rich nuclear phosphoprotein 32 family, member C	606877				
4.606	8	25	17	4q32.3	ELA, LOC100506013		Elabela	615594				
4.607	8	30	07	4q32.3	CINN		Cinnamon odor, pleasantness of	611109		max lod at AFM295YES	[Cinnamon odor, pleasantness of] (2)	
4.608	8	30	09	4q32.3	CPE		Carboxypeptidase E	114855				8(Cpe)
4.609	07	14	20	4q32.3	DDX60		DExD/H-box helicase 60	613974				
4.610	07	14	20	4q32.3	DDX60L		DExD/H-box 60 like	616725				
4.611	12	17	07	4q32.3	HDLCQ4		High density lipoprotein cholesterol level QTL 4	610239		between D4S1597 and D4S1539	[High density lipoprotein cholesterol level QTL 4] (2)	
4.612	8	26	15	4q33	MFAP3L, KIAA0626		Microfibrillar-associated protein 3-like	616523				
4.613	09	18	19	4q32.3	PALLD, KIAA0992, PNCA1		Palladin, cytoskeletal-associated protein	608092			{Pancreatic cancer, susceptibility to, 1}, 606856 (3)	
4.614	10	25	19	4q32-q33	SH3RF1, POSH, RNF142		SH3 domain-containing RING finger protein 1	618642				
4.615	1	11	07	4q32.3	SPOCK3		SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 3	607989				
4.616	1	12	07	4q32.3	ANXA10		Annexin A10	608008				8(Anxa10)
4.617	4	8	98	4q33	CLCN3		Chloride channel-3	600580				8(Clcn3)
4.618	11	10	05	4q34.1	HAND2, DHAND2, DHAND		Heart- and neural crest derivative-expressed 2	602407				
4.619	5	19	16	4q33	HPF1, C4orf27		Histone parylation factor 1	616614				
4.620	3	5	18	4q33	NEK1, SRTD6, SRPS2A, ALS24		Never in mitosis gene A-related kinase 1	604588		1 patient showed heterozygous NEK2 and DYNC2H1 mutations	Short-rib thoracic dysplasia 6 with or without polydactyly, 263520 (3); {Amyotrophic lateral sclerosis, susceptibility to, 24}, 617892 (3)	
4.621	10	20	98	4q34.1	GLRA3		Glycine receptor, alpha-3 polypeptide	600421				8(Glra3)
4.622	4	3	03	4q34.1	MORF4, SEN1, CSRB		Mortality factor 4 (senescence-related, cellular, 1)	116960				
4.623	10	7	02	4q33-qter	HCA1		Hypercalciuria, absorptive, 1	607258			Hypercalciuria, absorptive (2)	
4.624	09	26	19	4q34.1	ADAM29		ADAM metallopeptidase domain 29	604778				
4.625	9	28	96	4q34.2	GPM6A, M6A		Glycoprotein M6A	601275				
4.626	11	2	04	4q34.2	WDR17		WD repeat-containing protein 17	609005				
4.627	12	19	18	4q34.3	VEGFC, VRP, LMPHM4		Vascular endothelial growth factor C	601528			Lymphatic malformation 4, 615907 (3)	
4.628	4	20	10	4q34.3-q35.1	SCA30		Spinocerebellar ataxia 30	613371		between rs1397413 and rs2175476; max lod 3.0	?Spinocerebellar ataxia 30 (2)	
4.629	10	16	12	4q34.3-q35.2	HMSN5		Hereditary motor and sensory neuropathy V	600361		D4S1552 and D4S2930	Hereditary motor and sensory neuropathy V (2)	
4.630	9	18	08	4q35.1	ACSL1, FACL2, FACL1, LACS, ACS1		Acyl-CoA synthetase long-chain family member 1	152425				
4.631	09	19	19	4q35.2	FAT1, FAT		FAT atypical cadherin 1	600976				
4.632	07	28	20	4q34.1	HPGD, PGDH1, PHOAR1		Hydroxyprostaglandin dehydrogenase 15-(NAD)	601688		mutation identified in 1 DIGC family	Cranioosteoarthropathy, 259100 (3); Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3); ?Digital clubbing, isolated congenital, 119900 (3)	
4.633	9	9	08	4q34.1	FBXO8, FBX8, FBS		F-box only protein 8	605649				8(Fbxo8)
4.634	4	6	13	4q34.1	GALNTL6, GALNACT20		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6	615138				
4.635	12	6	16	4q34.1	HAND2AS1, UPH, DEIN		HAND2 antisense RNA 1, noncoding (Upperhand)	617240				
4.636	3	23	15	4q34.1	MIR4276		Micro RNA 4276	616274				
4.637	7	20	12	4q34.1	SAP30		SIN3-associated polypeptide, 30kD	603378				
4.638	8	16	12	4q34.1	SCRG1		Scraptie-responsive gene 1	603163				
4.639	3	22	06	4q34.2	SPATA4, TSARG2		Spermatogenesis-associated protein 4	609879				
4.640	1	31	13	4q34.2	ASB5		Ankyrin repeat- and SOCS box-containing protein 5	615050				
4.641	04	24	20	4q34.2	SPCS3, SPC3, SPC22, SPC23		Signal peptidase complex, subunit 3	618854				
4.642	5	7	01	4q35.1	ALP		Actinin-associated LIM protein	605889				
4.643	5	8	97	4q35.1	CASP3, CPP32		Caspase 3, apoptosis-related cysteine protease	600636				
4.644	10	25	12	4q35.2	DBET		D4A4 binding element transcript, noncoding	614865				
4.645	3	19	03	4q35.1	DCTD		Deoxycytidylate deaminase	607638				
4.646	3	22	01	4q35	DKBI		Dyskeratosis, hereditary benign intraepithelial	127600			Dyskeratosis, hereditary benign intraepithelial (2)	
4.647	6	18	01	4q35.2	DUX4		Double homeo box protein 4	606009				
4.648	12	27	13	4q35.2	DUX4L9, DUX4C		Double homeobox 4-like 9	615581				
4.649	12	22	08	4q35.2	F11		Coagulation factor XI (plasma thromboplastin antecedent)	264900		not closely linked to MNS	Factor XI deficiency, autosomal recessive, 612416 (3); Factor XI deficiency, autosomal dominant, 612416 (3)	8(cf11)
4.650	8	18	98	4q35.2	FRG1, FSG1		Facioscapulohumeral muscular dystrophy region gene-1	601278				
4.651	11	22	05	4q35.2	FRG2		Facioscapulohumeral muscular dystrophy region gene 2	609032				
4.652	7	19	04	4q35	FSHD1, FSHD1A		Facioscapulohumeral muscular dystrophy 1	158900		due to D4Z4 macrosatellite repeat on 4q35	Facioscapulohumeral muscular dystrophy 1 (4)	?8(myd)
4.653	7	30	15	4q35.2	KLKB1, KLK3, PKKD		Kallikrein B plasma 1 (Fletcher factor)	229000		similar to F11	Fletcher factor (prekallikrein) deficiency, 612423 (3)	8(Kal3)
4.654	09	11	20	4q35.1	ANKRD37		Ankyrin repeat domain-containing protein 37	619021				
4.655	11	22	16	4q35.1	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2		Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle)	103220			Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3); Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD, 617184 (3); Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR, 615418 (3)	8(Ant1)
4.656	2	24	17	4q35.1	STOX2, KIAA1392		Storkhead box 2	617359				
4.657	3	14	18	4q35.1	TLR3, IIAE2		Toll-like receptor-3	603029			{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}, 613002 (3); {HIV1 infection, resistance to}, 609423 (3)	
4.658	9	27	01	4q35-qter	DFNA24		Deafness, autosomal dominant 24	606282			Deafness, autosomal dominant 24 (2)	
4.659	9	23	13	4q35.1	CCDC111, MYP22		Coiled-coil domain containing 111	615421			Myopia 22, autosomal dominant, 615420 (3)	
4.660	8	18	14	4q35.1	CDKN2AIP, CARF		Cyclin-dependent kinase inhibitor 2A-interacting protein	615914				
4.661	10	12	14	4q35.1	CFAP97, HMW, KIAA1430		Cilia- and flagella-associated protein 97	616047				
4.662	5	31	05	4q35.1-q35.2	CYP4V2, BCD		Cytochrome P450, family 4, subfamily V, polypeptide 2	608614			Bietti crystalline corneoretinal dystrophy, 210370 (3)	
4.663	6	28	16	4q35.1	ENPP6		Ectonucleotide pyrophosphatase/phosphodiesterase 6	616983				
4.664	6	27	17	4q35.1	HELT, HESL, MGN		HELT basic helix-loop-helix transcription factor	617546				8(Helt)
4.665	3	2	06	4q35.1	ING2, ING1L		Inhibitor of growth 2	604215				
4.666	11	4	93	4q35.1	IRF2		Interferon regulatory factor-2	147576				
4.667	8	1	05	4q35.1	KMHN1		Cancer/testis antigen KM-HN-1	609488				
4.668	09	11	20	4q35.1	LRP2BP, MEGBP		LRP2-binding protein	619020				
4.669	10	8	07	4q35.1	MLF1IP, CENPU, CENP50		MLF1-interacting protein (centromere protein U)	611511				8(Mlf1ip)
4.670	10	22	95	4q35.2	MTNR1A		Melatonin receptor 1A	600665				8(Mtnr1a)
4.671	5	19	15	4q35.1	SORBS2, ARGBP2, KIAA0777		Sorbin and SH3 domains-containing protein 2	616349				
4.672	08	22	19	4q34.3-q35.1	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9, MCOPS15		Teneurin transmembrane protein 3	610083		mutation identified in 1 MCOPCB9 family	?Microphthalmia, isolated, with coloboma 9, 615145 (3); Microphthalmia, syndromic 15, 615145 (3)	
4.673	09	27	18	4q35.1	TRAPPC11, C4orf41, LGMDR18		Trafficking protein particle complex, subunit 11	614138			Muscular dystrophy, limb-girdle, autosomal recessive 18, 615356 (3)	
4.674	5	11	18	4q35.1	UFSP2, C4orf20, BHD, SEMDDR		UFM1-specific peptidase 2	611482		mutation identified in 1 BHD family	?Hip dysplasia, Beukes type, 142669 (3); ?Spondyloepimetaphyseal dysplasia, Di Rocco type, 617974 (3)	
4.675	10	2	12	4q35.2	DUX2		Double homeobox protein 2	611442		?10q26.3		
4.676	4	19	12	4q35.2	ZFP42, REX1		Zinc finger protein 42	614572				8(Zfp42)
4.677	12	21	09	4p16.1	MIR95, MIRN95		Micro RNA 95	613185				
4.678	10	23	87	Chr.4	TS13		Temperature sensitivity complementation, ts13	187320				
5.1	12	13	18	5p15.33	NDUFS6, MC1DN9		NADH-ubiquinone oxidoreductase subunit S6	603848			Mitochondrial complex I deficiency, nuclear type 9, 618232 (3)	
5.2	5	9	18	5p15.32	ICE1, KIAA0947		Interactor of little elongation complex ELL subunit 1	617958				
5.3	1	11	93	5p15.31	ADCY2		Adenylyl cyclase-2, brain	103071				13(Adcy2)
5.4	12	27	01	5p15.33	AHRR, KIAA1234		Arylhydrocarbon receptor repressor	606517				13(Ahrr)
5.5	8	17	01	5p15.33	IRX1		Iroquois homeo box protein 1	606197				
5.6	8	17	01	5p15.33	IRX2		Iroquois homeo box protein 2	606198				
5.7	7	3	06	5p15.33	IRX4		Iroquois homeobox protein 4	606199				13(Irx4)
5.8	3	5	08	5p15.33	MRPL36		Mitochondrial ribosomal protein L36	611842				
5.9	04	27	20	5p15.33	NKD2		NKD inhibitor of WNT signaling pathway 2	607852				
5.10	5	12	00	5p15.33	SLC12A7, KCC4		Solute carrier family 12 (potassium/chloride transporters), member 7	604879				
5.11	7	5	18	5p15.33	SLC6A3, DAT1, PKDYS1		Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3	126455			{Nicotine dependence, protection against}, 188890 (3); Parkinsonism-dystonia, infantile, 1, 613135 (3)	13(Dat1)
5.12	3	20	16	5p15.33	SLC9A3, NHE3, DIAR8		Solute carrier family 9 (sodium/hydrogen exchanger), member 3	182307		pseudogene on chr.10	Diarrhea 8, secretory sodium, congenital, 616868 (3)	13(Slc9a3)
5.13	7	22	09	5p15.33	TPPP, P25, P24		Tubulin polymerization-promoting protein	608773				
5.14	2	25	15	5p15.33	AYTL2, LPCAT, LPCAT1		Acyltransferase-like 2	610472				
5.15	10	6	09	5p15.33	BCC3		Basal cell carcinoma, susceptibility to, 3	613059			{Basal cell carcinoma, susceptibility to, 3} (2)	
5.16	06	11	19	5p15.33	BRD9		Bromodomain-containing protein 9	618465				
5.17	5	26	13	5p15.33	CEI		Coordinated expression to IRXA2	610522				
5.18	7	23	15	5p15.33	CEP72, KIAA1519		Centrosomal protein, 72kD	616475				
5.19	2	17	09	5p15.33	CLPTM1L, CRR9		CLPTM1-like protein	612585				
5.20	9	8	11	5p15.33	EXOC3, SEC6		Exocyst complex component 3	608186				
5.21	11	26	09	5p15.33	GLM8		Glioma susceptibility 8	613033		associated with rs2736100	{Glioma susceptibility 8} (2)	
5.22	2	18	09	5p15.33	LNCR3		Lung cancer susceptibility 3	612571		associated with rs402710 and rs2736100	{Lung cancer susceptibility 3} (2)	
5.23	5	22	14	5p15.33	LSINCT5		Long stress-induced noncoding transcript 5	615764				
5.24	11	11	14	5p15.33	PDCD6, ALG2		Programmed cell death 6	601057				
5.25	9	9	09	5p15.33	SLC6A18, XTRP2		Solute carrier family 6 (neurotransmitter transporter), member 18	610300				
5.26	4	20	10	5p15.33	SLC6A19, HND		Solute carrier family 6 (neurotransmitter transporter), member 19	608893			Hartnup disorder, 234500 (3); Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)	13(Slc6a19)
5.27	5	26	15	5p15.33	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9		Telomerase reverse transcriptase	187270		deleted in cri du chat	{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3); {Dyskeratosis congenita, autosomal recessive 4}, 613989 (3); {Dyskeratosis congenita, autosomal dominant 2}, 613989 (3); {Leukemia, acute myeloid}, 601626 (3); {Melanoma, cutaneous malignant, 9}, 615134 (3)	
5.28	09	08	20	5p15.33	TRIP13, 16E1BP, MVA3, OOMD9		Thyroid hormone receptor interactor 13	604507			Mosaic variegated aneuploidy syndrome 3, 617598 (3); Oocyte maturation defect 9, 619011 (3)	
5.29	1	27	09	5p15.33-p15.2	MYP16		Myopia 16	612554		max lod at D5S2505	Myopia 16 (2)	
5.30	8	29	08	5p15.33-p13.1	MCDR3		Macular dystrophy, retinal, 3	608850		maximum lod at D5S630	Macular dystrophy, retinal, 3 (2)	
5.31	6	17	17	5p15.31	FASTKD3		Fast kinase domains 3	617530				
5.32	6	1	15	5p15.31	LINC01018, SRHC		Long intergenic noncoding RNA 1018	616385				
5.33	10	30	08	5p15.31	MED10, NUT2		Mediator complex subunit 10	612382				
5.34	5	30	17	5p15.31	NSUN2, TRM4, SAKI, MISU, MRT5		NOP2/SUN RNA methyltransferase family, member 2	610916			Mental retardation, autosomal recessive 5, 611091 (3)	13(Nsun2)
5.35	6	22	14	2q11.2	SEMA4C, SEMAF, KIAA1739		Semaphorin 4C	604462				
5.36	7	18	14	5p15.31	UBE2QL1		Ubiquitin-conjugating enzyme E2Q family-like protein 1	615832				
5.37	7	31	06	5p15.31	MTRR		Methionine synthase reductase	602568			Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3); {Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	
5.38	09	04	19	5p15.2	ATPSCKMT, FAM173B		ATP synthase C subunit lysine N-methyltransferase	618568				
5.39	5	30	06	5p15.2	CCT5, KIAA0098, CCTE		chaperonin containing TCP1, subunit 5 (epsilon)	610150			Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)	
5.40	4	26	10	5p15.2	CMBL		Carboxymethylenebutenolidase-like protein	613379				15(Cmbl)
5.41	1	29	14	5p15.2	CTNND2, NPRAP		Catenin, delta-2	604275				
5.42	1	4	96	5p15.2	DAP		Death-associated protein	600954				
5.43	8	30	16	5p15.2	LINC01194, TAG		Long intergenic noncoding RNA 1194	617097				
5.44	11	15	19	5p15.2	MARCH6, TEB4, DOA10, KIAA0597, FAME3		Membrane-associated RING-CH finger protein 6	613297			Epilepsy, familial adult myoclonic, 3, 613608 (3)	
5.45	9	1	16	5p15.2	OTULIN, FAM105B, GUM, AIPDS		OTU deubiquitinase with linear linkage specificity	615712			Autoinflammation, panniculitis, and dermatosis syndrome, 617099 (3)	15(Otulin)
5.46	1	28	08	5p15.2	ROPN1L, ASP		ROPN1-like protein	611756				
5.47	10	14	09	5p15.31	SEMA5A, SEMF		Semaphorin 5a	609297				15(Sema5a)
5.48	7	1	02	5p14.3	CDH18, CDH14		Cadherin 18	603019				
5.49	2	17	09	5p15.2-p14	ADIPQTL2, CAQ5		Adiponectin, serum level of, QTL 2	606770		near D5S817	{Adiponectin, serum level of, QTL2} (2)	
5.50	09	19	19	5p15.2	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD		ANKH inorganic pyrophosphate transport regulator	605145			Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2, 118600 (3)	15(ank)
5.51	7	14	06	5p15.2-p14.3	ANIB4		Aneurysm, intracranial berry, 4	610213		max lod at D5S1954	Aneurysm, intracranial berry, 4 (2)	
5.52	10	8	07	5q12.3	CEMPK, SOLT		Centromeric protein K	611502				
5.53	11	13	09	5p15.1	FAM134B, HSAN2B		Family with sequence similarity 134, member B	613114			Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)	
5.54	8	31	09	5p15.1	FBXL7, FBL7		F-box and leucine-rich repeat protein 7	605656				15(Fbxl7)
5.55	6	7	10	5p15.1	MARCH11		Membrane-associated RING-CH finger protein 11	613338				
5.56	10	31	13	5p15.1	PVNH3		Periventricular nodular heterotopia 3	608098			Periventricular nodular heterotopia 3 (2)	
5.57	9	27	17	5p15.1	ZNF622, ZPR9		Zinc finger protein 622	608694				
5.58	5	7	01	5p15.1	BASP1, CAP23, NAP22		Brain-abundant signal protein, membrane-attached, 1	605940				
5.59	7	1	02	5p13.3	CDH6		Cadherin 6	603007				
5.60	5	30	17	5p13.2	RXFP3, RLN3R1, SALPR, GPCR135		Relaxin/insulin-like family peptide receptor 3	609445				
5.61	03	31	20	5p15.2	TRIO, MRD44, MRD63		Triple functional domain	601893			Intellectual developmental disorder, autosomal dominant 44, with microcephaly, 617061 (3); Intellectual developmental disorder, autosomal dominant 63, with macrocephaly, 618825 (3)	
5.62	11	12	96	5p15.1	MYO10		Myosin X	601481				15(Myo10)
5.63	6	11	11	5p15.1-p13.3	MYP19		Myopia 19, autosomal dominant	613969		highest lod at D5S419	Myopia 19 (2)	
5.64	09	26	19	5p15.32	ADAMTS16		ADAM metallopeptidase with thrombospondin type 1 motif, 16	607510				
5.65	8	25	11	5p15.33	SDHA, SDH1, SDHF, CMD1GG, PGL5		Succinate dehydrogenase complex, subunit A, flavoprotein	600857		copy on 3q29	Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex II deficiency, 252011 (3); Cardiomyopathy, dilated, 1GG, 613642 (3); Paragangliomas 5, 614165 (3)	
5.66	12	9	91	5p15.31	SRD5A1		Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)	184753		pseudogene on X		13(Srd5a1)
5.67	5	9	18	5p15.31	TENT4A, POLS, TRF4, POLK		Terminal nucleotidyltransferase 4A	605198				
5.68	4	5	00	5p15.3-p15.2	TRB7, T2R1		Taste receptor, family B, member 7	604796				15(T2R19)
5.69	11	22	10	5p15	TST2		Tuberculin skin test reactivity quantitative trait locus	613637		max lod at 16:2.70Mb	[Tuberculin skin test reactivity QTL] (2)	
5.70	12	4	08	5p15.2	DNAH5, HL1, PCD, CILD3		Dynein, axonemal, heavy chain 5	603335			Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	15(Dnahc5)
5.71	4	26	17	5q14.3	POLR3G, RPC32, RPC7		Polymerase III, RNA, subunit G	617456				
5.72	3	24	06	5p14.1	CDH9		Cadherin 9	609974				
5.73	8	15	90	5p14	MLVI2		Moloney leukemia virus integration site-2	157960				15(Mlvi2)
5.74	3	18	94	5p14.3	PMCHL1		Pro-melanin-concentrating hormone-like 1	176793				
5.75	2	18	10	5p14.2	PRDM9		PR domain-containing protein 9	609760				
5.76	3	8	00	5p14.2-p14.1	CDH10		Cadherin 10	604555				
5.77	9	14	95	5p14.3	CDH12, CDHB		Cadherin-12 (N-cadherin 2)	600562		pseudogene on 5q13 in SMA region		
5.78	10	23	87	5p12	HMGCS1		3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1	142940		like HMGCR, regulated transcriptionally by steroid		
5.79	11	9	05	5p13.3	RNASEN, DROSHA, RANSE3L, RN3		Ribonuclease III, nuclear	608828				15(Rnasen)
5.80	1	1	96	5p13.3	NPR3, ANPRC		Natriuretic peptide receptor C	108962			?Hypertension, salt-resistant (1)	
5.81	9	2	08	5p13.3	GOLPH3, GPP34, MIDAS		Golgi phosphoprotein 3	612207				
5.82	8	31	09	5p13.3	MTMR12, 3PAP, KIAA1682		Myotubularin-related protein 12	606501				
5.83	8	9	13	5p13.2	SLC45A2, MATP, AIM1, SHEP5, OCA4		Solute carrier family 45, member 2	606202			Albinism, oculocutaneous, type IV, 606574 (3); [Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3); [Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3); [Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	
5.84	01	31	20	5p13.3	SUB1, PC4, p15		SUB1 regulator of transcription	600503				
5.85	2	13	14	5p13.3	ZFR		Zinc finger RNA-binding protein	615635				
5.86	12	17	14	5p13.3-p13.2	BDA1B		Brachydactyly, type A1, locus B	607004			Brachydactyly, type A1, B (2)	
5.87	08	21	19	5p13.2	RAD1		RAD1 checkpoint DNA exonuclease	603153				
5.88	12	27	01	5p13.2	RAI14, KIAA1334		Retinoic acid-induced 14	606586				
5.89	06	14	19	5p13.2	BRIX1		Biogenesis of ribosomes, Xenopus, homolog of, 1	618466				
5.90	03	02	20	5p13.2	CAPSL		Calcyphosine-like protein	618799				
5.91	4	24	18	5p13.2	CPLANE1, C5orf42, JBTS17, OFD6		Ciliogenesis and planar polarity effector 1	614571			Joubert syndrome 17, 614615 (3); Orofaciodigital syndrome VI, 277170 (3)	
5.92	8	1	16	5p13.2	DNAJC21, DNAJA5, BMFS3		DNAJ/HSP40 homolog, subfamily C, member 21	617048			Bone marrow failure syndrome 3, 617052 (3)	
5.93	9	21	17	5p13.2-p13.1	EGFLAM, PIKA, AGRINL		EGF-like, fibronectin type III, and laminin G domains-containing protein	617683				
5.94	2	23	09	5p13.2	MS3		Multiple sclerosis, susceptibility to, 3	612595		associated with rs6897932	{Multiple sclerosis, susceptibility to, 3} (2)	
5.95	03	31	20	5p13.2	NADK2, C5orf33, DECRD		NAD kinase 2, mitochondrial	615787			2,4-dienoyl-CoA reductase deficiency, 616034 (3)	
5.96	1	17	07	5p13.3	PDZD2, PAPIN, PIN1, AIPC		PDZ domain containing 2	610697				
5.97	01	08	19	5p13.2	PRLR, MFAB, HPRL		Prolactin receptor	176761			Multiple fibroadenomas of the breast, 615554 (3); Hyperprolactinemia, 615555 (3)	
5.98	6	2	15	5p13.2	RANBP3L		RAN-binding protein 3-like	616391				
5.99	01	31	20	5p13.2	SPEF2, KPL2, KIAA1770, SPGF43		Sperm flagellar protein 2	610172			Spermatogenic failure 43, 618751 (3)	
5.100	6	2	15	5p13.2	TTC23L		Tetratricopeptide repeat domain-containing protein 23-like	616344				
5.101	6	2	15	5p13.2	UGT3A1		Uridine diphosphate glucuronosyltransferase 3 family, member A1	616383				15(Ugt3a1)
5.102	6	2	15	5p13.2	UGT3A2		Uridine diphosphate glucuronosyltransferase 3 family, member A2	616384				15(Ugt3a2)
5.103	12	6	16	5p13.2	WDR70		WD repeat-containing protein 70	617233				
5.104	10	26	11	5p13.2	AMACR, CBAS4, AMACRD		Alpha-methylacyl-CoA racemase	604489			Alpha-methylacyl-CoA racemase deficiency, 614307 (3); Bile acid synthesis defect, congenital, 4, 214950 (3)	
5.105	05	28	19	5p13.1	FYB1, SLAP130, ADAP, THC3		FYN-binding protein 1	602731			Thrombocytopenia 3, 273900 (3)	
5.106	9	24	08	5p13.1	IBD18		Inflammatory bowel disease 18	612262		associated with rs1373692	{Inflammatory bowel disease 18} (2)	
5.107	2	10	04	5p13.1	LIFR, STWS, SWS, SJS2		Leukemia inhibitory factor receptor	151443			Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	15(Lifr)
5.108	2	26	08	5p13.1	OSMR, OSMRB, PLCA1		Oncostatin M receptor	601743			Amyloidosis, primary localized cutaneous, 1, 105250 (3)	
5.109	5	19	04	5p13.2	NIPBL, CDLS1		Nipped-B-like (delangin)	608667			Cornelia de Lange syndrome 1, 122470 (3)	15(Nipbl)
5.110	7	1	16	5p13.1	PLCXD3		Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 3	617016				
5.111	12	14	99	5p13.1	PTGER4		Prostaglandin E receptor 4, EP4 subtype	601586				
5.112	09	06	18	5p13.1	RICTOR, AVO3, KIAA1999		Rapamycin-insensitive campion of mTOR	609022				
5.113	3	23	06	5p13.1	CARD6, CINCIN1		Caspase recruitment domain-containing protein 6	609986				15(Card6)
5.114	1	25	11	5p13.2	GDNF, HSCR3		Glial cell line derived neurotrophic factor	600837			Central hypoventilation syndrome, 209880 (3); {Pheochromocytoma, modifier of}, 171300 (3); {Hirschsprung disease, susceptibility to, 3}, 613711 (3)	
5.115	9	22	04	5p13	ADHD4		Attention deficit-hyperactivity disorder, susceptibility to, 4	608906			{Attention deficit-hyperactivity disorder}, 143465 (2)	
5.116	5	30	17	5p13.2	AGXT2, AGT2, BAIBA		Alanine-glyoxylate aminotransferase 2	612471			[Beta-aminoisobutyric acid, urinary excretion of], 210100 (3)	
5.117	6	9	08	5p13.2	C1ATNF3, CTRP3, CORS26		C1q- and tumor necrosis factor-related protein 3	612045				15(C1qtnf3)
5.118	12	4	08	5p13.1	C6		Complement component-6	217050			C6 deficiency, 612446 (3); Combined C6/C7 deficiency (3)	15(C6)
5.119	7	3	06	5p13.1	C7		Complement component-7	217070			C7 deficiency, 610102 (3)	15(C7)
5.120	1	7	14	5p13.1	C9, C9D, ARMD15		Complement component-9	120940			C9 deficiency, 613825 (3); {Macular degeneration, age-related, 15, susceptibility to}, 615591 (3)	
5.121	12	18	98	5p13.1	DAB2, DOC2		Disabled, Drosophila, homolog of, 2 (differentially expressed in ovarian cancer-2)	601236				
5.122	2	16	10	5p13	DUP5p13, C5DUPp13		Chromosome 5p13 duplication syndrome	613174			Chromosome 5p13 duplication syndrome (4)	
5.123	1	20	09	5p13.2	IL7R, IL7RA, CD127		Interleukin-7 receptor	146661			Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3)	
5.124	7	3	06	5p13	KYPSC1		Kyphoscoliosis 1	610170			Kyphoscoliosis 1 (2)	
5.125	5	22	14	5p13.2	NUP155, KIAA0791, ATFB15		Nucleoporin, 155kD	606694		mutation identified in 1 ATFB15 family	?Atrial fibrillation 15, 615770 (3)	
5.126	8	25	06	5p13.1	OXCT1, OXCT, SCOT		3-oxoacid CoA transferase 1	601424			Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)	
5.127	9	23	96	5p13.2	SKP2		S-phase kinase-associated protein 2 (p45)	601436				
5.128	3	31	09	5p13.2	SLC1A3, EAAT1, EA6		Solute carrier family 1 (glial high affinity glutamate transporter), member 3	600111			Episodic ataxia, type 6, 612656 (3)	15(Eaat1)
5.129	5	2	06	5p12	FGF10		Fibroblast growth factor-10	602115			Aplasia of lacrimal and salivary glands, 180920 (3); LADD syndrome, 149730 (3)	
5.130	5	17	18	5p13-p12	GHR, GHIP		Growth hormone receptor	600946			Laron dwarfism, 262500 (3); {Hypercholesterolemia, familial, modifier of}, 143890 (3); Increased responsiveness to growth hormone, 604271 (3); Growth hormone insensitivity, partial, 604271 (3)	15(Ghr)
5.131	08	21	19	5p13.3	TARS1, TARS, TTD7		Threonyl-tRNA synthetase 1	187790		linked to LARS	Trichothiodystrophy 7, nonphotosensitive, 618546 (3)	
5.132	7	18	06	5p13-q12	HYT6		Hypertension, essential, susceptibility to, 6	610262			{Hypertension, essential, susceptibility to, 6}, 145500 (2)	
5.133	5	24	13	5p12	ANXA2R, C5orf39, AX2R, AXIIR		Annexin A2 receptor	611296				
5.134	9	9	08	5p12	CCL28		Chemokine, C-C motif, ligand 28	605240				13(Ccl28)
5.135	9	9	08	5p13.1	FBXO4, FBX4		F-box only protein 4	609090				15(Fbxo4)
5.136	10	23	20	5p12	HCN1, BCNG1, DEE24, GEFSP10		Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1	602780			Developmental and epileptic encephalopathy 24, 615871 (3); Generalized epilepsy with febrile seizures plus, type 10, 618482 (3)	
5.137	10	11	16	5p12	NNT, GCCD4		Nicotinamide nucleotide transhydrogenase	607878			Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency, 614736 (3)	13(Nnt)
5.138	8	20	07	5p12	PAIP1		Polyadenylate-binding protein-interacting protein 1	605184				
5.139	11	20	98	5p13.1	PRKAA1		Protein kinase, AMP-activated, catalytic, alpha-1	602739				
5.140	5	4	00	5p12	ZNF131		Zinc finger protein -31	604073				
5.141	4	24	08	5p12	MRPS30		Mitochondrial ribosomal protein S30	611991				
5.142	11	18	16	5p12	SELENOP, SEPP1		Selenoprotein P	601484				
5.143	9	12	08	5p	ASD1		Atrial septal defect 1	108800		max lod at D5S406	Atrial septal defect 1 (2)	
5.144	8	4	97	5p	MHS6		Malignant hyperthermia susceptibility 6	601888			{Malignant hyperthermia susceptibility 6} (2)	
5.145	10	20	99	5p13.1	RPL37		Ribosomal protein L37	604181				
5.146	5	19	06	5q	BSZQTL2		Bone size quantitative trait locus 2	609657			{Bone size QTL} (2)	
5.147	3	5	95	5q11.1	ISL1		ISL1 transcription factor, LIM/homeodomain (islet-1)	600366		between D5S395 and D5S407; proximal 5q		
5.148	10	2	09	5q35.3	PROP1, CPHD2		Prophet of Pit1, paired-like homeodomain transcription factor	601538			Pituitary hormone deficiency, combined, 2, 262600 (3)	11(df, Prop1)
5.149	5	6	13	5q11.2	ANKRD55		Ankyrin repeat domain-containing protein 55	615189				
5.150	08	02	19	5q11.2	IL6ST, HIES4		Interleukin-6 signal transducer (gp130, oncostatin M receptor)	600694			Hyper-IgE recurrent infection syndrome 4, autosomal recessive, 618523 (3)	
5.151	11	4	13	5q11.2	MOCS2, MPTS, MOCODB		Molybdenum cofactor synthesis-2	603708			Molybdenum cofactor deficiency B, 252160 (3)	
5.152	8	13	98	5q11.2	GZMA, CTLA3, HFSP		Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factor serine protease)	140050				13(Ctla3)
5.153	09	19	19	5q14.1	MSH3, FAP4		mutS homolog 3	600887		5' to DHFR	Endometrial carcinoma, somatic, 608089 (3); Familial adenomatous polyposis 4, 617100 (3)	13(Msh3)
5.154	2	1	11	5q14.1	ARSB, MPS6		Arylsulfatase B	611542			Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)	13(As1)
5.155	11	16	00	5q13.3	IQGAP2		IQ motif-containing GTPase-activating protein-2	605401				
5.156	3	7	14	5q11.1	EMB, GP70		Embigin	615669				
5.157	12	13	18	5q11.2	NDUFS4, AQDQ, MC1DN1		NADH-ubiquinone oxidoreductase subunit S4	602694			Mitochondrial complex I deficiency, nuclear type 1, 252010 (3)	
5.158	10	4	12	5q11.2	ACTBL2		Actin, beta-like, 2	614835				
5.159	03	10	20	5q11.2	BDPLT9		Bleeding disorder, platelet-type, 9	614200			Bleeding disorder, platelet-type, 9 (2)	
5.160	7	17	14	5q11.2	CCNO, UNG2, CILD29		Cyclin O	607752			Ciliary dyskinesia, primary, 29, 615872 (3)	
5.161	07	13	20	5q11.2	DHX29		DExH-box helicase 29	612720				
5.162	6	22	14	5q11.2	ESM1		Endothelial cell-specific molecule 1	601521				
5.163	2	20	01	5q11.2	FST, FS		Follistatin	136470				
5.164	8	18	08	5q11.2	GPBP1, GPBP		GC-rich promoter-binding protein 1	608412				
5.165	11	23	16	5q11.2	GPX8		Glutathione peroxidase 8	617172				
5.166	9	26	17	5q11.2	GZMK, TRYP2		Granzyme K	600784				
5.167	9	11	14	5q11.2	HSPB3, HSPL27, HMN2C, DHMN2C		Heat-shock 27kD protein 3	604624		mutation identified in 1 HMN2C family	?Neuronopathy, distal hereditary motor, type IIC, 613376 (3)	
5.168	3	6	18	5q11.2	IL31RA, GLMR, GPL, PLCA2		Interleukin 31 receptor A	609510		mutation identified in 1 PLCA2 patient	?Amyloidosis, primary localized cutaneous, 2, 613955 (3)	13(Il31ra)
5.169	8	31	09	5q11.2	ITGA1, VLA1		Integrin, alpha-1	192968				13(Vla1)
5.170	8	29	11	5q11.2	MAP3K1, MEKK1, MEKK, SRXY6		Mitogen-activated protein kinase kinase kinase 1	600982			46XY sex reversal 6, 613762 (3)	13(Mekk)
5.171	12	13	19	5q11.2	MCIDAS, IDAS, CILD42		IDAS	614086			Ciliary dyskinesia, primary, 42, 618695 (3)	
5.172	12	2	09	5q11.2	MIR449A, MIRN449A		Micro RNA 449A	613131				
5.173	12	2	09	5q11.2	MIR449B, MIRN449B		Micro RNA 449B	613132				
5.174	10	10	18	5q11.2	MTREX, MTR4, SKIV2L2		MTR4 exosome RNA helicase	618122				
5.175	07	31	20	5q11.2	PELO		Pelota mRNA surveillance and ribosome rescue factor	605757				
5.176	10	26	17	5q11.2	PLPP1, PPAP2A		Phopshplipid phosphatase 1	607124				
5.177	12	28	08	5q13.1-q13.2	SLC30A5, ZNT5, ZTL1		Solute carrier family 30 (zinc transporter), member 5	607819				
5.178	3	31	15	5q11.2	SLC38A9, URLC11		Solute carrier family 38, member 9	616203				
5.179	07	14	20	5q11.2	DDX4, VASA		DEAD-box helicase 4	605281				13(Ddx4)
5.180	12	19	11	5q12.3	SREK1, SFRS12, SRRp508		Splicing regulatory glutamine/lysine-rich protein 1	609268				
5.181	6	7	12	5q12.3	HTR1A, ADRB2RL1, PFMCD		5-hydroxytryptamine (serotonin) receptor-1A	109760			Periodic fever, menstrual cycle dependent, 614674 (3)	13(Htr1a)
5.182	12	4	01	5q13.2	TAF9, TAF2G, TAFII32		TAF9 RNA polymerase II, TATA box-binding protein-associated factor, 32kD	600822				
5.183	3	31	11	5q14.1	DHFR		Dihydrofolate reductase	126060			Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3)	13(Dhfr)
5.184	3	5	95	5q13.3	CRHBP		Corticotropin releasing hormone-binding protein	122559				13(Crhbp)
5.185	09	26	19	5q12.3	ADAMTS6		ADAM metallopeptidase with thrombospondin type 1 motif, 6	605008				
5.186	8	24	92	5q13.2	CCNB1		Cyclin B1	123836				13(Cycb4)
5.187	1	23	13	5q12.3	CD180, LY64, RP105		CD180 antigen	602226				13(Ly64)
5.188	3	7	14	5q12	DEL5q12, C5DELq12		Chromosome 5q12 deletion syndrome	615668			Chromosome 5q12 deletion syndrome (4)	
5.189	6	11	02	5q12.3	ERBB2IP, ERBIN		ERBB2 interacting protein	606944				
5.190	5	25	12	5q12.1	ERCC8, CKN1, CSA, UVSS2		Excision repair cross-complementing rodent repair deficiency, complementation group 8	609412			Cockayne syndrome, type A, 216400 (3); UV-sensitive syndrome 2, 614621 (3)	
5.191	2	2	16	5q13.3	GCNT4		Glucosaminyl (N-acetyl) transferase 4, core 2	616782				
5.192	6	1	00	5q12.1	PART1		Prostate androgen-regulated transcript 1	604991				
5.193	02	26	19	5q11.2-q12.1	PDE4D, DPDE3, ACRDYS2		Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3)	600129			Acrodysostosis 2, with or without hormone resistance, 614613 (3)	13(Pde4D)
5.194	02	26	19	5q12	STRK1		Stroke, susceptibility to, 1	606799		association with PDE4D	{Stroke, susceptibility to, 1} (2)	
5.195	8	27	01	5q13.2	ANKRA2, ANKRA		Ankyrin repeat-containing protein, family A, member 2	605787				
5.196	8	29	08	5q14.1	CMYA5, MYOSPRYN, TRIM76		Cardiomyopathy-associated protein 5	612193				13(Cmya5)
5.197	4	24	96	5q13.2	FOXD1, FKHL8		Forkhead box D1	601091				
5.198	5	31	05	5q13.2	MCCC2, MCCB		3-Methylcrotonyl-CoA carboxylase 2	609014			3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)	
5.199	8	9	05	5q11.2	PLK2, SNK		Polo-like kinase 2	607023				
5.200	3	18	94	5q13.2	PMCHL2		Pro-melanin-concentrating hormone-like 2	176794				
5.201	10	11	07	5q12-q14	EJM4		Myoclonic epilepsy, juvenile, 4	611364		max lod at D5S459	Myoclonic epilepsy, juvenile, 4 (2)	
5.202	10	12	10	5q14.2-q14.3	VCAN, CSPG2, WGN, WGN1, ERVR		Versican (chondroitin sulfate proteoglycan-2)	118661			Wagner syndrome 1, 143200 (3)	13(Cspg2)
5.203	11	3	14	5q12.1	DEPDC1B		DEP domain-containing protein 1B	616073				
5.204	2	1	11	5q12.1	DIMT1L, DIM1, HUSSY5		Dimethyladenosine transferase 1-like	612499		previously assigned to 8p12		
5.205	1	30	12	5q12.1	ELOVL7		Elongation of very long chain fatty acids-like 6	614451				
5.206	3	29	07	5q12.1	IPO11, RANBP11, SLRN		Importin 11	610889				
5.207	9	23	13	5q12.1	KIF2A, CDCBM3		Kinesin, heavy chain, 2	602591			Cortical dysplasia, complex, with other brain malformations 3, 615411 (3)	
5.208	4	24	08	5q13.2	MRPS36		Mitochondrial ribosomal protein S36	611996		6 pseudogenes		
5.209	12	13	18	5q12.1	NDUFAF2, NDUFA12L, MMTN, B17.2L, MC1DN10		NADH-ubiquinone oxidoreductase complex assembly factor 2	609653		pseudogene on chr.2	Mitochondrial complex I deficiency, nuclear type 10, 618233 (3)	
5.210	2	16	18	5q12.1	ZSWIM6, KIAA1577, AFND, NEDMAGA		Zinc finger SWIM domain-containing protein 6	615951			Acromelic frontonasal dysostosis, 603671 (3); Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features, 617865 (3)	
5.211	2	28	03	5q13.2	BIRC1, NAIP		Baculoviral IAP repeat-containing 1 (neuronal apoptosis inhibitory protein)	600355		?involved in SMA		13(Naip)
5.212	4	19	01	5q14.1	DMGDH, DMGDHD		Dimethylglycine dehydrogenase	605849			Dimethylglycine dehydrogenase deficiency, 605850 (3)	
5.213	4	21	97	5q13.2	GTF2H2		General transcription factor IIH, polypeptide 2 (44kD subunit)	601748		2 copies		
5.214	9	28	00	5q13.2	SERF1A, H4F5, SMAM1		Small EDRK-rich factor 1A	603011				13(M4f5)
5.215	9	30	03	5q13.2	SMN1, SMA1, SMA2, SMA3, SMA4		Survival of motor neuron 1, telomeric	600354			Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2, 253550 (3); Spinal muscular atrophy-3, 253400 (3); Spinal muscular atrophy-4, 271150 (3)	13(Smn)
5.216	09	19	19	5q12.3	CWC27, SDCCAG10, RPSKA		CWC27 spliceosome-associated cyclophilin	617170			Retinitis pigmentosa with or without skeletal anomalies, 250410 (3)	
5.217	10	13	09	5q12.3	NLN, KIAA1226, AGTBP		Neurolysin	611530				
5.218	01	07	19	5q12.3	PPWD1		Peptidylprolyl isomerase domain- and WD40 repeat-containing protein 1	618274				
5.219	3	29	07	5q12.3	RGS7BP, R7BP		Regulator of G protein signaling 7-binding protein	610890				13(Rgs7bp)
5.220	6	26	18	5q12.3	SHLD3, RINN1		Shield complex, subunit 3	618030				
5.221	7	14	14	5q12.3	TRIM23, ARD1		Tripartite motif-containing protein 23	601747				
5.222	9	22	14	5q12.3	RNF180, RINES		RING finger protein 180	616015				
5.223	10	12	09	5q13.2	SMN2		Survival of motor neuron 2, centromeric	601627			{Spinal muscular atrophy, type III, modifier of}, 253400 (3)	
5.224	12	18	18	5q13.2	BDP1, TFNR, DFNB112		B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB	607012		mutation identified in 1 DFNB112 family	?Deafness, autosomal recessive 112, 618257 (3)	
5.225	04	19	19	5q13.3	GFM2, EFG2, RRF		Mitochondrial elongation factor G2	606544			Combined oxidative phosphorylation deficiency 39, 618397 (3)	
5.226	9	20	00	5q13.3	ENC1, PIG10		Ectodermal-neural cortex 1	605173				13(Enc1)
5.227	11	4	93	5q13.3	F2R, CF2R, PAR1		Coagulation factor II (thrombin) receptor	187930		within 900kb of GPR11		13(Cf2r)
5.228	6	28	00	5q13.3	F2RL1, GPR11, PAR2		Coagulation factor II, thrombin, receptor-like 1 (G protein-coupled receptor-11)	600933		within 900kb of F2R		
5.229	8	24	98	5q13.3	F2RL2, PAR3		Coagulation factor II receptor-like 2 (protease-activated receptor 3)	601919		order: PAR2-PAR1-PAR3		
5.230	11	23	09	5q13.3	HEXB		Hexosaminidase B, beta polypeptide	606873			Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)	13(Hex2)
5.231	06	29	20	5q13.2	MAP1B, PVNH9		Microtubule-associated protein-1B	157129			Periventricular nodular heterotopia 9, 618918 (3)	
5.232	6	1	18	5q12.3	MAST4		Microtubule-associated serine-threonine kinase 4	618002				
5.233	8	25	11	5q13.3	PDE8B, PPNAD3, ADSD		Phosphodiesterase 8B	603390			Pigmented nodular adrenocortical disease, primary, 3, 614190 (3); Striatal degeneration, autosomal dominant, 609161 (3)	
5.234	9	22	14	5q13.1	PIK3R1, GRB1, AGM7, SHORT, IMD36		Phosphatidylinositol 3-kinase, regulatory, 1	171833		mutation identified in 1 AGM7 family	?Agammaglobulinemia 7, autosomal recessive, 615214 (3); SHORT syndrome, 269880 (3); Immunodeficiency 36, 616005 (3)	13(Pik3r1)
5.235	7	16	09	5q11.2	RAB3C		Ras-associated protein RAB3C	612829				
5.236	08	21	19	5q13.2	RAD17		RAD17 checkpoint clamp loader component	603139				13(Rad17)
5.237	12	11	02	5q14.1	RASGRF2		Ras protein-specific guanine nucleotide-releasing factor 2	606614				13(Rasgrf2)
5.238	9	22	08	5q13	TSHQTL1		Thyroid-stimulating hormone level QTL 1	612306		associated with rs4704397	[Thyroid-stimulating hormone level QTL 1] (2)	
5.239	7	12	02	5q13-q14	AAT2, FAA2		Aortic aneurysm, familial thoracic 2	607087			Aortic aneurysm, familial thoracic 2 (2)	
5.240	9	3	15	5q14.2	XRCC4, SSMED		X-ray repair, complementing defective, repair in Chinese hamster cells-4	194363		between D5S427 and D5S401	Short stature, microcephaly, and endocrine dysfunction, 616541 (3)	
5.241	4	24	02	5q13-q22	GINGF2, GGF2, HGF2		Fibromatosis, gingival, 2	605544		formerly GINGF2 used for a locus on 2p16-p13	Fibromatosis, gingival, 2 (2)	
5.242	9	21	11	5q14.3	HAPLN1, CRTL1		Hyaluronan and proteoglycan link protein 1	115435				
5.243	9	5	91	5q21.3	RPS20A		Ribosomal protein S20A	180463		?pseudogene		
5.244	12	29	06	5q13.2	MARVELD2, MARVD2, TRIC, DFNB49		Marvel domain-containing protein 2 (tricellulin)	610572			Deafness, autosomal recessive 49, 610153 (3)	13(tric)
5.245	3	27	17	5q13.2	OCLN, BLCPMG, PTORCH1		Occludin	602876			Pseudo-TORCH syndrome 1, 251290 (3)	
5.246	2	20	01	5q13.3	POLK, POLQ, DINB1		Polymerase, DNA, kappa	605650				
5.247	4	30	09	5q14.1	BHMT		Betaine-homocysteine methyltransferase	602888				
5.248	5	7	01	5q14.1	BHMT2		Betaine-homocysteine methyltransferase 2	605932				13(Bhmt2)
5.249	5	5	15	5q13.2	CARTPT, CART		Cocaine- and amphetamine-regulated transcript prepropeptide	602606		mutation identified in 1 family	{?Obesity, susceptibility to}, 601665 (3)	
5.250	3	24	11	5q13.2	CCDC125, KENAE		Coiled-coil domain-containing protein 125	613781				
5.251	2	24	98	5q13.2	CDK7, STK1, CAK1		Cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase)	601955		previously mapped to 2p15-cen		
5.252	4	10	14	5q13.2	CENPH		Centromeric protein H	605607				
5.253	9	7	10	5q13.2	FCHO2		FCH domain-only protein 2	613438				
5.254	11	5	99	5q14.1	JMY		Junction-mediating and regulatory protein	604279				
5.255	4	24	08	5q13.2	MRPS27, KIAA0264		Mitochondrial ribosomal protein S27	611989				
5.256	11	10	13	5q13.2	PTCD2		Pentatricopeptide repeat domain-containing protein 2	615484				
5.257	5	26	09	5q13.2	RGNEF, p190RHOGEF		Rgnef, mouse, homolog of	612790				
5.258	12	10	12	5q13.2	TMEM174		Transmembrane protein 174	614909				
5.259	4	19	06	5q13.2	TNPO1, KPNB2, MIP1		Transportin 1	602901				
5.260	2	4	15	5q13.2	UTP15		UTP15, U3 small nucleolar ribonucleoprotein, S. cerevisiae, homolog of	616194				
5.261	4	6	15	5q13.2	ZNF366, DCSCRIPT		Zinc finger protein 366	610159				
5.262	1	8	07	5q13.3	AGGF1, VG5Q, HUS84971, FLJ10283		Angiogenic factor with G patch and FHA domains 1	608464				
5.263	05	07	19	5q13.3	ANKRD31		Ankyrin repeat domain-containing protein 31	618423				
5.264	1	2	95	5q14.1	CKMT2		Creatine kinase, mitochondrial-2 (sarcomeric)	123295				
5.265	5	11	15	5q13.3	COL4A3BP, GPBP, CERT, MRD34		COL4A3-binding protein (ceramide transporter)	604677			Mental retardation, autosomal dominant 34, 616351 (3)	
5.266	5	22	14	5q13.3	FAM169A, SLAP75, KIAA0888		Family with sequence similarity 169, member A	615769				
5.267	12	11	18	5q13.3	LINC01157		Long intergenic noncoding RNA 1157	618214				13(Linc01157)
5.268	09	27	20	5q14.1	OTP		Orthopedia homeobox	604529				
5.269	11	26	18	5q14.3	RASA1, GAP, CMAVM1, PKWS		RAS p21 protein activator 1 (GTPase activating protein)	139150			Capillary malformation-arteriovenous malformation 1, 608354 (3); Basal cell carcinoma, somatic, 605462 (3)	13(Gap)
5.270	7	3	06	5q13.3	S100Z		S100 calcium-binding protein, zeta	610103				
5.271	12	4	02	5q14.1	SSBP2		Single-stranded DNA-binding protein 2	607389				
5.272	8	3	12	5q13.3	SV2C		Synaptic vesicle glycoprotein 2C	610291				
5.273	12	22	08	5q13.3	TINP1, NSA2, HUSSY29		Transforming growth factor-beta-inducible nuclear protein 1	612497				
5.274	5	30	17	5q13.3-q14.1	WDR41		WD repeat-containing protein 41	617502				
5.275	5	31	13	5q13.3	ZBED3		Zinc finger BED domain-containing protein 3	615250				
5.276	6	19	98	5q14.3	CCNH, CAK		Cyclin H	601953				
5.277	5	18	09	5q13.3	HMGCR, LDLCQ3		3-hydroxy-3-methylglutaryl-Coenzyme A reductase; HMG CoA reductase	142910			[Statins, attenuated cholesterol lowering by] (3); [Low density lipoprotein cholesterol level QTL 3] (3)	13(Hmgcr)
5.278	5	13	02	5q14.1	SCAMP1, SCAMP37		Secretory carrier membrane protein 1	606911				
5.279	6	15	99	5q14.3	COX7C		Cytochrome C oxidase, subunit VII C	603774		pseudogene on 13q14-q21		
5.280	04	19	19	15q14	DPH6		Diphthamide biosynthesis protein 6	618391				
5.281	4	1	96	5q15	GLRX, GRX		Glutaredoxin (thioltransferase)	600443				
5.282	6	5	13	5q14	HBT		Telangiectasia, hereditary benign	187260		max lod at D5S641	Telangiectasia, hereditary benign (2)	
5.283	7	8	10	5q14.3	MEF2C, C5DELq14.3, DEL5q14.3		MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)	600662			Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3); Chromosome 5q14.3 deletion syndrome, 613443 (4)	13(mef2c)
5.284	7	7	14	5q15	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS		Nuclear receptor subfamily 2, group F, member 1 (transcription factor COUP 1)	132890			Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	13(Tcfcoup1)
5.285	2	28	94	5q21.1	PAM		Peptidylglycine alpha-amidating monooxygenase	170270				1(Pam)
5.286	10	28	11	5q14.1	ACOT12, CACH		Acyl-CoA thioesterase 12	614315				13(Acot12)
5.287	09	12	19	5q14.1	ANKRD34B, DP58		Ankyrin repeat domain-containing protein 34B	618581				
5.288	5	31	05	5q14.1	AP3B1, ADTB3A, HPS2		Adaptor-related protein complex 3, beta 1 subunit (adaptin, beta-3a)	603401			Hermansky-Pudlak syndrome 2, 608233 (3)	13(Ap3bi, pe)
5.289	12	28	08	5q14.1	LHFPL2, KIAA0206		LHFP-like protein 2	609718				
5.290	4	2	12	5q14.1	SERINC5, C5orf12, TPO1		Serine incorporator 5	614551				
5.291	09	05	18	5q14.1	SPZ1, PPP1R148		Spermatogenic leucine zipper protein 1	618068				
5.292	5	9	18	5q14.1	TENT2, APD4, GLD2		Terminal nucleotidyltransferase 1	614121				
5.293	9	26	17	5q14.1	THBS4		Thrombospondin IV	600715				
5.294	9	16	12	5q14.1	ZFYVE16, ENDOFIN, KIAA0305		Zinc finger FYVE domain-containing protein 16	608880				
5.295	5	9	12	5q14.1-q21.3	KTCN5		Keratoconus 5	614622		between D5S2499 and D5S495	Keratoconus 5 (2)	
5.296	09	19	19	5q14.1-q14.2	ATG10, APG10		Autophagy related 10	610800				
5.297	03	09	20	5q14.1	HOMER1, HOMER1B, HOMER1C, HOMER1A		Homer scaffold protein 1	604798				
5.298	8	11	17	5q14.2	RPS23, BTDD, MCINS		Ribosomal protein S23	603683			Brachycephaly, trichomegaly, and developmental delay, 617412 (3)	
5.299	4	2	16	5q14.2	SCARNA18		Small cajal body-specific RNA 18	611329		in intron 1 of TMEM167		
5.300	11	3	11	5q14.2	VUR4		Vesicoureteral reflux 4	614317		closest marker rs1501656	Vesicoureteral reflux 4 (2)	
5.301	5	13	02	5q15	LNPEP		Leucyl-cystinyl aminopeptidase	151300				
5.302	12	24	08	5q14.3	ARRDC3, TLIMP, KIAA1376		Arrestin domain-containing 3	612464				
5.303	1	4	16	5q14.3	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C		Adhesion G protein-coupled receptor V1	602851		mutation identified in 1 FEB4 family	?Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type 2C, 605472 (3); Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	13(Frings, mass1)
5.304	5	25	13	5q14.3	CETN3, CDC31		Centrin 3	602907				
5.305	10	23	15	5q14.3	LINC00461, VISC		Long intergenic noncoding RNA 461	616611				
5.306	11	15	18	5q14.3	LUCAT1, SCAL1		Lung cancer-associated transcript 1, noncoding	618190				
5.307	3	23	09	5q14.3	MIR9-2, MIRN9-2		Micro RNA 9-2	611187				
5.308	5	6	03	5q15	RHOBTB3, KIAA0878		Rho-related BTB domain-containing protein 3	607353				
5.309	10	31	13	5q14.3-q15	PVNH5		Periventricular nodular heterotopia 5	612881		deletion range 6.3-17Mb, common range 5.8Mb	Periventricular nodular heterotopia 5 (4)	
5.310	5	19	06	5q15	ARSK		Arylsulfatase K	610011				
5.311	6	10	08	5q15	ELL2		Elongation factor, RNA polymerase II, 2	601874				
5.312	6	10	08	5q15	ERAP1, ALAP, ARTS1, PILSAP, KIAA0525		Endoplasmic reticulum aminopeptidase 1	606832				
5.313	12	30	09	5q15	ERAP2, LRAP		Endoplasmic reticulum aminopeptidase 2	609497				
5.314	07	10	19	5q15	KIAA0825, PAPA10		KIAA0825 gene	617266			Polydactyly, postaxial, type A10, 618498 (3)	
5.315	09	27	20	5q15	LIX1		Limb and CNS expressed 1	610466				
5.316	4	7	15	5q15	MCTP1		Multiple C2 domains-containing transmembrane protein 1	616296				
5.317	10	31	17	5q15	RIOK2, RIO2		RIO kianse 2	617754				
5.318	06	14	19	5q15	SLF1, BRCTX		SMC5-SMC6 complex localization factor 1	618467				
5.319	4	27	12	5q15	TTC37, KIAA0372		Tetratricopeptide repeat domain 37	614589			Trichohepatoenteric syndrome 1, 222470 (3)	
5.320	4	7	15	5q15	CAST, PLACK		Calpastatin	114090			Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3)	
5.321	9	21	17	5q15-q21	CHD1, PILBOS		Chromodomain helicase DNA binding protein-1	602118			Pilarowski-Bjornsson syndrome, 617682 (3)	
5.322	10	29	08	5q15	PCSK1, NEC1, PC1, PC3, BMIQ12		Proprotein convertase subtilisin/kexin type 1	162150			Obesity with impaired prohormone processing, 600955 (3); {Obesity, susceptibility to, BMIQ12}, 612362 (3)	13(Nec1)
5.323	11	30	06	5q35.2	CPEB4, KIAA1673		Cytoplasmic polyadenylation element-binding protein 4	610607				
5.324	12	5	13	5q22.2	MCC		Mutated in colorectal cancers	159350			Colorectal cancer, somatic, 114500 (3)	18(Mcc)
5.325	9	14	05	5q21	MGR8		Migraine, susceptibility to, 8	609570			{Migraine, susceptibility to, 8} (2)	
5.326	7	14	98	5q21.1	PST, PST1		Polysialyltransferase	602547				
5.327	1	24	06	5q22.2	DCP2		Decapping enzyme 2, S. cerevisiae, homolog of	609844				
5.328	2	27	01	5q23.1	DMXL1		DMX-like 1	605671				
5.329	4	30	91	5q21.3	FER, TYK3		fer (fps/fes related) tyrosine kinase	176942				11(Fert)
5.330	10	26	97	5q21.3	MAN2A1, MANA2		Mannosidase, alpha, class 2A, member 1	154582				
5.331	5	27	93	5q22.2	SRP19		Signal recognition particle 19kD	182175		within 100kb of APC		
5.332	12	4	90	5q22.1	CAMK4		Ca(2+)-calmodulin-dependent protein kinase type IV of brain	114080				18(Camk4)
5.333	10	23	15	5q21.1	C5orf30		Chromosome 5 open reading frame 30	616608				
5.334	05	08	19	5q21.1	PPIP5K2, HISPPD1, VIP2, KIAA0433, DFNB100		Histidine acid phosphatase domain-containing protein 1	611648			Deafness, autosomal recessive 100, 618422 (3)	
5.335	3	31	09	5q15	RGMB, DRAGON		RGM domain family, member B	612687				
5.336	6	13	12	5q21.1	SLCO4C1, OATP4C1		Solute carrier organic anion transporter family, member 4C1	609013				
5.337	4	20	10	5q21.1	SLCO6A1, GST		Solute carrier organic anion transporter family, member 6A1	613365				
5.338	8	9	01	5q22.3	KCNN2, SK2		Potassium channel, calcium-activated, intermediate/small conductance, subfamily N, member 2	605879				
5.339	9	26	17	5q21.3	EFNA5, EPLG7, LERK7		Ephrin A5	601535				
5.340	9	9	08	5q21.3	FBXL17, FBL17, FBX13, FBXO13		F-box and leucine-rich repeat protein 17	609083				17(Fbxl17)
5.341	8	18	04	5q23.1	FTMT		Ferritin, mitochondrial	608847				
5.342	3	22	06	5q22.1	WDR36, TAWDRP, GLC1G		WD repeat-containing protein 36	609669			Glaucoma 1, open angle, G, 609887 (3)	
5.343	11	17	14	5q21.3-q33.2	MDBS2		Macular dystrophy, butterfly-shaped pigmentary, 2	608970		between D5S433 and D5S410	Macular dystrophy, butterfly-shaped pigmentary, 2 (2)	
5.344	7	8	10	5q22	EOE2		Esophagitis, eosinophilic, 2	613412		association with rs3806932	{Esophagitis, eosinophilic, 2} (2)	
5.345	6	28	02	5q22.1	STARD4		Start domain-containing protein 4	607049				
5.346	1	22	07	5q22.2	TSSK1, STK22D		Testis-specific serine/threonine kinase 1	610709		pseudogene on chr22		16(Tssk1)
5.347	7	10	08	5q22.1-q22.2	EPB41L4A, EPB41L4, NBL4		Erythrocyte membrane protein band 4.1-like 4A	612141				
5.348	10	25	19	5q22	ZRSR2P1, ZRSR1, U2AF1RS1		ZRSR2 pseudogene 1	601079				11(U2af1rs1)
5.349	8	9	99	5q22.3	CDO1		Cysteine dioxygenase, type 1	603943				18(Cdo1)
5.350	3	22	06	5q22.2	REEP5, D5S346, DP1, C5orf18		Receptor expression-enhancing protein 5	125265				
5.351	8	31	09	5q22.1	C5orf13, P311, PTZ17		P311 protein	607332				
5.352	9	9	08	5q22.1	TSLP		Thymic stromal lymphopoietin	607003				18(Tslp)
5.353	10	30	06	5q22.1-q32	GLC1M		Glaucoma 1, open angle, M	610535		between D5S2051 and D5S2090	Glaucoma 1, open angle, M (2)	
5.354	8	7	15	5q22.1	SLC25A46, HMSN6B		Solute carrier family 25, member 46	610826			Neuropathy, hereditary motor and sensory, type VIB, 616505 (3)	8(Slc25a46)
5.355	03	20	20	5q22.2	APC, GS, FPC, BTPS2, DESMD		Adenomatous polyposis coli	611731		150kb distal to MCC	Adenomatous polyposis coli, 175100 (3); Gastric cancer, somatic, 613659 (3); Adenoma, periampullary, somatic (3); Hepatoblastoma, somatic, 114550 (3); Desmoid disease, hereditary, 135290 (3); Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3); Gardner syndrome, 175100 (3)	18(Min, Apc)
5.356	11	13	13	5q22.3	PGGT1B		Protein geranylgeranyltransferase type I, beta subunit	602031				
5.357	8	17	17	5q22.3	TRIM36, RBCC728, ANPH		Tripartite motif-containing protein 36	609317		mutation identified in 1 ANPH patient	?Anencephaly, 206500 (3)	
5.358	09	26	19	5q35.3	ADAMTS2, NPI, EDSDERMS		ADAM metallopeptidase with thrombospondin type 1 motif, 2 (procollagen I N-proteinase)	604539			Ehlers-Danlos syndrome, dermatosparaxis type, 225410 (3)	11(Adamts2)
5.359	3	16	99	5q31.1	CAMLG		Calcium-modulating cyclophilin ligand	601118				13(Camlg)
5.360	10	28	99	5q23.2	CSNK1G3		Casein kinase I, gamma-3	604253				
5.361	5	19	06	5q31.3	HBEGF, DTR, DTSF, HEGFL		Heparin-binding EGF-like growth factor (diphtheria toxin receptor)	126150			{Diphtheria, susceptibility to} (1)	18(Hegfl)
5.362	5	15	01	5q23.2	SNX2		Sorting nexin 2	605929				
5.363	12	4	14	5q23.3	FBN2, CCA, EOMD		Fibrillin-2	612570			Contractural arachnodactyly, congenital, 121050 (3); Macular degeneration, early-onset, 616118 (3)	18(Fbn2)
5.364	03	09	20	5q11.2	ITGA2, CD49B, BR		Integrin, alpha-2 (CD49B; alpha-2 subunit of VLA-2 receptor; platelet antigen Br)	192974				
5.365	11	29	00	5q31.1	NEUROG1, NEUROD3		Neurogenin 1	601726				13(Neurod3)
5.366	09	12	19	5q31.2	NME5, NM23H5		NME/NM23 family, member 5	603575				
5.367	03	19	19	5q31.1	PPP2CA, NEDLBA		Protein phosphatase-2 (formerly 2A), catalytic subunit, alpha isoform	176915			Neurodevelopmental disorder and language delay with or without structural brain abnormalities, 618354 (3)	
5.368	03	09	20	5q31.1	UBE2B, RAD6B		Ubiquitin-conjugating enzyme E2B (RAD6 homolog)	179095				
5.369	6	4	99	5q31.2	NRG2		Neuregulin 2	603818				
5.370	8	18	98	5q33.3	FABP6, ILLBP		Fatty acid-binding protein 6, ileal (gastrotropin)	600422				11(Illbp)
5.371	5	5	09	5q23-q35	SCZD1		Schizophrenia susceptibility locus, chromosome 5-related	181510		max lod at D5S820	{Schizophrenia}, 181500 (2)	
5.372	2	1	11	5q22.3-q23.1	AP3S1, CLAPS3		Adaptor-related protein complex 3, sigma 1 subunit	601507		previously assigned to chr. 12 by FISH		
5.373	12	22	15	5q23.1	COMMD10		COMM domain-containing protein 10	616704				
5.374	04	24	19	5q23.1	FAM170A, ZNFD		Family with sequence similarity 170, member A	618401				
5.375	5	8	13	5q23.1	HSD17B4, PRLTS1		Hydroxysteroid (17-beta) dehydrogenase 4	601860			D-bifunctional protein deficiency, 261515 (3); Perrault syndrome 1, 233400 (3)	
5.376	6	9	06	5q23.1	LVRN		Laeverin	610046				
5.377	8	18	14	5q23.1	PRR16, LARGEN		Proline-rich protein 16	615931				
5.378	4	21	15	5q23.1	SEMA6A		Semaphorin 6A	605885				
5.379	3	14	07	5q23.1	SRFBP1, P49		Serum response factor binding protein 1	610479				
5.380	12	8	03	5q22.3	TIRP, TRAM		Toll/interleukin-1 receptor domain-containing protein	608321				
5.381	6	30	08	5q23.1	TNFAIP8, SCCS2		Tumor necrosis factor-alpha-induced protein 8	612111				
5.382	3	15	10	5q23.2	SNCAIP		Synuclein-alpha-interacting protein (synphilin 1)	603779				
5.383	11	7	17	5q23.2	CEP120, CCDC100, SRTD13, JBTS31		Centrosomal protein, 120kD	613446			Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3); Joubert syndrome 31, 617761 (3)	
5.384	01	24	20	5q23.2	KABE		Cortexin 3	618746				
5.385	11	11	13	5q23.2	LMNB1, ADLD		Lamin B1	150340			Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)	18(Lmnb)
5.386	6	7	10	5q23.2	MARCH3		Membrane-associated RING-CH finger protein 3	613333				
5.387	5	4	12	5q23.2	MEGF10, KIAA1780, EMARDD		Multiple epidermal growth factor-like domains 10	612453			Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3); Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)	
5.388	8	31	09	5q23.2	PPIC		Peptidyl-prolyl isomerase C	123842				
5.389	7	22	16	5q23.2	PRDM6, PRISM, PDA3		PR domain-containing protein 6	616982			Patent ductus arteriosus 3, 617039 (3)	
5.390	3	31	15	5q23.2	RNUXA, PHAX		RNA, U small nuclear, export adaptor	604924				
5.391	11	30	06	5q31.1	FNIP1, KIAA1961		Folliculin-interacting protein 1	610594				
5.392	3	3	16	5q23.3-q31.1	LYRM7, MZM1L, MC3DN8		LYR motif-containing protein 7	615831			Mitochondrial complex III deficiency, nuclear type 8, 615838 (3)	
5.393	11	09	20	5q23.3	SLC12A2, NKCC1, KILQS		Solute carrier family 12 (sodium/potassium/chloride transporters), member 2	600840			Kilquist syndrome, 619080 (3); Deafness, autosomal dominant 78, 619081 (3); Delpire-McNeill syndrome, 619083 (3)	
5.394	2	27	01	5q31.3	RNF14, ARA54		RING finger protein-14	605675				
5.395	10	25	16	5q23.1	LOX, AAT10		Lysyl oxidase	153455			Aortic aneurysm, familial thoracic 10, 617168 (3)	18(Lox)
5.396	9	18	08	5q31.1	ACSL6, FACL6, ACS2		Acyl-CoA synthetase long-chain family member 6	604443			Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)	
5.397	09	26	19	5q23.3	ADAMTS19		ADAM metallopeptidase domain with thrombospondin type 1 motif, 19	607513				
5.398	5	19	15	5q31.1	AFF4, AF5Q31, CHOPS		AF4/FMR2 family, member 4	604417			CHOPS syndrome, 616368 (3)	
5.399	3	26	07	5q23.2	ALDH7A1, ATQ1, EPD, PDE		Aldehyde dehydrogenase 7 family, member A1 (antiquitin 1)	107323			Epilepsy, pyridoxine-dependent, 266100 (3)	18(Atq1)
5.400	8	31	09	5q31.3	APBB3, FE65L2		Amyloid beta (A4) precursor protein-binding, family B, member 3	602711				
5.401	8	27	15	5q31.3	ARHGAP26, GRAF		RHO GTPase-activating protein 26	605370			Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	
5.402	3	22	93	5q31.2	CDC25C		Cell division cycle 25C	157680				
5.403	2	16	04	5q31.1	CDKL3, NKIAMRE		Cyclin-dependent kinase-like 3	608459				
5.404	4	13	10	5q23.3	CHSY3, CSS3		Chondroitin sulfate synthase 3	609963				
5.405	4	8	16	5q31.2	CTNNA1, MDPT2		Catenin (cadherin-associated protein), alpha 1, 102kD	116805			Macular dystrophy, patterned, 2, 608970 (3)	18(Catna1)
5.406	8	28	02	5q31.1	CXCL14, SCYB14, BRAK		Chemokine, C-X-C motif, ligand 14	604186				
5.407	07	20	20	5q31.3	DIAPH1, DFNA1, LFHL1, SCBMS		Diaphanous-related formin 1	602121			Deafness, autosomal dominant 1, with or without thrombocytopenia, 124900 (3); Seizures, cortical blindness, microcephaly syndrome, 616632 (3)	
5.408	2	20	14	5q31	DFNA54		Deafness, autosomal dominant 54	615649		between D5S1972 and D5S410	Deafness, autosomal dominant 54 (2)	
5.409	4	29	14	5q31.2	ECSCR, ECSM2, ARIA		Endothelial cell surface-expressed chemotaxis and apoptosis regulator	615736				
5.410	6	10	94	5q31.3	FGF1, FGFA		Fibroblast growth factor-1 (acidic)	131220				
5.411	3	2	01	5q31.2	GFRA3		GDNF family receptor alpha-3	605710				
5.412	2	19	10	5q31.3	GNPDA1, GNP1, GNPI, KIAA0060		Glucosamine 6-phosphate deaminase 1	601798				
5.413	8	15	00	5q31.3	HDAC3		Histone deacetylase 3	605166				
5.414	10	11	05	5q31.2	HNRPA0		Heterogeneous nuclear ribonucleoprotein A0	609409				
5.415	1	31	02	5q31	IBD5		Inflammatory bowel disease 5	606348			{Inflammatory bowel disease 5} (2)	
5.416	10	30	03	5q31.1	IL13, ALRH, BHR1		Interleukin-13	147683			{Asthma, susceptibility to}, 600807 (3); {Allergic rhinitis, susceptibility to}, 607154 (3)	
5.417	04	14	20	5q31.2	KDM3B, C5orf7, KIAA1082, JMJD1B, DIJOS		Lysine-specific demethylase 3B	609373			Diets-Jongmans syndrome, 618846 (3)	
5.418	12	29	00	5q31.1	KIF3A		Kinesin family member 3A	604683				
5.419	3	12	03	5q31.2	KIF20A, RAB6KIFL		Kinesin family member 20A	605664				
5.420	2	27	12	5q31.2	KLHL3, PHA2D		Kelch-like 3	605775			Pseudohypoaldosteronism, type IID, 614495 (3)	
5.421	10	14	98	5q31.1	MADH5, SMAD5		Mothers against decapentaplegic, Drosophila, homolog of, 5	603110				
5.422	7	17	14	5q35.1	NEURL1B, NEUR2		Neuralized E3 ubiquitin protein ligase 1B	615893				17(Neurl1b)
5.423	1	31	07	5q33.1	MYOZ3, FRP3		Myozenin 3	610735				
5.424	2	18	98	5q31.2	NPY6R, PP2		Neuropeptide Y receptor Y6	601770		?nonfunctional pseudogene		18(Npy6r)
5.425	9	5	14	5q31.3	NR3C1, GCR, GRL, GCRST		Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)	138040			Glucocorticoid resistance, 615962 (3)	18(Grl1)
5.426	12	6	16	5q31.1	P4HA2, MYP25		Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 2	600608			Myopia 25, autosomal dominant, 617238 (3)	
5.427	10	30	19	5q31.3	PCDH12, VECAD2, DMJDS1		Protocadherin 12 (cadherin, vascular endothelial, 2)	605622			Diencephalic-mesencephalic junction dysplasia syndrome 1, 251280 (3)	
5.428	5	24	00	5q31	PCDHA@		Protocadherin-alpha gene cluster	604966				
5.429	10	2	01	5q31.3	PCDHA1		Protocadherin-alpha 1	606307				
5.430	10	2	01	5q31.3	PCDHA2		Protocadherin-alpha 2	606308				
5.431	10	1	01	5q31.3	PCDHA3		Protocadherin-alpha 3	606309				
5.432	10	2	01	5q31.3	PCDHA4		Protocadherin-alpha 4	606310				
5.433	10	2	01	5q31.3	PCDHA5		Protocadherin-alpha 5	606311				
5.434	10	2	01	5q31.3	PCDHA6		Protocadherin-alpha 6	606312				
5.435	10	2	01	5q31.3	PCDHA7		Protocadherin-alpha 7	606313				
5.436	10	2	01	5q31.3	PCDHA8		Protocadherin-alpha 8	606314				
5.437	10	2	01	5q31.3	PCDHA9		Protocadherin-alpha 9	606315				
5.438	10	2	01	5q31.3	PCDHA10		Protocadherin-alpha 10	606316				
5.439	10	2	01	5q31.3	PCDHA11		Protocadherin-alpha 11	606317				
5.440	10	2	01	5q31.3	PCDHA12		Protocadherin-alpha 12	606318				
5.441	10	2	01	5q31.3	PCDHA13		Protocadherin-alpha 13	606319				
5.442	10	2	01	5q31.3	PCDHAC1		Protocadherin-alpha, subfamily C, member 1	606320				
5.443	10	2	01	5q31.3	PCDHAC2		Protocadherin-alpha, subfamily C, member 2	606321				
5.444	5	24	00	5q31	PCDHB@		Protocadherin-beta gene cluster	604967				
5.445	10	2	01	5q31.3	PCDHB1		Protocadherin-beta 1	606327				
5.446	10	2	01	5q31.3	PCDHB2		Protocadherin-beta 2	606328				
5.447	10	2	01	5q31.3	PCDHB3		Protocadherin-beta 3	606329				
5.448	10	2	01	5q31.3	PCDHB4		Protocadherin-beta 4	606330				
5.449	10	2	01	5q31.3	PCDHB5		Protocadherin-beta 5	606331				
5.450	10	2	01	5q31.3	PCDHB6		Protocadherin-beta 6	606332				
5.451	10	2	01	5q31.3	PCDHB7		Protocadherin-beta 7	606333				
5.452	10	2	01	5q31.3	PCDHB8		Protocadherin-beta 8	606334				
5.453	10	2	01	5q31.3	PCDHB9		Protocadherin-beta 9	606335				
5.454	10	2	01	5q31.3	PCHB10		Protocadherin-beta 10	606336				
5.455	10	2	01	5q31.3	PCDHB11		Protocadherin-beta 11	606337				
5.456	10	2	01	5q31.3	PCDHB12		Protocadherin-beta 12	606338				
5.457	10	2	01	5q31.3	PCDHB13		Protocadherin-beta 13	606339				
5.458	10	2	01	5q31.3	PCDHB14		Protocadherin-beta 14	606340				
5.459	10	2	01	5q31.3	PCDHB15		Protocadherin-beta 15	606341				
5.460	10	2	01	5q31.3	PCDHB16		Protocadherin-beta 16	606345				
5.461	5	24	00	5q31	PCDHG		Protocadherin-gamma gene cluster	604968				
5.462	10	2	01	5q31.3	PCDHGA1		Protocadherin-gamma, subfamily A, member 1	606288				
5.463	10	2	01	5q31.3	PCDHGA2		Protocadherin-gamma, subfamily A, member 2	606289				
5.464	10	2	01	5q31.3	PCDHGA3		Protocadherin-gamma, subfamily A, member 3	606290				
5.465	10	2	01	5q31.3	PCDHGA4		Protocadherin-gamma, subfamily A, member 4	606291				
5.466	10	2	01	5q31.3	PCDHGA5		Protocadherin-gamma, subfamily A, member 5	606292				
5.467	10	2	01	5q31.3	PCDHGA6		Protocadherin-gamma, subfamily A, member 6	606293				
5.468	10	2	01	5q31.3	PCDHGA7		Protocadherin-gamma, subfamily A, member 7	606294				
5.469	10	2	01	5q31.3	PCDHGA8		Protocadherin-gamma, subfamily A, member 8	606295				
5.470	10	2	01	5q31.3	PCDHGA9		Protocadherin-gamma, subfamily A, member 9	606296				
5.471	10	2	01	5q31.3	PCDHGA10		Protocadherin-gamma, subfamily A, member 10	606297				
5.472	10	2	01	5q31.3	PCDHGA11		Protocadherin-gamma, subfamily A, member 11	606298				
5.473	10	2	01	5q31.3	PCDHGA12		Protocadherin-gamma, subfamily A, member 12	603059				
5.474	10	2	01	5q31.3	PCDHGB1		Protocadherin-gamma, subfamily B, member 1	606299				
5.475	10	2	01	5q31.3	PCDHGB2		Protocadherin-gamma, subfamily B, member 2	606300				
5.476	10	2	01	5q31.3	PCDHGB3		Protocadherin-gamma, subfamily B, member 3	606301				
5.477	10	2	01	5q31.3	PCDHGB4		Protocadherin-gamma, subfamily B, member 4	603058				
5.478	10	2	01	5q31.3	PCDHGB5		Protocadherin-gamma, subfamily B, member 5	606302				
5.479	10	2	01	5q31.3	PCDHGB6		Protocadherin-gamma, subfamily B, member 6	606303				
5.480	10	2	01	5q31.3	PCDHGB7		Protocadherin-gamma, subfamily B, member 7	606304				
5.481	10	2	01	5q31.3	PCDHGC3		Protocadherin-gamma, subfamily C, member 3	603627				
5.482	10	2	01	5q31.3	PCDHGC4		Protocadherin-gamma, subfamily C, member 4	606305				
5.483	10	2	01	5q31.3	PCDHGC5		Protocadherin-gamma, subfamily C, member 5	606306				
5.484	6	30	15	5q31	PDB4		Paget disease of bone 4	606263			Paget disease of bone 4 (2)	
5.485	7	9	06	5q31.3	PFDN1		Prefoldin 1	604897				
5.486	11	1	12	5q31.1	PITX1, PTX1, BFT, POTX, CCF, LBNBG		Paired-like homeodomain transcription factor-1	602149			Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3); Liebenberg syndrome, 186550 (4)	13(Ptx1)
5.487	5	4	00	5q31.2	PKD2L2		Polycystin 2-like 2	604669				
5.488	7	13	98	5q32	POU4F3, BRN3C		POU domain, class 4, transcription factor-3	602460			Deafness, autosomal dominant 15, 602459 (3)	18(pou4f3)
5.489	1	5	15	5q31.3	PURA, PUR1, MRD31		Purine-rich element binding protein A	600473			Mental retardation, autosomal dominant 31, 616158 (3)	
5.490	08	21	19	5q31.1	RAD50, NBSLD		RAD50 double strand break repair protein	604040			Nijmegen breakage syndrome-like disorder, 613078 (3)	
5.491	2	10	14	5q31.2	REEP2, C5orf19, SPG72		Receptor expression-enhancing protein 2	609347		mutation identified in 1 family each SPG72 AR and AD	?Spastic paraplegia 72, autosomal recessive, 615625 (3); ?Spastic paraplegia 72, autosomal dominant, 615625 (3)	
5.492	5	6	13	5q31	RLS8		Restless legs syndrome, susceptibility to, 8	615197			{Restless legs syndrome 8} (2)	
5.493	09	18	19	5q31.2	SIL1, BAP, MSS		SIL1 nucleotide exchange factor	608005			Marinesco-Sjogren syndrome, 248800 (3)	
5.494	7	7	14	5q31.1	SKP1, SKP1A, TCEB1L, OCP2		S-phase kinase-associated protein 1 (p19A)	601434		pseudogene on chr.7		
5.495	4	7	09	5q31.1	SLC22A4, OCTN1		Solute carrier family 22 (organic cation transporter), member 4	604190			{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
5.496	10	30	03	5q31.3	SLC25A2, ORNT2		Solute carrier family 25 (mitochondrial carrier, ornithine transporter), member 2	608157				
5.497	8	9	99	5q31.2	SPOCK		Testican	602264		previously mapped to chr.21		
5.498	12	4	01	5q31.3	TAF7, TAF2F, TAFII55		TAF7 RNA polymerase II, TATA box-binding protein-associated factor, 55kD	600573				18(Taf2f)
5.499	1	30	02	5q32	TCERG1, TAF2S, CA150		Transcription elongation regulator 1 (transcription factor CA150)	605409				18(Ca150)
5.500	1	19	07	5q31.1	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD		Transforming growth factor, beta-induced, 68kD	601692			Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy, lattice type I, 122200 (3); Corneal dystrophy, Reis-Bucklers type, 608470 (3); Corneal dystrophy, Avellino type, 607541 (3); Corneal dystrophy, lattice type IIIA, 608471 (3); Corneal dystrophy, Thiel-Behnke type, 602082 (3); Corneal dystrophy, epithelial basement membrane, 121820 (3)	
5.501	09	25	18	5q31.2	MYOT, TTOD, MFM3		Myotilin (titin immunoglobulin domain protein)	604103			Myopathy, myofibrillar, 3, 609200 (3); Myopathy, spheroid body, 182920 (3)	
5.502	2	4	00	5q31.1	VDAC1		Voltage-dependent anion channel 1	604492				11(Vdac1)
5.503	4	1	09	5q31.3	VTRNA1-1, HVG1, VAULTRC1		Vault RNA 1-1	612695				
5.504	3	31	09	5q31.3	VTRNA1-2, HVG2, VAULTRC2		Vault RNA 1-2	612696				
5.505	4	1	09	5q31.3	VTRNA1-3, HVG3, VAULTRC3		Vault RNA 1-3	612697				
5.506	12	17	12	5q31.1	VTRNA2-1, NC886, CBL3, VTRNA2		Vault RNA 2-1	614938				
5.507	8	28	01	5q32	SLC6A7, PROT		Solute carrier family 6 (neurotransmitter transporter, L-proline), member 7	606205				18(Slc6a7)
5.508	10	30	03	5q31-q33	AITD2		Autoimmune thyroid disease, susceptibility to, 2	608174			{Autoimmune thyroid disease, susceptibility to, 2} (2)	
5.509	10	12	09	5q31-q33	ATOD6		Dermatitis, atopic, 6	605845		between D5S436 and D5S643	{Dermatitis, atopic, susceptibility to, 6} (2)	
5.510	9	14	95	5q32	CDX1		Caudal type homeo box transcription factor 1	600746		100kb distal to CSF1R		18(Cdx1)
5.511	3	17	06	5q31-q33	CELIAC2		Celiac disease, susceptibility to, 2	609754			{Celiac disease, susceptibility to, 2} (2)	
5.512	9	9	08	5q33.2	CNOT8, CALIF, POP2		CCR4-NOT transcription complex, subunit 8	603731				
5.513	10	26	97	5q31-q33	EOS		Eosinophilia, familial	131400			Eosinophilia, familial (2)	
5.514	6	9	98	5q32	HTR4		5-hydroxytryptamine (serotonin) receptor-4	602164				
5.515	1	25	05	5q31-q33	PFBI		Plasmodium falciparum blood infection levels	248310			{Malaria, intensity of infection} (2)	
5.516	12	29	99	5q32	PPP2R2B		Protein phosphatase 2, regulatory subunit B, beta	604325			Spinocerebellar ataxia 12, 604326 (3)	
5.517	7	22	09	5q31.1	SEPT8, KIAA0202		Septin 8	608418				11(Sept8)
5.518	10	11	02	5q33.1	SLC36A1, LYAAT1, PAT1		Solute carrier family 36 (proton/amino acid symporter), member 1 (lysosomal amino acid transporter 1)	606561				
5.519	9	30	99	5q31-q33	SM1		Schistosoma mansoni infection, susceptibility/resistance to	181460			{Schistosoma mansoni infection, susceptibility/resistance to} (2)	
5.520	4	4	02	5q32	SCGB3A2, UGRP1		Secretoglobin, family 3A, member 2 (uteroglobin-related protein 1)	606531			{Asthma, susceptibility to}, 600807 (3)	18(Ugrp1)
5.521	11	15	05	5q31.1	C5orf20, DCNP1		Dendritic cell nuclear protein 1	609710				
5.522	3	28	11	5q31.1	CATSPER3, CACRC		Cation channel, sperm-associated, 3	609120				13(Catsper3)
5.523	7	11	93	5q31.3	CD14		CD14 antigen	158120				18(Cd14)
5.524	6	15	99	5q31.2	CDC23, APC8		Cell division cycle 23 (anaphase-promoting complex 8)	603462				
5.525	7	11	93	5q31.1	CSF2, GMCSF		Colony-stimulating factor-2 (granulocyte-macrophage)	138960		order: cen-CSF2-CSF1-FMS-qter		11(Csfgm)
5.526	1	24	18	5q31.1	DDX46, PRP5, KIAA0801		DEAD-box helicase 46	617848				
5.527	7	11	93	5q31.2	EGR1		Early growth response-1	128990				18(Egr1)
5.528	10	24	00	5q31.2	ETF1, RF1, ERF1		Eukaryotic translation termination factor-1	600285				
5.529	6	13	12	5q31.1	FBXL21, FBL21, FBXL3B, FBL3B		F-box and leucine-rich repeat protein 21	609087				
5.530	6	13	18	5q31.1	GDF9, POF14		Growth/differentiation factor 9	601918		mutation identified in 1 patient	?Premature ovarian failure 14, 618014 (3)	
5.531	10	22	20	5q31.1	HSPA4		Heat-shock protein family A (HSP70), member 4	601113				
5.532	7	26	95	5q31.1	IGES		Immunoglobulin E concentration, serum	147061			{?Allergy and asthma susceptibility} (2)	
5.533	7	11	93	5q31.1	IL3		Interleukin-3	147740		9kb from CSF2; order: cen-5'IL3-5'CF2-qter		11(Il3)
5.534	7	11	93	5q31.1	IL4		Interleukin-4	147780				11(Il4)
5.535	3	22	93	5q31.1	IL5		Interleukin-5	147850		< 310kb from IL4		11(Il5)
5.536	7	11	93	5q31.1	IL9		Interleukin-9	146931				13(Il9)
5.537	5	13	10	5q31.1	IRF1, MAR		Interferon regulatory factor-1	147575			Myelodysplastic syndrome, preleukemic (3); Myelogenous leukemia, acute (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3)	11(Irf1)
5.538	4	6	15	5q31.1	LEAP2		Liver-expressed antimicrobial peptide 2	611373				11(Leap2)
5.539	2	24	15	5q31.1	MEIKIN		Meiotic kinetochore factor	616232				
5.540	5	26	13	5q31.1	PHF15, JADE2, KIAA0239		PHD finger protein 15	610515				11(Phf15)
5.541	3	14	07	5q31.1	RAPGEF6, RAGEF2, PDZGEF2		RAP guanine nucleotide exchange factor 6	610499				
5.542	9	2	03	5q31.1	RIL		LIM domain protein ril	603422			{Osteoporosis, susceptibility to}, 166710 (3)	
5.543	4	2	09	5q31.1	SAR1B, CMRD, SARA2, ANDD		Sar1a, S. cerevisiae, homolog 2	607690			Chylomicron retention disease, 246700 (3)	
5.544	3	13	15	5q31.1	SEC24A		SEC24-related gene family, member A	607183				
5.545	5	23	13	5q31.1	SHROOM1, APXL2, KIAA1960		SHROOM family member 1	611179				
5.546	10	27	04	5q31.1	SLC22A5, OCTN2, CDSP, SCD		Solute carrier, family 22 (organic cation transporter), member 5	603377			Carnitine deficiency, systemic primary, 212140 (3)	11(jvs)
5.547	12	30	14	5q31.1	SLC25A48		Solute carrier family 25, member 48	616150				
5.548	9	5	91	5q31.1	TCF7		Transcription factor-7, T-cell specific	189908		originally called TCF-1		11(Tcf7)
5.549	11	16	17	5q31.1	TXNDC15, C5orf14, BUG		Thioredoxin domain-containing protein 15	617778				
5.550	4	8	13	5q31.1	UQCRQ, QPC, MC3DN4		Ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kD	612080			Mitochondrial complex III deficiency, nuclear type 4, 615159 (3)	
5.551	4	23	15	5q31.1	WSPAR, lncTCF7		WNT signaling pathway activating noncoding RNA	616333				
5.552	2	9	14	5q31.1-q32	DFNA52, DFNA42		Deafness, autosomal dominant 52	607683		max lod at D5S2017	Deafness, autosomal dominant 52 (2)	
5.553	10	14	98	5q31.1	LECT2		Leukocyte cell-derived chemotaxin 2	602882				13(Lect2)
5.554	1	31	01	5q31.1-q33.1	IDDM18		Insulin-dependent diabetes mellitus-18	605598		close to IL12B	{Diabetes mellitus, insulin-dependent, 18} (2)	
5.555	2	26	09	5q31.1-q33.1	PSORS11		Psoriasis susceptibility 11	612599		associated with rs10045431	{Psoriasis susceptibility 11} (2)	
5.556	4	7	94	5q34	GABRA6		Gamma-aminobutyric acid (GABA) A receptor, alpha-6	137143				
5.557	9	27	17	5q31.2	BRD8, SMAP		Bromodomain-containing protein 8	602848				
5.558	12	6	16	5q31.2	FAM53C, C5orf6		Family with sequence similarity 53, member C	609372				
5.559	12	6	16	5q31.2	FAM13B, C5orf5		Family with sequence similarity 13, member B	609371				18(C5orf5)
5.560	3	17	16	5q31.2	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4		Heat-shock 70kD protein-9 (mortalin)	600548			Anemia, sideroblastic, 4, 182170 (3); Even-plus syndrome, 616854 (3)	18,X(mot2)
5.561	4	29	14	5q31.2	MATR3, MPD2, ALS21		Matrin 3	164015			Amyotrophic lateral sclerosis 21, 606070 (3)	
5.562	09	17	20	5q31.3	NDUFA2, MC1DN13		NADH-ubiquinone oxidoreductase subunit A2	602137			Mitochondrial complex I deficiency, nuclear type 13, 618235 (3)	
5.563	10	17	12	5q23.3	HINT1, PRKCNH1, NMAN		Histidine triad nucleotide-binding protein 1 (protein kinase C inhibitor 1)	601314			Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3)	
5.564	3	26	07	5q31.2	LRRTM2, KIAA0416		Leucine-rich repeat transmembrane protein 2	610868				18(Lrrtm2)
5.565	4	29	14	5q31.2	MZB1, PACAP, MGC29506		Marginal zone B and B1 cell-specific protein	609447				
5.566	8	20	07	5q31.2	PAIP2, PAIP2A		Polyadenylate-binding protein-interacting protein 2	605604				
5.567	1	20	06	5q31.1	PCBD2, DCOH2, DCOHM		Pterin-4-alpha-carbinolamine dehydratase 2	609836				
5.568	3	23	09	5q31.1	TIFAB		TRAF-interacting protein with forkhead-associated domain, family member B	612663				13(Tifab)
5.569	10	08	19	5q31.2	STING1, TMEM173, MPYS, SAVI		Stimulator of interferon response cGAMP interactor 1	612374			STING-associated vasculopathy, infantile-onset, 615934 (3)	
5.570	6	13	12	5q31.2	UBE2D2, UBCH5B, UBC4		Ubiquitin-conjugating enzyme E2D 2	602962				
5.571	8	20	14	5q31.2	WNT8A		Wingless-type MMTV integration site family, member 8A	606360				
5.572	8	31	09	5q31.2	SLC23A1, SVCT1		Solute carrier family 23 (nucleobase transporter), member 1 (sodium-dependent vitamin C transporter 1)	603790		opposite orientation to MATR3		18(Slc23a1)
5.573	4	15	11	5q32	PDE6A, PDEA, RP43		Phosphodiesterase-6A, cGMP-specific, rod, alpha	180071			Retinitis pigmentosa 43, 613810 (3)	18(Pde6a)
5.574	10	30	06	5q31.3	ANKHD1, MASK, KIAA1085, VBARP		Ankyrin repeat and KH domain-containing protein 1	610500				
5.575	2	24	17	5q31.3	ARAP3, CENTD3		ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3	606647				
5.576	5	12	09	5q31.2	CXXC5		CXXC finger protein 5	612752				
5.577	5	25	05	5q31.3	DND1		Dead end, zebrafish, homolog of, 1	609385				
5.578	04	22	20	5q31.3	DELE1, KIAA0141		DAP3 binding cell death enhancer 1	615741				
5.579	11	27	18	5q31.3	EIF4EBP3		Eukaryotic translation initiation factor 4E-binding protein 3	603483				
5.580	7	6	17	5q31.3	FCHSD1, NWK2		FCH and double SH3 domains protein 1	617555				18(Fchsd1)
5.581	08	21	19	5q31.3	HARS1, HARS, USH3B, CMT2W		Histidyl-tRNA synthetase 1	142810			Usher syndrome type 3B, 614504 (3); Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3)	
5.582	10	26	20	5q31.3	HARS2, HARSL, HARSR, HO3, PRLTS2		Histidyl-tRNA synthetase 2	600783			Perrault syndrome 2, 614926 (3)	
5.583	4	20	11	5q31.3	IK, RED		IK cytokine, downregulator of HLA II	600549				
5.584	7	26	10	5q31.3	KCTD16, KIAA1317		Potassium channel tetramerization domain-containing 16	613423				
5.585	6	10	08	5q31.3	NDFIP1, N4WBP5		NEDD4 family-interacting protein 1	612050				
5.586	2	16	18	5q13.3	POC5, C5orf37		POC5 centriolar protein	617880				
5.587	5	26	13	5q31.3	RELL2		Relt-like 2	611213				
5.588	11	05	18	5q31.3	SLC4A9, AE4		Solute carrier family 4 (anion exchanger), member 9	610207				
5.589	09	19	19	5q31.3	SPRY4, HH17		SPRY domain containing 4	607984			Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3)	
5.590	09	19	19	5q31.3	SPRY4IT1		SPRY4 intronic transcript 1	617617		in intron 2 of SPRY4		
5.591	8	31	09	5q31.3	SRA1		Steroid receptor RNA activator 1	603819				
5.592	10	25	12	5q31.1	H2AFY, MH2A1		H2A histone family, member Y	610054				
5.593	12	22	10	5q31.3-q32	HHT3, ORW3		Hereditary hemorrhagic telangiectasia, type 3	601101			Telangiectasia, hereditary hemorrhagic, type 3 (2)	
5.594	8	6	15	5q33.1	SPARC, ON, OI17		Osteonectin (secreted protein, acidic, cysteine-rich)	182120			Osteogenesis imperfecta, type XVII, 616507 (3)	11(Sparc)
5.595	11	23	09	5q33.1	GM2A		GM2 ganglioside activator protein	613109		pseudogene on chr.3	GM2-gangliosidosis, AB variant, 272750 (3)	11(Gm2a)
5.596	4	2	16	5q32	ABLIM3, KIAA0843		Actin-binding LIM protein family, member 3	611305				
5.597	5	19	06	5q32	ARSI		Arylsulfatase I	610009				
5.598	3	1	00	5q33.1	ATOX1, HAH1		Antioxidant protein 1 (ATX, yeast, homolog of)	602270				
5.599	09	06	18	5q32	CAMK2A, KIAA0968, CAMKA, MRD53, MRT63		Calcium/calmodulin-dependent protein kinase II-alpha	114078		mutation identified in 1 MRT63 family	Mental retardation, autosomal dominant 53, 617798 (3); ?Mental retardation, autosomal recessive 63, 618095 (3)	18(Camk2a)
5.600	6	10	94	5q33.1	CD74, DHLAG		CD74 antigen (invariant polypeptide of major histocompatibility class II antigen-associated)	142790				18(Ii)
5.601	06	21	19	5q32	CSF1R, FMS, HDLS, BANDDOS		Colony-stimulating factor-1 receptor; oncogene FMS (McDonough feline sarcoma)	164770		FMS2 is 5' end	Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3); Brain abnormalities, neurodegeneration, and dysosteosclerosis, 618476 (3)	18(Fim2)
5.602	1	13	11	5q32	CSNK1A1		Casein kinase-1, alpha-1 polypeptide	600505		previously assigned to 13q13		
5.603	1	30	01	5q32	DPYSL3, ULIP, DRP3		Dihydropyrimidinase-like 3	601168				
5.604	6	13	18	5q33.1	GLRA1, STHE, HKPX1		Glycine receptor, alpha-1 polypeptide	138491			Hyperekplexia 1, 149400 (3)	11(spd)
5.605	12	23	19	5q32	GPR151, GALRL, GALR4		G protein -coupled receptor 151	618487				18(Gpr151)
5.606	08	19	19	5q32	GRPEL2		GrpE-like 2, mitochondrial	618545				
5.607	7	7	14	5q32	GRXCR2, DFNB101		Glutaredoxin, cysteine-rich, 2	615762		mutation identified in 1 DFNB101 family	?Deafness, autosomal recessive 101, 615837 (3)	18(Grxcr2)
5.608	3	23	06	5q31.3	HLA-HB1		Minor histocompatibility antigen HB-1	609961				
5.609	3	27	13	5q33.3	ITK, EMT, LPFS1		T-cell-specific tyrosine kinase; homolog of mouse T-cell itk/tsk tyrosine kinase	186973			Lymphoproliferative syndrome 1, 613011 (3)	11(Itk)
5.610	5	23	13	5q32	JAKMIP2, JAMIP2, NECC1, KIAA0555		Janus kinase and microtubule-interacting protein 2	611197				
5.611	08	21	19	5q32	LARS1, LARS, LFIS, ILFS1		Leucyl-tRNA synthetase 1	151350		mutation identified in 1 family	?Infantile liver failure syndrome 1, 615438 (3)	
5.612	10	13	15	5q32	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS		Platelet-derived growth factor receptor, beta polypeptide	173410		fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders	Myeloproliferative disorder with eosinophilia, 131440 (4); Basal ganglia calcification, idiopathic, 4, 615007 (3); Myofibromatosis, infantile, 1, 228550 (3); Premature aging syndrome, Penttinen type, 601812 (3); Kosaki overgrowth syndrome, 616592 (3)	18(Pdgfr)
5.613	5	13	10	5q33.1	RPS14, EMTB		Ribosomal protein S14	130620			Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)	
5.614	6	7	10	5q32	SH3RF2, HEPP1		SH3 domain-containing RING finger protein 2	613377				
5.615	8	20	10	5q32	SH3TC2, KIAA1985, MNMN		SH3 domain and tetratricopeptide repeat domain 2	608206			Charcot-Marie-Tooth disease, type 4C, 601596 (3); Mononeuropathy of the median nerve, mild, 613353 (3)	
5.616	11	22	13	5q33.1	SMIM3, NID67		Small integral membrane protein 3	608324				
5.617	12	20	11	5q32	SPINK1, PSTI, PCTT, TATI, TCP		Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor)	167790			Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3); Tropical calcific pancreatitis, 608189 (3)	
5.618	7	17	14	5q32	SPINK6		Serine peptidase inhibitor, KAZAL-type, 6	615868				
5.619	5	6	13	5q32	SPINK13		Serine protease inhibitor, Kazal-type, 13	615205				
5.620	7	31	17	5q32	SPINK5, LEKTI		Serine protease inhibitor, Kazal type, 5	605010			Netherton syndrome, 256500 (3)	
5.621	1	9	17	5q32	SPINK7, ECRG2		Serine peptidase inhibitor, Kazal-type, 7	617288				
5.622	10	2	07	5q31.3	YIPF5, SMAP5, YIP1A		Yip1 domain family, member 5	611483				
5.623	09	26	19	5q33.3	ADAM19, MLTNB		ADAM metallopeptidase domain 19	603640				11(Adam19)
5.624	09	19	19	5q33.1	FAT2, MEGF1, SCA45		FAT atypical cadherin 2	604269			Spinocerebellar ataxia 45, 617769 (3)	
5.625	8	28	01	5q35.1	GABRP		Gamma-aminobutyric acid receptor, pi	602729				
5.626	6	15	99	5q31.3	PCDH1, PC42		Protocadherin 1 (cadherin-like 1)	603626				18(Pcdh1)
5.627	1	30	96	5q33.1	GPX3		Glutathione peroxidase-3, plasma	138321				
5.628	3	23	18	5q32	SLC26A2, DTD, DTDST, D5S1708, EDM4		Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter)	606718		distal to APC	Diastrophic dysplasia, 222600 (3); Achondrogenesis Ib, 600972 (3); Epiphyseal dysplasia, multiple, 4, 226900 (3); Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3); De la Chapelle dysplasia, 256050 (3); Atelosteogenesis, type II, 256050 (3)	
5.629	1	31	11	5q32-q33	TCOF1, MFD1, TCS1		Treacle	606847		prox. to SPARC	Treacher Collins syndrome 1, 154500 (3)	18(Tcof1)
5.630	5	7	03	5q33.1	TNIP1, NAF1, KIAA0113		TNFAIP3-interacting protein 1	607714				
5.631	3	5	98	5q33.3	TTC1, TPR1		Tetratricopeptide repeat domain-1	601963				
5.632	6	13	95	5q33.2	MFAP3		Microfibrillar-associated protein-3	600491				
5.633	12	4	14	5q33.1	NDST1, HSST, MRT46		N-deacetylase/N-sulfotransferase (heparan sulfate-N-deacetylase/N-sulfotransferase)	600853			Mental retardation, autosomal recessive 46, 616116 (3)	
5.634	12	16	05	5q32	ADRB2		Adrenergic, beta-2-, receptor, surface	109690			{Asthma, nocturnal, susceptibility to}, 600807 (3); {Obesity, susceptibility to}, 601665 (3); Beta-2-adrenoreceptor agonist, reduced response to (3)	18(Adrb2)
5.635	2	1	90	5q33.1	ANXA6, CBP68		Annexin A6 (calcium-binding protein p68)	114070				
5.636	8	28	97	5q34	CCNG1		Cyclin G1	601578				11(Ccng1)
5.637	4	5	00	5q32	IL17B		Interleukin 17B	604627				
5.638	7	11	93	5q33.3	ADRA1B		Adrenergic, alpha-1B-, receptor	104220				11(Adra1)
5.639	3	1	94	5q33.2	GRIA1, GLUR1		Glutamate receptor, ionotropic, AMPA 1	138248				11(Glur1)
5.640	2	28	08	5q33.2	MRPL22		Mitochondrial ribosomal protein L22	611835				
5.641	1	18	13	5q33.3	NIPAL4, ICHYN, ARCI6		NIPA-like domain-containing 4	609383			Ichthyosis, congenital, autosomal recessive 6, 612281 (3)	
5.642	05	02	19	5q32	PPARGC1B, PGC1B, PERC		Peroxisome proliferator-activated receptor-gamma, coactivator 1, beta	608886				
5.643	9	3	99	5q33.3	PTTG1, EAP1, TUTR1		Pituitary tumor-transforming gene 1	604147				
5.644	09	27	18	5q33.2-q33.3	SGCD, SGD, LGMDR6, CMD1L		Sarcoglycan, delta (35kD dystrophin-associated glycoprotein)	601411		mutant in Syrian hamster cardiomyopathy	Muscular dystrophy, limb-girdle, autosomal recessive 6, 601287 (3); Cardiomyopathy, dilated, 1L, 606685 (3)	
5.645	12	29	06	5q35.3	F12, HAF, HAE3		Coagulation factor XII (Hageman factor)	610619			Factor XII deficiency, 234000 (3); Angioedema, hereditary, type III, 610618 (3)	
5.646	9	5	91	5q32	RPS20B		Ribosomal protein S20B	180464		?pseudogene		
5.647	1	5	12	5q32	AFAP1L1		Actin filament-associated protein 1-like 1	614410				
5.648	8	31	12	5q33.1	DCTN4, P62, DYN4		Dynactin 4	614758				
5.649	12	24	13	5q32	FBXO38, FBX38, MOKA, HMN2D		F-box only protein 38	608533			Neuronopathy, distal hereditary motor, type IID, 615575 (3)	18(Fbxo38)
5.650	9	2	11	5q33.1	G3BP1, G3BP		GTPase-activating protein SH3 domain-binding protein 1	608431				
5.651	8	2	16	5q33.1	IRGM, LRG47, IFI1, IBD19		Immunity-related GTPase family, M	608212			{Mycobacterium tuberculosis, protection against}, 607948 (3); {Inflammatory bowel disease (Crohn disease) 19}, 612278 (3)	
5.652	2	3	05	5q33.2	KIF4B		Kinesin family member 4B	609184				
5.653	3	23	09	5q32	MIR143, MIRN143		Micro RNA 143	612117				
5.654	3	23	09	5q32	MIR145, MIRN145		Micro RNA 145	611795				
5.655	3	23	09	5q32	MIR378, MIRN378		Micro RNA 378	611957				
5.656	5	19	06	5q33.1	NMUR2, NMU2R, FM4		Neuromedin U receptor 2	605108				
5.657	12	4	08	5q33.1	RBM22		RNA-binding motif protein 22	612430				
5.658	4	20	10	5q33.1	SLC36A2, PAT2		Solute carrier family 36 (proton/amino acid symporter), member 2	608331			Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)	11(Slc36a2)
5.659	12	15	10	5q32	SPINK9, LEKTI2		Serine protease inhibitor, Kazal-type, 9	613511				
5.660	3	22	07	5q33.1	SYNPO		Synaptopodin	608155				
5.661	12	18	08	5q33.1	ZNF300		Zinc finger protein 300	612429				
5.662	3	4	10	5q33.1-q35.2	FECD5, FCD3		Corneal dystrophy, Fuchs endothelial, 5	613269		flanked by D5S470 and D5S2108	Corneal dystrophy, Fuchs endothelial, 5 (2)	
5.663	1	26	97	5q35.1	LCP2, SLP76		Lymphocyte cytosolic protein-2 (SH2 domain-containing leukocyte protein of 76kD)	601603				
5.664	10	1	17	5q33.2	HAND1, EHAND		Heart- and neural crest derivatives-expressed 1	602406				
5.665	1	27	04	5q33.2	GALNT10, GalNAcT10		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10	608043				
5.666	8	31	09	5q33.2	GEMIN5		GEM-associated protein 5	607005				
5.667	7	31	17	5q33.3	HAVCR1, HAVCR		Hepatitis A virus cellular receptor 1	606518				
5.668	04	24	19	5q33.3	HAVCR2, TIM3, SPTCL		Hepatitis A virus cellular receptor 2	606652			T-cell lymphoma, subcutaneous panniculitis-like, 618398 (3)	11(Tim3)
5.669	12	7	07	5q34	HMMR		Hyaluronan-mediated motility receptor (RHAMM)	600936			{Breast cancer, susceptibility to}, 114480 (3)	11(hmmr)
5.670	10	30	19	5q33.2	LARP1, LARP, KIAA0731		La ribonucleoprotein 1, translational regulator	612059		incorrectly mapped to chromosome 10		
5.671	8	19	13	5q33.2	SAP30L		SAP30-like protein	610398				
5.672	8	19	13	5q33.3	TIMED4, TIM4, SMUCKLER		T-cell immunoglobulin and mucin domains-containing protein 4	610096				11(Tim4)
5.673	10	30	19	5q33.3	C1QTNF2, CTRP2		C1q- and TNF-related protein 2	618647				
5.674	5	4	09	5q33.3	CLINT1, EPN4, EPNR, KIAA0171		Clathrin interactor 1 (epsin 4)	607265				
5.675	12	01	20	5q33.3	CYFIP2, DEE65		Cytoplasmic FMRP interacting protein 2	606323			Developmental and epileptic encephalopathy 65, 618008 (3)	
5.676	5	19	15	5q33.3	IL12B, NKSF2, IMD29		Interleukin-12B (natural killer cell stimulatory factor-2, cytotoxic lymphocyte maturation factor-2, p40)	161561		between GLR1 and GABRA1	Immunodeficiency 29, mycobacteriosis, 614890 (3)	11(Il12b)
5.677	4	6	18	5q33.3	LSM11		Lsm11, U7 small nuclear RNA-associated protein	617910				
5.678	8	31	09	5q33.3	MED7, CRSP9, CRSP33		Mediator complex subunit 7	605045				
5.679	2	23	09	5q33.3	MIR146A, MIRN146A		Micro RNA 146A	610566				
5.680	12	22	17	5q33.3	PWWP2A		PWWP domain-containing protein 2A	617823				
5.681	7	2	18	5q33.3	SOX30		SRY-box 30	606698				
5.682	03	16	20	5q33.3	THG1L, THG1, ICF45, IHG1, SCAR28		tRNA-histidine guanylyltransferase 1-like protein	618802			Spinocerebellar ataxia, autosomal recessive 28, 618800 (3)	
5.683	2	7	06	5q33.3	UBLCP1		Ubiquitin-like domain-containing CTD phosphatase 1	609867				
5.684	10	25	19	5q33.3	ZBED8, C5orf54, BUSTER3		Zinc finger BED-type containing 8	615253				
5.685	12	14	95	5q35.1	DUSP1, CL100, PTPN10		Dual specificity phosphatase-1	600714				
5.686	8	10	98	5q33.3	EBF, OLF1		Early B-cell factor (olfactory neuronal transcription factor 1)	164343				11(Ebf)
5.687	1	23	01	5q35.1	FGF18		Fibroblast growth factor-18	603726				
5.688	12	7	07	5q35.1	FOXI1, FKHL10, FREAC6		Forkhead box I1	601093		some patients have digenic mutations with SLC26A4	Enlarged vestibular aqueduct, 600791 (3)	
5.689	12	01	20	5q34	GABRG2, DEE74, FEB8, ECA2, GEFSP3		Gamma-aminobutyric acid (GABA) A receptor, gamma-2	137164		in alpha/beta/gamma cluster	Epilepsy, generalized, with febrile seizures plus, type 3, 607681 (3); Febrile seizures, familial, 8, 607681 (3); Developmental and epileptic encephalopathy 74, 618396 (3)	
5.690	5	6	04	5q35.1	KCNMB1		Potassium large conductance calcium-activated channel, subfamily M, beta member 1	603951			{Hypertension, diastolic, resistance to}, 608622 (3)	
5.691	11	11	19	5q34	MAT2B		Methionine adenosyltransferase II, beta	605527				
5.692	12	21	09	5q34	MIR103-1, MIRN103-1		Micro RNA 103-1	613187				
5.693	1	29	16	5q34	MIR218-2		Micro RNA 218-2	616771		in intron of SLIT3		11(Mir218-2)
5.694	9	23	13	5q35.1	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2		NK2 homeobox-5 gene	600584		near border with 5q35	Atrial septal defect 7, with or without AV conduction defects, 108900 (3); Tetralogy of Fallot, 187500 (3); Hypothyroidism, congenital nongoitrous, 5, 225250 (3); Ventricular septal defect 3, 614432 (3); Hypoplastic left heart syndrome 2, 614435 (3); Conotruncal heart malformations, variable, 217095 (3)	17(Csx)
5.695	1	3	02	5q35.1	RANBP17		RAN-binding protein 17	606141				
5.696	08	21	19	5q34	RARS1, RARS, HLD9		Arginyl-tRNA synthetase 1	107820			Leukodystrophy, hypomyelinating, 9, 616140 (3)	
5.697	2	5	15	5q34	TENM2, ODZ2, TNM2, KIAA1127		Teneurin transmembrane protein 2	610119				
5.698	1	22	18	5q34	GABRB2, ICEE2		Gamma-aminobutyric acid (GABA) A receptor, beta-2	600232			Epileptic encephalopathy, infantile or early childhood, 2, 617829 (3)	
5.699	10	23	20	5q34	GABRA1, EJM5, ECA4, DEE19		Gamma-aminobutyric acid (GABA) A receptor, alpha-1	137160		in same 200kb as GABRG2	{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3); {Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3); Developmental and epileptic encephalopathy 19, 615744 (3)	11(Gabra1)
5.700	6	15	99	5q35.3	GFPT2, GFAT2		Glutamine: fructose-6-phosphate amidotransferase 2	603865				11(Gfat2)
5.701	08	21	19	5q35.2	MSX2, CRS2, HOX8		msh homeobox 2	123101			Craniosynostosis 2, 604757 (3); Parietal foramina 1, 168500 (3); Parietal foramina with cleidocranial dysplasia, 168550 (3)	
5.702	11	4	05	5q34-q35.2	NIDDM4		Diabetes mellitus, noninsulin-dependent, 4	608036			{Diabetes mellitus, noninsulin-dependent}, 125853 (2)	
5.703	1	14	14	5q34	WWC1, KIBRA, KIAA0869, MEMRYQTL		WW, C2, and coiled-coil domain-containing 1	610533			[Memory, enhanced, QTL], 615602 (3)	
5.704	09	26	19	5p13.3-p13.2	ADAMTS12		ADAM metallopeptidase with thrombospondin type 1 motif, 12	606184				
5.705	8	28	01	5q35.3	BTNL3		Butyrophilin-like protein 3	606192				
5.706	2	28	94	5q35.3	CANX		Calnexin	114217				
5.707	10	23	87	5q35	CHR		Chromate resistance (sulfate transport)	118840				
5.708	2	25	15	5q35.3	CLK4		CDC-like kinase 4	607969				
5.709	6	9	06	5q35.3	COL23A1		Collagen, type XXIII, alpha-1	610043				11(Col23a1)
5.710	5	29	12	5q35.3	GRK6, GPRK6		G protein-coupled receptor kinase 6	600869				
5.711	1	31	13	5q35.3	GRM6, MGLUR6, CSNB1B		Glutamate receptor, metabotropic, 6	604096			Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3)	
5.712	7	1	11	5q35.3	LTC4S		Leukotriene C4 synthase	246530			Leukotriene C4 synthase deficiency, 614037 (1)	
5.713	2	23	09	5q35.3	MAML1		Mastermind, Drosophila, homolog of, 1	605424				
5.714	11	20	98	5q35.3	MAPK9, PRKM9, JNK2		Mitogen-activated protein kinase 9	602896				
5.715	11	4	98	5q35.3	MGAT1, GLYT1		Mannosyl (alpha-1,3-)-glycoprotein beta-1,2, N-acetylglucosaminyltransferase	160995				11(Glyt1)
5.716	3	8	00	5q35.3	MGAT4B		Alpha-1,3-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B	604561				
5.717	03	10	20	5q35.3	NSD1, ARA267, STO, SOTOS1		Nuclear receptor binding SET domain protein 1	606681		fusion gene with NUP98 in AML	Sotos syndrome 1, 117550 (3)	
5.718	8	27	15	5q35.1	NPM1		Nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin)	164040		fused with RARA in APL	Leukemia, acute myeloid, somatic, 601626 (3)	
5.719	7	9	06	5q34	PANK3		Pantothenate kinase 3	606161				
5.720	3	25	02	5q35.3	SCGB3A1, HIN1		Secretoglobin, family 3A, member 1	606500				
5.721	5	25	17	5q35.3	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2		Solute carrier family 34 (sodium phosphate cotransporter), member 1	182309		mutation identified in 1 FRTS2 family	Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3); ?Fanconi renotubular syndrome 2, 613388 (3); Hypercalcemia, infantile, 2, 616963 (3)	13(Slc17a2)
5.722	09	12	19	5q34-q35	SLIT3, SLIL2, MEGF5		SLIT guidance ligand 3	603745				
5.723	6	21	05	5q35.2	SNCB		Synuclein, beta	602569			Dementia, Lewy body, 127750 (3)	
5.724	11	23	16	5q35.3	SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV		Sequestosome 1	601530			Paget disease of bone 3, 167250 (3); Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3); Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset, 617145 (3); Myopathy, distal, with rimmed vacuoles, 617158 (3)	
5.725	6	5	08	5q35.1	UBTD2, DCUBP, MGC30022		Ubiquitin domain-containing protein 2	610174				
5.726	2	25	08	5q35.2	UIMC1, RAP80		Ubiquitin interaction motif containing 1	609433				
5.727	8	20	07	5q35.1	ATP6V0E1, ATP6H		ATPase, H+ transporting, V0 subunit e1	603931		previously mapped to Chr.2		
5.728	6	22	12	5q35.1	BNIP1, NIP1		BCL2/adenovirus E1B 19kD protein-interacting protein 1	603291				
5.729	9	2	16	5q35.1	CREBRF, LRF, C5orf41		CREB3 recruitment factor	617109				
5.730	6	23	15	5q35.1	DOCK2, IMD40		Dedicator of cytokinesis 2	603122			Immunodeficiency 40, 616433 (3)	
5.731	8	24	92	5q35.2	DRD1		Dopamine receptor D1	126449		same 300kb fragment as GRL		
5.732	07	26	19	5q35.1	EFCAB9		EF-hand calcium-binding domain 9	618520				
5.733	06	16	20	5q35.1	FBXW11, FBXW1B, BTRC2, BTRCP2, NEDJED		F-box and WD40 domain protein 11	605651			Neurodevelopmental, jaw, eye, and digital syndrome, 618914 (3)	11(Fbxw11)
5.734	3	29	10	5q35.1	SH3PXD2B, TKS4, KIAA1295, FTHS		SH3 and PX domains-containing protein 2B	613293			Frank-ter Haar syndrome, 249420 (3)	11(Sh3pxd2b)
5.735	4	2	16	5q35.1	SNORA74B		Small nucleolar RNA, H/ACA box, 74B	611331		in intron 3 of ATP6V0E1		
5.736	6	3	15	5q35.1	SPDL1, CCDC99, SPINDLY		Spindly apparatus coiled-coil protein 1	616401				
5.737	3	31	15	5q35.2	STC2, STCRP		Stanniocalcin 2	603665				
5.738	6	22	99	5q35.1	STK10, LOK		Serine/threonine protein kinase-10	603919				11(Stk10)
5.739	7	15	02	5q35.1	TLX3, HOX11L2, RNX		T-cell leukemia, homeobox 3	604640		activated in T-cell ALL		11(Hox11l2)
5.740	2	20	03	5q35.2	FGFR4		Fibroblast growth factor receptor-4	134935		distal to DRD1	{Cancer progression/metastasis} (3)	13(Fgfr4)
5.741	1	11	16	5q35.2	BOD1, FAM44B		Biorientation of chromosomes in cell division 1	616745				
5.742	9	29	10	5q35.2	CLTB		Clathrin, light polypeptide (Lcb)	118970		previously mapped to chr. 4		
5.743	8	17	09	5q35.2	CPLX2, CPX2		Complexin 2	605033				
5.744	07	31	20	5q35.1	ERGIC1, ERGIC32, KIAA1181, AMC2		Endoplasmic reticulum-golgi intermediate compartment protein 1	617946		mutation identified in 1 AMCN family	?Arthrogryposis multiplex congenita 2, neurogenic type, 208100 (3)	
5.745	5	2	16	5q35.2	FAF2, ETEA, UBXD8, KIAA0887		Fas-associated factor family, member 2	616935				
5.746	5	26	13	5q35.2	GPRIN1, GRIN1, KIAA1893		G protein-regulated inducer of neurite outgrowth 1	611239				
5.747	9	28	96	5q35.2	HK3		Hexokinase-3, white cell	142570				
5.748	1	13	16	5q35.2	HMP19, NSG2		Hypothalamus golgi apparatus-expressed protein, 19kD	616752				
5.749	7	2	18	5q35.2	HRH2		Histamine receptor H2	142703				
5.750	7	7	09	5q35.2	MENOQ4		Menopause, natural, age at, QTL4	612886		associated with rs365132, rs7718874, rs402511, rs691141, rs2278493	{Menopause, natural, age at, QTL4} (2)	
5.751	7	13	09	5q35.2	NOP15, HSPC111		Nop16, S. cerevisiae, homolog of	612861				
5.752	7	15	09	5q35.3	PFN3		Profilin 3	612812				
5.753	12	29	13	5q35.2	SFXN1		Sideroflexin 1	615569				13(Sfxn1)
5.754	09	06	18	5q35.2	SIMC1, PLEIAD		SUMO-interacting motifs-containing protein 1	618102				
5.755	8	31	09	5q35.2	THOC3, TEX1		THO complex 3 (Tex1, yeast, homolog of)	606929				
5.756	09	11	19	5q35.2	UNC5A, UNC5H1		unc-5 netrin receptor A	607869				
5.757	9	27	17	5q35.2	ZNF346, JAZ		Zinc finger protein 346	605308				
5.758	12	22	17	5q35.3	B4GALT7, XGALT1, XGPT1, EDSSPD1		Beta-1,4-galactosyltransferase 7	604327			Ehlers-Danlos syndrome, spondylodysplastic type, 1, 130070 (3)	
5.759	2	2	14	5q35.3	BTNL8, BTN9.2		Butyrophilin-like protein 8	615606				
5.760	9	9	08	5q35.3	CNOT6, CCR4, KIAA1194		CCR4-NOT transcription complex, subunit 6	608951				
5.761	8	31	09	5q35.3	DBN1		Drebrin-1	126660				13(Dbn1)
5.762	07	14	20	5q35.3	DDX41, ABS, MPLPF		DEAD-box helicase 41	608170			{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3)	
5.763	7	26	10	5q35.3	DOK3, DOKL		Docking protein 3	611435				
5.764	7	14	14	5q35.3	FAM193B, IRIZIO, KIAA1931		Family with sequence similarity 193, member B	615813				
5.765	02	18	20	5q35.3	FLT4, VEGFR3, PCL, LMPHM1, CHTD7		fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3)	136352			Lymphatic malformation 1, 153100 (3); Hemangioma, capillary infantile, somatic, 602089 (3); Congenital heart defects, multiple types, 7, 618780 (3)	11(Flt4)
5.766	10	25	19	5q35.3	GMCL2		Germ cell-less 2, spermatogenesis associated	618629				
5.767	8	8	13	5q35.3	GNB2L1, RACK1		Guanine nucleotide-binding protein, beta-2-like 1	176981				
5.768	10	07	19	5q35.3	HEIH, LINC00848		Hepatocellular carcinoma-upregulated EZH2-associated long noncoding RNA	618615				
5.769	3	25	96	5q35.3	HNRPH1		Heterogeneous nuclear ribonucleoprotein H	601035				
5.770	6	30	05	5q35.3	MXD3, MAD3		MAX dimerization protein 3	609450				
5.771	10	12	16	5q35.3	MRNIP, C5orf45		MRN complex-interacting protein	617154				
5.772	7	1	11	5q35.3	NOLA2, NHP2, DKCB2		Nucleolar protein family A, member 2	606470			Dyskeratosis congenita, autosomal recessive 2, 613987 (3)	
5.773	3	8	04	5q35.3	PDLIM7, ENIGMA		PDZ and LIM domain 7 (enigma)	605903				
5.774	5	19	15	5q35.3	PHYKPL, AGXT2L2, PHLU		5-phosphohydroxy-L-lysine phospho-lyase	614683		mutation identified in 1 PHLU patient	[?Phosphohydroxylysinuria], 615011 (3)	
5.775	8	31	09	5q35.3	RGS14		Regulator of G protein signaling 14	602513				
5.776	7	22	09	5q35.3	PRELID1, PRELI, PX19		PRELI domain-containing protein 1	605733				
5.777	02	08	19	5q35.3	PRR7		Proline-rich protein 7	618306				
5.778	12	18	08	5q35.3	RAB24		Ras-associated protein 24	612415				
5.779	8	19	13	5q35.3	RUFY1		RUN and FYVE domains-containing protein 1	610327				
5.780	6	28	18	5q35.3	TBC1D9B, KIAA0676		TBC domain family, member 9B	618039				
5.781	3	18	98	5q35.3	TCF17, KID1		Transcription factor-17	602444				11(Tcf17)
5.782	7	1	05	5q35.3	TRIM7, GNIP		Tripartite motif-containing protein 7	609315				
5.783	10	30	06	5q35.3	TRIM41		Tripartite motif-containing 41	610530				
5.784	7	17	14	5q35.3	TRK-CTT2-4, TRNAK2, TRK2		Transfer RNA lysine (CTT) 2-4	612996				
5.785	10	24	14	5q35.3	TRP-TGG3-5, TRNAP3, TRP3		Transfer RNA-Pro (TGG) 3-5	189912				
5.786	10	24	14	5q35.3	TRT-TGT6-1, TRNAT1, TRT1		Transfer RNA-Thr (TGT) 6-1	189913				
5.787	7	18	14	5q35.3	TRV-AAC1-4, TRNAV1, TRV1		Transfer RNA valine (AAC) 1-4	189921				
5.788	7	17	14	5q35.3	TRV-CAC1-2, TRNAV2, TRV2		Transfer RNA valine (CAC) 1-2	612995				
5.789	4	21	10	5q35.3	ZFP62		Zinc finger protein 62	610281				11(Zfp62)
5.790	7	10	15	6q22.31	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3		Gap junction protein, alpha-1, 43kD (connexin 43)	121014		pseudogene on chr.5	Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III, 186100 (3); Hypoplastic left heart syndrome 1, 241550 (3); Atrioventricular septal defect 3, 600309 (3); Oculodentodigital dysplasia, autosomal recessive, 257850 (3); Craniometaphyseal dysplasia, autosomal recessive, 218400 (3); Erythrokeratodermia variabilis et progressiva 3, 617525 (3); Palmoplantar keratoderma with congenital alopecia, 104100 (3)	10(Gja1)
6.1	1	16	07	6p21.2	ZFAND3, TEX27		Zinc finger AN1 domain-containing protein 3	607455				
6.2	2	17	09	6pter-p24	DEL6pter, C6DELpter		Chromosome 6pter-p24 deletion syndrome	612582			Chromosome 6pter-p24 deletion syndrome (4)	
6.3	2	28	03	6p21.33	MDC1, NFBD1, KIAA0170		Mediator of DNA damage checkpoint protein 1	607593				
6.4	12	01	20	6p21.1	CNPY3, TNRC5, PRAT4A, ERDA5, DEE60		Canopy 3, zebrafish, homolog of	610774			Developmental and epileptic encephalopathy 60, 617929 (3)	
6.5	10	1	95	6p25.2	ELANH2, EI		Protease inhibitor 2 (anti-elastase), monocyte/neutrophil derived	130135				
6.6	3	8	91	6p21.31	CLPS		Colipase, pancreatic	120105				
6.7	5	9	07	6p21.31	ITPR3		Inositol 1,4,5-triphosphate receptor, type 3	147267			{Diabetes, type 1, susceptibility to}, 222100 (2)	
6.8	2	12	16	6p25.3	DUSP22, LMWDSP2, MKPX, VHX, JKAP, JSP1		Dual-specificity phosphatase 22	616778				
6.9	8	1	13	6p25.3	EXOC2, SEC5L1, SEC5		Exocyst complex component 2	615329				
6.10	12	4	98	6p25.3	FOXF2, FKHL6, FREAC2		Forkhead box F2	603250				
6.11	11	15	05	6p25.3	HUS1B		Hydroxyurea-sensitive 1, S. pombe, homolog of, B	609713				
6.12	12	4	03	6p24.3	CTAG3, CAGE1		Cancer/testis antigen 3	608304				
6.13	4	22	10	6p25.3-p22.3	INTLQ3		Intelligence quantitative trait locus 3	610294			{Intelligence QTL3} (2)	
6.14	11	11	14	6p25.2	ECI2, PECI, DRS1		Enoyl-CoA delta isomerase 2	608024				
6.15	7	20	12	6p25.2	FAM60B, X5L		Family with sequence similarity 50, member B	614686				
6.16	09	19	19	6p25.2	PRPF4B, PRP4		Pre-mRNA processing factor 4B	602338				
6.17	6	27	17	6p25.2	PSMG4, PAC4, C6orf86		Proteasome assembly chaperone 4	617550				
6.18	04	28	20	6p25.2	RIPK1, RIP1, RIP, IMD57, AIEFL		Receptor-interacting serine/threonine kinase 1	603453			Immunodeficiency 57 with autoinflammation, 618108 (3); Autoinflammation with episodic fever and lymphadenopathy, 618852 (3)	
6.19	1	2	08	6p25.2	SLC22A23, C6orf85		Solute carrier family 22, member 23	611697				19(Slc22a23)
6.20	4	29	14	6p25.2	TUBB2A, CDCBM5		Tubulin, beta-2A	615101			Cortical dysplasia, complex, with other brain malformations 5, 615763 (3)	
6.21	7	26	17	6p25.2	TUBB2B, CDCBM7		Tubulin, beta-2B	612850		TUBB2A is 70kb telomeric to TUBB2B	Cortical dysplasia, complex, with other brain malformations 7, 610031 (3)	
6.22	6	8	15	6p24.3	TXNDC5, ERP46, ENDOPDI, HCC2		Thioredoxin domain-containing protein 5	616412				13(Txndc5)
6.23	10	29	03	6p25.2	WRNIP1, WHIP		Werner helicase-interacting protein 1	608196				
6.24	9	1	09	6p25.1	CDYL		Chromodomain protein on Y chromosome-like	603778				13(Cdyl)
6.25	2	19	18	6p25.1	FARS2, FARS1, COXPD14, SPG77		Phenylalanyl-tRNA synthetase 2, mitochondrial	611592			Combined oxidative phosphorylation deficiency 14, 614946 (3); Spastic paraplegia 77, autosomal recessive, 617046 (3)	
6.26	11	11	14	6p25.1	LY86, MD1		Lymphocyte antigen 86	605241				
6.27	1	9	14	6p25.1	LYRM4, ISD11, C6orf149, COXPD19		LYR motif-containing protein 4	613311		mutation identified in 1 family	?Combined oxidative phosphorylation deficiency 19, 615595 (3)	
6.28	9	10	09	6p25.1	NRN1, NRN		Neuritin 1	607409				
6.29	9	10	09	6p25.1	RPP40		Ribonuclease P, 40kD subunit	606117				
6.30	9	18	08	6p24.3	EEF1E1		Eukaryotic translation elongation factor 1, epsilon-1	609206				
6.31	10	26	98	6p25.2	BPHL		Biphenyl hydrolase-like	603156				
6.32	1	27	09	6p25	CLLS4		Leukemia, chronic lymphocytic susceptibility to, 4	612558		associated with rs872071	{Leukemia, chronic lymphocytic susceptibility to, 4} (2)	
6.33	1	26	17	6p25.3	FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3		Forkhead, Drosophila, homolog-like 7	601090			Anterior segment dysgenesis 3, multiple subtypes, 601631 (3); Axenfeld-Rieger syndrome, type 3, 602482 (3)	13(Fkhl7, ch, Mfl)
6.34	9	22	14	6p25.3	FOXCUT, LINC01379		FOXC1 upstream transcript, noncoding	615976				
6.35	5	19	09	6p25.3	FOXQ1, HFH1		Forkhead box Q1	612788				13(Foxq1)
6.36	11	20	98	6p25.3	GMDS		GDP-mannose 4,6-dehydratase	602884				
6.37	4	15	04	6p25	LRSL		Larsen-like syndrome	608545			Larsen-like syndrome (2)	
6.38	4	6	10	6p25.2	NQO2, NMOR2		NAD(P)H dehydrogenase, quinone 2 (NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2)	160998			{?Breast cancer susceptibility}, 114480 (1)	
6.39	11	5	97	6p25.2	PI9, CAP3, SERPINB9		Protease inhibitor 9, ovalbumin type	601799				
6.40	5	28	98	6p24.3	RREB1		RAS-responsive element binding protein-1	602209				
6.41	7	28	14	6p25.2	SERPINB6, PI6, PTI, SPI3, DFNB91		Protease inhibitor 6 (placental thrombin inhibitor)	173321		mutation identified in 1 DFNB91 family	?Deafness, autosomal recessive 91, 613453 (3)	13(Spi3)
6.42	11	2	11	6p25.1	F13A1, F13A		Coagulation factor XIII, A polypeptide	134570			Factor XIIIA deficiency, 613225 (3); {Myocardial infarction, protection against}, 608446 (3); {Venous thrombosis, protection against}, 188050 (3)	
6.43	11	24	14	6p25.3	IRF4, LSIRF, SHEP8		Interferon regulatory factor-4	601900		dysregulated in t(6;14)	[Skin/hair/eye pigmentation, variation in, 8], 611724 (3)	
6.44	9	2	08	6p24.3	HULC		Highly upregulated in liver cancer	612210				
6.45	9	1	95	6p24.3	OFC1, CL		Orofacial cleft-1 (cleft lip with or without cleft palate; isolated cleft palate)	119530		probable heterogeneity	Orofacial cleft-1 (2)	
6.46	4	17	13	6p24.3	BLOC1S5, BLOS5, MUTED		Biogenesis of lysosome-related organelles complex 1, subunit 5	607289				13(mu)
6.47	10	31	17	6p24.3	RIOK1, RIO1		RIO kinase 1	617753				
6.48	3	15	07	6p24.3	SLC35B3, PAPST2		Solute carrier family 25 (3'-phosphoadenosine 5'-phosphosulfate transporter), member B3	610845				
6.49	6	13	12	6p24.3	SSR1		Signal sequence receptor, alpha	600868				
6.50	03	27	19	6p24.3	TFAP2AAS2, HIPSTR		TFAP2A antisense RNA 2	617136		overlaps TFAP2A		13(Hipstr)
6.51	2	23	08	6p24.2	ELOVL2, SSC2		Elongation of very long chain fatty acids-like 2	611814				
6.52	05	14	20	6p24.2	GCM2, GCMB, HRPT4, FIH2		Glial cells missing transcription factor 2	603716			Hypoparathyroidism, familial isolated 2, 618883 (3); Hyperparathyroidism 4, 617343 (3)	
6.53	8	25	11	6p24.2	MAK, RP62		Male germ cell-associated kinase	154235			Retinitis pigmentosa 62, 614181 (3)	13(Mak)
6.54	9	10	12	6p24.2	NEDD9, HEF1, CASL		Neural precursor cell expressed, developmentally downregulated 9	602265				
6.55	12	28	08	6p24.2	PAK1IP1, PIP1		PAK1-interacting protein	607811				
6.56	2	9	16	6p24.2	SYCP2L, C6orf177		Synaptonemal complex protein 2-like	616799				
6.57	7	22	13	6p24.2	TMEM14C		Transmembrane protein 14C	615318				
6.58	11	19	11	6p24.1	C6orf105, ADTRP		Chromosome 6 open reading frame 105 (androgen-dependent TFPI-regulating protein)	614348				
6.59	5	26	13	6p24.2	ERVFRD-1		Endogenous retrovirus group FRD, member 1	610524				
6.60	12	01	20	6p24.1	PHACTR1, KIAA1733, DEE70		Phosphatase and actin regulator 1	608723			Developmental and epileptic encephalopathy 70, 618298 (3)	
6.61	8	22	14	6p24.1	TBC1D7, PIG51, TBC7, MGCPH		TBC1 domain family, member 7	612655			Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3)	
6.62	7	1	11	6p24.1-p22.3	DFNA21		Deafness, autosomal dominant 21	607017		previously mapped to 6p21.3	Deafness, autosomal dominant 21 (2)	
6.63	11	24	14	6p24.3	DSP, KPPS2, PPKS2, DCWHKTA		Desmoplakin	125647		splice variants result in DP I and DP II	Keratosis palmoplantaris striata II, 612908 (3); Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3); Arrhythmogenic right ventricular dysplasia 8, 607450 (3); Skin fragility-woolly hair syndrome, 607655 (3); Epidermolysis bullosa, lethal acantholytic, 609638 (3); Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3)	
6.64	11	19	11	6p24.3	OFCC1, MRDS1		OFC1 candidate gene 1	614287				
6.65	6	27	08	6p24.3	TFAP2A, AP2TF, BOFS		Transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha)	107580			Branchiooculofacial syndrome, 113620 (3)	13(Tcfap2)
6.66	2	18	98	6p24.3	BMP6		Bone morphogenetic protein-6	112266				
6.67	3	24	14	6p24.1	EDN1, ARCND3, QME, HDLCQ7		Endothelin-1	131240			Auriculocondylar syndrome 3, 615706 (3); Question mark ears, isolated, 612798 (3); {High density lipoprotein cholesterol level QTL 7} (3)	13(Edn1)
6.68	5	6	15	6p24.3-p24.2	GCNT2, Ii, CTRCT13		Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme	600429		previously assigned to 9q21	[Blood group, Ii], 110800 (3); Cataract 13 with adult i phenotype, 116700 (3); Adult i phenotype without cataract, 110800 (3)	
6.69	8	18	97	6p22.3	JMJ		Jumonji	601594				13(jmj)
6.70	11	3	92	6p24.1	HIVEP1, ZNF40		Human immunodeficiency virus type I enhancer-binding protein-1	194540				
6.71	5	4	00	6p23	CD83, HB15, BL11		CD83 antigen	604534				13(Cd83)
6.72	12	13	96	6p22.3	ATXN1, ATX1, SCA1		Ataxin-1	601556			Spinocerebellar ataxia 1, 164400 (3)	13(Sca1, Atx1)
6.73	2	22	00	6p22.3	DEK, D6S231E		DEK oncogene	125264		fused with CAN in t(6;9)	Leukemia, acute nonlymphocytic (2)	
6.74	11	22	17	6p23	ETM3		Tremor, hereditary essential, 3	611456		max lod at D6S1630 and D6S1605	Essential tremor, hereditary, 3 (2)	
6.75	04	30	19	6p22.3	FAM8A1		Family with sequence similarity 8, member A1	618409				13(Fam8a1)
6.76	3	18	94	6p22.3	GMPR, GMPR1		Guanosine monophosphate reductase	139265				
6.77	1	22	08	6p22.3	MBOAT1		Membrane-bound O-acetyltransferase domain-containing 1	611732				
6.78	5	23	16	6p23	MCUR1, CCDC90A, FMP32		Mitochondrial calcium uniporter regulator 1	616952				
6.79	1	5	09	6p23	NOL7		Nucleolar protein 7	611533				
6.80	6	13	02	6p23	RANBP9, RANBPM		RAN-binding protein 9	603854				
6.81	12	14	98	6p23	SCZD3		Schizophrenia susceptibility locus, chromosome 6-related	600511		?same as DTNBP1; cognitive deficit type	{Schizophrenia}, 181500 (2)	
6.82	9	10	09	6p23	SIRT5		Sirtuin, S. cerevisiae, homolog 5	604483				
6.83	4	26	06	6p22.3	MYLIP, MIR		Myosin regulatory light chain-interacting protein	610082				
6.84	8	19	98	6p22.2	SLC17A1, NPT1		Solute carrier family 17, sodium phosphate, member-1 (Sodium phosphate transport 1, kidney)	182308				13(Slc17a1)
6.85	1	19	07	6p23-p21	SCAR3, SCABD		Spinocerebellar ataxia, autosomal recessive 3	271250			Spinocerebellar ataxia, autosomal recessive 3 (2)	
6.86	7	1	05	6p22.1	TRIM31, HCGI		Tripartite motif-containing protein 31	609316				
6.87	8	20	09	6p21.1	MEA1, MEA		Male-enhanced antigen 1	143170				
6.88	9	2	09	6p22.1	TRNAM2, TRNAMI2, RNTMI2		tRNA methionine-2	180620		2 of 12+ RNTMI genes are on chr. 6		
6.89	9	1	09	6p22.2	TRNAM1, TRMI2, TRM2, RNTMT1		tRNA methionine-1	180621				
6.90	3	7	14	6p22.3	ACOT13, THEM2		Acyl-CoA thioesterase 13	615652				
6.91	5	6	13	6p22.3	BWQTL4		Birth weight quantitative trait locus 4	615192		associated with rs7756992	[Birth weight QTL4] (2)	
6.92	04	15	19	6p22.3	CAP2		Cyclase-associated actin cytoskeleton regulatory protein 2	618385				
6.93	10	23	15	6p22.3	CASC15, LINC00340		Cancer susceptibility candidate 15, noncoding	616610				
6.94	3	20	18	6p22.3	CDKAL1		CDK5 regulatory subunit-associated protein 1-like 1	611259				
6.95	3	15	10	6p22.3	CIHL		Hearing loss, cisplatin-induced, susceptibility to	613290		associated with rs12201199	{?Hearing loss, cisplatin-induced, susceptibility to} (2)	
6.96	6	21	16	6p22.3	DTNBP1, HPS7		Dystrobrevin-binding protein 1 (dysbindin)	607145			Hermansky-Pudlak syndrome 7, 614076 (3)	13(Dtnbp1)
6.97	02	28	20	6p22.3	GMNN, MGORS6		Geminin DNA replication inhibitor	602842			Meier-Gorlin syndrome 6, 616835 (3)	
6.98	10	13	09	6p22.3	KDM1B, LSD2, AOF1		Lysine-specific demethylase 1B	613081				
6.99	7	20	12	6p22.3	KIF13A		Kinesin family member 13A	605433				
6.100	9	12	03	6p22.3	NHLRC1, EPM2A, EPM2B		NHL repeat-containing 1 gene (malin)	608072			Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)	
6.101	9	10	09	6p22.3	NUP153		Nucleoporin, 153kD	603948				
6.102	7	29	15	6p21.1	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11		Polymerase I, RNA, subunit C	610060			Treacher Collins syndrome 3, 248390 (3); Leukodystrophy, hypomyelinating, 11, 616494 (3)	
6.103	8	2	17	6p22.3	RBM24, RNPC6		RNA-binding motif protein 24	617603				
6.104	04	30	20	6p22.3	RNF144B		RING finger protein 144B	618869				
6.105	6	12	07	6p22.3-p21.3	OTSC3		Otosclerosis 3	608244			Otosclerosis 3 (2)	
6.106	07	17	19	6p22.3	SOX4, CSS10		SRY (sex determining region Y)-box 4	184430			Coffin-Siris syndrome 10, 618506 (3)	13(Sox4)
6.107	4	19	16	6p22.3	TPMT, TPMTD		Thiopurine S-methyltransferase	187680			{Thiopurines, poor metabolism of, 1}, 610460 (3)	
6.108	12	20	18	6p22.3	RIPOR2, FAM65B, C6orf32, KIAA0386, PL48, DFNB104		RHO family interacting cell polarization regulator 2	611410		mutation identified in 1 DFNB104 family	?Deafness, autosomal recessive 104, 616515 (3)	
6.109	11	30	20	6p22.3-p21.1	TRA-TGC7-1, TRNAA1		tRNA alanine (anticodon TGC) 7-1	601431				
6.110	9	2	09	6p22.2	TRNAR3, TRR3		tRNA arginine-3	601432				
6.111	5	23	16	6p22.3	TDP2, TTRAP		Tyrosyl-DNA phosphodiesterase 2	605764			Spinocerebellar ataxia, autosomal recessive 23, 616949 (3)	
6.112	3	8	07	6p22.1	ZNF323		Zinc finger protein 323	610794				
6.113	12	5	13	6p22.3-p22.2	CMAHP, CMAH		Cytidine monophospho-N-acetylneuraminic acid hydroxylase pseudogene	603209		mutation inactivates gene in humans		13(Cmah)
6.114	01	30	20	6p22.2	ABT1		Activator of basal transcription 1	618750				
6.115	09	04	18	6p22.2	CARMIL1, LRRC16A, LRRC16		Capping protein regulator and myosin 1 linker 1	609593				13(Lrrc16)
6.116	12	15	10	6p22.2	HISTH2AA, H2AFR, H2AA		Histone gene cluster 1, H2A histone family, member A	613499				
6.117	2	21	06	6p22.2	HIST1H2BA, TSH2B		Histone 1, H2BA	609904				
6.118	7	7	17	6p22.3	KIAA0319		KIAA0319 gene	609269				
6.119	7	22	13	6p22.2	TRNAR2		Transfer RNA arginine 2	615305				
6.120	7	22	13	6p22.2	TRNAV21		Transfer RNA valine 21	615306				
6.121	8	15	90	6p22.3	PRL		Prolactin	176760		?between 6cen and GLO1		11(Prl)
6.122	8	24	09	6p22.1	ZSCAN12, ZNF96, KIAA0426		Zinc finger- and SCAN domain-containing protein 12	603978				
6.123	2	1	11	6p22.2	BTN1A1, BTN		Butyrophilin	601610				13(Btn)
6.124	2	1	11	6p22.2	BTN2A1, BTF1		Butyrophilin, subfamily 2, member A1	613590				
6.125	2	1	11	6p22.2	BTN2A2, BTF2		Butyrophilin, subfamily 2, member A2	613591				
6.126	2	1	11	6p22.2	BTN2A3		Butyrophilin, subfamily 2, member A3	613592				
6.127	2	1	11	6p22.2	BTN3A1, BTF5, CD277		Butyrophilin, subfamily 3, member A1	613593				
6.128	2	1	11	6p22.2	BTN3A2, BTF4		Butyrophilin, subfamily 3, member A2	613594				
6.129	2	1	11	6p22.2	BTN3A3, BTF3		Butyrophilin, subfamily 3, member A3	613595				
6.130	3	19	01	6p22.3	GPLD1, PIGPLD, GPIPLD		Phospholipase D1, glycosylphosphatidylinositol-specific	602515				13(Gpld1)
6.131	11	19	11	6p22.1	GPX5		Glutathione peroxidase 5 (epididymal)	603435				13(Gpx5)
6.132	9	9	13	6p22.1	GPX6		Glutathione peroxidase 6	607913				
6.133	3	6	08	6p22.3	KAAG1, RU2AS		Kidney-associated antigen 1	608211				
6.134	2	21	13	6p22.1	OR2J3, C3HEXS		Olfactory receptor, family 2, subfamily J, member 3	615016			[C3HEX, ability to smell], 615082 (3)	
6.135	5	29	13	6p22.1	SCAND3, ZBED9, BUSTER4, KIAA1925		SCAN domain-containing protein 3	615254				
6.136	7	22	09	6p22.1	STQTL18		Stature quantitative trait locus 18	612892		associated with rs10946808	{Stature QTL 18} (2)	
6.137	6	17	16	6p22.1	TRIM40, RNF35		Tripartite motif-containing protein 40	616976				
6.138	7	17	14	6p22.1	TRS-TGA4-1, TRNAS3, TRS3		Transfer RNA serine (TGA) 4-1	606172				
6.139	7	22	13	6p22.1	TRNAT15		Transfer RNA threonine 15	615309				
6.140	7	22	13	6p22.1	TRNAV12		Transfer RNA valine 12	615307				
6.141	7	22	13	6p22.1	TRNAV17		Transfer RNA valine 17	615308				
6.142	7	18	14	6p22.1	TRS-AGA2-4, TRNAS2, TRS2, TRNS		Transfer RNA serine (AGA) 2-4	189910				
6.143	11	15	08	6p22.1	ZFP57, TNDM1		Zinc finger protein 57, mouse, homolog of	612192			Diabetes mellitus, transient neonatal 1, 601410 (3)	
6.144	7	16	02	6p22.1	TRIM39, RNF23, TFP		Tripartite motif-containing 39	605700				
6.145	3	28	17	6p22.3	DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC		Doublecortin domain-containing protein 2	605755		mutation identified in 1 DFNB66 family	Nephronophthisis 19, 616217 (3); ?Deafness, autosomal recessive 66, 610212 (3); Sclerosing cholangitis, neonatal, 617394 (3)	
6.146	5	26	09	6p22.1	ZKSCAN3, ZNF306		Zinc finger protein with KRAB and SCAN domains 3	612791				
6.147	4	10	14	6p22.1	ZNRD1AS1, TCTEX4, HTEX4		ZNRD1 antisense RNA 1	615714				17(Znrd1as1)
6.148	10	25	19	6p22.2	ZNF322, ZNF489		Zinc finger protein 322	610847				
6.149	11	11	14	6p22.1	ZNRD1, TCTEX6, HTEX6		Zinc ribbon domain-containing protein 1	607525				
6.150	7	23	15	6p22.1	ZSCAN26, SREZBP		Zinc finger- and SCAN domain-containing protein 26	616474				
6.151	5	19	06	6p22.3	ALDH5A1, SSADH		Succinic semialdehyde dehydrogenase	610045			Succinic semialdehyde dehydrogenase deficiency, 271980 (3)	
6.152	11	7	08	6p22	ALPQTL3		Alkaline phosphatase, plasma level of, QTL 3	612368		linkage with rs9467160	{Alkaline phosphatase, plasma level of, QTL3} (2)	
6.153	2	23	95	6p22.3	E2F3		E2F transcription factor 3	600427				
6.154	2	5	15	6p22.3	NBAT1		Neuroblastoma-associated transcript 1, noncoding	616206				
6.155	9	22	09	6p22	NBLST4		Neuroblastoma, susceptibility to, 4	613015		associated with rs6939340, rs4712653, rs9295536	{Neuroblastoma, susceptibility to, 4} (2)	
6.156	11	17	15	6p22.3	NRSN1, VMP		Neurensin 1	616630				
6.157	9	10	09	6p22.1	TRIM27, RFP		Tripartite motif-containing 27	602165				
6.158	08	21	19	6p22.1	ZSCAN16, ZNF435		Zinc finger- and SCAN domain-containing protein 16	618544				
6.159	2	14	03	6p22.1	HIST1H1B, H1F5		Histone 1, H1b	142711		~2Mb centromeric of H1F1 cluster		
6.160	1	14	13	6p22.1	HIST1H2AG, H2AG, H2AFP		Histone gene cluster 1, H2A histone family, member 6	615012				
6.161	1	14	13	6p22.1	HIST1H2AH, H2AH		Histone gene cluster 1, H2A histone family, member H	615013				
6.162	4	3	03	6p22.1	HIST1H2AI, H2AFC		Histone 1, H2ai	602787				
6.163	4	3	03	6p22.1	HIST1H2AK, HIST1H2AI, H2AFD		Histone 1, H2ak	602788				
6.164	4	3	03	6p22.1	HIST1H2AJ, HIST1H2AK, H2AFE		Histone 1, H2aj	602791				
6.165	2	14	03	6p22.1	HIST1H2AL, H2AFI		Histone 1, H2al	602793				
6.166	2	14	03	6p22.1	HIST1H2AM, H2AFN		Histone 1, H2am	602796				
6.167	1	31	13	6p22.1	HIST1H2BJ, H2BJ		Histone gene cluster 1, H2B histone family, member J	615044				
6.168	1	31	13	6p22.1	HIST1H2BK, H2BK		Histone gene cluster 1, H2B histone family, member K	615045				
6.169	3	11	03	6p22.1	HIST1H2BL, H2BFC		Histone 1, H2bl	602800				
6.170	3	11	03	6p22.1	HIST1H2BM, H2BFE		Histone 1, H2bm	602802				
6.171	3	11	03	6p22.1	HIST1H2BN, H2BFD		Histone 1, H2bn	602801				
6.172	4	3	03	6p22.1	HIST1H2BO, H2BFN		Histone 1, H2bo	602808				
6.173	3	11	03	6p22.1	HIST1H3I, H3FF		Histone 1, H3i	602814		in cluster of 16 histone genes centromeric of major cluster		
6.174	3	11	03	6p22.1	HIST1H3J, H3FJ		Histone 1, H3j	602817		in 2nd cluster on 6p		
6.175	3	11	03	6p22.1	HIST1H3H, H3FK		Histone 1, H3h	602818		in minor cluster on 6p		
6.176	3	11	03	6p22.1	HIST1H4J, H4FE		Histone 1, H4j	602826				
6.177	3	11	03	6p22.1	HIST1H4K, H4FD		Histone 1, H4k	602825				
6.178	3	11	03	6p22.1	HIST1H4L, H4FK		Histone 1, H4l	602831				
6.179	6	13	95	6p22.3	ID4		Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein	600581				
6.180	8	27	02	6p22.1	PRSS16, TSSP		Protease, serine, 16	607169				13(Prss16)
6.181	10	19	99	6p22.2	SLC17A4		Solute carrier family 17 (sodium phosphate), member 4	604216				
6.182	6	11	11	6p21.31	FANCE, FACE		Fanconi anemia, complementation group E gene	613976			Fanconi anemia, complementation group E, 600901 (3)	
6.183	10	29	99	6p21.33	ABCF1, ABC50		ATP-binding cassette 50, TNF-alpha stimulated	603429				
6.184	12	5	13	6p21.33	ATAT1, MEC17, C6orf134		Alpha-tubulin acetyltransferase 1	615556				
6.185	4	27	10	6p21.3	ATPLS		Antiphospholipid syndrome, familial	107320		possible linkage with HLA-DRB1*14	?Antiphospholipid syndrome, familial (2)	
6.186	4	28	10	6p21.33	AIF1, IRT1		Allograft inflammatory factor 1	601833		part of TNF block		
6.187	9	22	09	6p21.33	FL1		Follicular lymphoma, susceptibility to, 1	613024		associated with rs6457327	{Follicular lymphoma, susceptibility to, 1} (2)	
6.188	4	21	17	6p21.33	G6B, C6orf25, THAMY		G6B protein	606520		mutation identified in 1 THAMY family	?Thrombocytopenia, anemia, and myelofibrosis, 617441 (3)	
6.189	3	14	18	6p22.1	GABBR1, GABABR1		Gamma-aminobutyric acid B receptor 1	603540				17(Gabbr1)
6.190	2	18	09	6p21.33	LNCR4		Lung cancer susceptibility 4	612593		associated with rs3117582 and rs3131379	{Lung cancer susceptibility 4} (2)	
6.191	01	21	20	6p21.33	LY6G6F, C6orf21		Lymphocyte antigen 6 family, member G6F	611404				
6.192	3	23	09	6p21.33	MIR877, MIRN877		Micro RNA 877	611619				
6.193	6	26	16	6p21.33	MUC21, C6orf205		Mucin 21, cell surface-associated	616991				17(Muc21)
6.194	09	19	19	6p21.33	MSH5, POF13		mutS homolog 5	603382		mutation identified in POF13 family	?Premature ovarian failure 13, 617442 (3)	
6.195	7	20	12	6p21.33	VWA7, C6orf27, G7C		von Willebrand factor A domain-containing protein 7	609693				17(G7c)
6.196	12	18	07	6p22.1	ZKSCAN4, ZNF307		Zinc finger with KRAB and SCAN domains 4	611643				
6.197	2	21	06	6p21.32	EGFL8		Epidermal growth factor-like 8	609897				17(Eglf8)
6.198	08	28	19	6p21.32	GPSM3, AGS4		G protein signaling modulator 3	618558				
6.199	12	15	10	6p21.32	HLA-DQA2, HLA-DXA		Major histocompatibility complex, class II, DQ alpha-2	613503				
6.200	8	17	13	6p21.32	HLA-DQB2, HLA-DXB		Major histocompatibility complex, class II, DQ beta-2	615161				
6.201	3	23	09	6p21.32	MRI219-1, MIRN219-1		Micro RNA 219-1	611500				
6.202	5	23	16	6p21.32	CUTA, ACHAP, C6orf82		CutA, E. coli, homolog of	616953				
6.203	01	23	19	6p21.32	PRRT1, DSPD1		Proline-rich transmembrane protein 1	618297				
6.204	10	26	18	6p21.32	TSBP1, TSBP, C6orf10		Testis-expressed basic protein 1	618151				
6.205	3	10	16	6p21.31	BRPF3, KIAA1286		Bromodomain- and PHD finger-containing protein 3	616856				
6.206	9	2	08	6p21.31	C6orf106		Chromosome 6 open reading frame 106	612217				
6.207	09	09	20	6p21.31	DEF6, IBP, SLAT		DEF6 guanine nucleotide exchange factor	610094				17(Def6)
6.208	8	12	14	6p21.31	KCTD20		Potassium channel tetramerization domain-containing protein 20	615932				
6.209	6	7	16	6p21.31	LEMD2, NET25, CTRCT42		LEM domain-containing protein 2	616312			Cataract 46, juvenile-onset, 212500 (3)	
6.210	1	18	13	6p21.31	PNPLA1, ARCI10		Patatin-like phospholipase domain-containing protein 1	612121			Ichthyosis, congenital, autosomal recessive 10, 615024 (3)	
6.211	11	1	13	6p21.1	PRICKLE4, C6orf49, OBTP		Prickle, Drosophila, homolog of, 4	611389				17(Prickle4)
6.212	3	7	14	6p21.31	RPL10A, CSA19		Ribosomal protein L10A	615660				
6.213	7	3	13	6p21.31	SLC26A8, TAT1, SPGF3		Solute carrier family 26 (sulfate transporter), member 8	608480			Spermatogenic failure 3, 606766 (3)	
6.214	9	10	09	6p21.31	SNRPC		Small nuclear ribonucleoprotein polypeptide C	603522				
6.215	10	1	17	6p21.31	SRPK1		Protein kinase, serine/arginine-specific, 1	601939				
6.216	7	22	09	6p21.31	STQTL19		Stature quantitative trait locus 19	612893		associated with rs1776897	{Stature QTL 19} (2)	
6.217	9	10	09	6p21.31	TAF11, TAF2I, TAFII28		TAF11 RNA polymerase II, TATA box-binding protein-associated factor, 28kD	600772				
6.218	10	14	18	6p21.31	UQCC2, C6orf126, M19, MC3DN7		Ubiquinol-cytochrome c reductase complex assembly factor 2	614461			Mitochondrial complex III deficiency, nuclear type 7, 615824 (3)	
6.219	05	08	20	6p21.33	ABHD16A, BAT5, D6S82E		Abhydrolase domain-containing 16A, phospholipase	142620				
6.220	1	11	95	6p21.32	AGER, RAGE		Advanced glycosylation end product-specific receptor	600214		at junction of classes II, III MHC		
6.221	10	15	98	6p21.32	AGPAT1, LPAATA		1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase-alpha)	603099				
6.222	11	2	04	6p21.31	ANKS1, ODIN, KIAA0229		Ankyrin repeat and sterile alpha motif domains-containing protein 1	608994				
6.223	7	2	18	6p21.33	APOM, NG20		Apolipoprotein M	606907				
6.224	9	10	09	6p21.32	ATF6B, CREBL1		Activating transcription factor 6 beta	600984				
6.225	7	18	02	6p21.33	ATP6V1G2, ATP6G		ATPase, H+ transporting, V1 subunit G2	606853				
6.226	11	4	98	6p21.32	B3GALT4		UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 4	603095				
6.227	9	8	11	6p21.33	BAG6, BAT3, D6S52E		BCL2-associated athanogene 6	142590				
6.228	12	10	08	6p21.32	BRD2, RING3, FSRG1		Bromodomain-containing protein 2	601540		between HLA-DNA and HLA-DMA		
6.229	11	7	08	6p21.32	BTNL2, SS2		Butyrophilin-like protein 2	606000			{Sarcoidosis, susceptibility to, 2}, 612387 (3)	
6.230	12	27	13	6p21.33	C2, ARMD14		Complement component-2	613927		no crossover with BF	C2 deficiency, 217000 (3); {Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	17(C2)
6.231	12	19	11	6p21.33	C4A, C4S, C4AD		Complement component-4A	120810		order: HLA-B, C2, BF, C4A, C4B, CYP21, DR	C4a deficiency, 614380 (3); [Blood group, Rodgers], 614374 (3)	17(C4)
6.232	12	19	11	6p21.33	C4B, C4F, C4BD		Complement component-4B	120820		10kb from C4S	C4B deficiency, 614379 (3)	17(C4)
6.233	9	15	10	6p21.31	C6orf1, LBH		Chromosome 6, open reading frame 1	611419		opposite strand, tail-to-tail with HMGA1		
6.234	10	28	09	6p21.33	CCHCR1, HCR, C6orf18		Coiled-coil alpha-helical rod protein 1	605310		?role in psoriasis		
6.235	11	10	14	6p21.33	CDSN, HTSS1, HYPT2, PSS1		Corneodesmosin	602593			Hypotrichosis 2, 146520 (3); Peeling skin syndrome 1, 270300 (3)	
6.236	1	14	14	6p21.33	CFB, BF, GBG, AHUS4, ARMD14, CFBD		Complement factor B	138470		mutation identified in 1 CFBD family	{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3); ?Complement factor B deficiency, 615561 (3)	17(Bf)
6.237	7	24	17	6p21.32	COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB		Collagen XI, alpha-2 polypeptide	120290		45kb centromeric of HLA-DPB2; 3'--5'-cen	Otospondylomegaepiphyseal dysplasia, autosomal recessive, 215150 (3); Deafness, autosomal dominant 13, 601868 (3); Deafness, autosomal recessive 53, 609706 (3); Fibrochondrogenesis 2, 614524 (3); Otospondylomegaepiphyseal dysplasia, autosomal dominant, 184840 (3)	17(Col11a2)
6.238	7	16	09	6p21.3	CTEPH1		Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to	612862		associated with DPB1*0202	{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to} (2)	
6.239	01	20	20	6p21.33	CSNK2B, POBINDS		Casein kinase-2, beta polypeptide	115441			Poirier-Bienvenu neurodevelopmental syndrome, 618732 (3)	
6.240	3	24	11	6p21.33	CYP21A2, CYP21, CA21H		Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase)	613815		linked to C2, C4, BF; 2 loci, A and B; only B active; pseudogene CYP21P contiguous on 6p	Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3); Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	17(Cyp21)
6.241	10	26	98	6p21.32	DAXX		Death-associated protein 6	603186				
6.242	11	6	00	6p21.33	DDAH2		Dimethylarginine dimethylaminohydrolase-2	604744				
6.243	07	14	20	6p21.33	DDX39B, BAT1, D6S81E		DExD-box helicase 39B	142560		5 BATs in 160kb segment including also TNFA, TNFB		
6.244	9	18	08	6p21.3	DFNA31		Deafness, autosomal dominant 31	608645		between D6S276 and D6S273	Deafness, autosomal dominant 31 (2)	
6.245	07	13	20	6p21.33	DHX16, DDX16, DBP2, PRP8, NMOAS		DEAH-box helicase 16	603405			Neuromuscular disease and ocular or auditory anomalies with or without seizures, 618733 (3)	
6.246	09	19	19	6p21.33	DXO, DOM3Z		Decapping exoribonuclease	605996				
6.247	4	26	11	6p21.33	DPCR1, C6orf37		Diffuse panbronchiolitis critical region gene 1	613928				
6.248	7	7	17	6p22-p21	DYX2		Dyslexia, susceptibility to, 2	600202		?between D6S105 and TNFB	{Dyslexia, susceptibility to, 2} (2)	
6.249	6	1	11	6p21.33	EHMT2, GAT8, G9A, NG36		Euchromatic histone-lysine N-methyltransferase 2	604599				
6.250	8	17	16	6p21.32	FKBPL, DIR1, WISP39		FK506-binding protein-like	617076				
6.251	9	10	09	6p21.33	FLOT1		Flotillin 1	606998				
6.252	1	29	01	6p21.33	G8		G8 protein	605447				
6.253	9	14	95	6p21.33	GNL1, HSR1		Guanine nucleotide-binding protein-like 1	143024				
6.254	9	8	11	6p21.33	GPANK1, BAT4, D6S54E		G patch domain- and ankyrin repeats-containing protein 1	142610				
6.255	3	7	01	6p21.31	GRM4, MGLUR4		Glutamate receptor, metabotropic, 4	604100				
6.256	4	21	97	6p21.33	GTF2H4		General transcription factor IIH, polypeptide 4	601760				
6.257	6	7	10	6p21.33	HCP5, 6S2650E		Major histocompatibility complex, class I, gene P5-1	604676				
6.258	6	22	14	6p22.1	HCG9, HCGIX, HCGIX4		HLA complex group 9, noncoding	615797				
6.259	4	26	11	6p21.33	HCG22, PBMUCL2		HLA complex group 22	613918				
6.260	3	11	03	6p22.2	HIST1H1A, H1F1		Histone 1, H1a	142709				
6.261	3	11	03	6p22.2	HIST1H1C, H1F2		Histone 1, H1c	142710				13(Hist1)
6.262	3	11	03	6p22.2	HIST1H1D, H1F3		Histone 1, H1d	142210				
6.263	6	28	17	6p22.2	HIST1H1E, H1F4, RMNS		Histone 1, H1e	142220			Rahman syndrome, 617537 (3)	
6.264	3	11	03	6p22.2	HIST1H1T, H1FT		Histone 1, H1t	142712				
6.265	2	14	03	6p22.2	HIST1H2AB, H2AFM		Histone 1, H2ab	602795				
6.266	3	11	03	6p22.2	HIST1H2AC, H2AFL		Histone 1, H2ac	602794				
6.267	3	11	03	6p22.2	HIST1H2AD, H2AFG		Histone 1, H2ad	602792				
6.268	3	11	03	6p22.2	HIST1H2AE, H2AFA		Histone 1, H2ae	602786				
6.269	2	14	03	6p22.2	HIST1H2BB, H2BFF		Histone 1, H2bb	602803				
6.270	3	11	03	6p22.2	HIST1H2BC, H2BFL		Histone 1, H2bc	602847				
6.271	3	11	03	6p22.2	HIST1H2BD, H2BFB		Histone 1, H2bd	602799				
6.272	2	14	03	6p22.2	HIST1H2BE, H2BFH		Histone 1, H2be	602805				
6.273	4	3	03	6p22.2	HIST1H2BF, H2BFG		Histone 1, H2bf	602804				
6.274	2	14	03	6p22.2	HIST1H2BG, H2BFA		Histone 1, H2bg	602798				
6.275	3	11	03	6p22.2	HIST1H2BH, H2BFJ		Histone 1, H2bh	602806				
6.276	3	11	03	6p22.2	HIST1H2BI, H2BFK		Histone 1, H2bi	602807				
6.277	3	11	03	6p22.2	HIST1H3A, H3FA		Histone 1, H3a	602810				
6.278	3	11	03	6p22.2	HIST1H3B, H3FL		Histone 1, H3fl	602819		in major cluster on 6p		
6.279	3	11	03	6p22.2	HIST1H3C, H3FC		Histone 1, H3c	602812				
6.280	3	11	03	6p22.2	HIST1H3D, H3FB		Histone 1, H3d	602811				
6.281	12	14	01	6p22.2	HIST1H3E, H3FD, H3.1		Histone 1, H3e	602813		in cluster of 35 histone genes		
6.282	3	11	03	6p22.2	HIST1H3F		Histone 1, H3f	602816				
6.283	3	11	03	6p22.2	HIST1H3G, H3FH		Histone 1, H3g	602815				
6.284	3	11	03	6p22.2	HIST1H4A, H4FA		Histone 1, H4a	602822				
6.285	3	11	03	6p22.2	HIST1H4B, H4FI		Histone 1, H4b	602829				
6.286	3	11	02	6p22.2	HIST1H4C, H4FG		Histone 1, H4c	602827				
6.287	3	11	03	6p22.2	HIST1H4D, H4FB		Histone 1, H4d	602823				
6.288	3	11	03	6p22.2	HIST1H4E, H4FJ		Histone 1, H4e	602830				
6.289	3	11	03	6p22.2	HIST1H4F, H4FC		Histone 1, H4f	602824				
6.290	3	11	03	6p22.2	HIST1H4G, H4FL		Histone 1, H4g	602832				
6.291	3	11	93	6p22.2	HIST1H4H, H4FH		Histone 1, H4h	602828				
6.292	2	14	03	6p22.1	HIST1H4I, H4FM, H4M		Histone 1, H4i	602833				
6.293	01	20	20	6p22.2	HFE, HLA-H, HFE1, MVCD7, TFQTL2		Homeostatic iron regulator	613609			Hemochromatosis, 235200 (3); {Microvascular complications of diabetes 7}, 612635 (3); {Porphyria variegata, susceptibility to}, 176200 (3); {Porphyria cutanea tarda, susceptibility to}, 176100 (3); {Alzheimer disease, susceptibility to}, 104300 (3); [Transferrin serum level QTL2], 614193 (3)	13(Mr2, Hfe)
6.294	6	13	11	6p22.1	HLA-A		Major histocompatibility complex, class I, A	142800			{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)	17(H2)
6.295	6	13	11	6p21.33	HLA-B, SPDA1		Major histocompatibility complex, class I, B	142830			{Spondyloarthropathy, susceptibility to, 1}, 106300 (3); {Abacavir hypersensitivity, susceptibility to} (3); {Synovitis, chronic, susceptibility to} (3); {Drug-induced liver injury due to flucloxacillin} (3); {Toxic epidermal necrolysis, susceptibility to}, 608579 (3); {Stevens-Johnson syndrome, susceptibility to}, 608579 (3)	
6.296	3	16	10	6p21.33	HLA-C, PSORS1		Major histocompatibility complex, class I, C	142840			{Psoriasis susceptibility 1}, 177900 (3); {HIV-1 viremia, susceptibility to}, 609423 (3)	17(H2L)
6.297	5	24	90	6p22.1	HLA-F, HLA-CDA12, HLAF		Major histocompatibility complex, class I, F	143110				
6.298	1	8	95	6p21.32	HLA-DMA, RING6		Major histocompatibility complex, class II, DM alpha	142855				
6.299	1	8	95	6p21.32	HLA-DMB, RING7		Major histocompatibility complex, class II, DM beta	142856				
6.300	7	6	95	6p21.32	HLA-DOB		Major histocompatibility complex, class II, DO beta	600629				
6.301	10	23	87	6p21.32	HLA-DPA1, HLADP		Major histocompatibility complex, class II, DP alpha-1	142880		2 different alpha, 2 different beta chains		
6.302	10	28	93	6p21.32	HLA-DPB1		Major histocompatibility complex, class II, DP beta-1	142858			{Beryllium disease, chronic, susceptibility to} (3)	
6.303	10	31	07	6p21.32	HLA-DQA1, CELIAC1		Major histocompatibility complex, class II, DQ alpha-1	146880			{Celiac disease, susceptibility to}, 212750 (3)	
6.304	10	31	07	6p21.32	HLA-DQB1, CELIAC1		Major histocompatibility complex, class II, DQ beta-1	604305			{Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3); {Multiple sclerosis, susceptibility to, 1}, 126200 (3); {Celiac disease, susceptibility to}, 212750 (3)	
6.305	8	28	17	6p21.32	HLA-DRB1, SS1		Major histocompatibility complex, class II, DR beta-1	142857			{Sarcoidosis, susceptibility to, 1}, 181000 (3); {Multiple sclerosis, susceptibility to, 1}, 126200 (3)	
6.306	5	15	89	6p21.32	HLA-DRA		Major histocompatibility complex, class II, DR alpha	142860		1 alpha, 3 different beta chains		17(H2I)
6.307	10	23	87	6p21.32	HLA-DNA		Major histocompatibility complex, class II, DN alpha	142930				
6.308	5	5	09	6p21.3	HLA-DRB3, HLA-DR52		Major histocompatibility complex, class II, DR beta-3	612735				
6.309	4	6	00	6p21.32	HLA-DRB5		Major histocompatibility complex, class II, DR beta-5	604776				
6.310	6	8	89	6p22.1	HLA-E		Major histocompatibility complex, class I, E	143010				
6.311	1	25	05	6p22.1	HLA-G		HLA-G histocompatibility antigen, class I	142871			{Asthma, susceptibility to}, 600807 (2)	17(Qa)
6.312	2	19	02	6p21.32	HSD17B8, FABGL, D6S2245E, HKE6		Hydroxysteroid (17-beta) dehydrogenase 8 (Ke6 gene, mouse, homolog of)	601417				17(Ke6)
6.313	12	18	91	6p21.33	HSPA1A		Heat-shock 70kD protein-1A	140550		also 14q22-q24, chr.21, and at least 1 other chromosome		17(Hsp70)
6.314	1	13	99	6p21.33	HSPA1B		Heat-shock 70kD protein-1B	603012				
6.315	12	18	91	6p21.33	HSPA1L		Heat-shock 70kD protein-like-1	140559				
6.316	10	22	08	6p21.3	IBD3		Inflammatory bowel disease 3	604519			{Inflammatory bowel disease 3} (2)	
6.317	6	11	01	6p21.3	IDDM1		Insulin-dependent diabetes mellitus-1	222100		linkage or association, with HLA	{Diabetes mellitus, insulin-dependent-1} (2)	
6.318	11	3	98	6p21.33	IER3, DIF2, IEX1, PRG1, GLY96		Immediate early response-3	602996				
6.319	4	21	99	6p21.3	IGAD1		Immunoglobulin A deficiency	137100			Immunoglobulin A deficiency (2)	
6.320	4	24	88	6p21.3	IGLP1		Immune response to synthetic polypeptides-1	147080				
6.321	4	24	88	6p21.3	IGLP2		Immune response to synthetic polypeptides-2	147090				
6.322	3	9	92	6p21.3	IGAT		Immune response to synthetic polypeptide--IRGAT	146820		in B/D segment		
6.323	10	23	87	6p21.3	ISCW		Immune suppression to streptococcal antigen	146850		HLA-linked		
6.324	3	23	09	6p21.32	KIFC1, KNSL2, HSET		Kinesin family member C1	603763				
6.325	1	31	08	6p21.31	LHFPL5, TMHS, DFNB67		LHFP-like protein 5	609427			Deafness, autosomal recessive 67, 610265 (3)	17(Lhfp15)
6.326	9	10	09	6p21.33	LSM2, C6orf28		LSM2 protein	607282				
6.327	1	6	09	6p21.33	LTA, TNFB		Lymphotoxin alpha (formerly tumor necrosis factor beta)	153440		cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B	{Myocardial infarction, susceptibility to}, 608446 (3); {Psoriatic arthritis, susceptibility to}, 607507 (3); {Leprosy, susceptibility to, 4}, 610988 (3)	17(Tnfb)
6.328	1	27	97	6p21.33	LTB, TNFC		Lymphotoxin B	600978				
6.329	5	24	13	6p21.33	LY6G5B, G5B		Lymphocyte antigen 6 complex, locus G5B	610433				
6.330	5	24	13	6p21.33	LY6G5C, G5C		Lymphocyte antigen 6 complex, locus G5C	610434				
6.331	5	24	13	6p21.33	LY6G6C, G6C		Lymphocyte antigen 6 complex, locus G6C	610435				
6.332	8	28	02	6p21.33	LY6G6D, MEGT1, G6D, C6orf23		Lymphocyte antigen 6 complex, locus G6D	606038				
6.333	10	12	20	6p21.33	LY6G6E, G6E		Lymphocyte antigen 6 family member G6E, pseudogene	610437				
6.334	10	4	05	6p21.33	MCCD1		Mitochondrial coiled-coil domain 1	609624				
6.335	12	14	95	6p21.33	MICA		MHC class I polypeptide-related sequence A	600169				
6.336	3	18	98	6p21.33	MICB		MHC class I polypeptide-related sequence B	602436				
6.337	1	7	95	6p21.31	MLN		Motilin	158270				
6.338	11	4	13	6p21.2	MOCS1, MOCODA		Molybdenum cofactor synthesis-1	603707			Molybdenum cofactor deficiency A, 252150 (3)	
6.339	7	27	15	6p22.1	MOG, NRCLP7		Myelin-oligodendrocyte glycoprotein	159465		60kb telomeric to HLA-F; mutation identified in 1 NRCLP7 family	?Narcolepsy 7, 614250 (3)	17(Mog)
6.340	2	26	08	6p21.1	MRPL2		Mitochondrial ribosomal protein L2	611822				
6.341	2	26	08	6p21.1	MRPL14, MRPL32		Mitochondrial ribosomal protein L14	611827				
6.342	4	24	08	6p21.1	MRPS18A, MRPS18-3		Mitochondrial ribosomal protein S18A	611981				
6.343	4	24	08	6p21.33	MRPS18B, MRPS18-2		Mitochondrial ribosomal protein S18B	611982		pseudogenes on chromosomes 1 and 2		
6.344	10	18	11	6p21.33	MUC22, PBMUCL1		Mucin 22	613917				
6.345	7	2	02	6p21.3	MYAS1		Myasthenia gravis with thymus hyperplasia	607085			Myasthenia gravis with thymus hyperplasia (2)	
6.346	3	20	08	6p21.33	NCR3, 1C7, NKP30, CD337, MALS		Natural cytotoxicity triggering receptor 3	611550			{Malaria, mild, susceptibility to}, 609148 (3)	
6.347	11	01	19	6p21.33	NELFE, RDBP		Negative elongation factor complex, member E	154040				17(rd)
6.348	6	1	99	6p21.33	NEP, EDDR1, NTRK4, TRKE		Neuroepithelial tyrosine kinase	600408				17(Nep)
6.349	12	3	03	6p21.33	NEU1, NEU, SIAL1		Neuraminidase 1 (lysosomal sialidase; sialidase 1)	608272			Sialidosis, type I, 256550 (3); Sialidosis, type II, 256550 (3)	17(Neu1)
6.350	05	19	20	6p21.33	NFKBIL1		Nuclear factor-kappa-B inhibitor-like protein 1	601022			{Rheumatoid arthritis, susceptibility to}, 180300 (3)	
6.351	12	9	91	6p21.1	NFYA		Transcription factor NF-Y, A subunit	189903				17(Nfya)
6.352	8	29	91	6p21.3	NKS1, EC1		Susceptibility to lysis by alloreactive natural killer cells	272370			{Lysis by alloreactive natural killer cells, susceptibility to} (2)	17(Hh1)
6.353	12	11	12	6p21.3	MBNP		Membranous nephropathy, susceptibility to	614692			{?Membranous nephropathy, susceptibility to} (2)	
6.354	11	4	98	6p21.32	NOTCH4, INT3		Notch, Drosophila, homolog of, 4	164951				
6.355	11	3	09	6p21.3	NPCA2		Nasopharyngeal carcinoma, susceptibility to, 2	161550		associated with rs2517713 and rs2975042	{Nasopharyngeal carcinoma, susceptibility to, 2} (2)	
6.356	7	9	95	6p22.1	OR2H3, OLFR2		Olfactory receptor, family 2, subfamily H, member 3 (olfactory receptor 2)	600578		in class I MHC region		
6.357	9	10	09	6p21.3	PBC2		Biliary cirrhosis, primary, 2	613007		associated with rs2856683	{Biliary cirrhosis, primary, 2} (2)	
6.358	9	10	09	6p21.3	PBCA		Pancreatic beta cell, agenesis of	600089		uniparental disomy	?Diabetes mellitus, insulin-dependent, neonatal (2)	
6.359	4	10	00	6p21.3	PBLT		Panbronchiolitis, diffuse	604809			Panbronchiolitis, diffuse (2)	
6.360	9	12	96	6p21.32	PBX2, HOX12, G17		Pre-B-cell leukemia transcription factor-2	176311				
6.361	4	27	12	6p21.3	PDCOS		Podoconiosis, susceptibility to	614590			{Podoconiosis, susceptibility to} (2)	
6.362	5	25	13	6p21.33	PPP1R10, PNUTS		Protein phosphatase 1, regulatory subunit 10	603771				
6.363	9	8	11	6p21.33	PRRC2A, BAT2, D6S51E		Proline-rich coiled-coil protein 2A	142580				
6.364	4	19	02	6p21.1	PTCRA		Pre-T-cell receptor, alpha-chain precursor	606817				17(Ptcra)
6.365	11	20	98	6p21.32	PHF1		PHD finger protein-1	602881				
6.366	9	12	93	6p21.33	POU5F1, OTF3, OCT3		Pou domain, class 5, transcription factor 1 (octamer-binding transcription factor 3)	164177		OTF3L on 12; ?related pseudogene on chr.8		17(Otf3)
6.367	2	4	02	6p22.1	PPP1R11, TCTEX5		Protein phosphatase 1, regulatory subunit 11	606670				17(Ppp1r11)
6.368	4	27	17	6p21.33	PPP1R18, KIAA1949		Protein phosphatase 1 regulatory subunit 18	610990				
6.369	11	19	98	6p21.32	PPT2		Palmitoyl-protein thioesterase-2	603298				
6.370	7	19	18	6p21.32	PSMB8, LMP7, RING10, JMP, NKJO, ALDD, PRAAS1		Proteasome subunit, beta type, 8 (large multifunctional protease-7)	177046		between TAP1 and TAP2	Proteasome-associated autoinflammatory syndrome 1 and digenic forms, 256040 (3)	
6.371	7	19	18	6p21.32	PSMB9, LMP2, RING12, PRAAS3		Proteasome subunit, beta type, 9	177045		mutation identified in 1 digenic family	?Proteasome-associated autoinflammatory syndrome 3, digenic, 617591 (3)	17(Lmp2)
6.372	3	5	98	6p21.32	RAB2L		RAB2, member RAS oncogene family-like	602306				
6.373	3	5	98	6p21.32	RING1, RNF1		RING finger protein-1	602045				
6.374	6	10	98	6p21.32	RNF5, RING5		RING finger protein-5	602677				
6.375	1	2	08	6p21.2	RNF8, KIAA0646		Ring finger protein 8	611685				
6.376	2	28	01	6p22.1	RNF9, RFB30, HERF1		RING finger protein-9	605701				
6.377	4	29	03	6p22.1	RNF39, HZFW, HZF, LIRF		Ring finger protein 39	607524				
6.378	12	14	95	6p21.32	RPS18		Ribosomal protein S18	180473				17(Ke3)
6.379	10	23	87	6p21.3	RWS		Ragweed sensitivity	179450		?linkage or association, with HLA	?Ragweed sensitivity (2)	
6.380	3	22	93	6p21.32	RXRB		Retinoid X receptor, beta	180246				17(Rxrb)
6.381	7	11	12	6p21.31	SCUBE3		Signal peptide-, CUB domain-, and EGF-like domains-containing protein 3	614708				17(Scube3)
6.382	8	27	15	6p21.33	SEEK1, C6orf16, PSORS1C1		SEEK1 gene	613525				
6.383	8	20	07	6p22.2	SLC17A2, NPT3		Solute carrier family 17 (sodium phosphate cotransporter), member 2	611049				
6.384	2	25	16	6p22.2	SLC17A3, NPT4, UAQTL4, GOUT4		Solute carrier family 17 (sodium phosphate cotransporter), member 3	611034			[Uric acid concentration, serum, QTL4], 612671 (3); {Gout susceptibility 4}, 612671 (3)	
6.385	6	1	04	6p21.32	SLC39A7, D6S2244E, HKE4		Solute carrier family 39 (zinc transporter), member 7 (Ke4 gene, mouse, homolog of)	601416				17(Ke4)
6.386	8	7	17	6p21.33	SLC44A4, CTL4, C6orf29, DFNA72		Solute carrier family 44, member 4	606107		mutation identified in 1 DFNA72 family	?Deafness, autosomal dominant 72, 617606 (3)	
6.387	8	25	04	6p21.31	SPDEF, PDEF		SAM pointed domain-containing ETS transcription factor	608144				
6.388	5	25	00	6p21.33	STK19		Serine/threonine protein kinase 19	604977				
6.389	3	7	13	6p21.32	SYNGAP1, MRD5		Synaptic Ras GTPase activating protein 1	603384			Mental retardation, autosomal dominant 5, 612621 (3)	
6.390	10	14	05	6p21.32	TAP1, ABCB2, RING4, PSF1		Transporter 1, ATP-binding cassette, subfamily B	170260		~7kb telomeric to TAP2	Bare lymphocyte syndrome, type I, 604571 (3)	17(Ham1)
6.391	09	11	18	6p21.32	TAP2, ABCB3, PSF2, RING11		Transporter 2, ATP-binding cassette, subfamily B	170261		tel-TAP1-LMP2-LMP1-TAP2-cen	Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)	17(Ham2)
6.392	10	25	02	6p21.32	TAPBP, TPSN		TAP-binding protein (tapasin)	601962			Bare lymphocyte syndrome, type I, 604571 (3)	17(Tapbp)
6.393	1	1	96	6p21.33	TCF19, SC1		Transcription factor-19 (SC1)	600912				
6.394	8	9	99	6p21.31	TEAD3, TEF5, TEAD5		TEA domain family member 3 (transcriptional enhancer factor 5)	603170				17(Tead3)
6.395	6	23	06	6p21.33	TNF, TNFA		Tumor necrosis factor (cachectin)	191160		5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B	{Malaria, cerebral, susceptibility to}, 611162 (3); {Septic shock, susceptibility to} (3); {Asthma, susceptibility to}, 600807 (3); {Dementia, vascular, susceptibility to} (3); {Migraine without aura, susceptibility to}, 157300 (3)	17(Tnfa)
6.396	5	31	18	6p21.33-p21.32	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL1, VUR8		Tenascin XB	600985			Ehlers-Danlos syndrome, classic-like, 1 606408 (3); Vesicoureteral reflux 8, 615963 (3)	
6.397	1	7	16	6p21.33	TUBB, TUBB5, M40, CDCBM6, CSCSC1		Tubulin, beta polypeptide	191130			Cortical dysplasia, complex, with other brain malformations 6, 615771 (3); Symmetric circumferential skin creases, congenital, 1, 156610 (3)	
6.398	3	28	11	6p21.31	TULP1, RP14, LCA15		Tubby-like protein-1	602280			Retinitis pigmentosa 14, 600132 (3); Leber congenital amaurosis 15, 613843 (3)	
6.399	8	20	08	6p22.1	UBD, FAT10		Ubiquitin D	606050				
6.400	08	21	19	6p21.33	VARS1, VARS, G7A, VARS2, NDMSCA		Valyl-tRNA synthetase 1	192150			Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, 617802 (3)	17(Vars2)
6.401	8	5	14	6p21.33	VARS2, KIAA1885, COXPD20		Valyl-tRNA synthetase 2	612802			Combined oxidative phosphorylation deficiency 20, 615917 (3)	
6.402	11	19	11	6p21.3	VAMAS6		Vitiligo-associated multiple autoimmune disease susceptibility 6	193200		possible second locus on 1p31.3-p32.2	{Vitiligo-associated multiple autoimmune disease susceptibility 6} (2)	
6.403	10	03	19	6p21.32	VPS52, SACM2L		VPS52 subunit of GARP complex	603443				
6.404	8	27	15	6p21.32	WDR46, BING4		WD repeat-containing protein 46	611440				
6.405	09	11	18	6p21.3	GPA, WG		Granulomatosis with polyangiitis	608710			Granulomatosis with polyangiitis (2)	
6.406	8	27	15	6p21.32	ZBTB22, BING1		Zinc finger- and BTB domain-containing protein 22	611439				
6.407	12	4	95	6p22.1	ZNF173		Zinc finger protein-173	600830				
6.408	10	20	99	6p22.1	ZNF184		Zinc finger protein-184	602277				
6.409	3	5	98	6p22.1	ZNF192		Zinc finger protein-192	602240				
6.410	3	5	98	6p22.1	ZNF193		Zinc finger protein-193	602246				
6.411	11	17	98	6p21.3	ZNF204		Zinc finger protein-204	603282		?pseudogene		
6.412	8	26	98	6p21.31	BAK1		BCL2-antagonist/killer 1	600516		centromeric to MHC region		17(bak)
6.413	9	16	88	6p21.3-p21.2	CP20		Lymphocyte cytosolic protein, molecular weight 20kD	153380				
6.414	5	31	05	6p21.31	FKBP5, FKBP51		FK506-binding protein 5	602623			{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)	
6.415	1	20	11	6p21.2	GLO1		Glyoxalase I	138750		~3cM proximal to HLA		17(Glo1)
6.416	10	23	87	6p21.3-p21.2	LAP		Laryngeal adductor paralysis	150270		?linkage to HLA and GLO1	?Laryngeal adductor paralysis (2)	
6.417	12	4	95	6p21.31	MAPK14, CSBP1		Mitogen-activated protein kinase 14 (cytokine suppressive anti-inflammatory drug binding protein 1)	600289				
6.418	5	29	12	6p21.3-p21.2	MPVQTL4		Mean platelet volume quantitative trait locus 4	614644		associated with rs210134	Mean platelet volume QTL4 (2)	
6.419	11	5	92	6p21.31	TCP11, D6S230E		T-complex homolog tcp-11	186982		expressed only in testis at same time as ZNF76 (day 20 after birth)		17(tcp11)
6.420	11	5	92	6p21.31	ZNF76, D6S229E		Zinc finger protein-76 (expressed in testis)	194549		same 300kb fragment as TCP11		17(Znf76)
6.421	10	11	99	6p21.33	LST1, D6S49E, B144		Leukocyte-specific transcript 1 (B144 protein)	109170		10kb 3' from TNFA		
6.422	3	27	90	6p21.1	PGC		Preprogastricsin	169740		cen-PGG-GLO1-HLA		17(Upg1)
6.423	8	12	91	6p21.1	TCTE1		T-complex-associated-testis-expressed-1	186975				
6.424	3	7	13	6p21.2	AD17		Alzheimer disease 17	615080		associated with rs75932628T	Alzheimer disease 17 (2)	
6.425	11	20	15	6p21.2	C6orf89, BRAP, AMFION		Bombesin receptor-activated protein	616642				
6.426	2	4	15	6p21.2	CMTR1, MTR1, ISG95, FTSJD2, KIAA0082		CAP methyltransferase 1	616189				
6.427	9	10	09	6p21.2	DAAM2, KIAA0381		Dishevelled-associated activator of morphogenesis 2	606627				
6.428	11	11	14	6p21.2	FGD2		FYVE, RhoGEF, and PH domain-containing protein 2	605091				17(Fgd2)
6.429	7	15	09	6p21.2-p21.1	LRFN2, SALM1, KIAA1246		Leucine-rich repeat and fibronectin type III domain-containing protein 2	612808				17(Lrfn2)
6.430	11	23	16	6p21.2	PANDAR		Promoter of CDKN1A antisense DNA damage-activated RNA	617179				
6.431	11	6	92	6p21.2	PIM1		Oncogene PIM1	164960				17(Pim1)
6.432	10	17	95	6p21.2	CDKN1A, WAF1, CIP1, CDKN1		Cyclin-dependent kinase inhibitor 1A (p21, Cip1)	116899				17(Waf1)
6.433	9	7	12	6p21.2	MTCH1, PSAP		Mitochondrial carrier homolog 1	610449				
6.434	3	29	16	6p21.2	TBC1D22B, C6orf197		TBC1 domain family, member 22B	616880				
6.435	6	2	15	6p21.2	TP53COR1		Tumor protein p53 pathway corepressor 1, noncoding	616343				17(Tp53cor1)
6.436	11	16	18	6p21.1	TREM2, PLOSL2		Triggering receptor expressed on myeloid cells 2	605086			Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2, 618193 (3)	
6.437	4	30	09	6p12.3	CRISP1, AEGL1		Cysteine-rich secretory protein 1	601193				17(Aeg1)
6.438	5	22	18	6p21.1	GTPBP2, JABELS		GTP-binding protein 2	607434			Jaberi-Elahi syndrome, 617988 (3)	17(Gtpbp2)
6.439	11	22	02	6p21.2	KCNK16, TALK1		Potassium channel, subfamily K, member 16	607369				
6.440	11	22	02	6p21.2	KCNK17, TASK4, TALK2		Potassium channel, subfamily K, member 17	607370				
6.441	1	16	96	6p12.3	MEP1A		Meprin A, alpha	600388				17(Mep1a)
6.442	9	23	96	6p21.31	PPARD, NUC1		Peroxisome proliferative activated receptor, delta	600409				
6.443	1	29	01	6p21.1	SLC22A7, OAT2		Solute carrier family 22 (organic anion transporter), member 7	604995				
6.444	3	5	98	6p21.1	SLC29A1, ENT1		Solute carrier family 29 (nucleoside transporters), member 1 (equilibrative nucleoside transporter-1)	602193				
6.445	3	6	14	6p21.2	TDRG1, LINC00532		Testis development-related gene 1, noncoding	615676				
6.446	12	23	05	6p21.1	YIPF3, KLIP1		YIP1 domain family, member 3	609775				
6.447	10	18	11	6p12.3	PLA2G7, PAFAH, PAFAD		Phospholipase A2, group VII (platelet-activating factor acetylhydrolase)	601690			Platelet-activating factor acetylhydrolase deficiency, 614278 (3); {Asthma, susceptibility to}, 600807 (3); {Atopy, susceptibility to}, 147050 (3)	
6.448	2	18	96	6p22.1	ZNF165, LD65		Zinc finger protein-165	600834				
6.449	8	11	14	6p21.1	AARS2, KIAA1270, MTALARS, COXPD8, LKENP		Alanyl-tRNA synthetase 2	612035			Combined oxidative phosphorylation deficiency 8, 614096 (3); Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	
6.450	12	24	08	6p21.1	ABCC10, MRP7		ATP-binding cassette, subfamily C, member 10	612509				
6.451	07	16	19	6p21.1	BICRAL, GLTSCR1L, KIAA0240		BRD4-interacting chromatin remodeling complex-associated protein-like	618502				
6.452	6	18	99	6p21.1	BYSL		By the ribosomal protein S6 gene, Drosophila, homolog-like (bystin)	603871				
6.453	4	17	14	6p21.1	CUL7, 3M1		Cullin 7	609577			3-M syndrome 1, 273750 (3)	
6.454	6	13	12	6p21.1	CUL9, PARC, KIAA0708		Cullin 9	607489				
6.455	01	31	20	6p21.1	DNPH1		2'-deoxynucleoside 5'-phosphate N-hydrolase 1	618762				
6.456	6	26	16	6p21.1	ENPP4, NPP4, KIAA0879		Ectonucleotide pyrophosphatase/phosphodiesterase 4	617000				
6.457	6	26	16	6p21.1	ENPP5, NPP5		Ectonucleotide pyrophosphatase/phosphodiesterase 5	617001				
6.458	9	15	10	6p21.1	FOXP4		Forkhead box P4	608924				
6.459	4	28	10	6p21.1	GUCA1A, GCAP, COD3, CORD14		Guanylate cyclase activator 1A, retina	600364			Cone dystrophy-3, 602093 (3); Cone-rod dystrophy 14, 602093 (3)	
6.460	3	24	11	6p21.1	GUCA1B, GCAP2, GUCA2, RP48		Guanylate cyclase activator 1B, retina	602275			Retinitis pigmentosa 48, 613827 (3)	
6.461	10	15	20	6p12.1	HMGCLL1, ERCHL		3-hydroxy-3-methylglutaryl-CoA lyase-like protein 1	619050				
6.462	9	8	08	6p21.1	HSP90AB1, HSPCB, HSPC2, HSP90B		Heas-shock protein, 90kD, alpha, class B, member 1	140572				
6.463	8	19	13	6p21.1	KLHDC3, PEAS		KELCH domain-containing protein 3	611248				17(Klhdc3)
6.464	10	09	18	6p21.1	MAD2L1BP		MAD2L1-binding protein	618136				
6.465	7	22	09	6p21.1	MED20, TRFP		Mediator complex subunit 20	612915				
6.466	12	28	08	6p21.1	NCR2, LY95, NKP44		Natural cytotoxicity triggering receptor 2 (lymphocyte antigen 95, mouse, homolog of)	604531				17(Ncr2)
6.467	05	19	20	6p21.1	NFKBIE, IKBE		Nuclear factor kappa-B inhibitor, epsilon	604548				
6.468	12	09	19	6p21.1	OARD1, C6orf130		O-acyl-ADP-ribose deacylase 1	614393				
6.469	10	26	15	6p21.1	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2		Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1)	601498			Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3); Peroxisome biogenesis disorder 4B, 614863 (3); Heimler syndrome 2, 616617 (3)	17(Pxaaa1)
6.470	5	28	99	6p21.2	PPIL1, CYPL1		Peptidylprolyl isomerase (cyclophilin)-like 1	601301		previously assigned to chr.2		
6.471	5	12	15	6p21.1	PPP2R5D, MRD35		Protein phosphatase-2, regulatory subunit B (B56), delta isoform	601646			Mental retardation, autosomal dominant 35, 616355 (3)	
6.472	11	30	10	6p21.1	PPR1		Photoparoxysmal response 1	132100		max lod at D6S2427	Photoparoxysmal response 1 (2)	
6.473	4	21	17	6p21.1	RPL7L1		Ribosomal protein L7-like 1	617417				
6.474	9	29	10	6p21.1	RRP36, C6orf153		Ribosomal RNA-processing factor, 36	613475				
6.475	08	21	19	6p21.1	RSPH9, CILD12		Radial spoke head 9 homolog	612648			Ciliary dyskinesia, primary, 12, 612650 (3)	
6.476	10	2	12	6p21.1	SRF		Serum response factor	600589				
6.477	11	12	20	6p21.1	SUPT3H, SPT3		SPT3 homolog, SAGA and STAGA complex component	602947				
6.478	02	27	20	6p21.1	TAF8, TBN		TATA-box binding protein-associated factor 8	609514				
6.479	8	18	14	6p21.1	TBCC, CFC		Tubulin-specific chaperone C	602971				
6.480	3	23	09	6p21.1	TJAP1, PILT, TJP4		Tight junction-associated protein 1	612658				
6.481	09	17	20	6p21.1	TOMM6, TOM6		Translocase of outer mitochondrial membrane 6	616168				
6.482	8	19	13	6p21.1	TRERF1, TREP132		Transcriptional regulating factor 1	610322				
6.483	12	28	08	6p21.1	TREM1		Triggering receptor expressed on myeloid cells 1	605085				17(Trem1)
6.484	12	28	08	6p21.1	TREML1, TLT1		Triggering receptor expressed on myeloid cells-like protein 1	609714				17(Treml1)
6.485	12	28	08	6p21.1	TREML2, TLT2		Triggering receptor expressed on myeloid cells-like protein 2	609715				17(Treml2)
6.486	12	28	08	6p21.1	TREML3, TLT3		Triggering receptor expressed on myeloid cells-like protein 3	609716				17(Treml3)
6.487	4	1	08	6p21.1	UBR2, C6orf133, KIAA0349		Ubiquitin-protein ligase E3 component N-recognin 2	609134				17(Ubr2)
6.488	09	11	19	6p21.1	UNC5CL, ZUD		unc-5 family C-terminal like protein	617464				
6.489	12	23	05	6p21.1	XPO5, KIAA1291		Exportin 5	607845				
6.490	6	12	17	6p21.1	ZNF318, TZF, ZFP318		Zinc finger protein 318	617512				
6.491	11	24	14	6p21.1	CLIC5, DFNB103		Chloride intracellular channel 5	607293		mutation identified in 1 DFNB103 family	?Deafness, autosomal recessive 103, 616042 (3)	
6.492	4	23	08	6p21.1	MRPS10		Mitochondrial ribosomal protein S10	611976		5 pseudogenes on chromosomes 1, 3, and 9		
6.493	7	3	06	6p12.3	TFAP2D, TFAP2BL1		Transcription factor AP2-delta	610161				
6.494	2	21	03	6p21.1-p12.2	MGR3		Migraine with or without aura, susceptibility to, 3	607498		lod 5.78 at D6S452	{Migraine with or without aura, susceptibility to, 3} (2)	
6.495	6	25	97	6p21.1	PTK7		PTK7 protein tyrosine kinase 7	601890				
6.496	4	19	02	6p12.3	PGK2		Phosphoglycerate kinase-2 (testicular PGK)	172270		pseudogene on chr.12		17(Pgk2)
6.497	1	23	01	6p21.1	POLH, XPV		Polymerase, DNA, eta	603968			Xeroderma pigmentosum, variant type, 278750 (3)	
6.498	5	7	01	6p12.3	CYP39A1		Cytochrome P450, subfamily XXXIXA (oxysterol 7-alpha-hydroxylase), polypeptide 1	605994				17(Cyp39a1)
6.499	5	17	18	6p12.3	RHAG, RH50A, OHST, RHNR		Rhesus blood group-associated glycoprotein	180297			Anemia, hemolytic, Rh-null, regulator type, 268150 (3); Overhydrated hereditary stomatocytosis, 185000 (3)	
6.500	08	22	19	6p21.1	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1		Peripherin 2	179605		digenic RP with ROM1	Retinitis pigmentosa 7 and digenic form, 608133 (3); Leber congenital amaurosis 18, 608133 (3); Macular dystrophy, patterned, 1, 169150 (3); Retinitis punctata albescens, 136880 (3); Choroidal dystrophy, central areolar 2, 613105 (3); Macular dystrophy, vitelliform, 3, 608161 (3)	17(rds)
6.501	1	29	01	6p21.1	APOBEC2		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2	604797				17(Apobec2)
6.502	7	16	09	6p21.2	BTBD9, KIAA1880		BTB/POZ domain-containing protein 9	611237				
6.503	7	12	92	6p21.1	CCND3		Cyclin D3	123834		pseudogene also on 6p21		
6.504	08	23	19	6p21.1	CDC5L		Cell division cycle 5-like	602868				
6.505	10	20	99	6p21.2	CPNE5, CPN5		Copine V	604209				
6.506	11	13	20	6p21.2	DNAH8, HDHC9, SPGF46		Dynein, axonemal, heavy chain 8	603337			Spermatogenic failure 46, 619095 (3)	
6.507	8	25	04	6p21	EJM3		Epilepsy, juvenile myoclonic 3	608816			Epilepsy, juvenile myoclonic 3 (2)	
6.508	7	22	09	6p21.31	ETV7, TEL2, TELB		ETS variant gene 7	605255				
6.509	5	9	95	6p21.2	GLP1R		Glucagon-like peptide 1 receptor	138032				17(Glp1r)
6.510	09	02	20	6p21.31	HMGA1, HMGIY		High-mobility group AT-hook 1	600701			{Type 2 diabetes mellitus, susceptibility to}, 125853 (3)	
6.511	9	30	02	6p21.31	IHPK3, INSP6K3, IP6K3		Inositol hexaphosphate kinase 3	606993		pseudogene on 6p24.1		
6.512	6	18	99	6p21.2	KCNK5, TASK2		Potassium channel, subfamily K, member 5	603493				
6.513	4	26	11	6p21.2	KIF6		Kinesin family member 6	613919				
6.514	4	29	02	6p21	LATD		Laterality defects, autosomal dominant	601086		max lod 2.95 at theta = 0		
6.515	3	31	09	6p22.1	MAS1L, MRG		MAS1 oncogene-like	607235				
6.516	10	4	05	6p21.2	MDGA1, GPIM		MAM domain-containing glycosylphosphatidylinositol anchor 1	609626				
6.517	7	6	00	6p21.1	MDFI		MYOD family inhibitor	604971				17(Mdfi)
6.518	02	27	20	6p12.3	MMUT, MUT, MCM		Methylmalonyl-CoA mutase	609058			Methylmalonic aciduria, mut(0) type, 251000 (3)	17(Mut)
6.519	12	27	01	6p21.31	PACSIN1, KIAA1379		Protein kinase C and casein kinase substrate in neurons 1	606512				
6.520	12	09	19	6p21.33	PSORS1C3		Psoriasis susceptibility 1 candidate 3, noncoding	618690				
6.521	7	16	09	6p21	RLS6		Restless legs syndrome, susceptibility to, 6	611185		associated with rs9296249 and rs9357271	{Restless legs syndrome 6} (2)	
6.522	1	13	09	6p22.1	RPP21		Ribonuclease P/MRP, 21kD subunit	612524				
6.523	3	15	13	6p21.1	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD		Runt-related transcription factor 2	600211			Cleidocranial dysplasia, 119600 (3); Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3); Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3); Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	17(Cbfa1)
6.524	4	27	12	6p21.33	SKIV2L, SKI2, SKI2W, THES2		Superkiller viralicidic activity 2, S. cerevisiae, homolog, like	600478			Trichohepatoenteric syndrome 2, 614602 (3)	
6.525	12	19	11	6p21.3-p21.2	SRSF3, SFRS3, SRP20		Splicing factor, arginine/serine-rich, 3	603364				17(Sfrs3)
6.526	9	10	09	6p21.31	STK38, NDR		Serine/threonine protein kinase 38	606964				
6.527	10	1	95	6p21.1	TFEB, TCFEB		Transcription factor EB	600744				17(Tcfeb)
6.528	5	29	12	6p21.1	TREML4, TLT4		Triggering receptor expressed on myeloid cells-like protein 4	614664				17(Treml4)
6.529	4	20	17	6p12.3	ADGRF1, GPR110		Adhesion G protein-coupled receptor F1	617430				
6.530	9	1	16	6p12.3	ADGRF4, GPR115		Adhesion G protein-coupled receptor F4	614268				
6.531	10	8	07	6p12.3	CENPQ		Centromeric protein Q	611506				
6.532	7	25	18	6p12.3	CRISP3, SGP28		Cysteine-rich secretory protein 3	618062				
6.533	8	21	12	6p12.3	GLYATL3		Glycine N-acyltransferase-like 3	614763				
6.534	4	6	18	6p12.1	ICK, MRK, KIAA0936, ECO, EJM10		Intestinal cell kinase	612325			Endocrine-cerebroosteodysplasia, 612651 (3); {Epilepsy, juvenile myoclonic, susceptibility to, 10}, 617924 (3)	
6.535	3	7	14	6p12.3	OPN5, GRP136, PGR12		Opsin 5	609042				
6.536	4	21	16	6p12.3	PTCHD4, PTCH53, C6orf138		Patched domain-containing protein 4	616908				
6.537	9	24	08	6p12.3	RCAN2, ZAKI4, DSCR1L1, MCIP2, CSP2		Regulator of calcineurin 2	604876				
6.538	7	8	11	6p12.3	SLC25A27, UCP4		Solute carrier family 25, member 17	613725				
6.539	5	26	13	6p12.3	TDRD6		TUDOR domain-containing protein 6	611200				
6.540	11	27	19	6p12.3	TNFRSF21, DR6		Tumor necrosis factor receptor superfamily, member 21	605732				
6.541	10	29	03	6p12.1	LRRC1, LANO		Leucine-rich repeat-containing protein 1	608195				
6.542	09	04	19	6p12.3-p12.2	FCYT, PKHD1, ARPKD, PKD4		Fibrocystin	606702			Polycystic kidney disease 4, with or without hepatic disease, 263200 (3)	13(Pkhd1)
6.543	3	24	06	6p12.1	COL21A1		Collagen, type XXI, alpha-1 polypeptide	610002				
6.544	9	9	08	6p12.1	FBXO9, FBX9		F-box only protein 9	609091				9(Fbxo9)
6.545	3	6	94	6p12.2	GSTA1		Glutathione S-transferase A1	138359				
6.546	12	6	91	6p12.2	GSTA2, GST2		Glutathione S-transferase A2	138360				9(Gsta)
6.547	3	11	03	6p12.2	GSTA3		Glutathione S-transferase, alpha-3	605449				
6.548	3	11	03	6p12.2	GSTA4		Glutathione S-transferase, alpha-4	605450				
6.549	3	10	03	6p12.2	GSTA5		Glutathione S-transferase, alpha-5	607605				
6.550	11	16	98	6p12.2	IL17A, IL17, CTLA8		Interleukin-17a	603149		previously mapped to 2q31		1(Il17)
6.551	12	12	12	6p12.2	LINCMD1		Long intergenic noncoding RNA, muscle differentiation 1	614933				
6.552	3	20	16	6p12.2	TMEM14A		Transmembrane protein 14A	616870				
6.553	3	23	09	6p12.2	MIR133B, MIRN133B		Micro RNA 133B	610946				
6.554	3	23	09	6p12.2	MIR206, MIRN206		Micro RNA 206	611599				1(Mirn206)
6.555	8	8	13	6p12.2	TRAM2, KIAA0057		Translocation-associated membrane protein 2	608485				
6.556	11	19	11	6p12.2-q12	MRT24		Mental retardation, autosomal recessive 24	614345		between rs651733 and rs1508668	Mental retardation, autosomal recessive 24 (2)	
6.557	9	1	09	6p12.1	BMP5		Bone morphogenetic protein-5	112265				
6.558	09	16	19	6p12.1	GCM1, GCMA		Glial cells missing transcription factor 1	603715				
6.559	1	30	18	6p12.1	GFRAL, GRAL		GDNF family receptor alpha-like protein	617837				
6.560	9	27	17	6p12.1	HCRTR2, OX2R		Hypocretin receptor 2	602393				
6.561	9	8	11	6p12.1	MLIP, C6orf142		Muscular LMNA-interating protein	614106				
6.562	12	7	04	6p12.2	RN7SK, 7SK		RNA, 7SK small nuclear	606515				
6.563	3	25	14	6p12.1	ZNF451, COASTER		Zinc finger protein 451	615708				
6.564	3	8	07	6p21.1	SLC35B2, PAPST1, SLL		Solute carrier family 35 (3'-phosphoadenosine 5')-phosphosulfate transporter), member B2	610788				
6.565	4	19	12	6p12.2	PAQR8, C6orf33, LMPB1, MPRB		Progestin and ADIPOQ receptor family, member 8	607780				
6.566	1	29	01	6p21.1	CAPN11		Calpain 11	604822				
6.567	10	28	08	6p12.3	CD2AP, CMS		CD2-associated protein	604241			Glomerulosclerosis, focal segmental, 3, 607832 (3)	
6.568	4	30	09	6p12.3	CRISP2, TPX1, TSP1		Cysteine-rich secretory protein 2	187430				17(Tpx1)
6.569	5	23	13	6p12.3	DEFB114, DEFB14		Defensin, beta, 114	615243				
6.570	9	20	14	6p12.1	ELOVL5, HELO1, SCA38		Elongation of very long chain fatty acids-like 5	611805			Spinocerebellar ataxia 38, 615957 (3)	
6.571	1	6	09	6p12.1	GCLC, GLCLC		Glutamate-cysteine ligase, catalytic subunit	606857			Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3); {Myocardial infarction, susceptibility to}, 608446 (3)	9(Glclc)
6.572	1	24	02	6p21.1	GNMT		Glycine N-methyltransferase	606628			Glycine N-methyltransferase deficiency, 606664 (3)	
6.573	6	22	15	6p12.2	IL17F, ML1, CANDF6		Interleukin 17F	606496		mutation identified in 1 CANDF6 family	?Candidiasis, familial, 6, autosomal dominant, 613956 (3)	
6.574	2	7	07	6p12.1	KLHL31, KLHL		Kelch-like 31	610749				9(Klhl31)
6.575	11	4	98	6p12.2	MCM3		Minichromosome maintenance, S. cerevisiae, homolog of, 3	602693				
6.576	4	16	14	6p12	NYS2, NYSA		Nystagmus 2, congenital, autosomal dominant	164100			Nystagmus 2, congenital, autosomal dominant (2)	
6.577	7	14	16	6p12.3	TFAP2B, CHAR, PDA2		Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta)	601601			Char syndrome, 169100 (3); Patent ductus arteriosus 2, 617035 (3)	1(Tfap2b)
6.578	2	18	09	6p21.1	VEGF, MVCD1		Vascular endothelial growth factor	192240			{Microvascular complications of diabetes 1}, 603933 (3)	
6.579	3	3	03	6p12.1	TINAG, TIN1, TIN2		Tubulointerstitial nephritis antigen	606749				
6.580	10	1	95	6p11.2	PRIM2A		Primase polypeptide 2A, 58kD	176636				2(Prim2)
6.581	7	30	14	6p12.1	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2		Dystonin (bullous pemphigoid antigen 1)	113810		?mutation identified in 1 HSAN6 family	?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3); Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	1(Bpag1)
6.582	10	6	09	6p12.2	EFHC1, FLJ10466, EJM1, JAE, EJA1		EF hand domain (C-terminal)-containing 1	608815			{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3); {Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	
6.583	7	22	13	6p12-q12	CTRCT28, ARCC1		Cataract 28	609026			{Cataract 28, age-related cortical, susceptibility to} (2)	
6.584	5	25	13	6p12.1	BAG2		BCL2-associated athanogene 2	603882				
6.585	10	30	03	6p11	AITD1		Autoimmune thyroid disease, susceptibility to, 1	608173			{Autoimmune thyroid disease, susceptibility to, 1} (2)	
6.586	5	31	07	6p12.1-p11.2	RAB23		Ras-associated protein RAB23	606144			Carpenter syndrome, 201000 (3)	
6.587	10	23	87	6p	CSCI		Corticosterone side-chain isomerase	122550		?linked to MHC		
6.588	3	29	10	6p21.31	RPS10, DBA9		Ribosomal protein S10	603632			Diamond-Blackfan anemia 9, 613308 (3)	
6.589	4	14	05	6q	BPPV		Vertigo, benign paroxysmal positional	193007		max lod at D6S1556	Vestibulopathy, familial (2)	
6.590	8	9	99	6q23.2	RPS12		Ribosomal protein S12	603660				
6.591	8	31	10	6q11-q14	DEL6q11q14, C6DELq11q14		Chromosome 6q11-q14 deletion syndrome	613544		contiguous gene deletion syndrome	Chromosome 6q11-q14 deletion syndrome (4)	
6.592	5	24	13	6q11.1	KHDRBS2, SLM1		KH domain-containing, RNA-binding, signal transduction-associated protein 2	610487				
6.593	9	30	04	6q12	ADHD3		Attention deficit-hyperactivity disorder, susceptibility to, 2	608905			{Attention deficit-hyperactivity disorder}, 143465 (2)	
6.594	9	1	16	6q12-q13	ADGRB3, BAI3		Adhesion G protein-coupled receptor B3	602684				
6.595	9	5	03	6q14.1	COX7A2		Cytochrome c oxidase, subunit VIIa, polypeptide-2, liver	123996		previously thought to be on chr.4		
6.596	11	20	08	6q12	EYS, RP25		Eyes shut, Drosophila, homolog of	612424			Retinitis pigmentosa 25, 602772 (3)	
6.597	10	22	18	6q12	GLULD1, LGS		Glutamate-ammonia ligase (glutamine synthetase) domain-containing 1	611470				
6.598	10	23	87	6q14.2	ME1		Malic enzyme, cytoplasmic	154250				9(Mod1)
6.599	6	27	14	6q14.1	PGM3, AGM1, IMD23		Phosphoglucomutase-3 (N-acetylglucosamine-phosphate mutase 1)	172100			Immunodeficiency 23, 615816 (3)	9(Pgm3)
6.600	5	22	03	6q12	PHF3, KIAA0244		PHD finger protein 3	607789				
6.601	3	1	01	6q12	PTP4A1, HH72, PRL1		Protein tyrosine phosphatase, type 4A, 1	601585				
6.602	07	14	20	6q13	DDX43, HAGE		DEAD-box helicase 43	606286				
6.603	10	11	07	6q13	RIMS1, RIM1, RIM, KIAA0340, CORD7		Regulating synaptic membrane exocytosis 1	606629			Cone-rod dystrophy 7, 603649 (3)	
6.604	3	2	01	6q13	COL19A1, D6S228E, COL9A1L		Collagen XIX, alpha-1 polypeptide	120165				1(Col19a1)
6.605	11	19	11	6q12-q15	MRT30		Mental retardation, autosomal recessive 30	614342		between rs4612125 and rs285651	Mental retardation, autosomal recessive 30 (2)	
6.606	1	30	01	6q12-q16	CMD1K		Cardiomyopathy, dilated, 1K	605582			Cardiomyopathy, dilated, 1K (2)	
6.607	5	29	91	6q14.3	CGA		Chorionic gonadotropin, alpha polypeptide	118850		shared with LH, FSH, TSH		4(Tsha)
6.608	1	11	07	6q13	CD109		CD109 antigen	608859				
6.609	12	8	14	6q13	COL9A1, EDM6, STL4		Collagen IX, alpha-1 polypeptide	120210		mutation identified in 1 EDM6 family	?Epiphyseal dysplasia, multiple, 6, 614135 (3); Stickler syndrome, type IV, 614134 (3)	1(Col9a1)
6.610	8	22	07	6q13	DPPA5, ESG1		Developmental pluripotency-associated gene 5	611111				
6.611	3	3	03	6q13	GLCATS, KIAA1963		UDP-glucuronyltransferase S	607497				1(Glcats)
6.612	8	20	92	6q14.1	HTR1B		5-hydroxytryptamine (serotonin) receptor-1B	182131				
6.613	1	2	08	6q13	KHDC1		KH homology domain-containing protein 1	611688				1(Khdc1)
6.614	3	7	13	6q13	KHDC3L, C6orf221, ECAT1, HYDM2		KH domain containing 3-like, subcortical maternal complex member	611687			Hydatidiform mole, recurrent, 2, 614293 (3)	
6.615	10	17	12	6q13	LMBRD1, LMBD1, NESI, MAHCF		LMBR1 domain-containing protein 1	612625			Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	
6.616	4	6	18	6q13	CGAS, MB21D1, C6orf150		Cyclic GMP-AMP synthase	613973				
6.617	3	23	09	6q13	MIR30A, MIRN30A		Micro RNA 30A	612329				
6.618	09	19	19	6q13	MTO1, COXPD10		Mitochondrial tRNA translation optimization 1	614667			Combined oxidative phosphorylation deficiency 10, 614702 (3)	
6.619	1	7	11	6q14.1	MYO6, DFNA22, DFNB37		Myosin VI	600970			Deafness, autosomal dominant 22, 606346 (3); Deafness, autosomal recessive 37, 607821 (3); Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)	9(Sv, Myo6)
6.620	1	2	08	6q13	OOEP, KHDC2		Oocyte-expressed protein, Dog, homolog of	611689				9(Ooep)
6.621	12	28	08	6q14.1	SENP6, SSP1, SUSP1		Sentrin-specific protease family, member 6	605003				
6.622	4	21	16	6q13	SMAP1		Small ADP-ribosylation factor GTPase-activating protein 1	611372				
6.623	10	15	04	6q14.1	IBTK		Inhibitor of Bruton agammaglobulinemia tyrosine kinase	606457				
6.624	4	5	18	6q13-q14	COL12A1, UCMD2, BTHLM2, EDSMYP		Collagen, type XII, alpha-1	120320		mutation identified in 1 UCMD2 family	?Ullrich congenital muscular dystrophy 2, 616470 (3); Bethlem myopathy 2, 616471 (3)	
6.625	12	30	14	6q14.1	IMPG1, IPM150, VMD4		Interphotoreceptor matrix proteoglycan-1	602870			Macular dystrophy, vitelliform, 4, 616151 (3)	
6.626	12	7	07	6q13-q16.1	OTSC7		Otosclerosis 7	611572		between D6S1036 and D6S300	Otosclerosis 7 (2)	
6.627	2	2	01	6q14.1	TTK, MPS1L1, PYT		TTK protein kinase	604092				
6.628	5	5	09	6q13-q26	SCZD5		Schizophrenia susceptibility locus, chromosome 6q-related	603175		max lod at D6S1626 and D6S292	{Schizophrenia}, 181500 (2)	
6.629	10	30	06	6q14.1	BCKDHB, E1B		Branched chain keto acid dehydrogenase E1, beta polypeptide	248611			Maple syrup urine disease, type Ib, 248600 (3)	
6.630	8	20	98	6q13	EEF1A1, EF1A		Eukaryotic translation elongation factor-1, alpha-1	130590				
6.631	7	31	17	6q14.1	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34		Elongation of very long chain fatty acids 4	605512			Stargardt disease 3, 600110 (3); Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3); Spinocerebellar ataxia 34, 133190 (3)	
6.632	8	4	17	6q13	KCNQ5, MRD46		Potassium channel, voltage-gated, KQT-like subfamily, member 5	607357			Mental retardation, autosomal dominant 46, 617601 (3)	
6.633	12	02	19	6q14.1	PHIP, CHUJANS, DIDOD		Pleckstrin homology domain-interacting protein	612870			Chung-Jansen syndrome, 617991 (3)	
6.634	5	3	18	6q14.1	TENT5A, FAM46A, C6orf37, OI18		Terminal nucleotidyltransferase 5A	611357			Osteogenesis imperfecta, type XVIII, 617952 (3)	9(Fam46a)
6.635	8	19	98	6q15	CNR1		Cannabinoid receptor-1, brain	114610				4(Cnr1)
6.636	3	20	09	6q14.2	CYB5R4, NCB5OR		Cytochrome b5 reductase 4	608343				
6.637	10	13	94	6q14.3	HTR1E		5-hydroxytryptamine (serotonin) receptor-1E	182132				
6.638	12	30	99	6q13	SLC17A5, SIASD, SLD		Solute carrier family 17 (sodium phosphate), member 5	604322			Salla disease, 604369 (3); Sialic acid storage disorder, infantile, 269920 (3)	
6.639	8	13	91	6q14.1	TPBG		Trophoblast glycoprotein	190920				
6.640	12	29	06	6q15	ANKRD6, KIAA0957		Ankyrin repeat domain-containing protein 6	610583				
6.641	10	5	07	6q14-q16	ATFB2		Atrial fibrillation, familial, 2	608988		max lod between D6S286 and D6S1021	Atrial fibrillation, familial, 2 (2)	
6.642	6	16	99	6q14-q16.2	PBCRA, CRAPB		Progressive bifocal chorioretinal atrophy	600790			Chorioretinal atrophy, progressive bifocal (2)	
6.643	5	22	92	6q15	GABRR1		Gamma-aminobutyric acid (GABA) A receptor, rho-1	137161				4(Gabbr1)
6.644	5	22	92	6q15	GABRR2		Gamma-aminobutyric acid (GABA) A receptor, rho-2	137162				4(Gabbr2)
6.645	7	8	11	6q14.3	NT5E, NT5		5' nucleotidase, ecto (CD73)	129190			Calcification of joints and arteries, 211800 (3)	
6.646	05	05	20	6q14.1	DOP1A, DOPEY1, DOP1, KIAA1117		DOP1 leucine zipper-like protein A	616823				
6.647	10	4	16	6q15	MAP3K7, TAK1, CSCF, FMD2		Mitogen-activated protein kinase kinase kinase 7	602614			Cardiospondylocarpofacial syndrome, 157800 (3); Frontometaphyseal dysplasia 2, 617137 (3)	
6.648	9	2	09	6q14.1	FILIP, KIAA1275		Filamin A-interacting protein	607307				
6.649	9	10	09	6q14.1	HMGN3, TRIP7		High-mobility group nucleosomal binding protein 3 (thyroid hormone receptor interactor 7)	604502				
6.650	9	9	13	6q14.1	IRAK1BP1, SIMPL		Interleukin 1 receptor-associated kinase 1-binding protein 1	615375				
6.651	9	10	07	6q14.1	LCA5, C6orf152		Lebercilin	611408			Leber congenital amaurosis 5, 604537 (3)	
6.652	05	06	19	6q14.1	MEI4		Meiotic double-stranded break formation protein 4	618417				
6.653	3	7	14	6q14.1	SH3BGRL2		SH3 domain-binding glutamic acid-rich protein-like protein 2	615678				
6.654	1	9	13	6q14.1	SHFLD2		Split-hand/foot malformation with long bone deficiency 2	610685		between rs623155 and rs1547251	Split-hand/foot malformation with long bone deficiency 2 (2)	
6.655	5	23	13	5q14.1	TBCA		Tubulin-specific chaperone A	610058				
6.656	8	20	07	6q14.1	TMEM30A, CDC50A		Transmembrane protein 30A	611028				
6.657	12	22	08	6q14.1	UBE2CBP, H10BH		Ubiquitin-conjugating enzyme E2C-binding protein	612495				
6.658	4	29	16	6q14.2	MRAP2, C6orf117, BMIQ18		Melanocortin 2 receptor accessory protein 2	615410		mutation identified in 1 BMIQ18 individual	{?Obesity, susceptibility to, BMIQ18}, 615457 (3)	
6.659	9	24	15	6q14.2	RIPPLY2, C6orf59, SCDO6		Ripply2, zebrafish, homolog of	609891		mutation identified in 1 SCDO6 family	?Spondylocostal dysostosis 6, 616566 (3)	
6.660	2	25	15	6q14.2	SNAP91, AP180, KIAA0656		Synaptosomal-associated protein, 91kD	607923				
6.661	6	4	15	6q14.2-q14.3	CEP162, KIAA1009		Centrosomal protein, 162kD	610201				
6.662	5	13	15	6q14.3	SNX14, SCAR20		Sorting nexin 14	616105			Spinocerebellar ataxia, autosomal recessive 20, 616354 (3)	
6.663	12	9	15	6q14.3	SYNCRIP, NSAP1, GRYRBP, HNRNPQ		Synaptotagmin-binding cytoplasmic RNA-interacting protein	616686				
6.664	12	3	15	6q14.3	TBX18, CAKUT2		T-box 18	604613			Congenital anomalies of kidney and urinary tract 2, 143400 (3)	
6.665	2	5	15	6q14.3	ZNF292, ZFP292, KIAA0530		Zinc finger protein 292	616213				4(Znf292)
6.666	4	17	13	6q15	AKIRIN2		Akirin 2	615165				
6.667	04	17	19	6q15	BACH2, IMD60		BTB and CNC homology 2	605394			Immunodeficiency 60, 618394 (3)	
6.668	9	1	09	6q15	CASP8AP2, FLASH		Caspase 8-associated protein 2	606880				
6.669	4	1	08	6q15	GJA10, CX62		Gap junction protein, alpha-10	611924				
6.670	4	1	08	6q14-q15	GJB7, CX25		Gap junction protein, beta-7	611921				
6.671	11	27	18	6q15	MDN1		Midasin AAA Atpase 1	618200				
6.672	12	23	19	6q15	ORC3, ORC3L, LAT		Origin recognition complex, subunit 3	604972				4(Orc3)
6.673	8	18	14	6q15	PM20D2, ACY1L2		Peptidase M20 domain-containing 2	615913				
6.674	3	11	08	6q15	PNRC1, PROL2		Proline-rich nuclear receptor coactivator 1	606714				
6.675	7	10	07	6q15	SLC35A1, CST, CDG2F		Solute carrier family 35 (CMP-sialic acid transporter), member 1	605634			Congenital disorder of glycosylation, type IIf, 603585 (3)	
6.676	3	4	10	6q14.3	SNHG5, U50HG		Small nucleolar RNA host gene 5	613263				
6.677	11	12	09	6q14.3	SNORD50A, RNU50		Small nucleolar RNA, C/D box, 50A	613117				
6.678	3	4	10	6q14.3	SNORD50B		Small nucleolar RNA, C/D box	613264				
6.679	2	4	15	6q15	UBE2J1, UBC6E		Ubiquitin-conjugating enzyme E2J 1	616175				
6.680	3	6	08	6q15	RRAGD, RAGD		RAS-related GTP-binding protein D	608268				
6.681	5	5	09	6q15	SPACA1, SAMP32		Sperm acrosome-associated 1	612739				
6.682	4	22	02	6q16.1	FUT9		Fucosyltransferase 9	606865				
6.683	10	7	08	6q16.1	MANEA, ENDO		Mannosidase, endo-alpha	612327				
6.684	5	9	95	6q16.1	POU3F2, OCT7		POU domain, class 3, transcription factor 2	600494				4(Pou3f2)
6.685	6	18	99	6q15	RNGTT, HCE1, CAP1A		RNA guanylyltransferase and 5'-phosphatase	603512				
6.686	8	19	14	6q16.1	EPHA7, HEK11		Ephrin receptor EphA7	602190				
6.687	10	28	08	6q21	MICAL1, NICAL, MICAL		Microtubule-associated monooxygenase, calponin and LIM domains-containing 1	607129				
6.688	2	2	14	6q16.1	MMS22L, C6orf167		MMS22-like protein	615614				
6.689	12	13	18	6q16.1	NDUFAF4, HRPAP20, C6orf66, MC1DN15		NADH-ubiquinone oxidoreductase complex assembly factor 4	611776			Mitochondrial complex I deficiency, nuclear type 15, 618237 (3)	
6.690	4	22	15	6q16.1	PNKY		Long intergenic noncoding RNA Pinky	616328				
6.691	10	15	07	6q15	RARS2, RARSL, PCH6		Arginyl-tRNA synthetase 2	611524			Pontocerebellar hypoplasia, type 6, 611523 (3)	
6.692	2	4	15	6q16.1	UFL1, KIAA0776, NLBP		UFM1-specific ligase 1	613372				
6.693	11	1	13	6q16.1-q16.2	FBXL4, FBL4, MTDPS13		F-box and leucine-rich repeat protein 4	605654			Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3)	4(Fbxl4)
6.694	2	2	10	6q16.1	FHL5, ACT		Four-and-a-half LIM domains 5	605126				
6.695	5	13	02	6q16.1	GPR63		G protein-coupled receptor 63	606915				
6.696	3	3	16	6q16.2	DHS6S1, MCDR1		DNase1 hypersensitivity, chromosome 6, site 1	616842		upstream of PRDM13 and CCNC	Macular dystrophy, North Carolina type, 136550 (3)	
6.697	11	20	15	6q16.2	PNISR, SRRP130, SFRS18		PNN-interacting serine/arginine-rich protein	616653				
6.698	1	8	16	6q16.2	PRDM13		PR domain-containing protein 13	616741				
6.699	07	24	19	6q16.2	USP45, LCA19		Ubiquitin-specific protease 45	618439		mutation identified in 1 LCA19 patient	?Leber congenital amaurosis 19, 618513 (3)	
6.700	7	18	01	6q16.2	MCHR2, MCH2R, SLT, MCH2		Melanin-concentrating hormone receptor 2	606111				
6.701	12	19	18	6q16.2-q22.1	LMPHM2		Lymphatic malformation 2	611944		max lod at D6S1671	Lymphatic malformation 2 (2)	
6.702	9	8	11	6q16.3	ASCC3, p200		Activating signal cointegrator 1 complex, subunit 3	614217				
6.703	04	30	19	6q16.3	SIM1		Single-minded, Drosophila, homolog of, 1	603128				10(Sim1)
6.704	9	11	12	6q16.3-q22.31	GEFSP8		Generalized epilepsy with febrile seizures plus, type 8	613828		between D6S962 and D6S287	Epilepsy, generalized, with febrile seizures plus, type 8 (2)	
6.705	4	26	17	6q21	AFG1L, AFG1, LACE1		AFG1-like ATPase	617469				
6.706	7	11	97	6q21	AIM1, ST4		Absent in melanoma 1	601797				10(Aim1)
6.707	9	9	13	6q21	AK9		Adenylate kinase 9	615358				
6.708	09	19	19	6q21	ATG5, APG5, APG5L, ASP, SCAR25		Autophagy related 5	604261		mutation identified in one SCAR25 family	?Spinocerebellar ataxia, autosomal recessive 25, 617584 (3)	
6.709	05	16	19	6q21	ARMC2, SPGF38		Armadillo repeat-containing protein 2	618424			Spermatogenic failure 38, 618433 (3)	
6.710	5	19	15	6q21	BEND3, KIAA1553		BEN domain-containing protein 3	616374				
6.711	04	22	19	6q21	BVES, HBVES, POPDC1, LGMDR25		Blood vessel epicardial substance	604577			Muscular dystrophy, limb-girdle, autosomal recessive 25, 616812 (3)	
6.712	7	10	95	6q16.2	CCNC		Cyclin C	123838				
6.713	9	7	12	6q21	CD24		CD24 antigen	600074		pseudogenes at 15q21-q22; Yq11		
6.714	6	2	16	6q21	CD164, DFNA66		CD164 antigen	603356		mutation identified in 1 DFNA66 family	?Deafness, autosomal dominant 66, 616969 (3)	
6.715	10	23	20	6q21	CDK19, KIAA1028, DEE87		Cyclin-dependent kinase 19	614720			Developmental and epileptic encephalopathy 87, 618916 (3)	
6.716	8	8	13	6q21	DDO, DASOX		D-aspartate oxidase	124450				
6.717	09	09	19	6q21	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP		FIG4 phosphoinositide 5-phosphatase	609390		mutation identified in 1 BTOP family	Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateral sclerosis 11, 612577 (3); Yunis-Varon syndrome, 216340 (3); ?Polymicrogyria, bilateral temporooccipital, 612691 (3)	
6.718	9	9	08	6q21	FOXO3A, FOXO3, FKHRL1		Forkhead box O3A	602681				
6.719	1	4	93	6q21	FYN		FYN oncogene related to SRC, FGR, YES	137025		proximal 6q21		10(Fyn)
6.720	4	30	15	6q22.1	GOPC, PIST, FIG, CAL		Golgi-associated PDZ and coiled-coil domains-containing protein	606845				
6.721	10	15	07	6q16.3	GRIK2, GLUR6, MRT6		Glutamate receptor, ionotropic, kainate 2	138244			Mental retardation, autosomal recessive, 6, 611092 (3)	
6.722	2	11	08	6q21	GTF3C6, C6orf51		General transcription factor 3C, polypeptide 6	611784				
6.723	2	5	16	6q16.3	HACE1, KIAA1320, SPPRS		HECT domain- and ankyrin repeat-containing E3 ubiquitin protein ligase 1	610876			Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3)	
6.724	1	8	01	6q21	HDAC2		Histone deacetylase 2	605164				10(Hdac2)
6.725	06	15	20	6q22.31	HEY2, HERP1, GRL		HES-related family bHLH transcription factor with YRPW motif 2	604674				
6.726	10	4	01	6q21	HTX3		Heterotaxy, visceral, 3, autosomal	606325			?Heterotaxy, visceral, 3, autosomal (2)	
6.727	12	9	98	6q21	IDDM15		Insulin-dependent diabetes mellitus-15	601666			{Diabetes mellitus, insulin-dependent, 15} (2)	
6.728	5	24	13	6q21	LAMA4, LAMA3, CMD1JJ		Laminin, alpha-4	600133			Cardiomyopathy, dilated, 1JJ, 615235 (3)	
6.729	7	23	09	6q21	LGV2		Longevity 2	606460		associated with rs2802292	[Longevity 2] (2)	
6.730	09	11	19	6q16-q21	LIN28B		lin-28 homolog B	611044				6(Lin28b)
6.731	1	31	11	6q21	MCOPS8, MMEP		Microphthalmia, syndromic 8	601349		translocation with 13q12	Microphthalmia, syndromic 8 (2)	
6.732	7	20	09	6q21	MENAQ2		Menarche, age at, QTL2	612882		associated with rs7759938	{Menarche, age at, QTL2} (2)	
6.733	2	2	17	6q21	MFSD4B, NAGLT1, Kiaa1919		Major facilitator superfamily domain-containing protein 4B	617331				
6.734	09	12	19	6q21	MTRES1, C6orf203, HSPC230		Mitochondrial transcription rescue factor 1	618583				
6.735	5	14	09	6q22.31	NKAIN2, TCBA		Na+/K+ transporting ATPase interacting 2	609758		fused with SUSP1 in T-cell lymphoma/leukemia		
6.736	6	4	99	6q21	NR2E1, TLX		Nuclear receptor subfamily 2, group E, member 1 (tailless, Drosophila, homolog of)	603849				
6.737	10	3	07	6q21	OSTM1, GL, OPTB5		Osteopetrosis associated transmembrane protein 1 (grey-lethal, mouse, homolog of)	607649			Osteopetrosis, autosomal recessive 5, 259720 (3)	
6.738	5	24	12	6q21	PDSS2, DLP1, C6orf210, COQ10D3		Prenyl diphosphate synthase, subunit 2	610564			Coenzyme Q10 deficiency, primary, 3, 614652 (3)	
6.739	04	20	20	6q21	POPDC3, POP3, LGMDR26		Popeye domain-containing protein 3	605824			Muscular dystrophy, limb-girdle, autosomal recessive 26, 618848 (3)	
6.740	04	13	20	6q21	QRSL1, GATA, COXPD40		Glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like protein 1	617209			Combined oxidative phosphorylation deficiency 40, 618835 (3)	
6.741	12	27	16	6q21	REV3L, POLZ, REV3		Rev-3, yeast, homolog-like (polymerase, DNA, zeta)	602776				
6.742	06	13	19	6q21	RPF2, BXDC1		Ribosome production factor 2, S. cerevisiae, homolog of	618471				
6.743	1	6	16	6q21	RTN4IP1, NIMP, OPA10		Reticulon 4-interacting protein 1	610502			Optic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3)	
6.744	10	07	19	6q21	SEC63, PCLD2		SEC63 homolog, protein translocation regulator	608648			Polycystic liver disease 2, 617004 (3)	
6.745	1	11	07	6q21	SESN1, SEST1, PA26		Sestrin 1	606103				4(Pa26)
6.746	3	22	07	6q21	SLC22A16, FLIPT2, CT2		Solute carrier family 22 (organic cation transporter), member 16	608276				
6.747	11	27	18	6q21	SMPD2, NSMASE1		Sphingomyelin phosphodiesterase 2	603498				
6.748	7	25	06	6q21	SNX3		Sorting nexin 3	605930		t(6;13)(q21;q12)		
6.749	09	19	19	6q21	SOBP, JXC1, MRAMS		Sine oculis-binding protein homolog	613667			Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3)	
6.750	11	15	13	6q21	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8		TRAF3-interacting protein 2	607043		mutation identified in 1 family with CANDF8	{Psoriasis susceptibility 13}, 614070 (3); ?Candidiasis, familial, 8, 615527 (3)	
6.751	7	22	09	6q21	TUBE1, TUBE		Tubulin, epsilon-1	607345				
6.752	3	24	06	6q22.1	VGLL2, VGL2, VITO1		Vestigial-like 2	609979				
6.753	7	1	11	6q21	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2		Zinc finger- and BTB domain-containing protein 24	614064			Immunodeficiency-centromeric instability-facial anomalies syndrome 2, 614069 (3)	
6.754	11	20	95	6q21	AMD1		S-adenosylmethionine decarboxylase-1	180980		pseudogene AMD2 on Xq28		
6.755	8	18	04	6q21-q22	PLF		Pulmonary function	608852		close to D6S281	{Pulmonary function} (2)	
6.756	2	28	03	6q21	SLC16A10, TAT1		Solute carrier family 16 (monocarboxylic acid transporter), member 10	607550				
6.757	12	19	19	6q21	WASF1, WAVE, WAVE1, SCAR1, NEDALVS		WAS protein family member 1	605035			Neurodevelopmental disorder with absent language and variable seizures, 618707 (3)	
6.758	6	12	95	6q21	GPR6		G protein-coupled receptor-6	600553				
6.759	6	18	99	6q21	PRDM1, BLIMP1		PR domain-containing protein 1 (B-lymphocyte-induced maturation protein 1)	603423				10(Blimp1)
6.760	8	9	99	6q22.1	COL10A1		Collagen X, alpha-1 polypeptide	120110			Metaphyseal chondrodysplasia, Schmid type, 156500 (3)	10(Col10a1)
6.761	1	7	02	6q22.1	FRK, RAK, GTK		FYN-related kinase	606573				
6.762	8	11	91	6q24.1	NMBR		Neuromedin B receptor	162341				
6.763	11	8	17	6q22.1	DSE, SART2, EDSMC2		Dermatan sulfate epimerase	605942			Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3)	
6.764	9	28	00	6q23.2	ENPP3, PDNP3		Ectonucleotide pyrophosphatase/phosphodiesterase 3	602182				
6.765	9	10	09	6q22.31	MAN1A1		Mannosidase, alpha, class 1A, member 1	604344				
6.766	12	07	07	6q23.3	MYB		Avian myeloblastosis viral (v-myb) oncogene homolog	189990			{T-cell acute lymphoblastic leukemia} (3)	10(Myb)
6.767	2	10	97	6q21	PREP		Prolyl endopeptidase	600400				
6.768	1	4	93	6q22.1	ROS1, MCF3		Avian UR2 sarcoma virus oncogene (v-ros) homolog 1	165020				10(Ros1)
6.769	2	17	09	6q23.3	BCLAF1, BTF, KIAA0164		BCL2-associated transcription factor 1	612588				
6.770	7	2	14	6q23.2	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED		Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of)	173335			{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3); {Obesity, susceptibility to}, 601665 (3); Arterial calcification, generalized, of infancy, 1, 208000 (3); Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3); Cole disease, 615522 (3)	10(Ly41, Pca1)
6.771	11	3	98	6q23.1-q23.2	EPB41L2		Erythrocyte membrane protein band 4.1-like 2	603237				
6.772	3	18	10	6q22.31	FABP7, FABPB, BLBP		Fatty acid-binding protein 7	602965				
6.773	1	7	14	6q22-q23	IGAN1		IgA nephropathy, susceptibility to, 1	161950			{IgA nephropathy, susceptibility to, 1} (2)	
6.774	10	09	18	6q22.33	LAMA2, LAMM, MDC1A		Laminin, alpha-2 (merosin)	156225			Muscular dystrophy, limb-girdle, autosomal recessive 23, 618138 (3); Muscular dystrophy, congenital, merosin deficient or partially deficient, 607855 (3)	10(dy, Lamm)
6.775	4	17	00	6q22-q23	SM2		Hepatic fibrosis susceptibility due to Schistosoma mansoni infection	604201		?polymorphism of INFGR1	{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection} (2)	
6.776	10	15	13	6q22.31	TRDN, TDN, CPVT5		Triadin	603283			Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3)	
6.777	7	19	04	6q22.1	TSPYL1, TSPYL, SIDDT		Y-encoded testis-specific protein-like	604714			Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	10(Tspyl)
6.778	10	07	20	6q21	WISP3, PPAC, PPRD		Wnt-1 inducible signaling pathway protein 3	603400			Progressive pseudorheumatoid dysplasia, 208230 (3)	
6.779	6	7	10	6q22.33	ARHGAP18		RHO GTPase-activating protein 18	613351				
6.780	8	9	05	6q22-q24	FEB5		Febrile seizures, familial, 5	609255		between D6S1572 and D6S472	Febrile seizures, familial, 5 (2)	
6.781	6	27	08	6q22-q24	FIQTL1		Fasting insulin level quantitative trait locus 1	606035		max lod at D6S1569	[Fasting insulin level quantitative trait locus 1] (2)	
6.782	10	18	00	6q23.3	MAP7, EMAP115		Microtubule-associated protein-7	604108				10(Map7)
6.783	9	8	11	6q22.1	BET3L, TRAPPC3L		Bet3, S. cerevisiae, homolog-like	614137				
6.784	08	23	19	6q21	CDC40, PRP17		Cell division cycle 40	605585				
6.785	1	20	17	6q22.1	FAM26F, INAM		Family with sequence similarity 26, member F	617305				
6.786	4	25	14	6q22.1	KPNA5		Karyopherin alpha-5	604545				
6.787	4	11	11	6q22.31	PLN, PLB, CMD1P, CMH18		Phospholamban	172405			Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, hypertrophic, 18, 613874 (3)	
6.788	08	21	19	6q22.1	RSPH4A, CILD11		Radial spoke head component 4A	612647			Ciliary dyskinesia, primary, 11, 612649 (3)	
6.789	8	17	15	6q22.31	MCM9, MCMDC1, ODG4		Minichromosome maintenance complex component 9	610098			Ovarian dysgenesis 4, 616185 (3)	10(Mcm9)
6.790	8	18	08	6q22.33	RNF146		Ring finger protein 146	612137				
6.791	6	29	94	6q21	MRACKS, MACS, PKCSL		Myristoylated alanine-rich protein kinase C substrate (MARCKS, 80K-L)	177061		monomorphic		10(Macs)
6.792	4	16	14	6q22.1	RFX6, RFXDC1, MTCHRS		Regulatory factor X, 6	612659			Mitchell-Riley syndrome, 615710 (3)	
6.793	09	19	19	6q22.33	RSPO3, PWTSR, CRISTIN1		R-spondin 3	610574				10(Rspo3)
6.794	5	20	99	6q22.33	PTPRK		Protein-tyrosine phosphatase, receptor type, kappa	602545				10(Ptprk)
6.795	4	20	10	6q23.2	C6orf192		Chromosome 6 open reading frame 192	613361				
6.796	8	23	05	6q22.31	HSF2		Heat-shock transcription factor 2	140581				
6.797	2	3	05	6q22.31	ASF1A, CIA		Anti-silencing function 1, S. cerevisiae, homolog of, A	609189				
6.798	05	11	20	6q22.31	CEP85L, C6orf204, LIS10		CEP85-like protein	618865			Lissencephaly 10, 618873 (3)	
6.799	5	11	16	6q22.31	CLVS2		Clavesin 2	616945				
6.800	6	30	05	6q21-q22	HS3ST5, 3OST5		Heparan sulfate 3-O-sulfotransferase 5	609407				
6.801	10	03	19	6q22.1	NUS1, NGBR, C6orf68, CDG1AA, MRD55		NUS1 dehydrodolichyl diphosphate synthase subunit	610463		mutation identified in 1 CDG1AA family	?Congenital disorder of glycosylation, type 1aa, 617082 (3); Mental retardation, autosomal dominant 55, with seizures, 617831 (3)	
6.802	9	10	09	6q22.31	PKIB		Protein kinase, cAMP-dependent catalytic, inhibitor beta	606914				
6.803	09	17	19	6q22.31	RNF217, OSTL, IBRDC1, C6orf172		Ring finger potein 217	618592		overlaps STL in opposite orientation		
6.804	4	2	12	6q22.31	SERINC1, TMS2, KIAA1253		Serine incorporator 1	614548				
6.805	1	29	07	6q22.31	SMPDL3A, ASML3A		Sphingomyelin phosphodiesterase, acid-like, 3A	610728				
6.806	7	3	14	6q22.31	TBC1D32, BROMI		TBC1 domain family, member 32	615867				10(Tbc1d32)
6.807	5	25	13	6q22.31	TPD52L1, D53		Tumor protein D52-like 1	604069				10(Tdp52l1)
6.808	4	6	13	6q22.32	CEMPW, C6orf173, CUG2		Centromeric protein W	611264				
6.809	8	18	08	6q22.33	ECHDC1		Enoyl coenzyme A hydratase domain-containing protein 1	612136				
6.810	3	24	06	6q22.32	HINT3		Histidine triad nucleotide-binding protein 3	609998				
6.811	6	23	99	6q23.3	MAP3K5, MEKK5, MAPKKK5, ASK1		Mitogen-activated protein kinase kinase kinase 5	602448				
6.812	12	23	05	6q22.31-q22.32	NCOA7, ERAP140		Nuclear receptor coactivator 7	609752				
6.813	1	27	11	6q22.33	THEMIS, GASP, SPOT, C6orf190		Thymocyte-expressed molecule involved in selection	613607				10(Themis)
6.814	11	13	07	6q22.3-q23.1	HBFQTL2, FCP		Fetal hemoglobin quantitative trait locus 2	142470			Fetal hemoglobin quantitative trait locus 2 (2)	
6.815	10	9	96	6q25.1	PCMT1		Protein-L-isoaspartate (D-aspartate) O-methyltransferase	176851				10(Pcmt1)
6.816	12	3	03	6q23.2	ARG1		Arginase, liver	608313			Argininemia, 207800 (3)	
6.817	4	4	11	6q23	CMD1F, CDCD3, LGMD1D		Cardiomyopathy, dilated-1F, autosomal dominant	602067			Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D (2)	
6.818	09	19	19	6q23.2	EYA4, DFNA10, CMD1J		EYA transcriptional coactivator and phosphatase 4	603550		mutation identified in 1 CMD1J family	Deafness, autosomal dominant 10, 601316 (3); ?Cardiomyopathy, dilated, 1J, 605362 (3)	
6.819	3	15	10	6q23	HCHGQ1		Hematocrit/hemoglobin quantitative trait locus 1	609319			[Hematocrit/hemoglobin quantitative trait locus 1] (2)	
6.820	3	19	01	6q23.3	IL20RA		Interleukin 20 receptor, alpha	605620				
6.821	04	09	20	6q23.1	L3MGTL3, MBT1, KIAA1798		L3MBTL histone methyl-lysine-binding protein 3	618844				
6.822	2	25	12	6q23	RP63		Retinitis pigmentosa 63	614494		between D6S457 and D6S1656	Retinitis pigmentosa 63 (2)	
6.823	1	31	08	6q23	RA		Rheumatoid arthritis, susceptibility to	180300		associated with SNP rs10499194 and rs6920220	{Rheumatoid arthritis, susceptibility to} (2)	
6.824	1	13	99	6q23.2	SGK1		Serum/glucocorticoid-regulated kinase 1	602958				
6.825	10	30	08	6q23	SLEB13		Systemic lupus erythematosus, susceptibility to, 13	612378		associated with rs5029939	{Systemic lupus erythematosus, susceptibility to, 13} (2)	
6.826	08	23	19	6q22.31	RNF217AS1, STL		RNF217 antisense RNA 1	602532				
6.827	1	13	16	6q23.3	TNFAIP3, A20, OTUD7C, AISBL		Tumor necrosis factor-alpha-induced protein 3	191163			Autoinflammatory syndrome, familial, Behcet-like, 616744 (3)	
6.828	6	17	16	6q24.2	HIVEP2, MRD43		Human immunodeficiency virus type I enhancer-binding protein-2	143054			Mental retardation, autosomal dominant 43, 616977 (3)	
6.829	5	2	08	6q23-q24	MAFD6, BPAD		Major affective disorder 6	611536			{Major affective disorder 6} (2)	
6.830	3	5	98	6q23-q24	NTT		Noncoding transcript in T cells	602154				
6.831	12	21	09	6q23.3	PBOV1, UROC28, UC28		Prostate and breast cancer overexpressed 1	605669				
6.832	11	23	98	6q23.2	TCF21, POD1		Transcription factor-21 (epicardin; podocyte-expressed 1)	603306				10(Tcf21)
6.833	12	17	07	6q23.2	VNN1, HDLCQ8		Vanin 1	603570			[High density lipoprotein cholesterol level QTL 8] (3)	10(Vnn1)
6.834	6	18	99	6q23.2	VNN2		Vanin 2	603571				
6.835	2	20	02	6q23.2	VNN3		Vanin 3	606592				10(Vnn3)
6.836	4	27	12	6q23-q24.1	SPG25		Spastic paraplegia 25, autosomal recessive, with disc herniation	608220			Spastic paraplegia 25, autosomal recessive (2)	
6.837	10	08	08	6q23-q25	BMIQ3		Body mass index quantitative trait locus 3	607446		max lod at D6S305	[Body mass index QTL3] (2)	
6.838	9	22	04	6q23-q25	LNCR1		Lung cancer 1	608935		max hlod at D6S2436	{Lung cancer susceptibility} (2)	
6.839	7	11	93	6q23.2	CTGF, NOV2		Connective tissue growth factor	121009		proximal to MYB		
6.840	7	1	05	6q23.2	TAAR1, TA1		Trace amine-associated receptor 1	609333				10(Taar1)
6.841	11	2	04	6q23.2	MOXD1, MOX		Monooxygenase, DBH-like, 1	609000				
6.842	3	27	18	6q24.1	REPS1, NBIA7		RALBP1-associated EPS domain-containing protein 1	614825		mutation identified in 1 NBIA7 family	?Neurodegeneration with brain iron accumulation 7, 617916 (3)	
6.843	9	1	09	6q23.3	ALDH8A1, ALDH12		Aldehyde dehydrogenase 8 family, member A1	606467				
6.844	5	28	02	6q23.2	GPR102, TA5		G protein-coupled receptor 102	606927				
6.845	9	26	11	6q23.2	MED23, MRT18		Mediator complex subunit 23	605042			Mental retardation, autosomal recessive 18, 614249 (3)	
6.846	2	28	03	6q23.2	PNR		Putative neurotransmitter receptor	607405				
6.847	8	19	13	6q23.2	SLC2A12, GLUT12		Solute carrier family 2 (facilitated glucose transporter), member 12	610372				10(Slc2a12)
6.848	9	22	04	6q23.2	STX7		Syntaxin 7	603217				
6.849	12	5	03	6q23.2	TAR3, TA3		Trace amine receptor 3	608282				
6.850	10	24	14	6q23.2	TARID		TCF21 antisense RNA inducing promoter demethylation	616058				
6.851	5	5	09	6q23.2	TAAR6, TRAR4		Trace amine-associated receptor 6	608923				
6.852	9	15	04	6q23.3	AHI1		Abelson helper integration site 1	608894			Joubert syndrome 3, 608629 (3)	
6.853	1	18	12	6q24.1	CITED2, MRG1, P35SRJ, VSD2, ASD8		CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2	602937		?pseudogene on 1q22	Ventricular septal defect 2, 614431 (3); Atrial septal defect 8, 614433 (3)	
6.854	9	22	14	6q23.3	IFNGR1, IMD27A, IMD27B		Immune interferon, receptor for	107470			Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3); {H. pylori infection, susceptibility to}, 600263 (3); {Tuberculosis, susceptibility to}, 607948 (3); Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3); {Tuberculosis infection, protection against}, 607948 (3); {Hepatitis B virus infection, susceptibility to}, 610424 (3)	10(Ifgr)
6.855	5	29	12	6q23.3	MPVQTL5		Mean platelet volume quantitative trait locus 5	614645		associated with rs9399137	Mean platelet volume QTL5 (2)	
6.856	7	1	05	6q23.3	OLIG3, BHLHB7		Oligodendrocyte lineage transcription factor 3	609323				
6.857	7	17	14	6q23.3	PDE7B		Phosphodiesterase 7B, cAMP-specific, high-affinity	604645				
6.858	12	6	16	6q23.3	PERP		p53 effector related to PMP22	609301				
6.859	1	11	16	6q23.3	PEX7, RCDP1, PBD9B		Peroxisomal biogenesis factor-7	601757			Rhizomelic chondrodysplasia punctata, type 1, 215100 (3); Peroxisome biogenesis disorder 9B, 614879 (3)	
6.860	1	7	09	6q23.3	SLC35D3		Solute carrier family 35, member D3	612519				10(Slc35d3)
6.861	07	17	19	6q23.3	WAKMAR2		Wound- and keratinocyte migration-associated long noncoding RNA 2	618508		partially overlaps TNFAIP on opposite strand		
6.862	3	28	17	6q23.3-q24.1	ARFGEF3, BIG3, KIAA1244		ADP-ribosylation factor guanine nucleotide exchange factor 3	617411				
6.863	8	27	01	6q24.1	C6orf34, SOUL		Soul, chicken, homolog of	605825				
6.864	12	18	19	6q24.3	EPM2A, MELF, EPM2		EPM2A glucan phosphatase, laforin	607566			Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)	
6.865	9	9	08	6q24.3	FBXO30, FBX30		F-box only protein 30	609101				10(Fbxo30)
6.866	9	18	17	6q24.3	GRM1, MGLUR1, GRM1A, SCAR13, SCA44		Glutamate receptor, metabotropic, 1	604473			Spinocerebellar ataxia, autosomal recessive 13, 614831 (3); Spinocerebellar ataxia 44, 617691 (3)	
6.867	12	24	08	6q23.3	HBS1L, KIAA1038, ERFS		HBS1-like protein	612450				
6.868	02	15	19	6q24.2	HYMAI		Hydatidiform mole-associated and imprinted transcript	606546		relaxed imprinting in TNDM		
6.869	02	15	19	6q24.2	PLAGL1, ZAC, LOT1		Pleomorphic adenoma gene-like 1 (ZAC tumor suppressor)	603044		relaxed imprinting in TNDM		10(Zac)
6.870	3	13	06	6q24.2	STX11, FHL4, HPLH4, HLH4		Syntaxin-11	605014			Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	
6.871	4	26	05	6q23.2	TAAR2, GPR58		Trace amine-associated receptor 2	604849				
6.872	02	15	19	6q24	TNDM1		Transient neonatal diabetes mellitus 1	601410		disordered imprinting of PLAGL1 and HYMAI	{Diabetes mellitus, transient neonatal 1}, 601410 (4)	
6.873	7	8	96	6q24.2	UTRN, DMDL, DRP1		Utrophin (homologous to dystrophin)	128240		near dy in mouse		10(Dmdl)
6.874	9	30	10	6q24-q25	DEL6q24q25, C6DELq25q25		Chromosome 6q24-q25 deletion syndrome	612863			Chromosome 6q25-q25 deletion syndrome (4)	
6.875	9	29	09	6q25.1	IYD, DEHAL1, TDH4		Iodotyrosine deiodinase	612025			Thyroid dyshormonogenesis 4, 274800 (3)	
6.876	10	8	09	6q25.2	OPRM1		Opioid receptor, mu-1	600018				10(Oprm)
6.877	3	10	03	6q25.1	PPIL4		Peptidyl-prolyl isomerase-like 4	607609				
6.878	2	17	09	6q24-q25	STQTL1		Stature quantitative trait locus 1	606255		associated with rs4896582 and rs3748069	{Stature QTL 1} (2)	
6.879	8	28	92	6q25.3	MAS1		Oncogene MAS1	165180				17(Mas1)
6.880	4	17	07	6q24.1-q24.2	C6orf55, SBP1, LIP5, VTA1, DRG1		SKD1-binding protein 1	610902				
6.881	8	2	13	6q24.1	CCDC28A, C6orf80		Coiled-coil domain-containing 28A	615353				
6.882	8	31	16	6q24.2	ADGRG6, PR126, VIGR, LCCS9		Adhesion G protein-coupled receptor G6	612243			Lethal congenital contracture syndrome 9, 616503 (3)	10(Gpr126)
6.883	11	11	20	6q24.1	HECA, HDC		HDC homolog, cell cycle regulator	607977				
6.884	1	30	02	6q23.3	IL22BP, IL22RA2		Interleukin 22-binding protein	606648				
6.885	9	9	13	6q24.2	ADAT2, TAD2		Adenosine deaminase, tRNA-specific, 2	615388				
6.886	2	24	12	6q24.2	FUCA2		Fucosidase, alpha-L- 2, plasma	136820		linked to PLG		
6.887	3	9	17	6q24.2	PEX3, PBD10A, PBD10B		Peroxisomal biogenesis factor-3	603164		mutation identified in 1 PBD10B patient	Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3); ?Peroxisome biogenesis disorder 10B, 617370 (3)	
6.888	7	16	12	6q24.2	PHACTR2, KIAA0680		Phosphatase and actin regulator 2	608724				
6.889	1	24	18	6q24.2	SF3B5, SF3B10		Splicing factor 3B, subunit 5	617847				
6.890	5	5	09	6q24.2-q25.2	DUH1, DUH		Dyschromatosis universalis hereditaria 1	127500		max lod at D6S1553	Dyschromatosis universalis hereditaria 1 (2)	
6.891	8	20	07	6q25.1	RAET1L		Retinoic acid early transcript 1L	611047				
6.892	6	1	12	6q24.3	ADGB		Androglobin	614630				
6.893	12	5	03	6q25.1	NUP43		Nucleoporin, 43kD	608141				
6.894	2	21	10	6q25.1	PPP1R14C, KEPI		Protein phosphatase 1, regulatory subunit 14C	613242				
6.895	7	22	09	6q24.3	RAB32		Ras-associated protein RAB32	612906				
6.896	03	29	19	6q24.3-q25.1	SASH1, KIAA0790, CAPOK, DUH1		Sterile alpha motifs- and SH3 domain-containing protein 1	607955		mutation identified in 1 CAPOK family	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma, 618373 (3); Dyschromatosis universalis hereditaria 1, 127500 (3)	
6.897	8	24	04	6q24.3	STXBP5		Syntaxin-binding protein 5 (tomosyn)	604586				
6.898	6	30	08	6q25	BMND11		Bone mineral density quantitative trait locus 11	612114		associated with rs4870044, rs1038304, and rs1999805	[Bone mineral density QTL 11] (2)	
6.899	3	23	06	6q25.3	FNDC1, AGS8, KIAA1866		Fibronectin type III domain-containing protein 1	609991				
6.900	1	7	09	6q25	IDDM21		Diabetes mellitus, insulin-dependent, 21	612521		associated with rs1738074	{Diabetes mellitus, insulin-dependent, 21} (2)	
6.901	02	26	19	6q25	LPRS2		Leprosy, susceptibility to, 2	607572		association with PARK2	{Leprosy, susceptibility to, 2} (2)	
6.902	2	12	16	6q25.2	MYCT1, MTLC		MYC target in myeloid cells 1	616805				
6.903	09	19	19	6q25.1	RMND1, COXPD11		Required for meiotic nuclear division 1 homolog	614917			Combined oxidative phosphorylation deficiency 11, 614922 (3)	
6.904	07	31	20	6q25.2	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4, AMC3		Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1)	608441			Spinocerebellar ataxia, autosomal recessive 8, 610743 (3); Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3); Arthrogryposis multiplex congenita 3, myogenic type, 618484 (3)	
6.905	5	31	05	6q25.1	SUMO4, IDDM5		Small ubiquitin-like modifier 4	608829			{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)	
6.906	1	11	16	6q25.1	TAB2, MAP3K7IP2, KIAA0733, CHTD2		Tak1 (MAP3K7) binding protein 2	605101			Congenital heart defects, nonsyndromic, 2, 614980 (3)	
6.907	9	10	09	6q25.3	TFB1M, CGI75		Transcription factor B1, mitochondrial	607033				
6.908	2	28	01	6q25.1	ULBP1		UL16-binding protein 1	605697				
6.909	2	28	01	6q25.1	ULBP2		UL16-binding protein 2	605698				
6.910	2	28	01	6q25.1	ULBP3		UL16-binding protein 3	605699				
6.911	9	9	08	6q25.2	FBXO5, FBX5, EMI1		F-box only protein 5	606013				10(Fbxo5)
6.912	12	29	89	6q25-q26	RCD1		Retinal cone dystrophy-1	180020			?Retinal cone dystrophy-1 (2)	
6.913	12	9	98	6q25-q27	IDDM8		Insulin-dependent diabetes mellitus-8	600883			{Diabetes mellitus, insulin-dependent, 8} (2)	
6.914	1	29	04	6q26	PACRG		Parkin coregulated gene	608427		shares 5' regulatory region and both 3' UTRs with PARK2		17(Pacrg)
6.915	4	28	16	6q25.3	ARID1B, BAF250B, KIAA1235, MRD12, CSS1		AT-rich interaction domain-containing protein 1B	614556			Coffin-Siris syndrome 1, 135900 (3)	
6.916	4	30	15	6q25.1	ARMT1, C6orf211		Acidic residue methyltransferase 1	616332				
6.917	09	18	19	6q25.1-q25.2	ESR1, ESR, ESTRR		Estrogen receptor 1	133430			Estrogen resistance, 615363 (3); {Migraine, susceptibility to}, 157300 (3); {Myocardial infarction, susceptibility to}, 608446 (3); Breast cancer, somatic, 114480 (3)	10(Esr)
6.918	9	10	09	6q25.1	KATNA1		Katanin, p60 subunit, A1	606696				
6.919	04	09	20	6q25.1	LATS1		Large tumor suppressor kinase 1	603473				
6.920	9	10	09	6q25.3	NOX3		NADPH oxidase 3	607105				
6.921	2	12	07	6q25.1	UST		Uronyl 2-sulfotransferase	610752				
6.922	6	13	07	6q25.1	ZC3H12D, p34, C6orf95		Zinc finger CCCH domain-containing protein 12D	611106				
6.923	10	23	15	6q25.1	ZBTB2, ZNF437, KIAA1483		Zinc finger- and BTB domain-containing protein 2	616595				
6.924	5	10	17	6q25.2	CNKSR3, CNK3		CNKSR family, member 3	617476				
6.925	2	3	14	6q25.1	MTHFD1L, MTC1THFS		Methylenetetrahydrofolate dehydrogenase 1-like, NADP(+)-dependent	611427				
6.926	9	30	14	6q25.2	SCAF8, KIAA1116		SR-related C-terminal domain-associated factor 8	616024				
6.927	8	28	97	6q25.3	TCTEL1		T-complex-associated-testis-expressed 1-like 1	601554				
6.928	10	2	12	6q25.2-q25.3	TIAM2		T-cell lymphoma invasion and metastasis 2	604709				
6.929	02	26	19	6q26	PRKN, PARK2, PDJ		Parkin	602544		shares 5' regulatory region and both 3' UTRs with PACRG	Parkinson disease, juvenile, type 2, 600116 (3); Adenocarcinoma of lung, somatic, 211980 (3); Ovarian cancer, somatic, 167000 (3)	17(Park2)
6.930	5	28	08	6q25.3	CELIAC12		Celiac disease, susceptibility to, 12	612010		in LD block containing TAGAP	{Celiac disease, susceptibility to, 12} (2)	
6.931	4	6	15	6q25.3	EZR, VIL2, CVL		Ezrin	123900		coamplified with MYB		
6.932	6	2	15	6q25.3	GTF2H5, TTD3, TFB5, C6orf175, TTDA		General transcription factor IIH, polypeptide 5	608780			Trichothiodystrophy 3, photosensitive, 616395 (3)	
6.933	2	28	08	6q25.3	MRPL18		Mitochondrial ribosomal protein L18	611831				
6.934	08	21	19	6q25.3	RSPH3, RSHL2, RSP3, CILD32		Radial spoke head 3	615876			Ciliary dyskinesia, primary, 32, 616481 (3)	
6.935	7	25	12	6q25.3	SERAC1, MEGDEL		Serine active site-containing protein 1	614725			3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3)	
6.936	7	9	09	6q25.3	SOD2, MNSOD, MVCD6		Superoxide dismutase-2, mitochondrial	147460			{Microvascular complications of diabetes 6}, 612634 (3)	17(Sod2)
6.937	6	30	05	6q25.3	SYNJ2, KIAA0348		Synaptojanin 2	609410				17(Synj2)
6.938	12	28	08	6q25.3	TAGAP		T-cell activation GTPase-activating protein	609667				
6.939	2	18	10	6q25.3	TMEM181, GPR178, KIAA1423		Transmembrane protein 181	613209				
6.940	12	10	15	6q25.3	WTAP		Wilms tumor 1-associating protein	605442				17(Wtap)
6.941	9	28	96	6q25.3	ACAT2		Acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase)	100678		encoded on strand opposite TCP1	?ACAT2 deficiency, 614055 (1)	
6.942	9	28	96	6q25.3	TCP1		T-complex locus TCP-1	186980		tightly linked to PLG; ~15cM proximal to TCP10; overlap with ACAT2		17(Tcp1)
6.943	9	2	12	6q26	AGPAT4		1-acylglycerol-3-phosphate O-acyltransferase 4	614795				
6.944	3	3	10	6q25.3	AIRN, AIR		Antisense IGF2R RNA, noncoding	604893				17(Airn)
6.945	9	20	14	6q26	CAHM, LINC00468		Colorectal adenocarcinoma hypermethylated gene, noncoding	615930				
6.946	12	5	13	6q25.3	IGF2R, MPRI		Insulin-like growth factor-2 receptor (mannose-6-phosphate receptor, cation-independent)	147280		behaves as a tumor suppressor	Hepatocellular carcinoma, somatic, 114550 (3)	17(Igf2r)
6.947	9	10	09	6q26	MAP3K4, MEKK4, MTK1, MAPKKK4		Mitogen-activated protein kinase kinase kinase 4	602425				
6.948	9	4	14	6q26	PLG		Plasminogen	173350		20cM from TCP10A	Dysplasminogenemia, 217090 (3); Plasminogen deficiency, type I, 217090 (3)	17(Plg)
6.949	02	18	20	6q26	QKI, QK1		QKI, KH domain-containing RNA-binding protein	609590				
6.950	6	9	98	6q25.3	SLC22A1, OCT1		Solute carrier family 22 (organic cation transporter), member 1	602607				
6.951	6	9	98	6q25.3	SLC22A2, OCT2		Solute carrier family 22 (organic cation transporter), member 2	602608				17(Slc22a2)
6.952	1	27	04	6q26-q27	DFNB38		Deafness, autosomal recessive 38	608219			Deafness, autosomal recessive 38 (2)	
6.953	9	24	08	6q27	FAM120B, PGCC1, CCPG, KIAA1838		Family with sequence similarity 120, member B	612266				17(Fam120b)
6.954	12	17	07	6q25.3	LPAL2, APOARGC		Lipoprotein(a)-like 2	611682				
6.955	11	19	11	6q26-q27	MRT28		Mental retardation, autosomal recessive 28	614347		between rs6935718 and rs3886091	Mental retardation, autosomal recessive 28 (2)	
6.956	11	22	88	6q25.2	VIP		Vasoactive intestinal peptide	192320				
6.957	9	10	09	6q25.3	SNX9, SH3PX1		Sorting nexin 9	605952				
6.958	5	8	17	6q27	AFDN, MLLT4, AF6		Afadin	159559				
6.959	6	26	16	6q27	C6orf120		Chromosome 6 open reading frame 120	616987				
6.960	9	9	08	6q27	CCR6, CMKBR6, CKRL3, GPR29, GPRCY4		Chemokine (C-C) receptor 6	601835				
6.961	7	22	16	6q27	CHDM		Chordoma	215400		associated with duplication of the T gene	{Chordoma, susceptibility to} (4)	
6.962	9	10	09	6q27	DACT2, DPR2, DAPPER2		Dapper, antagonist of beta-catenin, 2	608966				
6.963	12	23	19	6q27	DLL1, DELTA1, NEDBAS		Delta-like canonical Notch ligand 1	606582			Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, 618709 (3)	
6.964	11	27	13	6q27	ERMARD, C6orf70, PVNH6		Endoplasmic reticulum membrane-associated RNA degradation protein	615532			?Periventricular nodular heterotopia 6, 615544 (3)	
6.965	5	21	03	6q27	FGFR1OP, FOP		Fibroblast growth factor receptor-1 oncogene partner	605392		fusion gene with ZNF198, CEP1, and FGFR1	Myeloproliferative disorder (2)	
6.966	3	5	98	6q27	GPR31		G protein-coupled receptor-31	602043				
6.967	3	8	16	6q27	HPAT5		Human pluripotency-associated transcript 5, noncoding	616837				
6.968	2	14	13	6q27	KAZA3		Kala-azar, susceptibility to, 3	611382			{Kala-azar, susceptibility to, 3} (2)	
6.969	3	22	06	6q27	KIF25, KNSL3		Kinesin family member 25	603815				
6.970	03	11	20	6q25-q26	LPA		Apolipoprotein Lp(a)	152200		absent in mice	{Coronary artery disease, susceptibility to}, 618807 (3); [LPA deficiency, congenital], 618807 (3)	
6.971	10	25	19	6q27	MPC1, BRP44L, MPYCD		Mitochondrial pyruvate carrier 1	614738			Mitochondrial pyruvate carrier deficiency, 614741 (3)	
6.972	12	14	95	6q27	PDCD2		Programmed cell death 2	600866				17(Pdcd2)
6.973	5	2	16	6q27	PDE10A, IOLOD, ADSD2		Phosphodiesterase 10A	610652			Dyskinesia, limb and orofacial, infantile-onset, 616921 (3); Striatal degeneration, autosomal dominant, 616922 (3)	
6.974	10	13	09	6q27	PHF10, BAF45A		PHD finger protein 10	613069				
6.975	6	9	06	6q27	PSMB1		Proteasome subunit, beta type, 1	602017		incorrectly assigned to 7p		
6.976	8	24	09	6q27	RNASET2, RNASE6PL		Ribonuclease T2	612944			Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)	
6.977	12	9	98	6q27	RPS6KA2, RSK3		Ribosomal protein S6 kinase, 90kD, 2	601685				
6.978	10	17	00	6q25.3	SLC22A3, EMT		Solute carrier family 22 (extraneuronal monoamine transporter), member 3	604842				17(Slc22a3)
6.979	1	26	12	6q27	SMOC2, SMAP2, DTDP1		Secreted modular calcium-binding protein 2	607223			Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)	
6.980	06	27	19	6q27	TBXT, T, TFT, SAVA		T-box transcription factor T	601397			{Neural tube defects, susceptibility to}, 182940 (3); Sacral agenesis with vertebral anomalies, 615709 (3)	17(T)
6.981	11	15	10	6q27	TBP, SCA17, HDL4		TATA box binding protein	600075			Spinocerebellar ataxia 17, 607136 (3); {Parkinson disease, susceptibility to}, 168600 (3)	17(Tbp)
6.982	8	21	92	6q27	TCTE3		T-complex-associated-testis-expressed-3	186977				
6.983	6	26	08	6q27	THBS2		Thrombospondin 2	188061			{Lumbar disc herniation, susceptibility to}, 603932 (3)	17(Thbs2)
6.984	8	28	92	6q27	TCP10		T-complex 10 (a murine tcp homolog)	187020				17(Tcp10)
6.985	09	11	19	6q27	UNC93A		unc-93 homolog A	607995				
6.986	9	10	09	Chr.6	BEVI		Baboon M7 virus replication	109180				
6.987	10	23	87	Chr.6	FEA		F9 embryonic antigen	137010				
6.988	9	10	09	Chr.6	LAKLG, LAKL		Lymphokine-activated killer cell ligand	153435				
6.989	10	23	87	Chr.6	MRBC		Monkey RBC receptor	158050				
6.990	10	23	87	Chr.6	TS546		Temperature sensitivity complementation, cell cycle specific, ts546 cells	187330				
7.1	9	12	93	7p22.3	PRKAR1B		Protein kinase, cAMP-dependent, regulatory, type I, beta	176911				
7.2	4	17	13	7p22.3	AMZ1, KIAA1950		Archaelysin family metallopeptidase 1	615168				
7.3	08	10	18	7p22.3	BRAT1, BAAT1, C7orf27, RMFSL, NEDCAS		BRCA1-associated ATM activator 1	614506			Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3); Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, 618056 (3)	
7.4	5	10	04	7p22.3	CENTA1		Centaurin, alpha-1	608114				
7.5	3	19	13	7p22.3	COX19		Cytochrome c oxidase assembly protein Cox19	610429				
7.6	9	20	14	7p22.3	CYP2W1		Cytochrome P450, family 2, subfamily W, polypeptide 1	615967				
7.7	12	17	12	7p22.3	ELFN1, PPP1R28		Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 1	614964				
7.8	9	8	10	7p22.3	GET4, C7orf20, CEE		Golgi to ER traffic protein 4, S. cerevisiae, homolog of	612056				
7.9	10	25	17	7p22.3	DNAAF5, HEATR2, CILD18		Dynein axonemal assembly factor 5	614864			Ciliary dyskinesia, primary, 18, 614874 (3)	
7.10	09	10	19	7p22.3	INTS1, INT1, KIAA1440, NDCAGF		Integrator complex subunit 1	611345			Neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies, 618571 (3)	
7.11	09	11	20	7p22.3	IQCE, KIAA1023, PAPA7		IQ domain-containing protein E	617631			Polydactyly, postaxial, type A7, 617642 (3)	
7.12	9	22	14	7p22.3	MIR339		Micro RNA 339	615977				
7.13	6	17	17	7p22.3	PSMG3, PAC3		Proteasome assembly chaperone 3	617528				
7.14	12	10	12	7p22.3	SNX8		Sorting nexin 8	614905				
7.15	09	11	19	7p22.3	SUN1, UNC84A, KIAA0810		SAD1 and UNC84 domain-containing protein 1	607723				
7.16	1	16	07	7p22.3	ZFAND2A, AIRAP		Zinc finger AN1 domain-containing protein 2A	610699				
7.17	9	28	11	7p22.3-p21.3	HYPT10		Hypotrichosis 10	614238		between D7S1532 and D7S3047	Hypotrichosis 10 (2)	
7.18	10	3	07	7p22.3	EIF3B, EIF3S9, PRT1		Eukaryotic translation initiation factor 3, subunit B	603917				
7.19	3	11	08	7p22.3-p22.2	GNA12		Guanine nucleotide-binding protein, alpha-12	604394				
7.20	09	30	20	7p22.2	SDK1		Sidekick cell adhesion molecule 1	607216				5(Sdk1)
7.21	6	9	08	7p13	TMED4		Transmembrane p24 trafficking protein 4	612038				
7.22	05	31	19	7p22.1	WIPI2, IDDSSA		WD40 repeat protein interacting with phosphoinositides 2	609225		mutation identified in 1 IDDSSA family	?Intellectual developmental disorder with short stature and variable skeletal anomalies, 618453 (3)	
7.23	9	18	12	7p22.1	AP5Z1, KIAA0415, SPG48		Adaptor-related protein complex 5, zeta-1 subunit	613653			Spastic paraplegia 48, autosomal recessive, 613647 (3)	
7.24	9	30	09	7p22.1	CYTH3, PSCD3, ARNO3, GRP1		Cytohesin 3	605081				
7.25	9	8	11	7p22.1	DAGLB		Diacylglycerol lipase, beta	614016				
7.26	05	13	20	7p22.1	EIF2AK1, HRI, LEMSPAD		Eukaryotic translation initiation factor 2-alpha kinase 1	613635		mutation identified in 1 LEMSPAD patient	?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome, 618878 (3)	
7.27	10	28	15	7p22.1	FAM220A, SIPAR, ACPIN1, C7orf70		Family with sequence similarity 220, member A	616628				5(Fam220A)
7.28	6	13	12	7p22.1	FBXL18, FBL18		F-box and leucine-rich repeat protein 18	609084				
7.29	4	10	15	7p22.1	FOXK1, MNF		Forkhead box K1	616302				5(Foxk1)
7.30	12	18	20	7p22.1	KDELR2, ELP1, OI21		KDEL endoplasmic reticulum protein retention receptor 2	609024			Osteogenesis imperfecta 21, 619131 (3)	
7.31	4	19	12	7p22.1	MMD2, PAQR10		Monocyte-to-macrophage differentiation-associated protein 2	614581				
7.32	7	19	06	7p22.1	PAPOLB, TPAP		Poly(A) polymerase, beta	607436				
7.33	09	12	19	7p22.1	RAC1, MRD48		Rac family small GTPase 1	602048			Mental retardation, autosomal dominant 48, 617751 (3)	
7.34	10	2	07	7p22.1	RADIL, KIAA1849		RAP GTPase interactor	611491				
7.35	08	12	20	7p22.1	RBAK		RB-associated KRAB zinc finger	608191				
7.36	2	4	13	7p22.1	SLC29A4, PMAT, ENT4		Solute carrier family 29 (monoamine transporter), member 4	609149				
7.37	10	4	05	7p22.1	STBMS1		Strabismus, susceptibility to, 1	185100		max lod at marker 1911/1912	{Strabismus, susceptibility to, 1} (2)	
7.38	6	13	95	7p21.2	MEOX2		Mesenchyme homeo box 2	600535				
7.39	6	5	18	7p22.1	AIMP2, JTV1, HLD17		Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2	600859			Leukodystrophy, hypomyelinating, 17, 618006 (3)	
7.40	8	25	17	7p22.2	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A		Caspase recruitment domain-containing protein 11	607210			B-cell expansion with NFKB and T-cell anergy, 616452 (3); Immunodeficiency 11A, 615206 (3); Immunodeficiency 11B with atopic dermatitis, 617638 (3)	
7.41	8	19	13	7p22.3	CHST12, C4ST2		Carbohydrate sulfotransferase 12	610129				
7.42	9	8	11	7p22	ERVK-6		Endogenous retroviral group K, member 6	605626				
7.43	8	18	02	7p22.1	FSCN1, SNL		Fascin homolog 1, actin-bundling protein (singed, Drosophila, homolog-like)	602689				
7.44	1	1	12	7p21.3	GLCCI1, TSSN1, GCTR		Glucocorticoid-induced transcript 1	614283			{Glucocorticoid therapy, response to}, 614400 (3)	6(Glcci1)
7.45	6	21	10	7p22.3	GPER, CMKRL2, GPR30		G protein-coupled estrogen receptor 1	601805				
7.46	2	20	97	7p21.3	ICA1		Islet cell autoantigen 1, 69kD	147625				6(Ica1)
7.47	08	08	19	7p22.3	LFNG, SCDO3		LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase	602576			Spondylocostal dysostosis 3, autosomal recessive, 609813 (3)	5(Lfng)
7.48	8	29	01	7p22.3	MAD1L1, TXBP181		Mitotic arrest-deficient 1, yeast, homolog-like 1	602686			Lymphoma, somatic (3); Prostate cancer, somatic, 176807 (3)	5(Mad1l1)
7.49	7	10	95	7p21.2	ETV1		ETS variant gene-1	600541		fused with EWS in some Ewing sarcoma		
7.50	8	21	07	7p22.3	FAM20C, DMP4		Family with sequence similarity 20, member C	611061			Raine syndrome, 259775 (3)	
7.51	03	02	20	7p22.3	MAFK, NFE2U		MAF bZIP transcription factor K	600197				5(Nfe2u)
7.52	09	04	19	7p22.3	MRM2, FTSJ2, FJH1, MTDPS17		Mitochondrial ribosomal RNA methyltransferase 2	606906		mutation identified in 1 MTDPS17 patient	?Mitochondrial DNA depletion syndrome 17, 618567 (3)	
7.53	6	8	95	7p22.3	NUDT1, MTH1		Nudix-type motif 1	600312				
7.54	8	28	92	7p22.3	PDGFA		Platelet-derived growth factor, alpha polypeptide	173430				
7.55	11	24	20	7p22.1	PMS2, PMSL2, HNPCC4, MMRCS4		PMS1 homolog 2, mismatch repair system component	600259			Mismatch repair cancer syndrome 4, 619101 (3); Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)	
7.56	7	23	13	7p22.1	RNF216, TRIAD3, ZIN, CAHH		RING finger protein 216	609948			Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3)	
7.57	4	7	94	7p21.3	RPA3		Replication protein A3, 14kD	179837				
7.58	6	7	91	7p22.1	ZNF12		Zinc finger protein-12 (KOX3)	194536				
7.59	12	4	90	7p14.1	RALA		RAS-like protein A (Simian leukemia viral (v-ral) oncogene homolog A, ras-related)	179550				13(Ral)
7.60	5	24	12	7p22.1	ACTB, BRWS1		Actin, beta	102630		~20 pseudogenes also; mutation identified in twin DJO patients	?Dystonia, juvenile-onset, 607371 (3); Baraitser-Winter syndrome 1, 243310 (3)	5(Actb)
7.61	11	28	01	7p21.1	AGR2, AG2		Anterior gradient 2, Xenopus, homolog of	606358				
7.62	9	24	08	7p21.1	AGR3, BCMP11		Anterior gradient 3, Xenopus, homolog of	609482				
7.63	12	04	20	7p21.3	ARL4A, ARL4		ADP ribosylation factor-like GTPase 4A	604786				12(Arl4)
7.64	3	23	06	7p21.3	COL28A1		Collagen, type XXVIII, alpha-1 polypeptide	609996				6(Col28a1)
7.65	8	7	13	7p21.3	MIOS		Missing oocyte/meiosis regulator, Drosophila, homolog of	615359				
7.66	10	23	20	7p21.3	COXFA4, NDUFA4, MC4DN21		Cytochrome c oxidase subunit FA4	603833		mutation identified in 1 MC4DN21 family	?Mitochondrial complex IV deficiency, nuclear type 21, 619065 (3)	
7.67	7	18	14	7p21.3	NXPH1, NPH1		Neurexophilin 1	604639				
7.68	7	26	10	7p21.3	SCIN, KIAA1905		Scinderin	613416				
7.69	9	24	08	7p21.3	THSD7A, KIAA0960		Thrombospondin type-1 domain-containing protein 7A	612249				
7.70	5	9	18	7p21.3	TMEM106B, HLD16		Transmembrane protein 106B	613413			Leukodystrophy, hypomyelinating, 16, 617964 (3)	
7.71	6	26	16	7p21.3-p21.2	LOC105375159		Long intergenic noncoding RNA AC011288.2	616986				
7.72	4	26	11	7p21.2	AGMO, TMEM195		Alkylglycerol monooxygenase	613738				
7.73	12	14	20	7p21.2	CRPPA, ISPD, MDDGA7, MDDGC7, LGMDR20		CDP-L-ribitol pyrophosphorylase A	614631			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3)	
7.74	9	29	09	7p21.2	DGKB, DGK, KIAA0718		Diacylglycerol kinase, beta, 90kD	604070				
7.75	10	30	07	7p21.1	PRPS1L1, PRPS3		Phosphoribosylpyrophosphate synthetase 1-like 1	611566				
7.76	12	28	08	7p21.2	SOSTDC1, ECTODIN, USAG1		Sclerostin domain-containing protein 1	609675				
7.77	7	8	10	7p21.2	FGQTL4		Fasting plasma glucose level QTL 4	613462		associated with rs2191349	[Fasting plasma glucose level QTL 4] (2)	
7.78	10	07	20	7p21.1	FERD3L, NTWIST, NATO3, PTFB		FER3-like bHLH transcription factor	617578				12(Ferd3l)
7.79	01	04	19	7p21.1	ITGB8		Integrin, beta-8	604160				
7.80	3	11	09	7p21.1	MACC1		Metastasis-associated gene in colon cancer 1	612646				
7.81	4	18	05	7p21.1	SNX13, KIAA0713		Sorting nexin 13	606589				
7.82	12	21	09	7p21.1	TSPAN13, NET6		Tetraspanin 13	613139				
7.83	9	28	10	7p21.2-p14.3	EDSS2		Ectodermal dysplasia-syndactyly syndrome 2	613576		between D7S488 and D7S817	Ectodermal dysplasia-syndactyly syndrome 2 (2)	
7.84	12	3	08	7p15.3	DNAH11, DNAHC11, CILD7, DNAHBL		Dynein, axonemal, heavy chain-11	603339			Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	
7.85	1	24	09	7p15.3	IL6, IFNB2, BSF2, HSF, HGF		Interleukin-6 (interferon, beta-2)	147620			{Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi sarcoma, susceptibility to}, 148000 (3); {Diabetes, susceptibility to}, 222100, 125853 (3); {Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3); {Crohn disease-associated growth failure}, 266600 (3)	5(Il6)
7.86	12	8	03	7p21.1	SP8, BTD		Transcription factor Sp8	608306				
7.87	10	26	17	7p21.1	TWIST1, ACS3, SCS, CRS1, SWCOS		TWIST, Drosophila, homolog of, 1	601622			Saethre-Chotzen syndrome with or without eyelid anomalies, 101400 (3); Craniosynostosis 1, 123100 (3); Robinow-Sorauf syndrome, 180750 (3); Sweeney-Cox syndrome, 617746 (3)	12(Twist)
7.88	12	4	03	7p21.1	TWISTNB		TWIST neighbor	608312		pseudogene on 6q14.3		12(Twistnb)
7.89	3	5	98	7p14.3	CRHR2, CRFR2		Corticotropin releasing hormone receptor-2	602034				6(Crhr2)
7.90	12	11	01	7p21.1	HDAC9, MITR, HDAC7B, KIAA0744		Histone deacetylase 9	606543				
7.91	4	7	94	7p21-p15	MDDC		Macular dystrophy, dominant cystoid	153880		?allelic to RP9	Macular dystrophy, dominant cystoid (2)	
7.92	9	30	02	7p15.3	MPP6, VAM1, PALS2		Membrane protein, palmitoylated 6	606959				6(Pals2)
7.93	4	1	08	7q22.1	TSC22D4, THG1		TSC22 domain family, member 4	611914				
7.94	5	10	04	7p14.3	FAPP2		Phosphatidylinositol 4-phosphate adaptor protein 2	608639				
7.95	2	11	08	7p21.1	ABCB5		ATP-binding cassette, subfamily B, member 5	611785				
7.96	11	3	14	7p15.3	C7orf31		Chromosome 7 open reading frame 31	616071				
7.97	8	10	98	7p14.3	CHN2, ARHGAP3, RHOGAP3		Chimerin 2 (GTPase-activating protein, rho, 3)	602857				
7.98	12	5	08	7p15.3	FAM126A, DRCTNNB1A, HLD5		Hyccin	610531			Leukodystrophy, hypomyelinating, 5, 610532 (3)	
7.99	3	27	18	7p15.3	GPNMB, PLCA3		Glycoprotein NMB	604368			Amyloidosis, primary localized cutaneous, 3, 617920 (3)	
7.100	9	28	05	7p15.2	HOXA1, HOX1F, BSAS		Homeo box-A1	142955			Bosley-Salih-Alorainy syndrome, 601536 (3); Athabaskan brainstem dysgenesis syndrome, 601536 (3)	6(Hox1.6)
7.101	01	08	20	7p15.3	KLHL7, RP42, PERCHING		Kelch-like 7	611119			Retinitis pigmentosa 42, 612943 (3); PERCHING syndrome, 617055 (3)	
7.102	5	8	12	7p15.3	MALSU1, C7orf30		Mitochondrial assembly of ribosomal large subunit 1	614624				
7.103	6	26	16	7p15.3	NPVF, RFRP, C7orf9		Neuropeptide VF precursor	616984				
7.104	9	30	09	7p15.3	STK31		Serine/threonine kinase 31	605790				
7.105	09	17	20	7p15.3	TOMM7		Translocase of outer mitochondrial membrane 7	607980				
7.106	03	06	20	7p15.3	TRA2A		Transformer 2 alpha homolog	602718				
7.107	5	11	00	7p14.3	INMT		Indolethylamine N-methyltransferase	604854				
7.108	11	11	14	7p15.2	CBX3		Chromobox homolog 3	604477				
7.109	1	14	09	7p15.3	CYCS, CYC, THC4		Cytochrome C, somatic	123970			Thrombocytopenia 4, 612004 (3)	
7.110	8	8	13	7p15.2	HIBADH		3-hydroxyisobutyrate dehydrogenase	608475				
7.111	7	1	11	7p15.2	HOTTIP, NCRNA00213		HOXA distal transcript antisense RNA	614060				
7.112	9	20	14	7p15.2	HOXA11AS		Homeo box A11, antisense	607530				6(Hoxa11s)
7.113	11	3	14	7p15.2	HOXAAS2		HOXA cluster antisense RNA 2	616068				
7.114	12	19	19	7p15.2	HOXAAS3		HOXA cluster antisense RNA 3, noncoding	618706				
7.115	5	15	11	7p15.2	MIR148A, MIRN148A		Micro RNA 148A	613786				
7.116	6	22	14	7p15.2	SKAP2, SCAP2, SKAP55R		src kinase associated phosphoprotein 2	605215				
7.117	2	21	13	7p15.2	SNX10, OPTB8		Sorting nexin 10	614780			Osteopetrosis, autosomal recessive 8, 615085 (3)	
7.118	12	22	17	7p14.3	FKBP14, EDSKSCL2		FK506-binding protein 14	614505			Ehlers-Danlos syndrome, kyphoscoliotic type, 2, 614557 (3)	
7.119	5	9	95	7p15.3	NPY		Neuropeptide Y	162640				6(Npy)
7.120	12	4	08	7p14.3	WIPF3, CR16		WAS/WASL-interacting protein family, member 3	612432				
7.121	6	10	08	7p14.3	ZNRF2		Zinc finger and ring finger protein 2	612061				
7.122	12	28	18	7p15.1-p14.3	CREB5, CREBPA		cAMP response element-binding protein 5	618262				
7.123	03	04	19	7p21.1	AHR, RP85		Aryl hydrocarbon receptor	600253		mutation identified in 1 RP85 family	?Retinitis pigmentosa 85, 618345 (3)	
7.124	12	28	08	7p15.3	CDCA7L, R1, JPO2		Cell division cycle-associated protein 7-like	609685				
7.125	12	17	20	7p14.3	GARS1, GARS, SMAD1, CMT2D, HMN5A, SMAJI		Glycyl-tRNA synthetase 1	600287			Charcot-Marie-Tooth disease, type 2D, 601472 (3); Neuronopathy, distal hereditary motor, type VA, 600794 (3); Spinal muscular atrophy, infantile, James type, 619042 (3)	
7.126	8	28	17	7p15.3	GSDME, DFNA5		Gasdermin E	608798			Deafness, autosomal dominant 5, 600994 (3)	6(Dfna5)
7.127	12	30	03	7p14.3	GSBS		G-substrate	604088			{Hypercholesterolemia, susceptibility to}, 143890 (3)	
7.128	10	7	13	7p15.2	HNRPA2B1, IBMPFD2		Heterogeneous nuclear ribonucleoprotein A2/B1	600124		mutation identified in 1 family	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3)	
7.129	3	22	06	7p15.3	IGF2BP3, IMP3, KOC1, VICKZ3		Insulin-like growth factor 2 mRNA-binding protein 3	608259				6(Imp3)
7.130	6	22	14	7p15.2-p15.1	JAZF1, TIP27		JAZF1 gene	606246		fused with JJAZ1		
7.131	8	21	91	7p15	MYCLK1		Avian myelocytomatosis viral (v-myc) oncogene homolog like 1	164865				
7.132	3	2	10	7p15	MYP17, MYP4		Myopia 17	608367		previously assigned to 7q36 (MYP4)	Myopia 17 (2)	
7.133	5	7	03	7p15.3	OSBPL3, ORP3, KIAA0704		Oxysterol-binding protein-like protein 3	606732				
7.134	6	13	95	7p15.3	SP4		Sp4 transcription factor	600540				
7.135	5	5	09	7p15	STQTL17		Stature quantitative trait locus 17	612737		associated with rs1635852 and rs849140	{Stature QTL 17} (2)	
7.136	9	30	09	7p15.2	TAX1BP1, TXBP151		TAX1-binding protein 1	605326				
7.137	12	20	05	7p14.3	CPVL, HVLP		Carboxypeptidase, vitellogenic-like	609780				
7.138	12	24	08	7p14.3	GGCT, GCTG, C7orf24		Gamma-glutamylcyclotransferase	137170				6(Ggc)
7.139	11	01	18	7p14.3	GHRHR, GHRFR, IGHD4		Growth hormone releasing hormone receptor	139191			Growth hormone deficiency, isolated, type IV, 618157 (3)	6(Lit, Ghrhr)
7.140	1	23	07	7p14.3	NOD1, CARD4		Nucleotide-binding oligomerization domain protein 1	605980				
7.141	7	11	11	7p14.1	TARP		T-cell antigen receptor, gamma subunit, alternate reading frame protein	609642				
7.142	2	26	93	7p15.2	HOXA3, HOX1E		Homeo box-A3	142954		homolog of Drosophila zen1, zen2		6(Hox1.5)
7.143	2	26	93	7p15.2	HOXA4, HOX1D		Homeo box-A4	142953		homolog of Drosophila Dfd		6(Hox1.4)
7.144	2	26	93	7p15.2	HOXA5, HOX1C		Homeo box-A5	142952				6(Hox1.3)
7.145	2	26	93	7p15.2	HOXA6, HOX1B		Homeo box-A6	142951				6(Hox1.2)
7.146	2	26	93	7p15.2	HOXA7, HOX1A		Homeo box-A7	142950		homolog of Drosophila Antp		6(Hox1.1)
7.147	2	26	93	7p15.2	HOXA9, HOX1G		Homeo box-A9	142956		homolog of Drosophila Abd-B; fused to NUP98 in myeloid leukemia		6(Hox1.7)
7.148	2	26	93	7p15.2	HOXA10, HOX1H		Homeo box-A10	142957				
7.149	11	8	16	7p15.2	HOXA11, HOX1I, RUSAT1		Homeo box-A11	142958			Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3)	
7.150	06	14	19	7p15.2	HOXA13, HOX1J		Homeo box-A13	142959		mutation identified in 1 GTMS family	Hand-foot-uterus syndrome, 140000 (3); ?Guttmacher syndrome, 176305 (3)	6(Hoxa13, Hd)
7.151	3	23	09	7p15.2	MIR196B, MIRN196B		Micro RNA 196B	609688				
7.152	4	21	04	7p14.3	AAA1		Asthma-associated alternatively spliced gene 1	608596				
7.153	3	23	95	7p15.2	EVX1		Even-skipped homeo box-1 (homolog of Drosophila)	142996		at 5' end of HOX1 cluster		
7.154	4	24	18	7p15.2	HOXA2, MCOHI		Homeobox A2	604685		mutation identified in 1 MCOHICP family	?Microtia, hearing impairment, and cleft palate (AR), 612290 (3); Microtia with or without hearing impairment (AD), 612290 (3)	
7.155	10	08	07	7p14.3	NEUROD6, ATOH2, MATH2		Neurogenic differentiation 6	611513				
7.156	10	20	99	7p15.2	NFE2L3, NRF3		Nuclear factor erythroid 2-like 3	604135				
7.157	5	21	09	7p14.3	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2		Neuropeptide S receptor 1	608595			{Asthma, susceptibility to, 2}, 608584 (3)	
7.158	11	19	13	7p14.3	NT5C3A, NT5C3, UMPH1, PSN1		5' nucleotidase, cytosolic IIIA (uridine 5' monophosphate hydrolase 1)	606224		pseudogenes on chr.4 and chr.7	Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	
7.159	8	29	07	7p14.2	TBX20, ASD4		T-box 20	606061			Atrial septal defect 4, 611363 (3)	
7.160	7	8	10	7p15-p13	FGQTL2, BWQTL1		Fasting plasma glucose level QTL 2; Birth weight QTL 1	613219		associated with rs4607517	[Fasting plasma glucose level QTL 2] (2); [Birth weight QTL 1] (2)	
7.161	04	30	20	7p13	GCK, HHF3, PNDM1		Glucokinase (hexokinase-4)	138079		proximal to TCRB	MODY, type II, 125851 (3); Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3); Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3); Diabetes mellitus, permanent neonatal 1, 606176 (3)	
7.162	2	4	89	7p14.1	INHBA		Inhibin, beta-1	147290				13(Inhba)
7.163	8	17	09	7p14.3	AVL9, KIAA0241		AVL9, S. cerevisiae, homolog of	612927				
7.164	3	28	11	7p14.3	BMPER, CV2		BMP binding endothelial regulator	608699			Diaphanospondylodysostosis, 608022 (3)	9(Bmper)
7.165	7	15	11	7p14.2	DPY19L1, KIAA0877		DPY19-like 1	613892				7p14.3
7.166	9	30	09	7p14.3	LSM5		LSM5 protein	607285				
7.167	10	14	18	7p14.3	PDE1C, HCAM3, DFNA74		Phosphodiesterase 1C	602987		mutation identified in 1 DFNA74 family	?Deafness, autosomal dominant 74, 618140 (3)	
7.168	02	28	19	7p14.3	PRR15		Proline-rich protein 15	618344				
7.169	4	26	10	7p14.3	TRIL, KIAA0644		TLR4 interactor with leucine-rich repeats	613356				
7.170	12	17	12	7p14.3	SCRN1, SES1, KIAA0193		Secernin 1	614965				
7.171	9	30	14	7p14.2	ANLN, FSFS8		Actin-binding protein anillin	616027			Focal segmental glomerulosclerosis 8, 616032 (3)	
7.172	11	23	16	7p14.2	EEPD1, KIAA1706		Endonuclease/exonuclease/phosphatase family domain-containing protein 1	617192				
7.173	3	21	14	7p14.3	RP9, PAP1		RP9 gene (pim1-associated protein, mouse, homolog of)	607331		mutation identified in 1 patient	?Retinitis pigmentosa 9, 180104 (3)	
7.174	2	24	17	7p14.1	CDK13, CDC2L5, CHED, CHDFIDD		Cyclin-dependent kinase 13	603309			Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder, 617360 (3)	
7.175	6	13	12	7p14.1	GPR141, PGR13		G protein -coupled receptor 141	609045				13(Gpr141)
7.176	3	14	13	7p14.1	NME8, TXNDC3, SPTRX2, CILD6		NME/NM23 family member 8	607421			Ciliary dyskinesia, primary, 6, 610852 (3)	
7.177	7	14	16	7p14.1	SFRP4, FRPHE, PYL		Secreted frizzled-related protein 4	606570			Pyle disease, 265900 (3)	13(Sfrp4)
7.178	10	15	13	7p14.1	TRGC1		T-cell receptor gamma chain constant region 1	186970				13(Tcrg)
7.179	10	15	13	7p14.1	TRGC2		T-cell receptor gamma chain constant region 2	615450				
7.180	10	15	13	7p14.1	TRGV@		T-cell receptor gamma chain variable gene cluster	615454				
7.181	10	15	13	7p14.1	TRGJ@		T-cell receptor gamma chain joining gene cluster	615455				
7.182	12	27	19	7p14.1	VPS41		VPS41 subunit of HOPS complex	605485				
7.183	1	7	95	7p14.3	ADCYAP1R1, PACAPR		Adenylate cyclase activating polypeptide-1 (pituitary) receptor type 1	102981				
7.184	2	5	18	7p14.3	AQP1, CHIP28, CO		Aquaporin-1 (channel-forming integral protein, 28kD)	107776			[Blood group, Colton], 110450 (3); [Aquaporin-1 deficiency], 110450 (3)	6(Aqp1)
7.185	7	24	15	7p14.1	C7orf10, GA3		Chromosome 7 open reading frame 10	609187			Glutaric aciduria III, 231690 (3)	
7.186	12	7	17	7p13	CAMK2B, MRD54		Calcium/calmodulin-dependent protein kinase II-beta	607707			Mental retardation, autosomal dominant 54, 617799 (3)	
7.187	9	30	09	7p14.2-p14.1	ELMO1, CED12		Engulfment and cell motility gene 1	606420				
7.188	12	29	06	7p14	HHT4		Telangiectasia, hereditary hemorrhagic, type 4	610655		between D7S2252 and D7S510	Telangiectasia, hereditary hemorrhagic, type 4 (2)	
7.189	6	2	15	7p14.1	MPLKIP, C7orf11, ABHS, TTDN1, TTD4		M-phase specific PLK1 interacting protein	609188			Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	
7.190	2	28	08	7p14.1	MRPL32		Mitochondrial ribosomal protein L32	611839				
7.191	4	24	08	7p13	MRPS24		Mitochondrial ribosomal protein S24	611986				
7.192	10	16	14	7p14.3	PTHB1, BBS9		Parathyroid hormone-responsive B1 gene	607968			Bardet-Biedl syndrome 9, 615986 (3)	
7.193	10	1	07	7p14.2	SEPT7, CDC10		Septin 7	603151				
7.194	3	26	95	7p14.1	AMPH		Amphiphysin	600418				13(Amph)
7.195	11	8	06	7p22.1-p21.3	C1GALT1		Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	610555				
7.196	9	21	09	7p13	OGDH		Oxoglutarate dehydrogenase, lipoamide (alpha-ketoglutarate dehydrogenase)	613022			Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1)	
7.197	12	7	04	7p14.1	POU6F2, WTSL, WT5		POU domain, class 6, transcription factor 2	609062			{Wilms tumor susceptibility-5}, 601583 (3)	
7.198	1	28	08	7p14.1	STARD3NL, MENTHO		STARD3 N-terminal like	611759				
7.199	10	13	94	7p14.2	AOAH		Acyloxyacyl hydrolase (neutrophil)	102593				
7.200	2	9	92	7p12.3	IGFBP1		Insulin-like growth factor-binding protein-1	146730				
7.201	2	9	92	7p12.3	IGFBP3		Insulin-like growth factor-binding protein-3	146732		tail-to-tail 20kb from IGFBP1		
7.202	5	31	18	7p13	AEBP1, ACLP		AE-binding protein 1	602981			Ehlers-Danlos syndrome, classic-like, 2, 618000 (3)	
7.203	8	16	11	7p13	BLVRA		Biliverdin reductase A	109750			Hyperbiliverdinemia, 614156 (3)	2(Blvr)
7.204	2	10	04	7p13	C7orf22, CCM2, MGC4067		Malcavernin	607929			Cerebral cavernous malformations-2, 603284 (3)	
7.205	8	21	12	7p13	COA1, C7orf44		Cytochrome c oxidase assembly factor 1, S. cerevisiae, homolog of	614769				
7.206	8	29	13	7p13	DBNL, HIP55		Drebrin-like	610106				
7.207	07	14	20	7p13	DDX56, NOH61		DEAD-box helicase 56	608023				
7.208	8	5	11	7p14.1	GLI3, PAPA, PAPB		GLI-Kruppel family member GLI3 (oncogene GLI3)	165240		amplified in glioblastoma	Greig cephalopolysyndactyly syndrome, 175700 (3); Pallister-Hall syndrome, 146510 (3); Polydactyly, preaxial, type IV, 174700 (3); Polydactyly, postaxial, types A1 and B, 174200 (3); {Hypothalamic hamartomas, somatic}, 241800 (3)	13(Xt)
7.209	8	19	13	7p14-p13	HECW1, NEDL1, KIAA0322		HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 1	610384				
7.210	11	02	18	7p13	LUARIS, lncRNA32		Long noncoding RNA upregulator of antiviral response interferon signaling	618172		overlaps in antisense orientation with HECW1 gene		
7.211	9	8	11	7p13	MYL7, MYL2A, MLC2A, MYLC2A		Myosin, light chain 7, regulatory	613993				11(Myl7)
7.212	7	2	14	7p13	MYO1G, HA2, HLA-HA2		Myosin IG	600642				
7.213	5	24	13	7p13	NUDCD3, KIAA1068, NUDCL		NUDC domain-containing protein 3	610296				
7.214	04	13	20	7p13	NPC1L1, LDLCQ7		NPC1-like intracellular cholesterol transporter 1	608010			[Ezetimibe, nonresponse to], 617966 (3); [Low density lipoprotein cholesterol level QTL 7], 617966 (3)	
7.215	9	30	09	7p13	POLD2		Polymerase (DNA directed), delta 2, regulatory subunit, 50kD	600815				
7.216	9	20	14	7p13	POLM		Polymerase, DNA, mu	606344				
7.217	4	30	97	7p13	PPIA		Peptidylprolyl isomerase A (cyclophilin A)	123840				
7.218	6	9	06	7p14.1	PSMA2, PSC2, HC3		Proteasome (prosome, macropain) subunit, alpha type, 2	176842		incorrectly assigned to 6q		
7.219	9	16	12	7p13	PURB		Purine-rich element-binding protein B	608887				
7.220	2	23	08	7p12.3	SEPT13		Septin 13	611563				
7.221	4	2	16	7p13	SNORA5C		Small nucleolar RNA, H/ACA box, 5C	611335		in intron 3 of TBRG4		
7.222	8	28	17	7p13	SPDYE1, SPDYB2L2, RINGO1		SPEEDY/RINGO cell cycle regulator family, member E1	617623				
7.223	10	2	12	7p13	STK17A, DRAK1		Serine/threonine protein kinase 17A	604726				
7.224	4	6	15	7p13	TBRG4, KIAA0948, CPR2		Transforming growth factor-beta regulator 4	611325				
7.225	2	19	10	7p13	URGCP, URG4		Upregulator of cell proliferation	610337				
7.226	7	2	18	7p13	YKT6		Ykt6, S. cerevisiae, homolog of	606209				
7.227	5	23	13	7p13	ZMIZ2, KIAA1886, ZIMP7		Zinc finger MIZ-domain containing 2	611196				
7.228	8	17	09	7p13	PGAM2, PGAMM, GSD10		Phosphoglycerate mutase, muscle form	612931			Glycogen storage disease X, 261670 (3)	
7.229	7	17	14	7p12.3	ADCY1, DFNB44		Adenylate cyclase-1, brain	103072		mutation identified in 1 DFNB44 family	?Deafness, autosomal recessive 44, 610154 (3)	11(Adcy1, brl)
7.230	6	16	99	7p12.3	HUS1		Hydroxyurea-sensitive 1, S. pombe, homolog of	603760				
7.231	11	23	16	7p12.3	PKD1L1, HTX8		Polycystin 1L1	609721			Heterotaxy, visceral, 8, autosomal, 617205 (3)	11(Pkd1l1)
7.232	2	15	01	7p13	RAMP3		Receptor activity-modifying protein 3	605155				11(Ramp3)
7.233	2	23	92	7p22.1	OCM		Oncomodulin	164795				5(Ocm)
7.234	10	29	20	7p13-q32	SRS2		Silver-Russell syndrome	618905		maternal uniparental disomy of chromosome 7; 7p13-p11.2 and 7q32 have been implicated	Silver-Russell syndrome 2 (4)	
7.235	12	28	08	7p12.3	ABCA13		ATP-binding cassette, subfamily A, member 13	607807				11(Abca13)
7.236	08	13	20	7p12.3	SUN3, SUNC1		SAD1 and UNC84 domain-containing protein 3	618984				
7.237	1	2	08	7p12.3	TNS3, TEM6		Tensin 3	606825				
7.238	1	23	08	7p12.3	UPP1, UP		Uridine phosphorylase 1	191730				
7.239	11	3	14	7p11.2	EGFR, NISBD2		Epidermal growth factor receptor	131550		same as oncogene ERBB; mutation identified in 1 NISBD2 family	Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3); Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3); {Nonsmall cell lung cancer, susceptibility to}, 211980 (3); ?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3)	11(Erbb)
7.240	10	13	09	7p12.2	ALL2		Leukemia, acute lymphoblastic, susceptibility to, 2	613067		associated with rs11978267	{Leukemia, acute lymphoblastic, susceptibility to, 2} (2)	
7.241	6	13	07	7p12.2	VWC2, BRORIN		von Willebrand factor C domain-containing protein 2	611108				
7.242	8	8	13	7p12.2	ZPBP, SP38		Zona pellucida-binding protein	608498				
7.243	9	9	13	7p12.2	FIGNL1		Fidgetin-like protein 1	615383				
7.244	6	7	12	7p12.1-q21	CMH21		Cardiomyopathy, familial hypertrophic, 21	614676		max lod at D7S669	Cardiomyopathy, hypertrophic, 21 (2)	
7.245	8	19	13	7p12.1	COBL, KIAA0633		Cordon-bleu, mouse, homolog of	610317				11(Cobl)
7.246	3	12	15	7p14.3	FKBP9, FKBP60, FKBP63		FK506-binding protein 9	616257				
7.247	12	15	98	7p11.2	GBAS, NIPSNAP2		Glioblastoma amplified sequence	603004				
7.248	3	25	16	7p12.2	IKZF1, ZNFN1A1, IK1, LYF1, CVID13		Ikaros family zinc finger 1	603023		fused with BCL6 in DLBL	Immunodeficiency, common variable, 13, 616873 (3)	11(Ikaros)
7.249	1	7	02	7p12.1	GRB10, RSS		Growth factor receptor-bound protein-10	601523				11(Grb1)
7.250	7	11	93	7p12-cen	TTIM1		T-cell tumor invasion and metastasis-1 (invasion-metastasis of neoplasms, chromosome 7 determined)	147830				
7.251	10	12	90	7p11.2	PHKG1		Phosphorylase kinase, gamma 1, muscle	172470		presumed pseudogene on 11		5(Phkg)
7.252	8	8	13	7p11.2	CCT6A, CCT6, HTR3, TCP20		Chaperonin containing T-complex polypeptide 1, subunit 6A	104613				
7.253	12	28	15	7p11.2	CHCHD2, PARK22		Coiled-coil-helix-coiled-coil-helix domain-containing protein 2	616244			Parkinson disease 22, autosomal dominant, 616710 (3)	
7.254	12	11	18	7p11.2	ELDR, LINC01156, FABL		EGFR long noncoding downstream RNA	618217				1(Eldr)
7.255	7	22	09	7p11.2	LANCL2, TASP		LanC-like 2	612919				
7.256	4	14	14	7p11.2	NYS3		Nystagmus 3, congenital, autosomal dominant	608345		translocation t(7;15)(p11.2;q11.2)	Nystagmus 3, congenital, autosomal dominant (2)	
7.257	3	24	14	7p11.2	PSPH, PSP, PSPHD		Phosphoserine phosphatase	172480			Phosphoserine phosphatase deficiency, 614023 (3)	5(Psph)
7.258	01	04	19	7p11.2	SEC61G		SEC61 translocon, gamma subunit	609215				
7.259	7	10	08	7p11.2	SEPT14		Septin 14	612140				
7.260	2	25	15	7p11.2	SUMF2		Sulfatase-modifying factor 2	607940				
7.261	5	24	13	7p11.2	VOPP1, ECOP, GASP		Vesicular, overexpressed in cancer, prosurvival protein 1	611915				
7.262	4	20	17	7p11.2	ZNF479, KR19		Zinc finger protein 479	617444				
7.263	1	12	15	7p11.2	ZNF713		Zinc finger protein 713	616181				
7.264	8	25	04	7p12.2-p12.1	DDC		DOPA decarboxylase (aromatic L-amino acid decarboxylase)	107930			Aromatic L-amino acid decarboxylase deficiency, 608643 (3)	
7.265	12	4	03	7q11.21	ASL		Argininosuccinate lyase	608310			Argininosuccinic aciduria, 207900 (3)	5(Asl)
7.266	8	11	91	7q	HRX		Hyperreflexia	145290		linked to KEL		
7.267	12	1	98	7q11.23	CLDN3, CPETR2		Claudin-3 (Clostridium perfringens enterotoxin receptor 2)	602910				
7.268	7	22	15	7q11.21	SBDS, SDS		SBDS gene	607444			Shwachman-Diamond syndrome, 260400 (3); {Aplastic anemia, susceptibility to}, 609135 (3)	
7.269	2	28	01	7q11.23	BAZ1B, WSTF, WBSCR9		Bromodomain adjacent to zinc finger domain, 1B	605681				
7.270	4	23	08	7p11.2	MRPS17		Mitochondrial ribosomal protein S17	611980		9 pseudogenes		
7.271	02	12	19	7p11-q21	HPC4		Prostate cancer, hereditary, 4	608658			{Prostate cancer, susceptibility to, 4} (2)	
7.272	10	19	01	7q11.2	ANIB1		Aneurysm, intracranial berry, 1	105800		in or near ELN	Aneurysm, intracranial berry, 1 (2)	
7.273	2	28	08	7q22.1	ARMC10, SVH		Armadillo repeat-containing protein 10	611864				
7.274	7	18	14	7q11.22	KIAA0442, MRD26		KIAA0442 gene	607270		translocation break at 7q11.2	Mental retardation, autosomal dominant 26, 615834 (3)	
7.275	7	16	09	7q11.23	CCL26, SCYA26		Chemokine, C-C motif, ligand 26	604697				
7.276	5	30	17	7q11.23	ELN, SVAS, ADCL1		Elastin	130160			Supravalvar aortic stenosis, 185500 (3); Cutis laxa, autosomal dominant, 123700 (3)	5(Eln)
7.277	7	8	10	7q11.2	EOE1, EE		Esophagitis, eosinophilic, 1	610247		associated with rs2302009	{Esophagitis, eosinophilic, 1} (2)	
7.278	2	1	01	7q11.21	ERV3		Endogenous retroviral sequence-3 (includes zinc finger protein H-plk)	131170				
7.279	9	30	09	7q11.23	FGL2		Fibrinogen-like 2	605351				
7.280	3	22	06	7q22.1	POLR2J2, RPB11		RNA polymerase II polypeptide J-related gene	609881				
7.281	3	22	00	7q11.23	POMZP3		POM121/ZP3 fusion protein	600587				
7.282	1	27	11	7q11.23	POR		Cytochrome P450 oxidoreductase	124015			Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3); Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)	
7.283	09	29	20	7p11.2	PSPHP1, PSPHL, CO9		Phosphoserine phosphatase pseudogene 1	604239				
7.284	6	16	99	7q11.23	STX1A, STX1		Syntaxin 1A, brain	186590				
7.285	6	6	00	7q11.21	ZNF107		Zinc finger protein-107	603989				
7.286	9	12	93	7q11.21	ZNF117		Zinc finger protein-117	194624				
7.287	2	20	03	7q21.2	CCM1, CAM, KRIT1		KREV interaction trapped 1	604214			Cerebral cavernous malformations-1, 116860 (3); Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3); Cavernous malformations of CNS and retina, 116860 (3)	
7.288	10	6	92	7q11.2-q21.3	EEC1		Ectrodactyly, ectodermal dysplasia, cleft lip/palate, 1	129900			?EEC syndrome-1 (2)	
7.289	8	20	12	7q11.21	KCTD7, EPM3, CLN14		Potassium channel tetramerization domain containing 7	611725			Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3)	
7.290	12	28	08	7q11.21	RABGEF1, RABEX5		RAB guanine nucleotide exchange factor 1	609700				
7.291	9	30	09	7q11.21	TPST1		Tyrosylprotein sulfotransferase 1	603125				
7.292	5	26	13	7q11.21	TYW1		tRNA-wybutosine-synthesizing protein 1, S. cerevisiae, homolog of	611243				
7.293	9	16	12	7q11.21	VKORC1L1		Vitamin K epoxide reductase complex, subunit 1-like 1	608838				
7.294	2	1	11	7q11.21	ZNF92		Zinc finger protein-92	603974		sequence aligns with sequence on 19p13.1-p12		
7.295	9	27	17	7q11.21	ZNF273, HZF9		Zinc finger protein 273	604756				
7.296	2	2	01	7q11.21	ZNF138		Zinc finger protein-138	604080				
7.297	4	6	13	7q11.22	WBSCR17, GALNTL3, GALNACT17		Williams-Beuren syndrome chromosome region 17	615137				
7.298	4	17	01	7q11.23	BCL7B		B-cell CLL/lymphoma 7B	605846				
7.299	11	10	17	7q11.23	BUD23, WBSCR22, MERM1		rRNA methyltransferase and ribosome maturation factor Bud23	615733				5(Wbscr22)
7.300	8	29	02	7q11.23	CCL24, SCYA24, MPIF2		Chemokine, C-C motif, ligand 24	602495				
7.301	10	4	05	7q11.23	CLDN4, CPETR1, CPER		Claudin 4	602909				5(Cldn4)
7.302	2	11	09	7q11.23	CLIP2, CYLN2, WBSCR4, WSCR4		CAP-GLY domain-containing linker protein 2	603432		?neurodevelopmental defect of Williams syndrome		5(Cyln2)
7.303	2	22	11	7q11.23	DEL7q11.23, C7DELq11.23		Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729		contiguous gene deletion syndrome	Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)	
7.304	11	27	18	7q11.23	DNAJC30, WBSCR18		DNAJ/HSP40 homolog, subfamily C, member 30	618202				
7.305	01	13	20	7q11.23	DTX2, KIAA1528		Deltex E3 ubiquitin ligase 2	613141				
7.306	1	15	09	7q11.23	DUP7q11.23, C7DUPq11.23		Chromosome 7q11.23 duplication syndrome	609757			Chromosome 7q11.23 duplication syndrome (4)	
7.307	2	12	09	7q11.23	EIF4H, WBSCR1, WSCR1		Eukaryotic translation initiation factor 4H	603431				
7.308	5	11	00	7q11.23	FKBP6		FK506-binding protein 6	604839				
7.309	09	12	19	7q11.23	FZD9, FZD3		Frizzled class receptor 9	601766				
7.310	08	14	19	7q11.23	CASTOR2, GATSL2		Cytosolic arginine sensor for mTORC1 subunit 2	617033				
7.311	1	9	14	7q11.23	GSAP, PION		Gamma-secretase-activating protein	613552				
7.312	9	12	06	7q11.23	GTF2I, BAP135, WBS		General transcription factor II-I (BTK-associated protein, 135kD)	601679				
7.313	9	12	06	7q11.23	GTF2IRD1, GTF3, MUSTRD1, WBS		GTF21 repeat domain-containing protein 1	604318				
7.314	02	12	19	7q11.23	HIP1		Huntingtin interacting protein-1	601767				5(Hip1)
7.315	02	19	20	7q11.23	HSPB1, HSP27, CMT2F, HMN2B		Heat-shock 27kD protein-1	602195			Neuronopathy, distal hereditary motor, type IIB, 608634 (3); Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	5(Hsp105)
7.316	2	12	09	7q11.23	LAT2, WBSCR5, LAB, NTAL		Linker for activation of T cells family, member 2	605719				5(Wbscr5)
7.317	9	3	96	7q11.23	LIMK1		LIM domain kinase 1	601329				5(Limk1)
7.318	11	05	20	7q11.23	MDH2, DEE51		Malate dehydrogenase, mitochondrial	154100			Developmental and epileptic encephalopathy 51, 617339 (3)	5(Mor1)
7.319	3	17	08	7q11.23	MLXIPL, WBSCR14, MONDOB, CHREBP		MLX interacting protein-like	605678				
7.320	2	12	13	7q11.23	MIR590		Micro RNA 590	615070				
7.321	07	07	20	7q11.23	NCF1, CGD1		Neutrophil cytosolic factor-1, 47kD	608512			Chronic granulomatous disease 1, autosomal recessive, 233700 (3)	
7.322	5	30	17	7q11.23	NSUN5, WBSCR20, WBSCR20A		NOP2/SUN RNA methyltransferase family, member 5	615732				
7.323	6	22	14	7q11.23	POM121, POM121A, KIAA0618		POM121 transmembrane nucleoporin	615753				
7.324	6	22	14	7q11.23	POM121C, POM121-2		POM121 Transmembrane nucleoporin C	615754				
7.325	12	5	13	7q11.23	PTPN12, PTPG1		Protein tyrosine phosphatase, nonreceptor-type, 12	600079			Colon cancer, somatic, 114500 (3)	5(Ptpn12)
7.326	3	6	95	7q11.23	RFC2		Replication factor C2, 40kD (activator 1, 40kD)	600404				
7.327	5	6	13	7q11.23	RHBDD2		Rhomboid domain-containing protein 2	615203				
7.328	11	14	18	7q11.23	SSC4D, SRCRB4D		Scavenger receptor cysteine-rich family member with 4 domains	607639				
7.329	12	17	15	7q11.23	STYXL1, MKSTYX, DUSP24		Serine/threonine/tyrosine-interacting protein-like 1	616695				
7.330	4	17	01	7q11.23	TBL2		Transducin-beta-like 2	605842				5(Tbl2)
7.331	9	24	15	7q11.23	TMEM120A, TMPIT, NET29		Transmembrane protein 120A	616550				
7.332	1	24	09	7q11.23	TRIM50, TRIM50A		Tripartite motif-containing protein 50	612548				5(Trim50)
7.333	1	24	09	7q11.23	TRIM73, TRIM50B		Tripartite motif-containing protein 73	612549				
7.334	1	24	09	7q11.23	TRIM74, TRIM50C		Tripartite motif-containing protein 74	612550				
7.335	3	11	08	7q11.23	UPK3B, UPIIIB, P35		Uroplakin 3B	611887				
7.336	12	27	19	7q11.23	VPS37D, WBSCR24		VPS37D subunit of ESCRT-I	610039				
7.337	1	13	09	7q11.23	WBS, WMS, WS, DEL7q11, C7DELq11		Williams-Beuren syndrome (chromosome 7q11.23 deletion syndrome)	194050		contiguous gene syndrome	Williams-Beuren syndrome (4)	
7.338	1	24	09	7q11.23	WBSCR26		Williams-Beuren syndrome chromosome region 26	612545				5(Wbscr26)
7.339	1	24	09	7q11.23	WBSCR27		Williams-Beuren syndrome chromosome region 27	612546				5(Wbscr27)
7.340	1	24	09	7q11.23	WBSCR28		Williams-Beuren syndrome chromosome region 28	612547				5(Wbscr28)
7.341	11	05	20	7q11.23	YWHAG, DEE56		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma isoform	605356			Developmental and epileptic encephalopathy 56, 617665 (3)	
7.342	10	10	17	7q11.23	ZP3, ZP3A, ZP3B, OOMD3		Zona pellucida glycoprotein-3 (sperm receptor)	182889			Oocyte maturation defect 3, 617712 (3)	5(Zp3)
7.343	2	2	16	7q11.23-q21.11	PHTF2		Putative homeodomain transcription factor 2	616785				
7.344	6	23	15	7q21.11	PCLO, PCH3		Piccolo, mouse, homolog of	604918		mutation identified in 1 PCHD3 family	?Pontocerebellar hypoplasia, type 3, 608027 (3)	
7.345	6	24	16	7q31.1	PPP1R3A, PPP1R3		Protein phosphatase 1, regulatory subunit 3A	600917			Insulin resistance, severe, digenic, 125853 (3)	
7.346	12	01	20	7q21.12	ADAM22, DEE61		ADAM metallopeptidase domain 22	603709		mutation identified in 1 DEE61 patient	?Developmental and epileptic encephalopathy 61, 617933 (3)	
7.347	10	12	14	7q11.23	APTR		Alu-mediated CDKN1A/p21 transcriptional regulator, noncoding	616048				
7.348	8	1	17	7q21.3	BHLHA15, MIST1		Basic helix-loop-helix family, member A15	608606				
7.349	1	2	08	7q21.3	CASD1, C7orf12		CAS1 domain-containing protein 1	611686				
7.350	8	19	13	7q21.13	CLKDN12		Claudin 12	611232				
7.351	4	6	18	7q22.1	EPO, MVCD2, ECYT5, DBAL		Erythropoietin	133170		mutation identified in 1 DBAL family	{Microvascular complications of diabetes 2}, 612623 (3); Erythrocytosis, familial, 5, 617907 (3); ?Diamond-Blackfan anemia-like, 617911 (3)	5(Epo)
7.352	09	12	19	7q21.13	FZD1		Frizzled class receptor 1	603408				
7.353	6	1	88	7q21.11	GNAI1		Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-1	139310				5(Gnai1)
7.354	2	10	00	7q22.1	GNB2		Guanine nucleotide-binding protein, beta polypeptide-2	139390		30-70kb from EPO		5(Gnb2)
7.355	07	27	18	7q21.11	MAGI2, AIP1, KIAA0705, NPHS15		Membrane-associated guanylate kinase, WW and PDZ domains-containing, 2	606382			Nephrotic syndrome, type 15, 617609 (3)	
7.356	1	27	11	7q21	MAGI2IT, PR47		MAGI2 intronic transcript	608950				
7.357	12	22	05	7q21.3	PEG10, KIAA1051		Paternally expressed gene 10	609810				6(Peg10)
7.358	12	10	20	7q21.2	SAMD9, NFTC, MIRAGE, M7MLS2		Sterile alpha motif domain-containing protein 9	610456			Tumoral calcinosis, familial, normophosphatemic, 610455 (3); MIRAGE syndrome, 617053 (3); Monosomy 7 myelodysplasia and leukemia syndrome 2, 619041 (3)	
7.359	9	9	03	7q21.3	SGCE, DYT11		Sarcoglycan, epsilon	604149		pseudogene on 2q21; maternally imprinted	Dystonia-11, myoclonic, 159900 (3)	6(Sgce)
7.360	08	23	19	7q21.13	STEAP1		STEAP family member 1	604415				
7.361	08	23	19	7q21.13	STEAP2, STAMP1, IPCA1, PCANAP1		STEAP2 metalloreductase	605094				
7.362	08	23	19	7q21.12	STEAP4, STAMP2, TIARP		STEAP4 metalloreductase	611098				
7.363	2	17	09	7q21	STQTL11		Stature quantitative trait locus 11	612223		associated with rs2282978	{Stature QTL 11} (2)	
7.364	2	26	08	7q21.2	AKAP9, YOTIAO, AKAP450, LQT11		A-kinase anchor protein 9	604001		mutation identified in 1 LQT11 family	?Long QT syndrome 11, 611820 (3)	
7.365	3	15	10	7q22.1	ARPC1A, SOP2L		Actin-related protein 2/3 complex, subunit 1A	604220				
7.366	08	03	20	7q22.1	ARPC1B, ARC41, IMD71		Actin-related protein 2/3 complex, subunit 1B	604223			Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia, 617718 (3)	
7.367	7	17	01	7q21.3	ASB4		Ankyrin repeat-containing SOCS box protein 4	605761				6(Asb4)
7.368	8	5	97	7q21.11	CACNA2, CACNL2A		Calcium channel, voltage-dependent, L type, alpha 2/delta subunit	114204				
7.369	6	6	00	7q22.1	CPSF4, CPSF30, NEB1		Cleavage-polyadenylation specificity factor 4, 30kD	603052				
7.370	11	5	14	7q21.2	CDK6, PLSTIRE, MCPH12		Cyclin-dependent kinase 6	603368		mutation identified in 1 MCPH12 family	?Microcephaly 12, primary, autosomal recessive, 616080 (3)	
7.371	5	2	16	7q21.2	ERVW1, ERVWE1, HERVW		Endogenous retroviral family W, member 1 (syncytin)	604659				
7.372	8	5	97	7q21-q22	MHS3		Malignant hyperthermia susceptibility 3	154276		?mutation in CACNA2	{Malignant hyperthermia susceptibility 3} (2)	
7.373	10	28	15	7q21.2	PEX1, ZWS1, PBD1A, PBD1B, HMLR1		Peroxisome biogenesis factor-1	602136			Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3); Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3); Heimler syndrome 1, 234580 (3)	
7.374	8	9	99	7q21.3	TAC1, TAC2, NKNA		Tachykinin 1 (substance K; neurokinin A; neurokinin 2; neuromedin L; neuropeptide gamma; tachykinin 2)	162320				6(Nkna)
7.375	9	28	96	7q22.1	ZNF36, KOX18		Zinc finger protein-36 (KOX 18)	601260				
7.376	9	28	96	7q22.1	ZNF38, KOX25		Zinc finger protein-38 (KOX 25)	601261				
7.377	12	24	13	7q21.3	ASNS, ASNSD		Asparagine synthetase	108370		temperature sensitive G1 mutant	Asparagine synthetase deficiency, 615574 (3)	
7.378	12	7	12	7q21.12	ABCB4, PGY3, MDR3, ICP3		ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3)	171060		within 500kb of MDR1	Cholestasis, progressive familial intrahepatic 3, 602347 (3); Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3); Gallbladder disease 1, 600803 (3)	
7.379	5	4	12	7q21.12	ABCB1, PGY1, MDR1, IBD13, CLCs		ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1)	171050			{Colchicine resistance}, 120080 (3); {Inflammatory bowel disease 13}, 612244 (3)	5(Pgy1)
7.380	7	11	01	7q21.12	CROT, COT		Carnitine octanoyltransferase	606090				
7.381	8	24	09	7q21.11	HGF, DFNB39		Hepatic growth factor	142409			Deafness, autosomal recessive 39, 608265 (3)	
7.382	6	4	89	7q21.12	SRI, SCN		Sorcin (class 4 gene)	182520				
7.383	6	4	98	7q21.11-q21.12	GRM3		Glutamate receptor, metabotropic-3	601115				
7.384	1	30	01	7q22.1	SMURF1		SMAD ubiquitination regulatory factor 1	605568				
7.385	03	10	20	7q21.11	CD36, CHDS7, BDPLT10		CD36 antigen (collagen type I)	173510			Platelet glycoprotein IV deficiency, 608404 (3); {Malaria, cerebral, susceptibility to}, 611162 (3); {Malaria, cerebral, reduced risk of}, 611162 (3); {Coronary heart disease, susceptibility to, 7}, 610938 (3)	
7.386	7	17	14	7q21.11	GNAT3, GDCA		Guanine nucleotide-binding protein, alpha-transducing activity polypeptide 3	139395				
7.387	8	21	91	7q11.21	GUSB, MPS7		Glucuronidase, beta-	611499			Mucopolysaccharidosis VII, 253220 (3)	5(Gus)
7.388	6	11	13	7q21.11	SEMA3A, SEMAD, COLL1, HH16		Semaphorin 3A	603961			{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3)	
7.389	4	21	15	7q21.11	SEMA3C		Semaphorin 3C	602645				
7.390	4	21	15	7q21.11	SEMA3D		Semaphorin 3D	609907				
7.391	8	8	13	7q21.12	DMTF1, DMP1		Cyclin D-binding MYB-like transcription factor 1	608491				
7.392	1	13	16	7q21.11	SEMA3E, SEMAH, KIAA0331		Semaphorin 3E	608166		mutation identified in 1 CHARGE patient	?CHARGE syndrome, 214800 (3)	
7.393	9	8	11	7q21.12	KIAA1324L, EIG121L		KIAA1324-like gene	614048				
7.394	1	9	17	7q21.12	RUNDC3B, RPIP9		RUN domain-containing protein 3B	617295				
7.395	3	12	07	7q21.12	SLC25A40		Solute carrier family 25, member 40	610821				5(Slc25a40)
7.396	6	26	16	7q21.12	TMEM243, C7orf23, MMTRAG		Transmembrane protein 243	616993				
7.397	6	23	15	7q21.12	TP53TG1		TP53 target gene 1	616403				
7.398	4	17	13	7q21.13	CDK14, PFTK1, PFTAIRE1, KIAA0834		Cyclin-dependent kinase 14	610679				
7.399	5	9	18	7q21.13	CFAP69, C7orf63, SPGF24		Cilia- and flagella-associated protein 69	617949			Spermatogenic failure 24, 617959 (3)	5(Cfap69)
7.400	4	18	07	7q21.13	GTPBP10, OBGH2		GTP-binding protein 10	610920				
7.401	4	22	15	7q21.2	GATAD1, ODAG, CMD2B		GATA zinc finger domain-containing protein 1	614518		mutation identified in 1 GATAD1 family	?Cardiomyopathy, dilated, 2B, 614672 (3)	
7.402	10	7	13	7q21.2	MTERF		Transcription termination factor, mitochondrial	602318				
7.403	12	10	20	7q21.2	SAMD9L, ATXPC, M7MLS1		Sterile alpha motif domain-containing 9-like	611170			Ataxia-pancytopenia syndrome, 159550 (3); Monosomy 7 myelodysplasia and leukemia syndrome 1, 252270 (3)	
7.404	3	5	03	7q21.2	CYP51A1, CYP51		Cytochrome P450, family 51, subfamily A, polypeptide 1 (lanosterol 14-alpha-demethylase)	601637				
7.405	9	8	11	7q21.2	HEPACAM2, MIKI		Hepacam family member 2	614133				
7.406	10	03	19	7q21.2-q21.3	VPS50, CCDC132, KIAA1861		VPS50, EARP/GARPII complex subunit	616465				
7.407	02	18	20	7q22.1	TRRAP, DEDDFA, DFNA75		Transformation/transcription domain-associated protein	603015		?mutation identified in 1 DFNA75 family	Developmental delay with or without dysmorphic facies and autism, 618454 (3); ?Deafness, autosomal dominant 75, 618778 (3)	
7.408	7	14	14	7q21.3	BET1		Bet1 golgi vesicular membrane-trafficking protein	605456				
7.409	2	13	14	7q21.3	BRI3		Brain protein I3	615628				
7.410	3	16	99	7q21.3	CALCR, CRT		Calcitonin receptor	114131		not deleted in Williams syndrome	{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)	6(Calcr)
7.411	05	05	20	7q21.12	DBF4, ASK		DBF4 zinc finger	604281				5(Dbf4)
7.412	5	25	13	7q21.3	GNG11		Guanine nucleotide-binding protein, gamma 11	604390				
7.413	6	16	99	7q21.3	GNGT1		Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 1	189970				
7.414	3	30	12	7q21.3	MIR489		Micro RNA 489	614523		in intron 4 of CALCR		
7.415	7	8	10	7q21.3	PON1, PON, ESA, MVCD5		Paraoxonase-1	168820			{Coronary artery disease, susceptibility to} (3); {Coronary artery spasm 2, susceptibility to (3); {Organophosphate poisoning, sensitivity to} (3); {Microvascular complications of diabetes 5}, 612633 (3)	6(Pon1)
7.416	9	9	98	7q21.3	PON2		Paraoxonase-2	602447			{Coronary artery disease, susceptibility to} (3)	
7.417	9	9	98	7q21.3	PON3		Paraoxonase-3	602720				
7.418	10	20	04	7q21.3	PPP1R9A, NRBI, NRB1, KIAA1222		Protein phosphatase 1, regulatory subunit 9A (neurabin I)	602468				
7.419	05	05	20	7q21.3	SDHAF3, ACN9		Succinate dehydrogenase complex assembly factor 3	615773				
7.420	09	04	19	7q21.3	SLC25A13, CTLN2, NICCD		Solute carrier family 25 (mitochondrial carrier, citrin), member 13	603859			Citrullinemia, adult-onset type II, 603471 (3); Citrullinemia, type II, neonatal-onset, 605814 (3)	
7.421	8	31	12	7q21.3	TECPR1, KIAA1358		Tectonin beta-propeller repeat-containing 1	614781				
7.422	1	7	95	7q22.1	PCOLCE		Procollagen C-endopeptidase enhancer	600270				5(Pcolce)
7.423	4	13	10	7q22.1	PAI1, PLANH1, SERPINE1		Plasminogen activator inhibitor, type I	173360			Plasminogen activator inhibitor-1 deficiency, 613329 (3); {Transcription of plasminogen activator inhibitor, modulator of} (3)	
7.424	8	28	01	7q11.21	RCP		Calcitonin gene-related peptide receptor component protein	606121				
7.425	3	5	08	7q21.3-q22.1	BAIAP2L1, IRTKS		BAI1-associated protein 2-like 1	611877				
7.426	6	16	99	7q21.3	DNCI1		Dynein, cytoplasmic, intermediate chain 1	603772				6(Dnci1)
7.427	5	22	07	7q21.3	LMTK2, KPI2, BREK, KIAA1079		Lemur tyrosine kinase 2	610989				
7.428	8	18	97	7q22.1	MCM7, MCM2		Minichromosome maintenance deficient, S. cerevisiae, homolog of, 7	600592				
7.429	9	20	95	7q22.1	NPTX2		Pentraxin II	600750				
7.430	11	4	98	7q21.3	PDK4		Pyruvate dehydrogenase kinase, isoenzyme 4	602527				
7.431	11	29	17	7q21.3	SEM!, DSS1		Proteasome 26S subunit SEM1	601285		?gene mutant in SHFM1		
7.432	8	28	92	7q22.1	ACHE, YT		Acetylcholinesterase (YT blood group)	100740		blood group YT (112100) = epitope of ACHE	[Blood group, Yt system], 112100 (3)	5(Ache)
7.433	12	01	20	7q22.1	ACTL6B, BAF53B, IDDSSAD, DEE76		Actin-like 6B	612458			Intellectual developmental disorder with severe speech and ambulation defects, 618470 (3); Developmental and epileptic encephalopathy 76, 618468 (3)	
7.434	1	31	01	7q22.1	APS		Adaptor protein containing PH and SH2 domains	605300				
7.435	5	16	07	7q22	AUTS1		Autism, susceptibility to, 1	209850			{Autism susceptibility 1} (2)	
7.436	02	15	19	7q22.1	CUX1, CUTL1, CDP, GDDI		Cut-like homeobox 1	116896			Global developmental delay with or without impaired intellectual development, 618330 (3)	
7.437	05	12	20	7q21.3	DLX5, SHFM1D, SHFM1		Distal-less homeo box-5	600028		mutation identified in 1 SHFM1D family	?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3); Split-hand/foot malformation 1, 183600 (3)	6(Dlx5)
7.438	1	8	95	7q21.3	DLX6		Distal-less homeo box-6	600030				
7.439	12	20	18	7q22.1	EPHB4, HTK, MYK1, HFASD, CMAVM2, LMPHM7		Ephrin receptor EphB4 (hepatoma transmembrane kinase)	600011			Lymphatic malformation 7, 617300 (3); Capillary malformation-arteriovenous malformation 2, 618196 (3)	
7.440	9	30	09	7q22.1	DNAJC2, ZRF1, MPP11		DnaJ (Hsp40) homolog, subfamily C, member 2	605502				
7.441	9	9	08	7q22.1	FBXO24, FBX24		F-box only protein 24	609097				5(Fbxo24)
7.442	2	7	07	7q22.1	GAL3ST4		Galactose-3-O-sulfotransferase 4	608235				
7.443	1	18	11	7q22	IBD11		Inflammatory bowel disease 11	191390		associated with MUC3A	{Inflammatory bowel disease 11} (2)	
7.444	07	25	19	7q22.3	KMT2E, MLL5, ODLURO		Lysine (K)-specific methyltransferase 2E	608444			O'Donnell-Luria-Rodan syndrome, 618512 (3)	
7.445	10	13	09	7q22.1	MEPCE, BCDIN3		Methylphosphate capping enzyme	611478				
7.446	9	2	09	7q22.1	MIR93, MIRN9		Micro RNA 93	612984				
7.447	9	3	09	7q22.1	MIR106B, MIRN106B		Micro RNA 106B	612983				
7.448	1	18	11	7q22.1	MUC3A		Mucin 3A, intestinal	158371				
7.449	2	12	01	7q22	MUC3B		Mucin 3B, intestinal	605633				
7.450	1	4	08	7q22.1	MUC12, MUC11		Mucin 12	604609				
7.451	11	5	08	7q22.1	MUC17		Mucin 17	608424				
7.452	4	15	04	7q22	MYH16		Myosin, heavy chain 16, skeletal muscle	608580		inactivated in humans; expressed in masticatory muscles in nonhuman primates		
7.453	8	24	04	7q22	PAPA4		Polydactyly, postaxial, type A4	608562		highest lod with D7S1799	Polydactyly, postaxial, type A4 (2)	
7.454	9	20	00	7q22.3	PIK3CG		Phosphatidylinositol 3-kinase, catalytic, gamma	601232				
7.455	1	31	01	7q22.1	PILRA		Paired immunoglobulin-like receptor, alpha	605341				
7.456	1	31	01	7q22.1	PILRB		Paired immunoglobulin-like receptor, beta	605342				
7.457	12	16	08	7q22.1	PLOD3, LH3		Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (lysyl hydroxylase 3)	603066		previously assigned to 7q36	Lysyl hydroxylase 3 deficiency, 612394 (3)	5(Plod3)
7.458	9	30	09	7q22.1	POP7, RPP20		Processing of precursor 7, S. cerevisiae, homolog of	606113				
7.459	5	23	95	7q22.3	PRKAR2B		Protein kinase, cAMP-dependent, regulatory, type II, beta	176912				
7.460	9	7	10	7q22.1	RASA4, CAPRI, GAPL, KIAA0538		Ras p21 protein activator 4	607943				
7.461	6	23	15	7q22.1	RELN, RL, LIS2, ETL7		Reelin	600514			Lissencephaly 2 (Norman-Roberts type), 257320 (3); {Epilepsy, familial temporal lobe, 7}, 616436 (3)	5(rl)
7.462	3	16	16	7q22.1	SLC12A9, CIP1, CCC6		Solute carrier family 12 (potassium/chloride transporter), member 9	616861				
7.463	07	17	20	7q22.1	SRRT, ARS2		Serrate RNA effector molecule	614469				
7.464	4	8	16	7q22.1	STAG3, POF8		Stromalin 3	608489			Premature ovarian failure 8, 615723 (3)	5(Stag3)
7.465	9	15	96	7q21.3	TFPI2		Tissue factor pathway inhibitor-2	600033				
7.466	5	3	00	7q22.1	TFR2, HFE3		Transferrin receptor 2	604720			Hemochromatosis, type 3, 604250 (3)	
7.467	11	20	98	7q22.1	TRIP6, OIP1		Thyroid hormone receptor interactor-6	602933				
7.468	3	5	98	7q22.1	VGF		VGF nerve growth factor inducible	602186				
7.469	6	19	98	7q22.1	ZAN		Zonadhesin	602372				5(Zan)
7.470	9	21	17	7q22.1	ZASP		ZO2-associated speckle protein	617677				5(Zasp)
7.471	6	16	99	7q31.1	IFRD1		Interferon-related developmental regulator 1	603502				
7.472	8	4	97	7q22.3	GPR22		G protein-coupled receptor-22	601910				
7.473	10	19	99	7q22.1	POLR2J		Polymerase II, RNA, subunit J	604150				
7.474	6	22	14	7q22.3-q31.1	SLC26A3, DRA, CLD		Solute carrier family 26 (sulfate transporter), member 3	126650		5' and close to PDS	Diarrhea 1, secretory chloride, congenital, 214700 (3)	
7.475	9	14	89	7q22-q32	G7P1		Kinase-like protein	148750				
7.476	11	4	04	7q22-q32	SCA18, SMNA		Spinal cerebellar ataxia 18	607458		between D7S2418 and D7S1804	Spinocerebellar ataxia 18 (2)	
7.477	9	9	08	7q33	CNOT4, NOT4		CCR4-NOT transcription complex, subunit 4	604911				
7.478	7	18	14	7q22.1	AGFG2, HRBL, RABR		ADP-ribosylation factor GTPase-activating protein with FG repeats 2	604019				
7.479	10	28	19	7q22.1	ALKBH4, ABH4		AlkB homolog 4, lysine demethylase	613302				
7.480	1	14	13	7q22.1	AP1S1, CLAPS1, AP19, MEDNIK		Adaptor-related protein complex 1, sigma 1 subunit	603531			MEDNIK syndrome, 609313 (3)	
7.481	4	27	12	7q22.1	AP4M1, SPG50, CPSQ3		Adaptor-related protein complex 4, mu-1 subunit	602296			Spastic paraplegia 50, autosomal recessive, 612936 (3)	
7.482	3	18	94	7q22.1	AZGP1, ZAG		Alpha-2-glycoprotein, zinc	194460				
7.483	5	25	13	7q22.1	BUD31, G10		Bud31, S. cerevisiae, homolog of	603477				
7.484	6	22	14	7q22.1	CLDN15		Claudin 15	615778				
7.485	4	23	09	7q22.1	CNPY4, PRAT4B, MGC40499		Canopy 4, zebrafish, homolog of	610047				
7.486	10	18	18	7q21.3	COL1A2, EDSCV, EDSARTH2		Collagen I, alpha-2 polypeptide	120160		~17cM from CF	Ehlers-Danlos syndrome, arthrochalasia type, 2, 617821 (3); Osteogenesis imperfecta, type IV, 166220 (3); Osteogenesis imperfecta, type III, 259420 (3); Osteogenesis imperfecta, type II, 166210 (3); {Osteoporosis, postmenopausal}, 166710 (3); Ehlers-Danlos syndrome, cardiac valvular type, 225320 (3); Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2, 619120 (3)	6(Cola2)
7.487	7	18	12	7q22.1	COPS6, CSN6		COP9 signalosome, subunit 6	614729				
7.488	11	12	20	7q22.1	CYP3A4, VDDR3		Cytochrome P450, subfamily IIIA (nifedipine oxidase) polypeptide 4	124010			Vitamin D-dependent rickets, type 3, 619073 (3)	6(Cyp3)
7.489	1	25	05	7q22.1	CYP3A5, P450PCN3		Cytochrome P450, subfamily IIIA, polypeptide 5	605325			{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)	
7.490	12	7	03	7q22.1	CYP3A7		Cytochrome P450, subfamily IIIA, polypeptide 7	605340				
7.491	12	11	01	7q22.1	CYP3A43		Cytochrome P450, subfamily IIIa, polypeptide 43	606534				
7.492	6	13	12	7q22.1	EBXL13, FBL13		F-box and leucine-rich repeat protein 13	609080				5(Fbxl13)
7.493	09	06	19	7q22.1	EMSLR, EMS		E2F1 mRNA stabilizing long noncoding RNA	618575				
7.494	11	15	19	7q22.1	FIS1, TTC11		Fission, mitochondrial 1	609003				
7.495	8	18	08	7q22.1	GAEC1		Gene amplified in esophageal cancer 1	612130				
7.496	6	10	08	7q22.1	GIGYF1		GRB10-interacting GYF protein 1	612064				5(Gigyf1)
7.497	4	1	08	7q22.1	GJC3, CX30.2, CX31.3		Gap junction protein, gamma-3	611925				
7.498	05	24	19	7q22.1	GPC2		Glypican 2	618446				
7.499	9	8	11	7q22.1	KPNA7		Karyopherin alpha 7	614107				
7.500	04	03	20	7q22.1	LAMTOR4, C7orf59		Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 4	618834				
7.501	12	28	08	7q22.2-q22.3	LHFPL3		LHFP-like protein 3	609719				
7.502	01	24	20	7q22.1	LRRC17		Leucine-rich repeat-containing protein 17	618749				
7.503	4	17	13	7q22.1	LRWD1, ORCA		Leucine-rich repeats- and WD repeat domain-containing protein 1	615167				5(Lrwd1)
7.504	03	07	19	7q22.1	MAP11, C7orf43, MCPH25		Microtubule-associated protein 11	618350		mutation identified in 1 MCHP25 family	?Microcephaly 25, primary, autosomal recessive, 618351 (3)	
7.505	3	23	09	7q22.1	MIR25, MIRN25		Micro RNA 25	612150				
7.506	8	3	12	7q22.1	MOGAT3, MGAT3		Monoacylglycerol O-acyltransferase 3	610184				
7.507	11	23	16	7q22.1	MYL10, PLRLC		Myosin light chain 10	617177				
7.508	10	7	08	7q22.1	NAPEPLD		N-acyl phosphatidylethanolamine-hydrolyzing phospholipase D	612334				
7.509	6	22	14	7q22.1	NAT16		N-acetyltransferase 16	615783				
7.510	8	18	08	7q22.1	NFE4		Transcription factor NFE4	612133				
7.511	12	10	13	7q22.1	NYPA1		Neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1	615477				
7.512	7	22	09	7q22.1	ORAI2, MEM142B, C7orf19		ORAI calcium release-activated calcium modulator 2	610929				
7.513	12	23	19	7q22.1-q22.2	ORC5, ORC5L		Origin recognition complex, subunit 5	602331				
7.514	9	30	09	7q22.1	PDAP1, PAP1, PAP		PDGFA-associated protein 1	607075				
7.515	5	3	18	7q22.1	PMPCB, MPPB		Peptidase, mitochondrial processing, beta	603131			Multiple mitochondrial dysfunctions syndrome 6, 617954 (3)	
7.516	11	11	14	7q22.1	PMS2P1, PMS2L1, PMS3		Postmeiotic segregation increased 2 pseudogene 1	605038				
7.517	07	08	20	7q22.1	PPP1R35, C7orf47		Protein phosphatase 1, regulatory subunit 35	618937				
7.518	4	26	17	7q22.1	PRKRIP1, C114		PRKR-interacting protein 1, IL11-inducible	617458				
7.519	8	21	12	7q22.1	PTCD1, KIAA0632		Pentatricopeptide repeat domain 1	614774				
7.520	7	27	16	7q22.1	PVRIG, CD112R, C7orf15		Poliovirus receptor-related immunoglobulin domain-containing protein	617012				
7.521	6	9	15	7q22.1	SLC26A5, PRES, DFNB61		Solute carrier family 26, member 5	604943		mutation identified in 1 DFNB61 family	?Deafness, autosomal recessive 61, 613865 (3)	
7.522	11	05	18	7q22.1	SPDYE2, SPDYB2L1		SPEEDY/RINGO cell cycle regulator family, member E2	617624				
7.523	8	28	17	7q22.1	SPDYE3, SPDYB2		SPEEDY/RINGO cell cycle regulator family, member E3	617625				5(Spdye3)
7.524	9	22	16	7q22.1	TAF6, TAF2E, TAFII80, ALYUS		TAF6 RNA polymerase II, TATA box-binding protein-associated factor, 80kD	602955			Alazami-Yuan syndrome, 617126 (3)	
7.525	6	26	16	7q22.1	TRIM56		Tripartite motif-containing protein 56	616996				
7.526	5	24	13	7q22.1	ZKSCAN5, ZFP95, KIAA1015		Zinc finger protein with KRAB and SCAN domains 5	611272				5(Zkscan5)
7.527	10	09	19	7q22.1	ZNHIT1, ZNFN4A1		Zinc finger HIT domain-containing protein 1	618617				
7.528	10	13	09	7q22.1	UFSP1		UFM1-specific peptidase 1	611481				
7.529	07	08	20	7q22.1	ZCWPW1		Zinc finger CW-type domain- and PWWP domain-containing protein 1	618900				
7.530	9	30	09	7q22.1	ZNF3		Zinc finger protein-3	194510		?relation to ZNF4, ZNF5; previous assignment to Chr.5		
7.531	3	1	18	7q22.1	ZNF655, VIK		Zinc finger protein 655	617891				
7.532	11	4	98	7q22.1	PSMC2, MSS1, S7		Proteasome 26S subunit, ATPase, 2	154365				
7.533	4	8	08	7q22.3	NAMPT, PBEF1, VF, PBEF		Nicotinamide phosphoribosyltransferase	608764				
7.534	10	9	08	7q22.3	CBLL1, HAKAI, RNF188		Cas-Br-M murine ectopic retroviral transforming sequence like-1	606872				
7.535	2	2	14	7q22.3	CDHR3		Cadherin-related family, member 3	615610				
7.536	12	22	15	7q22.3	HBP1		HMG-box transcription factor 1	616714				
7.537	5	29	12	7q22.3	MPVQTL6		Mean platelet volume quantitative trait locus 6	614646		associated with rs342293	Mean platelet volume QTL6 (2)	
7.538	03	04	19	7q22.3	PUS7, KIAA1897, IDDABS		Pseudouridylate synthase 7, putative	616261			Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature, 618342 (3)	
7.539	10	25	19	7q22.3	RINT1, ILFS3		RAD50-interacting protein 1	610089			Infantile liver failure syndrome 3, 618641 (3)	
7.540	12	1	15	7q22.3	SYPL1, SYPL		Synaptophysin-like 1	616665				
7.541	3	1	06	7q22.3-q31.1	CMD1Q		Cardiomyopathy, dilated, 1Q	609915		between D7S2545 and D7S2554	Cardiomyopathy, dilated, 1Q (2)	
7.542	11	19	13	7q31	AUTS9		Autism, susceptibility to, 9	611015		max lod near D7S530	{Autism, susceptibility to, 9} (2)	
7.543	1	18	11	7q22.3	COG5, GOLTC1, GTC90, CDG2I		Component of oligomeric golgi complex 5	606821			Congenital disorder of glycosylation, type IIi, 613612 (3)	
7.544	12	20	05	7q31.31	CTTNBP2, CORTBP2, KIAA1758		Cortactin-binding protein 2	609772				
7.545	5	20	99	7q31	DFNB14		Deafness, autosomal recessive 14	603678		?same as DFNB17	Deafness, autosomal recessive 14 (2)	
7.546	9	9	98	7q31	DFNB17		Deafness, autosomal recessive 17	603010			Deafness, autosomal recessive 17 (2)	
7.547	4	9	03	7q31.1	DOCK4, KIAA0716		Dedicator of cytokinesis 4	607679				12(Dock4)
7.548	11	4	98	7q31.33	GPR37		G protein-coupled receptor-37	602583				
7.549	9	15	00	7q31.1	GPR85, SREB2		G protein-coupled receptor-85	605188				
7.550	5	4	00	7q31.32	HYAL4		Hyaluronoglucosaminidase 4	604510				
7.551	10	6	08	7q31.1	IMMP2L, IMP2		Inner mitochondrial membrane peptidase, subunit 2, S. cerevisiae, homolog of	605977				
7.552	1	27	03	7q31.31	ING3, P47ING3		Inhibitor of growth family, member 3	607493				
7.553	11	27	00	7q31.31	KCND2, KIAA1044		Potassium voltage-gated channel, Shal-related subfamily, member 2	605410				
7.554	4	21	16	7q31.2	MET, DFNB97, OSFD		Oncogene MET	164860		mutation identified in 1 DFNB97 family	Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3); Hepatocellular carcinoma, childhood type, somatic, 114550 (3); ?Deafness, autosomal recessive 97, 616705 (3); {Osteofibrous dysplasia, susceptibility to}, 607278 (3)	6(Met)
7.555	5	4	15	7q31.1	PNPLA8, MMLA		Patatin-like phospholipase domain-containing protein 8	612123		mutation identified in 1 MMLA family	?Mitochondrial myopathy with lactic acidosis, 251950 (3)	
7.556	7	6	12	7q22.3	SLC26A4, PDS, DFNB4, EVA, TDH2B		Solute carrier family 26 (sulfate transporter), member 4	605646		some patients have digenic mutations with FOXI1	Pendred syndrome, 274600 (3); Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	
7.557	11	13	95	7q31.32	SPAM1		Sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)	600930				
7.558	3	23	06	7q33	STRA8		Stimulated by retinoic acid 8, mouse, homolog of	609987				
7.559	11	26	01	7q31.1	FOXP2, SPCH1, TNRC10, CAGH44		Forkhead box P2	605317			Speech-language disorder-1, 602081 (3)	
7.560	9	8	11	7q33	EXOC4, SEC8, KIAA1699		Exocyst complex component 4	608185				
7.561	5	9	18	7q31.32	TAS2R16, T2R16, BGLPT		Taste receptor type 2, member 16	604867			[Beta-glycopyranoside tasting], 617956 (3) {Alcohol dependence, susceptibility to}, 103780 (3)	6(T2r18)
7.562	6	10	94	7q31.2	WNT2, INT1L1		Wingless-type MMTV integration site family, member 2	147870		isolated by CMGT with MET		6(Irp, Wnt2)
7.563	12	4	90	7q36.1	ABP1		Amiloride-binding protein-1	104610				
7.564	3	20	08	7q32.1	CCDC136, NAG6, KIAA1793		Coiled-coil domain-containing protein 136	611902				
7.565	3	7	13	7q31.1	DLD, LAD, PHE3, DLDD		Dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex)	238331			Dihydrolipoamide dehydrogenase deficiency, 246900 (3)	12(Dld)
7.566	8	28	01	7q31.32	SLC13A1, NAS1		Solute carrier family 13 (sodium/sulfate symporters), member 1	606193				
7.567	08	07	20	7q32.1	SMO, SMOH, CRJS, PHLS		Smoothened, frizzled class receptor	601500			Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3); Pallister-Hall-like syndrome, 241800 (3)	
7.568	01	23	19	7q33	BPGM, ECYT8		2,3-bisphosphoglycerate mutase	613896			Erythrocytosis, familial, 8, 222800 (3)	
7.569	1	30	18	7q31.1	BMT2, SAMTOR, C7orf60		Base methyltransferase of 25S rRNA 2, S. cerevisiae, homolog of	617855				
7.570	03	27	19	7q31.2	CAV1, BSCL3, CGL3, PPH3, LCCNS		Caveolin-1	601047		mutation identified in 1 CGL3 family	?Lipodystrophy, congenital generalized, type 3, 612526 (3); Pulmonary hypertension, primary, 3, 615343 (3); Lipodystrophy, familial partial, type 7, 606721 (3)	
7.571	3	29	99	7q31.2	CAV2		Caveolin-2	601048				6(Cav2)
7.572	2	1	11	7q31.1	DNAJB9, MDG1		DnaJ, E. coli, homolog of, subfamily B, member 9 (microvascular endothelial differentiation gene-1)	602634		previously assigned to chr.14 by FISH		
7.573	6	2	15	7q31.1	LAMB4		Laminin, beta-4	616380				
7.574	3	29	12	7q31.1-q31.2	MDFIC, HIC		MYOD family inhibitor domain-containing protein	614511				
7.575	11	7	01	7q31.2	ST7, TSG7, RAY1, FAM4A1		Suppressor of tumorigenicity 7 (breast)	600833				
7.576	3	29	10	7q31.31	TSPAN12, NET2, EVR5		Tetraspanin 12	613138			Exudative vitreoretinopathy 5, 613310 (3)	6(Tspan12)
7.577	1	20	09	7q31.1	THAP5		THAP domain-containing protein 5	612534				
7.578	1	29	01	7q31.1	ZNF277		Zinc finger protein-277	605465				
7.579	1	21	97	7q31.1	NRCAM		Neuronal cell adhesion molecule	601581				
7.580	4	23	13	7q31.1	LAMB1, LIS5		Laminin, beta-1	150240			Lissencephaly 5, 615191 (3)	1(Lamb1)
7.581	4	9	18	7q31.2	CFTR, ABCC7, CF, MRP7		Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7)	602421		distal and 5' to MET	Cystic fibrosis, 219700 (3); Congenital bilateral absence of vas deferens, 277180 (3); Sweat chloride elevation without CF (3); {Pancreatitis, hereditary}, 167800 (3); {Hypertrypsinemia, neonatal} (3); {Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)	6(Cftr)
7.582	7	11	01	7q31.2	TES		Testin	606085				6(Tes)
7.583	7	17	14	7q31.2	TFEC, TFECL		Transcription factor EC	604732				
7.584	2	19	97	7q31.2	CAPZA2, CAPPA2		Capping protein (actin filament) muscle Z-line, alpha 2	601571				6(Cappa2)
7.585	03	10	20	7q31.32	AASS		Alpha-aminoadipic semialdehyde synthase	605113			Hyperlysinemia, 238700 (3)	
7.586	1	30	07	7q31.31	ANKRD7		Ankyrin repeat domain-containing protein 7	610731				
7.587	5	12	99	7q32.1	ARF5		ADP-ribosylation factor 5	103188				
7.588	4	30	09	7q31.2	ASZ1, ALP1, ANKL1, GASZ		Ankyrin repeat, SAM, and basic leucine zipper domain-containing 1	605797				
7.589	3	24	06	7q31.32	CADPS2, KIAA1591		Calcium-dependent activator protein for secretion 2	609978				
7.590	5	28	13	7q31.31	FAM3C		Family with sequence similarity 3, member C	608618				
7.591	2	6	14	7q31.32	FEZF1, FEZ, ZNF312B, HH22		FEZ family zinc finger protein 1	613301			Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3)	
7.592	11	25	14	7q31.32	LMOD2, CLMOD		Leiomodin 2	608006				
7.593	6	22	14	7q32.1	FSCN3		Fascin actin-bundling protein 3, testicular	615800				
7.594	12	11	12	7q32.1	LEP, OB, LEPD		Leptin (murine obesity homolog)	164160		in mouse cen-Cola-2-Met-ob-Cpa-Tcrb-tel	Obesity, morbid, due to leptin deficiency, 614962 (3)	6(ob)
7.595	1	23	01	7q32.1	P100, SND1		EBNA-2 coactivator p100	602181				
7.596	7	13	18	7q31.32	PTPRZ1, PTP18		Protein-tyrosine phosphatase, receptor-type, zeta-1, polypeptide	176891				
7.597	2	17	09	7q31.3	STQTL2		Stature quantitative trait locus 2	606256		max lod at D7S195	{Stature QTL 2} (2)	
7.598	2	25	15	7q31.32	WASL, NWASP		Wiskott-Aldrich syndrome gene-like	605056				
7.599	7	19	12	7q31.31	WNT16		Wingless-type MMTV integration site family, member 16	606267				
7.600	3	19	14	7q31.31	LSM8		LSM8, S. cerevisiae, homolog of, U6 small nuclear RNA associated	607288				
7.601	3	31	11	7q32.1	IMPDH1, RP10, LCA11		Inosine-5'-monophosphate dehydrogenase, type I	146690		pseudogene on 16p13.13	Retinitis pigmentosa 10, 180105 (3); Leber congenital amaurosis 11, 613837 (3)	
7.602	8	30	10	7q32.1	OPN1SW, BCP, CBT		Blue cone pigment (opsin 1, short-wave-sensitive)	613522			Colorblindness, tritan, 190900 (3)	6(Bcp)
7.603	4	28	00	7q34	TAS2R3, T2R3		Taste receptor type 2, member 3	604868				
7.604	4	28	00	7q34	TAS2R4, T2R4		Taste receptor type 2, member 4	604869				6(T2R8)
7.605	1	31	01	7q34	TAS2R5, T2R5		Taste receptor type 2, member 5	605062				
7.606	6	4	98	7q31.33	GRM8		Glutamate receptor, metabotropic-8	601116				
7.607	9	24	15	7q31.33	POT1, CMM10, GLM9		Protection of telomeres 1	606478			{Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3); {Glioma susceptibility 9}, 616568 (3)	
7.608	10	6	09	7q32	BCC6		Basal cell carcinoma, susceptibility to, 6	613063		associated with rs157935	{Basal cell carcinoma, susceptibility to, 6} (2)	
7.609	2	9	12	7q32.2	CEP41, TSGA14, JBTS15		Centrosomal protein, 41kD	610523			Joubert syndrome 15, 614464 (3)	
7.610	5	26	13	7q32.2	COPG2IT1, CIT1		Coatomer protein complex, subunit gamma-2, intronic transcript 1	610581				
7.611	3	20	03	7q32.2	CPA4, CPA3		Carboxypeptidase A4	607635				
7.612	11	12	96	7q32.2	MEST, PEG1		Mesoderm specific transcript, mouse, homolog of	601029		imprinted maternally		6(Mest)
7.613	1	13	99	7q32.1	CALU		Calumenin	603420				7(Calu)
7.614	4	19	01	7q32	CATR1		CATR tumorigenic conversion 1	600676				
7.615	2	1	00	7q32.2	COPG2		Coatomer protein complex, subunit gamma-2	604355				
7.616	4	19	01	7q32.2	CPA2		Carboxypeptidase A2, pancreatic	600688				
7.617	06	23	20	7q32.1	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5		Filamin C (actin-binding protein-280)	102565			Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065 (3); Cardiomyopathy, familial hypertrophic, 26, 617047 (3); Cardiomyopathy, familial restrictive 5, 617047 (3)	6(Fln2)
7.618	9	24	08	7q32.1	IRF5, IBD14, SLEB10		Interferon regulatory factor 5	607218			{Inflammatory bowel disease 14}, 612245 (3); {Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)	
7.619	2	9	01	7q32.3	MKLN1		Muskelin 1	605623				6(Mkln1)
7.620	5	8	97	7q31.32	NDUFA5, UQOR13		NADH-ubiquinone oxidoreductase subunit A5	601677				
7.621	4	1	96	7q32.2	NRF1		Nuclear respiratory factor 1	600879		earlier location = 7q31		
7.622	8	5	15	7q32.1	PAX4, MODY9, KPD		Paired box homeotic gene-4	167413			Maturity-onset diabetes of the young, type IX, 612225 (3); Diabetes mellitus, type 2, 125853 (3); {Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3)	6(Pax4)
7.623	9	12	11	7q32	PBC4		Biliary cirrhosis, primary, 4	614220		associated with rs10488631	Biliary cirrhosis, primary, 4 (2)	
7.624	9	28	05	7q32	PPR3		Photoparoxysmal response 3	609573		max lod at D7S1804	Photoparoxysmal response 3 (2)	
7.625	4	19	01	7q32.2	UBE2H, UBCH2, UBC8		Ubiquitin-conjugating enzyme E2H (homologous to yeast UBC8)	601082				
7.626	1	23	09	7q33	AKR1D1, SRD5B1, CBAS2		Bile acid synthesis defect, congenital, 2	604741			Bile acid synthesis defect, congenital, 2, 235555 (3)	
7.627	11	4	98	7q32.3	PODXL, PCLP		Podocalyxin-like	602632				
7.628	4	19	11	7q32-q33	SCA32		Spinocerebellar ataxia 32	613909		between rs3847110 and rs2241728	Spinocerebellar ataxia 32 (2)	
7.629	4	24	08	7q34	MRPS33		Mitochondrial ribosomal protein S33	611993		4 pseudogenes		
7.630	8	14	15	7q33-q34	TRIM24, TIF1, TIF1A, PTC6		Tripartite motif-containing protein 24 (Transcriptional intermediary factor 1)	603406		fused with RET to form PTC6		
7.631	11	5	97	7q34-q35	EPHA1, EPHT1		eph tyrosine kinase 1 (erythropoietin-producing hepatoma amplified sequence; oncogene EPH; ephrin receptor EphA1)	179610				
7.632	7	13	89	7q34	PIP		Prolactin-inducible protein	176720				
7.633	6	11	91	7q32.2	CPA1		Carboxypeptidase A	114850		both CPA and TRY1 = serine proteases		6(Cpa)
7.634	8	26	16	7q32.1	AHCYL2		Adenosylhomocysteinase-like 2	616520				
7.635	4	23	09	7q32.1	GCC1, GCC88		GRIP and coiled-coil domains-containing protein 1	607418				
7.636	3	13	18	7q32.1	HILPDA, HIG2		Hypoxia-inducible lipid droplet-associated protein	617905				
7.637	2	25	15	7q32.1	LRRC4		Leucine-rich repeat-containing protein 4	610486				
7.638	06	03	20	7q32.1	METTL2B, METL		Methyltransferase-like 2B	607846				
7.639	2	9	15	7q32.1	RBM28, ANES		RNA-binding motif protein 28	612074		mutation identified in 1 ANES family	?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)	
7.640	3	23	18	7q32.1	STRIP2, FAR11B, FAM40B		Striatin-interacting protein 2	617919				
7.641	09	27	18	7q32.1	TNPO3, TRNSR, LGMDD2		Transportin 3	610032			Muscular dystrophy, limb-girdle, autosomal dominant 2, 608423 (3)	
7.642	3	20	14	7q32.1	TSPAN33, PEN		Tetraspanin 33	610120				
7.643	4	8	13	7q32.2	KLHDC10, SLIM		KELCH domain-containing protein 10	615152				
7.644	6	26	11	7q32.2	LKF14, BTEB5		Kruppel-like factor 14	609393				6(Klf14)
7.645	10	12	09	7q32.2	MIR96, MIRN96, DFNA50		Micro RNA 96	611606			Deafness, autosomal dominant 50, 613074 (3)	6(Mirn96)
7.646	3	23	09	7q32.2	MIR182, MIRN182		Micro RNA 182	611607				6(Mirn182)
7.647	3	23	09	7q32.2	MIR183, MIRN183		Micro RNA 183	611608				
7.648	9	12	11	7q32.2-q36.1	HYSP3		Hypospadias 3, autosomal	146450		between D7S2519 and D7S2442.	Hypospadias 3, autosomal (2)	
7.649	7	1	05	7q32.1	KCP		Kielin/chordin-like protein	609344				6(Kcp)
7.650	3	23	09	7q32.3	MIR29A, MIRN29A		Micro RNA 29A	610782				
7.651	10	08	08	7q32.3	BMIQ1		Body mass index quantitative trait locus 1	606641		max lod at D7S1804	[Body mass index QTL1] (2)	
7.652	12	11	18	7q32.3	LINC-PINT, PINT		Long intergenic noncoding RNA, p53-induced transcript	618212				6(Linc-Pint)
7.653	3	23	09	7q32.3	MIR29B1, MIRN29B1		Micro RNA 29B1	610783				
7.654	9	30	09	7q32.3	PLXNA4		Plexin A4	604280				
7.655	2	2	01	7q33	DGKI		Diacylglycerol kinase, iota, 130-kD	604072				
7.656	2	21	11	7q32-q33	CHCHD3		Coiled-coil-helix-coiled-coil-helix domain-containing protein 3	613748				
7.657	2	9	17	7q33	AGBL3, CCP3		ATP/GTP-binding protein-like 3	617346				
7.658	5	29	12	7q33	AKR1B10, ARL1		Aldo-keto reductase family 1, member B10	604707				
7.659	4	30	15	7q33	AKR1B15, AKR1B10L, AKR1R1B7		Aldo-keto reductase family 1, member B15	616336				
7.660	1	5	93	7q33	CALD1, CDM		Caldesmon-1	114213				
7.661	3	24	06	7q34	CLEC5A, CLECSF5, MDL1		C-type lectin domain family 5, member A	604987				
7.662	9	16	12	7q33	CREB3L2, BBF2H7		cAMP response element-binding protein 3-like 2	608834				
7.663	08	10	18	7q33	CYREN, C7orf49, MRI		Cell cycle regulator of nonhomologous end joining	616980				
7.664	9	11	12	7q34	KEL		Kell blood group	613883			[Blood group, Kell], 110900 (3)	
7.665	8	26	15	7q33	LRGUK		Leucine-rich repeats- and guanylate kinase domain-containing protein	616478				
7.666	4	23	09	7q33	LUZP6, MPD6		Leucine zipper protein 6	611050				
7.667	6	2	16	7q33	MIR490		Micro RNA 490	616972				
7.668	4	7	16	7q33	NUP205, C7orf14, KIAA0225, NPHS13		Nucleoporin, 205kD	614352		mutation identified in 1 NPHS13 family	?Nephrotic syndrome, type 13, 616893 (3)	
7.669	9	27	94	7q33	PTN, NEGF1		Pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1)	162095				6(Ptn)
7.670	12	14	99	7q33	SLC13A4, SUT1		Solute carrier family 13 (sodium/sulfate symporters), member 4 (sulfate transporter 1)	604309				
7.671	4	18	07	7q33	SLC35B4		Solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4	610923				
7.672	01	31	20	7q33	STMP1, C7orf73, MM47		Short transmembrane mitochondrial protein 1	618755				
7.673	5	23	16	7q33	WDR91, SORF1		WD repeat-containing protein 91	616303				
7.674	08	28	20	7q34	ATP6V0A4, ATP6N1B, VPP2, RTA1C, DRTA3		ATPase, H+ transporting, lysosomal, V0 subunit A, isoform 4	605239			Distal renal tubular acidosis 3, with or without sensorineural hearing loss, 602722 (3)	
7.675	4	23	02	7q34	HIPK2		Homeodomain-interacting protein kinase 2	606868				
7.676	11	15	18	7q34	TRPV6, ECAC2, CAT1, CATL, HRPTTN		Transient receptor potential cation channel, subfamily V, member 6	606680			Hyperparathyroidism, transient neonatal, 618188 (3)	
7.677	1	23	01	7q35	ARHGEF5, TIM		Rho guanine nucleotide exchange factor-5 (oncogene TIM)	600888				
7.678	7	10	98	7q34	EPHB6, HEP		Ephrin receptor EPHB6	602757				
7.679	1	10	02	7q33	MTPN		Myotrophin	606484				
7.680	7	23	13	7q34	AGK, MULK, MTDPS10, CATC5, CTRCT38		Acylglycerol kinase	610345			Sengers syndrome, 212350 (3); Cataract 38, autosomal recessive, 614691 (3)	
7.681	03	10	20	7q34	BDPLT14		Bleeding disorder, platelet-type, 14	614158			Bleeding disorder, platelet-type, 14 (2)	
7.682	01	29	20	7q34	BRAF, NS7		B-Raf proto-oncogene, serine/threonine kinase	164757		pseudogene BRAF2 on Xq13 or 7q	Melanoma, malignant, somatic (3); Colorectal cancer, somatic (3); Adenocarcinoma of lung, somatic, 211980 (3); Nonsmall cell lung cancer, somatic (3); Cardiofaciocutaneous syndrome, 115150 (3); Noonan syndrome 7, 613706 (3); LEOPARD syndrome 3, 613707 (3)	10(Braf)
7.683	10	2	12	7q34	GSTK1		Glutathione S-transferase, kappa-1	602321				
7.684	10	03	19	7q34	KIAA1549, RP86		KIAA1549 gene	613344			Retinitis pigmentosa 86, 618613 (3)	
7.685	07	10	20	7q34	LLCFC1, C7orf34, SOF1		LLLL motif- and CFNLAS motif-containing protein 1	618946				
7.686	11	20	20	7q34	LUC7L2		LUC7-like 2 pre-mRNA splicing factor	613056				6(Luc7l2)
7.687	4	1	03	7q34	MGAM, MGA		Maltase-glucoamylase	154360		similar to EST GS1365		
7.688	11	27	18	7q34	NDUFB2		NADH-ubiquinone oxidoreductase subunit B2	603838				
7.689	12	17	08	7q34	PARP12, ZC3HDC1, FLJ22693		Poly(ADP-ribose) polymerase family, member 12	612481				
7.690	09	08	20	7q34	SSBP1, SSBP, OPA13		Single-stranded DNA-binding protein 1	600439			Optic atrophy 13 with retinal and foveal abnormalities, 165510 (3)	
7.691	1	2	08	7q34	SVOPL		SV2-related protein-like	611700				6(Svopl)
7.692	03	10	20	7q34	TBXAS1, GHOSAL, CYP5		Thromboxane A synthase 1, platelet	274180			Ghosal hematodiaphyseal syndrome, 231095 (3)	6(Tbxas1)
7.693	5	10	18	7q34	TAS2R38, T2R61, PTC, THIOT		Taste receptor, type 2, member 38	607751			[Phenylthiocarbamide tasting], 171200 (3)	
7.694	6	27	11	7q34	TAS2R40, T2R40		Taste receptor, type 2, member 40	613964				
7.695	8	26	15	7q34	TMEM139		Transmembrane protein 139	616524				
7.696	2	13	12	7q35	TPK1, THMD5		Thiamine pyrophosphokinase	606370			Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3)	
7.697	10	15	13	7q34	TRBC1		T-cell receptor beta chain constant region 1	186930				6(Tcrb)
7.698	10	15	13	7q34	TRBC2		T-cell receptor beta chain constant region 2	615445				
7.699	10	15	13	7q34	TRBV@		T-cell receptor beta chain variable gene cluster	615446				
7.700	10	15	13	7q34	TRBJ@		T-cell receptor beta chain joining gene cluster	615449				
7.701	10	15	13	7q34	TRBD1		T-cell receptor beta chain diversity gene 1	615447				
7.702	10	15	13	7q34	TRBD2		T-cell receptor beta chain diversity gene 2	615448				
7.703	4	27	17	7q34	TTC26, IFT56		Tetratricopeptide repeat domain-containing protein 26	617453				
7.704	3	31	11	7q34	UBN2		Ubinuclein 2	613841				
7.705	6	10	18	7q34	WEE2, WEE1B, OOMD5		Wee1, S. pombe, homolog of, 2	614084			Oocyte maturation defect 5, 617996 (3)	
7.706	11	30	06	7q34	ZC3HAV1, ZAP, FLJ13288, FLB6421		Zinc finger CCCH domain-containing antiviral protein 1	607312				6(Zap)
7.707	9	30	98	7q34	ZYX		Zyxin	602002				
7.708	10	16	12	7q34-q36	DHMN1		Neuronopathy, distal hereditary motor, type I	182960		between D7S2513 and D7S637	Neuronopathy, distal hereditary motor, type I (2)	
7.709	10	15	98	7q34-q36	DFNB13		Deafness, autosomal recessive 13	603098			Deafness, autosomal recessive 13 (2)	
7.710	3	12	01	7q34-q36	OTSC2		Otosclerosis 2	605727			Otosclerosis 2 (2)	
7.711	1	22	08	7q36.1	ACCN3, ASIC3, TNAC1, DRASIC		Cation channel, amiloride-sensitive, neuronal 3	611741				
7.712	12	2	99	7q33	AKR1B1, ALDR1		Aldo-keto reductase family 1, member B1	103880				
7.713	8	30	95	7q34	CLCN1		Chloride channel-1, skeletal muscle	118425			Myotonia congenita, recessive, 255700 (3); Myotonia congenita, dominant, 160800 (3); Myotonia levior, recessive (3)	6(adr, Clc1)
7.714	8	19	98	7q34	CASP2, NEDD2, ICH1		Caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2)	600639				
7.715	5	20	13	7q36.1	EZH2, EZH1, WVS		Enhancer of zeste, Drosophila, homolog of, 2	601573		pseudogene on 21q22	Weaver syndrome, 277590 (3)	6(Ezh2)
7.716	10	6	08	7q36.1	FASTK, FAST		Fas-activated serine/threonine kinase	606965				
7.717	09	11	19	7q35	NOBOX, POF5		NOBOX oogenesis homeobox	610934			Premature ovarian failure 5, 611548 (3)	6(Nobox)
7.718	8	8	13	7q35	OR2F1, OLF3		Olfactory receptor, family 2, subfamily F, member 1	608497				
7.719	03	10	20	7q34	PRSS1, TRY1		Protease, serine, 1 (trypsin 1)	276000		8 trypsinogen genes embedded in TCRB locus	Pancreatitis, hereditary, 167800 (3)	6(Try1)
7.720	5	31	06	7q34	PRSS2, TRY2		Protease, serine, 2 (trypsin 2)	601564			{Pancreatitis, chronic, protection against}, 167800 (3)	
7.721	6	26	11	7q35	TAS2R41, T2R59		Taste receptor, type 2, member 41	613965				
7.722	6	26	11	7q35	TAS2R60, T2R60		Taste receptor, type 2, member 60	613968				
7.723	1	4	16	7q35	TCAF1, FAM115A, KIAA0738		TRPM8 channel-associated factor 1	616251				
7.724	1	4	16	7q35	TCAF2, FAM115C, FAM139A		TRPM8 channel-associated factor 2	616252				
7.725	5	7	03	7q34	TRPV5, ECAC1, CAT2		Transient receptor potential cation channel, subfamily V, member 5	606679				
7.726	1	29	01	7q36.1	ABCB8, MABC1		ATP-binding cassette, subfamily B, member 8	605464				
7.727	2	19	10	7q35-q36	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1		Contactin-associated protein-like 2	604569			Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism susceptibility 15}, 612100 (3); Pitt-Hopkins like syndrome 1, 610042 (3)	
7.728	8	11	91	7q33	CHRM2		Cholinergic receptor, muscarinic, 2	118493				
7.729	11	3	98	7q35-q36	GPDS1, PDS1		Glaucoma-related pigment dispersion syndrome-1	600510			Pigment dispersion syndrome (2)	
7.730	1	13	11	7q36.1	KCNH2, LQT2, HERG, SQT1		Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene)	152427			Long QT syndrome 2, 613688 (3); {Long QT syndrome 2, acquired, susceptibility to}, 613688 (3); Short QT syndrome 1, 609620 (3)	
7.731	11	28	94	7q36.1	SLC4A2, AE2, EPB3L1		Solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1)	109280				5(Ae2)
7.732	1	5	09	7q35-q36	SLI4		Specific language impairment 4	612514		associated with rs1723629	{Specific language impairment 4} (2)	
7.733	6	16	99	7q36.1	SMARCD3, BAF60C		SWI/SNF related, matrix-associated, actin-dependent regulator of chromatin, subfamily D, member 3	601737				
7.734	12	24	08	7q36.1	ABCF2, HUSSY18		ATP-binding cassette, subfamily F, member 2	612510				
7.735	6	14	01	7q36	ACRPS		Acropectoral syndrome	605967			Acropectoral syndrome (2)	
7.736	10	7	05	7q36	AD10		Alzheimer disease-10	609636		max lod with D7S798	Alzheimer disease-10 (2)	
7.737	6	12	12	7q36.1	ATP6V0E2		ATPase, H+ transporting, V0 subunit e2	611019				
7.738	11	19	13	7q36	AUTS10		Autism, susceptibility to, 10	611016		max lod at D7S483	{Autism, susceptibility to, 10} (2)	
7.739	2	16	04	7q36.3	BLACE		B-cell acute lymphoblastic leukemia-expressed gene	608450				
7.740	5	24	13	7q36.3	C7orf13		Chromosome 7 open reading frame 13	610242		overlaps RNF32 on the opposite strand		
7.741	5	4	15	7q36.1	CDK5, LIS7		Cyclin-dependent kinase 5	123831		mutation identified in 1 LIS7 family	?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3)	5(cdk5)
7.742	11	19	13	7q36.3	EN2		Engrailed-2	131310				5(En2)
7.743	6	16	99	7q36.1	GBX1		Gastrulation brain homeobox 1	603354				5(Gbx1)
7.744	11	5	97	7q36.3	INSIG1		Insulin-induced gene 1	602055				
7.745	11	14	17	7q36.1	KMT2C, MLL3, KIAA1506, KLEFS2		Lysine (K)-specific methyltransferase 2C	606833			Kleefstra syndrome 2, 617768 (3)	
7.746	11	6	14	7q36.3	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS		Limb region 1, mouse, homolog of	605522			Acheiropody, 200500 (3); Polydactyly, preaxial type II, 174500 (3); Triphalangeal thumb, type I, 174500 (3); Triphalangeal thumb-polysyndactyly syndrome, 174500 (3); Syndactyly, type IV, 186200 (3); Hypoplastic or aplastic tibia with polydactyly, 188740 (3); Laurin-Sandrow syndrome, 135750 (3)	5(Lmbr1)
7.747	2	21	10	7q36.3	MNX1, HLXB9, HOXHB9, SCRA1		Motor neuron and pancreas homeobox 1	142994			Currarino syndrome, 176450 (3)	
7.748	5	26	13	7q36.3	NOM1, C7orf3		Nucleolar protein with MIF4G domain 1	611269				5(Nom1)
7.749	7	8	10	7q36.1	NOS3		Nitric oxide synthase 3, endothelial cell	163729			{Coronary artery spasm 1, susceptibility to} (3); {Alzheimer disease, late-onset, susceptibility to}, 104300 (3); {Hypertension, susceptibility to}, 145500 (3); {Hypertension, pregnancy-induced}, 189800 (3); {Placental abruption} (3); {Ischemic stroke, susceptibility to}, 601367 (3)	5(Nos3)
7.750	10	11	05	7q36.2	PAXIP1, PAXIP1L, PTIP		PAX transcription activation domain-interacting protein 1	608254				
7.751	1	22	09	7q36.1	PRKAG2, WPWS, CMH6		Protein kinase, AMP-activated, noncatalytic, gamma-2	602743			Wolff-Parkinson-White syndrome, 194200 (3); Cardiomyopathy, hypertrophic 6, 600858 (3); Glycogen storage disease of heart, lethal congenital, 261740 (3)	
7.752	3	23	06	7q36.3	PTPRN2, IAR, ICAAR		Protein-tyrosine phosphatase, receptor-type, N, polypeptide 2	601698				
7.753	9	10	09	7q36.1	RHEB, RHEB2		Ras homolog enriched in brain	601293				
7.754	5	24	13	7q36.3	RNF32		RING finger protein 32	610241				
7.755	7	12	02	7q36.1	RNY1, Y1		RNA, Y1 small cytoplasmic	601821				
7.756	7	12	02	7q36.1	RNY3, Y3		RNA, Y3 small cytoplasmic	601822				
7.757	7	12	02	7q36.1	RNY4, Y4		RNA, Y4 small cytoplasmic	601823				
7.758	7	12	02	7q36.1	RNY5, Y5		RNA, Y5 small cytoplasmic	601824				
7.759	2	7	12	7q36.3	SHH, HPE3, HLP3, SMMCI, MCOPCB5		Sonic hedgehog signaling molecule	600725		separate from TPT1	Holoprosencephaly 3, 142945 (3); Single median maxillary central incisor, 147250 (3); Microphthalmia with coloboma 5, 611638 (3); Schizencephaly, 269160 (3)	
7.760	2	12	16	7q36.1	AGAP3, CENTG3, CRAG		ARF GTPase-activating protein with GTPase domain, ankyrin repeat, and pleckstrin homology domain 3	616813				
7.761	8	6	13	7q36.1	ASB10, GLC1F		Ankyrin repeat- and SOCS box-containing protein 10	615054			Glaucoma 1, open angle, F, 603383 (3)	
7.762	09	19	19	7q36.1	ATG9B, NOS3AS, APG9L2, SONE		Autophagy related 9B	612205				
7.763	2	1	11	7q36.1	CHPF2, KIAA1402, CSGlcAT		Chondroitin polymerizing factor 2	608037				
7.764	6	13	12	7q36.1	CUL1		Cullin 1	603134				
7.765	4	6	13	7q36.1	GALNT11, GALNACT11		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11	615130				5(Galnt11)
7.766	4	6	13	7q36.1	GALNTL5, GALNACT19		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 5	615133				
7.767	7	23	96	7q36.2	HTR5A		5-hydroxytryptamine (serotonin) receptor-5A	601305				5(Htr5a)
7.768	1	27	11	7q36.1	GIMAP1, IMAP1		GTPase, IMAP family, member 1	608084				
7.769	1	27	11	7q36.1	GIMAP2, IMAP2		GTPase, IMAP family, member 2	608085				
7.770	1	27	11	7q36.1	GIMAP4, IMAP4, IAN1		GTPase, IMAP family, member 4	608087				
7.771	1	27	11	7q36.1	GIMAP5, IAN4L1, IMAP3		GTPase, IMAP family, member 5	608086				6
7.772	6	2	16	7q36.1	GIMAP6		GTPase, IMAP family, member 6	616960				
7.773	6	2	16	7q36.1	GIMAP7		GTPase IMAP family, member 7	616961				
7.774	6	2	16	7q36.1	GIMAP8		GTPase, IMAP family, member 8	616962				
7.775	4	17	13	7q36.1	LOC100134040		LOC100134040 gene	615171				
7.776	8	19	13	7q36.1	LR8		LR8 protein	610385				
7.777	5	23	13	7q36.1	MIR671		Micro RNA 671	615245				
7.778	6	24	13	7q36.1	NUB1		Negative regulator of ubiquitin-like proteins 1	607981				
7.779	5	11	09	7q36.1	RARRES2, TIG2		Retinoic acid receptor responder 2	601973				
7.780	10	02	20	7q36.1	REPIN1, RIP60, AP4		Replication initiator 1	619039				
7.781	10	12	20	7q36.1	SSPOP, SSPO		SCO-spondin, pseudogene	617356				6(Sspo)
7.782	8	19	13	7q36.1	TEM176A, HCA112, GS188		Transmembrane protein 176A	610334				6(Gs188)
7.783	9	2	12	7q36.1	TMUB1, DULP, SB144, C7orf21		Transmembrane and ubiquitin-like domain-containing protein 1	614792				
7.784	12	15	16	7q36.1	XRCC2, FANCU		X-ray repair, complementing defective, repair in Chinese hamster cells-2	600375		mutation identified in 1 FANCU patient	?Fanconi anemia, complementation group U, 617247 (3)	
7.785	5	31	13	7q36.1	ZBED6CL, C7orf29		ZBED6 C terminus-like protein	615252				
7.786	3	17	06	7q36.1	ZNF212, ZNFC150, ZNF182		Zinc finger protein 212	602386				
7.787	7	20	12	7q36.1	ZNF282, HUB1		Zinc finger protein 282	603397				
7.788	09	18	19	7q36.1	ZNF398, ZER6		Zinc finger protein 398	618593				
7.789	9	8	11	7q36.1	ZNF467, EZI, ZFP467		Zinc finger protein 467	614040				
7.790	4	19	11	7q36.1	ZNF746, PARIS		Zinc finger protein 746	613914				
7.791	4	14	15	7q36.2	DPP6, VF2, MRD33		Dipeptidylpeptidase VI	126141			{Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3); Mental retardation, autosomal dominant 33, 616311 (3)	5(Dppx, Dpp6)
7.792	06	07	19	7q36.3	NCAPG2, CAPG2, MTB, 3KS		Non-SMC condensin II complex subunit G2	608532			Khan-Khan-Katsanis syndrome, 618460 (3)	
7.793	12	22	08	7q36.3	CNPY1		Canopy 1, zebrafish, homolog of	612493				
7.794	09	27	18	7q36.3	DNAJB6, MRJ, DJ4, LGMDD1		DNAJ/HSP40 homolog, subfamily B, member 6	611332			Muscular dystrophy, limb-girdle, autosomal dominant 1, 603511 (3)	
7.795	12	11	15	7q36.3	ESYT2, FAM62B		Extended synaptotagmin-like protein 2	616691				
7.796	11	22	11	7q36.3	SCZD16, C16DUPq36.3, DUP7q36.3		Chromosome 7q36.3 duplication syndrome, 362kb	613959		362kb duplication that includes VIPR2	Schizophrenia 16 (4)	
7.797	1	30	12	7q36.3	UBE3C, HECTH2, KIAA0010, KIAA10		Ubiquitin protein ligase E3C	614454				
7.798	11	22	11	7q36.3	VIPR2		Vasoactive intestinal peptide receptor 2	601970				12(Vipr2)
7.799	2	11	14	7q36.3	WDR60, SRTD8, SRPS6		WD repeat containing protein 60	615462			Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3)	
7.800	11	19	11	Chr.7	AIS2, VAMAS3		Autoimmune disease, susceptibility to, 2	608391			{Autoimmune disease, susceptibility to, 2} (2)	
7.801	10	23	87	Chr.7	NHCP2		Nonhistone chromosomal protein-2	118880				
8.1	9	9	08	8p23.3	FBXO25, FBX25		F-box only protein 25	609098				8(Fbxo25)
8.2	02	27	20	8p23.3	KBTBD11, KIAA0711		Kelch repeat- and BTB/POZ domain-containing protein 11	618794				
8.3	6	16	99	8p23.3	MYOM2		Myomesin 2	603509				
8.4	7	20	01	8p23.3-p22	DBA2		Diamond-Blackfan anemia 2	606129			Diamond-Blackfan anemia 2 (2)	
8.5	9	2	12	8p23.1	AGPAT5		1-acylglycerol-3-phosphate O-acyltransferase 5	614796				
8.6	5	26	13	8p23.1	CLDN23		Claudin 23	609203				
8.7	9	9	08	8p23.1	DEFA1, DEF1, MRS		Defensin, alpha-1, myeloid-related sequence	125220				8(Defcr)
8.8	9	9	08	8p23.1	DEFA5, DEF5		Defensin, alpha-5, Paneth cell-specific	600472				
8.9	2	11	96	8p23.1	DEFA6, DEF6		Defensin, alpha-6, Paneth cell-specific	600471				
8.10	9	9	08	8p23.1	DEFB1		Defensin, beta-1	602056				8(Defb1)
8.11	3	9	12	8p23.1	DEFB4A, DEFB4, DEFB2		Defensin, beta-4a (formerly defensin, beta-2)	602215				
8.12	4	18	07	8p23.1	DEFB103A, DEFB3, HBD3, HBP3		Defensin, beta 103A	606611				
8.13	12	29	05	8p23.1	DIH2		Hernia, congenital diaphragmatic 2	222400			Hernia, congenital diaphragmatic 2 (2)	
8.14	12	18	14	8p23.1	FAM86B1		Family with sequence similarity 86, member B1	616122				
8.15	12	18	14	8p23.1	FAM86B2		Family with sequence similarity 86, member B2	616123				
8.16	09	29	20	8p23.1	FAM90A3P, FAM90A3		Family with sequence similarity 90, member A3, pseudogene	613042		copy 2		
8.17	09	29	20	8p23.1	FAM90A5P, FAM90A5		Family with sequence similarity 90, member A5, pseudogene	613043		copy 5		
8.18	09	29	20	8p23.1	FAM90A7P, FAM90A7		Family with sequence similarity 90, member A7, pseudogene	613044		copy 8		
8.19	09	29	20	8p23.1	FAM90A8P, FAM90A8		Family with sequence similarity 90, member A8, pseudogene	613045		copy 15		
8.20	09	29	20	8p23.1	FAM90A9P, FAM90A9		Family with sequence similarity 90, member A9, pseudogene	613046		copy 18		
8.21	09	29	20	8p23.1	FAM90A10P, FAM90A10		Family with sequence similarity 90, member A10, pseudogene	613047		copy 19		
8.22	09	29	20	8p23.1	FAM90A12P, FAM90A12		Family with sequence similarity 90, member A12, pseudogene	613048		copy 22		
8.23	09	29	20	8p23.1	FAM90A13P, FAM90A13		Family with sequence similarity 90, member A13, pseudogene	613049		copy 4		
8.24	09	29	20	8p23.1	FAM90A14P, FAM90A14		Family with sequence similarity 90, member A14, pseudogene	613050		copy 12		
8.25	09	29	20	8p23.1	FAM90A15P, FAM90A15		Family with sequence similarity 90, member A15, pseudogene	613051		copy 1		
8.26	09	29	20	8p23.1	FAM90A18P, FAM90A18		Family with sequence similarity 90, member A18, pseudogene	613052		copy 13		
8.27	09	29	20	8p23.1	FAM90A19P, FAM90A19		Family with sequence similarity 90, member A19, pseudogene	613053		copy 17		
8.28	09	29	20	8p23.1	FAM90A20P, FAM90A20		Family with sequence similarity 90, member A20, pseudogene	613054		copy 6		
8.29	11	26	01	8p23.1	MFHAS1, MASL1		Malignant fibrous histiocytoma-amplified sequences with leucine-rich tandem repeats-1	605352			Malignant fibrous histiocytoma (2)	
8.30	3	23	09	8p23.1	MIR124-1, MIR124A		Micro RNA 124-1	609327				
8.31	9	26	17	8p23.1	MSRA		Peptide methionine sulfoxide reductase	601250				14(Msra)
8.32	6	6	17	8p23.1	NEIL2, NEI2		Endonuclease VIII-like 2	608933				
8.33	2	9	17	8p23.1	PRAG1, PRAGMIN, NACK		PEAK1-related kinase-activating pseudokinase 1	617344				
8.34	4	8	13	8p23.1	PRSS55, TSP1		Protease, serine, 55	615144				
8.35	9	24	08	8p23.1	SLEB12		Systemic lupus erythematosus, susceptibility to, 12	612254		associated with rs13277113	{Systemic lupus erythematosus, susceptibility to, 12} (2)	
8.36	3	20	14	8p23.1	USP17L2, DUB3		Ubiquitin specific peptidase 17-like family member 2	610186				
8.37	11	20	95	8p22	NAT1, AAC1		Arylamine N-acetyltransferase-1	108345				8(Nat1)
8.38	8	29	08	8p22	NAT2, AAC2		Arylamine N-acetyltransferase-2	612182		acetylation polymorphism	[Acetylation, slow], 243400 (3)	8(Nat2)
8.39	10	25	18	8p23.1	FDFT1, DGPT, SQSD		Farnesyl-diphosphate farnesyltransferase 1 (squalene synthase)	184420			Squalene synthase deficiency, 618156 (3)	
8.40	9	11	14	8p23.1	GATA4, ASD2, VSD1, TACHD, TOF		GATA-binding protein-4	600576		mutations identified in 1 TACHD family	Atrial septal defect 2, 607941 (3); Ventricular septal defect 1, 614429 (3); Atrioventricular septal defect 4, 614430 (3); ?Testicular anomalies with or without congenital heart disease, 615542 (3); Tetralogy of Fallot, 187500 (3)	14(Gata4)
8.41	8	20	02	8p23.1	ANGPT2, ANG2		Angiopoietin 2	601922		close to MCPH1		8(Angpt2)
8.42	9	17	14	8p23.3	ARHGEF10, KIAA0294, SNCV		Rho guanine nucleotide exchange factor 10	608136		mutation identified in 1 SNCV family	?Slowed nerve conduction velocity, AD, 608236 (3)	
8.43	08	11	20	8p23.3	CLN8, EPMR		CLN8 transmembrane ER and ERGIC protein	607837			Ceroid lipofuscinosis, neuronal, 8, 600143 (3); Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)	8(mnd)
8.44	1	27	04	8p23.2	CSMD1, KIAA1890		Cub and Sushi multiple domains 1	608397				
8.45	10	6	09	8p23.1	DEFA4, DEF4, HP4		Defensin, alpha-4, corticostatin	601157				
8.46	5	13	11	8p23.1	MCPH1		Microcephalin	607117		genetic heterogeneity	Microcephaly 1, primary, autosomal recessive, 251200 (3)	8(Mcph1)
8.47	4	13	05	8p23	MYP10		Myopia 10	609259			Myopia 10 (2)	
8.48	12	27	01	8p23.1	PINX1		PIN2-interacting protein 1	606505				
8.49	5	26	13	8p23.1	PPP1R3B, GL		Protein phosphatase 1, regulatory subunit 3B	610541				
8.50	03	26	20	8p23.1	RP1L1, OCMD, RP88		RP1-like protein 1	608581			Occult macular dystrophy, 613587 (3); Retinitis pigmentosa 88, 618826 (3)	14(Rp1l1)
8.51	10	15	20	8p23.3	TDRP		Testis development-related protein	619049				
8.52	3	16	10	8p23	WS2C		Waardenburg syndrome, type 2C	606662			Waardenburg syndrome, type 2C (2)	
8.53	02	14	20	8p23.1	BLK, MODY11		BLK protooncogene, SRC family tyrosinase kinase	191305			Maturity-onset diabetes of the young, type 11, 613375 (3)	14(Blk)
8.54	8	29	08	8p23.1	FAM167A, C8orf13		Family with sequence similarity 167, member A	610085				
8.55	9	5	02	8p23.1	MTMR9, MTMR8		Myotubularin-related protein 9	606260				
8.56	12	27	01	8p23.1	SPAG11, HE2, EP2		Sperm-associated antigen 11	606560				
8.57	4	17	13	8p23-p22	TDH		L-threonine dehydrogenase, pseudogene	615174				
8.58	1	13	99	8p21.3	EGR3		Early growth response 3	602419				
8.59	9	11	12	8p23-p21	GEFSP6		Generalized epilepsy with febrile seizures plus, type 6	612279		between D8S1706 and D8S549	Epilepsy, generalized, with febrile seizures plus, type 6 (2)	
8.60	12	27	19	8p22	VPS37A, HCRP1, SPG53		VPS37A subunit of ESCRIT-I	609927			Spastic paraplegia 53, autosomal recessive, 614898 (3)	
8.61	10	18	11	8p22	ANIB11		Aneurysm, intracranial berry, 11	614252		max lod at D8S552	Aneurysm, intracranial berry, 11 (2)	
8.62	6	9	08	8p22	CHDS9		Coronary heart disease, susceptibility to, 9	612030		max lod at D8S1106	{Coronary heart disease, susceptibility to, 9} (2)	
8.63	09	06	18	8p23.1	CTSB, CPSB, RECEUP		Cathepsin B (regulatory element, cis-acting, enhancer upstream of CTSB, included)	116810		KWE due to duplication upstream of CTSB that disrupts a cis-acting regulatory element	Keratolytic winter erythema, 148370 (4)	8(Ctsb)
8.64	10	7	09	8p22	FGL1, HFREP1		Fibrinogen-like 1	605776				
8.65	2	25	14	8p22	KIAA1456, TRM9L		KIAA1456 gene	615666				
8.66	05	31	19	8p21.3	LPL, LIPD, HDLCQ11		Lipoprotein lipase	609708			Lipoprotein lipase deficiency, 238600 (3); Combined hyperlipidemia, familial, 144250 (3); [High density lipoprotein cholesterol level QTL 11], 238600 (3)	8(Lpl)
8.67	02	12	19	8p21.3	LZTS1, F37, FEZ1		Leucine zipper, putative tumor suppressor 1	606551			Esophageal squamous cell carcinoma, somatic, 133239 (3)	
8.68	1	14	14	8p22	MICU3, EFHA2		Mitochondrial calcium uptake protein 3	610633				
8.69	3	27	18	8p22	MSR1, SCARA1, SRA		Macrophage scavenger receptor	153622		~11cM distal to LPL	Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	
8.70	6	16	99	8p22	MTMR7		Myotubularin-related protein 7	603562				
8.71	6	19	01	8q22.2	POLR2K, RPB12		Polymerase II, RNA, subunit K	606033				
8.72	1	30	12	8p22	PSD3, HCA67, EFA6R		Pleckstrin and Sec7 domains-containing protein 3	614440				
8.73	11	11	14	8p22	SGCZ, ZSG1		Sarcoglycan, zeta	608113				
8.74	12	17	12	8p21.3	SH2D4A, SH2A, PPP1R38		SH2 domain-containing protein 4A	614968				
8.75	3	2	98	8p22	SLC7A2, ATRC2, HCAT2		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2	601872				
8.76	8	29	08	8p23.1	SOX7		SRY-box 7	612202				14(Sox7)
8.77	11	18	11	8p22	TUSC3, M33, D8S1992, MRT7, MRT22		Tumor suppressor candidate 3	601385			Mental retardation, autosomal recessive 7, 611093 (3)	
8.78	10	11	19	8p22	ZDHHC2, DHHC2, ZNF372, REAM		Zinc finger DHHC-type palmitoyltransferase 2	618621				
8.79	7	20	12	8p22	ASAH1, AC, SMAPME		N-acylsphingosine amidohydrolase (acid ceramidase) 1	613468			Farber lipogranulomatosis, 228000 (3); Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3)	
8.80	9	9	08	8p22	CNOT7, CAF1		CCR4-NOT transcription complex, subunit 7	604913				
8.81	6	11	09	8p22-p21.3	DFNB71		Deafness, autosomal recessive 71	612789		max lod at D8S261	Deafness, autosomal recessive 71 (2)	
8.82	11	26	19	8p22	DLC1		DLC1 Rho GTPase activating protein	604258			Colorectal cancer, somatic, 114500 (3)	
8.83	4	10	14	8p22	FGF20, RHDA2		Fibroblast growth factor-20	605558		mutation identified in 1 RHDA2 family	?Renal hypodysplasia/aplasia 2, 615721 (3)	
8.84	8	14	15	8p22	PCM1, PTC4		Pericentriolar material 1	600299		fused with RET to form PTC4		
8.85	2	19	13	8p22	PDGFRL, PDGRL, PRLTS		Platelet-derived growth factor receptor-like	604584			Hepatocellular cancer, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3)	
8.86	11	16	05	8p21.3	TNFRSF10B, DR5, TRAILR2		Tumor necrosis factor receptor superfamily, member 10B	603612			Squamous cell carcinoma, head and neck, 275355 (3)	
8.87	8	17	99	8p21.3	TNFRSF10C, DCR1, TRAILR3, TRID		Tumor necrosis factor receptor superfamily, member 10C	603613				
8.88	1	12	99	8p21.2	PTK2B, FAK2, PYK2		Protein tyrosine kinase-2, beta (focal adhesion kinase 2)	601212				
8.89	5	23	13	3p25.1	TPRXL		Tetrapeptide repeat homeobox-like	611167				
8.90	11	4	93	8p11.21	FNTA		Farnesyltransferase, CAAX box, alpha	134635		related FNTAL1 on 11, FNTAL2 on 13		8(Fnta)
8.91	7	3	06	8p22-q11	MPD3		Myopathy, distal 3	610099		possible locus on 12q13-q22	Myopathy, distal, 3 (2)	
8.92	7	13	93	8p12	NRG1, HGL, HRGA, ARIA		Neuregulin 1 (heregulin, alpha, 45kD; ERBB2 p185-activator)	142445			{?Schizophrenia, susceptibility to}, 603013 (1)	7(Nrg1)
8.93	5	23	16	8p21.3	ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2		ATPase, H+ transporting, V1 subunit B2	606939			Zimmermann-Laband syndrome 2, 616455 (3); Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	
8.94	10	6	09	8p21.3	BIN3		Bridging integrator 3	606396				
8.95	8	11	17	8p21.3	CCAR2, DBC1, KIAA1967		Cell division cycle and apoptosis regulator 2	607359				
8.96	12	23	19	8p21.3	CHMP7		Charged multivesicular body protein 7	611130				
8.97	05	01	20	8p21.3	CSGALNACT1, SDJLABA		Chondroitin sulfate N-acetylgalactosaminyltransferase 1	616615			Skeletal dysplasia, mild, with joint laxity and advanced bone age, 618870 (3)	
8.98	7	26	10	8p21.3	DOK2, P56DOK		Docking protein 2	604997				
8.99	1	13	16	8p21.3	ENTPD4, LYSAL1, LAP70, KIAA0392		Ectonucleoside triphosphate diphosphohydrolase 4	607577				
8.100	6	11	13	8p21.3	FGF17, HH20		Fibroblast growth factor 17	603725			Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3)	
8.101	3	24	14	8p21.3	INTS10, INT10		Integrator complex subunit 10	611353				
8.102	12	4	03	8p21.3	LGI3		Leucine-rich gene, glioma-inactivated, 3	608302				14(Lgi3)
8.103	7	22	11	8p21.3	MIR320A, MIRN320A		Micro RNA 320A	614112				
8.104	9	16	03	8p21.3	NPM2		Nucleophosmin/nucleoplasmin family, member 2	608073				14(Npm2)
8.105	6	22	14	8p21.3	NUDT18, MTH3		Nucleoside diphosphate-linked moiety X motif 18	615791				
8.106	12	19	08	8p21.3	PIWIL2, MILI		PIWI-like 2	610312				14(Piwil2)
8.107	7	1	05	8p21.3	REEP4, C8orf20		Receptor expression-enhancing protein 4	609349				
8.108	9	29	96	8p21.3	SLC18A1, VMAT1, VAT1, CGAT		Solute carrier family 18 (vesicular monoamine), member 1	193002				19(Slc18a1)
8.109	5	6	13	8p23.1	SLC35G5, AMAC, AMAC1L2		Solute carrier family 35, member G5	615199				
8.110	5	9	18	8p21.3	SLC39A14, ZIP14, KIAA0062, HMNDYT2, HCIN		Solute carrier family 39 (zinc transporter), member 14	608736		mutation identified in 1 HCTN family	Hypermanganesemia with dystonia 2, 617013 (3); ?Hyperostosis cranalis interna, 144755 (3)	
8.111	3	8	07	8p21.3	SORBS3, SCAM1, SH3D4		Sorbin and SH3 domains-containing 3	610795				
8.112	8	3	12	8p21.3	XPO7, RANBP16, KIAA0745		Exportin 7	606140				
8.113	2	4	02	8p21.3	LOXL2		Lysyl oxidase-like 2	606663				
8.114	02	20	20	8p21.2	CDCA2, PPP1R81		Cell division cycle-associated protein 2	618785				
8.115	4	21	16	8p21.2	DOCK5		Dedicator of cytokinesis 5	616904				
8.116	3	22	06	8p21.2	EBF2		Early B-cell factor 2	609934				
8.117	09	12	19	8p21.3	HR, AU, MUHH1, HYPT4		HR lysine demethylase and nuclear receptor corepressor	602302			Alopecia universalis, 203655 (3); Atrichia with papular lesions, 209500 (3); Hypotrichosis 4, 146550 (3)	14(hr)
8.118	12	22	16	8p21.2	KCTD9, BTBD27		Potassium channel tetramerization domain-containing protein 9	617265				
8.119	12	28	08	8p21.3	PDLIM2, MYSTIQUE		PDZ and LIM domain protein 2	609722				
8.120	12	17	08	8p21.3	PEPB4, CORK1		Phosphatidylethanolamine-binding protein 4	612473				
8.121	3	4	17	8p21.2	PNMA2, MA2, MM2		Paraneoplastic MA antigen 2	603970				
8.122	12	01	20	8p21.3	RHOBTB2, DBC2, KIAA0717, DEE64		Rho-related BTB domain-containing protein 2	607352			Developmental and epileptic encephalopathy 64, 618004 (3)	
8.123	11	21	02	8p12	LEPROTL1		Leptin receptor overlapping transcript-like 1	607338				
8.124	11	16	20	8p21.1	CCDC25		Coiled-coil domain-containing protein 25	619100				
8.125	5	7	09	8p21.1	ELP3, KAT9		Elongation protein 3, S. cerevisiae, homolog of	612722				
8.126	06	30	20	8p21.1	ESCO2		Establishment of sister chromatid cohesion N-acetyltransferase 2	609353			Roberts syndrome, 268300 (3); SC phocomelia syndrome, 269000 (3)	
8.127	11	20	95	8p21.3	EPB49, DMT		Erythrocyte membrane protein band 49 (dematin)	125305				14(Epb4.9)
8.128	9	9	08	8p21.1	FBXO16, FBX16		F-box only protein 16	608519		?8p12		14(Fbxo16)
8.129	11	27	19	8p12	GSR, GSRD		Glutathione reductase	138300			Hemolytic anemia due to glutathione reductase deficiency, 618660 (3)	8(Gr1)
8.130	8	4	97	8p21.1	GULOP, GULO		Gulonolactone (L-) oxidase pseudogene	240400			Scurvy (3)	
8.131	3	23	14	8p21.1	INTS9, INT9, RC74		Integrator complex subunit 9	611352				
8.132	11	09	20	8p21.1	NUGGC, SLIPGC		Nuclear GTPase, germinal center-associated	619088				
8.133	8	19	13	8p21.1	PBK, TOPK		PDZ-binding kinase	611210				
8.134	12	10	13	8p21.1	SCARA5		Scavenger receptor class A, member 5	611306				
8.135	6	27	16	8p21.2	TRIM35, MAIR, HLS5, KIAA1098		Tripartite motif-containing protein 35	617007				
8.136	9	27	17	8p21.1	ZNF395, PBF, HDBP2		Zinc finger protein 395	609494				
8.137	10	03	19	8p21-p12	HMBOX1, TAH1, PBHNF		Homeobox-containing protein 1	618610				
8.138	4	27	12	8p21.1-q13.3	SPG37		Spastic paraplegia 37	611945		max lod at D8S601	Spastic paraplegia 37, autosomal dominant (2)	
8.139	9	14	92	8p21.2	ADRA1C		Adrenergic, alpha-1C-, receptor	104221		.03cM from NEFL		
8.140	10	11	12	8p21.3	BMP1, OI13		Bone morphogenetic protein-1	112264		1kb 3' to SFTP2	Osteogenesis imperfecta, type XIII, 614856 (3)	14(Bmp1)
8.141	10	26	00	8p21.2	BNIP3L, NIX		BCL2/adenovirus E1B 19-kD protein-interacting protein 3-like	605368				
8.142	8	28	06	8p21.2	CHRNA2		Cholinergic receptor, nicotinic, alpha polypeptide-2	118502			Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)	14(Acra2)
8.143	5	1	98	8p21.2	DPYSL2, DRP2, CRMP2		Dihydropyrimidinase-like 2	602463				
8.144	4	17	17	8p21.1	EXTL3, EXTR1, ISDNA		Exostosin-like 3	605744			Immunoskeletal dysplasia with neurodevelopmental abnormalities, 617425 (3)	
8.145	09	12	19	8p21.1	FZD3		Frizzled class receptor 3	606143				14(Fzd3)
8.146	7	15	99	8p21.3	GFRA2, GDNFRB		GDNF family receptor alpha-2	601956				14(Gdnfrb)
8.147	5	19	06	3p24-p21.2	TRICY1		Trichilemmal cyst 1	609649		max lod at D3S1277	Trichilemmal cyst 1 (2)	
8.148	7	17	14	8p21.2	NEFM, NEF3, NFM		Neurofilament protein, medium polypeptide	162250				
8.149	3	6	18	8p21.2	NEFL, CMT2E, CMT1F, CMTDIG		Neurofilament, light polypeptide	162280			Charcot-Marie-Tooth disease, type 2E, 607684 (3); Charcot-Marie-Tooth disease, type 1F, 607734 (3); Charcot-Marie-Tooth disease, dominant intermediate G, 617882 (3)	14(Nfl)
8.150	7	18	14	8p21.2	NKX2-6, CSX2, CTHM		NK2, Drosophila, homolog of, 6	611770			Persistent truncus arteriosus, 217095 (3); Conotruncal heart malformations, 217095 (3)	
8.151	4	14	10	8p21.2	NKX3-1, NKX3A, BAPX2		NK3 homeo box 1	602041				
8.152	10	18	96	8p21.1	PNOC, PPNOC		Prepronociceptin	601459				
8.153	9	5	02	8p21.1	SCARA3, MSLR1, CSR		Scavenger receptor class A, member 3	602728				
8.154	12	15	98	8p21	SCZD6		Schizophrenia susceptibility locus, chromosome 8p-related	603013		?neuregulin 1	{Schizophrenia}, 181500 (2)	
8.155	5	21	07	8p21.3	SFTPC, SFTP2, SMDP2		Surfactant, pulmonary-associated protein C (pulmonary surfactant apoprotein-2, SP-C)	178620			Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)	14(Sftp2)
8.156	8	19	13	8p21.2	SLC25A37, MFRN, MFRN1		Solute carrier family 25 (mitochondrial iron carrier), member 37	610387				14(Slc25a37)
8.157	8	17	99	8p21.3	TNFRSF10A, DR4, TRAILR1, APO2		Tumor necrosis factor receptor superfamily, member 10A	603611				
8.158	8	17	99	8p21.3	TNFRSF10D, DCR2, TRAILR4		Tumor necrosis factor receptor superfamily, member 10D	603614				
8.159	3	30	00	8p21.1	CLU, CLI, SGP2, TRPM2		Clusterin (complement lysis inhibitor, SP-40,40; sulfated glycoprotein 2; testosterone-repressed prostate message-2; apolipoprotein J)	185430				14(Sgp2, Clu)
8.160	5	26	05	8p21.2-p21.1	EPHX2		Epoxide hydrolase 2, cytoplasmic	132811			{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3)	14(Ephx2)
8.161	5	11	16	8p12	GTF2E2, TTD6		General transcription factor IIE, polypeptide 2, beta subunit, 34kD	189964			Trichothiodystrophy 6, nonphotosensitive, 616943 (3)	
8.162	11	19	14	8p21.2	GNRH1, LNRH, HH12		Gonadotropin-releasing hormone-1 (luteinizing-releasing hormone)	152760		mutation identified in 1 HH12 family	?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3)	14(Gnrh)
8.163	1	7	99	8p21.2	STC1, STC		Stanniocalcin 1	601185				
8.164	09	26	19	8p21.2	ADAM7		ADAM metallopeptidase domain 7	607310				
8.165	09	26	19	8p21.2	ADAM28, MDCL		ADAM metallopeptidase domain 28	606188				
8.166	09	26	19	8p21.2	ADAMDEC1, DECYSIN		ADAM-like decysin 1	606393				
8.167	9	1	16	8p11.23	ADGRA2, GPR124, TEM5, KIAA1531		Adhesion G protein-coupled receptor A2	606823				
8.168	03	27	19	8p12	DUSP26, MKP8, LDP4, NEAP		Dual-specificity phosphatase 26	618368				
8.169	6	19	98	8p11.23	EIF4EBP1, 4EBP1		Eukaryotic translation initiation factor-4E binding protein-1	602223				8(Eif4ebp1)
8.170	5	2	16	8p12	FUT10, FUCTX		Fucosyltransferase 10	616931				
8.171	8	18	08	8p11.21	IDO2, INDOL1		Indoleamine 2,3-dioxygenase 2	612129				
8.172	7	20	12	8p12	KIF13B, GAKIN, KIAA0639		Kinesin family member 13B	607350				
8.173	4	15	08	8p12	MBOAT4, GOAT		Membrane-bound O-acetyltransferase domain-containing 4	611940				
8.174	11	02	18	8p11.23	NSD3, WHSC1L1		Nuclear receptor-binding SET domain protein 3	607083		pseudogene on 17q21; fusion partner with NUP98 in AML		
8.175	10	28	08	8p11.21	PLAT, TPA		Plasminogen activator, tissue type	173370			Thrombophilia, familial, due to decreased release of PLAT, 612348 (1); Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)	8(Plat)
8.176	6	28	18	8p12	PURG, PURGA, PURGB		Purine-rich element-binding protein G	618041				
8.177	09	22	20	8p12	RBPMS		RNA-binding protein, mRNA-processing factor	601558				
8.178	12	1	15	8p12	SNORD13		Small nucleolar RNA, C/D box, 13	616664				
8.179	5	9	18	8p12	TEX15, SPGF25		Testis-expressed gene 15	605795			Spermatogenic failure 25, 617960 (3)	
8.180	3	1	12	8p12	THPH9		Thrombophilia due to decreased release of tissue plasminogen activator	612348			?Thrombophilia due to decreased release of tissue plasminogen (1)	
8.181	8	21	12	8p12	TMEM66, SARAF		Transmembrane protein 66	614768				
8.182	11	22	13	8p12	TTI2, C8orf41, MRT39		TELO2-interacting protein 2	614426			Mental retardation, autosomal recessive 39, 615541 (3)	
8.183	09	11	19	8p12	UNC5D, UNC5H4		unc-5 netrin receptor D	616466				
8.184	6	1	05	8p11.23	ADRB3		Adrenergic, beta-3-, receptor	109691			{Obesity, susceptibility to}, 601665 (3)	8(Adrb3)
8.185	7	13	93	8p12	PPP2CB		Protein phosphatase-2 (formerly 2A), catalytic subunit, beta isoform	176916		pseudogene on 16		
8.186	8	12	03	8p12	RECQL2, RECQ3, WRN		DNA helicase, RecQ-like 2	604611			Werner syndrome, 277700 (3)	8(wrn)
8.187	3	29	10	8p12	UBXN8, D8S2298E, REP8		UBX domain protein 8	602155				
8.188	10	22	99	8p11.21	SFRP1, FRP, SARP2		Secreted frizzled-related protein 1	604156				
8.189	9	10	09	8p12	DCTN6, WS3, P27		Dynactin 6	612963				
8.190	11	20	98	8p12	DUSP4, MKP2, HVH2		Dual-specificity phosphatase-4 (MAP kinase phosphatase-2)	602747				
8.191	9	9	08	8p11.21	IDO1, INDO, IDO		Indoleamine 2,3-dioxygenase	147435				
8.192	6	4	07	8p12-q22	AD12		Alzheimer disease 12	611073		max lod at D8S1119	{Alzheimer disease 12} (2)	
8.193	12	29	06	8p11.23	RAB11FIP1, RCP		RAB11 family-interacting protein 1	608737				
8.194	8	19	13	8p11.22	TM2D2, BLP1		TM2 domain-containing protein 2	610081				
8.195	09	26	19	8p11.22	ADAM9, MDC9, MCMP, CORD9		ADAM metallopeptidase domain 9	602713			Cone-rod dystrophy 9, 612775 (3)	
8.196	11	29	12	8p11.23	BAG4, SODD		Bcl2-associated athanogene 4	603884				
8.197	10	6	09	8p11.23	BRF2, BRFU, TFIIIB50		BRF2 subunit of RNA polymerase III transcription initiation factor	607013				
8.198	1	29	13	8p11.23	DDHD2, KIAA0725, SPG54		DDHD domain-containing protein 2	615003			Spastic paraplegia 54, autosomal recessive, 615033 (3)	
8.199	1	16	07	8p11.22	HTRA4		HTRA serine peptidase 4	610700				
8.200	5	6	13	8p11.23	KCNU1, SLO3		Potassium channel, subfamily U, member 1	615215				
8.201	10	26	17	8p11.23	PLPP5, PPAPDC1B, HTPAP		Phospholipid phosphatase 5	610626				
8.202	08	17	20	8p11.23	LSM1, CASM		LSM1 homolog, mRNA degradation-associated	607281				
8.203	7	22	16	8p11.23	ZNF703, ZEPPO1, NLZ1		Zinc finger protein 703	617045				
8.204	6	9	08	8p11.21	AGPAT6, LPAATZ		1-acylglycerol-3-phosphate O-acyltransferase 6	608143				
8.205	5	5	10	8p11.21	CHRNA6		Cholinergic receptor, neuronal nicotinic, alpha polypeptide 6	606888				
8.206	11	30	06	8p11.21	GINS4, SLD5		GINS complex subunit 4	610611				
8.207	7	7	09	8p11.21	HOOK3, HK3		Hook, Drosophila, homolog of, 3	607825				
8.208	10	14	19	8p11.21	SLC20A2, MLVAR, GLVR2, IBGC1, IBGC2		Solute carrier family 20, phosphate transporter, member 2	158378			Basal ganglia calcification, idiopathic, 1, 213600 (3)	
8.209	5	14	09	8p11.21	THAP1, DYT6		THAP domain-containing protein 1	609520			Dystonia 6, torsion, 602629 (3)	
8.210	2	20	07	8p11.21	NKX6-3, NKX6.3		NK6, Drosophila, homolog of	610772				8(Nkx6-3)
8.211	09	26	19	8p11.22	ADAM2, FTNB, PH30, CRYN1, CRYN2		ADAM metallopeptidase domain 2 (fertilin, beta)	601533				14(Ftnb)
8.212	11	17	15	8p11.21	ANK1, SPH1		Ankyrin-1, erythrocytic	612641			Spherocytosis, type 1, 182900 (3)	8(nb)
8.213	5	24	13	8p11.21	AP3M2, CLA20		Adaptor-related protein complex 3, mu-2 subunit	610469				
8.214	1	29	01	8p11.23	ASH2L, ASH2L2, ASH2L1		ASH2, Drosophila, homolog of	604782				
8.215	6	10	94	8p11.21	CHRNB3		Cholinergic receptor, nicotinic, beta polypeptide-3	118508				
8.216	4	27	12	8p11.23	ERLIN2, SPFH2, C8orf2, SPG18		Endoplasmic reticulum lipid raft-associated protein 2	611605			Spastic paraplegia 18, autosomal recessive, 611225 (3)	
8.217	06	23	20	8p11.21	IKBKB, NFKBIKB, IMD15B, IMD15A		Inhibitor of nuclear factor kappa-B kinase, subunit beta	603258			Immunodeficiency 15B, 615592 (3); Immunodeficiency 15A, 618204 (3)	
8.218	3	8	95	8p11.21	POLB		Polymerase (DNA directed), beta	174760				8(Polb)
8.219	03	19	19	8p11.23	PLPBP, PROSC, EPVB6D		Pyridoxal phosphate-binding protein	604436			Epilepsy, early-onset, vitamin B6-dependent, 617290 (3)	
8.220	5	29	12	8p11.21	RNF170, SNAX1		RING finger protein 170	614649			Ataxia, sensory, 1, autosomal dominant, 608984 (3)	
8.221	9	27	17	8p11.21	TCIM, C8orf4		Transcriptional and immune response regulator	607702				
8.222	2	12	96	8p11.23	STAR		Steroidogenic acute regulatory protein	600617			Lipoid adrenal hyperplasia, 201710 (3)	
8.223	4	19	06	8p11.21	VDAC3		Voltage-dependent anion channel 3	610029				8(Vdac3)
8.224	11	20	95	8q11.21	CEBPD		CCAAT/enhancer-binding protein (C/EBP), delta	116898		earlier mapped to 8q11		16(Cebpd)
8.225	03	02	20	8p11.21	DKK4		Dickkopf WNT signaling pathway inhibitor 4	605417				
8.226	07	23	19	8p11.23	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL		Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2)	136350		fused with BCR, CEP1, FOP, FIM in hematologic malignancies	Pfeiffer syndrome, 101600 (3); Jackson-Weiss syndrome, 123150 (3); Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3); Osteoglophonic dysplasia, 166250 (3); Trigonocephaly 1, 190440 (3); Hartsfield syndrome, 615465 (3); Encephalocraniocutaneous lipomatosis, somatic mosaic, 613001 (3)	
8.227	9	10	15	8p11.2-p11.1	HGSNAT, TMEM76, MPS3C, RP73		Heparan-alpha-glucosaminide N-acetyltransferase	610453			Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3); Retinitis pigmentosa 73, 616544 (3)	
8.228	03	03	20	8p11.21	KAT6A, MYST3, MOZ, ZNF220, ARTHS		K(lysine) acetyltransferase 6A	601408			Arboleda-Tham syndrome, 616268 (3)	
8.229	11	24	14	8p11.21	POMK, SGK196, MDDGA12, MDDGC12		Protein-O-mannose kinase	615247		mutation in 1 MDDGC12 family has been reported	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3); ?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3)	
8.230	1	13	11	8p11	SCLL		Chromosome 8p11 myeloproliferative syndrome (stem cell leukemia/lymphoma)	613523		translocation of FGFR1 (8p11) and various partners	Chromosome 8p11 myeloproliferative syndrome (4)	
8.231	1	31	01	8p11.22	TACC1		Transforming, acidic, coiled-coil-containing protein-1	605301				
8.232	11	30	00	8p23.3	DLGAP2, DAP2		Discs large associated protein 2	605438				
8.233	6	15	99	8q	CCAL1		Chondrocalcinosis 1	600668			Chondrocalcinosis with early-onset osteoarthritis (2)	
8.234	11	13	07	8q	HBFQTL4		Fetal hemoglobin quantitative trait locus 4	606789			Fetal hemoglobin quantitative trait locus 4 (2)	
8.235	10	20	99	8q21.11	RPL7		Ribosomal protein L7	604166		pseudogene on chr.5		
8.236	10	20	99	8q24.3	RPL8		Ribosomal protein L8	604177				
8.237	12	14	00	8q24.13	ZHX1		Zinc finger and homeodomain protein 1	604764				
8.238	09	26	19	8p11.22	ADAM32		ADAM metallopeptidase domain 32	618602				8(Adam32)
8.239	7	13	93	8q12.1	MOS		Oncogene MOS, Moloney murine sarcoma virus	190060				4(Mos)
8.240	8	31	15	8q11.21	PRKDC, HYRC1, DNPK1, IMD26		Protein kinase, DNA-activated, catalytic polypeptide (hyperradiosensitivity of murine SCID mutation, complementing-1)	600899			Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3)	16(scid)
8.241	8	18	14	8q11.22-q11.23	PXDNL, PMR1, VPO2		Peroxidasin, Drosophila, homolog-like	615904				
8.242	2	20	03	8q11.23	RB1CC1, CC1, KIAA0203		RB1-inducible coiled-coil 1	606837			Breast cancer, somatic, 114480 (3)	
8.243	1	21	11	8q11.21	SNAI2, SLUG, WS2D		snail, Drosophila, homolog of, 2 (Neural crest transcription factor SLUG)	602150			Waardenburg syndrome, type 2D, 608890 (3); Piebaldism, 172800 (3)	16(Slug)
8.244	11	30	06	8q11.21	SNTG1, SYN4		Syntrophin, gamma-1	608714		implicated in idiopathic scoliosis		
8.245	2	21	06	8q12.1	TGS1, NCOA6IP, PIMT		Trimethylguanosine synthase, S. cerevisiae, homolog of	606461				
8.246	2	21	10	8q12.1	CA8, CALS, CARP, CAMRQ3		Carbonic anhydrase VIII	114815			Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)	4(Car)
8.247	10	7	02	8q24.3	CHARC1, CHARC15, YCL1		Chromatin accessibility complex, subunit 1	607268				
8.248	11	19	98	8q12.1	CYP7A1, CYP7		Cytochrome P450, subfamily VII (cholesterol 7-alpha-monooxygenase), polypeptide 1	118455				
8.249	1	21	04	8q11.2-q12.1	RP1, ORP1		Oxygen-regulated photoreceptor protein-1 (retinitis pigmentosa-1)	603937			Retinitis pigmentosa 1, 180100 (3)	
8.250	2	25	15	8q11.1	BEYLA		BEYLA gene	609543				
8.251	1	16	18	8q11.21	MCM4, NKGCD, NKCD, IMD54		Minichromosome maintenance deficient, S. cerevisiae, homolog of, 4	602638			Immunodeficiency 54, 609981 (3)	
8.252	3	18	94	8q11.23	OPRK1		Opiate receptor, kappa-1	165196				
8.253	9	9	13	8q11.21	SPIDR, KIAA0146		Scaffolding protein involved in DNA repair	615384				
8.254	6	13	12	8q11.21	UBE2V2, UEV2, DDVIT1, EDPF1, MMS2		Ubiquitin-conjugating enzyme E2 variant 2	603001				
8.255	2	11	11	8q11.23	NPBWR1, GPR7		Neuropeptides B and W receptor 1	600730		previously assigned to 10q11.2-q21.1 by FISH		
8.256	10	12	16	8q11.23	ST18, ZNF387, KIAA0535		Suppression of tumorigenicity 18	617155				
8.257	12	15	98	8q11.23	TCEA1, TF2S, GTF2S		Transcription elongation factor A, SII, 1	601425		previously mapped to 3p22-p21.3		
8.258	2	26	08	8q11.23	MRPL15		Mitochondrial ribosomal protein L15	611828				
8.259	4	28	10	8q11.2-q13.2	GCCD3, FGD3, GCCD2		Glucocorticoid deficiency 3	609197		between D8S285 and D8S1718	Glucocorticoid deficiency 3 (2)	
8.260	4	1	03	8q11.1-q13.3	PAFC		Preauricular fistulae, congenital	128700		between D8S532 and D8S279	?Preauricular fistulae, congenital (2)	
8.261	7	23	07	8q12.1	CHCHD7		Coiled-coil-helix-coiled-coil-helix domain-containing protein 7	611238				
8.262	3	12	15	8q12	IS3		Scoliosis, isolated, susceptibility to, 3	608765			{Scoliosis, isolated, susceptibility to, 3} (2)	
8.263	06	15	20	8q12.1	PLAG1, SGPA, PSA, SRS4		PLAG1 zinc finger protein	603026		fused with CTNNB1 in SGPA	Adenomas, salivary gland pleomorphic, somatic, 181030 (3); Silver-Russell syndrome 4, 618907 (3)	
8.264	8	20	07	8q12-q13	MTBS2		Mycobacterium tuberculosis, susceptibility to, 2	611046		max lod at D8S1723	{Mycobacterium tuberculosis, susceptibility to, 2} (2)	
8.265	10	24	00	8q12.1	NSMAF, FAN		Neutral sphingomyelinase activation-associated factor	603043				
8.266	12	21	10	8q11.23	SOX17, VUR3		SRY-box 17	610928			Vesicoureteral reflux 3, 613674 (3)	
8.267	2	18	09	8q12.1	ANIB10		Aneurysm, intracranial berry, 10	612587		associated with rs10958409	{Aneurysm, intracranial berry, 10} (2)	
8.268	7	15	14	8q12.3	ASPH, HAAH, FDLAB		Aspartate beta-hydroxylase (junctin; junctate)	600582			Traboulsi syndrome, 601552 (3)	
8.269	3	12	14	8q12.2	CHD7, HH5		Chromodomain helicase DNA binding protein 7	608892			CHARGE syndrome, 214800 (3); Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3)	
8.270	4	2	16	8q12.1	FAM110B, C8orf72		Family with sequence similarity 110, member B	611394				
8.271	7	22	11	8q12.1	IMPAD1, GPAPP, IMPA3		Inositol monophosphatase domain-containing protein 1	614010			Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3)	
8.272	2	28	03	8q12.1-q12.2	RAB2, RAB2A		Ras-associated protein RAB2	179509				
8.273	11	2	04	8q12.1	RDHE2		Retinal dehydrogenase, epidermal, 2	608989				
8.274	9	19	00	8q12.1	RPS20		Ribosomal protein S20	603682				
8.275	9	20	14	8q12.1	SDCBP, TACIP18, MDA9		Syndecan-binding protein	602217				
8.276	3	22	13	8q12.1	TOX, KIAA0808		Thymus high mobility group box protein, mouse, homolog of	606863				
8.277	6	2	15	8q12.1	UBXN2B, LOC137886, p37		UBX domain protein 2B	610686				
8.278	5	11	16	8q12.2-q12.3	CLVS1, RLBP1L1, CRALBPL		Clavesin 1	611292				
8.279	5	4	12	8q12.2-q21.2	DEL8q12q21, C8DELq12q21		Bor-Duane hydrocephalus contiguous gene syndrome (chromosome 8q12.1-q21.2 deletion syndrome)	600257			Bor-Duane hydrocephalus contiguous gene syndrome (4)	
8.280	7	16	09	8q12.3	NKAIN3		Na+/K+ transporting ATPase-interacting 3	612872				4(Nkain3)
8.281	2	22	13	8q12.2-q21.2	HDCPH1		Hydrocephalus, autosomal dominant	123155			?Hydrocephalus, autosomal dominant (2)	
8.282	7	18	06	8q12.3	GGH		Gamma-glutamyl hydrolase	601509				
8.283	11	22	19	8q12.3	YTHDF3		YTH N6-methyladenosine RNA-binding protein 3	618669				
8.284	5	24	13	8q13.1	SGK3, SGKL, CISK		Serum/glucocorticoid-regulated kinase 3	607591				
8.285	8	31	99	8q13.2	ARFGEF1, ARFGEP1, BIG1, P200		ADP-ribosylation factor guanine nucleotide exchange factor 1	604141				
8.286	9	30	10	8q12.3	BHLHE22, BHLHB5, BETA3		Basic helix-loop-helix family, member E22	613483				3(Bhlhe22)
8.287	1	18	12	8q13.2	CPA6, CPAH, ETL5, FEB11		Carboxypeptidase A6	609562			Epilepsy, familial temporal lobe, 5, 614417 (3); Febrile seizures, familial, 11, 614418 (3)	
8.288	9	3	09	8q13.1	CRH		Corticotropin releasing hormone	122560				3(Crh)
8.289	10	29	10	8q13	DEL8q13, C8DELq13		Mesomelia-synostoses syndrome (Chromosome 8q13 deletion syndrome)	600383		contiguous gene deletion of SULF1 and SLCO5A1	Mesomelia-synostoses syndrome (4)	
8.290	8	9	99	8q13	DURS1, DUS		Duane retraction syndrome 1	126800			Duane retraction syndrome 1 (2)	
8.291	9	2	08	8q13.1	SNHG6, U87HG		Small nucleolar RNA host gene 6	612215				
8.292	6	29	98	8q21.11	TERF1, TRF1		Telomeric repeat binding factor 1	600951				17(Trf1)
8.293	9	2	08	8q13.1	SNORD87, U87		Small nucleolar RNA, C/D box, 87	612216		within intron 2 of SNHG6		
8.294	7	28	17	8q21.11	TRPA1, ANKTM1, FEPS1		Transient receptor potential cation channel, subfamily A, member 1 (ankyrin-like protein with transmembrane domains 1)	604775		mutation identified in 1 FEPS1 family	?Episodic pain syndrome, familial, 1, 615040 (3)	
8.295	1	22	08	8q13.1	VCPIP1 VCIP135, KIAA1850		VCP/p47 complex-interacting protein 1	611745				
8.296	8	9	05	8q13-q21	FEB1		Febrile seizures, familial, 1	121210			Febrile seizures, familial, 1 (2)	
8.297	2	18	96	8q22.1	GEM		GTP-binding protein overexpressed in skeletal muscle	600164				4(Gem)
8.298	5	14	01	8q21.11	STAU2		Staufen, Drosophila, homolog of, 2	605920				
8.299	11	3	11	8q21.11	UBE2W, UBC16		Ubiquitin-conjugating enzyme 2W	614277				
8.300	10	13	94	8q13.1	PDE7A, HCP1		Phosphodiesterase-7A	171885				
8.301	3	25	15	8q13-q23	CMT2H		Charcot-Marie-Tooth disease, axonal, type 2H	607731		between D8S1807 and D8S548	Charcot-Marie-Tooth disease, axonal, type 2H (2)	
8.302	8	22	90	8q12.1	LYN		Yamaguchi sarcoma viral (v-yes-1) related oncogene homolog	165120				4(Lyn)
8.303	8	21	07	8q13.1	ADHFE1, HOT, ADH8		Alcohol dehydrogenase, iron-containing, 1	611083				
8.304	5	23	11	8q13.1	DNAJC5B		DNAJ/HSP40 homolog, subfamily C, member 5, beta	613945				
8.305	6	27	17	8q13.1	MCMDC2, C8orf45		Minichromosome maintenance domain-containing protein 2	617545				
8.306	10	25	17	8q13.1	PPP1R42, TLRR, LRRC67		Protein phosphatase 1, rebulatory subunit 42	617720				
8.307	02	08	19	8q13.1	RRS1		Ribosome biogenesis regulator 1, S. cerevisiae, homolog of	618311				
8.308	2	5	13	8q13.1	TRIM55, RNF29, MURF2		Tripartite motif containing 55	606469				
8.309	10	10	11	8q13.2	PREX2, DEPDC2		Phosphatidylinositol 3,4,5-trisphosphate-dependent RAC exchanger 2	612139				
8.310	12	11	95	8q12.3	TTPA, TTP1, AVED		Tocopherol, alpha, transfer protein	600415			Ataxia with isolated vitamin E deficiency, 277460 (3)	
8.311	6	13	12	8q13.1	COPS5, JAB1, SGN5		COP9, subunit 5	604850				
8.312	2	21	14	8q13.1-q13.2	CSPP1, CSPP, JBTS21		Centrosome spindle pole-associated protein 1	611654			Joubert syndrome 21, 615636 (3)	
8.313	9	7	10	8q13.3	NCOA2, GRIP1, TIF2, SRC2		Nuclear receptor coactivator 2	601993				
8.314	1	5	17	8q13.3	EYA1, BOR, BOS1, OFC1		Eyes absent, Drosophila, homolog of, 1	601653		mutation identified in 1 OFC1 family	Branchiootorenal syndrome 1, with or without cataracts, 113650 (3); Anterior segment anomalies with or without cataract, 602588 (3); Branchiootic syndrome 1, 602588 (3); ?Otofaciocervical syndrome, 166780 (3)	
8.315	06	23	20	8q13.3	LACTB2		Lactamase, beta-2	618921				
8.316	8	18	14	8q13.3	MSC, ABF1, MYOR		Musculin	603628				
8.317	12	13	18	8q24.13	NDUFB9, UQOR22, MC1DN24		NADH-ubiquinone oxidoreductase subunit B9	601445		mutation identified in 1 MC1DN24 family	?Mitochondrial complex I deficiency, nuclear type 24, 618245 (3)	
8.318	2	11	08	8q13.3	PRDM14, PFM11		PR domain-containing protein 14	611781				
8.319	8	27	15	8q13.3	SLCO5A1, OATPRP4, SLC21A15, OATPJ, OATP5A1		Solute carrier organic anion transporter family, member 5A1	613543				
8.320	5	19	06	8q13.2-q13.3	SULF1, KIAA1077		Sulfatase 1	610012				1(Sulf1)
8.321	11	27	13	8p21.3	POLR3D, BN51T, TSBN51		Polymerase III, RNA, subunit D	187280				
8.322	12	9	15	8q21.11	JPH1, JP1, CMT2K		Junctophilin 1	605266		mutation identified in 1 CMT2K family	?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3)	
8.323	05	01	20	8q21.3	CNGB3, ACHM3, ACHM1		Cyclic nucleotide-gated channel, beta-3	605080			Achromatopsia 3, 262300 (3)	
8.324	11	10	06	8q21-q22	OPA6		Optic atrophy 6	258500		between D8S1702 and D8S1794	Optic atrophy 6 (2)	
8.325	12	14	06	8q24.3	CYP11B1, P450C11, FHI		Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase; corticosteroid methyl-oxidase II (CMO II))	610613		chimeric CYP11B1/CYP11B2 gene = anti-Lepore-like	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3); Aldosteronism, glucocorticoid-remediable, 103900 (3)	
8.326	12	14	06	8q24.3	CYP11B2		Cytochrome P450, subfamily XIB, polypeptide 2	124080			Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3); Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3); {Low renin hypertension, susceptibility to} (3); Aldosterone to renin ratio raised (3)	
8.327	6	19	98	8q21.13	FABP4		Fatty acid-binding protein-4, adipocyte	600434				
8.328	06	23	20	8q21.13	FABP12		Fatty acid-binding protein 12	618923				9(Fabp12)
8.329	10	7	09	8q21.13	HNF4G		Hepatocyte nuclear factor 4-gamma	605966				3(Hnf4g)
8.330	3	2	98	8q21.3	MMP16		Matrix metalloproteinase 16 (membrane-inserted)	602262				
8.331	1	7	16	8q21.3	NBN, NBS1		Nibrin	602667			Nijmegen breakage syndrome, 251260 (3); Aplastic anemia, 609135 (3); Leukemia, acute lymphoblastic, 613065 (3)	
8.332	09	12	19	8q21.13	SLC10A5, P5		Solute carrier family 10 (sodium/bile acid cotransporter family), member A5	618582				
8.333	5	25	13	8q21.13	TPD52, D52		Tumor protein D52	604068				
8.334	8	24	09	8q21.3	WWP1, TIUL1		WW domain-containing protein 1	602307				
8.335	10	25	12	8q21.13	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3		Peroxisome biogenesis factor 2	170993			Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3); Peroxisome biogenesis disorder 5B, 614867 (3)	3(Pxmp3)
8.336	07	29	20	8q21.13	MRPS28, MRPS35, COXPD47		Mitochondrial ribosomal protein S28	611990		mutation identified in 1 COXPD47 patient	?Combined oxidative phosphorylation deficiency 47, 618958 (3)	
8.337	9	21	11	8q21.11	DEL8q21.11, C8DELq21.11		Chromosome 8q21.11 deletion syndrome	614230		contiguous gene deletion; minimal region (GRCh37, 8:77226464-77766239	Chromosome 8q21.11 deletion syndrome (4)	
8.338	8	29	13	8q21.11	GDAP1, CMT4A, CMT2K, CMTRIA		Ganglioside-induced differentiation-associated protein 1	606598			Charcot-Marie-Tooth disease, type 4A, 214400 (3); Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3); Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3); Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	
8.339	5	30	13	8q21.11	LY96, MD2		Lymphocyte antigen 96	605243				
8.340	7	1	11	8q21.11	TMEM70, MC5DN2		Transmembrane protein 70	612418			Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3)	
8.341	12	23	19	8q21.13	CHMP4C, SNF7-3		Charged multivesicular body protein 4C	610899				
8.342	6	11	02	8q21.13	ZFHX4, ZFH4		Zinc finger homeobox 4	606940			?Ptosis, congenital, 178300 (2)	
8.343	10	6	09	8q21.13	FABP5, PAFABP, EFABP		Fatty acid-binding protein 5	605168				3(Fabp5)
8.344	06	15	20	8q21.13	HEY1, HERP2, HESR1		HES-related family bHLH transcription factor with YRPW motif 1	602953				3(Hey1)
8.345	02	08	19	8q21.13	IL7		Interleukin-7	146660		mutation identified in 1 EV5 family	{?Epidermodysplasia verruciformis, susceptibility to, 5}, 618309 (3)	
8.346	9	20	14	8q21.13	PI15, P25TI		Protease inhibitor 15	607076				
8.347	12	10	12	8q21.13	SNX16		Sorting nexin 16	614903				
8.348	5	4	12	8q21.13	STMN2, SCGN10, SCG10		Stathmin-like 2	600621				
8.349	2	17	09	8q21.13	STQTL15		Stature quantitative trait locus 15	612578		associated with rs2220456	{Stature QTL 15} (2)	
8.350	09	06	19	8q21.13	ZBTB10, RINZF		Zinc finger and BTB domain-containing protein 10	618576				
8.351	2	2	17	8q21.13	IMPA1, MRT59		Inositol(myo)-1(or 4)-monophosphatase-1	602064			Mental retardation, autosomal recessive 59, 617323 (3)	
8.352	12	11	18	8q22.1	TMEM67, MKS3, JBTS6, NPHP11		Transmembrane protein 67 (meckelin)	609884		mutation identified in 1 RHYNS patient	Meckel syndrome 3, 607361 (3); Joubert syndrome 6, 610688 (3); {Bardet-Biedl syndrome 14, modifier of}, 615991 (3); COACH syndrome 1, 216360 (3); Nephronophthisis 11, 613550 (3); ?RHYNS syndrome, 602152 (3)	
8.353	8	18	14	8q21.2	E2F5		E2F transcription factor 5	600967				
8.354	11	29	17	8q21.2	LRRCC1, CLERK, KIAA1764		Leucine-rich repeat- and coiled-coil domain-containing centrosomal protein 1	617791				
8.355	5	18	12	8q21.2	RALYL		RALY-like protein	614648				
8.356	10	12	20	8q22.3	SLC25A32, MFT, GLYB, RREI		Solute carrier family 25 (mitochondrial carrier, folate), member 32	138480		mutation identified in 1 RREI patient	?Exercise intolerance, riboflavin-responsive, 616839 (3)	15(Slc25a32)
8.357	3	22	06	8q21.3	TMEM55A		Transmembrane protein 55A	609864				
8.358	7	25	18	8q21.3	ATP6V0D2		ATPase, H+ transporting, V0 subunit D2	618072				
8.359	10	6	09	8q21.3	CPNE3, CPN3		Copine III	604207				
8.360	4	25	12	8q12.3	CYP7B1, CBAS3, SPG5A		Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1	603711			Bile acid synthesis defect, congenital, 3, 613812 (3); Spastic paraplegia 5A, autosomal recessive, 270800 (3)	
8.361	9	23	14	8q21.3	DECR1		2,4-dienoyl CoA reductase	222745				
8.362	3	4	08	8q21.3	FAM82B, RMD1		Family with sequence similarity 82, member B	611871				
8.363	3	23	14	8q21.3	OSGIN2, C8orf1		Oxidative stress-induced growth inhibitor family member 2	604598				
8.364	5	3	17	8q21.3	OTUD6B, DUBA5, IDDFSDA		OTU domain-containing protein 6B	612021			Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, 617452 (3)	
8.365	5	21	14	8q21.3	RIPK2, CARDIAK, RIP2, RICK		Receptor-interacting serine/threonine kinase 2	603455				
8.366	12	15	16	8q21.3	SLC7A13, AGT1, XAT2		Solute carrier family 7, member 13	617256				
8.367	08	21	19	8q22.1	RAD54B		RAD54 homolog B	604289			Lymphoma, non-Hodgkin, somatic, 605027 (3); Colon cancer, somatic, 114500 (3)	
8.368	9	13	99	8q21.3	CALB1		Calbindin 1, 28kD	114050				4(Calb)
8.369	01	16	19	8q21.13	PMP2, CMT1G		Peripheral myelin protein-2	170715			Charcot-Marie-Tooth disease, demyelinating, type 1G, 618279 (3)	
8.370	6	28	99	8q23.1	ANGPT1, ANG1		Angiopoietin-1	601667				15(Angpt1)
8.371	10	13	94	8q21.2	CA1		Carbonic anhydrase I	114800				3(Car1)
8.372	10	3	07	8q21.2	CA2		Carbonic anhydrase II	611492		CA1, CA2 linked in monkey and mouse	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3)	3(Car2)
8.373	6	4	90	8q21.2	CA3		Carbonic anhydrase III	114750				3(Car3)
8.374	4	14	10	8q22.3	DPYS, DHP		Dihydropyrimidinase	613326			Dihydropyrimidinuria, 222748 (3)	
8.375	6	28	18	8q22.3	GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4		Grainyhead-like 2	608576			Deafness, autosomal dominant 28, 608641 (3); Ectodermal dysplasia/short stature syndrome, 616029 (3); Corneal dystrophy, posterior polymorphous, 4, 618031 (3)	
8.376	6	30	05	8q22.2	HRSP12, PSP, UK114		Heat-responsive protein 12	602487				
8.377	1	25	05	8q22	HTC1		Hypertrichosis universalis congenita, Ambras type	145701			?Hypertrichosis universalis congenita, Ambras type (2)	
8.378	11	20	98	8q22.2	KCNS2		Potassium voltage-gated channel, delayed-rectifier, subfamily S, member-2	602906				
8.379	1	23	01	8q22.1-q22.2	MATN2		Matrilin 2	602108				
8.380	9	19	91	8q13.1	MYBL1		Avian myeloblastosis viral (v-myb) oncogene homolog like-1	159405				
8.381	11	27	94	8q22.3	ODF1		Outer dense fiber of sperm tails 1	182878				15(Odf1)
8.382	09	12	19	8q22.2	POP1, ANXD2		POP1 homolog, ribonuclease P/MRP subunit	602486			Anauxetic dysplasia 2, 617396 (3)	
8.383	2	10	14	8q22.1	PTDSS1, PSS1, KIAA0024, LMHD		Phosphatidylserine synthase 1	612792			Lenz-Majewski hyperostotic dwarfism, 151050 (3)	13(Pss1)
8.384	4	24	12	8q21.3	RUNX1T1, CBFA2T1, AML1T1, ETO		unt-related transcription factor 1, translocated to, 1, cyclin D-related	133435		fused with AML1 in t(8;21)		4(Cbfa2t1h)
8.385	1	28	01	8q22.1	TP53DINP1, P53DINP1		Tumor protein p53 inducible nuclear protein 1	606185				
8.386	5	4	00	8q22.3	PABPC1, PAB1, PABP1, PABP		Polyadenylate-binding protein, cytoplasmic, 1	604679				
8.387	11	11	13	8q22.2	SPAG1, CILD28		Sperm-associated antigen-1	603395			Ciliary dyskinesia, primary, 28, 615505 (3)	
8.388	5	19	06	8q22.3	TM7SF4, DCSTAMP, FIND		Transmembrane 7 superfamily, member 4	605933				
8.389	7	18	12	8q22.1	TSPYL5, KIAA1750		TSPY-like 5	614721				
8.390	4	8	13	8q22.1	UQCRB, UQBP, QPC, MC3DN3		Ubiquinol-cytochrome c reductase binding protein	191330			Mitochondrial complex III deficiency, nuclear type 3, 615158 (3)	
8.391	6	16	99	8q22.2	COX6C		Cytochrome c oxidase, subunit VIc	124090		pseudogene on 16p12		
8.392	10	3	07	8q23.1	EIF3E, EIF3S6, INT6		Eukaryotic translation initiation factor 3, subunit E (oncogene INT6)	602210				15(Int6)
8.393	9	9	09	8q22.1	MTDH, AEG1, LYRIC		Metadherin	610323				15(Mtdh)
8.394	12	27	19	8q22.2	VPS13B, KIAA0532, COH1		Vacuolar protein sorting 12 homolog B	607817			Cohen syndrome, 216550 (3)	
8.395	8	19	98	8q22.1	SDC2, HSPG1		Syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated; fibroglycan)	142460				
8.396	3	28	17	8q22.1	C8orf37, CORD16, RP64, BBS21		Chromosome 8 open reading frame 37	614477			Retinitis pigmentosa 64, 614500 (3); Cone-rod dystrophy 16, 614500 (3); Bardet-Biedl syndrome 21, 617406 (3)	
8.397	3	31	15	8q22.1	CCNE2		Cyclin E2	603775				
8.398	11	4	98	8q22.1	CDH17, CDH16, HPT1		Cadherin-17, liver-intestine	603017				
8.399	4	28	14	8q22.1	DUP8q22.1, C8DUPq22.1		Chromosome 8q22.1 duplication syndrome (Leri pleonosteosis)	151200		duplication of 0.9-1.2 Mb on 8q22.1	Leri pleonosteosis chromosome duplication syndrome (4)	
8.400	12	04	18	8q22.1	FAM92A, FAM92A1, PAPA9		Family with sequence similarity 92, member A	617273		mutation identified in 1 PAPA9 family	?Polydactyly, postaxial, type A9, 618219 (3)	
8.401	4	10	15	8q22.1	FSBP		Fibrinogen silencer-binding protein	616306				
8.402	09	10	19	8q22.1	INTS8, INT8, NEDCHS		Integrator complex subunit 8	611351		mutation identified in 1 NEDCHS family	?Neurodevelopmental disorder with cerebellar hypoplasia and spasticity, 618572 (3)	
8.403	7	9	15	8q22.1	KIAA1429		KIAA1429 gene	616447				
8.404	5	2	16	8q22.1	MTERF3, MTERFD1		Transcription termination factor 3, mitochondrial	616930				
8.405	06	15	20	8q22.1	NDUFAF6, C8orf38, MC1DN17, FRTS5		NADH-ubiquinone oxidoreductase complex assembly factor 6	612392			Mitochondrial complex I deficiency, nuclear type 17, 618239 (3); Fanconi renotubular syndrome 5, 618913 (3)	
8.406	5	4	12	8q22.1	NMLFS, DEL8q22.1, C8DELq22.1		Nablus mask-like facial syndrome (chromosome 8q22.1 deletion syndrome)	608156			Nablus mask-like facial syndrome (4)	
8.407	4	15	11	8q22.1	DPY19L4		DPY19-like 4	613895				
8.408	6	13	18	8q22.1	ESRP1, RMB35A, DFNB109		Epithelial splicing regulatory protein 1	612959		mutation identified in 1 DFNB109 family	?Deafness, autosomal recessive 109, 618013 (3)	
8.409	3	5	18	8q22.1	GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4		Growth/differentiation factor 6	601147			Klippel-Feil syndrome 1, autosomal dominant, 118100 (3); Microphthalmia, isolated 4, 613094 (3); Microphthalmia with coloboma 6, digenic, 613703 (3); Leber congenital amaurosis 17, 615360 (3); Multiple synostoses syndrome 4, 617898 (3)	
8.410	3	16	10	8q22.1	LAPTM4B		Lysosome-associated protein, transmembrane 4, beta	613296		pseudogenes on 1q, 3q,3p, 4q, and 7q33-q35		
8.411	2	2	10	8q22.1	PDP1, PPM2C, PDPC		Pyruvate dehydrogenase phosphatase catalytic subunit 1	605993			Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	
8.412	5	6	13	8q22.1	PLEKHF2, EAPF, PHAFIN2		Pleckstrin homology domain-containing protein, family F, member 2	615208				
8.413	5	13	13	8q22.3	KLF10, TIEG		Kruppel-like factor 10	601878				1(Klf10)
8.414	6	17	02	8q22.3	NCALD		Neurocalcin, delta	606722				
8.415	2	25	14	8q22.2	RGS22		Regulator of G protein signaling 22	615650				
8.416	11	11	14	8q22.2	STK3, MST2, KRS1		Serine/threonine protein kinase 3	605030				
8.417	10	6	09	8q22.3	ATP6V1C1, ATP6C, ATP6D		ATPase, H+ transporting, V1 subunit C1	603097				
8.418	8	18	08	8q22.3	AZIN1, OAZIN		Antizyme inhibitor 1	607909				
8.419	1	11	02	8q22.3	BAALC		Brain and acute leukemia gene, cytoplasmic	606602				
8.420	10	5	11	8q22.3	CTHRC1		Collagen triple-helix repeat-containing protein 1	610635			Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	
8.421	2	4	15	8q22.3	DCAF13, WDSOF1		DDB1- and CUL4-associated factor 13	616196				
8.422	9	9	08	8q22.2	FBXO43, EMI2, ERP1, FBX43		F-box only protein 43	609110				15(Fbxo43)
8.423	1	8	06	8q22.3	KTWS, KTS		Klippel-Trenaunay-Weber syndrome	149000		translocation with 14q13	Klippel-Trenaunay-Weber syndrome (2)	
8.424	10	25	19	8q22.3	LRP12, MIG13A		Low density lipoprotein receptor-related protein 12	618299			Oculopharyngodistal myopathy 1, 164310 (3)	
8.425	10	8	12	8q22.3	UBR5, EDD1, HYD, KIAA0896		Ubiquitin protein ligase E3 component n-recognin 5	608413				
8.426	10	10	19	8q22.3	YWHAZ		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide	601288		pseudogene on 2p25		
8.427	3	29	10	8q22.3	MMD2		Miyoshi muscular dystrophy 2	613318		max lod at D10S2325	Miyoshi muscular dystrophy 2 (2)	
8.428	07	29	20	8q22.3	RIMS2, KIAA0751, RIM2, OBOE, CRSDS		Regulating synaptic membrane exocytosis-2	606630			Cone-rod synaptic disorder syndrome, congenital nonprogressive, 618970 (3)	
8.429	03	17	20	8q22.3	FZD6, NDNC1		Frizzled class receptor 6	603409			Nail disorder, nonsyndromic congenital, 1, 161050 (3)	15(Mfz6)
8.430	3	22	07	8q23.2	KCNV1, KV8.1		Potassium channel, voltage-gated, subfamily V, member 1	608164				
8.431	12	7	07	8q23.1	ABRA, STARS		Actin-binding RHO-activating protein	609747				
8.432	7	17	01	8q23.1	CML66		Immunogenic tumor antigen CML66	606109				
8.433	6	16	99	8q24.12	COL14A1, UND		Collagen, type XIV, alpha-1 (undulin)	120324				
8.434	8	20	08	8q23	CRCS6		Colorectal cancer, susceptibility to, 6	612231		associated with rs16892766	{Colorectal cancer, susceptibility to, 6} (2)	
8.435	4	19	01	8q23.2	EBAG9, RCAS1, EB9		Estrogen receptor-binding site-associated antigen 9	605772				
8.436	9	9	98	8q23	GLC1D		Glaucoma 1, open angle, D	602429			Glaucoma 1D, primary open angle (2)	
8.437	12	7	07	8q23.2	GOLSYN, SYBU, KIAA1472		Golgi-localized syntaphilin-related protein	611568				15(Golsyn)
8.438	12	17	07	8q23	HDLCQ2		High density lipoprotein cholesterol level QTL 2	607053			[High density lipoprotein cholesterol level QTL 2] (2)	
8.439	5	4	09	8q23	LBMQTL1		Lean body mass quantitative trait locus 1	612729		associated with rs16892496 and rs7832552	[Lean body mass QTL 1] (2)	
8.440	10	24	12	8q23	MYMY3		Moyamoya disease 3	608796		max lod at D8S546	Moyamoya disease 3 (2)	
8.441	7	30	09	8q22.2	OSR2		Odd-skipped-related 2	611297				
8.442	01	24	20	8q23.1	OXR1, CHEGDD		Oxidation resistance 1	605609			Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, 213000 (3)	
8.443	9	2	09	8q23.1-q23.2	PKHD1L1		PKHD1-like 1	607843				
8.444	09	06	19	8q23.1	TRHR, CHNG7		Thyrotropin-releasing hormone receptor	188545			Hypothyroidism, congenital, nongoitrous, 7, 618573 (3)	15(Trhr)
8.445	11	3	14	8q23.1	ZFPM2, FOG2, DIH3, SRXY9		Zinc finger protein, multitype 2 (friend of GATA2)	603693			Tetralogy of Fallot, 187500 (3); Diaphragmatic hernia 3, 610187 (3); 46XY sex reversal 9, 616067 (3)	
8.446	1	10	02	8q23-q24	HT		Hashimoto thyroiditis	140300		?chr.12	Hashimoto thyroiditis (2)	
8.447	10	11	07	8q23-q24	MGS		Mungan syndrome	611376		between D8S1830 and D8S1799	Mungan syndrome (2)	
8.448	10	23	87	8q12.1	PENK		Proenkephalin	131330				
8.449	1	8	95	8q24.12	SNT2B1, A1B, SNTB1		Syntrophin, beta 1 (dystrophin-associated protein A1, 59kD, basic basic component 1)	600026				
8.450	4	18	07	8q24.22	ZFAT1, ZNF406, AITD3		Zinc finger gene in autoimmune thyroid disease 1	610931			{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	
8.451	4	17	17	8q24.12	COLEC10, CLL1, 3MC3		Collectin 10	607620			3MC syndrome 3, 248340 (3)	
8.452	2	25	15	8q23.1	EMC2, KIAA0103		ER membrane protein complex subunit 2	607722				
8.453	09	08	20	8q23.1	ENY2, SUS1		ENY2 transcription and export complex 2 subunit	619015				
8.454	12	27	10	8q22.3	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B		Ribonucleotide reductase M2 B, TP53 inducible	604712			Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3); Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	
8.455	09	19	19	8q23.1	RSPO2, CRISTIN2, TETAMS2, HHRRD		R-spondin member 2	610575		mutation identified in 1 HHRRD family	Tetraamelia syndrome 2, 618021 (3); ?Humerofemoral hypoplasia with radiotibial ray deficiency, 618022 (3)	15(Rspo2)
8.456	4	26	11	8q23.1	TMEM74		Transmembrane protein 74	613935				
8.457	1	27	04	8q23.3	CSMD3, KIAA1894		Cub and Sushi multiple domains 3	608399				
8.458	12	24	08	8q24.3	ARC, KIAA0278		Activity-regulated cytoskeleton-associated protein	612461				
8.459	9	1	16	8q24.3	ADGRB1, BAI1, GDAIF		Adhesion G protein-coupled receptor B1	602682				
8.460	11	30	06	8q24.3	BOP1, KIAA0124		Block of proliferation 1	610596				
8.461	12	29	06	8q24	BSZQTL3		Bone size quantitative trait locus 3	610649			[Bone size quantitative trait locus 3] (2)	
8.462	8	20	08	8q24	CRCS2		Colorectal cancer, susceptibility to, 2	611469		associated with rs7014346	{Colorectal cancer, susceptibility to, 2} (2)	
8.463	11	11	98	8q24	ECA1		Epilepsy, childhood absence, 1	600131			Epilepsy, childhood absence, 1 (2)	
8.464	10	28	10	8q24	EIG1		Epilepsy, idiopathic generalized, susceptibility to 1	600669		?same as EBN2	{Epilepsy, idiopathic generalized, susceptibility to, 1} (2)	
8.465	5	11	16	8q24.3	AGO2, EIF2C2		Argonaute 2, RISC catalytic component	606229				
8.466	5	17	18	8q24.21	FAM149B		Family with sequence similarity 49, member B	617978				
8.467	12	15	17	8q24.3	GPAA1, GAA1, GPIBD15		Glycophosphatidylinositol anchor attachment protein 1	603048			Glycosylphosphatidylinositol biosynthesis defect 15, 617810 (3)	
8.468	8	10	99	8q24.22	HHLA1		Human endogenous retrovirus-H long terminal repeat-associating 1	604109				
8.469	8	9	07	8q24	HPC10		Prostate cancer, hereditary, 10	611100		strongest assoc. with rs1447295	{Prostate cancer, hereditary, 10} (2)	
8.470	2	22	92	8q24	HPV18I1		Human papillomavirus type 18 integration site-1	167959				
8.471	02	27	20	8q24.3	JRK, JH8		JRK helix-turn-helix protein	603210				15(Jrk)
8.472	2	2	18	8q24.22	KCNQ3, EBN2, BFNC2		Potassium voltage-gated channel, KQT-like subfamily, member 3	602232			Seizures, benign neonatal, 2, 121201 (3)	
8.473	03	02	20	8q24.3	MAFA, RIPE3B1, INSDM		MAF bZIP transcription factor A	610303			Insulinomatosis and diabetes mellitus, 147630 (3)	
8.474	8	10	99	8q24.22	OC90, PLA2L		Otoconin 90 (phospholipase A2-like)	601658		PLA2L = fusion between HHLA1 and OC90		
8.475	10	12	14	8q24.21	PCAT1		Prostate cancer-associated transcript 1, noncoding	616043				
8.476	09	27	18	8q24.3	PLEC1, PLEC, PLTN, EBS1, LGMDR17, EBSOG, EBSPA, EBSMD, EBSND		Plectin 1	601282		mutation identified in 1 EBSND family	Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3); Epidermolysis bullosa simplex, Ogna type, 131950 (3); Epidermolysis bullosa simplex with pyloric atresia, 612138 (3); Muscular dystrophy, limb-girdle, autosomal recessive 17, 613723 (3); ?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	
8.477	10	15	13	8q24.21	PRNCR1, PCAT8		Prostate cancer-associated noncoding RNA 1	615452				
8.478	4	20	17	8q24.22	PTCSC1, NCRNA00197		Papillary thyroid carcinoma susceptibility candidate 1 gene	617440				
8.479	10	23	87	8q24.21	PVT1		Oncogene PVT-1 (MYC activator)	165140				
8.480	08	21	19	8q24.11	RAD21, SCC1, NXP1, KIAA0078, CDLS4, MGS		RAD21 cohesin complex component	606462		mutation identified in 1 MGS family	Cornelia de Lange syndrome 4, 614701 (3); ?Mungan syndrome, 611376 (3)	
8.481	3	26	07	8q24.3	SPATC1		Spermatogenesis- and centriole-associated 1 (speriolin)	610874				15(Spatc1)
8.482	6	30	15	8q24.12	TNFRSF11B, OPG, OCIF, PDB5		Tumor necrosis factor receptor superfamily, member 11B (osteoprotegerin)	602643			Paget disease of bone 5, juvenile-onset, 239000 (3)	
8.483	7	13	93	8q24.3	ZNF7, KOX4		Zinc finger protein-7 (KOX4)	194531				
8.484	9	28	96	8q24.3	ZNF16, KOX9		Zinc finger protein-16 (KOX 9)	601262				
8.485	8	28	01	8q24.3	LY6D, E48		Lymphocyte antigen 6 complex, locus D	606204		?pseudogene ono 15q22		
8.486	7	6	99	8q24.3	PTK2, FADK		PTK2 protein tyrosine kinase	600758				15(Fadk)
8.487	9	28	00	8q24.12	ENPP2, PDNP2		Ectonucleotide pyrophosphatase/phosphodiesterase 2	601060				
8.488	2	26	04	8q24.13	MTSS1, MIM, KIAA0429		Metastasis suppressor 1	608486				
8.489	7	13	93	8q24.12	NOV		Nephroblastoma overexpressed gene	164958		proximal to MYC		15(nov)
8.490	8	20	07	8q24.13	RNF139, TRC8, RCA1		RING finger protein 139	603046			Renal cell carcinoma, 144700 (3)	
8.491	8	1	18	8q24.11-q24.12	SAMD12		Sterile alpha motif domain containing 12	618073			Epilepsy, familial adult myoclonic, 1, 601068 (3)	
8.492	8	16	99	8q24.13	SQLE		Squalene epoxidase	602019				
8.493	10	1	99	8q24.1	THM		Tibial hemimelia	275220			?Tibial hemimelia (2)	
8.494	10	16	98	8q24.13	ANX13, ISA		Annexin XIII	602573				
8.495	7	20	15	8q24.21-q24.22	ASAP1, DDEF1		Arf GTPase-activating protein with SH3 domain, ankyrin repeat, and PH domain 1	605953				
8.496	10	13	09	8q24.21	GSDMC, MLZE		Gasdermin C	608384				
8.497	11	30	20	8q24.3	KCNK9, TASK32, BIBARS		Potassium channel, subfamily K, member 9	605874			Birk-Barel syndrome, 612292 (3)	
8.498	09	06	19	8q24.12	MDM2BP, MTBP		MDM2-binding protein	605927				
8.499	3	29	99	8q24.22	WISP1		Wnt-1 inducible signaling pathway protein 1	603398				
8.500	10	3	07	8q23.3-q24.1	EIF3H, EIF3S3		Eukaryotic translation initiation factor 3, subunit H	603912				
8.501	1	27	11	8q24.11	MED30, TRAP25, THRAP6		Mediator complex subunit 30	610237				
8.502	2	25	08	8q24.11	SLC30A8, ZNT8		Solute carrier family 30 (zinc transporter), member 8	611145			{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	15(Slc30a8)
8.503	1	27	04	8q24.11	EXT1		Exostosin 1	608177		distal to TRPS1	Exostoses, multiple, type 1, 133700 (3); Chondrosarcoma, 215300 (3)	15(Ext1)
8.504	12	14	10	8q24.11-q24.13	TRPS2, LGCR, LGS		Trichorhinophalangeal syndrome, type II (Langer-Giedion syndrome)	150230		contiguous gene syndrome involving TRPS1 and EXT1	Trichorhinophalangeal syndrome, type II (4)	
8.505	9	10	09	8q24.12	DEPDC6, DEPTOR		DEP domain-containing protein 6	612974				
8.506	11	27	19	8q24.12	DSCC1, DCC1		DNA replication and sister chromatid cohesion 1	613203				
8.507	6	19	98	8q24.13	HAS2		Hyaluronan synthase-2	601636				15(Has2)
8.508	4	6	15	8q24.12	MRPL13, RPML13, L13A		Mitochondrial ribosomal protein L13	610200				
8.509	1	14	14	8q24.12	TAF2, TAF2B, TAFII150, CIF150, MRT40		TAF2 RAN polymerase II, TATA box-binding protein-associated factor, 150kD	604912			Mental retardation, autosomal recessive 40, 615599 (3)	
8.510	7	20	06	8q23.3	TRPS1		Zinc finger transcription factor TRPS1	604386			Trichorhinophalangeal syndrome, type I, 190350 (3); Trichorhinophalangeal syndrome, type III, 190351 (3)	
8.511	09	06	19	8q24.21	MYC		MYC protooncogene, bHLH transcription factor	190080		cen-5'-3'-ter	Burkitt lymphoma, somatic, 113970 (3)	15(Myc)
8.512	11	4	93	8q24.3	ZNF34, KOX32		Zinc finger protein-34 (KOX32)	194526				
8.513	4	15	08	8q24.13	ATAD2, ANCCA		ATPase family, AAA domain-containing, member 2	611941				
8.514	5	24	13	8q24.13	DERL1, DER1		DER1-like domain family, member 1	608813				
8.515	9	9	08	8q24.13	FBXO32, MAFBX, FLJ32424, ATROGIN1		F-box only protein 32	606604				15(Fbxo32)
8.516	12	1	11	8q24.13	HAS2AS1, HASNT		HAS2 antisense RNA 1	614353				
8.517	01	21	20	8q24.13	NSMCE2, NSE2, MMS21		NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase	617246			Seckel syndrome 10, 617253 (3)	
8.518	10	28	15	8q24.13	TMEM65		Transmembrane protein 65	616609				2(Tmem65)
8.519	09	13	19	8q24.13	TRIB1, TRB1, SKIP1, C8FW		Tribbles pseudokinase 1	609461				
8.520	09	11	19	8q24.13	TRMT12, TRM12		tRNA methyltransferase 12 homolog	611244				
8.521	10	26	20	8q24.13	WASHC5, KIAA0196, SPG8, RTSC1		WASH complex, subunit 5	610657			Spastic paraplegia 8, autosomal dominant, 603563 (3); Ritscher-Schinzel syndrome 1, 220210 (3)	
8.522	12	17	12	8q24.13-q24.21	PPKP1B		Keratoderma, palmoplantar, punctate type IB	614936		between D8S1804 and D8S1720	Keratoderma, palmoplantar, punctate type IB (2)	
8.523	12	22	08	8q24.13-q24.22	ARHI1		Age-related hearing impairment 1	612448		between rs3765212 and rs4601326	{Age-related hearing impairment 1} (2)	
8.524	9	19	94	8q24.22	ADCY8, ADCY3		Adenylyl cyclase-8, brain	103070				
8.525	4	19	06	8q24.2-q24.3	COL22A1		Collagen, type XXII, alpha-1 polypeptide	610026				15(Col22a1)
8.526	2	18	08	8q24.22	EFR3A, KIAA0143		EFR3, S. cerevisiae, homolog of, A	611798				15(Efr3a)
8.527	2	28	07	8q24.23	KHDRBS3, TSTAR, SALP, SLM2, ETOILE		KH domain-containing, RNA-binding, signal transduction-associated protein 3	610421				15(Khdrbs3)
8.528	4	8	98	8q24.3	PSCA		Prostate stem cell antigen	602470				
8.529	8	4	97	8q24.3	GPR20		G protein-coupled receptor-20	601908				
8.530	9	11	98	8q24.22	SLA		Src-like-adaptor	601099		in intron of TG		15(Slap)
8.531	10	11	17	8q24.21	CASC8, LINC00860, CARLO1		Cancer susceptibility candidate 8, noncoding	617701				
8.532	10	11	17	8q24.21	CASC11, LINC00990, CARLO7		Cancer susceptibility candidate 11, noncoding	617704				
8.533	10	11	17	8q24.21	CASC19, LINC01245, CARLO6		Cancer susceptibility candidate 19, noncoding	617703				
8.534	10	11	17	8q24.21	CASC21, LINC01244, CARLO2		Cancer susceptibility candidate 21, noncoding	617702				
8.535	10	1	17	8q24.21	CCAT1, CARLO5		Colon cancer-associated transcript 1, noncoding	617705				
8.536	9	29	09	8q24.22	TG, AITD3, TDH3		Thyroglobulin	188450		distal to MYC	Thyroid dyshormonogenesis 3, 274700 (3); {Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	15(Tgn; cog)
8.537	9	30	09	8q24.21	CCD26, RAM		Coiled-coil domain-containing protein 26	613040				
8.538	9	24	08	8q24.21	FAM84B, BCMP101		Family with sequence similarity 84, member B	609483				
8.539	4	17	13	8q24.21	GLM7		Glioma susceptibility 7	613032		associated with rs55705857	{Glioma susceptibility 7} (2)	
8.540	9	21	17	8q24.21	PCAT2, PCA2, CARLO4		Prostate cancer-associated transcript 2, noncoding	617678				
8.541	4	29	14	8q24.21	POU5F1B, POU5F1P1, OCT4PG1		POU domain, class 5, transcription factor 1B	615739				
8.542	11	29	12	8q24.22	LRRC6, LRTP, CILD19		Leucine-rich repeat-containing protein 6	614930			Ciliary dyskinesia, primary, 19, 614935 (3)	
8.543	09	10	20	8q24.22	MIR30B		Micro RNA 30B	619018				
8.544	09	10	20	8q24.22	MIR30D		Micro RNA 30D	619019				
8.545	7	17	14	8q24.3	ARHGAP39, VILSE, KIAA1688		RHO GTPase-activating protein 39	615880				
8.546	6	26	16	8q24.3	C8orf17, MOST1		Chromosome 8 open reading frame 17	616992				
8.547	11	18	15	8q24.3	CYHR1, KIAA0496		Cysteine- and histidine-rich protein 1	616635				
8.548	6	9	08	8q24.3	COMMD5, HCARG		COMM domain-containing protein 5	608216				
8.549	03	28	20	8q24.3	CPSF1, CPSF160, MYP27		Cleavage and polyadenylation specificity factor 1	606027			Myopia 27, 618827 (3)	
8.550	10	15	13	8q24.3	CYC1, MC3DN6		Cytochrome c1	123980			Mitochondrial complex III deficiency, nuclear type 6, 615453 (3)	
8.551	5	30	17	8q24.3	DENND3, KIAA0870		DENN domain-containing protein 3	617503				
8.552	11	14	18	8q24.3	DGAT1, ARGP1, DIAR7		Diacylglycerol O-acyltransferase 1	604900		mutation identified in 1 DIAR7 family	?Diarrhea 7, protein-losing enteropathy type, 615863 (3)	15(Dgat)
8.553	9	18	08	8q24.3	EEF1D, EF1D		Eukaryotic translation elongation factor 1, delta	130592				
8.554	8	18	14	8q24.3	EPPK1		Epiplakin 1	607553				
8.555	10	07	19	8q24.3	MAPK15, ERK8		Mitogen-activated protein kianse 15	618616				
8.556	6	1	12	8q24.3	EXOSC4, RRP41		Exosome component 4	606491				
8.557	8	4	17	8q24.3	FAM83H, AI3A		Family with sequence similarity 83, member H	611927			Amelogenesis imperfecta, type IIIA, 130900 (3)	
8.558	3	30	99	8q24.3	FAST1		Forkhead activin signal transducer 1, Xenopus, homolog of	603621				
8.559	6	13	12	8q24.3	FBXL6, FBL6, FBL6A		F-box and leucine-rich repeat protein 6	609076				15(FBXL6)
8.560	9	29	96	8q24.3	GLI4, HKR4		GLI-Kruppel family member GLI4 (oncogene HKR4)	165280				
8.561	6	19	98	8q24.3	GML		Glycosylphosphatidylinositol-anchored molecule-like protein	602370				
8.562	8	22	14	8q24.3	GPIHBP1, HYPL1D		Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1	612757			Hyperlipoproteinemia, type 1D, 615947 (3)	
8.563	7	22	16	8q24.3	GSDMD, GSDMDC1, DFNA5L		Gasdermin D	617042				
8.564	07	08	20	8q24.3	IQANK1, FAM83HAS1		IQ motif- and ankyrin repeat-containing protein 1	618942				
8.565	5	19	16	8q24.3	KIFC2		Kinesin family member C2	615216				
8.566	7	11	12	8q24.3	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2		Solute carrier family 52, riboflavin transporter, member 2	607882			Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	
8.567	6	17	99	8q24.3	GPT, GPT1, AAT1		Glutamic-pyruvate transaminase (alanine aminotransferase)	138200				15(Gpt1)
8.568	3	14	96	8q24.3	GRINA, NMDARA1		Glutamate receptor, ionotropic, N-methyl	138251				
8.569	9	9	08	8q24.3	HSF1		Heat-shock transcription factor 1	140580				
8.570	1	7	99	8q24.3	LY6E, RIGE, SCA2		Lymphocyte antigen 6 complex, locus E (retinoic acid induced gene E)	601384				15(Ly6e)
8.571	8	17	99	8q24.3	LY6H		Lymphocyte antigen 6 complex, locus H	603625				
8.572	3	14	13	8q24.3	LY6K		Lymphocyte antigen 6 complex, locus K	615093				
8.573	1	28	11	8q24.3	MAF1		Maf1, S. cerevisiae, homolog of	610210				
8.574	1	31	11	8q24.3	MIR661, MIRN661		Micro RNA 661	613716				
8.575	12	09	19	8q24.3	NAPRT, NAPRT1		Nicotinate phosphoribosyltransferase	611552				
8.576	10	2	03	8q24.22	NDRG1, HMSNL, CMT4D		N-myc downstream-regulated gene 1	605262			Charcot-Marie-Tooth disease, type 4D, 601455 (3)	
8.577	07	24	19	8q24.3	TONSL, NFKBIL2, IKBR, SEMDSP		Tonsoku-like DNA repair protein	604546			Spondyloepimetaphyseal dysplasia, sponastrime type, 271510 (3)	
8.578	12	27	13	8q24.3	NRBP2		Nuclear receptor-binding protein 2	615563				
8.579	7	13	09	8q24.3	OFC12		Orofacial cleft 12	612858		associated with rs987525	Orofacial cleft 12 (2)	
8.580	3	30	12	8q24.3	OPLAH, OPLAHD		5-oxoprolinase (ATP-hydrolyzing)	614243			5-oxoprolinase deficiency, 260005 (3)	
8.581	12	6	01	8q24.3	PTP4A3, PRL3		Protein-tyrosine phosphatase, type 4A, 3	606449				
8.582	1	7	14	8q24.3	PUF60, FIR, SIAHBP1, VRJS		Poly-U-binding splicing factor, 60kD	604819			Verheij syndrome, 615583 (3)	
8.583	6	3	15	8q24.3	PYCRL, PYCR3		Pyrroline-5-carboxylate reductase-like	616408				
8.584	10	18	19	8q24.3	RECQL4, RTS, RECQ4		DNA helicase, RecQ-like 4	603780			Rothmund-Thomson syndrome, type 2, , 268400 (3); Baller-Gerold syndrome, 218600 (3); RAPADILINO syndrome, 266280 (3)	
8.585	8	18	14	8q24.3	RHPN1, ODF5		Rhophilin 1	601031				
8.586	03	02	20	8q24.3	SCRIB, SCRB1, KIAA0147		Scribble planar cell polarity protein	607733				
8.587	02	27	20	8q24.3	SCX, SCXA, SCXB		Scleraxis bHLH transcription factor	609067				
8.588	3	11	08	8q24.3	SHARPIN, SIPL1		SHANK-associated RH domain interactor	611885				
8.589	6	24	02	8q24.3	SLC39A4, ZIP4		Solute carrier family 36 (zinc transporter), member 4	607059			Acrodermatitis enteropathica, 201100 (3)	
8.590	10	15	01	8q24.3	TOP1MT		Topoisomerase I, mitochondrial	606387				
8.591	12	30	09	8q24.3	TRAPPC9, NIBP, KIAA1882, MRT13		Trafficking protein particle complex 9	611966			Mental retardation, autosomal recessive 13, 613192 (3)	
8.592	11	20	98	8q24.3	TSTA3		Tissue-specific transplantation antigen-3	137020				
8.593	12	27	19	8q24.3	VPS28		VPS28 subunit of ESCRT-I	611952				
8.594	10	25	19	8q24.3	ZC3H3, SMICL		Zinc finger CCCH domain-containing protein 3	618640				
8.595	8	23	01	8q24.3	SLURP1, MDM		Secreted LY6/uPAR-related protein 1	606119			Meleda disease, 248300 (3)	
8.596	11	19	11	Chr.8	AIS3, VAMAS4		Autoimmune disease, susceptibility to, 3	608392			{Autoimmune disease, susceptibility to, 3} (2)	
8.597	5	28	99	Chr.8	IFNB3		Interferon, beta-3, fibroblast	147860		previously assigned to 2p23-qter		
8.598	5	22	03	8q21.11	KCNB2, KV2.2		Potassium channel, voltage-gated, shab-related subfamily, member 2	607738				
8.599	3	17	03	8q24.3	LYNX1		Lynx1, mouse, homolog of	606110				
8.600	1	30	01	8q11.23	LYPLA1		Lysophospholipase I	605599				
8.601	8	27	01	8q21.13	PAG		Phosphoprotein associated with glycosphingolipid-enriched microdomains	605767				
8.602	6	26	01	8q21.13	PKIA		Protein kinase, cAMP-dependent catalytic, inhibitor alpha	606059				
8.603	5	22	03	8p11.22	PLEKHA2, TAPP2		Pleckstrin homology domain-containing protein, family A, member 2	607773				
8.604	1	22	93	8p21.3	PPP3CC, CALNA3		Protein phosphatase-3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma)	114107				
8.605	3	10	03	8q21.11	RDH10		Retinol dehydrogenase 10	607599				
8.606	7	13	92	8q22.2	RPL30		Ribosomal protein L30	180467				
8.607	6	21	01	8q24.3	SCRT1		Scratch, mouse, homolog of	605858				
8.608	2	21	03	8q21.11	TCEB1		Transcription elongation factor B, polypeptide 1, 15kD (elongin C)	600788				
8.609	8	27	02	8p23.1	TNKS		TRF1-interacting, ankyrin-related ADP-ribose polymerase (tankyrase)	603303				8(Tnks)
8.610	9	20	00	8q13.3	TRAM		Translocating chain-associating membrane protein	605190				
9.1	10	23	87	9p24.1	RLN1		Relaxin, H1	179730				19(Rln1)
9.2	10	23	87	9p24.1	RLN2		Relaxin, H2	179740				
9.3	8	21	07	9p24.3	CBWD1		Cobalamin synthetase W domain-containing protein 1	611078				19(Cbwd)
9.4	8	29	11	9p24.3	DEL9p24.3, C9DELp24.3, SRXY4		Chromosome 9p24.3 deletion syndrome	154230			46XY sex reversal 4 (4)	
9.5	6	23	99	9p24.3	DMRT1, DMT1		Double sex and mab-3-related transcription factor-1	602424				
9.6	5	12	00	9p24.3	DMRT2		Double sex and mab-3-related transcription factor-2	604935				
9.7	8	3	12	9p24.3	DMRT3, DMRTA3		Doublesex-and mab3-related transcription factor 3	614754				
9.8	5	4	12	9p24.3	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2		KN motif- and ankyrin repeat domain-containing protein 1	607704			Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	
9.9	4	20	17	9p24.3	WASHC1, WASH1		WASH complex, subunit 1	613632		pseudogenes on 1p, 15q, 16p, Xq/Yq		
9.10	5	19	16	9p24.2	GLIS3, ZNF515, NDH		GLIS family zinc finger protein 3	610192			Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)	19(Glis3)
9.11	8	8	08	9p24-p23	PTPRD, PTPD, HPTP		Protein tyrosine phosphatase, receptor type, delta polypeptide	601598				4(Ptprd)
9.12	3	31	10	9p24.2	KCNV2, KV11.1, RCD3B		Potassium channel, voltage-gated, subfamily V, member 2	607604			Retinal cone dystrophy 3B, 610356 (3)	
9.13	3	19	01	9p24.1	PDCD1L2, PDL2		Programmed cell death 1 ligand 2	605723				19(Pdcd1l2)
9.14	02	27	20	9p24.2	PUM3, KIAA0020, HLA-HA8		Pumilio RNA-binding family, member 3	609960				
9.15	5	25	13	9p24.2	RFX3		Regulatory factor X, 3	601337				
9.16	7	1	13	9p24.1	AK3, AK3L1		Adenylate kinase 3	609290				4(Ak3)
9.17	8	19	13	9p24.1	CDC37L1, HARC, FLJ20639		CDC37-like 1	610346				
9.18	01	31	20	9p24.1	RIC1, CIP150, KIAA1432, CATIFA		RIC1 homolog, RAB6A GEF complex partner 1	610354			CATIFA syndrome, 618761 (3)	
9.19	4	1	08	9p24.1	IL33, C9orf26, NFEHEV		Interleukin 33	608678				19(Il33)
9.20	7	20	12	9p24.1	KDM4C, JMJD2C, GASC1, KIAA0780		Lysine-specific demethylase 4C	605469				
9.21	1	30	01	9p24.1	MLANA, MART1		Melan A	605513				
9.22	3	23	09	9p24.1	MIR101-2, MIRN101-2		Micro RNA 101-2	612512		another locus, MIRN101-1, on 1p31		
9.23	01	23	19	9p23-p22	NFIB, MACID		Nuclear factor I/B	600728			Macrocephaly, acquired, with impaired intellectual development, 618286 (3)	4(Nfib)
9.24	05	24	19	9p24.1	PLGRKT		Plasminogen receptor with C-terminal lysine	618444				
9.25	12	02	19	9p24.1	PLPP6, PPAPDC2		PPAP2 domain-containing protein 2	611666				
9.26	5	26	13	9p24.1	RCL1, RPCL1, RNAC		RNA terminal phosphate cyclase-like 1	611405				
9.27	7	11	17	9p24.1	TPD52L3		Tumor protein D52-like 3	617567				
9.28	12	22	16	9p24.1	TMEM261, DMAC1, C9orf123		Transmembrane protein 261	617261				
9.29	5	6	13	9p24.1	UHRF2, NIRF		Ubiquitin-like protein containing PDH and RING finger domains 2, E3 ubiquitin protein ligase	615211				
9.30	3	4	10	9p24.1-p22.1	FECD7, FCD4		Corneal dystrophy, Fuchs endothelial, 7	613271		max lod at D9S256	Corneal dystrophy, Fuchs endothelial, 7 (2)	
9.31	11	13	17	9p24.1	CD274, PDCD1LG1, B7H1		CD274 molecule	605402				
9.32	8	4	15	9p24.3	DOCK8		Dedicator of cytokinesis 8	611432			Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3)	
9.33	4	23	09	9p24.1	ERMP1, KIAA1815, FXNA		Endoplasmic reticulum metallopeptidase 1	611156				
9.34	5	24	13	9p24.2	SLC1A1, EAAC1, SCZD18, DCBXA		Solute carrier family 1, member 1 (high-affinity glutamate transporter; excitatory amino acid carrier 1)	133550		mutation identified in 1 SCZD18 family	{?Schizophrenia susceptibility 18}, 615232 (3); Dicarboxylic aminoaciduria, 222730 (3)	
9.35	11	6	95	9p24.1	INSL4		Insulin-like 4, placenta	600910				
9.36	11	1	01	9p24.1	INSL6		Insulin-like 6	606414				19(Insl6)
9.37	8	23	17	9p24.1	JAK2, THCYT3		Janus kinase 2 (a protein-tyrosine kinase)	147796			Polycythemia vera, somatic, 263300 (3); Thrombocythemia 3, 614521 (3); Myelofibrosis, somatic, 254450 (3); Erythrocytosis, somatic, 133100 (3); Leukemia, acute myeloid, somatic, 601626 (3); {Budd-Chiari syndrome, somatic}, 600880 (3)	19(Jak2)
9.38	11	30	15	9p24	MRD2		Mental retardation, autosomal dominant 2	614113		2 patients reported with genomic deletion or rearrangement including disruption of DOCK8	Mental retardation, autosomal dominant 2 (4)	
9.39	2	21	10	9p24.2	VLDLR, CAMRQ1		Very low density lipoprotein receptor	192977			Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3)	19(Vldlr)
9.40	10	30	08	9p24-p22	RLS3		Restless legs syndrome, susceptibility to, 3	610438		associated with rs4626664 and rs1975197	{Restless legs syndrome 3} (2)	
9.41	5	4	12	9p24.3	SMARCA2, SNF2L2, NCBRS		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2	600014			Nicolaides-Baraitser syndrome, 601358 (3)	19(Snf2l2)
9.42	12	30	14	9p23	LURAP1L, LRAP35B		Leucine-rich adaptor protein 1-like	616130				
9.43	09	06	18	9p23	MPDZ, MUPP1, HYC2		Multiple PDZ domain protein	603785			Hydrocephalus, congenital, 2, with or without brain or eye anomalies, 615219 (3)	
9.44	2	25	16	9p23	TYRP1, CAS2, GP75, SHEP11		Tyrosinase-related protein 1	115501			Albinism, oculocutaneous, type III, 203290 (3); [Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3)	4(b;trp1)
9.45	9	6	11	9p23-p13.3	MRT16		Mental retardation, autosomal recessive 16	614208		between rs10738277 and rs12376565	Mental retardation, autosomal recessive 16 (2)	
9.46	9	5	01	9p23-p11	FRDA2		Friedreich ataxia 2	601992			Friedreich ataxia 2 (2)	
9.47	1	7	11	9p23-p21.2	DFNB83		Deafness, autosomal recessive 83	613685		between rs4742645 and rs1471364	Deafness, autosomal recessive 83 (2)	
9.48	2	20	12	9p22.3	FREM1, C9orf154, BNAR, MOTA, TRIGNO2		FRAS1-related extracellular matrix protein 1	608944			Bifid nose with or without anorectal and renal anomalies, 608980 (3); Manitoba oculotrichoanal syndrome, 248450 (3); Trigonocephaly 2, 614485 (3)	
9.49	10	2	12	9p22.3	SNAPC3, SNAP50		Small nuclear RNA-activating protein complex, polypeptide 3	602348				
9.50	10	5	10	9p22.3	TTC39B		Tetratricopeptide repeat domain 39B	613574				
9.51	4	27	12	9p22.3	ZDHHC21, DHHC21		Zinc finger DHHC domain-containing protein 21	614605				
9.52	3	4	08	9p22.2	CNTLN, C9orf101, C9orf39		Centlein	611870				
9.53	8	3	06	9p22.3	PSIP1, LEDGF		PC4- and SFRS1-interacting protein 1	603620				
9.54	12	15	10	9p22.1	ACER2		Alkaline ceramidase 2	613492				
9.55	7	12	06	9p22.1	AD11		Alzheimer disease 11	609790		between D9S157 and D9S259	Alzheimer disease-11 (2)	
9.56	10	07	19	9p22.3-p22.2	BNC2, LUTO		Basonuclin 2	608669			Lower urinary tract obstruction, congenital, 618612 (3)	4(Bnc2)
9.57	9	7	10	9p22.1	HAUS6, DGT6, FAM29A		HAUS, augmin-like complex, subunit 6	613433				
9.58	1	21	01	9p22.1	PLIN2		Perilipin 2	103195				4(Plin2)
9.59	8	29	08	9p22.1	RRAGA, RAGA, FIP1		Ras-related GTP-binding protein A	612194				
9.60	4	10	15	9p22.1	SAXO1, FAM154A		Stabilizer of axonemal microtubules 1	616292				
9.61	2	25	14	9p22.1	SCARNA8		Small Cajal body-specific RNA 8	615646				
9.62	12	24	08	9p13.3	UBE2R2, UBC3B		Ubiquitin-conjugating enzyme E2R 2	612506				
9.63	5	27	09	9p22.2-p22.1	ADAMTSL1		ADAMTS-like protein 1	609198				4(Adamtsl1)
9.64	6	14	99	9p22.3	CER1		Cerebrus 1, Xenopus, homolog of	603777				4(Cer1)
9.65	5	4	01	9p24.1	GLDC, HYGN1, GCSP, GCE, NKH		Glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)	238300			Glycine encephalopathy, 605899 (3)	19(Gldc)
9.66	12	14	95	9p21.3	IFNA1, IFNA@		Interferon, alpha-1	147660		very close to IFF by Fd, LD; 15-30 genes	Interferon, alpha, deficiency (1)	4(Ifa)
9.67	12	14	95	9p21.3	IFNA2		Interferon, alpha-2	147562				
9.68	12	14	95	9p21.3	IFNA4		Interferon, alpha-4	147564				
9.69	12	14	95	9p21.3	IFNA5		Interferon, alpha-5	147565				
9.70	12	14	95	9p21.3	IFNA6		Interferon, alpha-6	147566				
9.71	12	14	95	9p21.3	IFNA7		Interferon, alpha-7	147567				
9.72	12	15	95	9p21.3	IFNA8		Interferon, alpha-8	147568				
9.73	12	15	95	9p21.3	IFNA10		Interferon, alpha-10	147577				
9.74	12	15	95	9p21.3	IFNA13		Interferon, alpha-13	147578				4(Ifna13)
9.75	12	15	95	9p21.3	IFNA14		Interferon, alpha-14	147579				
9.76	12	15	95	9p21.3	IFNA16		Interferon, alpha-16	147580				
9.77	12	15	95	9p21.3	IFNA17		Interferon, alpha-17	147583				
9.78	12	15	95	9p21.3	IFNA21		Interferon, alpha-21	147584				
9.79	7	13	93	9p21.3	MLLT3, AF9		Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 3	159558		fuses with ALL1		
9.80	5	4	00	9p22.2	SH3GL2, SH3P4		SH3 domain, GRB2-like, 2	604465				
9.81	1	20	06	9p22.1-p21.3	SLC24A2, NCKX2		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2	609838				
9.82	1	6	11	9p22-p21	DFNA47, DFNB83		Deafness, autosomal dominant 47	608652		between D9S268 and D9S942; possibly allelic to DFNB83	Deafness, autosomal dominant 47 (2)	
9.83	11	7	89	9p22-p21	LALL		Lymphomatous acute lymphoblastic leukemia	247640			Leukemia, acute lymphoblastic (2)	
9.84	05	14	19	9p13.3	UBAP1, UBAP, SPG80		Ubiquitin-associated protein 1	609787			Spastic paraplegia 80, autosomal dominant, 618418 (3)	
9.85	12	23	05	9p21.2-p21.1	LRRN6C, LINGO2, LERN3		Leucine-rich repeat protein, neuronal, 6C	609793				
9.86	2	20	11	9p21.1	ACO1, IREB1		Aconitase, soluble (iron-responsive element-binding protein-1)	100880				4(Aco1)
9.87	8	31	17	9p21.2	EMICER1		EQTN, MOB3B, IFNK, and C9orf72 enhancer RNA I, noncoding	617651				
9.88	8	31	17	9p21.2	EQTN, AFAF, SPACA8, C9orf11		Equatorin	617653				
9.89	7	23	13	9p21.2	IFNK		Interferon, kappa	615326				
9.90	08	12	19	9p21.2	IFT74, CCDC2, CMG1, BBS20		Intraflagellar transport 74	608040		mutation identified in 1 BBS20 patient	?Bardet-Biedl syndrome 20, 617119 (3)	
9.91	10	22	20	9p21.2	LRRC19		Leucine-rich repeat-containing protein 19	619068				4(Lrrc19)
9.92	8	30	17	9p21.2	MOB3B, MOB1D, MOBKL2B, C9orf35		MOB kinase activator 3B	617652				
9.93	6	27	17	9p21.2	PLAA, PLAP, NDMSBA		Phospholipase A2-activating protein	603873			Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, 617527 (3)	
9.94	07	14	20	9p21.1	DDX58, RIGI, SGMRT2		DExD/H-box helicase 58	609631			Singleton-Merten syndrome 2, 616298 (3)	
9.95	12	30	14	9p21.1	MIR873		Micro RNA 873	616137				
9.96	11	27	18	9p21.1	NDUFB6		NADH-ubiquinone oxidoreductase subunit B6	603322				
9.97	12	15	17	9p21.1	SMU1		DNA replication regulator and spliceosomal factor SMU1	617811				
9.98	3	13	08	9p21	AAA3		Aneurysm, familial abdominal 3	611891		associated with rs10757278	{Aneurysm, familial abdominal 3} (2)	
9.99	3	13	08	9p21	ANIB6		Aneurysm, intracranial berry, 6	611892		associated with rs10757278	{Aneurysm, intracranial berry, 6} (2)	
9.100	10	6	09	9p21	BCC5		Basal cell carcinoma, susceptibility to, 5	613062		associated with rs2151280	{Basal cell carcinoma, susceptibility to, 5} (2)	
9.101	7	7	15	9p21.2	C9orf72, FTDALS1, FTDALS, ALSFTD		Chromosome 9 open reading frame 72	614260			Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	
9.102	11	25	19	9p21.3	CDKN2A, MTS1, P16, MLM, CMM2		Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4)	600160			{Melanoma, cutaneous malignant, 2}, 155601 (3); {Melanoma and neural system tumor syndrome}, 155755 (3); {Melanoma-pancreatic cancer syndrome}, 606719 (3)	4(Cdkn2a)
9.103	7	10	95	9p21.3	CDKN2B, MTS2, P15, INK4B		Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)	600431		tandem with MTS1		
9.104	12	21	09	9p21.3	CDKN2BAS, ANRIL		CDKN2B antisense RNA	613149				
9.105	2	23	08	9p21	CHDS8		Coronary heart disease, susceptibility to, 8	611139		strongest linkage with dbSNP rs1333049	{Coronary heart disease, susceptibility to, 8} (2)	
9.106	09	19	19	9p21.3	ELAVL2, HELN1, HUB		ELAV-like RNA binding protein 2 (Hu antigen B)	601673				4(Hub)
9.107	4	10	90	9p21.3	IFNB1		Interferon, beta-1, fibroblast	147640		distal to IFL; ?9p23-p22; IFF duplicate in some		4(Ifb)
9.108	5	6	13	9p21.3	IFNE, INFE1, IFNT1		Interferon, epsilon	615223				
9.109	5	6	97	9p21.3	IFNW1		Interferon, omega-1	147553		pseudogene IFNWP2; interspersed with IFNA		
9.110	6	16	08	9p21	MFT2, TEM		Trichoepithelioma, multiple familial, 2	612099		max lod at D9S171	Trichoepithelioma, multiple familial, 2 (2)	
9.111	9	10	12	9p21.3	DMRTA1, DMRT4		Doublesex- and MAB3-related transcription factor A1	614803				4(Dmrta1))
9.112	5	4	12	9p21.3	FOCAD, KIAA1797		Focadhesin	614606				
9.113	4	13	10	9p21.3	GLM5		Glioma susceptibility 5	613030		associated with rs4977756	{Glioma susceptibility 5} (2)	
9.114	05	28	20	9p21.3	IZUMO3		IZUMO family, member 3	618896				
9.115	5	6	13	9p21.3	KLHL9, KIAA1354		Kelch-like 9	611201				4(Klhl9)
9.116	3	23	09	9p21.3	MIR31, MIRN31		Micro RNA 31	612155				
9.117	6	2	15	9p21.3	MIR31HG, LOC554202		Micro RNA 31 host gene, noncoding	616356				
9.118	8	18	14	9p21.3	PTPLAD2, HACD4		Protein tyrosine phosphatase-like A domain-containing protein 2	615941				
9.119	5	4	12	9p21.3	MTAP, DMSMFH		Methylthioadenosine phosphorylase	156540			Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3)	
9.120	1	6	93	9p22.1	RPS6		Ribosomal protein S6	180460				
9.121	12	23	16	9p21.2	TEK, TIE2, VMCM, GLC3E		TEK tyrosine kinase, endothelial	600221			Venous malformations, multiple cutaneous and mucosal, 600195 (3); Glaucoma 3, primary congenital, E, 617272 (3)	4(tek)
9.122	11	13	07	9p21.1	TOPORS, P53BP3, LUN, RP31		Topoisomerase I-binding arginine/serine-rich protein	609507			Retinitis pigmentosa 31, 609923 (3)	
9.123	10	30	06	9p21.2	TUSC1, TSG9		Tumor suppressor candidate 1	610529				4(Tusc1)
9.124	8	26	15	9p13.3	NPR2, ANPRB, AMDM, ECDM, SNSK		Natiuretic peptide receptor 2	108961			Acromesomelic dysplasia, Maroteaux type, 602875 (3); Epiphyseal chondrodysplasia, Miura type, 615923 (3); Short stature with nonspecific skeletal abnormalities, 616255 (3)	
9.125	10	17	05	9p13.3	RMRP, RMRPR, CHH		Mitochondrial RNA-processing endoribonuclease	157660			Cartilage-hair hypoplasia, 250250 (3); Metaphyseal dysplasia without hypotrichosis, 250460 (3); Anauxetic dysplasia 1, 607095 (3)	4(Rmrpn)
9.126	5	24	13	9p12	CNTNAP3, KIAA1714		Contactin-associated protein-like 3	610517				
9.127	9	9	08	9p13.2	FBXO10, FBX10		F-box only protein 10	609092				4(Fbxo10)
9.128	9	7	12	9p13.1	IGFBPL1, IGFBPRP4		Insulin-like growth factor binding protein-like 1	610413				
9.129	11	27	17	9p13.3	RUSC2, KIAA0375, IPORIN, MRT61		RUN and SH3 domain-containing 2	611053			Mental retardation, autosomal recessive 61, 617773 (3)	
9.130	12	4	03	9p13.3	STOML2		Stomatin-like protein 2	608292				
9.131	6	27	08	9p13.1-q21.11	OTSC8		Otosclerosis 8	612096		between D9S970 and D9S1799	Otosclerosis 8 (2)	
9.132	06	26	20	9p13.3	ANKRD18B		Ankyrin repeat domain-containing protein 18B	618930				
9.133	6	1	12	9p21.1	APTX, AOA, AOA1		Aprataxin	606350			Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	
9.134	2	1	11	9p13.3	CA9, MN		Carbonic anhydrase IX	603179		previously assigned to 17q21.2		
9.135	4	10	14	9p13.3	CCIN		Calicin	603960				
9.136	12	23	19	9p13.3	CHMP5		Charged multivesicular body protein 5	610900				
9.137	1	13	11	9p13.3	CLTA		Clathrin, light polypeptide (Lca)	118960		previously mapped to 12q23-q24		
9.138	9	16	16	9p13.3	CREB3, LZIP		cAMP response element-binding protein 3	606443				
9.139	2	6	13	9p13.3	DNAI1, CILD1, ICS, PCD		Dynein, axonemal, intermediate chain 1	604366			Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	
9.140	3	23	14	9p13.3	DNAJB5, KIAA1045, HSC40		DNAJ/HSP40 homolog, subfamily B, member 5	611328				
9.141	08	28	19	9p13.3	ENHO		Energy homeostasis-associated protein	618556				
9.142	4	17	13	9p13.3	GBA2, KIAA1605, SPG46		Glucosidase, beta, acid 2	609471			Spastic paraplegia 46, autosomal recessive, 614409 (3)	
9.143	2	21	13	9p13.3	GLIPR2, GAPR1, C9orf19		GLI pathogenesis-related 2	607141				
9.144	12	10	15	9p13.3	GNE, GLCNE, IBM2, DMRV, NM		UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase	603824			Sialuria, 269921 (3); Nonaka myopathy, 605820 (3)	
9.145	2	21	11	9p13.3	KIF24		Kinesin family member 24	613747				
9.146	02	12	19	9p13.3	MYORG, NET37, KIAA1161, IBGC7		Myogenesis-regulating glycosidase	618255			Basal ganglia calcification, idiopathic, 7, autosomal recessive, 618317 (3)	
9.147	10	15	13	9p13.3	MSMP, PSMP		Microseminoprotein, prostate-associated	612191				4(Psmp)
9.148	11	11	14	9p13.3	NFX1		Nuclear transcription factor, X box-binding, protein 1	603255				4(Nfx1)
9.149	8	27	15	9p13.3	PTENP1		Phosphatase and tensin homolog pseudogene 1 (functional)	613531				
9.150	4	29	14	9p13.3	RGP1, KIAA0258		RGP1 retrograde golgi transport, S. cerevisiae, homolog of	615742				
9.151	8	28	17	9p13.3	SPAAR, LINC00961		Small regulatory polypeptide of amino acid response	617627				
9.152	4	25	11	9p13.3	SPINK4, PEC60		Serine protease inhibitor, Kazal-type, 4	613929				
9.153	4	8	16	9p13.3	TMEM8B, NGX6, NAG5		Transmembrane protein 8B	616888				
9.154	09	11	19	9p13.3	UNC13B, UNC13, MUNC13		unc-13 homolog B	605836				
9.155	6	13	12	9p13.2	EXOSC3, RRP40, PCH1B		Exosome component 3	606489			Pontocerebellar hypoplasia, type 1B, 614678 (3)	
9.156	4	27	16	9p13.2	FRMPD1, FRMD2, KIAA0967		FERM and PDZ domains-containing protein 1	616919				
9.157	09	17	20	9p13.2	TOMM5, TOM5		Translocase of outer mitochondrial membrane 5	616169				
9.158	10	13	15	9p13.2	ZBTB5, KIAA0354		Zinc finger- and BTB domain-containing protein 5	616590				
9.159	05	16	19	9p13.3	TPM2, TMSB, AMCD1, DA1, DA2B4, NEM4		Tropomyosin-2, beta	190990			Arthrogryposis, distal, type 1A, 108120 (3); Arthrogryposis, distal, type 2B4, 108120 (3); Nemaline myopathy 4, autosomal dominant, 609285 (3); CAP myopathy 2, 609285 (3)	
9.160	4	2	01	9p13.1	ALDH1B1, ALDH5		Aldehyde dehydrogenase 1 family, member B1	100670				
9.161	2	28	03	9p13.3	AQP3		Aquaporin-3	600170		incorrectly mapped to chr.7	[Blood group GIL], 607457 (3)	
9.162	1	5	12	9p13.3	AQP7, GLYCQTL		Aquaporin-7	602974			[Glycerol quantitative trait locus], 614411 (3)	
9.163	7	11	02	9p21.1	B4GALT1, GGTB2, GT1, GTB, CDG2D		Glycoprotein-4-beta-galactosyltransferase-2 (EC 2.4.1.22)	137060			Congenital disorder of glycosylation, type IId, 607091 (3)	4(Ggtb)
9.164	8	29	02	9p13.3	CCL19, SCYA19, ELC, MIP3B		Chemokine, C-C motif, ligand 19	602227				
9.165	8	29	02	9p13.3	CCL21, SCYA21, SLC		Chemokine, C-C motif, ligand 21	602737				
9.166	8	29	02	9p13.3	CCL27, SCYA27, ILC, CTACK		Chemokine, C-C motif, ligand 27	604833				4(Scya27)
9.167	1	2	96	9p13.3	CNTFR		Ciliary neurotrophic factor receptor	118946				4(Cntfr)
9.168	12	4	02	9p13.3	DCTN3, DCTN22		Dynactin 3	607387				
9.169	6	10	02	9p13.3	GALT		Galactose-1-phosphate uridyltransferase	606999			Galactosemia, 230400 (3)	4(Galt)
9.170	8	25	11	9p13.3	IL11RA, CRSDA		Interleukin-11 receptor, alpha	600939			Craniosynostosis and dental anomalies, 614188 (3)	4(Il11ra, Etl2)
9.171	1	5	09	9p13.3	NOL6, NRAP		Nucleolar protein 6	611532				
9.172	9	3	99	9p13.3	NUDT2, APAH1		Nudix-type motif 1 (AP4A hydrolase-1)	602852				
9.173	2	21	14	9p13.2	PAX5, BSAP, ALL3		Paired box homeotic gene-5 (B-cell lineage specific activator protein)	167414			{Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3)	4(Pax5)
9.174	10	11	05	9p13	PEE3		Preeclampsia/eclampsia 3	609403			Preeclampsia/eclampsia 3 (2)	
9.175	8	20	12	9p13.3	PIGO, HPMRS2		Phosphatidylinositol glycan, class O	614730			Hyperphosphatasia with mental retardation syndrome 2, 614749 (3)	
9.176	10	5	10	9p13.3	PRSS3, TRY3, T9		Protease, serine, 3	613578				
9.177	12	14	10	9q21.2	PRUNE2, BMCC1, KIAA0367		PRUNE, Drosophila, homolog of, 2	610691				
9.178	12	24	08	9p13.2	RNF38		Ring finger protein 38	612488				
9.179	10	23	15	9p13.3	SIGMAR1, SRBP, ALS16, DSMA2		Sigma nonopioid intracellular receptor 1	601978		mutation identified in 1 ALS16 family and 1 DSMA2 family	?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3); ?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3)	
9.180	5	15	97	9p13.3	TESK1		Testis-specific protein kinase-1	601782				
9.181	7	13	11	9p13.3	XRCC9, FANCG		X-ray repair, complementing defective, in Chinese hamster, 9	602956			Fanconi anemia, complementation group G, 614082 (3)	
9.182	9	20	00	9p13.3	RECK, ST15		Reversion-inducing cysteine-rich protein with kazal motifs (suppressor of tumorigenicity 15)	605227				
9.183	2	20	02	9p13.3	SIT		SHP2-interacting transmembrane adaptor protein	604964				
9.184	3	19	01	9p13.3	SPAG8, SMP1		Sperm-associated antigen 8	605731				
9.185	12	17	15	9p13.3	VCP, IBMPFD1, ALS14, CMT2Y		Valosin-containing protein	601023			Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3); Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3); Charcot-Marie-Tooth disease, type 2Y, 616687 (3)	4(Vcp)
9.186	11	13	96	9p13.3	BAG1		BCL2-associated athanogene	601497				
9.187	6	8	95	9p13.1	SHB		SHB adaptor protein (a Src homology 2 protein)	600314				
9.188	11	6	00	9p12-q12	ACP		Cerebral palsy, ataxic, autosomal recessive	605388			Cerebral palsy, ataxic, autosomal recessive (2)	
9.189	2	18	96	9q21.11	PGM5		Phosphoglucomutase-5	600981				19(Pgm5)
9.190	8	26	15	9q21.11	FOXD4L4, FOXD4L2		Forkhead box D4-like 4	611085				
9.191	3	24	06	9p13.3	HINT2		Histidine triad nucleotide-binding protein 2	609997				
9.192	3	8	95	9p11	MROS		Melkersson-Rosenthal syndrome	155900			?Melkersson-Rosenthal syndrome (2)	
9.193	11	4	91	9p13.3	CD72, LYB2		CD72 antigen	107272				4(Lyb2)
9.194	1	24	09	9p	DEL9p, C9DELp		Chromosome 9p deletion syndrome	158170			Chromosome 9p deletion syndrome (4)	
9.195	12	17	07	9p	HDLCQ1		High density lipoprotein cholesterol level QTL 1	606613			[High density lipoprotein cholesterol level QTL 1] (2)	
9.196	10	1	95	9p13.3	TLN1		Talin 1	186745				
9.197	11	22	99	9p13.2	GRHPR, GLXR		Glyoxylate reductase/hydroxypyruvate reductase	604296			Hyperoxaluria, primary, type II, 260000 (3)	
9.198	6	11	94	9q34.11	FPGS		Folylpolyglutamate synthetase	136510				2(Fpgs)
9.199	3	15	10	9q	HCHGQ2		Hematocrit/hemoglobin quantitative trait locus 2	609320			[Hematocrit/hemoglobin quantitative trait locus 2] (2)	
9.200	4	27	12	9q	SPG19		Spastic paraplegia-19	607152			Spastic paraplegia 19, autosomal dominant (2)	
9.201	1	25	91	9q21.13	ANXA1, LPC1		Annexin A1 (lipocortin I)	151690				19(Lpc1)
9.202	1	29	01	9q22.32	BARX1		BarH-like homeo box gene 1	603260				
9.203	10	23	87	9q12	DNCM		Cytoplasmic membrane DNA	126330		in 9qh		
9.204	10	13	15	9q12	SPATA31A7, AEP1, FAM75A7, C9orf36		Spermatogenesis-associated protein 31, subfamily A, member 7	616584				
9.205	7	17	14	9q21.11	TJP2, ZO2, PFIC4		Tight junction protein 2	607709			Hypercholanemia, familial, 607748 (3); Cholestasis, progressive familial intrahepatic 4, 615878 (3)	
9.206	1	13	99	9q21.12	BTEB1, BTEB		Basic transcription element-binding protein 1	602902				
9.207	8	21	07	9q21.11	CBWD3		Cobalamin synthetase W domain-containing protein 3	611080				
9.208	11	12	96	9q13	CMD1B, CMPD1, FDC		Cardiomyopathy, dilated-1B, autosomal dominant	600884			Cardiomyopathy, dilated 1B (2)	
9.209	8	21	07	9q21.11	FOXD4L3		Forkhead box D4-like 3	611086				
9.210	11	30	06	9q21.11	FXN, FRDA, FARR, X25		Frataxin	606829			Friedreich ataxia, 229300 (3); Friedreich ataxia with retained reflexes, 229300 (3)	
9.211	4	10	02	9q21.13	GCNT1		Glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase)	600391				13(Gcnt1)
9.212	9	18	98	9q21.11	PIP5K1B, STM7, MSS4		Phosphatidylinositol-4-phosphate 5-kinase, type I, beta	602745				
9.213	2	13	98	9q13-q21	GSM1, GSP		Geniospasm 1	190100			Geniospasm (2)	
9.214	2	26	02	9q21.13	TMC1, DFNB7, DFNB11, DFNA36		Transmembrane channel-like protein 1	606706			Deafness, autosomal recessive 7, 600974 (3); Deafness, autosomal dominant 36, 606705 (3)	19(Tmc1, dn, Bth)
9.215	4	26	01	9q21.13	TMEM2		Transmembrane protein 2	605835				19(Tmem2)
9.216	5	7	03	9q21.12	X123		X123 gene	607710				
9.217	1	16	07	9q21.13	ZFAND5, ZNF216		Zinc finger AN1 domain-containing protein 5	604761				19(Znf216)
9.218	7	22	13	9q13-q22	CTRCT26, CAAR		Cataract 26, multiple types	605749			Cataract 26, multiple types (2)	
9.219	1	28	88	9q21.13	ALDH1A1		Aldehyde dehydrogenase-1 family, member A1, soluble	100640				19(Ahd2)
9.220	1	3	00	9q21.2	GNA14		Guanine nucleotide-binding protein, alpha-14	604397				
9.221	6	11	13	9q21.2	GNAQ, SWS, CMC1		Guanine nucleotide-binding protein (G protein), q	600998		pseudogene on 2q	Sturge-Weber syndrome, somatic, mosaic, 185300 (3); Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3)	
9.222	08	21	19	9q22.31	IARS1, IARS, GRIDHH		Isoleucine-tRNA synthetase 1	600709			Growth retardation, impaired intellectual development, hypotonia, and hepatopathy, 617093 (3)	
9.223	10	15	09	9q21	PVOP2		Pelvic organ prolapse, susceptibility to, 2	613088		between rs4077632 and rs10868525	{Pelvic organ prolapse, susceptibility to, 2} (2)	
9.224	12	27	19	9q21.2	VPS13A, CHAC		Vacuolar protein sorting 13 homolog A (chorein)	605978			Choreoacanthocytosis, 200150 (3)	
9.225	10	20	92	9q22.33	COL15A1		Collagen XV, alpha-1 polypeptide	120325				4(Col15a1)
9.226	3	22	93	9q21.33	CTSL		Cathepsin L	116880		\'like\' sequence on 10q23-q24		13(Ctsl)
9.227	1	10	12	9q21-q22	ETL4, ETOLM		Epilepsy, familial temporal lobe, 4	611631		between GATA152H04 and D9S253	Epilepsy, familial temporal lobe, 4 (2)	
9.228	1	12	08	9q21.32	FRMD3, EPB41LO		FERM domain-containing 3	607619				
9.229	1	29	01	9q21.2	PCA3, DD3		Prostate cancer antigen 3	604845				
9.230	12	27	16	9q21.11	FAM122A, C9orf42		Family with sequence similarity 122, member A	617249				
9.231	9	16	09	9q21.13	RFK		Riboflavin kinase	613010				
9.232	11	1	10	9q21.11	DFNA51, C9DUPq21.11, DUP9q21.11		Deafness, autosomal dominant 51 (chromosome 9q21.11 duplication syndrome)	613558		259kb duplication involving TJP2 and FAM189A2	Deafness, autosomal dominant 51 (4)	
9.233	10	2	13	9p24.3	FOXD4, FKHL9		Forkhead box D4	601092				19(Foxd4)
9.234	7	20	09	9q21.12	MAMDC2		MAM domain-containing 2	612879				
9.235	12	28	15	9q21.12	MIR204, MIRN204, RDICC		Micro RNA 204	610942		mutation identified in 1 RDICC family	?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3)	
9.236	9	1	16	9q21.11	PRKACG, BDPLT19		Protein kinase, cAMP-dependent, catalytic, gamma	176893		mutation identified in 1 BDPLT19 family	?Bleeding disorder, platelet-type, 19, 616176 (3)	
9.237	10	4	05	9q21.12	SMC5L1, SMC5, KIAA0594		Structural maintenance of chromosomes 5-like 1	609386				
9.238	1	4	16	9q21.11	ZNF658		Zinc finger protein 658	616290				
9.239	8	20	98	9q21.12	APBA1, X11, D9S411E, MINT1, LIN10		Amyloid beta A4 precursor protein-binding, family A, member 1	602414				
9.240	10	31	08	9q21.12-q21.13	TRPM3, MLSN2, LTRPC3, KIAA1616		Transient receptor potential cation channel, subfamily M, member 3	608961				
9.241	05	08	20	9q21.13	ABHD17B, FAM108B1		Abhydrolase domain-containing protein 17B, depalmitoylase	617943				
9.242	9	24	15	9q21.13	CARNMT1, C9orf41, UPF0586		Carnosine N-methyltransferase 1	616552				
9.243	9	9	13	9q21.13	GDA, CYPIN		Guanine deaminase	139260				
9.244	8	3	18	9q21.13	NMRK1, C9orf95		Nicotinamide riboside kinase 1	608704				
9.245	12	27	16	9q21.13	OSTF1, OSF, SH3P2		Osteoclast-stimulating factor 1	610180				
9.246	12	6	16	9q21.2	CEP78, CRDHL		Centrosomal protein, 78kD	617110			Cone-rod dystrophy and hearing loss, 617236 (3)	
9.247	6	26	00	9q21.32	UBQLN1, DA41		Ubiquilin 1 (Da41, rat, homolog of)	605046				
9.248	08	29	19	9q21.33	ISCA1, HBLD2, HISCA, MMDS5		Iron-sulfur cluster assembly 1	611006			Multiple mitochondrial dysfunctions syndrome 5, 617613 (3)	
9.249	5	1	97	9q21.13	PCSK5		Proprotein convertase subtilisin/kexin type 5	600488		?close to LPC1 on 9q		19(Pcsk5)
9.250	03	19	20	9q21.32	TLE1, ESG1, GRG1		TLE family member 1, transcptional corepressor	600189		conflicting assignment to chr.19		
9.251	4	15	09	9q22.31	ASPN, PLAP1, OS3		Asporin	608135			{Osteoarthritis susceptibility 3}, 607850 (3); {Lumbar disc degeneration}, 603932 (3)	
9.252	3	13	06	9q21.3-q22	FHL1, HPLH1, HLH1		Hemophagocytic lymphohistiocytosis, familial, 1	267700			Hemophagocytic lymphohistiocytosis, familial, 1 (2)	
9.253	3	18	94	9q21.33	GAS1		Growth arrest-specific gene-1	139185				13(Gas1)
9.254	10	2	14	9q21.2	PSAT1, PSAT, EPIP, PSATD, NLS2		Phosphoserine aminotransferase 1	610936		mutation identified in 1 PSATD family	?Phosphoserine aminotransferase deficiency, 610992 (3); Neu-Laxova syndrome 2, 616038 (3)	
9.255	3	23	14	9q21.32	C9orf64		Chromosome 9 open reading frame 64	611342				
9.256	3	23	14	9q21.32	C9orf103		Chromosome 9 open reading frame 103	611343				
9.257	4	2	16	9q21.32	GKAP1, GKAP42		G kinase-anchoring protein 1	611356				
9.258	5	26	13	9q21.32	KIF27		Kinesin family member 27	611253				
9.259	5	24	13	9q21.32	MIR7-1		Micro RNA 7-1	615239				
9.260	2	23	14	9q21.32	RASEF		RAS and EF-hand domains-containing protein	611344				
9.261	08	21	18	9q21.32	RMI1, BLAP75, C9orf76		RecQ-mediated genome instability 1, S. cerevisiae, homolog of	610404				
9.262	10	13	15	9q21.32	HNRNPK, HNRPK, AUKS		Heterogeneous nuclear ribonucleoprotein K	600712			Au-Kline syndrome, 616580 (3)	
9.263	01	11	19	9q21.33	AGTPBP1, NNA1, KIAA1035, CCP1, CONDCA		ATP/GTP-binding protein 1	606830			Neurodegeneration, childhood-onset, with cerebellar atrophy, 618276 (3)	
9.264	8	14	14	9q21.33	GOLM1, GOLPH2, GP73, C9orf155		Golgi membrane protein 1	606804				
9.265	11	05	20	9q21.33	NTRK2, TRKB, OBHD, DEE58		Neurotrophic tyrosine kinase, receptor, type 2	600456			Obesity, hyperphagia, and developmental delay, 613886 (3); Developmental and epileptic encephalopathy 58, 617830 (3)	
9.266	10	25	19	9q21.33	TUT6, ZCCHC6, KIAA1711		Terminal uridylyl transferase 7	613467				
9.267	01	03	20	9q22.33	ALG2, CDGII, CMSTA3, CMS14		ALG2 alpha-1,3/1,6-mannosyltransferase	607905		mutation identified in 1 CDGII patient	?Congenital disorder of glycosylation, type Ii, 607906 (3); Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)	
9.268	9	2	08	9q31.1	CSMF		Chondrosarcoma, extraskeletal myxoid, fused to EWS in	600542		t(9;17)(q22;q11); t(9;22)(q22;q11-q12)	Chondrosarcoma, extraskeletal myxoid, 612237 (3)	
9.269	9	2	15	9q22.33	FOXE1, FKHL15, TITF2, TTF2, NMTC4		Forkhead box E1 (thyroid transcription factor-2)	602617			Bamforth-Lazarus syndrome, 241850 (3); {Thyroid cancer, nonmedullary, 4}, 616534 (3)	4(Titf2)
9.270	10	5	10	9q22.33	GALNT12, CRCS1		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12	610290			{Colorectal cancer, susceptibility to, 1}, 608812 (3)	
9.271	1	23	07	9q22.33	HEMGN, EDAG		Hemogen	610715				4(Hemgn)
9.272	11	17	94	9q22.32	HSD17B3, EDH17B3		Hydroxysteroid (17-beta) dehydrogenase 3	605573			Pseudohermaphroditism, male, with gynecomastia, 264300 (3)	
9.273	8	25	04	9q22	JOAG2		Glaucoma, primary open angle, juvenile-onset, 2	608695		between D9S1803 and D9S196	Glaucoma, primary open angle, juvenile-onset, 2 (2)	
9.274	6	9	98	9q22.31	NINJ1		Ninjurin	602062				13(Ninj1)
9.275	2	2	01	9q22.31	PHF2		PHD finger protein-2	604351				
9.276	8	14	00	9q22.31	ROR2, BDB1, BDB, NTRKR2		Receptor tyrosine kinase-like orphan receptor 2	602337			Brachydactyly, type B1, 113000 (3); Robinow syndrome, autosomal recessive, 268310 (3)	13(Ror2)
9.277	03	19	19	9q21.13	RORB, RZRB, EIG15		RAR-related orphan receptor B	601972			{Epilepsy, idiopathic generalized, susceptibility to, 15}, 618357 (3)	4(Rorb)
9.278	7	3	06	9q22	STQTL8		Stature quantitative trait locus 8	610114		between GATA81C04M and ATA18A07M	{Stature QTL 8} (2)	
9.279	1	7	95	9q22.2	SYK		Spleen tyrosine kinase	600085				13(Syk)
9.280	4	7	14	9q22.33	TGFBR1, ALK5, AAT5, LDS1, MSSE		Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD)	190181			Loeys-Dietz syndrome 1, 609192 (3); {Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3)	4(Tgfbr1)
9.281	9	30	02	9q21.13	TRPM6, CHAK2, HOMG1		Transient receptor potential cation channel, subfamily M, member 6	607009			Hypomagnesemia 1, intestinal, 602014 (3)	
9.282	08	19	19	9q31.1	ABCA1, ABC1, HPALP1, TGD, HDLCQTL13		ATP-binding cassette 1	600046			Tangier disease, 205400 (3); HDL deficiency, familial, 1, 604091 (3)	
9.283	12	27	01	9q22.33	TRIM14, KIAA0129		Tripartite motif-containing protein 14	606556				
9.284	10	15	98	9q31.1	ZNF189		Zinc finger protein-189	603132				
9.285	4	17	13	9q22.1	CDK20, CCRK, CDCH, P42		Cyclin-dependent kinase 20	610076				
9.286	11	05	20	9q22.33	GABBR2, GPR51, DEE59, NDPLHS		Gamma-aminobutyric acid B receptor 2	607340			{Nicotine dependence, susceptibility to}, 188890 (3); {Nicotine dependence, protection against}, 188890 (3); Developmental and epileptic encephalopathy 59, 617904 (3); Neurodevelopmental disorder with poor language and loss of hand skills, 617903 (3)	
9.287	7	12	13	9q22.1	NXNL2, RDCVF2		Nucleoredoxin-like protein 2	615299				13(Nxnl2)
9.288	11	11	14	9q22.1	SHC3, NSHC, RAI, SHCC		SHC transforming protein 3	605263				
9.289	9	18	08	9q22.1	S1PR3, EDG3		Sphingosine-1-phosphate receptor 3	601965				
9.290	5	25	00	9q22.2	GADD45G, GRP17		Growth arrest- and DNA damage-inducible gene 45, gamma	604949				
9.291	10	11	00	9q22.31	NFIL3, NFIL3A, E4BP4		Nuclear factor, interleukin 3-regulated	605327				
9.292	3	2	06	9q22.1	SPIN, SPIN1		Spindlin	609936				
9.293	3	5	01	9q22.31	SPTLC1, LBC1, SPT1, HSN1, HSAN		Serine palmitoyltransferase, long-chain base subunit 1	605712			Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	
9.294	3	31	15	9q22.2	CKS2		CDC2-associated protein CKS2	116901				
9.295	08	12	19	9q22.33	CTSV, CTSL2		Cathepsin V	603308				
9.296	3	31	15	9q22.2	DIRAS2		DIRAS family, GTP-binding Ras-like protein 2	607863				
9.297	11	9	05	9q22.2	SECISBP2, SBP2		Selenocysteine insertion sequence-binding protein 2	607693			Thyroid hormone metabolism, abnormal, 609698 (3)	
9.298	9	27	17	9q22.2	SEMA4D, SEMAJ, CD100, COLL4		Semaphorin 4D	601866				
9.299	3	22	07	9q21.32-q21.33	SLC28A3, CNT3		Solute carrier family (sodium-coupled nucleoside transporter), member 3	608269				
9.300	11	13	07	9q22.32	FBP1		Fructose-bisphosphatase 1	611570			Fructose-1,6-bisphosphatase deficiency, 229700 (3)	
9.301	4	30	09	9q31.1	ALDOB		Aldolase B, fructose-bisphosphatase	612724			Fructose intolerance, hereditary, 229600 (3)	4(Aldo2)
9.302	5	2	03	9q31.1	BAAT		Bile acid coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase)	602938			Hypercholanemia, familial, 607748 (3)	4(Baat)
9.303	03	09	20	9q22.31	BICD2, KIAA0699, SMALED2A, SMALED2B		BICD carbo adaptor 2	609797			Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant, 615290 (3); Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant, 618291 (3)	
9.304	10	20	99	9q22.33	CORO2A, WDR2, IR10		Coronin 2A	602159				
9.305	6	14	99	9q22.31	ECM2		Extracellular matrix protein-2	603479				
9.306	4	19	11	9q22.32	FANCC, FACC		Fanconi anemia, complementation group C	613899			Fanconi anemia, complementation group C, 227645 (3)	13(Facc)
9.307	5	4	00	9q22.31	OGN, OIF		Osteoglycin	602383				
9.308	08	08	19	9q22.32	PTCH1, NBCCS, BCNS, HPE7		Patched 1	601309			Basal cell nevus syndrome, 109400 (3); Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3)	13(Ptc)
9.309	2	3	05	9q22.32	SLC35D2, HFRC1, SQV7L		Solute carrier family 35, member D2	609182				
9.310	3	22	06	9q22.33	TBC1D2, PARIS1		TBC1 domain family, member 2	609871				
9.311	5	20	99	9q22.33	TMOD		Tropomodulin	190930				4(Tmod)
9.312	5	26	05	9q22.31	WNK2, PRKWNK2		WNK lysine deficient protein kinase 2	606249				
9.313	8	30	07	9q22.33	XPA, XPAC		XPA complementing gene	611153			Xeroderma pigmentosum, group A, 278700 (3)	4(Xpa)
9.314	1	12	99	9q22.32	ZNF169		Zinc finger protein-169	603404				
9.315	5	9	97	9q22.33	NCBP1		Nuclear cap binding protein 1, 80kD	600469		in 500kb of XPA		4(Ncbp)
9.316	8	9	12	9q22.31	AUH		AU-specific RNA-binding protein (3-methylglutaconyl-CoA hydratase)	600529			3-methylglutaconic aciduria, type I, 250950 (3)	
9.317	10	08	07	9q22.31	CENPP		Centromeric protein P	611505				
9.318	9	24	08	9q22.31	FAM120A, C9orf10, KIAA0183		Family with sequence similarity 120, member A	612265				
9.319	6	30	17	9q22.31	FGD3, ZFYVE5		FYVE, RhoGEF, and Ph domain-containing protein 3	617554				
9.320	10	07	20	9q22.31	IPPK, IP5K		Inositol-pentakisphosphate 2-kinase	619043				
9.321	06	26	20	9q22.31	OMD, OSAD		Osteomodulin	618926				
9.322	6	23	15	9q22.31	SUSD3		SUSHI domain-containing protein 3	616429				
9.323	10	25	17	9q22.31	CARD19, BINCARD, C9orf89		Caspase recruitment domain-containing protein 19	617726				
9.324	4	10	14	9q22.32	ERCC6L2, RAD26L, BMFS2		ERCC6-like 2	615667			Bone marrow failure syndrome 2, 615715 (3)	
9.325	11	21	18	9q22.32	HABP4, IHABP4		Hyaluronan-binding protein 4	617369				
9.326	3	23	09	9q22.32	MIR189, MIRN24-1		Micro RNA 24-1	609705				
9.327	3	23	09	9q22.32	MIR23B, MIRN23B		Micro RNA 23B	610723				
9.328	3	23	09	9q22.32	MIR27B, MIRN27B		Micro RNA 27B	610636				
9.329	3	23	09	9q22.32	MIRLET7A1, LET7A1, MIRNLET7A1		Micro RNA Let7a1	605386				
9.330	3	23	09	9q22.32	MIRLET7D, LET7D, MIRNLET7D		Micro RNA Let7d	612145				
9.331	3	23	09	9q22.32	MIRLET7F1, LET7F1, MIRNLET7F1		Micro RNA Let7f1	612146				
9.332	8	20	08	9q22.31	NOL8, NOP132		Nucleolar protein 8	611534				
9.333	8	19	13	9q22.32	ZNF367, AFF29		Zinc finger protein 367	610160				
9.334	08	23	19	9q22.32-q22.33	CDC14B		Cell division cycle 14B	603505				
9.335	9	9	13	9q22.33	ANKS6, PKDR1, NPHP16		Ankyrin repeat and sterile alpha motif domains-containing protein 6	615370			Nephronophthisis 16, 615382 (3)	
9.336	8	29	16	9q22.33	NANS, SAS, SEMDCG		N-acetylneuraminic acid synthase (sialic acid synthase)	605202			Spondyloepimetaphyseal dysplasia, Camera-Genevieve type, 610442 (3)	
9.337	01	04	19	9q22.33	SEC61B		SEC61 translocon, beta subunit	609214				
9.338	7	23	13	9q22.33	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36		Tudor domain-containing protein 7	611258			Cataract 36, 613887 (3)	
9.339	1	12	07	9q31.3	ACTL7A		Actin-like 7A	604303				4(Actl7a)
9.340	1	12	07	9q31.3	ACTL7B		Actin-like 7B	604304				4(Actl7b)
9.341	10	11	17	9q31.1	CAVIN4, MURC		Caveolae-associated protein 4	617714				
9.342	09	27	18	9q31.2	FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4		Fukutin	607440			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3); Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3); Cardiomyopathy, dilated, 1X, 611615 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	
9.343	3	20	06	9q31.2	FSD1NL, FSD1L, MIR1, CCDC10		FSD1 N-terminus-like protein	609829				
9.344	2	2	11	9q31	HSCR5		Hirschsprung disease, susceptibility to, 5	600156			{Hirschsprung disease, susceptibility to, 5} (2)	
9.345	02	12	20	9q31.3	ELP1, IKBKAP, IKAP		Elongator complex protein 1	603722			Dysautonomia, familial, 223900 (3)	
9.346	8	12	03	9q31.1	INVS, INV, NPHP2, NPH2		Inversin	243305			Nephronophthisis 2, infantile, 602088 (3)	
9.347	1	29	01	9q31.2	KLF4, EZF, GKLF		Kruppel-like factor 4	602253				4(Ezf)
9.348	12	20	05	9q31	PAND2		Panic disorder 2	607853		max lod at D9S271	Panic disorder 2 (2)	
9.349	12	19	01	9q34.11	SIAT7D, SIAT3C		Sialyltransferase 7D	606378				
9.350	12	8	04	9q31.1	STX17		Syntaxin 17	604204				
9.351	8	28	15	9q31.2	TAL2		T-cell acute lymphocytic leukemia-2	186855		33kb from breakpoint in t(7;9)	Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	4(Tal2)
9.352	6	14	99	9q31.1	TMEFF1, C9orf2		Transmembrane protein with EGF-like and 2 follistatin-like domains 1	603421				
9.353	5	9	95	9q31.3	TXN		Thioredoxin	187700		incorrectly assigned to 3		4(Txn)
9.354	8	10	98	9q31.3	UGCG, GCS		UDP-glucose ceramide glucosyltransferase	602874				4(Ugcg)
9.355	4	21	10	9q31.3	EPB41L4B, EHM2		Erythrocyte membrane protein band 4.1-like 4B	610340				
9.356	6	29	05	9q31-q32	HNP1		Hypertensive nephropathy	608026			Hypertensive nephropathy (2)	
9.357	11	4	98	9q32	SLC31A1, COPT1, CTR1		Solute carrier family 31 (copper transporter), member 1	603085				
9.358	12	13	00	9q32	SLC13A2, COPT2, CTR2		Solute carrier family 31 (copper transporter), member 2	603088				
9.359	11	22	04	9q31.3	AKAP2, AKAPKL, KIAA0920, PALM2		A-kinase anchor protein 2	604582		multiple splice variants		
9.360	09	19	19	9q32	PRPF4, PRP4, HPRP4, RP70		Pre-mRNA processing factor 4	607795			Retinitis pigmentosa 70, 615922 (3)	
9.361	3	5	98	9q32	RGS3		Regulator of G-protein signaling-3	602189				
9.362	12	17	07	9q32	SLC46A2, TSCOT		Solute carrier family 46, member 2	608956				4(Slc46a2)
9.363	1	19	07	9q31-q34	SPDA2		Spondyloarthropathy, susceptibility to, 2	183840		max lod at D9S1776	{Spondyloarthropathy, susceptibility to, 2} (2)	
9.364	09	27	18	9q33.1	TRIM32, HT2A, LGMDR8, BBS11		Tripartite-motif-containing protein 32	602290		mutation identified in 1 BBS11 family	Muscular dystrophy, limb-girdle, autosomal recessive 8, 254110 (3); ?Bardet-Biedl syndrome 11, 615988 (3)	
9.365	11	30	12	9q31.1	CHDT3		Congenital heart defects, multiple types, 3	614954		max lod at D9S1690	Congenital heart defects, multiple types, 3 (2)	
9.366	3	24	09	9q31.1	CYLC2		Cylicin 2	604035				
9.367	3	24	09	9q31.1	GRIN3A, NR3A		Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	606650				
9.368	3	5	08	9q31.1	MRPL50		Mitochondrial ribosomal protein L50	611854		pseudogenes on 2, 5, and 10		
9.369	9	16	12	9q31.1	NIPSNAP3A, TASSC		NIPSNAP, C. elegans, homolog of, 3A	608871				
9.370	4	15	11	9q31.1	PPP3R2, PPP3RL, CBLP		Protein phosphatase 3, regulatory subunit B, beta	613821				
9.371	4	21	14	9q31.1	RNF20, BRE1A		Ring finger protein 20	607699				
9.372	12	23	15	9q31.1	TEX10		Testis-expressed gene 10	616717				
9.373	10	7	13	9q31.1	TXNDC4, KIAA0573		Thioredoxin domain-containing protein 4	609170				
9.374	1	12	07	9q31.3	CTNNAL1		Catenin, alpha-like, 1	604785				
9.375	7	20	09	9q31.2	MENAQ3		Menarche, age at, QTL3	612883		associated with rs2090409	{Menarche, age at, QTL3} (2)	
9.376	08	21	19	9q31.2	RAD23B		RAD23 homolog B, nucleotide excision repair protein	600062		previously 3p25.1		4(Rad23b)
9.377	05	04	20	9q31.1-q31.2	SLC44A1, CTL1, CDW92, CONATOC		Solute carrier family 44, member 1	606105			Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline, 618868 (3)	
9.378	2	8	13	9q31.2	TMEM38B, TRICB, OI14		Transmembrane protein 38B	611236			Osteogenesis imperfecta, type XIV, 615066 (3)	
9.379	10	11	19	9q31.2	ZNF462, KIAA1803, WSKA		Zinc finger protein 462	617371			Weiss-Kruszka syndrome, 618619 (3)	
9.380	9	22	08	9q31.2-q34.2	IS4		Scoliosis, idiopathic, susceptibility to, 4	612238		max lod at D9S2157	{Scoliosis, idiopathic, susceptibility to, 4} (2)	
9.381	12	18	19	9q31.3	SHOC1, C9orf84, ZIP2		Shortage in chiasmata 1	618038				
9.382	10	23	20	9q31.3	FRRS1L, C9orf4, CG6, DEE37		Ferric-chelate reductase 1-like	604574			Developmental and epileptic encephalopathy 37, 616981 (3)	
9.383	5	25	13	9q31.3	GNG10		Guanine nucleotide-binding protein, gamma 10	604389				
9.384	02	20	20	9q31.3	ECPAS, ECM29, KIAA0368		ECM29 proteasome adaptor and scaffold protein	616694				
9.385	9	18	08	9q31.3	LPAR1, EDG2, LPA1, VZG1		Lysophosphatidic acid receptor 1	602282				4(vzg1)
9.386	3	23	09	9q31.3	MIR32, MIRN32		Micro RNA 32	609355				
9.387	4	10	14	9q31.3	PTGR1, LTB4DH		Prostaglandin reductase 1	601274				
9.388	8	8	13	9q31.3	PTPN3, PTPH1		Protein-tyrosine phosphatase, nonreceptor-type, 3	176877				
9.389	04	11	19	9q31.3	MUSK, CMS9, FADS1		Receptor tyrosine kinase MuSK	601296			Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3); Fetal akinesia deformation sequence 1, 208150 (3)	4(Musk)
9.390	08	08	18	9q32	ATP6V1G1, ATP6G1		ATPase, H+ transporting, V1 subunit G1	607296				
9.391	08	23	19	9q32	CDC26, APC12		Cell division cycle 26	614533		pseudogene on 7q32.1		
9.392	08	01	18	9q32	COL27A1, KIAA1870, STLS		Collagen, type XXVII, alpha-1	608461			Steel syndrome, 615155 (3)	4(Col27a1)
9.393	02	12	19	9q33.1	DEC1		Deleted in esophageal cancer 1	604767				
9.394	3	27	17	9q32	FKBP15, FKBP133, KIAA0674, WAFL		FK506-binding protein 15	617398				
9.395	4	30	09	9q32	IBD16		Inflammatory bowel disease 16, susceptibility to	612259			{Inflammatory bowel disease 16} (2)	
9.396	8	2	17	9q32	INIP, C9orf80, SOSSC		INST3- and NABP-interacting protein	613273				
9.397	3	9	17	9q32	KIAA1958		KIAA1958 gene	617390				
9.398	8	19	13	9q32	KIF12		Kinesin family member 12	611278				
9.399	08	13	20	9q32	PTBP3, ROD1		Polypyrimidine tract binding protein 3	607527				
9.400	1	2	08	9q31.3	SVEP1, POLYDOM, SELOB		Sushi, von willebrand factor type A, EGF, and pentraxin domain-containing 1	611691				4(Svep1)
9.401	9	26	08	9q32	TNFSF15, TL1, VEGI		Tumor necrosis factor ligand superfamily, member 15 (vascular endothelial growth inhibitor)	604052				
9.402	11	29	17	9q31.3	TXNDC8, SPTRX3		Thioredoxin domain-containing protein 8	617789				
9.403	8	10	98	9q32	ZFP37		Zinc finger protein-37, mouse, homolog of	602951		?candidate for Nager syndrome		4(Zfp37)
9.404	8	17	16	9q32	ZNF618, NEDD10, KIAA1952		Zinc finger protein 618	617077				
9.405	1	6	93	9q32	AMBP, ITIL, ITI, HCP		Alpha-1-microglobulin/bikunin precursor (inter-alpha-trypsin inhibitor, light chain; protein HC)	176870				4(Intin4)
9.406	5	5	16	9q32-q33	ARMD10		Macular degeneration, age-related, 10	611488			Macular degeneration, age-related, 10 (2)	
9.407	10	6	09	9q32-q33	EIG3		Epilepsy, idiopathic generalized, susceptibility to 3	608762			{Epilepsy, idiopathic generalized, susceptibility to, 3} (2)	
9.408	5	5	16	9q33.1	TLR4		Toll-like receptor-4	603030				
9.409	12	24	08	9q33.2	MEGF9, EGFL5		Multiple epidermal growth factor-like domains 9	604268				
9.410	1	7	95	9q33.2	PTGS1, COX1, PGHS1, COX3, PCOX1		Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)	176805				
9.411	10	11	07	9q32	WHRN, CIP98, KIAA1526, DFNB31, USH2D		Whirlin	607928			Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type 2D, 611383 (3)	4(Whrn)
9.412	1	8	01	9q33.2	MRFF, RRF		Ribosome-recycling factor, mitochondrial	604602				
9.413	3	29	10	9q33	ASRT8		Asthma-related traits, susceptibility to, 8	613207		associated with rs3789873	{Asthma-related traits, susceptibility to, 8} (2)	
9.414	1	30	01	9q33.2	CEP1, CEP110, FAN		Centrosomal protein 1	605496				2(Cep1)
9.415	5	5	10	9q33.2	DAB2IP, AIP1, KIAA1743		DAB2-interacting protein	609205				
9.416	8	4	97	9q33.2	GPR21		G protein-coupled receptor-21	601909				
9.417	5	30	17	9q33.3	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4		Nuclear receptor subfamily 5, group A, member 1	184757			46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964 (3); Adrenocortical insufficiency, 612964 (3); 46, XX sex reversal 4, 617480 (3); Spermatogenic failure 8, 613957 (3)	2(Ftzf1)
9.418	10	7	02	9q32	POLE3, CHARAC17, YBL1		Polymerase, DNA, epsilon-3	607267				
9.419	2	10	14	9q33.1	TNC, HXB, DFNA56		Tenascin C (hexabrachion)	187380		proximal to ABL	Deafness, autosomal dominant 56, 615629 (3)	4(Hxb)
9.420	6	14	99	9q32-q33	TNFSF8, CD30L, CD30LG		Tumor necrosis factor ligand superfamily, member 8 (CD30 ligand)	603875				4(Cd30l)
9.421	8	20	98	9q33.3	GCNF		Germ cell nuclear factor	602778				
9.422	12	22	17	9q33.2	GGTA1P, GGTA1		Glycoprotein, alpha-galactosyltransferase-1 pseudogene	104175		processed pseudogene GGTA1P on 12q14-q15		
9.423	7	27	11	9q34.12	LAMC3, OCCM		Laminin, gamma-3	604349			Cortical malformations, occipital, 614115 (3)	
9.424	6	11	94	9q33.3	PBX3		Pre-B-cell leukemia transcription factor-3	176312				2(Pbx3)
9.425	10	23	20	9q34.11	SPTAN1, NEAS, DEE5		Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin)	182810			Developmental and epileptic encephalopathy 5, 613477 (3)	2(Spna2)
9.426	3	2	98	9q33.2	TRAF1		TNF receptor-associated factor 2	601711				
9.427	6	30	08	8q24	BMND10		Bone mineral density quantitative trait locus 10	612113		associated with rs6469804 and rs6993813	[Bone mineral density QTL 10] (2)	
9.428	7	12	99	9q33.3	LHX2, LH2		LIM/homeodomain protein LHX2	603759				
9.429	7	13	09	9q33.1	ASTN2, KIAA0634		Astrotactin 2	612856				
9.430	4	29	14	9q33.1	BRINP1, DBC1, DBCCR1		Bone morphogenetic protein/retinoic acid-inducible neural-specific protein 1	602865				
9.431	1	8	07	9q33.1	DIPAS		DIPLA1, antisense	610689				
9.432	7	13	93	9q33.1	PAPPA		Pregnancy-associated plasma protein A	176385				4(Pappa)
9.433	11	22	10	9q33.3	DENND1A, KIAA1608		DENN/MADD domain-containing protein 1A	613633				
9.434	12	10	13	9q33.2	LHX6		LIM homeobox gene 6	608215				
9.435	9	8	17	9q33.2	PSMD5, S5B		Proteasome 26S subunit, non-ATPase, 5	604452				
9.436	3	31	09	9q33.2	RAB14		Ras-associated protein	612673				
9.437	7	17	14	9q33.2-q33.3	RABGAP1, GAPCENA, TBC1D11		RAB GTPase-activating protein 1	615882				
9.438	6	15	99	9q33.2	NDUFA8		NADH-ubiquinone oxidoreductase subunit A8	603359				
9.439	2	25	15	9q33.3	ANGPTL2, ARP2		Angiopoietin-like 2	605001				
9.440	4	25	05	9q33.2	CDK5RAP2, KIAA1633, MCPH3		CDK5 regulatory subunit-associated protein 2	608201			Microcephaly 3, primary, autosomal recessive, 604804 (3)	
9.441	09	16	19	9q33.3	CRB2, FSGS9, VMCKD		Crumbs cell polarity complex component 2	609720			Focal segmental glomerulosclerosis 9, 616220 (3); Ventriculomegaly with cystic kidney disease, 219730 (3)	2(Crb2)
9.442	1	4	08	9q33.3	GAPVD1, RAP6, GAPEX5, KIAA1521		GTPase-activating protein and VPS9 domains 1	611714				
9.443	5	25	13	9q33.3	GOLGA1		Golgi autoantigen, golgin subfamily A, 1	602502				
9.444	5	26	13	9q33.3	MAPKAP1, SIN1, MIP1, JC310		Mitogen-activated protein kinase-associated protein 1	610558				
9.445	5	11	09	9q33.3	MIR181A2, MIRN181A2		Micro RNA 181A2	612743				
9.446	5	11	09	9q33.3	MIR181B2, MIRN181B2		Micro RNA 181B2	612745				
9.447	8	1	14	9q33.3	OLFML2A		Olfactomedin-like 2A	615899				
9.448	12	23	05	9q33.2	PHF19		PHD finger protein 19	609740				
9.449	4	15	09	9q33.3	PPP6C		Protein phosphatase 6, catalytic subunit	612725		highly related sequence on Xq22.3		
9.450	1	30	12	9q33.3	RALGPS1, RALGEF2, KIAA0351		Ral guanine nucleotide exchange factor with PH domain and SH3 domain-binding motif 1	614444				
9.451	8	21	07	9q33.3	RPL12		Ribosomal protein L12	180475				
9.452	02	08	19	9q33.3	RPL35, DBA19		Ribosomal protein L35	618315		mutation identified in 1 DBA19 family	?Diamond-Blackfan anemia 19, 618312 (3)	
9.453	1	2	08	9q33.3	ZBTB34, KIAA1993		Zinc finger- and BTB domain-containing protein 34	611692				
9.454	11	22	19	9q33.3	ZBTB43		Zinc finger- and BTB domain-containing protein 43	618676				
9.455	1	19	12	9q33.3-q34.1	LRSAM1, TAL, RIFLE, CMT2P		Leucine-rich repeat- and sterile alpha motif-containing 1	610933			Charcot-Marie-Tooth disease, axonal, type 2P, 614436 (3)	
9.456	5	11	00	9q33.3	NEK6		Never-in-mitosis gene A-related kinase 6	604884				
9.457	03	26	20	9q34.3	ABCA2, ABC2, IDPOGSA		ATP-binding cassette 2	600047			Intellectual developmental disorder with poor growth and with or without seizures or ataxia, 618808 (3)	
9.458	11	18	14	9q34.2	ABO		ABO glycosyltransferase	110300		linked to AK1	[Blood group, ABO system], 616093 (3)	
9.459	03	02	20	9q34.2	ADAMTS13, VWFCP, TTP		ADAM metallopeptidase domain with thrombospondin type 1 motif, 13	604134			Thrombotic thrombocytopenic purpura, hereditary, 274150 (3)	
9.460	5	19	09	9q32	ALAD, ALADH, PBGS		Aminolevulinate, delta-, dehydratase	125270		linked to ABO; ORM-ALAD-AK-ABO	Porphyria, acute hepatic, 612740 (3); {Lead poisoning, susceptibility to}, 612740 (3)	4(Lv)
9.461	4	8	02	9q34.13	BARHL1		BARH-like 1	605211				2(Barh1)
9.462	07	17	19	9q34.3	CACNA1B, CACNL1A5, NEDNEH		Calcium channel, voltage-dependent, L type, alpha 1B subunit	601012			Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, 618497 (3)	
9.463	10	9	12	9q34.11	CIZ1, ZNF356, LSFR1, NP94		CDKN1A-interacting zinc finger protein 1	611420				
9.464	06	06	19	9q34	DYT23		Dystonia 23	614860		linkage to D9S159 and D9S1818	Dystonia 23 (2)	
9.465	6	13	12	9q33.2	FBXW2, FBW2, FWD2		F-box and WD40 domain protein 2	609071				2(Fbxw2)
9.466	11	7	08	9q34.13	MED27, CRSP8, CRAP34		Mediator complex subunit 27	605044				
9.467	11	14	18	9q34.2	DBH, ORTHYP1		Dopamine-beta-hydroxylase	609312		tightly linked to ABO	Orthostatic hypotension 1, due to DBH deficiency, 223360 (3)	2(Dbh)
9.468	10	23	20	9q34.11	DNM1, DEE31		Dynamin-1	602377			Developmental and epileptic encephalopathy 31, 616346 (3)	2(Dnm1)
9.469	07	31	20	9q34.11	DYT1, TOR1A, AMC5		Torsin A	605204			Dystonia-1, torsion, 128100 (3); {Dystonia-1, modifier of} (3); Arthrogryposis multiplex congenita 5, 618947 (3)	
9.470	9	28	00	9q34.3	ENTPD2, CD39L1		Ectonucleoside triphosphate diphosphohydrolase 2	602012		same cosmid as ABC2		
9.471	1	13	16	9q34.3	ENTPD8		Ectonucleoside triphosphate diphosphohydrolase 8	616748				
9.472	2	26	04	9q34.11	FNBP1, FBP17		Formin-binding protein 17	606191		fused with MLL in chronic myeloid leukemia		
9.473	6	5	97	9q34.3	FCN1		Ficolin (collagen/fibrinogen domain-containing) 1	601252				
9.474	6	5	97	9q34.3	FCN2		Ficolin (collagen/fibrinogen domain-containing lectin) 2	601624				
9.475	7	17	01	9q34.2	GBGT1, FS		Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (Forssman synthetase)	606074				
9.476	2	9	92	9q33.2	GSN		Gelsolin	137350		40kb proximal to ABL	Amyloidosis, Finnish type, 105120 (3)	2(Gsn)
9.477	8	5	97	9q33.3	HSPA5, GRP78		Heat-shock 70kD protein-5 (glucose-regulated protein, 78kD)	138120				2(Grp78)
9.478	02	27	19	9q34.11	GLE1, GLE1L, LCCS, LCCS1, CAAHD		Gle1, RNA export mediator, S. cerevisiae, homolog of	603371			Lethal congenital contracture syndrome 1, 253310 (3); Congenital arthrogryposis with anterior horn cell disease, 611890 (3)	
9.479	5	9	12	9q34	KTCN6		Keratoconus 6	614623		max lod at 159cM	Keratoconus 6 (2)	
9.480	10	13	94	9q34.3	LCN1		Lipocalin 1 (protein migrating faster than albumin, tear prealbumin)	151675				2(Lcn1)
9.481	11	22	94	9q34.11	LCN2, NGAL		Lipocalin 2 (oncogene 24p3)	600181				2(Lcn2)
9.482	5	23	05	9q34.3	LCN6		Lipocalin 6	609379				
9.483	7	22	09	9q34.3	LCN8		Lipocalin 8	612902				2(Lcn8)
9.484	7	22	09	9q34.3	LCN9		Lipocalin 9	612903				2(Lcn9)
9.485	7	22	09	9q34.3	LCN10		Lipocalin 10	612904				2(Lcn10)
9.486	7	22	09	9q34.3	LCN12		Lipocalin 12	612905				2(Lcn12)
9.487	5	9	18	9q34.3	MRPS2, COXPD36		Mitochondrial ribosomal protein S2	611971			Combined oxidative phosphorylation deficiency 36, 617950 (3)	
9.488	05	05	20	9q34.11	NCS1, FREQ		Neuronal calcium sensor 1	603315				
9.489	11	01	19	9q34.3	NELFB, COBRA1, KIAA1182		Negative elongation factor complex, member B	611180				
9.490	6	15	99	9q34.11	ODF2, ODF84		Outer dense fiber of sperm tails 2	602015				
9.491	2	28	00	9q34.3	OBP2A		Odorant-binding protein 2A	164320				
9.492	2	28	00	9q34.2	OBP2B		Odorant-binding protein 2B	604606				
9.493	9	4	91	9q34.3	PAEP, PP14		Progestagen-associated endometrial protein (placental protein 14)	173310				2(Paep)
9.494	10	1	95	9q34.11	PPP2R4, PTPA		Protein phosphatase-2A, regulatory subunit B' (PR 53)	600756		proximal to ABL		
9.495	8	18	97	9q34.1-q34.2	RALGDS		ral guanine nucleotide dissociation stimulator	601619				
9.496	5	24	13	9q33.2	RC3H2, MNAB		RING finger and CCCH-type zinc finger domains-containing protein 2	615231				
9.497	9	28	05	9q34.2	REXO4, XPMC2H		RNA exonuclease 4, S. cerevisiae, homolog of	602930				
9.498	12	3	96	9q34.2	RING3L, ORFX		RING3-like gene (open reading frame X)	601541				
9.499	5	27	93	9q34.2	RPL7A, SURF3		Ribosomal protein L7a (surfeit-3)	185640		in cluster with SURF1		2(Surf3)
9.500	04	19	19	9q34.13	SETX, SCAN2, AOA2, ALS4		Senataxin	608465			Amyotrophic lateral sclerosis 4, juvenile, 602433 (3); Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2, 606002 (3)	
9.501	09	06	18	9q34.11	SET, MRD58		SET gene	600960		fused with CAIN in acute undifferentiated leukemia	Mental retardation, autosomal dominant 58, 618106 (3)	
9.502	4	4	02	9q34.2	SLC2A6		Solute carrier family 2, member 6	606813				
9.503	10	12	09	9q34.11	SLC27A4, FATP4, IPS		Solute carrier family 27 (fatty acid transporter), member 4	604194			Ichthyosis prematurity syndrome, 608649 (3)	
9.504	2	14	06	9q34.3	SLC34A3, NPTIIC, HHRH		Solute carrier family 34 (sodium/phosphate cotransporter), member 3	609826			Hypophosphatemic rickets with hypercalciuria, 241530 (3)	
9.505	9	10	07	9q33.3	STRBP, SPNR, p74		Spermatid perinuclear RNA-binding protein	611138				2(Spnr)
9.506	10	23	20	9q34.2	SURF1, CMT4K, MC4DN1		Surfeit-1	185620		distal to ABL, CAN	Mitochondrial complex IV deficiency, nuclear type 1, 220110 (3); Charcot-Marie-Tooth disease, type 4K, 616684 (3)	2(Surf)
9.507	5	27	93	9q34.2	SURF2		Surfeit-2	185630				2(Surf2)
9.508	5	27	93	9q34.2	SURF4		Surfeit-4	185660				2(Surf4)
9.509	5	27	93	9q34.2	SURF5		Surfeit-5	185641				2(Surf5)
9.510	8	25	03	9q34.11	TOR1B, DQ1		Torsin 1B	608050		centromeric to TOR1A; pseudogene on chr.2		
9.511	4	20	17	9q34.13	TSC1, LAM		Hamartin (tuberous sclerosis 1 gene)	605284		linked to ABO, ABL	Tuberous sclerosis-1, 191100 (3); Lymphangioleiomyomatosis, 606690 (3); Focal cortical dysplasia, type II, somatic, 607341 (3)	
9.512	5	27	93	9q34.2	SURF6		Surfeit-6	185642				2(Surf6)
9.513	8	2	17	19p13.2	TSPAN16, TM4SF16		Tetraspanin 16	617580				
9.514	5	14	95	9q34.2	VAV2		Oncogene VAV2	600428				
9.515	7	13	93	9q33.3	ZNF79		Zinc finger protein-79 (pT7)	194552				
9.516	03	09	20	9q34.12	ABL1, CHDSKM		ABL protooncogene 1, nonreceptor tyrosine kinase	189980		fusion hybrid gene with BCR1 in CML	Leukemia, Philadelphia chromosome-positive, resistant to imatinib, 608232 (3); Congenital heart defects and skeletal malformations syndrome, 617602 (3)	2(Abl)
9.517	2	23	09	9q34.11	AK1		Adenylate kinase-1	103000		proximal to Ph1 break, 9q34.1; AK1 to ORM = 17cM	Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)	2(Ak1)
9.518	9	28	09	9q34.11	ASS1, ASS		Argininosuccinate synthetase 1	603470		14 pseudogenes on 11 chromosomes, including X and Y and ASSP2 on 6p23-q12	Citrullinemia, 215700 (3)	2(Ass1)
9.519	9	30	14	9q33.2	C5, C5D, ECLZB		Complement component-5	120900			C5 deficiency, 609536 (3); [Eculizumab, poor response to], 615749 (3)	2(Hc)
9.520	11	5	98	9q34.11	CDK9, CDC2L4		Cyclin-dependent kinase-9	603251				
9.521	1	27	09	9q34.1	CLLS3		Leukemia, chronic lymphocytic, susceptibility to, 3	612557		associated with SNP -6531 upstream of DAPK1 promoter	{Leukemia, chronic lymphocytic, susceptibility to, 3} (2)	
9.522	3	27	18	9q34.11	CRAT, CAT1, NBIA8		Carnitine acetyltransferase	600184		mutation identified in 1 NBIA8 patient	?Neurodegeneration with brain iron accumulation 8, 617917 (3)	
9.523	10	14	95	9q21.33	DAPK1		Death-associated protein kinase-1	600831				
9.524	3	29	12	9q34.11	DOLPP1, LSFR2		Dolichyl pyrophosphate phosphatase 1	614516				
9.525	3	9	95	9q34.11	ENDOG		Endonuclease G	600440				
9.526	10	13	97	9q34.11	ENG, END, HHT1, ORW		Endoglin	131195			Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	2(Eng)
9.527	6	7	10	9q34.12	FIBCD1		Fibrinogene C domain-containing protein 1	613357				
9.528	12	07	20	9q33.3	LMX1B, NPS1, FSGS10		LIM homeo box transcription factor 1, beta	602575			Nail-patella syndrome, 161200 (3); Focal segmental glomerulosclerosis 10, 256020 (3)	2(Lmx1b)
9.529	06	18	19	9q34.13	NUP214, D9S46E, CAN, CAIN, IIAE9		Nucleoporin, 214kD	114350		fused with DEK in AML; fused with ABL1 in T-ALL	Leukemia, acute myeloid, somatic, 601626 (3); Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3); {Encephalopathy, acute, infection-induced, susceptibility to, 9}, 618426 (3)	2(D2H9S46E)
9.530	09	27	18	9q34.13	POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11		Protein O-mannosyltransferase 1	607423			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	
9.531	7	29	15	9q34.12	PRDM12, HSAN8		PR domain-containing protein 12	616458			Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3)	
9.532	2	6	01	9q34.11	PRRX2, PRX2		Paired-related homeo box gene 2	604675				
9.533	12	10	15	9q33.2	STOM, EPB72, BND7		Stomatin (erythrocyte membrane protein band 7.2)	133090		proximal to ABL		2(Epb7.2)
9.534	10	23	20	9q34.11	STXBP1, UNC18, DEE4		Syntaxin-binding protein 1	602926			Developmental and epileptic encephalopathy 4, 612164 (3)	
9.535	8	20	88	9q32	ORM1, AGP1		Orosomucoid-1 (alpha-1-acid glycoprotein-1)	138600		linked to ABO, AK1, ALAD		4(Orm1)
9.536	8	20	88	9q32	ORM2		Orosomucoid-2	138610				4(Orm2)
9.537	1	31	13	9q34.11	ASB6		Ankyrin repeat- and SOCS box-containing protein 6	615051				
9.538	12	29	06	9q34.11	C9orf90, NAIF1		Nuclear apoptosis-inducing factor 1	610673				
9.539	12	29	06	9q34.11	CCBL1		Cysteine conjugate beta-lyase 1	600547				
9.540	10	28	15	9q34.11	CERCAM		Cerebral endothelial cell adhesion molecule	616626				
9.541	3	27	17	9q34.11	DOLK, TMEM15, DK1, SEC59, KIAA1094, CDG1M		Dolichol kinase	610746			Congenital disorder of glycosylation, type Im, 610768 (3)	
9.542	1	31	13	9q34.11	DPM2, CDG1U		Dolichyl-phosphate mannosyltransferase 2, regulatory subunit	603564			Congenital disorder of glycosylation, type Iu, 615042 (3)	
9.543	8	26	15	9q34.11	GOLGA2, GM130		Golgi autoantigen, golgin subfamily A, 2	602580				
9.544	12	23	19	9q34.11	GPR107, LUSTR1		G protein-coupled receptor 107	618490				2(Gpr107)
9.545	9	2	12	9q34.11	MIR199B		Micro RNA 199B	614791				
9.546	7	8	10	9q34.11	MIR2861, MIRN2861, BMND15		Micro RNA 2861	613405			[Bone mineral density QTL 15], 613418 (3)	
9.547	7	17	14	9q34.11	NTMT1, METTL11A, NRMT, C9orf32		N-terminal X-Pro-Lys N-methyltransferase 1	613560				
9.548	03	06	20	9q34.11	NUP188, KIAA1069, SANDSTEF		Nucleoporin, 188kD	615587			Sandestig-Stefanova syndrome, 618804 (3)	
9.549	7	13	09	9q34.11	PIP5KL1, PIPKH		Phosphatidylinositol-4-phosphate-5-kinase-like 1	612865				
9.550	2	7	07	9q34.11	PKN3		Protein kinase N3	610714				
9.551	8	23	12	9q34.11	SH2D3C, NSP3		SH2 domain-containing protein 3C	604722				
9.552	8	9	17	9q34.11	SPOUT1, CENP32, C9orf114		SPOUT domain-containing methyltransferase 1	617614				
9.553	3	20	14	9q34.11	ST6GALNAC6, SIAT7F		ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6	610135				
9.554	8	26	15	9q34.11	SWI5, SAE3, C9orf119		SWi5 homologous recombination repair protein	616528				
9.555	2	17	15	9q34.11	TBC1D13		TBC1 domain family, member 13	616218				
9.556	7	17	14	9q34.11	TOR2A, TORP1		Torsin 2A	608052				
9.557	1	29	07	9q34.11	TRUB2		TRUB pseudouridine synthase, E. coli, homolog of, 2	610727				
9.558	3	31	09	9q34.11	URM1		Ubiquitin-related modifier 1, S. cerevisiae, homolog of	612693				
9.559	4	8	13	9q34.11	USP20, VDU2		Ubiquitin-specific protease 20	615143				
9.560	2	9	14	9q34.11	WDR34, SRTD11		WD repeat-containing protein 34	613363			Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3)	
9.561	11	10	17	9q34.11	ZER1, ZYG11BL, C9orf60		Zyg11-related cell cycle regulator	617764				
9.562	5	25	13	9q34.11-q34.12	FUBP3, FBP3		FAR upstream element-binding protein 3	603536				
9.563	8	17	99	9q33.3	PSMB7		Proteasome subunit, beta-type, 7	604030				
9.564	11	10	17	9q34.12	EXOSC2, RRP4, SHRF		Exosome component 2	602238			Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, 617763 (3)	
9.565	9	16	12	9q34.12	QRFP, P518, 26RFA		Pyroglutamylated FR-amide peptide precursor protein	609795				
9.566	8	11	13	9q34.13	AK8		Adenylate kinase 8	615365				
9.567	11	7	08	9q34.13	ALPQTL1		Alkaline phosphatase, plasma level of, QTL 1	171720		linkage with rs657152	{Alkaline phosphatase, plasma level of, QTL1} (2)	
9.568	3	28	15	9q34.11	COQ4, COQ10D7		Coenzyme Q4, S. cerevisiae, homolog of	612898			Coenzyme Q10 deficiency, primary, 7, 616276 (3)	
9.569	07	14	20	9q34.13	DDX31, PPP1R25		DEAD-box helicase 31	616533				
9.570	3	29	07	9q34.11	FAM102A, EEIG1		Family with sequence similarity 102, member A	610891				
9.571	9	8	11	9q34.11	FAM129B, MINERVA		Family with sequence similarity 129, member B	614045				
9.572	2	2	14	9q34.13	GFI1B, BDPLT17		Growth factor-independent 1B	604383			Bleeding disorder, platelet-type, 17, 187900 (3)	
9.573	3	28	16	9q34.11	LRRC8A, KIAA1437, AGM5		Leucine-rich repeat-containing 8A	608360		mutation identified in 1 AGM5 patient	?Agammaglobulinemia 5, 613506 (3)	2(Lrrc8)
9.574	12	27	19	9q34.13	NTNG2, NEDBASH		Netrin G2	618689			Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia, 618718 (3)	
9.575	01	20	20	9q34.13	PLPP7, PPAPDC3, NET39, C9orf67		Phospholipid phosphatase 7	618743				
9.576	3	22	07	9q34.11	PTGES2, PGES2, GBF1		Prostaglandin E synthase 2	608152				
9.577	08	23	19	9q34.13	SPACA9		Sperm acrosome associated 9	618552				2(Spaca9)
9.578	9	26	17	9q34.13	TTF1		Transcription termination factor, RNA polymerase I	600777				
9.579	8	31	11	9q34.2	ADAMTSL2, KIAA0605, GPHYSD1		ADAMTS-like protein 2	612277			Geleophysic dysplasia 1, 231050 (3)	
9.580	08	10	18	9q34.2	CACFD1, FLOWER, C9orf7		Calcium channel FLOWER-domain containing protein 1	613104				
9.581	7	18	14	9q34.13	GTF3C5, TFIIIC63		General transcription factor 3C, polypeptide 5	604890				
9.582	7	25	17	9q34.2	MYMK, TMEM8C		Myomaker	615345			Carey-Fineman-Ziter syndrome, 254940 (3)	
9.583	9	26	17	9q34.2	RNU6ATAC, U6ATAC		RNA, U6ATAC small nuclear	601429				
9.584	08	09	19	9q34.2	STKLD1, C9orf96		Serine/threonine kinase-like domain containing protein 1	618530				
9.585	7	1	05	9q34.13	UCK1		Uridine/cytidine kinase 1	609328				
9.586	1	31	13	9q34.2	SARDH, SARD, SAR		Sarcosine dehydrogenase	604455			[Sarcosinemia], 268900 (3)	2(sar)
9.587	12	22	17	9q34.3	COL5A1, EDSCL1		Collagen V, alpha-1 polypeptide	120215			Ehlers-Danlos syndrome, classic type, 1, 130000 (3)	2(Col5a1)
9.588	6	11	94	9q34.3	PTGDS		Prostaglandin D2 synthase (21kD, brain)	176803		distal to ABL		2(Ptgds)
9.589	5	5	04	9q34.3	AGPAT2, LPAAB, BSCL, BSCL1		1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase-beta)	603100			Lipodystrophy, congenital generalized, type 1, 608594 (3)	
9.590	11	26	97	9q34.3	C8G		Complement component-8, gamma polypeptide	120930				2(C8g)
9.591	3	29	12	9q34.3	C9orf116, PIERCE1		p53-induced expression in RB-null cells 1	614502				2(Pierce1)
9.592	3	24	11	9q34.3	CAMSAP1		Calmodulin-regulated spectrin-associated protein 1	613774				
9.593	4	26	10	9q34.3	CARD9, CANDF2		Caspase recruitment domain-containing protein 9	607212			Candidiasis, familial, 2, autosomal recessive, 212050 (3)	
9.594	8	17	14	9q34.3	CCDC183, KIAA1984		Coiled-coil domain-containing protein 183	615955				
9.595	11	30	06	9q34.13	CEL, BSSL, CELL, MODY8		Carboxyl-ester lipase (bile-salt stimulated lipase)	114840			Maturity-onset diabetes of the young, type VIII, 609812 (3)	
9.596	02	25	19	9q34.3	DPH7, WDR85		Diphthamide biosynthesis 7	613210				
9.597	5	26	13	9q34.3	DPP7, QPP		Dipeptidyl peptidase VII	610537				
9.598	11	12	09	9q34.3	EGFL7		Epidermal growth factor-like 7	608582				2(Egfl7)
9.599	11	15	17	9q34.3	EHMT1, EUHMTASE1, KMT1D, DEL9q34, KLEFS1		Euchromatic histone methyltransferase 1	607001			Kleefstra syndrome 1, 610253 (3)	
9.600	12	23	19	9q34.3	ENTR1, SDDAG3		Endosome-associated trafficking regulator 1	618289				
9.601	4	2	12	9q34.3	FAM69B		Family with sequence similarity 69, member B	614543				
9.602	6	13	12	9q34.3	FBXW5, FBW5		F-box and WD40 domain protein 5	609072				2(Fbxw5)
9.603	1	16	18	9q34.3	GRIN1, NMDAR1, NDHMSR, NDHMSD		Glutamate receptor, ionotropic, N-methyl D-aspartate 1	138249			Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive, 617820 (3); Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant, 614254 (3)	
9.604	1	20	11	9q34.3	GLT6D1, GT6M7, GLTDC1		Glycosyltransferase 6 domain-containing 1	613699				
9.605	8	15	14	9q34.3	INPP5E, MORMS, JBTS1, CORS1		Inositol polyphosphate-5-phosphatase, 72kD	613037			Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3); Joubert syndrome 1, 213300 (3)	
9.606	10	23	20	9q34.3	KCNT1, KIAA1422, DEE14, ENFL5		Potassium channel, subfamily T, member 1	608167			Developmental and epileptic encephalopathy 14, 614959 (3); Epilepsy nocturnal frontal lobe, 5, 615005 (3)	
9.607	10	2	09	9q34.3	LHX3, CPHD3		LIM/homeodomain protein LHX3	600577		in mouse, close to Notch1; centromeric to ABL	Pituitary hormone deficiency, combined, 3, 221750 (3)	2(Lhx3)
9.608	12	15	10	9q34.3	LRRC26, CAPC		Leucine-rich repeat-containing protein 26	613505				
9.609	10	27	20	9q34.3	MAN1B1, MRT15		Mannosidase, alpha, class 1B member 1	604346			Rafiq syndrome, 614202 (3)	
9.610	3	23	09	9q34.3	MIR126, MIRN126		Micro RNA 126	611767				
9.611	3	5	08	9q34.3	MRPL41, MRPL27		Mitochondrial ribosomal protein L41	611846				
9.612	11	23	16	9q34.3	MAMDC4		MAM domain-containing protein 4	617208				
9.613	6	22	14	9q34.3	NACC2, RBB		NACC family, member 2, BEN and BTB/POZ domains-containing	615786				
9.614	3	14	13	9q34.3	NSMF, NELF, HH9		NMDA receptor synaptonuclear signaling and neuronal migration factor	608137			Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3)	
9.615	07	26	19	9q34.3	NOTCH1, TAN1, AOS5, AOVD1		Notch receptor 1	190198			Aortic valve disease 1, 109730 (3); Adams-Oliver syndrome 5, 616028 (3)	2(Notch1)
9.616	5	26	13	9q34.3	NOXA1		NADPH oxidase activator 1	611255				2(Noxa1)
9.617	7	17	01	9q34.3	NR1		NADPH-dependent FMN- and FAD-containing oxidoreductase	606073				
9.618	4	14	15	9q34.3	PAXX, C9orf142		Paralog of XRCC4 and XLF	616315				
9.619	7	3	06	9q34.3	PHPT1		Phosphohistidine phosphatase 1	610167				
9.620	2	5	16	9q34.3	PMPCA, KIAA0123, SCAR2		Peptidase, mitochondrial processing, alpha	613036			Spinocerebellar ataxia, autosomal recessive 2, 213200 (3)	
9.621	8	27	08	9q34.3	PNPLA7		Patatin-like phospholipase domain containing 7	612122				
9.622	6	1	12	9q34.3	PPP1R26, KIAA0649		Protein phosphatase 1, regulatory subunit 26	614056				
9.623	8	23	00	9q34.11	PTGES, PGES, PIG12, MGST1L1		Prostaglandin E synthase	605172				
9.624	7	13	09	9q34.3	QSOX2, SOXN		Quiescin Q6 sulfhydryl oxidase 2	612860				
9.625	8	3	17	9q34.3	RABL6, PARF, C9orf86		RAB-like protein 6	610615				
9.626	3	14	07	9q34.13	RAPGEF1, GRF2, C3G		RAP guanine nucleotide exchange factor 1	600303				
9.627	08	20	20	9q34.3	RNF208		RING finger protein 208	618993				
9.628	5	19	94	9q34.2	RXRA		Retinoid X receptor, alpha	180245		distal to DBH		2(Rxra)
9.629	08	10	18	9q34.3	SAPCD2, C9orf140, P42.3		Suppressor APC domain-containing protein 2	612057				2(P42.3)
9.630	10	07	19	9q34.3	SEC16A, SEC16L, KIAA0310, p250		SEC16 homolog A, endoplasmic reticulum export factor	612854				
9.631	10	2	12	9q34.3	SNAPC4, SNAP190		Small nuclear RNA-activating protein complex, polypeptide 4	602777				
9.632	09	12	18	9q34.3	SOHLH1, NOHLH, TEB2, ODG5, SPGF32		Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 1	610224			Ovarian dysgenesis 5, 617690 (3); Spermatogenic failure 32, 618115 (3)	
9.633	4	17	07	9q34.3	SSNA1, NA14		Sjogren syndrome nuclear autoantigen 1	610882				
9.634	9	12	15	9q34.3	TMEM203		Transmembrane protein 203	616499				
9.635	4	20	10	9q34.3	TPRN, C9orf75, DFNB79		Taperin	613354			Deafness, autosomal recessive 79, 613307 (3)	2(Tprn)
9.636	8	19	14	9q34.3	TRAF2, TRAP		TNF receptor-associated factor 2	601895				
9.637	2	16	18	9q34.3	TUBB4B, TUBB2C, LCAEOD		Tubulin, beta-4B	602660			Leber congenital amaurosis with early-onset deafness, 617879 (3)	
9.638	4	1	09	9q34.3	UBAC1, GBDR1		Ubiquitin-associated domain-containing protein 1	608129				
9.639	9	18	08	9q34.3	ZMYND19, MIZIP		Zinc finger MYND domain-containing protein 19	611424				2(Zmynd19)
9.640	5	16	02	9q34.3	ANAPC2, APC2, KIAA1406		Anaphase-promoting complex, subunit 2	606946				
9.641	1	24	01	9q31.1	CAPE		Chromosome-associated protein E	605576				
9.642	12	27	01	9q34.3	CLIC3		Chloride intracellular channel 3	606533				
9.643	7	15	02	9q22.32	FBP2		Fructose-1,6-bisphosphatase 2	603027				
9.644	3	5	98	9q34.3	FUT7		Fucosyltransferase 7 (alpha (1,3) fucosyltransferase)	602030				
9.645	10	23	87	Chr.9	H142T		Temperature sensitivity complementation, H142	187290				
9.646	6	13	02	9p13.2	MELK, KIAA0175		Maternal embryonic leucine zipper kinase	607025				4(Melk)
9.647	8	27	01	9q34.3	NPDC1, CAB1		Neural proliferation, differentiation, and control protein 1	605798				
9.648	12	14	01	9q34.3	OLFM1, AMY		Olfactomedin 1	605366				
9.649	5	4	00	9q33.2	PDCL		Phosducin-like	604421				
9.650	11	15	00	9q33.3	SLC2A8, GLUT8		Solute carrier family 2, (facilitated glucose transporter) member 8	605245				
10.1	3	6	94	10p15.1	CALML3		Calmodulin-like 3	114184				
10.2	10	15	97	10p13	PHYH, PAHX		Phytanoyl-CoA hydroxylase	602026			Refsum disease, 266500 (3)	
10.3	3	6	00	10pter-q11	ST12, PAC1		Suppression of tumorigenicity 12, prostate	601188			Prostate adenocarcinoma (2)	
10.4	09	18	19	10p15.3	DIP2C, KIAA0934		Disco-interacting protein 2 homolog C	611380				
10.5	10	30	19	10p15.3	LARP4B, LARP5, KIAA0217		La ribonucleoprotein 4B	616513				
10.6	2	2	16	10p15.3	TUBB8, OOMD2		Tubulin, beta 8	616768			Oocyte maturation defect 2, 616780 (3)	
10.7	2	9	92	10p15.2	PFKP		Phosphofructokinase, platelet type	171840				
10.8	12	11	18	10p15.2	PITRM1, MP1, PREP		Pitrilysin metallopeptidase 1	618211				
10.9	6	20	18	10p15.1	ANKRD16		Ankyrin repeat domain-containing protein 16	618017				
10.10	1	31	13	10p15.1	ASB13		Ankyrin repeat- and SOCS box-containing protein 13	615055				
10.11	4	25	17	10p15.1	AKR1E2, HTSP, TAKR		Aldo-keto reductase family 1, member E2	617451				
10.12	09	25	20	10p14	ATP5F1C, ATP5C1, ATP5CL1, ATP5C		ATP synthase F1, subunit gamma	108729				
10.13	9	9	08	10p15.1	FBXO18, FBH1, FBX18		F-box only protein 18	607222				2(Fbxo18)
10.14	7	20	15	10p15.1	IL2RA, CD25, IL2R, IDDM10, IMD41		Interleukin-2 receptor, alpha	147730			Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3); {Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	2(Il2ra)
10.15	07	06	20	10p15.1	LASTR, LINC02657		Long noncoding RNA associated with SART3 regulation of splicing	618938				
10.16	2	23	09	10p15.1	MS2		Multiple sclerosis, susceptibility to, 2	612594		associated with rs12722489 and rs2104286	{Multiple sclerosis, susceptibility to, 2} (2)	
10.17	7	2	18	10p15.1	NET1		Neuroepithelial cell transforming gene 1	606450				
10.18	9	17	07	10p15.1	RBM17, SPF45		RNA binding motif protein 17	606935				
10.19	7	9	09	10p13	TRDMT1, DMNT2		tRNA aspartic acid methyltransferase 1 (DNA methyltransferase 2)	602478				
10.20	3	6	98	10p15.3	ADARB2, RED2		Adenosine deaminase, RNA-specific, B2 (homolog of rat BLUE)	602065				
10.21	8	3	11	10p14	GATA3, HDR, HDRS		GATA-binding protein-3	131320			Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	2(Gata3)
10.22	1	13	99	10p15.1	GDI2, RABGDIB		GDP dissociation inhibitor 2	600767		pseudogene on chr.7		
10.23	9	9	13	10p15.3	IDI1		Isopentenyl-diphosphate delta isomerase 1	604055				13(Idi1)
10.24	9	9	13	10p15.3	IDI2, IPPI2		Isopentenyl-diphosphate delta isomerase 2	615389				13(Idi2)
10.25	9	9	13	10p15.3	IDI2AS1		IDI2 antisense RNA 1, noncoding	615391				
10.26	10	6	92	10p14	ITIH2		Inter-alpha (globulin) inhibitor, H2 polypeptide	146640				2(Intin2)
10.27	12	20	05	10p14	ITIH5		Inter-alpha-trypsin inhibitor, heavy chain 5	609783				
10.28	10	7	05	10p15.2	KLF6, COPEB, BCD1, ZF9		Kruppel-like factor-6	602053			Prostate cancer, somatic, 176807 (3); Gastric cancer, somatic, 613659 (3)	
10.29	8	2	13	10p15	PFFE1		Plasmodium falciparum fever episodes QTL1	611384			{Plasmodium falciparum fever episodes QTL1} (2)	
10.30	9	27	95	10p15.1	PRKCQ		Protein kinase C, theta	600448				2(Pkcq)
10.31	8	18	99	10p15.1	AKR1C1, DDH1, DD1, HAKRC		Aldo-keto reductase family 1, member 1 (dihydrodiol dehydrogenase, type 1)	600449				
10.32	4	24	18	10p15.1	AKR1C2, DDH2, DD2, HAKRD, SRXY8		Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase, type II)	600450			46XY sex reversal 8, 614279 (3)	
10.33	8	18	99	10p15.1	AKR1C3, HAKRB, DD3		Aldo-keto reductase family 1, member C3	603966				
10.34	10	10	11	10p15.1	AKR1C4, CHDR, CDR, HAKRA, DD4		Aldo-keto reductase family 1, member C4 (chlordecone reductase)	600451			{46XY sex reversal 8, modifier of}, 614279 (3)	
10.35	2	15	96	10p15.1	IL15RA		Interleukin-15 receptor, alpha	601070				2(Il15ra)
10.36	2	26	01	10p14	KIN, KIN17, BTCD		Antigenic determinant of recombination protein A, mouse, homolog of	601720				2(kin17)
10.37	7	26	10	10p13	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12		Optineurin	602432			Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension, susceptibility to}, 606657 (3); Amyotrophic lateral sclerosis 12, 613435 (3)	
10.38	1	31	01	10p15.1	PFKFB3, IPFK2		6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3	605319				
10.39	09	23	19	10p14	UPF2, RENT2		UPF2 regulator of nonsense-mediated mRNA decay	605529				
10.40	8	20	08	10p14	CRCS5		Colorectal cancer, susceptibility to, 5	612230		associated with rs10795668	{Colorectal cancer, susceptibility to, 5} (2)	
10.41	11	21	14	10p14	DHTKD1, KIAA1630, AMOXAD, CMT2Q		Dehydrogenase E1 and transketolase domains-containing protein 1	614984		mutation identified in 1 CMT2Q family	2-aminoadipic 2-oxoadipic aciduria, 204750 (3); ?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3)	
10.42	01	03	19	10p14	SEC61A2		SEC61 translocon, alpha-2 subunit	618271				
10.43	10	11	12	10p14	TAF3, TAFII140		TAF3 RNA polymerase II, TATA box-binding protein-associated factor, 140kD	606576				
10.44	1	20	17	10p12.1	YME1L1, YME1L, PAMP, OPA11		Mitochondrial escape 1-like 1	607472		mutation identified in1 OPA11 family	?Optic atrophy 11, 617302 (3)	
10.45	9	9	13	10p14	SFMBT2, KIAA1617		SCM-like protein with 4 MBT domains 2	615392				2(Sfmbt2)
10.46	11	6	14	10p15.3	ZMYND11, BS69, BRAM1, MRD30		Zinc finger MYND domain-containing protein 11	608668			Mental retardation, autosomal dominant 30, 616083 (3)	
10.47	10	1	17	10p14-p13	CDC123		Cell division cycle 123	617708				
10.48	9	2	96	10p14-p13	DGCR2, DGS2		DiGeorge syndrome chromosome region-2	601362			DiGeorge syndrome/velocardiofacial syndrome complex-2 (2)	
10.49	3	2	98	10p12.33	STAM		Signal transducing adaptor molecule	601899				2(Stam)
10.50	1	6	00	10p14-p12	ARVD6		Arrhythmogenic right ventricular dysplasia 6	604401			Arrhythmogenic right ventricular dysplasia 6 (2)	
10.51	12	15	05	10p13	AD7		Alzheimer disease 7	606187		max LOD at D10S1423	Alzheimer disease-7 (2)	
10.52	5	26	13	10p13	ARMETL1, CDNF		Arginine-rich protein mutated in early stage tumors-like 1	611233				
10.53	11	4	93	10p12.2	BMI1		Oncogene BMI-1	164831				
10.54	5	13	13	10p13	C1QL3, CTRP13, K100		Complement component 1, q subcomponent-like 3	615227				1(C1ql3)
10.55	2	25	15	10p13	CAMK1D, CKLIK		Calcium/calmodulin-dependent protein kinase I-delta	607957				
10.56	8	2	13	10p14	CELF2, CUGBP2, ETR3, BRUNOL3		CUGbp- and ELAV-like family, member 2	602538				
10.57	2	17	16	10p13	FRMD4A, KIAA1294, CCAFCA		FERM domain-containing protein 4A	616305		mutation identified in 1 CCAFCA family	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3)	
10.58	4	10	14	10p13	ITGA8, RHDA1		Integrin, alpha-8	604063			Renal hypodysplasia/aplasia 1, 191830 (3)	
10.59	2	16	06	10p13	LPRS		Leprosy, paucibacillary type, susceptibility to	609888			{Leprosy, paucibacillary type, susceptibility to} (2)	
10.60	5	16	05	10p13	MCM10, CNA43		Minichromosome maintenance 10, S. cerevisiae, homolog of	609357				
10.61	9	6	11	10p13	MEIG1		Meiosis-expressed gene 1, mouse, homolog of	614174				
10.62	8	3	17	10p13	MINDY3, C10orf97, CARP		MINDY lysine-48 deubiquitinase 3	611649				
10.63	10	14	94	10p12.33	MRC1, MMR		Mannose receptor, C type 1	153618				2(Mrc1)
10.64	9	17	08	10p13	NMT2		N-myristoyltransferase 2	603801				
10.65	09	19	19	10p13	PRPF18, PRP18		Pre-mRNA processing factor 18	604993				
10.66	8	26	09	10p13	RPP38		Ribonuclease P, 38-kD subunit	606116				
10.67	8	26	09	10p13	RSU1		Ras suppressor protein 1	179555				
10.68	3	24	11	10p13	SEPHS1, SPS1		Selenophosphate synthetase 1	600902				
10.69	8	26	09	10p13	SUV39H2, FLJ23414		Suppressor of variegation 3-9, Drosophila, homolog of, 2	606503				2(Suv39h2)
10.70	8	25	04	10p14	USP6NL, RNTRE		USP6 N-terminal-like	605405				
10.71	5	10	17	10p13	VIM, CTRCT30		Vimentin	193060			Cataract 30, pulverulent, 116300 (3)	2(Vim)
10.72	1	12	09	10p12.31	NEBL		Nebulette	605491				
10.73	6	4	10	10p11.22	ARHGAP12		Rho GTPase-activating protein 12	610577				
10.74	1	8	16	10p12.33	HACD1, PTPLA		3-hydroxyacyl-CoA dehydratase 1	610467				
10.75	12	04	20	10p12.31	ARL5B, ARL8		ADP ribosylation factor-like GTPase 5B	608909				
10.76	10	11	17	10p12.31	MALRD1, C10orf112, DIET1		MAM and LDL receptor class A domain-containing protein 1	617715				2(Malrd1)
10.77	8	19	13	10p12.31	DNAJC1, HTJ1		DNAJ/HSP40 homolog, subfamily C, member 1	611207				
10.78	5	6	13	10p12.31	MIR1915		Micro RNA 1915	615202				
10.79	11	23	16	10p12.31	NSUN6		NOP2/SUN RNA methyltransferase family, member 6	617199				
10.80	4	6	15	10p12.33	ST8SIA6, SIAT8F		ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6	610139				
10.81	3	22	06	10p12.1	ARHGAP21, KIAA1424		GTPase-activating protein, Rho, 21	609870		pseudogene on chr.6		
10.82	3	3	10	10p12.31	EBLN1		Endogenous Borna-like N element-containing protein 1	613249				
10.83	9	9	08	10p13	HSPA14, HSP70L1		Heat-shock 70kD protein 14	610369				
10.84	11	30	06	10p12.31	PLXDC2, TEM7R		Plexin domain containing 2	606827				
10.85	7	19	06	10p12.1	BAMBI, NMA		BMP and activin membrane-bound inhibitor, xenopus, homolog of	604444				
10.86	8	18	14	10p12.2	PTF1A, PACA, PAGEN2		Pancreas transcription factor 1, alpha subunit	607194			Pancreatic and cerebellar agenesis, 609069 (3); Pancreatic agenesis 2, 615935 (3)	
10.87	5	26	13	10p12.2	ARMC3		Armadillo repeat-containing protein 3	611226				
10.88	12	22	15	10p12.2	COMMD3		COMM domain-containing protein 3	616700				
10.89	2	24	17	10p12.2-p12.1	KIAA1217, SKT		KIAA1217 gene	617367				
10.90	6	5	08	10p12.2	OTUD1, DUBA7		OTU domain-containing protein 1	612022				
10.91	7	22	16	10p12.2	PIP4K2A, PI5P4KA, PIP5K2A		Phosphatidylinositol 5-phosphate 4-kinase, type II, alpha	603140				
10.92	04	28	20	10p12.1	ACBD5, KIAA1996, RDLKD		Acyl-CoA-binding domain-containing protein 5	616618			Retinal dystrophy with leukodystrophy, 618863 (3)	
10.93	2	24	11	10p12.1	ANKRD26, KIAA1074, THC2		Ankyrin repeat domain-containing protein 26	610855			Thrombocytopenia 2, 188000 (3)	6(Ankrd26)
10.94	10	15	13	10p12.1	ARMC4, CILD23		Armadillo repeat-containing protein 4	615408			Ciliary dyskinesia, primary, 23, 615451 (3)	
10.95	05	19	20	10p13	CUBN, IFCR, IGS1		Cubilin (intrinsic factor-cobalamin receptor)	602997			Imerslund-Grasbeck syndrome 1, 261100 (3); [Proteinuria, chronic benign], 618884 (3)	
10.96	7	14	14	10p12.1	ENKUR, C10orf63		Enkurin, TRPC channel-interacting protein	611025				2(4933434I06Rik)
10.97	4	19	12	10p12.1	GPR158, KIAA1136		G protein-coupled receptor 158	614573				2(Gpr158)
10.98	11	1	16	10p12.1	MASTL, FLJ14813, GWL		Microtubule-associated serine/threonine kinase-like	608221				
10.99	4	1	09	10p12.1	MKX, IFRX, IRXL1		Mohawk homeobox	601332				18(Mkx)
10.100	5	21	07	10p12.1	MPP7		Membrane protein, palmitoylated 7	610973				
10.101	5	24	12	10p12.1	PDSS1, TPT, COQ1, COQ10D2		Prenyl diphosphate synthase, subunit 1	607429			Coenzyme Q10 deficiency, primary, 2, 614651 (3)	
10.102	2	12	07	10p12.1	PRTFDC1		Phosphoribosyl transferase domain-containing protein 1	610751				
10.103	2	14	08	10p12.1	PTCHD3		Patched domain-containing protein 3	611791				
10.104	9	17	11	10p12.1	RAB18, WARBM3		Ras-associated protein RAB18	602207			Warburg micro syndrome 3, 614222 (3)	18(Rab18)
10.105	5	26	13	10p12.1	THNSL1, TSH1		Threonine synthase-like 1	611260				
10.106	3	6	94	10p11.21	CREM		cAMP-responsive element modulator	123812				18(Crem)
10.107	1	13	16	10p12.1	WAC, KIAA1844, DESSH		WW domain-containing adaptor with coiled-coil region	615049			Desanto-Shinawi syndrome, 616708 (3)	
10.108	8	28	15	10p12.31	AF10		ALL1 fused gene from chromosome 10	602409		fuses with MLL and HEAB	Leukemia, acute myeloid, 601626 (3)	
10.109	3	5	08	10p12.33-p12.31	CACNB2		Calcium channel, voltage-dependent, beta 2 subunit	600003			Brugada syndrome 4, 611876 (3)	
10.110	3	24	11	10p12.2	MSRB2, CBS1		Methionine sulfoxide reductase B2	613782				
10.111	5	25	00	10p11.22	NRP1, NRP, VEGF165R		Neuropilin 1	602069				
10.112	5	4	00	10p13	PTER		Phosphotriesterase-related protein	604446				
10.113	3	19	01	10p12.2	SPAG6		Sperm-associated antigen 6	605730				
10.114	3	9	95	10p12.1	GAD2		Glutamate decarboxylase-2, pancreas	138275				2(Gad2)
10.115	5	12	09	10p11.23	LYZL2		Lysozyme-like 2	612748				
10.116	10	27	16	10p11.23	MTPAP, PAPD1, SPAX4		Mitochondrial poly(A) polymerase	613669		mutation identified in 1 SPAX4 family	?Spastic ataxia 4, autosomal recessive, 613672 (3)	
10.117	5	5	09	10p11.23-q21.1	DFNB33		Deafness, autosomal recessive 33	607239		prev. assignment to chr. 9 an error	Deafness, autosomal recessive 33 (2)	
10.118	4	15	08	10p11.22	EIG5		Epilepsy, idiopathic generalized, susceptibility to, 5	611934		max lod at D10S1426	{Epilepsy, idiopathic generalized, susceptibility to, 5} (2)	
10.119	9	23	13	10p11.22	KIF5B, KNS1, UKHC		Kinesin 1	602809				18(Ukhc)
10.120	4	21	16	10p11.22	ZEB1AS1		ZEB1 antisense RNA 1, noncoding	616915				
10.121	3	20	07	10p11.21	ANKRD30A		Ankyrin repeat domain-containing protein 30A	610856				
10.122	4	1	08	10p11.21	GJD4, CX40.1		Gap junction protein, delta-4	611922				
10.123	09	15	20	10p11.22-p11.21	PARD3, PAR3		PAR3 family cell polarity regulator	606745				
10.124	1	9	13	10p11.21-q21.1	USH1K		Usher syndrome, type IK	614990		max lod at D10S539	Usher syndrome, type IK (2)	
10.125	10	7	98	10p12.1	ABI1		ABL-interactor 1	603050				
10.126	5	19	09	10p11.21	CCNY, CFP1, CCNX, C10orf9		Cyclin Y	612786				
10.127	09	12	19	10p11.21	FZD8		Frizzled class receptor 8	606146				18(Fzd8)
10.128	3	13	92	10p11.22	ITGB1, FNRB		Integrin, beta-1 (fibronectin receptor, beta polypeptide; antigen CD29 includes MDF2, MSK12)	135630		pseudogene FNRBL on 19p		
10.129	10	4	05	10p11.23	MAP3K8, COT, EST, TPL2		Mitogen-activated protein kinase kinase kinase 8 (cancer Osaka thyroid oncogene)	191195			Lung cancer, somatic, 211980 (3)	18(Tpl2)
10.130	10	12	20	10p11.23	SVIL, MFM10		Supervillin	604126			Myofibrillar myopathy 10, 619040 (3)	
10.131	2	25	10	10p11.22	ZEB1, TCF8, NIL2A, PPCD3, FECD6		Zinc finger E box-binding homeobox 1	189909			Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	
10.132	5	12	09	10p11.21	CUL2		Cullin 2	603135				
10.133	8	20	92	10p11.21	ZNF25, KOX19		Zinc finger protein-25 (KOX 19)	194528				
10.134	8	27	15	10p12.1	MYO3A, DFNB30		Myosin IIIA	606808			Deafness, autosomal recessive 30, 607101 (3)	
10.135	11	11	14	10p11.1	ZNF37A, KOX21, ZNF37		Zinc finger protein 37A	616085				
10.136	8	20	07	10p11.22	EPC1		Enhancer of polycomb, Drosophila, homolog of, 1	610999				
10.137	12	19	11	10p11.23	KIAA1462, JCAD		KIAA1462 gene	614398				
10.138	2	21	03	10p	BULN		Bulimia nervosa, susceptibility to	607499		between D10S1430 and D10S1423	{Bulimia nervosa, susceptibility to} (2)	
10.139	9	14	05	10p13	DCLRE1C, ARTEMIS, SCIDA		DNA cross-link repair protein 1C	605988			Severe combined immunodeficiency, Athabascan type, 602450 (3); Omenn syndrome, 603554 (3)	
10.140	10	8	08	10p	BMIQ8		Body mass index quantitative trait locus 8	603188			{Obesity, susceptibility to, BMIQ8} (2)	
10.141	10	30	03	10q	AITD4		Autoimmune thyroid disease, susceptibility to, 4	608176			{Autoimmune thyroid disease, susceptibility to, 4} (2)	
10.142	1	12	99	10q26.11	TIAL1, TIAR, TCBP		Tia1 cytotoxic granule-associated RNA-binding protein-like 1	603413				
10.143	5	26	13	10q11.22-q11.23	ARHGAP22		Rho GTPase-activating protein 22	610585				
10.144	5	19	16	10q11.23	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11		Excision repair cross complementing rodent repair deficiency, complementation group 6	609413			Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal syndrome 1, 214150 (3); De Sanctis-Cacchione syndrome, 278800 (3); {Macular degeneration, age-related, susceptibility to, 5}, 613761 (3); UV-sensitive syndrome 1, 600630 (3); {Lung cancer, susceptibility to}, 211980 (3); Premature ovarian failure 11, 616946 (3)	
10.145	8	18	98	10q22.1	TACR2, TAC2R, NKNAR		Tachykinin receptor 2 (substance K receptor; neurokinin 2 receptor)	162321				
10.146	10	24	11	10q22.2	ADK		Adenosine kinase	102750			Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)	14(Adk)
10.147	8	30	02	10q11.21	CXCL12, SDF1		Chemokine, C-X-C motif, ligand 12 (stromal cell-derived factor 1)	600835			{AIDS, resistance to}, 609423 (3)	
10.148	9	16	03	10q11.22	SYT15		Synaptotagmin 15	608081				14(Syt15)
10.149	5	27	05	10q11.21	ALOX5		Arachidonate 5-lipoxygenase	152390			{Atherosclerosis, susceptibility to} (3); {Asthma, diminished response to antileukotriene treatment in}, 600807 (3)	
10.150	3	6	98	10q11.22	ANXA8		Annexin A8	602396				14(Anx8)
10.151	4	30	15	10q11.23	CHAT, CMS6		Choline acetyltransferase	118490			Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3)	
10.152	03	02	20	10q21.1	DKK1		Dickkopf WNT signaling pathway inhibitor 1	605189				
10.153	3	23	06	10q11.22	MAPK8, PRKM8, JNK1, SAPK1		Mitogen-activated protein kinase 8	601158				
10.154	4	23	08	10q11.22	MSMB, HPC13		Microseminoprotein, beta	157145			{Prostate cancer, hereditary, 13}, 611928 (3)	
10.155	8	14	15	10q11.22	NCOA4, ELE1, PTC3		Nuclear receptor coactivator 4	601984		fused with RET to form PTC3		
10.156	8	10	13	10q11.22	PTPN20A		Protein tyrosine phosphatase, nonreceptor-type, 20A	610630				
10.157	8	19	13	10q11.22	PTPN20B		Protein tyrosine phosphatase, nonreceptor-type, 20B	610631				
10.158	9	29	13	10q11.2-q21.1	PRKG1, PRKG1B, PRKGR1B, AAT8		Protein kinase, cGMP-dependent, regulatory, type I	176894			Aortic aneurysm, familial thoracic 8, 615436 (3)	
10.159	6	4	13	10q11.22	RBP3, RP66		Retinol-binding protein-3, interstitial	180290		1 family identified with mutation	?Retinitis pigmentosa 66, 615233 (3)	14(Rbp3)
10.160	4	24	17	10q11.21	RET, MEN2A, HSCR1		RET transforming sequence; oncogene RET	164761			Multiple endocrine neoplasia IIA, 171400 (3); Medullary thyroid carcinoma, 155240 (3); Multiple endocrine neoplasia IIB, 162300 (3); Central hypoventilation syndrome, congenital, 209880 (3); Pheochromocytoma, 171300 (3); {Hirschsprung disease, susceptibility to, 1}, 142623 (3); {Hirschsprung disease, protection against}, 142623 (3)	
10.161	12	7	07	10q11.23	SGMS1, SMS1, TMEM23, MOB		Sphingomyelin synthase 1	611573				
10.162	12	6	16	10q11.23	SLC18A3, VACHT, CMS21		Solute carrier family 18 (vesicular acetylcholine), member 3	600336			Myasthenic syndrome, congenital, 21, presynaptic, 617239 (3)	
10.163	8	28	92	10q11.21	ZNF22, KOX15		Zinc finger protein-22 (KOX15)	194529				
10.164	3	12	07	10p11.1	ZNF33A, NF11A, KOX2		Zinc finger protein-33a	194521				
10.165	3	12	07	10q11.21	ZNF33B, ZNF11B, KOX2		Zinc finger protein-33b	194522				
10.166	8	26	09	10q11.21	ZNF239, MOK2		Zinc finger protein-239	601069		previously 19q13.2-q13.3		6(Mok2)
10.167	12	21	12	10q21.1	MBL2, MBL, MBP1, MBL2D, MBPD		Mannose-binding lectin 2, soluble (opsonic defect)	154545		near MEN2A	{Chronic infections, due to MBL deficiency}, 614372 (3)	14(Mbl1)
10.168	1	30	09	10q11.2-q21	STHAG5		Tooth agenesis, selective, 5	610926		D10S604 and D10S568	Tooth agenesis, selective, 5 (2)	
10.169	12	5	07	10q21.1	UBE2D1, UBCH5A, UBCH5		Ubiquitin-conjugating enzyme E2D 1	602961				
10.170	2	18	98	10q11.22	PPYR1, NPY4R, PP1		Pancreatic polypeptide receptor-1	601790				14(Ppyr1)
10.171	11	21	18	10q11.23	A1CF, ASP		APOBEC1 complementation factor	618199				
10.172	09	19	19	10q11.21	BMS1, BMS1L, KIAA0187, ACC		BMS1 ribosome biogenesis factor	611448		mutation identified in one ACC family	?Aplasia cutis congenita, nonsyndromic, 107600 (3)	
10.173	08	04	20	10q11.21	DEPP1, C10orf10, DEPP, FIG		DEPP1 autophagy regulator	611309				
10.174	4	27	16	10q11.21	FXYD4, CHIF		FXYD domain-containing ion transport regulator 4	616926				
10.175	6	7	10	10q11.21-q11.22	MARCH8		Membrane-associated RING-CH finger protein 8	613335				
10.176	3	30	12	10q11.21	RASFEF1A		RASGEF domain family, member 1A	614531				
10.177	5	26	13	10q11.21	RASSF4, AD037		Ras association domain family, member 4	610559				
10.178	3	25	96	10q11.21	HNRPF		Heterogeneous nuclear ribonucleoprotein F	601037				
10.179	04	27	20	10q11.22	TIMM23		Translocase of inner mitochondrial membrane 23	605034				
10.180	10	28	15	10q11.21	CSGALNACT2		Chondroitin sulfate N-acetylgalactosaminyltransferase 2	616616				
10.181	3	29	10	10q11.22	FRMPD2		FERM and PDZ domains-containing protein 2	613323				
10.182	11	11	13	10q11.22	GDF2, BMP9, HHT5		Growth differentiation factor 2 (bone morphogenetic protein 9)	605120			Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3)	
10.183	9	26	17	10q11.22	GDF10, BMP3B		Growth/differentiation factor 10	601361				
10.184	5	26	13	10q11.22	GPRIN2, GRIN2		G protein-regulated inducer of neurite outgrowth 2	611240				
10.185	4	20	17	10q11.22	WASHC2C, FAM21C, VPEF, KIAA0592		WASH complex, subunit 2C	613631				
10.186	3	29	10	10q11.23	WDFY4, KIAA1607		WD repeat- and FYVE domain-containing protein 4	613316				
10.187	5	26	13	10q11.23	ASAH2		N-acylsphingosine amidohydrolase 2	611202				
10.188	02	26	20	10q11.23	ASAH2B, ASAH2C, ASAH2L		N-acylsphingosine amidohydrolase 2B	610987				
10.189	8	26	09	10q11.23	DRGX, DRG11		Dorsal root ganglia homeobox	606701				
10.190	08	27	20	10q11.23	LRRC18		Leucine-rich repeat-containing protein 18	619002				
10.191	6	12	17	10q11.23	OGDHL, KIAA1290		Oxoglutarate dehydrogenase-like protein	617513				
10.192	2	20	01	10q11.23	PARG		Poly(ADP-ribose) glycohydrolase	603501				14(Parg)
10.193	9	28	11	10q11.23-q22.3	HYPT9		Hypotrichosis 9	614237		between D10S538 and D10S2327	Hypotrichosis 9 (2)	
10.194	10	13	09	10q21	ALL1		Leukemia, acute lymphocytic, susceptibility to, 1	613065		associated with rs10821936	{Leukemia, acute lymphocytic, susceptibility to, 1} (2)	
10.195	11	7	08	10q21	ALPQTL4		Alkaline phosphatase, plasma level of, QTL 4	612369		linkage with rs12355784	{Alkaline phosphatase, plasma level of, QTL4} (2)	
10.196	06	16	20	10q21.2	ANK3, MRT37		Ankyrin-3, node of Ranvier	600465			Mental retardation, autosomal recessive, 37, 615493 (3)	10(Ank3)
10.197	8	14	15	10q21.2	CCDC6, D10S170, H4, TST1		Coiled-coil domain-containing 6	601985		fused with RET to form PTC1		
10.198	2	2	14	10q21.3	CTNNA3, ARVD13		Catenin, alpha-3	607667			Arrhythmogenic right ventricular dysplasia, familial, 13, 615616 (3)	
10.199	07	14	20	10q22.1	DDX21		DExD-box helicase 21	606357				10(Ddx21)
10.200	9	24	08	10q21	IBD15		Inflammatory bowel disease 15	612255		association with rs10761659	{Inflammatory bowel disease 15} (2)	
10.201	3	20	06	10q21.1	IPMK		Inositol polyphosphate multikinase	609851				
10.202	10	30	08	10q21	MAFD8		Major affective disorder 8	612357		associated with rs20994336	{Major affective disorder-8, susceptibility to} (2)	
10.203	03	19	19	10q22.1	NPFFR1, NPFF1, GPR147		Neuropeptide FF receptor 1	607448				
10.204	10	17	16	10q21.1	TFAM, TCF6L2, TCF6L1, TCF6L3, MTTF1, TCF6, MTDPS15		Transcription factor A, mitochondrial	600438		mutation identified in 1 MTDPS15 family	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type), 617156 (3)	10(Tfam)
10.205	8	26	17	10q22.1	CDH23, USH1D, DFNB12, PITA5		Cadherin-23 (otocadherin)	605516		between D10S529 and D10S573	Usher syndrome, type 1D, 601067 (3); Deafness, autosomal recessive 12, 601386 (3); Usher syndrome, type 1D/F digenic, 601067 (3); {Pituitary adenoma 5, multiple types}, 617540 (3)	10(Cdh23, v)
10.206	6	19	98	10q22.1	EIF4EBP2, 4EBP2		Eukaryotic translation initiation factor-4E binding protein-1	602224				10(Eif4ebp2)
10.207	3	18	08	10q21.1	PCDH15, DFNB23, USH1F		Protocadherin 15	605514			Usher syndrome, type 1F, 602083 (3); Deafness, autosomal recessive 23, 609533 (3); Usher syndrome, type 1D/F digenic, 601067 (3)	10(av)
10.208	9	29	96	10q22.2	PPP3CB, CALNB		Protein phosphatase-3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta)	114106				
10.209	09	11	19	10q22.1	UNC5B, UNC5H2		unc-5 netrin receptor B	607870				
10.210	2	2	16	10q21.1	ZWINT, SIP30		ZW10 interacting kinetochore protein	609177				
10.211	1	11	07	10q22.1	SPOCK2, KIAA0275		SPARC/osteonectin, CWCV, and KAZAL-like domains proteoglycan 2	607988				
10.212	5	14	95	10q23.31	HTR7		5-hydroxytryptamine (serotonin) receptor-7, adenylate cyclase-coupled	182137				
10.213	6	14	10	10q21.2	CDK1, CDC2		Cyclin-dependent kinase 1	116940				10(Cdc2a)
10.214	4	8	08	10q21.1	CISD1, MITONEET		CDGSH iron sulfur domain protein 1	611932				
10.215	3	9	17	10q21.3	DNAJC12, JDP1, HPANBH4		DNAJ/HSP40 homolog, subfamily C, member 12	606060			Hyperphenylalaninemia, mild, non-BH4-deficient, 617384 (3)	
10.216	5	4	09	10q21.1	MYP15		Myopia 15	612717		max lod at D10S1643	Myopia 15 (2)	
10.217	2	7	13	10q21.3	MYPN, CMD1DD, CMH22, RCM4, NEM11		Myopalladin	608517			Cardiomyopathy, dilated, 1KK, 615248 (3); Cardiomyopathy, hypertrophic, 22, 615248 (3); Cardiomyopathy, familial restrictive, 4, 615248 (3); Nemaline myopathy 11, autosomal recessive, 617336 (3)	
10.218	8	29	08	10q21.3	PBLD, MAWBP, MAWDBP		Phenazine biosynthesis-like protein domain-containing protein	612189				
10.219	5	6	03	10q21.2	RHOBTB1, KIAA0740		Rho-related BTB domain-containing protein 1	607351				
10.220	8	19	13	10q21.3	RUFY2, KIAA1537		RUN and FYVE domains-containing protein 2	610328				
10.221	12	27	19	10q22.1	VPS26A, VPS26, HB58		VPS26 retromer complex component A	605506				
10.222	10	13	94	10q22.2	ANXA7, SNX		Annexin A7 (synexin)	186360				14(Anx7)
10.223	11	28	18	10q21.3	EGR2, KROX20, CHN1		KROX-20, Drosophila, homolog of (early growth response-2)	129010			Hypomyelinating neuropathy, congenital, 1, 605253 (3); Charcot-Marie-Tooth disease, type 1D, 607678 (3); Dejerine-Sottas disease, 145900 (3)	10(Krox20; Egr2)
10.224	9	10	09	10q21.2	ARID5B, MRF2, DESRT		AT-rich interaction domain-containing protein 5B	608538				
10.225	2	22	18	10q21.1	BICC1, BICC, CYSRD		Bicaudal C, Drosophila, homolog of, 1	614295			{Renal dysplasia, cystic, susceptibility to}, 601331 (3)	10(Bicc1)
10.226	2	27	15	10q21.2	MRLN, LINC00948		Myoregulin	616246				10(Mrln)
10.227	9	28	11	10q21.2	SLC16A9, MCT9		Solute carrier family 16 (monocarboxylic acid transporter), member 9	614242				
10.228	12	8	17	10q21.2	TMEM26		Transmembrane protein 26	617803				
10.229	5	31	05	10q21.2	ZNF365, UAN		Zinc finger protein 365	607818			{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)	
10.230	12	20	12	10q21.3	ADO, C10orf22		2-aminoethanethiol dioxygenase	611392				
10.231	2	12	09	10q21.3	CCAR1, CARP1		Cell division cycle and apoptosis regulator 1	612569				
10.232	4	6	16	10q21.3	JMJD1C, TRIP8, KIAA1380		Jumonji domain-containing protein 1C	604503				
10.233	3	26	07	10q21.3	LRRTM3		Leucine-rich repeat transmembrane protein 3	610869				10(Lrrtm3)
10.234	1	9	13	10q21.3	MSE		Myelinating Schwann cell element	614996				
10.235	1	6	09	10q22.1	NEUROG3, NGN3, ATOH5		Neurogenin 3	604882			Diarrhea 4, malabsorptive, congenital, 610370 (3)	
10.236	7	23	15	10q21.3	NRBF2, COPR		Nuclear receptor-binding factor 2	616477				
10.237	7	1	05	10q22.1	OIT3, LZP		Oncoprotein-induced transcript 3, mouse, homolog of	609330				10(Lzp)
10.238	3	24	06	10q22.1	PP		Inorganic pyrophosphatase	179030				10(Pyp)
10.239	7	1	05	10q21.3	REEP3, C10orf74		Receptor expression-enhancing protein 3	609348				
10.240	05	31	19	10q21.2	RTKN2		Rhotekin 2	618450				
10.241	9	9	08	10q21.3	SIRT1, SIR2L1		Sirtuin, S. cerevisiae, homolog 1	604479				
10.242	8	25	14	10q21.3	ATOH7, PHPVAR, NCRNA		Atonal, Drosophila, homolog of, 7	609875			Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3)	10(Atoh7)
10.243	09	09	19	10q21.3	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8		DNA replication helicase/nuclease 2	601810		mutation identified in 1 SCKL8 family	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3); ?Seckel syndrome 8, 615807 (3)	
10.244	4	16	14	10q21.3-q22.1	HCFP2		Facial paresis, hereditary congenital, 2	604185			Facial paresis, hereditary congenital, 2 (2)	
10.245	8	2	99	10q21.3	SLC25A16, D10S105E, GDA		Solute carrier family 25 (mitochondrial carrier), member 16 (Graves disease autoantigen)	139080				
10.246	4	10	90	10q22.1	P4HA1, P4HA		Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide 1	176710				
10.247	4	14	10	10q21.3-q22.3	HWE1		Epilepsy, hot water, 1	613339		max lod at D10S412	Epilepsy, hot water, 1 (2)	
10.248	07	30	19	10q22.2	CAMK2G, CAMKG, MRD59		Calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma	602123		in intron of PCDH15	Mental retardation, autosomal dominant 59, 618522 (3)	14(Camkg)
10.249	12	30	15	10q22.1	COL13A1, CMS19		Collagen XIII, alpha-1 polypeptide	120350		~550kb proximal to P4HA	Myasthenic syndrome, congenital, 19, 616720 (3)	
10.250	8	25	11	10q24.2	GOLGA7B, C10orf132		Golgin A7 family, member B	614189				
10.251	1	5	07	10q23.1-q23.2	GRID1, KIAA1220		Glutamate receptor, inotropic, delta 1	610659				14(Grid1)
10.252	08	21	19	10q22.1	HK1, HKD, HMSNR, RP79, NEDVIBA		Hexokinase-1	142600			Hemolytic anemia due to hexokinase deficiency, 235700 (3); Neuropathy, hereditary motor and sensory, Russe type, 605285 (3); Retinitis pigmentosa 79, 617460 (3); Neurodevelopmental disorder with visual defects and brain anomalies, 618547 (3)	10(Hk1)
10.253	6	19	98	10q21.3	HNRPH3, 2H9		Heterogeneous nuclear ribonucleoprotein H3	602324				
10.254	4	19	12	10q22.2	KAT6B, MYST4, MORF, GTPTS		Lysine acetyltransferase 6B	605880			SBBYSS syndrome, 603736 (3); Genitopatellar syndrome, 606170 (3)	
10.255	9	18	08	10q22.3	MAT1A, MATA1, SAMS1		Methionine adenosyltransferase I, alpha	610550			Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3); Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)	
10.256	11	16	98	10q22.2	NDST2		N-deacetylase/N-sulfotransferase 2	603268		in intron of PCDH15		
10.257	1	8	01	10q23.1	NRG3		Neuregulin 3	605533				
10.258	1	30	15	10q22.1	PCBD1, DCOH		Pterin-4a-carbinolamine dehydratase 1	126090			Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)	10(Dcoh)
10.259	7	22	15	10q22.1	PRF1, HPLH2, FLH2		Perforin	170280		mistakenly assigned to chr.17	Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3); Lymphoma, non-Hodgkin, 605027 (3); Aplastic anemia, 609135 (3)	10(Prf1)
10.260	5	9	07	10q22	SQTL1		Smoking as a quantitative trait locus 1	611003		near D10S1432	{Smoking as a quantitative trait locus 1} (2)	
10.261	5	28	09	10q21.3	TET1, CXXC6, LCX, KIAA1676		tet oncogene 1	607790				
10.262	2	4	00	10q22.2	VDAC2		Voltage-dependent anion channel 2	193245				14(Vdac2)
10.263	12	5	01	10q23.32	BTAF1, TAFII170, TAF172, MOT1		BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kD (Mot1, S. cerevisiae, homolog of)	605191				
10.264	4	23	08	10q21.1	CSTF2T, KIAA0689		Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD, tau variant	611968				19(Cstf2t)
10.265	6	27	08	10q22-q23	MGR12		Migraine, with or without aura, susceptibility to, 12	611706		max lod at 100cM	{Migraine, with or without aura, susceptibility to, 12} (2)	
10.266	3	1	00	10q22.3	PPIF, CYP3		Peptidylprolyl-cis-trans-isomerase, mitochondrial	604486				
10.267	3	11	09	10q22.3	SFTPA2, SPA2, COLEC5		Surfactant, pulmonary-associated protein A2	178642		contiguous with SFTPA1	Pulmonary fibrosis, idiopathic, 178500 (3)	
10.268	12	29	06	10q22.3	RPS24, DBA3		Ribosomal protein S24	602412			Diamond-blackfan anemia 3, 610629 (3)	
10.269	7	1	11	10q23.31	ACTA2, ACTSA, AAT6, MYMY5		Actin, alpha-2, smooth muscle, aorta	102620			Aortic aneurysm, familial thoracic 6, 611788 (3); Multisystemic smooth muscle dysfunction syndrome, 613834 (3); Moyamoya disease 5, 614042 (3)	
10.270	8	29	07	10q23.31	MPHOSPH1, MPP1		M-phase phosphoprotein 1	605498				
10.271	1	14	13	10q23.2-q23.3	PAPSS2, ATPSK2, BCYM4		3'-phosphoadenosine 5'-phosphosulfate synthase 2	603005			Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3)	19(Atpsk2, bm)
10.272	10	5	07	10q22-q24	ATFB1		Atrial fibrillation, familial, 1	608583			Atrial fibrillation, familial, 1 (2)	
10.273	09	26	19	10q22.1	ADAMTS14		ADAM metallopeptidase domain with thrombospondin type 1 motif, 14	607506				
10.274	7	26	10	10q22.1	ANAPC16, MSAG, C10orf104		Anaphase-promoting complex, subunit 16	613427				
10.275	01	03	20	10q22.1	ASCC1, p50, SMABF2		Activating signal cointegrator 1 complex, subunit 1	614215			Barrett esophagus/esophageal adenocarcinoma, 614266 (3); Spinal muscular atrophy with congenital bone fractures 2, 616867 (3)	
10.276	3	3	09	10q22.1	C10orf27		chromosome 10 open reading frame 27	612640				
10.277	11	22	19	10q22.2	CFAP70, TTC18, SPGF41		Cilia- and flagella-associated protein 70	618661		mutation identified in 1 SPGF41 patient	?Spermatogenic failure 41, 618670 (3)	
10.278	11	18	10	10q22.1	CHST3, C6ST, C6ST1, HSD		Carbohydrate sulfotransferase 3	603799			Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	
10.279	07	14	20	10q22.1	DDX50, GUB		DExD-box helicase 50	610373				10(Ddx50)
10.280	11	23	16	10q22.1	HKDC1		Hexokinase domain-containing protein 1	617221				
10.281	5	29	12	10q22.1	KIAA1274, PALD		Paladin, mouse, homolog of	614656				
10.282	7	1	05	10q22.1	KIAA1279		KIAA1279 gene	609367			Goldberg-Shprintzen megacolon syndrome, 609460 (3)	
10.283	9	2	11	10q22.1	MCU, CCDC109A		Mitochondrial calcium uniporter	614197				
10.284	3	5	14	10q22.1	MICU1, CBARA1, MPXPS		Mitochondrial calcium uptake protein 1	605084			Myopathy with extrapyramidal signs, 615673 (3)	
10.285	1	5	07	10q22.2	MRPS16, COXPD2		Mitochondrial ribosomal protein S16	609204			Combined oxidative phosphorylation deficiency 2, 610498 (3)	
10.286	1	30	01	10q22.2	MYOZ1		Myozenin 1 (calsarcin 2)	605603				
10.287	8	26	09	10q22.1	NODAL, HTX5		Nodal, mouse, homolog of	601265			Heterotaxy, visceral, 5, 270100 (3)	10(nodal)
10.288	12	18	07	10q22.1	PLA2G12B, GXIIB		Phospholipase A2, group XIIB	611653				
10.289	1	22	08	10q22.1	PSAP, SAP1		Prosaposin (sphingolipid activator protein-1)	176801			Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3); Gaucher disease, atypical, 610539 (3); Combined SAP deficiency, 611721 (3); Krabbe disease, atypical, 611722 (3)	10(Psap)
10.290	12	30	19	10q22.1	SARA1, SAR1A		Secretion-associated RAS-related GTPase 1A	607691				
10.291	4	18	12	10q22.1	SLC29A3, ENT3, PHID, HCLAP		Solute carrier family 29 (nucleoside transporter), member 3	612373			Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	
10.292	07	27	18	10q22.1	SGPL1, SPL, NPHS14		Sphingosine-1-phosphate lyase 1	603729			Nephrotic syndrome, type 14, 617575 (3)	10(Spl)
10.293	12	21	09	10q22.1	SRGN, PRG1, PRG		Serglycin	177040				
10.294	10	11	05	10q22.1	STOX1, PEE4		Storkhead box 1	609397			Preeclampsia/eclampsia 4, 609404 (3)	
10.295	1	31	01	10q22.1	SUPV3L1		Suv3-like 1	605122				
10.296	12	21	09	10q22.1	TSPAN15, NET7		Tetraspanin 15	613140				
10.297	8	20	07	10q22.1	TYSND1		Trypsin domain-containing protein 1	611017				
10.298	08	10	18	10q22.1	VSIR, C10orf54, B7H5		V-set immunoregulatory receptor	615608				
10.299	3	3	10	10q22.2	VCL, CMD1W, CMH15		Vinculin	193065			Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, hypertrophic, 15, 613255 (3)	
10.300	4	27	12	10q22.1-q24.1	SPG27		Spastic paraplegia-27, autosomal recessive	609041		between D10S606 and D10S1758	Spastic paraplegia 27, autosomal recessive (2)	
10.301	5	24	13	10q22.2	AP3M1		Adaptor-related protein complex 3, mu-1 subunit	610366				
10.302	1	27	04	10q22.1	DNAJB12, DJ10, FLJ0027		DNAJ, E. coli, homolog of, subfamily B, member 12	608376				
10.303	9	24	08	10q22.2	DNAJC9, JDD1, KIAA0974		DNAJ/HSP40 homolog, subfamily C, member 9	611206				
10.304	09	06	19	10q22.2	DUPD1, DUSP27, FMDSP		Dual-specificity phosphatase domain- and proline isomerase	618574				
10.305	12	21	09	10q22.2	DUSP13, TMDP, MDSP		Dual-specificity phosphatase 13	613191				
10.306	04	14	20	10q22.2	ECD, SGT1		Ecdysoneless cell cycle regulator	616464				
10.307	11	05	18	10q22.2	FUT11, FUCTXI		Fucosyltransferase 11	616932				
10.308	02	05	20	10q22.2	FAM149B1, KIAA0974, JBTS36		Family with sequence similarity 149, member B1	618413			Joubert syndrome 36, 618763 (3)	
10.309	11	24	20	10q22.2	MSS51, ZMYND17		MSS51 mitochondrial translational activator	614773				
10.310	12	7	07	10q22.2	SAMD8, SMSR		Sterile alpha motif domain-containing 8	611575				
10.311	3	13	15	10q22.2	SEC24C, KIAA0079		SEC24-related gene family, member C	607185				
10.312	4	26	11	10q22.2	ZNF503, NOLZ1		Zinc finger protein 503	613902				
10.313	3	20	18	10q22.3	SFTPA1, SFTP1		Surfactant, pulmonary-associated protein A1	178630		contiguous with SFTPA2		14(Sftp1)
10.314	4	21	15	10q23.2	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3		LIM domain binding 3	605906			Myopathy, myofibrillar, 4, 609452 (3); Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3); Cardiomyopathy, hypertrophic, 24, 601493 (3); Left ventricular noncompaction 3, 601493 (3)	
10.315	1	2	08	10q23.2	BMPR1A, ACVRLK3, ALK3		Bone morphogenetic protein receptor, type IA	601299			Polyposis, juvenile intestinal, 174900 (3); Polyposis syndrome, hereditary mixed, 2, 610069 (3); Juvenile polyposis syndrome, infantile form, 174900 (3)	
10.316	2	4	15	10q22.1	H2AFY2		H2A histone family, member Y2	616141				
10.317	01	10	20	10q22.3	KCNMA1, SLO, PNKD3, CADEDS, IEG16, LIWAS		Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of)	600150			Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy, 609446 (3); Cerebellar atrophy, developmental delay, and seizures, 617643 (3); {Epilepsy, idiopathic generalized, susceptibility to, 16}, 618596 (3); Liang-Wang syndrome, 618729 (3)	
10.318	07	19	18	10q22.2-q22.3	LRMDA, C10orf11, OCA7		Leucine-rich melanocyte differentiation-associated protein	614537			Albinism, oculocutaneous, type VII, 615179 (3)	
10.319	7	13	09	10q22.3	PLAC9		Placenta-specific gene 9	612857				15(Plac9)
10.320	02	08	19	10q22.3	POLR3A, RPC1, RPC155, ADDH, HLD7, WDRTS		Polymerase III, RNA, subunit A	614258			Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3); Wiedemann-Rautenstrauch syndrome, 264090 (3)	
10.321	9	22	03	10q22.3	SCZD11		Schizophrenia susceptibility locus, chromosome 10q-related	608078		between D10S1677 and D10S1753	{Schizophrenia}, 181500 (2)	
10.322	12	11	03	10q22.3	SLEN1		Systemic lupus erythematosus with nephritis, susceptibility to, 1	607965			{Systemic lupus erythematosus with nephritis, susceptibility to, 1} (2)	
10.323	11	07	08	10q22.3	SS3		Sarcoidosis, susceptibility to, 3	612388		associated with rs2789679 and rs1049550	{Sarcoidosis, susceptibility to, 3} (2)	
10.324	1	29	18	10q22.3	ANXA11, ANX11, ALS23		Annexin A11 (annexin XI)	602572			Amytrophic lateral sclerosis 23, 617839 (3)	
10.325	3	28	15	10q23	DEL10q23, C10DELq23		Chromosome 10q22.3-q23.2 deletion syndrome	612242			Chromosome 10q22.3-q23.2 deletion syndrome (4)	
10.326	3	9	00	10q23.31	CH25H		Cholesterol 25-hydroxylase	604551				
10.327	09	09	19	10q22.3	DLG5, PDLG, KIAA0583		Discs large MAGUK scaffold protein 5	604090				
10.328	3	15	13	10q23.31	KLLN, CWS4		Killin	612105			Cowden syndrome 4, 615107 (3)	
10.329	02	12	19	10q23.2	MINPP1, HIPER1		Multiple inositol polyphosphate phosphatase 1	605391			{Thyroid carcinoma, follicular}, 188470 (3)	19(Minpp1)
10.330	7	9	06	10q23.31	PANK1		Pantothenate kinase 1	606160				
10.331	1	26	07	10q23.33	PLCE1, KIAA1516, NPHS3		Phospholipase C, epsilon-1	608414			Nephrotic syndrome, type 3, 610725 (3)	
10.332	8	26	09	10q24.32	POLL		Polymerase, DNA, lambda	606343				
10.333	2	25	11	10q23.1	RGR, RP44		Retinal G protein coupled receptor	600342			Retinitis pigmentosa 44, 613769 (3)	
10.334	11	22	19	10q22.3	ZMIZ1, RAI17, KIAA1224, ZIMP10, NEDDFSA		Zinc finger MIZ-domain containing 1	607159			Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies, 618659 (3)	
10.335	3	16	99	10q25.2	SMNR, SPF30		Survival motor neuron-related protein	603519				
10.336	10	28	08	10q23.31	STAMBPL1, KIAA1373		STAM-binding protein-like 1	612352				19(Stambpl1)
10.337	5	22	03	10q24.2	CNNM1, ACDP1		Cyclin M1 (ancient conserved domain protein 1)	607802				
10.338	3	31	08	10q23-q24	CPROTQ		C-reactive protein QTL	611920		max lod at D10S1239	[C-reactive protein QTL] (2)	
10.339	6	15	99	10q23.33	CYP26A1		Cytochrome p450, subfamily XXVIA, polypeptide 1	602239				19(Cyp26a1)
10.340	10	23	87	10q24.1	DNTT, TDT		Terminal deoxynucleotidyltransferase	187410				19(Tdt)
10.341	1	14	16	10q24.2	ENTPD7, LALP1		Ectonucleoside triphosphate diphosphohydrolase 7	616753				
10.342	3	15	13	10q24.2	HPSE2, HPA2, UFS1		Heparanase 2	613469			Urofacial syndrome 1, 236730 (3)	
10.343	10	21	08	10q23-q24	IBD20		Inflammatory bowel disease 20	612288		associated with rs11190140	{Inflammatory bowel disease 20} (2)	
10.344	8	20	01	10q23.32	PPP1R3C, PPP1R5		Phosphatase 1, regulatory subunit 3C	602999				
10.345	3	6	02	10q24.1	TLL2, KIAA0932		Tolloid-like 2	606743				19(Tll2)
10.346	11	4	93	10q11.21	ZNF32, KOX30		Zinc finger protein-32 (KOX30)	194539				8(Zfp4)
10.347	2	9	92	10q23.33	IDE		Insulin-degrading enzyme	146680				19(Ide)
10.348	11	14	17	10q23.1	C10orf99, CSBF, AP57		Chromosome 10 open reading frame 99	617775				
10.349	10	8	12	10q23.1	CDHR1, PCDH21, PRCAD, CORD15, RP65		Cadherin-related family, member 1	609502			Cone-rod dystrophy 15, 613660 (3); Retinitis pigmentosa 65, 613660 (3)	
10.350	4	8	13	10q23.1	DYDC1		DPY30 domain-containing protein 1	615154				
10.351	10	25	16	10q23.1	FAM213A, PAMM		Family with sequence similarity 213, member A	617165				
10.352	4	20	17	10q23.1	HOST2		Long noncoding RNA HOST2	617434				
10.353	06	16	20	10q24.2	HPS1		HPS1 biogenesis of lysosomal organelles complex 3 subunit 1	604982			Hermansky-Pudlak syndrome 1, 203300 (3)	19(ep, ru)
10.354	11	24	14	10q23.1	LRIT1, PAL		Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 1	616103		REc, A		
10.355	1	11	18	10q24.1	BLNK, SLP65, AGM4		B-cell linker protein (SH2 domain-containing leukocyte protein, 65kD)	604515		mutation identified in 1 AGM4 family	?Agammaglobulinemia 4, 613502 (3)	
10.356	8	19	13	10q23.2	MIR346		Micro RNA 346	611190				
10.357	10	25	19	10q22.3	NUTM2B-AS1, OPML1		NUTM2B antisense RNA 1	618639		mutation identified in 1 OPML1 family	?Oculopharyngeal myopathy with leukoencephalopathy 1, 618637 (3)	
10.358	4	10	15	10q23.2	OPN4		Opsin 4	606665				
10.359	6	26	18	10q23.2	SHLD2, RINN2, FAM35A		Shield complex, subunit 2	618029				
10.360	2	12	07	10q23.2	WAPAL, KIAA0261, FOE, WAPL		Wings apart-like protein, Drosophila, homolog of	610754				
10.361	10	15	98	10q23.2	SNCG, BCSG1		Synuclein, gamma (breast cancer-specific gene 1)	602998				
10.362	12	13	18	10q24.31	NDUFB8, MC1DN32		NADH-ubiquinone oxidoreductase subunit B8	602140		previously assigned to 12q21	Mitochondrial complex I deficiency, nuclear type 32, 618252 (3)	
10.363	12	04	20	10q24.32	ARL3, ARFL3, JBTS35, RP83		ADP ribosylation factor-like GTPase 3	604695			Joubert syndrome 35, 618161 (3); Retinitis pigmentosa 83, 618173 (3)	
10.364	11	30	06	10q23.32	CPEB3, KIAA0940		Cytoplasmic polyadenylation element-binding protein 3	610606				
10.365	6	22	18	10q23.33	CYP2C8, CYP2C8DM		Cytochrome P450, subfamily IIc, polypeptide 8	601129			{Drug metabolism, altered, CYP2C8-related}, 618018 (3)	
10.366	1	15	13	10q23.33	CYP26C1, FFDD4		Cytochrome P450, subfamily XXVIC, polypeptide 1	608428			Focal facial dermal dysplasia 4, 614974 (3)	
10.367	2	21	02	10q23.2	GLUD1		Glutamate dehydrogenase-1	138130		pseudogene on Xq26-q28	Hyperinsulinism-hyperammonemia syndrome, 606762 (3)	14(Glud)
10.368	5	4	00	10q23.31	IFIT1, IFI56, G10P1, IFNAI1		Interferon-induced protein with tetratricopeptide repeats 1	147690		10q25-q26 = conflicting site		
10.369	5	4	00	10q23.31	IFIT4		Interferon-induced protein with tetratricopeptide repeats 4	604650				
10.370	5	4	00	10q23.31	IFIT2, IFI54, G10P2		Interferon-induced protein with tetratricopeptide repeats 2	147040				
10.371	6	7	10	10q23.32-q23.33	MARCH5		Membrane-associated RING-CH finger protein 5	610637				
10.372	11	18	08	10q23.3	RCM2		Cardiomyopathy, familial restrictive, 2	609578		max lod at D10S1242	Cardiomyopathy, familial restrictive, 2 (2)	
10.373	8	19	98	10q22.3	SFTPD, SFTP4		Surfactant, pulmonary-associated protein D	178635				
10.374	8	2	16	10q23.31	SLC16A12, MCT12, CTRCT47		Solute carrier family 16 (monocarboxylic acid transporter), member 12	611910		mutation identified in 1 CTRCT47 family	Cataract 47, juvenile, with microcornea, 612018 (3)	
10.375	01	13	20	10q25.1	SORCS1		Sortilin-related VPS10 domain-containing receptor 1	606283				
10.376	10	10	01	10q25.1	SORCS3, KIAA1059		SORCS receptor 3	606285				
10.377	2	8	08	10q23.33	C10orf4, FRA10AC1, FRA10A		Chromosome 10 open reading frame 4	608866				
10.378	9	27	17	10q23.33	CEP55, MARCH		Centrosomal protein, 55kD	610000			Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3)	
10.379	9	26	17	10q23.33	CYP2C18		Cytochrome P450, subfamily IIC, polypeptide 18	601131				
10.380	12	28	08	10q23.33	EXOC6, SEC15L1, SEC15L, SEC15		Exocyst complex component 6	609672				
10.381	3	14	13	10q23.33	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10		Free fatty acid receptor 4	609044			{Obesity, susceptibility to}, 607514 (3)	
10.382	5	29	12	10q23.33	KIF11, KNSL1, MCLMR		Kinesin family member 11	148760			Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)	18(Kns)
10.383	9	9	09	10q23.31	RNLS, C10orf59		Renalase	609360				
10.384	10	25	16	10q23.33	SLC35G1, POST, TMEM20, C10orf60		Solute carrier family 35, member G1	617167				
10.385	7	18	06	10q24.1	SORBS1, SH3D5, SH3P12, KIAA1296		Sorbin and SH3 domain containing 1	605264				
10.386	4	21	16	10q23.33	HELLS, LSH, ICF4		Helicase, lymphoid-specific	603946			Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3)	19(Hells)
10.387	10	28	14	10q23.31	ANKRD1, CARP		Ankyrin repeat domain-containing protein 1	609599				
10.388	6	10	18	10q23.31	ATAD1, THORASE, HKPX4		ATPase family, AAA domain-containing, member 1	614452			Hyperekplexia 4, 618011 (3)	
10.389	9	9	09	10q23.31	IDDM24		Diabetes mellitus, insulin-dependent, 24	613006		associated with rs10509540	{Diabetes mellitus, insulin-dependent, 24} (2)	
10.390	12	30	14	10q23.31	IFIT5, RI58, ISG58		Interferon-induced protein with tetratricopeptide repeats 5	616135				
10.391	12	15	10	10q23.31	LIPA, CESD		Lipase A, lysosomal acid, cholesterol esterase	613497		?close to GOT	Wolman disease, 278000 (3); Cholesteryl ester storage disease, 278000 (3)	19(Lip1)
10.392	9	27	17	10q23.31	LIPF		Lipase F, gastric type	601980				
10.393	4	26	11	10q23.31	LIPM, LIPL3		Lipase family, member M	613923				19(Lipm)
10.394	1	18	13	10q23.31	LIPN, LIPL4, ARCI8, LI4		Lipase family, member N	613924			Ichthyosis, congenital, autosomal recessive 8, 613943 (3)	19(Lipn)
10.395	4	26	11	10q23.31	LIPK, LIPL2		Lipase family, member K	613922				19(Lipk)
10.396	4	26	11	10q23.31	LIPJ, LIPL1		Lipase J	613921				19(Lipj)
10.397	12	21	09	10q23.31	MIR107, MIRN107		Micro RNA 107	613189				
10.398	02	26	19	10q23.31	PTEN, MMAC1, GLM2, CWS1		Phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	601728			Cowden syndrome 1, 158350 (3); Lhermitte-Duclos syndrome, 158350 (3); {Meningioma}, 607174 (3); {Glioma susceptibility 2}, 613028 (3); Macrocephaly/autism syndrome, 605309 (3); Prostate cancer, somatic, 176807 (3)	19(Pten)
10.399	8	26	09	10q23.31	RPP30		Ribonuclease P, 30kD subunit	606115				
10.400	1	30	07	10q24.2	ANKRD2, ARPP		Ankyrin repeat domain-containing protein 2	610734				
10.401	3	28	17	10q23.32	PCGF5		Polycomb group ring finger protein 5	617407				19(Pcgf5)
10.402	11	1	99	10q24.2	ABCC2, CMOAT		ATP-binding cassette, subfamily C, member 2 (canalicular multispecific organic anion transporter)	601107			Dubin-Johnson syndrome, 237500 (3)	19(Cmoat)
10.403	7	26	16	10q24	AD6		Alzheimer disease 6	605526			Alzheimer disease 6 (2)	
10.404	2	23	08	10q24.32	AS3MT, CYT19		Arsenic (+3 oxidation state) methyltransferase	611806				
10.405	06	23	20	10q24.31	CHUK, IKBKA, NFKBIKA, IKKA, IKK1		Component of nuclear factor kappa-B kinase complex	600664			Cocoon syndrome, 613630 (3)	
10.406	10	23	20	10q24.2	COX15, MC4DN6		Cytochrome c oxidase, subunit 15	603646			Mitochondrial complex IV deficiency, nuclear type 6, 615119 (3)	
10.407	7	3	06	10q24.2	CUTC		CutC copper transporter, E. coli, homolog of	610101				
10.408	8	3	99	10q23.33	CYP2C9		Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9	601130			Tolbutamide poor metabolizer (3); Warfarin sensitivity, 122700 (3)	7(War)
10.409	10	14	15	10q24.1	ENTPD1, CD39, SPG64		Ectonucleoside triphosphate diphosphohydrolase 1 (CD39 antigen)	601752			Spastic paraplegia 64, autosomal recessive, 615683 (3)	
10.410	9	22	08	10q24.31	FAM178A, C10orf6		Family with sequence similarity 178, member A	610348				
10.411	5	2	07	10q24.32	FBXW4, DAC, FBW4, FBWD4		F-box and WD repeat domain containing 4	608071				19(Dac)
10.412	9	28	12	10q24.32	FGF8, HH6		Fibroblast growth factor-8	600483			Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3)	19(Fgf8)
10.413	6	15	99	10q24.32	GBF1		Golgi-specific brefeldin-A resistance factor 1	603698				
10.414	3	3	03	10q23.33	HHEX, PRHX, PRH		Hematopoietically expressed homeo box	604420				
10.415	12	11	02	10q24.31	HIF1AN, FIH1		Hypoxia-inducible factor 1-alpha inhibitor	606615				
10.416	1	10	12	10q23.33	LGI1, EPT, ETL1, ADLTE, ADPEAF		Leucine-rich gene, glioma-inactivated, 1	604619			Epilepsy, familial temporal lobe, 1, 600512 (3)	
10.417	10	26	99	10q24.32	LBX1, LBX1H		Lady bird late, Drosophila, homolog of, 1	604255				19(Lbx1)
10.418	2	28	03	10q24.2	LOXL4		Lysyl oxidate-like 4	607318				
10.419	3	5	08	10q24.31	MRPL43		Mitochondrial ribosomal protein L43	611848				
10.420	5	31	12	10q23.33	MYOF, FER1L3		Myoferlin	604603				
10.421	05	19	20	10q24.32	NFKB2, LYT10, CVID10		Nuclear factor kappa-B, subunit 2 (p49/p100)	164012			Immunodeficiency, common variable, 10, 615577 (3)	
10.422	12	02	20	10q23.33	NOC3L, FAD24		NOC3-like DNA replication regulator	610769				
10.423	11	21	16	10q24.1	OPALIN, TMEM10, TMP10		Oligodendrocytic myelin paranodal and inner loop protein	617200				
10.424	3	20	08	10q25.2	PDCD4		Programmed cell death 4	608610				
10.425	11	3	09	10q23.33	PDE6C, PDEA2, COD4		Phosphodiesterase-6C, cGMP-specific, cone, alpha prime	600827			Cone dystrophy 4, 613093 (3)	
10.426	3	18	08	10q24.2	PI4K2A		Phosphatidylinositol 4-kinase type 2 alpha	609763				
10.427	9	12	11	10q22.2	PLAU, URK, QPD, BDPLT5		Plasminogen activator, urokinase	191840		proximal to HOX11	{Alzheimer disease, late-onset, susceptibility to}, 104300 (3); Quebec platelet disorder, 601709 (3)	14(Plau)
10.428	2	18	98	10q24.32	PSD		Pleckstrin and Sec7 domain protein	602327				
10.429	6	19	15	10q23.33	RBP4, RDCCAS, MCOPCB10		Retinol-binding protein-4, interstitial	180250		just centromeric of CYP2C cluster	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3); Microphthalmia, isolated, with coloboma 10, 616428 (3)	19(Rbp4)
10.430	8	10	10	10q24	SHFM3, SHSF3, DUP10q24, C10DUPq24		Split-hand/foot malformation 3 (Chromosome 10q24 duplication syndrome)	246560		contiguous gene duplication syndrome	Split-hand/foot malformation 3, gene duplication syndrome (4)	
10.431	1	12	06	10q24.2	SLC25A28, MRS4L, NPD016		Solute carrier family 25 (mitochondrial carrier), member 28	609767				
10.432	5	4	09	10q24.31	TD1		TLX1 divergent gene	612734				
10.433	7	17	02	10q24.31	TLX1, HOX11, TCL3		T-cell leukemia, homeobox 1	186770		t(7;10) or t(10;4) in T-ALL		
10.434	3	28	17	10q24.31	TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5		Twinkle mtDNA helicase	606075		PEO digenic with POLG	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3); Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3); Perrault syndrome 5, 616138 (3)	
10.435	12	03	19	10q24.33	ATP5MD, USMG5, DAPIT, MC5DN6		ATP synthase membrane subunit DAPIT	615204			Mitochondrial complex V (ATP synthase) deficiency, nuclear type 6, 618683 (3)	19(Usmg5)
10.436	8	29	96	10q24.31	WNT8B		Wingless-type MMTV integration site family, member 8B	601396				
10.437	1	13	16	10q24.1	ZDHHC16, APH2		Zinc finger DHHC domain-containing protein 16	616750				
10.438	8	18	99	10q24.32	BTRC, BTRCP		Beta-transducin repeat-containing protein	603482				
10.439	8	26	09	10q25.1	GSTO1		Glutathione S-transferase, omega-1	605482				
10.440	10	6	08	10q25.1	GSTO2		Glutathione S-transferase, omega-2	612314				
10.441	2	4	99	10q24.32	LDB1, CLIM2, NLI		LIM domain-binding factor-1	603451				19(Ldb1)
10.442	3	9	00	10q24.31	PKD2L1, PKDL, PKD2L		Polycystin L	604532				19(Pkdl)
10.443	11	7	17	10q24.32	SUFU, SUFUXL, SUFUH, JBTS32		Suppressor of fused	607035			Medulloblastoma, desmoplastic, 155255 (3); {Meningioma, familial, susceptibility to}, 607174 (3); Basal cell nevus syndrome, 109400 (3); Joubert syndrome 32, 617757 (3)	
10.444	12	4	01	10q24.33	TAF5, TAF2D, TAFII100		TAF5 RNA polymerase II, TATA box binding protein-associated factor, 100kD	601787				
10.445	3	7	92	10q25.2	ADRA2A, ADRA2R		Adrenergic, alpha-2A-, receptor	104210				19(Adra2)
10.446	09	26	19	10q25.3	ADRB1, ADRB1R, RHR, FNSS2		Adrenergic, beta-1-, receptor	109630		close linkage to ADRA2R	[Resting heart rate], 607276 (3); [Short sleep, familial natural, 2], 618591 (3)	19(Adrb1)
10.447	09	12	19	10q26.13	BUB3		BUB3 mitotic checkpoint protein	603719				
10.448	1	13	99	10q25.2	GPAM		Glycerol-3-phosphate acyltransferase	602395				19(Gpam)
10.449	1	10	02	10q24.32	NPM3		Nucleophosmin/nucleoplasmin family, member 3	606456				19(Npm3)
10.450	11	20	98	10q25.3	NRAP		Nebulin-related anchoring protein	602873				19(Nrap)
10.451	5	29	12	10q26.11	GRK5, GPRK5		G protein-coupled receptor kinase 5	600870				
10.452	12	7	07	10q24.1	ARHGAP19		RHO GTPase-activating protein 19	611587				
10.453	6	1	12	10q24.1	EXOSC1, CSL4		Exosome component 1	606493				
10.454	12	30	14	10q23.31	FAS, TNFRSF6, APT1, CD95, ALPS1A		Fas cell surface death receptor	134637			{Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	19(Fas1)
10.455	11	27	18	10q24.1	FRAT1		Frequently rearranged in advanced T-cell lymphomas 1	602503				19(Frat1)
10.456	8	27	01	10q24.1	FRAT2		Frequently rearranged in advanced T-cell lymphomas 2	605006				
10.457	2	18	08	10q24.1	LCOR, MLR2, KIAA1795		Ligand-dependent nuclear receptor corepressor	607698				
10.458	8	31	12	10q24.1	MMS19, MMS19L		MMS19 nucleotide excision repair, S. Cerevisiae, homolog of	614777				
10.459	9	20	14	10q24.1	PIK3AP1, BCAP, FLJ35564		Phosphoinositide 3-kinase adaptor protein 1	607942				
10.460	10	25	17	10q24.1	RRP12, KIAA0690		Ribosomal RNA-processing protein 12, S. cerevisiae, homolog of	617723				
10.461	10	22	99	10q24.2	SFRP5, SARP3		Secreted frizzled-related protein 5	604158				
10.462	09	12	19	10q24.1	SLIT1, SLIL1, MEGF4		SLIT guidance ligand 1	603742				
10.463	9	10	12	10q24.1	TCTN3, TECT3, C10orf61, OFD4, JBTS18		Tectonic family, member 3	613847			Orofaciodigital syndrome IV, 258860 (3); Joubert syndrome 18, 614815 (3)	
10.464	3	24	16	10q24.1	TM9SF3, SMBP		Transmembrane 9 superfamily, member 3	616872				
10.465	10	25	17	10q24.1	ZNF518A, KIAA0335		Zinc finger protein 518A	617733				
10.466	6	1	15	10q24.1-q24.2	UBTD1		Ubiquitin domain-containing protein 1	616388				
10.467	11	24	15	10q23.33	CYP2C, CYP2C19		Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase)	124020		4 genes in order: cen-C18-C19-C9-C8-tel	Mephenytoin poor metabolizer, 609535 (3); Omeprazole poor metabolizer, 609535 (3); Proguanil poor metabolizer, 609535 (3); Clopidogrel, impaired responsiveness to, 609535 (3)	19(P4502c)
10.468	8	31	99	10q24.32	MGEA5		Meningioma-expressed antigen 5	604039				
10.469	7	25	12	10q24.1-q25.1	CMTDIA		Charcot-Marie-Tooth disease, dominant intermediate A	606483			Charcot-Marie-Tooth disease, dominant intermediate A (2)	
10.470	1	18	12	10q24.2	GOT1, ASTQTL1		Glutamic-oxaloacetic transaminase 1, soluble	138180		10q26.1 = conflicting localization	Aspartate aminotransferase, serum level of, QTL1, 614419 (3)	19(Got1)
10.471	08	13	19	10q24.2	AVPI1, VIT32		Arginine vasopressin-induced protein 1	618537				19(Vit32)
10.472	3	10	03	10q24.2	CPN1, SCPN, CPN		Carboxypeptidase N, polypeptide 1, 50-kD	603103			Carboxypeptidase N deficiency, 212070 (3)	
10.473	7	2	18	10q24.2	CRTAC1, CEP68, LOTUS		Cartilage acidic protein 1	606276				
10.474	05	06	19	10q24.2	DNMBP, TUBA, KIAA1010, CTRCT48		Dynamin-binding protein	611282			Cataract 48, 618415 (3)	19(Dnmbp)
10.475	12	17	12	10q24.2	HOGA1, DHDPSL, HP3		4-hydroxy-2-oxoglutarate aldolase 1	613597			Hyperoxaluria, primary, type III, 613616 (3)	
10.476	6	26	16	10q24.2	MARVELD1, MARVD1		Marvel domain-containing protein 1	616970				
10.477	10	25	17	10q24.2	MORN4, RTP, UTA		MORN repeat-containing protein 4	617736				
10.478	6	16	08	10q24.2	NKX2C, NK2.3, CSX3		NK2, Drosophila, homolog of, C	606727				
10.479	3	1	18	10q24.2	PYROXD2, C10orf33, YUEF		Pyridine nucleotide-disulphide oxidoreductase domain-containing protein 2	617889				
10.480	4	27	12	10q24.2	ZFYVE27, SPG33		Zinc finger FYVE domain-containing protein 27	610243			Spastic paraplegia 33, autosomal dominant, 610244 (3)	
10.481	6	30	16	10q25.1-q25.2	ADD3, ADDL, CPSQ3		Adducin-3, gamma	601568		fusion with NUP98 in T-ALL	Cerebral palsy, spastic quadriplegic, 3, 617008 (3)	
10.482	4	26	17	10q24.32	PPRC1, PRC, KIAA0595		Peroxisome proliferator-activated receptor-gamma, coactivator-related protein 1	617462				
10.483	10	7	08	10q24.33	PDCD11, ALG4, NFBP, KIAA0185		Programmed cell death 11	612333				
10.484	10	23	15	10q24.1	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3		Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase)	138250		GOT1 and GSAS in same pathway	Cutis laxa, autosomal recessive, type IIIA, 219150 (3); Spastic paraplegia 9A, autosomal dominant, 601162 (3); Spastic paraplegia 9B, autosomal recessive, 616586 (3); Cutis laxa, autosomal dominant 3, 616603 (3)	
10.485	9	24	15	10q25.1	COL17A1, BPAG2, ERED		Collagen XVII, alpha-1 polypeptide	113811			Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Epidermolysis bullosa, junctional, localisata variant, 226650 (3); Epithelial recurrent erosion dystrophy, 122400 (3)	19(Bpag2)
10.486	8	9	05	10q24.32	CYP17A1, CYP17, P450C17		Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase)	609300		at least 2 genes; distal to GOT1	17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3); 17,20-lyase deficiency, isolated, 202110 (3)	19(Cyp17)
10.487	5	24	13	10q24.31	LZTS2, KIAA1813, LAPSER1		Leucine zipper, putative tumor suppressor 2	610454				
10.488	10	14	15	10q24.32-q24.33	NT5C2, NT5B, PNT5, SPG45		5' nucleotidase, cytosolic II	600417			Spastic paraplegia 45, autosomal recessive, 613162 (3)	
10.489	6	1	18	10q24.31	PDZD7, DFNB57		PDZ domain-containing 7	612971			{Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3); Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3); Deafness, autosomal recessive 57, 618003 (3)	
10.490	10	07	19	10q24.31	SEC31B, SEC31L2		SEC31 homolog B, COPII coat complex component	610258				
10.491	7	10	02	10q24.32	TRIM8, RNF27, GERP		Tripartite motif-containing 8	606125				
10.492	10	23	15	10q24.31	PAX2, PAPRS, FSGS7		Paired box homeotic gene-2	167409			Papillorenal syndrome, 120330 (3); Glomerulosclerosis, focal segmental, 7, 616002 (3)	19(Pax2)
10.493	8	28	97	10q26.3	CYP2E, CYP2E1, P450C2E		Cytochrome P450, subfamily IIE, ethanol-inducible	124040				7(Cyp2e)
10.494	12	28	08	10q24.31	BLOC1S2, BLOS2		Biogenesis of lysosome-related organelles complex 1, subunit 2	609768				
10.495	12	27	19	10q24.31	CWF19L1, C19L1, SCAR17		CWF19-like cell cycle control factor 1	616120			Spinocerebellar ataxia, autosomal recessive 17, 616127 (3)	
10.496	5	23	16	10q24.31	ERLIN1, SPG62		Endoplasmic reticulum lipid raft-associated protein 1	611604			Spastic paraplegia 62, 615681 (3)	
10.497	2	25	15	10q24.31	OLMALINC, LINC00263, OLMALINCAS		Oligodendrocyte maturation-associated long intergenic noncoding RNA	616240		OLMALINCAS is on opposite strand overlapping exon 1 of OLMALINC		
10.498	8	26	09	10q24.31	SCD		Stearoyl-CoA desaturase	604031		pseudogene on chr.17		19(ab)
10.499	08	19	20	10q24.31	SEMA4G		Semaphorin 4G	618991				19(Sema4g)
10.500	12	27	13	10q24.31	SFXN3		Sideroflexin 3	615571				
10.501	4	2	16	10q24.31	SNORA12		Small nucleolar RNA, H/ACA box, 12	611330		in intron 11 of CWF19L1		
10.502	8	31	12	10q24.32	ACTR1A, ARP1		Actin-related protein 1A	605143				
10.503	10	23	15	10q24.32	BORCS7, C10orf32		BLOC1-related complex, subunit 7	616600				
10.504	9	10	07	10q24.32	C10orf26, OPAL1		Chromosome 10 open reading frame 26	611129				
10.505	8	6	11	10q24.32	CUEDC2		Cue domain-containing protein 2	614142				
10.506	7	28	15	10q24.32	DPCD		Deleted in primary ciliary dyskinesia, mouse, homolog of	616467				19(Dpcd)
10.507	2	23	08	10q24.32	ELOVL3, CIG30		Elongation of very long chain fatty acids-like 3	611815				
10.508	5	24	13	10q24.32	FBXL15, JET		F-box and leucine-rich repeat protein 15	610287				
10.509	06	26	20	10q24.32	HPS6, RU		HPS6 biogenesis of lysosomal organelles complex 2 subunit 3	607522			Hermansky-Pudlak syndrome 6, 614075 (3)	19(ru)
10.510	5	26	13	10q24.32	MIR146B		Micro RNA 146B	610567				
10.511	10	2	12	10q24.32	NOLC1, p130, NOPP140		Nucleolar and coiled-body phosphoprotein 1	602394				
10.512	12	27	13	10q24.32	SFXN2		Sideroflexin 2	615570				
10.513	11	14	12	10q24.32-q25.1	ECTD5		Ectodermal dysplasia 5, hair/nail type	614927		between D10S1239 and D10S1264	Ectodermal dysplasia 5, hair/nail type (2)	
10.514	9	8	08	10q24.33	CALHM1, FAM26C		Calcium homeostasis modulator 1	612234		?Alzheimer disease, 605526		
10.515	9	8	08	10q24.33	CALHM2, FAM26B		Calcium homeostasis modulator 2	612235				
10.516	12	28	18	10q24.33	CALHM3		Calcium homeostasis modulator 3	618263				
10.517	6	17	15	10q24.32	CNNM2, ACDP2, HOMG6, HOMGSMR		Cyclin M2	607803			Hypomagnesemia 6, renal, 613882 (3); Hypomagnesemia, seizures, and mental retardation, 616418 (3)	19(Cnnm2)
10.518	1	27	11	10q22.1	DDIT4, REDD1, RTP801		DNA damage-inducible transcript 4	607729				
10.519	2	10	17	10q24.33	STN1, OBFC1, AAF44		STN1, CST complex subunit	613128			Cerebroretinal microangiopathy with calcifications and cysts 2, 617341 (3)	19(Obfc1)
10.520	12	28	08	10q24.33	PCGF6, RNF134, MBLR		Polycomb group ring finger 6	607816				
10.521	9	24	15	10q24.3-q25.1	SLK, LOSK, KIAA0204		STE20-like protein kinase	616563				
10.522	11	13	15	10q25.2	SMC3, CSPG6, HCAP, BAM, CDLS3		Structural maintenance of chromosomes 3	606062			Cornelia de Lange syndrome 3, 610759 (3)	19(Bam)
10.523	11	4	98	10q25.2	DUSP5, HVH3		Dual-specificity phosphatase-5	603069				
10.524	12	9	98	10q25	IDDM17		Insulin-dependent diabetes mellitus-17	603266			{Diabetes mellitus, insulin-dependent, 17} (2)	
10.525	2	18	98	10q25.3	LIMAB1		LIM actin-binding protein-1	602330				19(Limab1)
10.526	02	12	19	10q25.2	MXI1		MAX-interacting protein 1	600020			Neurofibrosarcoma, somatic (3); Prostate cancer, somatic, 176807 (3)	19(Mxi1)
10.527	01	14	19	10q25.3	NHLRC2, FINCA		NHL repeat-containing protein 2	618277			FINCA syndrome, 618278 (3)	
10.528	1	26	17	10q24.32	PITX3, CTPP4, CTRCT11, ASGD1		Paired-like homeodomain transcription factor-3	602669			Anterior segment dysgenesis 1, multiple subtypes, 107250 (3); Cataract 11, multiple types, 610623 (3); Cataract 11, syndromic, autosomal recessive, 610623 (3)	19(Pitx3)
10.529	07	27	20	10q25.2	SHOC2, SIAA0862, SOC2, SUR8, NSLH1		SHOC2 leucine-rich repeat scaffold protein	602775			Noonan syndrome-like with loose anagen hair 1, 607721 (3)	
10.530	7	5	18	10q25.3	SLC18A2, VAT2, SVMT, PKDYS2		Solute carrier family 18 (vesicular monoamine), member 2	193001		mutation identified in 1 PKDYS2 family	?Parkinsonism-dystonia, infantile, 2, 618049 (3)	19(Slc18a2)
10.531	5	19	06	10q26.13	ACADSB, SBCAD		Acyl-Coenzyme A dehydrogenase, short/branched chain	600301			2-methylbutyrylglycinuria, 610006 (3)	
10.532	12	2	05	10q25-q26	EIG4		Epilepsy, idiopathic generalized, susceptibility to 4	609750		between D16S397 and D16S3095	{Epilepsy, idiopathic generalized, susceptibility to 4} (2)	
10.533	9	1	15	10q25.3	HABP2, PHBP, HGFAL, FSAP, NMTC5		Hyaluronan-binding protein 2	603924		mutation identified in 1 NMTC5 family	{?Thyroid cancer, nonmedullary, 5}, 616535 (3); {Venous thromboembolism, susceptibility to}, 188050 (3)	
10.534	12	14	00	10q26.11	PRDX3, AOP1		Peroxiredoxin 3 (antioxidant protein 1)	604769				19(Aop1)
10.535	10	15	91	10q26.2	MKI67		Proliferation-related Ki-67 antigen	176741				7(Mki67)
10.536	01	31	20	10q25.1	CFAP43, WDR96, C10orf79, SPGF19, HYDNP1		Cilia- and flagella-associated protein 43	617558		mutation identified in 1 HYDNP1 family	Spermatogenic failure 19, 617592 (3); Hydrocephalus, normal pressure, 1, 236690 (3)	
10.537	12	18	20	10q25.1	CFAP58		Cilia- and flagella-associated protein 58	619129				
10.538	12	28	08	10q25.3	DCLRE1A, SNM1, SNM1A, KIAA0086		DNA cross-link repair protein 1A	609682				
10.539	7	17	14	10q24.33	NEURL1, NEURL, NEUR1		Neuralized E3 ubiquitin protein ligase 1	603804				
10.540	8	26	15	10q25.1	SFR1, MEI5, C10orf78		SWI5-dependent homologous recombination repair protein 1	616527				
10.541	9	18	08	10q25.2	ACSL5, FACL5, ACS5		Acyl-CoA synthetase long-chain family member 5	605677				
10.542	7	1	97	10q25.3	CASP7, MCH3		Caspase 7, apoptosis-related cysteine protease	601761				
10.543	10	24	14	10q25.2	BBIP1, NCRNA00081, BBIP10, BBS18		BBSome interacting protein 1	613605		mutation identified in 1 BBS18 family	?Bardet-Biedl syndrome 18, 615995 (3)	
10.544	12	21	09	10q25.2	RBM20		RNA-binding motif protein 20	613171			Cardiomyopathy, dilated, 1DD, 613172 (3)	
10.545	11	10	14	10q25.2	VTI1A, VTI1RP2, MMDS3		VTI1, S. cerevisiae, homolog of, A	614316				
10.546	12	23	19	10q25.2	ZDHHC6, DHHC6		Zinc finger DHHC-type palmitoyltransferase 6	618715				
10.547	1	27	04	10q26.3	DPYSL4, CRMP3, ULIP4		Dihydropyrimidinase-like 4	608407				7(Ulip4)
10.548	8	6	13	10q26.11	BAG3, MFM6		BCL2-associated athanogene 3	603883			Myopathy, myofibrillar, 6, 612954 (3); Cardiomyopathy, dilated, 1HH, 613881 (3)	
10.549	9	27	17	10q25.2	TECTB		Tectorin, beta	602653				
10.550	3	20	97	10q26.13	HMX2		Homeo box (H6 family) 2	600647				
10.551	5	14	02	10q26.2	UROS		Uroporphyrinogen III synthase	606938			Porphyria, congenital erythropoietic, 263700 (3)	7(Uros)
10.552	12	18	08	10q25.3	AFAP1L2, XB130, KIAA1914		Actin filament-associated protein 1-like protein 2	612420				
10.553	1	26	17	10q25.3	FAM160B1, KIAA1600		Family with sequence similarity 160, member B1	617312				
10.554	4	24	18	10q25.3	SHTN1, KIAA1598, SHOOTIN1		Shootin1	611171				
10.555	11	22	10	10q25.3	KCNK18, TRESK, TRIK, MGR13		Potassium channel, subfamily K, member 18	613655			{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)	19(Kcnk18)
10.556	6	5	89	10q24.1	PGAM1		Phosphoglycerate mutase A, nonmuscle form	172250				19(Pgam1)
10.557	3	18	12	10q25.3	PNLIPRP1, PLRP1		Pancreatic lipase-related protein 1	604422				
10.558	8	23	10	10q25.3	PNLIPRP2, PLRP2		Pancreatic lipase-related protein 2	604423				
10.559	7	3	06	10q25.2-q25.3	TCF7L2, TCF4		Transcription factor 7-like 2	602228			{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	
10.560	8	26	09	10q25.3	TDRD1		Tudor domain protein 1	605796				
10.561	1	29	07	10q25.3	TRUB1, PUS4		TRUB pseudouridine synthase, E. coli, homolog of, 1	610726				
10.562	01	11	19	10q25.3	VWA2, CCSP2, AMACO		von Willebrand factor A domain-containing protein 2	618281				19(Vwa2)
10.563	10	11	05	10q25.1	XPNPEP1, SAMP, XPNPEPL		X-prolyl aminopeptidase P1	602443				
10.564	11	5	95	10q26.11	GPR10		G protein-coupled receptor-10	600895				
10.565	10	29	09	10q26.13	DMBT1		Deleted in malignant brain tumors 1	601969				
10.566	9	21	11	10q25.3-q26.1	PDZD8		PDZ domain-containing protein 8	614235				
10.567	3	11	08	10q26.2	BCCIP, TOK1		BRCA2- and CDKN1A-interacting protein	611883				
10.568	2	3	16	10q26.13	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2		HTRA serine peptidase 1	602194			{Macular degeneration, age-related, 7}, 610149 (3); {Macular degeneration, age-related, neovascular type}, 610149 (3); CARASIL syndrome, 600142 (3); Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	
10.569	2	25	16	10q26.13	PLEKHA1, TAPP1		Pleckstrin homology domain-containing protein, family A, member 1	607772				
10.570	7	20	09	10q25.3	ATRNL1, KIAA0534, ALP		Attractin-like 1	612869				
10.571	7	1	09	10q26.11	CASC2		Cancer susceptibility candidate 2	608598		head-to-head orientation with RAB11FIP2		
10.572	9	7	10	10q26.13	CHST15, BRAG, KIAA0598		Carbohydrate sulfotransferase 15	608277				
10.573	4	7	13	10q26	CORD17		Cone-rod dystrophy 17	615163		between D10S1757 and D10S1782	Cone-rod dystrophy 17 (2)	
10.574	11	16	08	10q26	DEL10q26, C10q26DEL		Chromosome 10q26 deletion syndrome	609625			Chromosome 10q26 deletion syndrome (4)	
10.575	07	13	20	10q26.2	DHX32, DDX32		DEAH-box helicase 32 (putative)	607960				
10.576	10	3	07	10q26.11	EIF3A, EIF3S10, P167		Eukaryotic translation initiation factor 3, subunit A	602039				
10.577	9	1	05	10q26	ENDO1		Endometriosis, susceptibility to, 1	131200		max lod at D10S587	{Endometriosis, susceptibility to, 1} (2)	
10.578	2	19	04	10q26.13	FGFR2, BEK, CFD1, JWS, TK14, BBDS		Fibroblast growth factor receptor-2 (bacteria-expressed kinase)	176943			Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600 (3); Apert syndrome, 101200 (3); Saethre-Chotzen syndrome, 101400 (3); Craniosynostosis, nonspecific (3); Gastric cancer, somatic, 613659 (3); Craniofacial-skeletal-dermatologic dysplasia, 101600 (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3); Scaphocephaly and Axenfeld-Rieger anomaly (3); LADD syndrome, 149730 (3); Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3); Bent bone dysplasia syndrome, 614592 (3)	7(Fgfr2)
10.579	6	29	98	10q25.3	GFRA1, GDNFRA, GDNFR		GDNF family receptor, alpha-1	601496				19(Gfra1)
10.580	9	12	93	10q26.3	MGMT		Methylguanine-DNA methyltransferase	156569				
10.581	7	28	17	10q26.3	NKX6-2, NKX6B, NKX6.2, SPAX8		NK6 transcription factor related, locus 2 (Drosophila)	605955			Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy, 617560 (3)	7(Nkx6b)
10.582	4	20	10	10q26.13	OAT, GACR		Ornithine aminotransferase	613349		pseudogene at Xp11.2	Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3)	7(Oat)
10.583	5	7	01	10q23.33	PDLIM1, CLP36, CLIM1		PDZ and LIM domain protein 1	605900				
10.584	1	1	96	10q26.2	PTPRE		Protein tyrosine phosphatase, receptor type, epsilon	600926				7(Ptpre)
10.585	12	29	06	10q26.11	RAB11FIP2, KIAA0941		RAB11 family-interacting protein 2	608599				
10.586	1	25	05	10q26	RRIS		Respiratory rhythmicity in sleep	609116			[Respiratory rhythmicity in sleep] (2)	
10.587	1	31	01	10q26.13	TACC2		Transforming, acidic, coiled-coil-containing protein 2	605302				
10.588	8	17	99	10q26.3	UTF1		Undifferentiated embryonic cell transcription factor 1	604130				7(Utf1)
10.589	10	11	12	10q26.12	WDR11, DR11, KIAA1351, BRWD2, HH14		WD repeat-containing protein 11	606417			Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	
10.590	08	12	19	10q26.11	EMX2		Empty spiracles homeobox 2	600035		close to VAX1	Schizencephaly, 269160 (3)	19(Emx2)
10.591	5	23	14	10q26.3	JAKMIP3, C10orf39, NECC2, JAMIP3		Janus kinase and microtubule interacting protein 3	611198				
10.592	08	12	19	10q26.11	EMX2OS		EMX2 opposite strand/ antisense RNA	607637		non-coding RNA		19(Emx2os)
10.593	5	30	17	10q25.3	PNLIP, PNLIPD		Pancreatic lipase	246600		mutation identified in 1 family	?Pancreatic lipase deficiency, 614338 (3)	
10.594	2	2	15	10q25.3	VAX1, MCOPS11		Ventral anterior homeo box 1	604294		mutation identified in one MCOPS11 family	?Microphthalmia, syndromic 11, 614402 (3)	19(Vax1)
10.595	01	31	20	10q26.11	CACUL1, CAC1, C10orf46		CDK2-associated cullin domain-containing protein 1	618764				
10.596	12	6	16	10q26.11	INPP5F, SAC2, KIAA0966		Inositol polyphosphate 5-phosphatase F	609389				
10.597	4	17	07	10q26.11	MCMBP, C10orf119		Minichromosome maintenance complex-binding protein	610909				
10.598	12	19	19	10q26.11	NANOS1, NOS1, SPGF12		NANOS C2HC-type zinc finger 1	608226			Spermatogenic failure 12, 615413 (3)	
10.599	1	2	14	10q26.11	SFXN4, COXPD18		Sideroflexin 4	615564			Combined oxidative phosphorylation deficiency 18, 615578 (3)	
10.600	1	25	18	10q26.11-q26.12	SEC23IP		SEC23-interacting protein	617852				
10.601	1	16	07	10q25.3	HSPA12A, KIAA0417		Heat-shock 70kD protein 12A	610701				19(Hspa12a)
10.602	2	10	17	10q26.13	CPXM2, CPX2		Carboxypeptidase X, M14 family, member 2	617348				
10.603	4	23	08	10q26.13	CTBP2		C-terminal-binding protein 2	602619				
10.604	11	20	15	10q26.13	CUZD1, ERG1, ITMAP1		Cub and zona pellucida-like domains 1	616644				
10.605	12	6	17	10q26.13	EEF1AKMT2, METTL10		EEF1A lysine methyltransferase 2	617794				
10.606	1	9	17	10q26.13	FAM53B, KIAA0140		Family with sequence similarity 53, member B	617289				
10.607	4	23	09	10q26.13	FAM175B, ABRO1, KIAA0157		Family with sequence similarity 175, member B	611144				
10.608	4	26	10	10q26.13	HMX3, NKX5.1		H6 family homeobox 3	613380				7(Hmx3)
10.609	9	27	17	10q26.13	IFZF5, ZNFN1A5, PEGASUS		Ikaros family zinc finger 5	606238				
10.610	12	5	16	10q26.13	LHPP		Phospholysine phosphohistidine inorganic pyrophosphate phosphatase	617231				
10.611	3	10	11	10q26.13	LOC387715, ARMD8		LOC387715 gene	611313			{Macular degeneration, age-related, 8}, 613778 (3)	
10.612	1	20	16	10q26.2	MMP21, HTX7		Matrix metalloproteinase 21	608416			Heterotaxy, visceral, 7, autosomal, 616749 (3)	
10.613	01	21	20	10q26.13	NSMCE4A, NSE4A		NSE4 homolog A, SMC5-SMC6 complex component	612987				
10.614	4	6	15	10q26.13	PSTK, C10orf89		Phosphoseryl-tRNA kinase	611310				
10.615	1	23	08	10q26.13	ZRANB1, TRABID		Zinc finger- and RAN-binding domain-containing protein 1	611749				
10.616	6	3	98	10q26.2	DOCK1, DOCK180		Dedicator of cytokinesis-1	601403				
10.617	10	25	17	10q26.2	C10orf90, FATS		Chromosome 10 open reading frame 90	617735				
10.618	9	26	16	10q26.2	FAM196A, C10orf141, INSYN2		Family with sequence similarity 196, member A	617129				
10.619	12	18	07	10q26.2	FANK1		Fibronectin type III and ankyrin repeat domains 1	611640				
10.620	11	23	16	10q26.2	FOXI2		Forkhead box I2	617202				
10.621	8	17	09	10q26.2	NPS		Neuropeptide S	609513				
10.622	3	27	15	10q26.3	ECHS1, SCEH, ECHS1D		Enoyl-CoA hydratase, short-chain, 1, mitochondrial	602292			Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3)	
10.623	5	11	00	10q26.13	GPR26		G protein-coupled receptor 26	604847				
10.624	09	26	19	10q26.3	ADAM8, CD156		ADAM metallopeptidase domain 8	602267				7(Adam8)
10.625	09	26	19	10q26.2	ADAM12, MLTN		ADAM metallopeptidase domain 12	602714				
10.626	9	1	16	10q26.3	ADGRA1, GPR123, KIAA1828		Adhesion G protein-coupled receptor A1	612302				
10.627	6	10	11	10q26.3	BNIP3, NIP3		BCL2/adenovirus E1B 19-kD protein-interacting protein 3	603293				
10.628	6	27	14	10q26.3	CALY, DRD1IP		Calcyon neuron-specific vesicular protein	604647				
10.629	08	19	19	10q26.3	CFAP46, TTC40		Cilia- and flagella-associated protein 46	618543				
10.630	2	9	17	10q26.3	EBF3, COE3, HADDS		Early B-cell factor 3	607407			Hypotonia, ataxia, and delayed development syndrome, 617330 (3)	
10.631	10	25	17	10q26.3	FUOM, FUCU		Fucose mutarotase	617725				
10.632	5	12	09	10q26.3	GLRX3, PICOT		Glutaredoxin 3	612754				
10.633	1	20	98	10q26.3	INPP5A		Inositol polyphosphate-5-phosphatase, 40kD	600106				
10.634	2	25	15	10q26.3	KNDC1, RASGEF2, KIAA1768		Kinase noncatalytic C-lobe domain-containing protein 1	616237				
10.635	7	18	14	10q26.3	PAOX, PAO		Polyamine oxidase	615853				7(Paox)
10.636	9	8	11	10q26.3	PPP2R2D		Protein phosphatase 2, regulatory subunit B, delta	613992				
10.637	12	20	05	10q26.3	PRAP1		Proline-rich acidic protein 1	609776				
10.638	12	1	06	10q26.3	SPRN, SHADOO, SHO		Shadow of prion protein	610447				7(Sprn)
10.639	5	23	16	10q26.3	SYCE1, POF12, SPGF15		Synaptonemal complex central element protein 1	611486		mutation identified in 1 POF12 and 1 SPGF15 family	?Premature ovarian failure 12, 616947 (3); ?Spermatogenic failure 15, 616950 (3)	
10.640	01	20	20	10q26.3	TUBGCP2, GCP2, GRIP103, SPC97, ALP4, PAMDDFS		Tubulin-gamma complex-associated protein 2	617817			Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures, 618737 (3)	
10.641	6	12	12	10q26.3	VENTX, VENTX2, HPX42B		VENT homeobox	607158				
11.1	01	03	20	11q14.1	ALG8, CDG1H, PCLD3		ALG8 alpha-1,3-glucosyltransferase	608103			Congenital disorder of glycosylation, type Ih, 608104 (3); Polycystic liver disease 3 with or without kidney cysts, 617874 (3)	
11.2	10	21	19	11p15.2	RRAS2, TC21, NS12		Related Ras viral oncogene homolog 2	600098			Ovarian carcinoma (3); Noonan syndrome 12, 618624 (3)	
11.3	7	20	09	11p15.4	AMPD3		Adenosine monophosphate deaminase-3, isoform E	102772			[AMP deaminase deficiency, erythrocytic], 612874 (3)	7(Ampd3)
11.4	5	4	12	11p13	CD44, MDU2, MDU3, MIC4, IN		CD44 antigen (homing function)	107269			[Blood group, Indian system], 609027 (3)	2(Ly24)
11.5	3	6	94	11pter-p11.2	TP250		T-cell activation antigen p250	186710				
11.6	5	12	08	11p15.5	AP2A2, KIAA0899		Adaptor-related protein complex 2, alpha-2 subunit	607242				
11.7	8	4	97	11p15.5	ASCL2		Achaete-scute complex, Drosophila, homolog-like 2	601886				
11.8	9	23	13	11p15.5	BET1L, GS15		BET1-like protein	615417				
11.9	5	23	13	11p15.5	BRSK2, SAD1, PEN11B		BR serine/threonine kinase 2	609236				
11.10	8	20	07	11p15.5	C11orf21		Chromosome 11 open reading frame 21	611033				
11.11	05	27	20	11p15.4	CARS1, CARS, MDBH		Cysteinyl-tRNA synthetase 1	123859			Microcephaly, developmental delay, and brittle hair syndrome, 618891 (3)	
11.12	7	20	06	11p15.5	CD151, PETA3, SFA1, MER2		CD151 antigen	602243			Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3); [Blood group, Raph], 179620 (3)	
11.13	12	10	10	11p15.5	CDHR5, MUCDHL		Cadherin-related family, member 5	606839				
11.14	7	20	12	11p15.4	CDKN1C, KIP2, BWS, IMAGE		Cyclin-dependent kinase inhibitor 1C (p57, Kip2)	600856		rare cause of BWS	Beckwith-Wiedemann syndrome, 130650 (3); IMAGE syndrome, 614732 (3)	7(Kip2)
11.15	12	19	11	11p15.5	CEND1, BM88		Cell cycle exit and neuronal differentiation 1	608213				
11.16	3	14	14	11p15.5	CHID1, SICLP		Chitinase domain-containing protein 1	615692				
11.17	11	28	01	11p15.4	CHRNA10		Cholinergic receptor, neuronal nicotinic, alpha polypeptide 10	606372				
11.18	5	31	06	11p15.5	CTSD, CPSD, CLN10		Cathepsin D (lysosomal aspartyl protease)	116840			Ceroid lipofuscinosis, neuronal, 10, 610127 (3)	
11.19	07	13	20	11p15.5	DEAF1, SPN, ZMYND5, VSVS, NEDHELS		DEAF1 transcription factor	602635			Vulto-van Silfout-de Vries syndrome, 615828 (3); Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures, 617171 (3)	
11.20	03	10	20	11p15.5	DRD4		Dopamine receptor D4	126452		proximal to HRAS	Autonomic nervous system dysfunction (3); {Attention deficit-hyperactivity disorder}, 143465 (3)	
11.21	3	9	98	11p15.5	DUSP8, HVH8		Dual specificity phosphatase-8	602038		pseudogene on 10q11.2		7(Dusp8)
11.22	9	6	11	11p15.5	EFCAB4A, CRACR2B		EF-hand calcium-binding domain-containing protein 4A	614177				
11.23	06	10	20	11p15.5	H19, D11S813E, ASM1		H19 gene	103280		same 200kb fragment as IGF2		7(H19)
11.24	4	23	08	11p15.5	HCCA2		HCCA2 gene	611969				
11.25	06	15	20	11p15.5	ICR1, BWS, WT2, SRS1		H19-IGF2-imprinting control region	616186			Beckwith-Wiedemann syndrome, 130650 (3); Wilms tumor 2, 194071 (3); Silver-Russell syndrome 1, 180860 (3)	
11.26	8	9	12	11p15.5	IFITM1, IFI17, LEU13		Interferon-induced transmembrane protein 1	604456				
11.27	8	9	12	11p15.5	IFITM2		Interferon-induced transmembrane protein 1	605578				
11.28	7	20	12	11p15.5	IFITM3		Interferon-induced transmembrane protein 3	605579			{Influenza, severe, susceptibility to}, 614680 (3)	
11.29	9	21	12	11p15.5	IFITM5, OI5		Interferon-induced transmembrane protein 5	614757			Osteogenesis imperfecta, type V, 610967 (3)	
11.30	01	23	19	11p15.5	IFITM10, DSPA3		Interferon-induced transmembrane protein 10	618293				7(Dspa3)
11.31	5	13	15	11p15.5	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39		Interferon regulatory factor 7	605047		mutation identified in 1 family	?Immunodeficiency 39, 616345 (3)	
11.32	10	28	10	11p15.5-p15.4	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2		Potassium voltage-gated channel, KQT-like subfamily, member 1	607542			Long QT syndrome 1, 192500 (3); Jervell and Lange-Nielsen syndrome, 220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Short QT syndrome 2, 609621 (3); {Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	7(Kcnq1)
11.33	8	25	03	11p15.4	LCRB		Locus control region beta	152424			Thalassemia, Hispanic gamma-delta-beta, 613985 (3)	
11.34	12	28	18	11p15.5	LRRC56, CILD39		Leucine-rich repeat-containing protein 56	618227			Ciliary dyskinesia, primary, 39, 618254 (3)	
11.35	9	9	09	11p15.5	MIR210, MIRN210		Micro RNA 210	612982				
11.36	3	31	09	11p15.4	MRGPRG, MRGG		MAS-related G protein-coupled receptor family, member G	607234				
11.37	8	28	92	11p15.5	MUC2		Mucin 2, intestinal/tracheal	158370				
11.38	6	13	95	11p15.5	MUC5AC, MUC5		Mucin 5, subtypes A and C, tracheobronchial/gastric	158373				
11.39	6	14	18	11p15.4	HBB, ECYT6		Hemoglobin beta	141900		pseudogene HBBP1 between HBG and HBD loci	Sickle cell anemia, 603903 (3); Thalassemia, beta, 613985 (3); Methemoglobinemia, beta type, 617971 (3); Heinz body anemia, 140700 (3); Thalassemia-beta, dominant inclusion-body, 603902 (3); Delta-beta thalassemia, 141749 (3); Hereditary persistence of fetal hemoglobin, 141749 (3); {Malaria, resistance to}, 611162 (3); Erythrocytosis 6, 617980 (3)	7(Hbb)
11.40	6	16	97	11p15.4	HBD		Hemoglobin delta	142000			Thalassemia, delta- (3); Thalassemia due to Hb Lepore (3)	
11.41	11	13	07	11p15.4	HBG1		Hemoglobin, gamma A	142200			Fetal hemoglobin quantitative trait locus 1, 141749 (3)	
11.42	6	15	11	11p15.4	HBG2, TNCY		Hemoglobin, gamma G	142250			Fetal hemoglobin quantitative trait locus 1, 141749 (3); Cyanosis, transient neonatal, 613977 (3)	
11.43	3	1	89	11p15.4	HBE1		Hemoglobin epsilon	142100				
11.44	02	12	19	11p15.5	HRAS		Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog	190020		pseudogene HRASP on X	Bladder cancer, somatic, 109800 (3); Costello syndrome, 218040 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Congenital myopathy with excess of muscle spindles, 218040 (3); Nevus sebaceous or woolly hair nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Spitz nevus or nevus spilus, somatic, 137550 (3)	7(Hras1)
11.45	06	15	20	11p15.5	IGF2, GRDF, SRS3		Insulin-like growth factor-2, or somatomedin A	147470		mutation identified in 1 GRDF family	Silver-Russell syndrome 3, 616489 (3)	7(Igf2)
11.46	7	8	13	11p15.5	IGF2AS, PEG8		Insulin-like growth factor II, antisense	610146				
11.47	12	01	20	11p15.5	INS, MODY10, IDDM2, PNDM4		Insulin	176730		5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-TH	Hyperproinsulinemia, 616214 (3); Maturity-onset diabetes of the young, type 10, 613370 (3); Diabetes mellitus, permanent neonatal 4, 618858 (3); Diabetes mellitus, insulin-dependent, 2, 125852 (3)	6(Ins1); 7(Ins2)
11.48	2	28	03	11p15.5	IRDN, ILPR		Insulin-related DNA polymorphism (insulin-related VNTR)	147510				
11.49	5	22	07	11p15.4	KCNQ1DN		KCNQ1 downstream neighbor	610980				
11.50	4	29	17	11p15.5	PHRF1, KIAA1542		PHD and RING finger domain-containing protein 1	611780				
11.51	8	16	99	11p15.5	KCNQ1OT1, LIT1		KCNQ1-overlapping transcript 1	604115			Beckwith-Wiedemann syndrome, 130650 (3)	7(Kcnq10t1)
11.52	12	19	90	11p15.5	KRTAP5-1, KRN1L		Keratin associated protein 5-1	148022				
11.53	3	23	93	11p15.5	LSP1		Lymphocyte-specific protein pp52	153432				
11.54	11	22	13	11p15.5	MIR675		Micro RNA 675	615509				
11.55	3	7	06	11p15.5	NALP6, PYPAF5		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 6	609650				
11.56	6	9	98	11p15.4	NAP1L4, NAP2L, NAP2		Nucleosome assembly protein 1-like 4	601651				
11.57	1	27	04	11p15.5	ODF3, SHIPPO1		Outer dense fiber of sperm tails 3	608356				7(Odf3)
11.58	5	23	13	11p15.4	PGAP2, FRAG1, HPMRS3, MRT17, MRT21		Post-GPI attachment to proteins 2	615187			Hyperphosphatasia with mental retardation syndrome 3, 614207 (3)	
11.59	7	14	16	11p15.5	PGGHG, ATHL1		Protein-glucosylgalactosylhydroxylysine glucosidase	617032				
11.60	10	28	04	11p15.4	PHLDA2, TSSC3, IPL, BRW1C		Pleckstrin homology-like domain, family A, member 2	602131				7(Ipl)
11.61	11	11	14	11p15.5	PIDD1, LRDD		p53-induced death domain protein 1	605247				
11.62	1	24	07	11p15.5	PNPLA2, TTS2, ATGL		Patatin-like phospholipase domain-containing protein 2	609059			Neutral lipid storage disease with myopathy, 610717 (3)	7(Pnpla2)
11.63	9	24	12	11p15.5	PSMD13, S11		Proteasome 26S subunit, non-ATPase, 13	603481				
11.64	5	26	09	11p15.5	PTDSS2, PSS2		Phosphatidylserine synthase 2	612793				
11.65	9	7	12	11p15.5	RASSF7, C11orf13, HRC1		RAS association domain family, member 7	143023		29kb 5' to HRAS1; divergently transcribed		
11.66	09	09	19	11p15.5	RIC8A		RIC8 guanine nucleotide exchange factor A	609146				
11.67	1	22	15	11p15.5	RNH1, RNH		Ribonuclease/angiogenin inhibitor 1	173320				
11.68	12	22	98	11p15.5	RPL23L, L23MRP, MRPL23		Ribosomal protein L23-like (L23 mitochondrial-related protein)	600789				
11.69	6	22	12	11p15.5	RPLP2		Ribosomal phosphoprotein, large, P2	180530				
11.70	7	13	93	11p15.4	RRM1		Ribonucleotide reductase, M1 polypeptide	180410				7(Rrm1)
11.71	2	25	15	11p15.5	SCGB1C1, RYD5		Secretoglobin, family 1C, member 1	610176				
11.72	2	14	01	11p15.5	SCT		Secretin	182099				
11.73	1	30	01	11p15.5	SIGIRR		Single immunoglobulin domain-containing IL1R-related protein	605478				
11.74	5	4	00	11p15.5	SIRT3, SIR2L3		Sirtuin, S. cerevisiae, homolog 3	604481				
11.75	2	3	00	11p15.4	SLC22A1LS, ORCTL2S, BWSCR1B		Solute carrier family 22, member 1-like-antisense	603240				
11.76	6	23	11	11p15.4	SLC22A1L, BWSCR1A, IMPT1		Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A; organic-cation transporter-like 2)	602631			Breast cancer, somatic, 114480 (3); Rhabdomyosarcoma, somatic, 268210 (3); Lung cancer, somatic, 211980 (3)	
11.77	10	23	20	11p15.5	SLC25A22, GC1, DEE3		Solute carrier family 25 (mitochondrial carrier, glutamate), member 22	609302			Developmental and epileptic encephalopathy 3, 609304 (3)	
11.78	12	11	03	11p15.5	SLEN3		Systemic lupus erythematosus with nephritis, susceptibility to, 3	607967			{Systemic lupus erythematosus with nephritis, susceptibility to, 3} (2)	
11.79	7	17	14	11p15.4	STIM1, TAM1, IMD10, STRMK		Stromal interaction molecule 1	605921			Immunodeficiency 10, 612783 (3); Myopathy, tubular aggregate, 1, 160565 (3); Stormorken syndrome, 185070 (3)	
11.80	5	22	13	11p15.5	SYT8		Synaptotagmin 8	607719				
11.81	1	20	09	11p15.5	TH, TYH		Tyrosine hydroxylase	191290		distal to HRAS1	Segawa syndrome, recessive, 605407 (3)	7(Th)
11.82	05	16	19	11p15.5	TNNI2, AMCD2B, DA2B1, FSSV		Troponin I, fast-twitch skeletal muscle isoform	191043			Arthrogryposis, distal, type 2B1, 601680 (3)	
11.83	05	16	19	11p15.5	TNNT3, AMCD2B, DA2B2, FSSV		Troponin-T3, skeletal, fast	600692			Arthrogryposis, distal, type 2B2, 618435 (3)	7(Tnnt3)
11.84	3	8	07	11p15.4	TRIM21, SSA1, RO52		Tripartite motif-containing protein 21	109092				
11.85	7	9	06	11p15.5	TOLLIP		Toll-interacting protein	606277				
11.86	1	14	14	11p15.4	TPP1, CLN2, SCAR7		Tripeptidyl peptidase 1	607998			Ceroid lipofuscinosis, neuronal, 2, 204500 (3); Spinocerebellar ataxia, autosomal recessive 7, 609270 (3)	
11.87	1	14	02	11p15.5	TRPM5, MTR1		Transient receptor potential cation channel, subfamily M, member 5 (MLSN1- and TRP-related gene 1)	604600		maternal allele imprinted		7(Mtr1)
11.88	1	20	06	11p15.5	TSPAN4, TM4SF7, NAG2		Tetraspanin 4	602644				
11.89	1	20	06	11p15.5	TSPAN32, PHEMX, TSSC6		Tetraspanin 32	603853		not imprinted		
11.90	11	2	04	11p15.4	TSSC2		Tumor-suppressing subtransferable fragment candidate gene 2	608999				
11.91	8	31	99	11p15.5	TSSC4		Tumor-suppressing subchromosomal transferable fragment cDNA 4	603852		not imprinted		
11.92	3	9	98	11p15.4	ZNF195		Zinc finger protein-195	602187				
11.93	12	4	02	11p15.4	FXC1, TIMM10B		Fracture callus 1, rat, homolog of	607388				
11.94	7	13	93	11p15.4	ARHG		ras homolog gene family, member G (rho G)	179505				
11.95	3	6	94	11p15.4	CCKBR, GASR		Cholecystokinin B receptor	118445				7(Cckbr)
11.96	12	17	87	11p15.4	HPX		Hemopexin	142290				
11.97	6	25	99	11p15.4	ILK, P59		Integrin-linked kinase	602366				
11.98	2	26	08	11p15.4	MRPL17		Mitochondrial ribosomal protein L17	611830				
11.99	2	20	97	11p15.5	MUC6		Mucin 6, gastric	158374		order: tel-HRAS-MUC6-MUC2-MUC5AC-MUC5B-IGF2-cen		
11.100	8	9	01	11p15.5	TALDO1		Transaldolase-1	602063		pseudogene on chr.1	Transaldolase deficiency, 606003 (3)	
11.101	10	16	89	11p15.1	LDHC, LDH3		Lactate dehydrogenase C	150150		closely linked to LDHB in other species; in man syntenic with LDHA; ?close to LDHA		7(Ldh3)
11.102	7	15	99	11p15.4	ADM		Adrenomedullin	103275				7(Adm)
11.103	10	2	12	11p15.4	ARFIP2, POR1		ADP-ribosylation factor-interacting protein 2	601638				
11.104	4	13	15	11p15.4	BGLT3, LINC01083		Beta-globin locus transcript 3, noncoding	616308				
11.105	01	29	19	11p15.4	CAVIN3, SRBC		Caveolae-associated protein 3	618303				
11.106	3	20	09	11p15.4	CYB5R2		Cytochrome b5 reductase 2	608342				
11.107	11	17	15	11p15.4	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2		Dachsous, Drosophila, homolog of, 1	603057			Van Maldergem syndrome 1, 601390 (3); Mitral valve prolapse 2, 607829 (3)	
11.108	11	05	20	11p15.4	DENND5A, RAB6IP1, KIAA1091, DEE49		DENN domain-containing protein 5A	617278			Developmental and epileptic encephalopathy 49, 617281 (3)	
11.109	12	27	16	11p15.4	DHND1, FLJ00251		Dynein heavy chain domain 1	617277				
11.110	01	25	19	11p15.4	EIF3F, EIF3S5, MRT67		Eukaryotic translation initiation factor 3, subunit F	603914			Mental retardation, autosomal recessive 67, 618295 (3)	
11.111	12	8	14	11p15.4	GVINP1, VLIG1		GTPase, very large interferon-inducible, pseudogene 1	616121				7(Gvin1)
11.112	8	17	09	11p15.1	LDHA, LDH1, GSD11		Lactate dehydrogenase A	150000			Glycogen storage disease XI, 612933 (3)	7(Ldh1)
11.113	3	31	09	11p15.4	MRGPRE, MRGE		Mas-related G protein-coupled receptor family, member E	607232				
11.114	10	07	20	11p15.1	MYOD1, MYF3, MYODRIF		Myogenic differentiation 1	159970		proximal to CALCA, HBB, BWS, PTH; ?11p14.3	Myopathy, congenital, with diaphragmatic defects, respiratory insufficiency, and dysmorphic facies, 618975 (3)	7(Myod1)
11.115	4	17	13	11p15.4	NLRP1, NALP14, NOD5		NLR family, pyrin domain containing 1	609665				
11.116	8	8	13	11p15.4	OR10A1		Olfactory receptor, family 10, subfamily A, member 1	608493				
11.117	8	8	13	11p15.4	OR2D2		Olfactory receptor, family 2, subfamily D, member 2	608494				
11.118	8	19	13	11p15.4	OR51E1, DGPCR, PSGR2		Olfactory receptor, family 51, subfamily E, member 1	611267				
11.119	8	19	13	11p15.4	OR51E2, PSGR		Olfactory receptor, family 51, subfamily E, member 2	611268				
11.120	5	7	03	11p15.4	OSBPL5, ORP5, KIAA1534		Oxysterol-binding protein-like protein 5	606733				
11.121	07	22	20	11p15.4	OVCH2		Ovochymase 2	618962				
11.122	11	27	18	11p15.4	PPFIB2		Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein-binding protein 2	603142				
11.123	09	09	19	11p15.4	RIC3		RIC3 acetylcholine receptor chaperone	610509				
11.124	7	18	14	11p15.4	RRP8, NML, KIAA0409		Ribosomal RNA processing protein 8, homolog of	615818				
11.125	4	19	12	11p15.4	SCUBE2		Signal peptide-, CUB domain-, and EGF-like domains-containing protein 2	611747				
11.126	4	2	16	11p15.4	SNORA3B, SNORA45		Small nucleolar RNA, H/ACA box 3B	611333				
11.127	8	17	10	11p15.4	SYT9		Synaptotagmin 9	613528				
11.128	4	17	12	11p15.4	TRIM3, RNF22, BERP		Tripartite motif-containing 3	605493				
11.129	4	23	08	11p15.4	TRIM66, TIF1D, KIAA0298		Tripartite motif-containing protein 66	612000				
11.130	12	21	09	11p15.4	TRIM68, SS56, GC109		Tripartite motif-containing protein 68	613184		incorrectly assigned to 2p24 by FISH		
11.131	2	3	15	11p15.4	TUB, RDOB		Tubby, mouse, homolog of	601197		mutation identified in 1 RDOB family	?Retinal dystrophy and obesity, 616188 (3)	
11.132	6	26	00	11p15.4	ZNF214		Zinc finger protein-214	605015				
11.133	6	26	00	11p15.4	ZNF215		Zinc finger protein-215	605016				
11.134	2	25	15	11p15.4	MRVI1, IRAG		Murine retrovirus integration site 1, homolog of	604673				
11.135	2	28	01	11p15.4	TRIM34, RNF21, IFP1		Tripartite motif-containing 34 (RING finger protein-21)	605684				
11.136	6	6	00	11p15.4	ZNF143, SBF		Zinc finger protein-143	603433				
11.137	3	31	03	11p15.4	SMPD1, NPD		Sphingomyelin phosphodiesterase-1, acid lysosomal	607608			Niemann-Pick disease, type A, 257200 (3); Niemann-Pick disease, type B, 607616 (3)	7(Smpd1)
11.138	9	11	08	11p15.4	AKIP1, BCA3, C11orf17		Protein kinase A-interacting protein 1	609191				7(Akip1)
11.139	4	6	13	11p15.4	GALNT18, GALNACT18, GALNTL4		UPD-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 18	615136				
11.140	02	20	19	11p15.3	LINC00958, BLACAT2		Long intergenic noncoding RNA 958	618335				
11.141	10	28	08	11p15.3	MICAL2, KIAA0750		Microtubule-associated monooxygenase, calponin and LIM domains-containing 2	608881				
11.142	10	28	08	11p15.3	MICALCL, EBITEIN1		MICAL C terminus-like protein	612355				
11.143	12	2	09	11p15.4	NRIP3		Nuclear receptor-interacting protein 3	613125				
11.144	5	16	05	11p15.4	SH2BP1, KIAA0155, p150		SH2 domain-binding protein 1	609366				7(Sh2bl1)
11.145	4	3	03	11p15.4	STK33		Serine/threonine protein kinase 33	607670				7(Stk33)
11.146	12	4	01	11p15.4	TAF10, TAF2H, TAF2A		TAF10 RNA polymerase II, TATA box-binding protein-associated factor, 30kD	600475				
11.147	2	23	12	11p15.3	USP47		Ubiquitin-specific protease 47	614460				
11.148	5	29	13	11p15.4	ZBED5, BUSTER1		Zinc finger BED domain-containing protein 5	615251				
11.149	08	05	20	11p15.2	SOX6, TOLCAS		SRY-box 6	607257			Tolchin-Le Caignec syndrome, 618971 (3)	7(Sox6)
11.150	05	14	20	11p15.3	PTH, FIH1		Parathyroid hormone	168450		~9cM distal to CALC1; distal to MYOD	Hypoparathyroidism, familial isolated 1, 146200 (3)	7(Pth)
11.151	08	23	19	11p15.4	WEE1		WEE1 G2 checkpoint kinase	193525				
11.152	8	21	91	11p15.1	TPH1, TPH		Tryptophan hydroxylase 1 (tryptophan-5-monooxygenase)	191060				7(Tph)
11.153	8	12	14	11p15.3	BTBD10		BTB/POZ domain-containing protein 10	615933				
11.154	10	15	10	11p15.2	COPB1, COPB		Coatomer protein complex, subunit beta 1	600959				
11.155	10	12	20	11p15.2	CYP2R1		Cytochrome P450, subfamily IIR, polypeptide 1 (vitamin D 25-hydroxylase)	608713			Rickets due to defect in vitamin D 25-hydroxylation deficiency, 600081 (3)	
11.156	1	5	15	11p15.3	FAR1, MLSTD2, PFCRD		Fatty acyl CoA reductase 1	616107			Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3)	7(Far1)
11.157	09	01	20	11p15.2	INSC		INSC spindle orientation adaptor protein	610668				
11.158	7	18	12	11p15.3	RASSF10		Ras association domain family, member 10	614713				
11.159	9	18	06	11p15.3	TEAD1, TCF13, REF1		TEA domain family member 1	189967			Sveinsson chorioretinal atrophy, 108985 (3)	
11.160	5	8	97	11p15.2	CALCA, CALC1		Calcitonin/calcitonin-related polypeptide, alpha	114130		same 220kb fragment as CALCB		7(Calc)
11.161	3	23	93	11p15.2	CALCB, CALC2		Calcitonin-related polypeptide, beta	114160				
11.162	6	19	98	11p15.1	NELL1		Nel-like 1	602319				
11.163	2	18	96	11p15.1	PTPN5, STEP, STEP61		Protein tyrosine phosphatase, nonreceptor-type, 5 (striatum-enriched)	176879				7(Ptpn5)
11.164	5	10	12	11p15.1	SLC6A5, GLYT2, HKPX3		Solute carrier family 6 (neurotransmitter transporter, glycine), member 5	604159			Hyperekplexia 3, 614618 (3)	
11.165	08	16	18	11p15.1	TSG101		Tumor susceptibility gene 101	601387				
11.166	4	27	07	11p15.1	UEVLD, UEV3, ATTP		Ubiquitin E2 variant and lactate/malate dehydrogenase domains-containing protein	610985				
11.167	7	14	98	11p14.3	GAS2		Growth arrest-specific 2	602835				7(Gas2)
11.168	04	30	20	11p15.1	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2, PNDM3		ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor)	600509			Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3); Hypoglycemia of infancy, leucine-sensitive, 240800 (3); Diabetes mellitus, transient neonatal 2, 610374 (3); Diabetes mellitus, noninsulin-dependent, 125853 (3); Diabetes mellitus, permanent neonatal 3, with or without neurologic features, 618857 (3)	
11.169	1	31	11	11p15.1	B7H6		B7 homolog 6	613714				
11.170	6	24	08	11p15.1	CSRP3, CRP3, CLP, CMD1M, CMH12		Cysteine- and glycine-rich protein 3	600824		mutation identified in 1 CMD1M family	?Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy, hypertrophic, 12, 612124 (3)	
11.171	03	02	20	11p15.3	DKK3, RIG		Dickkopf WNT signaling pathway inhibitor 3	605416				
11.172	6	9	08	11p15.1	E2F8		E2F transcription factor 8	612047				7(E2f8)
11.173	6	1	04	11p15.1	HTATIP2, TIP30, CC3		HIV-1 TAT-interacting protein 2, 30kD	605628				
11.174	05	01	20	11p15.1	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13, PNDM2		Potassium inwardly-rectifying channel, subfamily J, member 11	600937		4.5kb 3' of SUR	Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3); Diabetes, permanent neonatal 2, with or without neurologic features, 618856 (3); {Diabetes mellitus, type 2, susceptibility to}, 125853 (3); Diabetes mellitus, transient neonatal 3, 610582 (3); Maturity-onset diabetes of the young, type 13, 616329 (3)	
11.175	06	26	20	11p15.1	LDHAL6A		Lactate dehydrogenase A-like protein 6A	618928				
11.176	3	31	09	11p15.1	MRGPRX1, MRGX1		Mas-related G protein-coupled receptor family, member X1	607227				
11.177	3	31	09	11p15.1	MRGPRX2, MRGX2		Mas-related G protein-coupled receptor family, member X2	607228				
11.178	3	31	09	11p15.1	MRGPRX3, MRGX3		Mas-related G protein-coupled receptor family, member X3	607229				
11.179	3	31	09	11p15.1	MRGPRX4, MRGX4		Mas-related G protein-coupled receptor family, member X4	607230				
11.180	1	2	08	11p15.1	NAV2, RAINB1, KIAA1419		Neuron navigator 2	607026				
11.181	05	21	19	11p15.1	PIK3C2A, CPK, OCSKD		Phosphatidylinositol 3-kinase, class 2, alpha	603601			Oculoskeletodental syndrome, 618440 (3)	
11.182	3	31	09	11p15.2-p15.1	PLEKHA7		Pleckstrin homology domain-containing protein, family A, member 7	612686				
11.183	1	13	99	11p15.2	PSMA1, PROS30		Proteasome subunit, alpha-type, 1	602854				
11.184	3	18	94	11p15.1	SAA1		Serum amyloid A1	104750				7(Saa1)
11.185	3	18	94	11p15.1	SAA2		Serum amyloid A2	104751		pseudogene = SAA3		
11.186	3	18	94	11p15.1	SAA4		Serum amyloid A4, constitutive	104752				7(Saa4)
11.187	02	06	20	11p15.1	USH1C, DFNB18A		USH1 protein network component harmonin	605242		Acadian and Samaritan variety	Usher syndrome, type 1C, 276904 (3); Deafness, autosomal recessive 18A, 602092 (3)	
11.188	7	15	09	11p15.1	ZDHHC13, HIP14L		Zinc finger DHHC domain-containing protein 13	612815				
11.189	3	18	95	11p15.1	GTF2H1		General transcription factor IIH, polypeptide 1 (62kD subunit)	189972		within 50kb of LDHA		
11.190	6	19	98	11p15.4	APBB1, FE65		Amyloid beta A4 precursor protein-binding, family B, member-1	602709				7(Apbb1)
11.191	8	20	98	11p15.3	ARNTL, BMAL1, TIC		Aryl hydrocarbon receptor nuclear translocator-like	602550				7(Arntl)
11.192	2	24	97	11p15.4	ART1		ADP-ribosyltransferase 1	601625				7(Art1)
11.193	11	30	06	11p15.4	ART5		ADP-ribosyltransferase 5	610625				7(Art5)
11.194	08	29	19	11p15.5	B4GALNT4		Beta-1,4-N-acetyl-galactosaminyltransferase 4	618560				
11.195	6	19	98	11p15.4	EIF4G2, DAP5		Eukaryotic translation initiation factor 4G-like 1	602325				7(Eif4G2)
11.196	8	23	17	11p15.5	EPS8L2, EPS8R2, DFNB106		EPS8-like protein 2	614988			Deafness autosomal recessive 106, 617637 (3)	7(Eps8l2)
11.197	12	29	99	11p14.3	FANCF		Fanconi anemia, complementation group F	613897			Fanconi anemia, complementation group F, 603467 (3)	
11.198	8	20	07	11p15	GINGF4, HGF4, GGF4		Fibromatosis, gingival, 4	611010		between D11S1984 and D11S1338	Fibromatosis, gingival, 4 (2)	
11.199	2	12	07	11p15	IH, HHP		Hemihyperplasia, isolated	235000		epigenetic or uniparental disomy	Hemihypertrophy (2)	
11.200	2	4	15	11p15.1	KCNC1, EPM7		Potassium voltage-gated channel, Shaw-related subfamily, member 1	176258			Epilepsy, progressive myoclonic 7, 616187 (3)	7(Kcnc1)
11.201	4	17	97	11p15.4	LMO1, RBTN1, RHOM1		LIM domain only 1 (rhombotin 1)	186921			Leukemia, T-cell acute lymphoblastic (2)	7(Ttg1)
11.202	7	26	10	11p15	LVNC2		Left ventricular noncompaction 2	609470		max lod at D11S902	Left ventricular noncompaction 2 (2)	
11.203	1	8	01	11p15.4	MMP26		Matrix metalloproteinase 26 (matrilysin 2)	605470				
11.204	7	22	11	11p15.5	MUC5B		Mucin 5, subtype B, tracheobronchial	600770			{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	
11.205	2	5	16	11p15	NBLST7		Neuroblastoma, susceptibility to, 7	616792		associated with rs2168101	{Neuroblastoma, susceptibility to, 7} (2)	
11.206	4	17	13	11p15.4	NLRP10, NALP10, PYNOD, NOD8		NLR family, pyrin domain containing 10	609662				
11.207	2	4	00	11p15.4	NUP98		Nucleoporin, 98kD	601021		fused with HOXA9, NSD1, NSD3, PMX1, HOXC13, DDX10, TOP1, HOXD11 in myeloid leukemia		
11.208	7	9	14	11p15.4	OR6A2, OR6A1		Olfactory receptor, family 6, subfamily A, member 2	608495				
11.209	10	29	09	11p15.3	PARVA		Parvin, alpha	608120				
11.210	3	9	98	11p15.2	PDE3B		Phosphodiesterase-3B, cGMP-inhibited	602047				
11.211	3	6	01	11p15.5	PKP3		Plakophilin-3	605561				
11.212	2	16	01	11p15.5	POLR2L, RPB10		Polymerase II, RNA, subunit L	601189				
11.213	9	24	08	11p15.4	RBMXL2, HNRNPGT, HNRPGT		RNA-binding motif protein, X chromosome, like 2	605444				
11.214	11	20	15	11p15.4	RNF141, ZNF230		RING finger protein 141	616641				7(Rnf141)
11.215	2	20	01	11p15.4	RPL27A		Ribosomal protein L27a	603637				7(Rpl27a)
11.216	11	16	05	11p15.4	SBF2, MTMR13, CMT4B2		SET binding factor 2 (myotubularin-related 13)	607697			Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	
11.217	10	23	92	11p15.4	ST5, HTS1		Suppression of tumorigenicity-5	140750				
11.218	5	23	00	11p15.4	SWAP70		Switch-associated protein 70	604762				7(Swap70)
11.219	2	26	04	11p15.4	TRIM5, RNF88		Tripartite motif-containing protein 5	608487				
11.220	2	19	03	11p15.4	TRIM6		Tripartite motif-containing protein 6	607564				
11.221	2	19	03	11p15.4	TRIM22, STAF50		Tripartite motif-containing protein 22	606559				
11.222	1	30	01	11p15.4	UBQLN3		Ubiquilin 3	605473				
11.223	1	20	09	11p15-p14	DEL11p15p14, C11DELp15p14		Chromosome 11p15-p14 deletion syndrome (homozygous)	606528		contiguous gene deletion syndrome	Chromosome 11p15-p14 deletion syndrome (4)	
11.224	1	12	07	11p15.1	NUCB2, NEFA		Nucleobindin 2	608020				
11.225	1	9	01	11p13	ELF5, ESE2		E74-like factor 5 (epithelium-specific ETS factor 2)	605169				
11.226	06	26	20	11p15.1	HPS5, RU2, KIAA1017		HPS5 biogenesis of lysosomal organelles complex 2 subunit 2	607521			Hermansky-Pudlak syndrome 5, 614074 (3)	7(ru2)
11.227	09	27	18	11p14.3	ANO5, TMEM16E, GDD1, LGMDR12		Anoctamin 5	608662			Gnathodiaphyseal dysplasia, 166260 (3); Muscular dystrophy, limb-girdle, autosomal recessive 12, 611307 (3); Miyoshi muscular dystrophy 3, 613319 (3)	7(Tmem16e)
11.228	11	29	12	11p15.1	OTOG, OTGN, DFNB18B		Otogelin	604487			Deafness, autosomal recessive 18B, 614945 (3)	7(Otog)
11.229	2	19	03	11p14.3	SLC17A6, VGLUT2, DNPI		Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6	607563				
11.230	4	10	90	11p14.3-p12	ST2		Suppression of tumorigenicity-2	185440				
11.231	9	28	11	11p14.2	BBOX1, BBOX		Butyrobetaine-gamma, 2-oxoglutarate dioxygenase 1	603312				
11.232	8	22	16	11p14.2	FIBIN		Fin bud initiation factor, zebrafish, homolog of	617085				2(Fibin)
11.233	12	24	08	11p14.2	SLC5A12, SMCT2		Solute carrier family 5 (sodium/glucose cotransporter), member 12	612455				
11.234	3	19	09	11p14.2-q12.3	DFNA59		Deafness, autosomal dominant 59	612642		between D22S929 and D11S480	Deafness, autosomal dominant 59 (2)	
11.235	10	6	08	11p14.1	CCDC34		Coiled-coil domain-containing protein 34	612324				
11.236	9	8	08	11p14.1	HSP90AA2, HSPCAL3		Heat-shock protein, 90kD, alpha, class A, member 2	140575				
11.237	7	22	13	11p14.1	LGR4, GPR48, BNMD17		Leucine-rich repeat-containing G protein-coupled receptor 4	606666		previously mapped to 5q34-q35.1	{Bone mineral density, low, susceptibility to}, 615311 (3)	
11.238	10	7	08	11p14.1	LIN7C, VELI3, MALS3		Lin7, C. elegans, homolog of, C	612332				
11.239	12	19	19	11p14.1	METTL15		Methyltransferase-like 15	618711				
11.240	3	23	09	11p14.1	MIR610, MIRN610		Micro RNA 610	612330				
11.241	9	23	08	11p14.1	C11orf46		Chromosome 11 open reading frame 46	612295				
11.242	9	23	08	11p13	LOC283267		LOC283267 gene	612296				
11.243	4	20	10	11p14.1-p11.2	SPG41		Spastic paraplegia 41	613364		max lod 2.36; between D11S1324 and D11S1993	?Spastic paraplegia 41, autosomal dominant (2)	
11.244	1	28	13	11p14.3-p14.2	ANO3, TMEM16C, C11orf25, DYT24		Anoctamin 3	610110			Dystonia 24, 615034 (3)	
11.245	8	27	15	11p14.1	BDNFAS, BDNFOS		BDNF antisense RNA	611468				
11.246	8	19	13	11p14.1	KIF18A		Kinesin family member 18A	611271				
11.247	8	1	13	11p15.1	SERGEF, DELGEF		Secretion-regulating guanine nucleotide exchange factor	606051				
11.248	11	10	10	11p14	TST1		Tuberculin skin test reactivity, absence of	613636		at chr11:26.37M	[Tuberculin skin test reactivity, absence of] (2)	
11.249	1	27	04	11p14.3	LUZP2		Leucine zipper protein 2	608178				
11.250	3	16	10	11p14.1	MPPED2, C11orf8, D11S302E, 239FB		Metallophosphoesterase domain-containing protein 2	600911				
11.251	12	22	08	11p13	APIP, CGI29, MMRP19		APAF1-interacting protein	612491				
11.252	4	25	18	11p14.1	BDNF		Brain-derived neurotrophic factor	113505		homeology with NRF3 on 12p; at p14 boundary		1(Bdnf)
11.253	4	21	16	11p13	DEL11p13, C11DELp13		Chromosome 11p13 deletion syndrome, distal	616902			Chromosome 11p13 deletion syndrome, distal, 616902 (4)	
11.254	12	14	10	11p13	DEL11p13, C11DELp13, WAGR		Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (chromosome 11p13 deletion syndrome)	194072		deletion of WT1 and PAX6 genes	Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (4)	
11.255	9	23	08	11p13	C11orf41, G2		Chromosome 11 open reading frame 41	612297				
11.256	11	19	13	11p13	CAPRIN1, M11S1, GPIAP1, GRIP137		Cell cycle associated protein 1	601178				
11.257	9	21	11	11p13	CAT		Catalase	115500		cen-CAT-WT1-AN2-pter	Acatalasemia, 614097 (3)	2(Cas1)
11.258	10	7	08	11p13	CCDC73		Coiled-coil domain-containing protein 73	612328				
11.259	9	23	08	11p13	CD59, MIC11		CD59 antigen (p18-20)	107271		in mouse Ly-6 = multigene complex	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3)	15(Ly6)
11.260	9	23	08	11p13	COMM9		COMM domain-containing protein 9	612299				
11.261	5	25	13	11p13	CSTF3		Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kD	600367				
11.262	03	06	20	11p14-p13	DCDC1, DCDC5		Doublecortin domain-containing protein 1	608062				2(Dcdc1)
11.263	9	23	08	11p13	DEPDC7, TR2		DEP domain-containing protein 7	612294				
11.264	02	26	19	11p13	DNAJC24, DPH4		DNAJ/HSP40 homolog, subfamily C, member 24	611072				
11.265	3	9	10	11p13	ECT, BECTS		Centrotemporal epilepsy	117100		previously assigned to 15q14	Centrotemporal epilepsy (2)	
11.266	10	3	07	11p13	EIF3M, PCID1, B5, GA17		Eukaryotic translation initiation factor 3, subunit M	609641				
11.267	10	3	16	11p13	ELP4, PAX6NEB, AN2		Elongation protein 4, S. cerevisiae, homolog of	606985		mutation identified in 1 AN2 patient	?Aniridia 2, 617141 (3)	
11.268	9	9	08	11p13	FBXO3, FBX3, FBA		F-box only protein 3	609089				2(Fbxo3)
11.269	8	29	08	11p13	FJX1		Four-jointed box, Drosophila, homolog of, 1	612206				
11.270	4	6	15	11p14.1	FSHB, HH24		Follicle-stimulating hormone, beta polypeptide	136530		distal to AN2	Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3)	2(Fshb)
11.271	10	24	00	11p13	HIPK3, PKY, DYRK6		Homeodomain-interacting protein kinase-3	604424				
11.272	11	30	20	11p13	IMMP1L, IMP1		Inner mitochondrial membrane peptidase, subunit 1	612323				
11.273	5	17	18	11p13	LDLRAD3, LRAD3		Low density lipoprotein receptor class A domain-containing protein 3	617986				
11.274	12	11	95	11p13	LMO2, RBTNL1, RHOM2, TTG2		LIM domain only 2 (rhombotin-like 1)	180385		3rd rhombotin gene not on 11	Leukemia, acute T-cell (2)	
11.275	4	13	05	11p13	MYP7		Myopia 7	609256			Myopia 7 (2)	
11.276	5	9	14	11p13	NAT10, ALP, KIAA1709		N-acetyltransferase 10	609221				
11.277	1	27	17	11p13	PAX6, AN2, MGDA, FVH1, ASGD5		Paired box homeotic gene-6	607108		mutation identified in 1 patient each with MDGA, COLBN, or COLB	Aniridia, 106210 (3); Cataract with late-onset corneal dystrophy, 106210 (3); Anterior segment dysgenesis 5, multiple subtypes, 604229 (3); Foveal hypoplasia 1, 136520 (3); Keratitis, 148190 (3); Optic nerve hypoplasia, 165550 (3); ?Morning glory disc anomaly, 120430 (3); ?Coloboma of optic nerve, 120430 (3); ?Coloboma, ocular, 120200 (3)	2(Sey)
11.278	12	15	17	11p13	PDHX, PDX1, E3BP, PDHXD		Pyruvate dehydrogenase complex, lipoyl-containing component X	608769			Lacticacidemia due to PDX1 deficiency, 245349 (3)	
11.279	1	2	08	11p13	PRRG4, PRGP4, TMG4		Proline-rich gamma-carboxyglutamic acid protein 4	611690				
11.280	6	9	08	11p12	RAG1		Recombination activating gene-1	179615		assignment to 14 in error	Severe combined immunodeficiency, B cell-negative, 601457 (3); Omenn syndrome, 603554 (3); Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3)	2(Rag1)
11.281	6	9	08	11p12	RAG2		Recombination activating gene-2	179616		assignment to 14 in error	Severe combined immunodeficiency, B cell-negative, 601457 (3); Omenn syndrome, 603554 (3); Combined cellular and humoral immune defects with granulomas, 233650 (3)	2(Rag2)
11.282	7	13	98	11p13	RCN1		Reticulocalbin 1	602735				2(Rcn1)
11.283	10	3	16	11p13	TRIM44, AN3		Tripartite motif-containing protein 44	612298		mutation identified in 1 AN3 family	?Aniridia 3, 617142 (3)	
11.284	8	16	11	11p13	WT1, NPHS4		Wilms tumor-1	607102		clumped: pter-FSHB-AN2-WT1-CAT	Wilms tumor, type 1, 194070 (3); Denys-Drash syndrome, 194080 (3); Nephrotic syndrome, type 4, 256370 (3); Frasier syndrome, 136680 (3); Meacham syndrome, 608978 (3); Mesothelioma, somatic, 156240 (3)	2(Wt1)
11.285	2	12	16	11p13	WT1AS, WIT1		WT1 antisense RNA	607899				
11.286	3	13	06	11p13-p12	DFNB51		Deafness, autosomal recessive 51	609941		max lod at D11S4102	Deafness, autosomal recessive 51 (2)	
11.287	4	6	01	11p13-p12	EVR3		Exudative vitreoretinopathy 3	605750			Exudative vitreoretinopathy 3 (2)	
11.288	11	24	15	11p13-p12	PRR5L, PROTOR2, FLJ14213		Proline-rich protein 5-like	611728				
11.289	2	24	97	11p11.2	PSMC3, TBP1		Proteasome (prosome, macropain) 26S subunit, ATPase, 3	186852				
11.290	11	05	20	11p13	SLC1A2, EAAT2, DEE41		Solute carrier family 1 (glial high affinity glutamate transporter), member 2	600300			Developmental and epileptic encephalopathy 41, 617105 (3)	2(Eaat2)
11.291	12	24	08	11p13-p12	WAGRO, DEL11p14p12		Wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome	612469		contiguous gene deletion syndrome	WAGRO syndrome (4)	
11.292	7	20	09	11q14.3	FOLH1B, PSMAL, GCP3		Folate hydrolase 1B	609020				
11.293	4	26	10	11p13-q12	CANDF3, CANDN1, FCNC		Candidiasis, familial, 3	607644		between D11S1312 and D11S4191	Candidiasis, familial, 3 (2)	
11.294	11	18	11	11p13-q14.1	MRT23		Mental retardation, autosomal recessive 23	614344		between rs604518 and rs10899421	Mental retardation, autosomal recessive 23 (2)	
11.295	12	23	05	11p12	API5, AAC11		Apoptosis inhibitor 5	609774				
11.296	1	22	08	11p12	BMND8		Bone mineral density QTL 8	611739		between D11S1392 and D11S4102	{Osteoporosis}, 166710 (2)	
11.297	1	29	01	11p13	EHF, ESE3		ETS homologous factor	605439				
11.298	9	12	08	11p12	LRRC4C, NGL1, KIAA1580		Leucine rich repeat containing 4C (netrin-G1 ligand)	608817				
11.299	3	13	06	11p12	TRAF6		TNF receptor-associated factor 6	602355				
11.300	3	15	92	11p11.2	CHRM4		Cholinergic receptor, muscarinic, 4	118495				
11.301	4	30	15	11p11.2	LRP4, MEGF7, CLSS, SOST2, CMS17		Low density lipoprotein receptor-related protein 4	604270		mutation identified in 1 CMS17 family	Cenani-Lenz syndactyly syndrome, 212780 (3); Sclerosteosis 2, 614305 (3); ?Myasthenic syndrome, congenital, 17, 616304 (3)	
11.302	3	1	00	11p11.2	MAPK8IP1, IB1		Mitogen-activated protein kinase 8-interacting protein 1	604641			{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
11.303	12	28	16	11p11.2	PEX16, PBD8A, PBD8B		Peroxisome biogenesis factor 16	603360			Peroxisome biogenesis disorder 8A (Zellweger), 614876 (3); Peroxisome biogenesis disorder 8B, 614877 (3)	2(Pex16)
11.304	12	13	96	11p11.2	DDB2		Damage-specific DNA binding protein 2, 48kD	600811			Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)	
11.305	08	02	19	11p11.2	EXT2, SSMS		Exostosin glycosyltransferase 2	608210			Exostoses, multiple, type 2, 133701 (3); Seizures, scoliosis, and macrocephaly syndrome, 616682 (3)	2(Ext2)
11.306	4	17	07	11p12-p11	PSNP3		Supranuclear palsy, progressive, 3	610898			Supranuclear palsy, progressive, 3 (2)	
11.307	3	14	07	11p11.2	ARHGAP1, RHOGAP1, CDC42GAP		RHO GTPase-activating protein 1	602732				
11.308	10	2	91	11q24.2	ACRV1		Acrosomal vesicle protein-1	102525				
11.309	4	20	11	11p11.2	ACP2		Acid phosphatase 2, lysosomal	171650			?Lysosomal acid phosphatase deficiency, 200950 (1)	2(Acp2)
11.310	2	9	17	11p11.2	AGBL2, CCP2		ATP/GTP-binding protein-like 2	617345				
11.311	11	19	13	11p11.2	ALX4, PFM2, FPP, FND2, CRS5		Aristaless-like 4, mouse, homolog of	605420			Parietal foramina 2, 609597 (3); Frontonasal dysplasia 2, 613451 (3); {Craniosynostosis 5, susceptibility to}, 615529 (3)	
11.312	9	9	10	11p11.2	AMBRA1, KIAA1736		Activating molecule in beclin 1-regulated autophagy	611359				
11.313	09	19	19	11p11.2	ATG13, KIAA0652, PARATARG8		Autophagy related 13	615088				
11.314	12	10	12	11p11.2	C1QTNF4, CTRP4		C1q- and tumor necrosis factor-related protein 4	614911				
11.315	02	12	19	11p11.2	CD82, SAR2, KAI1, ST6		CD82 antigen	600623				
11.316	2	23	08	11p11.2	CKAP5, CHTOG, MSPS, KIAA0097		Cytoskeleton-associated protein 5	611142				
11.317	08	07	18	11p11.2	CREB3L1, OASIS, OI16		cAMP response element-binding protein 3-like 1	616215			Osteogenesis imperfecta, type XVI, 616229 (3)	
11.318	2	11	15	11p11.2	DGKZ		Diacylglycerol kinase, zeta, 104kD	601441				
11.319	6	4	13	11p11.2	FNBP4, FBP30, KIAA1014		Formin-binding protein 4	615265				
11.320	10	11	00	11p11.12	FOLH1, FOLH, PSM, PSMA		Folate hydrolase 1 (prostate-specific membrane antigen)	600934		?pseudogene on 11q14		
11.321	11	15	05	11p11.2	GYLTL1B, LARGE2		Glycosyltransferase-like 1B	609709				
11.322	3	7	13	11p11.2	HARBI1		Harbinger transposase-derived gene 1	615086				
11.323	8	31	17	11p11.2	KBTBD4, HSPC252, BKLHD4		KELCH repeat- and BTB/POZ domain-containing protein 4	617645				
11.324	09	18	20	11p11.2	MADD, DENN, NEDDISH, DEEAH		MAP kinase-activating death domain (differentially expressed in normal and neoplastic cells)	603584			Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia, 619005 (3); DEEAH syndrome, 619004 (3)	
11.325	6	13	12	17p12-p11	NCOR1		Nuclear receptor corepressor 1	600849				
11.326	9	14	94	11p11.2	MDK, NEGF2		Midkine (neurite growth-promoting factor 2)	162096				2(Mdk)
11.327	11	12	18	11p11.2	NUP160, KIAA0197, NPHS19		Nucleoporin, 160kD	607614		mutation identified in 1 NPHS19 family	?Nephrotic syndrome, type 19, 618178 (3)	
11.328	9	9	13	11p11.2	MYBPC3, CMH4, CMD1MM, LVNC10		Myosin-binding protein C, cardiac	600958			Cardiomyopathy, hypertrophic, 4, 115197 (3); Cardiomyopathy, dilated, 1MM, 615396 (3); Left ventricular noncompaction 10, 615396 (3)	
11.329	10	1	17	11p11.2	NR1H3, LXRA		Nuclear receptor subfamily 1, group H, member 3	602423				
11.330	02	11	20	11p11.2	PHF21A, BHC80, KIAA1696, IDDBCS		PHD finger protein 21A	608325			Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, 618725 (3)	
11.331	5	19	15	11p11.2	PRDM11, PFM8		PR domain-containing protein 11	616347				
11.332	5	13	10	11p11.2	PSS		Potocki-Shaffer syndrome	601224		contiguous gene syndrome caused by deletion of 11p11.2	Potocki-Shaffer syndrome (4)	
11.333	6	27	02	11p11.2	PTPRJ, DEP1		Protein tyrosine phosphatase, receptor type, J polypeptide	600925			Colon cancer, somatic, 114500 (3)	2(Ptprj)
11.334	2	10	05	11p11.2	SLC35C1, FUCT1, CDG2C		Solute carrier family 35, member C1 (GDP-Fucose transporter 1)	605881			Congenital disorder of glycosylation, type IIc, 266265 (3)	
11.335	4	5	18	11p11.2	SLC39A13, ZIP13, EDSSPD3		Solute carrier family 39 (zinc transporter), member 13	608735			Ehlers-Danlos syndrome, spondylodysplastic type, 3, 612350 (3)	
11.336	2	10	00	11p11.2	SPI1, SFPI1		Oncogene SPI1	165170				
11.337	2	16	18	11p11.2	TP53I11, PIG11		Tumor protein p53-inducible protein 11	617867				
11.338	9	19	88	11p11.2	TYRL		Tyrosinase-like	191270				
11.339	7	21	15	11p11.2	ZNF408, EVR6, RP72		Zinc finger protein 408	616454		mutation identified in 1 EVR6 family	?Exudative vitreoretinopathy 6, 616468 (3); Retinitis pigmentosa 72, 616469 (3)	
11.340	12	4	08	11p11.2	ARFGAP2, ZNF289		ADP-ribosylation factor GTPase-activating protein 2	606908				
11.341	9	3	04	11p11.2	CHST1, KSGAL6ST		Carbohydrate sulfotransferase-1	603797				
11.342	04	11	19	11p11.2	RAPSN, CMS1D, CMS11, FADS2		Receptor-associated protein of the synapse, 43kD	601592			Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3); Fetal akinesia deformation sequence 2, 618388 (3)	
11.343	3	8	07	11q12.1	SLC43A1, LAT3, POV1		Solute carrier family 43 (L-type amino acid transporter), member 1	603733				
11.344	10	28	19	11p11.2	ALKBH3, PCA1, DEPC1, ABH3		AlkB homolog 3, alpha-ketoglutarate-dependent dioxygenase	610603				
11.345	10	5	11	11q11	OR4C46		Olfactory receptor, family 4, subfamily C, member 46	614273				
11.346	7	20	01	11q14.3	RNF18		RING finger protein-18	606124				
11.347	12	13	18	11p11.2	NDUFS3, MC1DN8		NADH-ubiquinone oxidoreductase core subunit S3	603846			Mitochondrial complex I deficiency, nuclear type 8, 618230 (3)	
11.348	1	31	12	11p11.2	ACCS, ACS, PHACS		1-aminocyclopropane-1-carboxylate synthase	608405				
11.349	8	2	13	11p11.2	CELF1, CUGBP1, NAB50, BRUNOL2, CUGBP		CUGbp and ELAV-like family, member 1	601074				
11.350	5	22	14	11p11	CLLS1		Leukemia, chronic lymphocytic, susceptibility to, 1	609630			{Leukemia, chronic lymphocytic, susceptibility to, 1} (2)	
11.351	12	27	01	11p11.2	PACSIN3		Protein kinase C and casein kinase substrate in neurons 3	606513				
11.352	5	4	12	11p11.2	F2, THPH1, RPRGL2		Coagulation factor II (thrombin)	176930			Hypoprothrombinemia, 613679 (3); Dysprothrombinemia, 613679 (3); Thrombophilia due to thrombin defect, 188050 (3); {Stroke, ischemic, susceptibility to}, 601367 (3); {Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)	2(Cf2)
11.353	12	15	10	11p15.5	CD81, TAPA1, CVID6		CD81 antigen (target of antiproliferative antibody-1)	186845			Immunodeficiency, common variable, 6, 613496 (3)	7(Tapa1)
11.354	3	10	00	11p	HYPLIP2		Hyperlipidemia, combined, 2	604499			Hyperlipidemia, combined, 2 (2)	
11.355	12	15	98	11p	NNO1		Nanophthalmos 1	600165			Nanophthalmos-1 (2)	
11.356	8	9	99	11p15.1	RPS13		Ribosomal protein S13	180476				
11.357	4	4	02	11q12.1	PRG2, MBP		Proteoglycan 2	605601				
11.358	4	4	02	11q12.1	PRG3, MBPH		Proteoglycan 3	606814				
11.359	9	16	03	11q14.2	ME3		Malic enzyme 3	604626				
11.360	01	14	20	11q12.1	TMX2, NEDMCMS		Thioredoxin-related transmembrane protein 2	616715			Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity, 618730 (3)	
11.361	9	21	17	11q12.1	CTNND1, CTNND, BCDS2		Catenin (cadherin-associated protein), delta 1	601045			Blepharocheilodontic syndrome 2, 617681 (3)	2(Catns)
11.362	8	30	07	11q12.2	VWC1, URG11		von Willebrand factor C and EGF domain-containing protein	611115				
11.363	9	12	91	11q12.1	TCN1, TC1		Transcobalamin I	189905				
11.364	1	24	09	11q12.1	C1NH, HAE1, HAE2, SERPING1		Complement component-1 inhibitor	606860			Angioedema, hereditary, types I and II, 106100 (3); Complement component 4, partial deficiency of, 120790 (3)	2(C1nh)
11.365	5	24	13	11q12.2	CCDC86, CYCLON		Coiled-coil domain-containing protein 86	611293				19(Ccdc86)
11.366	1	9	14	11q12.1	APLNR, AGTRL1, APJ		Apelin receptor	600052				
11.367	11	5	97	11q13.1	ESRRA, ESRL1		Estrogen-related receptor, alpha	601998				19(Estrra)
11.368	3	18	95	11q12.2	FEN1		Flap structure-specific endonuclease 1	600393				19(Fen1)
11.369	10	24	18	11q13.1	FERMT3, KIND3, URP2, MIG2B		Fermitin family, member 3	607901			Leukocyte adhesion deficiency, type III, 612840 (3)	
11.370	12	15	17	11q13.1	LTBP3, LTBP2, DASS, GPHYSD3		Latent transforming growth factor beta binding protein-3	602090			Dental anomalies and short stature, 601216 (3); Geleophysic dysplasia 3, 617809 (3)	19(Ltbp2)
11.371	4	30	09	11q12.1	MIR130A, MIRN130A		Micro RNA 130A	610175				
11.372	1	2	08	11q13.1	NAALADL1, I100		N-acetylated alpha-linked acidic dipeptidase-like 1	602640				
11.373	7	14	98	11q12.1	P2RX3, P2X3		Purinergic receptor P2X, ligand-gated ion channel, 3	600843				2(P2rx3)
11.374	11	2	04	11q13.4	P4HA3		Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 3	608987				
11.375	5	24	13	11q21	PIWIL4, HIWI2, MIWI2		PIWI-like 4	610315				
11.376	4	11	11	11q12	SCA20, DUP11q12, C11DUPq12		Spinocerebellar ataxia 20 (chromosome 11q12 duplication syndrome, 260kb)	608687		contiguous gene duplication syndrome	Spinocerebellar ataxia 20 (4)	
11.377	5	15	14	11q12.2	SLC15A3, PHT2		Solute carrier family 15 (oligopeptide transporter), member 3	610408				
11.378	2	2	01	11q12.1	SSRP1, FACT		Structure-specific recognition protein 1	604328				
11.379	8	11	17	11q12.2	TMEM258, C11orf10		Transmembrane protein 258	617615				
11.380	7	12	02	11q12.1	TNKS1BP1, TAB182, KIAA1741		Tankyrase 1-binding protein 1, 182kD	607104				
11.381	2	1	01	11q12.1	UBE2L6, UBCH8		Ubiquitin-conjugating enzyme E2L 6	603890				
11.382	8	6	97	11q12.3	AHNAK		AHNAK nucleoprotein (desmoyokin)	103390				
11.383	5	5	16	11q12.3	B3GAT3, GLCATI, JDSCD		Beta-1,3-glucuronyltransferase 3	606374		pseudogene on chr.3	Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3)	
11.384	8	29	02	11q13.1	CDC42EP2, CEP2, BORG1		CDC42 effector protein 2	606132				
11.385	12	15	13	11q12.2	DDB1		Damage-specific DNA binding protein 1, 127kD	600045				19(Ddb1)
11.386	2	3	05	11q13.4	DHCR7, SLOS		Delta-7-dehydrocholesterol reductase	602858			Smith-Lemli-Opitz syndrome, 270400 (3)	
11.387	1	29	01	11q13.1	FLRT1		Fibronectin-like domain-containing leucine-rich transmembrane protein-1	604806				
11.388	11	19	13	11q12.3	FTH1, FTHL6, HFE5		Ferritin, heavy polypeptide 1	134770		mutation identified in 1 family	?Hemochromatosis, type 5, 615517 (3)	19(Fth)
11.389	2	16	16	11q13.2	KLC2, SPOAN		Kinesin, light chain 2	611729			Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3)	19(Klc2)
11.390	5	21	07	11q13.1	MARK2, EMK1		MAP/microtubule affinity-regulating kinase 2	600526				19(Emk1)
11.391	11	29	01	11q12.1	MS4A3, HTM4, CD20L		Membrane-spanning 4-domains, subfamily A, member 3	606498				
11.392	12	27	01	11q12.2	MS4A4A, MS4A4		Membrane-spanning 4-domains, subfamily A, member 4A	606547				
11.393	11	29	01	11q12.2	MS4A5, TETM4, CD20L2		Membrane-spanning 4-domains, subfamily A, member 5	606499				
11.394	12	27	01	11q12.2	MS4A6A, MS4A6		Membrane-spanning 4-domains, subfamily A, member 6A	606548				
11.395	11	27	01	11q12.2	MS4A7, CFFM4		Membrane-spanning 4-domains, subfamily A, member 7	606502				
11.396	12	27	01	11q12.2	MS4A8B		Membrane-spanning 4-domains, subfamily A, member 8B	606549				
11.397	12	27	01	11q12.2	MS4A12		Membrane-spanning 4-domains, subfamily A, member 12	606550				
11.398	12	21	03	11q12.3	NXF1, TAP, MEX67		Nuclear RNA export factor 1	602647				
11.399	01	25	19	11q13.1	RELA, NFKB3, CMCU		RELA proto-oncogene, NF-kB subunit	164014		mutation identified in 1 CMCU family	?Mucocutaneous ulceration, chronic, 618287 (3)	
11.400	12	11	02	11q13.2	DPP3		Dipeptidyl peptidase III	606818				
11.401	5	27	09	11q12.2	FADS1		Fatty acid desaturase 1	606148				
11.402	5	27	09	11q12.2	FADS2		Fatty acid desaturase 2	606149				
11.403	5	27	09	11q12.2	FADS3		Fatty acid desaturase 3	606150				
11.404	2	26	08	11q12.1	MRPL16		Mitochondrial ribosomal protein L16	611829				
11.405	1	27	04	11q12.2	MS4A4E		Membrane-spanning 4-domains, subfamily A, member 4E	608401				
11.406	1	27	04	11q12.2	MS4A6E		Membrane-spanning 4-domains, subfamily A, member 6E	608402				
11.407	1	27	04	11q12.2	MS4A10		Membrane-spanning 4-domains, subfamily A, member 10	608403				
11.408	6	22	14	11q12.3	MTA2, MTA1L1		Metastasis-associated protein 2	603947				
11.409	7	20	09	11q12-q13.1	PURAQTL1		Polyunsaturated fatty acids plasma level QTL1	612795		associated with rs174537	[Polyunsaturated fatty acids plasma level QTL1] (2)	
11.410	3	6	01	11q14.1	RAB30		Ras-associated protein RAB30	605693				
11.411	5	22	14	11q12.1	CLP1, HEAB, PCH10		Cleavage and polyadenylation factor I subunit 1, yeast, homolog of	608757			Pontocerebellar hypoplasia, type 10, 615803 (3)	
11.412	01	13	20	11q12.1	DTX4, RNF155, KIAA0937		Deltex E3 ubiquitin ligase 4	616110				
11.413	7	23	13	11q12.1	FAM111A, KIAA1895, KCS2, GCLEB		Family with sequence similarity 111, member A	615292			Kenny-Caffey syndrome, type 2, 127000 (3); Gracile bone dysplasia, 602361 (3)	
11.414	3	26	14	11q12.1	FAM111B, POIKTMP		Family with sequence similarity 111, member B	615584			Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3)	
11.415	8	21	12	11q12.1	GLYAT, ACGNAT, CAT		Glycine-N-acyltransferase	607424				
11.416	8	21	12	11q12.1	GLYATL1		Glycine-N-acyltransferase-like 1	614761				
11.417	8	21	12	11q12.1	GLYATL2		Glycine N-acyltransferase-like 2	614762				
11.418	9	8	17	11q12.1	LPXN		Leupaxin	605390				
11.419	5	6	13	11q12.1	LRRC55		Leucine-rich repeat-containing protein 55	615213				
11.420	11	7	08	11q12.1	MED19		Mediator complex subunit 19	612385				
11.421	8	19	13	11q12.1	MPEG1, MPG1		Macrophage expressed gene 1	610390				
11.422	2	19	10	11p11.2	MTCH2		Mitochondrial carrier homolog 2	613221				
11.423	3	25	14	11q12.1	OR5AN1		Olfactory receptor, family 5, subfamily AN, member 1	615702				
11.424	8	8	13	11q12.1	OR5F1		Olfactory receptor, family 5, subfamily F, member 1	608492				
11.425	8	8	13	11q12.1	OR5I1, OLF1		Olfactory receptor, family 5, subfamily I, member 1	608496				
11.426	5	7	03	11q12.1	OSBP		Oxysterol-binding protein	167040				19(Osbp)
11.427	09	19	19	11q12.1	PATL1, PAT1B		PAT1 homolog 1, processing body mRNA decay factor	614660				
11.428	5	24	13	11q12.1	RTN4RL2, NGRH1, NGR2		Reticulon 4 receptor-like 2	610462				
11.429	11	18	16	11q12.1	SELENOH, SELH		Selenoprotein H	607914				
11.430	6	28	18	11q12.1	SLC43A3, EEG1, ENBT1		Solute carrier family 43, member 3	618034				
11.431	12	14	10	11q12.1	SMTNL1, CHASM		Smoothelin-like 1	613664				
11.432	1	21	11	11q12.1	STX3, STX3A		Syntaxin 3	600876				
11.433	12	28	08	11q12.1	YPEL4		Yippee-like 4	609725				2(Ypel4)
11.434	4	27	12	11q12.1	ZDHHC5, DHHC5, ZNF375, KIAA1748		Zinc finger DHHC domain-containing protein 5	614586				
11.435	04	27	20	11q12.1	TIMM10, TIM10A, TIM10		Translocase of inner mitochondrial membrane 10	602251				
11.436	10	23	87	11q12.1-q13.5	FNL2		Fibronectin-like-2	135610				
11.437	7	13	93	11q12.1	CNTF		Ciliary neurotrophic factor	118945				19(Cntf)
11.438	01	31	20	11q12.2	CYB561A3, LCYTB, CYBASC3		Cytochrome b561 family, member A3	618757				
11.439	9	8	11	11q12.2	DAGLA, KIAA0659		Diacylglycerol lipase, alpha	614015				
11.440	01	11	19	11q12.2	MYRF, C11orf9, KIAA0954, MMERV, CUGS		Myelin regulatory factor	608329			Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, 618113 (3); Cardiac-urogenital syndrome, 618280 (3)	
11.441	10	14	20	11q12.2	PPP1R32, IIIG9, C11orf66		Protein phosphatase 1, regulatory subunit 32	619047				
11.442	09	19	19	11q12.2	PRPF19, PRP19, PSO4, NMP200		Pre-mRNA processing factor 19	608330				
11.443	7	23	15	11q12.2	PTGDR2, GPR44		Prostaglandin D2 receptor 2	604837				
11.444	03	06	20	11q12.2	TKFC, DAK, TKFCD		Triokinase and FMN cyclase	615844			Triokinase and FMN cyclase deficiency syndrome, 618805 (3)	
11.445	2	24	17	11q12.2	TMEM132A, KIAA1583		Transmembrane protein 132A	617363				
11.446	2	9	12	11q12.2	TMEM138, JBTS16		Transmembrane protein 138	614459			Joubert syndrome 16, 614465 (3)	
11.447	2	24	12	11q12.2	TMEM216, JBTS2, CORS2, MKS2		Transmembrane protein 216	613277			Joubert syndrome 2, 608091 (3); Meckel syndrome 2, 603194 (3)	
11.448	12	27	19	11q12.2	VPS37C		VPS37C subunit of ESCRT-I	610038				
11.449	2	11	16	11q12.2	ZP1, OOMD1		Zona pellucida glycoprotein 1	195000			Oocyte maturation defect 1, 615774 (3)	
11.450	3	5	18	11q12.3	CSKMT, METTL12		Citrate synthase lysine methyltransferase	617897				
11.451	9	18	08	11q12.3	EEF1G, EF1G		Eukaryotic translation elongation factor 1, gamma	130593				
11.452	10	10	18	11q12.3	EML3, EMAP3, EMAP95		Echinoderm microtubule-associated protein-like 3	618118				
11.453	11	11	14	11q12.3	INCENP		Inner centromere protein	604411				
11.454	3	23	14	11q12.3	INTS5, INT5, KIAA1698		Integrator complex subunit 5	611349				
11.455	10	07	19	11q12.3	PLAAT2, HRASLS2		Phospholipase A and acyltransferase 2	613866				
11.456	10	07	19	11q12.3	PLAAT4, RARRES3, TIG3		Phospholipase A and acyltransferase 4	605092				
11.457	10	07	19	11q12.3	PLAAT5, HRASLS5, RLP1, HRLP5		Phospholipase A and acyltransferase 5	611474				
11.458	2	22	13	11q12.3	SCGB2A1, MGB2, LPNC		Secretoglobin, family 2A, member 1 (mammaglobin 2)	604398				
11.459	2	22	13	11q12.3	SCGB1D1, LPNA		Secretoglobin, family 1D, member 1	615060		previously mapped to 15q12-q13		
11.460	2	22	13	11q12.3	SCGB1D2, LPNB		Secretoglobin, family 1D, member 2	615061		previously mapped to 10q23		
11.461	2	22	13	11q12.3	SCGB1D4, IIS		Secretoglobin, family 1D, member 4	615062				
11.462	8	18	14	11q12.3	SLC22A9, OAT4, UST3		Solute carrier family 22 (organic anion/cation transporter), member 9	607579				
11.463	8	18	14	11q12.3	SLC22A10, OAT5		Solute carrier family 22 (organic anion/cation transporter), member 10	607580				
11.464	1	2	08	11q12.3	SLC22A24		Solute carrier family 22, member 24	611698				19(Slc22a24)
11.465	1	21	11	11q12.3	STX5, STX5A		Syntaxin 5	603189				
11.466	5	29	15	11q12.3	UBXN1, SAKS1		UBX domain protein 1	616378				
11.467	12	1	14	11q12.3	UQCC3, C11orf83, MC3DN9		Ubiquinol-cytochrome C reductase complex assembly factor 3	616097		mutation identified in 1 MC3DN9 patient	?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3)	
11.468	3	8	07	11q12.3	UST6		Organic anion transporter UST6	610792				
11.469	4	24	18	11q12.3	WDR74		WD repeat-containing protein 74	617947				
11.470	3	23	02	11q12.3	MGB1, SCGB2A2		Mammaglobin 1 (secretoglobin, family 2A, member 2)	605562				
11.471	10	07	19	11q12.3-q13.1	PLAAT3, PLA2G16, HRASLS3, HRSL3, HREV107		Phospholipase A and acyltransferase 3	613867				
11.472	10	16	14	11q12.3	SCGB1A1, UGB, CC10, CCSP		Secretoglobin, family 1A, member 1 (uteroglobin)	192020				
11.473	11	24	08	11q13.3	ANO1, TMEM16A, FLJ10261		Anoctamin 1, calcium activated chloride channel	610108				7(Tmem16a)
11.474	12	04	20	11q13.1	ARL2, MRCS1		ADP ribosylation factor-like GTPase 2	601175		mutation identified in 1 MRCS1 family	?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 1, 619082 (3)	
11.475	12	11	95	11q13.4	ARRB1		Arrestin, beta 1	107940				
11.476	3	5	03	11q13.2	BBS1		BBS1 gene	209901			Bardet-Biedl syndrome 1, 209900 (3)	
11.477	12	17	20	11q12.3	BSCL2, SPG17, HMN5, PELD, HMN5C		Seipin	606158			Lipodystrophy, congenital generalized, type 2, 269700 (3); Silver spastic paraplegia syndrome, 270685 (3); Neuropathy, distal hereditary motor, type VC, 619112 (3); Encephalopathy, progressive, with or without lipodystrophy, 615924 (3)	
11.478	3	29	07	11q13.2	C11orf24		Chromosome 11 open reading frame 24	610880				
11.479	3	23	14	11q13.1	C11orf95		Chromosome 11 open reading frame 95	615699				
11.480	5	6	16	11q13.1	CAPN1, SPG76		Calpain, large polypeptide L1	114220			Spastic paraplegia 76, autosomal recessive, 616907 (3)	
11.481	4	20	10	11q13.2	CARNS1, ATPGD1, KIAA1394		Carnosine synthase 1	613368				19(Carns1)
11.482	2	13	14	11q13.3	CCND1, PRAD1, BCL1		Cyclin D1	168461		pseudogene on 11q13	{Colorectal cancer, susceptibility to}, 114500 (3); {von Hippel-Lindau syndrome, modifier of}, 193300 (3); {Multiple myeloma, susceptibility to}, 254500 (3)	
11.483	5	25	00	11q13.2	CCS		Copper chaperone for superoxide dismutase	603864				9(Ccs)
11.484	6	8	89	11q12.2	CD5, LEU1		CD5 antigen (p56-62)	153340				19(Ly1)
11.485	12	7	07	11q13.2	CD248, TEM1		CD248 antigen	606064				
11.486	9	8	11	11q13.1	CDC42BPG, MRCKG		CDC42-binding protein kinase, gamma	613991				
11.487	1	8	97	11q13.1	CFL1		Cofilin 1 (non-muscle)	601442				19(Cfl1)
11.488	8	6	97	11q12.3	CHRM1		Cholinergic receptor, muscarinic, 1	118510				
11.489	10	23	20	11q13.1	COX8A, MC4DN15		Cytochrome c oxidase, subunit VIIIA	123870		mutation identified in 1 MC4DN15 patient	?Mitochondrial complex IV deficiency, nuclear type 15, 619059 (3)	
11.490	10	8	98	11q13.3	CPT1A		Carnitine palmitoyltransferase I, liver	600528			CPT deficiency, hepatic, type IA, 255120 (3)	
11.491	08	12	19	11q13.1	CST6, ECTD15		Cystatin-M	601891		mutation identified in 1 ECTD15 family	?Ectodermal dysplasia 15, hypohidrotic/hair type, 618535 (3)	
11.492	9	24	08	11q13.3	CTTN, EMS1		Cortactin	164765		amplified in breast cancer and squamous cell cancer		
11.493	3	12	01	11q13.1	DANJC4, HSPF2		DnaJ, E. coli, homolog of, subfamily C, member 4 (heat-shock 40kD protein 2)	604189				
11.494	6	28	18	11q13.1	DPF2, REQ, UBID4, CSS7		D4, zinc, and double PHD fingers family, member 2	601671			Coffin-Siris syndrome 7, 618027 (3)	6(Req)
11.495	1	30	12	11q13.1	EFEMP2, FBLN4, UPH1, ARCL1B		EGF-containing fibulin-like extracellular matrix protein 2 (fibulin 4)	604633			Cutis laxa, autosomal recessive, type IB, 614437 (3)	
11.496	5	2	01	11q13.1	EHD1		EH domain-containing 1 protein	605888				19(Ehd1)
11.497	9	12	93	11q13.1	FAU		Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived)	134690				19(Fau)
11.498	3	8	92	11q13.3	FGF4, HSTF1		Fibroblast growth factor-4 (heparin secretory transforming protein-1; Kaposi sarcoma oncogene)	164980		coamplified with FGF3 in melanoma		7(Hstf1)
11.499	1	22	07	11q13.3	FGF3, INT2		Fibroblast growth factor-3 (oncogene INT2)	164950		35kb 5' to HST1	Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3)	7(Int2)
11.500	12	28	93	11q13.1	FOSL1		FOS-like antigen-1	136515				
11.501	2	7	07	11q13.1	GAL3ST3, GAL3ST2		Galactose-3-O-sulfotransferase 3	608234				
11.502	05	19	20	11q12.1	CBLIF, GIF, IF		Cobalamin-binding intrinsic factor (gastric intrinsic factor)	609342			Intrinsic factor deficiency, 261000 (3)	19(Gif)
11.503	7	6	99	11q13.2	GSTP1, GST3		Glutathione S-transferase pi	134660		formerly called GST1		19(Gst3)
11.504	3	15	04	11q14.1	HBXAP, RSF1		Hepatitis B virus X-associated protein	608522				
11.505	4	23	08	11q13	HPC14		Prostate cancer, hereditary, 14	611958		associated with rs7931342	{Prostate cancer, hereditary, 14} (2)	
11.506	12	9	98	11q13	IDDM4		Insulin-dependent diabetes mellitus-4	600319			{Diabetes mellitus, insulin-dependent, 4} (2)	
11.507	12	04	20	11q13.1	KAT5, HTATIP, TIP60, ESA1, PLIP, NEDFASB		Lysine acetyltransferase 5	601409			Neurodevelopmental disorder wtih dysmorphic facies, sleep disturbance, and brain abnormalities, 619103 (3)	
11.508	04	15	19	11q13.1	KCNK4, TRAAK, FHEIG		Potassium channel, subfamily K, member 4	605720			Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome, 618381 (3)	
11.509	6	6	00	11q13.1	KCNK7		Potassium channel, subfamily K, member 7	603940				
11.510	4	18	05	11q12.3	LGALS12		Lectin, galactoside-binding, soluble, 12	606096				
11.511	9	20	99	11q13.1	MAP4K2, RAB8IP, GCK		Mitogen-activating protein kinase kinase kinase kinase 2 (RAB8-interacting protein; germinal center kinase)	603166				
11.512	2	9	11	11q13.1	MEN1		Menin	613733		linked distal to PYGM	Multiple endocrine neoplasia 1, 131100 (3); Carcinoid tumor of lung (3); Parathyroid adenoma, somatic (3); Lipoma, somatic (3); Angiofibroma, somatic (3); Adrenal adenoma, somatic (3)	19(Men1)
11.513	9	26	17	11q13.3	CUPID1, LINC01488, BRCAT8		CCND1 upstream intergenic DNA repair 1, noncoding	617696				
11.514	9	28	17	11q13	CUPID2		CCND1 upstream intergenic DNA repair 2, noncoding	617697				
11.515	2	22	11	11q13.4	MIR326, MIRN326		Micro RNA 326	613755				
11.516	4	29	02	11q13.1	MRPL49, NOF1		Mitochondrial ribosomal protein L49	606866				19(Mrpl49)
11.517	9	27	01	11q12.1	MS4A2, FCER1B		Membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for, beta polypeptide)	147138			{Atopy, susceptibility to}, 147050 (3)	
11.518	09	17	20	11q12.2	MS4A1, CD20, CVID5		Membrane-spanning 4-domains, subfamily A, member 1	112210		mutation identified in 1 CVID5 patient	?Immunodeficiency, common variable, 5, 613495 (3)	19(Ly44)
11.519	10	10	19	11q13.1	MUS81		MUS81 structure-specific endonuclease subunit	606591				
11.520	12	13	18	11q13.2	NDUFS8, MC1DN2		NADH-ubiquinone oxidoreductase core subunit S8	602141		previously assigned to 3q28	Mitochondrial complex I deficiency, nuclear type 2, 618222 (3)	
11.521	12	13	18	11q13.2	NDUFV1, UQOR1, MC1DN4		NADH-ubiquinone oxidoreductase core subunit V1	161015			Mitochondrial complex I deficiency, nuclear type 4, 618225 (3)	
11.522	8	29	08	11q13.2	NPAS4, NXF		Neuronal PAS domain protein 4	608554				
11.523	6	6	00	11q13.1	NRXN2		Neurexin 2	600566				
11.524	8	28	15	11q13.4	NUMA1		Nuclear mitotic apparatus protein-1	164009		fused with RARA in APL	Leukemia, acute promyelocytic, somatic, 612376 (3)	
11.525	12	7	07	11q13.3	ORAOV1, TAOS1		Oral cancer overexpressed gene 1	607224				7(Oraov1)
11.526	5	4	12	11q13	OTDD, DEL11q13, C11DELq13		Otodental dysplasia (chromosome 11q13 deletion syndrome)	166750		between rs9666584 and rs41408348	Otodental dysplasia chromosome deletion syndrome (4)	
11.527	7	15	99	11q13.1	OVOL1		Ovo, Drosophila, homolog-like, 1	602313				19(Ovol1)
11.528	10	23	87	11q13	PGA3		Pepsinogen A3	169710				
11.529	10	23	87	11q12.2	PGA4		Pepsinogen A4	169720				
11.530	10	23	87	11q12.2	PGA5		Pepsinogen A5	169730		pter-5'HRAS--5'INS--cen		
11.531	07	22	20	11q13.1	PLCB3, SMDCD		Phospholipase C, beta 3 (phosphatidylinositol-specific)	600230		within 900kb of MEN1	Spondylometaphyseal dysplasia with corneal dystrophy, 618961 (3)	19(Plcb3)
11.532	10	13	09	11q13.2	POLD4, POLDS, P12		Polymerase, DNA-directed, delta 4	611525				
11.533	12	18	08	11q13.2	RBM14, PSP2, COAA, SIP		RNA-binding motif protein 14	612409				
11.534	12	29	15	11q13.1	SCYL1, NTKL, SCAR21		SCY1-like 1	607982			Spinocerebellar ataxia, autosomal recessive 21, 616719 (3)	
11.535	09	11	19	11q13.2	UNC93B1, IIAE1		unc-93 homolog B1, TLR signaling regulator	608204			{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}, 610551 (3)	
11.536	7	17	01	11q13.1	PPP1R14B, PLCB3N, PNG		Protein phosphatase 1, regulatory subunit 14B	601140				
11.537	8	20	98	11q13.2	PPP1CA, PPP1A		Protein phosphatase-1, catalytic subunit, alpha isoform	176875				7(Ppp1a)
11.538	10	19	97	11q13.1	PPP2R5B		Protein phosphatase-2, regulatory subunit B (B56), beta isoform	601644				
11.539	1	7	02	11q13.1	PRDX5, AOEB166		Peroxiredoxin 5	606583				
11.540	3	9	04	11q13.1	PYGM		Phosphorylase, glycogen, muscle	608455			McArdle disease, 232600 (3)	19(Pygm)
11.541	7	17	14	11q13.1	RASGRP2, CDC25L		Ras guanyl nucleotide-releasing protein 2	605577		mutation identified in 1 BDPLT18 family	?Bleeding disorder, platelet-type, 18, 615888 (3)	
11.542	6	25	99	11q13.2	RBM4. LARK		RNA-binding motif protein-4 (lark, Drosophila, homolog of)	602571				
11.543	12	18	13	11q13.2	RCE1		Ras converting CAAX endopeptidase 1	605385				
11.544	2	25	15	11q12.3	RNU22		RNA, U22 small nucleolar	603223				
11.545	2	25	15	11q12.3	RNU25		RNA, U25 small nucleolar	603224				
11.546	11	11	14	11q12.3	RNU26		RNA, U26 small nucleolar	603225				
11.547	11	11	14	11q12.3	RNU27		RNA, U27 small nucleolar	603226				
11.548	11	11	14	11q12.3	RNU28		RNA, U28 small nucleolar	603227				
11.549	11	11	14	11q12.3	RNU29		RNA, U29 small nucleolar	603228				
11.550	11	1	14	11q12.3	RNU30		RNA, U30 small nucleolar	603229				
11.551	11	11	14	11q12.3	RNU31		RNA, U31 small nucleolar	603230				
11.552	7	19	18	11q12.3	ROM1, ROSP1, RP7		Rod outer segment membrane protein-1	180721		digenic RP with RDS	Retinitis pigmentosa 7, digenic form, 608133 (3)	19(Rosp1)
11.553	10	22	99	11q13.1	RTN3, NSPL2		Reticulon 3	604249		pseudogene on chr.4		
11.554	3	29	07	11q13.2	SAPS3, PP6R3, C11orf23, KIAA1558		SAPS domain family, member 3	610879				
11.555	9	17	92	11q13	SEA		Oncogene SEA (S13 avian erythroblastosis)	165110				19(Sea)
11.556	1	28	01	11q13.1	SF1, ZNF162, D11S636, ZFM1		Splicing factor 1 (zinc finger protein-162)	601516				
11.557	5	30	00	11q12.3	SLC3A2, MDU1, NACAE		Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2	158070		prob. 11q13		19(Mdu1)
11.558	7	12	02	11q13.1	SLC22A11, OAT4		Solute carrier family 22 (organic anion/cation transporter), member 11	607097				
11.559	7	12	02	11q13.1	SLC22A12, OAT4L, URAT1		Solute carrier family 22 (urate transporter), member 12	607096			Hypouricemia, renal, 220150 (3)	
11.560	3	9	98	11q13.2	SLC29A2, HNP36, DER12		Solute carrier family 29 (nucleoside transporters), member 2 (hydrophobic nucleolar protein, 36kD)	602110				19(Hnp36)
11.561	7	2	02	11q13	SMAR		Spinal muscular atrophy, chronic distal, autosomal recessive	607088		no mutations found in IGHMBP2	Spinal muscular atrophy, chronic distal, autosomal recessive (2)	
11.562	5	25	01	11q13.1	SNX15		Sorting nexin 15	605964				
11.563	9	9	13	11q13.2	SPTBN2, SCA5, SCAR14		Spectrin, beta, nonerythrocytic, 2	604985			Spinocerebellar ataxia 5, 600224 (3); Spinocerebellar ataxia, autosomal recessive 14, 615386 (3)	19(Spnb3)
11.564	12	9	91	11q13	ST3		Suppression of tumorigenicity-3 (tumor-suppressor gene, HELA cell type)	191181			Cervical carcinoma (2)	
11.565	3	18	17	11q13.4	STARD10		START domain-containing protein 10	617382				
11.566	1	31	01	11q13.1	STIP1, HOP		Stress-induced phosphoprotein 1	605063				
11.567	6	6	00	11q12.2	SYT7		Synaptotagmin 7	604146				
11.568	12	7	05	11q13.1	SYVN1, HRD1, KIAA1810		Synovial apoptosis inhibitor 1	608046				
11.569	1	13	99	11q13.1	TM7SF2, ANG1		Transmembrane 7 superfamily, member 2	603414				
11.570	3	14	07	11q13.1	TRPT1		Transfer RNA phosphotransferase 1	610470				
11.571	10	08	08	11q13.4	UCP2, BMIQ4		Uncoupling protein-2	601693			{Obesity, susceptibility to, BMIQ4}, 607447 (3)	7(Ucp2)
11.572	5	31	05	11q13.4	UCP3		Uncoupling protein-3	602044			{Obesity, severe, and type II diabetes}, 601665 (3)	
11.573	11	5	98	11q12.3	UHG, U22HG		U22 host gene	603222				
11.574	6	25	99	11q13.5	UVRAG		UV radiation resistance-associated gene	602493				
11.575	11	03	20	11q12.3	BEST1, VMD2, ARB, RP50		Bestrophin 1	607854		mutation identified in 1 MRCS family	Macular dystrophy, vitelliform, 2, 153700 (3); Bestrophinopathy, autosomal recessive, 611809 (3); Vitreoretinochoroidopathy, 193220 (3); ?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2, 193220 (3); Retinitis pigmentosa-50, 613194 (3); Retinitis pigmentosa, concentric, 613194 (3)	
11.576	1	27	97	11q13.1	VEGFB, VRF		Vascular endothelial growth factor B	601398				
11.577	2	16	18	11q22.1	YAP1, COB1		Yes-associated protein 1, 65kD	606608			Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation, 120433 (3)	
11.578	11	24	20	11q13.2	YIF1A, YIF1		YIP1-interacting factor homolog A, membrane-trafficking protein	611484				
11.579	2	22	11	11q13.1	ZNHIT2, C11orf5, FON		Zinc finger HIT domain containing protein 2	604575				
11.580	10	30	17	11q13.2	ACTN3, ACTN3D		Actinin, alpha-3	102574			[Alpha-actinin-3 deficiency], 617749 (3); [Sprinting performance], 617749 (3)	19(Actn3)
11.581	11	23	09	11q13.4	KCNE3, HOKPP, HYPP		Potassium voltage-gated channel, ISK-related subfamily, member 3	604433		mutation identified in 1 BRGDA6 family	?Brugada syndrome 6, 613119 (3)	
11.582	01	08	19	11q13.5-q14.1	PAK1, IDDMSSD		p21/CDC42/RAC1-activated kinase 1	602590			Intellectual developmental disorder with macrocephaly, seizures, and speech delay, 618158 (3)	
11.583	3	25	03	11q13.4	PLEKHB1, PHR1, KPL1		Pleckstrin homology domain-containing protein, family B, member 1	607651				7(Tyr)
11.584	10	23	87	11q13-q22	ESA4		Esterase-A4	133220				9(Es17)
11.585	7	15	16	11q12.3	GANAB, PKD3		Neutral alpha-glucosidase AB	104160			Polycystic kidney disease 3, 600666 (3)	
11.586	9	18	12	11q13.1	AP5B1, DKFZp761E198		Adaptor-related protein complex 5, beta-1 subunit	614367				
11.587	09	19	19	11q13.1	ATG2A, KIAA0404		Autophagy related 2A	616225				
11.588	12	04	20	11q13.1	ATL3, HSN1F		Atlastin GTPase 3	609369			Neuropathy, hereditary sensory, type IF, 615632 (3)	
11.589	11	16	09	11q13.1	BAD, BCL2L8		BCL1 antagonist of cell death	603167				
11.590	7	1	11	11q13.1	BANF1, BAF, NGPS		Barrier to autointegration factor 1	603811			Nestor-Guillermo progeria syndrome, 614008 (3)	
11.591	1	15	13	11q13.1	BATF2, SARI		Basic leucine zipper transcription factor, ATF-like 2	614983				
11.592	10	26	12	11q13.2	CABP2, DFNB93		Calcium-binding protein 2	607314			Deafness, autosomal recessive 93, 614899 (3)	
11.593	6	21	15	11q13.2	CABP4, CRSD, CSNB2B		Calcium-binding protein 4	608965			Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3)	
11.594	11	3	11	11q13.1	CATSPER1, CATSPER, SPGF7		Cation channel, sperm-associated, 1	606389			Spermatogenic failure 7, 612997 (3)	
11.595	6	12	17	11q13.1	CATSPERZ, TEX40		Cation channel, sperm-associated, auxiliary subunit zeta	617511				11(Catsperz)
11.596	6	22	14	11q13.1	DIPA		Delta antigen-interacting protein A	605360				
11.597	8	30	11	11q13.1	CCDC88B, GIPIE		Coiled-coil domain-containing protein 88B	611205				
11.598	4	5	11	11q13.1	CDCA5, SORORIN		Cell division cycle-associated protein 5 (sororin)	609374				
11.599	8	19	13	11q13.2	CTSF, CLN13		Cathepsin F	603539			Ceroid lipofuscinosis, neuronal, 13, Kufs type, 615362 (3)	
11.600	2	12	99	11q13.1	CTSW		Cathepsin W	602364				
11.601	9	20	14	11q13.1	DRAP1		DR1-associated protein 1	602289				
11.602	06	13	19	11q13.1	EIF1AD, OBELIX		Eukaryotic translation initiation factor 1A domain-containing protein	618473				
11.603	12	18	14	11q13.1	FAM89B, MTVR, LRAP25		Family with sequence similarity 89, member B	616128				19(Fam89b)
11.604	11	16	06	11q13.3	FGF19		Fibroblast growth factor 19	603891				7(Fgf15)
11.605	9	16	16	11q13.1	FIBP, TROFAS		Fibroblast growth factor, acidic, intracellular binding protein	608296			Thauvin-Robinet-Faivre syndrome, 617107 (3)	
11.606	02	22	19	11q13.1	FRMD8, ITAP		FERM domain-containing protein 8	618337				
11.607	9	27	17	11q13.1	GPHA2, GPA2		Glycoprotein hormone, alpha-2	609651				
11.608	7	15	09	11q13.2	LRFN4, SALM3		Leucine-rich repeat and fibronectin type III domain-containing protein 4	612810				19(Lrfn4)
11.609	2	25	15	11q13.1	MACROD1, LRP16		Macro domain-containing 1	610400				
11.610	9	26	16	11q13.1	MAJIN, C11orf85		Membrane-anchored junction protein	617130				
11.611	5	19	09	11q13.1	MALAT1, PRO1073		Metastasis-associated lung adenocarcinoma transcript 1	607924		fused with TFEB in renal tumors		
11.612	3	23	09	11q13.1	MIR192, MIRN192		Micro RNA 192	610939				
11.613	3	23	09	11q13.1	MIR194-2, MIRN194-2		Micro RNA 194-2	610941				
11.614	3	1	01	11q13.3	MYEOV		Myeloma overexpressed gene	605625				
11.615	7	11	16	11q13.1	NEAT1, TNCRNA		Noncoding nuclear-enriched abundant transcript 1	612769				19(Ncrna00084)
11.616	6	5	08	11q13.1	OTUB1, OTU1, OTB1		OTU domain-containing ubiquitin aldehyde-binding protein 1	608337				
11.617	7	29	16	11q13.1-q13.2	PACS1, SHMS, MRD17		Phosphofurin acidic cluster sorting protein 1	607492			Schuurs-Hoeijmakers syndrome, 615009 (3)	
11.618	01	29	20	11q13.1	PCNX3		Pecanex 3	617657				19(Pcnx3)
11.619	10	15	97	11q12.3	POLR2G		Polymerase (RNA) II (DNA directed) polypeptide G	602013				
11.620	2	4	09	11q13.2	RAB1B		Ras-associated protein RAB1B	612565				
11.621	10	12	14	11q13.1	RCOR2		Rest corepressor 2	616019				
11.622	5	25	13	11q13.1	RPS6KA4, RSKB, MSK2		Ribosomal protein S6 kinase, 90kD, 4	603606				
11.623	02	28	20	11q13.1	SAC3D1, SHD1		SAC3 domain-containing protein 1	618796				
11.624	9	17	09	11q12.2	SDHAF2, SDH5, PGL2		Succinate dehydrogenase complex assembly factor 2	613019			Paragangliomas 2, 601650 (3)	
11.625	1	2	08	11q13.1	SLC22A20, OAT6		Solute carrier family 22, member 20	611696				19(Slc22a20)
11.626	3	12	07	11q13.1	SLC25A45		Solute carrier family 25, member 45	610825				19(Slc25a45)
11.627	9	8	11	11q13.1	SPDYC, RINGOC		Speedy, xenopus, homolog of, C	614030				
11.628	3	8	07	11q13.2	TBC1D10C, CARABIN		TBC1 domain family, member 10C	610831				
11.629	11	05	20	11q13.1	TIGD3		Tigger transposable element-derived gene 3	619084				
11.630	10	25	19	11q13.1	TRMT112		tRNA methyltransferase subunit 11-2	618630				
11.631	10	03	19	11q13.1	VPS51, ANG2, PCH13		VPS51 subunit of GARP complex	615738			Pontocerebellar hypoplasia, type 13, 618606 (3)	
11.632	07	24	19	11q13.2	BRMS1		BRMS1 transcriptional repressor and anoikis regulator	606259				
11.633	08	21	19	11q13.2	RAD9A, RAD9		RAD9 checkpoint clamp component A	603761				
11.634	2	27	03	11q12.3	SLC22A6, OAT1, PAHT		Solute carrier family 22 (organic anion transporter), member 6	607582				
11.635	12	13	00	11q13.2	TBX10		T-box 10	604648				19(Tbx10)
11.636	3	23	93	11q13.1	FKBP2		FK506-binding protein-2, 13kD	186946				
11.637	1	8	95	11q13.1	MAP3K11, MLK3, PTK1, SPRK		Mitogen-activated protein kinase kinase kinase 11	600050				
11.638	1	5	12	11q13.2	ACY3, HCBP1		Aminoacylase 3	614413				19(Acy3)
11.639	4	6	13	11q13.2	ANKRD13D		Ankyrin repeat domain-containing protein 13D	615126				
11.640	1	11	18	11q13.2	B4GAT1, B3GNT1, IGNT, IGAT, MDDGA13		Beta-1,4glucuronyltransferase 1	605517			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3)	
11.641	05	16	19	11q13.2	C11orf80, HYDM4		Chromosome 11 open reading frame 80	616109			Hydatidiform mole, recurrent, 4, 618432 (3)	
11.642	5	24	13	11q13.2	CNIH2, CNIL		Cornichon, Drosophila, homolog of, 2	611288				
11.643	7	22	11	11q13.2	CHKA, CHK		Choline kinase, alpha	118491				
11.644	1	24	06	11q13.2	CORO1B		Coronin 1B	609849				19(Coro1b)
11.645	10	24	18	11q13.2	GRK2, ADRBK1		G protein-coupled receptor kinase 2	109635				19(Adrbk1)
11.646	12	5	17	11q13.2	KMT5B, SUV420H1, CGI85, MRD51		Lysine methyltransferase 5B	610881			Mental retardation, autosomal dominant 51, 617788 (3)	
11.647	3	31	09	11q13.3	MRGPRD, MRGD		Mas-related G protein-coupled receptor family, member D	607231				
11.648	3	31	09	11q13.3	MRGPRF, MRGF, RTA		Mas-related G protein-coupled receptor family, member F	607233				
11.649	2	28	08	11q13.3	MRPL21		Mitochondrial ribosomal protein L21	611834				
11.650	3	5	08	11q13.4	MRPL48		Mitochondrial ribosomal protein L48	611853		pseudogene on 6		
11.651	04	13	20	11q13.4	NADSYN1, VCRL3		NAD synthetase 1	608285			Vertebral, cardiac, renal, and limb defects syndrome 3, 618845 (3)	
11.652	10	07	20	11q13.2	PELI3		Pellino E3 ubiquitin protein ligase 3	609827				
11.653	10	15	07	11q13.1	RNASEH2C, AYP1, FLJ20974, AGS3		Ribonuclease H2, subunit C	610330			Aicardi-Goutieres syndrome 3, 610329 (3)	
11.654	4	3	12	11q13.2	SSH3		Slingshot, Drosophila, homolog of, 3	606780				
11.655	6	7	10	11q13.2	SYT12, SRG1		Synaptotagmin 12	606436				
11.656	9	24	08	11q13.3	TPCN2, TPC2, SHEP10		Two-pore segment channel 2	612163			[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)	
11.657	2	2	01	11q13.3	MTL5, TESMIN		Metallothionein-like 5, testis-specific	604374				19(Mtl5)
11.658	1	5	15	11q13.3	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S		Immunoglobulin mu binding protein 2	600502			Neuronopathy, distal hereditary motor, type VI, 604320 (3); Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	19(Ighmbp2)
11.659	9	27	17	11q13.2	AIP, XAP2, ARA9, PITA1		Aryl hydrocarbon receptor-interacting protein	605555			Pituitary adenoma 1, multiple types, 102200 (3); Pituitary adenoma predisposition, 102200 (3)	
11.660	11	10	14	11q13.2	CLCF1, BSF3, CLC, CISS2		Cardiotrophin-like cytokine	607672			Cold-induced sweating syndrome 2, 610313 (3)	
11.661	9	1	16	11q13.4	DNAJB13, TSARG6, CILD34		DNAJ/HSP40 homolog, subfamily B, member 13	610263			Ciliary dyskinesia, primary, 34, 617091 (3)	
11.662	3	10	11	11q13.3	FADD		FAS-associating protein with death domain	602457			Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations, 613759 (3)	
11.663	2	26	08	11q13.2	MRPL11		Mitochondrial ribosomal protein L11	611826				
11.664	8	21	07	11q13.3	PPFIA1, LIP1		Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha-1	611054				
11.665	8	28	97	11q13.2	PTPRCAP, LPAP		Protein tyrosine phosphatase, receptor type, c polypeptide-associated protein	601577				
11.666	10	17	05	11q13.1	SIPA1, SPA1		Signal-induced proliferation-associated gene-1	602180				19(Spa1)
11.667	12	23	05	11q13.4	XRRA1		X-ray radiation resistance-associated 1	609788				
11.668	11	24	08	11q13.4	LRTOMT, LRTOMT1, LRTOMT2, DFNB63		Leucine-rich transmembrane O-methyltransferase	612414			Deafness, autosomal recessive 63, 611451 (3)	7(Lrrc51, Tomt)
11.669	10	10	19	11q13.4	PHOX2A, ARIX, CFEOM2		Paired-like homeobox 2a	602753			Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	7(Arix)
11.670	9	7	10	11q13.3-q13.4	SHANK2, CORTBP1, AUTS17		SH3 and multiple ankyrin repeat domains 2	603290			{Autism susceptibility 17}, 613436 (3)	
11.671	3	23	93	11q13.3-q13.4	ZNF126		Zinc finger protein-126 (HZF-2)	194633				
11.672	10	12	09	11q13.4	FOLR1, NCFTD		Folate receptor, alpha	136430		telomeric of FGF3	Neurodegeneration due to cerebral folate transport deficiency, 613068 (3)	
11.673	10	20	92	11q13.4	FOLR2		Folate receptor, beta	136425		23kb from FOLR1		
11.674	7	13	15	11q13.2	GAL, GALN, GLNN, ETL8		Galanin	137035		mutation identified in 1 ETL8 family	?Epilepsy, familial temporal lobe, 8, 616461 (3)	19(Glnn)
11.675	3	18	95	11q13.4	RNU15A		RNA, U15a small nucleolar	600455		processed from intron of RPS3		
11.676	3	18	95	11q13.4	RPS3		Ribosomal protein S3	600454				
11.677	7	13	12	11q13.4	ANAPC15, APC15		Anaphase-promoting complex, subunit 15	614717				
11.678	2	23	17	11q13.4	ARAP1, CENTD2, KIAA0782		ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1	606646				
11.679	7	22	16	11q13.4	ARHGEF17, RHOGEF17, TEM4, KIAA0337		Rho guanine nucleotide exchange factor 17	617043				
11.680	12	23	19	11q13.4	ATG16L2		Autophagy 16-like 2	618716				
11.681	04	19	19	11q13.4	C2CD3, OFD14		C2 calcium-dependent domain-containing protein 3	615944			Orofaciodigital syndrome XIV, 615948 (3)	
11.682	08	12	20	11q13.4	COA4, CHCHD8, E2IG2		Cytochrome c oxidase assembly factor 4 homolog	608016				
11.683	12	2	09	11q13.4	CHRDL2, CHL2, BNF1		Chordin-like 2	613127				7(Chrdl2)
11.684	12	17	19	11q13.4	CLPB, SKD3, MGCA7, MEGCANN		Caseinolytic peptidase B	616254			3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3)	
11.685	12	18	14	11q13.4	FAM86C1		Family with sequence similarity 86, member C1	616124				
11.686	7	6	17	11q13.4	FCHSD2, KIAA0769, NWK		FCH and double SH3 domains protein 2	617556				7(Fchsd2)
11.687	9	27	17	11q13.4	FOLR3		Folate receptor 3	602469				
11.688	4	22	15	11q13.4	RAM168A, TCRP1, KIAA0280		Family with sequence similarity 168, member A	616316				
11.689	08	22	19	11q13.4	IL18BP, FVH		Interleukin 18-binding protein	604113		mutation identified in 1 FVH patient	{?Hepatitis, fulminant viral, susceptibility to}, 618549 (3)	
11.690	2	5	15	11q13.4	LAMTOR1, C11orf59, PDRO		Late endosomal/lysosomal adaptor, mitogen-activated protein kinase and mammalian target of rapamycin activator 1	613510				
11.691	9	15	17	11q13.4	LIPT2		Lipoyl(octanoyl) transferase 2	617659			Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, 617668 (3)	
11.692	2	22	18	11q13.2	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4		Low density lipoprotein receptor-related protein-5	603506			Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density variability 1], 601884 (3); Hyperostosis, endosteal, 144750 (3); van Buchem disease, type 2, 607636 (3); Osteosclerosis, 144750 (3); {Osteoporosis}, 166710 (3); Exudative vitreoretinopathy 4, 601813 (3); Osteopetrosis, autosomal dominant 1, 607634 (3); Polycystic liver disease 4 with or without kidney cysts, 617875 (3)	19(Lrp5)
11.693	3	7	13	11q13.4	MIR139, MIR139-3p		Micro RNA 139	615017				
11.694	5	25	13	11q13.4	PDE2A		Phosphodiesterase 2A	602658				
11.695	2	18	08	11q13.4	PGM2L1		Phosphoglucomutase 2-like 1	611610				
11.696	9	10	07	11q13.4	PPME1		Protein phosphatase methylesterase 1	611117				
11.697	10	12	90	11q13.4	RAB6A, RAB6		Oncogene RAB6	179513		previously assigned to 2q14-q21		
11.698	04	15	19	11q13.4	RELT, TNFRSF19L, AI3C		Receptor expressed in lymphoid tissues	611211			Amelogenesis imperfecta, type IIIC, 618386 (3)	
11.699	11	07	19	11q13.4	RNF169, KIAA1991		RING finger protein 169	618650				
11.700	4	20	04	11q13.5	EMSY, C11orf30		EMSY gene	608574		100kb from GARP		
11.701	3	3	03	11q14.1	GAB2		GRB2-associated binding protein 2	606203				7(Gab2)
11.702	2	19	10	11q13.4-q13.5	GDPD5, GDE2, PP1665		Glycerophosphodiester phosphodiesterase domain-containing protein 3	609632				
11.703	8	25	04	11q13.2	PC		Pyruvate carboxylase	608786			Pyruvate carboxylase deficiency, 266150 (3)	19(Pc)
11.704	6	26	00	11q13.2	TCIRG1, TIRC7, OC116, OPTB1		T-cell immune regulator 1	604592			Osteopetrosis, autosomal recessive 1, 259700 (3)	19(oc)
11.705	01	16	19	11p14.1	KCNA4, KCNA8, MCIDDS		Potassium voltage-gated channel, shaker-related subfamily, member 4	176266		other map to 11p	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum, 618284 (3)	2(Kcna4)
11.706	3	23	93	11q13.5	OMP		Olfactory marker protein	164340				7(Omp)
11.707	11	10	17	11q13.5	ACER3, APHC, PHCA, PLDECO		Alkaline ceramidase 3	617036		mutation identified in 1 PLDECO family	?Leukodystrophy, progressive, early childhood-onset, 617762 (3)	
11.708	10	12	09	11q13.5	ATOD7		Dermatitis, atopic, 7	613064		associated with rs7927894	{Dermatitis, atopic, susceptibility to, 7} (2)	
11.709	2	18	16	11q13.5	DGAT2		Diacylglycerol O-acyltransferase 2	606983				
11.710	10	4	91	11q13.4	KRTAP5-9, KRN1		Keratin associated protein 5-9	148021				
11.711	10	29	20	11q13.5	LRRC32, GARP, D11S833E, CPPRDD		Leucine rich repeat containing 32	137207			Cleft palate, proliferative retinopathy, and developmental delay, 619074 (3)	7(Garp)
11.712	9	27	17	11q13.5	MAP6, MTAP6, STOP, KIAA1878		Microtubule-associated protein 6	601783				
11.713	8	3	12	11q13.5	MOGAT2, MGAT2		Monoacylglycerol O-acyltransferase 2	610270				
11.714	11	26	97	11q13.5	MYO7A, USH1B, DFNB2, DFNA11		Myosin VIIA	276903			Usher syndrome, type 1B, 276900 (3); Deafness, autosomal recessive 2, 600060 (3); Deafness, autosomal dominant 11, 601317 (3)	7(sh1, Myo7a)
11.715	3	9	00	11q13.4	NEU3, SIAL3		Neuraminidase 3 (membrane sialidase; sialidase 3)	604617				
11.716	7	15	99	11q13.4	P2RY2, P2Y2, P2U		Purinergic receptor P2Y, G-protein coupled, 2	600041				
11.717	7	15	99	11q13.4	P2RY6, P2Y6		Pyrimidinergic receptor P2Y, G protein-coupled, 6	602451				
11.718	7	14	14	11q13.5	PRKRIR		PRKR inhibitor, repressor of	607374				
11.719	10	12	16	11q13.5	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10		Serpin peptidase inhibitor, clade H, member 1	600943			{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3); Osteogenesis imperfecta, type X, 613848 (3)	
11.720	08	13	20	11q14.1	THRSP		Thyroid hormone-responsive protein	601926				
11.721	1	12	07	11q13.5	TSKU, E2IG4, TSK		Tsukushin	608015				
11.722	6	25	99	11q13.5	WNT11		Wingless-type MMTV integration site family, member 11	603699				
11.723	3	9	98	11q14.1	CLNS1A, CLNS1B		Chloride channel, nucleotide-sensitive, 1A	602158		CLNS1B on 6p12.1-q13 = pseudogene?		
11.724	11	21	02	11q14.2	RAB38		Ras-family, member RAB38	606281				7(Rab38, cht)
11.725	3	1	06	11q14.1	AQP11, AQPX1		Aquaporin 11	609914				
11.726	7	22	13	11q13.5	B3GNT6		Beta-1,3-N-acetylglucosaminyltransferase 6	615315				
11.727	2	21	14	11q13.5	CAPN5, HTRA3, VRNI		Calpain 5	602537			Vitreoretinopathy, neovascular inflammatory, 193235 (3)	
11.728	4	17	07	11q14	GCRG224		Gastric cancer-related gene 224	610888				
11.729	8	27	15	11q14.2	PICALM, CALM, CLTH, LAP		Phosphatidylinositol-binding clathrin assembly protein	603025		fuses with AF10 in t(10;11)	Leukemia, acute myeloid, somatic, 601626 (3)	
11.730	6	9	98	11q14.1	PRCP, PCP		Prolylcarboxypeptidase (angiotensinase C)	176785				
11.731	10	28	02	11q14	SLEH1		Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1	607279			{Systemic lupus erythematosus with hemolytic anemia} (2)	
11.732	7	20	09	11q14.1	SYTL2, SLP2, SLP2A, EXO4, KIAA1597		Synaptotagmin-like 2	612880				
11.733	12	14	98	11q14-q21	SCZD2		Schizophrenia susceptibility locus, chromosome 11-related	603342			{?Schizophrenia}, 181500 (2)	
11.734	8	25	14	11q14.2	FZD4, EVR1		Frizzled, Drosophila, homolog of, 4	604579			Exudative vitreoretinopathy 1, 133780 (3); Retinopathy of prematurity, 133780 (3)	
11.735	10	8	13	11q14.3	TYR, SHEP3, CMM8, OCA1A, ATN		Tyrosinase	606933			Albinism, oculocutaneous, type IA, 203100 (3); Waardenburg syndrome/albinism, digenic, 103470 (3); Albinism, oculocutaneous, type IB, 606952 (3); [Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3); {Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3); [Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	7(Tyr)
11.736	5	15	08	11q14-q22	IHPS3		Pyloric stenosis, infantile hypertrophic, 3	612017		max lod at rs541821	Pyloric stenosis, infantile hypertrophic, 3 (2)	
11.737	7	2	18	11q14.1	CREBZF, ZF		CREB/ATF bZIP transcription factor	606444				
11.738	7	2	18	11q14.1	DDIAS, NOXIN, C11orf82		DNA damage-induced apoptosis suppressor	618045				7(Ddias)
11.739	3	23	14	11q14.1	INTS4, INT4		Integrator complex subunit 4	611348				
11.740	02	24	20	11q14.1	KCTD21, KCASH2		Potassium channel tetramerization domain-containing protein 21	618790				
11.741	05	31	19	11q14.1	NARS2, COXPD24, DFNB94		Asparaginyl-tRNA synthetase 2	612803		mutation identified in 1 DFNB94 family	Combined oxidative phosphorylation deficiency 24, 616239 (3); ?Deafness, autosomal recessive 94, 618434 (3)	
11.742	5	25	13	11q14.1	NDUFC2		NADH-ubiquinone oxidoreductase subunit C2	603845				
11.743	9	16	12	11q14.1	PCF11, KIAA0824		PCF11, yeast, homolog of	608876				
11.744	03	29	19	11q14.2	PRSS23		Protease, serine, 23	618376				
11.745	11	22	17	11q14.1	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5		Teneurin transmembrane protein 4	610084			Essential tremor, hereditary, 5, 616736 (3)	7(Odz4)
11.746	12	13	18	11q14.1	TMEM126B, MC1DN29		Transmembrane protein 126B	615533			Mitochondrial complex I deficiency, nuclear type 29, 618250 (3)	
11.747	12	21	12	11q14.2	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD		Cathepsin C	602365			Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010 (3); Periodontitis 1, juvenile, 170650 (3)	7(Ctsc)
11.748	9	2	09	11q14.1	TMEM126A, OPA7		Transmembrane protein 126A	612988			Optic atrophy 7, 612989 (3)	
11.749	8	9	17	11q14.2	HIKESHI, C11orf73, HLD13		Hikeshi	614908			Leukodystrophy, hypomyelinating, 13, 616881 (3)	
11.750	5	19	15	11q14.2	TMEM135, PMP52		Transmembrane protein 135	616360				
11.751	4	19	12	11q14.2-q14.3	GRM5, MGLUR5		Glutamate receptor, metabotropic, 5	604102				7(Grm5)
11.752	7	12	02	11q14.3	NOX4, RENOX		NADPH oxidase 4	605261				
11.753	08	26	19	11q14.2	EED, WAIT1, COGIS		Embryonic ectoderm development protein	605984			Cohen-Gibson syndrome, 617561 (3)	
11.754	01	04	19	11q14.3	CHRODC1, CHP1		Cysteine- and histidine-rich domain-containing protein 1	604353				
11.755	8	3	12	11q13.2	RHOD, ARHD, RHOHP1		Ras homolog gene family, member D	605781				
11.756	3	24	11	11q21	SLC36A4, PAT4		Solute carrier family 36, member 4	613760				
11.757	1	18	11	11q14.3	UBTFL1, HMGPI		Upstream binding transcription factor (RNA polymerase I)-like 1	613696				
11.758	09	19	19	11q14.3	FAT3		FAT atypical cadherin 3	612483				
11.759	1	2	08	11q14.3	NAALAD2		N-acetylated alpha-linked acidic dipeptidase 2	611636				
11.760	5	29	12	11q21	AMOTL1, JEAP		Angiomotin-like 1	614657				
11.761	7	14	14	11q21	C11orf54, PTOD012		Chromosome 11 open reading frame 54	615810				
11.762	9	21	11	11q21	C11orf75, FN5		FN5, pufferfish, homolog of	609477				
11.763	7	28	11	11q21	CEP57, PIG8, TSP57, KIAA0092, MVA2		Centrosomal protein 57kD	607951			Mosaic variegated aneuploidy syndrome 2, 614114 (3)	
11.764	10	25	17	11q21	CEP295, KIAA1731		Centrosomal protein, 295kD	617728				
11.765	10	11	16	11q21	DEUP1, CCDC67		Deuterosome assembly protein 1	617148				
11.766	09	09	19	11q14.1	DLG2		Discs large MAGUK scaffold protein 2	603583				
11.767	4	22	05	11q21	GPR83, GIR, GPR72		G protein-coupled receptor 83	605569				9(Gpr83)
11.768	5	19	94	11q21	FUT4, FCT3A, CD15		Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)	104230				9(Fut4)
11.769	06	25	19	11q21	HEPHL1, ZP, HJDD		Hephaestin-like protein 1	618455		mutation identified in 1 HJDD patient	?Abnormal hair, joint laxity, and developmental delay, 261990 (3)	
11.770	12	15	20	11q21	IZUMO1R, FOLR4		Izumo1 receptor, Juno	615737				9(Folr4)
11.771	11	3	98	11q21	JRKL, HHMJG		Jerky, mouse, homolog-like	603211				
11.772	5	16	18	11q21	KDM4D, JMJD2D		Lysine demethylase 4D	609766				
11.773	9	29	15	11q21	KDM4E, JMJD2E		Lysine-specific demethylase 4E	616581				
11.774	3	3	03	11q21	MAML2, MAM3		Mastermind-like 2	607537		t(11;19)	Mucoepidermoid salivary gland carcinoma (3)	
11.775	12	21	10	11q21	MED17, CRSP6, CRSP77, TRAP80, DRIP80		Mediator complex subunit 17	603810			Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	
11.776	12	19	19	11q21	MRE11A, MRE11, ATLD		MRE11 homolog, double-strand break repair nuclease	600814			Ataxia-telangiectasia-like disorder 1, 604391 (3)	
11.777	08	23	19	11q21	PANX1, PX1, OOMD7		Pannexin 1	608420			Oocyte maturation defect 7, 618550 (3)	
11.778	5	13	03	11q21	SEST3		Sestrin 3	607768				10(Sest3)
11.779	7	16	09	11q21	TAF1D, RAFI41, JOSD3		TATA box-binding protein-associated factor 1D	612823				
11.780	2	21	10	11q21-q22	FGQTL3		Fasting plasma glucose level QTL 3	613233		associated with rs10830963	[Fasting plasma glucose level QTL 3] (2)	
11.781	8	18	98	11q22.3	GUCY1A2, GUC1A2		Guanylate cyclase 1, soluble, alpha 2	601244				
11.782	9	29	96	11q22.2	MMP7		Matrix metalloproteinase 7 (matrilysin, uterine)	178990				
11.783	11	15	94	11q22.2	MMP8, CLG1		Matrix metalloproteinase 8 (neutrophil collagenase)	120355				
11.784	3	30	12	11q14.3	MTNR1B		Melatonin receptor 1B	600804			{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	
11.785	9	9	13	11q21	MIR1260B		Micro RNA 1260B	615372				
11.786	7	6	05	11q22.1	TRPC6, TRP6, FSGS2		Transient receptor potential channel-6	603652			Glomerulosclerosis, focal segmental, 2, 603965 (3)	
11.787	10	17	02	11q22.1	CNTN5, NB2		Contactin 5	607219				
11.788	4	1	03	11q22.1	ANGPTL5		Angiopoietin-like 5	607666				
11.789	3	21	14	11q22.3	CARD16, COP1		Caspase recruitment domain-containing protein 16	615680				
11.790	10	27	92	11q22.3	FDX1, ADX		Ferredoxin-1 (adrenodoxin)	103260		pseudogene on 20q11-q12		
11.791	8	1	05	11q22.3	INCA		Inhibitory caspase recruitment domain protein	609490				
11.792	5	28	03	11q21	MTMR2, CMT4B1		Myotubularin-related protein 2	603557			Charcot-Marie-Tooth disease, type 4B1, 601382 (3)	
11.793	10	21	02	11q22.1	PGR		Progesterone receptor	607311		11q13 = earlier regionalization	?Progesterone resistance, 264080 (2)	9(Pgr)
11.794	12	19	11	11q21	SRSF8, SFRS2B, SRp46		Splicing factor, arginine/serine-rich, 8	603269				
11.795	9	22	98	11q22.2	API2, HAIP1		Apoptosis inhibitor-2	601721		fused with MALT1 in MALT lymphoma		
11.796	7	6	99	11q22.2	API1, HIAP2		Apoptosis inhibitor-1	601712				
11.797	08	23	19	11q24.2	CHEK1, CHK1		Checkpoint kinase 1	603078				
11.798	2	17	09	11q24.1	CRTAM		Cytotoxic and regulatory T-cell molecule	612597				9(Crtam)
11.799	1	7	99	11q22.3	CUL5, VACM1		Cullin-5 (vasopressin-activated calcium-mobilizing receptor-1)	601741				
11.800	07	13	20	11q22.3	DDX10		DEAD-box helicase 10	601235		400kb telomeric to ATM; pseudogene on 9q21-q22; fused with NUP98 in AML		
11.801	2	16	17	11q22.3	GRIA4, GLUR4, NEDSGA		Glutamate receptor, ionotropic, AMPA 4	138246			Neurodevelopmental disorder with or without seizures and gait abnormalities, 617864 (3)	9(Glur4)
11.802	3	9	98	11q23.1	HSPB2		Heat-shock 27kD protein-2	602179				
11.803	6	24	08	11q22.2	MMP1, CLG		Matrix metalloproteinase 1 (interstitial collagenase)	120353			COPD, rate of decline of lung function in, 606963 (3); {Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)	
11.804	5	28	98	11q22.3	SLN		Sarcolipin	602203				
11.805	02	11	19	11q23.1	PPP2R1B		Protein phosphatase 2, structural/regulatory subunit A, beta	603113			Lung cancer, somatic, 211980 (3)	
11.806	6	27	08	11q23.3	TECTA, DFNA8, DFNA12, DFNB21		Tectorin, alpha	602574			Deafness, autosomal dominant 8/12, 601543 (3); Deafness, autosomal recessive 21, 603629 (3)	
11.807	4	24	90	11q22-qter	ANC		Anal canal carcinoma	105580		3p22 also deleted	?Anal canal carcinoma (2)	
11.808	8	12	14	11q22.1	ARHGAP42, GRAF3		Rho GTPase-activating protein 42	615936				
11.809	8	3	18	11q22.1	CFAP300, C11orf70, CILD38		Cilia- and flagella-associated protein 300	618058			Ciliary dyskinesia, primary, 38, 618063 (3)	
11.810	6	1	12	11q22.1	KIAA1377		KIAA1377 gene	614634				
11.811	7	9	06	11q22.2	TMEM123, PORIMIN		Transmembrane protein 123	606356				
11.812	09	06	18	11q22.2	MMP27		Matrix metalloproteinase 27	618101				
11.813	8	20	98	11q22.3	CASP1, IL1BC		Caspase 1, apoptosis-related cysteine protease (interleukin-1, beta convertase)	147678				9(Ilb1bc)
11.814	3	16	99	11q22.3	CASP4		Caspase 4, apoptosis-related cysteine protease	602664				
11.815	3	16	99	11q22.3	CASP5		Caspase 5, apoptosis-related cysteine protease	602665				
11.816	6	25	99	11q23.1	IL18, IGIF		Interleukin-18	600953				
11.817	5	19	97	11q22.2	MMP12		Matrix metalloproteinase 12 (macrophage elastase)	601046				
11.818	12	6	16	11q22.3	AASDHPPT		Alpha-aminoadipate semialdehyde dehydrogenase-phosphopantetheinyl transferase	607756				
11.819	10	28	19	11q22.3	ALKBH8, ABH8, MRT71		AlkB homolog 8, tRNA methyltransferase	613306			Intellectual developmental disorder, autosomal recessive 71, 618504 (3)	
11.820	1	27	16	11q22.3	ATM, ATA, AT1		Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E)	607585			Ataxia-telangiectasia, 208900 (3); Lymphoma, B-cell non-Hodgkin, somatic (3); {Breast cancer, susceptibility to}, 114480 (3); Lymphoma, mantle cell, somatic (3); T-cell prolymphocytic leukemia, somatic (3)	9(Atm)
11.821	5	5	17	11q23.3	ATP5JG		ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G	617473				
11.822	3	21	14	11q22.3	CARD18, ICEBERG		Caspase recruitment domain-containing protein 18	605354				
11.823	5	31	05	11q22.3	CASP12, CASP12P1		Caspase 12, apoptosis-related cysteine protease	608633			{Sepsis, susceptibility to} (3)	
11.824	8	26	15	11q22.3	DCUN1D5, SCCRO5		DCN1 domain-containing protein 5	616522				
11.825	2	11	14	11q22.3	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3		Dynein, cytoplasmic-2, heavy chain-1	603297		1 patient showed heterozygous NEK2 and DYNC2H1 mutations	Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	
11.826	12	10	13	11q22.3	ELMOD1		ELMO/CED12 domain-containing protein 1	615456				
11.827	1	24	13	11q22.3	EXPH5, SLAC2B, KIAA0624		Exophilin 5	612878			Epidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3)	
11.828	1	7	95	11q23.3	GRIK4		Glutamate receptor, ionotropic, kainate 4	600282				9(Grik4)
11.829	09	17	20	11q22.2	MMP13, CLG3, MANDP1, MDST		Matrix metalloproteinase 13 (collagenase 3)	600108		mutation identified in 1 SEMDM family	?Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3); Metaphyseal anadysplasia 1, 602111 (3); Metaphyseal dysplasia, Spahr type, 250400 (3)	
11.830	1	12	99	11q22.3	NPAT, E14		Nuclear protein, ataxia-telangiectasia locus	601448				
11.831	12	28	08	11q22.3	PDGFD, SCDGFB, IEGF		Platelet-derived growth factor D	609673				
11.832	07	17	19	11q22.3	POGLUT3, KDELC2		Protein O-glucosyltransferase 3	618503				
11.833	1	9	13	11q22.3	ZC3H12C, MCPIP3		Zinc finger CCCH domain-containing protein 12C	615001				
11.834	7	13	94	11q22.2	MMP10, STMY2		Matrix metalloproteinase 10 (stromelysin 2)	185260				
11.835	8	4	09	11q22.2	MMP20, AI2A2		Matrix metalloproteinase-20 (enamelysin)	604629			Amelogenesis imperfecta, type IIA2, 612529 (3)	
11.836	10	29	03	11q22.3	ACAT1		Acetyl-Coenzyme A acetyltransferase-1 (acetoacetyl Coenzyme A thiolase)	607809		cluster: cen-STMY2-CLG-STMY1-ter	Alpha-methylacetoacetic aciduria, 203750 (3)	
11.837	1	4	18	11q23.1	BCO2, BCDO2		Beta-carotene oxygenase 2	611740				
11.838	8	6	13	11q23.1	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2		Crystallin, alpha B	123590			Myopathy, myofibrillar, 2, 608810 (3); Cataract 16, multiple types, 613763 (3); Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related, 613869 (3); Cardiomyopathy, dilated, 1II, 615184 (3)	
11.839	4	15	09	11q23.1	PTS		6-pyruvoyltetrahydropterin synthase	612719			Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)	
11.840	01	03	20	11q23.1	ALG9, DIBD1, CDG1L, GIKANIS		ALG9 alpha-1,2-mannosyltransferase	606941			Congenital disorder of glycosylation, type Il, 608776 (3); Gillessen-Kaesbach-Nishimura syndrome, 263210 (3)	
11.841	12	20	05	11q23.3	AMICA1, JAML		Adhesion molecule, interacts with CXADR antigen 1	609770				
11.842	08	19	19	11q23.3	APOA1, HPALP2		Apolipoprotein A-I	107680			ApoA-I and apoC-III deficiency, combined, 618463 (3); Hypoalphalipoproteinemia, primary, 2, with or without corneal clouding, 618463 (3); Amyloidosis, 3 or more types, 105200 (3)	9(Apoa1)
11.843	11	24	14	11q23.3	APOC3, HALP2		Apolipoprotein C-III	107720		2.6kb 3' to APOA1	Apolipoprotein C-III deficiency, 614028 (3)	
11.844	3	15	91	11q23.3	APOA4		Apolipoprotein A-IV	107690		12 kb 3' to APOA1		9(Apoa4)
11.845	11	14	05	11q23.3	APOA5		Apolipoprotein A-V	606368		proximal to APOA1, APOC3, APOA4	{Hypertriglyceridemia, susceptibility to}, 145750 (3); Hyperchylomicronemia, late-onset, 144650 (3)	
11.846	5	18	05	11q23	BMND5		Bone mineral density QTL 5	609354		between D11S901 and D11S925	[Bone mineral density QTL 5] (2)	
11.847	09	08	20	11q23.1	BTG4, PC3B, OOMD8		B-cell translocation gene 4	605673			Oocyte maturation defect 8, 619009 (3)	
11.848	2	5	14	11q23.3	CD3D, T3D, IMD19		CD3D antigen, delta polypeptide (TiT3 complex)	186790		3 CD3 genes in 50kb	Immunodeficiency 19, 615617 (3)	9(T3d)
11.849	2	10	14	11q23.3	CD3E, IMD18		CD3E antigen, epsilon polypeptide (TiT3 complex)	186830			Immunodeficiency 18, 615615 (3); Immunodeficiency 18, SCID variant, 615615 (3)	9(T3e)
11.850	2	2	14	11q23.3	CD3G, IMD17		CD3G antigen, gamma polypeptide (TiT3 complex)	186740			Immunodeficiency 17, CD3 gamma deficient, 615607 (3)	9(T3g)
11.851	3	23	14	11q23.1	COLCA1		Colorectal cancer-associated gene 1	615693				
11.852	3	23	14	11q23.1	COLCA2		Colorectal cancer-associated gene 2	615694		opposite strand from COLCA1		
11.853	8	20	08	11q23	CRCS7		Colorectal cancer, susceptibility to, 7	612232		associated with rs3802842	{Colorectal cancer, susceptibility to, 7} (2)	
11.854	07	10	20	11q23.3	DSCAML1, KIAA1132, DSCAM2		DS cell adhesion molecule-like 1	611782				9(Dscaml1)
11.855	8	3	12	11q24.2	EI24, PIG8, EPG4		Etoposide-induced 1.4 mRNA	605170				9(Ei24)
11.856	11	1	00	11q23.3	FXYD2, ATP1G1, HOMG2		FXYD domain-containing ion transport regulator 2 (sodium-potassium-ATPase, gamma polypeptide)	601814			Hypomagnesemia 2, renal, 154020 (3)	
11.857	11	21	00	11q23	GTS		Gilles de la Tourette syndrome	137580		several loci suspected (e.g., 17q25)	Tourette syndrome (2)	
11.858	3	7	13	11q13.4	INPPL1, OPSMD		Inositol polyphosphate phosphatase-like 1	600829			Opsismodysplasia, 258480 (3)	
11.859	03	09	20	11q23.3	KMT2A, MLL, HRX, WDSTS		Lysine (K)-specific methyltransferase 2E	159555		fuses with ENL, AF4, AF9, GMPS	Wiedemann-Steiner syndrome, 605130 (3)	9(All1)
11.860	5	4	12	11q23.3	MFRP, MCOP5, NNO2		Membrane-type frizzled-related protein	606227			Microphthalmia, isolated 5, 611040 (3); Nanophthalmos 2, 609549 (3)	
11.861	3	31	03	11q22.2	MMP3, STMY1, CHDS6		Matrix metalloproteinase 3 (stromelysin 1, progelatinase)	185250			{Coronary heart disease, susceptibility to, 6}, 614466 (3)	
11.862	6	7	10	11q23	NAFLD2		Fatty liver disease, nonalcoholic, susceptibility to, 2	613387		associated with rs2854116, rs2854117	{Fatty liver disease, nonalcoholic, susceptibility to, 2} (2)	
11.863	10	2	98	11q23.3	PAFAH1B2		Platelet-activating factor acetylhydrolase, isoform Ib, beta subunit	602508				
11.864	1	5	07	11q23.3	PDZD3, IKEPP		PDZ domain-containing 3	607146				
11.865	8	22	07	11q22.3	RDX, DFNB24		Radixin	179410			Deafness, autosomal recessive 24, 611022 (3)	
11.866	7	20	01	11q23.3	RNF26		RING finger protein-26	606130				
11.867	08	24	20	11q23.3	SCN2B, ATFB14		Sodium voltage-gated channel, beta subunit 1	601327			Atrial fibrillation, familial, 14, 615378 (3)	9(Scn2b)
11.868	08	24	20	11q23.3	SCN4B, LQT10, ATFB17		Sodium voltage-gated channel, beta subunit 4	608256			Long QT syndrome 10, 611819 (3); Atrial fibrillation, familial, 17, 611819 (3)	
11.869	07	28	18	11q23.1	SDHD, PGL1		Succinate dehydrogenase complex, subunit D, integral membrane protein	602690			Paragangliomas 1, with or without deafness, 168000 (3); Pheochromocytoma, 171300 (3); Paraganglioma and gastric stromal sarcoma, 606864 (3); Mitochondrial complex II deficiency, 252011 (3)	
11.870	5	19	09	11q23.3	SLC37A4, G6PT1		Solute carrier family 37 (glucose-6-phosphate transporter), member 4	602671			Glycogen storage disease Ib, 232220 (3); Glycogen storage disease Ic, 232240 (3)	
11.871	6	20	94	11q23	TCPT		Thrombocytopenia, Paris-Trousseau type (deletion 11q23 syndrome)	188025		contiguous gene deletion of 11q23	?Thrombocytopenia, Paris-Trousseau type (4)	
11.872	6	9	06	11q23.3	TMPRSS13, MSPL, MSPS		Transmembrane protease, serine 13	610050				
11.873	1	24	18	11q23.3	TREH, TREHD		Trehalase	275360			Trehalase deficiency, 612119 (3)	9(Treh)
11.874	12	31	99	11q23	TSG11		Tumor suppressor gene on chromosome 11	603040			{Nonsmall cell lung cancer} (2)	
11.875	2	7	07	11q23.2	USP28, KIAA1515		Ubiquitin-specific protease 28	610748				
11.876	7	20	12	11q24.2	VWA5A, LOH11CR2A, BCSC1		von Willebrand factor A domain-containing protein 5A	602929				
11.877	2	23	09	11q23-q24	ADIPQTL4		Adiponectin, serum level of, quantitative trait locus locus 4	612629		between D11S925 and D11S968	{Adiponectin, serum level of, QTL4} (2)	
11.878	3	29	16	11q24.2	SRPRA, SRPR, DP		Signal recognition particle receptor, alpha subunit	182180				
11.879	06	25	20	11q24.2	TIRAP, BACTS1		TIR domain-containing adaptor protein	606252			{Bacteremia, protection against}, 614382 (3); {Malaria, protection against}, 611162 (3); {Tuberculosis, protection against}, 607948 (3)	
11.880	09	09	19	11q24.2	ROBO3, RBIG1, RIG1, HGPPS1		Roundabout guidance receptor 3	608630			Gaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3)	
11.881	2	25	15	11q23.1	DIXDC1, CCD1, KIAA1735		DIX domain-containing protein 1	610493				
11.882	1	23	09	11q23.1	DLAT, PDCE2		Dihydrolipoamide S-acetyltransferase	608770			Pyruvate dehydrogenase E2 deficiency, 245348 (3)	
11.883	10	20	15	11q23.2	DRD2		Dopamine receptor D2	126450		11q22-q23 junction; 150kb 5' to NCAM; centromeric to APOA1; telomeric to STMY1		
11.884	10	23	87	11q23.1	EBVM1		Epstein-Barr virus modification site-1	132860				
11.885	3	9	00	11q23.2	HTR3B		5-hydroxytryptamine receptor 3B	604654				
11.886	04	07	20	11q23.1	LAYN		Layilin	618843				
11.887	3	23	14	11q23.1	MIR34B		Micro RNA 34B	611374				
11.888	4	2	16	11q23.1	MIR34C		Micro RNA 34C	611375				
11.889	8	20	98	11q23.2	NCAM1, MSK39		Neural cell adhesion molecule 1	116930		defective in "staggerer" in mice		9(Ncam)
11.890	10	4	05	11q23.2	NNMT		Nicotinamide N-methyltransferase	600008			Homocysteine plasma level (2)	
11.891	4	23	96	11q23.1	POU2AF1, OBF1		POU domain, class 2, associating factor 1	601206				
11.892	8	21	12	11q23.1	SIK2, KIAA0781		Salt-inducible kinase 2	608973				
11.893	04	27	20	11q23.1	TIMM8B, DDP2		Translocase of inner mitochondrial membrane 8B	606659				
11.894	12	4	08	11q23.2	ZBTB16, ZNF145, PLZF		Zinc finger- and BTB domain-containing protein 16 (promyelocytic leukemia zinc finger)	176797		fused with RARA in APL of t(11;17) type	Leukemia, acute promyelocytic, PL2F/RARA type (3); Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3)	9(lu)
11.895	12	9	95	11q23.2	HTR3		5-hydroxytryptamine (serotonin) receptor-3	182139				
11.896	12	18	08	11q23.2	RBM7		RNA-binding motif protein 7	612413				
11.897	9	28	05	11q23.2	REXO2, RFN		RNA exonuclease 2, S. cerevisiae, homolog of	607149				
11.898	10	25	19	11q23.1-q23.2	ZNF123P, ZNF123		Zinc finger protein 123, pseudogene	194630				
11.899	3	23	93	11q23.1-q23.2	ZNF125		Zinc finger protein-125 (HZF-3)	194632				
11.900	5	23	18	11q23.2	ANKK1		Ankyrin repeat and kinase domain containing 1	608774				
11.901	5	14	09	11q23.1	C11orf34, PLET1		Chromosome 11 open reading frame 34	611904				9(Plet1)
11.902	6	28	17	11q23.3	CADM1, IGSF4, TSLC1		Cell adhesion molecule 1	605686				
11.903	10	10	18	11q23.2	NXPE4, C11orf33		Neurexophilin and PC-esterase domain family, member 4	618133				
11.904	5	28	99	11q23.3	TAGLN, SMCC, SM22		Transgelin	600818				9(Tagln)
11.905	03	06	20	11q23.2	TTC12, TPARM, CILD45		Tetratricopeptide repeat domain 12	610732			Ciliary dyskinesia, primary, 45, 618801 (3)	
11.906	04	27	20	11q23.2	ZW10		ZW10 kinetochore protein	603954				
11.907	3	2	98	11q23.3	H2AX		H2AX histone	601772				
11.908	7	26	16	11q24.1	SORL1, LR11, SORLA		Sortilin-related receptor, L(DLR class) A repeats-containing	602005				
11.909	5	22	03	11q23.3	ABCG4, WHITE2		ATP-binding cassette, subfamily G, member 4	607784				9(Abcg4)
11.910	10	25	16	11q23.3	ARCN1, SRMMD		Archain 1	600820		60kb telomeric to MLL	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay, 617164 (3)	
11.911	6	25	15	11q23.3	ARHGEF12, LARG, KIAA0382		Rho guanine nucleotide exchange factor 12, leukemia-associated	604763		fused with MLL in AML		
11.912	2	20	01	11q23.3	BACE1, BACE		Beta-site amyloid beta A4 precursor protein-cleaving enzyme (secretase, beta; memapsin 2)	604252				
11.913	10	3	11	11q23.3	BACE1AS		BACE1 antisense RNA	614263				
11.914	11	2	04	11q23.3	BCL9L		B-cell CLL/lymphoma 9-like	609004				
11.915	5	31	05	11q23.3	C1QTNF5, CTRP5, LORD		C1q- and tumor necrosis factor-related protein 5	608752			Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	
11.916	12	23	19	11q23.3	CBL, CBL2, NSLL		CBL protooncogene	165360		mutation identified in 1 JMML family	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3); ?Juvenile myelomonocytic leukemia, 607785 (3)	9(Cbl2)
11.917	8	2	17	11q23.3	C2CD2L, TMEM24		C2 calcium-dependent domain-containing protein 2-like	617582				
11.918	10	4	12	11q23.3	CEP164, KIAA1052		Centrosomal protein, 164kD	614848			Nephronophthisis 15, 614845 (3)	
11.919	9	9	08	11q23.3	CXCR5, BLR1		Chemokine, CXC motif, receptor 5	601613				
11.920	07	14	20	11q23.3	DDX6, HLR2, IDDILF		DEAD-box helicase 6	600326			Intellectual developmental disorder with impaired language and dysmorphic facies, 618653 (3)	9(Ddx6)
11.921	4	30	15	11q23.3	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13		Dolichyl-phosphate N-acetylglucosamine phosphotransferase	191350			Congenital disorder of glycosylation, type Ij, 608093 (3); Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	17(Dpagt2)
11.922	1	13	93	11q24.3	ETS1		Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1	164720		shown by HSR; 19cM distal to THY1; Ewing sarcoma breakpoint region-2 splices to EWSR1		9(Ets1, Fli1)
11.923	4	29	14	11q23.3	FOXR1, FOXN5		Forkhead box R1	615755				
11.924	10	25	19	11q23.3	HINFP, MIZF		Histone H4 transcription factor	607099				
11.925	7	18	12	11q23.3	HDLCQ14, HYLAP		High density lipoprotein cholesterol level quantitative trait locus 14	605201			High density lipoprotein cholesterol level QTL14 (2)	
11.926	1	13	06	11q23.3	HMBS, PBGD, UPS		Hydroxymethylbilane synthase	609806			Porphyria, acute intermittent, 176000 (3); Porphyria, acute intermittent, nonerythroid variant, 176000 (3)	9(Ups)
11.927	12	27	18	11q23.3	HYOU1, IMD59		Hypoxia-upregulated 1	601746		mutation identified in 1 IMD59 patient	?Immunodeficiency 59 and hypoglycemia, 233600 (3)	
11.928	1	12	11	11q23.3	IL10RA, IL10R, IBD28		Interleukin-10 receptor, alpha	146933			Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)	
11.929	5	24	13	11q23.3	LRRC35, EL		Leucine-rich repeat-containing protein 35	610451				
11.930	6	18	12	11q23.3	MCAM, MUC18, CD146		Melanoma adhesion molecule	155735				
11.931	1	2	08	11q23.3	MPZL3		Myelin protein zero-like 3	611707				9(Mpzl3)
11.932	5	23	16	11q23.3	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1		Nectin 1	600644			Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3); Orofacial cleft 7, 225060 (3)	
11.933	4	23	08	11q23.3	NLRX1, NOD9, CLR11.3		NLR family member X1	611947				
11.934	8	3	12	11q23.3	PCSK7, PC8, PC7, LPC		Proprotein convertase, subtilisin/kexin-type, 7	604872				
11.935	7	16	09	11q23.3	PHLDB1, LL5A, KIAA0638		Pleckstrin homology-like domain, family B, member 1	612834				
11.936	12	4	02	11q23.3	POU2F3, OCT11		POU domain, class 2, transcription factor 3	607394				9(Oct11)
11.937	3	18	94	11q23.3	RPS25		Ribosomal protein S25	180465				
11.938	09	27	20	11q23.3-q24.1	SC5D, ERG3		Sterol C5-desaturase	602286			Lathosterolosis, 607330 (3)	
11.939	08	24	20	11q24.1	SCN3B, SCNB3, BRGDA7, ATFB16		Sodium voltage-gated channel, beta subunit 3	608214			Brugada syndrome 7, 613120 (3); Atrial fibrillation, familial, 16, 613120 (3)	
11.940	8	29	17	11q23.3	SIDT2		SID1 transmembrane family, member 2	617551				9(Sidt2)
11.941	11	05	18	11q23.3	SIK3, KIAA0999, SEMDK		Salt-inducible kinase 3	614776		mutation identified in 1 SEMDK family	?Spondyloepimetaphyseal dysplasia, Krakow type, 618162 (3)	
11.942	09	01	20	11q24.2	STT3A, ITM1, TMC		STT3A, subunit of the oligosaccharyltransferase complex (catalytic)	601134			Congenital disorder of glycosylation, type Iw, 615596 (3)	9(Itm1)
11.943	7	4	95	11q23.3	THY1		Thy-1 T-cell antigen	188230				9(Thy1)
11.944	4	26	11	11q23.3	TMEM25		Transmembrane protein 25	613934				9(Tmem25)
11.945	12	17	01	11q23.3	TMPRSS4		Transmembrane protease, serine 4	606565				
11.946	3	3	03	11q23.2	TMPRSS5		Transmembrane protease, serine 5	606751				
11.947	02	18	20	11q23.3	TRAPPC4, NEDESBA		Trafficking protein particle complex, subunit 4 (synbindin)	610971			Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy, 618741 (3)	
11.948	9	27	17	11q23.3	TRIM29, ATDC		Tripartite motif-containing protein 29	610658				
11.949	3	17	08	11q23.3	UPK2, UP2, UPII		Uroplakin 2	611558				
11.950	12	27	19	11q23.3	VPS11, HLD12		VPS11 core subunit of CORVET and HOPS complexes	608549			Leukodystrophy, hypomyelinating, 12, 616683 (3)	
11.951	6	25	99	11q24.1	ZNF202		Zinc finger protein-202	603430				
11.952	12	21	15	11q23.3	ZPR1, ZNF259		ZPR1 zinc finger protein	603901				
11.953	7	12	02	11q23.3-q24	AAT1, FAA1		Aortic aneurysm, familial thoracic 1	607086			Aortic aneurysm, familial thoracic 1 (2)	
11.954	08	05	20	11q23.3-q25	JBS		Jacobsen syndrome	147791		contiguous gene deletion syndrome	Jacobsen syndrome (4)	
11.955	10	4	95	11q24.1	HSPA8, HSP73		Heat-shock 70kD protein-8 (HSP73)	600816				
11.956	10	24	00	11q24.3	APLP2		Amyloid beta (A4) precursor-like protein-2	104776				9(Aplp2)
11.957	5	5	17	11q24.3	FLI1, BDPLT21		Friend leukemia virus integration 1	193067		fused with EWS in Ewing sarcoma	Bleeding disorder, platelet-type, 21, 617443 (3)	
11.958	4	3	03	11q24.2	GRTH		Gonadotropin-regulated testicular RNA helicase	607663				9(Grth)
11.959	5	23	11	11q24.2	HEPACAM, MLC2A, MLC2B		Hepatocyte cell adhesion molecule	611642			Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3); Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)	
11.960	8	23	04	11q24.3	KCNJ1, ROMK1		Potassium inwardly-rectifying channel, subfamily J, member 1	600359			Bartter syndrome, type 2, 241200 (3)	
11.961	6	11	11	11q24.3	KCNJ5, GIRK4, KATP1, LQT13		Potassium inwardly-rectifying channel, subfamily J, member 5	600734			Long QT syndrome 13, 613485 (3); Hyperaldosteronism, familial, type III, 613677 (3)	9(Girk4)
11.962	4	21	01	11q24	MGR9		Migraine with aura, susceptibility to, 9	609670		max lod at GATA64D03	{Migraine with aura, susceptibility to, 9} (2)	
11.963	10	14	18	11q23.3	MPZL2, EVA1, EVA, DFNB111		Myelin protein zero-like 2	604873			Deafness, autosomal recessive 111, 618145 (3)	9(Eva)
11.964	10	7	05	11q24	NEDE		Nephropathy, progressive, with deafness	609469		max lod at D11S4464	Nephropathy, progressive, with deafness (2)	
11.965	6	19	98	11q24.2	NRGN		Neurogranin	602350				9(Nrgn)
11.966	4	18	02	11q24.2	PATE		Prostate- and testis-expressed gene	606861				
11.967	1	26	12	11q24.2	SIAE, AIS6		Sialic acid acetylesterase	610079			{Autoimmune disease, susceptibility to, 6}, 613551 (3)	
11.968	6	22	14	11q24.3	TP53AIP1, P53AIP1		Tumor protein p53-regulated apoptosis-inducing protein 1	605426				
11.969	7	10	08	11q24-q25	ANIB7		Aneurysm, intracranial berry, 7	612161		between rs618176 and rs1940033	Aneurysm, intracranial berry, 7 (2)	
11.970	10	21	92	11q24.3	NFRKB		Nuclear factor related to kappa B-binding protein	164013		most telomeric 11q marker		
11.971	10	2	09	11q24.2	PKNOX2, PREP2		PBX/Knotted 1 homeobox 2	613066				
11.972	4	10	14	11q24.3	ST14, MTSP1, ARCI11		Suppression of tumorigenicity 14	606797			Ichthyosis, congenital, autosomal recessive 11, 602400 (3)	
11.973	9	24	08	11q24.1	BLID, BRCC@		BH3-like motif-containing cell death inducer	608853		distal to SORL1		
11.974	8	21	07	11q24.1	BSX1		Brain-specific homeobox, mouse, homolog of	611074				9(Bsx)
11.975	1	27	09	11q24.1	CLLS5		Leukemia, chronic lymphocytic susceptibility to, 5	612559		associated with rs735665	{Leukemia, chronic lymphocytic susceptibility to, 5} (2)	
11.976	5	24	13	11q24.1	CLMP, ASAM, ACAM, CSBS		Coxsackievirus- and adenovirus receptor-like membrane protein	611693			Congenital short bowel syndrome, 615237 (3)	9(Clmp)
11.977	7	30	18	11q24.1	JHY, C11orf63		Jhy, mouse, homology of	617594				9(Jhy)
11.978	12	21	09	11q24.1	MIR100, MIRN100		Micro RNA 100	613186				
11.979	9	20	14	11q24.1	MIR100HG, AGD1		MIR100-LET7A2 cluster host gene, noncoding	615965				
11.980	3	23	09	11q24.1	MIR125B1, MIRN125B1		Micro RNA 125B-1	610104				
11.981	3	23	09	11q24.1	MIRLET7A2, LET7A2, MIRNLET7A2		Micro RNA let7a2	612142				
11.982	7	14	14	11q24.3	SENCR, lncRNA9		Smooth muscle- and endothelial cell-enriched migration/differentiation-associated long noncoding RNA	615815				
11.983	7	10	08	11q24.1	UBASH3B, STS1, KIAA1959, P70		Ubiquitin-associated and SH3 domain-containing protein B	609201				
11.984	9	21	11	11q24.2	CDON, CDO, HPE11		Cell adhesion molecule-related/downregulated by oncogenes	608707			Holoprosencephaly 11, 614226 (3)	
11.985	7	13	15	11q24.2	DCPS, HINT5, DCS1, ARS		Decapping enzyme, scavenger	610534			Al-Raqad syndrome, 616459 (3)	
11.986	10	10	11	11q24.2	ESAM		Endothelial cell adhesion molecule	614281				
11.987	10	13	15	11q24.2	FAM118B		Family with sequence similarity 118, member B	616587				
11.988	11	16	11	11q24.2	FEZ1		Fasciculation and elongation protein zeta 1	604825				
11.989	12	13	18	11q24.2	FOXRED1, MC1DN19		FAD-dependent oxidoreductase domain-containing protein 1	613622			Mitochondrial complex I deficiency, nuclear type 19, 618241 (3)	
11.990	12	18	07	11q24.2	HEPN1		Cancer susceptibility gene HEPN1	611641				
11.991	1	10	07	11q24.2	HYLS1, FLJ32915		HYLS1 gene	610693			Hydrolethalus syndrome, 236680 (3)	
11.992	04	08	20	11q24.2	KIRREL3, NEPH2, KIAA1867, KIRRE		Kirre-like nephrin family adhesion molecule 3	607761				
11.993	4	25	18	11q24.2	MRD4		Mental retardation, autosomal dominant 4	612581		translocation t(11;16)(q24.2;q24)	Mental retardation, autosomal dominant 4 (2)	
11.994	11	2	14	11q24.2	PANX3, PX3		Pannexin 3	608422				
11.995	11	24	20	11q24.2	PUS3, MRT55, NEDMIGS		Pseudouridylate synthase 3	616283			Neurodevelopmental disorder with microcephaly and gray sclerae, 617051 (3)	
11.996	09	09	19	11q24.2	ROBO4, AOVD3		Roundabout guidance receptor 4	607528			Aortic valve disease 8, 618496 (3)	
11.997	11	12	17	11q24.2	RPUSD4		RNA pseudouridylate synthase domain-containing protein 4	617488				
11.998	7	14	14	11q24.2	ST3GAL4, SIAT4C, SIAT4, CGS23, NANTA3		ST3 beta-galactoside alpha-2,3-sialyltransferase 4	104240				
11.999	11	30	06	11q24.2	TBRG1, NIAM		Transforming growth factor-beta regulator 1	610614				
11.1000	9	27	17	11q24.2	VSIG2, CTXL		V-set and immunoglobulin domains-containing protein 2	606011				
11.1001	09	26	19	11q24.3	ADAMTS15		ADAM metallopeptidase domain with thrombospondin type 1 motif, 15	607509				
11.1002	12	10	12	11q24.3	ARHGAP32, RICS, GRIT, p200RHOGAP, p250GAP		Rho GTPase activating protein 32	608541				
11.1003	02	08	19	11q24.3	PRDM10, TRIS, KIAA1231		PR domain-containing protein 10	618319				
11.1004	8	30	07	11q25	ACAD8		Acyl-CoA dehydrogenase family, member 8	604773			Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)	
11.1005	09	26	19	11q24.3	ADAMTS8, METH2		ADAM metallopeptidase domain with thrombospondin type 1 motif, 8	605175				9(Adamts8)
11.1006	4	17	07	11q25	B3GAT1, GLCATP, CD57, HNK1		Beta-1,3-glucuronyltransferase 1	151290				
11.1007	1	29	01	11q24.3	BARX2		BarH-like homeo box gene 2	604823				
11.1008	2	24	11	11q25	IGSF9B, KIAA1030		Immunoglobulin superfamily, member 9B	613773				
11.1009	2	11	11	11q25	JAM3		Junctional adhesion molecule 3	606871			Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)	
11.1010	5	17	18	11q25	NCAPD3, CAPD3, KIAA0056, MCPH22		Non-SMC condensin II complex subunit D3	609276			Microcephaly 22, primary, autosomal recessive, 617984 (3)	
11.1011	1	11	07	11q25	NTM, HNT		Neurotrimin	607938				9(Ntm)
11.1012	02	12	19	11q25	OPCML		Opioid-binding protein/cell adhesion molecule-like	600632			Ovarian cancer, somatic, 167000 (3)	9(Obcam)
11.1013	12	23	05	11q25	SPATA19		Spermatogenesis-associated protein 19	609805				
11.1014	2	8	11	11q25	THYN1, HSPC144, THY28		Thymocyte nuclear protein 1	613739				
11.1015	12	27	19	11q25	VPS26B		VPS26 retromer complex component B	610027				9(Vps26b)
11.1016	10	20	99	11q25-qter	DFNB20		Deafness, autosomal recessive 20	604060			Deafness, autosomal recessive 20 (2)	
11.1017	4	2	01	11q13.2	ALDH3B1, ALDH7		Aldehyde dehydrogenase 3 family, member B1	600466				
11.1018	7	9	01	Chr.11	AOCH		Acromegaloid features, overgrowth, cleft palate, and hernia	606049		pericentric inversion (46,XY,inv(11)(p15.3;q23.3))	Acromegaloid features, overgrowth, cleft palate, and hernia (2)	
11.1019	4	2	01	11q13.2	ALDH3B2, ALDH8		Aldehyde dehydrogenase 3 family, member B2	601917				
11.1020	7	3	88	11q12.2	CD6, TP120		CD6 antigen	186720				
11.1021	4	28	99	11p11.2	CRY2		Cryptochrome 2	603732				2(Cry2)
11.1022	2	20	01	11q13.2	FBXL11, FBL11		F-box and leucine-rich repeat protein-11	605657				
11.1023	2	21	02	11q23.3	FXYD6		FXYD domain-containing ion transport regulator 6	606683				
11.1024	3	11	03	11p15.4	IPO7, RANBP7		Importin 7	605586				
11.1025	2	28	01	11p15.4	LYVE1		Lymphatic vessel endothelial hyaluronan receptor 1	605702				
11.1026	5	7	01	11q13.1	SART1, HOMS1		Squamous cell carcinoma antigen recognized by T cells 1	605941				
11.1027	2	5	01	11q13.1	SF3B2, SF3B145, SAP145		Splicing factor 3B, subunit 2	605591				
11.1028	1	29	01	11q13.4	SLC21A9, OATPB		Solute carrier family 21 (organic anion transporter), member 9	604988				
11.1029	2	27	03	11q12.3	SLC22A8, OAT3		Solute carrier family 22 (organic anion transporter), member 8	607581				
11.1030	1	29	01	11p15.2	SPON1		F-spondin, Rat, homolog of	604989				
11.1031	5	7	03	11p11.2	SYT13, KIAA1427		Synaptotagmin 13	607716				
11.1032	3	29	01	11q23.1	TEX12		Testis-expressed gene 12	605791				
11.1033	6	6	00	11q23.3	UBE4A, UFD2, E4		Ubiquitination factor E4A	603753				
12.1	1	24	06	12p13.33	DCP1B, DCP1		Decapping enzyme 1, S. cerevisiae, homolog of	609843				
12.2	6	13	12	12p13.33	FBXL14, FBL14		F-box and leucine-rich repeat protein 14	609081				6(Fbxl14)
12.3	4	20	17	12p13.33	ITFG2, FGGAP1		Integrin-alpha FG-GAP repeat-containing protein 2	617421				
12.4	12	11	18	12p13.32	C12orf4		Chromosome 12 open reading frame 4	616082			Mental retardation, autosomal recessive 66, 618221 (3)	
12.5	12	18	14	12p13.33	RHNO1, RHINO, C12orf32		Rad9-, Rad1-, and Hus1-interacting nuclear orphan 1	614085				
12.6	4	10	12	12p13.33	FKBP4, FKBP52		FK506-binding protein 4	600611				
12.7	6	30	08	12p13.33	IQSEC3, KIAA1110		IQ motif- and SEC7 domain-containing protein 3	612118				
12.8	4	8	13	12p13.32	DYRK4		Dual-specificity tyrosine phosphorylation-regulated kinase 4	609181				
12.9	9	6	11	12p13.32	EFCAB4B, CRACR2A		EF-hand calcium-binding domain-containing protein 4B	614178				
12.10	2	22	92	12p13.31	LAG3		Lymphocyte activation gene-3	153337				
12.11	12	21	09	12p13.33-p13.32	TSPAN9, NET5		Tetraspanin 9	613137				
12.12	12	1	11	12p13.31	ACSM4		Acyl-CoA synthetase medium-chain family, member 4	614360				
12.13	1	4	12	12p13.33	ADIPOR2, FLJ21432		Adiponectin receptor 2	607946				6(Adipor2)
12.14	07	17	19	12p13.31	ATN1, DRPLA, HRS, NOD, CHEDDA		Atrophin 1	607462			Dentatorubral-pallidoluysian atrophy, 125370 (3); Congenital hypotonia, epilepsy, developmental delay, and digital anomalies, 618494 (3)	6(Drpla)
12.15	7	6	18	12p13.31	A2ML1, OMS		Alpha-2-macroglobulin-like 1	610627			{Otitis media, susceptibility to}, 166760 (3)	
12.16	11	2	04	12p13.31	C1RL, CLSPA, C1RLP		Complement component C1r-like protein	608974				
12.17	11	11	14	12p13.31	C3AR1, C3AR		Complement component 3a receptor 1	605246				
12.18	5	23	11	12p13.31	CD4		CD4 antigen (p55)	186940		CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens	OKT4 epitope deficiency, 613949 (3)	6(Ly4)
12.19	1	13	09	12p13.31	CLEC2A		C-type lectin domain family 2, member A	612087				
12.20	9	24	08	12p13.2	CLEC9A, DNGR1		C-type lectin domain family 9, member A	612252				
12.21	2	12	14	12p13.31	CLECL1, DCAL1		C-type lectin-like 1	607467				
12.22	9	22	14	12p13.31	COPS7A, CSN7		COP9 signalosome, subunit 7A	616009				
12.23	1	27	04	12p13.31	DPPA3		Developmental pluripotency-associated gene 3	608408				6(Dppa3)
12.24	9	30	09	12p13.31	FAM90A1		Family with sequence similarity 90, member A1	613041		other family members on chr. 8		
12.25	2	25	15	12p13.31	IFFO1		Intermediate filament family orphan 1	610495				
12.26	3	15	04	12p13.31	ING4		Inhibitor of growth-4	608524				
12.27	03	16	20	12p13.31	KLRF2		Killer cell lectin-like receptor F2	618814				
12.28	3	23	14	12p13.31	KLRG1, MAFA, MAFAL		Killer cell lectin-like receptor, subfamily G, member 1	604874				6(Klrg1)
12.29	10	25	16	12p13.31	LPCAT3, MBOAT5, NESSY		Lysophosphatidylcholine acyltransferase 3	611950				
12.30	3	23	09	12p13.31	MIR141, MIRN141		Micro RNA 141	612093				
12.31	3	23	09	12p13.31	MIR200C, MIRN200C		Micro RNA 200C	612092				
12.32	6	13	12	12p13.31	NANOG		Homeobox transcription factor NANOG	607937				6(Nanog)
12.33	5	27	18	12p13.31	NCAPD2, CNAP1, KIAA0159, MCPH21		Non-SMC condensin I complex subunit D2	615638		mutation identified in 1 MCPH21 patient	?Microcephaly 21, primary, autosomal recessive, 617983 (3)	
12.34	10	23	20	12p13.31	NECAP1, DEE21		NECAP endocytosis-associated protein 1	611623			Developmental and epileptic encephalopathy 21, 615833 (3)	
12.35	9	23	13	12p13.31	PHC1, EDR1, HPH1, RAE28, MCPH11		Polyhomeotic-like 1	602978		mutations identified in 1 family	?Microcephaly 11, primary, autosomal recessive, 615414 (3)	
12.36	11	3	14	12p13.31	PIANP, PANP, LEDA1		PILR-alpha-associated neural protein	616065				
12.37	4	24	18	12p13.31	PLEKHG6, MYOGEF		Pleckstrin homology domain- and RhoGEF domain-containing protein G6	611743				
12.38	7	8	11	12p13.31	PTMS		Parathymosin	168440		previously assigned to 17q12-q22		
12.39	2	28	08	12p13.31	RBP5, CRBP3		Retinol-binding protein 5	611866				
12.40	7	1	11	12p13.31	RIMKLB, NAAGS		Ribosomal modification protein RimK-like family, member B	614054				
12.41	2	16	18	12p13.31	RNU7-1, RNU7		RNA, U7 small nuclear, 1	617876				6(Rnu7-1)
12.42	3	7	13	12p13.31	SCARNA10		Small cajal body-specific RNA 10	615639		in intron 4 of NCAPD2		
12.43	2	25	14	12p13.31	SCARNA12		Small Cajal body-specific RNA 12	615642				
12.44	12	18	07	12p13.31	SPSB2, SSB2		SPRY domain- and SOCS box-containing 2	611658				
12.45	02	18	19	12p13.31	VAMP1, SYB1, SPAX1, CMS25		Vesicle-associated membrane protein-1 (synaptobrevin-1)	185880			Spastic ataxia 1, autosomal dominant, 108600 (3); Myasthenic syndrome, congenital, 25, 618323 (3)	6(Syb1)
12.46	10	5	10	12p13.31	CLEC6A, CLEC4N		C-type lectin domain family 6, member A	613579				
12.47	10	23	87	12p13.31	GAPDH, GAPD		Glyceraldehyde-3-phosphate dehydrogenase	138400		pseudogene on Xp21-q11		6(Gapd)
12.48	9	2	08	12p13.33	B4GALNT3		Beta-1,4-N-acetylgalactosaminyltransferase 3	612220				
12.49	06	06	19	12p13.33	CACNA1C, CACNL1A1, CCHL1A1, TS. LQT8		Calcium channel, voltage-dependent, L type, alpha 1C subunit	114205			Timothy syndrome, 601005 (3); Brugada syndrome 3, 611875 (3); Long QT syndrome 8, 618447 (3)	
12.50	10	11	06	12p13.33	CACNA2D4, RCD4		Calcium channel, voltage-dependent, alpha-2/delta subunit 4	608171			Retinal cone dystrophy 4, 610478 (3)	
12.51	1	23	01	12p13.31	CD163		CD163 antigen (hemoglobin scavenger receptor)	605545				
12.52	9	30	09	12p13.31	CD164L1, CD163B, M160		CD164 antigen-like 1	606079				
12.53	03	10	20	12p13.32	FGF23, ADHR, HPDR2, PHPTC, HFTC2		Fibroblast growth factor 23	605380			Hypophosphatemic rickets, autosomal dominant, 193100 (3); Tumoral calcinosis, hyperphosphatemic, familial, 2, 617993 (3)	6(Fgf23)
12.54	1	27	04	12p13.32	GALNT8		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8	606250				
12.55	1	2	03	12p13.1	GPRC5D		G protein-coupled receptor, family C, group 5, member D	607437				
12.56	10	30	08	12p13.3	MAFD9		Major affective disorder 9	612372		associated with rs1006737	{Major affective disorder-9, susceptibility to} (2)	
12.57	12	23	15	12p13.32	PARP11, ARTD11		Poly(ADP-ribose) polymerase family, member 11	616706				
12.58	12	23	15	12p13.31	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5		Peroxisome biogenesis factor 5	600414			Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3); Peroxisome biogenesis disorder 2B, 202370 (3); Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	
12.59	4	6	15	12p13.32	PRMT8, HRMT1L3, HRMT1L4		Protein arginine methyltransferase 8	610086				6(Prmt8)
12.60	11	28	94	12p13.31	SLC2A3, GLUT3		Solute carrier family 2 (facilitated glucose transporter), member 3	138170		pseudogene SLC2A3P on 5q34		
12.61	8	20	07	12p13.31	SLC2A14, GLUT14		Solute carrier family 2 (facilitated glucose transporter), member 14	611039				
12.62	3	14	13	12p13.33	SLC6A13, GAT2, GAT3		Solute carrier family 6 (neurotransmitter transporter, GABA), member 13	615097				
12.63	7	2	02	12p13.31	TAPBPR		TAP-binding protein-related protein	607081				
12.64	2	20	07	12p13.32	TIGAR, C12orf5		TP53-induced glycolysis and apoptosis regulator	610775				
12.65	10	4	10	12p13.31	VWF, F8VWF		Coagulation factor VIII VWF (von Willebrand factor)	613160		pseudogene on chr. 22	von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3); von Willebrand disease, type 1, 193400 (3); von Willebrand disease, type 3, 277480 (3)	6(Vwf)
12.66	11	4	04	12p13.33	WNT5B		Wingless-type MMTV integration site family, member 5B	606361				
12.67	10	15	98	12p13.33	TEAD4, TCF13L1, RTEF1		TEA domain family, member 4	601714				6(Tcf13l1)
12.68	03	10	20	12p13.31	A2M		Alpha-2-macroglobulin	103950		cluster of genes	{Alzheimer disease, susceptibility to}, 104300 (3)	6(A2m)
12.69	3	5	08	12p13.31	MRPL51, MRP64		Mitochondrial ribosomal protein L51	611855				
12.70	12	28	15	12p13.2	LRP6, ADCAD2, STHAG7		Low density lipoprotein receptor-related protein 6	603507			{Coronary artery disease, autosomal dominant, 2}, 610947 (3); Tooth agenesis, selective, 7, 616724 (3)	6(Lrp6)
12.71	12	24	08	12p13.1	APOLD1, VERGE		Apolipoprotein L domain-containing 1	612456				
12.72	10	23	15	12p13.2	BORCS5, LOH12CR1, MYRLYSIN		BLOC1-related complex, subunit 5	616598				
12.73	7	13	17	12p13.2	CLEC12B		C-type lectin domain family 12, member B	617573				6(Clec12b)
12.74	3	27	90	12p13.2	PRB1		Proline-rich protein BstNI, subfamily-1	180989				
12.75	3	27	90	12p13.2	PRB2		Proline-rich protein BstNI, subfamily-2 (parotid size variant)	168810		Ps allele		
12.76	3	27	90	12p13.2	PRB3		Proline-rich protein BstNI, subfamily-3 (parotid salivary glycoprotein)	168840		G1 allele		
12.77	3	27	90	12p13.2	PRB4		Proline-rich protein BstNI, subfamily-4	180990		Po, CON1, CON2 alleles		
12.78	4	10	90	12p13.2	PRH1		Proline-rich protein HaeIII, subfamily-1	168730		Pa, Db, PIF alleles		
12.79	3	27	90	12p13.2	PRH2		Proline-rich protein HaeIII, subfamily-2	168790		Pr allele		
12.80	1	28	88	12p13.2	PCS		Parotid proline-rich salivary protein Pc	168710		linked to PRB2		
12.81	8	27	15	12p13.2	STYK1, NOK		Serine/threonine/tyrosine kinase 1	611433				
12.82	6	11	11	12p13.2	TAS2R20, T2R56		Taste receptor, type 2, member 20	613962				
12.83	6	27	11	12p13.2	TAS2R30, T2R30, T2R47		Taste receptor, type 2, member 30	613963		previously assigned to chr.1		
12.84	6	26	11	12p13.2	TAS2R45, T2R45		Taste receptor, type 2, member 45	613967				
12.85	3	23	09	12p13.2	TAS2R43, T2R52		Taste receptor, type 2, member 43	612668				
12.86	1	24	12	12p13.2	TAS2R31, TAS2R44, T2R53		Taste receptor, type 2, member 31	612669				
12.87	9	15	09	12p13.2	TAS2R46, T2R46, T2R54		Taste receptor, type 2, member 46	612774				
12.88	11	4	08	12p13.2	TAS2R50, T2R50, TAS2R51, T2R51		Taste receptor, type 2, member 50	609627				
12.89	9	7	12	12p13.31	TNFRSF1A, TNFR1, TNFAR, FPF, MS5		Tumor necrosis factor receptor superfamily, member 1A	191190			Periodic fever, familial, 142680 (3); {Multiple sclerosis, susceptibility to, 5}, 614810 (3)	6(Tnfr2)
12.90	11	12	07	12p13.32	RAD51AP1, PIR51		Rad51-associated protein 1	603070				6(Pir51)
12.91	2	15	02	12p13.31	CLEC4C, CLECSF11, DLEC, BDCA2		C-type lectin domain family 4, member C	606677				
12.92	9	8	11	12p13.2	CLEC7A, CLECSF12, DECTIN1, CANDF4		C-type lectin domain family 7, member A	606264		in natural killer gene complex	Candidiasis, familial, 4, autosomal recessive, 613108 (3); {Aspergillosis, susceptibility to}, 614079 (3)	
12.93	1	13	99	12p13.1	GPR19		G protein-coupled receptor-19	602927				
12.94	1	13	99	12p13.2	KLRC1, NKG2, NKG2A		Killer cell lectin-like receptor, subfamily C, member 1	161555		family of at least 3 genes on 12		6(Klrc1)
12.95	1	13	99	12p13.2	KLRC2, NKG2C		Killer cell lectin-like receptor, subfamily C, member 2	602891				
12.96	1	13	99	12p13.2	KLRC3, NKG2E		Killer cell lectin-like receptor, subfamily C, member 3	602892				
12.97	9	3	98	12p13.2	KLRC4, NKG2F, D12S2489E		Killer cell lectin-like receptor, subfamily C, member 4	602893				
12.98	1	13	99	12p13.2	KLRD1, CD94		Killer cell lectin-like receptor, subfamily D, member 1	602894				
12.99	1	29	01	12p13.31	KLRF1		Killer cell lectin-like receptor, subfamily F, member 1	605029				
12.100	2	26	08	12p13.2	KLRK1, NKG2D		Kill cell lectin-like receptor, subfamily K, member 1	611817				
12.101	7	18	06	12p13.2-p11.23	DFNB62		Deafness, autosomal recessive 62	610143		between D12S358 and D12S1042	Deafness, autosomal recessive 62 (2)	
12.102	1	6	97	12p13.2-q24.1	IBD2		Inflammatory bowel disease 2	601458		mainly ulcerative colitis	{Inflammatory bowel disease 2} (2)	
12.103	1	7	95	12p13.31	APOBEC1, BEDP		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1	600130				
12.104	11	22	10	12p13.1	ATF7IP, AM, MCAF, MCAF1		Activating transcription factor 7-interacting protein	613644				
12.105	1	22	99	12p13.2	CSDA, DBPA		Cold-shock domain protein A	603437				
12.106	07	14	20	12p13.1	DDX47		DEAD-box helicase 47	615428				
12.107	1	30	18	12p13.1	FAM234B, KIAA1467		Family with sequence similarity 234, member B	617838				
12.108	1	20	11	12p13.31	GDF3, KFS3, MCOPCB6, MCOP7		Growth differentiation factor 3	606522			Klippel-Feil syndrome 3, autosomal dominant, 613702 (3); Microphthalmia with coloboma 6, 613703 (3); Microphthalmia, isolated 7, 613704 (3)	
12.109	10	12	14	12p13.1	GNAI2P1, GNAI2L, GNAI2A		Guanine nucleotide-binding protein (G protein), alpha-inhibiting, polypeptide 2 pseudogene 1	139180				
12.110	2	8	13	12p12.3	HIST4H4		Histone gene cluster 4, H4 histone	615069				
12.111	1	8	15	12p13.31	MFAP5, MAGP2, AAT9		Microfibril-associated protein 5	601103			Aortic aneurysm, familial thoracic 9, 616166 (3)	
12.112	11	25	14	12p12.3	MGP		Matrix Gla protein	154870			Keutel syndrome, 245150 (3)	6(Mglap)
12.113	4	17	12	12p13.1	GPRC5A, RAI3, RAIG1		G protein-coupled receptor, family C, group 5, member A	604138				
12.114	12	23	19	12p13.1	PLBD1		Phospholipase B domain-containing protein 1	618486				
12.115	9	19	00	12p13.31	AICDA, AID, HIGM2		Activation-induced cytidine deaminase	605257			Immunodeficiency with hyper-IgM, type 2, 605258 (3)	
12.116	11	24	08	12p13.31	ANO2, TMEM16B, C12orf3		Anoctamin 2	610109				
12.117	10	29	16	12p13.31	C1R, EDSPD1		Complement component-1, r subcomponent	613785			Ehlers-Danlos syndrome, periodontal type, 1, 130080 (3)	
12.118	10	29	16	12p13.31	C1S, EDSPD2		Complement component-1, s subcomponent	120580			C1s deficiency, 613783 (3); Ehlers-Danlos syndrome, periodontal type, 2, 617174 (3)	
12.119	4	23	13	12p13.31	C12orf57, C10, TEMTYS		Chromosome 12 open reading frame 57	615140			Temtamy syndrome, 218340 (3)	6(C12orf57)
12.120	8	22	14	12p13.32	CCND2, MPPH3		Cyclin D2	123833			Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3)	
12.121	6	5	89	12p13.31	CD9, MIC3		CD9 antigen (p24)	143030				
12.122	5	22	07	12p13.1	CDKN1B, KIP1, CDKN4, MEN4		Cyclin-dependent kinase inhibitor 1B (p27, Kip1)	600778			Multiple endocrine neoplasia, type IV, 610755 (3)	7(Cdkn1b)
12.123	10	18	16	12p13.31	CHD4, SIHIWES		Chromodomain helicase DNA-binding protein-4	603277			Sifrim-Hitz-Weiss syndrome, 617159 (3)	
12.124	11	09	18	12p13.2	CLEC1A, CLEC1		C-type lectin domain family 1, member A	606782			{Aspergillosis, susceptibility to}, 614079 (3)	
12.125	3	26	02	12p13.3-p13.2	CLEC2B, CLEC2		C-type lectin domain family 1, member B	606783				
12.126	3	23	06	12p13.31	CLEC4D, CLECSF8, CLEC6		C-type lectin domain family 4, member D	609964				
12.127	3	24	06	12p13.31	CLEC2D, LLT1		C-type lectin domain family 2, member D	605659				
12.128	3	23	06	12p13.31	CLEC4E, MINCLE		C-type lectin domain family 4, member E	609962				6(Clec4e)
12.129	1	31	01	12p13.31	CLEC4A, CLECSF6, DCIR, DDB27		C-type lectin domain family 4, member A	605306				
12.130	6	27	08	12p13.31	CLEC12A, MICL		C-type lectin domain family 12, member A	612088				6(Clec12a)
12.131	3	23	13	12p13.31	CLSTN3, KIAA0726		Calsyntenin 3	611324				
12.132	6	25	99	12p13.1	CREBL2		Cyclic AMP response element-binding protein-like 2	603476				
12.133	07	13	20	12p13	DDX12P, CHLR2		DEAD/H-box helicase 12, pseudogene	601151				
12.134	10	10	19	12p13.31	EMG1, NEP1, C2F, BWCNS		EMG1 N1-specific pseudouridine methyltransferase	611531			Bowen-Conradi syndrome, 211180 (3)	
12.135	8	11	91	12p13.31	ENO2		Enolase-2, gamma, neuronal	131360				
12.136	2	13	15	12p13.2	ETV6, TEL, THC5		ETS variant gene-6 (TEL oncogene)	600618		fused to PDGFRB or AML1 in leukemia	Leukemia, acute myeloid, somatic, 601626 (3); Thrombocytopenia 5, 616216 (3)	
12.137	3	18	94	12p13.32	FGF6		Fibroblast growth factor-6	134921				
12.138	11	9	98	12p13.33	FOXM1, FKHL16, HFH11		Forkhead box M1	602341				
12.139	7	11	16	12p13.31	GNB3, CSNB1H		Guanine nucleotide-binding protein, beta polypeptide-3	139130			{Hypertension, essential, susceptibility to}, 145500 (3); Night blindness, congenital stationary, type 1H, 617024 (3)	6(Gnb3)
12.140	2	11	96	12p13.32	KCNA1, AEMK, EA1		Potassium voltage-gated channel, shaker-related subfamily, member 1	176260		close to VWF	Episodic ataxia/myokymia syndrome, 160120 (3)	6(Kcna1)
12.141	9	8	08	12p13.32	KCNA5, ATFB7		Potassium voltage-gated channel, shaker-related subfamily, member 5	176267			Atrial fibrillation, familial, 7, 612240 (3)	6(Kcna5)
12.142	3	17	94	12p13.32	KCNA6		Potassium voltage-gated channel, shaker-related subfamily, member 6	176257				6(Kcna6)
12.143	4	19	16	12p13.31	P3H3, LEPREL2		Prolyl 3-hydroxylase 3	610342				
12.144	8	21	98	12p12.3	LMO3, RBTNL2, RHOM3		LIM domain only 3 (rhombotin-like 2)	180386		expressed mainly in brain		
12.145	4	24	08	12p13.31	LPAR5, GPR92, GPR93, LPA5		Lysophosphatidic acid receptor 5	606926				
12.146	8	21	98	12p13.31	LTBR, TNFCR		Lymphotoxin-beta receptor (tumor necrosis factor C receptor)	600979		tightly linked to TNFR1 in mouse		6(Tnfcr)
12.147	12	4	95	12p13.31	M6PR		Mannose-6-phosphate receptor, cation-dependent	154540				6(Mprd)
12.148	8	29	96	12p13.31	MLF2		Myeloid leukemia factor-2	601401				
12.149	4	29	03	12p13.33	NINJ2		Nerve injury-induced protein 2	607297				
12.150	10	25	19	12p13.31	NOP2, NOL1		Nucleolar protein NOP2	164031				
12.151	6	21	91	12p13.31	NTF3		Neurotrophin-3	162660				6(Ntf3)
12.152	10	25	12	12p12.3	PDE6H, RCD3, ACHM6		Phosphodiesterase 6H, cGMP-specific, cone, gamma	601190			Retinal cone dystrophy 3, 610024 (3); Achromatopsia 6, 610024 (3)	
12.153	1	17	07	12p13.31	PHB2, REA		Prohibitin 2	610704				
12.154	12	30	14	Xp21.1	PRRG1, PRGP1		Proline-rich gamma-carboxyglutamic acid protein 1	300935				
12.155	1	6	93	12p13.31	PTPN6		Protein tyrosine phosphatase, nonreceptor-type, 6	176883				6(Hcph)
12.156	08	24	20	12p13.31	SCNN1A, BESC2, LIDLS3		Sodium channel, epithelial 1, subunit alpha	600228		mutation identified in 1 LIDLS3 patient	Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 2, 613021 (3); ?Liddle syndrome 3, 618126 (3)	6(Scnn1)
12.157	10	2	98	12p13.33	SLC6A12		Solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12	603080				
12.158	6	11	11	12p13.2	TAS2R19, T2R19, T2R48		Taste receptor, type 2, member 19	613961				
12.159	6	26	11	12p13.2	TAS2R42, T2R42, T2R55		Taste receptor, type 2, member 42	613966				
12.160	6	27	17	12p13.31	CD27, TNFRSF7, S152. LPFS2		CD27 antigen	186711			Lymphoproliferative syndrome 2, 615122 (3)	
12.161	11	13	13	12p13.31	TPI1, TPID		Triosephosphate isomerase-1	190450			Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3)	6(Tpi1)
12.162	4	5	00	12p13.2	TRB1, T2R14		Taste receptor, family B, member 1	604790				
12.163	4	5	00	12p13.2	TRB2, T2R10		Taste receptor, family B, member 2	604791				
12.164	4	5	00	12p13.2	TRB3, T2R13		Taste receptor, family B, member 3	604792				
12.165	4	5	00	12p13.2	TRB4, T2R7		Taste receptor, family B, member 4	604793				
12.166	4	5	00	12p13.2	TRB5, T2R8		Taste receptor, family B, member 5	604794				
12.167	4	5	00	12p13.2	TRB6, T2R9		Taste receptor, family B, member 6	604795				
12.168	12	14	00	12p13.33	TULP3		Tubby-like protein 3	604730				6(Tulp3)
12.169	2	5	99	12p13.31	USP5, ISOT		Ubiquitin-specific protease-5 (ubiquitin isopeptidase T)	601447				
12.170	2	27	12	12p13.33	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2		WNK lysine deficient protein kinase 1	605232			Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	
12.171	6	8	89	12p13.31	PZP		Pregnancy zone protein	176420				
12.172	08	21	19	12p13.33	RAD52		RAD52 homolog, DNA repair protein	600392				
12.173	10	24	14	12p12.3	ART4, DO, DOK1		ADP-ribosyltransferase-4 (Dombrock blood group)	110600			[Blood group, Dombrock], 616060 (3)	
12.174	3	1	94	12p13.31	CD69		CD69 antigen (p60, early T-cell activation antigen)	107273				
12.175	3	24	06	12p13.31	CLEC2B, CLECSF2, AICL		C-type lectin domain family 2, member B	603242				
12.176	09	29	20	12p13.2	KLRA1P, KLRA1, LY49L		Killer cell lectin like receptor A1, pseudogene	604274		?functional		6(Ly49)
12.177	1	13	99	12p13.31	KLRB1, NKRP1A		Killer cell lectin-like receptor, subfamily B, member 1	602890				
12.178	11	29	11	12p13.2	OLR1, LOX1		Low density lipoprotein, oxidized, receptor 1	602601			{Myocardial infarction, susceptibility to}, 608446 (3)	
12.179	9	6	11	12p12.3	PTPRO, GLEPP1, NPHS6		Protein tyrosine phosphatase, receptor type, O	600579			Nephrotic syndrome, type 6, 614196 (3)	
12.180	6	21	94	12q13.3	ATP5B, ATPSB		ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	102910				
12.181	4	24	18	12p12.3	AEBP2		AE-binding protein 2	617934				
12.182	7	14	98	12p12.3	ARHGDIB, GDID4, D4		Rho GDP dissociation inhibitor (GDI) beta	602843				
12.183	10	10	18	Xp11.3	PPP1R2C		Protein phosphatase 1, regulatory subunit 2C	301017				
12.184	10	20	99	12p13.1	EMP1, TMP		Epithelial membrane protein-1	602333				6(Emp1)
12.185	9	2	14	12p12.3	EPS8, DFNB102		Epidermal growth factor receptor pathway substrate-8	600206		mutation identified in 1 DFNB102 family	?Deafness, autosomal recessive 102, 615974 (3)	
12.186	2	28	03	12p13.2	GABARAPL1, GEC1		GABA-A receptor-associated protein-like protein 1	607420				
12.187	09	27	20	12p12.3	PLCZ1, SPGF17		Phospholipase C, zeta-1	608075			Spermatogenic failure 17, 617214 (3)	
12.188	7	18	14	12p11.23	STK38L, NDR2, KIAA0965		Serine/threonine protein kinase 38-like protein	615836				6(Stk38l)
12.189	5	18	10	12p12.3	STRAP, UNRIP, MAWD		Serine/threonine kinase receptor-associated protein	605986		previously assigned to 12q		
12.190	8	10	18	12p12.3	WBP11, NPWBP, SIPP1		WW-binding protein 11	618083				
12.191	4	25	93	12p12.1	IAPP		Islet amyloid polypeptide (diabetes-associated peptide; amylin)	147940				
12.192	4	23	13	12p12.1	GYS2		Glycogen synthase-2, liver	138571			Glycogen storage disease 0, liver, 240600 (3)	
12.193	6	23	15	12p12.2	PDE3A, HTNB		Phosphodiesterase 3A, cGMP-inhibited	123805			Hypertension and brachydactyly syndrome, 112410 (3)	
12.194	1	18	12	12p12.2	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR		Solute carrier organic anion transporter family, member 1B3	605495		HBLRR digenic with SLCO1B1	Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	
12.195	6	21	04	12p12.2-p12.1	HYT4		Hypertension, essential, susceptibility to, 4	608742			{Hypertension, essential, susceptibility to, 4}, 145500 (2)	
12.196	9	4	15	12p12.1	LDHB, LDHBD		Lactate dehydrogenase B	150100			[Lactate dehydrogenase-B deficiency], 614128 (3)	6(Ldh2)
12.197	02	12	20	12p12.1	ABCC9, SUR2, CMD1O, ATFB12, CANTU		ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2)	601439		mutation identified in 1 ATFB12 patient	Cardiomyopathy, dilated, 1O, 608569 (3); ?Atrial fibrillation, familial, 12, 614050 (3); Hypertrichotic osteochondrodysplasia, 239850 (3)	
12.198	6	28	18	12p12.1	C2CD5, CDP138, KIAA0528		C2 calcium-dependent domain-containing protein 5	618044				
12.199	4	19	16	12p12.1	CASC1, LAS1, PPP1R54		Cancer susceptibility candidate 1	616906				6(Casc1)
12.200	4	19	06	12p12.1	CMAS		Cytidine monophosphate N-acetylneuraminic acid synthetase	603316				
12.201	3	7	13	12p12.1	GOLT1B, GOT1B, GCT2		Golgi transport 1B	615078				
12.202	8	02	19	12p12.1	KRAS, KRAS2, RASK2, NS, CFC2, RALD, OES		KRAS protooncogene, GTPase	190070		pseudogene KRAS1P on 6p12-p11	Lung cancer, somatic, 211980 (3); Bladder cancer, somatic, 109800 (3); Pancreatic carcinoma, somatic, 260350 (3); Gastric cancer, somatic, 137215 (3); Leukemia, acute myeloid, somatic, 601626 (3); Noonan syndrome 3, 609942 (3); Cardiofaciocutaneous syndrome 2, 615278 (3); Breast cancer, somatic, 114480 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); RAS-associated autoimmune leukoproliferative disorder, 614470 (3); Arteriovenous malformation of the brain, somatic, 108010 (3); Oculoectodermal syndrome, somatic, 600268 (3)	6(Kras2)
12.203	12	15	16	12p12.1	LMNTD1, IFLTD1, LMNARS1, PAS1C1		Lamin tail domain-containing protein 1	617254				
12.204	4	29	14	12p12.1	LRMP, JAW1		Lymphoid-restricted membrane protein	602003				
12.205	12	19	16	12p12.1	PYROXD1, MFM8		Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1	617220			Myopathy, myofibrillar, 8, 617258 (3)	
12.206	9	7	12	12p12.1	RASSF8, C12orf2		RAS association domain family, member 8	608231				
12.207	2	12	16	12p12.1	SOX5, LAMSHF		SRY-box 5	604975		some LAMSHF patients have 12p12 deletions	Lamb-Shaffer syndrome, 616803 (3)	6(Sox5)
12.208	09	26	19	12p12.1	BHLHE41, BHLHB3, DEC2, SHARP1, FNSS1		Basic helix-loop-helix domain-containing protein, member E41	606200			[Short sleep, familial natural, 1], 612975 (3)	6(Dec2)
12.209	3	20	06	12p12.1	ETNK1, EKI1		Ethanolamine kinase 1	609858				12(Etnk1)
12.210	3	22	06	12p12.1	DADR		DAD1-related gene	609860				
12.211	4	24	18	12p11.22	PTHLH, BDE2		Parathyroid hormone-like hormone	168470			Brachydactyly, type E2, 613382 (3)	6(Pthlh)
12.212	3	14	96	12p12.1	SIAT8		Sialyltransferase-8 (alpha-N-acetylneuraminate: alpha-2,8-sialyltransferase, GD3 synthase)	601123				6(Siat8)
12.213	7	6	00	12q13.13	TARBP2		TAR RNA-binding protein 2	605053		pseudogene on 8q22-qter		15(Tarbp2)
12.214	04	13	20	12p12.1	BCAT1, BCT1		Branched chain aminotransferase-1, cytosolic	113520				6(Bcat1)
12.215	8	30	01	12p13.2	BCLG		Apoptosis regulator BCLG	606126				
12.216	6	10	04	12p12.3	CAPZA3, CAPPA3		Capping protein, actin, alpha-3	608722				6(Capza3)
12.217	6	27	12	12p13.2	DUSP16, MKP7, KIAA1700		Dual-specificity phosphatase 16	607175				
12.218	10	23	20	12p13.1	GRIN2B, NMDAR2B, MRD6, DEE27		Glutamate receptor, ionotropic, N-methyl D-aspartate 2B	138252			Mental retardation, autosomal dominant 6, 613970 (3); Developmental and epileptic encephalopathy 27, 616139 (3)	6(Nmdar2b)
12.219	5	29	12	12p12.3	GUCY2C, GUC2C, DIAR6, MECIL		Guanylate cyclase 2C (heat stable enterotoxin receptor)	601330			Diarrhea 6, 614616 (3); Meconium ileus, 614665 (3)	6(Gucy2c)
12.220	8	25	09	12p12.3	PEPP2, KIAA1686		Phosphatidylinositol 3-phosphate-binding PH domain protein 2	607770				
12.221	11	2	04	12p12.3	PIK3C2G		Phosphatidylinositol 3-kinase, class 2, gamma	609001				6(Pik3c2g)
12.222	3	23	09	12p12.3	RERG		Ras-like and estrogen-regulated growth inhibitor	612664				
12.223	7	7	14	12p12.3	SKP1P2, SKP1B		S-phase kinase-associated protein 1 pseudogene 2 (p19B)	601435				
12.224	1	13	99	12p12.1	SLC21A3, OATP		Solute carrier family 21 (organic anion transporter), member 3	602883				
12.225	1	18	12	12p12.1	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR		Solute carrier organic anion transporter family, member 1B1	604843		HBLRR digenic with SLCO1B3	Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	
12.226	6	7	10	12p12.2	SLCO1C1, OATPF, OATP14, SLC21A14		Solute carrier organic anion transporter family, member 1C1	613389				
12.227	3	14	06	12p13.31	ZNF384, CIZ, CAGH1, NMP4		Zinc finger protein 384	609951				6(Znf384)
12.228	5	22	14	12p12.1	RECQL, RECQL1		RecQ helicase-like (DNA helicase, RecQ-like 1)	600537				
12.229	11	19	13	12p11.21	CAPRIN2, C1QDC1, EEG1, KIAA1873		Caprin family, member 2	610375				
12.230	12	27	16	12p11.21	DENND5B		DENN domain-containing protein 5B	617279				
12.231	11	8	17	12p11.21	DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5		Dynamin 1-like	603850			Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, 614388 (3); Optic atrophy 5, 610708 (3)	
12.232	4	6	18	12p11.21	ETFBKMT, METTL20, C12orf72		Electron transfer flavoprotein beta-subunit lysine methyltransferase	615256				
12.233	12	30	14	12p11.21	H3F3C		H3 histone, family 3C	616134				
12.234	9	17	10	12p11.21	YARS2, TYRRS, MLASA2		Tyrosyl-tRNA synthetase 2	610957			Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)	
12.235	3	29	12	12p11.23	ARNTL2, BMAL2, CLIF		Aryl hydrocarbon receptor nuclear translocator-like protein 2	614517				
12.236	3	7	13	12p11.23	ASUN, MAT89BB, GCT1		Asunder, spermatogenesis regulator	615079				
12.237	1	8	15	12p11.22	FAR2, MLSTD1		Fatty acyl CoA reductase 2	616156				12(Far2)
12.238	2	5	15	12p12.1	KCNJ8		Potassium inwardly-rectifying channel, subfamily J, member 8	600935				
12.239	7	22	09	12p11.23	MED21, SURB7, SRB7		Mediator complex subunit 21	603800				
12.240	7	25	16	12p11.23-q13.12	AD5		Alzheimer disease, familial, type 5	602096			Alzheimer disease-5 (2)	
12.241	2	24	17	12p11.22	CCDC91		Coiled-coil domain-containing protein 91	617366				
12.242	9	22	08	12p11.22	ERGIC2, CDA14, PTX1		Endoplasmic reticulum-golgi intermediate compartment protein 2	612236				
12.243	06	23	20	12p11.22	KLHL42, KLHDC5, CTB9		Kelch-like family, member 42	618919				
12.244	3	15	07	12p11.22	REP15		Rab15 effector protein	610848				
12.245	7	18	14	12p11.22	TMTC1		Transmembrane and tetratricopeptide repeat domains-containing protein 1	615855				
12.246	7	2	07	12p11.21	FGD4, FRABIN, CMT4H		FYVE, RhoGEF, and PH domain-containing protein 4	611104			Charcot-Marie-Tooth disease, type 4H, 609311 (3)	
12.247	11	27	18	12p11.23-p11.22	PPFIBP1		Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein-binding protein 1	603141				
12.248	1	26	97	12p12.1	SSPN, KRAG		Sarcospan (Kirsten-ras associated gene)	601599				
12.249	03	09	20	12p11.21	BICD1		BICD cargo adaptor 1	602204				
12.250	1	18	13	12p11.2-q13.1	ARCI7		Ichthyosis, congenital, autosomal recessive 7	615022		between D12S345 and D12S390	Ichthyosis, congenital, autosomal recessive 7 (2)	
12.251	2	17	09	12p11.2-q14	STQTL3		Stature quantitative trait locus 3	606257		max lod at D12S398 and D12S10990	{Stature QTL 3} (2)	
12.252	01	03	20	12p11.1	ALG10, ALG10A		ALG10 alpha-1,2-glucosyltransferase	618355				
12.253	07	13	20	12p11.21	DDX11, CHLR1, KRG2		DEAD/H-box helicase 11	601150			Warsaw breakage syndrome, 613398 (3)	
12.254	4	3	15	12p11.23	ITPR2, ANHD		Inositol 1,4,5-triphosphate receptor, type 2	600144		mutation has been identified in 1 ANHD family	?Anhidrosis, isolated, with normal sweat glands, 106190 (3)	
12.255	7	9	09	12p13.33	KDM5A, JARID1A, RBP2, RBBP2		Lysine(K)-specific demethylase 5A	180202				
12.256	12	30	04	12p11.21	PKP2, ARVD9		Plakophilin-2	602861		pseudogene on 12p13	Arrhythmogenic right ventricular dysplasia 9, 609040 (3)	
12.257	11	10	17	12p11.21	SINHCAF, FAM60A		SIN3-HDAC complex associated factor	615027				
12.258	9	9	13	12p11-q13	VUR7		Vesicoureteral reflux 7	615390		max lod at D12S1048	Vesicoureteral reflux 7 (2)	
12.259	1	28	88	12p	KAR		Aromatic alpha-keto acid reductase	107920		?same as MDH1		
12.260	12	13	18	12p13.32	NDUFA9, MC1DN26		NADH-ubiquinone oxidoreductase subunit A9	603834			Mitochondrial complex I deficiency, nuclear type 26, 618247 (3)	
12.261	5	7	03	12q21.2	OSBPL8, ORP8, KIAA1451		Oxysterol-binding protein-like protein 8	606736				
12.262	5	4	12	12p	PKS		Pallister-Killian syndrome	601803			Pallister-Killian syndrome (4)	
12.263	12	12	18	12q21.2	SYT1, BAGOS		Synaptotagmin-1	185605			Baker-Gordon syndrome, 618218 (3)	10(Syt1)
12.264	7	8	10	12q	IHPS1, IHPS		Pyloric stenosis, infantile hypertrophic 1	179010			Pyloric stenosis, infantile hypertrophic 1 (2)	
12.265	6	25	99	12q24.13	RPL6		Ribosomal protein L6	603703				
12.266	3	29	10	12q13.2	RPS26, DBA10		Ribosomal protein S26	603701			Diamond-Blackfan anemia 10, 613309 (3)	
12.267	5	22	03	12q13.13	SMUG1		Single-strand-selective monofunctional uracil-DNA glycosylase 1	607753				
12.268	09	26	19	12q12	ADAMTS20		ADAM metallopeptidase domain with thrombospondin type 1 motif, 20	611681				
12.269	10	29	99	12q12	ABCD2, ALDR, ALDL1		ATP-binding cassette, subfamily D, member 2	601081				15(Aldl1)
12.270	7	7	14	12q12	CNTN1, MYPCN		Contactin 1	600016		mutation identified in 1 MYPCN family	?Myopathy, congenital, Compton-North, 612540 (3)	
12.271	1	31	01	12p11.23	TM7SF3		Transmembrane 7 superfamily, member 3	605181				
12.272	1	25	93	12q13.13	ITGA5, FNRA, VLA5A		Integrin, alpha-5 (fibronectin receptor, alpha subunit; very late activation protein-5, alpha subunit)	135620				15(Itga5)
12.273	6	7	95	12q13.13	KRT2, KRT2A, KRT2E		Keratin 2	600194			Ichthyosis bullosa of Siemens, 146800 (3)	
12.274	3	3	09	12q13.11-q13.12	CCNT1, CCNT		Cyclin T1	143055				
12.275	12	11	97	12q13.13	ACVRL1, ACVRLK1, ALK1, HHT2		Activin A receptor, type II-like kinase 1	601284			Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	
12.276	1	13	99	12q13.12	ACCN2		Cation channel, amiloride-sensitive, neuronal, 2	602866				
12.277	01	03	20	12q12	ALG10B, KCR1, ALG10		ALG10 alpha-1,2-glucosyltransferase B	603313			{Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3)	
12.278	9	15	11	12q12	ANO6, TMEM16F, SCTS, BDPLT7		Anoctamin 6	608663			Scott syndrome, 262890 (3)	15(Tmem16f)
12.279	12	15	17	12q12	ARID2, BAF200, KIAA1557, CSS6		AT-rich interaction domain-containing protein 2	609539			Coffin-Siris syndrome 6, 617808 (3)	
12.280	3	29	10	12q12	GXYLT1, GLT8D3		Glucoside xylosyltransferase 1	613321				
12.281	06	25	20	12q12	IRAK4, REN64, IPD1, IMD67		Interleukin 1 receptor-associated kinase 4	606883			Immunodeficiency 67, 607676 (3)	
12.282	2	17	10	12q12	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B		Kinesin family member 21A	608283			Fibrosis of extraocular muscles, congenital, 1, 135700 (3); Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	15(Kif21a)
12.283	4	10	15	12q12	LRRK2, PARK8		Leucine-rich repeat kinase 2 (dardarin)	609007			{Parkinson disease 8}, 607060 (3)	
12.284	7	31	08	12q12	MUC19		Mucin 19, oligomeric	612170				15(Muc19)
12.285	12	28	08	12q12	PDZRN4		PDZ domain-containing ring finger protein 4	609730				
12.286	7	9	06	12q13.13	PFDN5, MM1		Prefoldin 5	604899				
12.287	3	22	07	12q12	PPHLN1		Periphilin 1	608150				
12.288	12	24	08	12q12	PRICKLE1, RILP, EPM1B		Prickle-like 1	608500			Epilepsy, progressive myoclonic 1B, 612437 (3)	15(Prickle1)
12.289	8	20	07	12q12	SLC2A13, HMIT		Solute carrier family 2 (facilitated glucose transporter), member 13	611036				
12.290	08	07	20	12q12	TWF1, PTK9		Twinfilin actin-binding protein 1	610932				
12.291	8	18	14	12q12	YAF2		YY1-associated factor 2	607534				
12.292	2	12	07	12q12	ZCRB1, MADP1		Zinc finger CCHC domain- and RNA-binding motif-containing protein 1	610750		possible pseudogenes on chr16, X, and 6		
12.293	3	31	15	12q13.12	ADCY6, LCCS8		Adenylate cyclase-6	600294		mutation identified in 1 LCCS8 family	?Lethal congenital contracture syndrome 8, 616287 (3)	15(Adcy6)
12.294	10	1	95	12q13.2	CD63, MLA1		CD63 antigen (melanoma 1 antigen)	155740				10(Cd63)
12.295	2	21	12	12q13.12	GPD1, HTGTI		Glycerol-3-phosphate dehydrogenase, soluble	138420			Hypertriglyceridemia, transient infantile, 614480 (3)	15(Gdc1)
12.296	5	27	05	12q13.12	PRPH		Peripherin	170710			{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	15(Prph)
12.297	08	21	19	12q13.3	TIMELESS, TIM, TIM1		Timeless circadian regulator	603887				10(Tim)
12.298	5	6	13	12q13.12	WNT1, INT1, OI15, BMND16		Wingless-type MMTV integration site family, member 1 (oncogene INT1)	164820			Osteogenesis imperfecta, type XV, 615220 (3); {Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3)	15(Int1, Wnt1)
12.299	2	1	11	12q12	SCAF11, SFRS2IP, SIP1, CASP11, SRRP129		SR-related C-terminal domain-associated factor 11	603668		previously assigned to 21q22.3		
12.300	12	13	95	12q13.13	KRT7		Keratin 7	148059				
12.301	12	17	07	12q13.12	TUBA1A, TUBA3, LIS3		Tubulin, alpha-1A	602529			Lissencephaly 3, 611603 (3)	
12.302	03	10	20	12q13.11	VDR		Vitamin D (1,25-dihydroxyvitamin D3) receptor	601769			Rickets, vitamin D-resistant, type IIA, 277440 (3)	
12.303	2	28	07	12q12-q21	RLS1		Restless legs syndrome, susceptibility to, 1	102300		between D12S1044 and D12S78	{Restless legs syndrome 1} (2)	
12.304	11	1	00	12q13.13	AAAS, AAA		Aladin	605378			Achalasia-addisonianism-alacrimia syndrome, 231550 (3)	
12.305	4	26	01	12q13.13	ACVR1B, ACVRLK4, ALK4		Activin A receptor, type IB	601300			Pancreatic cancer, somatic (3)	
12.306	8	21	98	12q13.13	AMHR2, AMHR		Anti-Mullerian hormone receptor, type II	600956			Persistent Mullerian duct syndrome, type II, 261550 (3)	15(Amhr)
12.307	11	16	05	12q13.12	AQP2		Aquaporin-2 (collecting duct)	107777			Diabetes insipidus, nephrogenic, 125800 (3)	
12.308	11	5	97	12q13.12	AQP6, AQP2L		Aquaporin-6, kidney specific	601383				
12.309	10	7	13	12q13.12	AQP5, PPKB		Aquaporin-5	600442			Palmoplantar keratoderma, Bothnian type, 600231 (3)	15(Aqp2)
12.310	5	6	98	12q13.12	ARF3		ADP-ribosylation factor-3	103190				
12.311	1	31	13	12q13.11	ASB8		Ankyrin repeat- and SOCS box-containing protein 8	615053				
12.312	2	1	01	12q13.12	ATF1, TREB36		Activating transcription factor 1	123803		fused with EWS in soft tissue clear cell sarcoma, with FUS in angiomatoid fibrous histiocytoma		
12.313	10	6	09	12q13	BCC4		Basal cell carcinoma, susceptibility to, 4	613061		associated with rs11170164	{Basal cell carcinoma, susceptibility to, 4} (2)	
12.314	5	13	13	12q13.12	C1QL4, CTRP11		Complement component 1, q subcomponent-like 4	615229				5(C1ql4)
12.315	10	19	97	12q13.12	CACNB3		Calcium channel, voltage-dependent, beta 3 subunit	601958				
12.316	5	19	94	12q13.2	CDK2		Cyclin-dependent kinase 2	116953				
12.317	9	2	12	12q13.13	CELA1, ELA1		Chymotrypsin-like elastase family, member 1	130120		on proximal 12p		15(Ela1)
12.318	1	12	15	12q13	CMTS		Chronic mountain sickness, susceptibility to	616182			{Chronic mountain sickness, susceptibility to} (2)	
12.319	11	09	18	12q13.2	ERBB3, LCCS2, FERLK		Transformation gene ERBB-3	190151		mutations identified in 1 LCCS2 family and 1 FERLK family	?Lethal congenital contractural syndrome 2, 607598 (3); {?Erythroleukemia, familial, susceptibility to}, 133180 (3)	
12.320	3	10	09	12q13.13	ESPL1, ESP1		Extra spindle poles-like 1	604143		prev. mapping to chr.8		
12.321	7	20	04	12q13.12	FAIM2, LFG, NMP35		FAS apoptotic inhibitory molecule 2	604306				
12.322	5	26	13	12q13.12	FKBP11, FKBP19		FK506-binding protein 11	610571				
12.323	3	31	15	12q13.12	FMNL3, FRL2		Formin-like 3	616288				
12.324	1	27	04	12q13.13	GALNT6, GalNAcT6		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6	605148				
12.325	5	19	09	12q13.3	GLS2, GA		Glutaminase, liver	606365				
12.326	3	30	12	12q14.3	HELB, HDHB		Helicase, DNA, B	614539				
12.327	2	4	02	12q13.3	HSE		3-alpha-hydroxysteroid epimerase	606623				
12.328	2	26	93	12q13.13	HOXC4, HOX3E		Homeo box-C4	142974				
12.329	2	26	93	12q13.13	HOXC5, HOX3D		Homeo box-C5	142973				15(Hox6.2)
12.330	2	26	93	12q13.13	HOXC6, HOX3C		Homeo box-C6	142972				15(Hox6.1)
12.331	2	26	93	12q13.13	HOXC8, HOX3A		Homeo box-C8	142970				15(Hox3.1)
12.332	2	26	93	12q13.13	HOXC9, HOX3B		Homeo box-C9	142971				15(Hox3.2)
12.333	2	26	93	12q13.13	HOXC12, HOX3F		Homeo box-C12	142975				
12.334	11	19	12	12q13.13	HOXC13, HOX3G, ECTD9		Homeo box-C13	142976		fused with NUP98 in AML	Ectodermal dysplasia 9, hair/nail type, 614931 (3)	
12.335	12	9	91	12q13	HPV18I2		Human papillomavirus type 18 integration site-2	167960		on 8 near MYC in HeLa		
12.336	8	29	08	12q13.11	HRG1		Heme-responsive gene 1	612187				
12.337	9	10	07	12q13.2	IKZF4, ZNFN1A4, EOS, KIAA1782		Ikaros family zinc finger 4	606239				
12.338	2	2	10	12q13.2	ITGA7		Integrin, alpha-7	600536			Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)	
12.339	8	27	01	12q13.12	KCNH3, BEC1		Potassium voltage-gated channel, subfamily H (eag-related), member 3	604527				
12.340	3	30	18	12q13.3	KIF5A, NKHC, SPG10, NEIMY, ALS25		Kinesin family member 5A	602821			Spastic paraplegia 10, autosomal dominant, 604187 (3); Myoclonus, intractable, neonatal, 617235 (3); {Amyotrophic lateral sclerosis, susceptibility to, 25}, 617921 (3)	2(Nkhc)
12.341	2	3	12	12q13.13	KRT1, EPPK, NEPPK, EHK		Keratin 1	139350		close to Hox-3 in mouse; class II keratin	Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3); Ichthyosis histrix, Curth-Macklin type, 146590 (3); Palmoplantar keratoderma, nonepidermolytic, 600962 (3); Palmoplantar keratoderma, epidermolytic, 144200 (3); Keratosis palmoplantaris striata III, 607654 (3)	15(Krt2)
12.342	02	04	20	12q13.13	KRT3, MECD2		Keratin 3	148043			Meesmann corneal dystrophy 2, 618767 (3)	
12.343	5	22	14	12q13.13	KRT4, CYK4, WSN1		Keratin 4	123940		class II keratin	White sponge nevus 1, 193900 (3)	
12.344	11	1	13	12q13.13	KRT5, DDD1		Keratin 5	148040			Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3); Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3); Epidermolysis bullosa simplex-MP, 131960 (3); Dowling-Degos disease 1, 179850 (3); Epidermolysis bullosa simplex-MCR, 609352 (3); Epidermolysis bullosa simplex, recessive 1, 601001 (3)	
12.345	4	10	14	12q13.13	KRT6A, PC3		Keratin 6A	148041			Pachyonychia congenita 3, 615726 (3)	
12.346	4	10	14	12q13.13	KRT6B, PC4		Keratin 6B	148042			Pachyonychia congenita 4, 615728 (3)	
12.347	11	5	13	12q13.13	KRT8		Keratin 8	148060			Cirrhosis, cryptogenic, 215600 (3); {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	
12.348	12	5	13	12q13.13	KRT18		Keratin 18	148070		contiguous to KRT8, type II heteromer partner	Cirrhosis, cryptogenic, 215600 (3); {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	
12.349	7	17	14	12q13.13	KRT71, K6IRS1, KRT6IRS1, HYPT13		Keratin 71	608245		mutation identified in 1 HYPT13 family	?Hypotrichosis 13, 615896 (3)	
12.350	3	22	07	12q13.13	KRT72, K6IRS2, KRT6IRS2		Keratin 72	608246				
12.351	3	22	07	12q13.13	KRT73, K6IRS3, KRT6IRS3		Keratin 73	608247				
12.352	2	17	15	12q13.13	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH		Keratin 74	608248		mutation identified in 1 HYPT3 family and ECTD7 family	Woolly hair, autosomal dominant, 194300 (3); ?Hypotrichosis 3, 613981 (3); ?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	
12.353	10	9	08	12q13.13	KRT75, K6HF, PFB		Keratin 75	609025			{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)	
12.354	3	7	08	12q13.13	KRT81, KRTHB1, HB1		Keratin 81	602153			Monilethrix, 158000 (3)	
12.355	11	1	17	12q13.13	KRT83, KRTHB3, HB3, MNLIX, EKVP5		Keratin 83	602765			Monilethrix, 158000 (3); Erythrokeratodermia variabilis et progressiva 5, 617756 (3)	
12.356	12	17	12	12q13.13	KRT85, KRTHB5, HB5, ECTD4		Keratin 85	602767			Ectodermal dysplasia 4, hair/nail type, 602032 (3)	
12.357	3	7	08	12q13.13	KRT86, KRTHB6, HB6		Keratin 86	601928			Monilethrix, 158000 (3)	
12.358	12	18	02	12q13.2	LACRT		Lacritin	607360				
12.359	10	23	87	12q13.11	LALBA		Lactalbumin, alpha	149750				
12.360	08	10	18	12q13.12	LIMA1, EPLIN, SREBP3, LDLCQ8		LIM domain and actin-binding protein 1	608364			[Low density lipoprotein cholesterol level QTL 8], 618079 (3)	
12.361	2	2	01	12q14.1	METTL1		Methyltransferase-like 1	604466				
12.362	8	6	13	12q13.3	MIP, AQP0, CTRCT15		Major intrinsic protein of lens fiber	154050		slightly distal to AQP2	Cataract 15, multiple types, 615274 (3)	10(Mip)
12.363	3	23	09	12q13.13	MIR196A2, MIRN196A2		Micro RNA 196A2	609687				
12.364	03	31	20	12q13.13	MYG1, C12orf10		MYG1 exonuclease	611366				
12.365	1	2	08	12q13.2	NEUROD4, MATH3		Neurogenic differentiation 4	611635				10(Neurod4)
12.366	10	15	94	12q13.13	NFE2		Nuclear factor, erythroid-derived 2, 45kD	601490				15(Nfe2)
12.367	9	15	99	12q13.13	MAP3K12, ZPK		Mitogen-activated protein kinase kinase kinase 12	600447				
12.368	9	7	90	12q13.13	NR4A1, HMR, NP10, GFRP1		Nuclear receptor subfamily 4, group A, member 1	139139				15(np10)
12.369	3	17	16	12q13.12	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1		Solute carrier family 11 (proton-coupled divalent metal ion transporter) member 2	600523			Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	15(Nramp2, mk)
12.370	12	28	08	12q13.3-q14.1	OS9		Amplified in osteosarcoma 9	609677				
12.371	6	4	98	12q13.2	PA2G4		Proliferation-associated 2G4, 38kD	602145		family of genes on 7 chromosomes		
12.372	9	28	98	12q13.2	PDE1B1, PDES1B, PDE1B		Phosphodiesterase-1B	171891				15(Pde1b)
12.373	11	5	97	12q13.3	PRIM1		Primase, polypeptide-1, 49kD	176635				10(Prim1)
12.374	8	18	99	12q13.2	RAB5B		Ras-associated protein RAB5B	179514				
12.375	8	11	91	12q13.13	RARG		Retinoic acid receptor, gamma polypeptide	180190				15(Rarg)
12.376	9	8	11	12q13.2	SARNP, CIP29, HCC1, HSPC316		SAP domain-containing ribonucleoprotein	610049		fused with MLL in AML		
12.377	10	23	20	12q13.13	SCN8A, CIAT, DEE13, BFIS5, MYOCL2		Sodium voltage-gated channel, alpha subunit 8	600702		mutation identified in 1 MYOCL2 family	Cognitive impairment with or without cerebellar ataxia, 614306 (3); Developmental and epileptic encephalopathy 13, 614558 (3); Seizures, benign familial infantile, 5, 617080 (3); ?Myoclonus, familial, 2, 618364 (3)	2(med, Scn8a)
12.378	12	14	20	12q13.3	SHMT2, GLYA, NEDCASB		Serine hydroxymethyltransferase	138450		glycine A auxotroph	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities, 619121 (3)	
12.379	8	18	99	12q14.1	SLC16A7, MCT2		Solute carrier family 16 (monocarboxylic acid transporters), member 7	603654				
12.380	8	29	03	12q13.11	SLC38A4, NAT3, ATA3		Solute carrier family 38 (amino acid transporter), member 4	608065				
12.381	9	9	03	12q13.13	SOAT2, ACACT2		Sterol O-acyltransferase 2	601311				
12.382	9	10	14	12q13	SPDT		Spondyloepiphyseal dysplasia tarda, autosomal dominant	184100			Spondyloepiphyseal dysplasia tarda, autosomal dominant (2)	
12.383	6	10	98	12q13.3	STAT6		Signal transducer and activator of transcription-6, interleukin-4 induced	601512				10(Stat6)
12.384	4	24	96	12q13.12-q13.13	TFCP2		Transcription factor CP2, alpha globin	189889				
12.385	8	17	16	12q13.12	WNT10B, SHFM6, STHAG8		Wingless-type MMTV integration site family, member 10B	601906			Split-hand/foot malformation 6, 225300 (3); Tooth agenesis, selective, 8, 617073 (3)	
12.386	12	17	15	12q13-q14	DFNA48		Deafness, autosomal dominant 48	607841			Deafness, autosomal dominant 48 (2)	
12.387	10	18	96	12q13.2	GCN5L1		GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 1	601444				
12.388	3	11	03	12p11.21	IPO8, RANBP8		Importin 8	605600				
12.389	5	28	99	12q13-q14	PABPL2		Poly(A)-binding protein-like 2	604681		?pseudogenes on 3q and 13q		
12.390	6	2	99	12q13.2	RDH5		Retinol dehydrogenase-5	601617			Fundus albipunctatus, 136880 (3)	
12.391	8	31	98	12q13.2	SILV, D12S53E, PMEL17		Silver, mouse, homolog of	155550				10(si)
12.392	03	19	19	12q13.2	SMARCC2, BAF170, CSS8		SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2	601734			Coffin-Siris syndrome 8, 618362 (3)	
12.393	02	19	20	12q13.12	SMARCD1, BAF60A, CSS11		SW1/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1	601735			Coffin-Siris syndrome 11, 618779 (3)	
12.394	1	5	07	12q14.1	TSFM, COXPD3		Ts translation elongation factor, mitochondrial	604723			Combined oxidative phosphorylation deficiency 3, 610505 (3)	
12.395	1	20	06	12q14.1	TSPAN31, SAS		Tetraspanin 31	181035				
12.396	12	17	15	12q13.3	MYO1A		Myosin IA	601478				10(Myo1a)
12.397	6	2	98	12q15	YEATS4, GAS41		YEATS domain-containing protein 4	602116				
12.398	9	30	95	12q13-q21	ENUR2		Enuresis, nocturnal, 2	600808			Enuresis, nocturnal, 2 (2)	
12.399	9	28	12	12q13.3	TAC3, NKNB, HH10		Tachykinin 3 (neuromedin K, neurokinin B)	162330			Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3)	
12.400	3	18	94	12q24.33	ZNF10, KOX1		Zinc finger protein-10 (KOX 1)	194538		same 300kb fragment as ZNF26		
12.401	12	21	03	12q13.2	DCD		Dermcidin	606634				
12.402	11	30	06	12q13.12	DDN, KIAA0749		Dendrin	610588				
12.403	10	07	20	12q13.12	DHH, SRXY7, GDMN		Desert hedgehog signaling molecule	605423			46XY gonadal dysgenesis with minifascicular neuropathy, 607080 (3); 46XY sex reversal 7, 233420 (3)	
12.404	2	21	14	12q13.11	ENDOU, PP11		Endonuclease polyU-specific	606720				
12.405	11	5	13	12q13.13	HNRNPA1, IBMPFD3, ALS20		Heterogeneous nuclear ribonucleoprotein A1	164017		mutation identified in 1 family with IBMPFD3	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3, 615424 (3); Amyotrophic lateral sclerosis 20, 615426 (3)	
12.406	1	27	97	12q13.3	INHBC		Inhibin, beta C	601233				10(Inhbc)
12.407	03	04	19	12q13.1	MXLPO		Myxoid liposarcoma	613488		fusion of DDIT3 and FUS	Myxoid liposarcoma (4)	
12.408	08	17	20	12q13.1-q13.2	NCKAP1L, HEM1, IMD72		NCK associated protein 1-like	141180			Immunodeficiency 72 with autoinflammation, 618982 (3)	
12.409	1	13	99	12q13.12	PRKAG1		Protein kinase, AMP-activated, noncatalytic, gamma-1	602742				
12.410	7	10	08	12q13.11	SENP1		Sentrin-specific protease family, member 1	612157				
12.411	11	4	93	12q13.13	SP1		Sp1 transcription factor	189906				15(Sp1)
12.412	03	04	19	12q13.3	DDIT3, GADD153, CHOP10		DNA-damage-inducible transcript-3	126337		fused with FUS in myxoid liposarcoma		
12.413	8	26	03	12q13.2	DRIP78, HDJ3		Dopamine receptor-interacting protein, 78kD	606092				
12.414	4	17	06	12q14.1	CYP27B1, VDD1, PDDR		Cytochrome P450, subfamily XXVIIB, polypeptide 1	609506			Vitamin D-dependent rickets, type I, 264700 (3)	
12.415	11	23	16	12q13.3	LRP1, A2MR, KPA		Low density lipoprotein-related protein-1 (alpha-2-macroglobulin receptor)	107770		mutation identified in 1 KPA family	?Keratosis pilaris atrophicans, 604093 (3)	15(A2mr)
12.416	3	12	14	12q13.11	AMIGO2, ALI1		Adhesion molecule with Ig-like domain 2	615690				15(Amigo2)
12.417	9	30	13	12q13.11	ANP32D, PP32R2		Acidic leucine-rich nuclear phosphoprotein 32 family, member D	606878				
12.418	9	30	14	12q13.3	ARHGEF25, GEFT		Rho guanine nucleotide exchange factor 25	610215				
12.419	09	04	19	12q13.11	H1-7, H1FNT, HANP1, H1T2		H1.7 linker histone	618565				15(H1t2)
12.420	12	10	13	12q13.11	KANSL2, NSL2, C12orf41		KAT8 regulatory NSL complex, subunit 2	615488				15(Kansl2)
12.421	10	13	09	12q13.11	RPAP3		RNA polymerase II-associated protein 3	611477				
12.422	3	12	04	12q13.11	SLC38A1		Solute carrier family 38 (amino acid transporter), member 1	608490				
12.423	3	15	14	12q13.11	SLC38A2, ATA2, KIAA1382		Solute carrier family 38, member 2	605180				
12.424	4	8	16	12q13.11	SNORA2C, SNORA34, ACA34, MIR1291		Small nucleolar RNA, H/ACA box, 34	615487		MIR1291 in intron of SNORA34		
12.425	5	16	11	12q13.11	ZNF641		Zinc finger protein 641	613906				
12.426	6	19	98	12q12	NELL2		Nel-like 2	602320				
12.427	10	13	15	12q13.11	COL2A1		Collagen II, alpha-1 polypeptide	120140			Stickler syndrome, type I, 108300 (3); Kniest dysplasia, 156550 (3); Achondrogenesis, type II or hypochondrogenesis, 200610 (3); SED congenita, 183900 (3); SMED Strudwick type, 184250 (3); ?Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3); Spondyloperipheral dysplasia, 271700 (3); Osteoarthritis with mild chondrodysplasia, 604864 (3); Vitreoretinopathy with phalangeal epiphyseal dysplasia (3); Platyspondylic skeletal dysplasia, Torrance type, 151210 (3); Avascular necrosis of the femoral head, 608805 (3); Legg-Calve-Perthes disease, 150600 (3); Stickler sydrome, type I, nonsyndromic ocular, 609508 (3); Czech dysplasia, 609162 (3); Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3)	15(Col2a1, seds)
12.428	11	19	11	12q13.11-q15	MRT25		Mental retardation, autosomal recessive 25	614346		between rs4760658 and rs1882033	Mental retardation, autosomal recessive 25 (2)	
12.429	11	11	13	12q13.12	CCDC65, CILD27		Coiled-coil domain-containing protein 65	611088			Ciliary dyskinesia, primary, 27, 615504 (3)	
12.430	8	2	13	12q13.12	CERS5, LASS5, TRH4		Ceramide synthase 5	615335				
12.431	10	23	20	12q13.12	COX14, C12orf62, MC4DN10		Cytochrome c oxidase assembly protein COX14	614478		mutation identified in 1 MC4DN10 family	?Mitochondrial complex IV deficiency, nuclear type 10, 619053 (3)	15(C12orf62)
12.432	07	14	20	12q13.12	DDX23, PRP28		DEAD-box helicase 23	612172				
12.433	09	18	19	12q13.12	DIP2B, KIAA1463		Disco-interacting protein 2 homolog B	611379			Mental retardation, FRA12A type, 136630 (3)	
12.434	3	14	14	12q13.12	KMT2D, MLL2, ALR, KABUK1		Lysine (K)-specific methyltransferase 2D	602113			Kabuki syndrome 1, 147920 (3)	
12.435	11	08	19	12q13.12	LARP4		La ribonucleoprotein 4	618657				
12.436	10	22	20	12q13.12	LETMD1, HCCR		LETM1 domain-containing protein 1	619070				
12.437	3	28	06	12q13.12	LMBR1L, LIMR, KIAA1174		Limb region 1 homolog-like	610007				
12.438	2	25	15	12q13.12	MCRS1, MSP58, MCRS2		Microspherule protein 1 (microspherule protein 2, included)	609504				
12.439	02	25	19	12q13.12	METTL7A, AAMB		Methyltransferase-like protein 7A	618338				
12.440	3	14	13	12q13.12	NCKAP5L, KIAA1602		NCK-associated protein 5-like	615104				
12.441	5	13	13	12q13.12	RCGAP1, MGCRACGAP, CYK4		GTPase-activating protein, Rac, 1	604980				
12.442	07	17	20	12q13.12	RHEBL1, RHEB2		RHEB-like protein 1	618956				
12.443	6	13	12	12q13.12	RND1, RHO6		Rho family GTPase 1	609038				
12.444	6	22	14	12q13.12	TMBIM6, TEGT		Transmembrane BAX inhibitor motif-containing protein 6	600748				15(Tegt)
12.445	9	27	17	12q13.12	TUBA1B		Tubulin, alpha-1B	602530				15(Tuba1b)
12.446	3	9	98	12q13.13	PCBP2		Poly(rC)-binding protein-2	601210				
12.447	09	19	19	12q13.13	ATG101, C12orf44		Autophagy related 101	615089				
12.448	5	7	01	12q13.13	BIN2		Bridging integrator 2	605936		previously mapped to 4q22.1		
12.449	09	10	19	12q13.13	CBX5, HP1		Chromobox 5	604478				
12.450	12	10	13	12q13.13	COPZ1, COPZ		Coatomer protein complex, subunit zeta-1	615472				
12.451	9	28	15	12q13.13	CSAD, CSD, PCAP		Cysteine sulfinic acid decarboxylase	616569				
12.452	5	25	13	12q13.13	EIF4B		Eukaryotic translation initiation factor 4B	603928				
12.453	12	08	20	12q13.2	GDF11, BMP11, VHO		Growth/differentiation factor 11	603936		mutation identified in 1 VHO family	?Vertebral hypersegmentation and orofacial anomalies, 619122 (3)	
12.454	11	28	01	12q13.13	GPR84		G protein-coupled receptor 84	606383				15(Gpr84)
12.455	6	5	08	12q13.13	GRASP, TAMALIN		GRP1-associated scaffold protein	612027				
12.456	12	4	08	12q13.13	HOTAIR		Hox transcript antisense RNA	611400				
12.457	7	12	92	12q13.13	ITGB7		Integrin, beta-7	147559				15(Itgb7)
12.458	4	11	14	12q13.13	KRT6C, PPKNEFD		Keratin 6C	612315			Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3)	
12.459	12	2	15	12q13.13	KRT76, K76, KRT2P		Keratin 76, type II	616671				
12.460	2	25	08	12q13.13	KRT77, K1B		Keratin 77	611158				
12.461	2	25	08	12q13.13	KRT78, K5B		Keratin 78	611159				
12.462	3	7	08	12q13.13	KRT79,  KRT6L, K6L		Keratin 79	611160				
12.463	2	28	08	12q13.13	KRT80, KB20		Keratin 80	611161				
12.464	11	13	13	12q13.13	KRT82, KRTHB2, HB2		Keratin 82	601078				
12.465	11	13	13	12q13.13	KRT84, KRTHB4, HB4		Keratin 84	602766				
12.466	5	13	11	12q13.13	MIR148B, MIRN148B		Micro RNA 148B	613787				
12.467	7	20	09	12q13.2	MYL6B, MLC1SA		Myosin, light chain 6B, alkali, smooth muscle and nonmuscle, slow	609930				
12.468	6	28	18	12q13.13	POU6F1, BRN5, MPOU		POU domain, class 6, transcription factor 1	618043				
12.469	5	24	13	12q13.13	PRR13, TXR1		Proline-rich protein 13	610459				
12.470	08	31	18	12q13.13	SP7, OSX, OI12		Transcription factor Sp7	606633			Osteogenesis imperfecta, type XII, 613849 (3)	15(Sp7)
12.471	3	3	16	12q13.13	TNS2, TENC1, C1TEN, KIAA1075		Tensin 2	607717				
12.472	10	27	08	12q13.13	ZNF385A, ZNF385, RZF, HZF		Zinc finger protein 385A	609124				
12.473	12	1	15	12q13.2	ESYT1, MBC2, FAM62A		Extended synaptotagmin-like protein 1	616670				
12.474	5	17	17	12q13.13	GTSF1, FAM112B		Gametocyte-specific factor 1	617484				
12.475	2	6	09	12q13.3	IL23A, SGRF, P19, IL23P19		Interleukin 23, p19 subunit	605580				
12.476	2	25	09	12q14.1	LIRG3, LIG3		Leucine-rich repeats- and immunoglobulin-like domains-containing protein 3	608870				10(Lrig3)
12.477	3	1	06	12q13.2	MYL6		Myosin light chain 6, alkali, smooth muscle and nonmuscle	609931				
12.478	4	7	10	12q13.2	ORMDL2		ORM1-like protein 2	610074		pseudogene on 8q22.1		
12.479	3	3	10	12q13.2	PPP1R1A, IPP1, I1		Protein phosphatase 1, regulatory subunit 1A	613246				
12.480	3	29	10	12q13.2	RPL41, HG12		Ribosomal protein L41	613315				
12.481	3	20	07	12q13.2	SBEM		Small breast epithelial mucin	610857				
12.482	12	17	07	12q13.12	SPATS2, SPATA10, P59SCR, SCR59		Spermatogenesis-associated serine-rich protein 2	611667				
12.483	05	26	20	12q13.3	STAT2, IMD44, PTORCH3		Signal transducer and activator of transcription 2	600556			Immunodeficiency 44, 616636 (3); Pseudo-TORCH syndrome 3, 618886 (3)	
12.484	3	7	14	12q13.2	TESPA1, KIAA0748		Thymocyte-expressed positive selection-associated protein 1	615664				
12.485	11	27	18	12q13.12	TROAP, TASTIN		Trophinin-associated protein	603872				
12.486	11	23	09	12q13.3	CS		Citrate synthase, mitochondrial	118950				10(Cs)
12.487	05	02	19	12q13.3	GLI1, PAPA8, PPD1		GLI family zinc finger 1	165220		mutation identified in 1 PPD1 family	Polydactyly, postaxial, type A8, 618123 (3); Polydactyly, preaxial I, 174400 (3)	10(Gli)
12.488	12	19	11	12q13.3	AAA4		Aortic aneurysm, familial abdominal, 4	614375		associated with rs1466535	Aortic aneurysm, familial abdominal, 4 (2)	
12.489	12	3	13	12q13.3	APOF, LTIP		Apolipoprotein F	107760				
12.490	2	25	16	12q13.3	B4GALNT1, GALGT, GALNACT, SPG26		Beta-1,4-N-acetylgalactosaminyltransferase 1	601873			Spastic paraplegia 26, autosomal recessive, 609195 (3)	
12.491	12	17	15	12q13.3	DCTN2, DCTN50		Dynactin 2	607376				
12.492	10	15	98	12q13.2	DGKA, DAGK1		Diacylglycerol kinase, alpha, 80kD	125855				10(Dagk1)
12.493	01	13	20	12q13.3	DTX3		Deltex E3 ubiquitin ligase 3	613142				
12.494	6	9	08	12q13.3	INHBE		Inhibin, beta E	612031				
12.495	08	21	19	12q13.3	MARS1, MARS, MTRNS, METRS, ILLD, CMT2U		Methioninyl-tRNA synthetase 1	156560			Interstitial lung and liver disease, 615486 (3); Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	
12.496	2	20	12	12q13.3	MIR616		Micro RNA 616	614489				
12.497	1	13	16	12q13.3	NEMP1, TMEM194A		Nuclear envelope integral membrane protein 1	616496				
12.498	11	3	14	12q13.3	NXPH4, NPH4		Neuroexophilin 4	604637				
12.499	6	26	08	12q13.3	OBFC2B, SSB1		Oligonucleotide/oligosaccharide-binding fold-containing protein 2B	612104				
12.500	5	19	17	12q13.3	PAN2, USP52, KIAA0710		PABP-dependent poly(A) nuclease 2	617447				
12.501	3	12	07	12q13.11	PFKM, GSD7		Phosphofructokinase, muscle type	610681		incorrectly assigned to chr.1	Glycogen storage disease VII, 232800 (3)	15(Pfk4)
12.502	9	1	16	12q13.3	PIP4K2C, PIP5K2C		Phosphatidylinositol 5-phosphate 4-kinase, type II, gamma	617104				
12.503	3	1	11	12q13.3	PTGES3, P23, CPGES		Prostaglandin E synthase 3	607061				
12.504	9	20	14	12q13.3	RBMS2, SCR3		RNA-binding motif protein, single strand interacting, 2	602387				
12.505	7	14	17	12q13.3	SDR9C7, SDRO, ARCI13		Short chain dehydrogenase/reductase family 9C member 7	609769			Ichthyosis, congenital, autosomal recessive 13, 617574 (3)	10(Sdro)
12.506	8	22	14	12q13.3	SLC39A5, MYP24		Solute carrier family 39 (zinc transporter), member 5	608730			Myopia 24, autosomal dominant, 615946 (3)	
12.507	08	22	18	12q13.3	STAC3, NAM, MYPBB		SH3 and cystein-rich domains 3	615521			Myopathy, congenital, Baily-Bloch, 255995 (3)	
12.508	6	19	98	12q13.3	NAB2		NGFIA-binding protein-2	602381				10(Nab2)
12.509	09	27	19	12q14.1	AVIL, NPHS21		Advillin	613397			Nephrotic syndrome, type 21, 618594 (3)	10(Avil)
12.510	5	12	11	12q14.1	CDK4, CMM3		Cyclin-dependent kinase 4	123829			{Melanoma, cutaneous malignant, 3}, 609048 (3)	
12.511	11	5	13	12q13.3	ARHGAP9		Rho GTPase-activating protein 9	610576				
12.512	2	3	05	12q15	DYRK2		Dual-specificity tyrosine phosphorylation-regulated kinase 2	603496				
12.513	5	6	13	12q14	GLC1P		Glaucoma 1, open angle, P	177700		caused by 300kb duplication	Glaucoma 1, open angle, P (4)	
12.514	3	27	03	12q14.3	GNS, G6S		N-acetylglucosamine-6-sulfatase	607664			Mucopolysaccharidosis type IIID, 252940 (3)	
12.515	07	31	20	12q15	IFNG, IFG, IFI, IMD69		Interferon, gamma	147570		mutation identified in 1 IMD69 family	{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3); {Aplastic anemia}, 609135 (3); {Tuberculosis, protection against}, 607948 (3); {AIDS, rapid progression to}, 609423 (3);{Hepatitis C virus, response to therapy of}, 609532 (3); ?Immunodeficiency 69, mycobacteriosis, 618963 (3)	10(Ifg)
12.516	6	26	17	12q14.3	LEMD3, MAN1		LEM domain-containing 3	607844			Osteopoikilosis with or without melorheostosis, 166700 (3); Buschke-Ollendorff syndrome, 166700 (3)	
12.517	9	24	15	12q13.2	MMP19, MMP18, CODA		Matrix metalloproteinase-19	601807		triplication in upstream regulatory region	Cavitary optic disc anomalies, 611543 (3)	
12.518	12	1	11	12q14	PRO2268		PRO2268 gene	614354				
12.519	9	15	89	12q15	RAP1B		RAS-related protein RAP1B	179530				
12.520	8	5	97	12q14.2	AVPR1A		Arginine vasopressin receptor-1A	600821				
12.521	3	22	06	12q21.2	ZDHHC17, HIP14		Zinc finger DHHC domain-containing protein 17	607799				
12.522	2	11	16	12q14.1	AGAP2, CENTG1, PIKE		ARF-GAP with GTP-binding protein-like, ankyrin repeat, and pleckstrin homology domains 2	605476				
12.523	11	05	18	12q14.1	CTDSP2, SCP2, OS4		CTD small phosphatase 2	608711				
12.524	12	5	17	12q14.1	EEF1AKMT3, METTL21B, FAM119B		EEF1A lysine methyltransferase 3	615258				
12.525	5	30	17	12q14.1	FAM19A2, TAFA2		Family with sequence similarity 19, member A2, CC motif chemokine-like	617496				
12.526	6	7	10	12q14.1	MARCH9		Membrane-associated RING-CH finger protein 9	613336				
12.527	10	6	09	12q14.1	MIR26A2, MIRN26A2		Micro RNA 26A2	613057				
12.528	3	23	09	12q14.1	MIRLET7I, LET7I, MIRNLET7I		Micro RNA Let7i	612148				
12.529	2	17	16	12q14.1	MON2, KIAA1040		Mon2, S. cerevisiae, homolog of	616822				
12.530	9	30	02	12q14.2	RASSF3		Ras association domain family protein 3	607019				
12.531	10	2	12	12q14.1	USP15		Ubiquitin-specific protease 15	604731				
12.532	9	30	14	12q14.1-q14.2	PPM1H, KIAA1157		Protein phosphatase, magnesium/manganese-dependent, 1H	616016				
12.533	9	20	00	12q15	KCNMB4		Potassium large conductance calcium-activated channel, subfamily M, beta member 4	605223				
12.534	1	20	06	12q21.1	TSPAN8, TM4SF3		Tetraspanin 8	600769				
12.535	8	23	09	12q14.2	AUTS13		Autism, susceptibility to, 13	610908		linkage with rs1445442	{Autism susceptibility 13} (2)	
12.536	4	20	17	12q14.2	C12orf66		Chromosome 12 open reading frame 66	617420				
12.537	6	11	11	12q14.2	DPY19L2, SPGF9		DPY19-like 2	613893		pseudogene on 7p14.3	Spermatogenic failure 9, 613958 (3)	9(Dpy19l2)
12.538	9	1	15	12q14.2	SRGAP1, KIAA1304, NMTC2		Slit-robo GTPase-activating protein, rho, 1	606523			{Thyroid cancer, nonmedullary, 2}, 188470 (3)	
12.539	3	14	18	12q14.2	TBK1, NAK, FTDALS4, IIAE8		TANK-binding kinase 1	604834			Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3); {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}, 617900 (3)	
12.540	1	16	18	12q14.2	RXYLT1, TMEM5, MDDGA10		Ribitol xylosyltransferase 1	605862			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3)	
12.541	9	8	06	12q15	BEST3, VMD2L3		Bestrophin 3	607337				
12.542	9	13	17	12q14.3	GRIP1, FRASRS3		Glutamate receptor-interacting protein 1	604597			Fraser syndrome 3, 617667 (3)	
12.543	06	15	20	12q14.3	HMGA2, HMGIC, BABL, SRS5		High-mobility group AT-hook 2	600698		fusion partners with RAD51B, ALDH2, COX6C, HEI10 in uterine leiomyomas	Silver-Russell syndrome 5, 618908 (3)	10(pg, Hmgic)
12.544	5	31	07	12q14.3	IRAK3, IRAKM, ASRT5		Interleukin 1 receptor-associated kinase 3	604459			{Asthma susceptibility 5}, 611064 (3)	
12.545	6	26	16	12q14.3	LLPH		LLP, Aplysia, homolog of	616998				
12.546	2	1	11	12q14.3	MSRB3, DFNB74		Methionine sulfoxide reductase B3	613719			Deafness, autosomal recessive 74, 613718 (3)	
12.547	2	17	09	12q14.3	STQTL9		Stature quantitative trait locus 9	611547		associated with rs1042725	{Stature QTL 9} (2)	
12.548	3	7	13	12q14.3	TBC1D30, KIAA0984		TBC1 domain family, member 30	615077				
12.549	3	25	16	12q14.3	TMBIM4, GAAP		Transmembrane BAX inhibitor motif-containing protein 4	616874				
12.550	6	13	12	12q14-q15	CAND1, TIP120A, TIP120, KIAA0829		Cullin-associated neddylation-dissociated protein 1	607727				
12.551	11	27	19	12q15	MDM2, ACTFS, LSKB		MDM2 protooncogene	164785		mutation identified in 1 LSKB patient	{Accelerated tumor formation, susceptibility to}, 614401 (3); ?Lessel-Kubisch syndrome, 618681 (3)	10(Mdm2)
12.552	4	30	03	12q21.1-q21.2	CAPS2		Calcyphosine 2	607724				
12.553	10	07	19	12q15	CNOT2, NOT2, IDNADFS		CCR4-NOT transcription complex, subunit 2	604909			Intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies, 618608 (3)	
12.554	4	23	09	12q13.3	CNPY4, TMEM4, MSAP		Canopy 2, zebrafish, homolog of	605861				
12.555	2	18	96	12q15	CPM		Carboxypeptidase M	114860				
12.556	4	8	16	12q15	FRS2, FRS1A, SNT1		Fibroblast growth factor receptor substrate 2	607743				
12.557	3	3	09	12q15	IBD26		Inflammatory bowel disease 26	612639		associated with rs1558744	{Inflammatory bowel disease 26} (2)	
12.558	10	17	00	12q15	IL22, IL21, ILTIF		Interleukin 22	605330				
12.559	11	26	01	12q15	IL26, AK155		Interleukin 26	605679				
12.560	3	15	07	12q15	LRRC10, HRLRRP		Leucine-rich repeat-containing protein 10	610846				
12.561	1	9	09	12q15	LYZ		Lysozyme	153450			Amyloidosis, renal, 105200 (3)	
12.562	09	06	19	12q15	MDM1		MDM1 nuclear protein	613813				10(Mdm1)
12.563	03	11	19	12q15	NUP107, NUP84, NPHS11, ODG6; GAMOS7		Nucleoporin, 107kD	607617		mutation identified in 1 ODG6 family	Nephrotic syndrome, type 11, 616730 (3); ?Ovarian dysgenesis 6, 618078 (3); Galloway-Mowat syndrome 7, 618348 (3)	
12.564	11	06	20	12q15	PRANCR, LINC01481		Progenitor renewal-associated noncoding RNA	619085				
12.565	7	17	14	12q15	PTPRR, PCPTP1		Protein-tyrosine phosphatase, receptor type, R	602853				
12.566	4	25	93	12q15	PTPRB		Protein tyrosine phosphatase, receptor type, beta polypeptide	176882				
12.567	2	16	02	12q21.1	TRHDE		Thyrotropin-releasing hormone-degrading ectoenzyme	606950				
12.568	1	31	01	12q21.2	PHLDA1, TDAG51		Pleckstrin homology-like domain, family A, member 1	605335				
12.569	03	20	20	12q21.2-q21.3	PPP1R12A, MYPT1, GUBS		Protein phosphatase 1, regulatory subunit 12A (myosin phosphatase target subunit 1)	602021			Genitourinary and/or/brain malformation syndrome, 618820 (3)	
12.570	12	24	13	12q21.1	ATXN7L3B		Ataxin 7-like 3B	615579				
12.571	4	10	14	12q21.33	EPYC, DSPG3		Epiphycan	601657				
12.572	2	23	09	12q21.2	GLIPR1, GLIPR, RTVP1		Glioma pathogenesis-related protein 1	602692				10(Glipr1)
12.573	8	19	13	12q21.2	GLIPR1L1		GLIPR1-like protein 1	610395				10(Glipr1l1)
12.574	8	19	13	12q21.2	GLIPR1L2		GLIPR1-like protein 2	610394				10(Glipr1l2)
12.575	12	4	02	12q21.31-q21.32	GNTIVH		UDP-N-acetylglucosamine:alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV	607385				
12.576	10	25	18	12q21.31	MYF5, EORVA		Myogenic factor-5	159990			Ophthalmoplegia, external, with rib and vertebral anomalies, 618155 (3)	
12.577	02	08	19	12q21.31	MYF6, CNM3		Myogenic factor-6	159991				10(Myf6)
12.578	8	28	97	12q21.31	NTS		Neurotensin	162650				
12.579	12	15	98	12q21.2	PAWR, PAR4		PRKC, apoptosis, WT1, regulator	601936				
12.580	10	23	87	12q21	PEPB		Peptidase B	169900				10(Pep2)
12.581	1	27	11	12q23.1	RMST, NCRMS, NCRNA00054		Rhabdomyosarcoma 2-associated transcript	607045				
12.582	4	12	92	12q21.33	ATP2B1, PMCA1		ATPase, Ca++ transporting, plasma membrane, 1	108731				
12.583	5	5	09	12q21-q23	DUH2		Dyschromatosis universalis hereditaria 2	612715		between rs1921045 and rs2373584	Dyschromatosis universalis hereditaria 2 (2)	
12.584	11	12	98	12q21-q23	MYP3		Myopia, high grade, 3, autosomal dominant	603221			Myopia-3 (2)	
12.585	11	24	98	12q21.2	CSRP2, LMO5		Cysteine and glycine-rich protein-2 (LIM domain only 5, smooth muscle)	601871		pseudogene on 3q21.1		
12.586	2	2	17	12q21.1	KCNC2		Potassium voltage-gated channel, Shaw-related subfamily, member 2	176256		previously on 19q13.3-q13.4		10(Kcnc2)
12.587	10	29	18	12q21.1	LGR5, GPR49		Leucine-rich repeat-containing G protein-coupled receptor 5	606667				
12.588	2	6	08	12q21.2	NAV3, POMFIl1, KIAA0938		Neuron navigator 3	611629				
12.589	12	18	08	12q21.1	RAB21, KIAA0118		RAB-associated protein RAB21	612398				
12.590	3	23	09	12q21.1	TBC1D15		TBC1 domain family, member 15	612662				
12.591	1	20	09	12q21.1	THAP2		THAP domain-containing protein 2	612531				
12.592	9	8	09	12q21.1	TPH2, NTPH, ADHD7		Tryptophan hydroxylase 2	607478			{Unipolar depression, susceptibility to}, 608516 (3); {Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)	
12.593	4	24	08	12p11.22	MRPS35, MRPS28		Mitochondrial ribosomal protein S35	611995		3 pseudogenes		
12.594	10	16	14	12q21.2	BBS10, C12orf58, FLJ23560		BBS10 gene	610148			Bardet-Biedl syndrome 10, 615987 (3)	
12.595	09	27	20	12q21.2	KRR1		KRR1 small subunitprocessome component homolog	612817				
12.596	5	19	06	12q21.2	NAP1L1, NAP1L		Nucleosome assembly protein 1-like 1	164060				
12.597	9	12	17	12q21.31	PTPRQ, PTPGMC1, DFNB84A, DFNA73		Protein-tyrosine phosphatase, receptor-type, Q	603317		mutation identified in 1 DFNA73 family	Deafness, autosomal recessive 84A, 613391 (3); Deafness, autosomal dominant 73, 617663 (3)	10(Ptpgmc1)
12.598	10	11	14	12q21.32	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14		Centrosomal protein, 290kD	610142		mutation identified in 1 BBS14 family	Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3); Leber congenital amaurosis 10, 611755 (3); Meckel syndrome 4, 611134 (3); ?Bardet-Biedl syndrome 14, 615991 (3)	
12.599	3	11	09	12q21.33	DCN, CSCD		Decorin	125255		conflicting assignments to 12q23 and 12q13.2	Corneal dystrophy, congenital stromal, 610048 (3)	10(Dcn)
12.600	6	9	08	12q21.2	E2F7		E2F transcription factor 7	612046				10(E2f7)
12.601	03	16	20	12q21.31	ALX1, CART1, FND3		Aristaless-like homeobox 1 (cartilage homeoprotein 1)	601527			Frontonasal dysplasia 3, 613456 (3)	
12.602	6	25	99	12q21.33	GALNT4, GalNAcT4		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4	603565				
12.603	5	27	97	12q21.33	LUM, LDC		Lumican	600616				10(Ldc)
12.604	4	26	12	12q21.31	SLC6A15, SBAT1		Solute carrier family 6 (neurotransmitter transporter), member 15	607971				
12.605	12	1	11	12q21.31	ACSS3		Acyl-CoA synthetase short-chain family, member 3	614356				
12.606	10	1	17	12q21.31	LIN7A, VELI1, MALS1		Lin7, C. elegans, homolog of, A	603380				
12.607	12	29	06	12q24.31	MLXIP, MONDOA, KIAA0867		MLX-interacting protein	608090				
12.608	11	20	12	12q21.31	OTOGL, C12orf64, DFNB84B		Otogelin-like protein	614925			Deafness, autosomal recessive 84B, 614944 (3)	
12.609	11	27	18	12q21.31	PPFIA2		Protein-tyrosine phosphatase, receptor-type, F polypeptide-interacting protein alpha 2	603143				
12.610	7	18	12	12q21.31	RASSF9, PAMCI, PCIP1		Ras association domain family, member 9	610383				
12.611	7	18	14	12q21.31	TMTC2		Transmembrane and tetratricopeptide repeat domains-containing protein 2	615856				
12.612	12	19	16	12q21.32	TMTC3, SMILE, LIS8		Transmembrane and tetratricopeptide repeat domains-containing protein 3	617218			Lissencephaly 8, 617255 (3)	
12.613	7	22	16	12q21.33	CNA1		Cornea plana 1, autosomal dominant	121400		between D12S82 and D12S351	Cornea plana 1, autosomal dominant (2)	
12.614	6	11	13	12q21.33	DUSP6, MKP3, PYST1, HH19		Dual-specificity phosphatase-6	602748			Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3)	
12.615	5	24	16	12q21.33	PACD		Corneal dystrophy, posterior amorphous	612868		contiguous gene deletion syndrome	Corneal dystrophy, posterior amorphous (4)	
12.616	09	19	19	12q21.33	POC1B, PIX1, CORD20		POC1B antisense RNA 1	614784			Cone-rod dystrophy 20, 615973 (3)	
12.617	12	19	16	12q22	CRADD, RAIDD, MRT34		Caspase and RIP adaptor with death domain	603454			Mental retardation, autosomal recessive 34, with variant lissencephaly, 614499 (3)	10(Raidd)
12.618	3	17	94	12q21.33	BTG1		B-cell translocation gene 1, anti-proliferative	109580				
12.619	6	27	14	12q22	CEP83, CCDC41, NPHP18		Centrosomal protein, 83kD	615847			Nephronophthisis 18, 615862 (3)	
12.620	6	26	16	12q22	CLLU1		Chronic lymphocytic leukemia upregulated gene 1	616988				
12.621	6	26	16	12q22	CLLU1OS		Chronic lymphocytic leukemia upregulated 1, opposite strand	616989				
12.622	7	10	13	12q22	EEA1		Early endosome antigen 1	605070				
12.623	8	27	15	12q22	FGD6, ZFYVE24		FYVE, RhoGEF, and ph domain-containing protein 6	613520				
12.624	3	6	01	12q21.33	KERA, CNA2		Keratocan	603288			Cornea plana 2, autosomal recessive, 217300 (3)	10(Kera)
12.625	5	27	16	12q21.32	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69		KIT ligand (mast cell growth factor; steel, mouse, homolog of)	184745		associated with dbSNP rs12821256	[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3); Hyperpigmentation with or without hypopigmentation, 145250 (3); Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	10(Sl; Scf)
12.626	10	1	95	12q23.1	LTA4H		Leukotriene A4 hydrolase	151570				
12.627	8	3	12	12q22	METAP2, p67		Methionine aminopeptidase 2	601870				
12.628	12	19	11	12q22	MIR492		Micro RNA 492	614384		within KRT19		
12.629	3	5	08	12q22	MRPL42, MRPL31, MRPS32		Mitochondrial ribosomal protein L42	611847				
12.630	01	10	19	12q22	NDUFA12, MC1DN23		NADH-ubiquinone oxidoreductase subunit A12	614530		mutation identified in 1 MC1DN23 patient	?Mitochondrial complex I deficiency, nuclear type 23, 618244 (3)	
12.631	3	18	95	12q23.1	NEDD1		Neural precursor cell expressed, developmentally down-regulated 1	600372				
12.632	9	27	17	12q22	NR2C1, TR2		Nuclear receptor subfamily 2, group C, member 1	601529				
12.633	12	22	16	12q22	SOCS2AS1		SOCS2 antisense RNA 1	617269				
12.634	2	12	09	12q23.2	SPIC		SPIC transcription factor	612568				
12.635	4	26	17	12q22	TMCC3		Transmembrane and coiled-coil domain family, member 3	617459				
12.636	2	3	17	12q23.1	TMPO, LAP2		Thymopoietin	188380				10(Tmpo)
12.637	8	18	14	12q22	UBE2N, UBCHBEN; UBC13		Ubiquitin-conjugating enzyme E2N	603679				
12.638	08	22	19	12q23.2	ASCL1, ASH1		Achaete-scute family bHLH transcription factor 1	100790		distal to PAH and proximal to TRA1	Central hypoventilation syndrome, congenital, 209880 (3); Haddad syndrome, 209880 (3)	
12.639	07	14	20	12q24.13	DDX54, DP97		DEAD-box helicase 54	611665				
12.640	8	9	05	12q23.1	HAL, HSTD		Histidine ammonia-lyase (histidase)	609457			[Histidinemia], 235800 (3)	10(Hstd)
12.641	9	18	06	12q22	NTN4		Netrin 4	610401				
12.642	1	11	07	12q23.1-q23.2	SLC5A8, AIT, SMCT		Solute carrier family (iodide transporter), member 8	608044				
12.643	8	21	07	12q23.3	NT5DC3, TU12B1TY, GNN		5' nucleotidase domain-containing protein 3	611076				10(Nt5dc3)
12.644	6	7	04	12q22-q23.2	MDD1		Major depressive disorder	608520		max lod with D12S1706	Major depressive disorder 1, 608516 (2)	
12.645	1	10	12	12q22-q23.3	ETL2, FTLE		Epilepsy, familial temporal lobe	608096		max lod at D12S1706	Epilepsy, familial temporal lobe, 2 (2)	
12.646	8	25	04	12q23.2	IGF1		Insulin-like growth factor-1, or somatomedin C	147440			Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3)	10(Igf1)
12.647	4	30	02	12q24.31	ACADS, SCAD		Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain	606885			Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)	5(Bcd1)
12.648	10	24	00	12q23.1	APAF1		Apoptotic protease activating factor 1	602233				
12.649	1	12	11	12q23.2	C12orf48, AROM, PARPBP		Chromosome 12 open reading frame 48	613687				
12.650	11	02	18	12q23.3	CHST11, C4ST1, OCBMD		Carbohydrate sulfotransferase 11	610128		mutation identified in 1 OCBMD family	?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits, 618167 (3)	
12.651	1	7	95	12q23.1	ELK3, SAP2, ERP		ELK3, ETS-domain protein (SRF accessory protein 2)	600247				6(Scnn1)
12.652	2	7	06	12q23.1	IKIP		I-kappa-B kinase-interacting protein	609861				
12.653	9	24	08	12q23.1	SLC17A8, VGLUT3, DFNA25		Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (vesicular glutamate transporter 3)	607557			Deafness, autosomal dominant 25, 605583 (3)	
12.654	2	19	07	12q23.1	SLC25A3, PHC		Solute carrier family 25 (mitochondrial carrier), member 3	600370			Mitochondrial phosphate carrier deficiency, 610773 (3)	
12.655	2	12	16	12q23.2	SYCP3, SCP3, COR1, SPGF4, RPRGL4		Synaptonemal complex protein 3	604759			Spermatogenic failure 4, 270960 (3); Pregnancy loss, recurrent, 4, 270960 (3)	
12.656	11	24	08	12q23.1	TMEM16D, FLJ34272		Transmembrane protein 16D	610111				
12.657	5	22	07	12q22	USP44		Ubiquitin-specific protease 44	610993				
12.658	3	18	94	12q23.2	PMCH		Pro-melanin-concentrating hormone	176795				
12.659	8	16	99	12q24.13	RASAL1, RASAL		Ras protein activator-like 1	604118				
12.660	4	27	12	12q23-q24	SPG36		Spastic paraplegia-36	613096		between D12S360 and D12S354	Spastic paraplegia 36, autosomal dominant (2)	
12.661	12	22	08	12q24.11	USP30		Ubiquitin-specific protease 30	612492				
12.662	2	25	03	12q24.11	ATP2A2, ATP2B, DAR		ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2	108740			Darier disease, 124200 (3); Acrokeratosis verruciformis, 101900 (3)	11(Atpb2)
12.663	5	30	17	12q23.3	CRY1, PHLL1, DSPD		Cryptochrome 1 (photolyase-like)	601933			{Delayed sleep phase disorder, susceptibility to}, 614163 (3)	10(Cry1)
12.664	9	2	09	12q23.3	EID3, NSMCE4B, NSE4B		E1A-like inhibitor of differentiation 3	612986				10(Eid3)
12.665	1	27	97	12q13.3	NACA		Nascent-polypeptide-associated complex alpha polypeptide	601234				
12.666	4	10	96	12q24.31	PLA2G1B, PLA2A, PLA2, PPLA2		Phospholipase A2, group IB, pancreas	172410				
12.667	4	19	01	12q23.3	PRDM4, PFM1		PR domain-containing protein 4	605780				
12.668	12	4	03	12q24.31	RNF34, RFI		Ring finger protein 34	608299				
12.669	2	20	98	12q23.3	TXNRD1, TXNR		Thioredoxin reductase-1	601112				
12.670	6	15	12	12q24.11	UNG, DGU, HIGM5		Uracil-DNA glycosylase	191525			Immunodeficiency with hyper IgM, type 5, 608106 (3)	
12.671	6	16	10	12q24.11	MYL2, CMH10		Myosin, light polypeptide-2, regulatory, cardiac, slow	160781			Cardiomyopathy, hypertrophic, 10, 608758 (3)	
12.672	12	28	08	12q23.1	ANKS1B, EB1		Ankyrin repeat and sterile alpha motif domain-containing protein 1B	607815				
12.673	7	18	14	12q23.1	CDK17, PCTK2, PCTAIRE2		Cyclin-dependent kinase 17	603440				
12.674	11	23	16	12q23.1	GAS2L3, G2L3		Growth arrest-specific 2-like 3	617224				
12.675	8	1	16	12q23.1	NR1H4, FXR, RIP14, PFIC5		Nuclear receptor subfamily 1 group H member 4	603826			Cholestasis, progressive familial intrahepatic, 5, 617049 (3)	10(Fxr)
12.676	5	25	13	12q23.1	SNRPF		Small nuclear ribonucleoprotein polypeptide F	603541				
12.677	07	31	20	12q23.1	SCYL2, CVAK104, KIAA1360, AMC4		SCY1-like protein 2	616365			Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum, 618766 (3)	
12.678	12	04	20	12q23.2	ARL1		ADP ribosylation factor-like GTPase 1	603425				
12.679	1	11	16	12q23.2	CHPT1, CPT, CPT1		Choline phosphotransferase 1	616747				
12.680	4	20	10	12q23.2	DRAM1		Damage-regulated autophagy modulator 1	610776				
12.681	1	9	13	12q23.2	HELLPAR, lncHELLP		HELLP syndrome-associated long noncoding RNA	614985				
12.682	08	21	19	12q23.2	MYBPC1, LCCS4, MYOTREM		Myosin-binding protein C, slow type	160794			Arthrogryposis, distal, type 1B, 614335 (3); Lethal congenital contracture syndrome 4, 614915 (3); Myopathy, congenital, with tremor, 618524 (3)	
12.683	11	12	18	12q23.2	NUP37, p37, MCPH24		Nucleoporin, 37kD	609264		mutation identified in 1 MCPH24 family	?Microcephaly 24, primary, autosomal recessive, 618179 (3)	
12.684	7	16	09	12q23.2	UTP20, DRIM		UTP20, S. cerevisiae, homolog of	612822				
12.685	4	6	15	12q23.3	ALDH1L2		Aldehyde dehydrogenase 1 family, member L2	613584				
12.686	10	28	19	12q24.11	ALKBH2, ABH2		AlkB homolog 2, alpha-ketoglutarate-dependent dioxygenase	610602				
12.687	03	16	20	12q23.3	C12orf73, BR		Chromosome 12 open reading frame 73 (brawnin)	618812				
12.688	09	20	19	12q23.3	CKAP4, CLIMP63		Cytoskeleton-associated protein 4	618595				
12.689	3	13	08	12q23.2	GNPTAB, GNPTA		N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits	607840		conflicting assignment to 4q	Mucolipidosis III alpha/beta, 252600 (3); Mucolipidosis II alpha/beta, 252500 (3)	
12.690	9	7	04	12q23.3	HCFC2, HCF2		Host cell factor C2	607926				
12.691	9	8	08	12q23.3	HSP90B1, TRA1, GRP94, GP96		Heat-shock protein, 90kD, beta, 1	191175				10(Tra1)
12.692	5	2	16	12q23.3	MTERF2, MTERFD3		Transcription termination factor 2, mitochondrial	616929				
12.693	8	29	13	12q23.3	NFYB		Transcription factor NF-Y, B subunit	189904				10(Nfyb)
12.694	5	29	12	12q23.3	NUAK1, ARK5,  KIAA0537		NUAK family, SNF1-like kinase, 1	608130				
12.695	12	19	11	12q23.3	POLR3B, RPC2, C128, HLD8		Polymerase III, RNA, subunit B	614366			Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	
12.696	09	09	19	12q23.3	RIC8B		RIC8 guanine nucleotide exchange factor B	609147				
12.697	01	04	19	12q23.3	RFX4		Regulatory factor X, 4	603958				
12.698	2	27	07	12q23.3	SLC41A2		Solute carrier family 41, member 2	610802				10(Slc41a2)
12.699	08	17	20	12q23.3	TMEM119, OBIF		Transmembrane protein 119	618989				
12.700	4	20	17	12q23.3	WASHC4, KIAA1033, SWIP, MRT43		WASH complex, subunit 4	615748		mutation identified in 1 MRT43 family	?Mental retardation, autosomal recessive 43, 615817 (3)	
12.701	1	29	01	12q24.31	ABCB9		ATP-binding cassette, subfamily B, member 9	605453				
12.702	4	14	15	12q24.12	ATXN2, ATX2, SCA2, ASL13		Ataxin-2	601517			Spinocerebellar ataxia 2, 183090 (3); {Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3); {Parkinson disease, late-onset, susceptibility to}, 168600 (3)	
12.703	3	9	09	12q24.12	BRAP, BRAP2, IMP		BRCA1-associated protein	604986				
12.704	5	28	08	12q24	CELIAC13		Celiac disease, susceptibility to, 13	612011		associated with rs3184504	{Celiac disease, susceptibility to, 13} (2)	
12.705	2	10	04	12q24	CIMT		Carotid intimal medial thickness	608447		161cM from pter; near SCARB1	Carotid intimal medial thickness (2)	
12.706	5	16	18	12q24.11	DAO, DAMOX		D-amino-acid oxidase	124050				
12.707	01	13	20	12q24.13	DTX1		Deltex E3 ubiquitin ligase 1	602582				
12.708	02	19	20	12q24.23	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A		Heat-shock 22-kD protein 8	608014			Neuronopathy, distal hereditary motor, type IIA, 158590 (3); Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	
12.709	2	5	16	12q24.21	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD		Mediator complex subunit 13-like	608771			Transposition of the great arteries, dextro-looped 1, 608808 (3); Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	5(Med13l)
12.710	2	20	03	12q24.11	MMAB		MMAB gene	607568			Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3)	
12.711	11	7	15	12q24.11	MVK, MVLK, POROK3		Mevalonate kinase	251170			Mevalonic aciduria, 610377 (3); Hyper-IgD syndrome, 260920 (3); Porokeratosis 3, multiple types, 175900 (3)	
12.712	2	1	00	12q24.31	NCOR2, SMRT		Nuclear receptor corepressor 2	600848				
12.713	6	8	15	12q24.31	ORAI1, TMEM142A, CRACM1, IMD9, TAM2		ORAI calcium release-activated calcium modulator 1	610277			Immunodeficiency 9, 612782 (3); Myopathy, tubular aggregate, 2, 615883 (3)	
12.714	1	27	09	12q24.31	P2RX7, P2X7		Purinergic receptor P2X, ligand-gated ion channel, 7	602566				
12.715	8	17	12	12q24	PDA1		Patent ductus arteriosus	607411			{Patent ductus arteriosus, susceptibility to} (2)	
12.716	6	25	99	12q24.23	PXN		Paxillin	602505				
12.717	08	21	19	12q24.11	RAD9B		RAD9 checkpoint clamp component B	608368				5(Rad9b)
12.718	10	1	95	12q24.11	SELPLG, PSGL1		Selectin P ligand	600738				5(Selpl)
12.719	7	12	11	12q24.12	SH2B3, LNK		SH2B adaptor protein 3	605093			Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3); Erythrocytosis, somatic, 133100 (3)	
12.720	3	30	18	12q24.13	SLC8B1, SLC24A6, NCKX6		Solute carrier family 8 member B1	609841				5(Slc24a6)
12.721	2	16	04	12q24	SLEB4		Systemic lupus erythematosus, susceptibility to, 4	608437			{Systemic lupus erythematosus, susceptibility to, 4} (2)	
12.722	11	2	05	12q24.31	HPD		4-hydroxyphenylpyruvate dioxygenase	609695			Tyrosinemia, type III, 276710 (3); Hawkinsinuria, 140350 (3)	
12.723	6	9	98	12q24.11	ACACB, ACCB, ACC2		Acetyl-Coenzyme A carboxylase, beta	601557				
12.724	2	25	14	12q24.12	ACAD10		Acyl-CoA dehydrogenase family, member 10	611181				
12.725	2	20	07	12q23.3	APPL2, FLJ10659		Adaptor protein, phosphotyrosine interaction, PH domain, and leucine zipper-containing protein 2	606231				
12.726	8	21	98	12q24.31	BCL7A, BCL7		B-cell CLL/lymphoma-7A	601406			B-cell non-Hodgkin lymphoma, high-grade (3)	
12.727	3	16	99	12q23.3	CMKLR1		Chemokine-like receptor 1	602351				
12.728	1	31	01	12q24.11	CORO1C		Coronin 1C	605269				
12.729	12	01	20	12q24.11-q24.12	CUX2, CDP2, CUTL2, DEE67		Cut-like homeobox 2	610648			Developmental and epileptic encephalopathy 67, 618141 (3)	
12.730	6	30	05	12q24.11	FOXN4		Forkhead box N4	609429				
12.731	07	23	20	12q24.11	GIT2, CAT2		GIT ArfGAP 2	608564				
12.732	4	13	10	12q23.3	ISCU, HML		Iron-sulfur cluster scaffold, E. coli, homolog of	611911			Myopathy with lactic acidosis, hereditary, 255125 (3)	
12.733	3	24	09	12q23.2	PAH, PKU1		Phenylalanine hydroxylase	612349		close to IGF1	Phenylketonuria, 261600 (3); [Hyperphenylalaninemia, non-PKU mild], 261600 (3)	10(Pah)
12.734	12	02	20	12q24.11	PPTC7, TAPP2C		Protein phosphatase targeting CoQ7	609668				
12.735	1	13	99	12q24.23	PRKAB1		Protein kinase, AMP-activated, noncatalytic, beta-1	602740				
12.736	8	27	15	12q24.13	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS		Protein tyrosine phosphatase, nonreceptor-type, 11	176876			Noonan syndrome 1, 163950 (3); LEOPARD syndrome 1, 151100 (3); Leukemia, juvenile myelomonocytic, somatic, 607785 (3); Metachondromatosis, 156250 (3)	
12.737	7	10	08	12q24.13	RPH3A, KIAA0985		Rabphilin 3A	612159				
12.738	10	16	14	12q23.3	SART3, P100, KIAA0156, TIP110		Squamous cell carcinoma antigen recognized by T cells 3	611684				5(Sart3)
12.739	5	2	07	12q24.1	STUT2		Stuttering, familial persistent, 2	609261		max lod with PAH	Stuttering, familial persistent, 2 (2)	
12.740	1	2	08	12q24.11	SVOP		SV2-related protein	611699				5(Svop)
12.741	8	4	97	12q24.21	TBX3		T-box 3	601621			Ulnar-mammary syndrome, 181450 (3)	5(Tbx3)
12.742	2	19	97	12q24.21	TBX5		T-box 5	601620			Holt-Oram syndrome, 142900 (3)	5(Tbx5)
12.743	3	23	09	12q24.11	TCHP		Trichoplein	612654				
12.744	6	2	98	12q23.3	TDG		Thymine-DNA glycosylase	601423				10(Tdg)
12.745	8	25	11	12q24.11	TECT1, JBTS13		Tectonic family, member 1	609863			Joubert syndrome 13, 614173 (3)	5(Tect1)
12.746	5	19	06	12q24.13	TPCN1, TPC1, KIAA1169		Two-pore segment channel 1	609666				
12.747	7	18	12	12q24.11	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3		Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel)	605427		mutation identified in 1 ANFH2 family	Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3); Metatropic dysplasia, 156530 (3); Hereditary motor and sensory neuropathy, type IIc, 606071 (3); Scapuloperoneal spinal muscular atrophy, 181405 (3); [Sodium serum level QTL 1], 613508 (3); Parastremmatic dwarfism, 168400 (3); SED, Maroteaux type, 184095 (3); Neuronopathy, distal hereditary motor, type VIII, 600175 (3); Digital arthropathy-brachydactyly, familial, 606835 (3); ?Avascular necrosis of femoral head, primary, 2, 617383 (3)	5(Vroac)
12.748	8	16	94	12q24.11	PPP1CC		Protein phosphatase-1, catalytic subunit, gamma isoform	176914				10(Ppp1cc)
12.749	11	13	12	12q24.1-q24.2	POROK2, PPPD1		Porokeratosis 2, palmar, plantar, and disseminated	175850		between D12S1613 and D12S1341	Porokeratosis 2, palmar, plantar, and disseminated (2)	
12.750	9	2	16	12q24.23	CIT, STK21, CRIK, MCPH17		Citron rho-interacting serine/threonine kinase	605629			Microcephaly 17, primary, autosomal recessive, 617090 (3)	
12.751	10	23	20	12q24.31	MSI1		Musashi RNA binding protein 1	603328				
12.752	8	18	14	12q24.11	ANAPC7, APC7		Anaphase-promoting complex, subunit 7	606949				
12.753	4	5	13	12q24.11	ANKRD13A		Ankyrin repeat domain-containing protein 13A	615123				
12.754	11	11	14	12q24.11	ARPC3, ARC21		Actin-related protein 2/3 complex, subunit 3	604225				
12.755	5	9	18	12q24.11	CCDC63, ODA5		Coiled-coil domain-containing protein 63	617969				
12.756	11	1	13	12q24.11	GLTP		Glycolipid transfer protein	608949				
12.757	1	3	12	12q24.11	HVCN1, HV1, VSOP		Hydrogen voltage-gated channel 1	611227				
12.758	7	26	10	12q24.11	KCTD10		Potassium channel tetramerization domain-containing 10	613421				
12.759	6	1	12	12q24.11	MYO1H		Myosin IH	614636				
12.760	05	05	20	12q24.11	SSH1, KIAA1298		Slingshot protein phosphatase 1	606778				
12.761	4	10	15	12q24.11	UBE3B, BPIDS, KOS		Ubiquitin-protein ligase E3B	608047			Kaufman oculocerebrofacial syndrome, 244450 (3)	5(Ube3b)
12.762	12	27	19	12q24.11	VPS29, PEP11		VPS29 retromer complex component	606932				
12.763	9	30	11	12q24.12	FAM109A, SES1, IPIP27A		Family with sequence similarity 109, member A	614239				
12.764	7	8	10	12q24.12-q24.13	MAPKAPK5, PRAK		Mitogen-activated protein kinase-activated protein kinase 5	606723				
12.765	08	12	19	12q24.11	IFT81, DV1, CDV1R, SRTD19		Intraflagellar transport 81	605489			Short-rib thoracic dysplasia 19 with or without polydactyly, 617895 (3)	5(Cdv1, Cdv1r)
12.766	02	06	20	12q24.13	NAA25, MDM20, C12orf30		N-alpha-acetyltransferase 25, NatB auxiliary subunit	612755				
12.767	5	25	13	12q24.13	SDS, SDH		Serine dehydratase	182128				
12.768	12	29	09	12q24.13	TRAFD1, FLN29		TRAF-type zinc finger domain-containing 1	613197				
12.769	6	30	15	12q24.13-q24.21	RBM19, KIAA0682		RNA-binding motif protein 19	616444				
12.770	7	8	10	12q24.12	ALDH2		Aldehyde dehydrogenase 2 family, mitochondrial	100650			Alcohol sensitivity, acute, 610251 (3); {Hangover, susceptibility to}, 610251 (3); {Sublingual nitroglycerin, susceptibility to poor response to} (3); {Esophageal cancer, alcohol-related, susceptibility to} (3)	4(Aldh2)
12.771	1	9	13	12q24.31	CAMKK2, KIAA0787, CAMKKB		Calcium/calmodulin-dependent protein kinase kinase 2, beta	615002				
12.772	10	9	14	12q24.31	COX6A1, CMTRID		Cytochrome c oxidase, subunit VIa, polypeptide-1	602072		pseudogenes on chr.7 and chr.6	Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3)	
12.773	2	21	06	12q24.31	DYNLL1, DNCL1, DLC1, PIN		Dynein, light chain, LC8-type 1	601562		possible pseudogene on 14q24		
12.774	02	06	20	12q24.23	GCN1, GCN1L1		GCN1 activator of EIF2AK4	605614				
12.775	3	29	12	12q24.31	HNF1A, TCF1, MODY3, IDDM20		HNF1 homeobox B	142410			MODY, type III, 600496 (3); {Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3); {Diabetes mellitus, insulin-dependent}, 222100 (3); Hepatic adenoma, somatic, 142330 (3); Renal cell carcinoma, 144700 (3); Diabetes mellitus, insulin-dependent, 20, 612520 (3)	5(Tcf1)
12.776	8	8	13	12q24.22	HRK, DP5		Harakiri	603447				
12.777	1	31	07	12q24.22-q24.23	KSR2		Kinase suppressor of RAS 2	610737				
12.778	12	11	02	12q24.2	NIDDM2		Diabetes mellitus, noninsulin-dependent, 2	601407		no mutations found in HNF1A	Diabetes mellitus, noninsulin-dependent, 2 (2)	
12.779	7	3	18	12q24.13	OAS1, OIAS		2',5'-oligoadenylate synthetase-1	164350				
12.780	6	24	99	12q24.13	OAS2		2',5'-oligoadenylate synthetase-2	603350				
12.781	6	24	99	12q24.13	OAS3		2',5'-oligoadenylate synthetase-3	603351				
12.782	11	16	98	12q24.31	OASL, TRIP14		2',5'-oligoadenylate synthetase-like	603281				
12.783	12	7	07	12q24.22	TESC, TSC		Tescalcin, mouse, homolog of	611585				5(Tesc)
12.784	6	26	16	12q24.23	BICDL1, BICDR1, CCDC64		BICD family-like cargo adaptor 1	617002				
12.785	9	9	08	12q24.22	FBXO21, FBX21, KIAA0875		F-box only protein 21	609095				5(Fbxo21)
12.786	9	9	08	12q24.22	FBXW8, FBW8, FBXW6, FBW6, FBXO29, FBX29		F-box and WD40 domain protein 8	609073				5(Fbxw8)
12.787	9	8	08	12q24.23	PEBP1, PBP, RKIP		Phosphatidylethanolamine-binding protein 1	604591				
12.788	10	26	15	12q24.23	RAB35		Ras-associated protein Rab35	604199				
12.789	11	11	09	12q24.23	SRRM4, KIAA1853, NSR100		Serine/arginine repetitive matrix protein 4	613103				
12.790	12	18	19	12q24.23	SUDS3, SDS3, SAP45		SDS3 homolog, SIN3A corepressor complex component	608250				
12.791	12	22	15	12q24.23	TAOK3, JIK, DPK		TAO kinase 3	616711				
12.792	01	23	19	12q24.23	TMEM233, DSPB2		Transmembrane protein 233	618296				
12.793	8	18	16	12q24.2-q24.3	RPL21P1, ALFN1, HALF1		Ribosomal protein L21 pseudogene 1	603416				
12.794	7	23	13	12q24.2-q24.3	CTRCT37, CCA5		Cataract 37	614422		between D12S1718 and D12S1723	Cataract 37, autosomal dominant (2)	
12.795	5	19	09	12q24.31	HIP1R, HIP12		Huntingtin-interacting protein 1-related protein	605613				
12.796	11	16	98	12q24.31	PSMD9		Proteasome 26S subunit, non-ATPase, 9	603146				
12.797	7	8	10	12q24.22	NOS1		Nitric oxide synthase 1, neuronal	163731				5(Nos1)
12.798	3	18	95	12q24.23	RFC5		Replication factor C5, 36.5kD (activator 1, 36.5kD)	600407				
12.799	1	30	12	12q24.31	ATP6V0A2, WSS, ARCL2A		ATPase, H+ transporting, V0 subunit A2	611716			Cutis laxa, autosomal recessive, type IIA, 219200 (3); Wrinkly skin syndrome, 278250 (3)	
12.800	6	15	15	12q24.31	CLIP1, RSN, CYLN1, CLIP170		CAP-GLY domain containing linker protein 1	179838				
12.801	10	19	97	12q24.33	MUC8		Mucin 8, tracheobronchial	601932				
12.802	03	05	19	12q24.33	POLE, CRCS12, FILS, IMAGEI		Polymerase, DNA, epsilon	174762			{Colorectal cancer, susceptibility to, 12}, 615083 (3); FILS syndrome, 615139 (3); IMAGE-I syndrome, 618336 (3)	5(Pole)
12.803	6	1	09	12q24.33	RAN, ARA24		Ras-related nuclear protein	601179				
12.804	5	26	13	12q24.33	TMEM132D, KIAA1944, MOLT		Transmembrane protein 132D	611257				
12.805	2	9	92	12q24.31	UBC		Ubiquitin C	191340				
12.806	09	09	19	12q24.33	ULK1, UNC51		UNC51-like kinase 1	603168				
12.807	3	24	04	12q24.33	ZNF268		Zinc finger protein 268	604753				
12.808	3	1	18	12q24.31	ZNF664, ZFOC1		Zinc finger protein 664	617890				
12.809	2	28	01	12q13.3	BAZ2A		Bromodomain adjacent to zinc finger domain, 2A	605682				
12.810	12	6	11	12q24.31	AACS, ACSF1		Acetoacetyl-CoA synthetase	614364				
12.811	12	04	20	12q24.31	ARL6IP4		ADP ribosylation factor-like GTPase 6 interacting protein 4	607668				
12.812	4	26	10	12q24.31	B3GNT4		Beta-1,3-N-acetylglucosaminyltransferase 4	605864				
12.813	2	13	14	12q24.31	BRI3BP		BRI3-binding protein	615627				
12.814	12	5	13	12q24.31	C12orf65, COXPD7, SPG55		Chromosome 12 open reading frame 65	613541			Combined oxidative phosphorylation deficiency 7, 613559 (3); Spastic paraplegia 55, autosomal recessive, 615035 (3)	
12.815	9	29	10	12q24.31	CCDC62, ERAP75		Coiled-coil domain-containing protein 62	613481				
12.816	10	15	20	12q24.31	COQ5, COQ10D9		Coenzyme Q5, methyltransferasef	616359		mutation identified in 1 COQ10D9 family	?Coenzyme Q10 deficiency, primary, 9, 619028 (3)	
12.817	07	13	20	12q24.31	DHX37, KIAA1517, NEDBAVC, SRXY11		DEAH-box helicase 37	617362			Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies, 618731 (3); 46, XY sex reversal 11, 273250 (3)	
12.818	03	10	20	12q24.31	DIABLO, SMAC, DFNA64		Diablo IAP-binding mitochondrial protein	605219			Deafness, autosomal dominant 64, 614152 (3)	
12.819	12	10	15	12q24.31	EIF2B1, EIF2BA		Eukaryotic translation initiation factor 2B, subunit 1	606686			Leukoencephalopathy with vanishing white matter, 603896 (3)	
12.820	10	1	17	12q24.31	GTF2H3, TFB4		General transcription factor IIH, polypeptide 3	601750				
12.821	3	25	14	12q24.31	DENR, DRP		Density-regulated protein	604550				
12.822	04	13	20	12q24.31	GATC, COXPD42		Glutamyl-tRNA amidotransferase, subunit C	617210			Combined oxidative phosphorylation deficiency 42, 618839 (3)	
12.823	2	5	15	12q24.31	NRAV, DYNLL1AS1		Negative regulator of antiviral response, noncoding	616207		overlaps intron 1 of DYNLL1 in antisense orientation		
12.824	8	18	14	12q24.31	FAM101A, CFM2		Family with sequence similarity 101, member A	615927				
12.825	2	21	06	12q24.31	DNAH10		Dynein, axonemal, heavy chain 10	605884		previously assigned to 13q14		
12.826	6	26	01	12q24.31	CDK2AP1, DOC1		CDK-associated protein 1 (deleted in oral cancer-1)	602198				
12.827	7	14	14	12q24.31	HCAR1, GPR81, TAGPCR		Hydroxycarboxylic acid receptor 1	606923				
12.828	7	14	14	12q24.31	HCAR2, GPR109A, HM74A		Hydroxycarboxylic acid receptor 2	609163				
12.829	7	14	14	12q24.31	HCAR3, GPR109B, HM74, PUMAG		Hydroxycarboxylic acid receptor 3	606039				
12.830	2	25	15	12q24.31	IL31		Interleukin 31	609509				
12.831	5	6	15	12q24.31	KDM2B, FBXL10, FBL10, CXXC2, JHDM1B		Lysine-specific demethylase 2B	609078				
12.832	2	1	11	12q24.31	KNTC1, ROD, KIAA0166		Kinetochore-associated protein 1	607363		previously assigned to chr.17		
12.833	3	15	11	12q24.31	MLEC, KIAA0152		Malectin	613802				
12.834	3	11	09	12q24.31	MPVQTL1		Mean platelet volume quantitative trait locus 1	612573		associated with rs7961894	[Mean platelet volume QTL1] (2)	
12.835	3	23	06	12q24.31	POP5, HSPC004		Processing of precursor 5, S. cerevisiae, homolog of	609992				
12.836	04	29	20	12q24.31	RHOF, RIF		RAS homolog gene family, member F, filopodia-associated	618867				
12.837	7	22	11	12q24.31	RILPL1, RLP1, GOSPEL		RAB-interacting lysosomal protein-like 1	614092				5(Rilpl1)
12.838	7	22	11	12q24.31	RILPL2, RLP2		RAB-interacting lysosomal protein-like 2	614093				
12.839	9	22	14	12q24.31	RNF10, KIAA0262		RING finger protein 10	615998				5(Rnf10)
12.840	10	5	11	12q24.31	SBNO1		Strawberry notch, Drosophila, homolog of, 1	614274				
12.841	1	31	11	12q24.31	SCARB1, CD36L1, CLA1, HDLQTL6		Scavenger receptor class B, member 1 (CD36 antigen-like 1)	601040			[High density lipoprotein cholesterol level QTL6], 610762 (3)	
12.842	09	17	20	12q24.31	SETD1B, SET1B, KIAA1076, IDDSELD		SET domain-containing protein 1B	611055			Intellectual developmental disorder with seizures and language delay, 619000 (3)	
12.843	3	31	15	12q24.23-q24.31	SIRT4, SIR2L4		Sirtuin, S. cerevisiae, homolog 4	604482				
12.844	3	22	07	12q24.31	SPPL3, IMP2		Signal peptide peptidase-like 3	608240				
12.845	12	19	11	12q24.31	SRSF9, SFRS9, SRp30c		Splicing factor, serine/arginine-rich, 9	601943				
12.846	11	23	15	12q24.31	TCTN2, TECT2, MKS8, JBTS24		Tectonic family, member 2	613846		mutation identified in 1 MKS8 family	?Meckel syndrome 8, 613885 (3); Joubert syndrome 24, 616654 (3)	
12.847	2	2	14	12q24.31	THRIL, LINC1992, BRI3BPAS1		TNF- and HNRNPL-related immunoregulatory long noncoding RNA	615622				
12.848	9	24	15	12q24.31	TMEM120B		Transmembrane protein 120B	616551				
12.849	12	17	12	12q24.31	TRIAP1, HSPC132		TP53-regulated inhibitor of apoptosis 1	614943				
12.850	12	27	19	12q24.31	VPS33A, MPSPS		VPS33A core subunit of CORVET and HOPS complexes	610034			Mucopolysaccharidosis-plus syndrome, 617303 (3)	
12.851	11	27	19	12q24.31	ZCCHC8, PFBMFT5		Zinc finger CCHC domain-containing protein 8	616381		mutation identified in 1 PFBMFT5 family	?Pulmonary fibrosis and/or bone marrow failure, telomere-related, 5, 618674 (3)	
12.852	12	27	19	12q24.31	VPS37B		VPS37B subunit of ESCRT-I	610037				
12.853	10	22	18	12q24.31	WDR66, CFAP251, SPGF33		WD repeat-containing protein 66	618146			Spermatogenic failure 33, 618152 (3)	
12.854	6	8	01	12q24.13	LHX5		LIM homeo box protein 5	605992				
12.855	7	14	98	12q24.31	P2RX4, P2X4		Purinergic receptor P2X, ligand-gated ion channel, 4	600846				
12.856	6	22	14	12q24.33	SLC15A4, PHT1, PTR4		Solute carrier family 15 (oligopeptide transporter), member 4	615806				
12.857	6	19	00	12q24.33	ZNF140		Zinc finger protein-140	604082				
12.858	9	1	16	12q24.33	ADGRD1, GPR133, PGR25		Adhesion G protein-coupled receptor D1	613639				
12.859	06	25	19	12q24.33	ANKLE2, LEM4, KIAA0692, MCPH16		Ankyrin repeat- and LEM domain-containing protein 2	616062			Microcephaly 16, primary, autosomal recessive, 616681 (3)	
12.860	5	25	09	12q24.33	CHFR		Checkpoint protein with FHA and ring-finger domains	605209				
12.861	2	21	02	12q24.33	EP400, TNRC12, KIAA1498		p400 SWI2/SNF2-related protein	606265				
12.862	4	6	13	12q24.33	GALNT9, GALNACT9		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9	606251		REc		
12.863	9	30	09	12q24.33	STX2, EPIM, STX2C, STX2B, STX2A		Epimorphin (syntaxin 2)	132350				5(Epim)
12.864	09	12	19	12q24.33	FZD10		Frizzled class receptor 10	606147				
12.865	5	12	99	12q24.33	MMP17		Matrix metalloproteinase 17	602285				5(Mmp17)
12.866	12	02	20	12q24.33	NOC4L, NOC4		Nucleolar complex-associated protein 4 homolog	612819				
12.867	11	25	13	12q24.33	P2RX2, P2X2, DFNA41		Purinergic receptor P2X, ligand-gated ion channel, 2	600844			Deafness, autosomal dominant 41, 608224 (3)	
12.868	11	29	12	12q24.33	PGAM5		Phosphogycerate mutase family, member 5	614939				
12.869	3	17	16	12q24.33	PUS1, MLASA1		Pseudourine synthase 1	608109			Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3)	
12.870	3	27	17	12q24.33	PXMP2		Peroxisomal membrane protein 2	617399				
12.871	2	19	08	12q24.33	RIMBP2, KIAA0318		RIMS-binding protein 2	611602				
12.872	4	29	14	12q24.33	SFSWAP, SFRS8, SWAP		Splicing factor, suppressor-of-white-apricot family	601945				
12.873	6	7	91	12q24.33	ZNF26		Zinc finger protein-26 (KOX20)	194537				
12.874	08	28	19	12q24.33	ZNF84, HPF2		Zinc finger protein 84	618554				
12.875	5	16	02	12q24.31	ANAPC5, APC5		Anaphase-promoting complex, subunit 5	606948				
12.876	11	28	01	12q13.13	ATF7		Activating transcription factor 7	606371				
12.877	11	5	98	12q13.13	ATP5G2		ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 2	603193				
12.878	12	11	02	12q24.13	C12orf8, ERP28, ERP29		Endoplasmic reticulum lumenal protein 28	602287				
12.879	1	31	01	12q15	CCT2, CCTB		Chaperonin containing T-complex polypeptide 1, subunit 2	605139				
12.880	2	6	01	12q15	CPSF6, CFIM		Cleavage and polyadenylation specific factor 6, 68kD subunit	604979				
12.881	8	21	98	12p12.3	MGST1, GST12		Microsomal glutathione S-transferase 1	138330		pseudogene at 12q13-q14		
12.882	7	17	01	12q13.11	EPAC		cAMP-regulated guanine nucleotide exchange factor I	606057				
12.883	5	12	03	12q24.33	GOLGA3		Golgi autoantigen, golgin subfamily A, 3	602581				
12.884	12	11	01	12q13.11	HDAC7A, HDAC7		Histone deacetylase 7A	606542				
12.885	8	27	01	12p13.1	HEBP1, HBP		Heme-binding protein 1	605826				
12.886	1	19	01	12q13.13	HOXC10		Homeo box-C10	605560				15(Hoxc10)
12.887	1	19	01	12q13.13	HOXC11		Homeo box-C11	605559				15(Hoxc11)
12.888	1	25	93	12q13.13	IGFBP6		Insulin-like growth factor-binding protein-6	146735				
12.889	1	30	01	12q24.31	MPHOSPH9, MPP9		M-phase phosphoprotein 9	605501				
12.890	1	23	01	12q24.33	PIWIL1		Piwi, Drosophila, homolog of	605571				
12.891	1	28	02	12p13.2	PROL4, LPRP		Proline rich 4, lacrimal	605359				
12.892	4	15	02	12q24.23	RPLP0		Ribosomal phosphoprotein, large, P0	180510				
12.893	1	29	01	12q13.13	SLC4A8, NBC3		Solute carrier family 4 (sodium bicarbonate cotransporter), member 8	605024				
12.894	5	9	02	12q13.2	SUOX		Sulfite oxidase	606887			Sulfite oxidase deficiency, 272300 (3)	
12.895	4	16	93	Chr.12	TUBAL1		Tubulin, alpha-like-1	191120				
12.896	10	28	99	12q22	VESPR		Virus-encoded semaphorin protein receptor	604259				
12.897	4	3	02	12q14.3	WIF1		WNT inhibitory factor 1	605186				
13.1	9	2	11	13pter-q12.13	FECD2, FCD1		Corneal dystrophy, Fuchs endothelial, 2	610158		max lod at D13S1304	Corneal dystrophy, Fuchs endothelial, 2 (2)	
13.2	4	26	90	13p12	RNR1		Ribosomal RNA-1	180450				
13.3	2	20	07	13q	CLQTL1, CLF		Cholesterol level quantitative trait locus 1	604595			[Cholesterol level QTL 1] (2)	
13.4	7	25	13	13q12.11	GJA3, CX46, CZP3, CAE3, CTRCT14		Gap junction protein, alpha-3, 46kD (connexin 46)	121015			Cataract 14, multiple types, 601885 (3)	14(Gja3)
13.5	4	19	06	13q12.12	PARP4, ADPRTL1, VPARP, KIAA0177		Poly(ADP-ribose) polymerase 4	607519				
13.6	6	15	99	13q12.11	TUBA2		Tubulin, alpha 2	602528				
13.7	10	25	17	13q12.11	FGF9, SYNS3		Fibroblast growth factor-9 (glia-activating factor)	600921			Multiple synostoses syndrome 3, 612961 (3)	
13.8	03	10	20	13q12.11	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID, BAPS		Gap junction protein, beta-2, 26kD (connexin 26)	121011			Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal dominant 3A, 601544 (3); Vohwinkel syndrome, 124500 (3); Keratoderma, palmoplantar, with deafness, 148350 (3); Keratitis-ichthyosis-deafness syndrome, 148210 (3); Hystrix-like ichthyosis with deafness, 602540 (3); Bart-Pumphrey syndrome, 149200 (3)	14(Gjb2)
13.9	04	09	20	13q12.11	LATS2		Large tumor suppressor kinase 2	604861				14(Lats2)
13.10	1	6	09	13q12.3	ALOX5AP, FLAP		Arachidonate 5-lipoxygenase-activating protein	603700			{Stroke, susceptibility to}, 601367 (3)	
13.11	7	2	13	13q12.13	ATP8A2, ATPIB, CAMRQ4		ATPase, class I, type 8A, member 2	605870			?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3)	
13.12	01	31	20	13q12.13	CDK8, IDDHBA		Cyclin-dependent kinase 8	603184			Intellectual developmental disorder with hypotonia and behavioral abnormalities, 618748 (3)	
13.13	1	2	91	13q12.3	FLT1		fms-related tyrosine kinase-1 (vascular endothelial growth factor/vascular permeability factor receptor)	165070		150kb from FLT3		
13.14	8	27	15	13q12.2	FLT3		fms-related tyrosine kinase-3	136351			Leukemia, acute myeloid, reduced survival in, somatic, 601626 (3); Leukemia, acute myeloid, somatic, 601626 (3); Leukemia, acute lymphoblastic, somatic, 613065 (3)	5(Flt3)
13.15	12	17	12	13q12.11	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2		Gap junction protein, beta-6 (connexin-30)	604418			Deafness, autosomal dominant 3B, 612643 (3); Deafness, autosomal recessive 1B, 612645 (3); Deafness, digenic GJB2/GJB6, 220290 (3); Ectodermal dysplasia 2, Clouston type, 129500 (3)	
13.16	10	1	95	13q12.13	GPR12		G protein-coupled receptor-12	600752				
13.17	8	28	02	13q12.3	HMGB1, HMG1		High-mobility group box 1 (high-mobility group (nonhistone chromosomal) protein 1)	163905				5(Hmg1)
13.18	6	1	18	13q13.1	KL, KLOTHO, HFTC3		Klotho	604824		mutation identified in 1 HFTC3 patient	?Tumoral calcinosis, hyperphosphatemic, familial, 3, 617994 (3)	
13.19	5	7	03	13q13.3-q14.1	LHFP		Lipoma HMGIC fusion partner	606710				
13.20	1	6	09	13q12	MCI2		Myocardial infarction, susceptibility to, 2	608557		defined by 4-SNP haplotype HapA	{Myocardial infarction, susceptibility to, 2} (2)	
13.21	12	6	98	13q12.12	MIPEP, COXPD31		Mitochondrial intermediate peptidase	602241			Combined oxidative phosphorylation deficiency 31, 617228 (3)	
13.22	6	15	99	13q12.13	MTMR6		Myotubularin-related protein 6	603561				
13.23	2	1	00	13q12.12	SACS, ARSACS		Sacsin	604490			Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	1(Sacs)
13.24	09	27	18	13q12.12	SGCG, LGMDR5, DMDA1, SCG3		Sarcoglycan, gamma (35kD dystrophin-associated glycoprotein)	608896			Muscular dystrophy, limb-girdle, autosomal recessive 5, 253700 (3)	
13.25	11	13	17	13q12.13	WASF3, WAVE3, SCAR3		WAS protein family member 3	605068				
13.26	12	14	00	13q12.3	UBL3		Ubiquitin-like 3	604711				5(Ubl3)
13.27	10	12	09	13q12-q14	ATOD5		Dermatitis, atopic, 5	605844		max lod at D13S218	{Dermatitis, atopic, susceptibility to, 5} (2)	
13.28	8	2	13	13q13.3	MADH9, SMAD9, MADH6, PPH2		Mothers against decapentaplegic, Drosophila, homolog of, 9	603295			Pulmonary hypertension, primary, 2, 615342 (3)	
13.29	5	1	08	13q14.11	RGC32		Response gene to complement 32	610077				
13.30	3	29	99	13q14.13	TPT1, HRF		Tumor protein, translationally-controlled 1	600763				
13.31	08	12	19	13q12.11	IFT88, D13S1056E, TG737		Intraflagellar transport 88	600595				14(TgN737Rpw)
13.32	10	26	15	13q12.13	NUP58, NUPL1, KIAA0410		Nucleoporin 58kDa	607615				
13.33	8	22	16	13q12.2	PDX1, IPF1, MODY4, PAGEN1		Pancreas/duodenum homeobox protein 1	600733			Pancreatic agenesis 1, 260370 (3); MODY, type IV, 606392 (3); {Diabetes mellitus, type II, susceptibility to}, 125853 (3)	5(Ipf1)
13.34	7	27	09	13q12.12	RNF17		RING finger protein-17	605793				
13.35	11	8	00	13q12.12	ATP12A, ATP1AL1		ATPase, H+/K+ transporting, nongastric, alpha polypeptide	182360				
13.36	9	23	08	13q12.11	ADHD6		Attention deficit-hyperactivity disorder, susceptibility to, 6	612312		max lod at rs1974047	{Attention deficit-hyperactivity disorder, susceptibility to, 6} (2)	
13.37	2	22	10	13q12.11	CFEOM3C, FEOM4		Fibrosis of extraocular muscles, congenital, 3C	609384			Fibrosis of extraocular muscles, congenital, 3C (2)	
13.38	2	7	06	13q12.11	CRYL1		Crystallin, lambda-1	609877				14(Cryl1)
13.39	11	29	17	13q12.11	EEF1AKMT1, N6AMT2		EEF1A lysine methyltransferase 1	617793				
13.40	09	25	20	13q12.11	IL17D		Interleukin 17D	607587		?associated with Hodgkin lymphoma		
13.41	1	14	14	13q12.11	MICU2, EFHA1		Mitochondrial calcium uptake protein 2	610632				
13.42	2	6	08	13q12.11	MPHOSPH8, TWA3		M-phase phosphoprotein 8	611626				
13.43	4	24	08	13q12.11	MRP63		Mitochondrial ribosomal protein 63	611997		10 pseudogenes		
13.44	12	18	08	13q12.11	PSPC1, PSP1		Paraspeckle component 1	612408				
13.45	10	17	02	13q12.13	RNF6		RING finger protein-6	604242			Esophageal carcinoma, somatic, 133239 (3)	
13.46	8	3	12	13q12.11	SAP18		Sin3-associated polypeptide, 18kD	602949				
13.47	7	14	14	13q12.11	TPTE2, TPIP		Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	606791				
13.48	5	11	18	13q12.11	ZDHHC20, DHHC20		Zinc finger DHHC domain-containing protein 20	617972				
13.49	6	30	15	13q12.11	ZMYM2, ZNF198, RAMP, FIM		Zinc finger, MYM-type 2	602221				
13.50	6	30	15	13q12.11	ZMYM5, ZNF237, ZNF198L1		Zinc finger, MYM-type 5	616443				
13.51	8	30	01	13q12.12	TAJ, TROY		Toxicity and JNK inducer	606122				14(Troy)
13.52	11	19	11	13q12.12	C1QTNF9A, CTRP9, C1QTNF9		C1q- and tumor necrosis factor-related protein 9A	614285				14(C1qtnf9a)
13.53	8	5	11	13q12.12	C1QTNF9B, CTRP9B		C1q- and tumor necrosis factor-related protein 9B	614148				
13.54	9	22	16	13q12.12	C1QTNF9BAS1, PCOTH		C1QTNF9B antisense RNA 1	617122				
13.55	8	25	11	13q12.12	MYP20		Myopia 20, autosomal dominant	614166		associated with rs9318086	Myopia 20, autosomal dominant (2)	
13.56	3	29	10	13q12.12	SPATA13, ASEF2		Spermatogenesis-associated protein 13	613324				
13.57	5	29	12	13q12.13	FAM123A, AMER2		Family with sequence similarity 123, member A (APC membrane recruitment protein 2)	614659				
13.58	2	2	17	13q12.13	SHISA2, C13orf13, TMEM46		Shisa family, member 2	617324				
13.59	12	5	17	13q12.13	USP12, UBH1		Ubiquitin-specific protease 12	603091				
13.60	4	25	05	13q12.12-q12.13	CENPJ, CPAP, MCPH6, SCKL4		Centromeric protein J	609279		mutation identified in 1 SCKL4 family	Microcephaly 6, primary, autosomal recessive, 608393 (3); ?Seckel syndrome 4, 613676 (3)	
13.61	9	3	15	13q12.2	GSX1, GSH1		GS homeobox 1	616542				5(Gsx1)
13.62	12	28	08	13q12.2	LNX2, PDZRN1		Ligand of numb protein X2	609733				
13.63	5	19	17	13q12.2	PAN3		PABP-dependent poly(A) nuclease 3	617448				
13.64	1	31	11	13q12.2	POLR1D, RPA16, RPAC2, TCS2		Polymerase I, RNA, subunit D	613715			Treacher Collins syndrome 2, 613717 (3)	
13.65	12	18	08	13q12.2	RASL11A		RAS-like, family 11, member A	612403				
13.66	7	17	14	13q12.2	RPL21, HYPT12		Ribosomal protein L21	603636			Hypotrichosis 12, 615885 (3)	
13.67	6	22	14	13q12.2	URAD		Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase	615804				
13.68	4	17	00	13q12.2-q13	MBS, MBS1		Moebius syndrome	157900			?Moebius syndrome (2)	
13.69	2	19	16	13q12.3	B3GLCT, B3GALTL, B3GTL		Beta 3-glucosyltransferase	610308			Peters-plus syndrome, 261540 (3)	
13.70	11	16	15	13q13.1	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2		BRCA2 gene	600185			{Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia, complementation group D1, 605724 (3); {Prostate cancer}, 176807 (3); {Breast cancer, male, susceptibility to}, 114480 (3); Wilms tumor, 194070 (3); {Medulloblastoma}, 155255 (3); {Glioblastoma 3}, 613029 (3); {Pancreatic cancer 2}, 613347 (3)	5(Brca2)
13.71	8	21	98	13q12.2	CDX2, CDX3		Caudal type homeo box transcription factor 2	600297				5(Cdx2)
13.72	1	16	07	13q12.3	HSPH1, HSP105, KIAA0201		Heat-shock 105/110kD protein 1	610703				
13.73	8	21	12	13q12.3	KATNAL1		Katanin p60 subunit A-like 1	614764				
13.74	11	24	20	13q13.1	PDS5B, AS3, APRIN		PDS5 cohesin-associated factor B	605333				
13.75	7	19	18	13q12.3	POMP, UMP1, PRAAS2		Proteasome maturation protein	613386			Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3); Proteasome-associated autoinflammatory syndrome 2, 618048 (3)	
13.76	8	21	98	13q12.3	SLC7A1, ATRC1		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1	104615		distal to ATP1AL1		5(Rec1)
13.77	1	20	16	13q12.3	SLC46A3		Solute carrier family 46, member 3	616764				
13.78	7	26	02	13q13.3	SPG20		Spartin	607111			Troyer syndrome, 275900 (3)	
13.79	3	22	06	13q13.1-q13.2	STARD13, DLC2		Start domain-containing protein 13	609866				
13.80	4	28	17	13q12.3	USPL1		Ubiquitin-specific peptidase-like 1	617470				
13.81	6	6	00	13q13.3	CCNA1		Cyclin A1	604036				
13.82	3	20	95	13q13.2	RFC3		Replication factor C3, 38kD (activator 1, 38kD)	600405				
13.83	12	17	95	13q12.2	GTF3A, TFIIIA		General transcription factor IIIA	600860				
13.84	12	21	09	13q13.3	DCLK1, DCAMKL1, CLICK1, CL1, KIAA0369		Doublecortin-like kinase 1	604742				3(Dclk1)
13.85	09	09	19	13q13.3	MAB21L1, COFG		mab-21 like 1	601280			Cerebellar, ocular, craniofacial, and genital syndrome, 618479 (3)	
13.86	12	7	03	13q13.3	STOML3, SRO		Stomatin-like protein 3	608327				
13.87	7	4	95	13q13-q14.3	ENUR1		Enuresis, nocturnal, 1	600631			Enuresis, nocturnal, 1 (2)	
13.88	11	11	14	13q13.3	EXOSC8, OIP2, RRP43, PCH1C		Exosome component 8	606019			Pontocerebellar hypoplasia, type 1C, 616081 (3)	
13.89	10	07	20	13q13.1	FRY, C13orf14		FRY microtubule-binding protein	614818				
13.90	6	27	08	13q13.1	HPRHP		Hypophosphatemic rickets and hyperparathyroidism	612089		?due to altered KLOTHO expression	Hypophosphatemic rickets and hyperparathyroidism (2)	
13.91	8	5	15	13q13.1	LGR8, GREAT		Leucine-rich repeat-containing G protein-coupled receptor 8	606655				
13.92	6	22	14	13q13.1	N4BP2L2, PFAAP5		NEDD4-binding protein 2-like 2	615788				
13.93	3	3	03	13q13.3	TRPC4, TRP4		Transient receptor potential cation channel, subfamily C, member 4	603651				
13.94	3	14	06	13q13.3	NBEA		Neurobeachin	604889		site of FRA13A		3(Nbea)
13.95	01	03	20	13q13.3	ALG5		ALG5 dolichyl-phosphate beta-glucosyltransferase	604565				
13.96	8	14	13	13q14.11	COG6, COD2, KIAA1134, CDG2L, SHNS		Component of oligomeric golgi complex 6	606977			Congenital disorder of glycosylation, type IIl, 614576 (3); Shaheen syndrome, 615328 (3)	
13.97	2	28	03	13q14.11	EPSTI1		Epithelial stromal interaction 1	607441				
13.98	7	26	10	13q13.3	FAM48A, P38IP, C13orf19		Family with sequence similarity 48, member A	613417				
13.99	04	15	19	13q13.3	FREM2, FRASRS2, CRYPTOP		FRAS1-related extracellular matrix protein 2	608945			Fraser syndrome 2, 617666 (3); Cryptophthalmos, unilateral or bilateral, isolated, 123570 (3)	3(my)
13.100	6	9	09	13q13.3	IBD27		Inflammatory bowel disease 27	612796			{Inflammatory bowel disease 27} (2)	
13.101	4	24	08	13q14.11	MRPS31		Mitochondrial ribosomal protein S31	611992		4 pseudogenes		
13.102	11	3	14	13q13.3	SOHLH2		Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 2	616066				3(Sohlh2)
13.103	2	11	13	13q13.3-q21	PAPA5		Polydactyly, postaxial, type A5	263450		between D13S1288 and D13S632	Polydactyly, postaxial, type A5 (2)	
13.104	3	23	09	13q13.3	POSTN, OSF2, PN		Periostin	608777				
13.105	3	5	18	13q13.3	UFM1, HLD14		Ubiquitin-fold modifier 1	610553			Leukodystrophy, hypomyelinating, 14, 617899 (3)	
13.106	10	8	08	13q14	BMIQ2		Body mass index quantitative trait locus 2	606643		max lod at D13S257	[Body mass index QTL2] (2)	
13.107	6	30	08	13q14	BMND9		Bone mineral density quantitative trait locus 9	612110		associated with rs9594759	[Bone mineral density QTL 9] (2)	
13.108	12	7	07	13q14.3	CKAP2, TMAP, LB1		Cytoskeleton-associated protein 2	611569				
13.109	10	28	08	13q14.2	CLLD6, C13orf1		Chronic lymphocytic leukemia deletion region gene 6	607866				
13.110	8	29	02	13q14.2	CYSLTR2, CYSLT2		Cysteinyl leukotriene receptor 2	605666				
13.111	10	28	08	13q14	CLLS2, D13S25, DBM		Leukemia, chronic lymphocytic, susceptibility to, 2	109543		>530kb telomeric to RB1	{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)	
13.112	5	6	11	13q14	DEL13q14, C13DELq14		Chromosome 13q14 deletion syndrome	613884			Chromosome 13q14 deletion syndrome (4)	
13.113	4	19	01	13q14.2-q14.3	DLEU1, LEU1		Deleted in lymphocytic leukemia 1	605765				
13.114	4	19	01	13q14.2	DLEU2, LEU2, BCMSUN		Deleted in lymphocytic leukemia 2	605766				
13.115	10	25	19	13q14.3	DLEU7		Deleted in lymphocytic leukemia 7	618634				
13.116	10	24	00	13q14	GER		Gastroesophageal reflux	109350			Gastroesophageal reflux (2)	
13.117	11	11	14	13q14.2	ITM2B, BRI, ABRI, FBD, RDGCA		Integral membrane protein 2B (BRI gene)	603904		mutation identified in 1 RDGCA family	Dementia, familial British, 176500 (3); Dementia, familial Danish, 117300 (3); ?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3)	
13.118	12	18	08	13q14.1-q14.2	LRCH1, KIAA1016		Leucine-rich repeats and calponin homology domain-containing 1	610368				
13.119	2	1	01	13q14.12	NUFIP1, NUFIP		Nuclear fragile X mental retardation protein-interacting protein 1	604354		pseudogene on 6q12		
13.120	11	15	16	13q14.2	RCBTB1, CLLD7, GLP, RDEOA		RCC1 domain- and BTB domain-containing protein 1	607867			Retinal dystrophy with or without extraocular anomalies, 617175 (3)	
13.121	11	2	98	13q13.3	RFXAP		Regulatory factor X-associated protein	601861			Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)	
13.122	12	4	96	13q14	RIEG2, RGS2		Rieger syndrome, type 2	601499			Rieger syndrome, type 2 (2)	
13.123	10	28	08	13q14.2	SETDB2, CLLD8		SET domain protein, bifurcated, 2	607865				
13.124	6	4	99	13q14.11	SLC25A15, ORNT1, HHH		Solute carrier family 25 (mitochondrial carrier), member 15 (ornithine transporter 1)	603861		with deficiency of factors VII and X in 3 unrelated cases	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	
13.125	4	27	12	13q14	SPG24		Spastic paraplegia 24, autosomal recessive	607584			Spastic paraplegia 24, autosomal recessive (2)	
13.126	2	19	07	13q14.11	TSC22D1, TSC22		TSC22 domain family, member 1	607715				
13.127	12	7	07	13q14.11	TNFSF11, OPGL, TRANCE, OPTB2		Tumor necrosis factor ligand superfamily, member 11 (osteoprotegerin ligand)	602642			Osteopetrosis, autosomal recessive 2, 259710 (3)	14(Trance)
13.128	10	23	87	13q14	XRS		X-ray sensitivity	194370				
13.129	7	19	12	13q14.3	CTAGE3		Cutaneous T-cell lymphoma-associated antigen 3	608857				
13.130	5	31	06	13q14.2	HTR2A		5-hydroxytryptamine (serotonin) receptor-2A	182135			{Schizophrenia, susceptibility to}, 181500 (3); {Obsessive-compulsive disorder, susceptibility to}, 164230 (3); {Seasonal affective disorder, susceptibility to}, 608516 (3); {Alcohol dependence, susceptibility to}, 103780 (3); {Anorexia nervosa, susceptibility to}, 606788 (3); {Major depressive disorder, response to citalopram therapy in}, 608516 (3)	14(Htr2)
13.131	3	11	03	13q14.3	LECT1, CHM1		Leukocyte cell derived chemotaxin 1 (chondromodulin)	605147				
13.132	3	23	09	13q14.2	MLNR, GPR38		Motilin receptor	602885				
13.133	8	2	13	13q14.11	DNAJC15, MCJ		DNAJ/HSP40 homolog, subfamily C, member 15	615339				
13.134	8	28	02	13q14.11	FOXO1A, FKHR		Forkhead box O1A (forkhead in rhabdomyosarcoma)	136533		chimeric with PAX3 in t(2;13); fuses with PAX3	Rhabdomyosarcoma, alveolar, 268220 (3)	
13.135	8	1	17	13q14.2	PHF11, NYREN34		PHD finger protein 11	607796				
13.136	1	6	09	13q14.3	RNASEH2B, DLEU8, FLJ11712, AGS2		Ribonuclease H2, subunit B	610326			Aicardi-Goutieres syndrome 2, 610181 (3)	
13.137	6	16	97	13q14.2	RB1		Retinoblastoma-1	614041			Retinoblastoma, 180200 (3); Osteosarcoma, somatic, 259500 (3); Bladder cancer, somatic, 109800 (3); Small cell cancer of the lung, somatic, 182280 (3); Retinoblastoma, trilateral, 180200 (3)	14(Rb1)
13.138	10	23	87	13q14.13	LCP1		Lymphocyte cytosolic protein-1 (plasmin)	153430				
13.139	1	8	01	13q14.11	MTRF1		Translational release factor, mitochondrial, 1	604601				
13.140	12	10	13	13q14.11	AKAP11, AKAP220		A-kinase anchor protein 11	604696				
13.141	2	11	15	13q14.11	DGKH		Diacylglycerol kinase, eta, 130kD	604071				
13.142	02	28	20	13q14.11	LACC1, C13orf31, JUVAR		Laccase (multicopper reductase) domain-containing protein 1	613409			Juvenile arthritis, 618795 (3)	
13.143	7	6	10	13q14.11	CCDC122		Coiled-coil domain-containing protein 122	613408				
13.144	8	5	99	13q14.13	CPB2, CPU, TAFI		Carboxypeptidase B2, plasma (carboxypeptidase U)	603101				
13.145	8	8	13	13q14.11	ELF1, RIA1, EFTUD1		E74-like factor 1	189973				
13.146	4	4	07	13q14.11	ENOX1, CNOX		ECTO-NOX disulfide-thiol exchanger 1	610914				
13.147	10	23	87	13q14.2	ESD		Esterase D; S-formylglutathione hydrolase	133280		proximal to RB1, WND		14(Es10)
13.148	10	25	17	13q14.11	KBTBD6		Kelch repeat- and BTB domain-containing protein 6	617738				
13.149	10	25	17	13q14.11	KBTBD7		Kelch repeat- and BTB domain-containing protein 7	617739				
13.150	09	08	20	13q14.11	LINC00598, TTL		Long intergenic noncoding RNA 598	619008				
13.151	7	8	10	13q14.11	LPRS6		Leprosy, susceptibility to, 6	613407		associated with rs9533634 and rs3764147	{Leprosy, susceptibility to, 6} (2)	
13.152	3	8	07	13q14.13	SLC25A30, KMCP1		Solute carrier family 25 (mitochondrial carrier, kidney), member 30	610793				
13.153	6	12	17	13q14.11	VWA8, KIAA0564		von Willebrand factor A domain-containing protein 8	617509				14(Vwa8)
13.154	3	31	15	13q14.11	WBP4, FBP21		WW domain-containing binding protein 4	604981				
13.155	7	27	09	13q14.13	COG3, SEC34		Component of oligomeric golgi complex 3	606975				
13.156	2	2	14	13q14.13	SIAH3		SIAH E3 ubiquitin protein ligase family, member 3	615609				
13.157	5	25	13	13q14.12-q14.13	GTF2F2, TF2F2, RAP30		General transcription factor IIF, polypeptide 2, 30kD	189969				
13.158	11	3	11	13q14.2	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8		Lysophosphatidic acid receptor 6	609239		in intron 17 of RB gene	Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	
13.159	7	13	15	13q14.13	ZC3H13, KIAA0853		Zinc finger CCCH domain-containing protein 13	616453				
13.160	8	1	08	13q14.2	CAB39L		Calcium-binding protein 39-like protein	612175				
13.161	08	26	20	13q14.2	CDADC1		Cytidine and deoxycytidylate deaminase domain-containing protein 1	618997				
13.162	2	7	17	13q14.2	EBPL		Emopamil-binding protein-like	617335				
13.163	6	22	14	13q14.2	FNDC3A, KIAA0970, HUGO		Fibronectin type III domain-containing protein 3A	615794				
13.164	3	23	06	13q14.2	MED4, DRIP36, HSPC126		Mediator of RNA polymerase II transcription, subunit 4, S. cerevisiae, homolog of	605718				
13.165	7	17	02	13q14.3	NEK3		Never in mitosis gene A-related kinase 3	604044				
13.166	4	19	16	13q14.2	NUDT15, MTH2, NUDT15D		Nucleoside diphosphate-linked moiety X motif 15	615792			{Thiopurines, poor metabolism of, 2}, 616903 (3)	
13.167	6	2	15	13q14.2	SUCLA2, MTDPS5		Succinate-CoA ligase, ADP-forming, beta subunit	603921			Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3)	
13.168	8	15	03	13q14.2-q14.1	AUTS3		Autism, susceptibility to, 3	608049			{Autism susceptibility 3} (2)	
13.169	01	03	20	13q14.3	ALG11, KIAA1266, CDG1P		ALG11 alpha-1,2-mannosyltransferase	613666			Congenital disorder of glycosylation, type Ip, 613661 (3)	
13.170	12	04	20	13q14.2	ARL11, ARLTS1		ADP ribosylation factor-like GTPase 11	609351				
13.171	10	07	19	13q14.13	CBY2, NURIT, SPERT		Chibby family, member 2	618614				14(Cby2)
13.172	12	30	14	13q14.3	DHRS12, SDR40C1		Short-chain dehydrogenase reductase family, member 12	616163				
13.173	6	15	99	13q14.3	GUCY1B2		Guanylate cyclase 1, soluble, beta-2	603695				
13.174	3	23	14	13q14.3	INTS6, DDX26, DICE1		Integrator complex subunit 6	604331				
13.175	2	25	15	13q14.2	KCNRG, DLTET		Potassium channel regulator	607947				14(Kcnrg)
13.176	8	5	97	13q14.2	KPNA3		Karyopherin (importin) alpha-3	601892				
13.177	3	23	09	13q14.2	MIR15A, MIRN15A		Micro RNA 15A	609703				
13.178	3	23	09	13q14.2	MIR16-1, MIRN16-1		Micro RNA 16-1	609704				
13.179	1	13	16	13q14.3	NEK5		Never in mitosis gene A-related kinase 5	616731				
13.180	7	1	11	13q14.3	OLFM4, GC1, GW112		Olfactomedin 4	614061				
13.181	6	15	99	13q14.3	PCDH8		Protocadherin 8	603580				14(Pcdh8)
13.182	1	27	11	13q14.2	RCBTB2, CHC1L		RCC1 domain- and BTB domain-containing protein 2	603524				
13.183	7	22	09	13q14.3	STQTL20		Stature quantitative trait locus 20	612894		associated with rs3118914	{Stature QTL 20} (2)	
13.184	7	20	12	13q14.3	SUGT1, SGT1		Suppressor of G2 allele of Skp1, S. Cerevisiae, homolog of	604098				
13.185	01	10	20	13q14.3	THSD1, TMTSP, ANIB12		Thrombospondin type 1 domain-containing protein 1	616821		mutation identified in 1 ANIB12 family	?Aneurysm, intracranial berry, 12, 618734 (3)	
13.186	8	20	07	13q14.2	TRIM13, RFP2, LEU5		Tripartite motif-containing protein 13	605661				14(Trim13)
13.187	11	18	19	13q14.3	UTP14C, UTP14B, KIAA0266		UTP14C small subunit processome component	608969		pseudogene on chr.2		
13.188	12	27	19	13q14.3	VPS36, EAP45		Vacuolar protein sorting 36 homolog	610903				
13.189	5	24	13	13q14.3	WDFY2		WD repeat- and FYVE domain-containing protein 2	610418				
13.190	4	30	02	13q14.3	ATP7B, WND		ATPase, Cu++ transporting, beta polypeptide	606882			Wilson disease, 277900 (3)	8(Atp7b)
13.191	3	15	10	13q21	ATXN8		Ataxin 8	613289		CAG repeat results in polyglutamine expansion protein	Spinocerebellar ataxia 8, 608768 (3)	
13.192	02	28	19	13q21.33	ATXN8OS, SCA8, KLHL1AS		Ataxin 8 opposite strand	603680		due to CTG repeat in untranslated DNA	Spinocerebellar ataxia 8, 608768 (3); {Parkinson disease, susceptibility to}, 168600 (3)	
13.193	10	13	00	13q21.33	KLHL1		Kelch-like 1	605332				
13.194	5	26	13	13q22.3	KCTD12, PFET1, KIAA1778, C13orf2		Potassium channel tetramerization domain-containing protein 12	610521				14(Kctd12)
13.195	11	7	05	13q21	SLI3		Specific language impairment QTL, 3	607134		max with D13S1317	Specific language impairment QTL, 3 (2)	
13.196	09	19	19	13q21.33	DIS3, KIAA1008		DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease	607533				
13.197	11	10	17	13q21.3-q22.1	PIBF1, JBTS33		Progesterone-induced blocking factor 1	607532			Joubert syndrome 33, 617767 (3)	
13.198	9	9	08	13q22.2	LMO7, FBXO20, FBX20, KIAA0858		LIM domain only 7	604362				14(Lmo7)
13.199	10	27	97	13q21-q32	PAPA2		Postaxial polydactyly, type A2	602085			Postaxial polydactyly, type A2 (2)	
13.200	6	15	99	13q21.32	PCDH9		Protocadherin 9	603581				14(Pcdh9)
13.201	1	29	08	13q21.1	PCDH17, PCDH68		Protocadherin 17	611760				
13.202	2	28	97	13q31.1	POU4F1, BRN3A		POU domain, class 4, transcription factor 1	601632				
13.203	09	09	19	13q21.2	DIAPH3, DIA2, DRF3, AUNA1, NSDAN		Diaphanous-related formin 3	614567			Auditory neuropathy, autosomal dominant, 1, 609129 (3)	
13.204	1	30	12	13q21.2	PCDH20, PCDH13		Protocadherin 20	614449				
13.205	1	1	12	13q21.2	TDRD3		Tudor domain-containing protein 3	614392				
13.206	9	9	10	13q21.33	C13orf37, MOZART1		Mitotic spindle-organizing protein associated with a ring of gamma-tubulin	613448				
13.207	3	11	09	13q22.2	COMMD6		COMM domain-containing protein 6	612377				14(Commd6)
13.208	02	24	20	13q21.33	DACH1		Dachshund family transcription factor 1	603803				13(Dach)
13.209	2	2	14	13q22	DDH1		Developmental dysplasia of the hip 1	142700			Developmental dysplasia of the hip 1 (2)	
13.210	3	16	10	13q22.3	EDNRB, HSCR2, ABCDS, WS4A		Endothelin receptor type B	131244		?piebald lethal in mouse	{Hirschsprung disease, susceptibility to, 2}, 600155 (3); ABCD syndrome, 600501 (3); Waardenburg syndrome, type 4A, 277580 (3)	
13.211	05	02	19	13q22.3	FBXL3, FBXL3A, FBL3, IDDSFAS		F-box and leucine-rich repeat protein 3	605653			Intellectual developmental disorder with short stature, facial anomalies, and speech defects, 606220 (3)	14(Fbxl3)
13.212	2	3	03	13q22.1	KLF12, AP2REP		Kruppel-like factor 12	607531				
13.213	8	19	13	13q22.3	MYCBP2, PAM, KIAA0916		Myc-binding protein 2	610392				
13.214	8	10	99	13q22.3	SCEL		Sciellin	604112				
13.215	10	15	01	13q22.3	TNFRSF11B, OPG, OCIF		Tumor necrosis factor receptor superfamily, member 11B	602543				
13.216	3	11	09	13q22.2	UCHL3		Ubiquitin carboxyl-terminal esterase L3	603090				14(Uchl3)
13.217	12	20	04	13q22-q32	PAND1		Panic disorder syndrome 1	167870			Panic disorder syndrome 1 (2)	
13.218	5	26	13	13q21.33	BORA, C13orf34		Aurora borealis	610510				
13.219	6	9	06	13q31.1	NDFIP2, N4WBP5A, KIAA1165		NEDD4 family-interacting protein 2	610041				
13.220	12	30	14	13q22.2	TBC1D4, AS160, KIAA0603, NIDDM5		TPC1 domain family, member 4	612465			{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)	
13.221	3	2	18	13q22.3	ACOD1, IRG1		Aconitate decarboxylase 1	615275				
13.222	5	17	18	13q22.3	lncRNA-ACOD1, LOC105370268		Long noncoding RNA near ACOD1	617979				
13.223	08	11	20	13q22.3	CLN5		CLN5 intracellular trafficking protein	608102			Ceroid lipofuscinosis, neuronal, 5, 256731 (3)	
13.224	4	6	15	13q22.3	SLAIN1		SLAIN motif family, member 1	610491				14(Slain1)
13.225	11	30	06	13q34	ADPRHL1, ARH2		ADP-ribosylhydrolase-like 1	610620				
13.226	11	17	20	13q32.1	DZIP1, KIAA0996, SPGF47, MVP3		DAZ-interacting zinc finger protein 1	608671		mutation identified in 1 MVP3 family	Spermatogenic failure 47, 619102 (3); ?Mitral valve prolapse 3, 610840 (3)	
13.227	5	19	15	13q32.1	GPR180, ITR		G protein-coupled receptor 180	607787				
13.228	8	5	15	13q31.1	SLITRK1, KIAA1910, TTM		SLIT- and NTRK-like family, member 1	609678		mutation identified in 1 TTM patient	Tourette syndrome, 137580 (3); ?Trichotillomania, 613229 (3)	17(Slitrk1)
13.229	12	28	08	13q31.2	SLITRK5, KIAA0918		SLIT- and NTRK-like family, member 5	609680				14(Slitrk5)
13.230	11	22	13	13q31.1	SLITRK6, DFNMYP		SLIT- and NTRK-like family, member 6	609681			Deafness and myopia, 221200 (3)	14(Slitrk6)
13.231	8	21	98	13q32.1	DCT, TYRP2		Dopachrome tautomerase (dopachrome delta-isomerase; tyrosinase-related protein 2)	191275				14(Tyrp2)
13.232	1	29	01	13q32.1	SOX21		SRY-box 21	604974				
13.233	7	27	09	13q32.2	STK24, MST3, MST3B		Serine/threonine protein kinase 24	604984				
13.234	4	16	14	13q31-q33	NYS4		Nystagmus 4, congenital, autosomal dominant	193003			Nystagmus 4, congenital, autosomal dominant (2)	
13.235	02	27	20	13q31.1	OBI1, RNF219, C13orf7		ORC ubiquitin ligase 1	615906				
13.236	09	19	19	13q31.1	SPRY2, IGAN3		Sprouty RTK signaling antagonist 2	602466		mutation identified in 1 IGAN3 family	{?IgA nephropathy, susceptibility to, 3}, 616818 (3)	
13.237	5	13	13	13q31.1	LNCR13Q1		Long noncoding RNA on 13q (TCONS_00021856)	615230				
13.238	3	23	09	13q31.3	MIR17, MIR91, MIRN17		Micro RNA 17	609416		within C13orf25; sequence encodes 2 micro RNAs		
13.239	11	3	11	13q31.3	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2		Micro RNA 17 host gene	609415			Feingold syndrome 2, 614326 (3)	
13.240	3	23	09	13q31.3	MIR18A, MIRN18A		Micro RNA 18A	609417		within C13orf25		
13.241	3	23	09	13q31.3	MIR19A, MIRN19A		Micro RNA 19A	609418		within C13orf25		
13.242	3	23	09	13q31.3	MIR19B1, MIRN19B1		Micro RNA 19B1	609419		within C13orf25		
13.243	3	23	09	13q31.3	MIR20A, MIRN20A		Micro RNA 20A	609420		within C13orf25		
13.244	9	7	10	13q31.3	MIR92A1, MIR92-1, MIRN92-1		Micro RNA 92A1	609422		within C13orf25		
13.245	9	28	05	13q31.3	PPR2		Photoparoxysmal response 2	609572		max lod at D13S1230	Photoparoxysmal response 2 (2)	
13.246	9	1	00	13q32.1	ABCC4, MRP4, MOATB		ATP-binding cassette, subfamily C, member 4	605250				
13.247	09	01	20	13q33.1	BIVM		Basic immunoglobulin-like variable motif-containing protein	619006				
13.248	12	23	05	13q32.3	CLYBL, CLB		Citrate lyase beta-like	609686				
13.249	2	4	15	13q32.1	DNAJC3, PRKRI, P58, ACPHD		DnaJ, E. coli, homolog of, subfamily C, member 3 (protein kinase inhibitor p58)	601184		mutation identified in 1 ACPHD family	?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3)	
13.250	6	15	99	13q31.3	GPC5		Glypican 5	602446				
13.251	10	15	09	13q31.3-q32.1	GPC6, OMIMD1		Glypican 6	604404			Omodysplasia 1, 258315 (3)	
13.252	6	18	98	13q32.3	GPR18		G protein-coupled receptor-18	602042				14(Gpr18)
13.253	6	1	12	13q32	KTCN7		Keratoconus 7	614629		max lod at D13S159	Keratoconus 7 (2)	
13.254	5	19	15	13q32	MCOR, C13DELq32, DEL13q32		Microcoria, congenital (chromosome 13q32 deletion syndrome)	156600		35-80kb deletion encompassing TGDS and GPR180	Microcoria, congenital (4)	
13.255	6	21	01	13q32.3	PCCA		Propionyl Coenzyme A carboxylase, alpha polypeptide	232000			Propionicacidemia, 606054 (3)	14(Pcca)
13.256	12	15	98	13q32	SCZD7		Schizophrenia susceptibility locus, chromosome 13q-related	603176			{Schizophrenia}, 181500 (2)	
13.257	2	21	06	13q32	SLEB5		Systemic lupus erythematosus, susceptibility to, 5	609903		max lod at D13S892	{Systemic lupus erythematosus, susceptibility to, 5} (2)	
13.258	10	7	05	13q32.3	ZIC2, HPE5		ZIC family, member 2	603073			Holoprosencephaly 5, 609637 (3)	
13.259	6	30	05	13q32.1	HS6ST3		Heparan sulfate 6-O-sulfotransferase 3	609401				
13.260	2	17	09	13q32-q33	STQTL4		Stature quantitative trait locus 4	606258		max lod at D13S779 and D13S797	{Stature QTL 4} (2)	
13.261	9	15	93	13q33.1	TPP2		Tripeptidyl peptidase II	190470				1(Tpp2)
13.262	8	4	99	13q33.3	TNFSF13B, BLYS, BAFF		Tumor necrosis factor ligand superfamily, member 13B	603969				
13.263	9	15	17	13q32.1	CLDN10, OSPL, CPETRL3, HELIX		Claudin 10	617579			HELIX syndrome, 617671 (3)	
13.264	10	27	08	13q32.1	GPR80		G protein-coupled receptor 80	606922				
13.265	2	13	15	13q32.1	TGDS, SDR2E1, CATMANS		TDP-glucose 4,6-dehydratase	616146			Catel-Manzke syndrome, 616145 (3)	
13.266	8	27	09	13q32.1	UGGT2, HUGT2		UDP-glucose glycoprotein glucosyltransferase 2	605898				
13.267	12	10	13	13q32.2	FARP1, CDEP		FERM, ARHGEF, and pleckstrin domain-containing protein 1	602654				
13.268	9	27	17	13q32.2	IPO5, RANBP5, KPNB3		Importin 5	602008				
13.269	4	26	10	13q32.3	A2LD1, GGACT		AIG1-like domain-containing protein 1	613378				
13.270	9	29	10	13q32.3	GPR183, EBI2		G protein-coupled receptor 183	605741				
13.271	7	18	14	13q32.3	TM9SF2		Transmembrane 9 superfamily, member 2	604678				
13.272	11	27	18	13q32.3	TMTC4		Transmembrane and tetratricopeptide repeat domains-containing protein 4	618203				
13.273	3	5	18	13q32.3	ZIC5, OPR		Zic family, member 5	617896				
13.274	7	27	09	13q32.3	ZIZ1, KIAA1058		Zizimin 1	607325				
13.275	9	28	15	13q33.1	ERCC5, XPG, COFS3		Excision-repair, complementing defective, in Chinese hamster, number 5	133530			Xeroderma pigmentosum, group G, 278780 (3); Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3); Cerebrooculofacioskeletal syndrome 3, 616570 (3)	1(Ercc5)
13.276	11	5	97	13q33.3	EFNB2, EPLG5, LERK5, HTKL		eph-related receptor tyrosine kinase ligand 5 (ephrin-B2)	600527				8(Lerk5)
13.277	10	21	99	13q33.1	ITGBL1, TIED		Integrin, beta-like 1	604234				
13.278	07	17	19	13q33.1	POGLUT2, KDELC1, EP58		Protein O-glucosyltransferase 2	611613				
13.279	3	16	10	13q33.1	SLC10A2, NTCP2, PBAM		Solute carrier family 10 (sodium/bile acid cotransporter family), member 2	601295			Bile acid malabsorption, primary, 613291 (3)	8(Slc10a2)
13.280	8	21	98	13q32.2-q32.3	SLC15A1, HPECT1		Solute carrier family 15 (oligopeptide transporter), member 1	600544				
13.281	6	4	13	13q33.1	METTL21C, C13orf39		Methyltransferase-like 21C	615259				
13.282	2	11	16	13q32.3-q33.1	NALCN, IHPRF1, CLIFAHDD		Sodium leak channel, nonselective	611549			Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3); Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3)	
13.283	4	22	10	13q33.1-q34	OFC9		Orofacial cleft 9	610361		associated with rs1830756	Orofacial cleft 9 (2)	
13.284	11	3	11	13q33.2	VUR5		Vesicoureteral reflux 5	614318		nearest marker rs4476030	Vesicoureteral reflux 5 (2)	
13.285	9	8	11	13q33.3	ARGLU1		Arginine- and glutamate-rich protein 1	614046				
13.286	11	13	13	13q33.3	MYO16, MYAP3, KIAA0865		Myosin XVI	615479				
13.287	7	17	14	13q33.3	LIG4, LIG4S		Ligase IV, DNA, ATP-dependent	601837			LIG4 syndrome, 606593 (3); {Multiple myeloma, resistance to}, 254500 (3)	
13.288	7	27	09	13q34	ARHGEF7, PIXB, COOL1		Rho guanine nucleotide exchange factor 7 (PAK-interacting exchange factor, beta)	605477				
13.289	1	23	93	13q34	ATP4B		ATPase, H+, K+ transporting, beta	137217				
13.290	7	27	09	13q34	ATP11A, ATPIS, ATPIH		ATPase, class VI, type 11A	605868				
13.291	12	3	15	13q34	CARS2, COXPD27		Cysteinyl-tRNA synthetase 2	612800			Combined oxidative phosphorylation deficiency 27, 616672 (3)	
13.292	08	23	19	13q34	CDC16, APC6		Cell division cycle 16	603461				
13.293	9	29	15	13q34	CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40		Chromosome alignment-maintaining phosphoprotein 1	616327			Mental retardation, autosomal dominant 40, 616579 (3)	
13.294	09	06	19	13q34	COL4A1, BSVD1, HANAC, ICH, BSVD, RATOR, PADMAL		Collagen IV, alpha-1 polypeptide	120130		mutation identified in 1 RATOR family	Brain small vessel disease with or without ocular anomalies, 175780 (3); Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3); {Hemorrhage, intracerebral, susceptibility to}, 614519 (3); ?Retinal arteries, tortuosity of, 180000 (3); Microangiopathy and leukoencephalopathy, pontine, autosomal dominant, 618564 (3)	8(Col4a1)
13.295	03	22	19	13q34	COL4A2, BSVD2, ICH		Collagen IV, alpha-2 polypeptide	120090			Brain small vessel disease 2, 614483 (3); {Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	8(Col4a2)
13.296	10	29	09	13q34	CUL4A		Cullin 4A	603137				
13.297	5	19	09	13q33.2	DAOA, G72		D-amino acid oxidase activator	607408			{Schizophrenia}, 181500 (2)	
13.298	1	27	11	13q33.2	DAOAAS, G30		DAOA antisense RAN	607415				
13.299	9	15	11	13q34	DFNA33		Deafness, autosomal dominant 33	614211		maximum lod at D13S285	Deafness, autosomal dominant 33 (2)	
13.300	4	15	11	13q34	F7		Coagulation factor VII	613878			Factor VII deficiency, 227500 (3); {Myocardial infarction, decreased susceptibility to}, 608446 (3)	
13.301	10	23	87	13q34	F10		Coagulation factor X	613872			Factor X deficiency, 227600 (3)	8(Cf10)
13.302	8	9	05	13q33.1	FGF14, FHF4, SCA27		Fibroblast growth factor-14	601515			Spinocerebellar ataxia 27, 609307 (3)	14(Fhf4)
13.303	2	15	96	13q34	GAS6, AXLLG, AXSF		Growth arrest-specific 6	600441				8(Gas6)
13.304	4	2	07	13q34	GRK1, RHOK, RK		G protein-dependent receptor kinase 1 (rhodopsin kinase)	180381			Oguchi disease-2, 613411 (3)	
13.305	11	16	05	13q34	ING1		Inhibitor of growth 1	601566			Squamous cell carcinoma, head and neck, somatic, 275355 (3)	
13.306	2	5	01	13q34	IRS2		Insulin receptor substrate 2	600797			{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	
13.307	2	9	92	13q34	LAMP1		Lysosome-associated membrane protein-1	153330				8(Lamp1)
13.308	9	26	11	13q34	MCF2L, OST, KIAA0362		MCF2-like protein	609499				
13.309	02	12	19	13q34	NAXD, CARKD, PEBEL2		NAD(P)HX dehydratase	615910			Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2, 618321 (3)	
13.310	1	31	11	13q34	PCID2		PCI domain-containing protein 2	613713				
13.311	4	10	15	13q34	PROZ, PZ		Protein Z	176895			[Protein Z deficiency], 614024 (3)	
13.312	7	17	91	13q32.1	RAP2A		RAP2, member of RAS oncogene family (K-rev)	179540				
13.313	7	27	09	13q34	RASA3		Ras p21 protein activator 3	605182				
13.314	6	9	98	13q34	SOX1		SRY (sex determining region Y)-box 1	602148				
13.315	11	1	99	13q34	TFDP1, DP1, DRTF1		Transcription factor Dp-1	189902		pseudogene on 1q32.3		
13.316	9	29	16	13q34	TMCO3, C13orf11		Transmembrane and coiled-coil domains protein 3	617134				
13.317	12	22	17	13q34	TUBGCP3, GCP3, GRIP104, SPC98, ALP6		Tubulin-gamma complex-associated protein 3	617818				
13.318	09	23	19	13q34	UPF3A, RENT3A		UPF3A regulator of nonsense-mediated mRNA decay	605530				
13.319	12	07	20	3q29	ATP13A5		ATPase 13A5	619119				16(Atp13a5)
14.1	4	26	90	14p12	RNR2		Ribosomal RNA-2	180451				
14.2	2	17	09	14p11.2-q13	ADIPQTL3, CAQ14		Adiponectin, serum level of, quantitative trait locus 3	606771		between D14S608 and D14S599	{Adiponectin, serum level of, QTL3} (2)	
14.3	1	31	01	14q12	ADAP6, ADAP100		A-kinase anchor protein 6	604691				
14.4	8	14	15	14q32.12	GOLGA5, RFG5		Golgi autoantigen, golgin subfamily A, 5	606918		fused with RET to form PTC5		
14.5	11	16	18	14q23.2-q23.3	ESR2, ODG8		Estrogen receptor-2 (ER beta)	601663		mutation identified in 1 ODG8 patient	?Ovarian dysgenesis 8, 618187 (3)	
14.6	6	2	98	14q21.1	MGEA, MEA6		Meningioma-expressed antigen 6	602132		?pseudogenes on other chromosomes		
14.7	8	18	14	14q21.3	RPS29, DBA13		Ribosomal protein S29	603633			Diamond-Blackfan anemia 13, 615909 (3)	
14.8	7	7	17	14q32.2	YY1, GADEVS		YY1 transcription factor	600013			Gabriele-de Vries syndrome, 617557 (3)	12(Yy1)
14.9	07	29	19	14q11.2	RPGRIP1, LCA6, CORD13		RPGR interacting protein 1	605446			Leber congenital amaurosis 6, 613826 (3); Cone-rod dystrophy 13, 608194 (3)	
14.10	9	2	09	14q11.2	TRNAP1, TRP1		tRNA proline-1	189930				
14.11	1	16	18	14q11	ZFHX2AS1		ZFHX2 antisense RNA 1	617833				14(Zfhx2as1)
14.12	6	26	00	14q11.2	ZNF219		Zinc finger protein-219	605036				
14.13	5	6	09	14q11.2	DAD1		Defender against cell death 1	600243				14(Dad1)
14.14	2	21	02	14q11-q12	IBD4		Inflammatory bowel disease 4	606675			{Inflammatory bowel disease 4} (2)	
14.15	10	7	13	14q11.2	MMP14, WNCHRS		Matrix metalloproteinase 14 (membrane-inserted)	600754		mutation identified in 1 family	?Winchester syndrome, 277950 (3)	
14.16	3	28	15	14q11.2	TRL-AAG2-1, TRNAL1, TRL1		tRNA leucine (AAG) 2-1	189932				
14.17	9	2	09	14q11.2	TRNAP2, TRP2		tRNA proline-2	189931				
14.18	9	2	09	14q11.2	TRNAT2, TRT2		tRNA threonine-2	189933				
14.19	4	27	12	14q22.1	ATL1, SPG3A, HSN1D		Atlastin GTPase 1	606439			Spastic paraplegia 3A, autosomal dominant, 182600 (3); Neuropathy, hereditary sensory, type ID, 613708 (3)	
14.20	1	21	07	14q12	GMPR2		Guanosine monophosphate reductase 2	610781				
14.21	9	29	10	14q11-q22	DEL14q11q22, C14DELq11q22		Chromosome 14q11-q22 deletion syndrome	613457		contiguous gene syndrome	Chromosome 14q11-q22 deletion syndrome (4)	
14.22	1	27	04	14q11.2	C14orf18, HEI10		Human enhancer of invasion 10	608249				
14.23	12	17	08	14q11.2	METTL3, IME4		Methyltransferase-like 3	612472				
14.24	3	7	05	14q11-q12	NRL, D14S46E, RP27		Neural retina leucine zipper	162080			Retinitis pigmentosa 27, 613750 (3); Retinal degeneration, autosomal recessive, clumped pigment type (3)	14(Nrl)
14.25	1	14	03	14q11.2	RAB2B		Ras-associated protein RAB2B	607466				
14.26	9	8	14	14q11.2	SALL2, HSAL2, COLB		Sal-like 2	602219		mutation identified in 1 COLB family	?Coloboma, ocular, autosomal recessive, 216820 (3)	
14.27	4	30	12	14q11.2	ACIN1, KIAA0670		Acinus	604562				
14.28	5	16	95	14q12	ADCY4		Adenylate cyclase-4	600292				14(Adcy4)
14.29	02	27	20	14q11.2	AJUBA, JUB		AJUBA LIM protein	609066				
14.30	11	27	18	14q11.2	AP1G2		Adaptor-related protein complex 1, gamma-2 subunit	603534				
14.31	12	18	08	14q11.2	ANG, RNASE5, ALS9		Angiogenin	105850		proximal to TCRA/TCRD	Amyotrophic lateral sclerosis 9, 611895 (3)	14(Ang)
14.32	5	27	05	14q11.2	CEBPE, CRP1		CCAAT/enhancer-binding protein (C/EBP), epsilon	600749			Specific granule deficiency, 245480 (3)	14(Cebpe)
14.33	1	24	13	14q11.2	CHD8, DUPLIN, KIAA1564, AUTS18		Chromodomain helicase DNA-binding protein 8	610528			{Autism, susceptibility to, 18}, 615032 (3)	
14.34	12	23	19	14q11.2	CDH24		Cadherin 24	618599				
14.35	1	21	00	14q12	CMA1		Chymase-1, mast cell	118938				
14.36	12	5	11	14q11.2	CMTM5, CKLFSF5		CKLF-like marvel transmembrane domain-containing 5	607888				14(Cklfsf5)
14.37	2	28	01	14q11.2	CPNE6		Copine VI	605688				
14.38	4	25	93	14q12	CTSG		Cathepsin G	116830				
14.39	3	29	10	14q12	DCAF11, WDR23		DDB1- and CUL4-associated factor 11	613317				
14.40	5	6	13	14q11.2	DHRS2, HEP27		Short-chain dehydrogenase/reductase family, member 2	615194				
14.41	2	23	08	14q11.2	DHRS4, NRDR		Short-chain dehydrogenase/reductase family, member 4	611596				
14.42	4	27	16	14q11.2	DHRS4AS1, AS1DHRS4, C14orf67		DDHRS4 antisense RNA 1, noncoding	616925				
14.43	5	6	13	14q11.2	DHRS4L1		Short-chain dehydrogenase/reductase family, member 4-like 1	615195				
14.44	5	6	13	14q11.2	DHRS4L2		Short-chain dehydrogenase/reductase family, member 4-like 2	615196				
14.45	4	12	18	14q11.2	EDDM3A, FAM12A, HE3A		Epididymal protein 3A	611580				
14.46	12	7	07	14q11.2	FAM12B, HE3B		Family with sequence similarity 12, member B	611582				
14.47	8	21	98	14q12	GZMB, CTLA1, CSPB		Granzyme B (cytotoxic T-lymphocyte-associated serine esterase-1; cathepsin G-like 1)	123910				14(Ctla1)
14.48	8	20	98	14q12	GZMH, CTSGL2		Granzyme H (cathepsin G-like 2)	116831				
14.49	9	7	10	14q11.2	HAUS4, C14orf94		HAUS augmin-like complex, subunit 4	613431				
14.50	6	1	12	14q11.2	HNRNPC, HNRPC		Heterogeneous nuclear ribonucleoprotein C	164020				
14.51	11	11	14	14q11.2	HOMEZ, KIAA1443		Homeodomain leucine zipper-containing factor	608119				14(Homez)
14.52	2	2	07	14q11.2	IL25, IL17E		Interleukin 25	605658				
14.53	10	30	19	14q12	IRF9, ISGF3, ISGF3G		Interferon regulatory factor 9	147574			Immunodeficiency 65, susceptibility to viral infections, 618648 (3)	
14.54	3	1	06	14q11.2	LRP10, LRP9		Low density lipoprotein receptor-related protein 10	609921				14(Lrp10)
14.55	7	18	12	14q11.2	LRRC16B		Leucine-rich repeat-containing protein 16B	614716				
14.56	11	24	14	14q11.2	METTL17, METT11D1		Methyltransferase-like 17	616091				
14.57	11	24	14	14q11.2	MHRT		Myosin heavy chain-associated RNA transcript, noncoding	616096				14(Mhrt)
14.58	1	27	11	14q11.2	MIR208B, MIRN208B		Micro RNA 208B	613613				14(Mir208b)
14.59	3	5	08	14q11.2	MRPL52		Mitochondrial ribosomal protein L52	611856				
14.60	9	19	00	14q11.2	NDRG2		N-myc downstream-regulated gene 2	605272				
14.61	2	20	07	14q11.2	NGDN, NGD		Neuroguidin	610777				
14.62	7	13	09	14q11.2	NRCLP5		Narcolepsy 5	612851		associated with rs1154155, rs12587781, rs1263646	{Narcolepsy 5} (2)	
14.63	2	15	96	14q11.2	OXA1L		Oxidase (cytochrome c) assembly 1-like	601066				
14.64	4	19	06	14q11.2	PARP2, ADPRTL2, ADPRT2		Poly(ADP-ribose) polymerase 2	607725				14(Adprtl2)
14.65	01	04	19	14q11.2	PRMT5, SKB1, IBP72, JBP1, HSL7		Protein arginine methyltransferase 5	604045				
14.66	6	19	98	14q11.2	PSMB5, LMPX		Proteasome subunit, beta type, 5	600306				
14.67	9	10	07	14q11.2	PSMB11		Proteasome subunit, beta-type, 11	611137				
14.68	6	19	98	14q12	PSME1, IFI5111		Proteasome activator subunit-1	600654				
14.69	6	19	98	14q12	PSME2		Proteasome activator subunit-2	602161				
14.70	3	2	98	14q12	RABGGTA		Rab geranylgeranyltransferase, alpha subunit	601905				
14.71	6	2	16	14q11.2	REM2		RRAD- and GEM-like GTPase 2	616955				
14.72	8	27	01	14q12	RIPK3, RIP3		Receptor-interacting serine/threonine kinase 3	605817				
14.73	12	18	08	14q11.2	RNASE1, RNS1		Ribonuclease, RNase A family, 1 (pancreatic)	180440				14(Rib1)
14.74	12	18	08	14q11.2	RNASE2, RNS2, EDN		Ribonuclease, RNase A family, 2, liver (eosinophil-derived neurotoxin)	131410				
14.75	12	18	08	14q11.2	RNASE3, RNS3, ECP		Ribonuclease, RNase A family, 3 (eosinophil cationic protein)	131398				
14.76	12	18	08	14q11.2	RNASE4, RNS4		Ribonuclease, RNase A family, 4	601030				
14.77	12	18	08	14q11.2	RNASE6		Ribonuclease, RNase A family, k6	601981				
14.78	12	24	08	14q11.2	RNASE7		Ribonuclease A family 7	612484				
14.79	12	18	08	14q11.2	RNASE8		Ribonuclease A family, 8	612485				
14.80	9	8	11	14q11.2	RNAE9		Ribonuclease A family, 9	614014				
14.81	12	24	08	14q12	RNF31, ZIBRA		Ring finger protein 31	612487				
14.82	9	23	13	14q11.2	RPPH1, H1RNA		Ribonuclease P, RNA component H1	608513				
14.83	12	8	00	14q11.2	RSCIS		Radiation sensitivity/chromosome instability syndrome, autosomal dominant	605463			Radiation sensitivity/chromosome instability syndrome, autosomal dominant (1)	
14.84	3	10	99	14q11.2	SLC7A7, LPI		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7	603593			Lysinuric protein intolerance, 222700 (3)	
14.85	10	22	99	14q11.2	SLC7A8, LAT2		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 8	604235				
14.86	10	13	09	14q11.2	SLC22A17, NGALR, BOIT, BOCT, NGALR2, NGALR3		Solute carrier family 22, organic cation transporter, member 17	611461				
14.87	04	13	20	14q13.3	SLC25A21, ODC, MTDPS18		Solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21	607571		mutation identified in 1 MTDPS18 patient	?Mitochondrial DNA depletion syndrome 18, 618811 (3)	
14.88	7	31	08	14q11.2	SLC39A2, ZIP2		Solute carrier family 39 (zinc transporter), member 2	612166				
14.89	4	25	06	14q11.2	SOLO, FLJ10357		SOLO gene	610018				
14.90	11	12	20	14q11.2	SUPT16H, SPT16		SPT16 homolog, facilitates chromatin remodeling subunit	605012				
14.91	10	15	13	14q11.2	TRAC, TRCA, TRA, IMD7		T-cell receptor alpha	186880		cen--V-C--ter	Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3)	14(Tcra)
14.92	10	15	13	14q11.2	TRDC		T-cell receptor delta chain constant region	186810		in midst of TCRA		14(Tcrd)
14.93	10	15	13	14q11.2	TRDD@		T-cell receptor delta chain diversity gene cluster	615460				
14.94	10	15	13	14q11.2	TRDV@		T-cell receptor delta chain variable gene cluster	615459				
14.95	10	15	13	14q11.2	TRDJ@		T-cell receptor delta chain joining gene cluster	615461				
14.96	5	28	98	14q11.2	TEP1, TP1		Telomerase-associated protein-1	601686				14(Tep1)
14.97	1	18	13	14q12	TGM1, ICR2, ARCI1		Transglutaminase-1 (K polypeptide epidermal type I, protein-glutamine gamma-glutamyltransferase)	190195			Ichthyosis, congenital, autosomal recessive 1, 242300 (3)	
14.98	2	18	08	14q11.2	THTPA		Thiamine triphosphatase	611612				
14.99	6	8	11	14q11.2	TOX4, LCP1, KIAA0737		TOX high mobility group box family member 4	614032				
14.100	6	2	16	14q11.2	TPPP2, p18		Tubulin polymerization-promoting protein family, member 2	616956				
14.101	10	15	13	14q11.2	TRAJ@		T-cell receptor alpha chain joining gene cluster	615443				
14.102	10	15	13	14q11.2	TRAV@		T-cell receptor alpha chain variable gene cluster	615442				
14.103	1	22	07	14q12	TSSK4, TSSK5		Testis-specific serine/threonine kinase 4	610711				
14.104	09	08	20	14q11.2	TTC5		Tetratricopeptide repeat domain-containing protein 5	619014				
14.105	1	16	18	14q11.2	ZFHX2, ZFH5, ZNF409, KIAA1056, KIAA1762, MARSIS		Zinc finger homeobox 2	617828		mutation identified in 1 MARSIS family	?Marsili syndrome, 147430 (3)	
14.106	3	3	98	14q11.2	BCL2L2, BCLW		BCL2-like 2	601931				
14.107	3	16	06	14q11.2-q12	DFNA53		Deafness, autosomal dominant 53	609965		max lod at D14S1280	Deafness, autosomal dominant 53 (2)	
14.108	3	16	06	14q11.2	EFS		Embryonal FYN-associated substrate	609906				
14.109	10	15	98	14q12	LTB4R, CMKRL1, P2RY7, BLTR		Leukotriene b4 receptor (purinergic receptor P2Y, G protein-coupled, 7; chemokine receptor-like 1)	601531				
14.110	8	27	01	14q12	LTB4R2, BLTR2, BLT2		Leukotriene B4 receptor 2	605773				
14.111	12	20	11	14q11.2-q12	MRT9, MRT26		Mental retardation, autosomal recessive, 9/26	611095		between rs1998463 and rs243286	Mental retardation, autosomal recessive, 9/26 (2)	
14.112	5	24	13	14q11.2-q12	PAURT1		Preauricular tag, isolated, autosomal dominant, 1	610420		between D14S990 and D14S264	Preauricular tag, isolated, autosomal dominant, 1 (2)	
14.113	7	11	11	14q11-q12	PCK2, PEPCK2		Phosphoenolpyruvate carboxykinase 2, mitochondrial	614095			PEPCK deficiency, mitochondrial, 261650 (1)	
14.114	10	31	17	14q11.2	OSGEP, FLJ20411, GAMOS3		O-sialoglycoprotein endopeptidase	610107			Galloway-Mowat syndrome 3, 617729 (3)	
14.115	10	29	03	14q12	REC8L1, REC8		Rec8, S. pombe, homolog of	608193				
14.116	1	30	12	14q11.2-q13	HHPP		Hyperhidrosis palmaris et plantaris	144110		between D14S283 and D14S264	Hyperhidrosis palmaris et plantaris (2)	
14.117	11	16	05	14q11.2	PABPN1, PABP2, PAB2		Poly(A)-binding protein, nuclear 1	602279			Oculopharyngeal muscular dystrophy, 164300 (3)	
14.118	7	19	06	14q11.2-q12	SPD3		Synpolydactyly 3	610234		max lod at D14S264	Synpolydactyly 3 (2)	
14.119	4	27	12	14q12	AP4S1, CPSQ6, SPG52		Adaptor-related protein complex 4, sigma-1 subunit	607243			Spastic paraplegia 52, autosomal recessive, 614067 (3)	
14.120	6	24	94	14q11.2	APEX, APE		APEX nuclease (multifunctional DNA repair enzyme)	107748				14(Apex)
14.121	3	14	07	14q12	ARHGAP5, RHOGAP5		RHO GTPase-activating protein 5	602680				
14.122	9	9	09	14q12	CBLN3		Precerebellin 3	612978				14(Cbln3)
14.123	8	2	13	14q13.1	CFL2, NEM7		Cofilin 2, muscle	601443			Nemaline myopathy 7, autosomal recessive, 610687 (3)	
14.124	12	23	19	14q12	CHMP4A, SNF7		Charged multivesicular body protein 4A	610051				
14.125	01	04	19	14q12	CIDEB		Cell death-inducing DFFA-like effector B	604441				
14.126	12	3	96	14q12	DFNB5		Deafness, autosomal recessive 5	600792			Deafness, autosomal recessive 5 (2)	
14.127	2	16	18	14q12	FITM1, FIT1		Fat storage-inducing transmembrane protein 1	612028				
14.128	5	24	13	14q12	G2E3, KIAA1333		G2/M phase-specific E3 ubiquitin ligase	611299				
14.129	2	25	14	14q12	GPR33		G protein-coupled receptor 33	610118				
14.130	10	30	19	14q12	HECTD1		HECT domain-containing E3 ubiquitin protein ligase 1	618649				
14.131	1	27	11	14q11.2	MIR208A, MIRN208A, MIR208, MIRN208		Micro RNA 208A	611116				
14.132	7	22	11	14q11.2	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3		Myosin, heavy polypeptide-6, cardiac muscle, alpha	160710			Cardiomyopathy, hypertrophic, 14, 613251 (3); Atrial septal defect 3, 614089 (3); Cardiomyopathy, dilated, 1EE, 613252 (3); {Sick sinus syndrome 3}, 614090 (3)	14(Myhca)
14.133	6	9	15	14q11.2	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD		Myosin, heavy polypeptide-7, cardiac muscle, beta	160760		5'-B-4.5kb-A-3'	Cardiomyopathy, hypertrophic, 1, 192600 (3); Cardiomyopathy, dilated, 1S, 613426 (3); Myopathy, myosin storage, autosomal dominant, 608358 (3); Laing distal myopathy, 160500 (3); Scapuloperoneal syndrome, myopathic type, 181430 (3); Left ventricular noncompaction 5, 613426 (3); Myopathy, myosin storage, autosomal recessive, 255160 (3)	
14.134	6	13	12	14q12	NEDD8		Neural precursor cel expressed, developmentally downregulated 8	603171				
14.135	02	08	19	14q12	NOP9		NOP9, S. cerevisiae, homolog of	618308				
14.136	12	13	18	14q12	NUBPL, IND1, MC1DN21		Nucleotide-binding protein-like protein	613621			Mitochondrial complex I deficiency, nuclear type 21, 618242 (3)	
14.137	2	24	17	14q12	PRKD1, PRKCM, PKD, CHDED		Protein kinase D1	605435			Congenital heart defects and ectodermal dysplasia, 617364 (3)	
14.138	12	11	18	14q12	SCFD1, SLY1, RA410		Sec1 family domain-containing protein 1	618207				
14.139	12	30	14	14q12	SDR39U1		Short-chain dehydrogenase/reductase family 39U, member 1	616162				
14.140	8	21	12	14q12	STRN3, SG2NA		Striatin, calmodulin-binding protein 3	614766				
14.141	11	18	11	14q12	STXBP6, AMISYN, HSPC156		Syntaxin-binding protein 6	607958				
14.142	12	24	11	14q12	TINF2, TIN2, DKCA3		TRF1-interacting nuclear factor 2	604319			Dyskeratosis congenita, autosomal dominant 3, 613990 (3); Revesz syndrome, 268130 (3)	
14.143	07	28	20	14q12	TM9SF1, HMP70		Transmembrane protein 9 superfamily, member 1	618965				
14.144	5	29	13	1p34.3	ZMYM6, ZNF258		Zinc finger, MYM-type 6	613567				
14.145	2	28	01	14q13.1-q13.2	BAZ1A		Bromodomain adjacent to zinc finger domain, 1A	605680				
14.146	08	27	18	14q12	COCH, DFNA9, DFNB110		Cochlin	603196		mutation identified in 1 DFNB110 family	Deafness, autosomal dominant 9, 601369 (3); ?Deafness, autosomal recessive 110, 618094 (3)	12(Coch5B2)
14.147	2	11	08	14q13.3	NKX2-8, NKX2H, NKX2.8		NK2 homeobox 8	603245				12(Nkx2-9)
14.148	4	24	09	14q13.3	PAX9, STHAG3		Paired box gene 9	167416			Tooth agenesis, selective, 3, 604625 (3)	
14.149	4	27	12	14q12-q21	SPG32		Spastic paraplegia-32	611252		between D14S264 and D14S978	Spastic paraplegia 32, autosomal recessive (2)	
14.150	10	27	97	14q12-q22	ARVD3		Arrhythmogenic right ventricular dysplasia 3	602086		?distinct from ARVD1	Arrhythmogenic right ventricular dysplasia 3 (2)	
14.151	1	2	03	14q21.1	FOXA1, HNF3A		Forkhead box A1 (hepatocyte nuclear factor-3, alpha)	602294				12(Hnf3a)
14.152	7	22	11	14q12	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1		Forkhead box G1B	164874			Rett syndrome, congenital variant, 613454 (3)	
14.153	3	1	07	14q13	HPE8		Holoprosencephaly 8	609408		between D14S49 and D14S1014	Holoprosencephaly 8 (2)	
14.154	3	14	06	14q13.2	KIAA0391		KIAA0391 gene	609947				
14.155	11	6	14	14q13.3-q21.1	MIPOL1		MIPOL1 gene	606850				
14.156	05	19	20	14q13.2	NFKBIA, IKBA, EDAID2		Nuclear factor kappa-B inhibitor, alpha	164008			Ectodermal dysplasia and immunodeficiency 2, 612132 (3)	12(ikba)
14.157	9	1	15	14q13.3	NKX2-1, TITF1, NKX2A, TTF1, NMTC1		NK2 homeobox 1	600635			{Thyroid cancer, nonmedullary, 1}, 188550 (3); Chorea, hereditary benign, 118700 (3); Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	
14.158	9	8	17	14q12	NOVA1		NOVA alternative splicing regulator 1	602157				12(Nova1)
14.159	3	24	06	14q13.1	NPAS3, MOP6		Neuronal PAS domain protein 3	609430				12(Npas3)
14.160	11	2	11	14q13.2	PSMA6, PROS27, P27K		Proteasome subunit, alpha-type, 6	602855			{Myocardial infarction, susceptibility to}, 608446 (3)	
14.161	4	25	93	14q21.1	SSTR1		Somatostatin receptor-1	182451				12(Sstr1)
14.162	5	23	00	14q21.3	POLE2, DPE2		Polymerase, DNA, epsilon-2	602670				
14.163	8	25	04	14q13-q21	RLS2		Restless legs syndrome, susceptibility to, 2	608831		max lod at D14S288	{Restless legs syndrome 2} (2)	
14.164	09	30	19	14q13.1	EGLN3, PHD3, HIFP4H3		egl-9 family hypoxia inducible factor 3	606426				
14.165	12	17	09	14q11.2	PNP, NP		Purine nucleoside phosphorylase	164050		centromeric to TCRA	Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3)	14(Np1,2)
14.166	12	10	12	14q13.1	SNX6		Sorting nexin 6	606098				
14.167	07	24	19	14q13.2	BRMS1L		BRMS1-like transcriptional repressor	618514				
14.168	9	8	11	14q13.2	INSM2, IA6		Insulinoma-associated 2	614027				
14.169	9	10	12	14q13.1	SPTSSA, C14orf147, SSSPTA		Serine palmitoyltransferase, small subunit, A	613540				
14.170	05	07	19	14q13.2	PPP2R3C, G5PR, GDRM, SPGF36		Protein phosphatase 2, regulatory subunit B-double prime, gamma	615902			Gonadal dysgenesis, dysmorphic facies, retinal dystrophy, and myopathy, 618419 (3); Spermatogenic failure 36, 618420 (3)	
14.171	01	31	20	14q13.2	SRP54, SCN8		Signal recognition particle, 54kD	604857			Neutropenia, severe congenital, 8, autosomal dominant, 618752 (3)	
14.172	03	03	20	14q13.2	RALGAPA1, GARNL1, TULIP1, GRIPE, KIAA0884, NEDHRIT		Ral GTPase activating protein, alpha subunit 1 (catalytic)	608884		pseudogene on 9q31.1	Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation, 618797 (3)	12(Garnl1)
14.173	09	26	19	4q13.3	CABS1, CLPH, C4orf35		Calcium-binding protein, spermatid-associated 1	618600				5(Clph)
14.174	2	4	09	14q21.1	FBXO33, FBX33, BMND12		F-box only protein 33	609103				12(Fbxo33)
14.175	6	30	05	14q13.3	MBIP		MAP3K12-binding inhibitory protein	609431				
14.176	9	14	12	14q13.3	PTCSC3		PTCSC3 gene	614821				
14.177	1	3	18	14q13.3	SFTA3, SPH		Surfactant-associated protein 3	617860				
14.178	2	1	11	14q13.3-q21.1	HPV6AI1		Human papillomavirus type 6A integration site 1	604461		previously assigned to 10q24		
14.179	5	28	02	14q22.1	GNG2		Guanine nucleotide-binding protein, gamma-2	606981				14(Gng2)
14.180	9	10	07	14q21.3	MDGA2		MAM domain-containing glycosylphosphatidylinositol anchor 2	611128				12(Mdga2)
14.181	4	16	10	14q21.3	MGAT2, CDGS2, CDG2A		Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyl- transferase	602616			Congenital disorder of glycosylation, type IIa, 212066 (3)	
14.182	9	2	12	14q22.3	PELI2		Pellino, Drosophila, homolog of, 2	614798				
14.183	08	22	19	14q21.3	SOS2, NS9		SOS Ras/Rac guanine nucleotide exchange factor 2	601247			Noonan syndrome 9, 616559 (3)	12(Sos2)
14.184	04	27	20	14q23.1	TIMM9, TIM9		Translocase of inner mitochondrial membrane 9	607384				
14.185	10	15	97	14q22.3	LGALS3, MAC2, GALBP		Lectin, galactose-binding, soluble, 3	153619		assigned earlier to 1p13		
14.186	9	4	98	14q23.1	RTN1, NSP		Reticulon 1 (neuroendocrine-specific protein)	600865				
14.187	6	15	99	14q23.2	HIF1A, MOP1		Hypoxia-inducible factor 1, alpha subunit	603348				12(Hif1a)
14.188	12	27	01	14q22.1	TRIM9, SPRING, KIAA0282		Tripartite motif-containing protein 9	606555				
14.189	3	3	16	14q21.1	CLEC14A		C-type lectin domain family 14, member A	616845				
14.190	9	30	15	14q21.1	GEMIN2, SIP1		GEM-associated protein 2	602595				
14.191	10	07	19	14q21.1	SEC23A, CLSD		SEC23 homolog A, coat complex II component	610511			Craniolenticulosutural dysplasia, 607812 (3)	
14.192	2	16	18	14q21.1	TRAPPC6B, TPC6, NEDMEBA		Trafficking protein particle complex, subunit 6B	610397			Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, 617862 (3)	12(Trappc6b)
14.193	3	10	11	14q21.2	FKBP3, FKBP25		FK506-binding protein 3	186947				
14.194	7	15	09	14q21.1	LRFN5, SALM5		Leucine-rich repeat and fibronectin type III domain-containing protein 5	612811				12(Lrfn5)
14.195	10	09	18	14q21.2	MIS18BP, C14orf106		Mis18-binding protein 1	618139				
14.196	09	19	19	14q21.2	PRPF39		Pre-mRNA processing factor 39	614907				
14.197	8	11	17	14q21.2	TOGARAM1, FAM179B, KIAA0423		TOG array regulator of axonemal microtubules 1	617618				
14.198	3	3	03	14q21.2-q22.3	MGR4, MGOA		Migraine without aura, susceptibility to, 4	607501		between D14S976 and D14S978	{Migraine without aura, susceptibility to, 4} (2)	
14.199	9	16	12	14q21.3	ARF6		ADP-ribosylation factor 6	600464				
14.200	5	25	13	14q21.3	CDKL1, KKIALRE, p42		Cyclin-dependent kinase-like 1	603441				
14.201	09	10	19	14q21.3	DMAC2L, ATP5S, FB		Distal membrane arm assembly complex 2-like protein	618579				
14.202	9	7	12	14q12	DHRS1		Short-chain dehydrogenase/reductase family, member 1	610410				
14.203	08	27	18	14q21.2	FANCM, KIAA1596, SPGF28, POF15		FANCM gene	609644		mutation identified in 1 POF15 family	Spermatogenic failure 28, 618086 (3); ?Premature ovarian failure 15, 618096 (3)	
14.204	2	11	08	14q21.2	FSCB, C14orf155		Fibrous sheath cabyr-binding protein	611779				12(Fscb)
14.205	5	26	13	14q21.3	KLHDC1		KELCH domain-containing protein 1	611281				
14.206	5	26	13	14q21.3	KLHDC2, HCLP1		KELCH domain-containing protein 2	611280				
14.207	1	7	09	14q21.3	KTU, C14orf104, CILD10		Kintoun, Medaka, homolog of	612517			Ciliary dyskinesia, primary, 10, 612518 (3)	
14.208	1	10	18	14q21.3	VCPKMT, METTL21D, C14orf138		Valosin-containing protein lysine methyltransferase	615260				
14.209	11	21	20	14q21.3	NEMF, SDCCAG1, IDDSAPN		Nuclear export mediator factor	608378			Intellectual developmental disorder with speech delay and axonal peripheral neuropathy, 619099 (3)	
14.210	9	14	95	14q22.2	CDKN3		Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)	123832				
14.211	4	1	96	14q22.3	KTN1, CG1		Kinectin	600381				
14.212	8	21	07	14q22.1	PTGER2		Prostaglandin E receptor 2, EP2 subtype, 53kD	176804			{Asthma, aspirin-induced, susceptibility to}, 208550 (3)	15(Ptgerep2)
14.213	7	22	13	14q22-q23	CTRCT32, CTAA1, CAP, CTPP5		Cataract 32, multiple types	115650		between D14S980 and D14S1069	Cataract 32, multiple types (2)	
14.214	3	8	07	14q23.1	PRKCH, PKCL, PRKCL		Protein kinase C, eta	605437			{Cerebral infarction, susceptibility to}, 601367 (3)	
14.215	4	29	17	14q24.2	ZFYVE1, ZNFN2A1, DFCP1, TAFF1		Zinc finger FYVE type-containing protein 1	605471				
14.216	12	19	01	14q24.1	ZFP36L1, BRF1, ERF1		Zinc finger protein 36, C3H type-like 1 (butyrate response factor 1; EGF-response factor 1)	601064				
14.217	3	20	07	14q22.1	C14orf166, CGI99		Chromosome 14 open reading frame 166	610858				
14.218	1	29	13	14q22.1	DDHD1, PAPLA1, KIAA1705, SPG28		DDHD domain-containing protein 1	614603			Spastic paraplegia 28, autosomal recessive, 609340 (3)	
14.219	10	7	13	14q22.1	ERO1L, ERO1LA		Endoplasmic reticulum oxidoreduction 1-like	615435				14(Ero1l)
14.220	4	30	09	14q22.2	GCRRF1, CGR19		Cell growth regulator with ring finger domain 1	606138				
14.221	8	26	15	14q22.1	GNPNAT1, GNA1		Glucosamine-phosphate N-acetyltransferase 1	616510				
14.222	10	24	18	14q22.1	FERMT2, PLEKHC1, MIG2, UNC112, KIND2		Fermitin family, member 2	607746				
14.223	4	2	12	14q22.1	FRMD6, WILLIN, C14orf31		FERM domain-containing protein 6	614555				
14.224	10	7	05	14q21.3	L2HGDH, C14orf160, L2HGA		L-2-hydroxyglutarate dehydrogenase	609584			L-2-hydroxyglutaric aciduria, 236792 (3)	
14.225	5	1	16	14q22.1	NIN, KIAA1565, SCKL7		Ninein	608684		mutation identified in 1 SCKL7 family	?Seckel syndrome 7, 614851 (3)	
14.226	8	27	08	14q21.3	RN7SL1, 7SL, 7L1A		RNA, 7SL, cytoplasmic 1	612177				
14.227	8	27	08	14q21.3	RN7SL2, 7L1C		RNA, 7SL, cytoplasmic 2	612179				
14.228	8	27	08	14q21.3	RN7SL3		RNA, 7SL, cytoplasmic 3	612180				
14.229	2	1	11	14q22.1	PSMC6		Proteasome 26S subunit, ATPase, 6	602708		previously assigned to 12q15 by FISH		
14.230	12	9	04	14q22.1	PTGDR, AS1, ASRT1		Prostaglandin D2 receptor	604687			{Asthma, susceptibility to, 1}, 607277 (3)	
14.231	6	23	98	14q22.1	PYGL		Phosphorylase, glycogen, liver	613741			Glycogen storage disease VI, 232700 (3)	12(Pygl)
14.232	04	27	20	14q22.1	SAV1, WW45, SAV		Salvador family WW domain containing protein 1	607203				
14.233	7	16	09	14q23.2	SGPP1, SPPASE1		Sphingosine-1-phosphate phosphatase 1	612826				
14.234	7	14	14	14q22.1	STYX		Serine/threonine/tyrosine-interacting protein	615814				
14.235	10	27	06	14q22.1	TXNDC1, TMX		Thioredoxin domain-containing 1	610527				
14.236	2	4	15	14q22.1	TXNDC16, KIAA1344		Thioredoxin domain-containing protein 16	616179				
14.237	5	4	09	14q22.2	GCH1, DYT5, HPABH4B		GTP cyclohydrolase 1	600225			Dystonia, DOPA-responsive, with or without hyperphenylalaninemia, 128230 (3); Hyperphenylalaninemia, BH4-deficient, B, 233910 (3)	
14.238	6	3	14	14q22.1-q22.3	FRIASS, DEL14q22, C14DELq22		Frias syndrome	609640		deletion spans 4.1 Mb on 14q22.1-q22.3	Frias syndrome (4)	
14.239	3	7	11	14q22.1-q24.2	MYP18		Myopia 18	255500		between D14S984 and D14S999	Myopia 18 (2)	
14.240	3	7	14	14q22.2	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11		Bone morphogenetic protein-4	112262			Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625 (3)	14(Bmp2b1)
14.241	5	25	13	14q22.2	CNIH, TGAM77		Cornichon, Drosophila, homolog of	611287				
14.242	2	23	09	14q22.2	CRCS8		Colorectal cancer, susceptibility to, 8	612589		associated with rs4444235	{Colorectal cancer, susceptibility to, 8} (2)	
14.243	9	9	08	14q22.3	FBXO34, FBX34		F-box only protein 34	609104				14(Fbxo34)
14.244	9	27	17	14q22.2	GMFB, GMF		Glia maturation factor, beta	601713				
14.245	2	7	07	14q22.2	SAMD4A, SMAUG1, KIAA1053		Sterile alpha motif domain-containing 4A	610747				14(Samd4a)
14.246	11	11	14	14q22.2-q22.3	WDHD1, AND1		WD repeat and HMG-box DNA binding protein 1	608126				
14.247	9	18	12	14q22.3	AP5M1, MUDENG, MUD, C14orf108		Adaptor-related protein complex 5, mu-1 subunit	614368				
14.248	09	19	19	14q22.3	ATG14, ATG14L, KIAA0831, BARKOR		Autophagy related 14	613515				
14.249	5	1	17	14q23.1	DACT1, DPR1, DAPPER1, FRODO, TBS2		Dapper, antagonist of beta-catenin, 1	607861		mutation identified in 1 TBS2 family	?Townes-Brocks syndrome 2, 617466 (3)	
14.250	1	31	18	14q22.3	DLGAP5, DLG7, HURP, KIAA0008		Discs large-associated protein 5	617859				
14.251	9	8	11	14q22.3	EXOC5, SEC10L1		Exocyst complex component 5	604469				
14.252	11	23	16	14q22.3	MAP1IP1L, MISS		Mitogen-activated protein kinase 1-interacting protein 1-like protein	617226				
14.253	6	1	18	14q22.3	NAA30, NAT12, MAK3, C14orf35		N-alpha-acetyltransferase 30, NatC catalytic subunit	617989				
14.254	5	8	15	14q22.3	OTX2, MCOPS5, CPHD6		Orthodenticle, Drosophila, homolog of, 2	600037			Microphthalmia, syndromic 5, 610125 (3); Pituitary hormone deficiency, combined, 6, 613986 (3); Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3)	
14.255	4	30	15	14q22.3	SOCS4, SOCS7		Suppressor of cytokine signaling 4	616337				
14.256	4	24	17	14q22.3	TMEM260, C14orf101, SHDRA		Transmembrane protein 260	617449			Structural heart defects and renal anomalies syndrome, 617478 (3)	
14.257	7	10	08	14q23	ANIB8		Aneurysm, intracranial berry, 8	612162		associated with rs767603	Aneurysm, intracranial berry, 8 (2)	
14.258	10	6	09	14q23	EIG2		Epilepsy, idiopathic generalized, susceptibility to, 2	606972			{Epilepsy, idiopathic generalized, susceptibility to, 2} (2)	
14.259	02	20	19	14q23.3	FUT8, CDGF1		Fucosyltransferase 8	602589			Congenital disorder of glycosylation with defective fucosylation 1, 618005 (3)	
14.260	8	14	11	14q23.3	MAX		MAX protein	154950		interacts with MYC	{Pheochromocytoma, susceptibility to}, 171300 (3)	12 (Myn)
14.261	6	15	99	14q23.1	MNAT1, MAT1		Menage a trois 1	602659				
14.262	12	9	97	14q23.1	PSMA3		Proteasome (prosome, macropain) subunit, alpha type, 3	176843				
14.263	08	12	19	14q23.1	SIX1, BOS3, DFNA23		SIX homeobox 1	601205			Branchiootic syndrome 3, 608389 (3); Deafness, autosomal dominant 23, 605192 (3)	
14.264	08	12	19	14q23.1	SIX4		SIX homeobox 4	606342				
14.265	08	12	19	14q23.1	SIX6, ODRMD		SIX homeobox 6	606326			Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3)	
14.266	11	20	13	14q23.2	SYNE2, NUANCE, KIAA1011, EDMD5		Spectrin repeat-containing nuclear envelope protein 2 (nesprin 2)	608442			Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	
14.267	11	4	93	14q23.3	FNTB		Farnesyltransferase, CAAX box, beta	134636		related FNTBL1 on 9		
14.268	1	4	12	14q23.3	ZBTB25, ZNF46, KUP		Zinc finger and BTB domain containing 25	194541				
14.269	12	28	08	14q23.1	ARID4A, RBP1, RBBP1		AT-rich interactive domain-containing protein 4A	180201				
14.270	1	26	17	14q23.1	C14orf39, SIX6OS1		Chromosome 14 open reading frame 39	617307				
14.271	4	30	12	14q23.1	DAAM1, KIAA0666		Dishevelled-associated activator of morphogenesis 1	606626				
14.272	7	16	09	14q23.1	DHRS7, RETSDR4		Short-chain dehydrogenase/reductase family, member 7	612833				
14.273	2	25	15	14q23.1	GPR135		G protein-coupled receptor 135	607970				12(Gpr135)
14.274	5	23	13	14q23.1	JKAMP, C24orf100, JAMP		JNK1/MAPK8-associated membrane protein	611176				
14.275	9	21	15	14q23.1	KIAA0586, TALPID3, JBTS23, SRTD14		KIAA0586 gene	610178			Joubert syndrome 23, 616490 (3); Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3)	
14.276	9	10	12	14q23.1	L3HYPDH, C14orf149		L-3-hydroxyproline dehydratase, trans	614811				
14.277	10	12	14	14q23.1	PPM1A, PP2CA		Protein phosphatase, magnesium/manganese-dependent, 1A	606108				
14.278	10	7	05	14q23.2	PPP2R5E		Protein phosphatase-2, regulatory subunit B (B56), epsilon isoform	601647		incorrectly assigned to 7p12-p11.2 by FISH		
14.279	8	26	15	14q23.1	SLC38A6, SNAT6		Solute carrier family 38 (amino acid transporter), member 6	616518				
14.280	5	2	07	14q23.2	SYT16, STREP14		Synaptotagmin 16	610950				
14.281	8	20	07	14q23.1	TMEM30B, CDC50B		Transmembrane protein 30B	611029				
14.282	09	11	19	14q23.1	TRMT5, TRM5, KIAA1393, COXPD26		tRNA methyltransferase 5	611023			Combined oxidative phosphorylation deficiency 26, 616539 (3)	
14.283	9	27	17	14q23.2	GPHB5, GPB5		Glycoprotein hormone, beta-5	609652				
14.284	3	30	12	14q23.2	HIF1AAS1		HIF1A antisense RNA 1	614528				
14.285	3	30	12	14q23.2	HIF1AAS2		HIF1A antisense RNA 2	614529				
14.286	4	30	12	14q23.2	KCNH5		Potassium voltage-gated channel, subfamily H, member 5	605716				
14.287	4	30	12	14q23.2	RHOJ, ARHJ, TCL		Ras homolog gene family, member J	607653				
14.288	10	2	12	14q23.2	SNAPC1, SNAP43		Small nuclear RNA-activating protein complex, polypeptide 1	600591				
14.289	2	28	06	14q23.2	TELM		Telomere length, mean leukocyte	609113		suggestive QTL on 12, 10q, 3p	[Telomere length, mean leukocyte] (2)	
14.290	2	25	15	14q23.3	AKAP5, AKAP79		A-kinase anchor protein 5	604688				
14.291	9	26	16	14q23.3	CHURC1, CHCH, C14orf52		Churchill domain-containing 1	608577				
14.292	01	04	19	14q23.3	EIF2S1		Eukaryotic translation initiation factor 2, subunit 1	603907				
14.293	7	22	13	14q23.3	MPP5, PALS1		Membrane protein, palmitoylated 5	606958				12(Pals1)
14.294	7	17	14	14q23.3-q24.1	PLEK2		Pleckstrin 2	608007				
14.295	4	24	18	14q23.3	PLEKHG2, ARHGEF43, KIAA0599		Pleckstrin homology domain- and RhoGEF domain-containing protein G3	617940				
14.296	12	1	14	14q24.1	RDH11, PSDR1, RALR1, RDJCSS		Retinol dehydrogenase 11	607849		mutation identified in 1 RDJCSS family	?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3)	12(Rdh11)
14.297	9	23	04	14q24.1	RDH12, LCA13		Retinol dehydrogenase 12	608830		near RDH11	Leber congenital amaurosis 13, 612712 (3)	
14.298	4	25	18	14q23.3	SPTB, SPH2, EL3, HS2		Spectrin, beta, erythrocytic	182870			Elliptocytosis-3, 617948 (3); Spherocytosis, type 2, 616649 (3); Anemia, neonatal hemolytic, fatal or near-fatal, 617948 (3)	12(Sptb1)
14.299	9	28	15	14q23.3	ZBTB1		Zinc finger- and BTB domain-containing protein 1	616578				12(Zbtb1)
14.300	08	21	19	14q24.1	RAD51B, RAD51L1		RAD51 paralog B	602948		fused with HMGA2 in uterine leiomyoma		
14.301	10	28	19	14q24.3	ALKBH1, ALKB		AlkB homolog 1, histone H2A dioxygenase	605345				
14.302	12	6	16	14q23.3	ATP6V1D, ATP6M		ATPase, H+ transporting, V1 subunit D	609398				
14.303	12	17	08	14q24.3	BATF, BATF1, SFA2		Basic leucine zipper transcription factor, ATF-like	612476				
14.304	10	29	03	14q24.3	EIF2B2		Eukaryotic translation initiation factor 2B, subunit 2	606454			Leukoencephalopathy with vanishing white matter, 603896 (3); Ovarioleukodystrophy, 603896 (3)	
14.305	9	28	00	14q24.3	ENTPD5, CD39L4		Ectonucleoside triphosphate diphosphohydrolase 5	603162				12(Cd39l4)
14.306	11	8	17	14q24.3	ERG28, C14orf1		Ergosterol biosynthesis 28 homolog	604576				
14.307	11	4	13	14q23.3	GPHN, GPH, KIAA1385, GEPH, MOCODC		Gephyrin	603930			Molybdenum cofactor deficiency C, 615501 (3)	
14.308	11	20	17	14q24.3	LTBP2, LTBP3, GLC3D, MSPKA, WMS3		Latent transforming growth factor beta binding protein-2	602091		mutation identified in 1 WMS3 family	Glaucoma 3, primary congenital, D, 613086 (3); Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3); ?Weill-Marchesani syndrome 3, recessive, 614819 (3)	
14.309	11	21	17	14q23.3	MTHFD1, MTHFC, CIMAH		Methylenetetrahydrofolate dehydrogenase 1	172460		trifunctional protein	{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3); Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, 617780 (3)	
14.310	9	28	00	14q24.3	NGB		Neuroglobin	605304				
14.311	7	14	15	14q24.3	TGFB3, ARVD1, RNHF, LDS5		Transforming growth factor, beta-3	190230			Arrhythmogenic right ventricular dysplasia 1, 107970 (3); Loeys-Dietz syndrome 5, 615582 (3)	12(Tgfb3)
14.312	5	10	04	14q24.3	ZADH1		Zinc-binding alcohol dehydrogenase domain-containing protein 1	608642				
14.313	3	12	15	14q32.11	CALM1, PHKD, CPVT4, LQT14		Calmodulin-1 (phosphorylase kinase, delta)	114180			Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3); Long QT syndrome 14, 616247 (3)	
14.314	3	14	96	14q24.3	PGF, PLGF		Placental growth factor, vascular endothelial growth factor-related protein	601121				12(Plgf)
14.315	1	29	01	14q31.3	FLRT2		Fibronectin-like domain-containing leucine-rich transmembrane protein-2	604807				
14.316	5	3	13	14q24.1	ACTN1, BDPLT15		Actinin, alpha-1	102575			Bleeding disorder, platelet-type, 15, 615193 (3)	12(Actn1)
14.317	09	26	19	14q24.2	ADAM20		ADAM metallopeptidase domain 20	603712				
14.318	09	26	19	14q24.2	ADAM21		ADAM metallopeptidase domain 21	603713				
14.319	7	25	18	14q24.2	COX16		Cytochrome c oxidase assembly factor 16	618064				
14.320	02	27	20	14q24.1	ERH		ERH mRNA splicing and mitosis factor	601191		possible pseudogene on 7q34		
14.321	5	9	16	14q24.1	EXD2, EXDL2		Exonuclease 3'-to-5' domain-containing protein 2	616940				
14.322	4	6	13	14q24.1	GALNT16, GALNACT16, GALNTL1, KIAA1130		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16	615132				
14.323	4	9	96	14q23.3	GPX2		Glutathione peroxidase-2, gastrointestinal	138319				
14.324	10	15	94	14q23.3	HSPA2		Heat-shock 70kD protein-2	140560				12(Hspa2)
14.325	6	22	18	14q24.1	PIGH		Phosphatidylinositol glycan, class H	600154			Glycosylphosphatidylinositol biosynthesis defect 17, 618010 (3)	12(Pigh)
14.326	10	4	02	14q24.1	SLC10A1, NTCP1		Solute carrier family 10 (sodium/bile acid cotransporter family), member 1	182396				12(Slc10a1)
14.327	12	04	20	14q24.1	SLC39A9, ZIP9		Solute carrier family 39 (zinc transporter), member 9	619116				
14.328	2	21	11	14q24.2	SMOC1, OAS		SPARC-related modular calcium-binding 1	608488			Microphthalmia with limb anomalies, 206920 (3)	
14.329	1	15	16	14q24.1	SUSD6, DRAGO, KIAA0247		SUSHI domain-containing protein 6	616761				
14.330	09	14	20	14q24.1	TMEM229B		Transmembrane protein 229B	619022				
14.331	9	23	13	14q24.1	VTI1B, VTI1, VTI1L		Vti1, S. cerevisiae, homolog of, B	603207				
14.332	4	27	12	14q24.1	ZFYVE26, KIAA0321, SPG15		Zinc finger FYVE domain-containing protein 26	612012			Spastic paraplegia 15, autosomal recessive, 270700 (3)	
14.333	9	9	10	14q24.1	DCAF5, WDR22, BCRP2, D14S1461E		DDB1- and CUL4-associated factor 5	603812				
14.334	6	15	99	14q24.1	ARG2		Arginase II	107830				
14.335	11	21	02	14q32.11	KCNK13, THIK1		Potassium channel, subfamily K, member 13	607367				
14.336	5	19	15	14q24.2	DCAF4, WDR21, WDR21A		DDB1- and CUL4-associated factor 4	616372				
14.337	11	27	17	14q24.2	PAPLN, PPN		Papilin, proteoglycan-like sulfated glycoprotein	617785				
14.338	01	29	20	14q24.2	PCNX1, KIAA0995		Pecanex 1	617655				12(Pcnx1)
14.339	12	22	08	14q24.2	RBM25, RED120		RNA-binding motif protein 25	612427				
14.340	6	13	17	14q24.2	SIPA1L1, E6TP1, KIAA0440		SIPA1-like protein 1	617504				
14.341	12	19	11	14q24.1	SRSF5, SFRS5, SRp40		Splicing factor, serine/arginine-rich, 5	600914				
14.342	6	30	05	14q24.2	SYNJ2BP, OMP25, ARIP2		Synaptojanin 2-binding protein	609411				
14.343	2	25	15	14q24.2	TTC9, KIAA0227		Tetratricopeptide repeat domain-containing protein 9	610488				
14.344	10	17	12	14q24.3	ABCD4, PXMP1L, P79R, PMP69, MAHCJ		ATP-binding cassette, subfamily D, member 4 (peroxisomal membrane protein 1-like)	603214			Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	
14.345	10	25	11	14q24.3	ACOT1		Acyl-CoA thioesterase 1	614313				12(Acot1)
14.346	3	17	06	14q24.3	ACOT2, PTE2, MTE1		Acyl-CoA thioesterase 2	609972				12(Acot2)
14.347	10	28	11	14q24.3	ACOT4		Acyl-CoA thioesterase 4	614314		?pseudogene on 19q13.12		12(Acot4)
14.348	10	5	11	14q24.3	ACOT6		Acyl-CoA thioesterase 6	614267				12(Acot6)
14.349	5	25	00	14q24.3	ACYP1, ACYPE		Acylphosphatase, erythrocyte	600875				
14.350	8	8	13	14q24.3	AHSA1, AHA1		Activator of heat-shock 90kD protein ATPase 1	608466				
14.351	8	3	11	14q24.3	ALDH6A1, MMSDH		Aldehyde dehydrogenase 6 family, member A1 (methylmalonate semialdehyde dehydrogenase)	603178			Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)	
14.352	9	9	13	14q24.3	AREL1, KIAA0317		Apoptosis-resistant E3 ubiquitin protein ligase 1	615380				
14.353	2	16	18	14q24.3	RIOX1, C14orf169, NO66, MAPJD		Ribosomal oxygenase 1	611919				
14.354	7	17	06	14q24.3	CHX10, HOX10, MCOP2, MCOPCB3		C. elegans ceh-10 homeo domain-containing homolog	142993			Microphthalmia with coloboma 3, 610092 (3); Microphthalmia, isolated 2, 610093 (3)	12(Hox10)
14.355	6	26	16	14q24.3	CIPC, KIAA1737		Clock-interacting pacemaker	616995				
14.356	5	24	12	14q24.3	COQ6, CGI10, COQ10D6		Coq6, S. cerevisiae, homolog of	614647			Coenzyme Q10 deficiency, primary, 6, 614650 (3)	
14.357	11	9	05	14q31.1	DIO2, TXDI2, D2		Deiodinase, iodothyronine, type II	601413				
14.358	06	24	19	14q24.3	DLST, PGL7		Dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex)	126063			Paragangliomas 7, 618475 (3)	
14.359	6	8	11	14q24.3	DNAL1, C14orf168, CILD16		Dynein, axonemal, light chain 1	610062			Ciliary dyskinesia, primary, 16, 614017 (3)	12(Dnal1)
14.360	2	7	08	14q24.3	ESRRB, ESRL2, DFNB35		Estrogen-related receptor beta	602167			Deafness, autosomal recessive 35, 608565 (3)	12(Estrrb)
14.361	4	20	10	14q24.3	FLVCR2, C14orf58, CCT, PVHH, EPV		Feline leukemia virus subgroup C receptor 2	610865			Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, 225790 (3)	12(Flvcr2)
14.362	09	08	20	14q24.3	FOS		FOS protooncogene, AP1 transcription factor subunit	164810				12(Fos)
14.363	10	14	09	14q24.3	GLC3C		Glaucoma 3, primary congenital, C	613085		between D14S61 and D14S1000	Glaucoma 3, primary congenital, C (2)	
14.364	7	26	17	14q24.3	GSTZ1, MAAI, MAAID		Glutathione S-transferase, zeta-1 (maleylacetoacetate isomerase)	603758			[Maleylacetoacetate isomerase deficiency], 617596 (3)	
14.365	08	12	19	14q24.3	IFT43, C14orf179, CED3, SRTD18, RP81		Intraflagellar transport 43	614068		mutation identified in 1 CED3 family and 1 RP81 family	?Cranioectodermal dysplasia 3, 614099 (3); Short-rib thoracic dysplasia 18 with polydactyly, 617866 (3); ?Retinitis pigmentosa 81, 617871 (3)	
14.366	08	20	18	14q24.3	IRF2BPL, C14orf4, EAP1, NEDAMSS		Interferon regulatory factor 2-binding protein like	611720			Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3)	
14.367	08	29	19	14q24.3	ISCA2, MMDS4		Iron-sulfur cluster assembly 2	615317			Multiple mitochondrial dysfunctions syndrome 4, 616370 (3)	
14.368	08	19	19	14q24.3	ISM2, THSD3, TAIL1		Isthmin 2	612684				
14.369	7	24	13	14q24.3	JDP2		JUN dimerization protein 2	608657				
14.370	5	9	12	14q24.3	KTCN8		Keratoconus 8	614628		between rs1074501 and rs755212	Keratoconus 8 (2)	
14.371	10	28	08	14q24.3	MUSTQTL1		Muscle strength quantitative trait locus 1	612083			Muscle strength quantitative trait locus 1 (2)	
14.372	05	12	20	14q24.3	NPC2, HE1		NPC intracellular cholesterol tranporter 2	601015			Niemann-pick disease, type C2, 607625 (3)	
14.373	6	22	14	14q24.3	MLH3, HNPCC7		DNA mismatch repair gene MLH3	604395			Colorectal cancer, somatic, 114500 (3); Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3); {Endometrial cancer, susceptibility to}, 608089 (3)	12(Mlh3)
14.374	7	11	16	14q24.3	NEK9, NERCC1, LCCS10, APUG, NC		Never in mitosis gene A-related kinase 9	609798		mutation identified in 1 APUG family	Lethal congenital contracture syndrome 10, 617022 (3); ?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3); Nevus comedonicus, somatic, 617025 (3)	
14.375	6	15	99	14q24.2-q24.3	NUMB, S171		Numb, Drosophila, homolog of	603728				
14.376	3	7	14	14q24.3	PNMA1, MA1		Paraneoplastic MA antigen 1	604010				
14.377	09	27	18	14q24.3	POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14		Putative protein O-mannosyltransferase 2	607439			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	
14.378	3	14	13	14q24.3	PROX2		Prospero-related homeobox 2	615094				12(Prox2)
14.379	1	11	18	14q24.2	PSEN1, AD3, ACNINV3		Presenilin 1	104311		mutation identified in 1 ACNINV3 family	Alzheimer disease, type 3, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3); Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3); Dementia, frontotemporal, 600274 (3); Pick disease, 172700 (3); Cardiomyopathy, dilated, 1U, 613694 (3); ?Acne inversa, familial, 3, 613737 (3)	
14.380	8	18	99	14q24.2	RGS6		Regulator of G protein signaling 6	603894				
14.381	6	13	12	14q24.3	SKIIP, SKIP, SNW1, BX42		SKI-interacting protein	603055				
14.382	12	21	09	14q24.3	SLIRP, C14orf156		SRA stem loop-interacting RNA-binding protein	610211				
14.383	11	19	11	14q24.3	SYNDIG1L, TMEM90A, CAPUCIN		Synapse differentiation-induced gene 1-like	609999				12(Capucin)
14.384	7	15	14	14q24.3	TTLL5, STAMP, KIAA0998, CORD19		Tubulin tyrosine ligase-like family, member 5	612268			Cone-rod dystrophy 19, 615860 (3)	
14.385	5	23	06	14q24.3	TMED10, TMP21		Transmembrane p24 trafficking protein 10	605406				
14.386	3	14	13	14q24.3	VIPAS39, VIPAR, SPE39, C14orf133		VPS33B-interacting protein, apical-basolateral polarity regulator, spe-39 homolog	613401			Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	
14.387	5	6	98	14q22.3	UBE2L1, UBCL, UBC4		Ubiquitin-conjugating enzyme E2L 1	600012				
14.388	5	19	09	14q31.3-q32.1	FOXN3, CHES1		Forkhead box N3	602628				
14.389	12	9	98	14q24.3-q31	IDDM11		Insulin-dependent diabetes mellitus-11	601208			{Diabetes mellitus, insulin-dependent, 11} (2)	
14.390	12	17	95	14q24.2	MAP3K9, MLK1		Mitogen-activated protein kinase kinase kinase 9	600136				
14.391	11	17	10	14q24.3	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C		Serine palmitoyltransferase, long-chain base subunit 2	605713			Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	12(Sptlc2)
14.392	11	5	08	14q24.2	DPF3, CERD4		D4, zinc and double PHD fingers, family 3	601672				
14.393	10	4	02	14q24.3-q31.1	NRXN3		Neurexin 3	600567				
14.394	08	26	19	14q32.13	DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW		dicer 1, ribonuclease III	606241			Pleuropulmonary blastoma, 601200 (3); Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3); Rhabdomyosarcoma, embryonal, 2, 180295 (3); GLOW syndrome, somatic mosaic, 618272 (3)	
14.395	5	1	02	14q31.3	GALC		Galactosylceramidase	606890			Krabbe disease, 245200 (3)	12(tw)
14.396	10	14	09	14q31	GRD1		Graves disease, susceptibility to, 1	275000		associated with rs2268458	{Graves disease, susceptibility to, 1} (2)	
14.397	11	22	16	14q32.11	GPR68, OGR1, AI2A6		G protein-coupled receptor 68	601404			Amelogenesis imperfecta, hypomaturation type, IIA6, 617217 (3)	
14.398	8	25	11	14q31	HPPD		Hypertelorism, preauricular sinus, punctal pits, and deafness	614187			Hypertelorism, preauricular sinus, punctal pits, and deafness (2)	
14.399	4	24	01	14q31.3	KCNK10, TREK2		Potassium channel, subfamily K, member 10	605873				
14.400	2	18	98	14q31.1	SEL1L		Suppressor of lin 12 (sel-1), C. elegans, homolog of	602329				
14.401	2	21	06	14q31.1	TSHR, CHNG1		Thyroid-stimulating hormone receptor	603372			Hypothyroidism, congenital, nongoitrous, 1 275200 (3); Thyroid adenoma, hyperfunctioning, somatic (3); Hyperthyroidism, nonautoimmune, 609152 (3); Thyroid carcinoma with thyrotoxicosis (3); Hyperthyroidism, familial gestational, 603373 (3)	12(Tshr)
14.402	10	24	00	14q32.11	RPS6KA5, MSK1		Ribosomal protein S6 kinase, 90kD, 5	603607				
14.403	05	21	19	14q32.11	TDP1, SCAN1		Tyrosyl-DNA phosphodiesterase 1	607198		mutation identified in 1 SCAN1 family	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1, 607250 (3)	
14.404	02	25	19	14q32.12	TRIP11, TRIP230, CEV14, ACG1A, ODCD		Thyroid hormone receptor interactor 11	604505			Achondrogenesis, type IA, 200600 (3); Osteochondrodysplasia, 184260 (3)	
14.405	3	9	00	14q31.3	GPR65, TDAG8		G protein-coupled receptor 65	604620				
14.406	4	16	10	14q32.13	SERPINA4, KST, PI4		Serpin peptidase inhibitor, clade A, member 4	147935		in cluster with related AAT, AACT, CBG, PCI		
14.407	10	2	12	14q31.1	GTF2A1, TF2A1		General transcription factor IIA, alpha/beta subunits	600520				
14.408	10	10	18	14q31.3	EML5		Echinoderm microtubule-associated protein-like 5	618119				
14.409	8	8	13	14q31.1	STON2, STN2, STNB		Stonin 2	608467				
14.410	6	19	12	14q31.3	PTPN21, PTPD1		Protein-tyrosine phosphatase, nonreceptor-type, 21	603271				
14.411	1	3	13	14q31.3	SPATA7, HSD3, LCA3		Spermatogenesis-associated protein 7	609868			Leber congenital amaurosis 3, 604232 (3); Retinitis pigmentosa, juvenile, autosomal recessive, 604232 (3)	
14.412	9	22	16	14q31.3	ZC3H14, SUT2, MRT56		Zinc finger CCCH domain-containing protein 14	613279			Mental retardation, autosomal recessive 56, 617125 (3)	
14.413	05	19	20	14q32.32	AMN, IGS2		Amnion associated transmembrane protein	605799			Imerslund-Grasbeck syndrome 2, 618882 (3)	12(Amn)
14.414	10	26	18	14q32.2	CCNK, IDDHDF		Cyclin K	603544		mutation identified in 1 IDDHDF patient	?Intellectual developmental disorder with hypertelorism and distinctive facies, 618147 (3)	
14.415	12	4	03	14q32	CHDS4		Coronary heart disease, susceptibility to, 4	608318		highest LOD with D14S1426	{Coronary heart disease, susceptibility to, 4} (2)	
14.416	12	24	89	14q32.12	CHGA		Chromogranin A, parathyroid secretory protein-1	118910				12(Chga)
14.417	11	19	13	14q32.33	CKB, CKBB, BCK		Creatine kinase, brain type	123280		distal to PI and AACT; closely linked to AKT1 and IGH; proximal to IGH		
14.418	10	23	87	14q32	CKBE		Creatine kinase, ectopic expression	123270		linked to IGH, PI; ?same locus as CKBB	[Creatine kinase, brain type, ectopic expression of] (2)	
14.419	07	14	20	14q32.12	DDX24		DEAD-box helicase 24	606181				
14.420	5	25	00	14q32.31	DIO3, TXDI3		Deiodinase, iodothyronine, type 3	601038				12(Dio3)
14.421	3	15	04	14q32.31	DIO3OS		Deiodinase, iodothyronine, type 3, opposite strand	608523				12(Dio3os)
14.422	02	05	20	14q32.2	DLK1, PREF1, FA1		Delta-like noncanonical NOTCH ligand 1	176290				
14.423	10	21	15	14q32	DUP14q32, C14DUPq32		Chromosome 14q32 duplication syndrome, 700kB	616604		heterozygous germline duplication of 700kb	{Myeloproliferative neoplasms, familial, susceptibility to} (4)	
14.424	10	28	14	14q32.31	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1		Dynein, cytoplasmic-1, heavy chain-1	600112			Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3); Mental retardation, autosomal dominant 13, 614563 (3); Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	14(Dnecl)
14.425	9	22	16	14q32.2	EML1, EMAPL, EMAP, BH		Echinoderm microtubule associated protein like 1	602033			Band heterotopia, 600348 (3)	
14.426	9	7	04	14q32	GEVQ1		Gene expression, variation in, quantitative trait locus on chromosome 14	608875			{Gene expression, variation in, QTL} (2)	
14.427	3	20	16	14q32.13	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC		Glutaredoxin 5	609588			Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3); Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	
14.428	1	28	02	14q32	HFM		Hemifacial microsomia	164210			Hemifacial microsomia (2)	
14.429	12	17	95	14q32.12	IFI27		Interferon, alpha-inducible protein-27	600009				
14.430	2	4	02	14q32.33	JAG2		Jagged 2	602570				12(Jag2)
14.431	1	4	16	14q32	KAOGS		Kagami-Ogata syndrome	608149		uniparental isodisomy of imprinted region of chromosome 14	Kagami-Ogata syndrome (4)	
14.432	7	25	06	14q32	MCOP1		Microphthalmia, isolated 1	251600			Microphthalmia, isolated 1 (2)	
14.433	11	22	10	14q32.2-q32.3	MEG8		Maternally expressed gene 8	613648				
14.434	11	22	10	14q32.31	MIR380, MIRN380		Micro RNA 380	613654				12(Mir380)
14.435	8	27	01	14q32.31	RAGE, MOK		Renal tumor antigen	605762				
14.436	3	6	14	14q32.13	SERPINA9, GCET1, CENTERIN		Serpin peptidase inhibitor, clade A, member 9	615677				
14.437	3	24	14	14q32.31	SNORD114-1		Small nucleolar RNA, C/D box, 114-1	613651				
14.438	2	17	15	14q32	TEMPS		Temple syndrome (maternal uniparental disomy chromosome 14)	616222			Temple syndrome (4)	
14.439	4	10	14	14q32.2	TUNAR, TUNA, LINC00617		TCL1 upstream neural differentiation-associated RNA	615719				
14.440	11	20	98	14q32.32	TNFAIP2		Tumor necrosis factor, alpha-induced protein-2	603300				
14.441	9	20	14	14q32.12	SLC24A4, NCKX4, SHEP6, AI2A5		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4	609840			[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3); [Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3); Amelogenesis imperfecta, type IIA5, 615887 (3)	
14.442	2	22	13	14q32.2	SLC25A29, CACL, ORNT3		Solute carrier family 25 (carnitine/acylcarnitine translocase), member 29	615064				
14.443	11	22	10	14q32.2	SNORD112		Small nucleolar, C/D box, 112	613649		located in an intron of MEG8		
14.444	11	22	10	14q32.31	SNORD113-1		Small nucleolar RNA, C/D box, 113-1	613650				
14.445	11	3	09	14q32.2	VRK1, PCH1A		Vaccinia-related kinase-1	602168			Pontocerebellar hypoplasia type 1A, 607596 (3)	
14.446	7	25	18	14q32.2	WDR25		WD repeat-containing protein 25	618059				
14.447	08	21	19	14q32.2	BCL11B, CTIP2, IMD49, IDDFSTA		BAF chromatin remodeling complex subunit BCL11B	606558			Immunodeficiency 49, 617237 (3); Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities, 618092 (3)	
14.448	9	8	06	14q32.12	BTBD7, FUP1		BTB/POX domain-containing protein 7	610386				
14.449	10	4	07	14q32.13	CBG, SERPINA6		Corticosteroid-binding globulin	122500			Corticosteroid-binding globulin deficiency, 611489 (3)	
14.450	3	5	03	14q32.2	CYP46A1, CYP46		Cytochrome P450, family 46, subfamily A, polypeptide 1 (cholesterol 24-hydroxylase)	604087				
14.451	09	27	19	14q32.12	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD		Fibulin 5	604580		mutation identified in 1 ADCL2 patient	Cutis laxa, autosomal recessive, type IA, 219100 (3); ?Cutis laxa, autosomal dominant 2, 614434 (3); Macular degeneration, age-related, 3, 608895 (3); Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	
14.452	4	10	14	14q32.13	GSC, SAMS		Goosecoid	138890			Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3)	12(Gsc)
14.453	1	23	02	14q32.12	LGMN, PRSC1		Legumain (protease, cysteine, 1)	602620				
14.454	12	5	13	14q32.1	SERPINA2P, PIL, ATR, ARGS		Serpin peptidase inhibitor, clade A, member 2, pseudogene	107410		?pseudogene		
14.455	03	09	20	14q32.13	SERPINA1, PI, AAT		Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1)	107400			Emphysema due to AAT deficiency, 613490 (3); Emphysema-cirrhosis, due to AAT deficiency, 613490 (3); Hemorrhagic diathesis due to antithrombin Pittsburgh, 613490 (3)	12(Aat)
14.456	1	8	00	14q32.13	SERPINA3, AACT, ACT		Alpha-1-antichymotrypsin	107280		220kb from PI	Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular disease, occlusive (3)	
14.457	4	16	10	14q32.13	SERPNA5, PCI		Serpin peptidase inhibitor, clade A, member 5 (protein C inhibitor)	601841				
14.458	6	17	15	14q32.13	SERPINA10, ZPI		Serine (or cysteine) proteinase inhibitor, clade A, member 10 (protein Z-dependent protease inhibitor precursor)	605271				
14.459	5	3	17	14q32.13	SERPINA12, VASPIN		Serpin peptidase inhibitor, clade A, member 12 (vaspin)	617471				
14.460	12	21	98	14q32.13	TCL1A, TCL1		T-cell lymphoma/leukemia 1A	186960			Leukemia/lymphoma, T-cell (2)	
14.461	12	13	00	14q32.13	TCL1B, TML1		T-cell lymphoma/leukemia 1B	603769			Leukemia/lymphoma, T-cell (2)	
14.462	9	9	08	14q32.13	TCL6, TNG1, TNG2		T-cell leukemia/lymphoma 6	604412				
14.463	10	16	14	14q31.3	TTC8, BBS8, RP51		Tetratricopeptide repeat domain 8	608132		mutation identified in 1 RP51 family	Bardet-Biedl syndrome 8, 615985 (3); ?Retinitis pigmentosa 51, 613464 (3)	
14.464	2	11	96	14q32.2	BDKRB1		Bradykinin receptor B1	600337				
14.465	2	11	96	14q32.2	BDKRB2		Bradykinin receptor B2	113503				
14.466	3	16	01	14q32.2	PAPOLA, PAP		Poly(A) polymerase	605553				
14.467	7	9	18	14q32.11-q32.12	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC1, SCA40		Coiled-coil domain-containing protein 88C	611204		mutation identified in 1 SCA40 family	Hydrocephalus, congenital, 1, 236600 (3); ?Spinocerebellar ataxia 40, 616053 (3)	
14.468	10	21	19	14q32.11	NRDE2, C14orf102		NRDE2, necessary for RNA interference, domain containing	618631				
14.469	2	1	11	14q32.11	PSMC1, S4		Proteasome 26S subunit, ATPase, 1	602706		previously assigned to 19p13.3 by FISH		12(Psmc1)
14.470	4	30	12	14q32.12	ASB2		Ankyrin repeat-containing SOCS box protein 2	605759				12(Asb2)
14.471	2	7	14	14q32.12	ATXN3, MJD, SCA3		Ataxin-3 (josephin)	607047			Machado-Joseph disease, 109150 (3)	
14.472	3	28	11	14q32.12	CATSPERB, C14orf161		Cation channel, sperm-associated, beta	611169				
14.473	3	10	16	14q32.12	COX8C		Cytochrome c oxidase, subunit 8c	616855				12(Cox8c)
14.474	10	13	17	14q32.12	GON7, C14orf142		Gon7, S. cerevisiae, homolog of	617436				
14.475	4	2	16	14q32.12	IFI27L2, FAM14A, ISG12B		Interferon alpha inducible protein 27 like 2	611319				
14.476	8	18	14	14q32.12	ITPK1, ITRPK1		Inositol 1,3,4-trisphosphate 5/6-kinase	601838				
14.477	3	7	14	14q32.12	MOAP1, MAP1, PNMA4		Modulator of apoptosis 1	609485				
14.478	5	25	13	14q32.12	NDUFB1		NADH-ubiquinone oxidoreductase subunit B1	603837				
14.479	6	5	08	14q32.12	OTUB2, OTU2, OTB2, C14orf137		OTU domain-containing ubiquitin aldehyde-binding protein 2	608338				
14.480	3	31	11	14q32.12	PRIMA1, PRIMA		Proline-rich membrane anchor 1	613851				
14.481	2	6	16	14q32.12	PPP4R3A, SMEK1, PP4R3A, KIAA2010		Protein phosphatase 4, regulatory subunit 3, alpha	610351				
14.482	11	05	18	14q32.12	RIN3, FLJ22349		Ras and Rab interactor 3	610223				
14.483	4	15	11	14q32.12	UBR7		Ubiquitin protein ligase E3 component N-recognin 7	613816				
14.484	09	11	19	14q32.12	UNC79		unc-79 homolog, NALCN channel complex subunit	616884				12(Unc79)
14.485	9	10	07	14q32.13	CLMN, KIAA1188		Calmin	611121				
14.486	2	5	16	14q32.12-q32.13	PPP4R4, PP4R4, KIAA1622		Protein phosphatase 4, regulatory subunit 4	616790				
14.487	11	13	07	14q32.13	SYNE3, C14orf49		Spectrin repeat-containing nuclear envelope protein 3 (nesprin 3)	610861				12(C14orf49)
14.488	5	9	18	14q32.2	AK7, SPGF27		Adenylate kinase 7	615364		mutation identified in 1 SPGF27 family	?Spermatogenic failure 27, 617965 (3)	
14.489	09	19	19	14q32.2	ATG2B		Autophagy related 2B	616226				
14.490	09	24	19	14q32.2	BEGAIN		Brain-enriched guanylate kinase-associated protein	618597				12(Begain)
14.491	7	18	14	14q32.2	DEGS2, DES2		Delta(4)-desaturase, sphingolipid, 2	610862				
14.492	4	21	16	14q32.2	EVL		ENAH/VASP-like protein	616912				
14.493	10	20	15	14q32.2	GSKIP, C14orf129		GSK3B-interacting protein	616605				
14.494	9	8	08	14q32.31	HSP90AA1, HSPCA, HSPC1, HSP90A, HSP89A, HSPCAL4, LAP2		Heat-shock protein, 90kD, alpha, class A, member 1	140571				
14.495	3	17	08	14q32.2-q32.3	RTL1, PEG11		Retrotransposon-like gene 1	611896				12(Rtl1)
14.496	3	7	14	14q32.2	SETD3		SET domain-containing protein 3	615671				
14.497	03	09	20	14q32.33	AKT1, CWS6		AKT serine/threonine kinase 1	164730		proximal to IGH	Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic, 114500 (3); Ovarian cancer, somatic, 167000 (3); Proteus syndrome, somatic, 176920 (3); Cowden syndrome 6, 615109 (3)	12(Akt)
14.498	7	1	11	14q32.32	CDC42BPB, MRCKB		CDC42-binding protein kinase, beta	614062				
14.499	6	15	99	14q32.33	CRIP2, CRP2		Cysteine-rich intestinal protein 2	601183				
14.500	5	25	10	14q32.32	EIF5		Eukaryotic translation initiation factor 5	601710				
14.501	2	7	05	14q32.33	GPR132, G2A		G protein-coupled receptor-132	606167				
14.502	3	9	07	14q32.33	KLC1, KNS2, KNS2A		Kinesin, light chain 1	600025				
14.503	01	16	19	14q32.32-q32.33	MARK3, VIPB		MAP/microtubule affinity-regulating kinase-3	602678		mutation identified in 1 VIPB family	?Visual impairment and progressive phthisis bulbi, 618283 (3)	
14.504	1	12	05	14q32.2	MEG3, GTL2		Maternally expressed gene 3	605636		100kb from DLK1		
14.505	5	22	03	14q32.33	MTA1		Metastasis-associated gene 1	603526				12(Mta1)
14.506	5	12	11	14q32.33	XRCC3, CMM6		X-ray-repair, complementing defective, repair in Chinese hamster cells-3	600675			{Melanoma, cutaneous malignant, 6}, 613972 (3); {Breast cancer, susceptibility to}, 114480 (3)	
14.507	10	01	19	14q32.31	ANKRD9		Ankyrin repeat domain-containing protein 9	618605				
14.508	4	20	10	14q32.31	CINP		CDK2-interacting protein	613362				
14.509	10	10	14	14q32.2	HDMCP, C14orf68		Hepatocellular carcinoma-downregulated mitochondrial carrier protein	609911				12(Hdmcp)
14.510	3	23	09	14q32.2	MIR127, MIRN127		Micro RNA 127	611709				
14.511	3	23	09	14q32.31	MIR134		Micro RNA 134	610164				
14.512	3	23	09	14q32.2	MIR136, MIRN136		Micro RNA 136	611710				
14.513	6	22	14	14q32.31	MIR376C, MIR368		Micro RNA 368C	610983				
14.514	7	1	11	14q32.31	MIR369, MIR369-3, MIRN369-3		Micro RNA 369	611794				
14.515	1	24	09	14q32.31	MIR370, MIRN370		Micro RNA 370	612553				
14.516	3	23	09	14q32.31	MIR376A-1, MIRN376A-1		Micro RNA 376A-1	610959				
14.517	3	23	09	14q32.31	MIR376A-2, MIRN376A-2		Micro RNA 376A-2	610960				
14.518	3	23	09	14q32.31	MIR376B, MIRN376B		Micro RNA 376b	610961				
14.519	5	19	15	14q32.31	MIR379		Micro RNA 379	616358				12(Mir379)
14.520	7	1	11	14q32.31	MIR409, MIRN409		Micro RNA 409	614057				
14.521	1	29	13	14q32.31	MIR410		Micro RNA 410	615036				
14.522	3	23	09	14q32.2	MIR431, MIRN431		Micro RNA 431	611708				
14.523	3	23	09	14q32.2	MIR433, MIRN433		Micro RNA 433	611711				
14.524	9	9	13	14q32.31	MIR485		Micro RNA 485	615385				
14.525	1	29	13	14q32.31	MIR487B		Micro RNA 487B	615037				
14.526	10	12	14	14q32.31	MIR494		Micro RNA 494	616036				
14.527	10	07	19	14q32.31	MIR495		Micro RNA 495	615149				
14.528	5	19	15	14q32.31	MIR656		Micro RNA 656	616376				
14.529	6	4	97	14q32.31	PPP2R5C		Protein phosphatase-2, regulatory subunit B (B56), gamma isoform	601645		pseudogene on 3p21		
14.530	1	29	13	14q32.31	TECPR2, KIAA0329, SPG49		Tectonin beta-propeller repeat-containing protein 2	615000			Spastic paraplegia 49, autosomal recessive, 615031 (3)	
14.531	08	21	19	14q32.2	WARS1, WARS, HMN9		Tryptophanyl-tRNA synthetase 1	191050			Neuronopathy, distal hereditary motor, type IX, 617721 (3)	
14.532	10	25	17	14q32.31	WDR20		WD repeat-containing protein 20	617741				
14.533	3	14	18	14q32.32	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5		TNF receptor-associated factor 3	601896		mutation identified in 1 IIAE5 patient	{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}, 614849 (3)	
14.534	09	09	20	14q32.33	ADSS1, ADSSL1, MPD5		Adenylosuccinate synthase 1	612498			Myopathy, distal, 5, 617030 (3)	
14.535	10	23	20	14q32.33	APOPT1, APOP, MC4DN17		Apoptogenic protein 1, mitochondrial	616003			Mitochondrial complex IV deficiency, nuclear type 17, 619061 (3)	12(Apopt1)
14.536	06	13	19	14q32.33	ASPG, LYSOLP		Asparaginase	618472				
14.537	11	27	18	14q32.33	BAG5		BCL2-associated athanogene 5	603885				
14.538	2	3	15	14q32.33	BRF1, TAF3C, GTF3B, TF3B90, CFDS		BRF1, S. cerevisiae, homolog of (TATA box-binding protein-associated factor 3C)	604902			Cerebellofaciodental syndrome, 616202 (3)	
14.539	9	24	08	14q32.33	CDCA4, HEPP		Cell division cycle-associated protein 4	612270				
14.540	11	15	05	14q32.33	CRIP1, CRIP		Cysteine-rich intestinal protein 1	123875		previously assigned to 7q11.23		12(Crip)
14.541	07	31	20	14q32.33	ATP5MPL, C14orf2, MP68		ATP synthase membrane subunit 6.8PL	604573				
14.542	4	8	08	14q32.33	IGHD@		Immunoglobulin heavy chain diversity gene cluster	146910		many genes		
14.543	10	23	87	14q32.33	IGHA1		Constant region of heavy chain of IgA1	146900		Fused with IRTA1 in multiple myeloma		
14.544	10	23	87	14q32.33	IGHA2, A2M		Constant region of heavy chain of IgA2	147000				
14.545	4	30	91	14q32.33	IGHD		Constant region of heavy chain of IgD	147170				
14.546	4	8	08	14q32.33	IGHD3-3, DXP4		Immunoglobulin heavy chain diversity gene 3-3	611937				
14.547	10	23	87	14q32.33	IGHE		Constant region of heavy chain of IgE	147180		pseudogene IGHEP1 nearby; IGHEP2 on chr.9		
14.548	10	23	87	14q32.33	IGHG1		Constant region of heavy chain of IgG1	147100				
14.549	4	8	98	14q32.33	IGHG2		Constant region of heavy chain of IgG2	147110		5'-G2-17kb-G4-3'; closeness of IGG3 and IGG1 known from Lepore-like myeloma protein	IgG2 deficiency, selective (3)	
14.550	4	30	91	14q32.33	IGHG3		Constant region of heavy chain of IgG3	147120				
14.551	10	23	87	14q32.33	IGHG4		Constant region of heavy chain of IgG4	147130				
14.552	4	15	08	14q32.33	IGHJ@		Immunoglobulin heavy chain joining gene cluster	147010		more than 4 genes		
14.553	8	10	10	14q32.33	IGHM, MU, AGM1		Constant region of heavy chain of IgM	147020			Agammaglobulinemia 1, 601495 (3)	
14.554	9	15	89	14q32.33	IGHR		Immunoglobulin heavy chain regulator	144120			?Hyperimmunoglobulin G1 syndrome (2)	
14.555	4	15	08	14q32.33	IGHV@		Immunoglobin heavy polypeptide, variable gene cluster	147070		~250 genes; orientation: cen-PI-D14S1-IGH-IGHV--qter; 3' centromeric, 5' telomeric; IgM telomeric to IgG		
14.556	2	21	10	14q32.33	KIF26A, KIAA1236		Kinesin family member 26A	613231				
14.557	4	15	08	14q32.33	IGHV3-23, IGHV323, DP47, VH26		Immunoglobulin heavy chain variable gene 3-23	611939				
14.558	1	30	12	14q32.33	INF2, FSGS5, C14orf173, CMTDIE		Inverted formin 2	610982			Glomerulosclerosis, focal segmental, 5, 613237 (3); Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	
14.559	10	28	15	14q32.33	KIAA0125, FAM30A, C14orf110		KIAA0125 gene, noncoding	616623				
14.560	3	23	09	14q32.33	MIR203, MIRN203		Micro RNA 203	611899				
14.561	12	01	20	14q32.33	PACS2, KIAA0602, DEE66		Phosphofurin acidic cluster sorting protein 2	610423			Developmental and epileptic encephalopathy 66, 618067 (3)	
14.562	12	23	19	14q32.33	PLD4		Phospholipase D family, member 4	618488				
14.563	7	2	18	14q32.33	PPP1R13B, ASPP1, KIAA0771		Protein phosphatase 1, regulatory subunit 13B	606455				
14.564	09	07	18	14q32.33	TDRD9, C14orf75, HLS, SPNE, SPGF30		TUDOR domain-containing protein 9	617963		mutation identified in one SPGF30 family	?Spermatogenic failure 30, 618110 (3)	
14.565	2	25	15	14q32.33	ZBTB42, ZNF925, LCCS6		Zinc finger- and BTB domain-containing protein 42	613915		mutation identified in 1 LCCS6 family	?Lethal congenital contracture syndrome 6, 616248 (3)	
14.566	12	15	10	14q32.33	ZFYVE21, ZF21		Zinc finger FYVE domain-containing protein 21	613504				
14.567	10	23	87	Chr.14	LCH		Lentil agglutinin-binding	151020				
14.568	5	12	00	14q22.1	MAP4K5, MAPKKKK5		Mitogen-activated protein kinase kinase kinase kinase-5	604923				
14.569	9	3	02	14q12	NFATC4		Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 4	602699				
14.570	11	21	02	14q22.1	NID2		Nidogen 2	605399				14(Nid2)
14.571	1	27	04	Chr.14	PHOBS		Phobia, specific	608251			Phobia, specific (2)	
14.572	9	20	00	14q21.1	PNN, DRS		Pinin	603154				
14.573	10	21	15	Chr.14	RC14S		Ring chromosome 14 syndrome	616606			Ring chromosome 14 syndrome (4)	
14.574	4	4	03	14q32.31-q32.32	RCOR, COREST, KIAA0071		REST corepressor	607675				
14.575	1	28	02	14q21.3	RPL36AL, RPL36A		Ribosomal protein L36a-like	180469				
15.1	4	26	90	15p12	RNR3		Ribosomal RNA-3	180452				
15.2	11	16	98	15q13.1	APBA2		Amyloid beta A4 precursor protein-binding, family A, member 2	602712				7(Apba2)
15.3	2	1	00	15q	HYT2		Hypertension, essential, susceptibility to, 2	604329			{Hypertension, essential, susceptibility to, 2}, 145500 (2)	
15.4	5	24	01	15q	LCS1, CHLS		Cholestasis-lymphedema syndrome	214900			Cholestasis-lymphedema syndrome (2)	
15.5	1	13	99	15q21.3	NEDD4		Neural precursor cell expressed, developmentally downregulated-4	602278				
15.6	10	20	99	15q22.31	RPL4		Ribosomal protein L4	180479				
15.7	1	13	09	15q25.2	RPS17, RPS17L1, RPS17L2, DBA4		Ribosomal protein S17	180472		previously on chr.11; pseudogenes on 5q33-qter and 17q	Diamond-Blackfan anemia 4, 612527 (3)	
15.8	5	16	07	15q11	AUTS4		Autism, susceptibility to, 4	608636			{Autism susceptibility 4} (2)	
15.9	11	15	08	15q11.2	CYFIP1, KIAA0068		Cytoplasmic FMRP interacting protein 1	606322				
15.10	7	17	91	15q11-q12	IGHDY2		Immunoglobulin heavy chain diversity region-2	146990		?functional		
15.11	6	5	03	15q12	ATP10A, ATP10C, ATPVC		ATPase, class V, type 10A	605855				
15.12	4	4	06	15q11-q13	CELIAC5, GSES		Celiac disease, susceptibility to, 5	607202		in homogeneous Finnish population	{Celiac disease, susceptibility to, 5} (2)	
15.13	11	28	05	15q11-q13	GLC1I		Glaucoma 1, open angle, I	609745		max lod at GABRB3	Glaucoma 1, open angle, I (2)	
15.14	11	8	96	15q11.2	IPW		Imprinted in Prader-Willi syndrome	601491				
15.15	1	25	93	15q24.2	MAN2C1, MANA		Mannosidase, alpha, class 2C, member 1	154580				
15.16	8	1	13	15q11.2	MKRN3, ZFP127, ZNF127, CPPB2		Makorin 3	603856		expressed only from paternal allele	Precocious puberty, central, 2, 615346 (3)	7(Znf127)
15.17	11	3	99	15q11-q13	MRKN3-AS1, ZNF127AS		MKRN3 antisense RNA 1	603857				
15.18	4	5	00	15q11.2	NDN		Necdin	602117			Prader-Willi syndrome, 176270 (3)	7(Ndn)
15.19	11	13	94	15q11.2	D15S227E, PAR1		Prader-Willi/Angelman region-1	600161		paternally imprinted		
15.20	11	13	94	15q11.2	D15S226E, PAR5		Prader-Willi/Angelman syndrome-5	600162		paternally imprinted		
15.21	2	20	97	15q11.2	UBE3A, ANCR		Ubiquitin protein ligase E3A	601623		same location as PWS	Angelman syndrome, 105830 (3)	
15.22	6	6	12	15q13.3	SCG5, SGNE1		Secretogranin V (7B2 protein )	173120				2(Sgne1)
15.23	5	3	10	15q11-q21.1	RCHTS		Roifman-Chitayat syndrome	613328		?1p36.23-p33	?Roifman-Chitayat syndrome (2)	
15.24	7	5	92	15q11-qter	HCVS		Human coronavirus sensitivity	122460			{Human coronavirus sensitivity} (2)	
15.25	5	2	01	15q15.1	EHD4		EH domain-containing 4	605892				
15.26	4	27	12	15q11.2	NIPA1, SPG6		Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 1	608145			Spastic paraplegia 6, autosomal dominant, 600363 (3)	7(Nipa1)
15.27	3	7	14	15q11.2	DEL15q11.2, C15DELq11.2		Chromosome 15q11.2 deletion syndrome	615656		deleted region spans 300-500kb between BP1 and BP2	Chromosome 15q11.2 deletion syndrome (4)	
15.28	4	7	15	15q11.2	MAGEL2, NDNL1, SHFYNG		MAGE-like 2	605283			Schaaf-Yang syndrome, 615547 (3)	7(Magel2)
15.29	7	21	14	15q11.2	NBEAP1, BCL8		Neurobeachin pseudogene 1	601889				
15.30	4	25	06	15q11.2	NIPA2		Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 2	608146				7(Nipa2)
15.31	5	26	13	15q11.2	PWRN1		Prader-Willi region noncoding RNA 1	611215				
15.32	5	26	13	15q11.2	PWRN2		Prader-Willi region noncoding RNA 2	611217				
15.33	3	23	15	15q11.2	SNHG14, LNCAT, UBE3AATS		Small nucleolar RNA host gene 14	616259				7(Snhg14)
15.34	3	16	10	15q11.2	SNORD115-1, RNHBII52		Small nucleolar RNA, C/D box, 115-1	609837				
15.35	3	16	10	15q11.2	SNORD116-1, PWCR1		Small nucleolar RNA, C/D box, 116-1	605436				
15.36	11	21	03	15q11.2	TUBGCP5, GCP5, KIAA1899		Tubulin-gamma complex-associated protein 5	608147				7(Gcp5)
15.37	11	05	20	15q12	GABRB3, ECA5, DEE43		Gamma-aminobutyric acid (GABA) A receptor, beta-3	137192			{Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3); Developmental and epileptic encephalopathy 43, 617113 (3)	7(Gabrb3)
15.38	12	01	20	15q12	GABRA5, DEE79		Gamma-aminobutyric acid (GABA) A receptor, alpha-5	137142		100kb from GABRB3	Developmental and epileptic encephalopathy 79, 618559 (3)	7(Gabra5)
15.39	1	9	95	15q12	GABRG3		Gamma-aminobutyric acid (GABA) A receptor, gamma-3	600233		cen--G3--A5--B3		
15.40	4	18	05	15q11.2-q12	MGR7		Migraine with aura, susceptibility to, 7	609179		between D15S113 and D15S1019	{Migraine with aura, susceptibility to, 7} (2)	
15.41	1	17	08	15q12-q13	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1		Pink-eye dilution, murine, homolog of (oculocutaneous albinism II)	611409		?hypopigmentation in PWS and AS	Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown oculocutaneous, 203200 (3); [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	7(p)
15.42	8	21	07	15q12	HPC7		Prostate cancer, hereditary, 7	610321			{Prostate cancer, hereditary, 7} (2)	
15.43	12	14	10	15q13.3	KLF13, RFLAT1, FKLF2		Kruppel-like factor 13	605328				
15.44	6	15	12	15q11.2	NPAP1, C15orf2		Nuclear pore associated protein 1	610922				
15.45	4	5	00	15q11.2	SNRPN		Small nuclear ribonucleoprotein polypeptide N	182279			Prader-Willi syndrome, 176270 (3)	7(Snrpn)
15.46	7	25	06	15q12-q15	MCOPCB2		Microphthalmia, isolated, with coloboma 2	605738			Microphthalmia with coloboma 2 (2)	
15.47	1	13	17	15q15.1	MAPKBP1, JNKBP1, NPHP20		Mitogen-activated protein kinase-binding protein 1	616786			Nephronophthisis 20, 617271 (3)	
15.48	2	11	14	15q13	SRTD1, ATD1		Short-rib thoracic dysplasia 1 with or without polydactyly	208500			Short-rib thoracic dysplasia 1 with or without polydactyly (2)	
15.49	9	22	09	15q13	SCZD13		Schizophrenia 13	613025		associated with deletion at 15q13.3	{Schizophrenia, susceptibility to, 13} (2)	
15.50	2	18	96	15q13.1	TJP1		Tight junction protein 1 (zona occludens 1)	601009				7(Tjp1)
15.51	8	21	98	15q13.3	FMN, LD		Formin (limb deformity)	136535				2(ld)
15.52	10	7	02	15q14	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN		Solute carrier family 12 (potassium/chloride transporters), member 6	604878			Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	
15.53	1	31	13	15q13.3	TRPM1, MLSN1, CSNB1C		Transient receptor potential cation channel, subfamily M, member 1 (melastatin)	603576			Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)	7(Mlsn1)
15.54	10	23	87	15q13-q15	B2MR		Beta-2-microglobulin regulator	109710				
15.55	6	15	12	15q13.3	GREM1, CKTSF1B1		Gremlin 1 homolog, cystine knot superfamily	603054				
15.56	11	13	94	15q15.3	MAP1A, MAP1L		Microtubule-associated protein 1A	600178				
15.57	11	19	13	15q13.1	HERC2, SHEP1, MRT38		HECT domain and RCC1-like domain 2	605837		mutations in intron 4	[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3); [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3); Mental retardation, autosomal recessive 38, 615516 (3)	
15.58	12	5	16	15q13.1	NSMCE3, NDNL2, MAGEG1, LICS		NSE3 homolog, SMC5-SMC6 complex component	608243			Lung disease, immunodeficiency, and chromosome breakage syndrome, 617241 (3)	7(Ndnl2)
15.59	5	11	04	15q13.1-q15.1	CILD4		Ciliary dyskinesia, primary, 4	608646		between D15S1012 and D15S1048	Ciliary dyskinesia, primary, 4 (2)	
15.60	11	30	06	15q13.3	ARHGAP11A, KIAA0013		RHO GTPase-activating protein 11A	610589				
15.61	4	10	15	15q13.2	ARHGAP11B, FAM7B1		RHO GTPase-activating protein 11B	616310				
15.62	03	07	19	15q14	SPRED1, NFLS, LGSS		Sprouty-related EVH1 domain-containing protein 1	609291			Legius syndrome, 611431 (3)	2(Spred1)
15.63	9	14	12	15q13.3	FAN1, MTMR15, KIAA1018, KMIN		FANCD2/FANCI-associated nuclease 1	613534			Interstitial nephritis, karyomegalic, 614817 (3)	
15.64	05	24	19	15q15.1	CHP1, SPAX9		Calcineurin like EF-hand protein 1	606988		mutation identified in 1 SPAX9 family	?Spastic ataxia 9, autosomal recessive, 618438 (3)	
15.65	9	22	09	15q13.3	DEL15q13.3, MICRODEL15q13.3		Chromosome 15q13.3 microdeletion syndrome	612001			Chromosome 15q13.3 microdeletion syndrome (4)	
15.66	2	22	11	15q13.3	MIR211, MIRN211		Micro RNA 211	613753				
15.67	12	13	18	15q15.1	NDUFAF1, CIA30, CGI65, MC1DN11		NADH-ubiquinone oxidoreductase complex assembly factor 1	606934			Mitochondrial complex I deficiency, nuclear type 11, 618234 (3)	
15.68	6	5	08	15q13.3	OTUD7A, OTUD7, C16orf15, CEZANNE2		OTU domain-containing protein 7A	612024				
15.69	6	16	10	15q14	ACTC1, CMD1R, CMH11, ASD5, LVNC4		Actin, alpha, cardiac muscle	102540			Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, hypertrophic, 11, 612098 (3); Atrial septal defect 5, 612794 (3); Left ventricular noncompaction 4, 613424 (3)	2(Actc1)
15.70	6	9	08	15q14	AGPAT7, AYTL3		1-acylglycerol-3-phosphate O-acyltransferase 7	612039				
15.71	5	26	13	15q14	AQR, IBP160, KIAA0560		Aquarius, mouse, homolog of	610548				2(Aqr)
15.72	7	9	06	15q15.1	BMF		BCL2-modifying factor	606266				
15.73	2	13	14	15q14	C15orf41		Chromosome 15 open reading fram 41	615626			Dyserythropoietic anemia, congenital, type Ib, 615631 (3)	
15.74	8	14	17	15q13.3	CHRNA7		Cholinergic receptor, nicotinic, alpha polypeptide-7	118511				7(Acra7)
15.75	11	22	13	15q15.1	CHST14, D4ST1, ATCS, EDSMC1		Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	608429			Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3)	
15.76	9	22	09	15q14	EIG7, EJM2		Epilepsy, idiopathic generalized, susceptibility to, 7	604827		?role of CHRNA7	{Epilepsy, idiopathic generalized, susceptibility to, 7} (2); Epilepsy, juvenile myoclonic (2)	
15.77	2	25	15	15q14	EMC4, TMEM85, PIG17		ER membrane protein complex subunit 4	616245				
15.78	1	12	15	15q14	FAM98B		Family with sequence similarity 98, member B	616142				
15.79	6	22	14	15q14	FSIP1, HSD10		Fibrous sheath-interacting protein 1	615795				
15.80	12	27	07	15q14	GJD2, GJA9, CX36		Gap junction protein, delta-2 (connexin 36)	607058				2(Gja9)
15.81	1	12	15	15q14	GOLGA8A, KIAA0855		Golgin A8 family, member A	616180				
15.82	10	5	04	15q14	GOLGA8B, KIAA0855		Golgi autoantigen, golgin subfamily A, 8B	609619				
15.83	2	25	15	15q14	KATNBL1, C15orf29		Katanin, p80 subunit, B-like 1	616235				
15.84	8	29	08	15q14-q15	GPR176		G protein-coupled receptor 176	612183				
15.85	4	7	16	15q14	DEL15q14, C15DELq14		Chromosome 15q14 deletion syndrome	616898			Chromosome 15q14 deletion syndrome (4)	
15.86	3	31	03	15q15.1	IVD		Isovaleryl Coenzyme A dehydrogenase	607036			Isovaleric acidemia, 243500 (3)	
15.87	12	28	11	15q14	NOLA3, NOP10, DKCB1		Nucleolar protein family A, member 3	606471			Dyskeratosis congenita, autosomal recessive 1, 224230 (3)	
15.88	11	4	93	15q13-q14	RYR3		Ryanodine receptor-3	180903				2(Ryr3)
15.89	10	16	92	15q15.1	ITPKA		Inositol 1,4,5-trisphosphate 3-kinase A	147521				
15.90	08	26	19	15q14	MEIS2, MRG1, CPCMR		Meis homeobox 2	601740			Cleft palate, cardiac defects, and mental retardation, 600987 (3)	2(Mrg1)
15.91	6	9	17	15q21.1	BLOC1S6, BLOS6, PLDN, PA, HPS9		Biogenesis of lysosome-related organelles complex 1, subunit 6	604310		mutation identified in 1 HPS9 patient	?Hermansky-pudlak syndrome 9, 614171 (3)	2(Pa)
15.92	09	12	19	15q15.1	BUB1B, BUBR1, MVA1		BUB1 mitotic checkpoint serine/threonine kinase B	602860			Colorectal cancer, somatic, 114500 (3); Mosaic variegated aneuploidy syndrome 1, 257300 (3); [Premature chromatid separation trait], 176430 (3)	
15.93	2	13	14	15q15.2	CDAN1, CDA1, CDAN1A		Codanin 1	607465			Dyserythropoietic anemia, congenital, type Ia, 224120 (3)	
15.94	7	26	10	15q15.3	CKMT1A		Creatine kinase, mitochondrial 1A	613415		telomeric to CKMT1B		
15.95	1	9	95	15q15.3	CKMT1B, CKMT1		Creatine kinase, mitochondrial 1B	123290		centromeric to CKMT1A		2(Ckmt1)
15.96	5	19	09	15q21.1	DUOXA1		Dual oxidase maturation factor 1	612771		tail-to-tail with DUOXA2		
15.97	9	29	09	15q21.1	DUOXA2, TDH5		Dual oxidase maturation factor 2	612772		head-to-head with DUOX2	Thyroid dyshormonogenesis 5, 274900 (3)	
15.98	11	18	15	15q15.2	EPB42, SPH5		Erythrocyte surface protein band 4.2	177070			Spherocytosis, type 5, 612690 (3)	2(Epb4.2)
15.99	4	13	98	15q15.3	GRP58		Glucose regulated protein, 58kD	602046				2(Grp58)
15.100	10	24	14	15q15.1	MGA, KIAA0518		MAX dimerization protein MGA	616061				2(Mga)
15.101	7	13	09	15q15.1	PLA2G4D		Phospholipase A2, Group IVD	612864				
15.102	6	10	02	15q15.1	PLCB2		Phospholipase C, beta-2	604114			Platelet PLC beta-2 deficiency (1)	
15.103	08	13	19	15q14	RASGRP1, IMD64		Ras guanyl nucleotide releasing protein-1	603962			Immunodeficiency 64, 618534 (3)	2(Rasgrp1)
15.104	8	3	12	15q15	SCZD10		Schizophrenia 10	605419		between D15S1042 and D15S659	{Schizophrenia 10} (2)	
15.105	8	30	01	15q21.1	SLC28A2, CNT2, SPNT1		Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2	606208				2(Slc28a2)
15.106	6	1	12	15q15.2	STARD9, KIAA1300		START domain-containing protein 9	614642				
15.107	11	8	01	15q15.3	STRC, DFNB16		Stereocilin	606440			Deafness, autosomal recessive 16, 603720 (3)	
15.108	6	5	90	15q14	THBS1		Thrombospondin 1	188060				2(Thbs1)
15.109	5	4	15	15q15.3	TUBGCP4, GCP4, MCCRP3		Tubulin-gamma complex-associated protein 4	609610			Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3)	
15.110	1	12	95	15q15.3	MFAP1		Microfibrillar-associated protein-1	600215				
15.111	9	20	00	15q15.3	TP53BP1, 53BP1		Tumor protein p53-binding protein-1	605230				
15.112	01	14	20	15q15.3-q21.1	CTDSPL2, SCP4		CTD small phosphatase-like protein 2	618739				
15.113	6	19	98	15q21.1	DUT		dUTP pyrophosphatase	601266				
15.114	5	29	98	15q21.2	FGF7		Fibroblast growth factor-7 (keratinocyte growth factor)	148180				2(Fgf7)
15.115	8	23	04	15q21.1	SLC12A1, NKCC2		Solute carrier family 12 (sodium/potassium/chloride transporters), member 1	600839			Bartter syndrome, type 1, 601678 (3)	2(Slc12a1)
15.116	12	7	05	15q15.2	UBR1, JBS		Ubiquitin-protein ligase E3-alpha	605981			Johanson-Blizzard syndrome, 243800 (3)	2(Ubr1)
15.117	4	15	11	15q15.1	BAHD1, KIAA0945		BROMO-adjacent homology domain-containing protein 1	613880				
15.118	12	10	20	15q15.1	CCDC32, CFNDS		Coiled-coil domain-containing protein 32	618941			Cardiofacioneurodevelopmental syndrome, 619123 (3)	
15.119	03	31	20	15q15.1	DISP2, DISPB, KIAA1742		Dispatched RND transporter family, member 2	607503				
15.120	3	3	16	15q15.1	DNAJC17		DNAJ/HSP40 homolog, subfamily C, member 17	616844				2(Dnajc17)
15.121	10	7	14	15q15.1	KNSTRN, C15orf23, SKAP		Kinetochore-localized astrin/SPAG5 binding protein	614718				
15.122	4	27	12	15q15.1	CHAC1		ChaC, E. coli, homolog of, 1	614587				
15.123	2	13	14	15q15.1	EIF2AK4, GCN2, KIAA1338, PVOD2		Eukaryotic translation initiation factor 2-alpha kinase 4	609280			Pulmonary venoocclusive disease 2, 234810 (3)	
15.124	9	23	08	15q15.1	FAM82A2, FAM82C, RMD3, PTPIP51		Family with sequence similarity 82, member A2	611873				
15.125	5	25	13	15q15.1	GCHFR, GFRP		GTP cyclohydrolase I feedback regulatory protein	602437				
15.126	7	9	15	15q15.1	INO80, INOC1		INO80 complex subunit	610169				
15.127	6	12	17	15q15.1	KNL1, CASC5, AF15Q14, KIAA1570, D40, MCPH4		Kinetochore scaffold 1	609173			Microcephaly 4, primary, autosomal recessive, 604321 (3)	
15.128	7	15	09	15q15.1	NUSAP1, ANKT, NUSAP		Nucleolar and spindle-associated protein 1	612818				
15.129	10	09	18	15q15.1	OIP5, MIS18B		OPA-interacting protein 5	606020				
15.130	5	10	11	15q15.1	PAK6		p21-activated kinase 6	608110				
15.131	3	3	10	15q15.1	PPP1R14D, GBPI1		Protein phosphatase 1, regulatory subunit 14D	613256				
15.132	06	11	20	15q15.1	RAD51, RECA, MRMV2, FANCR		RAD51 recombinase	179617			{Breast cancer, susceptibility to}, 114480 (3); Mirror movements 2, 614508 (3); Fanconi anemia, complementation group R, 617244 (3)	2(Rad51)
15.133	10	13	09	15q15.1	RPAP1, KIAA1403		RNA polymerase II-associated protein 1	611475				
15.134	9	2	10	15q15.1	RTF1, KIAA0252		RTF1, S. cerevisiae, homolog of	611633				
15.135	9	16	16	15q15.1	TYRO3		TYRO3 protein tyrosine kinase	600341				2(Tyro3)
15.136	12	27	19	15q15.1	VPS18		VPS18 core subunit of CORVET and HOPS complexes	608551				
15.137	12	27	19	15q15.1	VPS39, VAM6, TLP, KIAA0770		VPS39 subunit of HOPS complex	612188				
15.138	1	2	03	15q15.1	GANC		Neutral alpha-glucosidase C	104180				
15.139	4	9	15	15q15.3	CATSPER2		Cation channel, sperm-associated, 2	607249		in region with tandem duplication containing a CATSPER2 pseudogene		2(Catsper2)
15.140	09	25	18	15q15.1	CAPN3, CANP3, LGMDR1, LGMDD4		Calpain, large polypeptide L3	114240			Muscular dystrophy, limb-girdle, autosomal recessive 1, 253600 (3); Muscular dystrophy, limb-girdle, autosomal dominant 4, 618129 (3)	2(Canp3)
15.141	1	9	95	15q15.1	LTK, TYK1		Leukocyte tyrosine kinase	151520				2(Ltk)
15.142	9	7	10	15q15.2	HAUS2, CEP27		HAUS augmin-like complex, subunit 2	613429				
15.143	11	10	14	15q15.2	TGM5, TGX, PSS2		Transglutaminase 5	603805			Peeling skin syndrome 2, 609796 (3)	
15.144	3	26	02	15q15.2-q15.3	TGM7, TGMZ		Transglutaminase 7	606776				2(Tgm7)
15.145	1	2	08	15q15.2	TTBK2, SCA11		Tau tubulin kinase 2	611695			Spinocerebellar ataxia 11, 604432 (3)	
15.146	1	15	09	15q15.3	DEL15q15.3, C15DELq15.3		Chromosome 15q15.3 deletion syndrome	611102			Deafness and male infertility (4)	
15.147	1	11	07	15q21.1	DUOX1, THOX1		Dual oxidase 1 (thyroid oxidase 1)	606758				2(Duox1)
15.148	9	29	09	15q21.1	DUOX2, THOX2, TDH6		Dual oxidase 2 (thyroid oxidase 2)	606759			Thyroid dyshormonogenesis 6, 607200 (3)	2(Duox2)
15.149	10	3	07	15q21.1	EIF3J, EIF3S1		Eukaryotic translation initiation factor 3, subunit J	603910				
15.150	2	10	06	15q15.3	ELL3		Elongation factor, RNA polymerase II, 3	609885				
15.151	4	13	15	15q15.3	FRMD5		FERM domain-containing protein 5	616309				
15.152	5	19	09	15q15.3	HYPK		Huntingtin-interacting protein K	612784				
15.153	5	26	13	15q15.3	LCMT2, TYW4, KIAA0547		Leucine carboxyl methyltransferase 2	611246				
15.154	10	30	06	15q21.2	LEO1, RDL		LEO1 RNA polymerase II associated factor, S. cerevisiae, homolog of	610507				
15.155	9	3	15	15q15.3	PPIP5K1, HISPPD2A, IPS1, KIAA0377		Diphosphoinositol pentakisphosphate kinase 1	610979				
15.156	3	25	14	15q15.3	SERF2, H4F5REL		Small EDRK-rich factor 2	605054				
15.157	4	2	12	15q15.3	SERINC4		Serine incorporator 4	614550				
15.158	06	22	20	15q21.1	SORD, SORD1, SORDD		Sorbitol dehydrogenase	182500			Sorbitol dehydrogenase deficiency with peripheral neuropathy, 618912 (3)	2(Sdh1)
15.159	11	12	03	15q21.2	SPPL2A, IMP3		Signal peptide peptidase-like 2A	608238				
15.160	6	15	12	15q15.3-q22.1	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq		Polyposis syndrome, mixed, hereditary 1	601228		duplication of 40kb of 15q resulting in overexpression of GREM1	Polyposis syndrome, mixed hereditary 1 (4); {Colorectal cancer, susceptibility to, 4} (4)	
15.161	6	13	02	15q21.2	BCL2L10		BCL2-like 10	606910				9(Bcl2l10)
15.162	3	20	95	15q21	CDAN3, CDA3		Congenital dyserythropoietic anemia, type III	105600			Dyserythropoietic anemia, congenital, type III (2)	
15.163	4	29	17	15q21.3	DNAAF4, DYX1C1, DYXC1, DYX1, CILD25		Dynein, axonemal, assembly factor 4	608706		not confirmed by some studies	{Dyslexia, susceptibility to, 1}, 127700 (3); Ciliary dyskinesia, primary, 25, 615482 (3)	
15.164	06	23	20	15q22.31	MAP2K1, PRKMK1, MKK1, MEK1, CFC3, MEL		Mitogen-activated protein kinase kinase 1	176872		pseudogene on 8p21	Cardiofaciocutaneous syndrome 3, 615279 (3); Melorheostosis, isolated, somatic mosaic, 155950 (3)	9(Mek1)
15.165	4	28	10	15q21.2	MYO5A, MYH12, GS1		Myosin Va	160777			Griscelli syndrome, type 1, 214450 (3)	9(d, Myh12)
15.166	4	19	06	15q21.2	MYO5C		Myosin Vc	610022				
15.167	6	25	08	15q22.31	OSTB		Organic solute transporter, beta	612085				9(Ostb)
15.168	3	17	03	15q21.3	RAB27A, RAM, GS2		Ras-associated protein RAB27A	603868			Griscelli syndrome, type 2, 607624 (3)	9(ash, Rab27a)
15.169	5	29	01	15q15.1	SPTBN5, BSPECV		Spectrin, beta, non-erythrocytic 5	605916				
15.170	7	22	13	15q21.3	TCF12, HTF4, CRS3		Transcription factor-12 (HTF4, helix-loop-helix transcription factors-4)	600480			Craniosynostosis 3, 615314 (3)	
15.171	5	2	06	15q21.2	TRPM7, LTRPC7, CHAK, ALSPDC		Transient receptor potential cation channel, subfamily M, member 7	605692			{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3)	
15.172	10	29	03	15q22.31	ACP33, MAST, SPG21		Acidic cluster protein, 33kD, (maspardin)	608181			Mast syndrome, 248900 (3)	
15.173	3	19	91	15q22.2	ANXA2, ANX2L4, LPC2D, LIP2		Annexin A2 (lipocortin I)	151740		pseudogenes ANX2P1 on 4q21-q31; ANX2P2 on 9p13; ANX2P3 on 10q24-q22		
15.174	11	17	15	15q21.1	B2M, IMD43		Beta-2-microglobulin	109700		mutation identified in 1 FVA family	Immunodeficiency 43, 241600 (3); ?Amyloidosis, familial visceral, 105200 (3)	2(B2m)
15.175	7	22	13	15q21-q22	CTRCT25, CCSSO		Cataract 25	605728			Cataract 25 (2)	
15.176	2	21	14	15q21.2	HDC		Histidine decarboxylase	142704			{Gilles de la Tourette syndrome, susceptibility to}, 137580 (3)	2(Hdc)
15.177	8	2	11	15q22.2	MYO1E, MYO1C, FSGS6		Myosin IE	601479			Glomerulosclerosis, focal segmental, 6, 614131 (3)	9(Myo1e)
15.178	10	23	20	15q21.3	PIGB, DEE80		Phosphatidylinositol glycan, class B	604122			Developmental and epileptic encephalopathy 80, 618580 (3)	
15.179	11	3	09	15q22.31	PPIB, CYPB, OI9		Peptidyl-prolyl isomerase B	123841			Osteogenesis imperfecta, type IX, 259440 (3)	
15.180	7	25	18	15q22.2	RORA, IDDECA		RAR-related orphan receptor A	600825			Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, 618060 (3)	9(Rora)
15.181	05	27	20	15q22.31	SMAD6, MADH6, AOVD2		SMAD family member 6	602931			Aortic valve disease 2, 614823 (3); {Craniosynostosis 7, susceptibility to}, 617439 (3); {Radioulnar synostosis, nonsyndromic}, 179300 (3)	
15.182	4	17	01	15q15.1-q15.2	SNAP23		Synaptosomal-associated protein, 23kD	602534				
15.183	08	11	20	15q23	CLN6, CLN4A		CLN6 transmembrane ER protein	606725			Ceroid lipofuscinosis, neuronal, 6, 601780 (3); Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)	9(nclf, Cln6)
15.184	1	4	13	15q21.1	CEP152, KIAA0912, MCPH9, SCKL5		Centrosomal protein, 152kD	613529			Microcephaly 9, primary, autosomal recessive, 614852 (3); Seckel syndrome 5, 613823 (3)	
15.185	9	20	10	15q21.2	CYP19A1, CYP19, ARO		Cytochrome P450, family 19, subfamily A, polypeptide 1 (aromatization of androgens)	107910		close to CYP11 in mouse	Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300 (3)	9(Cyp19)
15.186	10	29	19	15q15.1	DLL4, AOS6		Delta-like canonical Notch ligand 4	605185			Adams-Oliver syndrome 6, 616589 (3)	2(Dll4)
15.187	3	9	17	15q21.1	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS		Fibrillin-1	134797			Marfan syndrome, 154700 (3); Marfan lipodystrophy syndrome, 616914 (3); Ectopia lentis, familial, 129600 (3); MASS syndrome, 604308 (3); Weill-Marchesani syndrome 2, dominant, 608328 (3); Stiff skin syndrome, 184900 (3); Acromicric dysplasia, 102370 (3); Geleophysic dysplasia 2, 614185 (3)	2(Fbn1)
15.188	06	11	20	15q21.1	GATM, AGAT, CCDS3, FRTS1		L-arginine:glycine amidinotransferase	602360			Cerebral creatine deficiency syndrome 3, 612718 (3); Fanconi renotubular syndrome 1, 134600 (3)	2(Gatn)
15.189	4	2	16	15q21.1	HMGN2P46, C15orf21		High mobility group nucleosomal binding domain 2 pseudogene 46	611314				
15.190	09	12	19	15q21.1	C15orf48, NMES1		Chromosome 15 open reading frame 48	608409				
15.191	09	19	19	15q21.1	PATL2, PAT1A, OOMD4		PAT1 homolog 2	614661			Oocyte maturation defect 4, 617743 (3)	
15.192	4	29	14	15q21.1	SECISBP2L, SBP2L, KIAA0256		Selenocysteine insertion sequence-binding protein 2-like	615756				
15.193	4	21	15	15q21.1	SEMA6D, KIAA1479		Semaphorin 6D	609295				
15.194	3	18	17	15q21.1	SHC4, RALP, SHCD		SHC transforming protein 4	617372				
15.195	2	2	17	15q21.1	SHF		SH2 domain-containing adaptor protein F	617313				
15.196	8	8	13	15q21.1	SLC24A5, NCKX5, SHEP4, OCA6		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5	609802			[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3); Albinism, oculocutaneous, type VI, 113750 (3)	
15.197	9	12	01	15q21.1	SLC30A4, ZNT4		Solute carrier family 30 (zinc transporter), member 4	602095				2(lm, Slc30a4)
15.198	12	27	19	15q21.1	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X		SPG11 vesicle trafficking associated, spatacsin	610844			Spastic paraplegia 11, autosomal recessive, 604360 (3); Amyotrophic lateral sclerosis 5, juvenile, 602099 (3); Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	
15.199	9	1	17	15q21.1	SQOR, SQRDL		Sulfide quinone oxidoreductase	617658				
15.200	9	26	16	15q21.1	TERB2, C15orf43		Telomere repeat-binding bouquet formation protein 2	617131				
15.201	9	30	14	15q21.1	TRIM69, TRIF, RNF36		Tripartite motif-containing protein 69	616017				2(Trim69)
15.202	2	24	17	15q21.1	EID1, CRI1, C15orf3		EP300-interacting inhibitor of differentiation 1	605894				
15.203	10	20	99	15q21.3	ONECUT1, HNF6A, HNF6		One cut domain, family member 1 (hepatocyte nuclear factor 6-alpha)	604164				
15.204	4	17	01	15q21.2	TMOD2		Tropomodulin 2, neuronal	602928				9(Tmod2)
15.205	4	17	01	15q21.2	TMOD3		Tropomodulin 3	605112				9(Tmod3)
15.206	3	16	16	15q21.2	AP4E1, SPG51, CPSQ4, STUT1		Adaptor-related protein complex 4, epsilon-1 subunit	607244			Spastic paraplegia 51, autosomal recessive, 613744 (3); Stuttering, familial persistent, 1, 184450 (3)	
15.207	10	23	20	15q21.2	DMXL2, RC3, KIAA0856, PEPNS, DFNA71, DEE81		DMX-like 2	612186		mutation identified in 1 PEPNS family and 1 DFNA71 family	?Polyendocrine-polyneuropathy syndrome, 616113 (3); ?Deafness, autosomal dominant 71, 617605 (3); Developmental and epileptic encephalopathy 81, 618663 (3)	
15.208	11	22	16	15q21.2	GNB5, GB5, IDDCA, LADCI		Guanine nucleotide-binding protein, beta-5	604447			Intellectual developmental disorder with cardiac arrhythmia, 617173 (3); Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia, 617182 (3)	
15.209	11	22	16	15q21.2	GLDN, CRGL2, LCCS11		Gliomedin	608603			Lethal congenital contracture syndrome 11, 617194 (3)	
15.210	8	28	02	15q21.2	SLC27A2, FACVL1, VLACS		Solute carrier family 27 (fatty acid transporter), member 2 (fatty acid CoA ligase, very long-chain 1)	603247				
15.211	7	11	03	15q21.2	GABPB, BABPB2, GABPB1, E4TF1B, NRF2B1		GA-binding protein transcription factor, beta subunit	600610				
15.212	6	30	15	15q21.2	TNFAIP8L3, TIPE3		Tumor necrosis factor-alpha-induced protein 8-like 3	616438				
15.213	1	29	01	15q21.1	TRIP15, SGN2, COPS2		Thyroid hormone receptor interactor-15	604508				2(Cops2)
15.214	9	26	17	15q21.2	USP8, HUMORF8, PITA4		Ubiquitin-specific protease 8	603158			Pituitary adenoma 4, ACTH-secreting, somatic, 219090 (3)	
15.215	1	11	07	15q21.3	CGNL1, FLJ14957, KIAA1749		Cingulin-like 1	607856				
15.216	09	26	19	15q21.3	ADAM10, MADM, RAK, AD18		ADAM metallopeptidase domain 10	602192			Reticulate acropigmentation of Kitamura, 615537 (3); {Alzheimer disease 18, susceptibility to}, 615590 (3)	
15.217	6	10	14	15q21.3	ALDH1A2, RALDH2		Aldehyde dehydrogenase 1 family, member A2 (retinaldehyde dehydrogenase 2)	603687				
15.218	4	21	10	15q22.2	C2CD4B, NLF2		C2 calcium-dependent domain containing 4B	610344				
15.219	4	2	16	15q21.3	CCPG1, KIAA1254, CPR8		Cell cycle progression 1	611326				
15.220	4	10	02	15q22.2	GCNT3		Glucosaminyl (N-acetyl) transferase 3, mucin-type	606836				
15.221	7	1	11	15q21.3	LIPC, HL, LIPH, HDLCQ12		Lipase C, hepatic	151670			[High density lipoprotein cholesterol level QTL 12], 612797 (3); {Diabetes mellitus, noninsulin-dependent}, 125853 (3); Hepatic lipase deficiency, 614025 (3)	9(Hl)
15.222	07	22	20	15q21.3	MNS1, FLJ11222, HTX9		Meiosis-specific nuclear structural protein 1	610766			Heterotaxy, visceral, 9, autosomal, with male infertility, 618948 (3)	
15.223	3	6	07	15q22.2	NARG2		NMDA receptor-regulated 2	610835		pseudogenes on chr.4 and chr.3		9(narg2)
15.224	4	21	10	15q22.2	C2CD4A, NLF1		C2 calcium-dependent domain containing 4A	610343				
15.225	03	16	20	15q21.3	PIGBOS1		PIGB opposite strand 1	618809				
15.226	3	4	10	15q21.3	PRTG		Protogenin, chicken, homolog of	613261				9(Prtg)
15.227	7	2	18	15q21.3	PYGO1		Pygopus, Drosophila, homolog of, 1	606902				
15.228	3	23	09	15q21.3	RFX7, RFXDC2		Regulatory factor X, 7	612660				
15.229	3	4	10	15q21.3	RSL24D1, RLP24		Ribosomal protein L24 domain-containing protein 1	613262				
15.230	2	18	08	15q21.2	SCG3		Secretogranin III	611796				
15.231	09	11	19	15q21.3	UNC13C		unc-13 homolog C	614568				
15.232	9	18	12	15q21.3	GUP, GCOM1, MYOZAP		GRINL1A complex locus upstream gene	614071				
15.233	04	30	19	15q21.3-q22.1	MINDY2, FAM63B		MINDY lysine-48 deubiquitinase 2	618408				
15.234	7	11	14	15q21.3	WDR72, AI2A3		WD repeat-containing protein 72	613214			Amelogenesis imperfecta, type IIA3, 613211 (3)	
15.235	1	30	01	15q22.31	RAB11A		Ras family, member RAB11A	605570				
15.236	3	17	06	15q21.3	AQP9		Aquaporin 9	602914				
15.237	12	21	10	15q22.2	CA12		Carbonic anhydrase XII	603263			Hyperchlorhidrosis, isolated, 143860 (3)	
15.238	5	26	05	15q22.31	CILP		Cartilage intermediate layer protein	603489			{Lumbar disc disease, susceptibility to}, 603932 (3)	
15.239	12	11	02	15q22.31	DPP8		Dipeptidyl peptidase 8	606819				
15.240	4	21	10	15q24.1	GOLGA6, GLP		Golgi autoantigen, golgin subfamily A, 6	610288				
15.241	4	18	02	15q23	PIAS1, DDXBP1, GBP		protein inhibitor of activated STAT, 1	603566				
15.242	11	17	15	15q23	PKM, PKM2, PK3, THBP1		Pyruvate kinase, muscle	179050				9(Pk3)
15.243	9	23	97	15q24.1	PML, MYL		Promyelocytic leukemia, inducer of	102578		fused with RARA in APL	Leukemia, acute promyelocytic, PML/RARA type (3)	9(Pml)
15.244	10	11	10	15q23	SPESP1		Sperm equatorial segment protein 1	609399				
15.245	1	31	13	15q22.31	SLC24A1, NCKX1, CSNB1D		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1	603617			Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3)	
15.246	12	17	95	15q15.1	SRP14		Signal recognition particle 14kD (homologous Alu RNA-binding protein)	600708				
15.247	12	7	03	15q24.1	STOML1, STORP		Stomatin-like protein 1	608326				
15.248	2	11	96	15q23	TLE3, ESG		Transducin-like enhancer of split 3, homolog of Drosophila a E(spl)	600190				
15.249	11	30	18	15q23	MYO9A, CMS24		Myosin IXa	604875			Myasthenic syndrome, congenital, 24, presynaptic, 618198 (3)	
15.250	3	3	09	15q22-q23	USH1H		Usher syndrome, type 1H	612632		max lod at D15S980	Usher syndrome, type 1H (2)	
15.251	3	14	14	15q22-q24	GLC1N		Glaucoma 1, open angle, N	611274		max lod at D15S125	Glaucoma 1, open angle, N (2)	
15.252	5	26	98	15q24.1-q24.2	MPI, PMI1, CDG1B		Mannosephosphate isomerase (phosphomannose isomerase 1)	154550			Congenital disorder of glycosylation, type Ib, 602579 (3)	9(Mpi1)
15.253	1	9	95	15q25.2	NMB		Neuromedin B	162340				
15.254	6	13	12	15q22.31	FBXL22, FBL22		F-box and leucine-rich repeat protein 22	609088				9(Fbxl22)
15.255	2	16	04	15q22.2	LACTB		Lactamase, beta	608440				9(Lactb)
15.256	1	11	07	15q22.31	PAF, OEATC1, KIAA0101		PCNA-associated factor, 15kD	610696				
15.257	9	18	12	15q21.3	POLR2M, GDOWN, GRINL1A		Polymerase II, RNA, subunit M	606485				9(Grinl1a)
15.258	9	9	13	15q22.2	TPM1, CMH3, CMD1Y , LVNC9		Tropomyosin 1, alpha	191010			Cardiomyopathy, hypertrophic, 3, 115196 (3); Cardiomyopathy, dilated, 1Y, 611878 (3); Left ventricular noncompaction 9, 611878 (3)	9(Tpm1)
15.259	12	27	19	15q22.2	VPS13C, KIAA1421, PARK23		Vacuolar protein sorting 13 homolog C	608879			Parkinson disease 23, autosomal recessive, early onset, 616840 (3)	
15.260	7	19	12	15q22.1-q22.2	RNF111		Ring finger protein 111	605840				
15.261	7	9	06	15q22.31	CSNK1G1		Casein kinase I, gamma-1	606274				
15.262	09	19	19	15q22.2	APH1B		Aph-1 homolog B, gamma-secretase subunit	607630				
15.263	6	22	12	15q22.2	BNIP2, NIP2		BCL2/adenovirus E1B 19kD protein-interacting protein 2	603292				
15.264	11	11	14	15q22.2	CCNB2		Cyclin B2	602755				
15.265	10	2	12	15q22.2	GTF2A2, TF2A2		General transcription factor IIA, gamma subunit	600519		pseudogenes on chr. 1, 8, 9		
15.266	9	30	14	15q22.2	MIR190A		Micro RNA 190A	615845				
15.267	4	6	15	15q22.2	RAB8B		Ras-associated protein RAB8B	613532				
15.268	6	10	08	15q22.2	RPS27L		Ribosomal protein S27-like	612055				
15.269	7	18	14	15q22.2	TLN2, KIAA0320		Talin 2	607349				
15.270	8	26	15	5q22.2	YTHDC2, CAHL		YTH domain-containing protein 2	616530				
15.271	4	18	05	15q22.31	SNX1, SNX1A		Sorting nexin 1	601272				
15.272	1	24	07	15q22.31	TIPIN		Timeless-interacting protein	610716				9(Tipin)
15.273	4	18	05	15q22.31	USP3		Ubiquitin-specific protease 3	604728				
15.274	12	02	20	15q22.31	ZWILCH		ZWILCH kinetochore protein	609984				
15.275	2	15	02	15q23	ANP32A, PHAP1		Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A	600832				
15.276	10	16	14	15q24.1	BBS4		BBS4 gene	600374			Bardet-Biedl syndrome 4, 615982 (3)	
15.277	7	31	97	15q24.1	NEO1, NGN		Neogenin, chicken, homolog of, 1	601907				
15.278	10	20	99	15q22.31	PUNC		Putative neuronal cell adhesion molecule	604184				9(Punc)
15.279	12	23	05	15q24.1	UBL7		Ubiquitin-like 7	609748				
15.280	04	15	19	15q22.31	CIAO2A, CIA2A, FAM96A		Cytosolic iron-sulfur assembly component 2A	618382				
15.281	6	20	18	15q22.31	CLPX, EPP2		Caseinolytic mitochondrial matrix peptidase chaperone subunit	615611		mutation identified in 1 EPP2 family	?Protoporphyria, erythropoietic, 2, 618015 (3)	
15.282	9	28	15	15q22.31	DAPK2, DRP1		Death-associated protein kinase 2	616567				
15.283	5	25	13	15q22.31	DENND4A		DENN/MADD domain containing 4A	600382				
15.284	09	19	19	15q22.31	DIS3L, DIS3L1, KIAA1955		DIS3 like exosome 3'-5' exoribonuclease	614183				
15.285	7	14	16	15q22.31	HERC1, MDFPMR		HECT domain and RCC1-like domain 1	605109			Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3)	
15.286	2	12	16	15q22.31	IGDCC4, NOPE, KIAA1628		Immunoglobulin superfamily, DCC subclass, member 4	616810				9(Nope)
15.287	1	7	09	15q23	IQCH, NYDSP5		IQ motif-containing protein H	612523				
15.288	8	2	13	15q22.31	KBTBD13, NEM6		Kelch repeat and BTB/POZ domains-containing protein 13	613727			Nemaline myopathy 6, autosomal dominant, 609273 (3)	
15.289	8	2	16	15q22.31	LCTL, KLG, KLPH		Lactase-like protein	617060				
15.290	12	24	08	15q22.31	MEGF11, KIAA1781		Multiple epidermal growth factor-like domains 11	612454				
15.291	12	13	18	15q22.31	MTFMT, COXPD15, MC1DN27		Mitochondrial methionyl-tRNA formyltransferase	611766			Combined oxidative phosphorylation deficiency 15, 614947 (3); Mitochondrial complex I deficiency, nuclear type 27, 618248 (3)	
15.292	5	25	13	15q22.31	OAZ2		Ornithine decarboxylase antizyme 2	604152				
15.293	3	22	07	15q22.31	PDCD7		Programmed cell death 7	608138				
15.294	5	21	07	15q22.31	PIF1, PIF		Pif1, S. cerevisiae, homolog of	610953				
15.295	8	18	14	15q22.31	PTPLAD1, BIND1, HACD3		Protein tyrosine phosphatase-like A domain-containing protein 1	615940				
15.296	09	22	20	15q22.31	RBPMS2		RNA-binding protein, mRNA-processing factor, 2	619034				
15.297	6	24	08	15q22.31	RNU5A, RNU5		RNA, U5A small nuclear	180691				
15.298	01	14	20	15q22.33	SMAD3, MADH3, LDS3		SMAD family member 3	603109			Loeys-Dietz syndrome 3, 613795 (3)	
15.299	10	2	12	15q22.31	SNAPC5, SNAP19		Small nuclear RNA-activating protein complex, polypeptide 5	605979				
15.300	8	10	16	15q22.31	TRIP4, ASC1, SMABF1, MDCDC		Thyroid hormone receptor interactor 4	604501		mutation identified in 1 MDCDC family	Spinal muscular atrophy with congenital bone fractures 1, 616866 (3); ?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3)	
15.301	5	8	17	15q22.31	ZNF609, KIAA0295		Zinc finger ptoein 609	617474				9(Zfp609)
15.302	2	17	09	15q22.32	STQTL16		Stature quantitative trait locus 16	612579		associated with rs8038652	{Stature QTL 16} (2)	
15.303	12	12	12	15q23	AAGAB, p34, PPKP1A, PPKP1, KPPP1		Alpha- and gamma-adaptin-binding protein	614888			Keratoderma, palmoplantar, punctate type IA, 148600 (3)	
15.304	10	13	09	15q23	CORO2B, CLIPINC		Coronin 2B	605002				
15.305	6	1	15	15q23	DRAIC		Downregulated RNA in androgen-independent cells, noncoding	616387				
15.306	7	29	15	15q23	EWSAT1, LINC00277		Ewing sarcoma-associated transcript 1, noncoding	616492				
15.307	9	9	08	15q24.2	FBXO22, FBX22		F-box only protein 22	609096				9(Fbxo22)
15.308	8	27	15	15q23	FEM1B, KIAA0396		Fem1, C. elegans, homolog of, B	613539				9(Fem1b)
15.309	8	18	08	15q23	GLCE, HSEPI, KIAA0836		Glucuronic acid epimerase	612134				
15.310	4	6	00	15q23	ITGA11		Integrin, alpha-11	604789				
15.311	3	2	06	15q23	KIF23, KNSL5, MKLP1		Kinesin family member 23	605064				
15.312	10	30	19	15q23	LARP6, ACHN		La ribonucleoprotein 6, translational regulator	611300				
15.313	6	10	09	15q23	MAP2K5, PRKMK5, MEK5, MAPKK5		Mitogen-activated protein kinase kinase 5	602520				
15.314	1	24	13	15q23	NOX5		NADPH oxidase 5	606572				
15.315	7	9	07	15q23	NR2E3, PNR, ESCS, RP37		Nuclear receptor subfamily 2, group E, member 3	604485		near BBS4	Enhanced S-cone syndrome, 268100 (3); Retinitis pigmentosa 37, 611131 (3)	9(rd7)
15.316	4	19	12	15q23	PAQR5, MPRG		Progestin and ADIPOQ receptor family, member 5	607781				
15.317	3	23	15	15q23	PCAT29		Prostate cancer-associated transcript 29, noncoding	616273				
15.318	6	10	98	15q24.3	RCN2, ERC55		Reticulocalbin 2, EF-hand calcium binding domain (endoplasmic reticulum calcium-binding protein, 55kD)	602584				
15.319	6	24	08	15q23	RNU6-1, RNU6A, RNU6		RNA, U6 small nuclear 1	180692				
15.320	2	25	11	15q24.2	SCAMP5		Secretory carrier membrane protein 5	613766				
15.321	6	13	12	15q23	SENP8, NEDP1, DEN1		Sentrin-specific protease family, member 8	608659				
15.322	08	04	20	15q23	SKOR1, LBXCOR1, CORL1		SKI family transcriptional corepressor 1	611273				
15.323	1	20	09	15q23	THAP10		THAP domain-containing protein 10	612538				
15.324	2	21	12	15q23	THSD4, ADAMTSL6		Thrombospondin type-1 domain-containing 4	614476				9(Thsd4)
15.325	10	13	09	15q24.2	UBE2Q2, LOC92912		Ubiquitin-conjugating enzyme E2Q 2	612501				
15.326	12	1	11	15q25.1	ACSBG1, BG, BG1, KIAA0631		Acyl-CoA synthetase, bubble gum family, member 1	614362				
15.327	3	23	09	15q24.1	CD276, B7H3		CD276 molecule	605715				9(B7h3)
15.328	5	7	02	15q23	HEXA, TSD		Hexosaminidase A, alpha polypeptide	606869		on 15q+ in APL	Tay-Sachs disease, 272800 (3); GM2-gangliosidosis, several forms, 272800 (3); [Hex A pseudodeficiency], 272800 (3)	9(Hexa)
15.329	6	9	98	15q24.1	ISLR		Immunoglobulin superfamily containing leucine-rich repeat	602059				
15.330	8	14	92	15q24.1	CSK		c-src tyrosine kinase	124095				
15.331	8	25	03	15q24.2-q24.3	ETFA, GA2, MADD		Electron transfer flavoprotein, alpha polypeptide	608053			Glutaric acidemia IIA, 231680 (3)	13(Etfa)
15.332	4	30	91	15q25.1	FAH		Fumarylacetoacetase	613871			Tyrosinemia, type I, 276700 (3)	
15.333	10	29	09	15q23-q26.3	GLM4		Glioma susceptibility 4	607248		max lod at D15S130	{Glioma susceptibility 4} (2)	
15.334	09	26	19	15q26.3	ADAMTS17, WMS4		ADAM metallopeptidase domain with thrombospondin type 1 motif, 17	607511			Weill-Marchesani 4 syndrome, recessive, 613195 (3)	
15.335	12	24	08	15q24.1	ARID3B, DRIL2, BDP		AT-rich interactive domain-containing protein 3B	612457				
15.336	3	1	01	15q24.1	ARIH1, ARI, UBCH7BP		Ariadne, Drosophila, homolog of, 1	605624				
15.337	8	12	14	15q25.1	ARNT2, WEDAS		Aryl hydrocarbon receptor nuclear translocator 2	606036		mutation identified in 1 WEDAS family	?Webb-Dattani syndrome, 615926 (3)	
15.338	8	2	13	15q23	CELF6, BRUNOL6		CUGbp- and ELAV-like family, member 6	612681				
15.339	8	4	97	15q25.1	CRABP1, RBP5		Cellular retinoic acid-binding protein-1	180230		distal to APL breakpoint		9(Rbp5)
15.340	7	5	92	15q25.1	CHRNB4		Cholinergic receptor, neuronal nicotinic, beta polypeptide-4	118509				9(Acrb4)
15.341	10	17	12	15q25.1	CIB2, KIP2		Calcium- and integrin-binding protein 2	605564			Deafness, autosomal recessive 48, 609439 (3); Usher syndrome, type IJ, 614869 (3)	
15.342	6	15	99	15q24.1	CLK3		CDC-like kinase 3	602990				
15.343	11	11	98	15q24	ENFL2		Epilepsy, nocturnal frontal lobe, type 2	603204		some ENFL not on 20q or 15q	Epilepsy, nocturnal frontal lobe, type 2 (2)	
15.344	1	8	01	15q24.3	HMG20A		High mobility group protein 20A	605534				
15.345	9	2	09	15q24.2	IMP3, MRPS4, BRMS2		Imp3, S. cerevisiae, homolog of	612980				
15.346	1	27	04	15q25.1	KIAA1199		KIAA1199 gene	608366				
15.347	09	06	18	15q24.3	LINGO1, LRRN6A, LERN1, MRT64		Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 1	609791			Mental retardation, autosomal recessive 64, 618103 (3)	
15.348	6	6	03	15q25.1	MORF4L1, MRG15		Mortality factor 4-like 1	607303				
15.349	6	11	98	15q24	MRST		Mental retardation, severe, with spasticity and tapetoretinal degeneration	602685			Mental retardation, severe, with spasticity and tapetoretinal degeneration (2)	
15.350	11	21	18	15q24.3	SCAPER, KIAA1454, IDDRP		S-phase cyclin A-associated protein in the endoplasmic reticulum	611611			Intellectual developmental disorder and retinitis pigmentosa, 618195 (3)	
15.351	8	9	99	15q25.2	SH3GL3		SH3-domain GRB2-like 3	603362				
15.352	8	17	16	15q24.2	SIN3A, WITKOS		Sin3, yeast, homolog of, A	607776			Witteveen-Kolk syndrome, 613406 (3)	
15.353	1	6	09	15q23	UACA, NUCLING		Uveal autoantigen with coiled-coil domains and ankyrin repeats	612516				
15.354	6	13	02	15q25.3	AKAP13, HT31, LBC, BRX		A-kinase anchor protein 13	604686				
15.355	12	3	08	15q24-q25	CILD8		Ciliary dyskinesia, primary, 8	612274		max lod at D15S154	Ciliary dyskinesia, primary, 8 (2)	
15.356	1	9	94	15q25.1	CTSH		Cathepsin H	116820				9(Ctsh)
15.357	12	2	09	15q24.1	HCN4, SSS2		Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4	605206			Sick sinus syndrome 2, 163800 (3); Brugada syndrome 8, 613123 (3)	
15.358	3	5	08	15q25.3	MRPL46		Mitochondrial ribosomal protein L46	611851				
15.359	5	3	04	15q24.3	PSTPIP1, PSTPIP, CD2BP1, PAPAS		Proline-serine-threonine phosphatase-interacting protein 1	606347			Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	
15.360	12	27	01	15q25.2	TM6SF1		Transmembrane 6 superfamily, member 1	606562				
15.361	2	26	08	15q24.1	ADPGK		ADP-dependent glucokinase	611861				9(Adpgk)
15.362	9	26	16	15q24.1	C15orf59, INSYN1		Chromosome 15 open reading frame 59	617128				
15.363	08	09	19	15q24.1	CCDC33, CT61		Coiled-coil domain containing protein 33	618525				9(Ccdc33)
15.364	4	28	10	15q24.1	CYP1A1, CYP1		Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 1	108330		head-to-head with CYP1A2		9(Cyp1a1)
15.365	4	28	10	15q24.1	CYP1A2		Cytochrome P450, subfamily I, aromatic compound-inducible, polypeptide 2	124060		23.3kb from CYP1A1		9(Cyp1a2)
15.366	10	7	13	15q24.1	CYP11A1, P450SCC		Cytochrome P450, subfamily XIA, polypeptide 1 (cholesterol side chain cleavage enzyme)	118485			Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)	9(Cyp11a)
15.367	10	03	19	15q24.1	EDC3, YJDC, MRT50		Enhancer of mRNA decapping 3	609842		mutation identified in 1 MRT50 family	?Mental retardation, autosomal recessive 50, 616460 (3)	
15.368	9	6	11	15q24.1	ISLR2, LINX, KIAA1464		Immunoglobulin superfamily containing leucine-rich repeat 2	614179				
15.369	2	9	16	15q24.1	LOXL1, LOXL		Lysyl oxidase-like 1	153456			{Exfoliation syndrome, susceptibility to}, 177650 (3)	9(Loxl1)
15.370	2	9	16	15q24.1	LOXL1AS1		LOXL1 antisense RNA 1	616800				
15.371	1	29	13	15q24.1	NPTN, SDFR1, GP55, NP55, GP65, NP65		Neuroplastin	612820				
15.372	4	17	13	15q24.1	NPTNIT1		NPTN intronic transcript 1, noncoding	615176				
15.373	4	17	07	15q24.2	NRG4, HRG4		Neuregulin 4	610894				
15.374	05	07	19	15q24.1	REC114		Rec114 meiotic recombination protein	618421				
15.375	9	13	17	15q24.1	SEMA7A, SEMAL, SEMAK1, CDW108, JMH		Semaphorin 7A	607961			[Blood group, John-Milton-Hagen system], 614745 (3)	9(Sema7a)
15.376	11	30	12	15q24.1	STRA6, MCOPS9, MCOPCB8		Stimulated by retinoic acid 6, mouse, homolog of	610745			Microphthalmia, syndromic 9, 601186 (3); Microphthalmia, isolated, with coloboma 8, 601186 (3)	
15.377	9	29	10	15q24.1	ULK3		UNC51-like kinase 3	613472				
15.378	12	22	15	15q24.2	COMMD4		COMM domain-containing protein 4	616701				
15.379	4	27	12	15q24.2	CSPG4, MCSPG, MSK16, NG2		Chondroitin sulfate proteoglycan	601172				
15.380	9	16	12	15q24.2	NEIL1, NEI1, FPG1		Endonuclease VIII-like 1	608844				
15.381	3	20	06	15q24.2	PPCDC		Phosphopantothenoylcysteine decarboxylase	609854				
15.382	5	25	13	15q24.2	PTPN9		Protein-tyrosine phosphatase, nonreceptor-type, 9	600768				
15.383	11	21	20	15q24.2	SNX33		Sorting nexin 33	619107				
15.384	12	09	19	15q24.2	TMEM266, HVRP1, C15orf27		Transmembrane protein 266	618691				
15.385	6	9	98	15q25.1	BCL2A1		BCL2-related protein A1	601056				9(Bcl2a1)
15.386	03	09	20	15q25.2	HOMER2, HOMER2B, HOMER2A, DFNA68		Homer scaffold protein 2	604799		mutation identified in 1 DFNA68 family	?Deafness, autosomal dominant 68, 616707 (3)	
15.387	9	26	11	15q24.3	PEAK1, KIAA2002		Pseudopodium-enriched atypical kinase 1	614248				
15.388	12	2	09	15q24.3	TSPAN3		Tetraspanin 3	613134				
15.389	10	23	20	15q24.2	COX5A, MC4DN20		Cytochrome C oxidase, subunit Va	603773		pseudogene on 14q22; mutation identified in 1 MC4DN20 family	?Mitochondrial complex IV deficiency, nuclear type 20, 619064 (3)	
15.390	10	26	11	15q25	DEL15q25, C15DELq25		Chromosome 15q25 deletion syndrome	614294		chr15:82,889,423-83,552,890, NCBI36	Chromosome 15q25 deletion syndrome (4)	
15.391	11	20	15	15q25.2	HRP3, HDGFRP3		Hepatoma-derived growth factor-related protein 3	616643				
15.392	6	2	98	15q26.1	MAN2A2, MANA2X		Mannosidase, alpha-, type II, isozyme X	600988				
15.393	6	14	99	15q26.1	MFGE8		Milk fat globule-EGF factor 8	602281				
15.394	4	23	08	15q25.3	MRPS11		Mitochondrial ribosomal protein S11	611977				
15.395	10	19	97	15q25.3	NTRK3, TRKC		Neurotrophic tyrosine kinase, receptor, type 3	191316				
15.396	3	25	16	15q26.1	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS		Polymerase (DNA directed), gamma	174763		PEO also digenic with C10orf2	Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3); Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3); Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3); Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3); Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	7(Polg)
15.397	11	6	00	15q26.1	RHCG, RHGK		Rhesus blood group-associated kidney homolog	605381				
15.398	12	16	93	15q26.1	ANPEP, PEPN, CD13		Alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150)	151530				
15.399	11	13	01	15q25-q26	DFNA30		Deafness, autosomal dominant 30	606451			Deafness, autosomal dominant 30 (2)	
15.400	8	21	07	15q26.1	FANCI, KIAA1794		FANCI gene	611360			Fanconi anemia, complementation group I, 609053 (3)	
15.401	12	23	02	15q26.1	FURIN, PACE, FUR, PCSK3		Furin (paired basic amino acid cleaving enzyme)	136950		less than 1.1kb 5' to FES		7(Fur, Pcsk3)
15.402	4	30	09	15q26.3	IGF1R		Insulin-like growth factor-1 receptor	147370			Insulin-like growth factor I, resistance to, 270450 (3)	7(Igf1r)
15.403	06	17	19	15q25.3	SLC28A1, CNT1, URCTU		Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1	606207			[Uridine-cytidineuria], 618477 (3)	
15.404	09	11	19	15q26.1	UNC45A, SMAP1, GCUNC45		unc-45 myosin chaperone A	611219				7(Unc45a)
15.405	05	08	20	15q25.1	ABHD17C, FAM108C1		Abhydrolase domain-containing protein 17C, depalmitoylase	617944				
15.406	09	26	19	15q25.1	ADAMTS7		ADAM metallopeptidase domain with thrombospondin type 1 motif, 7	605009				
15.407	12	7	12	15q25.1	AGPHD1		Aminoglycoside phosphotransferase domain-containing protein 1	614681				
15.408	12	27	19	15q25.2	BNC1, POF16		Basonuclin	601930		mutation identified in 1 POF16 family	?Premature ovarian failure 16, 618723 (3)	
15.409	01	20	20	15q25.1	CHRNA3, LNCR2, PAOD2, BAIPRCK		Cholinergic receptor, neuronal nicotinic, alpha polypeptide-3	118503			{Lung cancer susceptibility 2}, 612052 (3); Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT, 191800 (3)	9(Acra3)
15.410	4	27	12	15q25.1	CHRNA5, LNCR2		Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5	118505			{Lung cancer susceptibility 2}, 612052 (3); {Nicotine dependence, susceptibility to}, 612052 (3)	9(Acra5)
15.411	11	07	19	15q25.1	IREB2, NDCAMA		Iron-responsive element-binding protein-2	147582			Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia, 618451 (3)	
15.412	07	19	18	15q25.1	KIAA1024, MINAR1		Major intrinsically disordered NOTCH2-binding receptor 1	618054				
15.413	10	25	19	15q25.1	MESD, MESDC2, BOCA, KIAA0081, OI20		Mesoderm development LRP chaperone	607783			Osteogenesis imperfecta, type XX, 618644 (3)	7(Mesdc2)
15.414	5	4	12	15q25.1	MIR184, MIRN184, KTCNCT, EDICT		Micro RNA 184	613146			EDICT syndrome, 614303 (3)	9(Mir184)
15.415	03	29	19	15q25.1	MTHFS, NEDMEHM		5,10-methenyltetrahydrofolate synthetase	604197			Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination, 618367 (3)	
15.416	12	17	07	15q25.1	PSMA4, PSC9, HC9		Proteasome subunit, alpha-type, 4	176846				
15.417	7	2	18	15q25.1	RASGRF1, GRF55		Ras protein-specific guanine nucleotide-releasing factor 1	606600				9(Rasgrf1)
15.418	10	14	19	15q25.1	TLNRD1, MESDC1		Talin rod domain containing 1	615466				7(Mesdc1)
15.419	11	23	15	15q25.1	TMC3		Transmembrane channel-like protein 3	617196				7(Tmc3)
15.420	1	16	07	15q25.1	ZFAND6, ZA20D3, AWP1		Zinc finger AN1 domain-containing protein 6	610183				
15.421	09	02	20	15q25.1	IDH3A, RP90		Isocitrate dehydrogenase 3 (NAD+) alpha	601149			Retinitis pigmentosa 90, 619007 (3)	
15.422	11	11	12	15q25.1-q26.1	POROK4, DSAP2		Porokeratosis 4, disseminated superficial actinic	607728		between D15S1023 and D15S1030	Porokeratosis 4, disseminated superficial actinic (2)	
15.423	5	27	09	15q25.2	ADAMTSL3, KIAA1233		ADAMTS-like protein 3	609199				7(Adamtsl3)
15.424	07	25	18	15q25.3	ALPK3, MIDORI, KIAA1330, CMH27		Alpha kinase 3	617608			Cardiomyopathy, familial hypertrophic 27, 618052 (3)	
15.425	11	05	20	15q25.2	AP3B2, NAPTB, DEE48		Adaptor-related protein complex 3, beta 2 subunit	602166			Developmental and epileptic encephalopathy 48, 617276 (3)	7(Naptb)
15.426	5	25	13	15q25.2	CPEB1		Cytoplasmic polyadenylation element-binding protein 1	607342				
15.427	4	24	18	15q25.2	EFL1, RIA1, EFTUD1, FAM42A, SDS2		Elongation factor-like GTPase 1	617538			Shwachman-Diamond syndrome 2, 617941 (3)	
15.428	4	2	12	15q25.2	FAM103A1, RAM		Family with sequence similarity 103, member A1	614547				
15.429	8	20	07	15q25.2	MEX3B, RKHD3		Mex-3, C. elegans, homolog of, B	611008				
15.430	5	24	13	15q25.2	SCAND2		SCAN domain-containing 2	610417				
15.431	3	31	09	15q25.2	SCARNA15, ACA45		Small cajal body-specific RNA 15	612675				
15.432	11	13	17	15q25.2	WDR73, HSPC264, GAMOS1		WD repeat-containing protein 73	616144			Galloway-Mowat syndrome 1, 251300 (3)	
15.433	4	21	16	15q25.2	WHAMM, KIAA1971		Was protein homolog associated with actin, golgi membranes, and microtubules	612393				
15.434	10	07	19	15q25.2-q25.3	SEC11A, SPC18		SEC11 homolog A, signal peptidase complex subunit	618258				
15.435	11	19	13	15q25.3	AGBL1, CCP4, FECD8		ATP/GTP-binding protein-like 1	615496			Corneal dystrophy, Fuchs endothelial, 8, 615523 (3)	
15.436	07	17	20	15q26.1	DET1		DET1 partner of COP1 E2 ubiquitin ligase	608727				
15.437	9	1	15	15q25.3	ZNF592, KIAA0211		Zinc finger protein 592	613624				
15.438	2	21	06	15q25.3-q26.1	CHNG3, RTSH		Hypothyroidism, congenital, nongoitrous, 3	609893		max lod at D15S655	Hypothyroidism, congenital, nongoitrous, 3 (2)	
15.439	01	03	19	15q26.1	CIB1, KIP		Calcium- and integrin-binding protein 1	602293			Epidermodysplasia verruciformis 3, 618267 (3)	
15.440	5	21	07	15q25.3	PDE8A		Phosphodiesterase 8A	602972				
15.441	6	7	04	15q25.3-q26.2	MDD2		Major depressive disorder 2	608691			Major depressive disorder 2, 608516 (2)	
15.442	3	15	13	15q26.3	ALDH1A3, ALDH6, MCOP8		Aldehyde dehydrogenase 1 family, member A3	600463			Microphthalmia, isolated 8, 615113 (3)	
15.443	8	19	13	15q26.1	CHD2, EEOC		Chromodomain helicase DNA binding protein-2	602119			Epileptic encephalopathy, childhood-onset, 615369 (3)	
15.444	12	4	90	15q14	CHRM5		Cholinergic receptor, muscarinic, 5	118496				
15.445	12	9	98	15q26	IDDM3		Insulin-dependent diabetes mellitus-3	600318			{Diabetes mellitus, insulin-dependent, 3} (2)	
15.446	2	6	01	15q26.1	IQGAP1, SAR1		RASGAP-like with IQ motifs (sar1, S. pombe, homolog of)	603379		amplified in gastric cancer		
15.447	2	7	01	15q26.1	ISG20, HEM45		Interferon-stimulated gene, 20kD	604533				
15.448	08	12	19	15q26.3	LINS1, WINS1, FLJ10583, MRT27		Lines homolog 1	610350			Mental retardation, autosomal recessive 27, 614340 (3)	
15.449	12	3	03	15q26.3	MEF2A, ADCAD1		MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A)	600660			{Coronary artery disease, autosomal dominant, 1}, 608320 (3)	7(Mef2a)
15.450	4	25	93	15q26.3	PCSK6, PACE4, SPC4		Proprotein convertase subtilisin/kexin type 6	167405				7(Pcsk6)
15.451	4	16	11	15q26.1	PLIN1, PLIN, FPLD4		Perilipin 1	170290			Lipodystrophy, familial partial, type 4, 613877 (3)	7(Plin)
15.452	4	2	09	15q26.1	RLBP1		Retinaldehyde-binding protein-1, cellular	180090			Fundus albipunctatus, 136880 (3); Retinitis punctata albescens, 136880 (3); Newfoundland rod-cone dystrophy, 607476 (3); Bothnia retinal dystrophy, 607475 (3)	7(Rlbp1)
15.453	12	4	08	15q26.1	SLCO3A1, OATPD, OATP3A1		Solute carrier organic anion transporter family, member 3A1	612435				
15.454	6	28	02	15q25.1	STARD5		Start domain-containing protein 5	607050				
15.455	7	13	98	15q26.1	STX		Sialyltransferase X	602546				
15.456	12	26	14	15q26	VVS		Syncope, familial vasovagal	609289			Syncope, familial vasovagal (2)	
15.457	3	19	09	15q26-qter	DEL15q26qter, C15DELq26qter		Chromosome 15q26-qter deletion syndrome	612626		contiguous gene deletion syndrome	Chromosome 15q26-qter deletion syndrome (4)	
15.458	10	25	12	15q26-qter	LVSKS		Levy-Shanske syndrome (tetrasomy 15q26)	614846			Levy-Shanske syndrome (4)	
15.459	05	08	20	15q26.1	ABHD2, LABH2		Abhydrolase domain-containing 2, acylglycerol lipase	612196				16(Abhd2)
15.460	02	18	19	15q26.1	ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD		Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122)	155760		mutation identified in 1 SEDK family	?Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3); Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3); Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3)	7(Agc1)
15.461	10	1	17	15q26.1	AP3S2		Adaptor-related protein complex 3, sigma-2 subunit	602416				
15.462	11	27	13	15q26.1	C15orf38, ARPIN		Chromosome 15 open reading frame 38	615543				
15.463	3	16	10	15q26.1	C15orf42, TRESLIN		Treslin	613298				
15.464	10	27	08	15q26.1	CRTC3, TORC3		CREB-regulated transcription coactivator 3	608986				
15.465	12	29	05	15q26.1	DIH1, HCD		Hernia, congenital diaphragmatic 1	142340			Hernia, congenital diaphragmatic 1 (2)	
15.466	7	13	93	15q26.1	FES		Oncogene FES, feline sarcoma virus	190030				7(Fes)
15.467	12	14	10	15q26.1	IDH2, IDPM, D2HGA2		Isocitrate dehydrogenase, mitochondrial	147650			D-2-hydroxyglutaric aciduria 2, 613657 (3)	7(Idh2)
15.468	6	16	06	15q26.1	ISG20L1, AEN		Interferon-stimulated exonuclease gene 20kD-like 1	610177				
15.469	11	3	99	15q25.1	IL16, LCF		Interleukin 16	603035				7(Il16)
15.470	1	21	16	15q26.1	KIF7, HLS2, ACLS, JBTS12, AGBK		Kinesin family member 7	611254		mutation identified in 1 HLS2 family and 1 AGBK family	?Hydrolethalus syndrome 2, 614120 (3); Acrocallosal syndrome, 200990 (3); Joubert syndrome 12, 200990 (3); ?Al-Gazali-Bakalinova syndrome, 607131 (3)	
15.471	10	13	15	15q26.1	MESP1		Mesoderm posterior bHLH transcription factor 1	608689				
15.472	6	4	04	15q26.1	MESP2, SCDO2		Mesoderm posterior bHLH transcription factor 2	605195			Spondylocostal dysostosis 2, autosomal recessive, 608681 (3)	
15.473	3	23	09	15q26.1	MIR9-3, MIRN9-3		Micro RNA 9-3	611188				
15.474	12	23	15	15q26.1	NGRN		Neurite outgrowth-associated protein	616718				
15.475	10	25	12	15q26.1	PEX11A		Peroxisome biogenesis factor 11A	603866				
15.476	5	29	10	15q26.1	PRC1		Protein regulating cytokinesis 1	603484				
15.477	6	1	18	15q26.1	RCCD1		RCC1 domain-containing protein 1	617997				
15.478	09	06	18	15q26.1	RECQL3, RECQ2, BLM, BS, MGRISCE1		DNA helicase, RecQ-like 3	604610			Bloom syndrome, 210900 (3)	
15.479	2	28	03	15q26.1	RGMA		RGM domain family, member A (repulsive guidance molecule)	607362				4(Ephb2)
15.480	7	14	16	15q26.1	SEMA4B		Semaphorin 4B	617029				
15.481	5	24	13	15q26.1	SV2B, KIAA0735		Synaptic vesicle glycoprotein 2B	185861				
15.482	12	27	19	15q26.1	VPS33B		VPS33B late endosome and lysosome associated	608552			Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)	
15.483	06	02	20	15q26.2	NR2F2, TFCOUP2, ARP1, CHTD4, SRXX5		Nuclear receptor subfamily 2, group F, member 2 (transcription factor COUP 2)	107773			Congenital heart defects, multiple types, 4, 615779 (3); 46,XX sex reversal 5, 618901 (3)	7(Tcfcoup2)
15.484	4	8	98	15q26.1-qter	OTSC1, OTS		Otosclerosis 1	166800			Otosclerosis 1 (2)	
15.485	4	7	15	15q26.2	MCTP2		Multiple C2 domains-containing transmembrane protein 2	616297				
15.486	5	3	11	15q26.2	SPATA8, SRG8		Spermatogenesis-associated protein 8	613948				
15.487	1	31	13	15q26.3	ASB7		Ankyrin repeat- and SOCS box-containing protein 7	615052				
15.488	7	9	13	15q26.3	CERS3, LASS3, ARCI9		Ceramide synthase 3	615276			Ichthyosis, congenital, autosomal recessive 9, 615023 (3)	
15.489	2	24	11	15q26.3	CHSY1, KIAA0990, TPBS		Carbohydrate synthase 1	608183			Temtamy preaxial brachydactyly syndrome, 605282 (3)	
15.490	4	27	07	15q26.3	LRRK1		Leucine-rich repeat kinase 1	610986				
15.491	11	17	16	15q26.3	SELENOS, SEPS1, SELS, VIMP, ADO15		Selenoprotein S	607918				
15.492	8	22	07	15q26.3	SNRPA1		Small nuclear ribonucleoprotein polypeptide A'	603521				7(Snrpa1)
15.493	02	04	19	15q26.3	SYNM, DMN		Synemin	606087				
15.494	4	19	06	15q26.3	TM2D3, BLP2		TM2 domain-containing protein 3	610014				
15.495	1	30	01	15q21.2	ARPP19, ARPP16		cAMP-regulated phosphoprotein, 19kD	605487				
15.496	1	31	01	15q14	AVEN		Cell death regulator AVEN	605265				
15.497	7	12	02	15q15.2	CCNDBP1, GCIP		Cyclin D-type-binding protein 1	607089				
15.498	4	26	90	Chr.15	COL1AR		Collagen I, alpha, receptor	120340				
15.499	1	24	93	15q21.1-q21.2	GALK2, GK2		Galactokinase-2	137028				
15.500	7	11	01	15q15.1	PLA2G4B		Phospholipase A2, group IVB	606088				
15.501	4	15	02	15q23	RPLP1		Ribosomal phosphoprotein, Large, P1	180520				
15.502	5	13	02	15q24.1	SCAMP2		Secretory carrier membrane protein 2	606912				
16.1	10	26	99	16p13.3	SYNGR3		Synaptogyrin 3	603927				
16.2	5	22	18	16p13.3	HBA1, HBH, METHBA, ECYT7		Hemoglobin alpha-1	141800		1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'	Thalassemias, alpha-, 604131 (3); Erythrocytosis 7, 617981 (3); Hemoglobin H disease, nondeletional, 613978 (3); Methemoglobinemia, alpha type, 617973 (3); Heinz body anemias, alpha-, 140700 (3)	11(Hba)
16.3	6	14	18	16p13.3	HBA2, HBH, ECYT7		Hemoglobin alpha-2	141850			Thalassemia, alpha-, 604131 (3); Heinz body anemia, 140700 (3); Hemoglobin H disease, deletional and nondeletional, 613978 (3); Erythrocytosis 7, 617981 (3)	11(Hba)
16.4	1	12	89	16p13.3	HBQ1		Hemoglobin theta-1	142240				
16.5	7	17	91	16p13.3	HBZ		Hemoglobin, zeta	142310				
16.6	6	11	93	16pter-p13.3	HBHR, ATR1		Alpha-thalassemia/mental retardation syndrome, type 1	141750		contiguous gene syndrome involving deletion of HBA1 and HBA2	Alpha-thalassemia/mental retardation syndrome, type 1 (4)	
16.7	10	15	95	16p13.3	MPG, MDG		N-methylpurine DNA glycosylase	156565		75kb upstream of HBZ		11(Mpg)
16.8	2	28	03	16pter-p13	CHDS1		Coronary heart disease, susceptibility to, 1	607339			{Coronary heart disease, susceptibility to} (2)	
16.9	1	26	97	16p13.3	ZNF75A		Zinc finger protein-75A	601473				
16.10	12	21	09	16p13.2	ABAT, GABAT		4-aminobutyrate aminotransferase	137150			GABA-transaminase deficiency, 613163 (3)	
16.11	5	21	07	16p13.3	ABCA3, ABC3, SMDP3		ATP-binding cassette-3	601615			Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)	
16.12	11	20	98	16p13.3	ADCY9		Adenylate cyclase-9	603302				16(Adcy9)
16.13	01	03	20	16p13.3	ALG1, HMAT1, HMT1, CDG1K		ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase	605907			Congenital disorder of glycosylation, type Ik, 608540 (3)	
16.14	1	26	17	16p13.3	ANKS3		Ankyrin repeat and sterile alpha motif domains-containing protein 3	617310				
16.15	09	04	19	16p13.3	ANTKMT		Adenine nucleotide translocase lysine methyltransferase	618566				
16.16	1	8	15	16p13.3	AXIN1, AXIN		Axis inhibitor 1	603816		hypermethylation of AXIN1 promoter seen in 1 CDUP patient	Hepatocellular carcinoma, somatic, 114550 (3); ?Caudal duplication anomaly, 607864 (3)	
16.17	7	18	02	16p13.3	ATP6V0C, ATP6L, ATP6C		ATPase, H+ transporting, V0 subunit c	108745				
16.18	10	26	99	16p13.3	BAIAP3, BAP3		BAI1-associated protein 3	604009				
16.19	6	26	16	16p13.3	BICDL2, BICDR2, CCDC64B		BICD family-like cargo adaptor 2	617003				
16.20	8	5	11	16p13.3	C1QTNF8, CTRP8		C1q- and tumor necrosis factor-related protein 8	614147				
16.21	7	25	18	16p13.3	CDIP1, C16orf5		Cell death-inducing p53 target 1	610503				
16.22	7	14	16	16p13.3	CACNA1H, EIG6, ECA6, HALD4		Calcium channel, voltage-dependent, T type, alpha-1H subunit	607904			{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3); {Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3); Hyperaldosteronism, familial, type IV, 617027 (3)	17(Cacna1h)
16.23	05	05	20	16p13.3	CAPN15, SOLH		Calpain 15	603267				
16.24	8	29	08	16p13.3	CASKIN1, KIAA1306		CASK-interacting protein 1	612184				
16.25	11	7	17	16p13.3	CCDC78, C16orf25, CNM4		Coiled-coil domain-containing protein 78	614666		mutation identified in 1 CNM4 family	?Centronuclear myopathy 4, 614807 (3)	
16.26	01	20	20	16p13.3	CCDC154, C16orf29		Coiled-coil domain-containing protein 154	618740				17(Ccdc154)
16.27	1	12	95	16p13.3	CCNF, FBX1		Cyclin F	600227				17(Ccnf)
16.28	8	30	07	16p13.3	CEMP1, CP23		Cementum protein 1	611113				
16.29	11	20	20	16p13.3	CHTF18, CHL12, CTF18		Chromosome transmission fidelity factor 18	613201				
16.30	6	22	14	16p13.3	CLDN6		Claudin 6	615798				
16.31	11	12	20	16p13.3	CLDN9, DFNB116		Claudin 9	615799		mutation identified in 1 DFNB116 family	?Deafness, autosomal recessive 116, 619093 (3)	
16.32	10	13	09	16p13.3	CORO7, POD1, CRN7		Coronin 7	611668				
16.33	02	22	19	16p13.3	CREBBP, CBP, RSTS1, MKHK1		CREB binding protein	600140		fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemia; fusion partner with MOZ in AML	Rubinstein-Taybi syndrome 1, 180849 (3); Menke-Hennekam syndrome 1, 618332 (3)	
16.34	7	18	14	16p13.3	DECR2, PDCR		2,4-dienoyl-CoA reductase 2, peroxisomal	615839				
16.35	1	27	04	16p13.3	DNAJA3, TID1		DNAJ, E. coli, homolog of, subfamily A, member 3	608382				
16.36	5	26	05	16p13.3	DNASE1, DNL1		Deoxyribonuclease I	125505			{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	
16.37	9	9	10	16p13.3	DUP16p13.3, C16DUPq13.3		Chromosome 16p13.3 duplication syndrome	613458		contiguous gene duplication syndrome	Chromosome 16p13.3 duplication syndrome (4)	
16.38	9	10	98	16p13.3	E4F1, E4F		E4F transcription factor 1	603022				17(E4fl)
16.39	7	18	14	16p13.3	ECI1, DCI		Enoyl-CoA delta isomerase 1	600305				
16.40	12	18	14	16p13.3	EEF2KMT, FAM86A		Eukaryotic elongation factor 2 lysine methyltransferase	615263				
16.41	11	12	20	16p13.3	EME2		Essential meiotic structure-specific endonuclease 2	610886				
16.42	4	22	15	16p13.3	FAHD1, FLJ36880		Fumarylacetoacetate hydrolase domain-containing protein 1	616320				
16.43	6	13	12	16p13.3	FBXL16, FBL16, C16orf22		F-box and leucine-rich repeat protein 16	609082				17(Fbxl16)
16.44	11	13	07	16p13.3	GLIS2, NPHP7		GLIS family zinc finger protein 2	608539			Nephronophthisis 7, 611498 (3)	16(Glis2)
16.45	4	29	03	16p13.3	GNG13		Guanine nucleotide-binding protein, gamma-13	607298				
16.46	10	10	05	16p13.3	HBM		Hemoglobin mu	609639		?functional		
16.47	03	19	20	16p13.3	HCFC1R1, HPIP		Host cell factor C1 regulator 1	618818				
16.48	5	23	94	16p13.3	HMOX2		Heme oxygenase 2	141251				
16.49	08	12	19	16p13.3	IFT140, KIAA0590, SRTD9, MZSDS, RP80		Intraflagellar transport 140	614620			Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3); Retinitis pigmentosa 80, 617781 (3)	
16.50	9	20	14	16p13.3	IGFALS, ALS, ACLSD		Insulin-like growth factor-binding protein, acid-labile subunit	601489			Acid-labile subunit, deficiency of, 615961 (3)	
16.51	5	2	05	16p13.3	IL32, NK4		Interleukin 32	606001				
16.52	5	26	13	16p13.3	KCTD5		Potassium channel tetramerization domain-containing protein 5	611285				
16.53	2	21	06	16p13.3	KREMEN2, KRM2		Kringle domain-containing transmembrane protein 2	609899				
16.54	1	29	08	16p13.3	LMF1, TMEM112		Lipase maturation factor 1	611761			Lipase deficiency, combined, 246650 (3)	17(Lmf1)
16.55	11	20	20	16p13.3	LUC7L		LUC7-like	607782				17(Luc7l)
16.56	05	24	19	16p13.3	MAPK8IP3, SYD2, JSAP1, JIP3, NEDBA		Mitogen-activated protein kinase 8-interacting protein 3	605431			Neurodevelopmental disorder with or without variable brain abnormalities, 618443 (3)	
16.57	10	1	17	16p13.3	MEIOB, SPGF22		Meiosis-specific protein with OB domains	617670		mutation identified in one SPGF22 family	?Spermatogenic failure 22, 617706 (3)	
16.58	7	26	06	16p13.3	MCOPCT1		Microphthalmia with cataract 1	156850		proximal to HBA1	Microphthalmia with cataract 1 (2)	
16.59	7	11	01	16p13.3	MSLN		Mesothelin	601051				
16.60	11	18	16	16p13.3	MSRB1, SEPX1, SELX		Methionine sulfoxide reductase B1	606216				
16.61	8	20	07	16p13.3	METRN		Meteorin	610998				17(Metrn)
16.62	2	12	03	16p13.3	MGRN1, KIAA0544		Mahogunin, ring finger 1	607559				16(Mgrn1)
16.63	3	23	09	16p13.3	MIR1225, MIRN1225		Micro RNA 1225	611621				
16.64	8	8	13	16p13.3	MMP25, MMP20A		Matrix metalloproteinase 25	608482				
16.65	3	11	08	16p13.3	MRPL28, MAAT1		Mitochondrial ribosomal protein L28	604853				
16.66	3	31	11	16p13.3	MLST8, GBL, LST8, WAT1, POP3		MTOR-associated protein LST8	612190				
16.67	9	24	11	16p13.3	NAA60, NAT15		N-alpha-acetyltransferase 60, NatF catalytic subunit	614246				
16.68	3	2	10	16p13.3	NAGPA, UCE		N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	607985				
16.69	9	10	07	16p13.3	NARFL, IOP1		Nuclear prelamin A recognition factor-like	611118				
16.70	09	08	20	16p13.3	NDUFB10, MC1DN35		NADH-ubiquinone oxidoreductase subunit B10	603843		mutation identified in 1 MC1DN35 patient	?Mitochondrial complex I deficiency, nuclear type 35, 619003 (3)	
16.71	3	7	14	16p13.3	NLRC3		NLR family, Caspase recruitment domain-containing 3	615648				
16.72	07	17	20	16p13.3	NME3, NM23H3		NME/NM23 nucleoside diphosphate kinase 3	601817				
16.73	09	12	19	16p13.3	NME4		NME/NM23 nucleoside diphosphate kinase 4	601818				
16.74	12	11	17	16p13.3	GLYR1, NP60		Glyoxylate reductase 1 homolog	610660				
16.75	9	22	16	16p13.3	NPRL3, CGTHBA, FFEVF3		Nitrogen permease regulator-like 3	600928			Epilepsy, familial focal, with variable foci 3, 617118 (3)	
16.76	2	25	15	16p13.3	NPW, PPNPW, PPL8		Neuropeptide W	607997				
16.77	4	24	18	16p13.3	NTN3, NTN2L		Netrin 3	602349				
16.78	2	22	07	16p13.3	NUBP2, CFD1		Nucleotide-binding protein 2	610779				17(Nubp2)
16.79	2	7	17	16p13.3	NUDT16L1, SDOS		Nudix hydrolase 16-like 1	617338				
16.80	09	18	19	16p13.3	PAM16, MAGMAS, SMDMDM		Presequence translocase-associated motor 16	614336			Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3)	
16.81	4	19	12	16p13.3	PAQR4		Progestin and ADIPOQ receptor family, member 4	614578				
16.82	8	22	07	16p13.3	PDIA2, PDIP		Protein disulfide isomerase, family A, member 2	608012				
16.83	1	31	01	16p13.3	PDPK1, PDK1		3-phosphoinositide-dependent protein kinase 1	605213				
16.84	11	14	19	16p13.3	PERCC1, ICR, DIAR11		Proline- and glutamate-rich protein with coiled-coil domain 1	618656		Intestine Critical Region (ICR) upstream of PERCC1 deleted in DIAR11	Diarrhea 11, malabsorptive, congenital, 618662 (3)	17(Percc1)
16.85	10	12	90	16p13.3	PGP		Phosphoglycolate phosphatase	172280		no recombination with PKD1		
16.86	12	01	20	16p13.3	PIGQ, DEE77		Phosphatidylinositol glycan anchor biosynthesis class Q protein	605754			Developmental and epileptic encephalopathy 77, 618548 (3)	
16.87	9	21	11	16p13.3	PKDTS		Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273		contiguous gene syndrome caused by deletion of TSC2 and PKD1	Polycystic kidney disease, infantile severe, with tuberous sclerosis (4)	
16.88	8	8	13	16p13.3	PKMYT1, MYT1		Protein kinase, membrane-associated tyrosine/threonine, 1	602474				
16.89	9	27	17	16p13.3	POLR3K, RPC11		Polymerase III, RNA, subunit K	606007				
16.90	8	22	90	16p13.13	PRM1		Sperm protamine P1	182880		16q21 = conflicting localization		16(Prm1)
16.91	8	22	90	16p13.13	PRM2		Sperm protamine P2	182890		in same 4.8kb fragment as PRM2		16(Prm2)
16.92	3	22	07	16p13.3	PRSS21, ESP1		Protease, serine, 21 (testisin)	608159				
16.93	7	1	05	16p13.3	PRSS22		Protease, serine, 22	609343				17(Prss22)
16.94	4	14	11	16p13.3	PRSS33, EOS		Protease, serine, 33	613797				
16.95	9	7	10	16p13.3	PTX4		Pentraxin 4, long	613442				17(Ptx4)
16.96	12	29	06	16p13.3	RAB11FIP3, EFERIN, KIAA0665		RAB11 family-interacting protein 3	608738				
16.97	12	8	00	16p13.3	RAB26		RAS-associated protein RAB26	605455				
16.98	1	1	12	16p13.3	RHBDF1, IRHOM1, DIST1		Rhomboid 5, Drosophila, homolog of, 1	614403				11(Rhbdf1)
16.99	6	24	10	16p13.3	RHBDL, RRP		Rhomboid, Drosophila, homolog of	603264				
16.100	4	15	11	16p13.3	RHOT2, MIRO2, ARHT2		Ras homolog gene family, member T2	613889				17(Rhot2)
16.101	7	2	18	16p13.3	RNPS1		RNA-binding protein S1	606447				
16.102	09	16	19	16p13.3	ROGDI, KTZS		Rogdi atypical leucine zipper	614574			Kohlschutter-Tonz syndrome, 226750 (3)	
16.103	4	21	17	16p13.3	RPL3L		Ribosomal protein L3-like	617416				
16.104	8	20	99	16p13.3	RS11		Regulator of G protein signaling 11	603895				
16.105	8	20	99	16p13.3	RPS2		Ribosomal protein S2	603624				
16.106	12	29	06	16p13.3	DEL16p13.3, RSTSS		Chromosome 16p13.3 deletion syndrome (Rubinstein-Taybi deletion syndrome)	610543		contiguous gene deletion syndrome	Chromosome 16p13.3 deletion syndrome (4)	
16.107	9	18	12	16p13.3	SEPT12, SPGF10		Septin 12	611562			Spermatogenic failure 10, 614822 (3)	
16.108	1	7	02	16p13.3	SLC9A3R2, SIP1, NHERF2		Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 2	606553				
16.109	10	10	19	16p13.3	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP		SLX4 structure-specific endonuclease subunit	613278			Fanconi anemia, complementation group P, 613951 (3)	
16.110	4	11	01	16p13.3	SOX8		SRY-box 8	605923				
16.111	12	18	07	16p13.3	SPSB3, SSB3		SPRY domain- and SOCS box-containing 3	611659				
16.112	1	29	01	16p13.3	SRL		Sarcalumenin	604992				
16.113	10	13	20	16p13.3	SSTR5		Somatostatin receptor-5	182455				17(Sstr5)
16.114	11	09	18	16p13.3	STUB1, CHIP, SCAR16, SCA48		STIP1 homologous and U box-containing protein 1	607207		mutation identified in 1 SCA48 family	Spinocerebellar ataxia, autosomal recessive 16, 615768 (3); ?Spinocerebellar ataxia 48, 618093 (3)	
16.115	10	23	20	16p13.3	TBC1D24, KIAA1171, FIME, DEE16, DOORS, DFNB86, DFNA65, EPRPDC		TBC1 domain family, member 24	613577			Myoclonic epilepsy, infantile, familial, 605021 (3); Developmental and epileptic encephalopathy 16, 615338 (3); DOORS syndrome, 220500 (3); Deafness , autosomal recessive 86, 614617 (3); Deafness, autosomal dominant 65, 616044 (3); Epilepsy, rolandic, with proxysmal exercise-induce dystonia and writer's cramp, 608105 (3)	
16.116	5	14	01	16p13.3	TBL3		Transducin-beta-like 3	605915				
16.117	9	26	17	16p13.3	TCEB2, ELOB		Transcription elongation factor B, polypeptide 2	600787				
16.118	6	26	16	16p13.3	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS		Telomere maintenance 2, S. cerevisiae, homolog of	611140			You-Hoover-Fong syndrome, 616954 (3)	
16.119	2	25	16	16p13.3	THOC6, FSAP35, BBIS		THO complex subunit 6	615403			Beaulieu-Boycott-Innes syndrome, 613680 (3)	
16.120	12	7	07	16p13.2	TMEM114		Transmembrane protein 114	611579				
16.121	7	14	14	16p13.3	TMEM204, C16orf30, CLP24		Transmembrane protein 204	611002				
16.122	12	23	02	16p13.3	TNFRSF12A, FN14, TWEAKR		Tumor necrosis factor receptor superfamily, member 12A	605914				17(Fn14)
16.123	4	25	93	16p13.13	TNP2		Transition protein-2 (during histone to protamine replacement)	190232		in 13kb segment with PRM1 and PRM2		16(Tnp2)
16.124	3	23	05	16p13.3	TPSAB1, TPS1		Tryptase, alpha/beta-1	191080				
16.125	3	23	05	16p13.3	TPSB2, TPS2		Tryptase, beta 2	191081				
16.126	3	23	05	16p13.3	TPSD1, MCP7L1		Tryptase, delta-1	609272				
16.127	7	1	05	16p13.3	TPSG1, TMT		Tryptase, gamma-1	609341				17(Tpsg1)
16.128	11	02	18	16p13.3	TRAF7, RFWD1, CAFDADD		TNF receptor-associated factor 7	606692			Cardiac, facial, and digital anomalies with developmental delay, 618164 (3)	
16.129	9	8	08	16p13.3	TRAP1, HSP75, HSP90L		Tumor necrosis factor receptor-associated protein 1	606219				
16.130	4	20	17	16p13.3	TSC2, LAM		Tuberin (tuberous sclerosis 2 gene)	191092		somatic mutation identified in 1 FCORD2 patient	Tuberous sclerosis-2, 613254 (3); Lymphangioleiomyomatosis, somatic, 606690 (3); ?Focal cortical dysplasia, type II, somatic, 607341 (3)	17(Tsc2)
16.131	8	1	16	16p13.3	TSR3		TSR3, aminocarboxypropyl transferase ribosome maturation factor	617058				
16.132	2	24	97	16p13.3	UBE2I		Ubiquitin-conjugating enzyme E2I (homologous to yeast UBC9)	601661				
16.133	12	20	05	16p13.3	UBN1		Ubinuclein 1	609771				16(Ubn1)
16.134	4	26	17	16p13.3	UNKL, ZC3H5L, C16orf28		Unkempt family-like zinc finger	617463				
16.135	07	10	20	16p13.2	USP7, HAUSP, HAFOUS		Ubiquitin-specific protease-7, herpes virus-associated	602519			Hao-Fountain syndrome, 616863 (3)	
16.136	8	19	04	16p13.3	VASN		Vasorin	608843				
16.137	01	23	19	16p13.3	WDR90, KIAA1924		WD repeat-containing protein 90	618290				
16.138	3	29	07	16p13.3	WFIKKN1, WFIKKN		WAP, follistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 1	608021				
16.139	6	15	99	16p13.3	ZNF174		Zinc finger protein-174	603900				
16.140	6	18	99	16p13.3	ZNF205, ZNF210		Zinc finger protein-205	603436				
16.141	1	27	04	16p13.3	ZNF213, CR53		Zinc finger protein 213	608387				
16.142	5	25	13	16p13.3	ZNF263		Zinc finger protein 263	604191				
16.143	7	20	12	16p13.3	ZNF597		Zinc finger protein 597	614685				
16.144	6	12	17	16p13.3	ZNF598		Zinc finger protein 598	617508				
16.145	03	25	19	16p13.3	ZSCAN10, ZFP206		Zinc finger- and SCAN domain-containing protein 10	618365				
16.146	9	15	98	16q21	CSNK2A2		Casein kinase-2, alpha-prime polypeptide	115442				8(Csnk2a2)
16.147	6	15	15	16p13.3	NTHL1, OCTS3, FAP3		Endonuclease III, E. coli, homolog of	602656			Familial adenomatous polyposis 3, 616415 (3)	
16.148	4	16	10	16p13.2	PMM2, CDG1A		Phosphomannomutase 2	601785			Congenital disorder of glycosylation, type Ia, 212065 (3)	
16.149	04	03	19	16p13.12	ERCC4, XPF, FANCQ, XFEPS		Excision-repair, complementing defective, in Chinese hamster, number 4	133520			Xeroderma pigmentosum, group F, 278760 (3); XFE progeroid syndrome, 610965 (3); Fanconi anemia, complementation group Q, 615272 (3); Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3)	
16.150	08	20	20	16p13.3	GFER, ERV1, ALR, MPMCD		Growth factor, augmenter of liver regeneration	600924			Myopathy, mitochondrial progressive, with congenital cataract and developmental delay, 613076 (3)	17(Gfer)
16.151	7	27	17	16p13.3	PKD1		Polycystin-1	601313			Polycystic kidney disease 1, 173900 (3)	17(Pkd1)
16.152	5	28	03	16p13.13	LITAF, CMT1C		LPS-induced TNFA factor	603795			Charcot-Marie-Tooth disease, type 1C, 601098 (3)	
16.153	3	30	16	16p13.2	CARHSP1, CRHSP24		Calcium-regulated heat-stable protein 1	616885				
16.154	6	27	14	16p13.13	EMP2, NPHS10		Epithelial membrane protein 2	602334			Nephrotic syndrome, type 10, 615861 (3)	16(Emp2)
16.155	6	4	13	16p13.2	METTL22, C16orf68		Methyltransferase-like 22	615261				
16.156	1	2	03	16p13.13	SOCS1, SSI1, CIS1, CISH1		Suppressor of cytokine signaling 1	603597				
16.157	11	22	10	16p13.2-p13.1	ATF7IP2, MCAF2		Activating transcription factor 7-interacting protein 2	613645				
16.158	2	21	11	16p13.13	BCAR4		Breast cancer antiestrogen resistance 4	613746				
16.159	9	15	10	16p13.13	CLEC16A, KIAA0350		C-type lectin domain family 16, member A	611303				
16.160	4	27	12	16p13.11	MARF1, KIAA0430, LKAP		Meiosis regulator and mRNA stability factor 1	614593				
16.161	7	25	18	16p13.13	RMI2, C16orf75, BLAP18		RecQ-mediated genome instability 2	612426				
16.162	12	02	19	16p13.13	TEKT5		Tektin 5	618686				
16.163	11	29	17	16p13.13	TXNDC11, EFP1		Thioredoxin domain-containing protein 11	617792				
16.164	2	28	06	16p13.11	MYH11, AAT4, FAA4		Myosin, heavy polypeptide-11, smooth muscle	160745		fused with CBFB by inversion in acute myelomonocytic leukemia	Aortic aneurysm, familial thoracic 4, 132900 (3)	16(Myh11)
16.165	1	15	14	16p13.12	CPPED1		Calcineurin-like phosphoesterase domain-containing protein 1	615603				
16.166	7	20	12	16p13.12	MIR193B		Micro RNA 193B	614734				16(Mir193b)
16.167	7	20	12	16p13.12	MIR365A		Micro RNA 365A	614735				16(Mir365a)
16.168	04	17	20	16p13.12	MRTFB, MKL2		Myocardin-related transcription factor B	609463				
16.169	6	1	15	16p13.12	PARN, DAN, DKCB6, PFBMFT4		Polyadenylate-specific ribonuclease	604212			Dyskeratosis congenita, autosomal recessive 6, 616353 (3); Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3)	
16.170	2	26	17	16p13.12	SHISA9, CKAMP44		Shisa family, member 9	613346				16(Shisa9)
16.171	6	10	08	16p12.3	ACSM3, SAH		Acyl-CoA synthetase medium-chain family member 3	145505			{?Hypertension, essential} (1)	
16.172	4	6	18	16p13.13	DEXI, MYLE		Dexamethasone-induced gene	617901				15(Dexi)
16.173	10	11	16	16p13.11	FOPNL, FOR20, C16orf63		FGFR1OP N-terminal domain-like protein	617149				
16.174	9	24	13	16p13.11	NOMO1		Nodal modulator 1	609157				
16.175	9	24	13	16p13.11	NOMO3		Nodal modulator 3	609159				
16.176	8	19	13	16p13.11	NTAN1		N-terminal asparagine amidase	615367				
16.177	9	28	11	16p13.11	PDXDC1, KIAA0251		Pyridoxal-dependent decarboxylase domain-containing protein 1	614244				
16.178	5	12	15	16p12.2	CRYM, DFNA40		Crystallin, mu	123740			Deafness, autosomal dominant 40, 616357 (3)	
16.179	06	22	20	16p13.11	ABCC1, MRP1, MRP, DFNA77		ATP-binding cassette, subfamily C, member 1 (multidrug resistance-associated protein 1)	158343		mutation identified in 1 DFNA77 family	?Deafness, autosomal dominant 77, 618915 (3)	
16.180	2	24	12	16p13.11	ABCC6, ARA, ABC34, MLP1, PXE, GACI2		ATP-binding cassette, subfamily C, member 6	603234			Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum, forme fruste, 177850 (3); Arterial calcification, generalized, of infancy, 2, 614473 (3)	
16.181	8	17	92	16p13.13	GSPT1		G1 to S phase transition-1	139259				
16.182	09	04	19	16p13.11	MPV17L		MPV17 mitochondrial inner membrane protein-like	618100				16(Mpv17l)
16.183	10	13	17	16p13.11	NDE1, NUDE, LIS4, MHAC		nudE neurodevelopment protein 1	609449		mutation identified in 1 MHAC family	Lissencephaly 4 (with microcephaly), 614019 (3); ?Microhydranencephaly, 605013 (3)	
16.184	11	2	01	16p13.11	NPIP		Nuclear pore complex-interacting protein	606406				
16.185	06	15	20	16p11.2	C16orf92, FIMP		Chromosome 16 open reading frame 92	618911				
16.186	2	22	07	16p13.13	NUBP1, NBP		Nucleotide-binding protein 1	600280				16(Nubp1)
16.187	12	18	98	16p13.13	TNFRSF17, BCMA		Tumor necrosis factor receptor superfamily, member 17 (B-cell maturation factor)	109545				
16.188	5	22	14	16p12.3	XYLT1, XT1, DBQD2		Xylosyltransferase 1	608124			{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3); Desbuquois dysplasia 2, 615777 (3)	
16.189	11	2	01	16p12.1	CACNG3		Calcium channel, voltage-dependent, gamma-3 subunit	606403				
16.190	8	21	91	16p12.2	CDR2		Cerebellar degeneration-related antigen-2, 62kD	117340				7(Cdr2)
16.191	1	13	16	16p12.3	COQ7, CLK1, COQ10D8		COQ7, S. cerevisiae, homolog of	601683		mutation identified in 1 COQ10D8 patient	?Coenzyme Q10 deficiency, primary, 8, 616733 (3)	
16.192	6	18	99	16p13.12	PLA2G10, SPLA2, GXSPLA2		Phospholipase A2, group X	603603				
16.193	12	30	09	16p11.2	TAOK2, TAO2, KIAA0881, PSK, PSK1		Tao kinase 2	613199				
16.194	11	19	12	16p12.2	EARS2, KIAA1970, COXPD12		Glutamyl-tRNA synthetase 2	612799			Combined oxidative phosphorylation deficiency 12, 614924 (3)	
16.195	1	31	01	16p11.2	MVP, LRP		Major vault protein, rat, homolog of	605088				
16.196	9	22	04	16p13	ADHD1		Attention deficit-hyperactivity disorder, susceptibility to, 1	608903		max lod at D16S3114	{Attention deficit-hyperactivity disorder}, 143465 (2)	
16.197	10	08	08	16p13	BMIQ5		Body mass index quantitative trait locus 5	608558		near D16S404 and D16S764	[Body mass index QTL5] (2)	
16.198	10	4	16	16p13.13	CIITA, MHC2TA, C2TA		Class II major histocompatibility complex transactivator	600005			Bare lymphocyte syndrome, type II, complementation group A, 209920 (3); {Rheumatoid arthritis, susceptibility to}, 180300 (3)	
16.199	11	19	13	16p13.2	GRIN2A, NMDAR2A, FESD, LKS		Glutamate receptor, ionotropic, N-methyl D-aspartate 2A	138253			Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3)	
16.200	2	8	16	16p13.3	CLUAP1, QILIN, FAP22, KIAA0643		Clusterin-associated protein 1	616787				
16.201	08	19	19	16p13.3	CLCN7, CLC7, OPTA2, OPTB4, HOD		Chloride channel-7	602727			Osteopetrosis, autosomal recessive 4, 611490 (3); Osteopetrosis, autosomal dominant 2, 166600 (3); Hypopigmentation, organomegaly, and delayed myelination and development, 618541 (3)	
16.202	7	1	11	16p13.3	HAGH, GLO2		Hydroxyacyl glutathione hydrolase; glyoxalase II	138760			[Glyoxalase II deficiency], 614033 (1)	
16.203	8	30	01	16p12.2	IGSF6, DORA		Immunoglobulin superfamily, member 6	606222				7(Igsf6)
16.204	06	15	20	16p13.3	MEFV, MEF, FMF, PAAND		MEFV innate immunity regulator, pyrin	608107		between D16S80 and D16S283	Familial Mediterranean fever, AR, 249100 (3); Familial Mediterranean fever, AD, 134610 (3); Neutrophilic dermatosis, acute febrile, 608068 (3)	16(Mefv)
16.205	5	26	13	16p13.3	NOXO1		NADPH oxidase organizer 1	611256				17(Noxo1)
16.206	11	5	98	16p13.3	OR1F1, OLFMF		Olfactory receptor, family 1, subfamily F, member 1	603232				
16.207	8	10	98	16p13.3	PPL		Periplakin	602871				16(Ppl)
16.208	9	8	11	16p13.3	RBFOX1, 2BP1, FOX1, HRNBP1		RNA-binding protein FOX1, C. elegans, homolog of, 1	605104				
16.209	7	17	14	16p13.13	RSL1D1, CSIG, PBK1		Ribosomal L1 domain-containing protein 1	615874				
16.210	9	15	98	16p13.13	SNN		Stannin	603032				16(Snn)
16.211	8	24	09	16p13.3	TIGD7, SANCHO		Tigger transposable element-derived gene 7	612969				
16.212	5	16	17	16p11.2	TP53TG3		TP53 target gene 3	617482				
16.213	11	5	98	16p13.3	ZNF200		Zinc finger protein-200	603231				
16.214	7	19	06	16p13-p12	IHPS2		Pyloric stenosis, infantile hypertrophic, 2	610260			Pyloric stenosis, infantile hypertrophic, 2 (2)	
16.215	08	24	20	16p12.2	SCNN1B, BESC1, LIDLS1		Sodium channel, epithelial 1, subunit beta	600760			Liddle syndrome 1, 177200 (3); Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)	7(Scnn1b)
16.216	08	24	20	16p12.2	SCNN1G, PHA1, BESC3, LDLS2		Sodium channel, epithelial 1, subunit gamma	600761		same 400kb fragment as SCNN1B	Liddle syndrome 2, 618114 (3); Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)	7(Scnn1g)
16.217	10	15	95	16p13.3	TFAP4		Transcription factor AP-4 (activating enhancer-binding protein 4)	600743				16(Tfp4)
16.218	12	1	11	16p12.3	ACSM1, MACS1		Acyl-CoA synthetase medium-chain family, member 1	614357				
16.219	12	1	11	16p12.3	ACSM2A		Acyl-CoA synthetase medium-chain family, member 2A	614358				
16.220	12	1	11	16p12.3	ACSM2B, HXMA		Acyl-CoA synthetase medium-chain family, member 2B	614359				
16.221	12	1	11	16p12.3	ACSM5		Acyl-CoA synthetase medium-chain family, member 5	614361				
16.222	4	8	13	16p12.3	CCP110, CP110, KIAA0419		Centrosomal coiled-coil protein, 110kD	609544				
16.223	1	8	15	16p12.3	DCUN1D3, SCCRO3		DCN1 domain-containing protein 3	616167				
16.224	2	1	11	16p12.3	GP2		Glycoprotein 2, zymogen granule membrane	602977		previously assigned to chr.9		
16.225	05	24	19	16p12.3	GPR139, GPRG1		G protein-coupled receptor 139	618448				
16.226	7	11	12	16p12.3	LYRM1		LYR motif-containing protein 1	614709				
16.227	9	24	13	16p12.3	NOMO2		Nodal modulator 2	609158				
16.228	09	13	19	16p12.3	PDILT, PDIA7		Protein disulfide isomerase-like protein, testis-expressed, 618588 (3)	618588				
16.229	02	08	19	16p12.3	RPS15A, DBA20		Ribosomal protein S15a	603674		mutation identified in 1 DBA20 family	?Diamond-Blackfan anemia 20, 618313 (3)	
16.230	11	23	16	16p12.3	TMC5		Transmembrane channel-like protein 5	617197				7(Tmc5)
16.231	11	23	16	16p12.3	TMC7		Transmembrane channel-like protein 7	617198				7(Tmc7)
16.232	4	6	15	16p12.3	TMEM159		Transmembrane protein 159	611304				
16.233	12	1	15	16p12.3	THUMPD1		THUMP domain-containing protein 1	616662				
16.234	11	3	09	16p12.3	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2		Uromodulin (uromucoid, Tamm-Horsfall glycoprotein)	191845			Hyperuricemic nephropathy, familial juvenile 1, 162000 (3); Medullary cystic kidney disease 2, 603860 (3); Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	7(Umod)
16.235	08	11	20	16p12.3	VPS36L, C16orf62, EC97		VPS35 endosomal protein-sorting factor-like	618981				
16.236	5	7	01	16p12.3	GPRC5B, RAIG2		G protein-coupled receptor, family C, group 5, member B	605948				
16.237	4	21	10	16p12.1	LCMT1		Leucine carboxyl methyltransferase 1	610286				
16.238	6	15	99	16p12.2	NDUFAB1		NADH-ubiquinone oxidoreductase subunit AB1	603836				
16.239	5	12	98	16p12.3-p12.1	RP22		Retinitis pigmentosa-22	602594			Retinitis pigmentosa 22 (2)	
16.240	02	26	19	16p12.3-q12.2	SLEB6		Systemic lupus erythematosus, susceptibility to, 6	609939			{Systemic lupus erythematosus, susceptibility to, 6} (2)	
16.241	3	9	10	16p12.2	ANKS4B, HARP, FLJ38819		Ankyrin repeat and sterile alpha motif domain-containing protein 4B	609901				7(Harp)
16.242	3	14	07	16p12.1	ARHGAP17, RICH1		RHO GTPase-activating protein 17	608293				
16.243	9	10	09	16p12.2	DCTN5, p25		Dynactin 5	612962				
16.244	12	10	13	16p12.2	ERN2		Endoplasmic reticulum-to-nucleus signaling 2	604034				7(Ern2)
16.245	12	6	16	16p12.2	METTL9, DREV		Methyltransferase-like 9	609388				
16.246	9	27	17	16p12.2	PLK1, STPK13		Polo-like kinase 1	602098				
16.247	12	22	17	16p12.2	POLR3E, SIN, KIAA1452		Polymerase III, RNA, subunit E	617815				
16.248	6	18	02	16p12.2	OTOA, DFNB22		Otoancorin	607038			Deafness, autosomal recessive 22, 607039 (3)	
16.249	11	1	10	16p12.2-p11.2	DEL16p12.1p11.2, C16DELp12.1p11.2		Chromosome 16p12.2-p11.2 deletion syndrome	613604		17.1-8.7 Mb contiguous gene deletion syndrome	Chromosome 16p12.2-p11.2 deletion syndrome (4)	
16.250	9	25	12	16p12.2-q12.1	MRT10, MRT20		611096	611096		between rs724466 and rs3901517, rs7197568 and rs71972227	Mental retardation, autosomal recessive 10/20 (2)	
16.251	03	20	20	16p12.1	CLN3, BTS		CLN3 lysosomal/endosomal transmembrane protein, Battenin	607042			Ceroid lipofuscinosis, neuronal, 3, 204200 (3)	7(Cln3)
16.252	10	25	16	16p12.1	GSG1L		GSG1-like protein	617161				
16.253	7	17	14	16p12.1	GTF3C1		General transcription factor 3C, polypeptide 1	603246				
16.254	2	8	18	16p12.1	KATNIP, KIAA0556		Katanin-interacting protein	616650			Joubert syndrome 26, 616784 (3)	
16.255	5	16	18	16p12.1	KDM8, JMJD5		Lysine demethylase 8	611917				
16.256	01	21	20	16p12.1	NSMCE1, NSE1		NSE1 homolog, SMC5-SMC6 complex component	617263				
16.257	3	23	14	16p11.2	PYDC1, POP1, PYC1, ASC2		Pyrin domain-containing protein 1	615700				
16.258	5	24	13	16p12.1	SLC5A11, KST1, SGLT6, SMIT2		Solute carrier family 5 (sodium/glucose cotransporter), member 11	610238				
16.259	1	27	04	16p12.1	XPO6, EXP6, KIAA0370		Exportin 6	608411				
16.260	3	20	06	16p12.1	IL4R, IL4RA		Interleukin-4 receptor	147781			{Atopy, susceptibility to}, 147050 (3); {AIDS, slow progression to}, 609423 (3)	7(Il4r)
16.261	1	11	07	16p12.1-p11.2	MMVP1, MVP, PMV		Mitral valve prolapse, myxomatous 1	157700			Mitral valve prolapse, myxomatous 1 (2)	
16.262	1	9	09	16p11.2	PHKG2, GSD9C		Phosphorylase kinase, gamma 2 (testis/liver)	172471			Glycogen storage disease IXc, 613027 (3); Cirrhosis due to liver phosphorylase kinase deficiency (3)	
16.263	5	27	97	16p11.2	SULT1A1, STP1, STP, PST		Sulfotransferase family 1A, phenol-preferring, member 1	171150				7(Stp)
16.264	8	18	99	16p11.2	SULT1A2, STP2		Sulfotransferase family 1A, phenol-preferring, member 2	601292		45kb from STP1		7(Stp)
16.265	10	8	96	16p11.2	ATP2A1, SERCA1		ATPase, Ca++ transporting, fast-twitch, 1	108730			Brody myopathy, 601003 (3)	7(Atp2a1)
16.266	5	4	12	16p12	DEL16p12.1, C16DELp12.1		Chromosome 16p12.1 deletion syndrome, 520kb	136570		between 21.85-22.37 Mb	Chromosome 16p12.1 deletion syndrome, 520kb (4)	
16.267	4	27	01	16p12.3	DNAH3, DNAHC3B		Dynein, axonemal, heavy chain 3	603334				
16.268	6	6	00	16p12.2	HS3ST2, 30ST2		Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 2	604056				7(30st2)
16.269	10	5	07	16p12	MAFD4, BPAD		Major affective disorder 4	611247		max lod at D16S769	Major affective disorder 4 (2)	
16.270	4	22	10	16p12.2	PALB2, FANCN, PNCA3		Partner and localizer of BRCA2	610355			Fanconi anemia, complementation group N, 610832 (3); {Breast cancer, susceptibility to}, 114480 (3); {Pancreatic cancer, susceptibility to, 3}, 613348 (3)	
16.271	9	14	05	16p13.11	RRN3, TIFIA		RRN3, S. cerevisiae, homolog of	605121				
16.272	07	16	20	16p12.3	SMG1, LIP, KIAA0421		SMG1 nonsense-mediated mRNA decay-associated PI3K-related kinase	607032				
16.273	8	11	18	16p12.1	TNRC6A, GW182, KIAA1460, FAME6		Trinucleotide repeat-containing gene 6A	610739		mutation identified in 1 FAME6 family	?Epilepsy, familial adult myoclonic, 6, 618074 (3)	
16.274	3	8	13	16p12.2	UQCRC2, MC3DN5		Ubiquinol-cytochrome c reductase core protein II	191329			Mitochondrial complex III deficiency, nuclear type 5, 615160 (3)	
16.275	03	08	19	16p12.3-p12.2	ZP2, OOMD6		Zona pellucida glycoprotein 2	182888			Oocyte maturation defect 6, 618353 (3)	
16.276	5	2	01	16p12.1	AQP8		Aquaporin 8	603750				7(Aqp8)
16.277	12	04	20	16p12.3	ARL6IP1, KIAA0069, SPG61		ADP ribosylation factor-like GTPase 6 interacting protein 1	607669		mutation identified in 1 family	?Spastic paraplegia 61, autosomal recessive, 615685 (3)	7(Arl6ip)
16.278	2	17	09	16p12.3	GDE1, MIR16		Glycerophosphodiester phosphodiesterase 1	605943				
16.279	2	15	12	16p11.2	HSD3B7, CBAS1		3-beta-hydroxy-delta-5-C27-steroid oxidoreductase	607764			Bile acid synthesis defect, congenital, 1, 607765 (3)	
16.280	4	10	02	16p11.2	PYCARD, TMS1, ASC		PYD and CARD domain-containing protein (target of methylation-induced silencing 1)	606838				
16.281	8	4	98	16p12.1	RBBP6		Retinoblastoma-binding protein-6	600938				
16.282	1	13	99	16p11.2	PPP4C, PP4, PPX		Protein phosphatase 4, catalytic subunit	602035				
16.283	8	24	09	16p11.2	ALDOA, GSD12		Aldolase A, fructose-bisphosphatase	103850		pseudogenes on 3 and 10	Glycogen storage disease XII, 611881 (3)	
16.284	6	3	14	16p12.1	APOBR, APOB48R		Apolipoprotein B receptor	605220				
16.285	8	22	14	16p11.2	ARMC5, AIMAH2		Armadillo repeat-containing protein 5	615549			ACTH-independent macronodular adrenal hyperplasia 2, 615954 (3)	
16.286	11	12	12	16p11.2	BCKDK, BDK, BCKDKD		Branched-chain alpha-keto acid dehydrogenase kinase	614901			Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3)	
16.287	4	26	10	16p11.2	CCDC101, STAF36		Coiled-coil domain-containing protein 101	613374				
16.288	12	15	10	16p11.2	CD19, CVID3		CD19 antigen	107265			Immunodeficiency, common variable, 3, 613493 (3)	
16.289	11	11	14	16p11.2	CD2BP2		CD2 antigen-binding protein 2	604470				
16.290	02	08	19	16p11.2	CCDC189, C16orf93		Coiled-coil domain-containing protein 189	618318				
16.291	9	12	13	16p11.2	CORO1A, TACO, CLIPINA, IMD8		Coronin 1A	605000			Immunodeficiency 8, 615401 (3)	
16.292	10	23	20	16p11.2	COX6A2, MC4DN18		Cytochrome c oxidase, subunit 6A2	602009			Mitochondrial complex IV deficiency, nuclear type 18, 619062 (3)	7(Cox6a2)
16.293	12	6	11	16p11.2	BMIQ16, DEL16p.11.2, C16DELp11.2		Chromosome 16p11.2 deletion syndrome, 220kb	613444			Chromosome 16p11.2 deletion syndrome, 220kb (4); [Body mass index QTL16] (4)	
16.294	7	18	14	16p11.2	DCTPP1		dCTP pyrophosphatase 1	615840				
16.295	6	7	12	16p11.2	DEL16p11.2, C16DELp11.2, AUTS14A		Chromosome 16p11.2 deletion syndrome, 593kb	611913			Chromosome 16p11.2 deletion syndrome, 593kb (4); {Autism susceptibility 14A} (2)	
16.296	6	7	12	16p11.2	DUP16p11.2, C16DUPp11.2, AUTS14B		Chromosome 16p11.2 duplication syndrome	614671			Chromosome 16p11.2 duplication syndrome (4); {Autism, susceptibility to, 14B} (2)	
16.297	1	12	07	16p11.2	DOC2A		Double C2-like domain-containing protein, alpha	604567				
16.298	10	3	07	16p11.2	EIF3C, EIF3S8		Eukaryotic translation initiation factor 3, subunit C	603916				
16.299	1	25	05	16p11.2	ERAF, EDRF, AHSP		Erythroid-associated factor (alpha-hemoglobin stabilizing protein)	605821				
16.300	4	17	13	16p11.2	FAM57B		Family with sequence similarity 57, member B	615175				
16.301	1	11	16	16p11.2	FBRS, FBS1		Fibrosin	608601				
16.302	7	1	11	16p11.2	FBXL19, FBL19		F-box and leucine-rich repeat protein 19	609085				
16.303	11	22	17	16p11.2	FUS, TLS, ALS6, ETM4		Fusion, derived from 12-16 translocation, malignant liposarcoma	137070		fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3); Essential tremor, hereditary, 4, 614782 (3)	
16.304	4	22	15	16p11.2	GDPD3, GDE7		Glycerophosphodiester phosphodiesterase domain-containing protein 3	616318				
16.305	7	20	12	16p11.2	HIRIP3		HIRA-interacting protein 3	603365				
16.306	6	6	00	16p12.1	HS3ST4, 30ST4		Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 4	604059				7(30st4)
16.307	3	31	98	16p11.2	ITGAD, CD11D		Integrin, alpha D	602453				
16.308	6	11	92	16p11.2	ITGAL, CD11A, LFA1A		Integrin, alpha-L (antigen CD11A (p180), lymphocyte function-associated antigen-1, alpha polypeptide)	153370				7(Ly15)
16.309	02	26	19	16p11.2	ITGAM, CR3A, CD11B, MAC1A, SLEB6		Integrin, alpha-M (complement component receptor-3, alpha; antigen CD11B (p170); macrophage antigen, alpha polypeptide)	120980		?in same restriction fragment as LFA1A		
16.310	1	9	94	16p11.2	ITGAX, CD11C		Integrin, alpha-X (antigen CD11C (p150), alpha polypeptide)	151510				
16.311	08	12	20	16p11.2	KAT8, MYST1, MOF, LIGOWS		K(lysine) acetyltransferase 8	609912			Li-Ghorgani-Weisz-Hubshman syndrome, 618974 (3)	
16.312	10	1	04	16p11.2	KCTD13, POLDIP1, FKSG86		Potassium channel tetramerization domain-containing 13	608947				
16.313	1	25	12	16p11.2	KIF22, KNSL4, KID, OBP, SEMDJL2		Kinesin family member 22	603213			Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	
16.314	6	8	17	16p11.2	LAT, IMD52		Linker for activation of T cells	602354			Immunodeficiency 52, 617514 (3)	
16.315	5	19	97	16p11.2	MAPK3, PRKM3, ERK1		Mitogen-activated protein kinase 3	601795				7(Prkm3)
16.316	10	26	98	16p11.2	MAZ, ZF87, PUR1		MYC-associated zinc finger protein	600999				
16.317	12	01	20	16p11.2	MYLPF, MLC2B, MRLC2, MYL11, DA1C		Myosin light chain, phosphorylatable, fast skeletal muscle	617378			Arthrogryposis, distal, type 1C, 619110 (3)	
16.318	3	30	12	16p11.2	NFATC2IP, NIP45		NFATC2-interacting protein	614525				
16.319	9	10	12	16p11.2	NUPR1, COM1, p8		Nuclear protein, transcriptional regulator, 1	614812				
16.320	7	22	09	16p11.2	ORAI3, TMEM142C		ORAI calcium release-activated calcium modulator 3	610930				
16.321	7	14	14	16p11.2	PAGR1, C16orf53, PA1		PAXIP1-associated glutamate-rich protein 1	612033				
16.322	8	13	91	16p12.2-p12.1	PRKCB1, PKCB		Protein kinase C, beta 1 polypeptide	176970				
16.323	4	20	17	16p11.2	PRR14		Proline-rich protein 14	617423				
16.324	11	21	12	16p11.2	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA		Proline-rich transmembrane protein 2	614386			Episodic kinesigenic dyskinesia 1, 128200 (3); Seizures, benign familial infantile, 2, 605751 (3); Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	
16.325	5	26	13	16p11.2	PRSS53, POL3S		Protease, serine, 53	610561				
16.326	4	1	96	16p11.2	PRSS8		Protease, serine, 8 (prostasin)	600823				
16.327	5	26	13	16p11.2	PRSS36		Protease, serine, 36	610560				
16.328	7	9	06	16p11.2	QPRT		Quinolinate phosphoribosyltransferase	606248				
16.329	10	2	13	16p11.2	RABEP2		RAB GTPase-binding effector protein 2	611869				
16.330	4	21	14	16p11.2	RNF40, BRE1B, RBP95, KIAA0661		Ring finger protein 40	607700				
16.331	2	15	12	16p11.2	SRCAP, SWR1, KIAA0309, FLHS		SNF2-related CBP activator protein	611421			Floating-Harbor syndrome, 136140 (3)	
16.332	2	1	11	16p11.2	SEPHS2, SPS2		Selenophosphate synthetase 2	606218				7(Sps2)
16.333	7	22	09	16p11.2	SEPT1, DIFF6		Septin 1	612897				
16.334	10	20	20	16p11.2	SETD1A, SET1A, SET1, KIAA0339, EPEDD, NEDSID		SET domain-containing protein 1A	611052			Epilepsy, early-onset, with or without developmental delay, 618832 (3); Neurodevelopmental disorder with speech impairment and dysmorphic facies, 619056 (3)	
16.335	12	1	15	16p11.2	SEZ6L2, BSRPA		SEZ6-like protein 2	616667				
16.336	6	3	14	16p11.2	SH2B1, SH2B, KIAA1299		SH2B adaptor protein 1	608937				7(Sh2b)
16.337	12	10	02	16p11.2	SLC5A2, SGLT2		Solute carrier family 5 (sodium/glucose cotransporter), member 2	182381			Renal glucosuria, 233100 (3)	
16.338	10	10	19	16p11.2	SLX1A, GIYD1		SLX1 homolog A, structure-specific endonuclease subunit	615822				
16.339	10	10	19	16p11.2	SLX1B, GIYD2		SLX1 homolog B, structure-specific endonuclease subunit	615823				
16.340	10	12	90	16p11.2	SPN, LSN, CD43		Sialophorin (leukosialin)	182160				7(Ly48)
16.341	2	17	09	16p11.2	SPNS1, SPIN1		Spinster, Drosophila, homolog of, 1	612583				
16.342	1	21	11	16p11.2	STX4, STX4A		Syntaxin 4	186591				
16.343	8	18	99	16p11.2	SULT1A3, STM		Sulfotransferase family 1A, phenol-preferring, member 3	600641				
16.344	7	14	14	16p11.2	SULT1A4		Sulfotransferase family 1A, cytosolic, phenol-preferring, member 4	615819				
16.345	1	12	15	16p11.2	STX1B, GEFSP9		Syntaxin 1B	601485			Generalized epilepsy with febrile seizures plus, type 9, 616172 (3)	
16.346	1	27	11	16p11.2	TBC1D10B		TBC1 domain family, member 10B	613620				
16.347	9	24	15	16p11.2	TBX6, SCDO5		T-box 6	602427			Spondylocostal dysostosis 5, 122600 (3)	7(Tbx6)
16.348	4	23	09	16p11.2	TGFB1I1, ARA55, HIC5		Transforming growth factor, beta-1-induced 1	602353				
16.349	3	9	10	16p11.2	TRIM72, MG53		Tripartite motif-containing protein 72	613288				
16.350	1	5	07	16p11.2	TUFM, EFTU, COXPD4		Tu translation elongation factor, mitochondrial	602389		pseudogene on chr.17	Combined oxidative phosphorylation deficiency 4, 610678 (3)	
16.351	4	21	04	16p11.2	VKORC1, VKOR, VKCFD2, FLJ00289		Vitamin K epoxide reductase complex, subunit 1	608547			Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3); Warfarin resistance, 122700 (3)	
16.352	12	28	08	16p11.2	YPEL3		Yippee-like 3	609724				7(Ypel3)
16.353	1	26	17	16p11.2	ZG16, ZG16A, JCLN1		Zymogen granule protein, 16-kD	617311				
16.354	9	1	16	16p11.2	ZNF668		Zinc finger protein 668	617103				
16.355	6	28	18	16p11.2	ZNF768		Zinc finger protein 768	618032				
16.356	6	28	18	16p11.2	ZNF689, TIPUH1		Zinc finger protein 689	618033				
16.357	1	31	01	16p11.2	CTF1, CT1		Cardiotrophin 1	600435				
16.358	7	21	14	16p11	INV16p11		Chromosome 16p11 inversion (0.45Mb)	615835				
16.359	11	5	04	16p11.2	ATXN2L, A2D		Ataxin 2-like	607931		pseudogene at 7p21		
16.360	4	17	01	16p11.2	BCL7C		B-cell CLL/lymphoma 7C	605847				
16.361	3	13	18	16p12.1	IL21R, IMD56		Interleukin 21 receptor	605383		fusion partner with BCL6	[IgE, elevated level of], 147050 (3); Immunodeficiency 56, 615207 (3)	
16.362	3	22	07	16p12.1-p11.2	IL27, IL30		Interleukin 27	608273				
16.363	7	7	04	16p12.2	COG7, CDG2E		Component of oligomeric golgi complex 7	606978			Congenital disorder of glycosylation, type IIe, 608779 (3)	
16.364	3	13	08	16p13.3	GNPTAG		N-acetylglucosamine-1-phosphotransferase, gamma subunit	607838			Mucolipidosis III gamma, 252605 (3)	
16.365	1	31	02	16p	IBD8		Inflammatory bowel disease 8	606668			{Inflammatory bowel disease 8} (2)	
16.366	8	30	02	16q21	CX3CL1, SCYD1, NTT, NTN		Chemokine, C-X3-C motif, ligand 1 (fractalkine; neurotactin)	601880				8(Ntt)
16.367	1	22	07	16q	PSORS8		Psoriasis susceptibility 8	610707		proximal to D16S3034	{Psoriasis susceptibility 8} (2)	
16.368	2	27	02	16q	SLI1		Specific language impairment QTL, 1	606711			Specific language impairment QTL, 1 (2)	
16.369	9	2	96	16q	WT3		Wilms tumor-3	194090		loss of heterozygosity	Wilms tumor, type 3 (2)	
16.370	7	23	03	16q12.1	NEOT2		Neuropilin and tolloid like 2	607974				
16.371	2	12	07	16q11-q22	AA2		Alopecia areata 2	610753		max lod at D16S415	Alopecia areata 2 (2)	
16.372	12	9	05	16q11.1-q22	DUPC1		Dupuytren contracture 1	126900		max lod at D16S415	Dupuytren contracture 1 (2)	
16.373	08	23	19	16p11.2	BOLA2		bolA family member 2	613182				
16.374	7	10	08	16q11.2	MYLK3, MLCK		Myosin light chain kinase 3	612147				8(Mylk3)
16.375	12	27	19	16q11.2	VPS35, MEM3, PARK17		VPS35 retromer complex component	601501			{Parkinson disease 17}, 614203 (3)	8(Mem3)
16.376	8	20	07	16q11.2	SHCBP1, PAL		SHC SH2 domain-binding protein 1	611027				
16.377	7	12	12	16q12.2	IRX5, HMMS		Iroquois homeo box protein 5	606195			Hamamy syndrome, 611174 (3)	
16.378	7	8	03	16q12.2	IRX6, IRX7		Iroquois homeo box protein 6	606196				
16.379	04	27	20	16q12.1	NKD1		NKD inhibitor of WNT signaling pathway 1	607851				
16.380	03	09	20	16q12.1	NOD2, CARD15, IBD1, CD, YAOS, BLAUS		Nucleotide-binding oligomerization domain protein 2	605956			{Inflammatory bowel disease 1, Crohn disease}, 266600 (3); Blau syndrome, 186580 (3); {Yao syndrome}, 617321 (3)	
16.381	12	23	19	16q11.2	ORC6, ORC6L		Origin recognition complex, subunit 6	607213			Meier-Gorlin syndrome 3, 613803 (3)	
16.382	5	28	98	16q12.1	SIAH1		Seven in absentia, Drosophila, homolog of, 1	602212				
16.383	10	25	12	16q12.1	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19		Zinc finger protein 423	604557			Nephronophthisis 14, 614844 (3); Joubert syndrome 19, 614844 (3)	8(Zfp423)
16.384	3	21	95	16q12.1	ADCY7		Adenylate cyclase-7	600385				
16.385	6	17	08	16q12.1	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS		CYLD gene	605018		behaves as tumor suppressor	Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome, 605041 (3); Trichoepithelioma, multiple familial, 1, 601606 (3)	
16.386	2	10	00	16q12.1	PHKB		Phosphorylase kinase, beta polypeptide	172490			Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)	
16.387	1	27	11	16q12.1	ABCC11, MRP8, EWWD, WW		ATP-binding cassette, subfamily C, member 11	607040			[Earwax, wet/dry], 117800 (3); [Axillary odor, variation in], 117800 (3); [Colostrum secretion, variation in], 117800 (3)	
16.388	6	28	02	16q12.1	ABCC12, MRP9		ATP-binding cassette, subfamily C, member 12	607041				
16.389	12	23	19	16q12.1	BRD7, BP75		Bromodomain-containing protein 7	618489				
16.390	3	20	16	16q12.1	CNEP1R1, NEP1R1, TMEM188		C-terminal domain nuclear envelope phosphatase 1 regulatory subunit 1	616869				
16.391	08	11	20	16q12.1	CBLN1		Precerebellin 1	600432				8(Cbln1)
16.392	11	4	08	16q11.2	DNAJA2, DJ3, CPR3		DNAJ/HSP40 homolog, subfamily A, member 2	611322				
16.393	11	06	20	16q11.2	GPT2, ALT2, NEDSPM		Glutamate pyruvate transaminase 2	138210			Neurodevelopmental disorder with microcephaly and spastic paraplegia, 616281 (3)	
16.394	12	17	12	16q12.1	HEATR3, SYO1		HEAT repeat-containing protein 3	614951				
16.395	2	23	08	16q12.1	ITFG1, TIP		Integrin-alpha FG-gap repeat-containing protein 1	611803				
16.396	11	14	17	16q12.1	LONP2, PLON, PSLON		LON peptidase 2, peroxisomal	617774				
16.397	6	29	04	16q12.1	SALL1, HSAL1, TBS		Sal-like 1	602218			Townes-Brocks syndrome 1, 107480 (3); Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	8(Sall1)
16.398	2	25	10	16q12.1	SNX20, SLIC1		Sorting nexin 20	613281				
16.399	4	24	09	16q12.1	STHAG2, HYD2		Tooth agenesis, selective, 2	602639			Tooth agenesis, selective, 2 (2)	
16.400	5	9	18	16q12.1	TENT4B, PAPD5, TUT3		Terminal nucleotidyltransferase 4B	605540				
16.401	11	07	19	10p15.3	WDR37, NOCGUS		WD repeat-containing protein 37	618586			Neurooculocardiogenitourinary syndrome, 618652 (3)	
16.402	6	7	12	16q12.1-q23.1	STUT4		Stuttering, familial persistent, 4	614668		max lod at D16S3043	Stuttering, familial persistent, 4 (2)	
16.403	5	21	07	16q12.2	AKTIP, FTS, FT1		AKT-interacting protein	608483				
16.404	11	22	19	16q12.2	CES5A, CAUXIN		Carboxylesterase 5A	618678				
16.405	5	2	16	16q12.2	CHD9, CREMM, PRIC320, KIAA0308		Chromodomain helicase DNA-binding protein 9	616936				
16.406	2	13	14	16q12.2	CRNDE		Colorectal neoplasia differentially expressed gene, noncoding	615624				
16.407	10	28	19	16q12.2	FTO, GDFD, BMIQ14		FTO alpha-ketoglutarate dependent dioxygenase	610966			Growth retardation, developmental delay, facial dysmorphism, 612938 (3); {Obesity, susceptibility to, BMIQ14}, 612460 (3)	
16.408	9	2	09	16q12.2	IRX3, IRXB1		Iroquois homeobox protein 3	612985				
16.409	6	9	08	16q12.2	LPCAT1, AYTL1		Lysophosphatidylcholine acyltransferase 2	612040				
16.410	6	13	16	16q13	NUDT21, CPSF5, CFIM25		Nudix hydrolase 21	604978				
16.411	12	01	20	16q12.2	RPGRIP1L, KIAA1005, JBTS7, MKS5, COACH3		RPGRIP1-like	610937		mutation identified in 1 COACH patient	Joubert syndrome 7, 611560 (3); Meckel syndrome 5, 611561 (3); ?COACH syndrome 3, 619113 (3)	
16.412	10	30	18	16q12.2	SLC6A2, NAT1, NET1		Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, cocaine- and antidepressant-sensitive	163970		mutation identified in 1 ORSTI family	?Orthostatic intolerance, 604715 (3)	8(Slc6a2)
16.413	5	23	94	16q12.2	RBL2		Retinoblastoma-like 2	180203				
16.414	9	16	03	16q13	HERPUD1, MIF1, HERP, KIAA0025		Homocysteine- and endoplasmic reticulum stress-inducible protein, ubiquitin-like domain-containing, 1	608070				
16.415	9	1	16	16q21	ADGRG1, GPR56, TM7XN1, BFPP, BPPR		Adhesion G protein-coupled receptor G1	604110			Polymicrogyria, bilateral frontoparietal, 606854 (3); Polymicrogyria, bilateral perisylvian, 615752 (3)	8(Gpr56)
16.416	12	04	20	16q13	ARL2BP, BART		ADP ribosylation factor-like GTPase 2 binding protein	615407			Retinitis pigmentosa with or without situs inversus, 615434 (3)	
16.417	8	29	02	16q21	CCL17, SCYA17, TARC		Chemokine, C-C motif, ligand 17	601520				
16.418	8	29	02	16q21	CCL22, SCYA22		Chemokine, C-C motif, ligand 22	602957				
16.419	5	25	13	16q13	CPNE2, CPN2		Copine II	604206				
16.420	5	24	12	16q21	COQ9, C16orf49, COQ10D5		Coq9, S. cerevisiae, homolog of	612837			Coenzyme Q10 deficiency, primary, 5, 614654 (3)	
16.421	12	11	03	16q21	DOK4		Docking protein 4	608333				
16.422	11	10	17	16q13	FAM192A, NIP30, C16orf94		Family with sequence similarity 192, member A	617766				8(Fam192a)
16.423	10	23	20	16q13	GNAO1, DEE17, NEDIM		Guanine nucleotide-binding protein (G protein), alpha-activating activity	139311		close to MT1 in mouse	Developmental and epileptic encephalopathy 17, 615473 (3); Neurodevelopmental disorder with involuntary movements, 617493 (3)	8(Gnao1)
16.424	6	7	10	16q13	MIR138-2, MIRN138-2		Micro RNA 138-2	613395				
16.425	11	1	13	16q12.2	MMP2, CLG4A, MONA		Matrix metalloproteinase 2 (gelatinase A, 72kD type IV collagenase)	120360		near MT1,2	Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3)	8(Mmp2)
16.426	2	23	92	16q13	MT1A		Metallothionein 1A (functional)	156350		proximal to FRA16B		8(Mt1)
16.427	2	23	92	16q13	MT1B		Metallothionein 1B (functional)	156349				
16.428	2	23	92	16q13	MT1E		Metallothionein 1E (functional)	156351				
16.429	2	23	92	16q13	MT1F		Metallothionein 1F (functional)	156352				
16.430	2	23	92	16q13	MT1G		Metallothionein 1G	156353				
16.431	2	23	92	16q13	MT1H		Metallothionein 1H	156354				
16.432	2	23	92	16q13	MT1I		Metallothionein 1I	156355				
16.433	2	23	92	16q13	MT1J		Metallothionein 1J	156356				
16.434	2	23	92	16q13	MT1K		Metallothionein 1K	156357				
16.435	2	23	92	16q13	MT1L		Metallothionein 1L	156358				
16.436	2	23	92	16q13	MT1X		Metallothionein 1X	156359				
16.437	2	23	92	16q13	MT2A, MT2		Metallothionein 2A	156360		pseudogene MT2P1 on 4cen-q21		8(Mt2)
16.438	12	16	93	16q13	MT3, GIFB		Metallothionein 3 (growth inhibitory factor (neurotrophic))	139255				
16.439	5	25	13	16q13	NLRC5		NLR family, caspase recruitment domain-containing 5	613537				
16.440	4	7	16	16q13	NUP93, NIC96, KIAA0095, NPHS12		Nucleoporin, 93kD	614351			Nephrotic syndrome, type 12, 616892 (3)	
16.441	7	18	14	16q13	OGFOD1		2-oxoglutarate- and iron-dependent oxygenase domain-containing protein 1	615857				
16.442	5	15	96	16q13	SLC12A3, NCCT, TSC		Solute carrier family 12 (sodium/potassium/chloride transporters), member 3	600968			Gitelman syndrome, 263800 (3)	
16.443	08	23	19	16q13	PLLP, PMLP, TM4SF11		Plasmolipin	600340				
16.444	12	28	15	16q13	RSPRY1, KIAA1972, SEMDFA		RING finger- and SPRY domain-containing protein 11	616585			Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, 616723 (3)	
16.445	8	3	12	16q21	TEPP		Testis-prostate-placenta-expressed protein	610264				
16.446	7	6	17	16q21	USB1, C16orf57, PN		U6 small nuclear RNA biogenesis phosphodiesterase 1	613276			Poikiloderma with neutropenia, 604173 (3)	
16.447	3	20	01	16q13-q21	ANMA		Anisomastia	605746			Anisomastia (2)	
16.448	2	7	01	16q21	KIFC3		Kinesin family member C3	604535				
16.449	1	13	99	16q21	MMP15		Matrix metalloproteinase 15	602261				
16.450	9	15	17	16p13.3	MRPS34, MRPS12, COXPD32		Mitochondrial ribosomal protein S34	611994			Combined oxidative phosphorylation deficiency 32, 617664 (3)	
16.451	5	23	94	16q21	POLR2C		Polymerase (RNA) II (DNA directed) polypeptide C, 33kD	180663				
16.452	07	23	18	16q12.2	CES1, SES1		Carboxylesterase 1 (monocyte/macrophage serine esterase 1)	114835			Drug metabolism, altered, CES1-related, 618057 (3)	8(Ces1)
16.453	8	20	07	16q13-q22.1	EKD2		Episodic kinesigenic dyskinesia 2	611031		max lod at D16S503	Episodic kinesigenic dyskinesia 2 (2)	
16.454	05	24	19	16q21	ADGRG3, GPR97		Adhesion G protein-coupled receptor G3	618441				
16.455	6	2	16	16q21	ADGRG5, GPR114		Adhesion G protein-coupled receptor G5	616965				
16.456	11	5	98	16q13	AMFR, GP78		Autocrine motility factor receptor	603243				
16.457	9	24	15	16q13	BBS2, RP74		Bardet-Biedl syndrome 2	606151			Bardet-Biedl syndrome 2, 615981 (3); Retinitis pigmentosa 74, 616562 (3)	
16.458	2	18	10	16q21	BEAN, SCA31		Brain-expressed, associated with NEDD4	612051			Spinocerebellar ataxia 31, 117210 (3)	
16.459	11	4	14	16q21	CCDC113		Coiled-coil domain-containing protein 113	616070				
16.460	2	12	07	16q22.1	CES3, ES31		Carboxylesterase 3	605279				
16.461	9	6	11	16q13	CETP, HDLCQ10		Cholesteryl ester transfer protein, plasma	118470			Hyperalphalipoproteinemia, 143470 (3); [High density lipoprotein cholesterol level QTL 10], 143470 (3)	
16.462	4	6	18	16q21	CFAP20, BUG22, C16orf80, FSAP23		Cilia- and flagella-associated protein 20	617906				
16.463	11	17	14	16q21	CIAPIN1		Cytokine-induced apoptosis inhibitor 1 (anamorsin)	608943				
16.464	12	11	18	16q21	CNGB1, CNCG3L, CNCG2, RP45		Cyclic nucleotide gated channel, beta 1	600724			Retinitis pigmentosa 45, 613767 (3)	
16.465	09	28	20	16q21	CNOT1, NOT1, HPE12, VIBOS		CCR4-NOT transcription complex, subunit 1	604917			Holoprosencephaly 12, with or without pancreatic agenesis, 618500 (3); Vissers-Bodmer syndrome, 619033 (3)	
16.466	9	30	11	16q21	SLC38A7, SNAT7		Solute carrier family 38 (amino acid transporter), member 7	614236				
16.467	11	30	06	16q21	GINS3, PSF3		GINS complex subunit 3	610610				
16.468	12	27	19	16q21	GOT2		Glutamic-oxaloacetic transaminase 2, mitochondrial	138150		?pseudogenes on 12 and 1	Epileptic encephalopathy, early infantile, 82, 618721 (3)	8(Got2)
16.469	2	13	15	16q21	KATNB1, LIS6		Katanin, p80 subunit, B1	602703			Lissencephaly 6, with microcephaly, 616212 (3)	
16.470	6	30	15	16q21	SETD6		SET domain-containing protein 6	616424				
16.471	10	11	01	16q22.1	WWP2		WW domain-containing protein 2	602308				
16.472	07	13	20	16q22.2	DHX38, DDX38, PRP16, RP84		DEAH-box helicase 38	605584			Retinitis pigmentosa 84, 618220 (3)	
16.473	11	20	15	16q21-q22	OPA8		Optic atrophy 8	616648		max lod at D16S752	Optic atrophy 8 (2)	
16.474	1	13	99	16q21	CDH8		Cadherin-8	603008				
16.475	5	9	18	16q21	CDH11, CAD11, ESWS		Cadherin-11 (OB-cadherin, osteoblast)	600023			Elsahy-Waters syndrome, 211380 (3)	8(cad11)
16.476	5	6	13	16q22.1	HSF4, CTM, CTRCT5		Heat-shock transcription factor 4	602438			Cataract 5, multiple types, 116800 (3)	
16.477	2	24	12	16q21	NDRG4, SMAP8, KIAA1180		NMYC downstream-regulated gene 4	614463				
16.478	1	4	18	16q23.2	BCO1, BCMO1, BCDO		Beta-carotene oxygenase 1	605748		mutation identified in 1 HCVAD patient	?Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3)	
16.479	10	27	89	16q22.1	CA7		Carbonic anhydrase VII	114770				
16.480	03	21	19	16q22.1	NOL3, NOP, MYC, ARC, FCM, MYOCL1		Nucleolar protein 3	605235		mutation identified in 1 MYOCL1 family	?Myoclonus, familial, 1, 614937 (3)	
16.481	10	23	20	16q22.1	AARS1, AARS, CMT2N, DEE29		Alanyl-tRNA synthetase 1	601065			Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3); Developmental and epileptic encephalopathy 29, 616339 (3)	
16.482	11	14	19	16q22.1	AGRP, ART, AGRT		Agouti-related neuropeptide	602311			{Obesity, late-onset}, 601665 (3); {Leanness, inherited}, 601665 (3)	
16.483	8	29	01	16q22	ANBC		Aneurysmal bone cysts	606179		t(16:17); ?defect at 17p13	Aneurysmal bone cysts (2)	
16.484	9	30	09	16q22	ATFB8		Atrial fibrillation, familial, 8	613055		associated with rs7193343	Atrial fibrillation, familial, 8 (2)	
16.485	6	13	02	16q22.1	ATP6V0D1		ATPase, H+ transporting, V0 subunit D1	607028				
16.486	3	27	12	16q22	C16DELq22, DEL16q22		Chromosome 16q22 deletion syndrome	614541			Chromosome 16q22 deletion syndrome (4)	
16.487	3	27	12	16q22.1	CBFB, PEBP2B		Core-binding factor, beta subunit	121360		inv(16)(p13;q22); fuses to MYH11	Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)	
16.488	9	28	00	16q23.1	CHST5		Carbohydrate sulfotransferase-5 (GlcNAc-6-O-sulfotransferase, intestinal)	604817				
16.489	9	28	00	16q23.1	CHST6, MCDC1		Carbohydrate sulfotransferase-6 (GlcNAc-6-sulfotransferase, corneal)	605294			Macular corneal dystrophy, 217800 (3)	
16.490	12	5	11	16q21	CMTM1, CKLFSF1		CKLF-like marvel transmembrane domain-containing 1	607884				8(Cklfsf1)
16.491	12	5	11	16q21	CMTM2, CKLFSF2		CKLF-like marvel transmembrane domain-containing 2	607885				8(Cklfsf2a/b)
16.492	12	5	11	16q22.1	CMTM3, CKLFSF3		CKLF-like marvel transmembrane domain-containing 3	607886				8(Cklfsf3)
16.493	12	5	11	16q21-q22	CMTM4, CKLFSF4		CKLF-like marvel transmembrane domain-containing 4	607887				8(Cklfsf4)
16.494	5	26	13	16q23.1	CNTNAP4, CASPR4, KIAA1763		Contactin-associated protein-like 4	610518				
16.495	5	28	10	16q22.2	DHODH, URA1, POADS		Dihydroorotate dehydrogenase	126064			Miller syndrome, 263750 (3)	
16.496	4	29	02	16q22.1	FHOD1, FHOS		Formin homology 2 domain-containing 1	606881				
16.497	9	24	11	16q22.1	HSD11B2, HSD11K, AME		Hydroxysteroid (11-beta) dehydrogenase 2	614232			Apparent mineralocorticoid excess, 218030 (3)	
16.498	4	16	09	16q22.1	NAE1, APPBP1		NEDD8 activating enzyme E1 subunit 1	603385				
16.499	9	1	16	16q22	NAIC		North American Indian childhood cirrhosis	604901			North American Indian childhood cirrhosis (2)	
16.500	9	26	96	16q22.1	RRAD		Ras-related associated with diabetes	179503				
16.501	8	17	16	16q21	TK2, MTDPS2, PEOB3		Thymidine kinase, mitochondrial	188250		mutation identified in 1 PEOB3 family	Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3); ?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3, 617069 (3)	
16.502	6	18	99	16q22.1	TRADD		TNRF1-associated death domain protein	603500				8(Tradd)
16.503	9	1	16	16q22.1	UTP4, CIRH1A, TEX292, KIAA1988		Utp4, S. cerevisiae, homolog of	607456				
16.504	12	27	19	16q22.1	VPS4A, VPS4		Vacuolar protein sorting 4 homolog A	609982				8(Vps4a)
16.505	2	9	92	16q22.2	ZNF19, KOX12		Zinc finger protein-19 (KOX12)	194525		?16q23, 19q13		8(Zfp1)
16.506	11	4	93	16q22.2	ZNF23, KOX16		Zinc finger protein-32 (KOX16)	194527				8(Zfp4)
16.507	10	15	95	16q23.1	GLG1		Golgi apparatus protein 1	600753				8(Glg1)
16.508	03	02	20	16q23.2	MAF, CCA4, CTRCT21, AYGRP		MAF bZIP transcription factor	177075			Cataract 21, multiple types, 610202 (3); Ayme-Gripp syndrome, 601088 (3)	
16.509	11	7	01	16q22.1	SNTB2, SNT2B2, SNTL		Syntrophin, beta-2	600027				8(Sntb2)
16.510	10	23	20	16q24.1	COX4I1, COX4, MC4DN16		Cytochrome c oxidase, subunit IV, isoform 1	123864			Mitochondrial complex IV deficiency, nuclear type 16, 619060 (3)	
16.511	09	06	19	16q22.1	ACD, PTOP, PIP1, TINT1		ACD shelterin complex subunit and telomerase recruitment factor	609377		mutation has been identified in 1 DKCA7 and 1 DKCB7 family	?Dyskeratosis congenita, autosomal dominant 6, 616553 (3); ?Dyskeratosis congenita, autosomal recessive 7, 616553 (3)	8(Acd)
16.512	6	28	94	16q22.2	CALB2		Calbindin 2, 29kD (calretinin)	114051				
16.513	10	09	18	16q22.1	CARMIL2, RLTPR, IMD58		Capping protein regulator and myosin 1 linker 2	610859			Immunodeficiency 58, 618131 (3)	
16.514	02	12	19	16q22.1	CDH1, UVO, LCAM, ECAD, BCDS1		Cadherin-1 (E-cadherin; uvomorulin)	192090		near LCAT	Endometrial carcinoma, somatic, 608089 (3); Ovarian cancer, somatic, 167000 (3); {Breast cancer, lobular}, 114480 (3); Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate, 137215 (3); {Prostate cancer, susceptibility to}, 176807 (3); Blepharocheilodontic syndrome 1, 119580 (3)	8(Um)
16.515	1	23	09	16q22.1	CDH3, CDHP, PCAD, HJMD		Cadherin-3 (P-cadherin)	114021		in mouse tightly linked to ECAD	Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3); Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	8(Pcad)
16.516	1	13	99	16q21	CDH5		Cadherin-5	601120				8(Cdh5)
16.517	1	13	05	16q22.1	CDH16		Cadherin-16	603118				8(Cdh16)
16.518	12	19	19	16q22.1	CENPT, SSMGA		Centromere protein T	611510		mutation identified in 1 SSMGA family	?Short stature and microcephaly with genital anomalies, 618702 (3)	
16.519	11	11	14	16q22.1	CES2		Carboxylesterase 2	605278				
16.520	11	20	20	16q22.1	CHTF8, CTF8		Chromosome transmission fidelity factor 8	613202				
16.521	9	28	15	16q22.1	CLEC18A		C-type lecting domain family 18, member A	616571				
16.522	9	28	15	16q22.1	CLEC18C		C-type lectin domain family 18, member C	616573				
16.523	10	26	18	16q22.1	COG4, COD1, CDG2J, SWILS		Component of oligomeric golgi complex 4	606976			Congenital disorder of glycosylation, type IIj, 613489 (3); Saul-Wilson syndrome, 618150 (3)	
16.524	7	10	07	16q22.1	COG8, DOR1, CDG2H		Component of oligomeric golgi complex 8	606979			Congenital disorder of glycosylation, type IIh, 611182 (3)	
16.525	2	23	09	16q22.1	CRCS9		Colorectal cancer, susceptibility to, 9	612590		associated with rs9929218	{Colorectal cancer, susceptibility to, 9} (2)	
16.526	11	5	13	16q22.1	CTCF, MRD21		CCCTC-binding factor	604167			Mental retardation, autosomal dominant 21, 615502 (3)	
16.527	11	4	93	16q22.1	CTRL		Chymotrypsin-like protease	118888				
16.528	4	23	08	16q22.1	CYB5B, CYPB5M		Cytochrome b5, type B (outer mitochondrial membrane)	611964				
16.529	07	13	20	16q22.1	DDX19B, DBP5		DEAD/H-box helicase 19B	605812				
16.530	07	14	20	16q22.1	DDX28, MDDX28		DEAD-box helicase 28	607618				
16.531	3	1	06	16q22.1	DPEP2, MBD2		Dipeptidase 2	609925				
16.532	3	1	06	16q22.1	DPEP3, MBD3		Dipeptidase 3	609926				
16.533	12	28	08	16q22.1	DUS2L, DUS2		Dihydrouridine synthase 2-like	609707				
16.534	10	2	95	16q22.1	E2F4		E2F transcription factor 4, p107/p130-binding	600659				
16.535	10	2	12	16q22.1	EDC4, RCD8, GE1, HEDL5		Enhancer of mRNA decapping 4	606030				
16.536	9	10	09	16q22.1	ESRP2, RBM35B		Epithelial splicing regulatory protein 2	612960				
16.537	9	8	11	16q22.1	EXOC3L1, EXOC3L		Exocyst complex component 3-like 1	614117				8(Exoc3l1)
16.538	6	1	12	16q22.1	EXOSC6, MTR3		Exosome component 6	606490				
16.539	8	31	12	16q22.1	FAM96B, MIP18		Family with sequence similarity 96, member B	614778				
16.540	6	13	12	16q22.1	FBXL8, FBL8		F-box and leucine-rich repeat protein 8	609077				
16.541	02	22	19	16q22.1	FCSK, FUK, CDGF2		Fucose kinase	608675			Congenital disorder of glycosylation with defective fucosylation 2, 618324 (3)	
16.542	6	18	99	16q22.1	HAS3		Hyaluronan synthase 3	602428				8(Has3)
16.543	7	22	11	16q22.2	HP		Haptoglobin	140100		just distal to fra16q22.1	[Anhaptoglobinemia], 614081 (3); [Hypohaptoglobinemia], 614081 (3)	8(Hp)
16.544	1	12	89	16q22.2	HPR		Haptoglobin-related locus	140210		2.2kb 3' to HP; multiple tandem genes in blacks		
16.545	6	25	08	16q22.1	IL34, C16orf77		Interleukin 34	612081				
16.546	5	29	02	16q22.1	LCAT		Lecithin-cholesterol acyltransferase	606967		very close to HP	Norum disease, 245900 (3); Fish-eye disease, 136120 (3)	8(Lcat)
16.547	5	16	05	16q22.1	LYPLA3, LLPL, ACS, LPLA2		Lysophospholipase 3	609362				
16.548	11	4	93	16q22.1	MECL1, LMP10, PSMB10		Proteosome subunit MECL1	176847		3.1kb from LCAT		8(Psmb10)
16.549	10	09	19	16q22.1	MIR140, MIRN140, SEDN		Micro RNA 140	611894			Spondyloepiphyseal dysplasia, Nishimura type, 618618 (3)	
16.550	1	20	11	16q22.1	MIR328, MIRN328		Micro RNA 328	613701				
16.551	5	23	16	16q22.1	MTSS1L, ABBA1		Metastasis suppressor 1-like protein	616951				
16.552	5	25	13	16q22.1	NFAT5, KIAA0827, NFATL1, TONEBP		Nuclear factor of activated T cells 5	604708				
16.553	9	24	08	16q22.1	NQO1, DIA4, NMOR1		NAD(P)H dehydrogenase, quinone 1 (diaphorase-4)	125860			{Benzene toxicity, susceptibility to} (3); {Leukemia, post-chemotherapy, susceptibility to} (3); {Breast cancer, poor survival after chemotherapy for} (3)	8(Nmor1)
16.554	09	15	20	16q22.1	PARD6A, TAX40		PAR6 family cell polarity regulator alpha	607484				
16.555	12	27	19	16q22.1	PDF		Peptide deformylase, mitochondrial	618720				
16.556	12	10	13	16q22.1	PDP2, KIAA1348		Pyruvate dehydrogenase phosphatase catalytic subunit 2	615499				
16.557	1	17	18	16q22.1	PDPR, KIAA1990		Pyruvate dehydrogenase phosphatase regulatory subunit	617835				
16.558	4	24	18	16q22.1	PLEKHG4		Pleckstrin homology domain- and RhoGEF domain-containing protein G4	609526				
16.559	10	18	16	16q22.1	PRMT7, KIAA1933, SBIDDS		Protein arginine N-methyltransferase 7	610087			Short stature, brachydactyly, intellectual developmental disability, and seizures, 617157 (3)	
16.560	10	27	93	16q22.1	PSKH1		Putative serine kinase H1	177015				
16.561	9	8	11	16q22.1	RANBP10, KIAA1464		Ran-binding protein 10	614031				
16.562	10	13	97	16q22.1	SCA4		Spinocerebellar ataxia 4	600223			Spinocerebellar ataxia 4 (2)	
16.563	6	5	12	16q22.1	SF3B3, SF3B130, SAP130		Splicing factor 3B, subunit 3	605592				
16.564	6	27	95	16q22.1	SLC9A5, NHE5		Solute carrier family 9 (sodium/hydrogen exchanger), member 5	600477				
16.565	8	17	99	16q22.1	SLC12A4, KCC1		Solute carrier family 12 (potassium/chloride transporters), member 4	604119				
16.566	2	2	17	16q22.1	TERB1, CCDC79		Telomere repeat-binding bouquet formation protein 1	617332				
16.567	6	22	99	16q22.1	TERF2, TRF2		Telomeric repeat-binding factor-2	602027				8(Terf2)
16.568	9	30	13	16q22.1	THAP11, RONIN		THAP domain-containing protein 11	609119				
16.569	6	2	16	16q22.1	TPPP3, p20		Tubulin polymerization-promoting protein family, member 3	616957				
16.570	12	6	16	16q22.1	TSNAXIP1, TXI1		Translin-associated factor X-interacting protein 1	607720				
16.571	12	30	19	16q22.1-q22.2	VAC14, TAX1BP2, TRX, SNDC		VAC14 component of PIKFYVE complex	604632			Striatonigral degeneration, childhood-onset, 617054 (3)	
16.572	6	30	05	16q22.1	ZFP90, NK10, KIAA1954		Zinc finger protein 90, mouse, homolog of	609451				8(Zfp90)
16.573	02	22	19	16q24.3	TRAPPC2L, PERRB		Trafficking protein particle complex 2-like	610970			Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis, 618331 (3)	
16.574	9	17	09	16q22.2	TAT		Tyrosine aminotransferase, soluble	613018			Tyrosinemia, type II, 276600 (3)	8(Tat)
16.575	12	7	07	16q22.1-q23.1	OTSC4		Otosclerosis 4	611571		between D16S3107 and D16S3097	{Otosclerosis 4} (2)	
16.576	12	7	04	16q22.2	PKD1L3		Polycystin 1-like 3	607895				8(Pkd1l3)
16.577	10	24	11	16q22.2	ATXN1L, BOAT1		Ataxin 1-like (brother of ataxin 1)	614301				
16.578	2	4	15	16q22.2	CMTR2, MTR2, FTSJD1		CAP methyltransferase 2	616190				
16.579	09	11	19	16q22.2	HYDIN, HYDIN1, CILD5		HYDIN axonemal central pair apparatus protein	610812		duplicated copy on 1q21.1	Ciliary dyskinesia, primary, 5, 608647 (3)	8(Hydin)
16.580	02	06	20	16q22.2	IST1, KIAA0174		IST1 factor associated with ESCRT-III	616434				
16.581	7	22	11	16q22.2	MARVELD3		Marvel domain-containing protein 3	614094				
16.582	09	07	18	16q22.2	PMFBP1, STAP, SPGF31		Polyamine-modulated factor 1-binding protein 1	618085			Spermatogenic failure 31, 618112 (3)	8(Pmfbp1)
16.583	10	25	17	16q22.2	TXNL4B, DLP, DIM2		Thioredoxin-like 4B	617722				
16.584	6	18	01	16q23.1	ADAT1		Adenosine deaminase, tRNA-specific, 1	604230				
16.585	1	27	04	16q23.1	CFDP1, CP27, BCNT		Craniofacial development protein 1	608108				
16.586	08	21	19	16q23.1	KARS1, KARS, CMTRIB, DFNB89		Lysyl-tRNA synthetase 1	601421		mutation identified in 1 CMTRIB patient	?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3); Deafness, autosomal recessive 89, 613916 (3)	
16.587	9	24	15	16q23.1	CLEC18B		C-type lectin domain family 18, member B	616572				
16.588	2	2	14	16q22.3	HCCAT5, HTA		Hepatocellular carcinoma-associated transcript 5	615613				
16.589	8	21	07	16q22.2	PHLPPL, PHLPP2		PH domain and leucine-rich repeat protein phosphatase-like	611066				
16.590	9	20	04	16q22.3-q23.1	KTCN2		Keratoconus 2	608932			Keratoconus 2 (2)	
16.591	2	28	03	16q23.1	GABARAPL2		GABA-A receptor-associated protein-like protein 2	607452				
16.592	02	12	19	16q22.2-q22.3	ZFHX3, ATBF1		Zinc finger homeobox 3	104155			Prostate cancer, somatic, 176807 (3)	8(Atbf1)
16.593	09	26	19	16q23.1	ADAMTS18, MMCAT		ADAM metallopeptidase domain with thrombospondin type 1 motif, 18	607512			Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3)	
16.594	9	18	00	16q22.2	AP1G1, ADTG, CLAPG1		Adaptor-related protein complex 1, gamma 1 subunit (adaptin, gamma)	603533				
16.595	5	4	09	16q23	BMND13		Bone mineral density quantitative trait locus 13	612727		associated with rs16945612	[Bone mineral density QTL 13] (2)	
16.596	11	3	14	16q21	CKLF, HSPC224		Chemokine-like factor	616074				
16.597	8	27	15	16q23.1	CLEC3A, CLECSF1		C-type lectin domain family 3, member A	613588				
16.598	5	23	11	16q23.1	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35		Fatty acid 2-hydroxylase	611026			Spastic paraplegia 35, autosomal recessive, 612319 (3)	8(Fa2h)
16.599	2	2	11	16q23	HSCR8		Hirschsprung disease, susceptibility to, 8	608462			{Hirschsprung disease, susceptibility to, 8} (2)	
16.600	8	24	98	16q23.1	PSMD7, MOV34		Proteasome 25S subunit, non-ATPase, 7 (Moloney leukemia virus-34 proviral integration homolog)	157970				8(Mov34)
16.601	05	19	20	16q23.1	BCAR1, CRKAS, CAS		BCAR1 scaffold protein, CAS family member	602941				
16.602	12	13	19	16q23.1	CPHXL, CPHXL1		Cytoplasmic polyadenylated homeobox-like	618700				
16.603	12	13	19	16q23.1	DUXB		Double homeobox B	618698				
16.604	05	15	20	16q23.1	LDHD, DLACD		D-lactate dehydrogenase	607490			D-lactic aciduria with susceptibility to gout, 245450 (3)	
16.605	4	8	13	16q23.1	MLKL		Mixed lineage kinase domain-like protein	615153				
16.606	6	7	10	16q23.1	MON1B, SRG1, KIAA0872		Mon1, S. cerevisiae, homolog of, B	608954				
16.607	11	29	17	16q23.1	RFWD3, FANCW		RING finger and WD repeat domains-containing protein 3	614151		mutation identified in 1 FANCW patient	?Fanconi anemia, complementation group W, 617784 (3)	
16.608	6	24	10	16q23.1	TERF2IP, RAP1		Telomeric repeat binding factor 2, interacting protein	605061				
16.609	7	21	14	16q23.1	TMEM231, JBTS20, MKS11		Transmembrane protein 231	614949			Joubert syndrome 20, 614970 (3); Meckel syndrome 11, 615397 (3)	
16.610	4	20	17	16q23.1	WDR59, KIAA1923		WD repeat-containing protein 59	617418				
16.611	12	5	16	16q23.1	ZFP1, ZNF475		Zinc finger protein 1, mouse, homolog of	617230				
16.612	6	10	08	16q23.1	ZNRF1, NIN283		Zinc finger and ring finger protein 1	612060				
16.613	07	19	18	16q23.2	ARLNC1, LINC02170		Androgen receptor-regulated long noncoding RNA 1	618053				
16.614	7	20	12	16q23.2	ATMIN, ASCIZ, KIAA0431		ATM interactor	614693				
16.615	05	05	20	16q23.2	CDYL2		CDY-like protein 2	618816				8(Cdyl2)
16.616	10	8	07	16q23.2	CENPN		Centromere protein N	611509				
16.617	3	13	15	16q23.2	MAFTRR, lincMAF4		MAF transcriptional regulator FNA, noncoding	616264				
16.618	3	31	15	16q23.2	PKD1L2, PC1L2, KIAA1879		Polycystin 1-like 2	607894				8(Pkd1l2)
16.619	6	21	91	16q23.1	CTRB1		Chymotrypsinogen B1	118890		HP-7cM-TAT-9cM-CTRB		8(Ctrb)
16.620	3	31	11	16q23.3	ADIPQTL5		Adiponectin, serum level of, quantitative trait locus 5	613836		associated with rs3865188	{Adiponectin, serum level of, QTL5] (2)	
16.621	2	21	06	16q23.2	DYNLRB2, DNCL2B		Dynein, light chain, roadblock-type 2	607168				
16.622	3	25	14	16q23.3	HSBP1		Heat-shock factor-binding protein 1	604553				
16.623	3	23	14	16q23.3	OSGIN1, OKL38		Oxidative stress-induced growth inhibitor 1	607975				
16.624	12	30	14	16q23.3	SDR42E1		Short-chain dehydrogenase/reductase family 42E, member 1	616164				
16.625	4	10	14	16q23.3	SLC38A8, FVH2		Solute carrier family 38 (amino acid transporter), member 8	615585			Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3)	
16.626	10	23	20	16q23.1-q23.2	WWOX, FOR, SCAR12, DEE28		WW domain-containing oxidoreductase	605131			Esophageal squamous cell carcinoma, somatic, 133239 (3); Spinocerebellar ataxia, autosomal recessive 12, 614322 (3); Developmental and epileptic encephalopathy 28, 616211 (3)	8(Wox1, Fra8E1)
16.627	9	10	98	16q24.3	AFG3L1, AFG3		ATPase family gene 3, yeast, homolog of	603020				
16.628	10	30	07	16q24.2	BANP, SMAR1		BTG3-associated nuclear protein	611564				8(Banp)
16.629	6	15	99	16q24.3	CBFA2T3, MTGR2, MTG16		Core-binding factor, alpha subunit 2, translocated to, 3	603870				
16.630	10	1	17	16q24.3	CDK10, PISSLRE, ALSAS		Cyclin-dependent kinase 10	603464			Al Kaissi syndrome, 617694 (3)	
16.631	2	13	09	16q23.2-q23.3	CMIP, KIAA1694, TCMIP		C-MAF-inducing protein	610112				
16.632	07	07	20	16q24.2	CYBA, CGD4		Cytochrome b-245, alpha polypeptide	608508			Chronic granulomatous disease 4, autosomal recessive, 233690 (3)	
16.633	8	18	09	16q24.1	FOXF1, FKHL5, ACDMPV		Forkhead box F1	601089			Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)	8(Foxf1)
16.634	4	27	18	16q23.2	GCSH, NKH		Glycine cleavage system H protein	238330		mutation identified in 1 NKH patient	?Glycine encephalopathy, 605899 (3)	
16.635	4	5	00	16q24.2	IL17C		Interleukin 17C	604628				
16.636	04	19	19	16q23.3-q24.1	MBTPS1, S1P, SEDKF		Membrane-bound transcription factor protease, site 1	603355		mutation identified in 1 SEDKF patient	?Spondyloepiphyseal dysplasia, Kondo-Fu type, 618392 (3)	
16.637	3	26	02	16q23.3	MLYCD, MCD		Malonyl-CoA decarboxylase	606761			Malonyl-CoA decarboxylase deficiency, 248360 (3)	
16.638	9	3	10	16q24	STQTL22		Stature quantitative trait locus 22	613547		linked to rs299956 and rs2076962	{Stature QTL 22} (2)	
16.639	2	1	01	16q24.1	TAF1C, TAFI110, SL1		TATA box-binding protein-associated factor 1C	604905				
16.640	4	21	10	16q24.1	USP10, KIAA0190		Ubiquitin-specific protein 10	609818				
16.641	6	11	08	16q24.2	ZNF469, KIAA1858, BCS1		Zinc finger protein 469	612078			Brittle cornea syndrome 1, 229200 (3)	
16.642	10	13	09	16q24.1	ATP2C2, SPCA2, KIAA0703		ATPase, Ca(2+)-transporting, type 2C, member 2	613082				
16.643	2	1	11	16q24.1	COTL1, CLP		Coactosin-like protein 1	606748		pseudogenes on 15, 17, and Y		
16.644	12	4	08	16q24.1	CRISPLD2		Cysteine-rich secretory protein, LCCL domain-containing, 2	612434				
16.645	10	12	16	16q24.1	DNAAF1, LRRC50, ODA7, CILD13		Dynein, axonemal, assembly factor 1	613190			Ciliary dyskinesia, primary, 13, 613193 (3)	
16.646	2	25	15	16q24.1	EMC8, NOC4		ER membrane protein complex subunit 8	604886				
16.647	12	27	16	16q24.1	FAM92B		Family with sequence similarity 92, member B	617274				
16.648	5	30	17	16q24.1	FENDRR, FOXF1AS1, TCONS_00024240		FOXF1 adjacent noncoding developmental regulatory RNA	614975		partial overlap with FOXF1 promoter		
16.649	5	4	09	16q24.1	FOXL1, FKHL11, FREAC7, FKH6		Forkhead box L1	603252				8(Foxl1)
16.650	11	2	00	16q23.2	GAN, GAN1		Gigaxonin	605379			Giant axonal neuropathy-1, 256850 (3)	
16.651	11	30	06	16q24.1	GINS2, PSF2		GINS complex subunit 2	610609				
16.652	3	30	16	16q24.1	GSE1, KIAA0182		GSE1 coiled-coil protein	616886				
16.653	4	23	03	16q24.1	HDLC3		High density lipoprotein cholesterol, low serum, 3	607687			{High density lipoprotein cholesterol, low serum, 3} (2)	
16.654	6	10	18	16q24.1	IRF8, ICSBP1, IMD32A, IMD32B		Interferon regulatory factor 8	601565			Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3); Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 226990 (3)	
16.655	3	10	03	16q24.1	KCNG4, KV6.3, KV6.4		Potassium channel, voltage-gated, subfamily G, member 4	607603				
16.656	12	17	07	16q24.1	KIAA0513		KIAA0513 gene	611675				
16.657	2	16	16	16q24.1	MTHFSD		Methenyltetrahydrofolate synthetase domain-containing protein	616820				
16.658	10	25	12	16q23.3	PLCG2, FCAS3, APLAID		Phospholipase C, gamma 2	600220			Familial cold autoinflammatory syndrome 3, 614468 (3); Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)	8(Plcg2)
16.659	1	14	13	16q24.1	TCONS00024492		Long noncoding RNA TCONS_00024492	614978				
16.660	8	14	14	16q24.1	LINC01081, TCONS00024764		Long intergenic non-protein coding RNA 1081	614977				
16.661	4	27	12	16q24.1	ZDHHC7, DHHC7		Zinc finger DHHC domain-containing protein 7	614604				
16.662	7	11	95	16q23.3	HSD17B2, EDH17B2		Hydroxysteroid (17-beta) dehydrogenase 2	109685				
16.663	10	20	20	16q24.1	HSDL1		Hydroxysteroid dehydrogenase-like protein 1	619067				
16.664	3	15	13	16q24.2	MAP1LC3B, LC3B		Microtubule-associated protein 1, light chain 3, beta	609604				
16.665	1	13	99	16q23.3	CDH13, CDHH		Cadherin-13 (H-cadherin, heart)	601364				
16.666	11	23	16	16q24.2-q24.3	RNF166		RING finger protein 166	617178				
16.667	10	1	11	16q24.3	ACSF3		Acyl-CoA synthetase family member 3	614245			Combined malonic and methylmalonic aciduria, 614265 (3)	
16.668	9	21	11	16q24.3	ANKRD11, ANCO1, KBGS		Ankyrin repeat domain-containing protein 11	611192			KBG syndrome, 148050 (3)	
16.669	9	21	12	16q24.3	APRT, APRTD		Adenine phosphoribosyltransferase	102600		telomeric to GALNS, transcribed in same cen-tel direction	Adenine phosphoribosyltransferase deficiency, 614723 (3)	8(Aprt)
16.670	4	29	14	16q24.2	CA5A, CA5AD		Carbonic anhydrase VA (mitochondrial)	114761		pseudogene on 16p	Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3)	8(Car5)
16.671	2	17	09	16q24.3	CDH15, CDH14, CDH3, MRD3		Cadherin-15, M-cadherin (myotubule)	114019		tightly linked to Aprt in mouse	Mental retardation, autosomal dominant 3, 612580 (3)	8(Cdh3)
16.672	3	15	11	16q24.3	CDT1		Chromatin licensing and DNA replication factor 1	605525			Meier-Gorlin syndrome 4, 613804 (3)	
16.673	12	23	19	16q24.3	CHMP1A, PCOLN3, PRSM1, PCH8		Charged multivesicular body protein 1A	164010			Pontocerebellar hypoplasia, type 8, 614961 (3)	
16.674	2	28	01	16q24.3	CPNE7		Copine VII	605689				
16.675	10	09	18	16q24.3	CTU2, C16orf84, NCS2, MFRG		Cytosolic thiouridylase, subunit 2	617057			Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, 618142 (3)	
16.676	4	25	93	16q24.3	DPEP1, RDP, MDP, MBD1		Dipeptidase 1	179780				
16.677	1	27	03	16q24.3	FANCA, FACA, FA1, FA, FAA		Fanconi anemia, complementation group A	607139		linkage heterogeneity	Fanconi anemia, complementation group A, 227650 (3)	8(Fanca)
16.678	9	22	14	16q24.2	FBXO31, FBX31, FBXO14, FBX14, MRT45		F-box only protein 31	609102		mutation identified in 1 MRT45 family	?Mental retardation, autosomal recessive 45, 615979 (3)	8(Fbxo31)
16.679	6	27	08	16q24.1	FOXC2, FKHL14, MFH1		Forkhead box C2	602402			Lymphedema-distichiasis syndrome, 153400 (3); Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)	8(Mfh1)
16.680	9	18	08	16q24.3	GALNS, MPS4A		Galactosamine (N-acetyl)-6-sulfate sulfatase	612222		centromeric to APRT	Mucopolysaccharidosis IVA, 253000 (3)	
16.681	1	11	16	16q24.3	GAS8, GAS11, CILD33		Growth arrest-specific 8	605178			Ciliary dyskinesia, primary, 33, 616726 (3)	
16.682	8	17	17	16q24.3	GAS8-AS1, C16orf3, EID1		GAS8 antisense RNA 1	605179				
16.683	1	24	09	16q24.3	IHPS5		Pyloric stenosis, infantile hypertrophic, 5	612525		between rs7197068 and rs750740	Pyloric stenosis, infantile hypertrophic, 5 (2)	
16.684	08	16	18	16q24.2	JPH3, JP3, HDL2		Junctophilin 3	605268		mutation identified in 1 HDL2 family	Huntington disease-like 2, 606438 (3)	
16.685	11	30	11	16q24.3	MC1R, SHEP2, CMM5		Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor)	155555			[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3); [Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3); [Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3); {UV-induced skin damage}, 266300 (3); {Albinism, oculocutaneous, type II, modifier of}, 203200 (3); {Melanoma, cutaneous malignant, 5}, 613099 (3)	8(Mc1r)
16.686	11	18	15	16q24.2	MVD, MPD, POROK7		Mevalonate pyrophosphate decarboxylase	603236			Porokeratosis 7, multiple types, 614714 (3)	
16.687	4	27	12	16q24.3	PGN, SPG7, CMAR, CAR		Paraplegin	602783			Spastic paraplegia 7, autosomal recessive, 607259 (3)	
16.688	12	20	18	16q24.3	PIEZO1, FAM38A, MIB, DHS, LMPHM6		PIEZO1 ion channel	611184			Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3); Lymphatic malformation 6, 616843 (3)	
16.689	01	07	20	16q24.3	RPL13, BBC1, D16S44E, SEMDIST		Ribosomal protein L13	113703			Spondyloepimetaphyseal dysplasia, Isidor-Toutain type, 618728 (3)	
16.690	2	19	99	16q24.2	SLC7A5, D16S469E, MPE16		Solute carrier family 7, member 5	600182				
16.691	5	5	09	16q24.2	SNAI3, SNAIL3, SMUC, ZFP293		SNAIL, Drosophila, homolog of, 3	612741				
16.692	9	23	13	16q24.3	SPATA33, C16orf55		Spermatogenesis-associated protein 33	615409				
16.693	08	17	20	16q24.3	SPIRE2, KIAA1832		Spire-type actin nucleation factor 2	609217				
16.694	10	7	08	16q24.3	TCF25, NULP1, KIAA1049		Transcription factor 25	612326				
16.695	9	23	13	16q24.3	TUBB3, TUBB4, CFEOM3A, CDCBM1		Tubulin, beta-3	602661			Fibrosis of extraocular muscles, congenital, 3A, 600638 (3); Cortical dysplasia, complex, with other brain malformations 1, 614039 (3)	
16.696	6	22	14	16q24.3	URAHP, URAH		Urate (hydroxyiso-) hydrolase, pseudogene	615805				
16.697	10	13	00	16q24.1	WFDC1, PS20		WAP four-disulfide core domain-1, mouse, homolog of	605322				
16.698	2	16	04	16q24.3	ZFP276		Zinc finger protein 276	608460				
16.699	2	28	03	16q24.2	ZFPM1, FOG, FOG1		Zinc finger protein, multitype 1 (friend of GATA1)	601950				
16.700	9	30	02	16p12.2	EEF2K		Elongation factor 2 kinase	606968				
16.701	11	2	01	16q22.1	ELMO3		Engulfment and cell motility gene 3	606422				
16.702	10	23	87	Chr.16	ESB3		Esterase-B3	133290				8(Es6)
16.703	6	14	95	Chr.16	GRLL1		Glucocorticoid receptor-like 1	138060				
16.704	8	21	91	Chr.16	IFNR		Interferon production regulator	147573				
16.705	10	23	87	Chr.16	LIPB		Lipase B, lysosomal acid	247980				
16.706	1	30	01	16q23.3	MPHOSPH6, MPP		M-phase phosphoprotein 6	605500				
16.707	8	30	01	16q13	MT4, MTIV		Metallothionein 4	606206				8(Mt4)
16.708	9	3	02	16q22.1	NFATC3		Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 3	602698				
16.709	10	23	87	Chr.16	NHCP1		Nonhistone chromosomal protein-1	118870				
16.710	2	15	01	16q22.1	SLC7A6		Solute carrier family 7 (y+L-type amino acid transporter), member 6	605641				
16.711	9	25	01	16p13.3	SRRM2, SRM300, KIAA0324		Serine/arginine repetitive matrix 2 (ser/arg-rich splicing factor-related nuclear matrix protein, 300kD)	606032				
16.712	2	25	02	16p11.2	ZNF267, HZF2		Zinc finger protein-167	604752				
16.713	10	10	18	16q23.3	NECAB2		N-terminal EF-hand calcium-binding protein 2	618130				
17.1	8	15	03	17p13.2	ASPA		Aspartoacylase (aminoacylase-2)	608034			Canavan disease, 271900 (3)	
17.2	9	10	14	17p13.2	ENO3, GSD13		Enolase-3, beta, muscle	131370		mutation identified in 1 GSD13 patient	?Glycogen storage disease XIII, 612932 (3)	
17.3	1	24	09	17p13.2	GP1BA, BSS, BDPLT1, VWDP, BDPLT3		Glycoprotein Ib, platelet, alpha polypeptide	606672			Bernard-Soulier syndrome, type A1 (recessive), 231200 (3); {Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3); Bernard-Soulier syndrome, type A2 (dominant), 153670 (3); von Willebrand disease, platelet-type, 177820 (3)	
17.4	12	21	09	17p13.3	PLI, SERPINF2		Alpha-2-plasmin inhibitor	613168			Alpha-2-plasmin inhibitor deficiency, 262850 (3)	
17.5	10	12	90	17p13.2	ZFP3		Zinc finger protein-3	194480		probably in cluster with ZNF29 proximal to TP53		11(Zfp3)
17.6	3	26	95	17p13.3	ABR		Active BCR-related gene	600365				
17.7	5	12	99	17p13.2	ALOX15		Arachidonate 15-lipoxygenase	152392				11(Alox15)
17.8	8	12	98	17p13.2	ATP2A3, SERCA3		ATPase, Ca(2+)-transporting, ubiquitous	601929				
17.9	1	23	96	17p13.3	BCPR		Breast cancer-related regulator of TP53	113721			Breast cancer (1)	
17.10	7	25	16	17p13.3	BHLHA9, BHLHF42, MSSD, CCSPD		Basic helix-loop-helix family, member A9	615416		mutation identified in 1 CCSPD family	Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3); ?Camptosynpolydactyly, complex, 607539 (3)	
17.11	10	12	17	17p13.2	C1QBP, HABP1, COXPD33		Complement component C1q binding protein (hyaluronic acid-binding protein 1)	601269			Combined oxidative phosphorylation deficiency 33, 617713 (3)	
17.12	2	3	15	17p13.3	CLUH, CLU1, KIAA0664		Clustered mitochondria, D. discoideum, homolog of	616184				
17.13	11	4	93	17p13.3	CRK		Avian sarcoma virus CT10 (v-crk) oncogene homolog	164762				
17.14	2	2	18	17p13.3	DDD3		Dowling-Degos disease 3	615674		max lod at D17S1529	Dowling-Degos disease 3 (2)	
17.15	1	12	07	17p13.3	DOC2B		Double C2-like domain-containing protein, beta	604568				
17.16	08	09	19	17p13.3	DPH1, DPH2L1, OVCA1, DEDSSH		Diphthamide biosynthesis protein 1	603527			Developmental delay with short stature, dysmorphic facial features, and sparse hair, 616901 (3)	
17.17	3	23	18	17p13.3	GEMIN4, NEDMCR		Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	606969			Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities, 617913 (3)	
17.18	4	4	17	17p13.3	INPP5K, SKIP, MDCCAID		Inositol polyphosphate-5-phosphatase K	607875			Muscular dystrophy, congenital, with cataracts and intellectual disability, 617404 (3)	
17.19	5	13	10	17p13.3	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3		Miller-Dieker lissencephaly syndrome (chromosome 17p13.3 deletion syndrome)	247200			Miller-Dieker lissencephaly syndrome (4)	
17.20	2	19	10	17p13.3	DUP17p13.3, C17DUPp13.3		Chromosome 17p13.3 duplication syndrome	613215		includes LIS1 and/or YWHAE	Chromosome 17p13.3 duplication syndrome (4)	
17.21	2	6	08	17p13.3	FAM57A, CT120		Family with sequence similarity 57, member A	611627				
17.22	8	18	14	17p13.3	FAM101B, CFM1		Family with sequence similarity 101, member B	615928				
17.23	6	16	99	17p13.1	GLP2R		Glucagon-like peptide 2 receptor	603659				
17.24	6	4	99	17p13.3	HIC1		Hypermethylated in cancer	603825				11(Hic1)
17.25	3	23	09	17p13.3	MIR22, MIRN22		Micro RNA 22	612077				
17.26	3	23	09	17p13.3	MIR132, MIRN132		Micro RNA 132	610016				
17.27	7	16	10	17p13.3	MIR212, MIRN212		Micro RNA 212	613487				
17.28	9	18	98	17p13.3	MNT, ROX		MAX-binding protein	603039				11(Mnt)
17.29	5	11	00	17p13.2	MYBBP1A, P160		MYB-binding protein 1A	604885				11(Mybbp1a)
17.30	08	08	19	17p13.3	NXN, RRS2		Nucleoredoxin	612895			Robinow syndrome, autosomal recessive 2, 618529 (3)	11(Nxn)
17.31	7	2	18	17p13.3	OR1A1		Olfactory receptor, family 1, subfamily A, member 1	618046				
17.32	7	2	18	17p13.3	OR1A2		Olfactory receptor, family 1, subfamily A, member 2	618047				
17.33	8	24	98	17p13.3	OR1D2, OLFR1		Olfactory receptor, family 1, subfamily D, member 2	164342		cluster of 16 genes in 350kb		
17.34	3	31	15	17p13.3	OVCA2		Ovarian cancer-associated gene 2	607896				
17.35	7	16	17	17p13.2	P2RX1, P2X1		Purinergic receptor P2X, ligand-gated ion channel, 1	600845				11(P2rx1)
17.36	1	3	03	17p13.3	PAFAH1B1, LIS1		Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit	601545			Lissencephaly 1, 607432 (3); Subcortical laminar heterotopia, 607432 (3)	
17.37	12	22	15	17p13.2	PELP1, MNAR		Proline-, glutamic acid-, and leucine-rich protein 1	609455				
17.38	9	10	12	17p13.2	PFN1, ALS18		Profilin-1	176610			Amyotrophic lateral sclerosis 18, 614808 (3)	11(Pfn1)
17.39	9	7	10	17p13.3	PITPNA, PITPN		Phosphotidylinositol transfer protein, alpha	600174				11(Pitpn)
17.40	3	31	15	17p13.3	RILP		RAB-interacting lysosomal protein	607848				11(Rilp)
17.41	09	19	19	17p13.3	PRPF8, PRPC8, RP13		Pre-mRNA processing factor 8	607300			Retinitis pigmentosa 13, 600059 (3)	
17.42	12	23	19	17p13.3	RAP1GAP2, GARNL4, KIAA1039		RAP1 GTPase-activating protein 2	618714				
17.43	2	17	09	17p13.3	RNMTL1, HC90		RNA methyltransferase-like 1	612600				
17.44	4	11	94	17p13.3	RPA1		Replication protein A1, 70kD	179835				
17.45	7	14	00	17p13.3	RPH3AL, NOC2		Rabphilin 3A-like	604881				
17.46	5	24	13	17p13.3	RTN4RL1, NGRH2, NGR3		Reticulon 4 receptor-like 1	610461				
17.47	3	13	08	17p13.3	SCARF1, SREC, KIAA0149		Scavenger receptor class F, member 1	607873				
17.48	2	2	12	17p13.3	SERPINF1, PEDF, OI6		Serpin peptidase inhibitor, clade F, member 1	172860		same region as RP13	Osteogenesis imperfecta, type VI, 613982 (3)	
17.49	9	24	11	17p13.3	SGSM2, KIAA0397		Small G protein signaling modulator 2	611418				
17.50	06	24	19	17p13.2	SLC25A11, SLC20A4, OGC, PGL6		Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11	604165			Paragangliomas 6, 618464 (3)	
17.51	3	8	07	17p13.3	SLC43A2, LAT4		Solute carrier family 43 (L-type amino acid transporter, member 2	610791				
17.52	07	16	20	17p13.3	SMG6, EST1A, KIAA0732		SMG6 nonsense-mediated mRNA decay factor	610963				
17.53	12	27	01	17p13.3	SRR		Serine racemase	606477				
17.54	04	27	20	17p13.3	TIMM22, TIM22, COXPD43		Translocase of inner mitochondrial membrane 22	607251		mutation identified in 1 COXPD43 patient	?Combined oxidative phosphorylation deficiency 43, 618851 (3)	
17.55	1	8	01	17p13.2	TM4SF5		Transmembrane 4 superfamily, member 5	604657				
17.56	12	14	98	17p13.1	TNFSF12, TWEAK, APO3L, DR3LG		Tumor necrosis factor ligand superfamily, member 12	602695				
17.57	5	24	13	17p13.3	TSR1, KIAA1401		TSR1, 20S r RNA accumulation, S. cerevisiae, homolog of	611214				
17.58	9	2	08	17p13.3	TUSC5, LOST1		Tumor suppressor candidate 5	612211				
17.59	10	03	19	17p13.3	VPS53, HCCS1, PCH2E		VPS53 subunit of GARP complex	615850			Pontocerebellar hypoplasia, type 2E, 615851 (3)	
17.60	7	9	18	17p13.3	WDR81, CAMRQ2, HYC3		WD repeat-containing protein 81	614218			Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2, 610185 (3); Hydrocephalus, congenital, 3, with brain anomalies, 617967 (3)	11(Wdr81)
17.61	5	13	10	17p13.3	YWHAE, MDCR, MDS		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon isoform	605066				11(Ywhae)
17.62	12	18	14	17p13.3-p13.1	SHFLD3, DUP17p13.3, C17DUPp13.3		Split-hand/foot malformation with long bone deficiency 3	612576		max lod at or near D17S1533; contiguous gene duplication syndrome	Split-hand/foot malformation with long bone deficiency 3 (4)	
17.63	5	27	16	17p13.3-p12	MSPC		Palmoplantar carcinoma, multiple self-healing	616964		between rs8065368 and rs2322788	Palmoplantar carcinoma, multiple self-healing (2)	
17.64	2	25	15	17p13.2	ANKFY1, ANKHZN, KIAA1255		Ankyrin repeats- and FYVE domain-containing protein 1	607927				
17.65	10	8	07	17p13.2	CAMTA2, KIAA0909		Calmodulin-binding transcription activator 2	611508				
17.66	5	24	13	17p13.2	DERL2		DER1-like domain family, member 2	610304				
17.67	07	13	20	17p13.2	DHX33		DEAH-box helicase 33	614405				
17.68	9	9	08	17p13.1	FBXO39, FBX39		F-box protein 39	609106				11(Fbxo39)
17.69	10	9	08	17p13.2	GGT6		Gamma-glutamyltransferase 6	612341				
17.70	09	19	19	17p13.1	HES7, SCDO4		Hes family bHLH transcription factor 7	608059			Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)	11(Hes7)
17.71	1	24	06	17p13.1	KCTD11, REn		Potassium channel tetramerization domain-containing protein 11	609848				11(Kcntd11)
17.72	2	2	14	17p13.2	KIF1C, LTXS1, KIAA0706, SPAX2		Kinesin family member 1C	603060			Spastic ataxia 2, autosomal recessive, 611302 (3)	
17.73	11	7	08	17p13.2	MED11		Mediator complex subunit 11	612383				
17.74	2	2	16	17p13.2	MIS12		Mis12, S. pombe, homolog of	609178				
17.75	10	28	15	17p13.2	NCBP3, C17orf85		Nuclear cap-binding protein 3	616624				
17.76	8	8	17	17p13.2	PIMREG, RCS1, FAM64A		PICALM-interacting mitotic regulator	617611				
17.77	9	16	17	17p13.2	PSMB6, LMPY		Proteasome subunit, beta-type, 6	600307				
17.78	5	24	13	17p13.2	RNF167, RING105		RING finger protein 167	610431				
17.79	1	1	12	17p13.2	SCIMP, C17orf87		SLP adaptor- and CSK-interacting membrane protein	614406				
17.80	4	29	14	17p13.1	SLC16A11, MCT11		Solute carrier family 16, member 11	615765				
17.81	1	31	13	17p13.2	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD		Solute carrier family 52, riboflavin transporter, member 1	607883			Riboflavin deficiency, 615026 (3)	
17.82	8	19	13	17p13.2	SPAG7		Sperm-associated antigen 7	610056				
17.83	9	15	17	17p13.2	SPATA22		Spermatogenesis-associated protein 22	617673				
17.84	06	06	19	17p13.2	SPNS2, DFNB115		Sphingolipid transporter 2	612584		mutation identified in 1 DFNB115 patient	?Deafness, autosomal recessive 115, 618457 (3)	
17.85	1	2	08	17p13.2	SPNS3		Spinster, Drosophila, homolog of, 3	611701				11(Spns3)
17.86	4	20	11	17p13.2	UBE2G		Ubiquitin-conjugating enzyme E2G (UBC7, C. elegans, homolog of)	601569		possible pseudogene on 1q42		
17.87	5	7	03	17p13.1	XAF1		XIAP-associated factor 1	606717				
17.88	7	7	14	17p13.2	ZMYND15, SPGF14		Zinc finger MYND-containing protein 15	614312		mutation identified in 1 SPGF14 family	?Spermatogenic failure 14, 615842 (3)	11(Zmynd15)
17.89	7	9	15	17p13.2	ZNF232, ZSCAN11		Zinc finger protein 232	616463				
17.90	11	19	11	17p13.2-p13.1	MRT33		Mental retardation, autosomal recessive 33	614341		between rs1367950 and rs1826925	Mental retardation, autosomal recessive 33 (2)	
17.91	4	3	09	17p13.2	AIPL1, LCA4		Arylhydrocarbon-interacting receptor protein-like 1	604392		LCA1 due to GUCY2D mutation also on 17p13.1	Leber congenital amaurosis 4, 604393 (3); Retinitis pigmentosa, juvenile, 604393 (3); Cone-rod dystrophy, 604393 (3)	
17.92	1	25	93	17p13.1	ALOX12		Arachidonate 12-lipoxygenase	152391		pseudogene also on chr.17		
17.93	1	18	13	17p13.1	ALOX12B, ARCI2		Archidonate 12-lipoxygenase, R type	603741			Ichthyosis, congenital, autosomal recessive 2, 242100 (3)	
17.94	5	25	13	17p13.1	ALOX15B		Arachidonate 15-lipoxygenase, second type	603697				
17.95	1	18	13	17p13.1	ALOXE3, ARCI3		Arachidonate lipoxygenase 3	607206			Ichthyosis, congenital, autosomal recessive 3, 606545 (3)	
17.96	3	9	04	17p13.1	ARGEF15, KIAA0915		Rho guanine nucleotide exchange factor 15	608504				
17.97	11	2	04	17p13.1	BCL6B, BAZF		B-cell lymphoma 6B	608992				
17.98	10	23	15	17p13.1	BORCS6, C17orf59, LYSPERSIN		BLOC1-related complex, subunit 6	616599				
17.99	11	23	16	17p13.1	C17orf49, BAP18		Chromosome 17 open reading frame 49	617215				
17.100	6	3	14	17p13.1	CNTROB, LIP8		Centrosomal BRCA2-interacting protein	611425				
17.101	5	8	12	17p13.1	CTC1, CRMCC, C17orf68, AAF132		Conserved telomere maintenance component 1	613129			Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	11(Aaf132)
17.102	10	4	12	17p13.1	CTDNEP1, DULLARD		C-terminal domain nuclear envelope phosphatase 1	610684				
17.103	9	9	10	17p13.1	CLEC10A, CLECSF14, MGL, HML, CD301		C-type lectin domain family 10, member A	605999				
17.104	3	24	11	17p13.1	DEL17p13.1, C17DELp13.1		Chromosome 17p13.1 deletion syndrome	613776		contiguous gene deletion syndrome	Chromosome 17p13.1 deletion syndrome (4)	
17.105	12	30	14	17p13.1	DHRS7C, SDR32C2		Short-chain dehydrogenase reductase family, member 7C	616161				
17.106	02	27	20	17p13.1	DLG4, PSD95, SAP90, MRD62		Discs large MAGUK scaffold protein 4	602887			Intellectual developmental disorder 62, 618793 (3)	
17.107	9	27	17	17p13.1	DVL2		Dishevelled 2	602151				11(Dvl2)
17.108	3	7	13	17p13.1	ELP5, DERP6, C17orf81		Elongator acetyltransferase complex, subunit 5	615019				
17.109	10	17	00	17p13.1	FXR2		Fragile X mental retardation, autosomal homolog-2	605339				
17.110	10	1	17	17p13.1	GPS2		G protein pathway suppressor 2	601935				
17.111	4	14	10	17p13.1	GABARAP		GABA-A receptor-associated protein	605125				
17.112	08	28	19	17p13.1	GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1, CSNB1I		Guanylate cyclase 2D, membrane, retina-specific	600179		mutation identified in 1 CACD1 family	Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6, 601777 (3); ?Choroidal dystrophy, central areolar 1, 215500 (3); Night blindness, congenital stationary, type 1I, 618555 (3)	
17.113	6	6	00	17p13.1	KCNAB3, KCNA3B		Potassium voltage-gated channel, shaker-related subfamily, beta member 3	604111				
17.114	07	24	19	17p13.1	KDM6B, JMJD3, KIAA0346, NEDCFSA		Lysine-specific demethylase 6B	611577			Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, 618505 (3)	
17.115	9	22	16	17p13.1	KIAA0753, OFIP, OFD15		KIAA0753 gene	617112		mutation identified in 1 OFD15 patient	?Orofaciodigital syndrome XV, 617127 (3)	
17.116	04	13	20	17p13.1	MGR10		Migraine with or without aura, susceptibility to, 10	610208			{Migraine with or without aura, susceptibility to, 10} (2)	
17.117	6	30	05	17p13.2	MINK1, MINK		Misshapen/nik-related kinase 1	609426				
17.118	3	23	09	17p13.1	MIR195, MIRN195		Micro RNA 195	610718				
17.119	3	7	14	17p13.1	MIR497		Micro RNA 497	615672				
17.120	1	24	93	17p13.1	MYH1		Myosin, heavy polypeptide-1, skeletal muscle, adult	160730		cluster = 6 genes in 500kb		11(Myh)
17.121	3	19	15	17p13.1	MYH2, MYPOP		Myosin, heavy polypeptide-2, skeletal muscle, adult	160740			Proximal myopathy and ophthalmoplegia, 605637 (3)	
17.122	02	27	20	17p13.1	MYH3, DA2A, DA2B3, DA8, CPSFS1A, CPSFS1B		Myosin, heavy polypeptide-3, skeletal muscle, embryonic	160720			Arthrogryposis, distal, type 2A (Freeman-Sheldon), 193700 (3); Contractures, pterygia, and spondylocarpostarsal fusion syndrome 1A, 178110 (3); Arthrogryposis, distal, type 2B3 (Sheldon-Hall), 618436 (3); Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1B, 618469 (3)	
17.123	10	4	93	17p13.1	MYH4		Myosin, heavy polypeptide-4, skeletal muscle	160742				
17.124	2	24	15	17p13.1	MYH8, DA7		Myosin, heavy polypeptide-8, skeletal muscle, perinatal	160741			Carney complex variant, 608837 (3); Trismus-pseudocamptodactyly syndrome, 158300 (3)	
17.125	6	1	18	17p13.1	NAA38, LSMD1, MAK31		N-alpha-acetyltransferase 38, NatC auxiliary subunit	617990				
17.126	7	17	14	17p13.1	NEURL4, KIAA1787		Neuralized E3 ubiquitin protein ligase 4	615865				
17.127	01	08	19	17p13.1	NTN1, NTN1L, MRMV4		Netrin 1, mouse, homolog of	601614			Mirror movements 4, 618264 (3)	
17.128	7	3	06	17p13.1	ODF4, OPPO1		Outer dense fiber of sperm tails 4	610097				11(Odf4)
17.129	5	3	13	17p13.1	PIK3R5, p101		Phosphatidylinositol 3-kinase, regulatory subunit 5	611317			Ataxia-oculomotor apraxia 3, 615217 (3)	
17.130	9	27	17	17p13.1	PIK3R6, C17orf38		Phosphatidylinositol 3-kinase, regulatory subunit 6	611462				
17.131	6	24	08	17p12	PIRT		Phosphoinositide-interacting regulator of transient receptor potential channels	612068				
17.132	8	29	08	17p13.2-p13.1	PITPNM3, NIR1, CORD5		Phosphatidylinositol transfer protein, membrane-associated, 3	608921			Cone-rod dystrophy 5, 600977 (3)	
17.133	5	24	00	17p13.2	PLD2		Phospholipase D2	602384				11(Pld2)
17.134	3	10	03	17p13.1	PLSCR3		Phospholipid scramblase 3	607611				
17.135	09	27	19	17p13.1	POLR2A, RPOL2, NEDHIB		Polymerase (RNA) II (DNA directed) polypeptide A, 220kD	180660			Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities, 618603 (3)	11(Rpo21)
17.136	2	25	15	17p13.1	RANGRF, MOG1		RAN guanine nucleotide release factor	607954				
17.137	02	18	20	17p13.1	RCVRN, RCV1		Recoverin	179618				11(Rcvrn)
17.138	8	30	16	17p13.1	RNASEK		Ribonuclease K	617098				
17.139	10	13	09	17p13.1	SAT2, SSAT2		Spermidine/spermine N(1)-acetyltransferase 2	611463				
17.140	7	9	09	17p13.1	SENP3		Sentrin-specific protease family, member 3	612844				
17.141	3	12	07	17p13.1	SLC25A35		Solute carrier family 25, member 35	610818				11(Slc25a35)
17.142	10	11	16	17p13.1	SNORD118, LCC		Small nucleolar RNA, C/D box, 118	616663			Leukoencephalopathy, brain calcifications, and cysts, 614561 (3)	
17.143	8	28	17	17p13.1	SPDYE4		SPEEDY/RINGO cell cycle regulator family, member E4	617628				5(Spdye4)
17.144	3	15	13	17p13.1	SPEM1, C17orf83		Spermatid maturation protein 1	615116				
17.145	5	25	00	17p13.1	STK12, ARK2, AIK2, AIM1		Serine/threonine protein kinase 12	604970				11(Stk12)
17.146	11	2	04	17p13.1	TEKT1		Tektin 1	609002				
17.147	12	15	17	17p13.1	TMEM88		Transmembrane protein 88	617813				
17.148	12	15	17	17p13.1	TMEM95		Transmembrane protein 95	617814				
17.149	7	13	17	17p13.1	TMEM107, MKS13, JBTS29		Transmembrane protein 107	616183		mutation identified in 1 JBTS29	Meckel syndrome 13, 617562 (3); ?Joubert syndrome 29, 617562 (3); Orofaciodigital syndrome XVI, 617563 (3)	11(Tmem107)
17.150	11	11	14	17p13.1	TNFSF13, APRIL, TALL2		Tumor necrosis factor ligand superfamily, member 13	604472				
17.151	9	16	03	17p13.1	TNK1		Tyrosine kinase, nonreceptor, 1	608076				
17.152	11	01	18	17p13.1	TP53, P53, LFS1 , BCC7, BMFS5		Tumor protein p53	191170			Li-Fraumeni syndrome, 151623 (3); {Colorectal cancer}, 114500 (3); Hepatocellular carcinoma, somatic, 114550 (3); {Osteosarcoma}, 259500 (3); {Choroid plexus papilloma}, 260500 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); Pancreatic cancer, somatic 260350 (3); {Adrenocortical carcinoma, pediatric}, 202300 (3); Breast cancer, somatic, 114480 (3); {Basal cell carcinoma 7}, 614740 (3); {Glioma susceptibility 1}, 137800 (3); Bone marrow failure syndrome 5, 618165 (3)	11(Trp53)
17.153	4	26	11	17p13.1	TMEM102, CBAP		Transmembrane protein 102	613936				
17.154	11	16	17	17p13.1	TMEM256, C17orf61		Transmembrane protein 256	617779				
17.155	12	01	20	17p13.1	TRG-GCC2-6, TRNAG2, TRG2		tRNA glycine (anticodon GCC) 2-6	610407		at least 8 copies in this region		
17.156	11	30	20	17p13.1	TRNAK1, TRK1, TRK-TTT3-5		Transfer RNA lysine (TTT) 3-5	189918				
17.157	9	2	09	17p13.1	TRNAL2, TRL2		tRNA leucine-2	189920				
17.158	9	2	09	17p13.1	TRNAR1, TRR1		tRNA arginine-1	610406				
17.159	9	2	09	17p13.1	TRNAQ1, TRQ1		tRNA glutamine-1	189919				
17.160	6	2	16	17p13.1	TXNDC17, TRP14, TXNL5		Thioredoxin domain-containing protein 17	616967				
17.161	12	23	05	17p13.1	WDR16, WDRPUH		WD repeat-containing protein 16	609804				
17.162	8	27	15	17p13.1	YBX2, MSY2, CSDA3, DBPC		Y box-binding protein 2	611447				
17.163	9	22	08	17p13.1	ZBTB4, KIAA1538		Zinc finger and BTB domain-containing 4	612308				
17.164	2	10	05	17p13.1	MPDU1, SL15, CDGIF		Mannose-P-dolichol utilization defect 1	604041			Congenital disorder of glycosylation, type If, 609180 (3)	
17.165	6	25	99	17p13.1	MYH13		Myosin, heavy polypeptide 13, skeletal muscle	603487				11(Myh13)
17.166	3	16	99	17p13.1	EFNB3, EPLG8, LERK8, EFL6		Ephrin B3	602297				
17.167	09	29	20	17p11.2	NOS2P2, NOS2B		Nitric oxide synthase 2 pseudogene 2	600719				
17.168	09	29	20	17p13.1-q25	NOS2P1, NOS2C		Nitric oxide synthase 2 pseudogene 1	600720				
17.169	9	26	05	17p13.1	ACADVL, VLCAD		Acyl-Coenzyme A dehydrogenase, very long chain	609575			VLCAD deficiency, 201475 (3)	11(Acadvl)
17.170	11	27	94	17p13.2	ARRB2		Arrestin, beta 2	107941				
17.171	6	7	04	17p13	ASPG2		Asperger syndrome, susceptibility to, 2	608631		breakpoints between CHRNE and GP1BA	{Asperger syndrome susceptibility 2} (2)	
17.172	12	15	98	17p13.1	CD68		Macrophage antigen CD68 (macrosialin)	153634				11(Cd68)
17.173	12	11	18	17p13.1	CHD3, SNIBCPS		Chromodomain helicase DNA binding protein-3	602120			Snijders Blok-Campeau syndrome, 618205 (3)	
17.174	7	22	13	17p13	CTRCT24, CTAA2		Cataract 24, anterior polar	601202			Cataract 24, anterior polar (2)	
17.175	2	28	03	17p13.2	CTNS		Cystinosin	606272		?3 allelic forms	Cystinosis, nephropathic, 219800 (3); Cystinosis, ocular nonnephropathic, 219750 (3); Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3); Cystinosis, atypical nephropathic, 219800 (3)	
17.176	11	27	00	17p13.2	CXCL16		CXC chemokine ligand-16	605398				11(Cxcl16)
17.177	11	12	20	17p13.1	DNAH2, DNAHC2, SPGF45		Dynein, axonemal, heavy chain-2	603333			Spermatogenic failure 45, 619094 (3)	11(Dnach2)
17.178	12	15	98	17p13.1	EIF4A1, DDX2A		Eukaryotic translation initiation factor 4A, isoform 1	602641				11(Eif4a1)
17.179	3	18	17	17p13.2	INCA1, HSD45		Inhibitor of CDK, cyclin A1-interacting protein 1	617374				
17.180	8	1	14	17p13.2	ITGAE, CD103		Integrin, alpha-E	604682				11(Itgae1)
17.181	1	24	93	17p13.1	MYH10		Myosin, heavy polypeptide-10, non-muscle	160776				
17.182	12	27	01	17p13.3	MYO1C		Myosin IC	606538				
17.183	03	23	20	17p13.2	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, VAMAS1, MSPC, AIADK, JRRP		NLR family, pyrin domain containing 1	606636		mutation identified in 1 JRRP family	{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3); Palmoplantar carcinoma, multiple self-healing, 615225 (3); Autoinflammation with arthritis and dyskeratosis, 617388 (3); ?Respiratory papillomatosis, juvenile recurrent, congenital, 618803 (3)	
17.184	12	2	14	17p13	NDNC7		Nail disorder, nonsyndromic congenital, 7 (onychodysplasia, isolated congenital)	605779			Nail disorder, nonsyndromic congenital, 7 (2)	
17.185	04	19	19	17p13.2	NUP88, FADS4		Nucleoporin, 88-kD	602552			Fetal akinesia deformation sequence 4, 618393 (3)	
17.186	7	22	09	17p13.1	PHF23		PHD finger protein 23	612910				
17.187	3	4	08	17p13.2	RABEP1, RABPT5		RAB GTPase-binding effector protein 1	603616		fused to PDGFRB in CMML		
17.188	1	11	17	17p13.2	RPAIN, RIP		RPA-interacting protein	617299				
17.189	11	23	16	17p13.2	SHPK, CARKL		Sedoheptulokinase	605060			[Sedoheptulokinase deficiency], 617213 (3)	
17.190	10	16	14	17p13.1	SLC2A4, GLUT4		Solute carrier family 2 (facilitated glucose transporter), member 4	138190				
17.191	8	29	02	17p13.1	SOX15, SOX20		SRY (sex-determining region Y)-box 15	601297				
17.192	12	15	10	17p13	SXGQTL1		Sex hormone-binding globulin circulating level quantitative trait locus 1	613498		associated with rs1799941	[Sex hormone-binding globulin circulating level QTL 1] (2)	
17.193	7	28	15	17p13.2	TAX1BP3, TIP1		TAX1-binding protein 3	616484				
17.194	5	21	07	17p13.1	TRAPPC1, MUM2, BET5		Trafficking protein particle complex, subunit 1	610969				
17.195	3	23	02	17p13.2	TRPV1, VR1		Transient receptor potential cation channel, subfamily V, member 1 (vanilloid receptor 1; capsaicin receptor)	602076				11(Vr1)
17.196	6	3	15	17p13.2	TRPV3, OLMS, FNEPPK2		Transient receptor potential cation channel, subfamily V, member 3	607066		mutation identified in 1 FNEPPK2 family	Olmsted syndrome, 614594 (3); ?Palmoplantar keratoderma, nonepidermolytic, focal 2, 616400 (3)	11(Trpv3)
17.197	5	22	03	17p13.2	USP6, TRE2		Ubiquitin-specific protease 6	604334				
17.198	7	1	11	17p13.1	WRAP53, TCAB1, WDR79, DKCB3		WD repeat-containing protein antisense to TP53	612661			Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	
17.199	11	11	91	17p13.1	ASGR1		Asialoglycoprotein receptor-1	108360				11(Asgr1)
17.200	4	30	15	17p13.2	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C		Cholinergic receptor, nicotinic, epsilon polypeptide	100725			Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3); Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3); Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	
17.201	12	17	95	17p13.1	EIF5A		Eukaryotic translation initiation factor-5A	600187				
17.202	10	23	20	17p13.1	SCO1, SCOD1, MC4DN4		SCO cytochrome c oxidase assembly protein 1	603644			Mitochondrial complex IV deficiency, nuclear type 4, 619048 (3)	
17.203	6	21	91	17p13.1	SHBG, ABP		Sex hormone-binding globulin (androgen binding protein)	182205				11(Shbg)
17.204	10	23	20	17p13.1	SLC13A5, NACT, DEE25		Solute carrier family 13 (sodium-dependent citrate transporter), member 5	608305			Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta, 615905 (3)	
17.205	10	4	93	17p12	ZNF18, KOX11		Zinc finger protein-18 (KOX11)	194524				
17.206	10	25	19	17p12	ZNF29P		Zinc finger protein 29, pseudogene	194535		proximal to TP53		11(Zfp2)
17.207	1	22	01	17p12	AOMS2		Abdominal obesity-metabolic syndrome QTL2	605572		second QTL on 3q27	Abdominal obesity-metabolic syndrome (2)	
17.208	10	11	17	17p12	ARHGAP44, RICH2, KIAA0672		RHO GTPase-activating protein 44	617716				
17.209	01	29	19	17p12	DNAH9, DNAH17L, DNEL1, CILD40		Dynein, axonemal, heavy chain 9	603330			Ciliary dyskinesia, primary, 40, 618300 (3)	
17.210	12	17	07	17p11.2	FBXW10		F-box and WD40 domain protein 10	611679				11(Fbxw10)
17.211	08	21	19	17p13.1	PER1, PER, RIGUI		Period circadian regulator 1	602260				11(Per)
17.212	2	2	17	17p12	SHISA6		Shisa family, member 6	617327				
17.213	6	6	00	17p13.1	STX8		Syntaxin 8	604203				
17.214	3	31	09	17p12	TEKT3		Tektin 3	612683				
17.215	6	23	15	17p12	TTC19, MC3DN2		Tetratricopeptide repeat domain 19	613814			Mitochondrial complex III deficiency, nuclear type 2, 615157 (3)	
17.216	01	31	20	17p13.1	VAMP2, SYB2, NEDHAHM		Vesicle-associated membrane protein-2 (synaptobrevin-2)	185881			Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements, 618760 (3)	11(Syb2)
17.217	3	30	12	17p12	ZSWIM7, SWS1		Zinc finger SWIM domain-containing protein 7	614535				
17.218	3	26	95	17p12	ADORA2B		Adenosine A2b receptor	600446		incorrectly put on 10		
17.219	10	23	20	17p12	COX10, MC4DN3		Cytochrome c oxidase, subunit X	602125			Mitochondrial complex IV deficiency, nuclear type 3, 619046 (3)	
17.220	6	6	00	17p12	HS3ST3A1, 30ST3A1		Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 3A1	604057				11(30st3a1)
17.221	6	6	00	17p12	HS3ST3B1, 30ST3B1		Heparan sulfate D-glucosaminyl 3-0-sulfotransferase 3B1	604058				11(30st3B)
17.222	06	24	19	17p11.2	LLGL1, DLG4		LLGL scribble cell polarity complex component 1	600966				
17.223	5	4	12	17p11.2	PIGL, CHIME		Phosphatidylinositol glycan, class L	605947			CHIME syndrome, 280000 (3)	
17.224	6	25	99	17p11.2	PRPSAP2, PAP41		Phosphoribosylpyrophosphate synthetase-associated protein 2	603762				
17.225	09	06	18	17p11.2	TOP3A, MGRISCE2, PEOB5		Topoisomerase (DNA) III, alpha	601243		mutation identified in 1 PEOB5 patient	Microcephaly, growth restriction, and increased sister chromatid exchange 2, 618097 (3); ?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5, 618098 (3)	
17.226	11	23	15	17p12-p11.2	YUHAL		Yuan-Harel-Lupski syndrome	616652		contiguous gene duplication syndrome	Yuan-Harel-Lupski syndrome (4)	
17.227	12	03	18	17p11.2	UBB		Ubiquitin B	191339				
17.228	4	30	15	17p13.1	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C		Cholinergic receptor, nicotinic, beta polypeptide-1, muscle	100710		mutation identified in 1 CMS2C family	Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3); ?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3)	11(Acrb)
17.229	6	7	10	17p12-q11.2	DFNB85		Deafness, autosomal recessive 85	613392		between rs230884 and rs12603885	Deafness, autosomal recessive 85 (2)	
17.230	11	14	12	17p12-q21.2	ECTD6		Ectodermal dysplasia 6, hair/nail type	614928		between D17S839 and D17S1299	Ectodermal dysplasia 6, hair/nail type (2)	
17.231	3	27	95	17p11.2	ALDH3A1, ALDH3		Aldehyde dehydrogenase 3 family, member A1	100660				11(Ahd4)
17.232	8	9	05	17p11.2	ALDH3A2, ALDH10, SLS, FALDH		Aldehyde dehydrogenase 3 family, member A2 (fatty aldehyde dehydrogenase)	609523			Sjogren-Larsson syndrome, 270200 (3)	
17.233	10	28	19	17p11.2	ALKBH5, ABH5		AlkB homolog 5, RNA demethylase	613303				
17.234	8	16	17	17p11.2	ATPAF2, ATP12, MC5DN1		ATP synthase, mitochondrial F1 complex, assembly factor 2	608918		mutation identified in 1 MC5DN1 patient	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3)	11(Atpaf2)
17.235	9	24	16	17p11.2	B9D1, MKSR1, MKS9, JBTS27		B9 domain-containing protein 1	614144		mutation identified in 1 MKS9 patient	?Meckel syndrome 9, 614209 (3); Joubert syndrome 27, 617120 (3)	
17.236	4	23	10	17p11.2	CENPV, P30		Centromere protein V	608139				
17.237	1	8	01	17p11.2	COPS3, SGN3		COP9 signalosome, subunit 3	604665				
17.238	12	30	14	17p11.2	DHRS7B, SDR32C1		Short-chain dehydrogenase reductase family, member 7B	616160				
17.239	01	31	20	17p11.2	DRC3, LRRC48, CFAP134		Dynein regulatory complex subunit 3	618758				
17.240	3	6	01	17p11.2	DRG2		Developmentally regulated GTP-binding protein 2	602986				
17.241	3	7	05	17p11.2	FLCN, BHD		Folliculin	607273			Birt-Hogg-Dube syndrome, 135150 (3); Pneumothorax, primary spontaneous, 173600 (3); Renal carcinoma, chromophobe, somatic, 144700 (3); Colorectal cancer, somatic, 114500 (3)	
17.242	10	11	17	17p11.2	GID4, VID2, C17orf39		GID complex, subunit 4	617699				
17.243	06	03	19	17p11.2	GRAP, DFNB114		GRB2-related adaptor protein	604330			Deafness, autosomal recessive 114, 618456 (3)	
17.244	12	02	20	17p11.2	FLII		FLII actin remodeling protein	600362				
17.245	11	21	02	17p11.2	IS2, AIS2		Scoliosis, idiopathic 2	607354		between D17S947 and D17S798	Scoliosis, idiopathic 2 (2)	
17.246	2	21	10	17p11.2	KCNJ18, KIR2.6, TTPP2		Potassium channel, inwardly rectifying, subfamily J, member 18	613236			{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)	
17.247	6	25	99	17p11.2	MAPK7, PRKM7, ERK5		Mitogen-activated protein kinase 7 (extracellular signal-regulated kinase 5)	602521				
17.248	3	22	06	17p11.2	MED9, MED25, FLJ10193		Mediator of RNA polymerase II transcription, subunit 9, S. cerevisiae, homolog of	609878				
17.249	10	05	20	17p11.2	MEIF2, SMCR7, MID49, COXPD49		Mitochondrial elongation factor 2	615498		mutation identified in 1 COXPD49 patient	?Combined oxidative phosphorylation deficiency 49, 619024 (3)	
17.250	4	9	96	17p11.2	MFAP4		Microfibrillar-associated protein-4	600596				
17.251	10	12	10	17p11.2	MIR33B, MIRN33B		Micro RNA 33B	613486				
17.252	8	17	09	17p11.2	MPRIP, MRIP, KIAA0864, RIP3, P116RIP		Myosin phosphatase Rho-interacting protein	612935				
17.253	6	26	16	17p11.2	MTRNR2L1, HN1		MTRNR2-like 1	616985				
17.254	12	27	19	17p12	MYOCD, MGBL		Myocardin	606127			Megabladder, congenital, 618719 (3)	
17.255	5	28	98	17p11.2	MYO15A, DFNB3		Myosin XVA	602666			Deafness, autosomal recessive 3, 600316 (3)	11(sh2, Myo15)
17.256	6	21	01	17p11.2	NT5M, DNT2		Deoxyribonucleotidase, mitochondrial (5' nucleotidase, mitochondrial)	605292				
17.257	9	13	12	17p11.2	PEMT, PEMPT		Phosphatidylethanolamine N-methyltransferase	602391				
17.258	1	31	17	17p12	PMP22, CMT1A, CMT1E, DSS, CIDP		Peripheral myelin protein-22	601097		mutation identified in 1 CIDP family	Charcot-Marie-Tooth disease, type 1A, 118220 (3); Dejerine-Sottas disease, 145900 (3); Neuropathy, recurrent, with pressure palsies, 162500 (3); Charcot-Marie-Tooth disease, type 1E, 118300 (3); Roussy-Levy syndrome, 180800 (3); ?Neuropathy, inflammatory demyelinating, 139393 (3)	11(Tr)
17.259	12	17	12	17p11.2	PLD6, ZUC		Phospholipase D family, member 6	614960				
17.260	8	1	14	17p11.2	PRG4, FLJ36000		p53-responsive gene 4	605160				
17.261	4	17	07	17p11.2	PTLS		Potocki-Lupski syndrome	610883		contiguous gene syndrome	Potocki-Lupski syndrome (4)	
17.262	3	25	03	17p11.2	RAI1, SMCR, SMS		Retinoic acid-induced gene 1	607642			Smith-Magenis syndrome, 182290 (3)	
17.263	2	9	04	17p11.2	RASD1, DEXRAS1		Ras protein, dexamethasone-induced, 1	605550				
17.264	9	8	17	17p11.2	RNF112, ZNF179, BFP		RING finger protein 112	601237				11(Bfp)
17.265	9	22	93	17p11.2	RNU3		RNA, U3 small nuclear	180710		deleted in Smith-Magenis syndrome		
17.266	7	8	96	17p12	SERK1, PRKMK4, MAPKK4, JNKK1		SAPK/ERK kinase-1	601335				11(Serk1)
17.267	7	13	93	17p11.2	SHMT1		Serine hydroxymethyltransferase (soluble)	182144		?role in Smith-Magenis syndrome		
17.268	10	25	19	17p11.2	SLC5A10, SGLT5		Solute carrier family 5 (sodium/glucose cotransporter), member 10	618636				
17.269	7	9	09	17p11.2	SLC47A1, MATE1, FLJ10847		Solute carrier family 47, member 1	609832				11(Mate1)
17.270	7	9	09	17p11.2	SLC47A2, MATE2, FLJ31196, MATE2K		Solute carrier family 47, member 2	609833				11(Mate2)
17.271	8	17	16	17p11.2	SMCR8		Smith-Magenis syndrome chromosome region, candidate gene 8	617074				
17.272	9	8	11	17p11.2	SPECC1, HCMOGT1, NSP		Sperm antigen with calponin homology and coiled-coil domains 1	608793				
17.273	10	19	20	17p11.2	SREBF1, IFAP2, HMD		Sterol regulatory element binding transcription factor 1	184756			Ichthyosis, follicular, with atrichia and photophobia syndrome 2, 619016 (3); Mucoepithelial dysplasia, hereditary, 158310 (3)	
17.274	03	19	20	17p11.2	TMEM11		Transmembrane protein 11	618817				
17.275	12	15	10	17p11.2	TNFRSF13B, TACI, CVID2		Tumor necrosis factor receptor superfamily, member 13B	604907			Immunoglobulin A deficiency 2, 609529 (3); Immunodeficiency, common variable, 2, 240500 (3)	
17.276	11	19	13	17p11.2	TOM1L2		TOM1-like 2	615519				
17.277	2	25	15	17p12	TRIM16, EBBP		Tripartite motif-containing protein 16	609505				
17.278	3	14	13	17p11.2	ULK2, KIAA0623, UNC51.2		UNC51-like kinase 2	608650				11(Ulk2)
17.279	6	30	08	17p11.2	USP22, KIAA1064		Ubiquitin-specific protease 22	612116				
17.280	5	3	04	17p11.2	KCNJ12, KCNJN1		Potassium inwardly-rectifying channel, subfamily J, member 12	602323				
17.281	4	2	09	17p11.2	AKAP10		A-kinase anchor protein 10	604694			{Cardiac conduction defect, susceptibility to}, 115080 (3)	
17.282	08	12	19	17q11.2	IFT20		Intraflagellar transport 20	614394				
17.283	11	4	98	17q11.2	CPD		Carboxypeptidase D	603102				11(Cpd)
17.284	10	8	99	17q11.2	SLC13A2, NADC1		Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2	604148				
17.285	9	30	04	17p11	ADHD2		Attention deficit-hyperactivity disorder, susceptibility to, 2	608904			{Attention deficit-hyperactivity disorder}, 143465 (2)	
17.286	01	31	20	17p12	ELAC2, HPC2, COXPD17		elaC ribonuclease Z 2	605367		at ~365cR	{Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3); Combined oxidative phosphorylation deficiency 17, 615440 (3)	
17.287	1	2	91	17p13.1	ASGR2		Asialoglycoprotein receptor-2	108361				11(Asgr2)
17.288	4	12	92	17p13.1	ATP1B2, AMOG		ATPase, Na+K+ transporting, beta-2 polypeptide	182331				11(Atp1b2)
17.289	10	14	98	17p13.1	GAS7		Growth arrest-specific 7	603127				11(gas7)
17.290	11	4	13	17p13.1	RPL26, DBA11		Ribosomal protein L26	603704		mutation identified in 1 family	?Diamond-Blackfan anemia 11, 614900 (3)	
17.291	10	12	20	17q11.2	NOS2A, NOS2		Nitric oxide synthase 2A	163730		?cluster of 3 NOS2 genes	{Malaria, resistance to}, 611162 (3)	11(Nos2)
17.292	9	15	89	17q11.2	ALDOC		Aldolase C, fructose-bisphosphatase	103870				
17.293	8	4	99	17q	HYT1		Hypertension, essential, susceptibility to, 1	603918		~18cM distal to ACE	{Hypertension, essential, susceptibility to, 1}, 145500 (2)	
17.294	10	20	99	17q25.1	RPL38		Ribosomal protein L38	604182				
17.295	5	16	07	17q11	AUTS6		Autism, susceptibility to, 6	609378		max lod at D17S1800	{Autism susceptibility 6} (2)	
17.296	1	11	02	17q11	ERVE1, HERVE1		Endogenous retroviral sequence E, 1	606601				
17.297	8	20	99	17q11.2	GOSR1, GOS28, GS28		Golgi snap receptor complex member 1	604026				
17.298	3	3	03	17q11.2	PPY2		Pancreatic polypeptide 2	606638				
17.299	3	3	03	17q11.2	PYY2		Peptide YY, 2	606637				
17.300	08	21	19	17q12	RAD51D, RAD51L3, BROVCA4		RAD51 paralog D	602954			{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)	11(Rad51d)
17.301	03	05	19	17q11.2	RNF135		Ring finger protein 135	611358				
17.302	8	20	99	17q12	RPL23		Ribosomal protein L23	603662				
17.303	3	26	95	17q12	RPL19		Ribosomal protein L19	180466				
17.304	2	18	98	17q11.2	RPL23A		Ribosomal protein L23a	602326				
17.305	4	30	03	17q11.2	SARM, KIAA0524		Sterile alpha and heat/armadillo motifs-containing protein	607732				
17.306	09	11	19	17q12	UNC45B, SMUNC45, CTRCT43		unc-45 myosin chaperone B	611220		mutation identified in 1 CTRCT43 family	?Cataract 43, 616279 (3)	
17.307	8	7	92	17q11.2	VTN, VNT		Vitronectin (serum spreading factor, somatomedin B, complement S-protein)	193190				
17.308	8	24	98	17q11.2	FLOT2, M17S1, ECS1, ESA1		Flotillin 2 (epidermal surface antigen 1)	131560		~180kb centromeric to NF1		11(Esa1)
17.309	03	16	20	17q11.2	FOXN1, WHN, TIDAND, TLIND		Forkhead box N1 (winged helix nude)	600838			T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3); T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant, 618806 (3)	
17.310	12	27	01	17q11.2	MYO1D, KIAA0727		Myosin ID	606539				11(Myo1d)
17.311	6	28	02	17q12	STARD3, MLN64		Start domain-containing protein 3	607048				
17.312	4	2	01	17q21.2	DANJC7, TTC2, TPR2		DnaJ, E. coli, homolog of, subfamily C, member 7 (tetratricopeptide repeat domain 2)	601964				
17.313	11	14	18	17q23.3	CYB561, ORTHYP2		Cytochrome b-561	600019			Orthostatic hypotension 2, 618182 (3)	
17.314	8	1	08	17q25.1	ITGB4		Integrin, beta-4	147557			Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3); Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3); Epidermolysis bullosa of hands and feet, 131800 (3)	
17.315	2	15	18	17q11.2	NEK8, JCK, NPHP9, RHPD2		Never in mitosis gene A-related kinase 8	609799		mutations identified in 1 family with NPHP9	?Nephronophthisis 9, 613824 (3); Renal-hepatic-pancreatic dysplasia 2, 615415 (3)	
17.316	4	18	07	17q11.2	RAB34, RAH		Ras-associated protein 34	610917				
17.317	5	5	09	17q11.2	SLC46A1, HCP1, PCFT		Solute carrier family 46 (folate transporter), member 1	611672			Folate malabsorption, hereditary, 229050 (3)	11(Slc46a1)
17.318	3	24	14	17q11.1	WSB1, SWIP1		WD repeat- and SOCS box-containing protein 1	610091				
17.319	12	5	01	17q12	TAF15, TAF2N, RBP56		TAF15 RNA polymerase II, TATA box-binding protein-associated factor, 68kD	601574		fusion gene with CSMF	Chondrosarcoma, extraskeletal myxoid, 612237 (1)	
17.320	5	23	13	17q11.2	CRYBA1, CRYB1, CTRCT10		Crystallin, beta A1	123610		centromeric to NF1	Cataract 10, multiple types, 600881 (3)	11(Cryba1)
17.321	1	26	12	17q11.2	SLC6A4, HTT, OCD1		Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4	182138			{Anxiety-related personality traits}, 607834 (3); {Obsessive-compulsive disorder}, 164230 (3)	11(Htt)
17.322	7	17	14	17q11.2	ADAP2, CENTA2		ArfGAP with dual PH domains 2	608635				
17.323	4	6	13	17q11.2	ANKRD13B		Ankyrin repeat domain-containing protein 13B	615124				
17.324	1	12	12	17q11.2	ATAD5, C17orf41, FRAG1, FLJ12735		ATPase family, AAA domain containing 5	609534				11(Atad5)
17.325	7	26	16	17q11.2	BLMH, BMH		Bleomycin hydrolase	602403				
17.326	2	5	07	17q11.2	CCL3L1, SCYA3L1, LD78		Chemokine, C-C motif, ligand 3-like 1	601395		varies in copy number 1-10	{HIV/AIDS, susceptibility to}, 609423 (3)	
17.327	8	29	02	17q12	CCL8, SCYA8		Chemokine, C-C motif, ligand 8	602283				
17.328	8	29	02	17q12	CCL13, SCYA13, NCC1		Chemokine, C-C motif, ligand 13	601391				
17.329	8	29	02	17q12	CCL14, SCYA14, NCC2		Chemokine, C-C motif, ligand 14	601392				
17.330	5	27	97	17q12	CCL15, SCYA15, NCC3, LKN1		Chemokine, C-C motif, ligand 15	601393				
17.331	8	29	02	17q12	CCL16, SCYA16, NCC4		Chemokine, C-C motif, ligand 16	601394				
17.332	8	29	02	17q12	CCL18, SCYA18, PARC, AMAC1, DCCK1		Chemokine, C-C motif, ligand 18	603757		in 47kb, CCL18-CCL3-CCL4		
17.333	7	7	16	17q11.2	CDK5R1, p35		Cyclin-dependent kinase 5, regulatory subunit 1	603460				11(Cdk5r)
17.334	10	11	12	17q11.2	CRLF3, CYTOR4, CRLM9, CREME9		Cytokine receptor-like factor 3	614853				
17.335	1	21	11	17q11.2	DEL17q11.2, C17DELq11.2		Chromosome 17q11.2 deletion syndrome, 1.4Mb (NF1 microdeletion syndrome)	613675			Chromosome 17q11.2 deletion syndrome, 1.4Mb (4)	
17.336	05	07	20	17q11.2	DUP17q11.2, C17DUPq11.2		Chromosome 17q11.2 duplication syndrome, 1.4-Mb	618874			Chromosome 17q11.2 duplication syndrome, 1.4-Mb (4)	
17.337	12	30	14	17q11.2	DHRS13, SDR7C5		Short-chain dehydrogenase reductase family, member 13	616157				
17.338	7	11	17	17q11.2	ERAL1, ERAL1A, ERAL1B, PRLTS6		ERA G-protein-like 1	607435			Perrault syndrome 6, 617565 (3)	11(Eral1)
17.339	3	6	92	17q11.2	EVI2A, EVI2, EVDA		Ecotropic viral integration site 2A	158380		within the NF1 gene		11(Evi2)
17.340	3	4	92	17q11.2	EVI2B, EVDB		Ecotropic viral integration site 2B	158381		within the NF1 gene		
17.341	07	28	20	17q11.2	GIT1		GIT ArfGap 1	608434				
17.342	5	1	03	17q21.2	KRT24, FLJ20261		Keratin 24	607742				
17.343	1	31	07	17q11.2	KSR, KSR1		Kinase suppressor of RAS	601132				
17.344	4	18	05	17q11.2	LGALS9		Lectin, galactoside-binding, soluble, 9	601879				
17.345	9	24	15	17q11.2	LRRC37B		Leucine-rich repeat-containing protein 37B	616558				
17.346	5	12	09	17q12	LYZL6		Lysozyme-like 6	612751				
17.347	3	23	09	17q11.2	MIR144, MIRN144		Micro RNA 144	612070				
17.348	7	20	12	17q11.2	MIR193A		Micro RNA 193A	614733				11(Mir193a)
17.349	3	23	09	17q11.2	MIR451, MIRN451		Micro RNA 451	612071				
17.350	8	8	13	17q12	MMP28		Matrix metalloproteinase 28	608417				
17.351	3	11	09	17q11.2	MPVQTL3		Mean platelet volume quantitative trait locus 3	612575		associated with rs2138852	[Mean platelet volume QTL3] (2)	
17.352	3	16	10	17q11.2	MYO18A, SPR210		Myosin XVIIIA	610067				
17.353	8	20	14	17q11.2	NF1, VRNF, WSS, NFNS		Neurofibromin (neurofibromatosis, type I)	613113			Neurofibromatosis, type 1, 162200 (3); Leukemia, juvenile myelomonocytic, 607785 (3); Neurofibromatosis, familial spinal, 162210 (3); Neurofibromatosis-Noonan syndrome, 601321 (3); Watson syndrome, 193520 (3)	
17.354	5	18	99	17q21.1	NR1D1, THRAL, EAR1		Nuclear receptor 1, subfamily D, member 1 (thyroid hormone receptor, alpha-1-like)	602408				
17.355	1	12	15	17q11.2	NSRP1, NSRP70, CCDC55		Nuclear speckle splicing regulatory protein 1	616173				11(Nsrp1)
17.356	6	2	08	17q11.2	NUFIP2, KIAA1321, PIG1		Nuclear fragile X mental retardation protein-interacting protein 2	609356				
17.357	8	13	91	17q11.2	OMG, OMGP		Oligodendrocyte-myelin glycoprotein	164345		within the NF1 gene		
17.358	10	25	19	17q11.2	PHF12, PF1		PHD finger protein 12	618645				
17.359	10	11	18	17q11.2	PIGS, GPIBD18		Phosphatidylinositol glycan, class S	610271			Glycosylphosphatidylinositol biosynthesis defect 18, 618143 (3)	
17.360	11	05	18	17q11.2	PIPOX		Pipecolic acid oxidase	616713				
17.361	9	9	08	17q11.2	POLDIP2, PDIP38		Polymerase delta-interacting protein 2	611519				
17.362	6	23	99	17p11.2	PRKMK3, MAPKK3, MEK3		Protein kinase, mitogen-activated, kinase-3	602315				
17.363	3	18	17	17q11.2	PROCA1		Proline-rich cyclin A1-interacting protein	617376				
17.364	9	25	12	17q11.2	PSMD11, S9		Proteasome 26S subunit, non-ATPase, 11	604449				
17.365	4	23	08	17q11.2	RAB11FIP4, KIAA1821		RAB11 family-interacting protein 4	611999				
17.366	7	22	09	17q12	RDM1		RAD52 motif-containing protein 1	612896				
17.367	09	09	20	17q11.2	RHBDL3, VRHO		Rhomboid-like 3	619017				
17.368	4	15	11	17q11.2	RHOT1, MIRO1, ARHT1		Ras homolog gene family, member T1	613888				
17.369	8	6	98	17q11.2	SDF2		Stromal cell-derived factor-2	602934				
17.370	5	22	07	17q11.2	SEBOX, OG9		Skin-, embryo-, brain-, and oocyte-specific homeobox	610975				11(Sebox)
17.371	12	1	15	17q11.2	SEZ6, BSRPC		Seizure-related 6, mouse, homolog of	616666				
17.372	12	27	13	17q11.2	SPAG5, MAP126, ASTRIN		Sperm-associated antigen 5	615562				
17.373	4	3	12	17q11.2	SSH2, KIAA1725		Slingshot, Drosophila, homolog of, 2	606779				
17.374	08	24	20	17q21.2	STAT5B, GHISID2		Signal transducer and activator of transcription 5B	604260		fused with RARA in PML	Leukemia, acute promyelocytic, somatic, 102578 (3); Growth hormone insensitivity with immune dysregulation 1, autosomal recessive, 245590 (3); Growth hormone insensitivity with immune dysregulation 2, autosomal dominant, 618985 (3)	
17.375	11	12	20	17q11.2	SUPT6H		SPT6 homolog, histone chaperone and transcription elongation factor	601333				11(Supt6h)
17.376	02	21	20	17q11.2	SUZ12, JJAZ1, KIAA0160, IMMAS		SUZ12 polycomb repressive complex 2 subunit	606245			Imagawa-Matsumoto syndrome, 618786 (3)	
17.377	12	7	09	17q11.2	TAOK1, PSK2, TAO1, MARKK		TAO kinase 1	610266				
17.378	6	19	15	17q11.2	TEFM, C17orf42		Transcription elongation factor, mitochondrial	616422				
17.379	1	27	12	17q21.1	THRA, ERBA1, THRA1, CHNG6		Thyroid hormone receptor, alpha (oncogene ERBA1)	190120			Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	11(Erba)
17.380	4	19	06	17q11.2	TIAF1, MYO18A, MYSPDZ, MAJN, SPR210, KIAA0216		TGFB1-induced antiapoptotic factor 1	609517				
17.381	7	22	09	17q11.2	TMEM97, MAC30		Transmembrane protein 97	612912				
17.382	10	1	17	17q11.2	TRAF4, MLN62, CART1		TNF receptor-associated factor 4	602464				
17.383	3	10	16	17q11.2	TMEM98, NNO4		Transmembrane protein 98	615949			Nanophthalmos 4, 615972 (3)	
17.384	2	29	16	17q11.2	TMEM199, VMA12, VPH2, C17orf32, CDG2P		Transmembrane protein 199	616815			Congenital disorder of glycosylation, type IIp, 616829 (3)	
17.385	09	11	19	17q11.2	UNC119, HRG4, IMD13		unc-119 lipid binding chaperone	604011		mutation identified in 1 IMD13 family and CORD family	?Cone-rod dystrophy (3); ?Immunodeficiency 13, 615518 (3)	
17.386	6	18	99	17q11.2	ZNF207		Zinc finger protein-207	603428		mapped by FISH to 6p21.3		
17.387	2	16	04	17q12	AATF, CHE1		Apoptosis-antagonizing transcription factor	608463				11(Aatf)
17.388	7	13	98	17q11-q12	ACCN1, BNC1, MDEG		Amiloride-sensitive cation channel 1, neuronal (degenerin)	601784				
17.389	9	18	00	17q12	AP2B1, CLAPB1, ADTB2		Adaptor-related protein complex 2, beta 1 subunit	601025				
17.390	10	11	06	17q12	CCL2, SCYA2, MCP1, MCAF		Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je)	158105			{HIV-1, resistance to}, 609423 (3); {Spina bifida, susceptibility to}, 182940 (3); {Coronary artery disease, modifier of} (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
17.391	10	7	02	17q12	CCL5, SCYA5, D17S136E, TCP228		Chemokine, C-C motif, ligand 5	187011			{HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid progression of} (3)	
17.392	8	29	02	17q12	CCL7, SCYA7, MCP3		Chemokine, C-C motif, ligand 5	158106		close to ERBB2		
17.393	7	8	89	17q21.1	CSF3, GCSF		Colony-stimulating factor-3 (granulocyte)	138970				11(Csfq)
17.394	10	15	97	17q12	LIG3		Ligase III, DNA, ATP-dependent	600940				
17.395	10	15	94	17q11.2-q24	MHS2		Malignant hyperthermia susceptibility 2	154275		?due to mutation in SCN4A	{Malignant hyperthermia susceptibility 2} (2)	
17.396	11	30	06	17q12	ARHGAP23, KIAA1501		RHO GTPase-activating protein 23	610590				11(Arhgap23)
17.397	7	18	06	17q12	CCL3, SCYA3, MIP1A		Chemokine, C-C motif, ligand 3	182283		in 47kb, CCL18-CCL3-CCL4	{HIV infection, resistance to}, 609423 (2)	11(Mip1a)
17.398	2	2	04	17q12	CCL4, SCYA4, ACT2, MIP1B, AT744.1		Chemokine, C-C motif, ligand 4	182284				(Mip1b)
17.399	3	8	07	17q12	CCL4L, SCYA4L, LAG1		Chemokine, C-C motif, ligand 4-like	603782				
17.400	3	8	07	17q12	CCL4L2		Chemokine, CC motif, ligand 4-like 2	610757				
17.401	4	29	14	17q12	CCL23, SCYA23		Chemokine, C-C motif, ligand 23	602494				
17.402	1	30	07	17q12	CCT6B, CCTZ2		Chaperonin containing T-complex polypeptide 1, subunit 6B	610730				
17.403	4	8	08	17q12	CISD3, MINER2		CDGSH iron sulfur domain protein 3	611933				
17.404	3	30	12	17q12	DEL17q12, C17DELq12		Chromosome 17q12 deletion syndrome	614527			Chromosome 17q12 deletion syndrome (4)	
17.405	12	30	14	17q12	DHRS11, SDR24C1		Short-chain dehydrogenase reductase family, member 11	616159				
17.406	3	30	12	17q12	DUP17q12, C17DUPq12		Chromosome 17q12 duplication syndrome	614526			Chromosome 17q12 duplication syndrome (4)	
17.407	12	6	17	17q12	EPOP, C17orf96		Elongin BC- and polycomb repressive complex 2-associated protein	617795				
17.408	8	1	05	17q12	FBXO47		F-box only protein 47	609498				
17.409	05	31	19	17q12	GAS2L2, GAR17, CILD41		Growth arrest-specific 2-like 2	611398		mutation identified in 1 CILD41 patient	?Ciliary dyskinesia, primary, 41, 618449 (3)	
17.410	1	31	13	17q12	GPR179, GPR158L, GPR158L1, CSNB1E		G protein-coupled receptor 179	614515			Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3)	11(Gpr179)
17.411	4	23	08	17q12	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11		HNF1 homeobox B (transcription factor 2)	189907			Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus, noninsulin-dependent, 125853 (3); {Renal cell carcinoma}, 144700 (3)	11(Hnf2)
17.412	1	21	09	17q12	HPC11		Prostate cancer, hereditary, 11	611955		associated with rs4430796 and rs7501939	{Prostate cancer, hereditary, 11} (2)	
17.413	02	04	20	17q21.2	KRT12, MECD1		Keratin 12	601687			Meesmann corneal dystrophy 1, 122100 (3)	
17.414	12	2	10	17q12	LHX1, LIM1		LIM/homeodomain protein LHX1	601999		previously mapped to 11p13-p12 by FISH		11(Lhx1)
17.415	6	27	17	17q12	LINC00672		Long intergenic noncoding RNA 672	617544				
17.416	2	1	11	17q12	MED1, PPARBP, PBP, TRAP220		Mediator complex subunit 1 (peroxisome proliferator-activated receptor-binding protein)	604311				
17.417	12	15	17	17q12	MIEN1, C17orf37, RDX12		Migration and invasion enhancer 1	611802				
17.418	09	06	18	17q12	MRM1		Mitochondrial ribosomal RNA methyltransferase 1	618099				
17.419	3	18	17	17q12	MYO19, MYOHD1		Myosin XIX	617379				
17.420	03	29	19	17q12	PCGF2, RNF110, ZNF144, MEL18, TPFS		Polycomb group ring finger 2	600346			Turnpenny-Fry syndrome, 618371 (3)	10(Mel18)
17.421	12	01	20	17q12	NEUROD2, DEE72		Neurogenic differentiation 2	601725			Developmental and epileptic encephalopathy 72, 618374 (3)	11(Neurod2)
17.422	9	12	11	17q12	PBC5		Biliary cirrhosis, primary, 5	614221		associated with rs9303277	Biliary cirrhosis, primary, 5 (2)	
17.423	4	10	14	17q12	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4		Post-GPI attachment to proteins 3	611801			Hyperphosphatasia with mental retardation syndrome 4, 615716 (3)	
17.424	10	25	12	17q12	PEX12, PBD3A		Peroxisome biogenesis factor 12	601758			Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3); Peroxisome biogenesis disorder 3B, 266510 (3)	11(Pex12)
17.425	3	19	18	17q12	PIGW, HPMRS5		Phosphatidylinositol glycan, class W	610275			Glycosylphosphatidylinositol biosynthesis defect 11, 616025 (3)	
17.426	2	25	15	17q12	PIP4K2B, PIP5P4KB, PIP5K2B		Phosphatidylinositol 5-phosphate 4-kinase, type II, beta	603261				
17.427	10	24	14	17q12	PNMT, PENT		Phenylethanolamine N-methyltransferase	171190				
17.428	2	24	98	17q12	PSMB3		Proteasome subunit, beta type, 3	602176		previously assigned to 2q35		
17.429	8	18	08	17q12	RASL10B, RRP17		Ras-like, family 10, member B	612128				
17.430	11	28	05	17q12	RFFL		Ring finger and FYVE-like domain containing 1 (rififylin)	609735				11(Rffl)
17.431	12	17	12	17q12	SLFN5		Schlafen family, member 5	614952				
17.432	11	30	12	17q12	SLFN11		Schlafen family, member 11	614953				
17.433	12	17	12	17q12	SLFN12		Schlafen family, member 12	614955				
17.434	12	17	12	17q12	SLFN12L		Schlafen family, member 12-like	614956				
17.435	12	17	12	17q12	SLFN13		Schlafen family, member 13	614957				
17.436	4	21	16	17q12	SLFN14, BDPLT20		Schlafen family, member 14	614958			Bleeding disorder, platelet-type, 20, 616913 (3)	
17.437	2	24	17	17q12	SRCIN1, SNIP, KIAA1684		Src kinase signaling inhibitor 1	610786				
17.438	5	12	09	17q11.2	SPACA3, LYZL3, SLLP1, LYC3, ALLP17		Sperm acrosome-associated 3	612749				
17.439	5	12	03	17q12	TBC1D3, PRC17, TBC1D3A		TBC1D3 gene	607741				
17.440	10	27	08	17q12	TBC1D3B, PRC17		TBC1 domain family, member 3B	610144				
17.441	3	12	07	17q12	TBC1D3C		TBC1 domain family, member 3C	610806				
17.442	09	27	18	17q12	TCAP, LGMDR7, CMH25		Telethonin	604488			Muscular dystrophy, limb-girdle, autosomal recessive 7, 601954 (3); Cardiomyopathy, hypertrophic, 25, 607487 (3)	
17.443	09	02	20	17q12	TMEM132E, DFNB99		Transmembrane protein 132E	616178			Deafness, autosomal recessive 99, 618481 (3)	
17.444	6	12	17	17q12	ZNHIT3, TRIP3, PEHO		Zinc finger HIT domain-containing protein 3	604500			PEHO syndrome, 260565 (3)	
17.445	12	04	20	17q21.31	ARL4D, ARF4L		ADP ribosylation factor-like GTPase 4D	600732				
17.446	01	09	19	17q21.2	COASY, NBIA6, PCH12		Coenzyme A synthase	609855			Neurodegeneration with brain iron accumulation 6, 615643 (3); Pontocerebellar hypoplasia, type 12, 618266 (3)	
17.447	3	4	94	17q21.2	IGFBP4		Insulin-like growth factor-binding protein-4	146733				
17.448	9	27	13	17q21.2	KRT9, EPPK		Keratin 9	607606			Palmoplantar keratoderma, epidermolytic, 144200 (3)	
17.449	10	7	13	17q21.2	KRT14		Keratin 14	148066			Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3); Epidermolysis bullosa simplex, Koebner type, 131900 (3); Epidermolysis bullosa simplex, recessive 1, 601001 (3); Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3); Dermatopathia pigmentosa reticularis, 125595 (3); Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)	
17.450	4	10	14	17q21.2	KRT16, FNEPPK, PC1		Keratin 16	148067		probably 17q21-q22	Pachyonychia congenita 1, 167200 (3); Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)	
17.451	4	10	14	17q21.2	KRT17, PC2, PCHC1		Keratin 17	148069		~5' to KRT16; probably 17q21-q22	Pachyonychia congenita 2, 167210 (3); Steatocystoma multiplex, 184500 (3)	
17.452	3	22	07	17q21.2	KRT20, CD20, KRT21		Keratin 20	608218				
17.453	9	12	08	17q21.2	KRTAP1-1, KAP1.1, KAP1.7, KAP1.6		Keratin-associated protein 1-1	608819				
17.454	9	12	08	17q21.2	KRTAP1-3, KAP1.3, KAP1.2, KAP1.9		Keratin-associated protein 1-3	608820				
17.455	9	12	08	17q21.2	KRTAP1-4, KAP1.4		Keratin-associated protein 1-4	608821				
17.456	9	12	08	17q21.2	KRTAP-15, KAP1.5		Keratin-associated protein 1-5	608822				
17.457	2	18	08	17q21.2	TNS4, CTEN		Tensin 4	608385				
17.458	3	12	07	17q12	TBC1D3D		TBC1 domain family, member 3D	610807				
17.459	3	12	07	17q12	TBC1D3E		TBC1 domain family, member 3E	610808				
17.460	3	12	07	17q12	TBC1D3F		TBC1 domain family, member 3F	610809				
17.461	3	12	07	17q12	TBC1D3G		TBC1 domain family, member 3G	610810				
17.462	3	12	07	17q12	TBC1D3H		TBC1 domain family, member 3H	610811				
17.463	3	7	08	17q21.2	KRT31, KRTHA1, HA1		Keratin 31	601077				
17.464	3	8	08	17q21.2	KRT32, KRTHA2, HA2		Keratin 32	602760				
17.465	3	8	08	17q21.2	KRT33A, KRTHA3A, HA3I		Keratin 33A	602761				
17.466	3	8	08	17q21.2	KRT33B, KRTHA3A, HA3II		Keratin 33B	602762				
17.467	3	7	08	17q21.2	KRT34, KRTHA4, HA4		Keratin 34	602763				
17.468	3	7	08	17q21.2	KRT35, KRTHA5		Keratin 35	602764				
17.469	3	7	08	17q21.2	KRT36, KRTHA6, HA6		Keratin 36	604540				
17.470	3	7	08	17q21.2	KRT37, KRTHA7, HA7		Keratin 37	604541				
17.471	3	7	08	17q21.2	KRT38,  KRTHA8, HA8		Keratin 38	604542				
17.472	5	27	97	17q21.31	MPP2, DLG2		Membrane protein, palmitoylated-2 (MAGUK p55 subfamily member 2)	600723				
17.473	5	27	97	17q21.31	MPP3, DLG3		Membrane protein, palmitoylated-3 (MAGUK p55 subfamily member 3)	601114				
17.474	3	3	94	17q21.31	PPY		Pancreatic polypeptide	167780		in rat, close to GH		?11(Ppy)
17.475	1	31	01	17q21.31	PSME3, PA28G		Proteasome activator subunit 3	605129				14(Psme3)
17.476	4	29	14	17q21.31	SOST, VBCH, CDD, SOST1		Sclerostin	605740			Sclerosteosis 1, 269500 (3); Van Buchem disease, 239100 (3); Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	
17.477	4	26	10	17q12	TADA2L, TADA2A, ADA2A		Transcriptional adaptor 2A	602276				
17.478	9	2	96	17q12-q21	WT4		Wilms tumor-4	601363			Wilms tumor, type 4 (2)	
17.479	7	27	07	17q21.1	ZPBP2, ZPBPL		Zona pellucida-binding protein 2	608499				
17.480	9	24	08	17q12	GGNBP2, DIF3, LCRG1, LZK1		Gametogenetin-binding protein 2	612275				
17.481	2	14	01	17q21.2	RAMP2		Receptor activity-modifying protein 2	605154				11(Ramp2)
17.482	9	9	08	17q21.2	CCR7, CMKBR7, EBI1		Chemokine (C-C) receptor 7 (Epstein-Barr virus induced gene 1)	600242				
17.483	2	16	04	17q21.1	MLN51, CASC3		MLN51 gene	606504				
17.484	09	27	18	17q21.33	SGCA, ADL, DAG2, LGMDR3		Sarcoglycan, alpha (50kD dystrophin-associated glycoprotein; adhalin)	600119			Muscular dystrophy, limb-girdle, autosomal recessive 3, 608099 (3)	
17.485	10	15	95	17q21.31	CRHR1, CRHR		Corticotropin releasing hormone receptor 1	122561				
17.486	4	11	94	17q21.32	CDC27		Cell division cycle 27	116946		between ERBB2 and PRKCA		11(Cdc27)
17.487	5	23	11	17q12	ACACA, ACAC, ACC1, ACACAD		Acetyl-Coenzyme A carboxylase, alpha	200350		proximal to q21.33; others put at 17q12	Acetyl-CoA carboxylase deficiency, 613933 (1)	
17.488	3	16	99	17q21.31	AOC2, RAO		Amine oxidase, copper-containing, 2	602268				
17.489	6	25	99	17q21.31	AOC3, HPAO, VAP1		Amine oxidase, copper-containing 3	603735				
17.490	11	20	06	17q21.31	ARHGAP27, CAMGAP1		RHO GTPase-activating protein 27	610591				
17.491	2	29	08	17q21	ASRT6		Asthma-related traits, susceptibility to, 6	611403		strongly associated with rs7216389	{Asthma-related traits, susceptibility to, 6} (2)	
17.492	1	8	08	17q21.2	ATP6V0A1, ATP6N1A, VPP1		ATPase, H+ transporting, V0 subunit A1	192130				11(Atp6n1)
17.493	4	30	09	17q21	AUTS7		Autism, susceptibility to, 7	610676		max lod at D17S2180	{Autism susceptibility 7} (2)	
17.494	1	4	00	17q21.31	BECN1		Beclin 1	604378				
17.495	3	9	18	17q21.31	BRCA1, PSCP, BROVCA1, PNCA4, FANCS		Breast cancer-1 gene	113705			{Breast-ovarian cancer, familial, 1}, 604370 (3); {Pancreatic cancer, susceptibility to, 4}, 614320 (3); Fanconi anemia, complementation group S, 617883 (3)	11(Brca1)
17.496	11	20	13	17q12	CDK12, CRKRS, CRK7, KIAA0904		Cyclin-dependent kinase 12	615514				11(Cdk12)
17.497	12	7	07	17q21.31	C1QL1, CRF, C1QRF		Complement component 1, q subcomponent-like 1	611586				
17.498	9	22	17	17q21.2	CAVIN1, PTRF		Caveolae-associated protein 1	603198			Lipodystrophy, congenital generalized, type 4, 613327 (3)	11(Ptrf)
17.499	11	05	20	17q21.2	CNP, CNP1, HLD20		2', 3' cyclic nucleotide 3' phosphohydrolase	123830		mutation identified in 1 HLD20 family	?Leukodystrophy, hypomyelinating, 20, 619071 (3)	11(Cnp)
17.500	11	28	18	17q21.2	CNTNAP1, CASPR, P190, CHN3		Contactin-associated protein 1	602346			Lethal congenital contracture syndrome 7, 616286 (3); Hypomyelinating neuropathy, congenital, 3, 618186 (3)	
17.501	9	14	95	17q21.31	ETV4		ETS variant gene-4 (E1A enhancer-binding protein, E1AF)	600711				
17.502	12	17	07	17q21.31	DBF4B, DRF1, ASKL1		DBF4, S. cerevisiae, homolog of, B	611661				
17.503	1	14	97	17q21.31	DUSP3, VHR		Dual specificity phosphatase-3 (vaccinia virus phosphatase VH1-related)	600183				
17.504	2	24	97	17p13.1	FGF11, FHF3		Fibroblast growth factor-11	601514				11(Fhf3)
17.505	12	22	00	17q21.31	FMNL, C17orf1B		Formin-like	604656				
17.506	3	27	95	17q21.31	G6PC, G6PT		Glucose-6-phosphatase, catalytic	613742			Glycogen storage disease Ia, 232200 (3)	
17.507	6	7	11	17q21.31	G6PC3, UGRP, SCN4		Glucose-6-phosphatase, catalytic, 3	611045			Neutropenia, severe congenital 4, autosomal recessive, 612541 (3); Dursun syndrome, 612541 (3)	
17.508	12	18	19	17q21.2	GAST, GAS		Gastrin	137250				11(Gast)
17.509	1	8	01	17q21.31	GFAP, ALXDRD		Glial fibrillary acidic protein	137780			Alexander disease, 203450 (3)	11(Gfap)
17.510	1	13	11	17q21.32	GNGT2		Guanine nucleotide-binding protein, gamma-transducing activity polypeptide 2	139391				
17.511	7	1	11	17q21.32	GOSR2, GS27, EPM6		Golgi snap receptor complex member 2	604027			Epilepsy, progressive myoclonic 6, 614018 (3)	
17.512	10	13	09	17q21.1	GSDMA, GSDM1, GSDM		Gasdermin A	611218				11(Gsdma1-3)
17.513	10	1	09	17q21.1	GSDMB, GSDML		Gasdermin B	611221				
17.514	7	27	15	17q21.2	HCRT, OX, NRCLP1		Hypocretin	602358		mutation identified in 1 NRCLP1 patient	?Narcolepsy 1, 161400 (3)	
17.515	7	25	14	17q21.31	HDAC5		Histone deacetylase 5	605315				
17.516	1	8	97	17q21.31	IFI35		Interferon-induced protein-35	600735				
17.517	8	10	07	17q12-q21	IKZF3, ZNFN1A3, AIOLOS		Ikaros family zinc finger 3	606221				
17.518	11	13	07	17q21.2	JUP, DP3, PDGB, ARVD12		Junction plakoglobin	173325		incorrectly mapped to 7; close to BRCA1	Naxos disease, 601214 (3); Arrhythmogenic right ventricular dysplasia 12, 611528 (3)	11(Jup, Pkgb)
17.519	5	12	09	17q21.2	KAT2A, GCN5L2, GCN5		K(lysine) acetyltransferase 2A	602301				11(Gcn5l2)
17.520	1	24	01	17q21.32	KPNB1		Karyopherin beta-1	602738				11(Kpnb1)
17.521	3	21	03	17q12	LASP1, MLN50		LIM and SH3 protein 1	602920		fused to MLL in AML		11(Lasp1)
17.522	9	14	00	17q21.31	MAP3K14, NIK, HSNIK		Mitogen-activated protein kinase kinase kinase-14	604655				
17.523	2	22	13	17q21.31	MEOX1, MOX1, KFS2		Mesenchyme homeo box 1 (Mox1, mouse, homolog of)	600147			Klippel-Feil syndrome 2, 214300 (3)	
17.524	4	6	15	17q21.32	MIR10A		Micro RNA 10A	610173				
17.525	3	2	98	17q12	MLLT6, AF17		Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 6	600328				
17.526	1	20	06	17q21.33	MYCBPAP, AMAP1		MYCBP-associated protein	609835				
17.527	7	29	15	17q21.2	NAGLU, MPS3B, CMT2V		N-acetylglucosaminidase, alpha-	609701		mutation identified in 1 CMT2V family	Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3); ?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3)	
17.528	3	26	02	17q21.32	NPEPPS, PSA, MP100		Aminopeptidase, puromycin-sensitive	606793				11(Psa)
17.529	3	29	10	17q21.33	PHB		Prohibitin	176705			{Breast cancer, susceptibility to}, 114480 (3)	
17.530	5	5	15	17q21.31	PYY		Peptide YY	600781		10kb from PPY		
17.531	8	3	12	17q21.31	RND2, ARHN, RHO7		Ras homolog gene family, member N (GTP-binding protein Rho7)	601555				
17.532	6	30	16	17q21.2	STAT3, APRF, HIES, ADMIO1		Signal transducer and activator of transcription-3 (acute-phase response factor)	102582			Hyper-IgE recurrent infection syndrome, 147060 (3); Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3)	11(Stat3)
17.533	1	8	01	17q21.33	TOB1, TOB		Transducer of ERBB2, 1	605523				
17.534	9	23	13	17q21.2	TUBG1, CDCBM4		Tubulin, gamma 1	191135			Cortical dysplasia, complex, with other brain malformations 4, 615412 (3)	
17.535	4	4	01	17q21.2	TUBG2		Tubulin, gamma 2	605785		pseudogene on chr. 7		
17.536	3	9	00	17q21.31	VAT1		Vesicle amine transport protein 1	604631				
17.537	2	17	15	17q21.31-q21.32	WNT3, INT4, TETAMS		Wingless-type MMTV integration site family, member 3	165330		mutation identified in 1 TETAMS1 family	?Tetra-amelia syndrome 1, 273395 (3)	11(Wnt4)
17.538	8	10	98	17q21.32	WNT15		Wingless-type MMTV integration site family, member 15	602864				11(Wnt15)
17.539	4	29	97	17q12	CACNB1, CACNLB1, CCHLB1		Calcium channel, voltage-dependent, beta 1 subunit	114207				
17.540	11	28	01	17q12	GRB7		Growth factor receptor-bound protein 7	601522				11(Grb7)
17.541	7	26	12	17q21.32	HOXB1, HOX2I, HCFP3		Homeo box-B1	142968			Facial paresis, hereditary congenital, 3, 614744 (3)	11(Hox2.9)
17.542	1	20	95	17q21.32	HOXB2, HOX2H		Homeo box-B2	142967				11(Hox2.8)
17.543	1	20	95	17q21.32	HOXB3, HOX2G		Homeo box-B3	142966				11(Hox2.7)
17.544	1	20	95	17q21.32	HOXB4, HOX2F		Homeo box-B4	142965				11(Hox2.6)
17.545	1	20	95	17q21.32	HOXB5, HOX2A		Homeo box-B5	142960				11(Hox2.2)
17.546	1	20	95	17q21.32	HOXB6, HOX2B		Homeo box-B6	142961				11(Hox2.2)
17.547	1	20	95	17q21.32	HOXB7, HOX2C		Homeo box-B7	142962				11(Hox2.3)
17.548	1	20	95	17q21.32	HOXB8, HOX2D		Homeo box-B8	142963				11(Hox2.4)
17.549	1	20	95	17q21.32	HOXB9, HOX2E		Homeo box-B9	142964				11(Hox2.5)
17.550	8	20	07	17q21-q22	HPC9		Prostate cancer, hereditary, 9	610997		max LOD at D17S1820	{Prostate cancer, hereditary, 9} (2)	
17.551	12	21	10	17q21.2	KRT10, EHK, BCIE, BIE		Keratin 10	148080		in cluster of class I keratins	Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3); Ichthyosis with confetti, 609165 (3)	
17.552	10	4	91	17q21.2	KRT15		Keratin 15	148030		tightly linked to Hox-2 in mouse		11(Krt1)
17.553	6	9	98	17q21.2	KRT19		Keratin 19	148020		probably 17q21-q22		
17.554	3	23	09	17q21.32	MIR196A1, MIRN196A1		Micro RNA 196A1	608632				
17.555	2	19	04	17q21-q22	MYP5		Myopia 5	608474		between D17S787 and D17S1811	Myopia 5 (2)	
17.556	6	6	89	17q21.33	NGFR, TNFRSF16		Nerve growth factor receptor	162010		distal to APL breakpoint, q21; < 0.5mb from HOX2		11(Ngfr)
17.557	8	15	97	17q21.31	NSF		N-ethylmaleimide-sensitive factor	601633				11(Nsf)
17.558	8	18	08	17q21.31	RNU2-1, RNU2		RNA, U2 small nuclear, 1	180690				
17.559	7	17	01	17q22	PCTP		Phosphatidylcholine transfer protein	606055				11(Pctp)
17.560	3	10	00	17q21-q22	PTLAH, FPAH		Patella aplasia or hypoplasia	168860			Patella aplasia or hypoplasia (2)	
17.561	09	29	20	17q21.31	SHC1P2, SHCL1		SHC adaptor protein 1 pseudogene 2	600739				
17.562	12	9	15	17q21.31	SLC4A1, AE1, EPB3, SPH4, SAO, CHC		Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group)	109270			Ovalocytosis, SA type, 166900 (3); Spherocytosis, type 4, 612653 (3); [Malaria, resistance to], 611162 (3); Distal renal tubular acidosis 1, 179800 (3); Distal renal tubular acidosis 4 with hemolytic anemia, 611590 (3); [Blood group, Diego], 110500 (3); [Blood group, Waldner], 112010 (3); [Blood group, Wright], 112050 (3); [Blood group, Froese], 601551 (3); [Blood group, Swann], 601550 (3); Cryohydrocytosis, 185020 (3)	
17.563	08	04	20	17q23.2	TBX4, ICPPS, PAPPAS		T-box 4	601719			Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension, 147891 (3); Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome, 601360 (3)	
17.564	5	26	05	17q21.2	TOP2A, TOP2		Topoisomerase (DNA) II, alpha, 170kD	126430			DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)	11(Top2a)
17.565	2	27	12	17q21.2	WNK4, PRKWNK4, PHA2B		WNK lysine deficient protein kinase 4	601844			Pseudohypoaldosteronism, type IIB, 614491 (3)	
17.566	6	28	94	17q21.2	ACLY		ATP citrate lyase	108728				?11(Atpcl)
17.567	07	14	20	17q12	DDX52, ROK1, HUSSY19		DExD-box helicase 52	612500				
17.568	5	27	05	17q12	ERBB2, NGL, NEU, HER2		Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	164870			Adenocarcinoma of lung, somatic, 211980 (3); Glioblastoma, somatic, 137800 (3); Gastric cancer, somatic, 613659 (3); Ovarian cancer, somatic, (3)	
17.569	09	12	19	17q21.31	FZD2, OMOD2		Frizzled class receptor 2	600667			Omodysplasia 2, 164745 (3)	11(Fzd2)
17.570	01	10	20	17q21.2	GHDC, LGP1		GH3 domain-containing protein	608587				
17.571	12	28	07	17q21.2	GJD3, GJC1, CX31.9		Gap junction protein, delta-3 (31.9kD)	607425				
17.572	8	8	14	17q21.31	MAPT, MTBT1, DDPAC, MSTD		Microtubule-associated protein tau	157140		see 6p21	Dementia, frontotemporal, with or without parkinsonism, 600274 (3); Pick disease, 172700 (3); Supranuclear palsy, progressive, 601104 (3); Supranuclear palsy, progressive atypical, 260540 (3); {Parkinson disease, susceptibility to}, 168600 (3)	11(Mapt)
17.573	2	1	11	17q21.1	MED24, TRAP100, KIAA0130		Mediator complex subunit 24	607000				
17.574	3	17	08	17q21.2	MLX, TCFL4		MAX-like protein X	602976				
17.575	09	23	19	17q21.1	MSL1		MSL complex subunit 1	614801				
17.576	12	18	19	17q21.31	NBR1, M17S2		NBR1 autophagy cargo receptor	166945				
17.577	11	11	14	17q21.2	NKIRAS2, KBRAS2		NFKB inhibitor-interacting Ras-like protein 2	604497				
17.578	11	5	08	17q21.1	ORMDL3		ORM1-like protein 3	610075				
17.579	11	30	06	17q12	PLXDC1, TEM7		Plexin domain containing 1	606826				
17.580	9	21	17	17q21.1	PSMD3, RPN3		Proteasome 26S subunit, non-ATPase, 3	617676				
17.581	10	30	08	17q21.2	RARA		Retinoic acid receptor, alpha polypeptide	180240		fused with MYL in APL	Leukemia, acute promyelocytic, 612376 (1)	11(Rara)
17.582	7	17	02	17q21.31	STH		Saitohin	607067		in intron 9 of TAU		
17.583	8	20	07	17q12	CCL11, SCYA11		Chemokine, C-C motif, ligand 11	601156			{HIV1, resistance to}, 609423 (3); {Asthma, susceptibility to}, 600807 (3)	
17.584	3	28	17	17q21.31	RPL27, DBA16		Ribosomal protein L27	607526		mutation identified in 1 DBA16 patient	?Diamond-Blackfan anemia 16, 617408 (3)	
17.585	5	8	97	17q21.2	EZH1		Enhancer of zeste, Drosophila, homolog of, 1	601674				11(Ezh1)
17.586	8	10	06	17q21.32	B4GALGT2, GALGT2, SD		Beta-1,4-N-acetyl-galactosaminyl transferase 2	111730				11(B4galnt2)
17.587	7	28	15	17q21.2	CCR10, GPR2		Chemokine (C-C) receptor 10	600240				11(Gpr2)
17.588	08	23	19	17q21.2	CDC6, CDC18L, MGORS5		Cell division cycle 6	602627		mutation identified in 1 MGORS5 patient	?Meier-Gorlin syndrome 5, 613805 (3)	
17.589	07	13	20	17q21.2	DHX58, LGP2, D11LGP2		DExH-box helicase 58	608588				11(Lgp2)
17.590	8	12	15	17q21.2	FAM134C		Family with sequence similarity 134, member C	616498				
17.591	6	13	12	17q12	FBXL20, FBL20, FBL2, SCR		F-box and leucine-rich repeat protein 20	609086				11(Fbxl20)
17.592	2	13	15	17q21.2	FKBP10, FKBP65, OI11, BRKS1		FK506-binding protein 10	607063			Osteogenesis imperfecta, type XI, 610968 (3); Bruck syndrome 1, 259450 (3)	
17.593	10	30	18	17q21.32	HOXB13, HPC9		Homeo box B13	604607			{Prostate cancer, hereditary, 9}, 610997 (3)	11(Hoxb13)
17.594	5	8	13	17q21.2	HSD17B1, EDH17B2		Estradiol 17-beta-dehydrogenase-1	109684				
17.595	9	11	14	17q21.2	HSPB9		Heat-shock 27kD protein 9	608344				
17.596	1	14	09	17q21.2	IBD22		Inflammatory bowel disease 22	612380		associated with rs744166	{Inflammatory bowel disease 22} (2)	
17.597	3	1	13	17q21.2	KLHL10, SPGF11		Kelch-like 10	608778			Spermatogenic failure 11, 615081 (3)	11(Klhl10)
17.598	11	02	20	17q21.2	KLHL11		Kelch-like family, member 11	619078				
17.599	5	22	14	17q21.2	KRT13, WSN2		Keratin 13	148065		in same PFGE fragment as KRT10, KRT15	White sponge nevus 2, 615785 (3)	
17.600	11	13	13	17q21.2	KRT23		Keratin 23	606194				
17.601	1	15	16	17q21.2	KRT25, K25, KRT24IRS1, ARWH3		Keratin 25, type I	616646			Woolly hair, autosomal recessive 3, 616760 (3)	11(Krt25)
17.602	12	4	15	17q21.2	KRT26, K25, K25B, K25IRS2		Keratin 26, type I	616675				11(Krt26)
17.603	12	9	15	17q21.2	KRT28, K25D, K25IRS4		Keratin 28, type I	616677				
17.604	12	4	15	17q21.2	KRT27, KRT25C, K25IRS3		Keratin 27, type I	616676				11(Krt27)
17.605	12	9	15	17q21.2	KRT39		Keratin 38, type I	616678				11(Krt39)
17.606	12	9	15	17q21.2	KRT40, KA36		Keratin 40, type I	616679				11(Krt40)
17.607	5	7	03	17q21.32	OSBPL7, ORP7		Oxysterol-binding protein-like protein 7	606735				
17.608	4	20	17	17q21.2	P3H4, SC65, LEPREL4		Proyly 3-hydroxylase 4	617419				
17.609	11	3	11	17q21.2	PSMC3IP, TBPIP, GT198, HOP2, ODG3		PSMC3-interacting protein	608665			Ovarian dysgenesis 3, 614324 (3)	
17.610	10	26	99	17q21.2	RAB5C, RABL		Ras-associated protein RAB5c	604037				
17.611	5	11	16	17q21.2	SMARCE1, BAF57, CSS5		SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1	603111			{Meningioma, familial, susceptibility to}, 607174 (3); Coffin-Siris syndrome 5, 616938 (3)	
17.612	9	26	17	17q21.2	STAT5A, STAT5, MGF		Signal transducer and activator of transcription 5a	601511				11(Stat5a)
17.613	9	1	16	17q21.2	TTC25, CILD35		Tetratricopeptide repeat domain-containing protein 25	617095			Ciliary dyskinesia, primary, 35, 617092 (3)	
17.614	12	23	05	17q21.2	WIRE, WICH		WASP-interacting protein-related protein	609692				
17.615	10	30	08	17q21.2	HAP1, HLP, HAP2		Huntingtin-associated protein 1 (neuroan 1)	600947				11(Hap1)
17.616	11	02	18	17q21.2-q21.3	CNTD1, COSA1		Cyclin N-terminal domain-containing protein 1	618166				
17.617	09	26	19	17q21.31	ADAM11, MDC		ADAM metallopeptidase domain 11	155120				
17.618	11	12	20	17q21.33	EME1		Essential meiotic structure-specific endonuclease 1	610885				11(Eme1)
17.619	11	19	98	17q21.3	ERDA1		Expanded repeat domain, CAG/CTG, 1	603279		no apparent pathology		
17.620	12	4	03	17q21.32	IGF2BP1, IMP1, CRDBP, ZBP1		Insulin-like growth factor 2 mRNA-binding protein 1	608288				11(Crdbp)
17.621	11	20	20	17q21.33	LUC7L3, CROP, LUC7A		LUC7-like 3 pre-mRNA splicing factor	609434				
17.622	2	26	08	17q21.32	MRPL10, MRPL8		Mitochondrial ribosomal protein L10	611825				
17.623	11	28	01	17q21.32	NESH		NESH protein	606363				
17.624	5	17	95	17q21.32	NFE2L1, NRF1		Nuclear factor, erythroid-derived 2-like 1	163260				11(Nfe2l1)
17.625	09	12	19	17q21.33	NME1, NM23		NME/NM23 nucleoside diphosphate kinase 1	156490				
17.626	09	12	19	17q21.33	NME2		NME/NM23 nucleoside diphosphate kinase 2	156491				
17.627	09	04	18	17q21.31	PLEKHM1, AP162, KIAA0356, OPTB6, OPTA3		Pleckstrin homology domain-containing protein, family M, member 1	611466		mutation identified in 1 OPTB6 family	?Osteopetrosis, autosomal recessive 6, 611497 (3); Osteopetrosis, autosomal dominant 3, 618107 (3)	
17.628	2	21	07	17q21.32	PRAC1		Prostate, rectum, and colon gene	609819				
17.629	3	19	08	17q21.31	RUNDC3A, RPIP8		RUN domain contain 3A	605448				
17.630	7	19	12	17q21.33	RAC4, PPTC, HK1		Tachykinin 4	607833				
17.631	12	17	12	17q21.32	SCRN2, SES2		Secernin 2	614966				
17.632	4	17	06	17q21.32	TBX21, TBET		T-box 21	604895			{Asthma, aspirin-induced, susceptibility to}, 208550 (3); Asthma and nasal polyps, 208550 (3)	11(Tbx21)
17.633	9	15	17	17q21.31	UBTF, UBF, CONDBA		Upstream binding transcription factor, RNA polymerase I	600673			Neurodegeneration, childhood-onset, with brain atrophy, 617672 (3)	
17.634	12	27	19	17q21.2	VPS25, FAP20		Vacuolar protein sorting 25 homolog	610907				
17.635	4	17	07	17q21.33	WFIKKN2, WFIKKNRP		WAP, fillistatin, immunoglobulin, Kunitz, and NTR domains-containing protein 2	610895				
17.636	7	11	14	17q21.33	DLX3, TDO, AI4		Distal-less homeo box-3	600525			Trichodontoosseous syndrome, 190320 (3); Amelogenesis imperfecta, type IV, 104510 (3)	
17.637	2	4	16	17q21.33	DLX4, DLX7, DLX8, OFC15		Distal-less homeo box-4	601911		mutation identified in 1 OFC15 family	?Orofacial cleft 15, 616788 (3)	
17.638	3	20	94	17q21.32	GIP		Gastric inhibitory polypeptide	137240				11(Gip)
17.639	2	28	08	17q21.33	MRPL27		Mitochondrial ribosomal protein L27	611837				
17.640	12	19	11	17q22	SRSF1, SFRS1, ASF, SF2, SRp30a		Splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor)	600812				11(Sfrs1)
17.641	8	6	15	17q21.33	XYLT2, XT2, SOS		Xylosyltransferase 2	608125			{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3); Spondyloocular syndrome, 605822 (3)	
17.642	2	16	10	17q21.31	AARSD1		Alanyl-tRNA synthetase domain-containing 1	613212				
17.643	1	31	13	17q21.31	ASB16		Ankyrin repeat- and SOCS box-containing protein 16	615056				
17.644	09	08	20	17q21.31	ATXN7L3, SGF11		ATNX7-like 3	619010				
17.645	6	13	12	17q21.31	CCDC103, SMH, PR46B, CILD17		Coiled-coil domain-containing protein 103	614677			Ciliary dyskinesia, primary, 17, 614679 (3)	
17.646	5	24	13	17q21.31	CD300LG, TREM4, CLM9		CD300 antigen-like family, member G	610520				
17.647	10	23	20	17q21.2	COA3, CCDC56, MC4DN14		Cytochrome c oxidase assembly factor 3	614775		mutation identified in 1 MC4DN14 patient	?Mitochondrial complex IV deficiency, nuclear type 14, 619058 (3)	
17.648	1	27	11	17q21.31	DUP17q21.31, C17DUPq21.31		Chromosome 17q21.31 duplication syndrome	613533		contiguous gene duplication syndrome	Chromosome 17q21.31 duplication syndrome (4)	
17.649	10	29	03	17q21.32	CDK5RAP3		CDK5 regulatory subunit-associated protein 3	608202				
17.650	07	13	20	17q21.31	DHX8, DDX8, HRH1		DEAH-box helicase 8	600396				
17.651	3	7	13	17q21.31	EFTUD2, KIAA0031, MFDGA		Elongation factor Tu GTP-binding domain-containing 2	603892			Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3)	
17.652	11	05	18	17q21.31	GJC1, GJA7, CX45		Gap junction protein, gamma-1	608655				
17.653	12	19	11	17q21.31	GPATCH8, KIAA0553		G-patch domain-containing protein 8	614396				16(Gpatch8)
17.654	10	03	19	17q21.31	HROB, MCM8IP, C17orf53		Homologous recombination factor with OB-fold	618611				
17.655	12	5	03	17q21.31	IMP5		Intramembrane protease 5	608284				
17.656	10	4	12	17q21.31	KANSL1, KIAA1267, MSL1V1, KDVS		KAT8 regulatory NSL complex subunit 1	612452			Koolen-De Vries syndrome, 610443 (3)	
17.657	4	19	12	17q21.31	KIF18B		Kinesin family member 18B	614570				
17.658	2	14	08	17q21.31	LSM12		LSM12, S. cerevisiae, homolog of	611793				
17.659	5	2	16	17q21.31	MEIOC, C17orf104		Meiosis-specific protein with coiled-coil domain	616934				11(Meioc)
17.660	3	5	08	17q12	MRPL45		Mitochondrial ribosomal protein L45	611850		pseudogenes on 2 and 17		
17.661	12	21	03	17q21.31	NAGS		N-acetylglutamate synthase	608300			N-acetylglutamate synthase deficiency, 237310 (3)	11(Nags)
17.662	12	19	19	17q21.31	NBR2		Neighbor of BRCA1 gene 2, noncoding	618708		Head-to-head orientation with BRCA1		
17.663	9	17	08	17q21.31	NMT1, NMT		N-myristoyltransferase 1	160993				
17.664	7	22	13	17q21.31	SLC25A39, CGI69		Solute carrier family 25, member 39	610820				11(Slc25a39)
17.665	01	31	20	17q21.33	COL1A1, OI1, OI2, OI3, OI4, EDSARTH1, CAFYD		Collagen I, alpha-1 polypeptide	120150		fused with PDGFB in DFPB	Osteogenesis imperfecta, type I, 166200 (3); Osteogenesis imperfecta, type II, 166210 (3); Osteogenesis imperfecta, type III, 259420 (3); Caffey disease, 114000 (3); Osteogenesis imperfecta, type IV, 166220 (3); {Bone mineral density variation QTL, osteoporosis}, 166710 (3); Ehlers-Danlos syndrome, arthrochalasia type, 1, 130060 (3); Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1, 619115 (3)	11(Col1a1)
17.666	4	17	13	17q21.31-q22	MRT35		Mental retardation, autosomal recessive 35	615162		between rs4792947 and rs11079258	Mental retardation, autosomal recessive 35 (2)	
17.667	9	24	15	17q21.31	LRRC37A		Leucine-rich repeat-containing protein 37A	616555				
17.668	9	24	15	17q21.31-q21.32	LRRC37A2		Leucine-rich repeat-containing protein 37A2	616556				
17.669	09	10	19	17q21.32	CBX1		Chromobox 1	604511				
17.670	11	19	13	17q21.32	COPZ2		Coatomer protein complex, subunit zeta-2	615526				
17.671	7	18	12	17q21.31	GRN, CLN11		Granulin	138945			Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3); Aphasia, primary progressive, 607485 (3); Ceroid lipofuscinosis, neuronal, 11, 614706 (3)	
17.672	3	23	14	17q21.31	HEXIM2		Hexamethylene bis acetamide-inducible protein 2	615695				
17.673	7	25	18	17q21.32	HOXBAS1, HOXB3OS		Homeobox B cluster antisense RNA 1, noncoding	618066				11(Hoxb3os)
17.674	5	6	13	17q21.31	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16		Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B)	607759		3' to GP3A; BAK platelet antigen	Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal alloimmune, BAK antigen related (3); Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	
17.675	5	6	13	17q21.32	ITGB3, GP3A, GT, BDPLT2, BDPLT16		Integrin, beta-3 (platelet glycoprotein IIIa; antigen CD61)	173470		in same 260kb fragment as GP2B; PL(A) platelet antigen	Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal alloimmune (3); {Myocardial infarction, susceptibility to}, 608446 (3); Purpura, posttransfusion (3); Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	
17.676	3	23	15	17q21.33	KAT7, MYST2, HBO1		K(lysine) acetyltransferase 7	609880				
17.677	5	15	11	17q21.32	MIR152, MIRN152		Micro RNA 152	613788				
17.678	12	27	16	17q21.32	MYL4		Myosin, light polypeptide-4, alkali, atrial, embryonic	160770		mutation identified in 1 ATFB18 family	?Atrial fibrillation, familial, 18, 617280 (3)	11(Myla)
17.679	7	3	06	17q21.32	PNPO		Pyridoxamine 5'-phosphate oxidase	603287			Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)	11(Pnpo)
17.680	7	25	18	17q21.32	PRAC2, HOXBAS5		PRAC2 small nuclear protein	610787				
17.681	1	30	12	17q21.32	SKAP1, SCAP1, SKAP55		SRC kinase-associated phosphoprotein 1, 55kD	604969				
17.682	12	27	19	17q21.32	SNF8, VPS22, EAP30		SNF8 subunit of ESCRIT-II	610904				
17.683	12	10	12	17q21.32	SNX11		Sorting nexin 11	614906				
17.684	9	27	17	17q21.32	SP2		Transcription factor Sp2	601801				11(Sp2)
17.685	3	18	13	17q21.32	TBKBP1, PROSAPIP2, KIAA0775		TBK1-binding protein 1	608476				
17.686	3	15	07	17q21.32	TTLL6		Tubulin tyrosine ligase-like family, member 6	610849				
17.687	4	2	16	17q21.32	UBE2Z, USE1		Ubiquitin-conjugating enzyme E2Z	611362				
17.688	5	23	13	17q21.32-q21.33	ZNF652, KIAA0924		Zinc finger protein 652	613907				
17.689	6	10	08	17q21.33	ACSF2, FLJ20920		Acyl-CoA synthetase family member 2	610465				
17.690	6	25	99	17q21.33	CHAD		Chondroadherin	602178				
17.691	1	27	04	17q21.33	HILS1		Spermatid-specific linker histone H1-like protein	608101				11(Hils1)
17.692	12	21	12	17q21.33	ITGA3, CD49C, GAPB3, ILNEB		Integrin, alpha-3	605025			Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3)	
17.693	10	11	12	17q21.33	LRRC59, p34		Leucine-rich repeat-containing protein 59	614854				
17.694	12	19	19	17q21.33	MBTD1		MBT domain-containing protein 1	618705				
17.695	11	3	14	17q21.33	NXPH3, NPH3		Neuroexophilin 3	604636				
17.696	9	9	13	17q21.33	PDK2		Pyruvate dehydrogenase kinase, isoenzyme 2	602525				
17.697	10	1	17	17q21.33	PPP1R9B, SPINO		Protein phosphatase 1, regulatory subunit 9B	603325				
17.698	3	8	07	17q21.33	SLC35B1, UGTREL1		Solute carrier family 35, member B1	610790				
17.699	4	18	02	17q21.33	SPAG9, SYD1, KIAA0516		Sperm-associated antigen 9	605430				
17.700	5	16	11	17q21.33	SPATA20, SSP411		Spermatogenesis-associated protein 20	613939				
17.701	05	04	20	17q21.33	SPOP, NSDVS1, NSDVS2		Speckle-type POZ protein	602650			Nabais Sa-de Vries syndrome, type 1, 618828 (3); Nabais Sa-de Vries syndrome, type 2, 618829 (3)	
17.702	7	15	09	17q21.33	UTP18		UTP18, S. cerevisiae, homolog of	612816				
17.703	7	18	14	17q21-q22	CA10, CARPX		Carbonic anhydrase X	604642				
17.704	2	28	01	17q21.33	ABCC3, CMOAT2, MRP3, MLP2		ATP-binding cassette, sub-family C, member 3	604323				
17.705	2	22	92	17q22	BCL5		B-cell CLL/lymphoma-5	151441				
17.706	02	12	19	17q23.2	BRIP1, BACH1, FANCJ		BRCA1-associated C-terminal helicase 1	605882		?or 17q23	{Breast cancer, early-onset, susceptibility to}, 114480 (3); Fanconi anemia, complementation group J, 609054 (3)	
17.707	12	21	09	17q22	C17orf71, SMG8		Chromosome 17 open reading frame 71	613175				
17.708	08	16	18	17q21.33	CACNA1G, SCA42, SCA42ND		Calcium channel, voltage-dependent, T type, alpha-1G subunit	604065			Spinocerebellar ataxia 42, 616795 (3); Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits, 618087 (3)	11(Cacna1g)
17.709	8	20	99	17q22	COX11		Cytochrome c oxidase, subunit 11	603648		pseudogene on 6p23-p22		
17.710	7	23	15	17q22	DGKE, NPHS7, AHUS7		Diacylglycerol kinase, epsilon, 64-kD	601440			Nephrotic syndrome, type 7, 615008 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3)	
17.711	8	21	00	17q22	HLF		Hepatic leukemia factor	142385				
17.712	4	8	13	17q22	KIF2B		Kinesin family member 2B	615142				
17.713	3	7	14	17q22	MIR142		Micro RNA 142	615657				
17.714	3	23	14	17q22	MIR301A, MIR301		Micro RNA 301A	615675				
17.715	4	19	12	17q22	MMD, MMD1, PAQR11		Monocyte-to-macrophage differentiation-associated protein	604467				
17.716	10	23	20	17q22	MSI2		Musashi RNA binding protein 2	607897				11(Msi2)
17.717	10	23	15	17q22	NOG, SYM1, SYNS1A		Noggin, mouse, homolog of	602991			Symphalangism, proximal, 1A, 185800 (3); Multiple synostoses syndrome 1, 186500 (3); Tarsal-carpal coalition syndrome, 186570 (3); Stapes ankylosis with broad thumbs and toes, 184460 (3); Brachydactyly, type B2, 611377 (3)	
17.718	11	30	06	17q25.1	PRCD, RP36		PRCD, Dog, homolog of	610598			Retinitis pigmentosa 36, 610599 (3)	
17.719	08	21	19	17q22	RAD51C, FANCO, BROVCA3		RAD52 paralog C	602774			Fanconi anemia, complementation group O, 613390 (3); {Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)	
17.720	8	18	14	17q22	PRR11		Proline-rich protein 11	615920				
17.721	12	2	15	17q22	SKA2, FAM33A		Spindle- and kinetochore-associated complex, subunit 2	616674				
17.722	2	25	15	17q22	STXBP4, SYNIP		Syntaxin-binding protein 4	610415				
17.723	11	12	20	17q22	SUPT4H1		SPT4 homolog, DSIF elongation factor subunit	603555				11(Supt4h)
17.724	03	19	20	17q22	TEX14, SPGF23		Testis-expressed gene 14	605792			Spermatogenic failure 23, 617707 (3)	11(Tex14)
17.725	4	30	15	17q22	TMEM100		Transmembrane protein 100	616334				
17.726	7	11	12	17q22	TOM1L1		TOM1-like 1	604701				
17.727	5	12	03	17q23.1-q23.2	USP32, USP10		Ubiquitin-specific protease 32	607740				
17.728	9	24	08	17q22	VEZF1, ZNF161		Vascular endothelial zinc finger 1	606747				
17.729	9	30	02	17q23.2	APPBP2, PAT1		Amyloid beta precursor protein-binding protein 2	605324				
17.730	1	12	95	17q22	COIL, CLN80		Coilin p80	600272				
17.731	01	31	20	17q23.2	MED13, THRAP1, TRAP240, MRD61		Mediator complex subunit 13	603808			Intellectual developmental disorder 61, 618009 (3)	
17.732	07	29	20	17q22	MRPS23, COXPD46		Mitochondrial ribosomal protein S23	611985		mutation identified in 1 COXPD46 patient	?Combined oxidative phosphorylation defiency 46, 618952 (3)	
17.733	06	17	19	17q23.2	PPM1D, WIP1, JDVS		Protein phosphatase, magnesium-dependent, 1, delta isoform	605100		amplified in breast cancer	Jansen de Vries syndrome, 617450 (3); Breast cancer, somatic, 114480 (3)	
17.734	3	22	93	17q11.2	TNFAIP1		Tumor necrosis factor, alpha-induced protein-1 (endothelial)	191161				
17.735	11	26	01	17q22	TRIM37, MUL, KIAA0898		Tripartite motif-containing 37	605073			Mulibrey nanism, 253250 (3)	
17.736	3	17	98	17q24.2	PRKCA, PKCA		Protein kinase C, alpha polypeptide	176960		cen-COL1A1-PKCA-GH1	Pituitary tumor, invasive (3)	11(Pkca)
17.737	3	26	02	17q25.1	CMRF35, CMRF35A		CMRF35 antigen	606786				
17.738	7	18	91	17q23.3	CSH1, CSA, PL		Chorionic somatomammotropin hormone-1	150200			[Placental lactogen deficiency] (1)	13(Pl1)
17.739	7	18	91	17q23.3	CSH2, CSB		Chorionic somatomammotropin B	118820				13(Pl2)
17.740	6	25	99	17q23.3	CSHL1, CSL		Chorionic somatomammotropin hormone-like 1	603515				
17.741	7	14	09	17q23.3	GH1, GHN, IGHD1A, IGHD1B, IGHD2		Growth hormone-1	139250		5'-GH1-CSHP1-CSH1-GH2-CSH2-3'	Growth hormone deficiency, isolated, type IA, 262400 (3); Growth hormone deficiency, isolated, type IB, 612781 (3); Growth hormone deficiency, isolated, type II, 173100 (3); Kowarski syndrome, 262650 (3)	11(Gh)
17.742	9	16	88	17q23.3	GH2, GHV		Growth hormone-2	139240				
17.743	10	23	20	17q23.3	TACO1, CCDC44, MC4DN8		Translational activator of mitochondrially encoded cytochrome c oxidase subunit I	612958			Mitochondrial complex IV deficiency, nuclear type 8, 619052 (3)	
17.744	12	13	19	17q25.1	FOXJ1, FKHL13, HFH4, CILD43		Forkhead box J1	602291			Ciliary dyskinesia, primary, 43, 618699 (3)	
17.745	11	5	98	17q25.1	CDK3		Cyclin-dependent kinase 3	123828		distal to BRCA1		
17.746	7	25	16	17q23.3	ACE, DCP1, ACE1, MVCD3, ICH		Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1)	106180			{Myocardial infarction, susceptibility to} (3); {Microvascular complications of diabetes 3}, 612624 (3); [Angiotensin I-converting enzyme, benign serum increase] (3); {SARS, progression of} (3); Renal tubular dysgenesis, 267430 (3); {Stroke, hemorrhagic}, 614519 (3)	
17.747	5	19	06	17q23	BSZQTL		Bone size quantitative trait locus 1	609656			{Bone size QTL} (2)	
17.748	7	20	04	17q23.1	CA4, RP17		Carbonic anhydrase IV	114760			Retinitis pigmentosa 17, 600852 (3)	
17.749	8	3	10	17q23.3	CD79B, IGB, B29, AGM6		CD79B antigen	147245			Agammaglobulinemia 6, 612692 (3)	
17.750	2	16	18	17q23.1	CLTC, MRD56		Clathrin, heavy polypeptide (Hc)	118955		fusion gene with TFE3 in renal adenocarcinoma	Mental retardation, autosomal dominant 56, 617854 (3)	
17.751	12	02	20	17q22	MKS1, MKS, BBS13, JBTS28		MKS1 transition zone complex subunit 1	609883		frequent in Finland	Meckel syndrome 1, 249000 (3); Bardet-Biedl syndrome 13, 615990 (3); Joubert syndrome 28, 617121 (3)	
17.752	9	15	96	17q23.3	PECAM1		Platelet/endothelial cell adhesion molecule (CD31 antigen)	173445				6(Pecam1)
17.753	7	1	05	17q22	SEPT4, PNUTL2		Septin 4	603696				11(Sept4)
17.754	12	11	18	17q23.2	TBX2, VETD		T-box 2	600747			Vertebral anomalies and variable endocrine and T-cell dysfunction, 618223 (3)	11(Tbx2)
17.755	09	04	19	17q23.1	WFDC21P, LNCDC, LOC615638		WAP four-disulfide core domain 21, pseudogene	615772				
17.756	3	4	02	17q24.2	KPNA2, RCH1, QIP2		Karyopherin alpha-2	600685				
17.757	08	13	19	17q23.3	POLG2, POLGB, PEOA4, MTDPS16		Polymerase, DNA, gamma-2	604983			Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3); Mitochondrial DNA depletion syndrome 16 (hepatic type), 618528 (3)	
17.758	8	14	15	17q24.2	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1		Protein kinase, cAMP-dependent, regulatory, type I, alpha	188830		fused with RET to form PTC2	Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3); Pigmented nodular adrenocortical disease, primary, 1, 610489 (3); Adrenocortical tumor, somatic, (3); Acrodysostosis 1, with or without hormone resistance, 101800 (3)	11(Tse1)
17.759	1	27	04	17q24.1	RGS9, PERRS		Regulator of G protein signaling 9	604067			Bradyopsia, 608415 (3)	
17.760	5	30	17	17q23.3	SMARCD2, BAF60B, SGD2		SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2	601736			Specific granule deficiency 2, 617475 (3)	
17.761	07	15	20	17q23.3	DDX5, HLR1, G17P1		DEAD-box helicase 5	180630		near BRCA1		
17.762	10	4	91	17q23.3	ICAM2		Intercellular adhesion molecule-2	146630				
17.763	3	5	08	17q25.1	MRPL38		Mitochondrial ribosomal protein L38	611844				
17.764	2	15	18	17q25.1	MRPS7, COXPD34		Mitochondrial ribosomal protein S7	611974		mutation identified in 1 COXPD34 family	?Combined oxidative phosphorylation deficiency 34, 617872 (3)	
17.765	5	1	02	17q25.1	NT5C, UMPH2, DNT1		5', 3' nucleotidase, cytosolic	191720				11(Umph2)
17.766	1	24	11	17q24.2	APOH		Apolipoprotein H (beta-2-glycoprotein I)	138700				11(Apoh)
17.767	10	23	87	17q23-qter	PEPE		Peptidase E	170200				
17.768	8	18	15	17q22	EPX, EPXD		Eosinophil peroxidase	131399			[Eosinophil peroxidase deficiency], 261500 (3)	
17.769	3	9	01	17q22	LPO		Lactoperoxidase	150205				
17.770	5	5	09	17q23.1	MIR21, MIRN21		Micro RNA 21	611020				
17.771	8	30	07	17q22	MPO		Myeloperoxidase	606989		translocated in t(15;17)(q22;q11.2)	Myeloperoxidase deficiency, 254600 (3); {Alzheimer disease, susceptibility to}, 104300 (3); {Lung cancer, protection against, in smokers} (3)	11(Mpo)
17.772	3	13	15	17q23.1	PTRH2, BIT1, IMNEPD		Peptidyl-tRNA hydrolase 2	608625			Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3)	
17.773	4	17	13	17q23.1	RNFT1		RING finger protein, transmembrane 1	615172				11(Rnft1)
17.774	10	15	09	17q23.1	RPS6KB1, S6K1		Ribosomal protein S6 kinase, 70kD	608938				
17.775	3	23	95	17q22	TRIM25, ZNF147, EFP		Tripartite motif-containing 25	600453		300kb from MPO		11(Efp)
17.776	2	5	13	17q23.1	VMP1, TMEM49, EPG3		Vacuole membrane protein 1	611753				
17.777	4	20	10	17q23.1-q23.2	DEL17q23.1q23.2, C17DELq23.1q23.2		Chromosome 17q23.1-q23.2 deletion syndrome	613355			Chromosome 17q23.1-q23.2 deletion syndrome (4)	
17.778	11	1	10	17q23.1-q23.2	DUP17q23.1q23.2, C17DUPq23.1q23.2		Chromosome 17q23.1-q23.2 duplication syndrome	613618		2.2 Mb contiguous gene duplication syndrome	Chromosome 17q23.1-q23.2 duplication syndrome (4)	
17.779	9	12	12	17q24.3	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9		Potassium channel, inwardly rectifying, subfamily J, member 2	600681			Andersen syndrome, 170390 (3); Short QT syndrome 3, 609622 (3); Atrial fibrillation, familial, 9, 613980 (3)	11(Irk1)
17.780	08	24	20	17q23.3	SCN4A, HYPP, NAC1A, HOKPP2, CMS16		Sodium voltage-gated channel, alpha subunit 4	603967		21.5kb from GH1	Hyperkalemic periodic paralysis, type 2, 170500 (3); Paramyotonia congenita, 168300 (3); Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3); Myasthenic syndrome, congenital, 16, 614198 (3); Hypokalemic periodic paralysis, type 2, 613345 (3)	
17.781	4	1	09	17q22	BZRAP1, PRAX1, RIMBP1, KIAA0612		Benzodiazapine receptor (peripheral)-associated protein 1	610764				11(Bzrap1)
17.782	2	21	06	17q22	DYNLL2, DLC2		Dynein, light chain, LC8-type 2	608942				
17.783	4	14	15	17q22	GDPD1, GDE4		Glycerophosphodiester phosphodiesterase domain-containing protein 1	616317				
17.784	3	23	14	17q23.2	INTS2, INT2, KIAA1287		Integrator complex subunit 2	611346				
17.785	6	7	10	17q23.2	MARCH10		Membrane-associated RING-CH finger protein 10	613337				
17.786	06	03	20	17q23.2	METTL2A, METTL2		Methyltransferase-like 2A	618902				
17.787	9	24	08	17q23.2	MRC2, ENDO180, UPARAP, CD280		Mannose receptor, C-type, 2	612264				
17.788	9	27	16	17q22	RNF43, RNF124, SSPCS		Ring finger protein 43	612482			Sessile serrated polyposis cancer syndrome, 617108 (3)	
17.789	7	25	18	17q23.2	TLK2, MRD57		Tousled-like kinase 2	608439			Mental retardation, autosomal dominant 57, 618050 (3)	
17.790	12	29	08	17q22	YPEL2		Yippee-like 2	609723				11(Ypel2)
17.791	8	24	09	17q23.2-q25.1	BMIQ15		Body mass index quantitative trait locus 15	612967		associated with rs228883 and rs1005651	[Body mass index QTL 15] (2)	
17.792	01	02	19	17q23.3	CCDC47, THNS		Coiled-coil domain-containing protein 47	618260			Trichohepatoneurodevelopmental syndrome, 618268 (3)	
17.793	07	15	20	17q23.3	DDX42, RHELP		DEAD-box helicase 42	613369				
17.794	07	13	20	17q23.1	DHX40, DDX40		DEAH-box helicase 40	607570				
17.795	12	10	13	17q23.3	ERN1, IRE1, IRE1A		Endoplasmic reticulum-to-nucleus signaling 1	604033				
17.796	04	30	19	17q23.3	FTSJ3		FTSJ RNA 2-prime-O-methyltransferase 3	618411				
17.797	3	14	13	17q23.3	KCNH6, HERG2		Potassium channel, voltage-gated, subfamily H, member 6	608168				
17.798	6	26	14	17q23.3	MAP3K3, MEKK3, MAPKKK3		Mitogen-activated kinase kinase kinase 3	602539				
17.799	5	19	09	17q23.3	STRADA, STRAD, LYK5		STE20-related kinase adaptor alpha	608626			Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)	
17.800	06	18	20	17q23.2-q23.3	TANC2, KIAA1636, IDDALDS		Tetratricopeptide repeat-, ankyrin repeat-, and coiled-coil-containing protein 2	615047			Intellectual developmental disorder with autistic features and language delay, with or without seizures, 618906 (3)	
17.801	10	12	20	17q23.3	TCAM1P, TCAM1		Testicular cell adhesion molecule 1, pseudogene	612756				11(Tcam1)
17.802	4	21	14	17q23.3-q24.1	SMURF2		SMAD-specific E3 ubiquitin protein ligase 2	605532				
17.803	2	19	13	17q24.1	AXIN2, ODCRCS		Axis inhibitor 2 (conductin, mouse, homolog of)	604025			Oligodontia-colorectal cancer syndrome, 608615 (3); Colorectal cancer, somatic, 114500 (3)	
17.804	11	7	17	17q24.2	BPTF, FALZ, FAC1, NURF301, NEDDFL		Bromodomain PHD finger transcription factor	601819			Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3)	
17.805	4	29	97	17q24.2	CACNG1, CACNLG		Calcium channel, voltage-dependent, gamma-1 subunit	114209				
17.806	11	28	01	17q24.2	CACNG5		Calcium channel, voltage-dependent, gamma-5 subunit	606405				
17.807	5	13	13	17q24	CTRCT7, CCA1		Cataract 7	115660			Cataract 7 (2)	
17.808	5	6	03	17q25.1	CMRF35H, CMRF35H9		CMRF35H antigen	606790				
17.809	11	29	99	17q25.1	GALK1		Galactokinase-1	604313			Galactokinase deficiency with cataracts, 230200 (3)	11(Glk)
17.810	6	23	15	17q24	SRXY10		46,XY sex reversal 10	616425		deletion of 32.5kb XYSR regulatory region upstream of SOX9	46XY sex reversal 10 (4)	
17.811	2	3	03	17q25.1	SSTR2		Somatostatin receptor-2	182452				11(Sstr2)
17.812	12	12	00	17q25.1	CDC42EP4, BORG4		CDC42 effector protein 4 (binder of Rho GTPases 4)	605468				11(Borg4)
17.813	10	13	17	17q25.1	FDXR, ADXR, ANOA		Ferredoxin reductase (adrenodoxin reductase)	103270			Auditory neuropathy and optic atrophy, 617717 (3)	
17.814	10	20	99	17q25.1	GRB2		Growth factor receptor-bound protein 2	108355				11(Grb2)
17.815	10	22	96	17q25.1	PRPSAP1		Phosphoribosyl pyrophosphate synthetase-associated protein-1	601249				
17.816	2	24	97	17q23.3	PSMC5, TRIP1		Proteasome (prosome, macropain) 26S subunit, ATPase, 5	601681				
17.817	4	23	03	17q25.1	SANS, USH1G		Scaffold protein containing ankyrin repeats and SAM domain	607696		?allelic to DFNA20	Usher syndrome, type 1G, 606943 (3)	
17.818	5	22	07	17q25.1	TRIM47, GOA		Tripartite motif-containing protein 47	611041				
17.819	10	12	20	17q24.1	CEP112, CCDC46, MACOCO, SPGF44		Centrosomal protein, 112kD	618980			Spermatogenic failure 44, 619044 (3)	
17.820	9	24	15	17q24.1	LRRC37A3		Leucine-rich repeat-containing protein 37A3	616557				
17.821	11	12	18	17q24.3	ABCA5, KIAA1888, HTC3		ATP-binding cassette, subfamily A, member 5	612503		mutation identified in 1 HTC3 patient	?Hypertrichosis, congenital generalized, with gingival hyperplasia, 135400 (3)	
17.822	12	22	08	17q24.2-q24.3	ABCA6		ATP-binding cassette, subfamily A, member 6	612504				
17.823	12	22	08	17q24.2	ABCA8, KIAA0822		ATP-binding cassette, subfamily A, member 8	612505				
17.824	12	24	08	17q24.2	ABCA9		ATP-binding cassette, subfamily A, member 9	612507				
17.825	12	24	08	17q24.3	ABCA10		ATP-binding cassette, subfamily A, member 10	612508				
17.826	4	17	13	17q24.2	AMZ2		Archaelysin family metallopeptidase 2	615169				
17.827	10	14	18	17q24.2	ARSG, KIAA1001, USH4		Arylsulfatase G	610008			Usher syndrome, type IV, 618144 (3)	
17.828	7	2	18	17q24.2	CACNG4		Calcium channel, voltage-dependent, gamma-4 subunit	606404				
17.829	7	14	14	17q24.2	FAM20A, AIGFS, AI1G		Family with sequence similarity 20, member A	611062			Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3)	
17.830	12	5	17	17q24.2	HELZ, KIAA0054, HUMORF5		Helicase with zinc finger domain	606699				
17.831	8	19	13	17q24.2	NOL11		Nucleolar protein 11	615366				
17.832	7	14	14	17q24.2	PITPNC1, RDGBB		Phosphatidylinositol transfer protein, cytoplasmic, 1	605134				
17.833	6	12	17	17q24.2	PSMD12, P55, STISS		Proteasome 26S subunit, non-ATPase, 12	604450			Stankiewicz-Isidor syndrome, 617516 (3)	
17.834	11	27	18	17q24.2	SLC16A6, MCT7		Solute carrier family 16 (monocarboxylic acid transporter) member 6	603880				
17.835	8	24	09	17q24.2-q24.3	HTGH, DEL17q24		Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (chromosome 17q24 microdeletion syndrome)	135400			Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (4)	
17.836	3	11	08	17q24.1	GNA13		Guanine nucleotide-binding protein, alpha-13	604406				
17.837	8	17	16	17q24.3	LINC00673, HILNC75, SLNCR, LUCAIR1		Long intergenic noncoding RNA 673	617079				
17.838	11	19	10	17q24.3	MAP2K6, PRKMK6, MKK6, MEK6, MAPKK6		Mitogen-activated protein kinase kinase 6	601254				
17.839	3	30	18	17q24.3	TTPP3		Thyrotoxic periodic paralysis, susceptibility to, 3	614834		associated with rs312691	{Thyrotoxic periodic paralysis, susceptibility to, 3} (2)	
17.840	4	26	11	17q24.3-q25.1	SRXX2, DUP17q24.3		46XX sex reversal 2	278850		duplication or triplication of 68kb XXSR regulatory region upstream of SOX9	46XX sex reversal 2 (4)	
17.841	5	19	09	17q24.3-q25.1	PRBNS		Pierre Robin syndrome	261800		between D17S795 and D17S929	Pierre Robin syndrome (2)	
17.842	8	7	15	17q24.3-q25.1	SLC39A11, ZIP11, C17orf26		Solute carrier family 39 (zinc transporter), member 11	616508				
17.843	5	24	13	17q25.3	C1QTNF1, GIP		C1q- and tumor necrosis factor-related protein 1	610365				
17.844	6	23	15	17q24.3	SOX9, CMD1, SRA1		SRY (sex-determining region Y)-box 9	608160			Campomelic dysplasia with autosomal sex reversal, 114290 (3); Acampomelic campomelic dysplasia, 114290 (3); Campomelic dysplasia, 114290 (3)	11(Ts, Sox9)
17.845	12	30	15	17q25.1	AANAT, SNAT		Arylalkylamine N-acetyltransferase	600950				11(Nat4)
17.846	4	6	00	17q25.3	API4		Apoptosis inhibitor 4	603352				
17.847	6	7	06	17q25.3	ASPSCR1, RCC17, ASPL, ASPS		Alveolar soft-part sarcoma chromosome region, candidate 1	606236		t(X;17)(p11.2;q25)	Alveolar soft-part sarcoma, 606243 (3)	
17.848	2	26	02	17q25.3	BAIAP2, IRSP53		BAI1-associated protein 2	605475				
17.849	09	10	19	17q25.3	CBX2, M33, SRXY5		Chromobox 2	602770		mutation identified in 1 SRXY5 patient	?46XY sex reversal 5, 613080 (3)	
17.850	2	11	98	17q25	CDR3		Cerebellar degeneration-related autoantigen-3	602197				11(Cdr3)
17.851	5	13	13	17q25.3	CSNK1D, ASPS, FASPS2		Casein kinase-1, delta	600864			Advanced sleep-phase syndrome, familial, 2, 615224 (3)	
17.852	10	1	10	17q25.1	CYGB, HGB, STAP		Cytoglobin	608759				
17.853	9	30	09	17q25.3	CYTH1, D17S811E, SEC7		Cytohesin 1	182115				
17.854	10	25	19	17q25.3	DNAH17, DNEL2, SPGF39		Dynein, axonemal, heavy chain 17	610063			Spermatogenic failure 39, 618643 (3)	
17.855	12	3	08	17q25.1	DNAI2, CILD9		Dynein, axonemal, intermediate chain 2	605483			Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)	
17.856	12	30	15	17q25	DSPS		Delayed sleep phase syndrome, susceptibility to	614163		associated with rs28936679 in AANAT	{Delayed sleep phase syndrome, susceptibility to} (2)	
17.857	1	5	11	17q25	EPR1		Effector cell protease receptor 1	603411				
17.858	12	17	18	17q25.3	TMC8, EVER2, EV2		Transmembrane channel-like 8	605829		previously mapped to 2p24-p21	Epidermodysplasia verruciformis 2, 618231 (3)	
17.859	1	21	97	17q25.1	EVPL		Envoplakin	601590				
17.860	1	12	95	17q25.3	FASN		Fatty acid synthase	600212				
17.861	12	18	07	17q25.3	FN3KRP		Fructosamine 3-kinase-related protein	611683				
17.862	1	18	12	17q25.3	FOXK2, ILF1		Forkhead box K2 (interleukin enhancer-binding factor 1)	147685				
17.863	6	25	03	17q25.3	FSCN2, RFSN, RP30		Fascin, sea urchin, homolog of, 2	607643		within 200kb of ACTG1	Retinitis pigmentosa 30, 607921 (3)	
17.864	06	04	20	17q25.3	GCGR		Glucagon receptor	138033				
17.865	6	20	94	17q25.1	GRIN2C, NMDAR2C		Glutamate receptor, ionotropic, N-methyl D-aspartate 2C	138254				
17.866	2	16	96	17q25.1	H3F3B		H3 histone, family 3B (H3.3B)	601058				
17.867	2	7	01	17q25.3	HGS, HRS		Human growth factor-regulated tyrosine kinase substrate	604375				
17.868	11	12	07	17q25.1	JMJD6, PSR		Jumonji domain containing 6 (phosphatidylserine receptor)	604914				
17.869	5	29	01	17q24.3	KCNJ16, KIR5.1		Potassium channel, inwardly rectifying, subfamily J, member 16	605722				
17.870	7	12	95	17q25.3	LGALS3BP		Lectin, galactoside-binding, soluble, 3 binding protein (galectin 6 binding protein)	600626				11(Lgals3bp)
17.871	03	02	20	17q25.3	MAFG		MAF bZIP transcription factor G	602020				
17.872	4	7	15	17q25.3	P4HB, PROHB, CLCRP1		Procollagen-proline, 2-oxoglutarate-4-dioxygenase, beta polypeptide	176790			Cole-Carpenter syndrome 1, 112240 (3)	
17.873	10	7	10	17q25.3	PDE6G, PDEG, RP57		Phosphodiesterase-6G, cGMP-specific, rod, gamma	180073			Retinitis pigmentosa 57, 613582 (3)	11(Pdeg)
17.874	11	12	18	17q25.1	NUP85, PCNT1, PCNT, NPHS17		Nucleoporin 85kD	170285			Nephrotic syndrome, type 17, 618176 (3)	
17.875	5	22	14	17q25.1	RECQL5, RECQ5		DNA helicase, RecQ-like 5	603781				
17.876	10	20	99	17q25.3	RFNG		Radical fringe	602578				11(Rfng)
17.877	2	25	11	17q25.3	RNF213, ALO17, KIAA1618, MYMY2		Ring finger protein 213	613768			{Moyamoya disease 2, susceptibility to}, 607151 (3)	
17.878	03	09	20	17q25.3	SEPT9, MSF, MSF1, NAPB		Septin 9	604061			Amyotrophy, hereditary neuralgic, 162100 (3)	
17.879	4	6	15	17q25.3	SLC26A11		Solute carrier family 26 (sulfate transporter), member 11	610117				11(Slc26a11)
17.880	12	7	11	17q25.1	SRSF2, SFRS2, SC35		Serine/arginine-rich splicing factor 2	600813				11(Sfrs2)
17.881	11	22	16	17q25.3	TBCD, PEBAT		Tubulin-specific chaperone D	604649			Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3)	
17.882	9	22	93	17q25.3	TIMP2		Tissue inhibitor of metalloproteinase-2	188825				11(Timp2)
17.883	4	14	10	17q25.3	TMC6, EVER1, EV1		Transmembrane channel-like 6	605828			Epidermodysplasia verruciformis, 226400 (3)	
17.884	12	4	02	17q25.3	SYNGR2		Synaptogyrin 2	603926		pseudogene on 15q11; near EV1, EV2, TK1		
17.885	8	25	17	17q25.1	WBP2, DFNB107		WW domain-binding protein 2	606962			Deafness, autosomal recessive 107, 617639 (3)	
17.886	07	29	20	17q25.3	MRPL12, RPML12		Ribosomal protein, mitochondrial, L12	602375		mutation identified in 1 COXPD45 family	?Combined oxidative phosphorylation deficiency 45, 618951 (3)	
17.887	07	22	20	17q25.1	ACOX1, ACOX, SCOX, MITCH		Acyl-Coenzyme A oxidase 1, palmitoyl	609751			Peroxisomal acyl-CoA oxidase deficiency, 264470 (3); Mitchell syndrome, 618960 (3)	
17.888	10	10	18	17q25.1	ATP5PD, APT5H		ATP synthase, peripheral stalk, subunit D	618121				
17.889	9	24	15	17q25.1	CD300H		CD300H antigen	616560				
17.890	4	10	15	17q25.1	CD300LD, CD300D		CD300 antigen-like family, member D	616301				
17.891	1	22	07	17q25.1	CD300LB, TREM5, IREM3		CD300 antigen-like family, member B	610705				11(Cd300lb)
17.892	8	29	08	17q25.1	CASKIN2, KIAA1139		CASK-interacting protein 2	612185				
17.893	12	23	05	17q25.1	CD300E, CD300LE, IREM2, CLM2		CD300E antigen	609801				
17.894	12	23	05	17q25.1	CD300LF, IGSF13, IREM1, CLM1		CD300 antigen-like family, member F	609807				
17.895	1	14	11	17q25.1	COG1, LDLB, KIAA1381, CDG2G		Component of oligomeric golgi complex 1	606973			Congenital disorder of glycosylation, type IIg, 611209 (3)	
17.896	11	04	20	17q25.1	EXOC7, EX070, KIAA1067, NEDSEBA		Exocyst complex component 7	608163			Neurodevelopmental disorder with seizures and brain atrophy, 619072 (3)	
17.897	2	12	16	17q25.1	FGF1, ALB		FAS-binding factor 1	616807				
17.898	6	13	12	17q25.1	GPR142, PGR2		G protein-coupled receptor 142	609046				11(Gpr142)
17.899	11	27	17	17q25.1	HID1, 17orf28, DMC1		HID1 domain-containing protein 1	605752				
17.900	3	10	11	17q25.1	ICT1, DS1		Immature colon carcinoma transcript 1	603000				
17.901	7	26	10	17q25.1	KCTD2, KIAA0176		Potassium channel tetramerization domain-containing 2	613422				
17.902	06	24	19	17q25.1	LLGL2		LLGL scribble cell polarity complex component 2	618483				
17.903	8	22	14	17q25.1	METTL23, C17orf95, MRT44		Methyltransferase-like 23	615262			Mental retardation, autosomal recessive 44, 615942 (3)	
17.904	12	2	14	17q25.1-q25.3	NDNC9		Nail disorder, nonsyndromic congenital, 9 (anonychia-onycholysis)	614149		max lod at D17S1301	Nail disorder, nonsyndromic congenital, 9 (2)	
17.905	6	24	08	17q25.1	MIF4GD, SLIP1		MIF4G domain-containing protein	612072				
17.906	02	26	19	17q25.1	QRICH2, SPGF35		Glutamine-rich protein 2	618304			Spermatogenic failure 35, 618341 (3)	
17.907	3	14	06	17q25.1	RAB37		Pas-associated protein RAB37	609956				
17.908	4	19	12	17q25.1	RHBDF2, IRHOM2, TOC		Rhomboid 5, Drosophila, homolog of, 2	614404			Tylosis with esophageal cancer, 148500 (3)	
17.909	10	22	10	17q25.1	SAP30BP, HTRP, HCNGP, HTRG		SAP30-binding protein	610218				
17.910	09	30	20	17q25.1	SDK2, KIAA1514		Sidekick cell adhesion molecule 2	607217				
17.911	9	23	08	17q25.1	SLC9A3R1, EBP50, NHERF1, NPHLOP2		Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 1	604990			Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	
17.912	11	27	18	17q25.1	SLC16A5, MCT6		Solute carrier family 16 (monocarboxylic acid transporter) member 5	603879				
17.913	4	6	01	17q25.1	SRP68		Signal recognition particle, 68kD	604858				
17.914	8	19	13	17q25.1	ST6GALNAC1, SIAT7A, STYI		ST6 alpha-N-aetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	610138				
17.915	3	20	14	17q25.1	ST6GALNAC2, SIAT7B, SAITL1		ST6 alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2	610137				
17.916	2	10	17	17q25.1	TEN1, C17orf106		TEN1, CST complex subunit	613130				
17.917	02	08	19	17q25.1	TMEM94, KIAA0195, IDDCDF		Transmembrane protein 94	618163			Intellectual developmental disorder with cardiac defects and dysmorphic facies, 618316 (3)	
17.918	08	21	19	17q25.1	TSEN54, SEN54, PCH2A, PCH4, PCH5		tRNA splicing endonuclease, subunit 54	608755		mutation identified in 1 PCH5 patient	Pontocerebellar hypoplasia type 2A, 277470 (3); Pontocerebellar hypoplasia type 4, 225753 (3); ?Pontocerebellar hypoplasia type 5, 610204 (3)	
17.919	9	16	12	17q25.1	TTYH2		Tweety, Drosophila, homolog of, 2	608855				
17.920	8	31	17	17q25.1	UBE2O, KIAA1734		Ubiquitin-conjugating enzyme E2O	617649				11(Ube2o)
17.921	09	11	19	17q25.1	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3		unc-13 homolog D	608897			Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	
17.922	5	19	15	17q25.1	UNK, UNKEMPT, ZC3H5, KIAA1753		Unkempt family zinc finger protein	616375				
17.923	5	20	99	17q25.3	NPTX1, NP1		Pentraxin I, neuronal	602367				11(Nptx1)
17.924	10	07	19	17q25.2-q25.3	SEC14L		SEC14-like 1	601504				
17.925	5	7	01	17q25.1	GPRC5C, RAIG3		G protein-coupled receptor, family C, group 5, member C	605949				
17.926	7	12	02	17q25.1	SPHK1		Sphingosine kinase	603730				
17.927	1	2	91	17q25.3	CD7		CD7 antigen (p41)	186820				11(Cd7)
17.928	4	11	02	17q25.3	GAA		Glucosidase, acid alpha-	606800		distal to TK1	Glycogen storage disease II, 232300 (3)	
17.929	6	25	99	17q25.3	SECTM1, K12		Secreted and transmembrane 1	602602				
17.930	3	8	96	17q25.3	TK1		Thymidine kinase-1	188300				11(Tk1)
17.931	10	31	00	17q25.3	AATK, AATYK		Apoptosis-associated tyrosine kinase	605276				
17.932	4	19	12	17q25.3	ACTG1, DFNA20, DFNA26, BRWS2		Actin, gamma-1	102560			Deafness, autosomal dominant 20/26, 604717 (3); Baraitser-Winter syndrome 2, 614583 (3)	
17.933	5	2	16	17q25.3	ALYREF, THOC4, ALY, BEF		ALY/REF export factor	604171				
17.934	3	30	12	17q25.3	ANAPC11, APC11		Anaphase-promoting complex subunit 11	614534				
17.935	8	1	14	17q25.3	ARHGDIA, GDIA1, NPHS8		Rho GDP dissociation inhibitor (GDI) alpha	601925			Nephrotic syndrome, type 8, 615244 (3)	
17.936	12	04	20	17q25.3	ARL16		ADP ribosylation factor-like GTPase 16	619117				
17.937	10	12	09	17q25.3	ATOD4		Dermatitis, atopic, 4	605805		maximum lod at D17S1290	{Dermatitis, atopic, susceptibility to, 4} (2)	
17.938	2	1	11	17q25.3	AZI1, ZA1, KIAA1118		5-azacytidine-induced gene 1, mouse, homolog of	613479				
17.939	8	31	17	17q25.3	BAHCC1, BAHD2, KIAA1447		BAH domain- and coiled-coil domain-containing protein 1	617646				
17.940	8	2	13	17q25.3	B3GNTL1		Beat-1,3-N-acetylglucosaminyltransferase-like 1	615337				
17.941	3	23	14	17q25.3	C17orf70, FAAP100		Chromosome 17 open reading frame 70	611301				
17.942	10	13	17	17q25.3	CANT1, SCAN1, DBQD1, EDM7		Calcium-activated nucleotidase 1	613165			Desbuquois dysplasia 1, 251450 (3); Epiphyseal dysplasia, multiple, 7, 617719 (3)	
17.943	12	1	14	17q25.3	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP		Caspase recruitment domain-containing protein 14	607211			Psoriasis 2, 602723 (3); Pityriasis rubra pilaris, 173200 (3)	
17.944	09	10	19	17q25.3	CBX4, PC2		Chromobox 4	603079				
17.945	09	10	19	17q25.3	CBX8, PC3		Chromobox 8	617354				
17.946	3	15	11	17q25.3	CCDC40, KIAA1640		Coiled-coil domain-containing protein 40	613799			Ciliary dyskinesia, primary, 15, 613808 (3)	
17.947	10	5	11	17q25.3	CCDC137		Coiled-coil domain-containing protein 137	614271				
17.948	12	23	19	17q25.3	CHMP6		Charged multivesicular body protein 6	610901				
17.949	07	06	20	17q25.3	CYBC1, EROS, C17orf62, CGD5		Cytochrome b(-254) chaperone 1	618334			Chronic granulomatous disease 5, autosomal recessive, 618935 (3)	
17.950	4	7	14	17q25.3	DCXR, P34H, PNTSU		Dicarbonyl/L-xylulose reductase	608347			[Pentosuria], 260800 (3)	
17.951	10	25	19	17q25.3	EIF4A3, DDX48, MUK34, NMP265, KIAA0111, RCPS		Eukaryotic translation initiation factor 4A3	608546			Robin sequence with cleft mandible and limb anomalies, 268305 (3)	
17.952	6	26	16	17q25.3	ENPP7		Ectonucleotide pyrophosphatase/phosphodiesterase 7	616997				
17.953	8	26	15	17q25.3	FAM195B, MCRIP1		Family with sequence similarity 194, member B	616514				
17.954	8	8	13	17q25.3	FN3K		Fructosamine 3-kinase	608425				
17.955	6	25	99	17q25.1	GALR2, GALNR2		Galanin receptor 2	603691				
17.956	10	7	02	17q25.3	GPR14, UTR2, UTR		G protein-coupled receptor-14 (urotensin II receptor)	600896				
17.957	2	12	07	17q25.3	GPS1		G protein pathway suppressor 1	601934				
17.958	3	10	15	17q25.3	IS5		Scoliosis, idiopathic, susceptibility to, 5	612239		between D17S1806 and 17qter	{Scoliosis, idiopathic, susceptibility to, 5} (2)	
17.959	2	25	15	17q25.3	METRNL		Meteorin-like protein	616241				
17.960	12	4	08	17q25.2	MGAT5B		Alpha-1,6-mannosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase isozyme B	612441				
17.961	7	1	11	17q25.3	MIR338, MIRN338		Micro RNA 338	614059				
17.962	3	18	08	17q25.3	NAGLUEB, FLJ21865		N-acetylglucosaminidase, endo-beta	611898				
17.963	02	19	20	17q25.3	NDUFAF8, C17orf89, MC1DN34		NADH dehydrogenase (ubiquinone) complex I, assembly factor 8	618461			Mitochondrial complex I deficiency, nuclear type 34, 618776 (3)	
17.964	12	02	20	17q25.3	NOTUM		Notum, palmitoleoyl-protein carboxylesterase	609847				
17.965	2	25	15	17q25.3	NPB, PPL7		Neuropeptide B	607996				
17.966	6	13	14	17q25.1	OTOP2		Otopetrin 2	607827				11(Otop2)
17.967	6	13	14	17q25.1	OTOP3		Otopetrin 3	607828				11(Otop3)
17.968	02	14	20	17q25.3	PCYT2, ET, SPG82		Phosphate cytidylyltransferase 2, ethanolamine	602679			Spastic paraplegia 82, autosomal recessive, 618770 (3)	
17.969	12	17	12	17q25.3	PGS1		Phosphatidylglycerophosphate synthase 1	614942				
17.970	1	31	12	17q25.3	PYCR1, PRO3, ARCL2B, ARCL3B		Pyrroline-5-carboxylate reductase-1	179035			Cutis laxa, autosomal recessive, type IIB, 612940 (3); Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	
17.971	09	12	19	17q25.3	RAC3		Rac family small GTPase 3	602050			Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies, 618577 (3)	
17.972	6	26	16	17q25.3	RBFOX3, FOX3, NEUN, HRNBP3		RNA-binding protein FOX1, C. Elegans, homolog of, 3	616999				
17.973	12	2	09	17q25.3	RPTOR, RAPTOR, KIAA1303		Regulatory-associated protein of MTOR	607130				
17.974	2	2	11	17q25.3	SGSH, MPS3A, SFMD		N-sulfoglucosamine sulfohydrolase (sulfamidase)	605270			Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3)	11(Sgsh)
17.975	8	17	10	17q25.3	SIRT7, SIR2L7		Sirtuin 7 (Sir2, S. cerevisiae, homolog of, 7)	606212				
17.976	11	27	18	17q25.3	SLC16A3, MCT4		Solute carrier family 16 (monocarboxylic acid transporter) member 3	603877				
17.977	08	04	20	17q25.3	SLC25A10, DIC, MTDPS19		Solute carrier family 25 (mitochondrial carrier), member 10 (dicarboxylate ion carrier)	606794		mutation identified in 1 MTDPS19 patient	?Mitochondrial DNA depletion syndrome 19, 618972 (3)	
17.978	2	13	12	17q25.1	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4		Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19	606521			Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	
17.979	8	26	15	17q25.3	SLC38A10		Solute carrier family 38 (amino acid transporter), member 10	616525				
17.980	10	8	09	17q25.3	SOCS3, SSI3, CIS3		Suppressor of cytokine signaling 3	604176				
17.981	4	6	13	17q25.3	STRA13, CENPX, FAAP10, MHF2, D9		Stimulated by retinoic acid 13	615128				
17.982	11	15	15	17q25.3	TBC1D16		TBC1 domain family, member 16	616637				
17.983	2	13	14	17q25.3	TEX19		Testis-expressed gene 19	615647				
17.984	1	31	07	17q25.3	TNRC6C, KIAA1582		Trinucleotide repeat-containing gene 6C	610741				
17.985	10	25	19	17q25.1	ZACN, LGICZ1, ZAC, L2		Zinc activated ion channel	610935				
17.986	1	27	09	17q25.3	USP36, KIAA1453		Ubiquitin-specific protease 36	612543				
17.987	5	17	18	17q25.3	WDR45B, WIPI3, WDR45L, NEDSBAS		WD repeat domain 45B	609226			Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures, 617977 (3)	
17.988	7	9	06	17q25.3	ZNF750, FLJ13841		Zinc finger protein 750	610226			Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)	
17.989	11	20	20	17q25.3	NPL4, KIAA1499		NPL4 homolog, ubiquitin recognition factor	606590				
17.990	5	26	98	17q22	AKAP1, AKAP149, SAKAP84		A-kinase anchor protein 1, 149kD	602449				
17.991	4	30	03	17q12	AP1GBP1, SYNG		Adaptor-related protein complex 1 gamma subunit-binding protein 1	607291				
17.992	11	5	98	17q21.32	ATP5G1		ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C, isoform 1	603192				
17.993	8	29	02	17q12	CCL1, SCYA1		Chemokine, C-C motif, ligand 1	182281				
17.994	5	22	03	17p13.1	CENTB1, KIAA0050, ACAP1		Centaurin, beta-1	607763				
17.995	11	1	02	17q21.31	CLP1, HIS1		Cardiac lineage protein 1	607328				
17.996	12	11	02	17q12	DUSP14, MKP6		Dual-specificity phosphatase 14	606618				
17.997	10	7	02	17p11.2	EPN2, KIAA1065		Epsin 2	607263				
17.998	10	7	02	17q21.33	EPN3		Epsin 3	607264				
17.999	4	10	90	Chr.17	G6PDL		Glucose-6-phosphate dehydrogenase-like	138110				
17.1000	12	19	01	17q25.1	GGA3, KIAA0154		Golgi associated, gamma adaptin ear containing, ARF binding protein 3	606006				
17.1001	6	25	99	17q22	MTMR4		Myotubularin-related protein 4	603559				
17.1002	12	27	01	17p13.1	NLGN2, KIAA1366		Neuroligin 2	606479				
17.1003	2	3	03	17p13.1	NUDEL		Nude-like protein (endooligopeptidase A)	607538				
17.1004	3	20	15	Chr.17	ODS1		Opioid dependence, susceptibility to, 1	610064			{Opioid dependence, susceptibility to, 1} (2)	
17.1005	6	2	98	17p13.1	PFAS, FGARAT		phosphoribosylformylglycinamidine synthase (FGAR amidotransferase)	602133				
17.1006	3	23	02	17p11.2	TRPV2, VRL1		Transient receptor potential cation channel, subfamily V, member 2	606676				
17.1007	11	21	02	17q23.1	TUBD1, TUBD		Tubulin, delta-1	607344				
18.1	8	26	09	18p11.32	CETN1, CEN1		Centrin-1	603187				
18.2	6	14	94	18pter-p11.21	ERV1		Oncogene ERV1; endogenous retrovirus-1	131150				
18.3	3	10	03	18p11.32	COLEC12, SRCL, CLP1		Collectin 12	607621				
18.4	12	15	10	18p11.32	ENOSF1, RTS		Enolase superfamily member 1	607427				
18.5	2	27	17	18p11.32	SMCHD1, KIAA0650, BAMS		Structural maintenance of chromosomes flexible hinge domain-containing protein 1	614982			Fascioscapulohumeral muscular dystrophy 2, digenic, 158901 (3); Bosma arhinia microphthalmia syndrome, 603457 (3)	17(Smchd1)
18.6	10	20	92	18p11.32	TYMS, TS, TMS		Thymidylate synthase	188350		<50 kb from YES1		
18.7	8	26	09	18p11.32	THOC1, HPR1		THO complex 1 (nuclear matrix protein p84)	606930				
18.8	3	14	06	18p11.32-p11.31	DFNB46		Deafness, neurosensory, autosomal recessive 46	609647		between D18S59 and D18S391	Deafness, autosomal recessive 46 (2)	
18.9	11	30	06	18p11.31	ARHGAP28, KIAA1314		RHO GTPase-activating protein 28	610592				
18.10	6	19	15	18p11.31	C18orf42		Chromosome 18 open reading frame 42	616427				
18.11	7	14	14	18p11.31	DLGAP1, DAP1, DLGAP1A, DLGAP1B		Discs large-associated protein 1	605445				
18.12	04	09	20	18p11.31	L3MBTL4		L3MBTL histone methyl-lysine-binding protein 4	617135				
18.13	9	20	14	18p11.31	LAMA1, PTBHS		Laminin, alpha-1	150320			Poretti-Boltshauser syndrome, 615960 (3)	17(Lama)
18.14	7	20	09	18p11.31	MYL12B, MRLC2		Myosin, light chain 12B, regulatory	609211				
18.15	12	4	12	18p11.31	MYOM1, SKELEMIN		Myomesin 1	603508				
18.16	11	12	98	18p11.31	MYP2		Myopia, high grade, autosomal dominant 1	160700			Myopia 2 (2)	
18.17	12	13	18	18p11.22	NDUFV2, MC1DN7		NADH-ubiquinone oxidoreductase core subunit V2	600532		pseudogene on 19q13.3-qter	Mitochondrial complex I deficiency, nuclear type 7, 618229 (3)	
18.18	6	26	16	18p11.32	CLUL1		Clusterin-like protein 1	616990				
18.19	11	13	12	18p11.3	POROK6, DSAP4		Porokeratosis 6	612353		between telomere and D18S391	Porokeratosis 6, multiple types (2)	
18.20	4	3	01	18p11.31	EPB41L3, DAL1		Erythrocyte membrane protein band 4.1-like 3	605331				
18.21	11	18	11	18p11.3	MRT19		Mental retardation, autosomal recessive 19	614343		between rs4606805 and rs1787846	Mental retardation, autosomal recessive 19 (2)	
18.22	3	6	01	18p11.22	RAB31		Ras-associated protein RAB31	605694				
18.23	5	4	10	18p11.31	TGIF1, HPE4		TG-interacting factor 1	602630			Holoprosencephaly 4, 142946 (3)	
18.24	4	25	93	18p11.32	YES1		Oncogene YES-1	164880		<50 kb from TYMS		
18.25	2	12	07	18p11.3-p11.2	AA1		Alopecia areata 1	104000		max lod at D18S967	Alopecia areata 1 (2)	
18.26	7	13	93	18p11.21	PTPN2, PTPT		Protein tyrosine phosphatase, nonreceptor-type, 2	176887				18(Ptpt)
18.27	9	27	02	18p11.22	TWSG1, TSG		Twisted gastrulation, Drosophila, homolog of	605049				17(Tsg)
18.28	12	18	08	18p11.23	PSORS10		Psoriasis susceptibility 10	612410		between D18S63 and D18S967	{Psoriasis susceptibility 10} (2)	
18.29	6	18	99	18p11.21	RNMT, MET		RNA guanine-7-methyltransferase	603514				
18.30	1	28	05	18p11.23-q12.2	ANIC		Anosmia, isolated congenital	107200		max lod at D18S1108	Anosmia, isolated congenital (2)	
18.31	11	30	06	18p11.22	ANKRD12, ANCO1, KIAA0874		Ankyrin repeat domain-containing protein 12	610616				
18.32	12	30	14	18p11.22	GACAT2, MTCL1AS1		Gastric cancer-associated transcript 2, noncoding	616131				
18.33	4	29	14	18p11.22	MTCL1, KIAA0802		Microtubule crosslinking factor 1	615766				
18.34	4	29	14	18p11.22	NAPG		N-ethylmaleimide-sensitive factor attachment protein, gamma	603216				
18.35	10	12	16	18p11.22-p11.21	PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT		PIEZO-type mechanosensitive ion channel component 2	613629		mutation identified in 1 MWKS patient	Arthrogryposis, distal, type 5, 108145 (3); Arthrogryposis, distal, type 3, 114300 (3); ?Marden-Walker syndrome, 248700 (3); Arthrogryposis, distal, with impaired proprioception and touch, 617146 (3)	
18.36	8	26	09	18p11.22	PPP4R1, PP4R1		Protein phosphatase 4, regulatory subunit 1	604908				
18.37	7	20	15	18p11.22	RAB12		Ras-associated protein RAB12	616448				
18.38	11	29	17	18p11.22	TXNDC2, SPTRX1		Thioredoxin domain-containing protein 2	617790				
18.39	8	26	09	18p11.22	VAPA, VAP33		Vesicle-associated membrane protein-associated protein A	605703				
18.40	9	28	15	18p11.21	ANKRD30B		Ankyrin repeat domain-containing protein 30B	616565				
18.41	6	19	15	18p11.21	CEP192, PPP1R62, KIAA1569		Centrosomal protein, 192kD	616426				
18.42	2	14	12	18p11.21	CIDEA		Cell death-inducing DFFA-like effector A	604440				
18.43	5	17	18	18p11.21	FAM210A, C18orf19		Family with sequence similarity 210, member A	617975				
18.44	6	4	13	18p11.21	GNAL, DYT25		Guanine nucleotide-binding protein, alpha-subunit, olfactory type	139312			Dystonia 25, 615073 (3)	18(Gnal)
18.45	9	11	15	18p11.21	PRELID3A, SLMO1, C18orf43		PRELI domain-containing protein 3A	616545				
18.46	10	28	08	18p11.21	PSMG2, TNFSF5IP1, HCCA3, CLAST3, PAC2		Proteasome (prosome, macropain) assembly chaperone 1	609702				
18.47	4	14	05	18p11.21	SEH1L, SEH1, SEC13L		Seh1-like protein	609263				
18.48	08	17	20	18p11.21	SPIRE1, KIAA1135		Spire-type actin nucleation factor 1	609216				
18.49	10	25	17	18p11.21	TUBB6, FPVEPD		Tubulin, beta-6	615103		mutation identified in 1 FPVEPD family	?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction, 617732 (3)	
18.50	6	18	99	18p11.31	ZFP161, ZF5		Zinc finger protein-161	602126				17(Zfp161)
18.51	12	19	01	18p11.21	C18orf1		Chromosome 18 open reading frame 1	606571				
18.52	9	30	02	18p11.2	DYX6, DYXQTL18		Dyslexia, susceptibility to, 6	606616			{Dyslexia, susceptibility to, 6} (2)	
18.53	8	9	05	18p11.2	FEB6		Febrile seizures, familial, 6	609253		max lod at D18S1158	Febrile seizures, familial, 6 (2)	
18.54	5	16	01	18p11.21	IMPA2		Myo-inositol monophosphatase 2	605922				
18.55	12	4	02	18p11.21	MC2R		Melanocortin-2 receptor (ACTH receptor)	607397			Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)	18(Mc2r)
18.56	5	17	95	18p11.21	MC5R		Melanocortin-5 receptor	600042				
18.57	3	20	08	18p11.21	MPPE1		Metallophosphoesterase 1	611900				
18.58	11	4	93	18p11.23	PTPRM, PTPRL1, RPTPM		Protein tyrosine phosphatase, receptor type, mu polypeptide	176888				
18.59	7	13	93	18p11.32	ADCYAP1		Adenylate cyclase activating polypeptide-1 (pituitary)	102980				
18.60	08	14	20	18p11.21	AFG3L2, SCA28, SPAX5, OPA12		ATPase family gene 3-like 2	604581			Spinocerebellar ataxia 28, 610246 (3); Spastic ataxia 5, autosomal recessive, 614487 (3); Optic atrophy 12, 618977 (3)	
18.61	7	16	14	18p11.22	APCDD1, HHS, HYPT1, HTS		Adenomatosis polyposis coli down-regulated 1	607479			Hypotrichosis 1, 605389 (3)	
18.62	12	23	19	18p11.21	CHMP1B, C10orf2		Charged multivesicular body protein 1B	606486				
18.63	1	16	03	18p11	DYT15		Dystonia-15, myoclonic	607488			Dystonia-15, myoclonic (2)	
18.64	10	28	08	18p11	IBD21		Inflammatory bowel disease 21	612354		associated with rs2542151	{Inflammatory bowel disease 21} (2)	
18.65	8	27	01	18p11.22	RALBP1, RLIP76		RALA-binding protein 1	605801				
18.66	1	24	09	18p	DEL18p, C18DELp		Chromosome 18p deletion syndrome	146390			Chromosome 18p deletion syndrome (4)	
18.67	5	26	98	18p	DYT7		Dystonia-7 (torsion dystonia, adult-onset, focal)	602124			Dystonia-7, torsion (2)	
18.68	1	15	09	18p11.31	LPIN2		Lipin 2	605519			Majeed syndrome, 609628 (3)	17(Lpin2)
18.69	5	6	08	18p	MAFD1, BPAD, MD1		Major affective disorder 1	125480		?also 18q	{Major affective disorder 1} (2)	
18.70	12	15	98	18p	SCZD8		Schizophrenia susceptibility locus, chromosome 18-related	603206			{Schizophrenia}, 181500 (2)	
18.71	10	18	11	18p	TET18P		Tetrasomy 18p	614290			Tetrasomy 18p (4)	
18.72	2	28	03	18p11.32	USP14, TGT		Ubiquitin-specific protease 14	607274				18(Usp14, ax)
18.73	11	16	08	18q	DEL18q		Chromosome 18q deletion syndrome	601808			Chromosome 18q deletion syndrome (4)	
18.74	11	12	98	18q	OHDS		Orthostatic hypotensive disorder of Streeten	143850			Orthostatic hypotensive disorder of Streeten (2)	
18.75	8	20	99	18q21.1	RPL17		Ribosomal protein L17	603661				
18.76	10	26	99	18q12.1	B4GALT6		Beta-1,4-galactosyltransferase 6	604017				
18.77	05	12	20	18q11.2	NPC1, NPC		NPC intracellular cholesterol transporter 1	607623		some families not linked to 18; type D prob. allelic	Niemann-Pick disease, type C1, 257220 (3); Niemann-Pick disease, type D, 257220 (3)	18(spm)
18.78	5	7	03	18q11.2	OSBPL1A, ORP1		Oxysterol-binding protein-like protein 1A	606730				
18.79	4	5	11	18q12.3	SLC14A1, JK, UTE, UT1		Solute carrier family 14 (urea transporter), member 1 (Kidd blood group)	613868		previous suggestion of chr.7 or chr.2	[Blood group, Kidd], 111000 (3)	
18.80	05	08	20	18q11.2	ABHD3, LABH3		Abhydrolase domain-containing 3, phospholipase	612197				
18.81	12	19	17	18q11.1-q11.2	GREB1L, C18orf6, KIAA1772, RHDA3		GREB1-like protein	617782			Renal hypodysplasia/aplasia 3, 617805 (3)	
18.82	1	28	09	18q11.1	ROCK1		RHO-associated coiled-coil-containing protein kinase 1	601702				
18.83	2	24	12	18q11.2	GATA6, AVSD5, ASD9, PACHD		GATA-binding protein-6	601656			Atrioventricular septal defect 5, 614474 (3); Atrial septal defect 9, 614475 (3); Pancreatic agenesis and congenital heart defects, 600001 (3); Persistent truncus arteriosus, 217095 (3); Tetralogy of Fallot, 187500 (3)	
18.84	06	26	20	18q12.1	CDH2, NCAD, ARVD14, ACOGS		Cadherin 2 (cadherin, neuronal type; N-cadherin)	114020			Arrhythmogenic right ventricular dysplasia, familial, 14, 618920 (3); Agenesis of corpus callosum, cardiac, ocular, and genital syndrome, 618929 (3)	18(Ncad)
18.85	3	14	15	18q11.2	CHST9, GalNAc4ST2		Carbohydrate sulfotransferase 9	610191				
18.86	06	30	20	18q11.2	ESCO1, ECO1, CTF, ESO1, EFO1, KIAA1911		Establishment of sister chromatid cohesion N-acetyltransferase 1	609674				
18.87	5	6	03	18q11.2	HRH4, HH4R		Histamine receptor H4	606792				
18.88	7	22	13	18q11.2	KCTD1, SENS		Potassium channel tetramerization domain-containing 1	613420			Scalp-ear-nipple syndrome, 181270 (3)	
18.89	10	15	03	18q11.2	LAMA3, LOCS		Laminin, alpha-3 (nicein, 150kD; kalinin, 165kD; BM600, 150kD; epiligrin)	600805			Epidermolysis bullosa, junctional, Herlitz type, 226700 (3); Epidermolysis bullosa, generalized atrophic benign, 226650 (3); Laryngoonychocutaneous syndrome, 245660 (3)	
18.90	08	21	19	18q11.2	MIB1, MIB, DIP1, KIAA1323, LVNC7		Mindbomb E3 ubiquitin protein ligase 1	608677			Left ventricular noncompaction 7, 615092 (3)	
18.91	5	24	13	18q11.2	MIR1-2		Micro RNA 1-2	610252				
18.92	5	24	13	18q11.2	MIR133A1		Micro RNA 133A1	610254				
18.93	8	31	17	18q11.2	PCAT18, LINC01092		Prostate cancer-associated transcript 18, noncoding	617647				
18.94	1	19	18	18q11.2	PSMA8, PSMA7L		Proteasome subunit, alpha-type, 8	617841				
18.95	2	21	12	18q11.2	RBBP8, RIM, SCKL2, JWDS		Retinoblastoma-binding protein 8	604124			Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3); Jawad syndrome, 251255 (3)	
18.96	10	31	17	18q11.2	RIOK3, SUDD		RIO kinase 3	603579				
18.97	8	18	14	18q11.2	SNRPD1		Small nuclear ribonucleoprotein polypeptide D1	601063				
18.98	6	26	01	18q11.2	SS18, SSXT, SYT		Synovial sarcoma translocation, chromosome 18	600192		5' SYST/3' SSRC in t(X;18)	Sarcoma, synovial (1)	
18.99	7	7	14	18q11.2	TAF4B, TAF2C2, TAFII105, SPGF13		TAF4b RNA polymerase II, TATA box-binding protein-associated factor, 105kD	601689		mutation identified in 1 SPGF13 family	?Spermatogenic failure 13, 615841 (3)	
18.100	11	1	13	18q11.2	TMEM241, C18orf45		Transmembrane protein 241	615430				
18.101	5	22	07	18q11.2	ZNF521, EHZF, EVI3		Zinc finger protein 521	610974				
18.102	12	13	96	18q11.2	AQP4, MIWC		Aquaporin-4	600308				18(Aqp4)
18.103	7	23	13	18q11.2	IMPACT		Impact RWD domain protein	615319				18(Impact)
18.104	2	26	10	18q12.1	TTR, PALB		Transthyretin (prealbumin)	176300			Amyloidosis, hereditary, transthyretin-related, 105210 (3); [Dystransthyretinemic hyperthyroxinemia], 145680 (3); Carpal tunnel syndrome, familial, 115430 (3)	18(Palb)
18.105	5	23	11	18q11.2-q12.2	APMR3		Alopecia-mental retardation syndrome 3	613930		between D18S866 and D18S811	Alopecia-mental retardation syndrome 3 (2)	
18.106	8	2	13	18q12.2	CELF4, BRUNOL4		CUGbp- and ELAV-like family, member 4	612679				
18.107	7	16	14	18q12.1	DSG4, LAH, HYPT6		Desmoglein 4	607892			Hypotrichosis 6, 607903 (3)	
18.108	1	8	16	18q12.1-q12.2	MAPRE2, EB2, RP1, CSCSC2		Microtubule-associated protein, RP/EB family, member 2	605789			Symmetric circumferential skin creases, congenital, 2, 616734 (3)	
18.109	7	18	12	18q12.2	RPRD1A, P15RS, FLJ10656		Regulation of nuclear pre-mRNA domain-containing protein 1A	610347				
18.110	10	1	90	18q12.2	ZNF24		Zinc finger protein-24 (KOX17)	194534				
18.111	10	4	05	18q12.2	ZNF396		Zinc finger protein-396	609600				
18.112	10	4	05	18q12.2	ZNF397		Zinc finger protein-397	609601				
18.113	10	25	19	18q12	ZNF271P, ZNFEB, ZNF271		Zinc finger protein 271, pseudogene	604754				
18.114	10	13	09	18q21.1	LOXHD1, DFNB77		Lipoxygenase homology domains-containing 1	613072			Deafness, autosomal recessive 77, 613079 (3)	
18.115	5	29	97	18q21.1-q21.2	MAPK4, PRKM4, ERK3		Mitogen-activated protein kinase 4	176949				
18.116	3	4	05	18q21.1	DYM, FLJ90130, DMC, SMC		Dymeclin	607461			Dyggve-Melchior-Clausen disease, 223800 (3); Smith-McCort dysplasia, 607326 (3)	
18.117	01	08	20	18q12.1	ASXL3, KIAA1713, BRPS		ASXL transcriptional regulator 3	615115			Bainbridge-Ropers syndrome, 615485 (3)	
18.118	8	25	09	18q12.1	DSC1		Desmocollin-1	125643				
18.119	6	4	12	18q12.1	DSC2, DSC3, ARVD11		Desmocollin-2	125645			Arrhythmogenic right ventricular dysplasia 11, 610476 (3); Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)	18(Dsc2)
18.120	10	04	14	18q12.1	DSC3, DSC4		Desmocollin-3	600271		mutation identified in 1 HYPTSV family	?Hypotrichosis and recurrent skin vesicles, 613102 (3)	
18.121	2	12	99	18q12.2	GALNT1		UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1	602273				
18.122	6	1	18	18q12.1	GAREM1		GRB2-associated regulator of MAPK1, subtype 1	617998				
18.123	04	13	20	18q12.1	MGR11		Migraine with or without aura, susceptibility to, 11	610209			{Migraine with or without aura, susceptibility to, 11} (2)	
18.124	2	24	11	18q12.1	KLHL14, PRINTOR, KIAA1384		Kelch-like 14	613772				
18.125	5	22	14	18q12.1	NOL4, NOLP		Nucleolar protein 4	603577				
18.126	3	12	15	18q12.1	RNF125, TRAC1, TNORS		RING finger protein 125	610432			Tenorio syndrome, 616260 (3)	
18.127	4	22	15	18q12.1	RNF138, NARF		RING finger protein 138	616319				
18.128	12	30	14	18q12.1	SLC25A52, MCART2		Solute carrier family 25, member 52	616153				
18.129	9	8	11	18q12.1	TRAPPC8, KIAA1012		Trafficking protein particle complex, subunit 8	614136				
18.130	11	22	13	18q12.1	DSG1, PPKS1, SPPK1, EPKHE		Desmoglein-1	125670		pemphigus foliaceous antigen	Keratosis palmoplantaris striata I, AD, 148700 (3); Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3)	18(Dsg1)
18.131	7	17	09	18q12.1	DSG2, ARVD10, ARVC10, CMD1BB		Desmoglein-2	125671			Arrhythmogenic right ventricular dysplasia 10, 610193 (3); Cardiomyopathy, dilated, 1BB, 612877 (3)	
18.132	5	26	94	18q12.1	DSG3		Desmoglein-3 (pemphigus vulgaris antigen)	169615				18(Dsg3)
18.133	6	16	10	18q12.1	DTNA, D18S892E, DRP3, LVNC1		Dystobrevin, alpha (dystrophin-related protein 3)	601239			Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	
18.134	9	22	98	18q12.3	SLC14A2, UT2, UTR		Solute carrier family 14 (urea transporter), member 2	601611				
18.135	8	18	08	18q11.2	CABYR, FSP2		Calcium-binding tyrosine phosphorylation-regulated protein	612135				18(Cabyr)
18.136	12	22	16	18q12.2	ELP2, STATIP1, MRT58		Elongator acetyltransferase complex, subunit 2	616054			Mental retardation, autosomal recessive 58, 617270 (3)	
18.137	12	28	08	18q12.2	FHOD3, FHOS2, KIAA1695		Formin homology-2 domain-containing protein 3	609691				
18.138	7	28	15	18q12.2	KIAA1328, HINDERIN		Hinderin	616480				
18.139	3	31	09	18q12.2	MIR187, MIRN187		Micro RNA 187	612698				
18.140	7	27	16	18q12.2	MOCOS, MCS, XAN2		Molybdenum cofactor sulfurase	613274			Xanthinuria, type II, 603592 (3)	
18.141	3	27	95	18q12.1	MEP1B		Meprin A, beta	600389				8(Mep1b)
18.142	9	28	00	18q12.2-q12.3	OPA4		Optic atrophy 4	605293			Optic atrophy 4 (2)	
18.143	9	27	17	18q12.3	PIK3C3		Phosphatidylinositol 3-kinase, class 3	602609				
18.144	10	4	12	18q12.3	RIT2, RIN, ROC2		Ric-like protein without CAAX motif 2	609592				
18.145	6	2	16	18q12.3	SETBP1, KIAA0437, SEB, MRD29		SET-binding protein 1	611060		fused with NUP98 in ALL	Schinzel-Giedion midface retraction syndrome, 269150 (3); Mental retardation, autosomal dominant 29, 616078 (3)	
18.146	09	06	18	18q12.3	SIGLEC15		Sialic acid-binding immunoglobulin-like lectin 15	618105				
18.147	2	14	01	18q12.3	SYT4		Synaptotagmin-4	600103				18(Syt4)
18.148	11	3	11	18q12.3	VUR6		Vesicoureteral reflux 6	614319		closest marker rs1054986	Vesicoureteral reflux 6 (2)	
18.149	09	19	19	18q12.3-q21.1	EPG5, KIAA1632, HEEW1, VICIS		Ectopic P-granules autophagy protein 5 homolog	615068			Vici syndrome, 242840 (3)	
18.150	12	7	12	18q21.31	ATP8B1, FIC1, BRIC, PFIC1, ICP1		ATPase, class I, type 8B, member 1	602397			Cholestasis, progressive familial intrahepatic 1, 211600 (3); Cholestasis, benign recurrent intrahepatic, 243300 (3); Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	
18.151	12	2	05	18q21	ALS3		Amyotrophic lateral sclerosis 3	606640			Amyotrophic lateral sclerosis 3 (2)	
18.152	10	10	14	18q21.2	C18orf54, LAS2		Chromosome 18 open reading frame 54	613258				18(C18orf54)
18.153	01	31	20	18q21.2	ELAC1, D29		elaC ribonuclease Z 1	608079				
18.154	10	23	87	18q21.32	GRP		Gastrin-releasing peptide	137260		mammalian equivalent of bombesin		18(Grp)
18.155	12	9	98	18q21	IDDM6		Insulin-dependent diabetes mellitus-6	601941			{Diabetes mellitus, insulin-dependent, 6} (2)	
18.156	8	24	98	18q21.1	MADH2, JV18, SMAD2		Mothers against decapentaplegic, Drosophila, homolog of, 2	601366				
18.157	04	21	20	18q21.32	MALT1, MLT, IMD12		MALT1 paracaspase	604860		fused with API2 in MALT lymphoma	Immunodeficiency 12, 615468 (3)	
18.158	2	3	14	18q21.2	MBD2		Methyl-CpG-binding domain protein 2	603547				18(Mbd2)
18.159	3	20	15	18q21.2	ME2		Malic enzyme, mitochondrial	154270		10cM distal to F13A; previously mapped to chr.6		7(Mod2)
18.160	3	23	09	18q21.31	MIR122A, MIRN122A		Micro RNA 122A	609582				
18.161	8	27	08	18q21.2	MRO, B29		Maestro	608080				
18.162	1	24	09	18q21.1	MYO5B, KIAA1119		Myosin VB	606540			Microvillus inclusion disease, 251850 (3)	18(Myo5b)
18.163	11	22	16	18q21.31	NEDD4L, KIAA0439, RSP5, PVNH7		Ubiquitin protein ligase NEDD4-like	606384			Periventricular nodular heterotopia 7, 617201 (3)	
18.164	4	25	93	18q21	SSAV1		Simian sarcoma-associated virus-1/Gibbon ape leukemia virus	182090				
18.165	9	10	07	18q22.1	DSEL, C18orf4, NCAG1		Dermatan sulfate epimerase-like	611125				
18.166	6	28	02	18q21.2	STARD6		Start domain-containing protein 6	607051				
18.167	10	13	15	18q21.1	ZBTB7C, APM1		Zinc finger- and BTB domain-containing protein 7C	616591				
18.168	7	19	12	18q21.1	ACAA2		Acetyl-CoA acyltransferase 2	604770				
18.169	07	17	20	18q21.1	ATP5F1A, ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22		ATP synthase F1, alpha subunit	164360		pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4, 615228 (3); ?Combined oxidative phosphorylation deficiency 22, 616045 (3)	
18.170	8	31	12	18q21.1	CCDC11, HTX6		Coiled-coil domain-containing protein 11	614759			Heterotaxy, visceral, 6, autosomal recessive, 614779 (3)	
18.171	6	1	10	18q21.1	HAUS1, CCDC5, HEIC		HAUS augmin-like complex, subunit 1	608775		pseudogenes on 5, 8, and X		
18.172	6	2	16	18q21.1	IER3IP1, MEDS		Immediate-early response 3-interacting protein 1	609382			Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)	
18.173	7	6	12	18q21.1	KATNAL2		Katanin, p60 subunit, A-like protein 2	614697				
18.174	12	21	09	18q21.1	KIAA0427, CTIF		KIAA0427 gene	613178				
18.175	12	17	07	18q21.1	LIPG, EL, EDL		Lipase G, endothelial	603684				
18.176	7	6	99	18q21.1	MBD1, PCM1		Methyl=CpG binding domain protein 1 (protein containing methyl-CpG binding domain 1)	156535				18(Mbd1)
18.177	11	27	18	18q21.1	PIAS2, PIASX		Protein inhibitor of activated STAT2	603567				
18.178	10	24	00	18q21.2	POLI, RAD30B		Polymerase, DNA, iota	605252				18(Rad30b)
18.179	10	12	14	18q21.1	PSTPIP2, MAYP		Proline/serine/threonine phosphatase-interacting protein 2	616046				
18.180	2	25	14	18q21.1	SCARNA17		Small Cajal body-specific RNA 17	615645				
18.181	8	26	09	18q21.1	SIAT8E		Sialyltransferase 8E	607162				
18.182	12	2	15	18q21.1	SKA1, C18orf24		Spindle- and kinetochore-associated complex, subunit 1	616673				
18.183	10	11	16	18q21.1	SKOR2, FUSSEL18, CORL2		SKI family transcriptional corepressor 2	617138				
18.184	01	14	20	18q21.2	SMAD4, MADH4, DPC4, JIP, MYHRS		SMAD family member 4	600993			Pancreatic cancer, somatic, 260350 (3); Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3); Myhre syndrome, 139210 (3); Polyposis, juvenile intestinal, 174900 (3)	
18.185	01	14	20	18q21.1	SMAD7, MADH7, CRCS3		SMAD family member 7	602932			{Colorectal cancer, susceptibility to, 3}, 612229 (3)	
18.186	4	30	15	18q22.2	SOCS6, SSI4, STAT4, CIS4		Suppressor of cytokine signaling 6	605118				
18.187	5	25	00	18q21.31	ONECUT2, OC2		One cut domain, family member 2	604894				
18.188	7	13	95	18q21.1-q21.3	CORD1, CRD1		Cone rod dystrophy 1, autosomal dominant	600624			Cone-rod retinal dystrophy-1 (2)	
18.189	11	20	20	18q21.31	NARS1, NARS, ASNRS, NEDMILG, NEDMILEG		Asparaginyl-tRNA synthetase 1	108410			Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive, 619091 (3); Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant, 619092 (3)	
18.190	4	21	16	18q21.2	CCDC68		Coiled-coil domain-containing protein 68	616909				
18.191	12	4	08	18q21.2	HYT8		Hypertension, essential, susceptibility to, 8	611014		associated with rs1941958 and rs1893379	{Hypertension, essential, susceptibility to, 8} (2)	
18.192	4	17	13	18q21.31	LINC-ROR		Long intergenic noncoding RNA, regulator of reprogramming	615173				
18.193	12	4	08	18q21.2	MEX3C, RKHD2		Mex-3, C. elegans, homolog of, C	611005				
18.194	11	27	18	18q21.2	RAB27B		RAS-associated protein RAB27B	603869				
18.195	05	20	20	18q21.2	TCF4, SEF2, ITF2, PTHS, FECD3		Transcription factor-4 (immunoglobulin transcription factor-2)	602272			Pitt-Hopkins syndrome, 610954 (3); Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	
18.196	10	10	05	18q21.33	BCL2		B-cell CLL/lymphoma-2	151430		most frequent hematologic malignancy t(14;18)(q32;q21)	Leukemia/lymphoma, B-cell, 2 (3)	1(Bcl2)
18.197	5	27	97	18q21.3	CNSN		Carnosinemia (carnosinase)	212200			Carnosinemia (2)	
18.198	7	6	17	18q21.2	DCC, MRMV1, HGPPS2		Deleted in colorectal carcinoma	120470			Mirror movements 1 and/or agenesis of the corpus callosum, 157600 (3); Gaze palsy, familial horizontal, with progressive scoliosis, 2, 617542 (3); Colorectal cancer, somatic, 114500 (3); Esophageal carcinoma, somatic, 133239 (3)	18(Dcc)
18.199	6	20	18	18q21.31	FECH, FCE, EPP1		Ferrochelatase	612386			Protoporphyria, erythropoietic, 1, 177000 (3)	
18.200	6	13	17	18q21.33	KDSR, FVT1, EKVP4		3-ketodihydrosphingosine reductase	136440		~10kb 5' to BCL2	Erythrokeratodermia variabilis et progressiva 4, 617526 (3)	
18.201	6	25	08	18q22.1	HMSD		Minor histocompatibility antigen, serpin domain-containing	612086				
18.202	5	17	95	18q21.33	PI5, SERPINB5		Protease inhibitor 5 (maspin)	154790		in cluster of serpins		
18.203	9	16	16	18q22.1	SERPINB8, PI8, CAP2, PSS5		Serpin family B, member 8	601697			Peeling skin syndrome 5, 617115 (3)	
18.204	3	14	08	18q21.32	RAX, RX, MCOP3		Retina and anterior neural fold homeobox gene	601881			Microphthalmia, isolated 3, 611038 (3)	
18.205	6	7	10	18q21.3-q22.1	SERPINB2, PAI2, PLANH2		Serpin peptidase inhibitor, clade B (ovalbumin), member 2 (Plasminogen activator inhibitor, type II (arginine-serpin))	173390		600kb telomeric to BCL2		
18.206	3	23	14	18q21.33	SERPINB11		Serpin peptidase inhibitor, clade B (ovalbumin), member 11	615682				1(Serpinb11)
18.207	2	25	14	18q21.33	SERPINB12		Serpin peptidase inhibitor, clade (ovalbumin), member 12	615662				
18.208	11	27	00	18q21.33	SERPINB13, PI13, HURPIN		Protease inhibitor 13	604445				
18.209	4	11	11	18q21.33	SERPINB3, SCCA1		Serpin peptidase inhibitor, clade B (ovalbumin), member 3 (squamous cell carcinoma antigen 1)	600517				
18.210	3	21	02	18q21.33	SERPINB4, SCCA2		Serpin peptidase inhibitor, clade B (ovalbumin), member 4 (squamous cell carcinoma antigen 2)	600518				
18.211	1	7	14	18q21.33	SERPINB7, MEGSIN, PPKN		Serpin peptidase inhibitor, clade B (ovalbumin), member 7	603357			Palmoplantar keratoderma, Nagashima type, 615598 (3)	
18.212	11	5	97	18q22.1	SERPINB10, PI10		Protease inhibitor 10, ovalbumin type (bomapin)	602058				
18.213	12	27	19	18q21.33	VPS4B, SKD1		Vacuolar protein sorting 4 homolog B	609983				1(Vps4b)
18.214	9	29	10	18q21.31	WDR7, TRAG, KIAA0541		WD repeat-containing protein 7	613473				18(Wdr7)
18.215	6	16	98	18q21.32	LMAN1, ERGIC53, F5F8D, MCFD1		Lectin, mannose-binding, 1	601567			Combined factor V and VIII deficiency, 227300 (3)	
18.216	7	20	12	18q21.31	TXNL1, TXNL		Thioredoxin-like 1	603049				
18.217	9	30	14	18q21.32	CCBE1, KIAA1983, HKLLS1		Collagen and calcium-binding EGF domain-containing protein 1	612753			Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3)	
18.218	3	31	15	18q21.32	PMAIP1, APR, NOXA		Phorbol-12-myristate-13-acetate-induced protein 1	604959				
18.219	10	20	20	18q21.32	ZNF532		Zinc finger protein 532	619066				
18.220	3	8	12	18q21.33	PHLPP1, SCOP, KIAA0606		PH domain and leucine-rich repeat protein phosphatase	609396				
18.221	7	22	11	18q21.33	PIGN, MCAHS1		Phosphatidylinositol glycan, class N	606097			Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3)	
18.222	6	1	18	18q21.33	RELCH, KIAA1468		RAB11 effector containing LIS1 homology domain, coiled-coil domains, and HEAT repeats	618001				
18.223	8	26	15	18q21.33	RNF152		Ring finger protein 152	616512				
18.224	1	20	09	18q22	DUP18pDEL18q, DUP18qDEL18p		Chromosome 18 pericentric inversion	609334			Chromosome 18 pericentric inversion (4)	
18.225	05	02	19	18q21.32	MC4R, BMIQ20		Melanocortin-4 receptor	155541			Obesity (BMIQ20), 618406 (3); {Obesity, resistance to (BMIQ20)}, 618406 (3)	
18.226	4	1	01	18q22.1	CDH7		Cadherin-7	605806				
18.227	4	2	01	18q22.1	CDH19, CDH7		Cadherin 19	603016				
18.228	4	2	01	18q21.33	CDH20		Cadherin 20	605807				
18.229	7	23	03	18q22.3	NETO1, BCTL1		Neuropilin and tolloid like 1	607973				
18.230	1	8	01	18q23	ZNF236		Zinc finger protein-236	604760				
18.231	10	23	87	18q23	MBP		Myelin basic protein	159430		defective in "shiverer," neurologic mutant in mouse		18(Mbp, shi)
18.232	5	25	17	18q22.1	LINC00305		Long intergenic noncoding RNA 305	617489				
18.233	11	24	14	18q22.1	TMX3, TXNDC10, KIAA1830		Thioredoxin-related transmembrane protein 3	616102				
18.234	6	30	15	18q21.33	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2		Tumor necrosis factor receptor superfamily, member 11A	603499			Osteolysis, familial expansile, 174810 (3); {Paget disease of bone 2, early-onset}, 602080 (3); Osteopetrosis, autosomal recessive 7, 612301 (3)	
18.235	11	14	12	18q22.1-q22.3	ECTD8		Ectodermal dysplasia 8, hair/tooth/nail type	602401		between D18S857 and D18S815	Ectodermal dysplasia 8, hair/tooth/nail type (2)	
18.236	3	29	16	18q22.2	RTTN, MSSP		Rotatin	610436			Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3)	18(Rttn)
18.237	1	30	12	18q23	ATP9B		ATPase, class II, type 9B	614446				
18.238	1	24	13	18q22.3	CBLN2		Cerebellin 2 precursor	600433				18(Cbln1)
18.239	5	18	10	18q22.3	CNDP1, CN1		Carnosine dipeptidase 1	609064				
18.240	1	31	01	18q22.2	DNAM1, CD226		DNAX accessory molecule 1	605397				
18.241	4	2	12	18q22.3	FAM69C		Family with sequence similarity 69, member C	614544				
18.242	9	9	08	18q22.3	FBXO15, FBX15		F-box only protein 15	609093				18(Fbxo15)
18.243	04	27	20	18q22.3	TIMM21, TIM21		Translocase of inner mitochondrial membrane 21	615180				
18.244	1	30	12	18q22.3	TSHZ1, TSH1, CAA		Teashirt zinc finger homeobox 1	614427			Aural atresia, congenital, 607842 (3)	
18.245	7	17	14	18q22.3	ZNF407		Zinc finger protein 407	615894				
18.246	4	20	17	18q23	ADNP2, KIAA0863		Activity-dependent neuroprotector homeobox 2	617422				
18.247	5	31	05	18q23	CTDP1, FCP1, CCFDN		C-terminal domain of RNA polymerase II subunit A, phosphatase of, subunit 1	604927			Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	
18.248	5	17	18	18q22.3	CYB5A, MCB5, METAG		Cytochrome b5	613218		pseudogenes on X, 14q, 20p; mutation identified in 1 MET5 patient	Methemoglobinemia and ambiguous genitalia, 250790 (3)	
18.249	12	18	98	18q23	GALR1, GALNR1, GALNR		Galanin receptor 1	600377				18(Galnr)
18.250	5	17	95	18q23	NFATC1		Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1	600489				18(Nfatc)
18.251	11	2	04	18q23	PARD6G		partitioning-defective protein 6, C. elegans, homolog of	608976				
18.252	10	23	87	18q22.3	PEPA		Peptidase A	169800				18(Pep1)
18.253	7	22	09	18q23	SALL3		Sal-like 3	605079				
18.254	1	8	15	18q23	TXNL4A, DIM1, BMKS		Thioredoxin-like 4A	611595			Burn-McKeown syndrome, 608572 (3)	
18.255	3	15	13	18q23	ZNF516, KIAA0222		Zinc finger protein 516	615114				
19.1	9	20	11	19pter-p13.1	FPH1, MUH, HPP		Hyperpigmentation, familial progressive, 1	614233			Hyperpigmentation, familial progressive, 1 (2)	
19.2	10	23	87	19pter-q13	CXB3S		Coxsackie virus B3 sensitivity	120050				
19.3	11	1	13	19p13.3	EEF2, EF2, SCA26		Eukaryotic translation elongation factor-2	130610		mutation identified in 1 family	?Spinocerebellar ataxia 26, 609306 (3)	
19.4	4	27	16	19p13.3	ABCA7, ABCX, AD9		ATP-binding cassette, subfamily A, member 7	605414			{Alzheimer disease 9, susceptibility to}, 608907 (3)	
19.5	05	08	20	19p13.3	ABHD17A, FAM108A1		Abhydrolase domain-containing protein 17A, depalmitoylase	617942				
19.6	12	15	10	19p13.3	ACER1		Alkaline ceraminidase 1	613491				
19.7	12	6	11	19p13.3	ACSBG2, BGR		Acyl-CoA synthetase, bubblegum family, member 2	614363				
19.8	8	1	13	19p13.3	ADAT3, TAD3, MRT36		Adenosine deaminase, tRNA-specific, 3	615302			Mental retardation, autosomal recessive 36, 615286 (3)	
19.9	2	12	16	19p13.3-p13.2	ADGRE1, EMR1		Adhesion G protein-coupled receptor E1	600493				17(Emr1)
19.10	2	12	16	19p13.2	ADGRE4P, EMR4, GPR127, EMR4P, FIRE		Adhesion G protein-coupled receptor E4, pseudogene	612305				
19.11	6	30	15	19p13.12	ADGRL1, LPHN1, CIRL1, CL1, LEC2, KIAA0821		Adhesion G protein-coupled receptor L1	616416				
19.12	10	28	19	19p13.3	ALKBH7, ABH7		AlkB homolog 7	613305				
19.13	7	10	14	19p13.2	ANGPTL4, PGAR, HFARP, FIAF, TGQTL		Angiopoietin-like 4	605910			Plasma triglyceride level QTL, low, 615881 (3)	
19.14	7	26	16	19p13.3	AP3D1, HPS10		Adaptor-related protein complex 3, delta-1 subunit	607246		mutation identified in 1 HPS10 patient	?Hermansky-Pudlak syndrome 10, 617050 (3)	10(Ap3d1)
19.15	5	25	13	19p13.3	APBA3, X11L2, MINT3		Amyloid beta A4 precursor protein-binding, family A, member 3	604262				
19.16	11	25	19	19p13.3	APC2, APCL, SOTOS3		APC regulator of WNT signaling pathway 2	612034		mutation identified in 1 SOTOS3 family	?Sotos syndrome 3, 617169 (3); Cortical dysplasia, complex, with other brain malformations 10, 618677 (3)	10(Apc2)
19.17	11	22	10	19p13.3	DENND1C		DENN/MADD domain-containing protein 1C	613634				
19.18	9	3	02	19p13.3	IS1, AIS		Adolescent idiopathic scoliosis	181800			Scoliosis, idiopathic 1 (2)	
19.19	10	26	03	19p13.3	ATCAY, CLAC, KIAA1872		Caytaxin	608179			Ataxia, cerebellar, Cayman type, 601238 (3)	10(ji)
19.20	10	10	18	19p13.3	ATP5F1D, ATP5D, MC5DN5		ATP synthase F1 subunit delta	603150			Mitochondrial complex V (ATP synthase) deficiency, 618120 (3)	
19.21	5	2	01	19p13.3	ATP8B3, ATPIK		ATPase, class I, type 8B, member 3	605866				
19.22	10	26	92	19p13.3	AZU1, CAP37		Azurocidin-1 (cationic antimicrobial protein-37)	162815		5\(rm-AZU1-8kb-PR3-3kb-ELAN-3'		
19.23	3	13	01	19p13.3	BSG		Basigin (blood group OK)	109480			[Blood group, OK], 111380 (3)	10(Bsg)
19.24	4	21	10	19p13.3	C2CD4C, NLF3, KIAA1957		C2 calcium-dependent domain containing 4C	610336				
19.25	07	31	20	19p13.3	MYDGF, C19orf10, SF20, IL25		Myeloid-derived growth factor	606746				17(Il25)
19.26	08	13	19	19p13.3	CACTIN, C19orf29		Cactin, splicesome C complex subunit	618536				
19.27	3	8	91	19p13.3	CAPS		Calcyphosine	114212				
19.28	5	24	17	19p13.3	CATSPERD, TMEM146		Cation channel, sperm-associated, auxiliary subunit delta	617490				
19.29	12	5	11	19p13.2	CD209, CDSIGN		CD209 antigen	604672			{Dengue fever, protection against}, 614371 (3); {HIV type 1, susceptibility to}, 609423 (3); {Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	
19.30	6	14	94	19p13.3	CDC34		Cell division cycle 34	116948				
19.31	4	26	11	19p13.3	CFD, ADN		Complement factor D	134350			Complement factor D deficiency, 613912 (3)	
19.32	9	26	17	19p13.3	CHAF1A, CAF1B, CAF1P150		Chromatin assembly factor I, subunit A	601246				
19.33	5	28	98	19p13.3	CIRBP		Cold-inducible RNA-binding protein	602649				
19.34	3	13	15	19p13.2	CLEC4G, LSECTIN		C-type lectin domain family 4, member G	616256				
19.35	08	26	20	19p13.2	CLEC4M, CD209L, LSIGN, DCSIGNR		C-type lectin domain family 4, member M	605872				
19.36	12	15	14	19p13.3	CLPP, PRLTS3, DFNB81		ATP-dependent protease ClpAP, E. coli, proteolytic subunit, homolog of	601119			Perrault syndrome 3, 614129 (3)	
19.37	2	1	11	19p13.3	CNN2		Calonin 2	602373		previously assigned to 21q11.1		
19.38	09	16	19	19p13.3	CRB3		Crumbs cell polarity complex component 3	609737				
19.39	4	23	08	19p13.3	CREB3L3, CREBH		cAMP responsive element-binding protein 3-like 3	611998				
19.40	5	28	98	19p13.3	CSNK1G2		Casein kinase 1, gamma-2	602214				
19.41	3	31	15	19p13.3	DIRAS1, RIG		DIRAS family, GTP-binding Ras-like protein 1	607862				
19.42	5	26	13	19p13.3	DOHH, HLRC1		Deoxyhypusine hydroxylase	611262				
19.43	11	22	02	19p13.3	DOT1L, DOT1, KIAA1814		Dot1, yeast, homolog of	607375				
19.44	11	10	98	19p13.3	DRIL1		Dead ringer, Drosophila, homolog-like 1	603265				
19.45	8	27	01	19p13.3	EBI3		Epstein-Barr virus-induced gene 3	605816				
19.46	2	28	03	19p13.3	EFNA2, EPLG6, LERK6		Ephrin A2	602756				
19.47	6	7	11	19p13.3	ELANE, ELA2, SCN1		Elastase, neutrophil-expressed	130130			Neutropenia, cyclic, 162800 (3); Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)	10(Ela2)
19.48	4	25	93	19p13.2	FCER2, FCE2, CD23, CLEC4J		Fc fragment of IgE, low affinity II, receptor for (CD23A)	151445				
19.49	1	5	00	19p13.3	FEB2		Febrile seizures, familial, 2	602477			Febrile seizures, familial, 2 (2)	
19.50	8	27	15	19p13.3	FEM1A		Fem1, C. elegans, homolog of, A	613538				17(Fem1a)
19.51	4	26	01	19p13.3	FGF22		Fibroblast growth factor 22	605831				
19.52	3	18	07	19p13.3	FSD1, GLFND		Fibronectin type 3 and SPRY domains-containing protein 1	609828				
19.53	08	13	20	19p13.3	FUT3, LE		Fucosyltransferase 3	111100		cen-FUT5-23kb-FUT3-14kb-FUT6-ter	[Blood group, Lewis], 618983 (3)	
19.54	5	17	95	19p13.3	FUT5		Fucosyltransferase 5 (alpha (1,3) fucosyltransferase)	136835		cen-FUT5-FUT3-FUT6-ter		
19.55	06	03	20	19p13.3	FUT6		Fucosyltransferase 6 (alpha (1,3) fucosyltransferase)	136836		in cluster with FUT3, FUT5	[Fucosyltransferase 6 deficiency], 613852 (3)	
19.56	5	25	00	19p13.3	GADD45B, MYD118		Growth arrest- and DNA damage-inducible gene 45, beta	604948				
19.57	7	18	13	19p13.3	GAMT, CCDS2		Guanidinoacetate methyltransferase	601240			Cerebral creatine deficiency syndrome 2, 612736 (3)	10(Gamt)
19.58	7	26	11	19p13.3	GIPC3, DFNB15, DFNB72, DFNB95		GAIP C-terminus-interacting protein 3	608792			Deafness, autosomal recessive 15, 601869 (3)	
19.59	12	23	19	19p13.3	GPR108, LUSTR2		G protein-coupled receptor 108	618491				17(Gpr108)
19.60	1	11	16	19p13.3	GPX4, SMDS		Glutathione peroxidase-4 (phospholipid hydroperoxidase)	138322			Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3)	
19.61	7	2	18	19p13.3	GRIN3B		Glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	606651				
19.62	11	22	94	19p13.3	GTF2F1, RAP74		General transcription factor IIF, polypeptide 1 (74kD subunit)	189968				
19.63	6	9	95	19p13.3	GZMM		Granzyme M (lymphocyte met-ase 1)	600311				10(Gzmm)
19.64	3	30	99	19p13.3	HCDH, FZR		CDH1/HCT1, S. cerevisiae, homolog of	603619				
19.65	8	9	00	19p13.3	HCN2, BCNG2		Hyperpolarization-activated cyclic nucleotide-gated potassium channel 2	602781				
19.66	3	5	18	19p13.3	HDGFL2, HDGFRP2		Hepatoma-derived growth factor-like protein 2	617884				
19.67	3	23	09	19p13.3	HMHA1, HLA-HA1, KIAA0223		Minor histocompatibility antigen HA-1	601155				
19.68	1	8	01	19p13.3	HMG20B, BRAF35		High mobility group protein 20B	605535				
19.69	11	3	06	19q13.32	IGFL1		IGF-like family member 1	610544				7(Igfl1)
19.70	11	3	06	19q13.32	IGFL2		IGF-like family member 2	610545				7(Igfl2)
19.71	11	3	06	19q13.32	IGFL3		IGF-like family member 3	610546				7(Igfl3)
19.72	11	3	06	19q13.32	IGFL4		IGF-like family member 4	610547				7(Igfl4)
19.73	11	05	18	19p13.3	ITGB1BP3, MIBP		Integrin, beta-1, binding protein of, 3	608705				
19.74	05	28	20	19p13.3	IZUMO4		IZUMO family, member 4	618897				
19.75	7	20	12	19p13.3	KDM4B, JMJD2B, KIAA0876		Lysine-specific demethylase 4B	609765				
19.76	7	19	12	19p13.3	JSRP1, JP45		Junctional sarcoplasmic reticulum protein 1	608743				
19.77	4	20	06	19p13.3	KHSRP, KSRP, FUBP2, FBP2		KH-type splicing regulatory protein	603445				17(Khsrp)
19.78	8	24	09	19p13.3	KIR2DL5A, KIR2DL5		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A	605305				
19.79	8	1	13	19p13.3	KISS1R, GPR54, HH8, CPPB1		KISS1 receptor	604161		mutation identified in 1 CPPB1 patient	Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3); ?Precocious puberty, central, 1, 176400 (3)	
19.80	12	6	16	19p13.3	KLF16, BTEB4, DRRF		Kruppel-like factor 16	606139				10(Klf16)
19.81	9	24	15	19p13.3	LMNB2, LMN2, EPM9		Lamin B2	150341		mutation identified in 1 EPM9 family	{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3); ?Epilepsy, progressive myoclonic, 9, 616540 (3)	
19.82	12	10	13	19p13.3	LRG1, LRG		Leucine-rich alpha-2-glycoprotein 1	611289				11(Lrg1)
19.83	12	23	05	19p13.3	LRRN6B, LINGO3, LERN2		Leucine-rich repeat protein, neuronal, 6B	609792				
19.84	8	24	09	19p13.3	LSM7		LSM7 protein	607287				
19.85	9	21	11	19p13.2	ICAM4, CD242, LW		Intracellular adhesion molecule 4	614088		close to C3, LU	[Blood group, Landsteiner-Wiener], 111250 (3)	
19.86	3	3	98	19p13.3	MACAM1		Mucosal addressin cell adhesion molecule-1	102670				
19.87	6	20	13	19p13.3	MAP2K2, PRKMK2, MEK2, MKK2, CFC4		Mitogen-activated protein kinase kinase 2	601263		previously assigned to 7q32	Cardiofaciocutaneous syndrome 4, 615280 (3)	10(Mek2)
19.88	7	1	98	19p13.3	MATK, HYL, CTK		Megakaryocyte-associated tyrosine kinase	600038				10(Matk)
19.89	7	8	99	19p13.3	MBD3		Methyl-CpG-binding domain protein 3	603573				10(Mbd3)
19.90	6	19	97	19p13.3	MDRV		Muscular dystrophy with rimmed vacuoles	601846			Muscular dystrophy with rimmed vacuoles (2)	
19.91	2	25	15	19p13.2	MCEMP1		Mast cell-expressed membrane protein 1	609565				
19.92	01	04	19	19p13.3	MED16, THRAP5, DRIP92, TRAP95		Mediator complex subunit 16	604062				
19.93	8	20	07	19p13.3	MEX3D, RKHD1, TINO, KIAA2031		Mex-3, C. elegans, homolog of, D	611009				
19.94	10	26	17	19p13.3	MFSD12, PP3501		Major facilitator superfamily domain-containing protein 12	617745				
19.95	02	22	19	19p13.3	MICOS13, C19orf70, MIC13, QIL1		Mitochondrial contact site and cristae organizing system subunit 13	616658			Combined oxidative phosphorylation deficiency 37, 618329 (3)	
19.96	8	24	09	19p13.3	MIDN		Midnolin, mouse, homolog of	606700				
19.97	5	11	09	19p13.12	MIR181C, MIRN181C		Micro RNA 181C	612746				
19.98	5	6	13	19p13.3	MIR1909		Micro RNA 1909	615201				
19.99	6	26	13	19p13.3	MISP, C19orf21		Mitotic spindle-positioning protein	615289				
19.100	5	28	02	19p13.3	MKNK2, MNK2, GPRK7		Mitogen-activated protein kinase-interacting serine/threonine kinase-2	605069				
19.101	06	16	20	19p13.3	MLLT1, ENL		MLLT1 super elongation complex subunit	159556		fuses with ALL1		
19.102	3	11	08	19p13.3	MRPL54		Mitochondrial ribosomal protein L54	611858				
19.103	12	13	18	19p13.3	NDUFA11, MC1DN14		NADH-ubiquinone oxidoreductase subunit A11	612638			Mitochondrial complex I deficiency, nuclear type 14, 618236 (3)	
19.104	10	15	95	19p13.3	NFIC		Nuclear factor I/C (CCAAT-binding transcription factor)	600729		order: cen-NFIX-NFIC-tel		10(Nfic)
19.105	9	2	12	19p13.13	NFIX, NF1A, SOTOS2, MRSHSS		Nuclear factor I/X (CCAAT-binding transcription factor)	164005			Sotos syndrome 2, 614753 (3); Marshall-Smith syndrome, 602535 (3)	8(Nfix)
19.106	1	2	08	19p13.3	NRTN, NTN		Neurturin	602018				17(Nrtn)
19.107	8	28	97	19p13.3	OAZ1		Ornithine decarboxylase antizyme 1	601579				
19.108	11	11	14	19p13.3	PALM, KIAA0270		Paralemmin	608134				10(Palm)
19.109	8	24	09	19p13.3	PCSK4		Proprotein convertase subtilisin/kexin type 4	600487				10(Pcsk4)
19.110	08	22	19	19p13.3	PEAK3, C19orf35		PEAK family member 3	618526				
19.111	2	27	03	19p13.2	PEX11G		Peroxisome biogenesis factor 11G	607583				
19.112	2	9	16	19p13.3	PIAS4, PIASY		Protein inhibitor of activated STAT4	605989				
19.113	8	23	07	19p13.3	PIP5K1C, LCCS3		Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma	606102			Lethal congenital contractural syndrome 3, 611369 (3)	
19.114	1	16	18	19p13.3	PLEKHJ1, GNRPX		Pleckstrin homology domain-containing protein, family J, member 1	617834				10(Plekhj1)
19.115	1	21	10	19p13.3	PLIN3, M6PRBP1, TIP47		Perilipin 3	602702				
19.116	3	3	10	19p13.3	PLIN4, KIAA1881		Perilipin 4	613247				
19.117	3	3	10	19p13.3	PLIN5, LSDP5		Perilipin 5	613248				17(Plin5)
19.118	10	26	17	19p13.3	PLPP2, PPAP2C		Phospholipid phosphatase 2	607126				
19.119	1	9	17	19p13.3	PLPPR3, LPPR3, LPR3, PRG2		Phospholipid phosphatase-related protein 3	610391				
19.120	3	19	15	19p13.2	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS		Patatin-like phospholipase domain-containing protein 6	603197		mutation identified in 1 LMNS family	Spastic paraplegia 39, autosomal recessive, 612020 (3); Boucher-Neuhauser syndrome, 215470 (3); ?Laurence-Moon syndrome, 245800 (3); Oliver-McFarlane syndrome, 275400 (3)	8(Nte)
19.121	5	27	94	19p13.3	POLR2E		Polymerase (RNA) II (DNA directed) polypeptide E, 25kD	180664				
19.122	8	3	97	19p13.3	POLRMT, APOLMT		Polymerase (RNA) mitochondrial (DNA directed)	601778				
19.123	09	11	18	19p13.3	PRTN3, AGP7		Proteinase 3	177020				10(Prtn3)
19.124	7	24	13	19p13.3	ONECUT3, OC3		One cut homeobox 3	611294				10(Onecut3)
19.125	7	8	99	19p13.3	PSPN		Persephin	602921				
19.126	1	28	01	19p13.3	PTBP1, PTB, HNRNPI		Polypyrimidine tract-binding protein 1	600693		pseudogene on chr. 14		
19.127	8	28	97	19p13.3	PTPRS		Protein tyrosine phosphatase, receptor type, sigma	601576				17(Ptprs)
19.128	12	15	98	19p13.3	RANBP3		RAN-binding protein-3	603327				
19.129	10	23	15	19p13.3	RAX2, RAXL1, QRX, CORD11, ARMD6		Retina and anterior neural fold homeobox 2	610362		mutation identified in 1 ARMD6 patient	?Macular degeneration, age-related, 6, 613757 (3); Cone-rod dystrophy 11, 610381 (3)	
19.130	1	20	17	19p13.3	REEP6, DP1L1, TB2L1, C19orf32, RP77		Receptor expression-enhancing protein 6	609346			Retinitis pigmentosa 77, 617304 (3)	10(Dp1L1)
19.131	10	4	05	19p13.3	REXO1, REX1, ELOABP1, TCEB3BP1		RNA exonuclease 1, S. cerevisiae, homolog of	609614				
19.132	4	18	02	19p13.12	RLN3, H3, RXN3		Relaxin 3	606855				8(Rln3)
19.133	4	17	13	19p13.3	RNF126		RING finger protein 126	615177				
19.134	3	1	18	19p13.3	RPL36		Ribosomal protein L36	617893				
19.135	9	18	08	19p13.3	S1PR4, EDG6, S1P4		Sphingosine-1-phosphate receptor 4	603751				
19.136	8	29	03	19p13.3	SAFB2, KIAA0138		Scaffold attachment factor B2	608066				
19.137	4	29	14	19p13.3	SBNO2, KIAA0963		Strawberry notch, Drosophila, homolog of, 2	615729				
19.138	05	13	20	19p13.3	SEMA6B, EPM11		Semaphorin 6B	608873			Epilepsy, progressive myoclonic, 11, 618876 (3)	
19.139	3	24	11	19p13.3	SCAMP4		Secretory carrier membrane protein 4	613764				
19.140	7	7	13	19p13.3	SHC2, SHCB, SCK		SHC transforming protein 2	605217				
19.141	2	25	15	19p13.3	SHD		SH2 domain-containing protein D	610481				
19.142	3	1	01	19p13.3	SH3GL1, EEN		SH3 domain GRB2-like 1 (Extra 11-19 leukemia fusion gene)	601768			Leukemia, acute myeloid, 601626 (1)	
19.143	8	30	01	19p13.3	SIRT6, SIR2L6		Sirtuin 6 (Sir2, S. cerevisiae, homolog of, 6)	606211				
19.144	3	12	07	19p13.3	SLC25A41		Solute carrier family 25, member 41	610822				17(Slc25a41)
19.145	10	13	09	19p13.3	SLC39A3, ZIP3		Solute carrier family 39, zinc transporter, member 3	612168				
19.146	3	22	07	19p13.3	SNPPL2B, IMP4, KIAA1532		Signal peptide peptidase-like 2B	608239				
19.147	3	31	15	19p13.3	STAP2, BKS		Signal-transducing adaptor protein 2	607881				
19.148	02	12	19	19p13.3	STK11, PJS, LKB1		Serine/threonine protein kinase-11	602216			Peutz-Jeghers syndrome, 175200 (3); Melanoma, malignant, somatic (3); Pancreatic cancer, somatic, 260350 (3); Testicular tumor, somatic, 273300 (3)	10(Stk11)
19.149	9	15	11	19p13.3	TBXA2R, BDPLT13		Thromboxane A2 receptor	188070			{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)	10(Tbxa2r)
19.150	5	11	16	19p13.3	TCF3, E2A, AGM8		Transcription factor-3 (E2A immunoglobulin enhancer-binding factors E12/E47)	147141			Agammaglobulinemia 8, autosomal dominant, 616941 (3)	
19.151	2	25	15	19p13.3	THEG		Testicular haploid expressed gene, mouse, homolog of	609503				
19.152	12	11	98	19p13.3	THOP1		Thimet oligopeptidase-1	601117				
19.153	3	14	18	19p13.3	TICAM1, TRIF, IIAE6		TIR domain-containing adaptor molecule 1	607601			{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}, 614850 (3)	
19.154	04	27	20	19p13.3	TIMM13		Translocase of inner mitochondrial membrane 13	607383				
19.155	5	23	13	19p13.3	TINCR		Terminal differentiation-induced noncoding RNA	615241				17(Tincr)
19.156	3	31	09	19p13.3	TJP3, ZO3		Tight junction protein 3	612689				
19.157	2	11	96	19p13.3	TLE2, ESG2		Transducin-like enhancer of split 2 (homolog of Drosophila E(spl))	601041				
19.158	03	19	20	19p13.3	TLE5, AES, GRG5		TLE family member 5, transcriptional modulator	600188				
19.159	03	19	20	19p13.3	TLE6, GRG6, PREMBL		TLE family member 6, subcortical maternal complex member	612399			Preimplantation embryonic lethality, 616814 (3)	
19.160	11	16	17	19p13.3	TMEM259, C19orf6		Transmembrane protein 259 (membralin)	611011				10(Orf61)
19.161	7	13	12	19p13.3	TMIGD2, IGPR1		Transmembrane and immunoglobulin domains-containing protein 2 `	614715				
19.162	2	25	15	19p13.3	TMPRSS9		Transmembrane protease, serine 9	610477				10(Tmprss9)
19.163	8	30	01	19p13.3	TNFSF9		Tumor necrosis factor ligand superfamily, member 9	606182				
19.164	1	18	02	19p13.3	TNFSF14, HVEML		Tumor necrosis factor ligand superfamily, member 14	604520				
19.165	4	6	15	19p13.3	TRIP10, CIP4		Thyroid hormone receptor interactor 10	604504				
19.166	09	11	19	19p13.13	TRMT1, TRM1, MRT68		tRNA methyltransferase 1	611669			Mental retardation, autosomal recessive 68, 618302 (3)	
19.167	12	01	20	19p13.3	TRG-TCC1-1, TRNAG3		tRNA glycine (anticodon TCC) 1-1	615303				
19.168	7	22	13	19p13.3	TRNAV32		Transfer RNA valine 32	615304				
19.169	10	30	14	19p13.3	TUBB4A, DYT4, HLD6		Tubulin, beta-4A	602662			Dystonia 4, torsion, autosomal dominant, 128101 (3); Leukodystrophy, hypomyelinating, 6, 612438 (3)	
19.170	10	27	08	19p13.3	UHRF1, ICBP90, NP95		Ubiquitin-like protein containing PHD and RING finger domains 1	607990				
19.171	10	9	09	19p13.11	UNC13A, KIAA1032		UNC13, C. elegans, homolog of, A	609894				
19.172	11	15	05	19p13.3	UQCR		Ubiquinol-cytochrome c reductase, 6.4kD subunit	609711				
19.173	11	23	16	19p13.3	VMAC		Vimentin-type intermediate filament-associated coiled-coil protein	617204				
19.174	06	13	19	19p13.13	WDR83OS, C19orf56, ASTERIX		WDR83 opposite strand	618474				
19.175	8	1	13	19p13.3	ZBTB7A, FBI1, LRF		Zinc finger and BTB domain containing 7A	605878				
19.176	6	10	08	19p13.3	ZNRF4, SPERIZIN		Zinc finger and ring finger protein 4	612063				17(Znrf4)
19.177	09	26	19	19p13.2	ADAMTS10, WMS1		ADAM metallopeptidase domain with thrombospondin type 1 motif, 10	608990			Weill-Marchesani syndrome 1, recessive, 277600 (3)	
19.178	12	13	95	19p13.3	AMH, MIF		Anti-Mullerian hormone	600957			Persistent Mullerian duct syndrome, type I, 261550 (3)	10(Amh)
19.179	3	15	92	19p13.3-p13.2	ATHS, ALP		Atherosclerosis susceptibility (lipoprotein associated)	108725		closely linked to LDLR; may be LDLR	{Atherosclerosis, susceptibility to} (2)	
19.180	3	10	11	19p13.3	C3, ARMD9, AHUS5		Complement component-3	120700		LE ~7cM in males vs. C3 RFLP	C3 deficiency, 613779 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3); {Macular degeneration, age-related, 9}, 611378 (3)	17(C3)
19.181	7	2	13	19p13.2	DNMT1, MCMT, HSN1E, ADCADN		DNA methyltransferase 1	126375			Neuropathy, hereditary sensory, type IE, 614116 (3); Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3)	
19.182	3	23	93	19p13.2	EPOR		Erythropoietin receptor	133171			[Erythrocytosis, familial, 1], 133100 (3)	9(Epor)
19.183	4	5	00	19p13.2	ICAM1		Intercellular adhesion molecule-1	147840		close to Ldlr in mouse	{Malaria, cerebral, susceptibility to}, 611162 (3)	9(Icam1)
19.184	6	13	95	19p13.2	ICAM3, CDW50		Intercellular adhesion molecule-3	146631				
19.185	9	7	00	19p13.2	MCOLN1, ML4		Mucolipin 1	605248			Mucolipidosis IV, 252650 (3)	
19.186	11	12	96	19p13.2	MYO1F		Myosin IF	601480				17(Myo1f)
19.187	5	15	00	19p13.2	HNRPM, HNRPM4, NAGR1		Heterogeneous nuclear ribonucleoprotein M	160994				
19.188	8	21	92	19p13.3	RFX2		Regulatory factor (trans-acting) 2 (influences HLA class II expression)	142765				
19.189	8	24	98	19p13.3	SAFB, HET		Scaffold attachment factor B	602895				
19.190	3	29	00	19p13.3	SF3A2, SAP62, PRP11		Splicing factor 3a, subunit 2, 66kD	600796				10(Sap62)
19.191	5	4	12	19p13.2	STXBP2, UNC18B, FHL5		Syntaxin binding protein 2	601717			Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)	8(Stxbp2)
19.192	04	27	20	19p13.2	TIMM44		Translocase of inner mitochondrial membrane 44	605058				
19.193	8	24	98	19p13.3	VAV1, VAV		Oncogene VAV1	164875		close to INSR		
19.194	9	28	96	19p13.11	ZNF14, KOX6		Zinc finger protein-14 (KOX 6)	194556				
19.195	12	17	20	19q13.2	YIF1B, KABAMAS		YIP1-interacting factor homolog B, membrane-trafficking protein	619109			Kaya-Barakat-Masson syndrome, 619125 (3)	
19.196	9	28	96	19p13.2	ZNF20, KOX13		Zinc finger protein-14 (KOX 6)	194557				
19.197	6	11	11	19p13.2	ACP5, SPENCDI		Acid phosphatase 5, tartrate resistant	171640		incorrectly assigned to 15 by A	Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)	9(Acp5)
19.198	7	1	05	19p13.2	ANGPTL6, AGF		Angiopoietin-like 6	609336				
19.199	2	20	15	19p13.2	ANGPTL8, C19orf80, LIPASIN		Angiopoietin-like protein 8	616223		within intron of DOCK6		9(C19orf80)
19.200	2	28	03	19p13.2	AP1M2, MU1B		Adaptor-related protein complex 1, mu-2 subunit	607309				9(Ap1m2)
19.201	4	7	17	19p13.2	ARHGEF18, KIAA0521, RP78		Rho guanine nucleotide exchange factor 18	616432			Retinitis pigmentosa 78, 617433 (3)	
19.202	09	19	19	19p13.2	ATG4D, APG4D, AUTL4		Autophagy related 4D cysteine peptidase	611340				
19.203	6	8	95	19p13.11	BST2		Bone marrow stromal cell antigen	600534				
19.204	10	30	19	19p13.2	SHFL, C19orf66, RYDEN		Shiftless antiviral inhibitor of ribosomal frameshifting	616808				
19.205	2	10	14	19p13.13	CALR, SSA		Sicca syndrome antigen A (autoantigen Ro; calreticulin)	109091		distal to C3, near LDLR	Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic, 187950 (3)	8(Calr)
19.206	11	27	17	19p13.2	CAMSAP3, NEZHA, KIAA1543		Calmodulin-regulated spectrin-associated protein 3	612685				
19.207	7	7	13	19p13.2	CARM1, PRMT4		Coactivator-associated arginine methyltransferase 1	603934				
19.208	8	2	13	19p13.2	CERS4, LASS4, TRH1		Ceramide synthase 4	615334				
19.209	10	9	14	19p13.2	CCDC151, CILD30		Coiled-coil domain-containing protein 151	615956			Ciliary dyskinesia, primary, 30, 616037 (3)	
19.210	8	29	02	19p13.2	CCL25, SCYA25, TECK		Chemokine, C-C motif, ligand 25	602565				8(Teck)
19.211	1	20	17	19p13.2	CD320, 8D6, 8D6A, TCBLR		CD320 molecule	606475			Methylmalonic aciduria, transient, due to transcobalamin receptor defect, 613646 (3)	17(Cd320)
19.212	08	23	19	19p13.2	CDC37		Cell division cycle 37	605065				
19.213	3	16	99	19p13.2	CNN1, SMCC		Calponin 1	600806				9(Cnn1)
19.214	8	9	01	19p13.2	COL5A3		Collagen, type V, alpha-3 polypeptide	120216				9(Col5a3)
19.215	9	22	08	19p13.2	CTXN1, CTXN		Cortexin 1	600135				8(Ctxn)
19.216	9	30	99	19p13.12	CYP4F3, LTB4H		Cytochrome P450, subfamily IVF, polypeptide 3	601270				
19.217	3	12	01	19p13.12	DNAJB1, HSPF1		DnaJ, E. coli, homolog of, subfamily B, member 1 (heat-shock 40kD protein 1)	604572				
19.218	11	7	17	19p13.2	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5		Dynamin-2	602378		1 LCCS5 family identified with mutation	Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3); Centronuclear myopathy 1, 160150 (3); Charcot-Marie-Tooth disease, axonal type 2M, 606482 (3); Lethal congenital contracture syndrome 5, 615368 (3)	9(Dnm2)
19.219	9	12	11	19p13.2	DOCK6, KIAA1395, AOS2		Dedicator of cytokinesis 6	614194			Adams-Oliver syndrome 2, 614219 (3)	
19.220	10	3	07	19p13.2	EIF3G, EIF3S4		Eukaryotic translation initiation factor 3, subunit G	603913				
19.221	09	19	19	19p13.2	ELAVL1, HUR		ELAV-like RNA binding protein 1	603466				
19.222	09	19	19	19p13.2	ELAVL3, HUC, PLE21		ELAV-like RNA binding protein 3	603458		centromeric to ELAVL1		9(HuC)
19.223	09	08	20	19p13.13	FARSA, CML33, RILDBC2		Phenylalanine-tRNA synthetase, alpha subunit	602918		mutation identified in 1 RILDBC2	?Rajab interstitial lung disease with brain calcifications 2, 619013 (3)	
19.224	06	22	20	19p13.2	FBN3, KIAA1776		Fibrillin 3	608529				
19.225	6	13	12	19p13.2	FBXL12, FBL12		F-box and leucine-rich repeat protein 12	609079				9(Fbxl12)
19.226	6	13	12	19p13.13	FBXW9, FBW9		F-box and WD40 domain protein 9	609074				9(Fbxw9)
19.227	04	01	19	19p13.2	FDX2, FDX1L, MEOAL		Ferredoxin 2	614585			Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy, 251900 (3)	
19.228	8	25	04	19p13.13	GCDH		Glutaryl-Coenzyme A dehydrogenase	608801			Glutaricaciduria, type I, 231670 (3)	8(Gcdh)
19.229	12	19	19	19q13.2	LEUTX		Leucine twenty homeobox	618701				
19.230	3	14	13	19p13.13	MRI1, MRDI		Methylthioribose-1-phosphate isomerase, S. cerevisiae, homolog of	615105				
19.231	10	23	20	19p13.2	PET100, C19orf79, MC4DN12		PET100 cytochrome c oxidase chaperone	614770			Mitochondrial complex IV deficiency, nuclear type 12, 619055 (3)	
19.232	10	2	12	19p13.13	PRDX2, PRX2, TDPX1, PTX1, NKEFB		Peroxiredoxin 2	600538		prev. mapped to chr.13		
19.233	7	8	02	19p13.2	RAD3D, GOV		Ras family, member RAB3D	604350				
19.234	5	25	00	19p13.2	ICAM5, TLCN, TLN		Intercellular adhesion molecule 5 (telencephalin)	601852				
19.235	9	14	12	19p13.11	INSL3		Insulin-like 3, Leydig cell	146738			Cryptorchidism, 219050 (3)	
19.236	12	29	06	19p13.2	INSR, HHF5		Insulin receptor	147670		1 gene for alpha and beta subunits	Leprechaunism, 246200 (3); Rabson-Mendenhall syndrome, 262190 (3); Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3); Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)	8(Insr)
19.237	09	19	19	19p13.13	JUNB		Jun B proto-oncogene, AP-1 transcription factor subunit	165161				8(Junb)
19.238	07	27	18	19p13.2	KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16		KN motif- and ankyrin repeat domain-containing protein 2	614610			Palmoplantar keratoderma and woolly hair, 616099 (3); Nephrotic syndrome, type 16, 617783 (3)	
19.239	5	4	12	19p13.2	KANK3		KN motif- and ankyrin repeat domain-containing protein 3	614611				
19.240	1	16	07	19p13.2	KEAP1, KIAA0132		Kelch-like ECH-associated protein 1	606016				
19.241	06	19	19	19p13.2	LDLR, FHCL1, FHC, FH, LDLCQ2		Low density lipoprotein receptor	606945		~20cM distal to C3	Hypercholesterolemia, familial, 1, 143890 (3); LDL cholesterol level QTL2, 143890 (3)	9(Ldlr)
19.242	2	13	15	19p13.3	LONP1, PRSS15, LON, CODASS		lon peptidase 1, mitochondrial	605490			CODAS syndrome, 600373 (3)	
19.243	7	22	09	19p13.2	LRRC8E		Leucine-rich repeat-containing protein 8E	612891				8(Lrrc8e)
19.244	6	26	14	19p13.2	MAP2K7, PRKMK7, MKK7, JNKK2, MAPKK7		Mitogen-activated protein kinase kinase 7	603014				
19.245	6	7	10	19p13.2	MARCH2		Membrane-associated RING-CH finger protein 2	613332				
19.246	01	11	19	19p13.13	MAST1, SAST, KIAA0973, MCCCHCM		Microtubule-associated serine/threonine kinase 1	612256			Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, 618273 (3)	
19.247	2	25	15	19p13.2	MBD3L1		Methyl-CpG binding domain protein 3-like 1	607963				9(Mbd3l1)
19.248	2	25	15	19p13.2	MBD3L2		Methyl-CpG binding domain protein 3-like 2	607964				9(Mbd3l2)
19.249	3	23	09	19p13.2	MIR199A1, MIRN199A1		Micro RNA 199A1	610719				
19.250	2	26	08	19p13.2	MRPL4		Mitochondrial ribosomal protein L4	611823				
19.251	8	3	12	19p13.2	MUC16, CA125		Mucin 16	606154				
19.252	12	3	98	19p13.2	NDUFA7		NADH-ubiquinone oxidoreductase subunit A7	602139		previously assigned to 20p13		
19.253	9	12	11	19p13.2	NRCLP6		Narcolepsy 6	614223		associated with rs2305795	Narcolepsy 6 (2)	
19.254	5	30	17	19p13.2	OLFM2, NOE2		Olfactomedin 2	617492				
19.255	8	20	08	19p13.2	OR7D4, OR19B		Olfactory receptor, family 7, subfamily D, member 4	611538				
19.256	4	20	11	19p13.2	PCOS1, PCO1, PCO		Polycystic ovary syndrome 1	184700		max lod at D19S884	Polycystic ovary syndrome 1 (2)	
19.257	8	21	98	19p13.2	PDE4A, DPDE2		Phosphodiesterase-4A, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E2)	600126				9(Pde4a)
19.258	5	25	00	19p13.11	PGLS		6-phosphogluconolactonase	604951				
19.259	11	14	18	19p13.11	PLVAP, PV1, DIAR10		Plasmalemma vesicle-associated protein	607647			Diarrhea 10, protein-losing enteropathy type, 618183 (3)	8(Plvap)
19.260	7	2	18	19p13.2	PRAM1		PML-RARA target gene encoding an adaptor molecule 1	606466				
19.261	10	4	05	19p13.2	QTRT1, TGT		Queuine tRNA-ribosyltransferase 1	609615				
19.262	12	15	17	19p13.2	RAB11B, NDAGSCW		Ras-associated protein RAB11B	604198			Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter, 617807 (3)	
19.263	08	21	19	19p13.13	RAD23A, HHR23A		RAD23 homolog A, nucleotide excision repair protein	600061				8(Rad23a)
19.264	09	19	19	19p13.2	RAVER1, KIAA1978		Ribonucleoprotein, PTB binding 1	609950				
19.265	9	22	04	19p13.2	RETN, RSTN, FIZZ3		Resistin	605565			{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3); {Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)	
19.266	1	11	16	19p13.2	RGL3		Ral guanine nucleotide dissociation stimulator-like 3	616743				
19.267	3	29	15	19p13.2	RPS28, DBA15		Ribosomal protein S28	603685			Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3)	
19.268	3	16	16	19p13.2	S1PR2, EDG5, DFNB68		Sphingosine-1-phosphate receptor 2	605111			Deafness, autosomal recessive 68, 610419 (3)	
19.269	9	18	08	19p13.2	S1PR5, EDG8		Sphingosine-1-phosphate receptor 5	605146				
19.270	1	27	04	19p13.2	SITPEC, ECSIT		Signaling intermediate in toll pathway, evolutionarily conserved	608388				
19.271	4	29	16	19p13.2	SMARCA4, BRG1, RTPS2, MRD16, CSS4		SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4	603254			{Rhabdoid tumor predisposition syndrome 2}, 613325 (3); Coffin-Siris syndrome 4, 614609 (3)	
19.272	10	2	12	19p13.2	SNAPC2, SNAP45		Small nuclear RNA-activating protein complex, polypeptide 2	605076				
19.273	7	14	14	19p13.2	SPC24, SPBC24		SPC24, NDC80 kinetochore complex component	609394				
19.274	3	31	15	19p13.13	STX10, SYN10		Syntaxin 10	603765				
19.275	3	30	12	19p13.2	SWSAP1, ZSWIM7AP1, C19orf39		SWIM-type zinc finger domain-containing protein 7-associated protein 1	614536				
19.276	3	29	99	19p13.2	TCO		Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386			Thyroid carcinoma, nonmedullary, with cell oxyphilia (2)	
19.277	3	18	17	19p13.2	TIMM29, C19orf52		Translocase of inner mitochondrial membrane 29	617380				
19.278	5	23	06	19p13.2	TMED1, IL1RL1LG		Transmembrane p24 trafficking protein 1 (interleukin-1 receptor-like 1 ligand)	605395				
19.279	2	24	11	19p13.2	TMEM205		Transmembrane protein 205	613771				
19.280	9	12	14	19p13.2	TYK2, IMD35		Tyrosine kinase 2	176941			Immunodeficiency 35, 611521 (3)	
19.281	4	16	02	19p13.2	UBL5, HUB1		Ubiquitin-like 5	606849		pseudogene on 17p11.2		
19.282	3	15	07	19p13.2	XAB2		XPA-binding protein 2	610850				
19.283	6	12	17	19p13.2	YIPF2		YIP1 domain family, member 2	617522				
19.284	2	20	02	19p13.2	ZK1		Zinc finger protein ZK1	606697				
19.285	1	13	11	19p13.2	ZNF44, KOX7		Zinc finger protein-44 (KOX7)	194542		previously assigned to 16p11		
19.286	1	13	11	19p13.2	ZNF69		Zinc finger protein-69 (Cos5)	194543		previously assigned to 22q11.2		
19.287	8	24	09	19p13.2	ZNF266, HZF1		Zinc finger protein-266	604751				
19.288	9	24	08	19p13.2	ZNF627		Zinc finger protein 627	612248				
19.289	4	2	16	19p13.2	ZNF653, ZIP67		Zinc finger protein 653	611371				
19.290	9	20	14	19p13.2	ZNF699, FLJ38144		Zinc finger protein 699	609571				
19.291	12	16	11	19p13.2	ZGLP1, GLP1		Zinc finger GATA-like protein 1	611639				
19.292	6	13	12	19p13.13	DAND5, CER2, CERL2, DANTE, COCO		DAN domain family, member 5	609068				8(Crl2)
19.293	09	23	19	19p13.11	UPF1, RENT1, HUPF1		UPF1 RNA helicase and ATPase	601430				9(Rent1)
19.294	9	8	06	19p13.13	BEST2, VMD2L1		Bestrophin 2	607335				
19.295	6	19	00	19p13.2	ZNF136		Zinc finger protein-136	604078				
19.296	8	25	04	19p13.11	GDF15, PLAB, PDF, MIC1		Growth/differentiation factor-15 (bone morphogenetic protein, placental)	605312				
19.297	4	25	93	19p13.13	LYL1		Lymphoblastic leukemia derived sequence-1	151440			Leukemia, T-cell acute lymphoblastoid (2)	8(Lyl1)
19.298	12	13	18	19p13.11	NDUFA13, GRIM19, MC1DN28		NADH-ubiquinone oxidoreductase subunit A13	609435		mutation identified in 1 MC1DN28 family	{Thyroid carcinoma, Hurthle cell}, 607464 (3); ?Mitochondrial complex I deficiency, nuclear type 28, 618249 (3)	
19.299	2	3	16	19p13.12	NOTCH3, CADASIL1, CASIL, IMF2, LMNS		Notch, Drosophila, homolog of, 3	600276		mutation identified in 1 IMF2 family	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3); ?Myofibromatosis, infantile 2, 615293 (3); Lateral meningocele syndrome, 130720 (3)	17(Notch3)
19.300	2	28	03	19p13.2-p13.1	PAPA3		Polydactyly, postaxial, type A3	607324		between D19S1165 and D19S929	Polydactyly, postaxial, type A3 (2)	
19.301	7	22	16	19p13.2	PRKCSH, G19P1, PCLD1		Protein kinase C substrate 80K-H	177060			Polycystic liver disease 1, 174050 (3)	
19.302	11	26	09	19p13.11	LRRC25, MAPA		Leucine rich repeat containing 25	607518				
19.303	9	29	09	19p13.11	SLC5A5, NIS, TDH1		Solute carrier family 5 (sodium iodide symporter), member-5	601843			Thyroid dyshormonogenesis 1, 274400 (3)	
19.304	3	14	06	19p13.11	RAB8A, MEL		Ras-associated protein RAB8A (oncogene MEL)	165040				
19.305	10	27	93	19p13.2-q13.3	LPSA, D19S381E		Oncogene liposarcoma (DNA segment, single copy, expressed, probes MC15, MC6)	164953			Liposarcoma (1)	
19.306	5	29	97	19p13.13	DNASE2, DNL		Deoxyribonuclease II, lysosomal	126350				
19.307	2	3	05	19p13.12	ASF1B		Anti-silencing function 1, S. cerevisiae, homolog of, B	609190				
19.308	11	17	10	19p13.13	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13		Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome)	613638		contiguous gene syndrome	Chromosome 19p13.13 deletion syndrome (4); Chromosome 19p13.13 duplication syndrome (4)	
19.309	6	15	15	19p13.13	GADD45GIP1, PRG6, CRIF1		Growth arrest- and DNA damage-inducible DABB45G-interacting protein	605162				
19.310	07	15	20	19p13.12	GIPC1, RGS19IP1, C19orf3, OPDM2		GIPC PDZ domain-containing family member 1	605072			Oculopharyngodistal myopathy 2, 618940 (3)	
19.311	7	7	09	19p13.13	HOOK2, HK2		Hook, Drosophila, homolog of, 2	607824				
19.312	8	24	09	19p13.12	MIR23A, MIRN23A		Micro RNA 23a	607962				
19.313	3	28	17	19p13.13	NACC1, BTBD14B, NECFM		Nucleus accumbens-associated protein 1, BEN and BTB/POZ domains-containing	610672			Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, 617393 (3)	
19.314	12	19	19	19p13.12	NANOS3, NOS3		NANOS C2HC-type zinc finger 3	608229				
19.315	10	15	07	19p13.13	RNASEH2A, RNHIA, AGS4		Ribonuclease H2, large subunit	606034			Aicardi-Goutieres syndrome 4, 610333 (3)	
19.316	5	27	09	19p13.13	SYCE2, CESC1		Synaptonemal complex central element protein 2	611487				
19.317	4	19	06	19p13.13	TNPO2, TRN2, KPNB2B		Transportin 2	603002				
19.318	3	8	16	19p13.13	WDR83, MORG1		WD repeat-containing protein 83	616850				
19.319	2	12	14	19p13.13	KLF1, EKLF, INLU, HBFQTL6, CDAN4		Kruppel-like factor 1, erythroid	600599			Blood group--Lutheran inhibitor, 111150 (3); [Hereditary persistence of fetal hemoglobin], 613566 (3); Dyserythropoietic anemia, congenital, type IV, 613673 (3)	
19.320	2	25	15	19p13.12	AKAP8, AKAP95		A-kinase anchor protein 8	604692				
19.321	8	24	09	19p13.11	AP1M1, AP47, CLAPM2		Adaptor-related protein complex 1, mu 1 subunit	603535				
19.322	11	19	18	19p13.11	CALR3, CRT2		Calreticulin 3	611414				
19.323	5	2	06	19p13.12	CC2D1A, MRT3		Coiled-coil and C2 domain-containing 1A	610055			Mental retardation, autosomal recessive 3, 608443 (3)	
19.324	2	29	16	19p13.12	CLEC17A		C-type lectin domain family 17, member A	616838				
19.325	11	11	14	19p13.12	CYP4F2		Cytochrome P450, family 4, subfamily F, polypeptide 2	604426				
19.326	1	18	13	19p13.12	CYP4F22, ARCI5, LI3		Cytochrome P450, family 4, subfamily F, polypeptide 22	611495			Ichthyosis, congenital, autosomal recessive 5, 604777 (3)	
19.327	3	27	17	19p13.12	EPHX3, ABHD9		Epoxide hydrolase 3	617400				
19.328	4	2	12	19p13.11	FAM32A, OTAG12		Family with sequence similarity 32, member A	614554				8(Fam32a)
19.329	3	23	09	19p13.12	MIR24-2, MIRN24-2		Micro RNA 24-2	610724				
19.330	3	23	09	19p13.12	MIR27, MIRN27A		Micro RNA 27A	612153				
19.331	10	29	03	19p13.12	PGRPL		Peptidoglycan recognition protein, long	608199				
19.332	8	24	15	19p13.12	RASAL3		Ras protein activator-like 3	616561				
19.333	8	18	14	19p13.12	SLC1A6, EAAT4		Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6	600637				
19.334	3	17	17	19p13.12	SYDE1		Synapse defective Rho GTPase, C. elegans, homolog of, 1	617377				
19.335	6	2	11	19p13.12	TECR, GPSN2, TER, SC2, MRT14		Trans-2,3-enoyl-CoA reductase	610057			Mental retardation, autosomal recessive 14, 614020 (3)	
19.336	5	30	17	19p13.12	UCA1, LINC00178, CUDR		Urothelial cancer-associated gene 1	617500				
19.337	2	25	15	19p13.12	AKAP8L, HA95, NAKAP, HAP95		A-kinase anchor protein 8-like protein	609475				
19.338	06	24	19	19p13.13	DHPS, NEDSSWI		Deoxyhypusine synthase	600944			Neurodevelopmental disorder with seizures and speech and walking impairment, 618480 (3)	
19.339	6	15	99	19p13.12	NDUFB7		NADH-ubiquinone oxidoreductase subunit B7	603842				
19.340	1	8	01	19p12	ZNF254, ZNF91L		Zinc finger protein-254	604768				
19.341	12	07	20	19p13.11	ATP13A1		ATPase 13A1	619118				8(Atp13a1)
19.342	3	24	06	19p13.11	BCNP1		B-cell novel protein 1	609967				
19.343	10	23	15	19p13.11	BORCS8, MEF2BNB		BLOC1-related complex, subunit 8	616601				
19.344	5	12	09	19p13.11	C10orf62, MERIT40, NBA1		Chromosome 19 open reading frame 62	612766				
19.345	10	14	10	19p13.11	CILP2		Cartilage intermediate layer protein 2	612419				
19.346	03	22	19	19p13.11	COLGALT1, GLT25D1, BSVD3		Collagen beta(1-0)galactosyltransferase 1	617531			Brain small vessel disease 3, 618360 (3)	
19.347	8	24	09	19p13.11	COPE		Cotamer protein complex, subunit epsilon	606942				
19.348	1	27	17	19p13.11	CPAMD8, KIAA1283, ASGD8		Complement component 3- and pregnancy zone protein-like alpha-2-macroglobin domain-containing protein 8	608841			Anterior segment dysgenesis 8, 617319 (3)	
19.349	2	23	16	19p13.11	EPS15L1, EPS15R		EPS15-like protein 1	616826				
19.350	9	7	10	19p13.11	FCHO1		FCH domain-only protein 1	613437				
19.351	2	5	15	19p13.11	GTPBP3, MSS1, COXPD23		GTP-binding protein 3	608536			Combined oxidative phosphorylation deficiency 23, 616198 (3)	
19.352	9	7	10	19p13.11	HAUS8, DGT4, HICE1		HAUS augmin-like complex, subunit 8	613434				
19.353	03	09	20	19p13.11	HOMER3		Homer scaffold protein 3	604800				
19.354	6	22	10	19p13.11	IFI30, GILT		Interferon-gamma-inducible protein 30	604664				
19.355	4	17	13	19p13.11	KXD1, C10orf50		KXDL motif-containing protein 1	615178				
19.356	9	16	16	19p13.11	LINC00663		Long intergenic noncoding RNA 663	617117				
19.357	8	24	09	19p13.11	LSM4		LSM4 protein	607284				
19.358	4	10	14	19p13.11	MAP1S, BPY2IP1, VCY2IP1, C19orf5		Microtubule-associated protein 1S	607573				
19.359	9	24	08	19p13.11	MAST3, KIAA0561		Microtubule-associated serine/threonine kinase 3	612258				
19.360	09	27	20	19p13.11	MAU2, SCC4, KIAA0892		MAU2 chromatid cohesion factor	614560				
19.361	8	24	09	19p13.11	MED26, CRSP7, CRSP70		Mediator complex subunit 26	605043				
19.362	09	04	19	19p13.11	MPV17L2		MPV17 mitochondrial inner membrane protein-like 2	616133				
19.363	11	05	18	19p13.11	NR2C2AP, TRA16		Nuclear receptor 2C2 associated protein	608719				
19.364	7	12	13	19p13.11	NXNL1, RDCVF, TXNL6, LOC115861		Nucleoredoxin-like protein 1	608791				8(Nxnl1)
19.365	1	4	16	19p13.11	NWD1		NACHT domain- and WD repeat-containing protein 1	616250				
19.366	11	11	14	19p13.11	PBX4		Pre-B-cell leukemia transcription factor 4	608127				8(Pbx4)
19.367	1	10	07	19p13.11	PGPEP1, PCP, PGP		Pyroglutamyl peptidase I	610694				
19.368	11	10	17	19p13.11	SUGP1, SF4		SURP and G-patch domains-containing protein 1	607992				
19.369	8	24	09	19p13.11	SIN3B, KIAA0700		Sin3, yeast, homolog of, B	607777				
19.370	05	14	19	19p13.11	SLC25A42, MECREN		Solute carrier family 25, member 42	610823			Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, 618416 (3)	8(Slc25a42)
19.371	11	10	17	19p13.11	SUGP2, SRFS14, KIAA0365		SURP and G-patch domains-containing protein 2	607993				
19.372	11	6	00	19p13.12	TCCR, WSX1		T-cell cytokine receptor	605350				
19.373	11	24	08	19p13.11	TMEM16H, KIAA1623		Transmembrane protein 16H	610216				
19.374	4	6	15	19p13.11	TMEM38A, TRICA		Transmembrane protein 38A	611235				
19.375	07	28	20	19p13.11	TMEM161A, AROS29		Transmembrane protein 161A	618966				
19.376	1	23	07	19p13.11	TSSK6, SSTK, TSSK4		Testis-specific serine/threonine kinase 6	610712				8(Tssk6)
19.377	09	09	19	19p13.11	USE1, MDS032		Unconventional SNARE in the ER 1	610675				
19.378	10	01	19	19p13.11	YJEFN3		Yjef N-terminal domain-containing protein 3	618607				
19.379	2	11	16	19p13.12	ADGRE2, EMR2, VBU		Adhesion G protein-coupled receptor E2	606100			Vibratory urticaria, 125630 (3)	
19.380	2	23	16	19p13.12	ADGRE5, CD97		Adhesion G protein-coupled receptor E5	601211				
19.381	5	15	08	19p13.12	BRD4, CAP, HUNK1		Bromodomain-containing protein 4	608749		fused with NUT		17(Brd4)
19.382	1	27	17	19p13.12	CASP14, ARCI12		Caspase 14, apoptosis-related cysteine protease	605848			Ichthyosis, congenital, autosomal recessive 12, 617320 (3)	
19.383	08	13	19	19p13.11	CHERP		Calcium homeostasis endoplasmic reticulum protein	618539				
19.384	7	4	95	19p13.11	COMP, EDM1, MED, PSACH		Cartilage oligomeric matrix protein	600310			Pseudoachondroplasia, 177170 (3); Epiphyseal dysplasia, multiple, 1, 132400 (3)	
19.385	8	20	08	19p13.12	CYP4F8		Cytochrome P450, family 4, subfamily F, polypeptide 8	611545				
19.386	10	13	09	19p13.12	CYP4F11		Cytochrome P450, family 4, subfamily F, polypeptide 11	611517				
19.387	12	3	07	19p13.12	CYP4F12		Cytochrome P450, family 4, subfamily F, polypeptide 12	611485				
19.388	4	23	96	19p13.11	ELL		ELL gene (11-19 lysine-rich leukemia gene)	600284				
19.389	10	6	15	19p13.12	EMR3		EGF-like module-containing, mucin-like hormone receptor 3	606101				
19.390	9	8	14	19p13.11	IL12RB1, IMD30		Interleukin-12 receptor, beta-1	601604			Immunodeficiency 30, 614891 (3)	
19.391	4	19	01	19p13.12	ILVBL, AHAS		IlvB-like (acetolactate synthase, bacterial, homolog of)	605770				
19.392	12	17	07	19p13.11	ISYNA1, IPS		Myoinositol 1-phosphate synthase A1	611670		pseudogene on 4p15		
19.393	5	4	12	19p13.11	JAK3, JAKL		Janus kinase 3 (Janus kinase, leukocyte)	600173			SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)	
19.394	5	7	03	19p13.11	KLF2, LKLF		Kruppel-like factor 2	602016				
19.395	3	5	08	19p13.11	MRPL34		Mitochondrial ribosomal protein L34	611840				
19.396	12	7	05	19p13.11	MYO9B, MYR5, CELIAC4		Myosin IXB	602129			{Celiac disease, susceptibility to, 4}, 609753 (3)	
19.397	8	24	09	19p13.11	NR2F6, ERBAL2, EAR2		Nuclear receptor subfamily 2, group F, member 6	132880				
19.398	12	14	99	19p13.11	PDE4C, DPDE1		Phosphodiesterase-4C, cAMP-specific (dunce, Drosophila, homolog phosphodiesterase E1)	600128		between JUND (proximal) and RAB3A (distal)		8(Pde4c)
19.399	6	27	14	19p13.12	PRKACA		Protein kinase, cAMP-dependent, catalytic, alpha	601639			Cushing syndrome, ACTH-independent adrenal, somatic, 615830 (3)	
19.400	6	13	95	19p13.12	PTGER1		Prostaglandin E receptor 1, EP1 subtype, 42kD	176802				
19.401	10	15	97	19p13.12	RFX1		Regulatory factor (trans-acting) 1 (influences HLA class II expression)	600006				
19.402	1	8	01	19p13.11	SLC27A1, FATP, FATP1		Solute carrier family 27, member 1	600691				
19.403	4	24	09	19p13.2	SLC44A2, CTL2		Solute carrier family 44, member 2	606106				
19.404	12	4	02	19p13.11	SSBP4		Single-stranded DNA-binding protein 4	607391				
19.405	9	29	96	19p13.12-p13.11	TPM4		Tropomyosin 4	600317				
19.406	2	23	08	19p13.11	USHBP1, MCC2		USH1C-binding protein 1	611810				
19.407	2	23	08	19p13.12	ZNF333, KIAA1806		Zinc finger protein 333	611811				
19.408	09	19	19	19p13.11	JUND		Jun D proto-oncogene, AP-1 transcription factor subunit	165162				8(Jund)
19.409	4	25	93	19p13.11	RAB3A		RAS-associated protein RAB3A	179490				
19.410	6	19	00	19p12	ZNF43		Zinc finger protein-43	603972				
19.411	3	20	94	19p13.11	UBA52		Ubiquitin A-52 residue ribosomal protein fusion product 1	191321				
19.412	6	19	00	19p12	ZNF90		Zinc finger protein-90	603973				
19.413	6	19	00	19p12	ZNF91		Zinc finger protein-91	603971				
19.414	8	10	99	19p12	ZNF85		Zinc finger protein-85	603899				
19.415	6	19	00	19p12	ZNF93		Zinc finger protein-93	603975				
19.416	6	19	00	19p13.1-p12	ZNF94		Zinc finger protein-94	603976				
19.417	6	6	00	19p12	ZNF100		Zinc finger protein-100	603982				
19.418	6	6	00	19p13.11	ZNF101		Zinc finger protein-101	603983				
19.419	6	6	00	19p13.1-p12	ZNF110		Zinc finger protein-110	603992				
19.420	6	6	00	19p13.1-p12	ZNF111		Zinc finger protein-111	603993				
19.421	6	6	00	19q13.31	ZNF112		Zinc finger protein-112	603994				
19.422	6	19	00	19p13.1-p12	ZNF113		Zinc finger protein-113	603995		?13q21		
19.423	6	19	00	19p13.1-p12	ZNF118		Zinc finger protein-118	603997		?13q21		
19.424	6	6	00	19p13.1-p12	ZNF119		Zinc finger protein-119	603998				
19.425	6	6	00	19p13.1-p12	ZNF120		Zinc finger protein-120	603999				
19.426	6	6	00	19p13.1-p12	ZNF122		Zinc finger protein-122	604000				
19.427	9	9	09	19p12	ZNF208, ZNF95		Zinc finger protein-208	603977				
19.428	9	2	09	19p12	ZNF737, ZNF102		Zinc finger protein-737	603984				
19.429	11	05	20	19p13.13	CACNA1A, CACNL1A4, SCA6, DEE42		Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	601011			Migraine, familial hemiplegic, 1, 141500 (3); Episodic ataxia, type 2, 108500 (3); Spinocerebellar ataxia 6, 183086 (3); Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3); Developemental and epileptic encephalopathy 42, 617106 (3)	8(tg, Cacl1a4)
19.430	11	9	95	19p13.2	CDKN2D		Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)	600927		possible tumor suppressor		
19.431	8	2	13	19p13.3	CELF5, BRUNOL5		CUGbp- and ELAV-like family, member 5	612680				
19.432	10	27	08	19p13.11	CRTC1, MECT1, KIAA0616, FLJ14027		CREB-regulated transcription coactivator 1	607536		t(11;19)	Mucoepidermoid salivary gland carcinoma (3)	
19.433	10	17	00	19p13.3	FSTL3, FLRG		Follistatin-like 3	605343				
19.434	8	13	13	19p13.3	GNA11, HHC2, HYPOC2		Guanine nucleotide-binding protein, Gq class, GNA11	139313			Hypocalciuric hypercalcemia, type II, 145981 (3); Hypocalcemia, autosomal dominant 2, 615361 (3)	10(Gna11)
19.435	9	27	95	19p13.3	GNA15, GNA16		Guanine nucleotide-binding protein (G protein) alpha 15 (Gq class)	139314				10(Gna15)
19.436	2	21	02	19p13	IBD6		Inflammatory bowel disease 6	606674			{Inflammatory bowel disease 6} (2)	
19.437	5	6	03	19p13.2	ILF3, NF90, DRBP76, MPHOSPH4, NFAR		Interleukin enhancer-binding factor 3	603182				
19.438	10	24	03	19p13	MGR5		Migraine with or without aura, susceptibility to, 5	607508			{Migraine with or without aura, susceptibility to, 5} (2)	
19.439	12	13	18	19p13.3	NDUFS7, PSST, MC1DN3		NADH-ubiquinone oxidoreductase core subunit S7	601825			Mitochondrial complex I deficiency, nuclear type 3, 618224 (3)	
19.440	5	22	03	19p13.2	P2RY11		Purinergic receptor P2Y, G protein-coupled, 11	602697		fuses with PPAN		
19.441	3	9	98	19p13.2	PIN1, DOD		Peptidyl-prolyl cis/trans isomerase, NIMA-interacting	601052				
19.442	7	18	14	19p13	PPNAD4		Pigmented nodular adrenocortical disease, primary, 4	615830		duplication of 294kb to 2.7Mb on 19p13	Pigmented nodular adrenocortical disease, primary, 4 (4)	
19.443	5	22	03	19p13.2	PPAN, SSF1		Peter pan, Drosophila, homolog of	607793		fuses with P2RY11		
19.444	11	21	00	19p13	PSORS6		Psoriasis susceptibility 6	605364			{Psoriasis susceptibility 6} (2)	
19.445	8	25	05	19p13.13	RTBDN		Retbindin	609553				
19.446	4	15	04	19p13.2	RDH8, PRRDH		Retinol dehydrogenase 8	608575				
19.447	6	28	99	19p13.3	SGTA, SGT		Small glutamine-rich tetratricopeptide repeat-containing protein, alpha	603419				
19.448	02	07	20	19p13.3	CD70, TNFSF7, CD27L, LPFS3		CD70 molecule	602840			Lymphoproliferative syndrome 3, 618261 (3)	
19.449	6	4	13	19p13.3	UBXN6, UBXD1		UBX domain protein 6	611946				
19.450	9	9	10	19p13.2	ZNF177		Zinc finger protein 177	601276				
19.451	9	30	02	19p13.11	ZNF253		Zinc finger protein 253	606954				
19.452	4	6	11	19p13.2	ZNF317, KIAA1588		Zinc finger protein 317	613864				
19.453	5	27	93	19q13.33	CD37		Leukocyte surface antigen CD37	151523				
19.454	2	24	15	19p13.11	CERS1, LASS1, UOG1, EPM8		Ceramide synthase 1	606919		mutation identified in 1 EPM8 family	?Epilepsy, progressive myoclonic, 8, 616230 (3)	
19.455	11	10	14	19p13.11	CRLF1, CISS1		Cytokine-like factor 1	604237			Cold-induced sweating syndrome 1, 272430 (3)	
19.456	11	2	98	19p13.11	CSPG3, NCAN		Chondroitin sulfate proteoglycan 3 (neurocan)	600826				
19.457	2	3	99	19p13.11	F2RL3, PAR4		Coagulation factor II, thrombin, receptor-like 3 (protease-activated receptor-4)	602779				
19.458	1	24	04	19p13.11	FKBP8, FKBP38		FK506-binding protein 8	604840		pseudogene on 1q32		
19.459	4	24	18	19p13.11	GDF1, DTGA3, DORV, RAI, CHTD6		Growth/differentiation factor 1	602880			Congenital heart defects, multiple types, 6, 613854 (3); Right atrial isomerism (Ivemark), 208530 (3)	
19.460	9	18	08	19p13.11	LPAR2, EDG4		Lysophosphatidic acid receptor 2	605110				8(Edg4)
19.461	11	8	95	19p13.11	MEF2B		MADS box transcription enhancer factor 2, polypeptide B (myocyte enhancer factor 2B)	600661				?8(Mef2b)
19.462	11	30	06	19p13.12	PKN1, PRKCL1, PRK1, PAK1		Protein kinase N1	601032				8(Prkcl1)
19.463	11	2	98	19p13.11	RFXANK		Regulatory factor X, ankyrin repeat-containing	603200			MHC class II deficiency, complementation group B, 209920 (3)	
19.464	12	27	01	19p13.11	TM6SF2, KIAA1926		Transmembrane 6 superfamily, member 2	606563				
19.465	8	25	16	19p13.11	TMEM59L, BSMAP		Transmembrane protein 59-like	617096				8(Tmem59l)
19.466	8	24	09	19p12	ZNF98		Zinc finger protein-98	603980				
19.467	8	24	09	19p12	ZNF99		Zinc finger protein-99	603981				
19.468	11	20	12	19p12	ZNF257		Zinc finger protein 257	606957				
19.469	11	1	05	19p13.11	GMIP		GEM-interacting protein	609694				
19.470	11	30	94	19p	EXT3		Exostoses, multiple, 3	600209			Exostoses, multiple, type 3 (2)	
19.471	10	20	99	19p13.11	RPL18A		Ribosomal protein L18a	604178				
19.472	2	7	01	19p13.3	RPS15, RIG		Ribosomal protein S15	180535				
19.473	6	20	01	19p13.11	TMEM3, B3GNT3		Transmembrane protein 3 (beta-1,3-N-acetylglucosaminyltransferase 3)	605863				
19.474	7	13	93	19p13.3	ZNF77		Zinc finger protein-77 (pT1)	194551				
19.475	4	25	93	19p13.2	ZNF121, D19S204		Zinc finger protein-121 (clone ZHC32)	194628				
19.476	8	9	05	19p13.13	MAN2B1, MANB		Mannosidase, alpha, class 2B, member 1	609458			Mannosidosis, alpha-, types I and II, 248500 (3)	8(Man2b1)
19.477	2	21	10	19q13.11	PEPD		Peptidase D (prolidase)	613230		closely linked to APOC2	Prolidase deficiency, 170100 (3)	7(Pep4)
19.478	2	2	90	19q13.43	A1BG		Glycoprotein, alpha-1B	138670		order: C3-SE-LU-A1BG		
19.479	4	8	11	19q	BFIS1, BFIC1		Benign familial infantile seizures	601764			Seizures, benign familial infantile, 1 (2)	
19.480	12	23	19	19q13.43	CHMP2A, VPS2A, VPS2, BC2		Charged multivesicular body protein 2A	610893				
19.481	02	12	19	19q	HPCQTL19		Prostate cancer aggressiveness quantitative trait locus on chromosome 19	607592		D19S902	{Prostate cancer aggressiveness QTL} (2)	
19.482	8	27	01	19q13.32	PUMA		p53-upregulated modulator of apoptosis	605854				
19.483	02	08	19	19q13.33	RPL18, DBA18		Ribosomal protein L18	604179		mutation identified in 1 DBA18 family	?Diamond-Blackfan anemia 18, 618310 (3)	
19.484	7	13	92	19q13.33	RPS11		Ribosomal protein S11	180471				
19.485	2	7	01	19q13.2	RPS16		Ribosomal protein S16	603675				
19.486	2	7	01	19q13.2	SIRT2, SIR2L, SIR2L2		Sirtuin, S. cerevisiae, homolog 2	604480				
19.487	2	27	02	19q	SLI2		Specific language impairment QTL, 2	606712			Specific language impairment QTL, 2 (2)	
19.488	5	17	95	19q13.33	SYT3		Synaptotagmin-3	600327				7(Syt3)
19.489	3	9	11	19q13.2	CXCL17, VCC1, DMC		Chemokine (C-X-C motif) ligand 17	611387				
19.490	5	6	13	19q12	PLEKHF1, LAPF, PHAFIN1		Pleckstrin homolog domain-containing protein, family F, member 1	615200				7(Plekhf1)
19.491	3	19	93	19q13.11	HPN		Hepsin	142440				
19.492	11	20	13	19q12	C19orf12, NBIA4, SPG43		Chromosome 19 open reading frame 12	614297		mutation identified in 1 SPG43 family	Neurodegeneration with brain iron accumulation 4, 614298 (3); ?Spastic paraplegia 43, autosomal recessive, 615043 (3)	
19.493	1	25	11	19q12	HSCR7		Hirschsprung disease, susceptibility to, 7	606875			{Hirschsprung disease, susceptibility to, 7} (2)	
19.494	1	14	13	19q13.2	MEGF8, EGFL4, CRPT2		Multiple epidermal growth factor-like domains 8	604267			Carpenter syndrome 2, 614976 (3)	
19.495	5	27	94	19q13.12	POLR2I		Polymerase (RNA) II (DNA directed) polypeptide I, 14.5kD	180662				
19.496	02	20	20	19q12	POP4, RPP29		POP4 homolog, ribonuclease P/MRP subunit	606114				
19.497	3	15	10	19q13.11	UBA2, SAE2		Ubiquitin-like modifier-activating enzyme 2	613295				
19.498	02	14	20	19q12	UQCRFS1, MC3DN10		Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1	191327			Mitochondrial complex III deficiency, nuclear type 10, 618775 (3)	
19.499	4	27	17	19q12	URI1, NNX3, RMP		Prefoldin-like chaperone URI1	603494				
19.500	6	28	18	19q12	ZNF536, KIAA0390		Zinc finger protein 536	618037				
19.501	6	3	14	19q13.2	DYRK1B, MIRK, AOMS3		Dual-specificity tyrosine phosphorylation-regulated kinase 1B	604556			Abdominal obesity-metabolic syndrome 3, 615812 (3)	
19.502	10	12	14	19q13.2	ATP1A3, DYT12, RDP, AHC2, CAPOS		ATPase, Na+K+ transporting, alpha-3 polypeptide	182350			Dystonia-12, 128235 (3); Alternating hemiplegia of childhood 2, 614820 (3); CAPOS syndrome, 601338 (3)	7(Atpla3)
19.503	6	28	99	19q13.11	LRP3		Low density lipoprotein receptor related protein 3	603159				
19.504	7	9	09	19q13.12	SDHAF1		Succinate dehydrogenase complex assembly factor 1	612848			Mitochondrial complex II deficiency, 252011 (3)	
19.505	9	30	09	19q13	AAA1, AAA		Aortic aneurysm, familial abdominal 1	100070		near D19S416	Aortic aneurysm, familial abdominal 1 (2)	
19.506	3	1	00	19q13.2	ACTN4, FSGS1, FSGS		Actinin, alpha-4	604638			Glomerulosclerosis, focal segmental, 1, 603278 (3)	7(Actn4)
19.507	08	13	19	19q13.33	ACP4, ACPT, AI1J		Acid phosphatase 4	606362			Amelogenesis imperfecta, type IJ, 617297 (3)	
19.508	8	24	04	19q13	ANIB2		Aneurysm, intracranial berry, 2	608542		between D19S245 and D19S246	Aneurysm, intracranial berry, 2 (2)	
19.509	04	20	20	19q13.33	BCAT2, BCT2, HVLI		Branched chain aminotransferase-2, mitochondrial	113530		mutation identified in 1 HVLI patient	?Hypervalinemia or hyperleucine-isoleucinemia, 618850 (3)	7(Bcat2)
19.510	6	5	90	19q13.32	BCL3		B-cell CLL/lymphoma-3	109560			Leukemia/lymphoma, B-cell, 3 (2)	7(Bcl3)
19.511	2	3	06	19q13.32	BLOC1S3, BLOS3, HPS8		Biogenesis of lysosome-related organelles complex 1, subunit 3	609762			Hermansky-Pudlak syndrome 8, 614077 (3)	7(rp)
19.512	04	28	20	19q13.33	C19orf48		Chromosome 19 open reading frame 48	618864				
19.513	8	18	04	19q13.2	CAPN12		Calpain 12	608839				7(Capn12)
19.514	11	15	18	19q13.2	CEACAM21		Carcinoembryonic antigen-related cell adhesion molecule 21	618191				
19.515	7	23	13	19q13	CTRCT35, CATCN1		Cataract 35	609376		max lod at D19S416	Cataract 35, congenital nuclear (2)	
19.516	10	25	90	19q13.32	CKM, CKMM		Creatine kinase, muscle type	123310				7(Ckmm)
19.517	6	19	15	19q13.12	CLIP3, CLIPR59		CAP-GLY domain-containing linker protein 3, 607382 (3)	607382				
19.518	1	31	08	19q13.2	CNFN		Cornifelin	611764				7(Cnfn)
19.519	9	30	09	19q13.33	CYTH2, PSCD2, ARNO, PSCD2L		Cytohesin 2	602488				
19.520	10	29	19	19q13.2	DLL3, SCDO1		Delta-like canonical Notch ligand 3	602768			Spondylocostal dysostosis 1, autosomal recessive, 277300 (3)	7(Dll3)
19.521	4	1	08	19q13	EA7		Episodic ataxia, type 7	611907		between rs1366444 and rs952108	Episodic ataxia, type 7 (2)	
19.522	9	12	95	19q13.2	ECH1		Enoyl Coenzyme A hydratase 1, peroxisomal	600696				
19.523	12	7	04	19q13.42	EPN1		Epsin 1	607262				
19.524	6	30	05	19q13.33	FGF21		Fibroblast growth factor 21	609436				
19.525	08	08	19	19q13.33	FUZ, NTD		Fuzzy planar cell polarity protein	610622			{Neural tube defects, susceptibility to}, 182940 (3)	
19.526	10	19	10	19q13.12	HAMP, LEAP1, HEPC, HFE2B		Hepcidin antimicrobial peptide	606464		digenic form with HAMP and HFE mutations	Hemochromatosis, type 2B, 613313 (3)	7(Hepc1)
19.527	3	7	06	19q13.43	NALP5, MATER		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 5	609658				
19.528	9	1	95	19q13	OFC3		Orofacial cleft 3	600757		?role of BCL3	Orofacial cleft 3 (2)	7(Cebpa)
19.529	11	15	18	19q13.2	PCAT19, LINC01190		Prostate cancer-associated transcript 19, noncoding	618192				
19.530	10	29	03	19q13.32	PGRP, PGRPS		Peptidoglycan recognition protein	604963				
19.531	8	11	91	19q13.31	PLAUR, URKR		Plasminogen activator, urokinase, receptor	173391				
19.532	10	12	16	19q13.33	PRMT1, HRMT1L2, IR1B4		Protein arginine methyltransferase 1	602950				7(Prmt1)
19.533	9	27	01	19q13.33	SLC17A7, BNPI, VGLUT1		Solute carrier family 17, (sodium-dependent inorganic phosphate cotransporter), member 7	605208				
19.534	8	1	12	19q13	UAQTL5		Uric acid concentration, serum, quantitative trait locus 5	614746		associated with rs150414818	[Uric acid concentration, serum, QTL5] (2)	
19.535	9	30	02	19q13.43	ZNF256		Zinc finger protein 256	606956				
19.536	12	2	92	19q13.12	ATP4A, ATP6A		ATPase, H+, K+ transporting, alpha	137216				7(Atp4a)
19.537	9	7	10	19q13.2	CATSPERG		Cation channel, sperm-associated, gamma	613452				
19.538	3	31	15	19q12	CCNE1		Cyclin E1	123837				7(Ccne)
19.539	7	13	93	19q13.12	CD22		CD22 antigen	107266				
19.540	12	30	14	19q13.11	CEBPA, CEBP		CCAAT/enhancer-binding protein (C/EBP), alpha	116897		germline mutation identified in 1 AML family	?Leukemia, acute myeloid, 601626 (3); Leukemia, acute myeloid, somatic, 601626 (3)	
19.541	3	15	15	19q13.11	CHST8, GALNAC4ST1, PSS3		Carbohydrate sulfotransferase 8	610190		mutation has been identified in 1 PSS3 family	?Peeling skin syndrome 3, 616265 (3)	
19.542	11	4	93	19q13.2	CLC		Charcot-Leyden crystal protein	153310				
19.543	11	7	16	19q13.2	COQ8B, ADCK4, NPHS9		Coenzyme Q8B	615567			Nephrotic syndrome, type 9, 615573 (3)	
19.544	10	23	20	19q13.12	COX6B1, MC4DN7		Cytochrome c oxidase, subunit VIb polypeptide 1 (ubiquitous)	124089			Mitochondrial complex IV deficiency, nuclear type 7, 619051 (3)	
19.545	8	3	99	19q13.12	DAP10		DNAX-activation protein 10	604089				
19.546	11	23	16	19q13.12	DMKN		Dermokine	617211				7(Dmkn)
19.547	11	23	16	19q13.12	KDAP		Keratinocyte differentiation-associated protein	617212				7(Krtdap)
19.548	11	23	16	19q13.2	ERF, PE2, CRS4, CHYTS		ETS2 repressor factor	611888			Craniosynostosis 4, 600775 (3); Chitayat syndrome, 617180 (3)	7(Erf)
19.549	5	16	05	19q13.12	ETV2, ETSRP71		ETS variant gene 2	609358				
19.550	5	8	15	19q13.12	FFAR1, GPR40		Free fatty acid receptor 1	603820				
19.551	5	8	15	19q13.12	FFAR3, GPR41		Free fatty acid receptor 3	603821				
19.552	5	8	15	19q13.12	FFAR2, GPR43		Free fatty acid receptor 2	603823				
19.553	5	23	00	19q13.12	FXYD1, PLM		FXYD domain-containing ion transport regulator 1 (phospholemman)	602359				
19.554	1	25	05	19q13.12	GAPDHS, GAPD2		Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic	609169		9.5 Mbp prox. to APOE		
19.555	9	9	10	19q13.11	GPI		Glucose phosphate isomerase; neuroleukin	172400			Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3)	7(Gpi1)
19.556	5	21	99	19q13.12	GPR42		G protein-coupled receptor-42	603822				
19.557	5	2	01	19q13.2	KCNK6, TWIK2, TOSS		Potassium channel, subfamily K, member 6	603939				
19.558	1	9	17	19q13.12	KMT2B, MLL4, KIAA0304, DYT28		Lysine (K)-specific methyltransferase 2B	606834			Dystonia 28, childhood-onset, 617284 (3)	
19.559	4	18	05	19q13.2	LGALS13, GAL13, PP13		Lectin, galactoside-binding, soluble, 13	608717				
19.560	12	9	15	19q13.12	MAG, GMA, SPG75		Myelin-associated glycoprotein	159460			Spastic paraplegia 75, autosomal recessive, 616680 (3)	7(Mag)
19.561	04	08	20	19q13.12	KIRREL2, NEPH3, NLG1, FILTRIN		Kirre-like nephrin family adhesion molecule 2	607762				
19.562	05	19	20	19q13.2	NFKBIB, IKBB, TRIP9		Nuclear factor of kappa-B inhibitor, beta	604495				
19.563	10	25	10	19q13.12	NPHS1, NPHN		Nephrin	602716			Nephrotic syndrome, type 1, 256300 (3)	
19.564	6	30	15	19q13.12	OVOL3		ovo-like 3	616442				
19.565	10	2	98	19q13.2	PAFAH1B3		Platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit	603074				
19.566	9	10	98	19q13.2	MRPS12, RPSM12		Ribosomal protein, mitochondrial, S12	603021				
19.567	4	24	18	19q13.2	PLEKHG2, CLG, LDAMD		Pleckstrin homology domain- and RhoGEF domain-containing protein G2	611893			Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3)	
19.568	3	22	07	19q13.2	PPP1R14A, CPI17		Protein phosphatase 1, regulatory subunit 14A	608153				
19.569	09	19	19	19q13.12	PSENEN, PEN2, ACNINV2		Presenilin enhancer, gamma-secretase subunit	607632			Acne inversa, familial, 2, with or without Dowling-Degos disease, 613736 (3)	
19.570	2	28	03	19q13.2	RASGRP4		Ras guanyl nucleotide-releasing protein 4	607320				
19.571	7	12	13	19q13.2	RYR1, MHS, CCO		Ryanodine receptor-1, skeletal	180901			{Malignant hyperthermia susceptibility 1}, 145600 (3); Central core disease, 117000 (3); Minicore myopathy with external ophthalmoplegia, 255320 (3); Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3); King-Denborough syndrome, 145600 (3)	7(Ryr)
19.572	3	24	06	19q13.12	SBSN		Suprabasin	609969				7(Sbsn)
19.573	11	05	20	19q13.11	SCN1B, GEFSP1, BRGDA5, ATFB13, DEE52		Sodium voltage-gated channel, beta subunit 1	600235			Epilepsy, generalized, with febrile seizures plus, type 1, 604233 (3); Brugada syndrome 5, 612838 (3); Cardiac conduction defect, nonspecific, 612838 (3); Atrial fibrillation, familial, 13, 615377 (3); Developmental and epileptic encephalopathy 52, 617350 (3)	
19.574	8	18	08	19q13.2	SERTAD3, RBT1		SERTA domain-containing 3	612125				
19.575	3	8	16	19q13.1-q13.2	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45		SIPA1-like protein 3	616655		mutation identified in 1 CTRCT45 family	?Cataract 45, 616851 (3)	
19.576	4	21	10	19q13.11	SLC7A9, CSNU3		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9	604144			Cystinuria, 220100 (3)	
19.577	2	12	99	19q13.2	SNRPA		Small nuclear ribonucleoprotein polypeptide A	182285				
19.578	4	1	09	19q13.2	SPINT2, HAI2, DIAR3		Serine protease inhibitor, Kunitz-type, 2 (hepatocyte growth factor activator inhibitor 2; bikunin, placental)	605124			Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)	
19.579	12	03	18	19q13.2	TGFB1, DPD1, CED, IBDIMDE		Transforming growth factor, beta-1	190180			Camurati-Engelmann disease, 131300 (3); {Cystic fibrosis lung disease, modifier of}, 219700 (3); Inflammatory bowel disease, immunodeficiency, and encephalopathy, 618213 (3)	7(Tgfb1)
19.580	7	15	99	19q13.33	TULP2		Tubby-like protein-2	602309				
19.581	11	16	18	19q13.12	TYROBP, DAP12, PLOSL1		TYRO protein tyrosine kinase-binding protein	604142			Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, 221770 (3)	
19.582	3	17	08	19q13.12	UPK1A, UPIA		Uroplakin 1A	611557				
19.583	7	11	17	19q13.12	USF2, FIP		Upstream transcription factor 2, c-fos interacting	600390				7(Usf2)
19.584	1	17	07	19q13.12	ZBTB32, FAXF, TZFP, ROG		Zinc finger- and BTB domain-containing protein 32	605859				
19.585	8	19	91	19q13.2	ZFP36, TTP		Zfp36, mouse, homolog of	190700				7(Zfp36)
19.586	1	6	97	19q13.12	ZNF146, OZF		Zinc finger protein-146	601505				
19.587	11	27	19	19q13.2	AKT2, HIHGHH		AKT serine/threonine kinase 2	164731			Diabetes mellitus, type II, 125853 (3); Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3)	7(Akt2)
19.588	9	22	93	19q13.2	AXL		AXL transforming sequence (a receptor tyrosine kinase)	109135				
19.589	1	29	04	19q13.2	BCKDHA, MSUD1		Branched chain keto acid dehydrogenase E1, alpha polypeptide	608348			Maple syrup urine disease, type Ia, 248600 (3)	
19.590	2	9	15	19q13.2	LIPE, LHS, FPLD6		Lipase E, hormone-sensitive	151750			Lipodystrophy, familial partial, type 6, 615980 (3)	7(Lipe)
19.591	1	31	13	19q13.2	LTBP4, LTBP4S, LTBP4L, ARCL1C		Latent transforming growth factor-beta-binding protein 4	604710			Cutis laxa, autosomal recessive, type IC, 613177 (3)	
19.592	9	24	08	19q13.31	LYPD3		LY6/PLAUR domain-containing protein 3	609484				
19.593	4	6	00	19q13.2	MAP3K10, MLK2, MST		Mitogen-activated protein kinase kinase kinase 10	600137				
19.594	7	30	14	19q13.2	PRX, CMT4F		Periaxin	605725			Dejerine-Sottas disease, 145900 (3); Charcot-Marie-Tooth disease, type 4F, 614895 (3)	
19.595	11	12	20	19q13.2	SUPT5H, SPT5		SPT5 homolog, DSIF elongation factor subunit	602102				7(Supt5h)
19.596	1	12	07	19q13.2	MAP4K1, HPK1		Mitogen-activated protein kinase kinase kinase kinase 1	601983				
19.597	07	17	20	19q13.11	ANKRD27, VARP		Ankyrin repeat domain-containing protein 27	618957				
19.598	11	23	16	19q13.11	DEL19q13.11p, C19DELq13.11p		Chromosome 19q13.11 deletion syndrome, proximal	617219			Chromosome 19q13.11 deletion syndrome, proximal (4)	
19.599	11	23	16	19q13.11	DEL19q13.11d, C19DELq13.11d		Chromosome 19q13.11 deletion syndrome, distal	613026		contiguous gene syndrome	Chromosome 19q13.11 deletion syndrome, distal (4)	
19.600	10	23	87	19q13.1-qter	E11S		Echo 11 sensitivity	129150				
19.601	4	17	07	19q13.11	C19orf40, FAAP24		Chromosome 19 open reading frame 40 (Fanconi anemia-associated protein, 24kD	610884				
19.602	11	1	13	19q13.11	CEP89, CCDC123, CEP123, FLJ14640		Centrosomal protein, 89kD	615470				
19.603	1	9	14	19q13.11	CEBPG, GPE1BP		CCAAT/enhancer-binding protein, gamma	138972				
19.604	4	15	11	19q13.11	DPY19L3		DPY19-like 3	613894				
19.605	1	9	13	19p13.11	GATAD2A		GATA zinc finger domain-containing protein 2A	614997				
19.606	5	24	13	19q13.11	KCTD15		Potassium channel tetramerization domain-containing protein 15	615240				
19.607	07	31	20	19q13.12	LGI4, AMC1		Leucine-rich gene, glioma-inactivated, 4	608303			Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect, 617468 (3)	7(Lgi4)
19.608	4	13	15	19q13.11	LSM14A, RAP55		LSM14A protein	610677				
19.609	3	7	14	19q13.11	PDCD2L, MGC13096		Programmed cell death 2-like protein	615661				
19.610	3	25	14	19q13.11	PDCD5, TFAR19		Programmed cell death 5	604583				
19.611	2	7	07	19q13.11	RGS9BP, R9AP, RGS9, PERRS		Regulator of G protein signaling 9-binding protein	607814			Bradyopsia, 608415 (3)	
19.612	4	6	18	19q13.11	RHPN2		Rhophilin 2	617932				7(Rhpn2)
19.613	2	22	13	19q13.11	SCGB2B2		Secretoglobin, family 2B, member 2	615063				
19.614	2	25	15	19q13.11	SLC7A10, ASC1		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 10	607959				
19.615	7	27	11	19q12	TSHZ3, KIAA1474		Teashirt zinc finger homeobox 3	614119				
19.616	9	29	96	19q13.12	CKAP1		Cytoskeleton-associated protein 1	601303				
19.617	6	28	99	19q13.2	PSMC4, TBP7, S6		Proteasome 26S subunit, ATPase, 4	602707				
19.618	10	28	19	19q13.12	ALKBH6, ABH6		AlkB homolog 6	613304				
19.619	12	10	12	19q13.12	ARHGAP33, TCGAP		Rho GTPase-activating protein 33	614902				
19.620	8	24	09	19q13.12	CAPNS1, CAPN4		Calpain, small polypeptide	114170				
19.621	3	26	07	19q13.12	COX7A1, COX7AM		Cytochrome c oxidase, subunit VIIa, polypeptide-1, muscle	123995				
19.622	8	24	09	19q13.12	FXYD3, PLML, MAT8		FXYD domain-containing ion transport regulator 3	604996				
19.623	3	26	07	19q13.12	FXYD5		FXYD domain-containing ion transport regulator 5	606669				
19.624	8	24	09	19q13.12	FXYD7		FXYD domain-containing ion transport regulator 7	606684				
19.625	9	7	10	19q13.12	HAUS5, DGT5, KIAA0841		HAUS augmin-like complex, subunit 5	613432				
19.626	8	5	11	19q13.12	IGFLR1, TMEM149		IGF-like family receptor 1	614143				
19.627	9	30	15	19q13.12	LSR		Lipolysis-stimulated lipoprotein receptor	616582				
19.628	6	1	15	19q13.12	PRODH2, HYPDH		Proline dehydrogenase (oxidase) 2	616377				
19.629	2	21	10	19q13.12	RBM42		RNA-binding motif protein 42	613232				
19.630	11	22	13	19q13.12	SYNE4, NESP4, C19orf46, DFNB76		Spectrin repeat-containing nuclear envelope protein 4	615535			Deafness, autosomal recessive 76, 615540 (3)	
19.631	1	20	09	19q13.12	THAP8		THAP domain-containing protein 8	612536				
19.632	6	8	11	19q13.12	WDR62, C19orf14, MCPH2		WD repeat-containing protein 62	613583			Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)	
19.633	9	2	12	19q13.11	WTIP		WT1-interacting protein	614790				
19.634	1	26	17	19q13.12	ZFP30, ZNF745, KIAA0961		Zinc finger protein 30, mouse, homolog of	617317				7(Zfp30)
19.635	2	21	11	19q13.12	ZNF260, PEX1		Zinc finger protein 260	613749				7(Zfp260)
19.636	11	23	16	19q13.12	ZNF420, APAK		Zinc finger protein 420	617216				
19.637	10	5	11	19q13.12	ZNF565		Zinc finger protein 565	614275				
19.638	7	11	17	19q13.12	ZNF568, ZFP568		Zinc finger protein 568	617566				
19.639	5	16	11	19q13.12	ZNF569		Zinc finger protein 569	613904				
19.640	10	25	19	19q13.12	ZNF875, HKR1		Zinc finger protein 875	165250				
19.641	06	05	19	19q13.2	ARHGEF1, LBCL2, IMD62		Rho guanine nucleotide exchange factor, 115-kD	601855		mutation identified in 1 IMD62 family	?Immunodeficiency 62, 618459 (3)	
19.642	1	10	07	19q13.12	HSPB6, HSP20		Heat-shock 27kD protein 6	610695				
19.643	2	11	13	19q13.2	IFNL1, IL29		Interferon, lambda 1	607403				
19.644	2	11	13	19q13.2	IFNL2, IL28A		Interferon, lambda 2	607401				
19.645	2	11	13	19q13.2	IFNL3, IL28B		Interferon, lambda 3	607402			{Hepatitis C virus infection, response to therapy of}, 609532 (3)	
19.646	3	14	13	19q13.2	IFNL4		Interferon, lambda-4	615090				
19.647	1	26	12	19q13.12	ZNF382, KS1		Zinc finger protein 382	609516				
19.648	11	18	16	19q13.2	SELENOV, SELV		Selenoprotein V	607919				
19.649	10	11	07	19q13.2	SPRED3		Sprouty-related EVH1 domain-containing protein 3	609293				7(Spred3)
19.650	09	06	18	19q13.2	SPTBN4, QV, NEDHND, CMND		Spectrin, beta, nonerythrocytic, 4 (quivering, mouse, homolog of)	606214			Neurodevelopmental disorder with hypotonia, neuropathy, and deafness, 617519 (3)	7(Spnb4)
19.651	5	13	11	19q13.12	ZNF540		Zinc finger protein 540	613903				
19.652	1	1	96	19q13.2	BLVRB, BVRB, FLR		Biliverdin reductase B	600941				
19.653	12	18	08	19q13.2	DPF1, NEUD4		D4, zinc, and double PHD fingers family, member 1	601670				
19.654	2	1	00	19q13.2	NUMBL, NUMBR, NBL		Numb, Drosophila, homolog-like	604018				
19.655	11	05	20	19q13.33	GRIN2D, NMDAR2D, DEE46		Glutamate receptor, ionotropic, N-methyl-D-aspartate 2D	602717			Developmental and epileptic encephalopathy 46, 617162 (3)	
19.656	3	26	07	19q13.12	APLP1, APLP		Amyloid beta (A4) precursor-like protein-1	104775				
19.657	10	16	95	19q13.32	APOC4		Apolipoprotein C-IV	600745		555bp upstream of APOC2		
19.658	11	25	19	19q13.32	APOE, AD2, LPG, LDLCQ5		Apolipoprotein E	107741		mutation identified in 1 APOE3-Christchurch patient	Hyperlipoproteinemia, type III, 617347 (3); Alzheimer disease 2, 104310 (3); Sea-blue histiocyte disease, 269600 (3); {?Macular degeneration, age-related}, 603075 (3); Lipoprotein glomerulopathy, 611771 (3); {Coronary artery disease, severe, susceptibility to}, 617347 (3); {?Alzheimer disease, protection against, due to APOE3-Christchurch}, 607822 (3)	7(Apoe)
19.659	4	25	93	19q13.32	APOC1		Apolipoprotein C-I	107710				
19.660	10	29	03	19q13.32	APOC2		Apolipoprotein C-II	608083			Hyperlipoproteinemia, type Ib, 207750 (3)	
19.661	12	22	16	19q13.2	ATP5SL		ATP5S-like protein	617262				
19.662	11	15	17	19q13.2	B9D2, MKS10, JBTS34		B9 domain-containing protein 2	611951		mutation identified in 1 MKS10 family	?Meckel syndrome 10, 614175 (3); Joubert syndrome 34, 614175 (3)	7(B9d2)
19.663	8	7	13	19q13.2	B3GNT8, BGALT15, B3GALT7		Beta-1,3-galactosyltransferase 8	615357				7(B3gnt8)
19.664	6	27	17	19q13.31	CADM4, IGSF4C, TSLL2, NECL4, SYNCAM4		Cell adhesion molecule 4	609744				7(Igsf4c)
19.665	2	16	04	19q13.32	CBLC		CAS-BR-M murine ecotropic retroviral transforming sequence C	608453				
19.666	8	28	17	19q13.2	CCER2		Coiled-coil glutamate-rich protein 2	617634				
19.667	1	6	00	19q13.2	CEACAM1, BGP		Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)	109770		in CEA cluster		7(Bgp1)
19.668	1	6	00	19q13.2	CEACAM5, CEA		Carcinoembryonic antigen-related cell adhesion molecule 5	114890		proximal to PSG cluster in 1.1-1.2Mb segment		
19.669	1	6	00	19q13.2	CEACAM6, NCA		Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific crossreacting antigen)	163980		in CEA cluster		
19.670	5	22	14	19q13.2	CEACAM8, CD66B, CGM6		Carcinoembryonic antigen-related cell adhesion molecule 8	615747				
19.671	09	11	19	19q13.2	CIC, KIAA0306, MRD45		Capicua transcriptional repressor	612082			Mental retardation, autosomal dominant 45, 617600 (3)	
19.672	8	26	03	19q13.2	CYP2A7		Cytochrome P450, subfamily IIA, polypeptide 7	608054				
19.673	8	26	03	19q13.2	CYP2A13		Cytochrome P450, subfamily IIA, polypeptide 13	608055				
19.674	09	29	20	19q13.2	CYP2G1P, CYP2G1		Cytochrome P450, family 2, subfamily G, member 1, pseudogene	601133				
19.675	1	5	09	19q13.2	CYP2S1		Cytochrome P450, family 2, subfamily S, polypeptide 1	611529				
19.676	8	17	16	19q13.2	DEDD2, FLAME3		Death effector domain-containing protein 2	617078				
19.677	9	10	12	19q13.2	DMRTC2		Doublesex- and MAB3-related transcription factor C2	614806				
19.678	2	24	17	19q13.2	EID2, CRI2		EP300-interacting inhibitor of differentiation 2	609773				7(Cri2)
19.679	09	30	19	19q13.2	EGLN2, PHD1, HIFPH1		egl-9 family hypoxia inducible factor 2	606424				
19.680	6	1	12	19q13.2	EXOSC5, RRP46		Exosome component 5	606492				
19.681	9	29	10	19q13.2	FBL		Fibrillarin	134795				
19.682	9	9	08	19q13.2	FBXO17, FBX17, FBX26, FBG4		F-box only protein 17	609094				7(Fbxo17)
19.683	9	9	08	19q13.2	FBXO27, FBX27, FBG5		F-box only protein 27	609099				7(Fbxo27)
19.684	6	28	17	19q13.2	FCGBP		Fc fragment of IgG-binding protein	617553				
19.685	8	1	14	19q13.2	NCCRP1, FBXO50		Nonspecific cytotoxic cell receptor protein 1, zebrafish, homolog of	615901				
19.686	2	4	00	19q13.2	GMFG		Glia maturation factor, gamma	604104				
19.687	7	2	18	19q13.2	GSK3A		Glycogen synthase kinase 3-alpha	606784				
19.688	11	11	14	19q13.2	HNRNPL, HNRPL		Heterogeneous nuclear riboprotein 1	603083				
19.689	8	24	09	19q13.2	HNRNPUL1, HNRPUL1, E1BAP5		Heterogeneous nuclear ribonucleoprotein U-like 1	605800				
19.690	6	18	18	19p13.11	HSH2D, ALX		Hemotopoietic SH2 domain-containing protein	608349				
19.691	9	21	17	19q13.2	LGALS7B		Lectin, galactoside-binding, soluble, 7B	617139				
19.692	7	15	09	19q13.2	LRFN1, SALM2, KIAA1484		Leucine-rich repeat and fibronectin type III domain-containing protein 1	612807				
19.693	7	15	09	19q13.12	LRFN3, SALM4		Leucine-rich repeat and fibronectin type III domain-containing protein 3	612809				7(Lrfn3)
19.694	12	20	01	19q13.32	MARK4, KIAA1860, MARKL1		Map/microtubule affinity-regulating kinase-4	606495				
19.695	7	22	09	19q13.2	MED29, IXL		Mediator complex subunit 29	612914				
19.696	10	4	02	19q13.31	NB1, PRV1, CD177, HNA2A		Neutrophil-specific antigen 1	162860				
19.697	05	19	20	19q13.12	NFKBID, IKBNS		Nuclear factor kappa-B inhibitor, delta	618887				
19.698	11	16	17	19q13.2	PLD3, HUK4, SCA46		Phospholipase D family, member 3	615698		mutation identified in 1 SCA46 family	?Spinocerebellar ataxia 46, 617770 (3)	
19.699	8	24	09	19q13.2	POU2F2, OTF2, OCT2		POU domain, class 2, transcription factor 2	164176				7(Otf2)
19.700	09	29	20	19q13.2	PSG10P, PSG10, PSG12		Pregnancy-specific beta-1-glycoprotein 10, pseudogene	176399				
19.701	1	6	00	19q13.31	PSG11, PSG13, PSG14		Pregnancy-specific beta-1-glycoprotein-11	176401				
19.702	8	2	10	19q13.2	CD79A, IGA		CD79A antigen (immunoglobulin-associated alpha)	112205			Agammaglobulinemia 3, 613501 (3)	
19.703	5	8	07	19q13.2	CYP2A6, CYP2A3, CYP2A, P450C2A		Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6	122720			Coumarin resistance, 122700 (3); {Nicotine addiction, protection from}, 188890 (3); {Lung cancer, resistance to}, 211980 (3)	7(Cyp2a)
19.704	4	2	12	19q13.2	CYP2B6, CYP2B, EFVM		Cytochrome P450, family 2, subfamily B, polypeptide 6	123930		same NotI fragment as CYP2A	Efavirenz, poor metabolism of, 614546 (3); {Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3)	7(Cyp2b)
19.705	4	25	93	19q13.2	CYP2F1		Cytochrome P450, subfamily IIF, polypeptide 1	124070		CYP2A, CYP2B, CYP2F1 in 240kb		7(Cyp2f1)
19.706	10	3	07	19q13.2	EIF3K, PLAC24, EIF3S12		Eukaryotic translation initiation factor 3, subunit K	609596				
19.707	3	24	06	19q13.2	GGN		Gametogenetin, mouse, homolog of	609966				7(Ggn)
19.708	1	12	95	19q13.2	GRIK5		Glutamate receptor, ionotropic, kainate 5	600283				7(Grik5)
19.709	3	24	06	19q13.32	HIF3A, IPAS		Hypoxia-inducible factor 3, alpha subunit	609976				
19.710	1	4	08	19q13.2	HIPK4		Homeodomain-interacting protein kinase 4	611712				
19.711	05	06	20	19q13.2	ITPKC		Inositol 1,4,5-trisphosphate 3-kinase C	606476				
19.712	12	11	15	19q13.31	KCNN4, KCA4, SK4, DHS2		Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4	602754			Dehydrated hereditary stomatocytosis 2, 616689 (3)	
19.713	4	18	05	19q13.2	LGALS4		Lectin, galactoside-binding, soluble, 4	602518				
19.714	4	18	05	19q13.2	LGALS7		Lectin, galactoside-binding, soluble, 7 (galectin 7)	600615				
19.715	1	8	01	19q13.42	LILRA1, LIR6		Leukocyte immunoglobulin-like receptor, subfamily A, member 1	604810				
19.716	1	8	01	19q13.42	LILRB5, LIR8		Leukocyte immunoglobulin-like receptor, subfamily B, member 5	604814				
19.717	7	16	09	19q13.32	LU, AU, BCAM		B-cell adhesion molecule	612773		linked to SE	[Blood group, Lutheran system], 111200 (3); [Blood group, Auberger system], 111200 (3); [Blood group, Lutheran null], 247420 (3)	7(lu)
19.718	6	28	17	19q13.32	NECTIN2, PVRL2, HVEB, PVRR2, PRR2		Nectin 2	600798				
19.719	10	30	06	19q13.2	PAF1, PD2		PAF1 RNA polymerase II-associated factor, S. cerevisiae, homolog of	610506				
19.720	8	24	09	19q13.2	PAK4		p21-activated kinase 4	605451				
19.721	7	11	11	19q13.2	PAPL, FLJ16165		Purple acid phosphatase, long form	610490				
19.722	10	7	02	19q13.2	PPL13		Placental protein 13-like protein	607260				
19.723	8	20	07	19q13.33	PPP1R15A, GADD34		Protein phosphatase 1, regulatory subunit 15A	611048				
19.724	8	24	09	19q13.2	PRA1		Prenylated RAB acceptor 1	604925				
19.725	7	11	11	19q13.31	PRG1		p53-responsive gene 1	605157				
19.726	3	1	01	19q13.2	PSG1, PSBG1, B1G1, SP1		Pregnancy-specific beta-1-glycoprotein-1	176390		distal to CEA		
19.727	4	25	93	19q13.31	PSG2, PSBG2		Pregnancy-specific beta-1-glycoprotein-2	176391				
19.728	6	13	95	19q13.2	PSG3		Pregnancy-specific beta-1-glycoprotein-3	176392				
19.729	3	1	01	19q13.31	PSG4		Pregnancy-specific beta-1-glycoprotein-4	176393				
19.730	3	1	01	19q13.31	PSG5		Pregnancy-specific beta-1-glycoprotein-5	176394				
19.731	3	1	01	19q13.31	PSG6		Pregnancy-specific beta-1-glycoprotein-6	176395				
19.732	3	1	01	19q13.31	PSG7		Pregnancy-specific beta-1-glycoprotein-7	176396				
19.733	3	1	01	19q13.2	PSG8		Pregnancy-specific beta-1-glycoprotein-8	176397				
19.734	1	6	00	19q13.31	PSG9, PSG11		Pregnancy-specific beta-1-glycoprotein-9	176398				
19.735	1	23	18	19q13.2	PSMD8		Proteasome 26S subunit, non-ATPase, 8	617844				
19.736	8	9	99	19q13.2	RPS19, DBA, DBA1		Ribosomal protein S19	603474			Diamond-Blackfan anemia 1, 105650 (3)	
19.737	3	31	11	19q13.2	SARS2		Seryl-tRNA synthetase 2	612804			Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3)	
19.738	1	25	18	19q13.2	SERTAD1, TRIPBR1		SERTA domain-containing protein 1	617850				
19.739	2	2	17	19q13.2	SHKBP1, SB1		SH3KBP1-binding protein 1	617322				
19.740	8	24	09	19q13.33	SPHK2		Sphingosine kinase 2	607092				
19.741	1	11	07	19q13.2	TEC		Transient erythroblastopenia of childhood	227050			Transient erythroblastopenia of childhood (2)	
19.742	04	27	20	19q13.2	TIMM50, TIM50, MGCA9		Translocase of inner mitochondrial membrane 50	607381			3-methylglutaconic aciduria, type IX, 617698 (3)	
19.743	01	23	19	19q13.2	TMEM91, DSPC3		Transmembrane protein 91	618294				
19.744	09	17	20	19q13.32	TOMM40, TOM40, PEREC1		Translocase of outer mitochondrial membrane 40	608061				
19.745	7	7	14	19q13.12	U2AF1L4, U2AF1RS3		U2 small nuclear RNA auxillary factor 1-like 4	601080				
19.746	8	27	17	19q13.31	XRCC1, SCAR26		X-ray-repair, complementing defective, repair in Chinese hamster cells-1	194360		mutation identified in 1 SCAR26 patient	?Spinocerebellar ataxia, autosomal recessive 26, 617633 (3)	7(Xrcc1)
19.747	8	7	00	19q13.31	ZFP93, ANF270, HZF6		Zinc finger protein 93, mouse, homolog of	604749				7(Zfp93)
19.748	2	7	07	19q13.31	ZNF45, ZNF13, KOX5		Zinc finger protein-45	194554				
19.749	3	6	02	19q13.31	ZNF180		Zinc finger protein-180	606740				
19.750	3	6	02	19q13.11	ZNF181		Zinc finger protein-181	606741				
19.751	2	24	17	19q13.31	ZNF222		Zinc finger protein 222	617357				
19.752	12	19	11	19q13.2	ZNF526, KIAA1951		Zinc finger protein 526	614387				
19.753	2	12	13	19q13.32	AP2S1, CLAPS2, AP17, HHC3		Adaptor-related protein complex 2, sigma 1 subunit	602242			Hypocalciuric hypercalcemia, type III, 600740 (3)	
19.754	3	2	00	19q13.33	CA11, CARP2		Carbonic anhydrase XI	604644				
19.755	02	19	20	19q13.32	CALM3, LQT16, CPVT6		Calmodulin-3	114183		mutation identified in 1 CPVT6 family	Long QT syndrome 16, 618782 (3); ?Ventricular tachycardia, catecholaminergic polymorphic 6, 618782 (3)	
19.756	4	27	12	19q13.32	CD3EAP, ASE1, PAF49		CD3-epsilon-associated protein	107325				
19.757	11	3	00	19q13.32	DMPK, DM, DMK		Dystrophia myotonica-protein kinase	605377		distal to APOLP2; distal to CKM	Myotonic dystrophy 1, 160900 (3)	7(Dm15)
19.758	2	20	07	19q13.32	ERCC1, UV20, COFS4		Excision repair cross complementing rodent repair deficiency, complementation group-1	126380		distal to CKM	Cerebrooculofacioskeletal syndrome 4, 610758 (3)	
19.759	6	2	15	19q13.32	ERCC2, EM9, XPD, COFS2, TTD1		Excision repair cross complementing rodent repair deficiency, complementation group-2	126340		< 250kb from ERCC1; mutation identified in 1 COFS2 patient	Xeroderma pigmentosum, group D, 278730 (3); Trichothiodystrophy 1, photosensitive, 601675 (3); ?Cerebrooculofacioskeletal syndrome 2, 610756 (3)	7(Ercc2)
19.760	2	15	96	19q13.32	GPR4		G protein-coupled receptor-4	600551				
19.761	1	12	06	19q13.32	KLC3, KLC2L		Kinesin, light chain, 3	601334				
19.762	5	16	18	19q13.33	LIG1		Ligase I, DNA, ATP-dependent	126391				7(Lig1)
19.763	6	13	07	19q13.2-q13.3	MRT11		Mental retardation, autosomal recessive, 11	611097		between rs2109075 and rs8101149	Mental retardation, autosomal recessive, 11 (2)	
19.764	6	28	99	19q13.32	NPAS1, MOP5		Neuronal PAS domain protein 1	603346				7(Npas1)
19.765	06	16	20	19q13.32	OPA3, MGA3		Outer mitochondrial membrane lipid metabolism regulator OPA3	606580			3-methylglutaconic aciduria, type III, 258501 (3); Optic atrophy 3 with cataract, 165300 (3)	
19.766	5	2	11	19q13.31	PVR, PVS		Polio virus receptor	173850				9(Pvs)
19.767	9	10	09	19q13.2	RAB4B		Ras-associated protein RAB4B	612945				
19.768	10	27	10	19q13.2-q13.3	TRNAU1, TRSP		Transfer RNA selenocysteine 1 (anticodon UCA)	165060		pseudogene on 22		7(Trsp)
19.769	3	31	97	19q13.32	VASP		Vasodilator-stimulated phosphoprotein	601703				
19.770	4	17	14	19q13.32	CCDC8, 3M3		Coiled-coil domain-containing protein 8	614145			3-M syndrome 3, 614205 (3)	
19.771	6	19	00	19q13.31	ZNF155		Zinc finger protein-155	604086				
19.772	6	4	99	19q13.2-q13.4	CFM1		Cystic fibrosis modifier-1	603855			{Meconium ileus in cystic fibrosis, susceptibility to} (2)	7(Cfm1)
19.773	9	18	02	19q13.32	FOXA3, HNF3G		Forkhead box A3 (hepatocyte nuclear factor-3, gamma)	602295				7(Hnf3g)
19.774	3	19	01	19q13.32	GRLF1, P190A		Glucocorticoid receptor DNA-binding factor 1	605277				
19.775	9	15	96	19q13.33	NUCB1		Nucleobindin 1	601323				
19.776	8	22	14	19p13.11	PIK3R2, MPPH1		Phosphatidylinositol 3-kinase, regulatory subunit 2	603157			Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3)	
19.777	2	7	07	19q13.31	ZNF224, ZNF255, BMZF2, KOX22, ZNF27		Zinc finger protein-224	194555				
19.778	9	18	00	19q13.33	AP2A1, CLAPA1, ADTAA		Adaptor-related protein complex 2, alpha 1 subunit	601026		match to PAC AC006942		
19.779	6	3	02	19p13.13	ASNA1, ARSA1		arsA arsenite transporter, ATP-binding, E. coli, homolog of, 1	601913				8(Asna1)
19.780	8	24	09	19q13.33	ATF5, ATFX		Activating transcription factor 5	606398				
19.781	3	12	07	19q13.33	BCL2L12		BCL2-like 12	610837				
19.782	07	12	19	19q13.33	BICRA, GLTSCR1		BRD4-interacting chromatin remodeling complex-associated protein	605690				
19.783	11	09	20	19q13.33	CARD8, TUCAN, KIAA0955, NDPP1, IBD30		Caspase recruitment domain-containing protein 8	609051		mutation identified in 1 IBD30 family	?Inflammatory bowel disease (Crohn disease) 30, 619079 (3)	
19.784	2	8	13	19q13.33	CCDC114, CILD20		Coiled-coil domain-containing protein 114	615038			Ciliary dyskinesia, primary, 20, 615067 (3)	
19.785	2	22	18	19q13.33	CLEC11A, SCGF, LSLCL		C-type lectin domain family 11, member A	604713				7(Scgf)
19.786	7	18	14	19q13.32	CLPTM1		Cleft lip and palate-associated transmembrane protein 1	604783				
19.787	9	9	11	19q13.33	CRX, CORD2, CRD, LCA7		Cone-rod homeo box-containing gene	602225			Cone-rod retinal dystrophy-2, 120970 (3); Leber congenital amaurosis 7, 613829 (3)	
19.788	8	30	07	19q13.32	DACT3		Dapper, antagonist of beta-catenin, 3	611112				7(Dact3)
19.789	2	15	96	19q13.33	DBP		D site of albumin promoter binding protein	124097				7(Dbp)
19.790	3	20	06	19q13.32	DMWD, DMRN9		Dystrophia myotonica WD repeat-containing protein	609857				
19.791	5	2	01	19q13.33	EHD2		EH domain-containing 2	605890				
19.792	10	20	99	19q13.33	EMP3		Epithelial membrane protein 3	602335				7(Emp3)
19.793	8	25	03	19q13.41	ETFB, MADD		Electron transfer flavoprotein, beta polypeptide	130410			Glutaric acidemia IIB, 231680 (3)	7(Etfb)
19.794	9	9	08	19q13.32	FBXO46, FBX46		F-box only protein 46	609117				7(Fbxo46)
19.795	09	29	20	19q13.33	FCGRT		Fc fragment of IgG receptor and transporter	601437				
19.796	09	27	18	19q13.32	FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5		Fukutin-related protein	606596			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3); Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3); Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	
19.797	09	08	20	19q13.32	FOSB		FOSB protooncogene, AP1 transcription factor subunit	164772				7(Fosb)
19.798	1	14	16	19q13.33	FUT1, H, HH		Fucosyltransferase-1 (Bombay phenotype)	211100		SE tightly linked	[Bombay phenotype], 616754 (3)	
19.799	12	19	18	19q13.33	FUT2, SE, B12QTL1		Fucosyltransferase-2 (secretor)	182100		H, SE = alpha-L-fucosyltransferases; from common ancestral genes; tightly linked to FUT1	{Norwalk virus infection, resistance to} (3); {Vitamin B12 plasma level QTL1}, 612542 (3); [Bombay phenotype, digenic], 616754 (3)	
19.800	09	30	19	19q13.32	GIPR, PGQTL2		Gastric inhibitory polypeptide receptor	137241				
19.801	11	5	98	19q13.33	GPR32		G protein-coupled receptor-32	603195				
19.802	11	30	06	19q13.33	GRWD1, GRWD, KIAA1942		Glutamate-rich WD repeat-containing protein 1	610597				
19.803	11	13	07	19q13.33	GYS1, GYS		Glycogen synthase	138570			Glycogen storage disease 0, muscle, 611556 (3)	
19.804	1	25	91	19q13.33	HRC		Histidine-rich calcium-binding protein	142705				
19.805	9	5	02	19q13.33	KCNA7		Potassium voltage-gated channel, shaker-related subfamily, member 7	176268				7(Kcna7)
19.806	05	07	20	19q13.33	MED25, PTOV2, ARC92, BVSYS		Mediator of RNA polymerase II transcription, subunit 25, S. cerevisiae, homolog of	610197			Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	
19.807	2	24	04	19q13.32-q13.33	NAPA, SNAPA		N-ethylmaleimide-sensitive factor attachment protein, alpha	603215				7(hyh)
19.808	6	4	18	19q13.33	NOP53, GLTSCR2		NOP53 ribosome biogenesis factor	605691				
19.809	04	30	20	19q13.32	NOVA2, ANOVA, NEDASB		NOVA alternative splicing regulator 2	601991			Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities, 618859 (3)	
19.810	5	17	95	19q13.33	NR1H2, UNR		Nuclear receptor subfamily 1, group H, member 2 (ubiquitously-expressed nuclear receptor)	600380				
19.811	10	3	09	19q13.33	NTF4 , NTF5, NT5, NT4, GLC1O		Neurotrophin-4 (neurotrophin-4/5)	162662		3 genes, ? functional, also on 19	Glaucoma 1, open angle, 1O, 613100 (3)	7(Ntf5)
19.812	8	24	09	19q13.33	PLA2G4C		Phospholipase A2, group IVC	603602				
19.813	4	10	96	19q13.32	PPP5C, PP5		Protein phosphatase-5, catalytic subunit	600658				
19.814	8	24	09	19q13.32	PRKD2, PKD2		Protein kinase D2	607074				
19.815	6	13	95	19q13.32	PTGIR		Prostaglandin I2 (prostacyclin) receptor (IP)	600022				7(Ptgir)
19.816	09	06	19	19q13.32	RSPH6A, RSHL1		Radial spoke head 6 homolog A	607548				
19.817	3	29	12	19q13.32	RTN2, NSPL1, SPG12		Reticulon-2	603183			Spastic paraplegia 12, autosomal dominant, 604805 (3)	
19.818	2	20	01	19q13.33	RUVBL2, TIP48, ECP51		RUVB, E. coli, homolog-like 2 (TATA box-binding protein-interacting protein)	604788				7(Ruvbl2)
19.819	12	22	16	19q13.33	SCAF1		SR-related C-terminal domain-associated factor 1	617264				
19.820	11	17	16	19q13.33	SELENOW, SEPW1		Selenoprotein W	603235				
19.821	10	20	99	19q13.41	SIGLEC5, CD33L2, OBBP2		Sialic acid-binding Ig-like lectin 5	604200				
19.822	2	7	01	19q13.41	SIGLEC6, CD33L, CD33L1, OBBP1		Sialic acid-binding immunoglobulin-like lectin 6	604405				
19.823	2	1	00	19q13.41	SIGLEC7, AIRM1		Sialic acid-binding immunoglobulin-like lectin 7	604410				
19.824	08	12	19	19q13.32	SIX5, DMAHP, BOR2		SIX homeobox 5	600963			Branchiootorenal syndrome 2, 610896 (3)	
19.825	4	28	17	19q13.33	SNRP70, U1RNP, RNPU1Z, RPU1		Small nuclear ribonucleoprotein, U1 subunit, 70kD	180740				
19.826	6	4	99	19q13.32	SLC1A5, RDRC, M7V1, M7VS1		Solute carrier family 1 (neutral amino acid transporter), member 5 (receptor for RD114/simian type D retroviruses)	109190				
19.827	2	25	98	19q13.32	SPK		Symplekin	602388				
19.828	8	18	99	19q13.33	SULT2A1, STD		Sulfotransferase family 2A, dehydroepiandrosterone-preferring, member 1 (DHEA sulfotransferase)	125263				
19.829	7	13	17	19q13.33	SULT2B1, ARCI14		Sulfotransferase family 2B, member 1	604125			Ichthyosis, congenital, autosomal recessive 14, 617571 (3)	
19.830	1	5	04	19q13.33	SYNGR4		Synaptogyrin 4	608373				
19.831	6	28	99	19q13.33	TEAD2, TEF4		TEA domain family member 2	601729				
19.832	11	16	98	19p13.3	ZIPK		ZIP kinase	603289				
19.833	6	22	14	19q13.33	BAX		BCL2-associated X protein	600040			Colorectal cancer, somatic, 114500 (3); T-cell acute lymphoblastic leukemia, somatic, 613065 (3)	7(Bax)
19.834	9	16	16	19q13.32	C5AR1, C5R1, C5AR		Complement component 5a receptor 1	113995				
19.835	4	25	93	19q13.41	CD33		CD33 antigen (gp67)	159590				
19.836	8	24	09	19q13.41	FPR2, FPRL1, FPRH1, LXA4R, HM63		Formyl peptide receptor 2	136538				
19.837	8	24	09	19q13.41	FPR3, FPRL2, FPRH2		Formyl peptide receptor 3	136539				
19.838	1	15	14	19q13.33	FTL, NBIA3, LFTD		Ferritin, light chain	134790			Hyperferritinemia-cataract syndrome, 600886 (3); Neurodegeneration with brain iron accumulation 3, 606159 (3); L-ferritin deficiency, dominant and recessive, 615604 (3)	7(Ftl1)
19.839	6	28	99	19q13.41	HAS1		Hyaluronan synthase 1	601463				17(Has1)
19.840	12	28	08	19q13.33	IL4I1, FIG1		Interleukin 4-induced gene 1	609742				
19.841	8	11	91	19q13.42	IL11		Interleukin-11	147681				
19.842	3	14	18	19q13.33	IRF3, IIAE7		Interferon regulatory factor 3	603734			{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}, 616532 (3)	
19.843	5	2	06	19q13.33	KCNC3, SCA13		Potassium voltage-gated channel, Shaw-related subfamily, member 3	176264			Spinocerebellar ataxia 13, 605259 (3)	7(Kcnc3)
19.844	9	9	13	19q13.33	POLD1, CRCS10, MDPL		Polymerase (DNA directed), delta 1, catalytic subunit	174761			{Colorectal cancer, susceptibility to, 10}, 612591 (3); Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3)	7(Pold1)
19.845	3	3	10	19q13.42	PPP1R12C, MBS85		Protein phosphatase 1, regulatory subunit 12C	613245				
19.846	08	23	19	19q13.33	PTOV1, ACID2		PTOV1 extended AT-hook containg adaptor protein	610195				
19.847	8	27	02	19q13.33	SIGLEC11		Sialic acid-binding immunoglobulin-like lectin 11	607157		pseudogene 8kb upstream		
19.848	5	6	03	19q13.33	SPIB		SPIB transcription factor	606802				
19.849	10	15	94	19q13.41	ZNF83		Zinc finger protein-83	194558				
19.850	6	19	00	19q13.41	ZNF137		Zinc finger protein-137	604079				
19.851	3	27	95	19q13.41-q13.42	ZNF160		Zinc finger protein-160	600398				
19.852	11	6	01	19q13.41	ZNF320		Zinc finger protein 320	606427				
19.853	6	20	01	19q13.42	ZNF331, ZNF463		Zinc finger protein-331	606043				
19.854	8	24	09	19q13.33	RRAS		Oncogene RRAS	165090				7(Rras)
19.855	5	2	16	19q13.31	C19orf61, SMG9, HBMS		Chromosome 19 open reading frame 61	613176			Heart and brain malformation syndrome, 616920 (3)	
19.856	04	30	19	19q13.31-q13.32	CEACAM16, CEAL2, DFNA4B, DFNB113		Carcinoembryonic antigen-related cell adhesion molecule 16	614591			Deafness, autosomal dominant 4B, 614614 (3); Deafness, autosomal recessive 113, 618410 (3)	
19.857	7	2	18	19q13.31	CEACAM19, CEAL1		Carcinoembryonic antigen related cell adhesion molecule 19	606691				
19.858	3	23	09	19q13.31	TEX101, SGRG, TES101RP		Testis-expressed gene 101	612665				
19.859	9	27	17	19q13.31	ZNF234, ZNF269, HZF4		Zinc finger protein 234	604750				
19.860	9	2	08	19q13.33	BSPH1		Bovine seminal plasma protein-like 1	612213				7(Bsph1)
19.861	10	23	87	19q13.33	CGB		Chorionic gonadotropin, beta polypeptide	118860		at least 5 genes		7(Cgb)
19.862	08	09	19	19q13.32	CLASRP, CLASP		CLK4-associating serine/arginine-rich protein	618532				
19.863	07	13	20	19q13.32	DHX34, KIAA0134		DExH-box helicase 34	615475				
19.864	5	30	17	19q13.32	EML2, EMAP2, ELP70		Echinoderm microtubule-associated protein-like 2	617494				
19.865	2	10	04	19q13.31	ETHE1, HSCO, D83198		ETHE1 gene	608451			Ethylmalonic encephalopathy, 602473 (3)	
19.866	4	27	16	19q13.32	EXOC3L2, XTP7		Exocyst complex component 3-like 2	616927				7(Exoc3l2)
19.867	8	24	09	19q13.32	GEMIN7		GEM-associated protein 7	607419				
19.868	7	23	13	19q13.32	IRF2BP1		Interferon regulatory factor 2-binding protein 1	615331				
19.869	3	27	15	19q13.33	LHB, HH23		Luteinizing hormone, beta polypeptide	152780		beta chains of FSH, TSH on 11p, 1p, respectively	Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3)	7(Lhb)
19.870	1	31	18	19q13.32	MYPOP		MYB-related transcription factor, partner of profilin	617861				
19.871	12	19	19	19q13.32	NANOS2, NOS2		NANOS C2HC-type zinc finger 2	608228				
19.872	2	24	15	19q13.32	PPP1R13L, RAI, IASPP, NKIP1		Protein phosphatase 1, regulatory subunit 13-like	607463				7(Ppp1r13l)
19.873	7	24	17	19q13.32	RELB, IREL, IMD53		v-rel avian reticuloendotheliosis viral oncogene homolog B	604758		mutation identified in 1 IMD53 family	?Immunodeficiency 53, 617585 (3)	
19.874	3	15	10	19q13.32	SAE1, SUA1, AOS1		SUMO1-activating enzyme, subunit 1	613294				
19.875	2	1	11	19q13.32	SLC8A2, NCX2		Solute carrier family 8, member 2 (sodium-calcium exchanger 2)	601901				7(Slc8a2)
19.876	11	11	14	19q13.32	SNRPD2		Small nuclear ribonucleoprotein polypeptide D2	601061				
19.877	8	21	12	19q13.32	STRN4, ZIN		Striatin, calmodulin-binding protein 4	614767				
19.878	8	19	13	19q13.33	TPRX1		Tetrapeptide repeat homeobox 1	611166				
19.879	8	19	13	19q13.32	TRAPPC6A		Trafficking protein particle complex, subunit 6A	610396				7(Trappc6a)
19.880	08	09	19	19q13.33	TRPM4, PFHB1B, EKVP6		Transient receptor potential cation channel, subfamily M, member 4	606936			Progressive familial heart block, type IB, 604559 (3); Erythrokeratodermia veriabilis et progressiva 6, 618531 (3)	
19.881	2	21	10	19q13.32	ZNF296, ZFP296, ZNF342		Zinc finger protein 296	613226				7(Znf296)
19.882	1	8	97	19q13.2	MIA		Melanoma inhibitory activity	601340				
19.883	11	05	18	19q13.33	AKT1S1, PRAS40		AKT1 substrate 1, proline-rich	610221				
19.884	6	7	10	19q13.33	ALDH16A1		Aldehyde dehydrogenase 16 family, member A1	613358				
19.885	9	10	14	19q13.33	CABP5, CABP3		Calcium-binding protein 5	607315				
19.886	09	19	18	19q13.33	CCDC155, KASH5		Coiled-coil domain-containing protein 155	618125				
19.887	9	16	12	19q13.33	CGB1		Chorionic gonadotropin, beta polypeptide 1	608823				
19.888	9	16	12	19q13.33	CGB7, CGB6		Chorionic gonadotropin, beta polypeptide 7	608826				
19.889	3	28	15	19q13.33	CPT1C, SPG73		Carnitine palmitoyltransferase IC	608846		mutation identified in 1 SPG73 family	?Spastic paraplegia 73, autosomal dominant, 616282 (3)	
19.890	7	25	16	19q13.41	CTU1, ATPBD3		Cytothiouridylase subunit 1	612694				
19.891	7	2	18	19q13.33	DHDH, HUM2DD		Dimeric dihydrodiol dehydrogenase	606377				
19.892	8	24	09	19q13.33	DKKL1, SGY1, SGY		Dickkopf-like 1	605418				
19.893	6	13	12	19q13.33	ELSPBP1		Epididymal sperm binding protein 1	607443				
19.894	2	25	15	19q13.33	EMC10, C19orf63, HSS1, HSM1		ER membrane protein complex subunit 10	614545				
19.895	9	26	17	19q13.33	FLT3LG, FLG3L		FMS-related tyrosine kinase 3 ligand	600007				
19.896	12	09	19	19q13.33	GFY, GOOFY		Golgi-associated olfactory signaling regulator	618696				7(Gfy)
19.897	7	16	09	19q13.33	HSD17B14, DHRS10, RETSDR3		17-beta-hydroxysteroid dehydrogenase XIV	612832				
19.898	4	10	14	19q13.33	IZUMO1, MGC34799		Izumo sperm-egg fusion protein 1	609278				
19.899	05	28	20	19q13.33	IZUMO2		IZUMO family, member 2	618895				
19.900	7	23	13	19q13.33	JOSD2		Josephin domain-containing protein 2	615324				
19.901	01	04	19	19q13.33	KCNJ14		Potassium inwardly-rectifying channel, subfamily J, member 14	603953				
19.902	11	11	14	19q13.33	KDELR1, ERD2, HDEL		KDEL endoplasmic reticulum protein retention receptor 1	131235				
19.903	10	7	08	19q13.33	LIN7B, VELI2, MALS2		Lin7, C. elegans, homolog of, B	612331				
19.904	8	19	13	19q13.33	MAMSTR, MASTR		MEF2-activating SAP transcriptional regulator	610349				
19.905	6	10	09	19q13.41	MIR125A, MIRN125A		Micro RNA 125A	611191				
19.906	5	19	09	19q13.33	MIR150, MIRN150		Micro RNA 150	611114				
19.907	8	24	09	19q13.33	MYBPC2, MYBPCF		Myosin-binding protein C, fast type	160793				
19.908	12	26	14	19q13.33	MYH14, KIAA2034, DFNA4A, PNMHH		Myosin, heavy chain 14, nonmuscle	608568		mutation identified in 1 PNMHH family	Deafness, autosomal dominant 4A, 600652 (3); ?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)	7(Myh14)
19.909	2	19	04	19q13.33	NAPA, NAP1, SNAPA		Napsin A	605631				
19.910	1	15	16	19q13.33	NOSIP		Nitric oxide synthase-interacting protein	616759				
19.911	8	21	07	19q13.33	NUP62, SNDI, IBSN		Nucleoporin, 62-kD	605815			Striatonigral degeneration, infantile, 271930 (3)	
19.912	10	13	09	19q13.33	PIH1D1, NOP17		PIH1 domain-containing protein 1	611480				
19.913	8	24	09	19q13.33	PLEKHA4, PEPP1		Pleckstrin homology domain-containing protein, family A, member 4	607769				
19.914	8	24	09	19q13.33	PPFIA3, LPNA3		Protein tyrosine phosphatase, receptor type, f polypeptide (liprin-alpha-3)	603144				
19.915	11	17	15	19q13.33	PRR12, KIAA1205		Proline-rich protein 12	616633				
19.916	11	11	14	19q13.33	PRRG2, PRGP2		Proline-rich gamma-carboxyglutamic acid protein 2	604429				
19.917	3	23	18	19q13.33	PTH2, TIP39		Parathyroid hormone 2	608386				
19.918	10	4	05	19q13.33	RASIP1, RAIN		Ras-interacting protein 1	609623				
19.919	09	22	20	19q13.33	RCN3		Reticulocalbin 3	619032				
19.920	5	15	12	19q13.33	SHANK1, SSTRIP		SH3 and multiple ankyrin repeat domains 1	604999				
19.921	5	24	13	19q13.33	SLC6A16, NT5		Solute carrier family 6 (neurotransmitter transporter), member 16	607972				
19.922	3	2	06	19q13.33	SPACA4, SAMP14		Sperm acrosome-associated protein 4	609932				7(Spaca4)
19.923	11	23	15	19q13.33	TBC1D17		TBC1 domain family, member 17	616659				
19.924	8	24	09	19q13.33	ZNF114		Zinc finger protein-114	603996				
19.925	4	6	18	19q13.33	ZNF473, ZFP100, KIAA1141		Zinc finger protein 473	617908				7(Znf473)
19.926	3	23	06	19q13.42	MYADM		Myeloid-associated differentiation marker	609959				
19.927	2	15	01	19q13.41	SIGLEC8, SAF2, SIGLEC8L		Sialic acid-binding immunoglobulin-like lectin 8	605639				
19.928	7	7	09	19q13.42	BRSK1, KIAA1811		BR serine/threonine kinase 1	609235				
19.929	9	16	16	19q13.32	C5AR2, GPF77, C5L2		Complement component 5a receptor 2	609949				
19.930	5	1	02	19q13.42	CACNG6		Calcium channel, voltage-dependent, gamma-6 subunit	606898				
19.931	5	1	02	19q13.42	CACNG7		Calcium channel, voltage-dependent, gamma-7 subunit	606899				
19.932	5	1	02	19q13.42	CACNG8		Calcium channel, voltage-dependent, gamma-8 subunit	606900				
19.933	11	27	19	19q13.42	CNOT3, NOT3, IDDSADF		CCR4-NOT transcription complex, subunit 3	604910			Intellectual developmental disorder with speech delay, autism, and dysmorphic facies, 618672 (3)	
19.934	10	10	18	19q13.42	COX6B2, CT59		Cytochrome c oxidase, subunit 6B2	618127				7(Cox6b2)
19.935	5	9	12	19q13.42	DNAAF3, PF22, DAB1, CILD2		Dynein, axonemal, assembly factor 3	614566			Ciliary dyskinesia, primary, 2, 606763 (3)	
19.936	1	9	13	19q13.42	EPS8L1, EPS8R1		EPS8-like protein 1	614987				7(Eps8l1)
19.937	7	12	92	19q13.42	FCAR		Fc fragment of IgA, receptor for	147045				
19.938	8	24	09	19q13.41	FPR1		Formyl peptide receptor-1	136537				
19.939	8	19	13	19q13.43	GALP, ALARIN		Galanin-like peptide (GALP precursor protein)	611178				
19.940	9	15	11	19q13.42	GP6, GPIV, BDPLT11		Glycoprotein VI, platelet	605546			Bleeding disorder, platelet-type, 11, 614201 (3)	7(Gp6)
19.941	4	23	08	19q13.4	HPC15		Prostate cancer, hereditary, 15	611959		associated with rs2735839	{Prostate cancer, hereditary, 15} (2)	
19.942	3	14	18	19q13.42	LILRA9, ILT11, CD85F, LIR9		Leukocyte immunoglobulin-like receptor, subfamily A, member 5	606047				
19.943	5	12	00	19q13.42	KIR2DL1, NKAT1		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1	604936				
19.944	4	23	03	19q13.42	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1		Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1	604946			{AIDS, delayed/rapid progression to}, 609423 (3)	
19.945	5	12	00	19q13.42	KIR2DL3, NKAT2		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3	604938				
19.946	5	12	00	19q13.42	KIR2DL4, KIR103AS		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4	604945				
19.947	5	12	00	19q13.4	KIR2DS1		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1	604952				
19.948	5	12	00	19q13.42	KIR2DS4, NKAT8		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4	604955				
19.949	5	12	00	19q13.42	KIR3DL2, NKAT4		Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2	604947				
19.950	8	24	09	19q13.4	KIR2DL2, NKAT6		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2	604937				
19.951	4	29	14	19q13.4	KIR2DL5B		Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B	615727				
19.952	8	24	09	19q13.4	KIR2DS2, NKAT5		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2	604953				
19.953	8	24	09	19q13.4	KIR2DS3, NKAT7		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3	604954				
19.954	3	31	15	19q13.4	KIR2DS5, NKAT9, CD158G		Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5	604956				
19.955	8	19	13	19q13.42	KIR3KL3, KIRC1, KIR3DL7, KIR44		Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3	610095				
19.956	9	20	14	19q13.33	KLK1, KLKR		Kallikrein 1	147910		~10cM distal to APOC2	[Kallikrein, decreased urinary activity of], 615953 (3)	7(Kal)
19.957	11	30	06	19q13.33	KLK2		Kallikrein-related peptidase 2	147960		12kb from APS		
19.958	11	30	06	19q13.42	KIR3DP1, CD158C, KIRX, KIR48, KIR2DS6		Killer cell immunoglobulin-like receptor, three domains, pseudogene	610604		functional in some individuals		
19.959	5	12	99	19q13.33	KLK3, APS, PSA		Kallikrein-related peptidase 3	176820		probably with cluster KLK1, KLK2		7(Aps)
19.960	8	4	09	19q13.41	KLK4, EMSP1, PRSS17, AI2A1		Kallikrein-related peptidase 4	603767			Amelogenesis imperfecta, type IIA1, 204700 (3)	
19.961	2	15	01	19q13.41	KLK5, SCTE, KLKL2		Kallikrein-related peptidase 5	605643				
19.962	2	15	01	19q13.41	KLK8, TADG14, PRSS19		Kallikrein-related peptidase 8	605644				
19.963	11	30	06	19q13.41	KLK11, PRSS20, TLSP		Kallikrein-related peptidase 11	604434				
19.964	11	30	06	19q13.41	KLK12, KLKL5		Kallikrein-related peptidase 12	605539				
19.965	11	30	06	19q13.41	KLK13, KLKL4		Kallikrein-related peptidase 13	605505				
19.966	11	30	06	19q13.41	KLK6, PRSS9, ZYME		Kallikrein-related peptidase 6	602652				
19.967	11	30	06	19q13.41	KLK9, KLKL3		Kallikrein-related peptidase 9	605504				
19.968	11	30	06	19q13.41	KLK14		Kallikrein-related peptidase 14	606135				
19.969	11	30	06	19q13.41	KLK10, PRSSL1, NES1		Kallikrein-related peptidase 10	602673				
19.970	11	30	06	19q13.33	KLK15		Kallikrein-related peptidase 15	610601				
19.971	2	21	14	19q13.32	KPTN, 2E4, MRT41		Kaptin	615620			Mental retardation, autosomal recessive 41, 615637 (3)	
19.972	12	15	98	19q13.42	LAIR1		Leukocyte-associated immunoglobulin-like receptor 1	602992				
19.973	8	21	00	19q13.42	LILRA2, LIR7, ILT1		Leukocyte immunoglobulin-like receptor, subfamily A, member 2	604812				
19.974	8	21	00	19q13.42	LILRB1, LIR1, ILT2, MIR7, CD85		Leukocyte immunoglobulin-like receptor, subfamily B, member 1	604811				
19.975	8	21	00	19q13.42	LILRB2, LIR2, ILT4, MIR10		Leukocyte immunoglobulin-like receptor, subfamily B, member 2	604815				
19.976	8	21	00	19q13.42	LILRB3, LIR3, ILT5, HL9		Leukocyte immunoglobulin-like receptor, subfamily B, member 3	604820				
19.977	8	21	00	19q13.42	LILRB4, LIR5, ILT3, HM18		Leukocyte immunoglobulin-like receptor, subfamily B, member 4	604821				
19.978	8	21	00	19q13.4	LILRA3, LIR4, ILT6, HM43		Leukocyte immunoglobulin-like receptor, subfamily A, member 3	604818				
19.979	8	6	13	19q13.41	LIM2, MP19, CTRCT19		Lens intrinsic protein 2, 19kD	154045		same cosmid as ETFB	Cataract 19, multiple types, 615277 (3)	7(Lim2)
19.980	11	22	16	19q13.42	MBOAT7, BB1, LENG4, MRT57		Membrane bound O-acyltransferase domain containing 7	606048			Mental retardation, autosomal recessive 57, 617188 (3)	
19.981	7	7	09	19q13.4	MENOQ2		Menopause, natural, age at, QTL2	612884		associated with rs1172822, rs2384687, rs1551562, rs897798	{Menopause, natural, age at, QTL2} (2)	
19.982	5	16	05	19q13.42	NALP2, PAN1, PYPAF2		NACHT-, leucine-rich repeat-, and PYD-containing 2	609364				
19.983	3	7	06	19q13.43	NALP4, PAN2, PYPAF4		NACHT domain-, leucine-rich repeat-c and PYD-containing protein 4	609645				
19.984	11	14	14	19q13.42	NALP7, NOD12, PYPAF3, HYDM		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 7	609661			Hydatidiform mole, recurrent, 1, 231090 (3)	
19.985	3	7	06	19q13.43	NALP8, NOD16, PAN4		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 8	609659				
19.986	4	17	13	19q13.42	NLRP12, NALP12, PYPAF7, RNO, FCAS2		NLR family, pyrin domain containing 12	609648			Familial cold autoinflammatory syndrome 2, 611762 (3)	
19.987	3	7	06	19q13.42	NALP9, NOD6		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 9	609663				
19.988	3	7	06	19q13.42-q13.43	NALP11, PYPAF7, NOD17		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 11	609664				
19.989	3	7	06	19q13.43	NALP13, NOD14		NACHT domain-, leucine-rich repeat-, and PYD-containing protein 13	609660				
19.990	4	18	02	19q13.42	OSCAR		Osteoclast-associated receptor	606862				7(Oscar)
19.991	8	5	97	19q13.43	PEG3		Paternally expressed gene 3	601483				7(Peg3)
19.992	05	07	20	19q13.33	PNKP, PNK, MCSZ, AOA4, CMT2B2		Polynucleotide kinase 3' phosphatase	605610		mutation identified in 1 CMT2B2 family	Microcephaly, seizures, and developmental delay, 613402 (3); Ataxia-oculomotor apraxia 4, 616267 (3); ?Charcot-Marie-Tooth disease, type 2B2, 605589 (3)	
19.993	5	13	15	19q13.41	PPP2R1A, MRD36		Protein phosphatase 2, structural/regulatory subunit A, alpha	605983			Mental retardation, autosomal dominant 36, 616362 (3)	
19.994	4	23	03	19q13.42	PRKCG, PKCC, PKCG, SCA14		Protein kinase C, gamma polypeptide	176980			Spinocerebellar ataxia 14, 605361 (3)	7(Pkcc)
19.995	09	19	19	19q13.42	PRPF31, PRP31, RP11		Pre-mRNA processing factor 11	606419			Retinitis pigmentosa 11, 600138 (3)	
19.996	4	15	98	19q13.42	PTPRH		Protein tyrosine phosphatase, receptor type, H	602510				
19.997	2	17	09	19q13.42	RFPL4A, RNF210		Ret finger protein-like 4A	612601				7(Rfpl4a)
19.998	08	21	19	19q13.42	TSEN34, PCH2C, LENG5, SEN34		tRNA splicing endonuclease, subunit 34	608754		mutation identified in 1 PCH2C patient	?Pontocerebellar hypoplasia type 2C, 612390 (3)	
19.999	6	19	00	19q13.43	ZNF132		Zinc finger protein-132	604074				
19.1000	6	28	99	19q13.42	RPL28		Ribosomal protein L28	603638				
19.1001	6	28	99	19q13.43	RPS5		Ribosomal protein S5	603630				
19.1002	6	28	99	19q13.42	RPS9		Ribosomal protein S9	603631				
19.1003	2	15	01	19q13.41	SIGLEC9		Sialic acid-binding immunoglobulin-like lectin 9	605640				
19.1004	6	8	09	19q13.41	SIGLEC10		Sialic acid-binding immunoglobulin-like lectin 10	606091				
19.1005	9	21	11	19q13.41	SIGLEC12, SIGLECL1, S2V, SLG		Sialic acid-binding immunoglobulin-like lectin 12	606094				
19.1006	11	16	18	19q13.42	SSC5D		Scavenger receptor cysteine-rich family member with 5 domains	618194				
19.1007	2	11	16	19q13.42	TARM1		T cell-interacting activating receptor on myeloid cells 1	616802				
19.1008	2	20	08	19q13.42	TNNI3, CMH7, CMD2A, RCM1, CMD1FF		Troponin-I, cardiac	191044		mutation identified in 1 CMD2A family	Cardiomyopathy, hypertrophic, 7, 613690 (3); Cardiomyopathy, familial restrictive, 1, 115210 (3); ?Cardiomyopathy, dilated, 2A, 611880 (3); Cardiomyopathy, dilated, 1FF, 613286 (3)	7(Tnni3)
19.1009	8	2	13	19q13.42	TNNT1, ANM, NEM5		Troponin-T1, skeletal, slow	191041			Nemaline myopathy 5, Amish type, 605355 (3)	
19.1010	9	27	17	19q13.43	TRIM28, KAP1, TIF1B		Tripartite motif-containing protein 28	601742				
19.1011	4	4	01	19q13.42	TTYH1		Tweety, Drosophila, homolog of, 1	605784				
19.1012	3	14	03	19q13.43	VN1R1, V1RL1		Vomeronasal 1 receptor 1	605234				
19.1013	2	12	16	19q13.42	VSTM1, SIRL1		V-SET and transmembrane domains-containing protein 1	616804				
19.1014	9	2	10	19q13.43	ZNF71		Zinc finger protein-71 (Cos26)	194545		previously assigned to 22q11.2		
19.1015	6	19	00	19q13.43	ZNF134		Zinc finger protein-134	604076				
19.1016	6	19	00	19q13.43	ZNF135		Zinc finger protein-135	604077				
19.1017	6	19	00	19q13.43	ZNF154		Zinc finger protein-154	604085				
19.1018	10	4	99	19q13.41	ZNF175, OTK18		Zinc finger protein-175	601139				
19.1019	8	24	09	19q13.43	ZNF264		Zinc finger protein-264	604668				
19.1020	5	10	04	19q13.43	ZNF272, HZF8, ZNF460		Zinc finger protein-272	604755				
19.1021	8	24	09	19q13.43	ZNF274		Zinc finger protein-274	605467				
19.1022	5	10	04	19q13.12	ZNF461, GIOT1		Zinc finger protein-461	608640				
19.1023	12	29	06	19q13.42	ZNF628, ZEC		Zinc finger protein 628	610671				
19.1024	8	20	07	19q13.43	ZNF667, MIPU1		Zinc finger protein 667	611024				
19.1025	6	12	97	19q13.43	ZNFC25		Zinc finger protein-C2H2-25	601856				
19.1026	2	11	16	19q13.43	ZFP28		Zinc finger protein 28	616798				
19.1027	4	20	11	19q13.4-qter	AAVS1		Adeno-associated virus integration site-1	102699				
19.1028	04	27	20	19q13.41	IGLON5		IGLON family, member 5	618861				
19.1029	11	25	13	19q13.41	LKL7, PRSS6, SCCE		Kallikrein-related peptidase 7	604438				
19.1030	8	19	13	19q13.41	MIRLET7E, LET7E		Micro RNA Let7e	611250				
19.1031	3	29	12	19q13.41	MIR99B		Micro RNA 99B	614510				
19.1032	4	6	15	19q13.42	MIR371A		Micro RNA 371A	612043				
19.1033	3	23	09	19q13.42	MIR372, MIRN372		Micro RNA 372	612044				
19.1034	3	23	09	19q13.42	MIR373, MIRN373		Micro RNA 373	611954				
19.1035	10	10	18	19q13.41	SIGLEC14		Sialic acid-binding immunoglobulin-like lectin 14	618132				
19.1036	07	10	20	19q13.41	SPACA6		Sperm acrosome-associated protein 6	618945				
19.1037	10	26	17	19q13.41	VSIG10L		V-set and immunoglobulin domains-containing protein 10-like	617740				
19.1038	9	27	17	19q13.41	ZNF350, ZBRK1		Zinc finger protein 350	605422				
19.1039	3	1	16	19q13.41	ZNF468		Zinc finger protein 468	616841				
19.1040	5	16	11	19q13.41	ZNF480		Zinc finger protein 480	613910				
19.1041	12	26	13	19q13.41	ZNF528, KIAA1827		Zinc finger protein 528	615580				
19.1042	3	20	08	19q13.41	ZNF649		Zinc finger protein 649	611903				
19.1043	9	29	10	19q13.42	CCDC106		Coiled-coil domain-containing protein 106	613478				
19.1044	7	14	14	19q13.42	CDC42EP5, CEP5, BORG3		CDC42 effector protein 5	609171				
19.1045	8	19	13	19q13.42	DPRX		Divergent-paired related homeobox	611165		many pseudogenes		
19.1046	7	14	14	19q13.42	FIZ1, FLJ14768		FLT3-interacting zinc finger protein 1	609133				
19.1047	8	17	09	19q13.42	HSPBP1		Heat-shock 70kD protein-binding protein 1	612939				
19.1048	8	17	09	19q13.42	ISOC2		Isochorismatase domain-containing 2	612928				
19.1049	9	28	15	19q13.42	LENG8, KIAA1932		Leukocyte receptor cluster gene 8	616575				
19.1050	12	30	14	19q13.42	LIAR2, CD306		Leukocyte-associated immunoglobulin-like receptor 2	602993				
19.1051	11	11	14	19q13.42	LILRA4, ILT7		Leukocyte immunoglobulin-like receptor, subfamily A, member 4	607517				
19.1052	9	24	11	19q13.42	MIR519D, MIRN519D		Micro RNA 519D	614247				
19.1053	8	18	14	19q13.42	MIR520C		Micro RNA 520C	615908				
19.1054	3	25	15	19q13.42	MIR520G		Micro RNA 520G	616272				
19.1055	9	2	12	19q13.42	MIR520H		Micro RNA 520H	614755				
19.1056	8	24	09	19q13.42	NCR1, LY94, NKP46		Natural cytotoxicity triggering receptor 1 (lymphocyte antigen 94, mouse, homolog of)	604530				
19.1057	5	25	13	19q13.42	NDUFA3		NADH-ubiquinone oxidoreductase subunit A3	603832				
19.1058	3	29	07	19q13.42	SAPS1, PP6R1, KIAA1115		SAPS domain family, member 1	610875				
19.1059	2	2	17	19q13.42	SHISA7		Shisa family, member 7	617328				
19.1060	12	29	09	19q13.42	SUV420H2		Suppressor of variegation 4-20, Drosophila, homolog of, 2	613198				
19.1061	2	1	11	19q13.42	SYT5		Synaptotagmin-5	600782				7(Syt5)
19.1062	11	23	16	19q13.42	TMC4		Transmembrane channel-like protein 4	617181				7(Tmc4)
19.1063	12	22	17	19q13.42	TMEM86B		Transmembrane protein 86B	617806				
19.1064	1	9	17	19q13.42	TMEM150B, DRAM3, TTN2, TMEM224		Transmembrane protein 150B	617291				
19.1065	7	18	14	19q13.42	U2AF2, U2AF65		U2 small nuclear RNA auxiliary factor 2	191318				
19.1066	3	1	07	19q13.42	UBE2S, EPF5, E2EPF		Ubiquitin-conjugating enzyme E2S	610309				
19.1067	3	5	18	19q13.42	ZNF580		Zinc finger protein 580	617888				
19.1068	7	7	16	19q13.43	AURKC, STK13, AIE2, SPGF5		Aurora kinase C	603495			Spermatogenic failure 5, 243060 (3)	
19.1069	8	19	13	19q13.43	DUXA		Double homeobox A	611168		many pseudogenes		
19.1070	10	25	19	19q13.43	MZF1, ZNF42		Myeloid zinc finger 1	194550				
19.1071	8	24	09	19q13.43	SLC27A5, FATP5, VLACSR, VLCSH2		Solute carrier family 27 (fatty acid transporter), member 5	603314				
19.1072	6	13	12	19q13.43	UBE2M, UBC12		Ubiquitin-conjugating enzyme E2M	603173				
19.1073	1	13	11	19q13.43	ZNF8		Zinc finger protein-8	194532		previously assigned to 20q13		
19.1074	3	28	11	19q13.43	ZNF304		Zinc finger protein 304	613840				
19.1075	5	11	17	19q13.43	ZNF324, ZF5128		Zinc finger protein 324	617477				
19.1076	3	28	17	19q13.43	ZNF419		Zinc finger protein 419	617410				
19.1077	8	24	09	19q13.43	ZNF444, EZF2		Zinc finger protein 444	607874				
19.1078	3	8	16	19q13.43	ZNF543		Zinc finger protein 543	616847				
19.1079	1	7	14	19q13.43	ZNF582		Zinc finger protein 582	615600				
19.1080	5	16	11	19q13.43	ZNF606, ZNF328, KIAA1852		Zinc finger protein 606	613905				
19.1081	7	26	10	19q13.43	ZSCAN4, ZNF494		Zinc finger- and SCAN domain-containing protein 4	613419				7(Zscan4)
19.1082	8	24	09	19q13.43	ZSCAN22, HKR2		Zinc finger- and SCAN domain-containing protein 22	165260				
19.1083	6	19	00	Chr.19	ZNF97		Zinc finger protein-97	603979				
20.1	5	13	93	20p12.3	CHGB, SCG1		Chromogranin B (secretogranin B)	118920				2(Scg1)
20.2	10	28	99	20p13	PRND, DPL		Prion gene complex, downstream (doppel)	604263				2(Prnd)
20.3	11	27	13	20p13	PRNP, PRIP, KURU, CJD		Prion protein (p27-30)	176640		pter-PRNP-SCG1-BMP2A-PAX1-cen	Creutzfeldt-Jakob disease, 123400 (3); Gerstmann-Straussler disease, 137440 (3); Insomnia, fatal familial, 600072 (3); Prion disease with protracted course, 606688 (3); Huntington disease-like 1, 603218 (3); {Kuru, susceptibility to}, 245300 (3); Cerebral amyloid angiopathy, PRNP-related, 137440 (3)	2(Prnp)
20.4	10	8	08	20pter-p11.2	BMIQ6		Body mass index quantitative trait locus 6	608559		near D20S482 and D20S851	[Body mass index QTL6] (2)	
20.5	09	26	19	20p13	ADAM33		ADAM metallopeptidase domain 33	607114				
20.6	8	26	09	20p13	ADRA1D, ADRA1A		Adrenergic, alpha-1D-, receptor	104219		incorrectly assigned to 5q		11(Adra1a)
20.7	4	23	04	20p13	ALS7		Amyotrophic lateral sclerosis 7	608031		max lod at D20S103	Amyotrophic lateral sclerosis 7 (2)	
20.8	6	28	99	20p13	ANGPT4, ANG4		Angiopoietin 4	603705		no ANGT3 in human		2(Angpt3)
20.9	9	18	12	20p13	AP5S1, C20orf29		Adaptor-related protein complex 5, sigma-1 subunit	614824				
20.10	8	14	00	20p13	ATRN, MGCA		Attractin (mahogany, mouse, homolog of)	603130				2(Atrn)
20.11	4	25	93	20p13	AVP, AVRP, VP		Arginine vasopressin (neurophysin II, antidiuretic hormone)	192340		distal 20p	Diabetes insipidus, neurohypophyseal, 125700 (3)	2(Avp)
20.12	12	29	06	20p13	C20orf28, CLAMP, SPEF1		Sperm flagellar protein 1	610674				2(Spef1)
20.13	8	5	11	20p13	C20orf194		Chromosome 20 open reading frame 194	614146				
20.14	11	4	93	20p13	CDC25B		Cell division cycle 25B	116949				
20.15	6	15	99	20p12.3	CDS2		CDP-diacylglycerol synthase 2	603549				2(Cds2)
20.16	1	12	95	20p13	CENPB		Centromeric protein B	117140				
20.17	8	10	16	20p13	CSNK2A1, CK2A1, OCNDS		Casein kinase-2, alpha-1 polypeptide	115440		pseudogene on 11p15	Okur-Chung neurodevelopmental syndrome, 617062 (3)	
20.18	1	10	18	20p13	DDRGK1, UFBP1, C20orf116, SEMDSH		DDRGK domain-containing protein 1	616177			Spondyloepimetaphyseal dysplasia, Shohat type, 602557 (3)	
20.19	3	22	06	20p13	EBF4, KIAA1442		Early B-cell factor 4	609935				
20.20	3	23	14	20p13	FAM110A, C20orf55		Family with sequence similarity 110, member A	611393				
20.21	10	5	11	20p13	FASTKD5		Fast kinase domain-containing protein 5	614272				
20.22	4	25	93	20p13	FKBP1A, FKBP12		FK506-binding protein-1A, 12kD	186945				
20.23	11	25	19	20p13	GFRA4		GDNF family receptor alpha-4	618679				2(Gfra4)
20.24	2	18	98	20p13	GNRH2		Gonadotropin-releasing hormone-2	602352				
20.25	1	16	07	20p13	HSPA12B		Heat-shock 70kD protein 12B	610702				2(Hspa12b)
20.26	5	4	12	20p13	IDH3B, RP46		Isocitrate dehydrogenase 3, beta subunit	604526			Retinitis pigmentosa 46, 612572 (3)	
20.27	10	24	18	20p12.3	FERMT1, KIND1, URP1, C20orf42		Fermitin family, member 1	607900			Kindler syndrome, 173650 (3)	
20.28	10	12	09	20p13	MAVS, VISA, IPS1, CARDIF, KIAA1271		Mitochondrial antiviral signaling protein	609676				
20.29	12	21	09	20p13	MIR103-2, MIRN103-2		Micro RNA 103-2	613188				
20.30	8	9	11	20p13	MIR1292, MIRN1292		Micro RNA 1292	614155				
20.31	4	24	08	20p13	MRPS26, MRPS13		Mitochondrial ribosomal protein S26	611988				
20.32	9	6	11	20p13	NOP56, SCA36		Nop56, S. cerevisiae, homolog of	614154			Spinocerebellar ataxia 36, 614153 (3)	
20.33	12	29	06	20p13	NRSN2		Neurensin 2	610666				
20.34	4	25	93	20p13	OXT		Oxytocin-neurophysin I	167050		12kb from ARVP		2(Oxt)
20.35	12	21	10	20p13	PDYN, SCA23		Prodynorphin	131340			Spinocerebellar ataxia 23, 610245 (3)	
20.36	9	28	12	20p12.3	PROKR2, PKR2, GPR73L1, HH3		Prokineticin receptor 2	607123			Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3)	
20.37	7	11	11	20p13	PROSAPIP1, KIAA0552		Proline-rich synapse-associated protein-interacting protein 1	610484				
20.38	1	31	18	20p13	PSMF1, PI31		Proteasome inhibitor subunit 1	617858				
20.39	8	17	92	20p13	PTPRA, PTPA, PTPRL2, LRP		Protein tyrosine phosphatase, receptor type, alpha polypeptide	176884				2(Ptpa)
20.40	2	4	15	20p13	RBCK1, HOIL1, PGBM1, PBMEI		RANBP-type and C3HC4-type zinc finger-containing 1	610924			Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3)	
20.41	8	8	08	20p13	RLS5		Restless legs syndrome, susceptibility to, 5	611242		max lod at D20S849	{Restless legs syndrome 5} (2)	
20.42	09	19	19	20p13	RSPO4, CRISTIN4		R-spondin member 4	610573			Anonychia congenita, 206800 (3)	2(Rspo4)
20.43	2	24	17	20p13	SDCBP2, SITAC, ST2, SITAC18		Syndecan-binding protein 2	617358				
20.44	2	15	06	20p13	SIRPG, SIRPB2		Signal regulatory protein, gamma	605466				
20.45	1	28	16	20p13	SIGLEC1, SN, CD169		Sialic acid-binding immunoglobulin-like lectin 1 (sialoadhesin)	600751				2(Sn)
20.46	3	12	15	20p13	SNRPB, CCMS		Small nuclear ribonucleoprotein polypeptides B and B1	182282			Cerebrocostomandibular syndrome, 117650 (3)	
20.47	8	29	02	20p13	SOX12, SOX22		SRY (sex-determining region Y)-box 12	601947				
20.48	7	13	98	20p13	SHPS1		SHP substrate-1	602461				2(Shps1)
20.49	11	27	18	20p13	SIRPB1		Signal regulatory protein, beta-1	603889				
20.50	1	20	06	20p11.23	SLC24A3, NCKX3		Solute carrier family 24 (sodium/potassium/calcium exchanger), member 3	609839				
20.51	5	10	17	20p13	SLC52A3, C20orf54, RFT2, BVVLS1		Solute carrier family 52, riboflavin transporter, member 3	613350		mutation identified in 1 FZLD family	Brown-Vialetto-Van Laere syndrome 1, 211530 (3); ?Fazio-Londe disease, 211500 (3)	
20.52	7	18	14	20p13	SMOX, SMO, PAO1, C20orf16, PAOH		Spermine oxidase	615854				
20.53	12	7	07	20p13	SNPH		Syntaphilin	604942				
20.54	7	27	17	20p13	SRXN1, SRX		Sulfiredoxin 1	617583				
20.55	5	16	05	20p13	STK35, CLIK1		Serine/threonine kinase 35	609370				
20.56	2	25	14	20p13	TBC1D20, C20orf140, WARBM4		TBC1 domain family, member 20	611663			Warburg micro syndrome 4, 615663 (3)	
20.57	2	18	96	20p13	TCF15		Transcription factor-15 (basic helix-loop-helix)	601010				2(Meso1)
20.58	2	26	02	20p13	TMC2		Transmembrane channel-like protein 2	606707				
20.59	7	11	16	20p13-p12	TMEM230, C20orf30		Transmembrane protein 230	617019				
20.60	3	31	15	20p13	TRIB3, NIPK, SINK, C20orf97, SKIP3		Tribbles pseudokinase 3	607898				
20.61	12	27	19	20p13	VPS16		VPS16 core subunit of CORVET and HOPS complexes	608550				
20.62	02	15	19	20p13	ZCCHC3		Zinc finger CCHC domain-containing protein 3	618326				
20.63	10	5	10	20p12.3	CRLS1, GCD10, C20orf155		Cardiolipin synthase 1	608188				
20.64	3	19	15	20p12.3	MCM8, POF10		Minichromosome maintenance complement component 8	608187		mutation identified in 1 POF10 family	?Premature ovarian failure 10, 612885 (3)	
20.65	3	9	10	20p13	PANK2, NBIA1, PKAN, HARP		Pantothenate kinase 2	606157			Neurodegeneration with brain iron accumulation 1, 234200 (3); HARP syndrome, 607236 (3)	
20.66	7	22	11	20p13	TGM6, TG6, TGY, SCA35		Transglutaminase 6	613900			Spinocerebellar ataxia 35, 613908 (3)	2(Tgm6)
20.67	12	24	08	20p13	RNF24, G1L		Ring finger protein 24	612489				
20.68	3	30	16	20p13	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4		Solute carrier family 4 (sodium borate cotransporter), member 11	610206			Corneal endothelial dystrophy, autosomal recessive, 217700 (3); Corneal endothelial dystrophy and perceptive deafness, 217400 (3); Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	
20.69	8	26	09	20p13	SLC23A2, SVCT2		Solute carrier family 23 (nucleobase transporters), member 2 (sodium-dependent vitamin C transporter 2)	603791				
20.70	1	22	08	20p12.3	BMND7		Bone mineral density QTL 7	611738		most significant association with haplotype C	{Osteoporosis}, 166710 (2)	
20.71	2	23	09	20p12.3	CRCS11		Colorectal cancer, susceptibility to, 11	612592		associated with rs961253	{Colorectal cancer, susceptibility to, 11} (2)	
20.72	04	09	20	20p12.3	GPCPD1, GDE5, KIAA1434		Glycerophosphocholine phosphodiesterase 1	614124				
20.73	6	25	18	20p12.3	SHLD1, RINN3, C20orf196		Shield complex, subunit 1	618028				
20.74	1	21	16	20p12.3	TMX4		Thioredoxin-related transmembrane protein 4	616766				
20.75	9	10	07	20p12.1	SPTLC3, SPTLC2L		Serine palmitoyltransferase, long-chain base subunit 3	611120				
20.76	12	27	13	20p12.2	BTBD3, KIAA0952		BTB/POZ domain-containing protein 3	615566				
20.77	6	1	12	20p12.2	LAMP5, BADLAMP		Lysosome-associated membrane protein 5	614641				
20.78	9	20	14	20p12.2	SLX4IP, C20orf94		SLX4-interacting protein	615958				
20.79	9	11	08	20p12.1	DSTN, ADF		Destrin	609114				
20.80	01	31	20	20p12.1	ESF1, ABTAP		ESF1 nucleolar pre-rRNA-processing protein	618765				
20.81	6	22	14	20p12.1	ISM1, ISM		Isthmin 1, angiogenesis inhibitor	615793				2(Ism1)
20.82	11	02	18	20p12.1	KIF16B		Kinesin family member 16B	618171				
20.83	12	13	18	20p12.1	NDUFAF5, C20orf7, MC1DN16		NADH-ubiquinone oxidoreductase complex assembly factor 5	612360			Mitochondrial complex I deficiency, nuclear type 16, 618238 (3)	
20.84	10	18	11	20p12.1	SEL1L2		Suppressor of Lin12-like 2	614289				
20.85	5	25	13	20p12.1	SNRPB2		Small nuclear ribonucleoprotein polypeptide B-double prime	603520				
20.86	07	28	20	20p12.1	TASP1, C20orf13, SULEHS		Threonine aspartase 1	608270			Suleiman-El-Hattab syndrome, 618950 (3)	
20.87	5	9	17	20p12.1	BFSP1, CP115, CTRCT33		Beaded filament structural protein-1 (filensin)	603307			Cataract 33, multiple types, 611391 (3)	
20.88	2	16	18	20p12.3	BMP2, BMP2A, BDA2, SSFSC		Bone morphogenetic protein-2	112261			{HFE hemochromatosis, modifier of}, 235200 (3); Brachydactyly, type A2, 112600 (3); Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, 617877 (3)	2(Bmp2a)
20.89	8	29	05	20p12	GLC1K, JOAG3		Glaucoma 1K, primary open angle, juvenile-onset	608696		between D20S189 and D20S104	Glaucoma 1K, primary open angle, juvenile-onset (2)	
20.90	2	1	01	20p12.3	HAO1, GOX1		Hydroxyacid oxidase 1	605023				
20.91	5	22	18	20p12.2	JAG1, AGS1, AHD, DCHE		Jagged 1	601920		mutation identified in 1 DCHE family	Alagille syndrome 1, 118450 (3); Tetralogy of Fallot, 187500 (3); ?Deafness, congenital heart defects, and posterior embryotoxon, 617992 (3)	
20.92	2	23	08	20p12.1	MACROD2, C2orf133		Macro domain-containing 2	611567				
20.93	10	16	14	20p12.2	MKKS, HMCS, KMS, MKS, BBS6		McKusick-Kaufman syndrome gene	604896			McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6, 605231 (3)	
20.94	6	28	17	20p12.3	PCNA, ATLD2		Proliferating cell nuclear antigen	176740		pseudogenes on X and 6; mutation identified in one ATLD2 family	?Ataxia-telangiectasia-like disorder 2, 615919 (3)	
20.95	10	23	20	20p12.3	PLCB1, KIAA0581, PLCB1A, PLCB1B, DEE12		Phospholipase C, beta-1	607120			Developmental and epileptic encephalopathy 12, 613722 (3)	
20.96	6	4	12	20p12.3-p12.2	PLCB4, ARCND2		Phospholipase C, beta 4	600810			Auriculocondylar syndrome 2, 614669 (3)	
20.97	5	31	06	20p12	SLEB7		Systemic lupus erythematosus, susceptibility to, 7	610065			{Systemic lupus erythematosus, susceptibility to, 7} (2)	
20.98	8	27	01	20p11.21	NXT1, MTR2		NTF2-related export protein 1	605811				
20.99	5	19	98	20p12.1	RRBP1, ES130		Ribosome binding protein-1	601418				
20.100	1	9	13	20p11.23	LINC00237		Long intergenic noncoding RNA 237	614992				
20.101	5	30	17	20p11.23	KAT14, CRP2BP, CSRP2BP, ATAC2		Lysine acetyltransferase 14	617501				
20.102	5	22	14	20p11.23	KIZ, KIZUNA, C20orf19, RP69		Kizuna centrosomal protein	615757			Retinitis pigmentosa 69, 615780 (3)	
20.103	2	21	13	20p11.23	MGME1, C20orf72, MTDPS11		Mitochondrial genome maintenance exonuclease 1	615076			Mitochondrial DNA depletion syndrome 11, 615084 (3)	
20.104	3	30	16	20p11.23	OVOL2, ZNF339, PPCD1		ovo-like 2	616441			Corneal dystrophy, posterior polymorphous, 1, 122000 (3)	2(Ovol2)
20.105	10	23	20	20p11.23	PET117, MC4DN19		PET117 cytochrome c oxidase chaperone	614771		mutation identified in 1 MC4DN19 family	?Mitochondrial complex IV deficiency, nuclear type 19, 619063 (3)	
20.106	4	26	17	20p11.23	POLR3F, RPC39, RPC6		Polymerase III, RNA, subunit F	617455				
20.107	04	07	20	20p11.23	RALGAPA2, AS250, C20orf74		Ral GTPase-activating protein, catalytic subunit alpha-2	618836				
20.108	12	1	11	20p11.21	ACSS1, ACECS1		Acyl-CoA synthetase short-chain family, member 1	614355				
20.109	12	18	08	20p11.22	AGA3		Alopecia, androgenetic, 3	612421		associated with rs1160312	Alopecia, androgenetic, 3 (2)	
20.110	10	12	09	20p11.23	RIN2, MACS		RAS and RAB interactor 2	610222			Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)	
20.111	5	21	07	20p11.23	CRNKL1, CRN		Crooked neck pre-mRNA splicing factor-like 1	610952				
20.112	4	15	98	20p11.21	CST1		Cystatin SN	123855				
20.113	4	15	98	20p11.21	CST2		Cystatin SA	123856				
20.114	6	26	16	20p11.21	CST3, ARMD11		Cystatin C	604312		proximal to 20p11.2	Cerebral amyloid angiopathy, 105150 (3); {Macular degeneration, age-related, 11}, 611953 (3)	2(Cst3)
20.115	4	15	98	20p11.21	CST4		Cystatin S	123857				
20.116	05	08	20	20p11.21	ABHD12, PHARC		Abhydrolase domain-containing protein 12, lysophospholipase	613599			Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3)	
20.117	8	8	13	20p11.21	C1QR1, CD93, C1QR		Complement component 1, q subcomponent, receptor 1	120577				
20.118	3	31	97	20p11.21	CST5		Cystatin D	123858				
20.119	11	11	14	20p11.21	CST7, CMAP		Cystatin 7	603253				2(Cst7)
20.120	11	28	05	20p11.21	CST11, CST8L		Cystatin 11	609731				
20.121	1	16	18	20p11.21	GINS1, PSF1, KIAA0186, IMD55		GINS complex subunit 1	610608			Immunodeficiency 55, 617827 (3)	
20.122	9	14	17	20p11.21	GZF1, ZNF336, JLSM		GDNF-inducible zinc finger protein 1	613842			Joint laxity, short stature, and myopia, 617662 (3)	2(Gzf1)
20.123	8	19	13	20p11.21	NAPB, SNAPB		N-ethylmaleimide-sensitive factor attachment protein, beta	611270				
20.124	10	25	11	20p11.21	SYNDIG1, TMEM90B		Synapse differentiation-induced gene 1	614311				
20.125	07	17	19	20p11.21	WAKMAR1		Wound- and keratinocyte migration-associated long noncoding RNA 1	618507				
20.126	7	17	14	20p11.21	APMAP, C20orf3, BSCV		Adipocyte plasma membrane-associated protein	615884				
20.127	9	4	15	20p11.21	CST9, CLM		Cystatin 9	616543				
20.128	9	2	15	20p11.21	CST9L		Cystatin 9-like	616536				
20.129	8	9	99	20p11.23	INSM1, IA1		Insulinoma-associated 1	600010				
20.130	02	06	20	20p11.23	NAA20, NAT5, NAT3		N-alpha-acetyltransferase 20, NatB catalytic subunit	610833				
20.131	12	18	19	20p11.22	PAX1, OFC2		Paired box homeotic gene-1	167411			Otofaciocervical syndrome 2, 615560 (3)	2(Pax1)
20.132	5	14	95	20p11.21	SSTR4		Somatostatin receptor-4	182454				2(Sstr4)
20.133	9	29	96	20p12.1	PCSK2, NEC2, PC2		Proprotein convertase subtilisin/kexin type 2	162151				2(Nec2)
20.134	2	20	01	20p11.23	RBBP9, BOG		Retinoma-binding protein 9	602908				2(Rbbp9)
20.135	10	07	19	20p11.23	SEC23B, CDAN2, HEMPAS, CWS7		SEC23 homolog B, coat complex II component	610512		mutation identified in 1 CWS7 family	Dyserythropoietic anemia, congenital, type II, 224100 (3); ?Cowden syndrome 7, 616858 (3)	
20.136	4	30	15	20p12.2	SNAP25, CMS18		Synaptosomal-associated protein, 25kD	600322		mutation identified in 1 CMS18 patient	?Myasthenic syndrome, congenital, 18, 616330 (3)	2(Snap)
20.137	3	1	12	20p11.21	THBD, THRM, AHUS6, THPH12		Thrombomodulin	188040			Thrombophilia due to thrombomodulin defect, 614486 (3); {Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)	2(Thbd)
20.138	08	23	19	20p11.21	VSX1, RINX, KTCN1, CAASDS		Visual system homeobox 1	605020		mutation identified in 1 CAASDS family	Keratoconus 1, 148300 (3); ?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)	
20.139	6	19	00	20p11.23	ZNF133		Zinc finger protein-133	604075				
20.140	4	24	96	20p11.21	PYGB		Phosphorylase, glycogen, brain	138550				2(Pygb)
20.141	8	18	04	20p11.22	XRN2		Exoribonuclease 2	608851				
20.142	11	25	08	20p11.2-q13.12	DYT17		Dystonia-17, primary torsion	612406		between D20S472 and D20S911	Dystonia-17, primary torsion (2)	
20.143	10	9	08	20p11.21	GGTLC1, GGTL6, GGTLA4		Gamma-glutamyltransferase, light chain 1	612338				
20.144	5	22	07	20p11.23	DTD1, C20orf88		D-tyrosyl-tRNA deacylase 1, S. cerevisiae, homolog of	610996				
20.145	6	11	13	20p12.1	FLRT3, HH21		Fibronectin-like domain-containing leucine-rich transmembrane protein-3	604808			Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3)	
20.146	9	18	02	20p11.21	FOXA2, HNF3B		Forkhead box A2 (hepatic nuclear factor-3, beta)	600288				2(Hnf3b)
20.147	07	26	19	20p11.21	LINC00261, FALCOR, HCCDR1, DEANR1		Long intergenic noncoding RNA 261	618518				
20.148	2	16	07	20p11.21	NANP, HDHD4		N-acetylneuraminic acid phosphatase	610763				
20.149	2	11	08	20p11.22	NKX2-2, NKX2B		NK2, homeobox 2	604612				
20.150	2	11	08	20p11.22	NKX2-4, NKX2D		NK2 homeobox 4	607808				2(Nkx2d)
20.151	7	11	01	20p12.1	OTOR		Otoraplin	606067				2(Otor)
20.152	8	26	09	20p11.23	SNX5		Sorting nexin 5	605937				
20.153	10	23	20	20p13	ITPA, DEE35		Inosine triphosphatase-A	147520			[Inosine triphosphatase deficiency], 613850 (3); Developmental and epileptic encephalopathy 35, 616647 (3)	2(Itp)
20.154	4	10	97	20q11.22	MAP1ALC3, MAP1BLC3		Microtubule-associated proteins 1A and 1B, light chain 3	601242				
20.155	2	21	11	20q11.22	AHCY, SAHH		S-adenosylhomocysteine hydrolase	180960		~13cM from ADA	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3)	
20.156	7	25	16	20p	AD8		Alzheimer disease 8	607116		?related to CST3	Alzheimer disease 8 (2)	
20.157	10	12	09	20p	ATOD3		Dermatitis, atopic, 3	605804		max lod at D20S115	{Dermatitis, atopic, susceptibility to, 3} (2)	
20.158	12	11	02	20p13	P47		p47, rat, homolog of	606610				
20.159	1	8	01	20q12	LPIN3		Lipin 3	605520				2(Lpin3)
20.160	4	30	15	20q13.33	OSBPL2, ORP2, KIAA0772, DNFA67		Oxysterol-binding protein-like protein 2	606731			Deafness, autosomal dominant 67, 616340 (3)	
20.161	6	26	01	20q13.12	PKIG		Protein kinase, cAMP-dependent catalytic, inhibitor gamma	604932				
20.162	6	1	12	20q11.21	BPIFA1, PLUNC, SPLUNC1		BPI fold-containing protein, family A, member 1	607412				2(Plunc)
20.163	6	1	12	20q11.21	BPIFB2, BPIL1		BPI fold-containing protein, family B, member 2	614108				
20.164	6	1	12	20q11.21	BPIFB6, BPIL3		BPI fold-containing protein, family B, member 6	614110				
20.165	3	25	03	20q11.21	DEFB118, C20orf63, ESC42		Defensin, beta, 118	607650				
20.166	1	15	96	20q11.21	ID1		Inhibitor of DNA binding 1, dominant negative	600349				
20.167	12	19	01	20q11.22	NCOA6, ASC2, RAP250, NRC, PRIP		Nuclear receptor coactivator 6	605299				
20.168	3	8	07	20q11.21	PDRG1, PDRG, C20orf126		P53 and DNA damage-regulated 1	610789				2(Pdrg1)
20.169	10	23	87	20q11.21	HCK		Hemopoietic cell kinase	142370				
20.170	7	18	06	20q11-q13	HYT5		Hypertension, essential, susceptibility to, 5	610261			{Hypertension, essential, susceptibility to, 5}, 145500 (2)	
20.171	1	19	07	20q11-q13	SCAR6, CLA3		Spinocerebellar ataxia, autosomal recessive 6	608029		between D20S471 and D20S119	Spinocerebellar ataxia, autosomal recessive 6 (2)	
20.172	11	5	14	20q11.21	DEFB119, DEFB120, DEFB20		Defensin, beta, 119	615997				2(Defb19)
20.173	11	5	14	20q11.21	DEFB121, DEFB21		Defensin, beta, 121	616075				2(Defb21)
20.174	11	5	14	20q11.21	DEFB122, DEFB22		Defensin, beta, 122, pseudogene	616077				2(Defb22)
20.175	11	4	15	20q11.21	DEFB123, DEFB23		Defensin, beta, 123	616076				2(Defb23)
20.176	7	20	12	20q11.21	FOXS1, FKHL18, FREAC10		Forkhead box S1	602939				
20.177	8	27	01	20q11.21	MAPRE1, EB1		Microtubule-associated protein, RP/EB family, member 1	603108				
20.178	5	26	13	20q11.22-q11.23	PHF20, GLEA2, HCA58		PHD finger protein 20	610335				
20.179	11	30	11	20q11.22	ASIP, AGTIL, SHEP9		Agouti, mouse, signaling protein	600201			[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3); [Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)	2(a)
20.180	5	11	01	20q11.21	C20orf1, P100		Proliferation-associated nuclear protein, 100kD	605917				
20.181	4	4	05	20q11.21-q11.22	CBFA2T2, MTGR1, EHT		Core-binding factor, runt domain, alpha subunit 2, translocated to, 2 (ETO homolog on chromosome 20)	603672				
20.182	8	26	09	20q11.21	CDK5RAP1		CDK5 regulatory subunit-associated protein 1	608200				
20.183	04	01	19	20q11.22	CEP250, CEP2, CNAP1, CRDHL2		Centrosomal protein, 250kD	609689			Cone-rod dystrophy and hearing loss 2, 618358 (3)	
20.184	9	24	08	20q11.2	CMM7		Melanoma, cutaneous malignant, susceptibility to, 7	612263		between rs910873 and rs1885120	{Melanoma, cutaneous malignant, 7} (2)	
20.185	11	29	99	20q11.21	DNMT3B, ICF1		DNA methyltransferase 3B	602900			Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3)	
20.186	7	1	98	20q11.22	E2F1		E2F transcription factor-1	189971				
20.187	10	3	07	20q11.22	EIF6, EIF3A, ITGB4BP		Eukaryotic translation initiation factor 6	602912				
20.188	9	28	00	20p11.21	ENTPD6, CD39L2		Ectonucleoside triphosphate diphosphohydrolase 6	603160				
20.189	8	20	15	20q11.22	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B, DUPANS		Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1)	601146		mutation identified in 1 AMDHT family	?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3); Brachydactyly, type C, 113100 (3); Chondrodysplasia, Grebe type, 200700 (3); Du Pan syndrome, 228900 (3); Brachydactyly, type A2, 112600 (3); Symphalangism, proximal, 1B, 615298 (3); Multiple synostoses syndrome 2, 610017 (3); {Osteoarthritis-5}, 612400 (3); Brachydactyly, type A1, C, 615072 (3)	2(bp)
20.190	10	9	08	20q11.22	GGT7, GGTL3, GGTL5, GGT4		Gamma-glutamyltransferase 7	612342				
20.191	8	24	98	20q11.23	GHRH, GHRF		Growth hormone releasing hormone (somatocrinin)	139190			?Isolated growth hormone deficiency due to defect in GHRF (1); Gigantism due to GHRF hypersecretion (1)	
20.192	7	1	05	20q11.22	GSS, GSHS		Glutathione synthetase	601002			Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3); Glutathione synthetase deficiency, 266130 (3)	
20.193	5	11	00	20q11.22	MMP25		Matrix metalloproteinase 24	604871				
20.194	11	27	00	20q11.22	PROCR, EPCR, CCCA, CCD41		Protein C receptor	600646				2(Procr)
20.195	5	27	94	20q11.23	RBL1, CP107		Retinoblastoma-like 1 (p107)	116957				2(Rbl1)
20.196	8	18	17	20q11.22	RBM12, KIAA0765, SCZD19		RNA-binding motif protein 12	607179			{Schizophrenia 19, susceptibility to}, 617629 (3)	
20.197	1	4	16	20q11.23	SAMHD1, AGS5, DCIP, CHBL2		SAM domain- and HD domain-containing protein 1	606754		mutation identified in 1 CHBL2 family	Aicardi-Goutieres syndrome 5, 612952 (3); ?Chilblain lupus 2, 614415 (3)	
20.198	9	21	15	20q11.21	SNTA1, SNT1, TACIP1, LQT12		Syntrophin, alpha-1	601017			Long QT syndrome 12, 612955 (3)	2(Snta1)
20.199	11	22	16	20q11.21	SUN5, TSARG4, SPAG4L, SPGF16		Sad1 and Unc84 domain-containing protein 5	613942			Spermatogenic failure 16, 617187 (3)	
20.200	12	8	98	20q11.22	SPAG4		Sperm-associated antigen-4	603038				
20.201	6	27	17	20q11.22	TP53INP2, PIGU, DOR, C20orf110		Tumor protein p53-inducible nuclear protein 2	617549				
20.202	12	2	09	20q11.23	BLCAP, BC10		Bladder cancer-associated protein	613110				
20.203	8	20	08	20q11.23	CTNNBL1, NAP		Catenin, beta-like, 1	611537				2(Ctnnbl1)
20.204	3	5	14	20q11.23	EPB41L1, MRD11		Erythrocyte membrane protein band 4.1-like 1	602879		mutation identified in 1 patient	?Mental retardation, autosomal dominant 11, 614257 (3)	
20.205	3	31	09	20q11.2-q12	MLRL, MTS		Myeloid leukemia-related locus (myeloid tumor suppressor)	601308				
20.206	10	15	98	20q11.23	NNAT		Neuronatin	603106				2(Nnat)
20.207	2	28	03	20q11.23	TGIF2		Transforming growth factor-beta-induced factor 2	607294				
20.208	1	12	95	20q11.23	TGM2		Transglutaminase-2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)	190196				
20.209	03	02	20	20q12	MAFB, KRML, MCTO, DURS3		MAF bZIP transcription factor B	608968			Multicentric carpotarsal osteolysis syndrome, 166300 (3); Duane retraction syndrome 3, 617041 (3)	
20.210	10	12	09	20q13.12	MMP9, CLG4B, MANDP2		Matrix metalloproteinase 9 (gelatinase B, 92kD type IV collagenase)	120361			Metaphyseal anadysplasia 2, 613073 (3)	2(Clg4b)
20.211	02	18	19	20q13.12	ZNF335, NIF1, NIF2, MCPH10		Zinc finger protein 335	610827			Microcephaly 10, primary, autosomal recessive, 615095 (3)	
20.212	01	08	20	20q11.21	ASXL1, KIAA0978, BOPS, MDS		ASXL transcriptional regulator 1	612990			Bohring-Opitz syndrome, 605039 (3); Myelodysplastic syndrome, somatic, 614286 (3)	
20.213	3	17	03	20q11.21	BASE		Breast cancer- and salivary gland-expressed gene	607627				
20.214	3	1	10	20q11.21	BCL2L1, BCLX, BCLXL, BCLXS		BCL2-like 1	600039				
20.215	4	10	14	20q11.21	BPIFBP3, RYA3		BPI fold-containing protein, family B, member 3	615717				2(Bpifbp3)
20.216	4	10	14	20q11.21	BPIFB4, RY2G5		BPI fold-containing protein, family B, member 4	615718				2(Bpifb4)
20.217	12	22	15	20q11.21	COMMD7		COMM domain-containing protein 7	616703				
20.218	5	4	09	20q11.21	COX4I2		Cytochrome c oxidase, subunit IV, isoform 2	607976			Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3)	
20.219	12	23	19	20q11.22	CHMP4B, SNF7, CTPP3, CTRCT31		Charged multivesicular body protein 4B	610897			Cataract 31, multiple types, 605387 (3)	
20.220	1	29	16	20q11.21	DUSP15, VHY		Dual-specificity phosphatase 15	616776				
20.221	8	26	09	20q11.21	HM13, SPP		Minor histocompatibility 13 (signal peptide peptidase)	607106				
20.222	07	16	20	20q11.21	KIF3B, KIAA0359, RP89		Kinesin family member 3B	603754			Retinitis pigmentosa 89, 618955 (3)	
20.223	05	26	20	20q11.21	NOL4L, C20orf112		Nucleolar protein 4-like	618893				
20.224	8	3	12	20q11.21	PLAGL2		Pleomorphic adenoma gene-like 2	604866				
20.225	7	23	13	20q11.21	POFUT1, OFUCT1, KIAA0180, DDD2		Protein O-fucosyltransferase 1	607491			Dowling-Degos disease 2, 615327 (3)	
20.226	6	2	16	20q11.21	REM1, GES		RRAD- and GEM-like GTPase 1	610388				
20.227	10	25	17	20q11.21	TM9SF4, KIAA0255		Transmembrane 9 superfamily, member 4	617727				
20.228	9	19	00	20q11.23	NDRG3		N-myc downstream-regulated gene 3	605273				
20.229	5	13	08	20q11.22	ACSS2, ACS		Acetyl-CoA synthetase short-chain family member 2	605832				
20.230	5	25	13	20q11.22	CPNE1, CPN1		Copine I	604205				
20.231	5	24	13	20q11.22	EDEM2		Endoplasmic reticulum degradation-enhancing alpha-mannosidase-like protein 2	610302				
20.232	01	04	19	20q11.22	EIF2S2		Eukaryotic translation initiation factor 2, subunit 2	603908				
20.233	6	2	16	20q11.22	ERGIC3, C2orf47		Endoplasmic reticulum-golgi intermediate compartment protein 3	616971				
20.234	1	27	11	20q11.22	MIR499, MIRN499		Micro RNA 499	613614				2(Mir499)
20.235	3	1	06	20q11.22	MYH7B, MYH14, KIAA1512		Myosin, heavy chain 7B, cardiac muscle, beta	609928				
20.236	12	17	08	20q11.22	NECAB3, EFCBP3, NIP1, APBA2BP, XB51, STIP3		N-terminal EF-hand calcium-binding protein 3	612478				
20.237	3	5	18	20q11.22	NFS1, NIFS		Nitrogen fixation gene 1	603485				
20.238	05	18	20	20q11.22	PIGU, CDC91L1, GPIBD21, NEDBSS		Phosphatidylinositol glycan anchor biosynthesis class U protein	608528			Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis, 618590 (3)	
20.239	6	2	15	20q11.22	PXMP4, PMP24		Peroxisomal membrane protein 4	616397				
20.240	02	28	20	20q11.22	RALY		RALY heterogeneous nuclear ribonuclear protein	614663				2(Raly)
20.241	10	2	12	20q11.22	RBM39, CAPER, RNPC2		RNA binding motif protein 39	604739				
20.242	05	26	20	20q11.22	ROMO1, GLYRICHIN		Reactive oxygen species modulator 1	618894				
20.243	2	17	09	20q11.22	STQTL14		Stature quantitative trait locus 14	612228		associated with rs6060373	{Stature QTL 14} (2)	
20.244	2	17	09	20q11.22	UQCC, CBP3, BFZB, C20orf44		Ubiquinol-cytochrome C reductase complex chaperone	611797				
20.245	01	16	19	20q11.22	ZNF341, HIES3		Zinc finger protein 341	618269			Hyper-IgE recurrent infection syndrome 3, autosomal recessive, 618282 (3)	
20.246	9	20	14	20q11.22	ITCH, AIP4, NAPP1, ADMFD		Itchy, mouse, homolog of	606409			Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3)	2(Itch)
20.247	2	25	10	20q11.23	PPP1R16B, TIMAP, KIAA0823		Protein phosphatase 1, regulatory subunit 16B	613275				
20.248	11	20	20	20q11.23	AAR2, C20orf4		AAR2 splicing factor	617365				
20.249	2	13	13	20q11.23	ADIG, SMAF1		Adipogenin	611396				2(Smaf1)
20.250	2	4	15	20q11.23	DLGAP4, SAPAP4, KIAA0964		Discs LARGE-associated protein 4	616191		noncoding RNAs transcribed from intron 1 are expressed in all tissues		
20.251	2	2	16	20q11.23	DSN1, C20orf172		DSN1 homolog, MIS12 kinetochore complex component	609175				
20.252	04	15	19	20q11.23	FAM83D, CHICA		Family with sequence similarity 83, member D	618380				
20.253	7	15	16	20q12	LINC01370, HILNC25		Long intergenic noncoding RNA 1370	617038				
20.254	2	21	06	20q11.23	MYL9, MLC2		Myosin light chain 9, regulatory	609905				
20.255	7	14	16	20q11.23	NORAD, LINC00657		Noncoding RNA activated by DNA damage	617037				
20.256	04	02	20	20q11.23	RALGAPB		Ral GTPase-activating protein, noncatalytic subunit beta	618833				
20.257	7	18	12	20q11.23	RPRD1B, CREPT		Regulation of nuclear pre-mRNA domain-containing protein 1B	614694				
20.258	5	24	13	20q11.23	SCAND1, RAZ1, SDP1		SCAN domain-containing 1	610416				
20.259	8	26	09	20q11.23	SLA2, SLAP2		SRC-like adaptor 2	606577				
20.260	6	30	15	20q11.23	SLC32A1, VGAT, VIAAT		Solute carrier family 32 (GABA vesicular transporter), member 1	616440				
20.261	2	2	04	20q11.22	TRPC4AP, TRUSS		TRPC4-associated protein	608430				2(Trpc4ap)
20.262	1	18	12	20q11.23	TTI1, KIAA0406		TELO2-interacting protein 1	614425				
20.263	9	2	15	20q11.23	VSTM2L, C20orf102		V-SET and transmembrane domains-containing protein 2-like	616537				
20.264	12	3	14	20q12	CHD6, CHD5, RIGB		Chromodomain helicase DNA-binding protein 6	616114				
20.265	4	25	93	20q11.23	BPI		Bactericidal/permeability-increasing protein	109195				
20.266	4	25	93	20q11.23	LBP		Lipopolysaccharide-binding protein	151990				
20.267	2	23	17	20q11-q13	MBCS		Mulchandani-Bhoj-Conlin syndrome	617352		maternal uniparental disomy of imprinted region	Mulchandani-Bhoj-Conlin syndrome, 617352 (3)	
20.268	9	18	08	20q13.12	DBNDD2, HSMNP1		Dysbindin domain-containing 2	611453				
20.269	4	11	11	20q13.12	JPH2, JP2, CMH17		Junctophilin 2	605267			Cardiomyopathy, hypertrophic, 17, 613873 (3)	
20.270	04	09	20	20q13.12	L3MBTL1, L3MBTL, KIAA0681		L3MBTL histone methyl-lysine-binding protein 1	608802				
20.271	2	1	00	20q13.12	NCOA3, AIB1, TNRC14		Nuclear receptor coactivator 3 (amplified in breast cancer-1)	601937				
20.272	12	23	16	20p13	TGM3, UHS2		Transglutaminase-3 (E polypeptide, protein-glutamine-gamma-glutamyl transferase)	600238		mutation identified in 1 UHS2 patient	?Uncombable hair syndrome 2, 617251 (3)	
20.273	11	21	02	20q13.12	KCNK15, TASK5		Potassium channel, subfamily K, member 15	607368				
20.274	5	27	94	20q13.12	PI3		Protease inhibitor 3, skin derived (SKALP)	182257				
20.275	12	19	96	20q13.12	SDC4		Syndecan 4 (amphiglycan, ryudocan)	600017				2(Sdc4)
20.276	10	4	05	20q12	ZHX3, KIAA0395		Zinc finger and homeodomain protein-3	609598				
20.277	5	30	16	20q11.23	SRC, ASV, SRC1, THC6		Protooncogene SRC, Rous sarcoma	190090		mutation identified in 1 THC6 family	Colon cancer, advanced, somatic, 114500 (3); ?Thrombocytopenia 6, 616937 (3)	2(Src)
20.278	3	29	99	20q13.12	WISP2		Wnt-1 inducible signaling pathway protein 2	603399				
20.279	10	13	14	20q13.12	HNF4A, TCF14, MODY1, FRTS4		Hepatocyte nuclear factor 4, alpha (transcription factor-14)	600281			MODY, type I, 125850 (3); {Diabetes mellitus, noninsulin-dependent}, 125853 (3); Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3)	2(Hnf4a)
20.280	09	02	20	20q12-q13.1	T2D3		Type 2 diabetes mellitus 3	603694			{Type 2 diabetes mellitus 3} (2)	
20.281	7	12	94	20q12	PLCG1, PLC1		Phospholipase C, gamma 1 (formerly subtype 148)	172420				
20.282	12	17	07	20q13.12	PLTP, HDLCQ9		Phospholipid transfer protein	172425			[High density lipoprotein cholesterol level QTL 9] (3)	2(Pltp)
20.283	12	11	13	20q12-q13	PTPRT, KIAA0283		Protein-tyrosine phosphatase, receptor-type, T	608712				2(Ptprt)
20.284	12	10	91	20q11.23	RPN2		Ribophorin II	180490				2(Rpn2)
20.285	7	13	93	20q13.12	SEMG1, SEMG		Semenogelin	182140				
20.286	7	13	93	20q13.12	SEMG2		Semenogelin II	182141				
20.287	10	23	20	20q13.12	SLC12A5, KCC2, KIAA1176, DEE34, EIG14		Solute carrier family 12, (potassium-chloride transporter) member 5	606726			Developmental and epileptic encephalopathy 34, 616645 (3); {Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3)	5(Slc12a5)
20.288	04	15	19	20q13.12	SLC13A3, NADC3, ARLIAK		Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3	606411			Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, 618384 (3)	
20.289	5	16	11	20q13.12	SPINT3		Serin protease inhibitor, Kunitz-type, 3	613941				
20.290	5	26	05	20q12	TOP1		Topoisomerase (DNA) I	126420		pseudogenes on chr.1 and 22	DNA topoisomerase I, camptothecin-resistant (3)	2(Top1)
20.291	3	22	06	20q13.12	WFDC12, WAP2, SWAM2		Wap 4-disulfide core domain 12	609872				
20.292	5	28	09	20q11.22	DYNLRB1, DNCL2A, DNLC2A		Dynein, light chain, roadblock type, 1	607167				
20.293	6	1	98	20q13.12	TNNC2		Troponin C2, fast	191039				
20.294	5	6	11	20q12-q13.12	PSMNSW		Parasomnia, sleepwalking type	613938		between 55.6 and 61.4 cM	Parasomnia, sleepwalking type (2)	
20.295	7	1	11	20q13.12	CD40, TNFRSF5		CD40 antigen	109535			Immunodeficiency with hyper-IgM, type 3, 606843 (3)	2(Cd40)
20.296	1	12	05	20q13.12	WFDC5, PRG5, WAP1		WAP 4-disulfide core domain 5	605161				
20.297	9	30	10	20q13.33	BHLHE23, BHLHB4		Basic helix-loop-helix family, member E23	609331				2(Bhlhb4)
20.298	6	3	98	20q13.13	CSE1L, CAS		Chromosome segregation-1, yeast, homolog of, like	601342				
20.299	9	10	09	20q13.32	CTSZ		Cathepsin Z	603169				
20.300	10	23	20	20q13.33	EEF1A2, DEE33, MRD38		Eukaryotic translation elongation factor-1, alpha-2	602959			Mental retardation, autosomal dominant 38, 616393 (3); Developmental and epileptic encephalopathy 33, 616409 (3)	2(wst, Eef1a2)
20.301	9	16	16	20q13.12	ELMO2, CED12, VMPI		Engulfment and cell motility gene 2	606421			Vascular malformation, primary intraosseous, 606893 (3)	
20.302	9	7	04	20q13	GEVQ2		Gene expression, variation in, quantitative trait locus on chromosome 20	608878			{Gene expression, variation in, QTL} (2)	
20.303	02	12	19	20q13	HPC3		Prostate cancer, hereditary, 3	608656			{Prostate cancer, susceptibility to, 3} (2)	
20.304	2	12	09	20q13	IBD24		Inflammatory bowel disease 24	612566		associated with rs2315008 and rs4809330	{Inflammatory bowel disease 24} (2)	
20.305	5	21	99	20q13.13	KCNG1, KH2		Potassium voltage-gated channel, subfamily G, member 1	603788				
20.306	11	01	19	20q13.32	NELFCD, TH1L, TH1		Negative elongation factor complex member C/D	605297				
20.307	6	15	99	20q13.33	NTSR1		Neurotensin receptor	162651				2(Ntsr1)
20.308	3	7	13	20q13.31	PMEPA1, TMEPAI		Prostate transmembrane protein, androgen-induced	606564				
20.309	8	24	09	20q13	PSORS12		Psoriasis susceptibility 12	612950		associated with rs495337	{Psoriasis susceptibility 12} (2)	
20.310	12	24	08	20q13.13	RNF114, ZNF313		Ring finger protein 114	612451				
20.311	5	31	06	20q13	SLEB8		Systemic lupus erythematosus, susceptibility to, 8	610066			{Systemic lupus erythematosus, susceptibility to, 8} (2)	
20.312	1	12	99	20q13.33	TNFRSF6B, DCR3		Tumor necrosis factor receptor superfamily, member 6b (decoy receptor 3)	603361				
20.313	3	17	06	20q13.12	ACOT8, PTE1		Acyl-CoA thioesterase 8	608123				2(Acot8)
20.314	3	1	06	20q13.12	CDH22		Cadherin 22	609920				
20.315	9	12	92	20q13.13	CEBPB, TCF5		CCAAT/enhancer-binding protein (C/EBP), beta (transcription factor-5)	189965				2(Cebpb)
20.316	11	23	09	20q13.12	CTSA, PPGB, GSL, NGBE, GLB2		Cathepsin A (protective protein for beta-galactosidase)	613111			Galactosialidosis, 256540 (3)	2(Ppgb)
20.317	09	19	19	20q13.12	EYA2		EYA transcriptional coactivator and phosphatase 2	601654				2(Eya2)
20.318	9	23	96	20q13.12	MYBL2, BMYB		v-myb avian myeloblastosis viral oncogene homolog-like 2	601415				2(Mybl2)
20.319	2	19	15	20q13.12	NCOA5, CIA		Nuclear receptor coactivator 5	616825				
20.320	02	08	19	20q13.12	SLC2A10, GLUT10, ATORS		Solute carrier family 2 (facilitated glucose transporter), member 10	606145			Arterial tortuosity syndrome, 208050 (3)	
20.321	10	22	99	20q13.13	SNAI1		Snail 1, Drosophila, homolog of	604238		pseudogene on 2q34		
20.322	3	31	15	20q13.13	STAU1, STAU		Staufen, Drosophila, homolog of, 1	601716				
20.323	9	28	96	20q13.12	YWHAB		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide	601289				
20.324	11	29	99	20q13.13	B4GALT5		Beta-1,4-galactosyltransferase 5	604016		previously mapped to chr.11		
20.325	2	7	01	20q13.12	MATN4		Matrilin 4	603897				
20.326	1	7	09	20q13.13	PTPN1, PTP1B		Protein tyrosine phosphatase, nonreceptor-type, 1	176885		20pter-q12 by REa	{Insulin resistance, susceptibility to}, 125853 (3)	2(Ptpn1)
20.327	8	26	09	20q13.13	SPATA2, KIAA0757		Spermatogenesis-associated protein 2	607662				
20.328	8	26	09	20q13.31	BMP7		Bone morphogenetic protein-7 (osteogenic protein-1)	112267				2(Bmp7)
20.329	11	21	06	20q13.12	SERINC3, TDE1		Serine incorporator 3	607165				
20.330	5	31	05	20q13.12	ADA		Adenosine deaminase	608958			Severe combined immunodeficiency due to ADA deficiency, 102700 (3); Adenosine deaminase deficiency, partial, 102700 (3)	2(Ada)
20.331	10	14	09	20q13.11	GRD2		Graves disease, susceptibility to, 2	603388			{Graves disease, susceptibility to, 2} (2)	
20.332	12	19	11	20q13.11	SRSF6, SFRS6, SRp55		Splicing factor, serine/arginine-rich, 6	601944				
20.333	12	20	02	20q13.13	PTGIS, CYP8A1, PGIS, CYP8		Prostaglandin I2 synthase	601699			Hypertension, essential, 145500 (3)	
20.334	4	2	16	20q13.12	DNTTIP1, TDIF1, C20orf167		Deoxynucleotidyltransferase, terminal, interacting protein 1	611388				
20.335	10	25	19	20q13.12	FIT2, C20orf142, SIDDIS		Fat-inducing transcript 2	612029			Siddiqi syndrome, 618635 (3)	
20.336	08	12	19	20q13.12	IFT52		Intraflagellar transport 52	617094			Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3)	
20.337	7	20	12	20q13.12	KCNS1, KV9.1		Potassium channel, voltage-gated, delayed-rectifier, subfamily S, member 1	602905				
20.338	10	18	19	20q13.12	PCIF1, CAPAM, PPP1R121, C20orf67		phosphorylated C-terminal domain-interacting factor 1	618626				
20.339	1	21	16	20q13.12	PIGT, NDAP, PNH2, MCAHS3		Phosphatidylinositol glycan, class T	610272		mutation identified in 1 PNH2 family	?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3); Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3)	
20.340	11	24	14	20q13.12	RBPJL, RBPL, SUHL		RBPJ-like protein	616104				
20.341	8	8	13	20q13.12	SLPI, HUSI		Secretory leukocyte protease inhibitor	107285				2(Slpi)
20.342	06	30	20	20q13.12	SPATA25, TSG23, C20orf165		Spermatogenesis-associated protein 25	618936				
20.343	5	19	06	20q13.12	SULF2, KIAA1247		Sulfatase 2	610013				2(Sulf2)
20.344	11	24	20	20q13.12	SYS1		SYS1 golgi trafficking protein	612979				
20.345	09	17	20	20q13.12	TOMM34, TOM34		Translocase of outer mitochondrial membrane 34	616049				
20.346	8	19	13	20q13.12	TOX2, GCX1, C20orf100		TOX high mobility group box family member 2	611163				
20.347	10	31	17	20q13.12	TP53RK, PRPK, GAMOS4		TP53-regulating kinase	608679			Galloway-Mowat syndrome 4, 617730 (3)	
20.348	3	5	18	20q13.12	TP53TG5		TP53 target gene 5	617316				
20.349	10	31	08	20q13.12	UBE2C, UBCH10		Ubiquitin-conjugating enzyme E2C	605574				
20.350	6	27	17	20q13.12	WFDC2, HE4, WAP5		WAP 4-disulfide core domain 2	617548				
20.351	4	10	14	20q13.12	ZMYND8, PRKCBP1		Zinc finger MYND domain-containing protein 8	615713				
20.352	7	17	14	20q13.13	ADNP, ADNP1, KIAA0784, HVDAS, MRD28		Activity-dependent neuroprotector homeobox	611386			Helsmoortel-van der Aa syndrome, 615873 (3)	
20.353	8	17	09	20q13.13	ARFGEF2, BIG2, PVNH2		ADP-ribosylation factor guanine nucleotide-exchange factor 2, brefeldin A-inhibited	605371			Periventricular heterotopia with microcephaly, 608097 (3)	
20.354	11	15	08	20q13.13	BCAS4		Breast carcinoma amplified sequence 4	607471				
20.355	07	15	20	20q13.13	DDX27, RHLP		DEAD-box helicase 27	616621				
20.356	8	25	04	20q13.13	DPM1, MPDS, CDGIE		Dolichyl-phosphate mannosyltransferase 1, catalytic subunit	603503			Congenital disorder of glycosylation, type Ie, 608799 (3)	
20.357	09	15	20	20q13.13	PARD6B		PAR6 family cell polarity regulator beta	608975				
20.358	5	13	02	20q13.13	PREX1, KIAA1415		Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1	606905				
20.359	5	4	09	20q13.13	SLC9A8, NHE8, KIAA0939		Solute carrier family 9 (sodium/hydrogen exchanger), member 8	612730				
20.360	06	26	20	20q13.13	ZNFX1		Zincfinger NFX1-type domain-containing protein 1	618931				
20.361	4	17	07	20q13.2	SALL4, HSAL4		sal-like 4	607343			Duane-radial ray syndrome, 607323 (3); IVIC syndrome, 147750 (3)	
20.362	10	15	98	20q13.2	BCAS1, NABC1		Breast carcinoma amplified sequence	602968				
20.363	1	24	13	20q13.2	CBLN4		Precerebellin 4	615029				
20.364	5	25	13	20q13.2-q13.3	CSTF1		Cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kD	600369				
20.365	2	28	03	20q13.31	CTCFL, BORIS		CCCTC-binding factor-like protein	607022				
20.366	12	13	03	20q13.2	DOK5		Docking protein 5	608334				
20.367	12	27	19	20q13.2	FAM210B, C20orf108		Family with sequence similarity 210, member B	618722				
20.368	9	26	17	20q13.32	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3		GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1)	139320			Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome, somatic, mosaic 174800 (3); Pseudohypoparathyroidism Ic, 612462 (3); Osseous heteroplasia, progressive, 166350 (3); Pseudohypoparathyroidism Ib, 603233 (3); Pituitary adenoma 3, multiple types, somatic, 617686 (3); Pseudopseudohypoparathyroidism, 612463 (3); ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	2(Gnas)
20.369	4	27	12	20q13.32	GNASAS1, GNASAS, SANG, NESPAS		GNAS antisense RNA 1	610540			Pseudohypoparathyroidism, type IB, 603233 (3)	
20.370	10	23	20	20q13.13	KCNB1, DEE26		Potassium voltage-gated channel, Shab-related subfamily, member 1	600397			Developmental and epileptic encephalopathy 26, 616056 (3)	2(Kcnb1)
20.371	04	24	19	20q13.2	MC3R, BMIQ9		Melanocortin-3 receptor	155540			{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3)	2(Mc3r)
20.372	7	9	06	20q13.2	PFDN4, C1		Prefoldin 4	604898				
20.373	8	26	09	20q13.12	SGK2		Serum/glucocorticoid-regulated kinase 2	607589				
20.374	6	13	12	20q13.12	SPINLW1, EPPIN, WAP7		Serine protease inhibitor-like protein with Kunitz and WAP domains 1	609031				2(Spinlw1)
20.375	10	17	12	20q13.12	STK4, MST1, KRS2, TIIAC		Serine/threonine protein kinase 4	604965			T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)	
20.376	1	26	97	20q13.31	TFAP2C		Transcription factor AP-2 gamma (activating enhancer-binding protein 2 gamma)	601602				2(Tfap2c)
20.377	4	6	15	20q13.13	TMEM189, KUA		Transmembrane protein 189	610994				
20.378	7	27	11	20q13.2	TSHZ2		Teashirt zinc finger homeobox 2	614118				
20.379	11	4	98	20q13.13	UBE2V1, UEV1		Ubiquitin-conjugating enzyme E2 variant 1	602995				
20.380	09	07	18	20q13.2	ZFP64, ZNF338		Zinc finger protein 64	618111				
20.381	5	5	99	20q13.2	ZNF217		Zinc finger protein-217	602967				
20.382	4	17	06	20q13.2	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK		Aurora kinase A	603072			{Colon cancer, susceptibility to}, 114500 (3)	
20.383	7	19	04	20q13.33	CHRNA4, ENFL1		Cholinergic receptor, nicotinic, alpha polypeptide-4	118504			Epilepsy, nocturnal frontal lobe, 1, 600513 (3); {Nicotine addiction, susceptibility to}, 188890 (3)	2(Acra4)
20.384	6	2	16	20q13.2	CYP24A1, CYP24, HCINF1		Cytochrome P450, family 24, subfamily A, polypeptide 1 (vitamin D 24-hydroxylase)	126065			Hypercalcemia, infantile, 1, 143880 (3)	2(Cyp24)
20.385	7	19	06	20q13.2-q13.3	DFNB65		Deafness, autosomal recessive 65	610248		max lod at D20S840	Deafness, autosomal recessive 65 (2)	
20.386	1	25	11	20q13.32	EDN3, WS4B, HSCR4		Endothelin-3	131242			Waardenburg syndrome, type 4B, 613265 (3); Central hypoventilation syndrome, congenital, 209880 (3); {Hirschsprung disease, susceptibility to, 4}, 613712 (3)	2(Edn3)
20.387	06	25	20	20q13.2-q13.3	EEGV1, EEGL		Electroencephalographic variant pattern 1	130180			Electroencephalographic variant pattern 1 (2)	
20.388	3	30	18	20q13.33	GATA5, CHTD5		GATA-binding protein 5	611496			Congenital heart defects, multiple types, 5, 617912 (3)	2(Gata5)
20.389	10	19	97	20q13.33	LAMA5		Laminin, alpha-5	601033				2(Lama5)
20.390	2	14	97	20q13.2	NFATC2, NFATP		Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 2	600490				2(Nfatp)
20.391	7	14	00	20q13.31	SPO11		Spo11, S. cerevisiae, homolog of	605114				2(Spo11)
20.392	6	15	99	20q13.33	TPD52L2		Tumor protein D52-like 2	603747				
20.393	10	7	14	20q13.32	ATP5E, MC5DN3		ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	606153		pseudogene on 4q25; mutation identified in 1 MC5DN3 patient	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)	
20.394	3	19	01	20q13.33	BIRC7, MLIAP, KIAP, LIVIN		Baculoviral IAP repeat-containing protein 7	605737				
20.395	7	1	02	20q13.33	CDH4		Cadherin 4	603006				
20.396	6	3	02	20q13.33	COL9A3, EDM3, IDD		Collagen IX, alpha-3 polypeptide	120270			Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3); {Intervertebral disc disease, susceptibility to}, 603932 (3)	
20.397	9	14	95	20q13.33	GPR8		G protein-coupled receptor-8	600731		related sequence on 14		
20.398	12	01	20	20q13.33	KCNQ2, EBN1, DEE7, BFNS1		Potassium voltage-gated channel, KQT-like subfamily, member 2	602235			Seizures, benign neonatal, 1, 121200 (3); Myokymia, 121200 (3); Developmental and epileptic encephalopathy 7, 613720 (3)	
20.399	12	23	05	20q13.33	LIME1, LIME		LCK-interacting transmembrane adaptor 1	609809				
20.400	8	26	09	20q13.32	MIR296, MIRN296		Micro RNA 296	610945				
20.401	12	17	01	20q11.21	MYLK2, MLCK		Myosin light chain kinase 2	606566			Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3)	
20.402	11	1	09	20q13.33	MYT1, PLPB1		Myelin transcription factor 1	600379				2(Myt1)
20.403	8	23	01	20q13.33	PPP1R3D, PPP1R6		Protein phosphatase 1, regulatory subunit 3D	603326				
20.404	7	11	11	20q13.33	PRIC285, PDIP1, KIAA1769		Peroxisomal proliferator-activated receptor alpha-interacting cofactor complex, 285kD subunit	611265				
20.405	3	14	13	20q13.33	PTK6, BRK		Protein-tyrosine kinase 6	602004				
20.406	9	10	09	20q13.32	RAB22A		Ras-associated protein RAB22A	612966				
20.407	11	11	14	20q13.33	RGS19, GAIP		Regulator of G protein signaling 19	605071				2(Rgs19)
20.408	2	23	08	20q13.12	RIMS4		Protein regulating synaptic membrane exocytosis 4	611601				2(Rims4)
20.409	2	7	01	20q13.33	RPS21		Ribosomal protein S21	180477				
20.410	6	1	15	20q13.33	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3		Regulator of telomere elongation helicase 1	608833			Dyskeratosis congenita, autosomal recessive 5, 615190 (3); Dyskeratosis congenita, autosomal dominant 4, 615190 (3); Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	2(Rtel)
20.411	11	3	14	20q13.33	SLC17A9, C20orf59, POROK8		Solute carrier family 17, member 9	612107			Porokeratosis 8, disseminated superficial actinic type, 616063 (3)	
20.412	1	11	07	20q13.33	SS18L1, KIAA0693, CREST		SS18-like gene 1	606472				
20.413	1	27	04	20q13.33	STMN3, SCLIP		Stathmin-like 3	608362				
20.414	5	2	06	20q13.32	VAPB, VAPC, ALS8		Vesicle-associated membrane protein-associated protein B	605704			Amyotrophic lateral sclerosis 8, 608627 (3); Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)	
20.415	05	19	20	20q13.31	CASS4, HEPL, C20orf32		CAS scaffold protein family, member 4	618888				
20.416	12	22	08	20q13.31	RBM38, RNPC1		RNA-binding motif protein 38	612428				
20.417	10	11	17	20q13.31	PCK1, PCKDC		Phosphoenolpyruvate carboxykinase-1 (soluble)	614168		mutation identified in 1 PCKDC family	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3)	2(Pck1)
20.418	11	27	18	20q13.31	RAE1, MRNP41		RNA export 1, S. pombe, homolog of	603343				
20.419	12	2	09	20q13.32	TUBB1		Tubulin, beta-1	612901			Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3)	
20.420	8	23	02	20q13.31	ZBP1, C20orf183, DLM1		Z-DNA binding protein 1 (tumor stroma and activated macrophage protein DLM1)	606750				
20.421	4	20	11	20q13.31-q13.33	MTBS3		Mycobacterium tuberculosis, susceptibility to, 3	612929		associated with rs3827103	{Mycobacterium tuberculosis, susceptibility to, 3} (2)	
20.422	12	10	12	20q13.32	MIR298		Micro RNA 298	614914				
20.423	7	16	12	20q13.32-q13.33	PHACTR3, SCAPININ		Phosphatase and actin regulator 3	608725				
20.424	12	10	08	20q13.32	STX16, SYN16		Syntaxin 16	603666			Pseudohypoparathyroidism, type IB, 603233 (3)	
20.425	1	4	18	20q13.33	ADRM1, ARM1, RPN13		Adhesion-regulating molecule 1	610650				
20.426	1	27	04	20q13.33	ARFGAP1		ADP-ribosylation factor GTPase-activating protein 1	608377				
20.427	2	24	12	20q13.33	ARFRP1, ARP		ADP-ribosylation factor-related protein 1	604699				
20.428	02	10	20	20q13.33	CABLES2, C20orf150		CDK5 and ABL enzyme substrate 3	618772				
20.429	9	22	17	20q13.33	CDH26		Cadherin 26	617685				
20.430	11	4	05	20q13.33	DATF1, DIO1		Death-associated transcription factor 1	604140				
20.431	1	5	12	20q13.33	DNAJC5, DNAJC5A, CSP, CLN4B		DNAJ/HSP40 homolog, subfamily C, member 5	611203			Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)	
20.432	10	11	17	20q13.33	GID8, C20orf11, TWA1		GID complex, subunit 8	611625				
20.433	4	13	10	20q13.33	GLM6		Glioma susceptibility 6	613031		associated with rs6010620	{Glioma susceptibility 6} (2)	
20.434	8	26	09	20q13.33	GMEB2, KIAA1269		Glucocorticoid modulatory element-binding protein 2	607451				
20.435	4	18	07	20q13.33	GTPBP5, OBGH1		GTP-binding protein 5	610919				
20.436	1	6	09	20q13.33	HAR1A, HAR1F		Highly accelerated region gene 1A	610556				
20.437	1	6	09	20q13.33	HAR1B, HAR1R		Highly accelerated region gene 1B	610557				
20.438	3	25	14	20q13.33	HRH3, GPCR97		Histamine receptor H3	604525				
20.439	5	24	13	20q13.33	MIR1-1		Micro RNA 1-1	609326				
20.440	5	24	13	20q13.33	MIR133A2		Micro RNA 133A2	610255				2(Mir133a2)
20.441	8	18	15	20q13.33	MRGBP, C20orf20		MRG/MORF4L-binding protein	611157				
20.442	7	16	09	20q13.33	NKAIN4		Na+/K+ transporting ATPase-interacting 4	612873				2(Nkain4)
20.443	7	2	18	20q13.33	OGFR		Opioid growth factor receptor	606459				
20.444	9	27	17	20q13.33	OPRL1, NOP		Opioid receptor-like 1	602548				
20.445	09	19	19	20q13.33	PRPF6, PRP6, ANT1, TOM, C20orf14		Pre-mRNA processing factor 6	613979			Retinitis pigmentosa 60, 613983 (3)	
20.446	8	26	09	20q13.33	PSMA7		Proteasome subunit, alpha-type, 7	606607				
20.447	12	4	08	20q13.33	SLCO4A1, OATPE, OATP4A1		Solute carrier organic anion transporter family, member 4A1	612436				
20.448	6	2	15	20q13.33	SOX18, HLTS, HLTRS		SOX18, mouse, homolog of	601618			Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3); Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3)	2(Sox18, ragged)
20.449	12	5	17	20q13.33	SRMS, C20orf148		Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites	617797				2(Srms)
20.450	02	28	20	20q13.33	SYCP2, SCP2, SPGF1		Synaptonemal complex protein 2	604105			Spermatogenic failure 1, 258150 (3)	
20.451	8	26	09	20q13.33	TAF4, TAF2C1, TAFII130, TAF2C		TAF4 RNA polymerase II, TATA box-binding protein-associated factor, 135kD	601796				
20.452	3	26	07	20q13.33	UCKL1, UCK1L, URKL1		Uridine/cytidine kinase-like 1	610866				
20.453	8	26	15	20q13.33	YTHDF1		YTH N6-methyladenosine RNA-binding protein 1	616529				
20.454	7	20	12	20q13.33	ZBTB46, BZEL		Zinc finger- and BTB domain-containing protein 46	614639				
20.455	3	5	18	20q13.33	ZNF512B, KIAA1196		Zinc finger protein 512B	617886				
20.456	10	23	87	Chr.20	HTL, LEUT, HLT		Leucine transport, high	151310				
21.1	8	24	09	21p13-q11	AUTS12		Autism, susceptibility to, 12	610838		max lod at D21S1437	{Autism susceptibility 12} (2)	
21.2	4	26	90	21p12	RNR4		Ribosomal RNA-4	180453				
21.3	11	16	17	21p11.2	BAGE1, BAGE		BAGE family, member 1	605167		previously assigned to chr.13		
21.4	11	16	17	21p11.2	BAGE2		BAGE family, member 2	617776				
21.5	11	16	17	21p11.2	BAGE3		BAGE family, member 3	617777				
21.6	04	13	20	21p11.2	TPTE		Transmembrane phosphatase with tensin homology	604336				
21.7	01	10	19	21q11.2-q21.1	NRIP1, RIP140, CAKUT3		Nuclear receptor interacting protein 1 (receptor interacting protein 140)	602490		mutation identified in 1 CAKUT3 family	?Congenital anomalies of kidney and urinary tract 3, 618270 (3)	
21.8	3	5	96	21q11.2	STCH		Stress 70 protein chaperone, microsome-associated, p60	601100				
21.9	9	16	12	21q11.2	ABCC13		ATP-binding cassette, subfamily C, member 13	608835				
21.10	10	27	99	21q21.1	CXADR, CAR		Coxsackie virus and adenovirus receptor	602621		pseudogenes on chr.15 and chr.18		
21.11	06	25	19	21q11.2	LIPI, LPDL, PRED5		Lipase I	609252				16(Lipi)
21.12	12	15	04	21q11.2	NRCLP3		Narcolepsy 3	609039		max lod at D21S1245	Narcolepsy 3 (2)	
21.13	6	7	10	21q11.2	POTED, ANKRD21, POTE		POTE ankyrin domain family, member D	607549				
21.14	4	12	18	21q11.2	RBM11		RNA-binding motif protein 11	617937				
21.15	7	24	03	21q11.2	SAMSN1, HACS1		SAM domain, SH3 domain, and nuclear localization signals 1	607978				
21.16	3	26	96	21q11.2	TAM, MST		Myeloproliferative syndrome, transient (transient abnormal myelopoiesis)	159595			Leukemia, transient, of Down syndrome (2)	
21.17	3	5	08	21q21.3	MRPL39, MRPL5		Mitochondrial ribosomal protein L39	611845				
21.18	2	27	01	21q21.1	BTG3, ANA, TOB5		B-cell translocation gene 3	605674				
21.19	4	17	12	21q21.3	APP, AAA, CVAP, AD1		Amyloid beta (A4) precursor protein	104760		proximal to SOD; very distal q21 or boundary with q22	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3); Alzheimer disease 1, familial, 104300 (3)	16(App)
21.20	4	1	15	21q21.1	CHODL		Chondrolectin	607247				
21.21	11	6	00	21q21.1	NCAM2		Cell adhesion molecule, neural, 2	602040				
21.22	10	04	18	21q21.1	TMPRSS15, PRSS7, ENTK		Transmembrane protease, serine 15	606635			Enterokinase deficiency, 226200 (3)	
21.23	6	13	07	21q21.3	TAK1L, C21orf7		TAK1-like	611110				
21.24	5	29	98	21q21	USH1E		Usher syndrome-1E, autosomal recessive, severe	602097			Usher syndrome, type 1E (2)	
21.25	09	26	19	21q21.3	ADAMTS5, ADAMTS11		ADAM metallopeptidase domain with thrombospondin type 1 motif, 5 (aggrecanase 2)	605007				16(Adamts5)
21.26	10	17	95	21q21.3	GABPA, E4TF1A		GA-binding protein transcription factor, alpha subunit, 60kD	600609				
21.27	12	6	16	21q21.1	MIR99A		Micro RNA 99A	614509				
21.28	9	20	14	21q21.1	MIR99AHG, MONC, LINC00478		MIR99A-LET7C cluster host gene, noncoding	615964				
21.29	3	23	09	21q21.1	MIR125B2, MIRN125B2		Micro RNA 125B-2	610105				
21.30	3	23	09	21q21.1	MIRLET7C, MIRNLET7C, LET7C		Micro RNA Let7c	612144				
21.31	09	26	19	21q21.3	ADAMTS1, METH1		ADAM metallopeptidase domain with thrombospondin type 1 motif, 1	605174				
21.32	03	28	20	21q21.3	JAM2, VEJAM, IBGC8		Junctional adhesion molecule 2	606870			Basal ganglia calcification, idiopathic, 8, autosomal recessive, 618824 (3)	
21.33	07	17	20	21q21.3	ATP5PF, ATP5J, ATP5		ATP synthase peripheral stalk, subunit F6	603152				9(Atp5j)
21.34	11	29	17	21q21.3	CCT8, KIAA0002		Chaperonin containing T-complex polypeptide 1, subunit 8	617786				
21.35	6	27	16	21q21.3	CLDN17		Claudin 17	617005				
21.36	10	12	14	21q21.3	CYYR1		Cysteine/tyrosine-rich protein 1	616020				16(Cyyr1)
21.37	10	12	14	21q21.3	CYYR1AS1, CYYR1-AS1		CYRR1 antisense RNA 1	616021				
21.38	3	23	09	21q21.3	MIR155, BIC, MIRN155		Micro RNA 155	609337				
21.39	4	2	12	21q21.3	N6AMT1		N6 adenine-specific DNA methyltransferase 1, putative	614553				
21.40	12	10	13	21q21.3	USP16, UBPM		Ubiquitin-specific protease 16	604735				
21.41	4	24	08	21q22.11	MRPS6		Mitochondrial ribosomal protein S6	611973				
21.42	5	28	13	21q22.3	FAM3B		Family with sequence similarity 3, member B	608617				16(Fam3b)
21.43	8	20	08	21q22	FEB7		Febrile seizures, familial, 7	611515		max lod at D21S1910	Febrile seizures, familial, 7 (2)	
21.44	3	1	94	21q21.3	GRIK1, GLUR5		Glutamate receptor, ionotropic, kainate 1	138245				16(Glur5)
21.45	12	27	01	21q22.11	HUNK		Hormonally upregulated NEU-associated kinase	606532				16(Hunk)
21.46	9	28	11	21q22.3	RRP1B, KIAA0179, NNP1L		Ribosomal RNA-processing protein 1, S. cerevisiae, homolog of, B	610654				
21.47	3	27	95	21q22.11	SLC5A3		Solute carrier family 5 (inositol transporter), member 3	600444		?role in Down syndrome		
21.48	6	24	05	21q22	TUKLS		Tukel syndrome	609428		max lod at D21S1259	Tukel syndrome (2)	
21.49	11	28	01	21q21.3	BACH1		BTB and CNC homology 1	602751				
21.50	1	12	11	21q22.11	CRFB4, IBD25		Cytokine receptor, family II, member 4	123889		35kb distal to IFNAR; D21S58	{Hepatitis B virus, susceptibility to}, 610424 (3); Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3)	16(Crfb4)
21.51	6	18	99	21q22.11	CRYZL1		Crystallin, zeta-like 1	603920				
21.52	8	4	17	21q22.11	DONSON, C21orf60, MISSLA, MIMIS		Downstream neighbor of SON	611428			Microcephaly-micromelia syndrome, 251230 (3); Microcephaly, short stature, and limb abnormalities, 617604 (3)	
21.53	11	29	11	21q22.13	DYRK1A, MNBH, MNB, MRD7		Dual specificity tyrosine-(Y)-phosphorylation regulated kinase-1A (\'minibrain\', Drosophila, homolog of)	600855		?triplicate state responsible for mental defect in Down syndrome	Mental retardation, autosomal dominant 7, 614104 (3)	16(mmb)
21.54	6	3	94	21q22.11	GART, PRGS, PGFT		Phosphoribosylglycinamide formyltransferase (phosphoribosylglycinamide synthetase; phosphoribosylaminoimidazole synthetase)	138440		multifunctional protein: Ade(-)C, Ade(-)G, GART		16(Prgs)
21.55	2	20	03	21q22.13	HLCS, HCS		Holocarboxylase synthetase	609018			Holocarboxylase synthetase deficiency, 253270 (3)	16(Hlcs)
21.56	8	24	98	21q22.11	IFNAR1		Interferon, alpha, beta and omega, receptor 1	107450				16(Ifrc)
21.57	12	2	15	21q22.11	IFNAR2, IMD45		Interferon, alpha, beta, and omega, receptor 2	602376		mutation identified in 1 IMD45 family	{Hepatitis B virus, susceptibility to}, 610424 (3); ?Immunodeficiency 45, 616669 (3)	
21.58	1	14	11	21q22.11	KCNE2, MIRP1, LQT6, ATFB4		Potassium voltage-gated channel, Isk-related family, member 2	603796			Long QT syndrome 6, 613693 (3); Atrial fibrillation, familial, 4, 611493 (3)	
21.59	3	30	15	21q22.13	KCNJ6, GIRK2, KCNJ7, KPLBS		Potassium inwardly-rectifying channel, subfamily J, member 6	600877			Keppen-Lubinsky syndrome, 614098 (3)	16(Kcnj6)
21.60	06	26	20	21q22.11	KRTAP24-1		Keratin-associated protein 24-1	618927				
21.61	2	10	05	21q22.11	MRAP, FALP, C21orf61, GCCD2, FGD2		Melanocortin 2 receptor accessory protein	609196			Glucocorticoid deficiency 2, 607398 (3)	
21.62	1	23	18	21q21.3	RWDD2B, C21orf6		RWD domain-containing protein 2B	617843				
21.63	09	26	19	21q22.11	SOD1, ALS1, STAHP		Superoxide dismutase-1, soluble	147450		mid q22.1	Amyotrophic lateral sclerosis 1, 105400 (3); Spastic tetraplegia and axial hypotonia, progressive, 618598 (3)	16(Sod1)
21.64	1	27	04	21q22.11	TCP10L		T-complex protein 10-like	608365				
21.65	2	15	96	21q22.11	TIAM1		T-cell lymphoma invasion and metastasis 1	600687				16(Tiam1)
21.66	9	16	12	21q22.11	URB1, NPA1, C21orf108, KIAA0539		URB1 ribosome biogenesis 1 homolog (S. cerevisiae)	608865				
21.67	12	13	95	21q22.11	ATP5O		ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein)	600828				
21.68	9	8	14	21q22.11	IFNGR2, IFNGT1, IFGR2, IMD28		Interferon gamma receptor-2 (interferon gamma transducer 1)	147569			Immunodeficiency 28, mycobacteriosis, 614889 (3)	16(Ifgr2)
21.69	11	19	98	21q22.11	ITSN1, SH3D1A, SH3P17		Intersectin 1 (SH3 domain protein-1A)	602442				
21.70	1	14	11	21q22.12	KCNE1, JLNS, LQT5, JLNS2		Potassium voltage-gated channel, Isk-related subfamily, member 1	176261			Jervell and Lange-Nielsen syndrome 2, 612347 (3); Long QT syndrome 5, 613695 (3)	
21.71	11	05	20	21q22.13	PIGP, DSCR5, DEE55		Phosphatidylinositol glycan, class P	605938			Developmental and epileptic encephalopathy 55, 617599 (3)	16(Dscr5)
21.72	9	24	08	21q22.12	RCAN1, DSCR1, MCIP1, CSP1		Regulator of calcineurin 1	602917				16(Rcan1)
21.73	11	23	16	21q22.11	SON, TOKIMS		SON DNA-binding protein	182465			ZTTK syndrome, 617140 (3)	
21.74	08	04	20	21q22.11	CFAP298, C21orf59, CILD26		Cilia- and flagella-associated protein 298	615494			Ciliary dyskinesia, primary, 26, 615500 (3)	
21.75	5	26	13	21q22.11	CLDN8		Claudin 8	611231				
21.76	12	21	09	21q22.11	KRTAP11-1, HACL1		Keratin-associated protein 11-1	600064				16(Krtap11-1)
21.77	11	13	13	21q22.11	KRTAP13-1		Keratin-associated protein 13-1	608718				
21.78	9	29	10	21q21.3	LTN1, RNF160, KIAA0714		Listerin E3 ubiquitin protein ligase 1	613083				16(Rnf160)
21.79	10	09	18	21q22.11	MIS18A		Mis18 kinetochore protein A	618137				
21.80	9	20	14	21q22.11	OLIG1		Oligodendrocyte lineage transcription factor 1	606385				
21.81	3	11	08	21q22.11	OLIG2, PRKCBP2		Oligodendrocyte lineage transcription factor 2	606386				
21.82	8	28	17	21q22.11	PAXBP1, GCFC1, C21orf66		PAX3- and PAX7-binding protein 1	617621				
21.83	9	30	14	21q22.11	SCAF4, KIAA1172		SR-related C-terminal domain-associated factor 4	616023				
21.84	3	1	18	21q22.11	TMEM50B, C21orf4		Transmembrane protein 50B	617894				
21.85	8	24	98	21q22.12	CBR1		Carbonyl reductase 1	114830				16(Cbr1)
21.86	7	22	13	21q22.12	CLIC6, CLIC1L		Chloride intracellular channel 6	615321				
21.87	11	24	14	21q22.12	MIR802		Micro RNA 802	616090				
21.88	3	24	14	21q22.12	MORC3, NXP2		MORC family CW-type zinc finger 3	610078				
21.89	10	11	05	21q22.13	MAFD3, BPEO		Major affective disorder 3	609633		max lod at D21S1252	{Major affective disorder 3, early onset} (2)	
21.90	3	22	06	21q22.13-qter	BMND6		Bone mineral density QTL 6	609876		max lod at D21S1446	[Bone mineral density QTL 6] (2)	
21.91	9	12	96	21q22.12-q22.13	CAF1A		Chromatin assembly factor I, p60 subunit	601245				
21.92	2	6	01	21q22.12	CBR3		Carbonyl reductase 3	603608				
21.93	05	05	20	21q22.12	DOP1B, DOPEY2, 21orf5, KIAA0933		DOP1 leucine zipper-like protein B	604803				
21.94	07	10	20	21q22.2	DSCAM		DS cell adhesion molecule	602523				
21.95	5	11	00	21q22.13	DSCR4, DSCRB		Down syndrome critical region gene 4	604829				
21.96	6	7	10	21q22.13	DSCR8, MMA1		Down syndrome critical region gene 8	613396				
21.97	11	08	18	21q22.2	IGSF5, JAM4		Immunoglobulin superfamily, member 5	610638				
21.98	3	20	98	21q22.1-q22.2	KCNJ15		Potassium inwardly-rectifying channel, subfamily J, member 15	602106				
21.99	07	10	20	21q22.13	RIPPLY3, DSCR6		Ripply transcriptional repressor 3	609892				
21.100	7	31	97	21q22.13	SIM2		Single-minded, Drosophila, homolog of, 2	600892				
21.101	11	05	20	21q22.11	SYNJ1, PARK20, DEE53		Synaptojanin 1	604297			Parkinson disease 20, early-onset, 615530 (3); Developmental and epileptic encephalopathy 53, 617389 (3)	16(Synj1)
21.102	1	13	99	21q22.13	TTC3, TPRD		Tetratricopeptide repeat domain 3	602259				
21.103	07	10	20	21q22.13	VPS26C, DSCR3, DSCRA		VPS26 endosomal protein sorting factor C	605298				
21.104	12	22	17	21q22.2	BRWD1, WRD9, C21orf107		Bromodomain and WD repeat domain-containing protein 1	617824				16(Brwd1)
21.105	1	15	08	21q22.2	C21orf24		Chromosome 21 open reading frame 24	611723				
21.106	3	28	90	21q22.3	S100B		S100 calcium-binding protein, beta (neural)	176990				10(S100b)
21.107	10	29	99	21q22.3	ABCG1, ABC8, WHITE1		ATP-binding cassette, subfamily G, member 1 (white, Drosophila, homolog of)	603076				17(Abc8)
21.108	04	30	20	21q22.3	ADARB1, RED1, NEDHYMS		Adenosine deaminase, RNA-specific, B1 (RED1, rat, homolog of)	601218			Neurodevelopmental disorder with hypotonia, microcephaly, and seizures, 618862 (3)	
21.109	9	2	12	21q22.3	AGPAT3, LPAAT3		1-acylglycerol-3-phosphate O-acyltransferase 3	614794				
21.110	3	11	09	21q22.3	AIRE, APECED, APS1		Autoimmune regulator	607358			Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)	
21.111	5	23	00	21q22.2	B3GALT5, GLCT5		UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5	604066				
21.112	2	20	01	21q22.2-q22.3	BACE2, ALP56, DRAP		Beta-site amyloid beta A4 precursor protein-cleaving enzyme 2 (Down syndrome region aspartic protease)	605668				
21.113	8	2	17	21q22.3	C2CD2, TMEM24L, C21orf25		C2 calcium-dependent domain-containing protein 2	617581				
21.114	12	19	08	21q22.3	C21orf56		Chromosome 21 open reading frame 56	612412				
21.115	6	7	10	21q22.3	CBS		Cystathionine beta-synthase	613381		subtelomeric	Homocystinuria, B6-responsive and nonresponsive types, 236200 (3); Thrombosis, hyperhomocysteinemic, 236200 (3)	17(Cbs)
21.116	7	19	18	21q22.3	CFAP410, C21orf2, SMDAX, RDMS		Cilia and flagella-associated protein 410	603191			Spondylometaphyseal dysplasia, axial, 602271 (3); Retinal dystrophy with macular staphyloma, 617547 (3)	
21.117	7	1	11	21q22.13	CLDN14, DFNB29		Claudin 14	605608			Deafness, autosomal recessive 29, 614035 (3)	
21.118	7	20	15	21q22.3	COL6A1, BTHLM1, UCHMD1		Collagen VI, alpha-1 polypeptide	120220			Bethlem myopathy 1, 158810 (3); Ullrich congenital muscular dystrophy 1, 254090 (3)	10(Col6a1)
21.119	7	20	15	21q22.3	COL6A2, BTHLM1, UCMD1		Collagen VI, alpha-2 polypeptide	120240		mutation identified in 1 MYSCL family	Bethlem myopathy 1, 158810 (3); Ullrich congenital muscular dystrophy 1, 254090 (3); ?Myosclerosis, congenital, 255600 (3)	10(Col6a2)
21.120	05	11	20	21q22.3	COL18A1, KNO1, GLCC		Collagen XVIII, alpha-1 polypeptide	120328			Knobloch syndrome, type 1, 267750 (3); Glaucoma, primary closed-angle, 618880 (3)	10(Col18a1)
21.121	5	24	13	21q22.3	CRYAA, CRYA1, CTRCT9		Crystallin, alpha A	123580			Cataract 9, multiple types, 604219 (3)	17(Crya1)
21.122	12	7	11	21q22.3	CSTB, STFB, EPM1, PME, EPM1A, ULD		Cystatin B (stefin B)	601145			Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	
21.123	9	16	96	21q22.3	DCR, DSCR		Down syndrome chromosome region	190685		many genes are involved in this phenotype	Down syndrome (4)	
21.124	09	18	19	21q22.3	DIP2A, KIAA0184		Disco-interacting protein 2 homolog A	607711		previously mapped to Chr.2		10(Dip2)
21.125	1	7	02	21q22.3	DNMT3L		DNA methyltransferase 3-like protein	606588				
21.126	10	15	94	21q22.2	ERG		Erythroblastosis virus E26, avian, (v-ets) oncogene related	165080		fused with EWS in Ewing sarcoma, with FUS in leukemia		
21.127	3	18	91	21q22.2	ETS2		Oncogene ETS-2	164740		proximal q22.3		16(Ets2)
21.128	8	22	03	21q22.3	FTCD		Formiminotransferase cyclodeminase	606806			Glutamate formiminotransferase deficiency, 229100 (3)	10(Ftcd)
21.129	09	06	18	21q22.3	GATD3A, ES1, HES1, GT335, C21orf33		Glutamine amidotransferase-like class 1 domain-containing protein 3A	601659				
21.130	8	28	02	21q22.2	HMGN1, HMG14		High-mobility group nucleosomal binding protein 1	163920				
21.131	4	9	96	21q22.3	HPE1		Holoprosencephaly-1, alobar	236100			Holoprosencephaly 1 (2)	
21.132	10	19	97	21q22.3	HRMT1L1, PRMT2		HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 1	601961				
21.133	2	6	01	21q22.3	HSF2BP		Heat-shock transcription factor 2-binding protein	604554				
21.134	8	25	09	21q22.3	ICOSLG, B7H2, GL50, B7RP1		Inducible T-cell co-stimulator ligand	605717				
21.135	7	11	16	21q22.3	LINC00163, NCRNA00163, NLC1A		Long intergenic nonprotein coding RNA 163	610259				
21.136	10	08	18	21q22.3	MCM3AP, MAP80, GANP, PNRIID		Minichromosome maintenance 3-associated protein, 80-kD	603294			Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development, 618124 (3)	
21.137	07	24	19	21q22.3	PDXK, PNK, PKH, HMSN6C		Pyridoxal kinase	179020			Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy, 618511 (3)	
21.138	5	24	13	21q22.3	POFUT2, C21Orf80, KIAA0958		Protein O-fucosyltransferase 2	610249				
21.139	1	23	96	21q22.3	ITGB2, CD18, LCAMB, LAD		Integrin, beta-2 (antigen CD18 (p95), lymphocyte function-associated antigen-1; macrophage antigen, beta polypeptide)	600065		common subunit for CR3, LFA1, and P150,95	Leukocyte adhesion deficiency, 116920 (3)	7(Ly15)
21.140	8	11	17	21q22.3	LRRC3, C21orf102, C21orf30		Leucine-rich repeat-containing protein 3	617620				
21.141	04	07	20	21q22.3	LSS, OSC, CTRCT44, HYPT14, APMR4		Lanosterol synthase	600909			Cataract 44, 616509 (3); Hypotrichosis 14, 618275 (3); Alopecia-mental retardation syndrome 4, 618840 (3)	
21.142	11	27	19	21q22.3	MX1, MX, IFI78		MX dynamin-like GTPase 1	147150				16(Mx1)
21.143	11	27	19	21q22.3	MX2		MX dynamin-like GTPase 2	147890				16(Mx2)
21.144	8	20	98	21q22.3	NDUFV3		NADH-ubiquinone oxidoreductase subunit V3	602184				
21.145	3	16	05	21q22.3	PCBP3		Poly(rC)-binding protein 3	608502				10(Pcbp3)
21.146	11	11	10	21q22.3	PCNT, PCNT2, KEN, SCKL4, MOPD2		Pericentrin	605925			Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	
21.147	8	15	97	21q22.2	PCP4		Purkinje cell protein 4	601629				16(Pcp4)
21.148	6	18	99	21q22.3	PDE9A, HSPDE9A2		Phosphodiesterase 9A	602973				
21.149	3	18	91	21q22.3	PFKL		Phosphofructokinase, liver type	171860			Hemolytic anemia due to phosphofructokinase deficiency (1)	17(Pfkl)
21.150	11	23	16	21q22.3	PICSAR, LINC00162, NLC1C		p38-inhibited cutaneous squamous cell carcinoma-associated long intergenic noncoding RNA	617191				
21.151	6	18	99	21q22.3	PKNOX1		PBX/knotted 1 homeo box 1	602100				17(Pknox1)
21.152	2	24	11	21q22.2	PLAC4		Placenta-specific gene 4	613770				
21.153	9	18	17	21q22.3	PRDM15, ZNF298		PR domain-containing protein 15	617692				
21.154	9	24	08	21q22.2	PSMG1, DSCR2, C21LRP		Proteasome (prosome, macropain) assembly chaperone 1	605296				
21.155	8	8	00	21q22.3	PTTG1IP, C21orf1, C21orf3, PBF		Pituitary tumor-transforming gene 1 protein-interacting protein	603784				
21.156	09	27	20	21q22.3	PWP2H, PWP2		PWP2 small subunit processome component	601475				
21.157	10	14	18	21q22.3	RIPK4, NKRD3, DIK, PPS2, CHANDS		Receptor-interacting serine-threonine kinase 4	605706			Popliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3); CHAND syndrome, 214350 (3)	
21.158	08	21	19	21q22.3	RSPH1, TSGA2, TSA2, CILD24		Radial spoke head component 1	609314			Ciliary dyskinesia, primary, 24, 615481 (3)	17(Tsa2)
21.159	8	23	09	21q22.12	RUNX1, CBFA2, AML1		Runt-related transcription factor 1 (aml1 oncogene)	151385			Leukemia, acute myeloid, 601626 (3); Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	
21.160	1	19	98	21q22.2	SH3GBR		SH3 domain binding glutamic acid-rich protein	602230				
21.161	10	17	95	21q22.3	SLC19A1, FOLT		Solute carrier family 19 (folate transporter), member 1	600424				
21.162	9	16	03	21q22.3	SLC37A1, G3PP		Solute carrier family 37 (glycerol-3-phosphate transporter), member 1	608094				
21.163	10	23	20	21q22.3	SIK1, SNF1LK, MSK, DEE30		Salt-inducible kinase 1	605705			Developmental and epileptic encephalopathy 30, 616341 (3)	
21.164	8	25	04	21q22.3	SUMO3, SMT3H1		Small ubiquitin-like modifier 3	602231				
21.165	10	15	96	21q22.3	TFF1, BCEI		Trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in)	113710				
21.166	8	24	98	21q22.3	TFF2, SML1		Trefoil factor 2 (spasmolytic protein-1)	182590		within 230kb of BCEI		
21.167	4	9	96	21q22.3	TFF3, ITF		Trefoil factor 3 (intestinal)	600633				17(Tff3)
21.168	02	22	19	21q22.3	TRAPPC10, TMEM1, EHOC1		Trafficking protein particle complex, subunit 10	602103		near PWP2H		
21.169	6	9	98	21q22.3	TMPRSS2		Transmembrane protease, serine 2	602060				
21.170	1	9	13	21q22.3	TMPRSS3, ECHOS1, DFNB8, DFNB10		Transmembrane protease, serine 3	605511			Deafness, autosomal recessive 8/10, 601072 (3)	
21.171	6	18	99	21q22.3	TRPM2, TRPC7, KNP3		Transient receptor potential cation channel, subfamily M, member 2	603749				
21.172	11	09	18	21q22.3	TSPEAR, C21orf29, DFNB98, ECTD14		Thrombospondin-type laminin G domain and EAR repeats	612920		mutation identified in 1 DFNB98 family	?Deafness, autosomal recessive 98, 614861 (3); Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis, 618180 (3)	
21.173	9	28	96	21q22.3	U2AF1		U2(RNU2) small nuclear RNA auxillary factor 1	191317				
21.174	10	26	98	21q22.3	UBE2G2, UBC7		Ubiquitin-conjugating enzyme E2G 2	603124				
21.175	3	16	01	21q22.3	UBASH3A		Ubiquitin-associated and SH3 domain-containing protein A	605736				
21.176	4	6	11	21q22.3	UMODL1		Uromodulin-like 1	613859				
21.177	03	08	19	21q22.3	WDR4, MIGSB, GAMOS6		WD repeat-containing protein 4	605924			Microcephaly, growth deficiency, seizures, and brain malformations, 618346 (3); Galloway-Mowat syndrome 6, 618347 (3)	
21.178	5	5	99	21q22.2	WRB, CHD5		Tryptophan-rich basic protein	602915				
21.179	8	26	15	21q22.3	ZBTB21, ZNF295, KIAA1227		Zinc finger- and BTB domain-containing protein 21	616485				
21.180	10	23	87	Chr.21	BAS		Beta-adrenergic stimulation, response to	109670				
21.181	10	23	87	Chr.21	HTOR		5-hydroxytryptamine oxygenase regulator	143460				
21.182	4	26	17	21q22.3	YBEY, C21orf57		YBEY metallopeptidase	617461				
22.1	4	26	90	22p12	RNR5		Ribosomal RNA-5	180454				
22.2	8	20	92	22q11.1	ZNF72		Zinc finger protein-72 (Cos8)	194546				
22.3	8	20	92	22p11.2	ZNF73		Zinc finger protein-73 (Cos12)	194547				
22.4	08	22	19	22q12.2	UQCR10, UCRC		Ubiquinol-cytochrome C reductase, complex III subunit X	610843				
22.5	10	20	99	22q13.1	RPL3		Ribosomal protein L3	604163				
22.6	10	30	03	22q11	ACF		Asymmetric crying facies (Cayler cardiofacial syndrome)	125520			Cayler cardiofacial syndrome (2)	
22.7	11	27	94	22q12.1	ADRBK2, BARK2, GRK3		Adrenergic, beta, receptor kinase-2	109636				
22.8	11	12	20	22q11.21	ARVCF		ARVCF delta catenin family member	602269		?role in VCFS		
22.9	10	23	87	22q11	CECR, CES		Cat eye syndrome	115470		partial tetrasomy of 22q11	Cat eye syndrome (4)	
22.10	10	26	98	22q11.21	CRKL		v-crk avian sarcoma virus CT10 oncogene homolog-like	602007				
22.11	8	24	98	22q11.21	DGCR6		DiGeorge syndrome critical region 6	601279				
22.12	12	2	08	22q11.21	DGCR6L		DiGeorge syndrome critical region gene 6-like	609459				
22.13	09	29	20	22q11.21	DVL1P1, DVL, DVL1		Dishevelled segment polarity protein 1, pseudogene 1	601225				
22.14	3	1	12	22q11.21	HCF2, HC2, SERPIND1, THPH10		Heparin cofactor II	142360		proximal to BCR	Thrombophilia due to heparin cofactor II deficiency, 612356 (3)	
22.15	05	05	20	22q11.21	HIRA, TUPLE1		Histone cell cycle regulator	600237		?role in CATCH22		16(Tuple1)
22.16	4	5	05	22q13.2	NAGA		Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B)	104170		proximal to Ph1 break	Schindler disease, type I, 609241 (3); Kanzaki disease, 609242 (3); Schindler disease, type III, 609241 (3)	
22.17	9	16	03	22q11.21	P2RXL1, P2XM, P2X6		Purinergic receptor P2X-like 1	608077				
22.18	5	31	05	22q11.21	RTN4R, NOGOR		NOGO receptor (reticulon 4 receptor)	605566			{Schizophrenia, susceptibility to}, 181500 (3)	
22.19	3	15	11	22q11.21	SCARF2, SREC2, VDEGS		Scavenger receptor class F, member 2	613619			Van den Ende-Gupta syndrome, 600920 (3)	16(Scarf2)
22.20	03	16	20	22q11.21	SLC25A1, SLC20A3, CTP, D2L2AD, CMS23		Solute carrier family 25 (mitochondrial citrate transporter), member 1	190315			Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3); Myasthenic syndrome, congenital, 23, presynaptic, 618197 (3)	
22.21	2	2	18	22q11.23	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	601607			Rhabdoid tumors, somatic, 609322 (3); {Rhabdoid tumor predisposition syndrome 1}, 609322 (3); Coffin-Siris syndrome 3, 614608 (3); {Schwannomatosis-1, susceptibility to}, 162091 (3)	
22.22	6	29	99	22q11.22	TOP3B		Topoisomerase, DNA, III, beta	603582				
22.23	7	26	17	22q11.21	TUBA8, TUBAL2, CDCBM8		Tubulin, alpha 8	605742			Cortical dysplasia, complex, with other brain malformations 8, 613180 (3)	
22.24	2	1	01	22q11.23	VPREB3		Pre-B-lymphocyte gene 3	605017				10(Vpreb3)
22.25	02	20	20	22q12.1	HSC20, HSCB, JAC1		HSCB mitochondrial iron-sulfur cluster cochaperone	608142				
22.26	2	9	92	22q11-q12	LRE1, L1.2		Line-1.2 retrotransposable element	151626				
22.27	9	17	09	22q13.2	XRCC6, G22P1, TLAA, Ku70		X-ray repair, complementing defecting, in chinese hamster, 6	152690		tight linkage to CYP2D		15(Ku70)
22.28	6	7	10	22q11.1	POTEH, POTE22, ACTBL1		POTE ankyrin domain family, member H	608913				
22.29	12	17	07	22q11.1	XKR3, XTES, XRG3		X Kell blood group precursor-related family, member 3	611674				
22.30	12	18	18	22q11.21	LZTR1, SWNTS2, NS10, NS2		Leucine-zipper-like regulator-1	600574			{Schwannomatosis-2, susceptibility to}, 615670 (3); Noonan syndrome 10, 616564 (3); Noonan syndrome 2, 605275 (3)	
22.31	12	7	98	22q11.21	GGT2		Gamma-glutamyltransferase-2	137181			[Gamma-glutamyltransferase, familial high serum] (2)	
22.32	04	03	19	22q11.1	ADA2, CECR1, VAIHS, SNEDS		Adenosine deaminase 2	607575		mutation identified in 1 SNEDS family	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome, 615688 (3); ?Sneddon syndrome, 182410 (3)	
22.33	8	28	97	22q11.23	ADORA2A		Adenosine A2a receptor	102776		incorrectly assigned to 11q		
22.34	3	27	17	22q11.21	ATP6V1E1, ATP6E, ARCL2C		ATPase, H+ transporting, V1 subunit E1	108746			Cutis laxa, autosomal recessive, type IIC, 617402 (3)	6(Atp6e)
22.35	12	3	98	22q11.21	BID		BH3-interacting domain death agonist	601997				6(Bid)
22.36	4	14	10	22q11.23	CABIN1, CAIN		Calcineurin-binding protein 1	604251				
22.37	11	16	08	22q11.2	DEL22q11.2, C22DELq11.2		Chromosome 22q11.2 deletion syndrome, distal	611867			Chromosome 22q11.2 deletion syndrome, distal (4)	
22.38	1	20	09	22q11.2	DUP22q11.2		Chromosome 22q11.2 microduplication syndrome	608363		contiguous gene microduplication syndrome	Chromosome 22q11.2 microduplication syndrome (4)	
22.39	1	20	11	22q11.2	DER22t8-22		Supernumerary der(22)t(8;22) syndrome	613700			Supernumerary der(22)t(8-22) syndrome (4)	
22.40	1	20	11	22q11.2	DER22t11-22		Emanuel syndrome (supernumerary der(22)t(11;22) syndrome)	609029			Emanuel syndrome (4)	
22.41	8	10	16	22q11.21	CDC45L, CDC45L2, MGORS7		Cell division cycle 45, S. Cerevisiae, homolog-like	603465			Meier-Gorlin syndrome 7, 617063 (3)	
22.42	2	26	03	22q11.1-q11.2	CECR2, KIAA1740		Cat eye syndrome chromosome region, candidate 2	607576				6(Cecr2)
22.43	2	3	99	22q11.21	CLDN5, TMVCF, AWAL		Claudin-5 (transmembrane protein deleted in velocardiofacial syndrome)	602101				16(Tmvcf)
22.44	12	19	05	22q11.21	COMT		Catechol-O-methyltransferase	116790			{Schizophrenia, susceptibility to}, 181500 (3); {Panic disorder, susceptibility to}, 167870 (3)	16(Comt)
22.45	5	12	99	22q11.21	CLTCL1, CLTD		Clathrin, heavy polypeptide-like 1	601273				11(Cltd)
22.46	8	3	99	22q11.23	DDT		D-dopachrome tautomerase	602750				10(Ddt)
22.47	2	18	98	22q11.21	DGCR2, IDD		DiGeorge critical region gene 2 (integral membrane protein deleted in DiGeorge syndrome)	600594				16(Idd)
22.48	6	28	18	22q11.21	DGCR5, LINC00037		Digeorge syndrome critical region gene 5	618040				
22.49	5	2	07	22q11.21	DGCR8		DiGeorge syndrome critical region gene 8	609030				16(Dgcr8)
22.50	9	27	17	22q11.21	ESS2, DGSI, DGCR14		Ess2 splicing factor, Xenopus, homolog of	601755				16(Dgsi)
22.51	8	25	09	22q12.2	EIF4ENIF1		Eukaryotic translation initiation factor 4E nuclear import factor 1	607445				
22.52	6	18	18	22q11.23	GGT1, GGT, GGTD		Gamma-glutamyltransferase 1	612346		mutation identified in 1 GGTD family	?Glutathioninuria, 231950 (3)	
22.53	10	9	08	22q11.23	GGT5		Gamma-glutamyltransferase 5	137168				
22.54	10	9	08	22q11.22	GGTLC2, GGTL4		Gamma-glutamyltransferase, light chain 2	612339				
22.55	10	9	08	22q11.21	GGTLC3		Gamma-glutamyltransferase, light chain 3	612340				
22.56	9	13	92	22q11.22-q11.23	GNAZ		Guanine nucleotide-binding protein (G protein), alpha z polypeptide	139160				10(Gnaz)
22.57	2	21	07	22q11.21	GNB1L, WDR14		Guanine nucleotide-binding protein, beta-1-like	610778				16(Gnb1l)
22.58	9	21	11	22q11.21	GP1BB, BS, BDPLT1		Glycoprotein Ib, platelet, beta polypeptide	138720			Bernard-Soulier syndrome, type B, 231200 (3); Giant platelet disorder, isolated, 231200 (3)	16(Gp1bb)
22.59	5	4	00	22q11.2	GSTT1		Glutathione S-transferase, theta-1	600436				
22.60	3	27	95	22q11.23	GSTT2		Glutathione S-transferase theta-2	600437				
22.61	5	7	03	22q11.21	HIC2, HRG22, KIAA1020		Hypermethylated in cancer 2	607712				
22.62	4	15	08	22q11.2	IGLV@		Immunoglobulin lambda light chain variable gene cluster	147240		many genes		
22.63	4	15	08	22q11.2	IGLJ@		Immunoglobulin lambda light chain joining gene cluster	147230		nine J-C duplexes		
22.64	12	7	98	22q11.22	IGLC1, IGLC		Constant region of lambda light chains	147220		several genes		16(Igl1)
22.65	11	09	20	22q11.22	MAPK1, PRKM1, ERK2, NS13		Mitogen-activated protein kinase 1	176948			Noonan syndrome 13, 619087 (3)	16(Prkm1)
22.66	1	27	11	22q11.21	MED15, PCQAP, TIG1, ARC105		Mediator complex subunit 15	607372				16(Pcqap)
22.67	3	30	04	22q11.23	MIF		Macrophage migration inhibitory factor	153620		previously assigned to chr.19	{Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3)	10(Mif)
22.68	7	13	94	22q11.23	MMP11, STMY3		Matrix metalloproteinase 11 (stromelysin 3)	185261				
22.69	6	13	18	22q12.3	MYH9, MHA, FTNS, DFNA17, BDPLT6, MATINS		Myosin, heavy polypeptide-9, nonmuscle	160775			Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, 155100 (3); Deafness, autosomal dominant 17, 603622 (3)	
22.70	5	24	13	22q11.23	PIWIL3		PIWI-like 3	610314				
22.71	5	31	05	22q11.21	PRODH, PRODH2, SCZD4		Proline dehydrogenase (proline oxidase)	606810			Hyperprolinemia, type I, 239500 (3); {Schizophrenia, susceptibility to, 4}, 600850 (3)	
22.72	2	20	01	22q11.23	RAB36		Ras family, member 36	605662				
22.73	9	2	08	22q11.23	RGL4, RGR		Ral guanine nucleotide dissociation stimulator-like 4	612214				
22.74	08	21	19	22q11.22-q11.23	RSPH14, RTDR1		Radial spoke head 14 homolog	605663				
22.75	2	28	03	22q11.21	SDF2L1		Stromal cell-derived factor 2-like 1	607551				
22.76	11	1	05	22q11.21	SEPT5, PNUTL1, CDCREL		Septin 5	602724		just 5' of GP1BB		
22.77	8	19	13	22q11.23	SLC2A11, GLUT11		Solute carrier family 2 (facilitated glucose transporter), member 11	610367				
22.78	5	12	99	22q11.21	SLC7A4, CAT4		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 4	603752				
22.79	4	7	05	22q11.21	SLC25A18, GC2		Solute carrier family 25 (mitochondrial carrier, glutamate), member 18	609303				
22.80	9	19	05	22q11.21	SNAP29, CEDNIK		Synaptosomal-associated protein, 29kD	604202			Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)	
22.81	09	19	19	22q11.21	TANGO2, C22orf25, MECRCN		Transport and golgi organization 2 homolog	616830			Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3)	
22.82	4	21	97	22q11.21	UFD1L		Ubiquitin fusion degradation 1-like	601754		?role in CATCH22		
22.83	2	8	13	22q11.21	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR		T-box 1	602054			Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome, 188400 (3); Velocardiofacial syndrome, 192430 (3); Tetralogy of Fallot, 187500 (3)	16(Tbx1)
22.84	12	22	17	22q11.21	TXNRD2, TRXR2, SELZ, GCCD5		Thioredoxin reductase 2	606448		mutation identified in 1 GCCD5 family	?Glucocorticoid deficiency 5, 617825 (3)	16(Txnrd2)
22.85	12	21	09	22q11.23	UPB1, BUP1		Beta-ureidopropionase	606673			Beta-ureidopropionase deficiency, 613161 (3)	
22.86	3	27	17	22q11.21	USP18, UBP43, ISG43, PTORCH2		Ubiquitin-specific protease 18	607057			Pseudo-TORCH syndrome 2, 617397 (3)	6(Usp18)
22.87	12	13	00	22q11.22	VPREB1, IGI, VPREB		Pre-B lymphocyte gene 1	605141				
22.88	9	16	03	22q11.21-q11.22	YPEL1		Yippee-like 1	608082		pseudogene on 9p24.3		16(Ypel1)
22.89	8	20	92	22q11.23	ZNF70		Zinc finger protein-70 (Cos17)	194544				
22.90	8	20	92	22q11.21	ZNF74		Zinc finger protein-74 (Cos52)	194548				
22.91	8	6	13	22q12.1	CRYBB1, CATCN3, CTRCT17		Crystallin, beta B1	600929			Cataract 17, multiple types, 611544 (3)	5(Crybb1)
22.92	5	3	13	22q11.23	CRYBB2, CRYB2, CTRCT3, CCA2		Crystallin, beta-B2	123620		2nd CRYB2 gene in same region	Cataract 3, multiple types, 601547 (3)	5(Crybb2)
22.93	12	27	16	22q11.23	CRYBB3, CRYB3, CATCN2, CTRCT22		Crystallin, beta-B3	123630			Cataract 22, 609741 (3)	5(Crybb3)
22.94	06	26	20	22q12.1	HPS4		HPS4 biogenesis of lysosomal organelles complex 3 subunit 2	606682			Hermansky-Pudlak syndrome 4, 614073 (3)	5(le)
22.95	07	17	19	22q12.3	IL2RB, IMD63		Interleukin-2 receptor, beta polypeptide	146710			Immunodeficiency 63 with lymphoproliferation and autoimmunity, 618495 (3)	15(Il2rb)
22.96	10	23	87	22q12.3	MB		Myoglobin	160000				
22.97	7	22	13	22q12.1	CRYBA4, CTRCT23		Crystallin, beta polypeptide A4	123631			Cataract 23, 610425 (3)	
22.98	2	7	01	22q11.21	UBE2L3, UBCH7		Ubiquitin-conjugating enzyme E2L 3	603721		pseudogenes on 12q12 and 19q13.1-q13.2		
22.99	8	25	09	22q12.2	INPP5J, PIB5PA, PIPP		Inositol polyphosphate-5-phosphatase J	606481				
22.100	12	18	07	22q12.2	PLA2G3, SPLA2III		Phospholipase A2, group III	611651				
22.101	6	29	99	22q12.3	MPST		Mercaptopyruvate sulfurtransferase	602496				
22.102	7	8	10	22q12.2	TCN2, TC2		Transcobalamin II	613441		linked to P1	Transcobalamin II deficiency, 275350 (3)	11(Tcn2)
22.103	6	29	99	22q12.3	TST, RDS		Thiosulfate sulfurtransferase (Rhodanese)	180370				
22.104	1	11	17	22q11.21	AIFM3, AIFL		Apoptosis-inducing factor, mitochondria-associated, 3	617298				
22.105	07	22	19	22q11.23	BCR, CML, PHL, ALL		Breakpoint cluster region	151410		Ph1=t(9;22) (q34.1;q11.21); fused with ABL in CML	Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic, 608232 (4); Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic, 613065 (4)	10(Bcr)
22.106	5	24	13	22q11.21	GSC2, GSCL		Goosecoid homeobox 2	601845				
22.107	8	10	10	22q11.23	IGLL1, IGO, IGL5, VPREB2, AGM2		Immunoglobulin lambda-like polypeptide 1 (immunoglobulin omega peptide)	146770		between BCR2 and BCR4; distal to IGLC	Agammaglobulinemia 2, 613500 (3)	
22.108	6	22	18	22q11.21	KLHL22		Kelch-like 22	618020				
22.109	10	28	08	22q11.21	MICAL3, KIAA1364		Microtubule-associated monooxygenase, calponin and LIM domains-containing 3	608882				
22.110	12	27	13	22q11.21	MIR185		Micro RNA 185	615576		within first intron of C22orf25		
22.111	2	5	15	22q11.21	MIR648		Micro RNA 648	616205		in intron 1 of MICAL3		
22.112	8	3	12	22q11.21	MRPL40, NLVCF, MRPL22		Mitochondrial ribosomal protein L40	605089				16(Nlvcf)
22.113	10	25	12	22q11.21	PEX26, PBD7A, PBD7B		Peroxisome biogenesis factor 26	608666			Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3); Peroxisome biogenesis disorder 7B, 614873 (3)	
22.114	9	2	15	22q11.21	PI4KA, PIK4CA, PMGYCHA		Phosphatidylinositol 4-kinase, catalytic, alpha	600286			Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3)	
22.115	2	28	03	22q11.21-q11.22	PPIL2, CYP60		Peptidyl-prolyl isomerase-like 2	607588				
22.116	8	8	13	22q11.21	RANBP1, HTF9A		RAN-binding protein 1	601180				
22.117	4	1	09	22q11.21	RIMBP3, RIMBP3A, KIAA1666		RIMS-binding protein 3	612699				16(Rimbp3)
22.118	4	1	09	22q11.21	RIMBP3B		RIMS-binding protein 3B	612700				16(Rimbp3)
22.119	4	1	09	22q11.21	RIMBP3C		RIMS-binding protein 3C	612701				16(Rimbp3)
22.120	09	11	19	22q11.21	TRMT2A, HTF9C		tRNA methyltransferase 2 homolog A	611151				
22.121	1	22	07	22q11.21	TSSK2, STK22B		Testis-specific serine/threonine kinase 2	610710				16(Tssk2)
22.122	3	22	06	22q11.21	ZDHHC8, ZNF378, KIAA1292		Zinc finger DHHC domain-containing protein 8	608784				
22.123	1	21	11	22q11.21	MIR130B, MIRN130B		Micro RNA 130B	613682				
22.124	11	21	03	22q11.21-q12.1	DFNB40		Deafness, autosomal recessive 40	608264			Deafness, autosomal recessive 40 (2)	
22.125	9	9	13	22q11.22	MIR650		Micro RNA 650	615379				
22.126	8	25	09	22q11.22	PRAME, MAPE, OIP4		Preferentially expressed antigen in melanoma	606021				
22.127	12	19	16	22q11.1	IL17RA, IL17R, IMD51		Interleukin 17 receptor A	605461			Immunodeficiency 51, 613953 (3)	6(Il17r)
22.128	2	5	15	22q11.23	CHCHD10, FTDALS2, SMAJ, IMMD		Coiled-coil-helix-coiled-coil-helix domain-containing protein 10	615903		mutation identified in 1 IMMD family	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3); ?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3); Spinal muscular atrophy, Jokela type, 615048 (3)	
22.129	5	24	13	22q11.23	DERL3		DER1-like domain family, member 3	610305				
22.130	9	28	17	22q11.23	SNRPD3		Small nuclear ribonucleoprotein polypeptide D3	601062				
22.131	11	15	18	22q11.23	SPECC1L, KIAA0376, OBLFC1, GBBB2, TBHS		Sperm antigen with calponin homology and coiled-coil domains 1-like	614140		mutation identified in 1 OBLFC1 patient	?Facial clefting, oblique, 1, 600251 (3); Opitz GBBB syndrome, type II, 145410 (3); Hypertelorism, Teebi type, 145420 (3)	
22.132	7	18	14	22q11.23	SUSD2		Sushi domain-containing protein 2	615825				
22.133	01	20	20	22q12.2	AP1B1, ADTB1, BAM22, CLAPB2, KIDAR		Adaptor-related protein complex 1, beta 1 subunit (adaptin, beta)	600157			Keratitis-ichthyosis-deafness syndrome, autosomal recessive, 242150 (3)	
22.134	11	23	09	22q12	BRV2		Vertigo, benign recurrent, 2	613106			Vertigo, benign recurrent, 2 (2)	
22.135	9	2	08	22q12.2	EWSR1, EWS		Ewing sarcoma breakpoint region-1	133450		t(11;22)(q24;q12); t(21;22)(q22;q12)	Ewing sarcoma, 612219 (3); Neuroepithelioma, 612219 (3)	
22.136	7	11	07	22q12.2	GAS2L1, GAR22		Growth arrest-specific 2 like 1	602128				
22.137	1	28	13	22q12.3	HMOX1, HMOX1D		Heme oxygenase 1	141250			Heme oxygenase-1 deficiency, 614034 (3); {Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)	
22.138	2	14	13	22q12	KAZA1		Kala-azar (visceral leishmaniasis), susceptibility to, 1	608207			{Kala-azar, susceptibility to, 1} (2)	
22.139	6	16	99	22q13.1	MFNG		Manic fringe	602577				15(Mfng)
22.140	6	29	99	22q12.2	MTMR3		Myotubularin-related protein 3	603558				
22.141	11	5	98	22q12.2	NIPSNAP1		4-nitrophenylphosphatase domain and nonneuronal SNAP25-like 1	603249				
22.142	5	7	03	22q12.2	OSBP2, ORP4, KIAA1664		Oxysterol-binding protein 2	606729				
22.143	05	20	20	22q12.2	PISD, PSD, PSSC, LIBF		Phosphatidylserine decarboxylase	612770			Liberfarb syndrome, 618889 (3)	
22.144	8	18	08	22q12.2	RASL10A, RRP22		Ras-like, family 10, member A	602220				
22.145	7	16	09	22q12.2	SEC14L3, TAP2		SEC14-like 3	612824				
22.146	7	16	09	22q12.2	SEC14L4, TAP3		SEC14-like 4	612825				
22.147	5	9	07	22q12	SQTL2		Smoking as a quantitative trait locus 2	611004		max lod at D22S315	{Smoking as a quantitative trait locus 2} (2)	
22.148	5	5	09	22q12.2	THOC5, FMIP		THO complex 5	612733				
22.149	10	30	08	22q12.1	XBP1, XBP2		X-box-binding protein-1	194355		pseudogene on chr.5	{Major affective disorder-7, susceptibility to}, 612371 (3)	
22.150	9	28	96	22q12.3	YWHAH, YWHA1		Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide 22	113508				
22.151	4	4	05	22q12.2	ZNF278, PATZ, MAZR		Zinc finger protein-278	605165				
22.152	10	07	19	22q13.1	CBY1, C22orf2		Chibby family, member 1	607757				
22.153	6	22	05	22q12-q13	CDAGS		Craniosynostosis, anal anomalies, and porokeratosis syndrome	603116			CDAGS syndrome (2)	
22.154	10	22	95	22q13.1	CSNK1E		Casein kinase-1, epsilon	600863				
22.155	3	31	09	22q12.3	FBXO7, FBX7, FBX, PKPS, PARK15		F-box only protein 7	605648			Parkinson disease 15, autosomal recessive, 260300 (3)	10(Fbxo7)
22.156	2	28	03	22q13.1	GCAT, KBL		Glycine C-acetyltransferase	607422				
22.157	3	15	10	22q12-q13	HCHGQ3		Hematocrit/hemoglobin quantitative trait locus 3	613284		associated with rs855791	[Hematocrit/hemoglobin quantitative trait locus 3] (2)	
22.158	6	8	01	22q12.2	RFPL1		RET finger protein-like 1	605968				
22.159	7	2	01	22q12.2	RFPL1S		Ret finger protein-like 1, antisense	605972				
22.160	6	8	01	22q12.3	RFPL2		RET finger protein-like 2	605969				
22.161	6	8	01	22q12.3	RFPL3		RET finger protein-like 3	605970				
22.162	7	2	01	22q12.3	RFPL3S		Ret finger protein-like 3, antisense	605971				
22.163	5	10	11	22q13.1	SUN2, UNC84B, KIAA0668		SAD1 and UNC84 domain-containing protein 2	613569				
22.164	5	30	08	22q12.3	TMPRSS6, IRIDA		Transmembrane protease, serine 6 (matriptase 2)	609862			Iron-refractory iron deficiency anemia, 206200 (3)	
22.165	09	17	20	22q13.1	TOMM22, TOM22		Translocase of outer mitochondrial membrane 22	607046				
22.166	1	2	03	22q13.1	GTPBP1, GP1		GTP-binding protein 1	602245				15(Gtpbp1)
22.167	4	25	93	22q13.1	LGALS1		Lectin, galactose-binding, soluble, 1	150570				15(Lgals1)
22.168	3	15	05	22q13.31	PPARA, PPAR		Peroxisome proliferator-activated receptor-alpha	170998			{Hyperapobetalipoproteinemia, susceptibility to} (3)	
22.169	3	18	91	22q12.3	PVALB		Parvalbumin	168890		?role in DiGeorge syndrome		15(Pva)
22.170	11	2	04	22q13.1	APOBEC3F		Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3F	608993				
22.171	5	22	03	22q13.1	APOBEC3G, MDS019, CEM15, FLJ12740		Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G	607113				
22.172	2	1	01	22q13.1	GRAP2, GRID		GRB2-related adaptor protein 2	604518				
22.173	8	27	01	22q12.2	PES1, PES		Pescadillo, zebrafish, homolog of, 1	605819				11(Pes1)
22.174	08	21	19	22q12.1	CHEK2, RAD53, CHK2, CDS1, LFS2		Checkpoint kinase 2	604373			Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3); {Breast cancer, susceptibility to}, 114480 (3); {Prostate cancer, familial, susceptibility to}, 176807 (3); {Breast and colorectal cancer, susceptibility to} (3)	
22.175	3	18	17	22q12.1	KREMEN1, KRM1, ECTD13		Kringle domain-containing transmembrane protein 1	609898			Ectodermal dysplasia 13, hair/tooth type, 617392 (3)	
22.176	11	2	11	22q12.1	MIAT, C22orf35		MIAT gene	611082			{Myocardial infarction, susceptibility to}, 608446 (3)	
22.177	9	21	15	22q12.1	MYO18B, KFS4		Myosin XVIIIB	607295			Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3)	
22.178	8	25	09	22q12.1	PITPNB		Phosphatidylinositol transfer protein, beta	606876				
22.179	9	30	02	22q12.1	SEZ6L		Seizure-related 6-like	607021				
22.180	1	27	11	22q12.1	SRRD		SRR1 domain-containing protein	602254				
22.181	5	11	09	22q12.1	TFIP11, TIP39, NTR1		Tuftelin-interacting protein 11	612747				5(Tfip11)
22.182	10	14	98	22q12.1	TPST2		Tyrosylprotein phosphotransferase 2	603126				
22.183	3	14	13	22q12.1	TTC28, TPRBK, KIAA1043		Tetratricopeptide repeat domain-containing protein 28	615098				
22.184	6	10	08	22q12.1	ZNRF3, KIAA1133		Zinc finger and ring finger protein 3	612062				
22.185	11	21	02	22q12.1-q12.2	ITS		Insulinoma tumor suppressor gene locus	606960			Insulinoma (1)	
22.186	9	28	93	22q12.2	LIF, HILDA		Leukemia inhibitory factor (cholinergic differentiation factor)	159540		distal to ES		11(Lif)
22.187	9	28	93	22q12.2	OSM		Oncostatin M	165095		10kb from LIF		
22.188	1	12	95	22q12.3	TIMP3, SFD		Tissue inhibitor of metalloproteinase-3	188826			Sorsby fundus dystrophy, 136900 (3)	
22.189	3	3	03	22q12.2	SEC14L2, TAP, KIAA1186		SEC14-like 2	607558				
22.190	4	25	06	22q12.2	TBC1D10A, EPI64		TBC1 domain family, member 10A	610020				
22.191	9	8	11	22q12.2	ASCC2, p100		Activating signal cointegrator 1 complex, subunit 2	614216				
22.192	01	31	20	22q12.2	CABP7, CALN2		Calcium-binding protein 7	618759				
22.193	01	04	19	22q12.2	DRG1, NEDD3		Developmentally regulated GTP-binding protein 1	603952				
22.194	2	7	07	22q12.2	GAL3ST1, CST		Galactose-3-O-sulfotransferase 1	602300				
22.195	08	14	19	22q12.2	CASTOR1, GATSL3		Cytosolic arginine sensor for mTORC1 subunit 1	617034				
22.196	04	07	20	22q12.2	HORMAD2		HORMA domain-containing protein 2	618842				
22.197	5	25	13	22q12.2	LIMK2		LIM domain kinase 2	601988				
22.198	12	17	15	22q12.2	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z		MORC family CW-type zinc finger protein 2	616661			Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	
22.199	5	24	13	22q12.2	MTFP1		Mitochondrial fission process 1	610235				
22.200	4	27	16	22q12.2	NEFH, CMT2CC		Neurofilament, heavy polypeptide	162230		mutation identified in 1 family with ALS susceptibility	?{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3); Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3)	11(Nfh)
22.201	1	17	18	22q12.2	NF2		Merlin	607379		loss of heterozygosity	Neurofibromatosis, type 2, 101000 (3); Meningioma, NF2-related, somatic, 607174 (3); Schwannomatosis, somatic, 162091 (3)	11(Nf2)
22.202	8	25	09	22q12.2	SF3A1, SF3A120, SAP114, PRP21		Splicing factor 3A, subunit 1	605595				
22.203	09	27	20	22q12.2	SFI1, KIAA0542		SFI1 centrin-binding protein	612765				
22.204	11	18	16	22q12.2	SELENOM, SELM, SEPM		Selenoprotein M	610918				
22.205	1	15	13	22q12.2	TUG1		Taurine-upregulated gene 1, noncoding	614971				
22.206	9	22	16	22q12.2-q12.3	DEPDC5, KIAA0645, FFEVF1		DEP domain-containing protein 5	614191			Epilepsy, familial focal, with variable foci 1, 604364 (3)	
22.207	12	5	11	22q12.3	CSF2RB, SMDP5		Colony-stimulating factor-2 receptor, beta, low-affinity	138981			Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)	
22.208	6	29	99	22q13.1	GALR3		Galanin receptor 3	603692				
22.209	03	02	20	22q13.1	MAFF		MAF bZIP transcription factor F	604877				
22.210	10	25	10	22q12.3	APOL1, FSGS4		Apolipoprotein L1	603743			{Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3); {End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)	
22.211	12	11	02	22q12.3	APOL2		Apolipoprotein L2	607252			{Schizophrenia}, 181500 (1)	
22.212	12	11	02	22q12.3	APOL3		Apolipoprotein L3	607253				
22.213	12	11	02	22q12.3	APOL4		Apolipoprotein L4	607254			{Schizophrenia}, 181500 (1)	
22.214	12	11	02	22q12.3	APOL5		Apolipoprotein L5	607255				
22.215	12	11	02	22q12.3	APOL6		Apolipoprotein L6	607256				
22.216	12	10	12	22q12.3	C1QTNF6, CTFP6		C1q- and tumor necrosis factor-related protein 6	614910				
22.217	3	24	11	22q12.3	FOXRED2, ERFAD		FAD-dependent oxidoreductase domain-containing protein 2	613777				
22.218	02	12	19	22q12.3	HPC6		Prostate cancer, hereditary, 6	609558		between D22S1265 and D22S277	{Prostate cancer, susceptibility to} (2)	
22.219	08	12	19	22q12.3	IFT27, RABL4, BBS19		Intraflagellar transport 27	615870		mutation identified in 1 BBS19 family	?Bardet-Biedl syndrome 19, 615996 (3)	
22.220	6	2	08	22q12.3	ISX, RAXLX		Intestine-specific homeobox	612019				
22.221	6	1	16	22q12.3	KCTD17		Potassium channel tetramerization domain-containing protein 17	616386			Dystonia 26, myoclonic, 616398 (3)	
22.222	6	10	09	22q12.3	RASD2, RHES, TEM2		RASD family, member 2	612842				
22.223	7	17	14	22q12.3	RTCB, C22orf28, HSPC117		RNA 2-prime, 3-prime cyclic phosphate and 5-prime-OH ligase	613901				
22.224	10	25	19	22q12.3	SLC5A4		Solute carrier family 5 (low-affinity glucose cotransporter), member 4	618633				
22.225	5	28	99	22q12.2	SMTN		Smoothelin	602127				11(Smtn)
22.226	8	20	98	22q12.3	SYN3		Synapsin III	602705		?relation to schizophrenia		
22.227	2	12	16	22q12.3	TXN2, TRX2, MTRX, COXPD29		Thioredoxin 2	609063		mutation identified in 1 COXPD29 patient	?Combined oxidative phosphorylation deficiency 29, 616811 (3)	
22.228	9	30	09	22q13.1	CYTH4, PSCD4, CYT4		Cytohesin 4	606514				
22.229	11	10	10	22q12.3	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6		Acetylglucosaminyltransferase-like protein	603590			Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3); Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	8(Large)
22.230	1	20	11	22q12.3-q13.1	MDNS		Mammary-digital-nail syndrome	613689		max lod at D22S277, D22S1142, D22S683, D22S283	Mammary-digital-nail syndrome (2)	
22.231	11	11	13	22q13.1	PDGFB, SIS, IBGC5		Platelet-derived growth factor, beta polypeptide (oncogene SIS)	190040		fused with COL1A1 in DFSP	Meningioma, SIS-related, 607174 (3); Dermatofibrosarcoma protuberans, 607907 (3); Basal ganglia calcification, idiopathic, 5, 615483 (3)	15(Pdgfb)
22.232	3	22	06	22q13.1	PICK1, PRKCABP		Protein interacting with C kinase 1	605926				
22.233	08	24	20	22q13.1	RAC2, IMD73A, IMD73B, IMD73C		Rac family small GTPase 2	602049		mutation identified in 1 IMD73C family	Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis, 608203 (3); Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia, 618986 (3); ?Immunodeficiency 73C with defective neutrophil chemotaxis and hypogammaglobulinemia, 618987 (3)	
22.234	2	25	15	22q13.1	SLC16A8, MCT3		Solute carrier family 16 (monocarboxylic acid transporter), member 8	610409				
22.235	02	14	20	22q12.1	MN1, MGCR, CEBALID		MN1 protooncogene, transcriptional regulator	156100		fused with TEL in AML	Meningioma, 607174 (3); CEBALID syndrome, 618774 (3)	
22.236	8	23	02	22q13.1	APOBEC3A, PHRBN		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A (phorbolin 1)	607109				
22.237	8	23	02	22q13.1	APOBEC3B, PHRBNL		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B	607110				
22.238	5	22	03	22q13.1	APOBEC3C		Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3C	607750				
22.239	8	30	07	22q13.31	ATXN10, SCA10		Ataxin 10	611150		ATTCTn repeat in intron 9	Spinocerebellar ataxia 10, 603516 (3)	
22.240	6	1	12	22q12.3	BPIFC, BPIL2		BPI fold-containing protein, family C	614109				
22.241	2	22	00	22q13.33	BRL		BR140-like gene	604589				
22.242	02	21	20	22q13.2	CCDC134		Coiled-coil domain-containing protein 134	618788				
22.243	5	24	13	22q13.31	CERK, KIAA1646		Ceramide kinase	610307				
22.244	7	22	11	22q13.33	CHKB, CHKL, CKEKB, EKB, MDCMC		Choline kinase, beta	612395			Muscular dystrophy, congenital, megaconial type, 602541 (3)	
22.245	10	13	09	22q13.33	CPT1B		Carnitine palmitoyltransferase I, muscle	601987				
22.246	11	20	13	22q13	DUP22q13, C22DUPq13		Chromosome 22q13 duplication syndrome	615538			Chromosome 22q13 duplication syndrome, 615538 (4)	
22.247	02	22	19	22q13.2	EP300, RSTS2, MKHK2		E1A-binding protein, 300kD	602700			Rubinstein-Taybi syndrome 2, 613684 (3); Colorectal cancer, somatic, 114500 (3); Menke-Hennekam syndrome 2, 618333 (3)	
22.248	5	26	13	22q13.33	IL17REL		Interleukin 17 receptor E-like	613414				
22.249	5	22	03	22q13.33	MAPK8IP2, JIP2, IB2		Mitogen-activated protein kinase 8-interacting protein 2	607755				
22.250	05	14	19	22q13.2	MEI1, SPATA38, HYDM3		Meiotic double-stranded break formation protein 1	608797			Hydatidiform mole, recurrent, 3, 618431 (3)	15(Mei1)
22.251	3	26	07	22q13	MENAQ1		Menarche, age at, QTL 1	610873		max lod at UT7136	{Menarche, age at, QTL} (2)	
22.252	3	23	09	22q13.31	MIRLET7B, LET7B, MIRNLET7B		Micro RNA Let7B	611249				
22.253	04	17	20	22q13.1-q13.2	MKL1, AMKL, MAL		Megakaryoblastic leukemia 1 gene	606078		mutation identified in 1 IMD66 patient	?Immunodeficiency 66, 618847 (3)	
22.254	6	7	10	22q13	NAFLD1		Fatty liver disease, nonalcoholic, susceptibility to, 1	613282		associated with rs738409	{Fatty liver disease, nonalcoholic, susceptibility to, 1} (2)	
22.255	12	4	08	22q13	NRCLP4		Narcolepsy 4	612417		associated with rs5770917	{Narcolepsy 4} (2)	
22.256	11	2	14	22q13.33	PANX2, PX2		Pannexin 2	608421				
22.257	3	9	10	22q13.31	PNPLA3, ADPN		Patatin-like phospholipase domain-containing protein 3	609567				
22.258	8	21	07	22q13.1	RNU86		RNA, U86 small nucleolar	611069				
22.259	10	23	20	22q13.33	SCO2, MC4DN2, MYP6		SCO2 cytochrome c oxidase assembly protein	604272			Mitochondrial complex IV deficiency, nuclear type 2, 604377 (3); Myopia 6, 608908 (3)	
22.260	1	22	08	22q13.2	SCUBE1		Signal peptide-, CUB domain-, and EGF-like domains-containing protein 1	611746				15(Scube1)
22.261	3	26	02	22q13.2	SLC25A17, PMP34		Solute carrier family 25 (mitochondrial carrier), member 17 (peroxisomal membrane protein, 34kD)	606795				
22.262	8	21	07	22q13.1	SNORD43, RNU43		Small nucleolar RNA, C/D box, 43	611068				
22.263	8	21	07	22q13.1	SNORD83A, RNU83A		Small nucleolar RNA, C/D box, 83A	611070				
22.264	8	21	07	22q13.1	SNORD83B, RNU83B		Small nucleolar RNA, C/D box, 83B	611071				
22.265	3	16	10	22q13.1	SOX10, WS4, WS4C, PCWH		SRY (sex-determining region Y)-box-10	602229		megacolon and spotting in mice	Waardenburg syndrome, type 4C, 613266 (3); Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3); PCWH syndrome, 609136 (3)	15(Sox10, Dom)
22.266	1	10	96	22q13.2	SREBF2		Sterol regulatory element binding transcription factor 2	600481				
22.267	3	3	03	22q13.2	ST13, P48, HOP		Suppression of tumorigenicity 13	606796				
22.268	2	7	01	22q13.1	SYNGR1		Synaptogyrin 1	603925				
22.269	11	17	94	22q13.2	TEF		Thyrotroph embryonic factor	188595				15(Tef)
22.270	10	28	11	22q13.31	TRMU, MTO2		tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase	610230			{Deafness, mitochondrial, modifier of}, 580000 (3); Liver failure, transient infantile, 613070 (3)	15(Trmu)
22.271	6	9	98	22q13.31	WNT7B		Wingless-type MMTV integration site family, member-7B	601967				
22.272	11	8	03	22q13.1	ADSL		Adenylosuccinate lyase	608222		ade(-)I; bifunctional	Adenylosuccinase deficiency, 103050 (3)	15(Adsl)
22.273	4	29	10	22q13.1	ANKRD54, LIAR		Ankyrin repeat domain-containing protein 54	613383				15(Ankrd54)
22.274	5	22	07	22q13.1	APOBEC3H, ARP10		Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H	610976				
22.275	2	10	09	22q13.1	ATF4, CREB2, TAXREB67		Activating transcription factor 4	604064				
22.276	6	20	17	22q13.1	BAIAP2L2, PINKBAR		Bai1-associated protein 2-like 2	617536				
22.277	3	22	07	22q13.1	CACNA1I, KIAA1120		Calcium channel, voltage-dependent, T type, alpha-1I subunit	608230				
22.278	3	8	17	22q12.3	CACNG2, MRD10		Calcium channel, voltage-dependent, gamma-2 subunit (stargazin)	602911		mutation identified one MRD10 patient	?Mental retardation, autosomal dominant 10, 614256 (3)	15(Cacng2)
22.279	8	25	09	22q13.1	CARD10, CARMA3, BIMP1		Caspase recruitment domain-containing protein 10	607209				
22.280	09	10	19	22q13.1	CBX6		Chromobox 6	617438				
22.281	09	10	19	22q13.1	CBX7		Chromobox 7	608457				
22.282	8	25	09	22q13.1	CDC42EP1, MSE55, BORG5, CEP1		CDC42 effector protein 1	606084				
22.283	1	20	09	22q13.2	CYP2D6, CPD6, P450DB1		Cytochrome P450, subfamily IID, polypeptide 6	124030			{Debrisoquine sensitivity}, 608902 (3); {Codeine sensitivity}, 608902 (3)	15(Cyp2d)
22.284	12	30	19	22q13.1	DMC1, LIM15		DNA meiotic recombinase 1	602721				
22.285	11	3	14	22q13.1	DNAL4, MRMV3		Dynein, axonemal, light chain 4	610565		mutation identified in 1 MRMV3 family	?Mirror movements 3, 616059 (3)	15(Dnal4)
22.286	07	13	20	22q13.1	DDX17, RH70, P72		DEAD-box helicase 17	608469				
22.287	10	3	07	22q12.3	EIF3D, EIF3S7		Eukaryotic translation initiation factor 3, subunit D	603915				
22.288	8	25	98	22q13.1	H1F0, H1FV		H1 histone family, member 0	142708				
22.289	5	18	95	22q13.1	KCNJ4, HIR		Potassium inwardly-rectifying channel, subfamily J, member 4	600504				
22.290	2	21	03	22q12.3	HMGXB4, HMG2L1		HMG box domain-containing 4	604702				
22.291	7	23	13	22q13.1	JOSD1, KIAA0063		Josephin domain-containing protein 1	615323				
22.292	4	18	05	22q13.1	LGALS2		Lectin, galactoside-binding, soluble, 2	150571			{Myocardial infarction, susceptibility to}, 608446 (3)	
22.293	7	11	17	22q12.3	MCM5, CDC46, MGORS8		Minichromosome maintenance, S. cerevisiae, homolog of, 5	602696		mutation identified in 1 MGORS8 patient	?Meier-Gorlin syndrome 8, 617564 (3)	
22.294	12	10	13	22q13.1	MEIF1, SMCR7L, MID51		Mitochondrial elongation factor 1	615497				
22.295	3	9	00	22q13.1	MGAT3, GNT3		Beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase	604621				
22.296	8	27	15	22q13.1	MIR659		Micro RNA 659	613556				
22.297	07	06	20	22q12.3	NCF4, P40PHOX, CGD3		Neutrophil cytosolic factor-4	601488			Chronic granulomatous disease 3, autosomal recessive, 613960 (3)	
22.298	12	13	18	22q13.2	NDUFA6, MC1DN33		NADH-ubiquinone oxidoreductase subunit A6	602138			Mitochondrial complex I deficiency, nuclear type 33, 618253 (3)	
22.299	3	9	10	22q13.1	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14		Phospholipase A2, group VI	603604			Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration with brain iron accumulation 2B, 610217 (3); Parkinson disease 14, autosomal recessive, 612953 (3)	
22.300	5	19	97	22q13.2	PMM1		Phosphomannomutase 1	601786				
22.301	2	7	01	22q13.1	POLR2F		Polymerase II, RNA, subunit F	604414				
22.302	7	18	16	22q12.3	RBFOX2, RBM9, FOX2, RTA		RNA binding protein, fox-1 homolog 2	612149				
22.303	6	30	06	22q13.1	RPS19BP1, S19BP, MGC52010		Ribosomal protein S19 binding protein 1	610225				15(Rps19bp1)
22.304	5	24	13	22q13.1	SGSM3, RUTBC3, MAP, RUSC3		Small G protein signaling modulator 3	610440				
22.305	2	24	17	22q13.1	SH3BP1, ARHGAP43, BGIN		SH3 domain-binding protein 1	617368				
22.306	4	16	02	22q12.3	SLC5A1, SGLT1		Solute carrier family 5 (sodium/glucose transporter), member 1	182380			Glucose/galactose malabsorption, 606824 (3)	
22.307	4	25	93	22q13.1	SSTR3		Somatostatin receptor-3	182453				15(Sstr3)
22.308	1	11	16	22q13.1	TAB1, MAP3K7IP1		Tak1 (MAP3K7) binding protein 1	602615				
22.309	1	31	07	22q13.1	TNRC6B, KIAA1093		Trinucleotide repeat-containing gene 6B	610740				
22.310	11	19	13	22q12.3	TOM1		Target of MYB1, chicken, homolog of	604700				8(Tom1)
22.311	1	11	06	22q13.1	TRIOBP, KIAA1662		Trio- and F-actin-binding protein	609761			Deafness, autosomal recessive 28, 609823 (3)	
22.312	3	15	07	22q13.2	TTLL1, KIAA0173		tubulin tyrosine ligase-like protein 1	608955				
22.313	12	15	10	22q13.2	TNFRSF13C, BAFFR, CVID4		Tumor necrosis factor receptor superfamily, member 13C	606269			Immunodeficiency, common variable, 4, 613494 (3)	15(Baffr)
22.314	12	4	02	22q13.2	TOB2, KIAA1663		Transducer of erbb2, 2	607396				
22.315	2	8	13	22q13.2	A4GALT, P1PK		Alpha 1,4-galactosyltransferase	607922			[Blood group, P1Pk system, p phenotype], 111400 (3); [Blood group, P1Pk system, P(2) phenotype], 111400 (3); NOR polyagglutination syndrome, 111400 (3)	
22.316	11	10	15	22q13.2	ACO2, ICRD, OPA9		Aconitase, mitochondrial	100850		distal to Ph1 break; mutation identified in 1 OPA9 family	Infantile cerebellar-retinal degeneration, 614559 (3); ?Optic atrophy 9, 616289 (3)	
22.317	12	4	08	22q13.2	ARFGAP3		ADP-ribosylation factor GTPase-activating protein 3	612439				
22.318	2	25	15	22q13.2	CHADL		Chondroadherin-like	616236				
22.319	9	22	17	22q13.2	CSDC2, PIPPIN		Cold-shock domain-containing protein C2	617689				
22.320	7	20	12	22q13.2	DESI1, PPPDE2		Desumoylating isopeptidase 1	614637				
22.321	3	23	14	22q13.2	DNAJB7, DJ5, HSC3		DNAJ/HSP40 homolog, subfamily B, member 7	611336				
22.322	9	30	11	22q13.2	FAM109B, SES2, IPIP27B		Family with sequence similarity 109, member B	614240				
22.323	3	23	09	22q13.2	MIR33A, MIRN33A		Micro RNA 33A	612156				
22.324	1	29	07	22q13.2	NFAM1, CNAIP		NFAT activating protein with ITAM motif 1	608740				
22.325	2	1	11	22q13.2	NHP2L1		Non-histone chromosome protein 2, S. cerevisiae, like 1	601304		previously assigned to 12q24.3 by FISH		
22.326	12	10	13	22q13.2	PACSIN2		Protein kinase C and casein kinase substrate in neurons 2	604960				
22.327	1	24	18	22q13.2	PHF5A, SF3B7, SF3B14B		PHD finger protein 5A	617846				15(Phf5a)
22.328	10	13	09	22q13.2	POLDIP3, SKAR, PDIP46		Polymerase delta-interacting protein 3	611520				
22.329	9	27	17	22q13.2	RANGAP1		GTPase-activating protein, RAN, 1	602362				
22.330	3	30	12	22q13.2	RBX1, ROC1		RING-box 1	603814				
22.331	12	7	03	22q13.2	SEPT3, SEP3		Septin 3	608314				
22.332	10	13	20	22q13.2	SERHL2		Serine hydrolase-like 2	619045				
22.333	10	13	20	22q13.2	SERHL		Serine hydrolase-like, pseudogene	607979				
22.334	2	2	17	22q13.2	SHISA8		Shisa family, member 8	617329				
22.335	1	7	14	22q13.2	SMDT1, EMRE, C22orf32		Single-pass membrane protein with aspartate-rich tail 1	615588				
22.336	5	22	07	22q13.2	WBP2NL, PAWP		WWBP2 N-terminal-like protein	610981				
22.337	11	28	18	22q13.2	ZC3H7B, ROXAN1, KIAA1031		Zinc finger CCCH domain-containing protein 7B	618206				
22.338	3	9	04	22q13.2	BIK, NBK		Bcl2-interacting killer	603392				
22.339	3	10	00	22q13.31	CELSR1		Cadherin EGF LAG seven-pass G-type receptor 1	604523				15(Celsr1)
22.340	7	15	14	22q13.31	FBLN1		Fibulin 1	135820			Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (4)	15(Fbln1)
22.341	04	09	20	22q13.2	L3MBTL2, L3MBT		L3MBTL histone methyl-lysine-binding protein 2	611865				15(L3mbtl2)
22.342	6	29	99	22q13.33	MAPK12, SAPK3, ERK3		Mitogen-activated protein kinase 12 (Stress-activated protein kinase-3)	602399				
22.343	6	7	10	22q13.2	MCHR1, GPR24, SLC1		Melanin-concentrating hormone receptor 1	601751				
22.344	1	9	01	22q13.31	NUP50, NPAP60L, NPAP60		Nucleoporin, 50 kD	604646				15(Npap60)
22.345	5	4	00	22q13.31	PKDREJ		Polycystic kidney disease and sea urchin REJ homolog-like	604670				
22.346	11	27	00	22q13.33	RABL2B		RAB-like 2B	605413				
22.347	3	28	12	22q13.33	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15		SH3 and multiple ankyrin repeat domains 3	606230			Phelan-McDermid syndrome, 606232 (3); {Schizophrenia 15}, 613950 (3)	
22.348	05	21	19	22q13.2	TCF20, SPBP, AR1, DDVIBA		Transcription factor 20	603107			Developmental delay with variable intellectual impairment and behavioral abnormalities, 618430 (3)	
22.349	6	30	05	22q13.31	ARHGAP8, BPGAP1		GTPase-activating protein, RHO, 8	609405				15(Arhgap8)
22.350	8	25	09	22q13.1	GGA1		Golgi associated, gamma adaptin ear containing, ARF binding protein 1	606004				
22.351	1	20	11	22q13.31	GRAMD4, KIAA0767, DIP		Gram domain-containing protein 4	613691				
22.352	2	24	12	22q13.2	MCAT		Malonyl CoA:ACP acyltransferase, mitochondrial	614479				
22.353	3	23	09	22q13.31	MIRLET7A3, LET7A3, MIRNLET7A3		Micro RNA let7a3	612143				
22.354	12	11	18	22q13.31	MIRLET7BHG, LINC-PPARA		MIRLET7B host gene, noncoding	618216				15(Mirlet7bhg)
22.355	3	16	10	22q13.2	MPPED1, C22orf1, 239AB		Metallophosphoesterase domain-containing protein 1	602112				
22.356	12	29	06	22q13.2	PANE1, C22orf18		Proliferation-associated nuclear element 1	610152				
22.357	10	29	09	22q13.31	PARVB		Parvin, beta	608121				
22.358	10	29	09	22q13.31	PARVG		Parvin, gamma	608122				
22.359	1	4	16	22q13.31	PHF21B, PHF4, BHC80L		PHD finger protein 21B	616727				
22.360	2	23	08	22q13.31	PNPLA5, GS2L		Patatin-like phospholipase domain-containing 5	611589				
22.361	6	30	05	22q13.31	PRR5, PP610		Proline-rich protein 5	609406				15(Prr5)
22.362	11	30	20	22q13.31	SAMM50, SAM50		SAMM50 sorting ans assembly machinery component	612058				
22.363	10	11	16	22q13.31	SULT4A1, BRSTL1		Sulfotransferase family 4A, member 1	608359				
22.364	3	29	16	22q13.31	TBC1D22A, C22orf4		TBC1 domain family, member 22A	616879				
22.365	7	9	10	22q13.2	TSPO, BZRP, PBR, PBS, BPBS		Translocator protein, 18kD (benzodiazepine receptor, peripheral type)	109610				15(Bzrp)
22.366	4	14	12	22q13.31	UPK3A, UPK3, UPIII		Uroplakin 3A	611559				
22.367	11	22	99	22q13.33	PLXNB2, MM1		Plexin B2	604293				
22.368	9	8	10	22q13.2	XPNPEP3, APP3, NPHPL1		X-prolyl aminopeptidase 3	613553			Nephronophthisis-like nephropathy 1, 613159 (3)	
22.369	2	27	03	22q13.33	ARSA		Arylsulfatase A	607574			Metachromatic leukodystrophy, 250100 (3)	15(As2)
22.370	2	21	10	22q13.2	CYB5R3, DIA1, B5R		Cytochrome b5 reductase 3	613213			Methemoglobinemia, type I, 250800 (3); Methemoglobinemia, type II, 250800 (3)	15(Dia1)
22.371	5	30	17	22q13.32	FAM19A5, TAFA5		Family with sequence similarity 19, member A5, CC motif chemokine-like	617499				
22.372	12	21	10	22q13.33	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1		Thymidine phosphorylase	131222			Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	
22.373	4	20	11	22q13.33	ACR		Acrosin	102480			?Male infertility due to acrosin deficiency (2)	15(Acr)
22.374	01	03	20	22q13.33	ALG12, CDG1G		ALG12 alpha-1,6-mannosyltransferase	607144			Congenital disorder of glycosylation, type Ig, 607143 (3)	
22.375	7	2	18	22q13.33	MIOX, ALDRL6		Myoinositol oxygenase	606774				
22.376	2	19	07	22q13.33	MLC1, LVM, VL		MLC1 gene	605908			Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)	
22.377	5	24	13	22q13.33	NCAPH2, CAPH2		Non-SMC condensin II complex subunit H2	611230				15(Ncaph2)
22.378	8	25	09	22q13.33	MOV10L1		Mov10-like 1	605794				
22.379	5	26	13	22q13.33	PIM3		Oncogene PIM3	610580				
22.380	3	29	07	22q13.33	SAPS2, PP6R2, KIAA0685		SAPS domain family, member 2	610877				
22.381	7	1	13	22q13.33	SBF1, MTMR5, CMT4B3		SET-binding factor 1 (myotubularin-related protein 5)	603560			Charcot-Marie-Tooth disease, type 4B3, 615284 (3)	
22.382	11	17	16	22q13.33	SELENOO, SELO		Selenoprotein O	607917				
22.383	6	22	14	22q13.33	SYCE3		Synaptonemal complex central element protein 3	615775				
22.384	1	12	15	22q13.33	TUBGCP6, GCP6, KIAA1669, MCCRP1		Tubulin-gamma complex-associated protein 6	610053			Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3)	
22.385	1	24	09	22q13.33	ZBED4, KIAA0637		Zinc finger BED domain-containing protein 4	612552				
23.1	7	9	90	Xpter-p22.32	ARSC2		Arylsulfatase C, f form	301780		probably close to STS = ARSC1, or s form		
23.2	4	25	93	Xp22.33	ASMT, HIOMT		Acetylserotonin methyltransferase	300015		pseudoautosomal		
23.3	12	3	98	Xp22.33	ASMTLX, ASTML		Acetylserotonin methyltransferase-like	300162				
23.4	2	14	03	Xp22.33	CD99, MIC2, MIC2X		CD99 antigen (MIC2 (monoclonal antibody 12E7))	313470		distal to STS		
23.5	4	30	98	Xp22.33	SHOX, GCFX, SS, PHOG		Short stature homeo box	312865		pseudoautosomal; ?gene causing short stature in Turner syndrome	Short stature, idiopathic familial, 300582 (3); Leri-Weill dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)	
23.6	12	31	99	Xpter-p22.32	HDPA		Hodgkin disease, susceptibility, pseudoautosomal	300221			{Hodgkin disease susceptibility, pseudoautosomal} (2)	
23.7	10	23	87	Xpter-p22.32	XG		Xg blood group	314700		nonlyonizing; spans pseudoautosomal boundary; XGPY on Yq11.21	[Blood group, XG system] (3)	
23.8	12	23	19	Xp22.33	DHRSX		Dehydrogenase/reductase, X-linked	301034				
23.9	8	30	11	Xp22.33	GTPBP6, PGPL		GTP-binding protein 6	300124				
23.10	4	6	15	Xp22.33	MXRA5		Matrix remodeling-associated protein 5	300938				
23.11	1	21	11	Xp22.32-p22.31	NLGN4, KIAA1260, AUTSX2, ASPGX2		Neuroligin 4	300427			{Autism susceptibility, X-linked 2}, 300495 (3); {Asperger syndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)	
23.12	7	1	16	Xp22.33	PLCXD1		Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 1	300974		in pseudoautosomal region		
23.13	5	28	13	Xp22.33	PPP2R3B, PR48		Protein phosphatase 2, regulatory subunit B-double prime, beta	300339				
23.14	10	23	00	Xp22.33	VSPA		Visuospatial/perceptual abilities	313000			Turner syndrome-associated neurocognitive phenotype (2); [Visuospatial/perceptual abilities] (2)	
23.15	1	6	09	Xp22.33	ZBED1, ALTE, KIAA0785, TRAMP		Zinc finger BED domain-containing protein 1	300178				
23.16	9	14	12	Xp22.33	XG, PBDX		XG glycoprotein	300879				
23.17	2	16	04	Xp22.31	FAM9A		Family with sequence similarity 9, member A	300477		pseudogene on Xq28, Yp11.31, 1p36.12, 8p11.1		
23.18	12	19	11	Xp22.33	AKAP17A, SFRS17A, DXYS155E, XE7		A kinase (PRKA) anchor protein 17A	312095		nonlyonizing		
23.19	12	5	11	Xp22.33	CSF2RA, SMDP4		Colony-stimulating factor-2 receptor, alpha, low-affinity, granulocyte-macrophage	306250		order in PAR: pter-CSF2RA-IL3RA-ANT3-ASMT-MIC2-cen	Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)	19(Csf2ra)
23.20	2	16	04	Xp22.31	FAM9B		Family with sequence similarity 9, member B	300478				
23.21	11	7	08	Xp22.31	HDHD1A, DXF68S1E, GS1		Haloacid dehalogenase-like hydrolase domain-containing 1A	306480		escapes X-inactivation; 100kb telomeric to STS		
23.22	3	6	00	Xp22.33	SLC25A6, ANT3		Solute carrier family 25 (mitochondrial carrier), member 6 (adenine nucleotide translocator-3, liver)	300151		1st intron ~1.3Mb from Xqter; nonlyonized		
23.23	4	30	09	Xp22.31	STS, ARSC1, ARSC, SSDD, XLI		Steroid sulfatase, microsomal (arylsulfatase C, isozyme S)	300747		nonlyonizing	Ichthyosis, X-linked, 308100 (3)	X,Y(Sts)
23.24	10	12	90	Xp22.32	XGR		XG/MIC2 regulator	314705		?between XG and MIC2		
23.25	12	30	19	Xp22.31	ANOS1, KAL1, KMS, ADMLX, HH1		Anosmin 1	300836		with ichthyosis in probable microdeletion syndrome	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3)	
23.26	11	30	06	Xp22.2	ASB11		Ankyrin repeat- and SOCS box-containing protein 11	300626				
23.27	7	9	09	Xp22.2	FANCB, FAAP95, FAAP90, FLJ34064		Fanconi anemia, complementation group B gene	300515			Fanconi anemia, complementation group B, 300514 (3)	
23.28	2	16	04	Xp22.2	FAM9C		Family with sequence similarity 9, member C	300479				
23.29	11	23	98	Xp22.2	FIGF, VEGFD		c-fos induced growth factor (vascular endothelial growth factor D)	300091				
23.30	8	30	16	Xp22.31	VCS3B, VCXC		Variably charged, X chromosome, 3B	300981				
23.31	2	18	98	Xp22.2	ARHGAP6		Rho GTPase-activating protein-6	300118				
23.32	3	28	03	Xp22.33	ARSE, CDPX1, CDPXR		Arylsulfatase E	300180		CDPX1 in contiguous gene syndrome with STS	Chondrodysplasia punctata, X-linked recessive, 302950 (3)	
23.33	2	14	97	Xp22.33	ARSD		Arylsulfatase D	300002				
23.34	2	14	97	Xp22.33	ARSF		Arylsulfatase F	300003				
23.35	5	19	06	Xp22.33	ARSH		Arylsulfatase H	300586				
23.36	11	09	18	Xp22.2	CLCN4, MRX49, MRX15, MRXSRC		Chloride channel-4	302910			Raynaud-Claes syndrome, 300114 (3)	
23.37	8	30	01	Xp22.33	CRLF2, CRL2		Cytokine receptor-like factor 2	300357		pseudoautosomal		
23.38	10	23	97	Xp22.31	DXS1283E		GS2 gene	300102				
23.39	10	19	99	Xp22.3	EMWX		Episodic muscle weakness, X-linked	300211			Episodic muscle weakness, X-linked (2)	
23.40	6	7	10	Xp22.2	GPR143, OA1, NYS6		G protein-coupled receptor 143	300808		linked to XG	Ocular albinism, type I, Nettleship-Falls type, 300500 (3); Nystagmus 6, congenital, X-linked, 300814 (3)	X(Oa1)
23.41	2	7	01	Xp22.33	GYG2, GN2		Glycogenin 2	300198				
23.42	10	4	93	Xp22.33	IL3RA		Interleukin-3 receptor, alpha subunit	308385		same 190kb segment as CSF2RA		14(Il3ra)
23.43	9	10	09	Xp22.3	LECD		Corneal dystrophy, Lisch epithelial	300778		max lod between DXYS233 and DXYS228X	Corneal dystrophy, Lisch epithelial (2)	
23.44	12	12	19	Xp22.2	MSL3, MSL3L1, MRXSBA		MSL complex subunit 3	300609			Basilicata-Akhtar syndrome, 301032 (3)	
23.45	3	26	03	Xp22.3	MRX2		Mental retardation, X-linked, 2	300428			Mental retardation, X-linked 2 (2)	
23.46	12	16	93	Xp22.3	OASD		Ocular albinism and sensorineural deafness	300650		?allelic to OA1	Ocular albinism with sensorineural deafness (2)	
23.47	7	28	11	Xp22.33	P2RY8, P2Y8		Pyrimidinergic receptor P2Y, G protein-coupled, 8	300525				
23.48	8	5	97	Xp22.33	PRKX		Protein kinase, X-linked	300083				
23.49	4	18	07	Xp22.2	SHROOM2, APXL		Shroom family member 2	300103				X(Apxl)
23.50	09	26	19	Xp22.3-p22.2	TBL1X, TBL1, CHNG8		Transducin-beta-like 1, X-linked	300196			Hypothyroidism, congenital, nongoitrous, 8, 301033 (3)	X(Tbl1)
23.51	4	14	05	Xp22.31	VCX, VCXB1, VCX10R		Variably charged, X chromosome	300229				
23.52	4	14	05	Xp22.31	VCX2, VCX2R, VCXB		Variably charged, X chromosome, 2	300532				
23.53	4	14	05	Xp22.31	VCX3A, VCX8R, VCXA		Variably charged, X chromosome, 3A	300533				
23.54	01	28	20	Xp22.2	OFD1, CXorf5, SGBS2, JBTS10, RP23		OFD1 centriole and centriolar satellite protein	300170		mutation identified in 1 RP23 family	Orofaciodigital syndrome I, 311200 (3); Simpson-Golabi-Behmel syndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3); ?Retinitis pigmentosa 23, 300424 (3)	
23.55	12	4	90	Xp22.2	PRPS2		Phosphoribosyl pyrophosphate synthetase-2	311860		between STS and ZFX		
23.56	08	26	20	Xp22.2	TLR7, IMD74		Toll-like receptor 7	300365		centromeric to TLR8	Immunodeficiency 74, COVID19-related, X-linked, 301051 (3)	
23.57	6	24	10	Xp22.2	TLR8		Toll-like receptor 8	300366		16kb telomeric to TLR7		
23.58	7	11	14	Xp22.2	AMELX, AMG, AIH1, AMGX, AI1E		Amelogenin	300391		also Y	Amelogenesis imperfecta, type 1E, 301200 (3)	X(Amel)
23.59	9	28	93	Xp22.2	GRPR		Gastrin-releasing peptide receptor	305670				
23.60	08	06	19	Xp22.1-p21.3	POLA1, VEODS		Polymerase, DNA, alpha-1	312040			Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3); Van Esch-O'Driscoll syndrome, 301030 (3)	X(Pola)
23.61	1	31	13	Xp22.2	ASB9		Ankyrin repeat- and SOCS box-containing protein 9	300890				
23.62	4	29	14	Xp22.2	ATXN3L		Ataxin 3-like	300920				
23.63	7	11	17	Xq26.2	FIRRE, LINC01200		Functional intergenic repeating RNA element	300999				X(Firre)
23.64	10	23	97	Xp22.2	BMX		BMX non-receptor tyrosine kinase	300101				
23.65	09	20	19	Xp22.2	CLTRN, TMEM27, NX17		Collectrin, amino acid transport regulator	300631				
23.66	1	10	92	Xp22.2	CMTX2		Charcot-Marie-Tooth disease, X-linked recessive, 2	302801			Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 (2)	
23.67	9	26	16	Xp22.2	FRMPD4, PRESO, KIAA0316, MRX104		FERM and PDZ domains-containing protein 4	300838			Mental retardation, X-linked 104, 300983 (3)	
23.68	02	28	20	Xp22.2	GEMIN8, FAM51A1		GEM nuclear organelle-associated protein 8	300962				
23.69	11	13	07	Xp22.2	HBFQTL3, FCP1, FCPX, FCP		Fetal hemoglobin quantitative trait locus 3	305435			Fetal hemoglobin quantitative trait locus 3 (2)	
23.70	9	28	96	Xp22.2	GPM6B, M6B		Glycoprotein M6B	300051				
23.71	5	26	13	Xp22.2	INE2		Inactivation escape 2	300165				
23.72	3	25	15	Xp22.2	MRX73		Mental retardation, X-linked 73	300355		between DXS8019 and DXS365	Mental retardation, X-linked 73 (2)	
23.73	9	20	14	Xp22.2	PIR		Pirin	300931				
23.74	12	5	00	Xp22.2	RAB9		RAS-associated protein RAB9	300284				
23.75	1	13	11	Xp22.2	RBBP7		Retinoblastoma-binding protein 7	300825				
23.76	04	02	20	Xp22.2	REPS2, POB1		RALBP1-associated EPS domain-containing protein 2	300317				
23.77	5	27	93	Xp22.11	ZFX		Zinc finger protein, X-linked	314980		nonlyonizing		X(Zfx)
23.78	1	18	18	Xp22.11	EIF2S3, EIF2G, MEHMO, MRXSBRK		Eukaryotic translation initiation factor 2, subunit 3	300161			MEHMO syndrome, 300148 (3)	
23.79	11	3	14	Xp22.12	PDHA1, PHE1A, PDHAD		Pyruvate dehydrogenase, E1-alpha polypeptide-1	300502			Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3)	X(Pdha1)
23.80	2	1	11	Xp22.11	PHEX, HYP, HPDR1, LXHR		Phosphate regulating endopeptidase homolog, X-linked	300550			Hypophosphatemic rickets, X-linked dominant, 307800 (3)	X(Phex, Gy)
23.81	10	1	09	Xp22.13	PHKA2, PHK, XLG, PYKL, GSD9A		Phosphorylase kinase, liver, alpha-2 subunit	300798			Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage disease, type IXa2, 306000 (3)	
23.82	6	9	98	Xp22.13	PPEF1		Protein phosphatase, EF hand calcium-binding domain 1	300109				
23.83	7	1	11	Xp22.12	RPS6KA3, RSK2, MRX19		Ribosomal protein S6 kinase, 90kD, polypeptide 3	300075			Coffin-Lowry syndrome, 303600 (3); Mental retardation, X-linked 19, 300844 (3)	
23.84	3	31	11	Xp22.13	RS1, XLRS1		Retinoschisin	300839		25cM from XG	Retinoschisis, 312700 (3)	
23.85	02	24	20	Xp22.13	SCML1		SCM polycomb group protein-like 1	300227				
23.86	3	14	07	Xp22.2	TRAPPC2, SEDL, SEDT		Trafficking protein particle complex 2 (sedlin)	300202			Spondyloepiphyseal dysplasia tarda, 313400 (3)	
23.87	5	28	13	Xp22.12	YY2, ZNF631		Transcription factor YY2	300570				
23.88	12	02	20	Xp21.3	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32		Aristaless-related homeobox, X-linked	300382			Developmental and epileptic encephalopathy 1, 308350 (3); Lissencephaly, X-linked 2, 300215 (3); Mental retardation, X-linked 29 and others, 300419 (3); Proud syndrome, 300004 (3); Partington syndrome, 309510 (3); Hydranencephaly with abnormal genitalia, 300215 (3)	
23.89	12	07	20	Xp22.2-p22.1	NHS, CXN, CTRCT40		NHS actin remodeling regulator	300457			Nance-Horan syndrome, 302350 (3); Cataract 40, X-linked, 302200 (3)	?X(Xcat)
23.90	12	8	17	Xp22.12	CNKSR2, CNK2, KIAA0902, MRXSHG		connector enhancer of KSR 2	300724		conflicting assignment to chr.1	Mental retardation, X-linked, syndromic, Houge type, 301008 (3)	
23.91	12	15	10	Xp22.12	MAP3K15, ASK3		Mitogen-activated protein kinase kinase kinase 15	300820				
23.92	8	19	18	Xp22.12	MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19		Membrane-bound transcription factor protease, site 2	300294		mutation identified in 1 OLMSX family	IFAP syndrome with or without BRESHECK syndrome, 308205 (3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3); ?Olmsted syndrome, X-linked, 300918 (3); Osteogenesis imperfecta, type XIX, 301014 (3)	
23.93	10	23	11	Xp22.11	ACOT9, MTACT48		Acyl-CoA thioesterase 9	300862				X(Acot9)
23.94	4	2	15	Xp22.11	PCYT1B		Phosphate cytidylyltransferase 1, choline, beta isoform	300948				
23.95	8	19	13	Xp22.11	PDK3, CMTX6		Pyruvate dehydrogenase kinase, isoenzyme 3	300906		1 family identified with mutation	?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3)	
23.96	8	18	14	Xp22.11	PRDX4, AOE372		Peroxiredoxin 4	300927				
23.97	10	13	15	Xp22.11	PTCHD1, AUTSX4		Patched domain-containing protein 1	300828			{Autism, susceptibility to, X-linked 4}, 300830 (3)	
23.98	12	17	08	Xp22.11	APOO, MYO25, FAM121B		Apolipoprotein O	300753				
23.99	3	9	00	Xp22.2	CA5B		Carbonic anhydrase VB, mitochondrial	300230				X(Car5b)
23.100	9	22	16	Xp22.11	KLHL15, KIAA1677		Kelch-like 15	300980			Mental retardation, X-linked 103, 300982 (3)	
23.101	6	3	14	Xp22.2	PIGA, PNH1, MCAHS2		Phosphatidylinositol glycan, class A	311770		pseudogene on chr.12	Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3); Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)	X(Piga)
23.102	10	13	15	Xp22.11	SAT1, SSAT		Spermidine/spermine N1-acetyltransferase 1	313020				
23.103	7	1	11	Xp22.12	SMPX, DFNX4		Small muscle protein, X-linked	300226			Deafness, X-linked 4, 300066 (3)	
23.104	5	6	04	Xp22.11	SMS, SRS, MRSR		Spermine synthase	300105			Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)	X(Sms)
23.105	05	13	20	Xp22.2	TXLNG, CXorf15, FIAT		Taxilin, gamma	300677				
23.106	4	10	97	Xp22.2	ZRSR2, U2AF1RS2		Zinc finger-, CCCH domain-, and RNA-binding motif-containing serine/arginine-rich protein 2	300028				X(U2af1rs2)
23.107	3	13	06	Xp21.3-p21.2	IL1RAPL1, IL1R8, MRX21, MRX34		Il-1 receptor accessory protein-like 1	300206			Mental retardation, X-linked 21/34, 300143 (3)	
23.108	04	23	19	Xp22.12	SH3KBP1, CIN85, IMD61, AGMX2		SH3-domain kinase-binding protein 1	300374		mutation identified in 1 IMD61 family	?Immunodeficiency 61, 300310 (3)	
23.109	10	12	90	Xp22.2	GLRA2		Glycine receptor, alpha-2 polypeptide	305990				X(Glra2)
23.110	2	23	17	Xp11.23	ZNF81		Zinc finger protein-81 (HFZ20)	314998				
23.111	2	2	14	Xp11.3	ZNF41		Zinc finger protein-41	314995				
23.112	5	16	01	Xp22.2	ACE2, ACEH		Angiotensin I converting enzyme 2	300335				
23.113	10	8	88	Xp22	AIC		Aicardi syndrome	304050		?in p22.31 with FDH as contiguous gene syndrome	Aicardi syndrome (2)	
23.114	5	29	12	Xp22	ANIB5		Aneurysm, intracranial berry, 5	300870			Aneurysm, intracranial berry, 5 (2)	
23.115	7	17	14	Xp22.2	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS		Adaptor-related protein complex 1, sigma-2 subunit	300629			Mental retardation, X-linked syndromic 5, 304340 (3)	
23.116	10	23	20	Xp22.13	CDKL5, STK9, ISSX, DEE2		Cyclin-dependent kinase-like 5 (serine/threonine protein kinase 9)	300203			Developmental and epileptic encephalopathy 2, 300672 (3)	X(Stk9)
23.117	5	7	03	Xp22.2	CTPS2		Cytidine 5-prime triphosphate synthetase 2	300380				
23.118	2	1	01	Xp22.2	EGFL6		Epidermal growth factor-like 6	300239				
23.119	5	13	15	Xp22.2	HCCS, MCOPS7, LSDMCA1		Holocytochrome c synthase (cytochrome c heme-lyase)	300056			Linear skin defects with multiple congenital anomalies 1, 309801 (3)	
23.120	12	30	03	Xp21.3	MAGEB5		Melanoma antigen, family B, 5	300466				
23.121	12	30	03	Xp21.3	MAGEB6		Melanoma antigen, family B, 6	300467				
23.122	9	26	16	Xp22.2	MID1, OGS1, BBBG1, FXY, OSX		Midline-1	300552		type II defect on chr.22	Opitz GBBB syndrome, type I, 300000 (3)	X(Mid1)
23.123	10	18	00	Xp22	MNG2		Multinodular goiter-2	300273			Goiter, multinodular, 2 (2)	
23.124	11	29	99	Xp22.13	RAI2		Retinoic acid-induced 2	300217				
23.125	02	24	20	Xp22.13	SCML2		SCM polycomb group protein-like 2	300208				
23.126	08	20	18	Xp22.13	ADGRG2, GPR64, HE6, CBAVDX		Adhesion G protein-coupled receptor G2	300572			Congenital bilateral absence of vas deferens, X-linked, 300985 (3)	X(Gpr64)
23.127	3	19	09	Xp21.2	MAGEB1, MAGEL1, DAM10		Melanoma antigen, family B, 1	300097				X(Smage1/2)
23.128	3	19	09	Xp21.2	MAGEB2, DAM6		Melanoma antigen, family B, 2	300098				
23.129	10	26	98	Xp21.2	MAGEB3		Melanoma antigen, family B, 3	300152				
23.130	10	26	98	Xp21.2	MAGEB4		Melanoma antigen, family B, 4	300153				
23.131	3	19	09	Xp21.3	MAGEB10		Melanoma antigen, family B, 10	300761				
23.132	3	19	09	Xp21.1	MAGEB16		Melanoma antigen, family B, 16	300762				
23.133	3	19	09	Xp22.2	MAGEB17		Melanoma antigen, family B, 17	300763				
23.134	3	26	07	Xp21.3	MENOQ1		Menopause, natural, age at, QTL 1	300488			{Menopause, natural, age at, QTL1} (2)	
23.135	2	28	03	Xq21.31	TGIF2LX, TGIFLX		Transforming growth factor-beta-induced factor 2-like, X-linked	300411				
23.136	6	12	17	Xp21.2	NR0B1, DAX1, AHC, AHX, SRXY2		Nuclear receptor subfamily 0, group B, member 1	300473		distal to GK	Adrenal hypoplasia, congenital, 300200 (3); 46XY sex reversal 2, dosage-sensitive, 300018 (3)	X(Ahch)
23.137	2	24	04	Xp21.2	GK		Glycerol kinase	300474		2Mb distal to DMD; pseudogene on 4q32	Glycerol kinase deficiency, 307030 (3)	X(Gyk)
23.138	1	25	93	Xp21.3-p21.2	RP6		Retinitis pigmentosa-6, X-linked recessive	312612			?Retinitis pigmentosa, X-linked recessive, 6 (2)	
23.139	3	18	08	Xp21.2	DFNX3, DFN4		Deafness, X-linked 3	300030		?same as DMD	Deafness, X-linked 3 (2)	
23.140	3	14	02	Xp21.2-p21.1	DMD, BMD, CMD3B		Dystrophin	300377		dystrophin gene; cen-5'-3'-pter; 2Mb; ?Xp21.13	Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy, 300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)	X(Dmd)
23.141	3	23	14	Xp21.2	FTHL17		Ferritin heavy polypeptide-like 17	300308				
23.142	1	11	16	Xp21.2	TAB3		Tak1 (MAP3K7) binding protein 3	300480				
23.143	10	12	20	Xp21.2	TASL, CXorf21		TLR adaptor interacting with endolysosomal SLC15A4	301049				
23.144	5	23	11	Xp21.1	XK, MCLDS		Kell blood group precursor	314850		~500kb distal to CGD	McLeod syndrome with or without chronic granulomatous disease, 300842 (3)	
23.145	2	5	99	Xp11.3	USP11, UHX1		Ubiquitin-specific protease-11 (ubiquitin carboxyl-terminal hydrolase)	300050				
23.146	8	25	98	Xp21.2-q21.1	XS, LUXS		Lutheran suppressor, X-linked	309050				
23.147	9	8	14	Xp21.1-p11.4	CYBB, CGD, AMCBX2, IMD34		Cytochrome b-245, beta polypeptide	300481		proximal to DMD	Chronic granulomatous disease, X-linked, 306400 (3); Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3)	X(Cybb)
23.148	12	4	03	Xp11.4	OTC		Ornithine transcarbamylase	300461		proximal to DMD, CGD	Ornithine transcarbamylase deficiency, 311250 (3)	X(spf; Otc)
23.149	12	31	99	Xp11.4	SRPX, ETX1		Sushi-repeat-containing protein, X chromosome	300187		probably between OTC and CGD		
23.150	10	5	11	Xp21.1-p11.23	MRXS17		Mental retardation, X-linked, syndromic 17	300858		between rs2748314 and rs5906782	Mental retardation, X-linked, syndromic 17 (2)	
23.151	9	9	10	Xp21	DELXp21, CXDELp21		Chromosome Xp21 deletion syndrome	300679		contiguous gene deletion syndrome	Chromosome Xp21 deletion syndrome (4)	
23.152	3	6	01	Xp11.4	TCTE1L		T complex-associated testis-expressed 1-like	300302				
23.153	04	21	20	Xp11.4	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS, CDG2R		ATPase, H+ transporting, lysosomal, accessory protein 2	300556		mutation identified in 1 XPDS family	Mental retardation, X-linked, syndromic, Hedera type, 300423 (3); ?Parkinsonism with spasticity, X-linked, 300911 (3); Congenital disorder of glycosylation, type IIr, 301045 (3)	
23.154	3	30	04	Xp11.4	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2		BCL6 corepressor	300485			Microphthalmia, syndromic 2, 300166 (3)	
23.155	3	28	12	Xp11.4	CASK, MICPCH, FGS4, CMG, MRXSNA		Calcium/calmodulin-dependent serine protein kinase	300172			Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3); FG syndrome 4, 300422 (3); Mental retardation, with or without nystagmus, 300422 (3)	
23.156	1	31	13	Xp11.4	NYX, CSNB1A, NBM1		Nyctalopin	300278			Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3)	
23.157	9	18	00	Xp11.4	GPR34		G protein-coupled receptor 34	300241				
23.158	10	29	08	Xp11.4	GPR82		G protein-coupled receptor 82	300748				
23.159	9	28	15	Xp11.4	MID1IP1, MIG12		MID1-interacting protein 1	300961				
23.160	8	25	14	Xp11.3	NDP, ND, EVR2		Norrin	300658			Norrie disease, 310600 (3); Exudative vitreoretinopathy 2, X-linked, 305390 (3)	X(Ndp)
23.161	6	7	10	Xp11.4	NYS5		Nystagmus 5, congenital, X-linked	300589		max lod at DXS993	Nystagmus 5, congenital, X-linked (2)	
23.162	3	5	13	Xp11.4	RPGR, RP3, CRD, RP15, COD1, CORDX1		Retinitis pigmentosa GTPase regulator	312610			Retinitis pigmentosa 3, 300029 (3); Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3); Macular degeneration, X-linked atrophic, 300834 (3); Cone-rod dystrophy, X-linked, 1, 304020 (3)	
23.163	2	28	08	Xp21.1	TMEM47, BCMP1		Transmembrane protein 47	300698				
23.164	3	1	16	Xp11.4	USP9X, DFFRX, MRX99, MRXS99F		Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked)	300072			Mental retardation, X-linked 99, 300919 (3); Mental retardation, X-linked 99, syndromic, female-restricted, 300968 (3)	
23.165	3	25	02	Xp11.23	PFC, PFD		Properdin P factor, complement	300383			Properdin deficiency, X-linked, 312060 (3)	X(Pfc)
23.166	9	9	11	Xp11.4-p11.21	OPA2		Optic atrophy, X-linked	311050			Optic atrophy 2, X-linked (2)	
23.167	3	21	94	Xp11.3	ARAF1, RAFA1, PKS2		Oncogene ARAF1	311010				X(Araf)
23.168	8	10	99	Xp11.4	MED14, CRSP2, CXorf4, TRAP170, EXLM1		Mediator complex subunit 14	300182				
23.169	8	24	04	Xp11.3-p11.2	SYN1		Synapsin I	313440		5kb from PFC	Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)	X(Syn1)
23.170	2	28	06	Xp11.3	CHST7, C6ST2		Carbohydrate sulfotransferase 7	300375				
23.171	9	24	15	Xp11.3	CXorf36, DIA1R		Chromosome X open reading frame 36	300959				
23.172	2	18	09	Xp11.3	DELXp11.3, CXDELp11.3		Chromosome Xp11.3 deletion syndrome (X-linked mental retardation with retinitis pigmentosa)	300578			Chromosome Xp11.3 deletion syndrome (4)	
23.173	5	28	13	Xp11.3	DUSP21, LMWDSP21		Dual-specificity phosphatase 21	300678				
23.174	9	9	10	Xp11.3	EFHC2		EF-hand domain (C-terminal)-containing protein 2	300817				
23.175	7	20	12	Xp11.3	FUNDC1		FUN14 domain-containing protein 1	300871				
23.176	3	23	09	Xp11.3	MIR221, MIRN221		Micro RNA 221	300568		near MIRN222		
23.177	3	23	09	Xp11.3	MIR222, MIRN222		Micro RNA 222	300569		near MIRN221		
23.178	2	2	14	Xp11.3	MRX89		Mental retardation, X-linked 89	300848		t(X;7)(p11.3;q11.21)	Mental retardation, X-linked 89 (2)	
23.179	1	24	14	Xp11.3	MRX92		Mental retardation, X-linked 92	300851		previously associated with ZNF674	Mental retardation, X-linked 92 (2)	
23.180	12	13	18	Xp11.3	NDUFB11, LSDMCA3, MC1DN30		NADH-ubiquinone oxidoreductase subunit B11	300403		mutation identified in 1 MC1DN30 patient	Linear skin defects with multiple congenital anomalies 3, 300952 (3); ?Mitochondrial complex I deficiency, nuclear type 30, 301021 (3)	
23.181	6	27	02	Xp11.23	PCSK1N, PROSAAS		Proprotein convertase, subtilisin/kexin-type, 1, inhibitor of	300399				
23.182	04	15	19	Xp11.3	SLC9A7, NHE7, MRX108		Solute carrier family 9 (sodium/hydrogen exchanger), member 7	300368			Intellectual developmental disorder, X-linked 108, 301024 (3)	
23.183	8	16	99	Xp11.23	ZNF21		Zinc finger protein-12	314993				
23.184	3	23	06	Xp11.3	ZNF673, FLJ20344		Zinc finger protein 673	300585				
23.185	4	17	13	Xp11.3	CDK16, PCTK1, PCTAIRE1		Cyclin-dependent kinase 16	311550				
23.186	07	15	20	Xp11.4	DDX3X, DDX3, DBX, MRX102, MRXSSB		DEAD-box helicase 3, X-linked	300160			Intellectual developmental disorder, X-linked, syndrome, Snijders Blok type, 300958 (3)	
23.187	12	18	07	Xp11.23	TBC1D25, OATL1		TBC1 domain family, member 25	311240				
23.188	8	21	91	Xp11.3	TIMP1, TIMP, EPA		Erythroid-potentiating activity (tissue inhibitor of metalloproteinases)	305370		in intron of SYN1		X(Timp)
23.189	2	24	17	Xp11.3-p11.21	MRX45		Mental retardation, X-linked 45	300498			Mental retardation,X-linked 45 (2)	
23.190	6	29	99	Xp11.3-p11.21	MRX50		Mental retardation, X-linked nonspecific, type 50	300115			Mental retardation, X-linked 50 (2)	
23.191	2	25	08	Xp11.3-q12	AGSPX		Angioma serptiginosum, X-linked	300652		between DXS8026 and DXS106	Angio serpiginosum (2)	
23.192	9	22	96	Xp11.3-q13.3	MRX14		Mental retardation, X-linked-14	300062			Mental retardation, X-linked 14 (2)	
23.193	11	9	11	Xp11.3-q22	MRXS7		Mental retardation, X-linked, syndromic 7	300218			Mental retardation, X-linked syndromic 7 (2)	
23.194	9	30	04	Xp11.3-q22.3	MRX84		Mental retardation, X-linked 84	300505		29 other MRX loci in same region	Mental retardation, X-linked 84 (2)	
23.195	1	31	13	Xp11.23	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2		Calcium channel, voltage-dependent, alpha-1F subunit	300110			Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)	
23.196	11	24	15	Xp11.23	CCDC22, RTSC2		Coiled-coil domain-containing protein 22	300859			Ritscher-Schinzel syndrome 2, 300963 (3)	
23.197	3	27	15	Xp11.23	CCDC120		Coiled-coil domain-containing protein 120	300947				
23.198	04	30	19	Xp11.23	FTSJ1, JM23, SPB1, MRX44, MRX9		FTSJ RNA 2-prime-O-methyltransferase 1	300499			Mental retardation, X-linked 9/44, 309549 (3)	
23.199	9	2	08	Xp11.23	GAGE1		G antigen 1	300594				
23.200	9	2	08	Xp11.23	GAGE2A		G antigen 2A	300720				
23.201	9	2	08	Xp11.23	GAGE2B		G antigen 2B	300726				
23.202	9	2	08	Xp11.23	GAGE2C, GAGE2		G antigen 2C	300595				
23.203	9	2	08	Xp11.23	GAGE2D		G antigen 2D	300735				
23.204	9	2	08	Xp11.23	GAGE2E		G antigen 2E	300736				
23.205	5	28	13	Xp11.23	GAGE3		G antigen 3	300596				
23.206	5	28	13	Xp11.23	GAGE4		G antigen 4	300597				
23.207	6	1	12	Xp11.23	GAGE5		G antigen 5	300598				
23.208	6	1	12	Xp11.23	GAGE6		G antigen 6	300599				
23.209	3	13	08	Xp11.23	GAGE7		G antigen 7	300601				
23.210	9	2	08	Xp11.23	GAGE7B		G antigen 7B	300637				
23.211	9	2	08	Xp11.23	GAGE10		G antigen 10	300737				
23.212	9	2	08	Xp11.23	GAGE12C		G antigen 12C	300727				
23.213	9	2	08	Xp11.23	GAGE12D		G antigen 12D	300728				
23.214	9	2	08	Xp11.23	GAGE12E		G antigen 12E	300729				
23.215	9	2	08	Xp11.23	GAGE12F		G antigen 12F	300730				
23.216	9	2	08	Xp11.23	GAGE12G		G antigen 12G	300731				
23.217	9	2	08	Xp11.23	GAGE12H		G antigen 12H	300732				
23.218	9	2	08	Xp11.23	GAGE12J		G antigen 12J	300733				
23.219	9	2	08	Xp11.23	GAGE13		G antigen 13	300734				
23.220	7	20	12	Xp11.23	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP		GATA-binding protein-1 (globin transcription factor-1)	305371			Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	X(Gf1)
23.221	8	28	17	Xp11.23	GPKOW, GPATCH5		G-patch domain and KO@ motifs	301003				
23.222	2	17	15	Xp11.23	GRIPAP1, GRASP1, KIAA1167		GRIP1-associated protein 1	300408				
23.223	2	17	15	Xp11.23	HDAC6, CPBHM		Histone deacetylase 6	300272		mutation identified in 1 CPBHM family	?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3)	
23.224	5	26	13	Xp11.3	INE1		Inactivation escape 1	300164				
23.225	6	1	12	Xp11.23	KCND1		Potassium voltage-gated channel, SHAL-related subfamily, member 1	300281				
23.226	2	7	01	Xp11.22	MAGED1		Melanoma antigen, family D, 1	300224				
23.227	7	26	16	Xp11.3	MAOA, BRNRS		Monoamine oxidase A	309850		NDP, MAOA, MAOB closely linked	Brunner syndrome, 300615 (3); {Antisocial behavior}, 300615 (3)	X(Maoa)
23.228	4	10	90	Xp11.3	MAOB		Monoamine oxidase B	309860				X(Maob)
23.229	4	17	13	Xp11.23	MIR502		Micro RNA 502	300893				
23.230	03	29	19	Xp11.23	MIR532		Micro RNA 532	301023				
23.231	3	13	08	Xp11.22	NUDT10, DIPP3A, APS2		Nucleoside diphosphate-linked moiety X motif 10	300527				
23.232	3	13	08	Xp11.22	NUDT11, DIPP3B, APS1		Nucleoside diphosphate-linked moiety X motif 11	300528				
23.233	6	5	08	Xp11.23	OTUD5, DUBA		OTU domain-containing protein 5	300713				
23.234	9	4	08	Xp11.23	GAGEB1, PAGE1		P antigen family, member 1	300288				
23.235	9	4	08	Xp11.23	PAGE4, GAGEC1		P antigen family, member 4	300287				
23.236	5	26	13	Xp11.3	PHF16, JADE3, KIAA0215		PHD finger protein 16	300618				X(Phf16)
23.237	09	16	19	Xp11.23	PORCN, PORC, DHOF, FODH		Porcupine O-acyltransferase	300651			Focal dermal hypoplasia, 305600 (3)	
23.238	4	6	11	Xp11.23	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8		Polyglutamine-binding protein 1	300463			Renpenning syndrome, 309500 (3)	
23.239	3	31	11	Xp11.23	PRAF2, JM4		PRA1 domain family, member 2	300840				
23.240	11	1	13	Xp11.23	PRICKLE3, LMO6		Prickle, Drosophila, homolog of, 3	300111				
23.241	2	19	96	Xp11.23	RBM3		RNA binding motif protein 3	300027				
23.242	7	8	10	Xp11.3	RBM10, DXS8237E, KIAA0122, TARPS		RNA-binding motif protein 10	300080			TARP syndrome, 311900 (3)	
23.243	6	18	10	Xp11.3	RP2		Retinitis pigmentosa-2, X-linked recessive	300757			Retinitis pigmentosa 2, 312600 (3)	
23.244	8	22	07	Xp11.23	SLC38A5, SN2		Solute carrier family 38 (amino acid transporter), member 5	300649				
23.245	3	13	08	Xp11.23	SPACA5, LOC389852		Sperm acrosome associated 5	300593				
23.246	5	28	13	Xp11.23	SSX1, SSRC		Synovial sarcoma, X breakpoint 1	312820		fused with SYT in synovial sarcoma	?Sarcoma, synovial, 300813 (3)	
23.247	5	28	13	Xp11.23	SSX3		Synovial sarcoma, X breakpoint 3	300325				
23.248	5	28	13	Xp11.23	SSX4		Synovial sarcoma, X breakpoint 4	300326				
23.249	5	28	13	Xp11.23	SSX6		Synovial sarcoma, X breakpoint 6	300541				
23.250	5	26	13	Xp11.23	SSX9		Sarcoma, synovial, X breakpoint 9	300544				
23.251	5	28	13	Xp11.23	SSX5		Synovial sarcoma, X breakpoint 5	300327				
23.252	2	1	01	Xp11.23	SUV39H1		Suppressor of variegation 3-9, Drosophila, homolog of, 1	300254				
23.253	11	12	20	Xp11.3	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1, VEXAS		Ubiquitin-like modifier-activating enzyme 1	314370		escapes inactivation	Spinal muscular atrophy, X-linked 2, infantile, 301830 (3); VEXAS syndrome, somatic, 301054 (3)	
23.254	6	1	12	Xp11.23	UXT		Ubiquitously expressed transcript	300234				
23.255	11	2	04	Xp11.23	WDR13		WD repeat-containing protein 13	300512				
23.256	4	17	13	Xp11.23	WDR45, WIPI4, NBIA5		WD repeat-containing protein 45	300526		?pseudogene on 4q31.3	Neurodegeneration with brain iron accumulation 5, 300894 (3)	
23.257	10	12	10	Xp11.23	ZNF630		Zinc finger protein 630	300819				
23.258	10	12	09	Xp11.23-p11.22	DUPXp11.23p11.22, CXDUPp11.23p11.22		Chromosome Xp11.23-p11.22 duplication syndrome	300801			Chromosome Xp11.23-p11.22 duplication syndrome (4)	
23.259	9	24	15	Xp11.23	EBP, CDPX2, CPXD, CPX, MEND		Emopamil-binding protein	300205			Chondrodysplasia punctata, X-linked dominant, 302960 (3); MEND syndrome, 300960 (3)	X(Bpa)
23.260	9	30	99	Xp11.23	PLP2		Proteolipid protein 2	300112				
23.261	8	6	13	Xp11.23	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M		Solute carrier family 35 (UDP-galactose transporter), member 2	314375			Congenital disorder of glycosylation, type IIm, 300896 (3)	
23.262	10	8	09	Xp11.23	SYP, MRXSYP		Synaptophysin	313475			Mental retardation, X-linked 96, 300802 (3)	X(Syp)
23.263	11	13	17	Xp11.23	WAS, IMD2, THC1, SCNX		Wiskott-Aldrich syndrome gene	300392		t(18;X)(q11.2;p11.2); distal to TIMP	Wiskott-Aldrich syndrome, 301000 (3); Thrombocytopenia, X-linked, 313900 (3); Neutropenia, severe congenital, X-linked, 300299 (3); Thrombocytopenia, X-linked, intermittent, 313900 (3)	X(Wasp, ?sf)
23.264	2	28	03	Xp11.22	GSPT2, GST2, ERF3B		G1- to S-phase transition 2	300418				
23.265	9	26	11	Xp11.21	UBQLN2, PLIC2, CHAP1, ALS15		Ubiquilin 2	300264			Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	
23.266	04	25	19	Xp11.23	FOXP3, IPEX, AIID, XPID, PIDX		Forkhead box P3 (scurfin)	300292			Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)	X(sf, Foxp3)
23.267	3	22	07	Xp11.22	CCNB3		Cyclin B3	300456				
23.268	8	31	07	Xp11.23	CLCN5, CLCK2, NPHL2, DENTS, NPHL1		Chloride channel-5	300008			Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3); Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	X(Clcn5)
23.269	3	9	11	Xp11.22	DGKK		Diacylglycerol kinase, kappa, 142kD	300837				
23.270	8	22	14	Xp11.22	DUPXp11.22, MRX17, MRX31		Xp11.22 microduplication syndrome	300705		minimal duplicated region 228 kb overlapping HUWE1 and HSD17B10	Xp11.22 microduplication syndrome (4)	
23.271	10	25	19	Xp11.22	EZHIP, CATACOMB, CXorf67		EZH inhibitory protein	301036				
23.272	7	18	12	Xp11.22	GNL3L		Guanine nucleotide binding protein-like 3-like protein	300873				
23.273	2	2	14	Xp11.22	GPR173, SREB3		G protein-coupled receptor 173	300253				
23.274	4	23	08	Xp11.22	HPCX2		Prostate cancer, hereditary, X-linked 2	300704		associated with rs5945572	{Prostate cancer, hereditary, X-linked 2} (2)	
23.275	9	12	11	Xp11.22	HYSP4		Hypospadias 4, X-linked, susceptibility to	300856		associated with rs1934179 and rs7063116	{Hypospadias 4, X-linked, susceptibility to} (2)	
23.276	5	11	16	Xp11.22	IQSEC2, KIAA0522, MRX1, MRX78		IQ motif- and Sec7 domain-containing protein 2	300522			Mental retardation, X-linked 1/78, 309530 (3)	X(Iqsec2)
23.277	12	11	18	Xp11.22	KANTR, LINC01155		KDM5C adjacent transcript, noncoding	301019				X(Kantr)
23.278	12	21	09	Xp11.22	MIR98, MIRN98		Micro RNA 98	300810				
23.279	3	23	09	Xp11.22	MIRLET7F2, LET7F2, MIRNLET7F2		Micro RNA Let7f2	300721				
23.280	5	28	13	Xp11.22	SSX2		Sarcoma, synovial, X breakpoint 2	300192			?Sarcoma, synovial, 300813 (3)	
23.281	5	29	13	Xp11.22	SSX7		Sarcoma, synovial, X breakpoint 7	300542				
23.282	5	28	13	Xp11.22	SSX8		Sarcoma, synovial, X breakpoint 8	300543				
23.283	9	20	11	Xp11.23	TFE3, RCCX1		Transcription factor for IgH enhancer	314310		fuses with PRCC in RCCP	Renal cell carcinoma, papillary, 1, 300854 (3)	X(Tfe3)
23.284	3	25	15	Xp11.22	TSR2, WGG1, DBA14		TSR2, 20S rRNA accumulation, S. cerevisiae, homolog of	300945		mutation identified in 1 DBA14 family	?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3)	
23.285	9	22	08	Xp11.22	XAGE1A		X antigen family, member 1A	300742				
23.286	9	22	08	Xp11.22	XAGE1B		X antigen family, member 1B	300743				
23.287	9	22	08	Xp11.22	XAGE1C		X antigen family, member 1C	300744				
23.288	9	22	08	Xp11.22	XAGE1E		X antigen family, member 1E	300745				
23.289	5	26	13	Xp11.22	XAGE2, GAGED3		X antigen family, member 2	300416				
23.290	9	8	08	Xp11.22	XAGE3, PLAC6		X antigen family, member 3	300740				
23.291	10	24	11	Xp11.22	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ		Lysine-specific demethylase 5C (Jumonji, AT-rich interactive domain 1C)	314690		escapes inactivation	Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	X(Smcx)
23.292	12	01	20	Xp11.22	SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2, DEE85		Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; DXS423E; SB1.8)	300040		escapes lyonization	Cornelia de Lange syndrome 2, 300590 (3); Developmental and epileptic encephalopathy 85, with or without midline brain defects, 301044 (3)	X(Sb1.8)
23.293	6	10	98	Xp11.21	TRO		Trophinin	300132				
23.294	3	17	16	Xp11.21	ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1		Aminolevulinate, delta-, synthase-2	301300			Anemia, sideroblastic, 1, 300751 (3); Protoporphyria, erythropoietic, X-linked, 300752 (3)	X(Alas)
23.295	5	12	09	Xp11.21	APEX2, APE2, XTH2, APEXL2		APEX nuclease (apurinic/apyrimidinic endonuclease) 2	300773				
23.296	5	26	13	Xp11.21	DSF34		DXF34 gene	300621				X(Dxf34)
23.297	10	27	11	Xp11.22	FGD1, FGDY, AAS, MRXS16		FYVE, RhoGEF, and PH domain-containing protein 1	300546			Aarskog-Scott syndrome, 305400 (3); Mental retardation, X-linked syndromic 16, 305400 (3)	X(Fgdy)
23.298	4	10	15	Xp11.21	FOXR2, FOXN6		Forkhead box R2	300949				X(Foxn6)
23.299	5	28	13	Xp11.21	MAGEH1, MAGEH		Melanoma antigen, family H, 1	300548				
23.300	9	4	08	Xp11.21	PAGE2, GAGEC2		P antigen family, member 2	300738				
23.301	9	4	08	Xp11.21	PAGE3, GAGEC1		P antigen family, member 3	300739				
23.302	12	22	17	Xp11.21	PAGE5, CT16, GAGEE1		P antigen family, member 5	301009				
23.303	4	27	00	Xp11.21	PFKFB1, PFRX		Fructose-2,6-bisphosphatase	311790		?Xq27-q25; ?Xcen-q13		
23.304	8	29	08	Xp11.21	RRAGB, RAGB		Ras-related GTP-binding protein B	300725				
23.305	5	26	13	Xp11.21	SNORA11		Small nucleolar RNA, H/ACA box, 11	300662		in intron 1 of MAGED2		
23.306	5	26	13	Xp11.21	SPIN2		Spindlin family, member 2	300517				
23.307	1	8	01	Xp11.21	ZXDA		Zinc finger-encoding gene, X-linked, duplicated, A	300235				
23.308	1	8	01	Xp11.21	ZXDB		Zinc finger-encoding gene, X-linked, duplicated, B	300236				
23.309	10	1	99	Xp11.22	AKAP4, AKAP82, HI, FSC1		A-kinase anchor protein 4, 82kD	300185				
23.310	8	31	06	Xp11.22	BMP15, GDF9B, ODG2, POF4		Bone morphogenetic protein 15	300247			Ovarian dysgenesis 2, 300510 (3); Premature ovarian failure 4, 300510 (3)	X(Bmp15)
23.311	9	22	08	Xp11.22	FAM120C, CXorf17		Family with sequence similarity 120, member C	300741				
23.312	5	10	17	Xp11.22	HSD17B10, HADH2, ERAB, MRXS10, HSD10MD		17-beta-hydroxysteroid dehydrogenase X	300256			HSD10 mitochondrial disease, 300438 (3)	
23.313	9	12	92	Xp11.23	ELK1		ELK1, member of ETS oncogene family	311040		distal to OATL1		X(Elk1)
23.314	7	2	03	Xp11.23	HRAS2, HRASP		v-Ha-ras harvey rat sarcoma viral oncogene homolog 2	300437				
23.315	05	07	19	Xp11.22	HUWE1, UREB1, KIAA0312, LASU1, MRXST		HECT, UBA, and WWE domains-containing protein 1	300697			Mental retardation, X-linked syndromic, Turner type, 309590 (3)	X(Huwe1)
23.316	1	26	12	Xp11.3	KDM6A, UTX, KABUK2		Lysine (K)-specific demethylase 6A	300128		UTY also in mouse and man; escapes inactivation	Kabuki syndrome 2, 300867 (3)	X(Utx)
23.317	5	19	16	Xp11.21	MAGED2, MAGED, BARTS5		Melanoma antigen, family D, 2	300470			Bartter syndrome, type 5, antenatal, transient, 300971 (3)	
23.318	4	17	06	Xp11.22	PHF8, ZNF422, KIAA1111, MRXSSD		PHD finger protein 8	300560			Mental retardation syndrome, X-linked, Siderius type, 300263 (3)	
23.319	4	20	17	Xp11.22	SHROOM4, KIAA1202, SDSX		Shroom family member 4	300579			Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)	
23.320	04	27	20	Xp11.23	TIMM17B, TIM17B		Translocase of inner mitochondrial membrane 17B	300249				
23.321	9	2	08	Xp11.22	TSPYL2, CDA1, DENTT, CINAP		TSPY-like 2	300564				
23.322	5	26	05	Xp11.22	WNK3, PRKWNK3, KIAA1566		WNK lysine deficient protein kinase 3	300358				
23.323	9	26	16	Xp11.23	USP27X, USP22L, MRX105		Ubiquitin-specific protease 27, X-linked	300975			Mental retardation, X-linked 105, 300984 (3)	
23.324	2	15	96	Xp11.3	ZNF157		Zinc finger protein-157 (HZF22)	300024				
23.325	10	22	99	Xp11.3	RGN, SMP30		Regucalcin	300212				
23.326	5	12	03	Xp11.2-q12	MRX81		Mental retardation, X-linked 81	300433		between DXS1039 and DXS1216	Mental retardation, X-linked 81 (2)	
23.327	2	24	17	Xp11.21	NBDY, LINC01420, NOBODY		Negative regulator of P-body association	300992				
23.328	3	13	08	Xp11.21	FAAH2		Fatty acid amide hydrolase 2	300654				
23.329	10	14	09	Xp11	GRDX, GD3		Graves disease, susceptibility to, X-linked	300351			{Graves disease, susceptibility to, X-linked} (2)	
23.330	6	29	98	Xp11	IDDMX		Diabetes mellitus, insulin-dependent, X-linked, susceptibility to	300136		only with DR3	{Diabetes mellitus, insulin-dependent, X-linked} (2)	
23.331	12	28	05	Xp11	LOAS		Leber optic atrophy, susceptibility to	308905			{Leber optic atrophy, susceptibility to} (2)	
23.332	3	11	08	Xp11.22	MAGED4, MAGEE1, KIAA1859		Melanoma antigen, family D, 4	300702				
23.333	3	19	09	Xp11.22	MAGED4B		Melanoma antigen, family D, 4B	300765				
23.334	2	17	06	Xp11	MRXS12		Mental retardation, X-linked, syndromic 12	309545			?Mental retardation, X-linked, syndromic 12 (2)	
23.335	5	26	13	Xp11.22	SPANXN5		SPANX family, member N5	300668				
23.336	1	24	14	Xp11.3	ZNF674		Zinc finger protein 674	300573				
23.337	4	16	96	Xp11-q21	MRX20		Mental retardation, X-linked-20	300047			Mental retardation, X-linked 20 (2)	
23.338	1	10	93	Xp11-q21	PRS, MRXS2		Prieto syndrome (mental retardation, X-linked, syndromic 2, with dysmorphism and cerebral atrophy)	309610			Prieto syndrome (2)	
23.339	12	1	94	Xp22.2	CALB3, CABP9K		Calbindin 3 (vitamin D-dependent calcium-binding protein)	302020				
23.340	12	22	17	Xq13.1	ARR3, MYP26		Arrestin 3, retinal	301770			Myopia 26, X-linked, female-limited, 301010 (3)	
23.341	8	5	97	Xq	CGF1		Cognitive function-1, social	300082		imprinted locus	[Social cognition] (2)	
23.342	3	28	90	Xq	DXS435E, A11		A-11 gene	300010				
23.343	11	29	11	Xq	MGR2		Migraine, familial typical, susceptibility to, 2	300125			{Migraine, familial typical, susceptibility to, 2} (2)	
23.344	8	15	13	Xq	MTBSX		Mycobacterium tuberculosis, susceptibility to, X-linked	300259			{Mycobacterium tuberculosis, susceptibility, X-linked} (2)	
23.345	11	8	03	Xp11.4	TSPAN7, TM4SF2, MXS1, A15, MRX58		Tetraspanin 7	300096			Mental retardation, X-linked 58, 300210 (3)	
23.346	5	15	08	Xq11-q12	AGA2		Alopecia, androgenetic, 2	300710		associated with rs6152	Alopecia, androgenetic, 2 (2)	
23.347	02	12	19	Xq12	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1		Androgen receptor (dihydrotestosterone receptor)	313700			Androgen insensitivity, 300068 (3); Spinal and bulbar muscular atrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); Hypospadias 1, X-linked, 300633 (3); {Prostate cancer, susceptibility to}, 176807 (3)	X(Tfm)
23.348	8	9	99	Xq12	HEPH		Hephaestin	300167				X(Heph)
23.349	9	23	13	Xq11.2	AMER1, FAM123B, WTX, OSCS		APC membrane recruitment protein 1	300647			Osteopathia striata with cranial sclerosis, 300373 (3)	
23.350	1	31	13	Xq11.2	ASB12		Ankyrin repeat- and SOCS box-containing protein 12	300891				
23.351	12	22	00	Xq11.2	SPG16		Spastic paraplegia 16, X-linked, complicated	300266			Spastic paraplegia 16, X-linked, complicated (2)	
23.352	04	09	20	Xq11.2	ZC4H2, KIAA1166, WRWF, MRXS4, WRWFFR		Zinc finger C4H2 domain-containing protein	300897			Wieacker-Wolff syndrome, 314580 (3); Wieacker-Wolff syndrome, female-restricted, 301041 (3)	
23.353	12	15	16	Xq12	MSN, IMD50		Moesin	309845			Immunodeficiency 50, 300988 (3)	X(Msn)
23.354	2	28	08	Xq12	EDAR2, XEDAR, EDAA2R		Ectodysplasin A2 receptor	300276				
23.355	6	23	04	Xq13.1	EFNB1, EPLG2, CFNS, CFND		eph-related receptor tyrosine kinase ligand 2 (ephrin B1)	300035		?CFNS also on Xp22	Craniofrontonasal dysplasia, 304110 (3)	X(Eplg2)
23.356	3	2	06	Xq13.1	INGX, ING2		Inhibitor of growth, X-linked	300452				
23.357	8	10	16	Xq12	LAS1L, WTS		Las1-like ribosome biogenesis factor	300964			Wilson-Turner syndrome, 309585 (3)	
23.358	3	23	09	Xq12	MIR223, MIRN223		Micro RNA 223	300694				
23.359	3	24	06	Xq12	OPHN1, MRX60		Oligophrenin-1	300127			Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3)	
23.360	8	30	01	Xq12	Z39IG		Immunoglobulin superfamily protein Z39IG	300353				
23.361	1	9	13	Xq11-q12	ZC3H12B, MCPIP2		Zinc finger CCCH domain-containing protein 12B	300889				
23.362	6	7	10	Xq21.1	ATP7A, MNK, MK, OHS, SMAX3		ATPase, Cu++ transporting, alpha polypeptide	300011		probably Xq13.2-q13.3, ~150kb prox. to PGK1	Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3); Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	X(Mnk)
23.363	5	16	01	Xq13.1	ITGB1BP2		Integrin, beta-1, binding protein of, 2	300332				X(Itgb1bp2)
23.364	2	6	07	Xp11.4-p11.2	GAGE8		G antigen 8	300638				
23.365	12	17	12	Xq13.1	EDA, ED1, ECTD1, HED1, STHAGX1		Ectodysplasin A	300451			Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3); Tooth agenesis, selective, X-linked 1, 313500 (3)	X(Ta)
23.366	6	12	17	Xq12-q13	YIPF6		YIP1 domain family, member 6	300996				
23.367	5	13	13	Xq21.1	TBX22, CPX, ABERS		T-box 22	300307		1 ABERS family identified with mutation	Cleft palate with ankyloglossia, 303400 (3); ?Abruzzo-Erickson syndrome, 302905 (3)	
23.368	10	10	02	Xp22.3	FGS3		FG syndrome 3	300406			FG syndrome 3 (2)	
23.369	12	11	03	Xq12-q21.3	MRX77		Mental retardation, X-linked 77	300454			Mental retardation, X-linked 77 (2)	
23.370	6	9	08	Xq12-q21.31	MRXS9		Mental retardation, X-linked, syndromic 9	300709		between DXS1111 and DXS1197	Mental retardation, X-linked, syndromic 9 (2)	
23.371	12	7	07	Xq21.1	ATRX, XH2, XNP, SHS, SFM1, MRXHF1		ATR-X gene (helicase 2; X-linked nuclear protein)	300032			Alpha-thalassemia/mental retardation syndrome, 301040 (3); Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	X(Xh2)
23.372	2	26	10	Xq21.1	BRWD3, MRX93		Bromodomain-and WD repeat-containing protein 3	300553			Mental retardation, X-linked 93, 300659 (3)	
23.373	3	1	06	Xq13.1	CXCR3, GPR9, CD182		Chemokine, C-X-C motif, receptor 3 (G protein-coupled receptor-9)	300574		previously assigned to chr.8		
23.374	9	10	12	Xq13.1	DMRTC1		Doublesex- and MAB3-related transcription factor C1	300878				
23.375	8	10	16	Xq13.1	HDAC8, MRXS6, CDLS5		Histone deacetylase 8	300269			Cornelia de Lange syndrome 5, 300882 (3)	
23.376	5	18	95	Xq13.1	IL2RG, SCIDX1, SCIDX, IMD4		Interleukin-2 receptor, gamma	308380		linked to DXS159	Severe combined immunodeficiency, X-linked, 300400 (3); Combined immunodeficiency, X-linked, moderate, 312863 (3)	X(Il2rg)
23.377	5	13	13	Xq13.1	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX		Mediator of RNA polymerase II transcription, subunit 12, S. cerevisiae, homolog of	300188			Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3); Ohdo syndrome, X-linked, 300895 (3)	X(Opa1)
23.378	12	16	05	Xq13.1	NLGN3, ASPGX1, AUTSX1		Neuroligin 3	300336			{Autism susceptibility, X-linked 1}, 300425 (3); {Asperger syndrome susceptibility, X-linked 1}, 300494 (3)	
23.379	12	11	02	Xq21.1	NSBP1		Nucleosomal binding protein 1	300385				X(Nsbp1)
23.380	6	28	17	Xq13.1	OGT, MRX106		O-linked N-acetylglucosamine transferase	300255			Mental retardation, X-linked 106, 300997 (3)	X(Ogt)
23.381	10	15	97	Xq13.1	P2RY4, NRU, P2Y4		Pyrimidinergic receptor P2Y, G-protein coupled, 4	300038				
23.382	7	2	07	Xq21.1	PGK1, PGKA		Phosphoglycerate kinase-1	311800		?Xq13.3; pseudogenes PGK1P1 on Xq, PGK1P2 on chr. 6	Phosphoglycerate kinase 1 deficiency, 300653 (3)	X(Pgk1)
23.383	5	15	07	Xq13.1	PHKA1		Phosphorylase kinase, muscle, alpha polypeptide	311870		?proximal and close to PGKA;	Muscle glycogenosis, 300559 (3)	X(Phka)
23.384	2	1	01	Xq13.1	PIN4, PAR14, EPVH		Peptidyl-prolyl cis/trans isomerase, nima-interacting, 4	300252				
23.385	1	11	16	Xq13.1	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33		TAF1 RNA polymerase II, TATA box-binding protein-associated factor, 250kD	313650		SVA retrotransposon insertion	Dystonia-Parkinsonism, X-linked, 314250 (3); Mental retardation, X-linked, syndromic 33, 300966 (3)	X(Ccg1)
23.386	8	29	02	Xq21.1	CYSLTR1, CYSLT1		Cysteinyl leukotriene receptor 1	300201				
23.387	10	30	18	Xq13.2	RLIM, RNF12, TOKAS		RING finger protein, LIM domain-interacting	300379			Tonne-Kalscheuer syndrome, 300978 (3)	X(Rnf12)
23.388	4	24	08	Xq21.1	LPAR4, LPA4, P2RY9, P2Y9, GPR23		Lysophosphatidic acid receptor 4	300086				
23.389	12	27	01	Xq13.1	ACRC		Acidic repeat-containing gene	300369				
23.390	7	18	14	Xq13.1	AWAT1, DGA2		Acyl-CoA wax alcohol acyltransferase 1	300924				
23.391	7	18	14	Xq13.1	DGAT2L6, DC3		Diacylglycerol O-acyltransferase 2-like 6	300926				
23.392	7	18	14	Xq13.1	AWAT2, DC4, MFAT		Acyl-CoA wax alcohol acyltransferase 2	300925				X(Awat2)
23.393	09	09	19	Xq13.1	DLG3, NEDLG, SAP102, MRX90		Discs large MAGUK scaffold protein 3	300189			Mental retardation, X-linked 90, 300850 (3)	
23.394	1	17	08	Xq13.1	ERCC6L, PICH		ERCC6-like	300687				
23.395	4	17	13	Xq13.1	FOXO4, MLLT7, AFX1		Forkhead box O4	300033				
23.396	8	1	16	Xq13.1	GDPD2, GDE3		Glycerophosphodiester phosphodiesterase domain-containing protein 2	300940				
23.397	10	27	93	Xq13.1	GJB1, CX32, CMTX1		Gap junction protein, beta-1, 32kD (connexin 32)	304040			Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)	X(Gjb1)
23.398	8	11	14	Xq13.1	KIF4A, KIF4, MRX100		Kinesin family member 4A	300521		mutation identified in 1 MRX100 family	?Mental retardation, X-linked 100, 300923 (3)	
23.399	3	19	09	Xq13.3	MAGEE1, DAMAGE, KIAA1587		Melanoma antigen, family E, 1	300759				
23.400	3	19	09	Xq13.3	MAGEE2		Melanoma antigen, family E, 2	300760				
23.401	1	13	99	Xq13.1	MSG1		Melanocyte-specific gene 1	300149				X(msg1)
23.402	2	19	16	Xq13.1	NONO, NRB54, MRXS34		Non-Pou domain-containing octamer (ATGCAAAT) binding protein (nuclear RNA-binding protein, 54-kD)	300084		2Mb proximal to PHKA1	Mental retardation, X-linked, syndromic 34, 300967 (3)	
23.403	6	5	08	Xq13.1	OTUD6A, DUBA2		OTU domain-containing protein 6A	300714				
23.404	1	5	07	Xq13.1	PDZD11, AIPP1, PISP		PDZ domain-containing 11	300632				
23.405	6	19	12	Xq13.1	PJA1		Praja 1	300420				
23.406	4	4	00	Xq13.1	RPS4X, CCG2, SCAR		Ribosomal protein S4, X-linked	312760		cen-RPS4X-PHKA1-XIST-qter in 2.6Mb		X(Rps4x)
23.407	5	28	13	Xq13.1	SLC7A3, CAT3		Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3	300443				
23.408	12	10	12	Xq13.1	SNX12		Sorting nexin 12	300883				
23.409	1	28	08	Xq13.1	STARD8, DLC3, STARTGAP3, KIAA0189		START domain-containing protein 8	300689				
23.410	6	18	15	Xq13.1	TEX11, SPGFX2		Testis-expressed gene 11	300311			Spermatogenic failure, X-linked, 2, 309120 (3)	
23.411	10	12	99	Xq13.1	ZMYM3, ZNF261, DXS6673E		Zinc finger, MYM-type 3	300061				
23.412	09	09	19	Xq21.1	MAGT1, IAP, XMEN, CDG1CC		Magnesium transporter 1	300715			Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3); Congenital disorder of glycosylation, type Icc, 301031 (3)	X(Magt1)
23.413	10	29	99	Xq13.3	ABCB7, ABC7, ASAT		ATP-binding cassette-7	300135			Anemia, sideroblastic, with ataxia, 301310 (3)	X(Abc7)
23.414	2	3	04	Xq13.1	IGBP1		Immunoglobulin-binding protein 1	300139			Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3)	
23.415	5	19	06	Xq13.1-q22.1	CFTDX		Myopathy, congenital, with fiber-type disproportion, X-linked	300580		between DXS8019 and DXS99	Myopathy, congenital, with fiber-type disproportion, X-linked (2)	
23.416	12	24	08	Xq21.1	TAF9B, TAF9L, TAFII31L		TAF9B RNA polymerase II, TATA box-binding protein-associated factor, 31kD	300754				
23.417	9	14	95	Xq13.2	CDX4		Caudal type homeo box transcription factor 4	300025				X(Cdx4)
23.418	6	22	14	Xq13.2	CHIC1, BRX		Cystein-rich hydrophobic domain protein 1	300922				
23.419	11	24	14	Xq13.2	FTX, LINC00182		FTX transcript, XIST regulator, noncoding	300936				X(Ftx)
23.420	10	25	11	Xq13.2	MRXSAB		Abidi X-linked mental retardation syndrome	300262			Mental retardation, X-linked syndromic, Abidi type (2)	
23.421	6	1	12	Xq13.2	NAP1L2, BPX		Nucleosome assembly protein 1-like 2	300026				
23.422	2	8	11	Xq13.2	NCRNA00183, JPX, ENOX		Noncoding RNA 183	300832				
23.423	9	13	17	Xq13.3	NEXMIF, KIAA2022, MRX98		Neurite extension and migration factor	300524		inv(X)(q13;p22)	Mental retardation, X-linked 98, 300912 (3)	
23.424	6	21	05	Xq13.2	SLC16A2, DXS128, XPCT		Solute carrier family 16 (monocarboxylic acid transporters), member 2	300095			Allan-Herndon-Dudley syndrome, 300523 (3)	
23.425	3	29	99	Xq13.2	TSIX		X-inactivation-specific transcript-antisense	300181				
23.426	3	17	98	Xq13.2	XIC, XCE, XIST, SXI1		X chromosome controlling element (X-inactivation center)	314670		q13-q21; metaphase bend, or fold, at q13.3-q21.1	X-inactivation, familial skewed, 300087 (3)	X(Xce)
23.427	8	26	15	Xq13.3	BRAFP1		BRAF pseudogene 1	300956				10(Brafrs1)
23.428	09	04	19	Xq13.3	MRX91		Mental retardation, X-linked 91	300577		t(X;15)(q13.3;cen)	Mental retardation, X-linked 91 (4)	
23.429	4	15	11	Xq21.1	PGAM4, PGAM3		Phosphoglycerate mutase family member 4	300567				
23.430	5	21	99	Xq21.1	SH3BGR		SH3-binding domain glutamic acid-rich protein-like	300190				
23.431	5	26	13	Xq13.3	UPRT		Uracil phosphoribosyltransferase, S. cerevisiae, homolog of	300656				
23.432	09	04	19	Xq13.3	ZDHHC15		Zinc finger DHHC domain-containing protein 15	300576				
23.433	3	8	00	Xq21.1	ITM2A, E25A		Integral membrane protein 2A	300222				X(Itm2a)
23.434	5	18	12	Xq21	DELXq21, CXDELq21		Chromosome Xq21 deletion syndrome	303110		at least CHM and POU3F4 deleted	Choroideremia, deafness, and mental retardation (4)	
23.435	7	17	06	Xq21.1	FLJ22792, POF1B, POF2B		FLJ22792 gene	300603		mutation identified in 1 POF2B family	?Premature ovarian failure 2B, 300604 (3)	
23.436	3	6	01	Xq21.1	RPS6KA6, RSK4		Ribosomal protein S6 kinase, 90kD, 6	300303				
23.437	7	17	01	Xq21.33	EPAG		Early lymphoid activation gene	300347				
23.438	4	10	15	Xq21-q25	PARK12		Parkinson disease-12	300557		max lod with DXS1106, DXS8055, DXS1001	{Parkinson disease 12} (2)	
23.439	3	24	09	Xq21.1	CYLC1		Cylicin 1	300768				
23.440	5	13	15	Xq21.1	COX7B, LSDMCA2		Cytochrome c oxidase, subunit VIIb	300885			Linear skin defects with multiple congenital anomalies 2, 300887 (3)	
23.441	7	11	16	Xq21.1	FAM46D		Family with sequence similarity 46, member D	300976				
23.442	10	15	13	Xq21.1	FGF16, MF4		Fibroblast growth factor 16	300827		previously mapped to 8q21.3	Metacarpal 4-5 fusion, 309630 (3)	
23.443	8	2	13	Xq21.1	GPR174, GPCR17		G protein-coupled receptor 174	300903				X(Gpr174)
23.444	5	30	17	Xq21.1	HDX, CXorf43		Highly divergent homeobox	300994				
23.445	5	28	13	Xq21.1	P2RY10, P2Y10		Purinergic receptor P2Y, G protein-coupled, 10	300529				
23.446	3	18	08	Xq21.1	POU3F4, DFN3, DFNX2		POU domain, class 3, transcription factor 4	300039			Deafness, X-linked 2, 304400 (3)	X(Pou3f4)
23.447	10	29	11	Xq21.1	ZNF711, ZNF6, CMPX1, MRX97		Zinc finger protein-711	314990			Mental retardation, X-linked 97, 300803 (3)	
23.448	7	28	15	Xq21.1	APOOL, FAM121A, Cxorf33		Apolipoprotein O-like	300955				
23.449	5	1	02	Xq21.2	CHM, TCD		Rab escort protein 1	300390			Choroideremia, 303100 (3)	X(rep1)
23.450	2	26	09	Xq21.3	AD16		Alzheimer disease 16	300756		associated with rs5984894	{Alzheimer disease 16} (2)	
23.451	02	24	20	Xq21.2	DACH2		Dachshund family transcription factor 2	300608				X(Dach2)
23.452	5	28	13	Xq21.31	KLHL4		Kelch-like 4	300348				
23.453	4	30	03	Xq21.31	PABPC5, PABP5		Polyadenylate-binding protein, cytoplasmic, 5	300407				
23.454	7	26	02	Xq21.31	PCDH11X, PCDH11, PCDHX		Protocadherin 11, X-linked	300246				
23.455	11	06	18	Xq22.1	BTK, AGMX1, IMD1, XLA, AT, IGHD3		Bruton agammaglobulinemia tyrosine kinase	300300			Agammaglobulinemia, X-linked 1, 300755 (3); Isolated growth hormone deficiency, type III, with agammaglobulinemia, 307200 (3)	X(xid, Btp)
23.456	6	29	99	Xq21.32	NAP1L3		Nucleosome assembly protein 1-like 3	300117				
23.457	6	29	99	Xp22.2	TMSB4X, TMSB4, TB4X, PTMB4		Thymosin, beta-4, X chromosome	300159				X(Tmsb4x)
23.458	8	27	01	Xq22.1	NXF3		Nuclear RNA export factor 3	300316				
23.459	3	23	09	Xq21.33	RPA4		Replication protein A4	300767				
23.460	7	31	08	Xq22.1	SYTL4		Synaptotagmin-like 4	300723				
23.461	3	14	06	Xq22.1	ARMCX1, ALEX1		Armadillo repeat-containing protein, X-linked 1	300362				
23.462	3	14	06	Xq22.1	ARMCX2, ALEX2, KIAA0512		Armadillo repeat-containing protein, X-linked 2	300363				
23.463	3	14	06	Xq22.1	ARMCX3, ALEX3		Armadillo repeat-containing protein, X-linked 3	300364				
23.464	10	28	11	Xq21.33-q23	MRXSCS		Mental retardation, X-linked, syndromic, Chudley-Schwartz type	300861		max lod at DXS1120	Mental retardation, X-linked, syndromic, Chudley-Schwartz type (2)	
23.465	10	16	14	Xq22.1	SRPX2, SRPUL, RESDX		SUSHI repeat-containing protein, X-linked, 2	300642		mutation identified in 1 RESDX family	?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)	
23.466	09	19	19	Xq22.3	ATG4A, APG4A, AUTL2		Autophagy related 4A cysteine peptidase	300663				
23.467	2	6	08	Xq22.2	BEX2		Brain-expressed X-linked gene 2	300691				
23.468	09	09	19	Xq21.33	DIAPH2, DIA, POF2A		diaphanous-related formin 2	300108		mutation identified in 1 POF2A family	?Premature ovarian failure 2A, 300511 (3)	
23.469	7	8	96	Xq22.1	DRP2		Dystrophin-related protein 2	300052				
23.470	10	21	96	Xq22.1	FSHPRH1, LRPR1		FSH primary response, rat, homolog of, 1	300065				
23.471	3	10	02	Xq22.1	GPRASP1, GASP, KIAA0443		G protein-coupled receptor-associated sorting protein 1	300417		conflicting assignment to chr.9		
23.472	3	28	07	Xq22.1	GLA		Galactosidase, alpha	300644			Fabry disease, 301500 (3); Fabry disease, cardiac variant, 301500 (3)	X(Ags)
23.473	5	29	98	Xq22-q23	GUCY2F, GUC2F		Guanylate cyclase 2F	300041				X(Gucy2f)
23.474	6	16	17	Xq22.1	HNRNPH2, NRPH2, MRXSB		Heterogeneous nuclear ribonucleoprotein H2	300610		second signal at 6q25.3-q26, pseudogene?	Mental retardation, X-linked, syndromic, Bain type, 300986 (3)	
23.475	11	4	00	Xq22.3	IL1RAPL2		Interleukin 1 receptor accessory protein-like 2	300277				
23.476	6	9	08	Xq23	KKLC1, CXorf61		Kita-Kyushu lung cancer antigen 1	300625				
23.477	8	12	14	Xq22.3	MID2, MRX101		Midline 2	300204		mutation identified in 1 MRX101 family	?Mental retardation, X-linked 101, 300928 (3)	X(Mid2)
23.478	6	6	03	Xq22.2	MORFL2, MRGX, KIAA0026		Mortality factor 4-like 2	300409				
23.479	01	03	00	Xq22.1	NOX1, MOX1, NOH1		NADPH oxidase 1	300225				
23.480	12	01	20	Xq22.1	PCDH19, KIAA1313, EFMR, DEE9		Protocadherin 19	300460			Developmental and epileptic encephalopathy 9, 300088 (3)	
23.481	1	29	13	Xq22.2	PLP1, PMD, HLD1, SPG2		Proteolipid protein 1	300401			Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia 2, X-linked, 312920 (3)	X(Plp(jp))
23.482	4	25	08	Xq22.1	TNMD, TEM, CHM1L		Tenomodulin	300459				
23.483	1	20	06	Xq22.1	TSPAN6, TM4SF6		Tetraspanin 6	300191				
23.484	04	27	20	Xq22.1	TIMM8A, DFN1, DDP, MTS, DDP1		Translocase of inner mitochondrial membrane 8A	300356			Mohr-Tranebjaerg syndrome, 304700 (3)	
23.485	7	8	89	Xq22.3	MYCL2		MYCL-related processed gene	310310		pseudogene on Xq27.3		
23.486	4	26	06	Xq24	MCTS1, MCT1		Malignant T-cell amplified sequence 1	300587				
23.487	5	22	03	Xq24	PGRMC1		Progesterone receptor membrane component 1	300435				
23.488	2	26	10	Xq22.3	PRPS1, CMTX5, DFNX1, DFN2		Phosphoribosyl pyrophosphate synthetase-1	311850			Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3); Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3); Arts syndrome, 301835 (3); Deafness, X-linked 1, 304500 (3)	
23.489	7	11	14	Xq22-q28	AI1E2, AIH3		Amelogenesis imperfecta, hypomaturation or hypoplastic type, X-linked 2	301201			?Amelogenesis imperfecta, type IE, X-linked 2 (2)	
23.490	10	23	20	Xq11.1	ARHGEF9, PEM2, KIAA0424, DEE8		Rho guanine nucleotide exchange factor 9	300429			Developmental and epileptic encephalopathy 8, 300607 (3)	
23.491	05	07	20	Xq22.1	ARMCX4		Armadillo repeat-containing protein, X-linked 4	301046				
23.492	05	07	20	Xq22.1	ARMCX		Armadillo repeat-containing protein, X-linked 6	301048				X(Armcx)
23.493	2	6	08	Xq22.1	BEX5, NGFRAP1L1		BEX family member 5	300693				
23.494	4	29	14	Xq22.1	BHLHB9, P60TRP, KIAA1701		Basic helix-loop-helix domain-containing protein, class B, 9	300921				
23.495	11	1	13	Xq22.1	CSTF64		Cleavage stimulation factor, 3-prime pre-RNA, subunit 2, 64kD	300907				
23.496	11	15	18	Xq22.1	GPRASP2, GASP2, DFNX7		G protein-coupled receptor-associated sorting protein 2	300969		mutation identified in 1 DFNX7 family	?Deafness, X-linked 7, 301018 (3)	
23.497	11	19	13	Xq22.1	NXF5		Nuclear RNA export factor 5	300319				
23.498	6	26	13	Xq22.1	RPL36A, RPL44		Ribosomal protein L36A	300902				
23.499	12	27	19	Xq22.1	TAF7L, TAF2Q		TATA-box binding protein-associated factor 7-like	300314				
23.500	4	04	00	Xq22.2	TCEAL1, P21, SIIR		Transcription elongation factor A-like 1	300237				
23.501	11	25	14	Xq22.1	TMSB15A, TMSB15, TMSNB		Thymosin, beta-15A	300939				
23.502	12	17	07	Xq22.1	XKRX, XPLAC, XKR2, XRG2		X Kell blood group precursor-related, X-linked	300684				
23.503	11	16	17	Xq22.1	ZMAT1, KIAA1789		Zinc finger, matrin-type 1	301007				
23.504	2	6	08	Xq22.1	BEX1		Brain-expressed X-linked gene 1	300690				X(Bex1)
23.505	5	10	04	Xq22.2	ESX1L, ESXR1		ESX1-like protein	300154				X(Esx1)
23.506	8	27	01	Xq22.1	NXF4		Nuclear RNA export factor 4	300318				
23.507	12	8	00	Xq22.2	RAB9B, RAB9L		RAS-associated protein RAB9B	300285				
23.508	5	5	09	Xq22.2	TCEAL7		Transcription elongation factor A-like 7	300771				
23.509	5	26	13	Xq22.3	VSIG1, GPA34		V-set and immunoglobulin domains-containing protein 1	300620				
23.510	4	10	12	Xq23	CHRDL1, VOPT, MGC1		Chordin-like 1	300350			Megalocornea 1, X-linked 309300 (3)	
23.511	10	10	01	Xq22.2	NGFRAP1, BEX3, NADE, DXS6984E		Nerve growth factor receptor (TNFRSF16) associated protein 1	300361				
23.512	2	6	08	Xq22.1	BEX4		BEX family member 4	300692				X(Bex4)
23.513	5	26	13	Xq22.2	H2BFWT		H2B histone family, member W, testis-specific	300507				
23.514	10	12	14	Xq22.1	RAB40AL, RLGP, MRXSMP		Ras-associated protein, RAB40A-like	300405				
23.515	12	30	14	Xq22.2	SLC25A53		Solute carrier family 25, member 53	300941				
23.516	9	16	16	Xq22.3	TBG, TBGQTL		Thyroxine-binding globulin	314200			[Thyroxine-binding globulin QTL], 300932 (3)	
23.517	2	20	07	Xq22.3	TSC22D3, DSIPI, GILZ		TSC22 domain family, member 3	300506				
23.518	1	23	18	Xq22.2	TMSB15B		Thymosin, beta-15B	301011		opposite strand relative to TMSB15A		
23.519	4	26	01	Xq22.2-q26	MRX53		Mental retardation, X-linked-53	300324			Mental retardation, X-linked 53 (2)	
23.520	9	18	08	Xq23	ACSL4, FACL4, ACS4, MRX63		Acyl-CoA synthetase long-chain family member 4	300157			Mental retardation, X-linked 63, 300387 (3)	
23.521	7	16	10	Xq22.3	AMMEC, DELXq22.3, CXDELq22.3		Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (AMME complex)	300194		contiguous gene deletion syndrome	Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (4)	
23.522	1	27	17	Xq23	AMMECR1, MFHIEN		Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis chromosomal region gene 1	300195			Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, 300990 (3)	
23.523	01	31	19	Xq22.3	COL4A5, ATS1		Collagen IV, alpha-5 polypeptide	303630		diffuse leiomyomatosis with Alport syndrome = contiguous gene syndrome with COL4A6	Alport syndrome 1, X-linked, 301050 (3)	X(Col4a5)
23.524	2	2	14	Xq22.3	COL4A6, DELXq22.3, CXDELq22.3, DFNX6		Collagen IV, alpha-6 polypeptide	303631		mutation identified in 1 DFNX6 family	?Deafness, X-linked 6, 300914 (3)	
23.525	3	14	06	Xq22.3	FGS5		FG syndrome 5	300581			FG syndrome 5 (2)	
23.526	10	11	17	Xq22.3	FRMPD3, KIAA1817		FERM- and PDZ domain-containing protein 3	301005				
23.527	09	26	19	Xq22.3	IRS4, CHNG9		Insulin receptor substrate 4	300904			Hypothyroidism, congenital, nongoitrous, 9, 301035 (3)	
23.528	4	17	01	Xq23	KCNE1L		Potassium voltage-gated channel, Isk-related family, member 1-like	300328				
23.529	4	21	16	Xq22.3	MORC4, ZCW4, ZCWCC2		MORC family CW-type zinc finger protein 4	300970				
23.530	8	17	09	Xq22.3	NRK, NESK		NIK-related kinase	300791				X(Nrk)
23.531	2	9	17	Xq22.3	PIH1D3, CILD36		PIH1 domain-containing protein 3	300933			Ciliary dyskinesia, primary, 36, X-linked, 300991 (3)	
23.532	9	24	12	Xq22.3	PSMD10, p28		Proteasome 26S subunit, non-ATPase, 10	300880				
23.533	3	22	06	Xq22.3	RIPPLY1		Ripply1, zebrafish, homolog of	300575				
23.534	5	15	11	Xq22.3	RNF128, GRAIL		Ring finger protein 128	300439				
23.535	07	16	19	Xq22.3	TBC1D8B, NPHS20		TBC1 domain family, member 8B	301027			Nephrotic syndrome, type 20, 301028 (3)	
23.536	5	28	13	Xq22.3	CLDN2		Claudin 2	300520				
23.537	8	25	98	Xq23	DCX, DBCN, LISX		Doublecortin	300121			Lissencephaly, X-linked, 300067 (3); Subcortical laminal heterotopia, X-linked, 300067 (3)	X(Dcx)
23.538	1	24	14	Xq23	AGTR2		Angiotensin receptor 2	300034				X(Agtr2)
23.539	10	23	20	Xq23	ALG13, GLT28D1, CDG1S, DEE36		ALG13 UDP-N-acetylglucosaminyltransferase subunit	300776		mutation identified in 1 CDG1S male patient	Developmental and epileptic encephalopathy 36, 300884 (3); ?Congenital disorder of glycosylation, type Is, 300884 (3)	
23.540	1	7	13	Xq24	C1GALT1C1, COSMC, C1GALT2, TNPS		C1GALT1-specific chaperone 1	300611			Tn polyagglutination syndrome, somatic, 300622 (3)	
23.541	5	26	13	Xq23	CAPN6		Calpain 6	300146				
23.542	1	24	11	Xq24	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15		Cullin-4B	300304			Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	
23.543	7	11	17	Xq23	DANT1		DXZ4-associated noncoding transcript 1, proximal	301001				X(Dant1)
23.544	8	31	17	Xq23	DANT2		DXZ4-associated noncoding transcript 2, distal	301004				
23.545	5	15	08	Xq23	IHPS4		Pyloric stenosis, infantile hypertrophic, 4	300711		max lod at rs3027802	Pyloric stenosis, infantile hypertrophic, 4 (2)	
23.546	12	28	08	Xq23	LHFPL1		LHFP-like protein 1	300566				
23.547	5	28	13	Xq23	LUZP4		Leucine zipper protein 4	300616				
23.548	3	23	09	Xq23	MIR448, MIRN448		Micro RNA 448	300686				
23.549	8	27	01	Xq23	NXT2		NTF2-related export protein 2	300320				
23.550	5	23	11	Xq23	PAK3, MRX30, MRX47		p21-activated kinase-3	300142			Mental retardation, X-linked 30/47, 300558 (3)	
23.551	11	11	13	Xq23	PLS3, BMND18		Plastin 3	300131			Bone mineral density QTL18, osteoporosis, 300910 (3)	
23.552	12	22	15	Xq23	RGAG1, MAR9, KIAA1318		Retrotransposon GAG domain-containing protein 1	300965				X(Rgag1)
23.553	5	7	01	Xq23	TRPC5, TRP5		Transient receptor potential channel 5	300334				
23.554	6	26	13	Xq23	XACT		Active X chromosome-coating transcript, noncoding	300901				
23.555	9	2	08	Xq24	ZBTB33, KAISO		Zinc finger- and BTB domain-containing protein 33	300329				X(Kaiso)
23.556	1	27	04	Xq23-q24	MRX23		Mental retardation, X-linked-23	300046		other MRX in same region MRX27, MRX30, MRX35, MRX47, MRX80	Mental retardation, X-linked 23 (2)	
23.557	02	26	19	Xq23	SLC6A14		Solute carrier family 6 (neurotransmitter transporter), member 14	300444				
23.558	12	4	03	Xq23-q26	CHDS3		Coronary heart disease, susceptibility to, 3	300464			{Coronary heart disease, susceptibility to, 3} (2)	
23.559	10	28	10	Xq23-q27.2	MYP13		Myopia 13	300613		between DXS1210 and DXS1227	Myopia 13 (2)	
23.560	3	7	05	Xq24	AKAP14, AKAP28		A-kinase anchor protein 14	300462				
23.561	02	26	19	Xq24	BMIQ11		Body Mass Index quantitative trait locus 11	300306			{Obesity, susceptibility to, BMIQ11} (2)	
23.562	7	20	09	Xq24	CT47A1		Cancer/testis antigen family 45, member A1	300780				
23.563	7	20	09	Xq24	CT47A2		Cancer/testis antigen family 47, member A2	300781				
23.564	7	20	09	Xq24	CT47A3		Cancer/testis antigen family 47, member A3	300782				
23.565	7	20	09	Xq24	CT47A4		Cancer/testis antigen family 47, member A4	300783				
23.566	7	20	09	Xq24	CT47A5		Cancer/testis antigen family 47, member A5	300784				
23.567	7	20	09	Xq24	CT47A6		Cancer/testis antigen family 47, member A6	300785				
23.568	7	20	09	Xq24	CT47A7		Cancer/testis antigen family 47, member A7	300786				
23.569	7	20	09	Xq24	CT47A8		Cancer/testis antigen family 47, member A8	300787				
23.570	7	20	09	Xq24	CT47A9		Cancer/testis antigen family 47, member A9	300788				
23.571	7	20	09	Xq24	CT47A10		Cancer/testis antigen family 47, member A10	300789				
23.572	5	18	09	Xq24	CT47A11, LOC255313		Cancer/testis antigen family 47, member A11	300592				
23.573	7	20	09	Xq24	CT47B1, CT47A13		Cancer/testis antigen family 47, member B1	300790				
23.574	4	30	18	Xq24	CXorf56, MRX107		Chromosome X open reading frame 56	301012		mutation identified in 1 MRX107 family	?Mental retardation, X-linked 107, 301013 (3)	
23.575	5	26	13	Xq24	DOCK11, ACG, ZIZ2		Dedicator of cytokinesis 11	300681				
23.576	5	18	95	Xq23	HTR2C		5-hydroxytryptamine (serotonin) receptor-2C	312861		formerly HTR1C		X(Htr2c)
23.577	8	25	98	Xq23	IL13RA2		Interleukin-13 receptor, alpha-2	300130				
23.578	6	12	17	Xq24	KIAA1210		Kiaa1210 gene	300995				X(Kiaa1210)
23.579	5	26	13	Xq24	KLHL13, KIAA1309		Kelch-like 13	300655				
23.580	08	07	19	Xq24	LAMP2, LAMPB, LGP110, DND		Lysosome-associated membrane protein-2	309060			Danon disease, 300257 (3)	X(Lamp2)
23.581	3	25	15	Xq24	MRX88		Mental retardation, X-linked 88	300852			Mental retardation, X-linked 88 (2)	
23.582	9	27	01	Xq24	MRSS		Mental retardation, X-linked, with short stature	300360			Mental retardation, X-linked, with short stature (2)	
23.583	12	13	18	Xq24	NDUFA1, MWFE, MC1DN12		NADH-ubiquinone oxidoreductase subunit A1	300078			Mitochondrial complex I deficiency, nuclear type 12, 301020 (3)	
23.584	03	16	20	Xq24	NKAP, MRXSHD		NFKB-activating protein	300766			Intellectual developmental disorder, X-linked, syndromic, Hackman-Di Donato type, 301039 (3)	
23.585	7	20	09	Xq24	NKRF, NRF		NFKB-repressing factor	300440				
23.586	5	4	12	Xq24	RHOXF1, OTEX, PEPP1		RHOX homeobox family, member 1	300446				X(Pem)
23.587	5	4	12	Xq24	RHOXF2, PEPP2		RHOX homeobox family, member 2	300447				X(Pem)
23.588	6	30	16	Xq24	RHOXF1P1		RHOX homeobox family member 1, pseudogene 1	300973				
23.589	05	11	20	Xq24	RNF113A, ZNF183, TTD5		RING finger protein 113A	300951			Trichothiodystrophy 5, nonphotosensitive, 300953 (3)	
23.590	5	29	13	Xq24	RPL39		Ribosomal protein L39	300899				
23.591	5	12	00	Xq26.1	SLC25A14, BMCP1		Solute carrier family 25 (mitochondrial carrier), member 14	300242				X(Slc25a14)
23.592	3	12	07	Xq24	SLC25A43		Solute carrier family 25, member 43	300641				X(Slc25a43)
23.593	9	1	16	Xq24	UBE2A, RAD6A, MRXSN, MRXS30		Ubiquitin-conjugating enzyme E2A (RAD6 homolog)	312180			Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)	
23.594	3	5	08	Xq24	ZCCHC12, SIZN1		Zinc finger CCHC domain-containing protein 12	300701				
23.595	2	10	05	Xq24-q25	MRX82		Mental retardation, X-linked 82	300518		between DXS6805 and DXS7346	Mental retardation, X-linked 82 (2)	
23.596	10	4	02	Xq24-q25	RRDX		Radial ray deficiency	300378			Radial ray deficiency (2)	
23.597	11	15	08	Xq24-q25	SPG34		Spastic paraplegia 34, X-linked	300750		max lod at DXS8057	Spastic paraplegia 34, X-linked (2)	
23.598	2	17	09	Xq24-q25	STQTL6		Stature quantitative trait locus 6	300591		max lod at DXS8067	{Stature QTL 6} (2)	
23.599	4	20	11	Xq24-q26	ADFN, ALDS		Albinism-deafness syndrome	300700		~8cM proximal to F9	Albinism-deafness syndrome (2)	
23.600	3	6	00	Xq24	SLC25A5, ANT2, T3		Solute carrier family 25 (mitochondrial carrier), member 5 (adenine nucleotide translocator-2, fibroblast)	300150				
23.601	10	17	95	Xq24-q27	BZX		Bazex syndrome	301845			Bazex syndrome (2)	
23.602	2	23	08	Xq24	SEPT6, SEP2, KIAA0128		Septin 6	300683				
23.603	5	24	00	Xq24-q27.1	PTOS2, PTOSX		Ptosis, hereditary congenital 2	300245			Ptosis, hereditary congenital 2 (2)	
23.604	9	11	02	Xq24-qter	CND		Corneal dermoids	304730			Dermoids of cornea (2)	
23.605	7	18	06	Xq25	ACTRT1, ARPT1		Actin-related protein T1	300487				
23.606	07	25	19	Xq26.1	BCORL1, SHUVER		BCL6 corepressor-like 1	300688			Shukla-Vernon syndrome, 301029 (3)	
23.607	4	17	07	Xq26.1	ENOX2		ECTO-NOX disulfide-thiol exchanger 2	300282				
23.608	9	16	16	Xq25	DUPXq25		Xq25 duplication syndrome	300979			Xq25 duplication syndrome (4)	
23.609	8	1	16	Xq24	GLUD2		Glutamate dehydrogenase-2	300144			{Parkinson disease, age of onset, modifier}, 168600 (3)	
23.610	1	14	13	Xq26.1	IGSF1, IGDC1, CHTE		Immunoglobulin superfamily, member 1	300137			Hypothyroidism, central, and testicular enlargement, 300888 (3)	
23.611	6	7	04	Xq25	SH2D1A, LYP, IMD5, XLP, XLPD1		SH2 domain protein 1A	300490		1cM from DXS42; no recombination with DXS37	Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	X(Sh2d1a)
23.612	04	14	20	Xq25	STAG2, SA2, MKMS, HPE13		Stromal antigen 2	300826			Mullegama-Klein-Martinez syndrome, 301022 (3); Holoprosencephaly 13, X-linked, 301043 (3)	
23.613	2	5	15	Xq25	TENM1, ODZ1, TNM1		Teneurin transmembrane protein 1	300588				
23.614	9	8	15	Xq25	THOC2, THO2, MRX12, MRX35		THO complex 2 (Tho2, yeast, homolog of)	300395			Mental retardation, X-linked 12/35, 300957 (3)	
23.615	7	16	09	Xq25	XECD		Corneal dystrophy, endothelial, X-linked	300779		between DXS8057 and DXS1047	Corneal dystrophy, endothelial, X-linked (2)	
23.616	1	7	11	Xq25	XIAP, BIRC4, API3, XLP2		Inhibitor of apoptosis, X-linked	300079			Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	X(Api3)
23.617	11	22	13	Xq26.1	XPNPEP2, AEACEI		X-prolyl aminopeptidase 2 (aminopeptidase P)	300145			{Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3)	
23.618	08	24	20	Xq25	GRIA3, GLUR3, MRXSW		Glutamate receptor, ionotropic, AMPA 3	305915			Intellectual developmental disorder, X-linked, syndromic, Wu type, 300699 (3)	X(Glur3)
23.619	11	21	18	Xq25-q26	MRX46		Mental retardation, X-linked 46	300436		between DXS8072 and DXS294	Mental retardation, X-linked 46 (2)	
23.620	3	29	99	Xq25-q26	SXI2		X inactivation, familial skewed, 2	300179			X inactivation, familial skewed, 2 (2)	
23.621	09	23	19	Xq24	UPF3B, RENT3B, MRXS14		UPF3B regulator of nonsense-mediated mRNA decay	300298			Mental retardation, X-linked, syndromic 14, 300676 (3)	
23.622	8	25	98	Xq25-q26.1	THAS, TAS		Thoracoabdominal syndrome	313850			Thoracoabdominal syndrome (2)	
23.623	3	1	01	Xq26.1	APLN		Apelin	300297				
23.624	4	23	08	Xq25-q27.1	SCAX5		Spinocerebellar ataxia, X-linked 5	300703		between DXS1047 and DXS1227	Spinocerebellar ataxia, X-linked 5 (2)	
23.625	11	21	18	Xq26.3	ARHGEF6, COOL2		Rho guanine nucleotide exchange factor-6	300267				
23.626	02	07	19	Xq26	CMTX3		Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802		genomic rearrangement between 8q24.3 and Xq27.1	Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 (4)	
23.627	10	28	99	Xq26.3	CXX1		CAAX box protein 1	300213				
23.628	7	13	09	Xq26.1	ELF4, MEF		E74-like factor 4	300775				
23.629	10	4	02	Xq26.2	GPC3, SDYS, SGBS1		Glypican 3	300037			Simpson-Golabi-Behmel syndrome, type 1, 312870 (3); Wilms tumor, somatic, 194070 (3)	
23.630	06	14	19	Xq26.2	GPC4, KPTS		Glypican 4	300168		centromeric to GPC3	Keipert syndrome, 301026 (3)	
23.631	7	14	93	Xq26	GUST		Gustavson mental retardation syndrome (with microcephaly, optic atrophy, deafness)	309555			Gustavson syndrome (2)	
23.632	2	7	01	Xq27.2	MAGEC1		Melanoma antigen, family C, 1	300223				
23.633	3	14	03	Xq26.2	MBNL3, MBXL		Muscleblind-like protein 3	300413				
23.634	1	23	02	Xq26	MRX42		Mental retardation, X-linked nonspecific, 42	300372		?pericentromeric region	Mental retardation, X-linked 42 (2)	
23.635	1	23	01	Xq26.3	PLAC1		Placenta-specific gene 1	300296				X(Plac1)
23.636	11	25	15	Xq26.3	RBMX, MRXS11		RNA-binding motif protein, X chromosome	300199		mutation identified in 1 MRXS11 family	?Mental retardation, X-linked, syndromic 11, Shashi type, 300238 (3)	X(Rbmx)
23.637	10	16	94	Xq26	SHFM2, SHFD2		Split hand/foot malformation, type (ectrodactyly) 2	313350			Split hand/foot malformation 2 (2)	
23.638	08	20	20	Xq26.2	STK26, MASK, MST4		Serine/threonine kinase 26	300547				
23.639	4	8	02	Xq26.3	TNFSF5, CD40LG, HIGM1, IGM		Tumor necrosis factor ligand superfamily, member 5	300386		Between DSX144E and DSX300	Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	X(CD40l)
23.640	2	22	10	Xq26.3	ZNF75D, ZNF75		Zinc finger protein-75D	314997		1Mb distal to HPRT		
23.641	6	2	08	Xq26-q27	CFSS		Craniofacioskeletal syndrome	300712			?Craniofacioskeletal syndrome (2)	
23.642	11	2	98	Xq26-q27	RP24		Retinitis pigmentosa-24	300155			Retinitis pigmentosa 24 (2)	
23.643	6	29	99	Xq26.3	BRS3		Bombesin-like receptor 3	300107				
23.644	9	8	17	Xq26-qter	INDX		Immunoneurologic syndrome X-linked, of Woods, Black, and Norbury	300076			Woods-Black-Norbury syndrome (2)	
23.645	11	27	19	Xq26.1	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5, SEMDHL		Apoptosis-inducing factor, mitochondrion-associated, 1	300169			Combined oxidative phosphorylation deficiency 6, 300816 (3); Cowchock syndrome, 310490 (3); Deafness, X-linked 5, 300614 (3); Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy, 300232 (3)	
23.646	11	24	14	Xq26.1	ARHGAP36		Rho GTPase-activating protein 36	300937				
23.647	5	26	13	Xq26.1	GPR119, GPCR2		G protein-coupled receptor 119	300513				X(Gpr119)
23.648	02	28	20	Xq26.1	OCRL, LOCR, OCRL1, NPHL2		OCRL inositol polyphosphate-5-phosphatase	300535			Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)	
23.649	5	28	13	Xq26.1	SASH3, HACS2, CXorf9, SLY		SAM and SH3 domain containing 3	300441				
23.650	8	19	98	Xq25-q26	SMARCA1, SNF2L1		SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1	300012				
23.651	5	28	13	Xq26.1	UTP14A		Utp14, S. cerevisiae, homolog of, A	300508				X(Utp14a)
23.652	12	2	09	Xq26.1	ZDHHC9, DHHC9, MRXSZ		Zinc finger DHHC domain-containing protein 9	300646			Mental retardation, X-linked syndromic, Raymond type, 300799 (3)	
23.653	3	24	06	Xq26.3	VGLL1, VGL1, TDU		Vestigial-like 1	300583				
23.654	11	19	11	Xq26.2	FRMD7, NYS1, XIPAN		FERM domain-containing 7	300628			Nystagmus 1, congenital, X-linked, 310700 (3); Nystagmus, infantile periodic alternating, X-linked, 310700 (3)	
23.655	09	08	20	Xq26.2-q26.3	HPRT1, HPRT		Hypoxanthine phosphoribosyltransferase 1	308000			Lesch-Nyhan syndrome, 300322 (3); Hyperuricemia, HRPT-related, 300323 (3)	X(Hprt)
23.656	06	18	19	Xq26.2	HS6ST2, MRXSPM		Heparan sulfate 6-O-sulfotransferase 2	300545		mutation identified in 1 MRXSPM family	?Paganini-Miozzo syndrome, 301025 (3)	
23.657	3	23	09	Xq26.2	MIR19B2, MIRN19B2		Micro RNA 19B2	300722				
23.658	4	13	15	Xq26.2	MIR20B		Micro RNA 20B	300950				
23.659	9	9	09	Xq26.2	MIR106A, MIRN106A		Micro RNA 106A	300792				
23.660	10	10	18	Xq26.2	RAP2C		Ras-related protein 2C	301016				
23.661	5	11	09	Xq26.2	TFDP3, HCA661, CT30, DP4		Transcription factor DP family, member 3	300772				
23.662	4	25	05	Xq26.2	USP26		Ubiquitin-specific protease 26	300309				
23.663	5	4	12	Xq26.3	ZIC3, HTX1, HTX, VACTERLX		Zic family, member 3	300265			Heterotaxy, visceral, 1, X-linked 306955 (3); Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3); VACTERL association, X-linked, 314390 (3)	
23.664	4	30	09	Xq26.3	CT45A1, CT45		Cancer/testis antigen family 45, member A1	300648				
23.665	9	2	09	Xq26.3	CT45A2, CT45.2		Cancer/testis antigen family 45, member A2	300793				
23.666	9	2	09	Xq26.3	CT45A3, CT45.3		Cancer/testis antigen family 45, member A3	300794				
23.667	9	2	09	Xq26.3	CT45A4, CT45.4		Cancer/testis antigen family 45, member A4	300795				
23.668	9	2	09	Xq26.3	CT45A5, CT45.5		Cancer/testis antigen family 45, member A5	300796				
23.669	9	2	09	Xq26.3	CT45A6, CT45.6		Cancer/testis antigen family 45, member A6	300797				
23.670	2	4	15	Xq26.3	CXDUPq26.3, DUPXq26.3, XLAG		Chromosome Xq26.3 duplication syndrome	300942			Chromosome Xq26.3 duplication syndrome (4)	
23.671	5	28	13	Xq26.3	MOSPD1		Motile sperm domain-containing protein 1	300674				X(Mospd1)
23.672	6	16	99	Xq26.2	PHF6, BFLS		PHD finger protein 6	300414			Borjeson-Forssman-Lehmann syndrome, 301900 (3)	
23.673	6	16	99	Xq26.3-q27.1	FGF13, FGF2		Fibroblast growth factor-13	300070				X(Fhf2)
23.674	9	26	17	Xq26.3	GPR101, PAGH2, PITA2		G protein-coupled receptor 101	300393			Pituitary adenoma 2, GH-secreting, 300943 (3)	
23.675	5	28	13	Xq26.3	HTATSF1, TATSF1		HIV-1 TAT stimulatory factor 1	300346				
23.676	9	20	14	Xq26.3	MAP7D3, MDP3		MAP7 domain-containing protein 3	300930				
23.677	3	23	09	Xq26.3	MIR424, MIRN424, MIR322		Micro RNA 424	300682				
23.678	12	19	11	Xq26.3	MIR503		Micro RNA 503	300865				
23.679	5	6	08	Xq26.3	SLC9A6, NHE6		Solute carrier family 9 (sodium/hydrogen exchanger), member 6	300231			Mental retardation, X-linked syndromic, Christianson type, 300243 (3)	
23.680	6	2	08	Xq27.1	SOX3, MRGH		SRY (sex determining region Y)-box 3	313430		P mutant in BFLS	Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3); Panhypopituitarism, X-linked, 312000 (3)	X(Sox3)
23.681	3	24	11	Xq26.3	SRXX3		46XX sex reversal 3	300833		due to deletion/duplication/rearrangement upstream of SOX3	46XX sex reversal 3 (4)	
23.682	11	30	06	Xq26.3	ZNF449, ZSCAN19		Zinc finger protein 449	300627				
23.683	4	30	01	Xq27.2	SPANXC, CTP11		Sperm protein associated with the nucleus, X chromosome, family member C	300330				
23.684	5	26	13	Xq27.1	ATP11C, ATPIQ, ATPIG, HACXL		ATPase, class VI, type 11C	300516		mutation identified in 1 HACXL patient	?Hemolytic anemia, congenital, X-linked, 301015 (3)	
23.685	5	18	05	Xq27	BMND4		Bone mineral density QTL 4	300536			[Bone mineral density QTL 4] (2)	
23.686	5	7	01	Xq28	CNGA2, CNG2, OCNC1		Cyclic nucleotide-gated channel, alpha-2	300338				
23.687	8	5	97	Xq27	COD2		Cone dystrophy-2, X-linked	300085			Cone dystrophy, progressive X-linked, 2 (2)	
23.688	06	08	20	Xq28	EOLA1, CXorf40A		Endothelium- and lymphocyte-associated ASCH domain 1	300954				
23.689	4	27	12	Xq27.3	FMR1AS1, ASFMR1		FMR1 antisense RNA 1	300805				
23.690	8	27	02	Xq27.1	LDOC1		Leucine zipper downregulated in cancer 1	300402				
23.691	12	30	03	Xq27.2	MAGEC3		Melanoma antigen, family C, 3	300469				
23.692	3	19	09	Xq27.2	MAGEC2, MAGEE1, CT10, HCA587		Melanoma antigen, family C, 2	300468				
23.693	1	25	91	Xq27.1	MCF2, DBL		Oncogene MCF2 (oncogene DBL)	311030		~60kb telomeric to F9; 5' replacement by chr.15 segment		X(Mcf2)
23.694	10	11	17	Xq27.3	SLITRK2, KIAA1854, CXorf1, CXorf2		SLIT- and NTRK-like family, member 2	300561				X(Slitrk2)
23.695	12	28	08	Xq27.3	SLITRK4		SLIT- and NTRK-like family, member 4	300562				X(Slitrk4)
23.696	5	26	13	Xq27.3	SPANXN1		SPANX family, member N1	300664				X(Spanxn)
23.697	5	28	13	Xq27.3	SPANXN2		SPANX family, member N2	300665				
23.698	5	26	13	Xq27.3	SPANXN3		SPANX family, member N3	300666				
23.699	5	28	13	Xq27.3	SPANXN4		SPANX family, member N4	300667				
23.700	2	1	00	Xq27	TGCT1		Testicular germ cell tumor 1	300228			Testicular germ cell tumor (2)	
23.701	9	29	98	Xq27-q28	HPCX1		Prostate cancer, hereditary, X-linked 1	300147		between D3S2390 and bG82i1.0	{Prostate cancer, hereditary, X-linked 1} (2)	
23.702	5	28	13	Xq27.1	CIRS7, CDR1AS		Circular RNA sponge for MIR7	300898				
23.703	02	06	19	Xq27.1	HPT, HPTX, HYPX		Hypoparathyroidism	307700		interstitial deletion/insertion on Xq27.1	Hypoparathyroidism, X-linked (4)	
23.704	9	21	11	Xq27.1	HTC2, HCG, CGH, CXINSq27.1		Hypertrichosis, congenital generalized	307150		palindrome-mediated interchromosomal insertion at Xq27.1	Hypertrichosis, congenital generalized (4)	
23.705	09	14	20	Xq27.1	MIR505		Micro RNA 505	301053				
23.706	3	19	01	Xq27.2	SPANXA1, SPANX		Sperm protein associated with the nucleus, X chromosome, family member A1	300305				
23.707	5	26	13	Xq27.2	SPANXD		SPANX family, member D	300670				
23.708	5	26	13	Xq27.2	SPANXE		SPANX family, member E	300671				
23.709	7	7	98	Xq27.1	CDR1, CDR62A		Cerebellar degeneration-related protein-1, 34kD	302650		between HPRT and F9		X(Cdr)
23.710	07	27	20	Xq27.1	F9, HEMB, THPH8		Coagulation factor IX (plasma thromboplastic component)	300746		distal to HPRT; proximal part of Xq27	Hemophilia B, 306900 (3); {Warfarin sensitivity}, 301052 (3); Thrombophilia, X-linked, due to factor IX defect, 300807 (3); {Deep venous thrombosis, protection against}, 300807 (3)	X(Cf9)
23.711	5	26	13	Xq27.1	SPANXB1, SPANXB		SPANX family, member B1	300669				
23.712	10	31	17	Xq26.3	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU		Four-and-a-half LIM domains 1	300163		mutation identified in 1 FCMSU family	Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy, X-linked, with postural muscle atrophy, 300696 (3); Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3); Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3); ?Uruguay faciocardiomusculoskeletal syndrome, 300280 (3)	
23.713	4	30	09	Xq27.2-q28	BPP, PMGX, CBPS		Polymicrogyria, bilateral perisylvian	300388		possible genetic heterogeneity	Polymicrogyria, bilateral perisylvian (2)	
23.714	12	23	05	Xq27.2	SPANXA2		Sperm protein associated with the nucleus, X chromosome, family member A2	300493				
23.715	10	21	04	Xq27.3	DYX9		Dyslexia, susceptibility to, 9	300509		max lod at DXS8043	{Dyslexia, susceptibility to, 9} (2)	
23.716	11	04	19	Xq27.3	FMR1, FRAXA, POF1		FMRP translational regulator 1	309550		8-8.7Mb from telomere	Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome, 300623 (3); Premature ovarian failure 1, 311360 (3)	X(Fmr1)
23.717	9	2	12	Xq27.3	MIR506		Micro RNA 506	300877				
23.718	9	2	12	Xq27.3	MIR508		Micro RNA 508	300874				
23.719	9	2	12	Xq27.3	MIR509-1		Micro RNA 509-2	300875				
23.720	9	2	12	Xq27.3	MIR509-3		Micro RNA 509-3	300876				
23.721	12	19	11	Xq27.3	MIR510		Micro RNA 510	300866				
23.722	3	28	12	Xq27.3-q28	DUPXq27.3q28, CXDUPq27.3q28		Chromosome Xq27.3-q28 duplication syndrome	300869			Chromosome Xq27.3-q28 duplication syndrome (4)	
23.723	8	3	95	Xq27.3-qter	EBM		Epidermolysis bullosa, macular type	302000				
23.724	6	21	13	Xq28	ABCD1, ALD, AMN		ATP-binding cassette, subfamily D, member 1	300371		about 650kb from GCP/RCP	Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, adult, 300100 (3)	X(Ald)
23.725	11	11	09	Xq28	AFF2, FMR2, FRAXE, MRX2		AF4/FMR2 family, member 2 (fragile site, X-linked, E)	300806			Mental retardation, X-linked, FRAXE type, 309548 (3)	
23.726	11	1	13	Xq28	BCAP31, BAP31, DXS1357E, DDCH		B-cell receptor-associated protein 31	300398			Deafness, dystonia, and cerebral hypomyelination, 300475 (3)	X(Bap31)
23.727	4	26	11	Xq28	BED		Bornholm eye disease	300843		linked to F8	Bornholm eye disease (2)	
23.728	2	14	13	Xq28	ATP2B3, PMCA3, SCAX1		ATPase, Ca++ transporting, plasma membrane, 3	300014		mutation identified in 1 family	?Spinocerebellar ataxia, X-linked 1, 302500 (3)	
23.729	6	26	16	Xq28	ATP6AP1, ATP6IP1, ATP6S1, VATPS1		ATPase, H+ transporting, lysosomal, accessory protein 1	300197			Immunodeficiency 47, 300972 (3)	
23.730	10	4	05	Xq28	AVPR2, DIR, DI1, ADHR		Arginine vasopressin receptor-2	300538			Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	
23.731	12	15	16	Xq28	BGN, SEMDX, MRLS		Biglycan	301870		proximal Xq28	Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3); Meester-Loeys syndrome, 300989 (3)	X(Bgn)
23.732	6	26	11	Xq28	BRCC3, BRCC36		BRCA1/BRCA2-containing complex, subunit 3	300617				
23.733	9	8	11	Xq28	CD99L2, CD99B		CD99 antigen-like 2	300846				X(Cd99l2)
23.734	5	18	95	Xq28	CETN2, CALT		Centrin, EF-hand protein, 2 (caltractin)	300006				
23.735	2	4	15	Xq28	CLIC2, XAP121, MRXS32		Chloride intracellular channel 2	300138		mutation identified in 1 MRXS32 family	?Mental retardation, X-linked, syndromic 32, 300886 (3)	
23.736	3	23	15	Xq28	CSAG1, CSAGE		CSAG family, member 1 `	300944				
23.737	5	26	13	Xq28	CTAG1A, LAGE2A		Cancer/testis antigen 1A	300657				
23.738	11	5	98	Xq28	CTAG1B, CTAG1		Cancer/testis antigen 1B	300156				
23.739	5	28	13	Xq28	CTAG2, LAGE1, CAMEL		Cancer/testis antigen 2	300396				
23.740	3	29	10	Xq28	DUPXq28, CXq28		Chromosome Xq28 duplication syndrome	300815			Chromosome Xq28 duplication syndrome (4)	
23.741	9	19	13	Xq28	DKC1, DKCX		Dyskerin	300126			Dyskeratosis congenita, X-linked, 305000 (3)	X(Dkc1)
23.742	5	19	97	Xq28	DNASE1L1, DNL1L		Deoxyribonuclease I-like 1	300081		between QM and DXS1010E		
23.743	5	28	13	Xq28	DUSP9, MKP4		Dual-specificity phosphatase 9	300134				
23.744	3	22	93	Xq28	DXS522E, F8B		DNA segment, single copy, expressed probes, intron 22 probe, F8B	305424				
23.745	4	4	02	Xq28	EMD, EDMD, STA		Emerin	300384		in distal Xq28	Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)	
23.746	9	13	92	Xq28	F8A, DXS522E, HAP40		Factor VIII associated gene 1	305423		3 copies, 1 in intron 22 of F8C		X(F8a)
23.747	9	28	00	Xq28	F8, F8C, HEMA		Coagulation factor VIII, procoagulant component	300841		cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomere	Hemophilia A, 306700 (3)	X(Cf8)
23.748	5	28	13	Xq28	FAM3A		Family with sequence similarity 3, member A	300492				
23.749	11	22	09	Xq28	FAM11A, FRAXF		Family with sequence similarity 11, member A	300031				
23.750	08	27	20	Xq28	FAM50A, DXS9928E, HXC26, MRXSA		Family with sequence similarity 50, member A	300453			Intellectual developmental disorder, X-linked, syndromic, Armfield type, 300261 (3)	
23.751	4	23	08	Xq28	FAM58A, STAR		Family with sequence similarity 58, member A	300708			STAR syndrome, 300707 (3)	
23.752	6	19	12	Xq28	FATE1		Fetal and adult testis-expressed gene 1	300450				
23.753	3	5	18	Xq28	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2		Filamin A, alpha (actin-binding protein-280)	300017		mutation identified in 1 FGS2 patient	Heterotopia, periventricular, 1, 300049 (3); Otopalatodigital syndrome, type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3); Frontometaphyseal dysplasia 1, 305620 (3); ?FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3); Congenital short bowel syndrome, 300048 (3)	X(Fln1)
23.754	04	07	20	Xq28	FUNDC2, HCBP6, HCC3		FUN14 domain-containing protein 2	301042				
23.755	01	9	18	Xq28	G6PD, G6PD1		Glucose-6-phosphate dehydrogenase	305900			Hemolytic anemia, G6PD deficient (favism), 300908 (3); {Resistance to malaria due to G6PD deficiency}, 611162 (3)	X(G6pd)
23.756	5	28	13	Xq28	GAB3		GRB2-associated binding protein 3	300482				
23.757	12	29	89	Xq28	GABRA3		Gamma-aminobutyric acid (GABA) A receptor, alpha-3	305660		4Mb from telomere		X(Gabra3)
23.758	6	9	98	Xq28	GABRE		Gamma-aminobutyric acid (GABA) A receptor, epsilon	300093				
23.759	8	30	01	Xq28	GABRQ		Gamma-aminobutyric acid receptor, theta	300349				
23.760	9	8	11	Xq28	GDI1, RABGD1A, MRX41, MRX48		GDP dissociation inhibitor 1	300104			Mental retardation, X-linked 41, 300849 (3)	
23.761	6	7	10	Xq28	HAUS7, UCHL5IP, UIP1		HAUS augmin-like complex, subunit 7	300540				
23.762	5	14	95	Xq28	HMS1, GAY1		Homosexuality, male	306995			[?Homosexuality, male] (2)	
23.763	2	7	01	Xq28	GPR50		G protein-coupled receptor 50	300207				X(Gpr50)
23.764	11	27	19	Xq28	H2AB1, H2AFB1		H2A.B variant histone 1	301037				
23.765	11	27	19	Xq28	H2AB2, H2AFB2		H2A.B variant histone 2	301038				
23.766	11	27	19	Xq28	H2AB3, H2AFB, H2ABBD		H2A.B variant histone 3	300445				
23.767	11	1	13	Xq28	HCFC1, HCF1, MRX3		Host cell factor C1 (VP16-accessory protein)	300019		50kb distal to V2R	Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3)	X(Hcfc1)
23.768	7	17	14	Xq28	HMGB3, HMG4, HMG2A, MCOPS13		High-mobility group box 3 (high mobility group protein 4)	300193		mutation identified in 1 MCOPS13 family	?Microphthalmia, syndromic 13, 300915 (3)	
23.769	4	21	99	Xq28	IDH3G		Isocitrate dehydrogenase 3 (NAD+), gamma	300089				
23.770	2	9	11	Xq28	IDS, MPS2, SIDS		Iduronate 2-sulfatase (Hunter syndrome)	300823		telomeric IDS2 source of inversion in IDS	Mucopolysaccharidosis II, 309900 (3)	X(Ids)
23.771	06	22	20	Xq28	IKBKG, NEMO, FIP3, IP, EDAID1, IMD33		Inhibitor of nuclear factor kappa B kinase, regulatory subunit gamma	300248			Incontinentia pigmenti, 308300 (3); Ectodermal dysplasia and immunodeficiency 1, 300291 (3); Immunodeficiency 33, 300636 (3)	X(Ikbkg)
23.772	11	6	95	Xq28	IL9R		Interleukin-9 receptor	300007		in PAR2 pseudoautosomal region		
23.773	2	1	01	Xq28	IRAK1		Interleukin 1 receptor-associated kinase 1	300283				X(Irak1)
23.774	1	29	13	Xq28	L1CAM, CAML1, HSAS1, MASA, SPG1		L1 cell adhesion molecule	308840		between RCP/GCP cluster and G6PD	Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome, 303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)	X(L1cam)
23.775	10	31	17	Xq28	LAGE3, ITBA2, GAMOS2		L antigen family member 3	300060			Galloway-Mowat syndrome 2, X-linked, 301006 (3)	
23.776	3	14	13	Xq28	LINC00850, KUCG1		Long intergenic noncoding RNA 850	300892				
23.777	5	6	08	Xq28	MAFD2, MDX		Major affective disorder 2	309200		linkage to G6PD,CB in non-Ashkenazi Jews	{?Major affective disorder 2} (2)	
23.778	2	5	96	Xq28	MAGE1		Melanoma antigen 1 (directs expression of antigen MZ2-E)	300016		cluster of 12 genes		
23.779	6	29	99	Xq28	MAGEA2, MAGE2		Melanoma antigen, family A, 2	300173				
23.780	5	26	13	Xq28	MAGEA2B		Melanoma antigen, family A, 2B	300549				
23.781	6	29	99	Xq28	MAGEA3, MAGE3		Melanoma antigen, family A, 3	300174				
23.782	6	29	99	Xq28	MAGEA4, MAGE4A, MAGE4B		Melanoma antigen, family A, 4	300175				
23.783	7	17	01	Xq28	MAGEA5, MAGE5		Melanoma antigen, family A, 5	300340				X(Mage5)
23.784	7	17	01	Xq28	MAGEA8, MAGE8		Melanoma antigen, family A, 8	300341				X(Mage8)
23.785	7	17	01	Xq28	MAGEA9, MAGE9		Melanoma antigen, family A, 9	300342				
23.786	3	19	09	Xq28	MAGEA9B		Melanoma antigen, family A, 9B	300764				
23.787	7	17	01	Xq28	MAGEA10, MAGE10		Melanoma antigen, family A, 10	300343				
23.788	7	17	01	Xq28	MAGEA11, MAGE11		Melanoma antigen, family A, 11	300344				
23.789	6	29	99	Xq28	MAGEA6, MAGE6		Melanoma antigen, family A, 6	300176				
23.790	6	29	99	Xq28	MAGEA12, MAGE12		Melanoma antigen, family A, 12	300177				
23.791	2	23	09	Xq28	MAMLD1, CXorf6, F18, HYSP2		Mastermind-like domain containing 1	300120		near MTM1 in microdeletion	Hypospadias 2, X-linked, 300758 (3)	
23.792	7	14	15	Xq28	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13		Methyl-CpG-binding protein-2	300005		70kb centromeric of RCP/GCP	Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic 13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked 3}, 300496 (3); Mental retardation, X-linked syndromic, Lubs type, 300260 (3); Rett syndrome, atypical, 312750 (3)	X(Mecp2)
23.793	12	21	09	Xq28	MIR105-1, MIRN105-1		Micro RNA 105-1	300811				
23.794	12	21	09	Xq28	MIR105-2, MIRN105-2		Micro RNA 105-2	300812				
23.795	9	20	14	Xq28	MIR718		Micro RNA 718	300929				
23.796	4	1	09	Xq28	MIR224, MIRN224		Micro RNA 224	300769				
23.797	10	21	92	Xq28	MPP1, PEMP, EMP55		Membrane protein, palmitoylated-1, 55kD	305360		~30kb 3' and centromeric to F8		X(Emp55)
23.798	10	23	87	Xq28	MRSD, CHRS		Mental retardation-skeletal dysplasia	309620			Mental retardation-skeletal dysplasia (2)	
23.799	9	19	00	Xq28	MRXSA		Armfield X-linked mental retardation syndrome	300261			Mental retardation syndrome, X-linked, Armfield type (2)	
23.800	6	15	99	Xq28	MTCP1		Mature T-cell proliferation 1	300116				
23.801	12	20	02	Xq28	MTM1, MTMX		Myotubularin	300415		close to F8	Myotubular myopathy, X-linked, 310400 (3)	
23.802	3	29	99	Xq28	MTMR1		Myotubularin-related protein-1	300171				
23.803	6	28	11	Xq28	MYMY4, CXDELq38		Moyamoya disease 4 with short stature, hypergonadotropic hypogonadism and facial dysmorphism	300845		contiguous gene deletion syndrome (3.4kb)	Moyamoya disease 4 (4)	
23.804	11	12	98	Xq28	MYP1		Myopia 1, X-linked	310460			Myopia-1 (2)	
23.805	07	10	20	Xq28	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1		N-alpha-acetyltransferase 10, NatA catalytic subunit	300013			Ogden syndrome, 300855 (3); Microphthalmia, syndromic 1, 309800 (3)	
23.806	2	11	11	Xq28	NSDHL		NAD(P)H steroid dehydrogenase-like protein	300275			CHILD syndrome, 308050 (3); CK syndrome, 300831 (3)	X(Nsdhl)
23.807	9	13	10	Xq28	OPN1C		OPN1LW and OPN1MW genes, controller of	300824				
23.808	9	13	10	Xq28	OPN1LW, RCP, CBP, CBBM		Red cone pigment (opsin 1, long-wave-sensitive)	300822		5' to CBD	Colorblindness, protan, 303900 (3); Blue cone monochromacy, 303700 (3)	X(Rsvp)
23.809	8	30	10	Xq28	OPN1MW, GCP, CBD, CBBM		Green cone pigment (opsin 1, medium-wave-sensitive)	300821		linked to G6PD; multiple genes	Colorblindness, deutan, 303800 (3); Blue cone monochromacy, 303700 (3)	X(Rsvp)
23.810	3	28	17	Xq28	PASD1, CT64, OXTES1		PAS domain-containing repressor 1	300993				
23.811	1	11	07	Xq28	PDZD4, PDZK4, PDZRN4L, KIAA1444, LU1		PDZ domain-containing 4	300634				X(Pdzd4)
23.812	11	29	99	Xq28	PLXNB3, PLXN6		Plexin B3	300214				
23.813	10	9	07	Xq28	PNCK, CAMK1B, BSTK3		Pregnancy-upregulated, nonubiquitous, CAM kinase	300680				X(Pnck)
23.814	5	26	13	Xq28	PNMA3, MA3		Paraneoplastic MA antigen 3	300675				
23.815	3	7	14	Xq28	PNMA5, KIAA1934		Paraneoplastic MA antigen family, member 5	300916				
23.816	3	7	14	Xq28	PNMA6A, PNMA6		Paraneoplastic MA antigen family, member 6A	300917				
23.817	1	2	08	Xq28	PRRG3, PRGP3, TMG3		Proline-rich gamma-carboxyglutamic acid protein 3	300685				
23.818	08	07	19	Xq28	RAB39B, MRX72, WSMN		Ras-associated protein RAB39B	300774			Mental retardation, X-linked 72, 300271 (3); Waisman syndrome, 311510 (3)	
23.819	6	14	94	Xq28	RENBP		Renin-binding protein	312420				
23.820	2	15	96	Xq28	RGC1		Rho-GAP hematopoietic protein C1	300023				
23.821	7	19	06	Xq28	RP34		Retinitis pigmentosa 34	300605			Retinitis pigmentosa 34 (2)	
23.822	7	6	17	Xq28	RPL10, DXS648, QM, AUTSX5, MRXS35		Ribosomal protein L10	312173			{Autism, susceptibility to, X-linked 5}, 300847 (3); Mental retardation, X-linked, syndromic, 35, 300998 (3)	
23.823	12	4	03	Xq26.3	SAGE		Sarcoma antigen	300359				
23.824	2	15	96	Xq28	SEX		Sex chromosome X transmembrane protein of HGF receptor family 3	300022				
23.825	7	18	13	Xq28	SLC6A8, CRTR, CCDS1		Solute carrier family 6 (neurotransmitter transporter, creatine), member 8	300036		distal to G6PD	Cerebral creatine deficiency syndrome 1, 300352 (3)	X(Slc6a8)
23.826	3	16	10	Xq28	SLC10A3, P3		Solute carrier family 10 (sodium/bile acid cotransporter family) member 3 (protein p3)	312090		order: G6PD-3'-(7kb)-5'-P3-3'-(0.5kb)-5'-GDX		X(P3)
23.827	2	2	10	Xq28	SLEB15		Systemic lupus erythematosus, susceptibility to, 15	300809		associated with rs17435	{Systemic lupus erythematosus, susceptibility to, 15} (2)	
23.828	09	19	19	Xq28	SPRY3		Sprouty RTK signaling antagonist 3	300531		in pseudoautosomal region PAR2		
23.829	7	27	17	Xq28	SRPK3, STK23, MSSK1		Protein kinase, serine/arginine-specific, 3	301002				X(Srpk3)
23.830	11	29	16	Xq28	SSR4, TRAPD, CDG1Y		Signal sequence receptor, delta	300090			Congenital disorder of glycosylation, type Iy, 300934 (3)	
23.831	7	17	12	Xq28	TAZ, EFE2, BTHS, CMD3A, LVNCX		Tafazzin	300394			Barth syndrome, 302060 (3)	
23.832	8	13	14	Xq28	TEX28		Testis-expressed gene on Xq28	300092				
23.833	8	25	98	Xq28	TKCR, TKC		Torticollis, keloids, cryptorchidism and renal dysplasia	314300		distal to G6PD	Goeminne TKCR syndrome (2)	
23.834	10	15	98	Xq28	TKTL1, TKT2, TKR		Transketolase-like 1	300044		between GCP and FLN1		
23.835	5	4	12	Xq28	TMEM187, CXorf12, DXS9878E, ITBA1 gene		Transmembrane protein 187	300059				
23.836	4	21	16	Xq28	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6		Epsilon-trimethyllysine hydroxylase	300777			{Autism, susceptibility to, X-linked 6}, 300872 (3)	
23.837	9	10	07	Xq28	UBL4A, GDX, UBL4, DX254E		Ubiquitin-like 4A	312070		40kb 3' to G6PD		X(Gdx)
23.838	12	11	02	Xq28	TREX2		3-prime repair exonuclease 2	300370				
23.839	10	12	09	Xq28	VAMP7, SYBL1, TIVAMP		Vesicle-associated membrane protein 7	300053				
23.840	7	13	98	Xq28	VBP1		Von Hippel-Lindau binding protein-1	300133				X(Vbp1)
23.841	9	11	15	Xq28	VMA21, XMEA		Vma21, S. cerevisiae, homolog of	300913			Myopathy, X-linked, with excessive autophagy, 310440 (3)	
23.842	10	23	87	Xq28	XM		Xm	314900		linked to DCB, PCB		
23.843	3	3	03	Xq28	ZNF185		Zinc finger protein 185	300381				
23.844	2	28	03	Xq23	AMOT, KIAA1071		Angiomotin	300410				
23.845	11	3	11	Chr.X	CCCSX		Cerebral-cerebellar-coloboma syndrome, X-linked	300864			Cerebral-cerebellar-coloboma syndrome, X-linked (2)	
23.846	2	3	04	Chr.X	CVMRF		Cubitus valgus with mental retardation and unusual facies	300471			Cubitus valgus with mental retardation and unusual facies (2)	
23.847	6	27	08	Chr.X	DFCTRPS		Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719			Deafness, cataract, retinitis pigmentosa, and sperm abnormalities (2)	
23.848	2	7	01	Xp22.12	EIF1A, EIF4C, EIF1AX		Eukaryotic translation initiation factor 1A	300186				
23.849	12	13	00	Xp11.22	GAGED2, XAGE1		G antigen, family D, 2	300289				
23.850	8	25	98	Xq24	IL13RA1		Interleukin-13 receptor, alpha-1	300119				
23.851	1	30	01	Xp11.21	KLF8, ZNF741, BKLF3		Kruppel-like factor 8	300286				
23.852	7	26	06	Chr.X	MCOPCB1		Microphthalmia, isolated, with coloboma 1	300345			Microphthalmia with coloboma 1 (2)	
23.853	2	2	14	Chr.X	MRX95		Mental retardation, X-linked 95	300716			Mental retardation, X-linked 95 (2)	
23.854	3	25	15	Chr.X	MRXSMP		Mental retardation, X-linked, syndromic, Martin-Probst type	300519			Mental retardation, X-linked, syndromic, Martin-Probst type (2)	
23.855	8	27	01	Xq22.1	NXF2		Nuclear RNA export factor 2	300315				
23.856	04	19	19	Chr.X	OFD8		Orofaciodigital syndrome VIII	300484			Orofaciodigital syndrome VIII (2)	
23.857	2	1	01	Xp11.23	PIM2		Oncogene PIM2	300295				
23.858	5	7	01	Xq26.1	RAB33A		Ras-associated protein RAB33A	300333				
23.859	3	29	01	Xq22.3	TEX13A		Testis-expressed gene 13A	300312				
23.860	3	29	01	Xq22.3	TEX13B		Testis-expressed gene 13B	300313				
24.1	12	19	11	Yp11.2	AKAP17A, SFRS17A, XE7Y		A kinase (PRKA) anchor protein 17A	465000		see 300015 locus		
24.2	10	4	93	Yp11.2	ASMTY		Acetylserotonin methyltransferase (Y chromosome)	402500		pseudoautosomal		
24.3	3	23	04	Yp11.2	ASMTLY		Acetylserotonin methyltransferase-like, Y-linked	400011				
24.4	10	4	93	Yp11.2	MIC2Y		Antigen identified by monoclonal 12E7, Y homolog	450000		pseudoautosomal		
24.5	11	16	09	Yp11.2	SHOXY		Short stature homeo box, Y-linked	400020		pseudoautosomal	Short stature, idiopathic familial, 300582 (3); Leri-Weill dyschondrosteosis, 127300 (3); Langer mesomelic dysplasia, 249700 (3)	
24.6	10	13	93	Yp11.2	TSPY1, TSPY		Testis-specific protein, Y-linked, 1	480100				
24.7	7	1	16	Yp11.32	PLCXD1Y		Phospholipase C, phosphatidylinositol-specific, X domain-containing protein 1	400046		in pseudoautosomal region		
24.8	9	5	01	Yp11.2	CRLF2Y		Cytokine receptor-like factor 2, Y-linked	400023		pseudoautosomal		
24.9	10	4	93	Yp11.2	IL3RA, IL3RY, IL3RAY		Interleukin-3 receptor (Y chromosome)	430000		308385 = X homolog; pseudoautosomal		
24.10	10	28	08	Yp11.2	RPS4Y1		Ribosomal protein S4, Y-linked, 1	470000				
24.11	8	20	09	Yp11.2	SRY, TDF, TDY, SRXX1, SRXY1		Sex-determining region Y (testis determining factor)	480000			46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (4)	Yp(Tdy, Sry)
24.12	1	13	95	Yp11.2	ZFY		Zinc finger protein, Y-linked	490000				
24.13	12	23	19	Yp11.2	DHRSY		Dehydrogenase/reductase, Y-linked	400049				
24.14	7	10	02	Yp11.2	PCDH11Y, PCDH22, PCDHY		Protocadherin 22	400022				
24.15	8	5	97	Yp11.2	PRKY		Protein kinase, Y-linked	400008				
24.16	04	16	19	Yp11.2	TBL1Y, DFNY2		Transducin-beta-like 1, Y-linked	400033		mutation identified in 1 DFNY2 family	?Deafness, Y-linked 2, 400047 (3)	
24.17	2	28	03	Yp11.2	TGIF2LY, TGIFLY		Transforming growth factor-beta-induced factor 2-like, Y-linked	400025				
24.18	10	4	93	Yp11.2	AMELY, AMGL		Amelogenin (Y chromosome)	410000		301200 = X homolog		
24.19	10	4	93	Yp11.2	CSF2RY		Granulocyte-macrophage colony-stimulating factor receptor, alpha subunit (Y chromosome)	425000		306250 = X homolog; distal to MIC2Y		
24.20	3	23	04	Yp11	XGR		XG regulator	489500		in pseudoautosomal region		
24.21	10	4	93	Yp11.2	ANT3Y		Adenine nucleotide translocator-3 (Y chromosome)	403000		300151 = X homolog; proximal to CSF2RY		
24.22	7	8	99	Yq11.223	BPY2		Basic protein on Y chromosome, 2	400013				
24.23	3	23	04	Yq	HEY		Hairy ears, Y-linked	425500			?Hairy ears, Y-linked (2)	
24.24	09	18	19	Yq11.223	DAZ1		Deleted in azoospermia 1	400003				17(dazla)
24.25	07	15	20	Yq11.221	DDX3Y, DBY		DEAD-box helicase 3, Y-linked	400010				
24.26	11	3	11	Yq11	DELYq11, CYDELq11, SPGFY1		Chromosome Yq11 interstitial deletion syndrome	400042		contiguous gene deletion syndrome	Spermatogenic failure, Y-linked, 1 (4)	
24.27	8	19	09	Yq11.223	KDM5D, JARID1D, SMCY, HYA		Lysine-specific demethylase 5D	426000		encodes H-Y epitope in mouse		Yp(Smcy)
24.28	7	9	99	Yq11.223	RBMY1A1, RBM1, YRRM1, RBM2		RNA binding motif protein, Y chromosome, family 1, member A1	400006				Y(Rbmy)
24.29	8	11	98	Yq11.221	UTY		Ubiquitously transcribed TPR gene on Y chromosome	400009				
24.30	3	23	04	Yq11.223	DAZ2		Deleted in azoospermia 2	400026				
24.31	3	23	04	Yq11.23	DAZ3		Deleted in azoospermia 3	400027				
24.32	09	18	19	Yq11.23	DAZ4		Deleted in azoospermia 4	400048				
24.33	3	23	04	Yq11.222-q11.223	CYorf15A		Chromosome Y open reading frame 15A	400031				
24.34	3	23	04	Yq11.222	HSFY		Heat shock transcription factor, Y-linked	400029				
24.35	3	23	04	Yq11.223	RPS4Y2		Ribosomal protein S4, Y-linked	400030				
24.36	3	23	04	Yq11.2	CYorf15B		Chromosome Y open reading frame 15B	400032				
24.37	3	23	04	Yq11.221	NLGN4Y, KIAA0951		Neuroligin 4, Y-linked	400028				
24.38	11	2	04	Yq11.223	PRY2		PTPBL-related gene on Y, 2	400041				
24.39	11	3	11	Yq11.221	USP9Y, DFFRY, SPGFY2		Ubiquitin-specific protease-9, Y chromosome (Drosophila fat facets related, Y-linked)	400005			Spermatogenic failure, Y-linked, 2, 415000 (3)	
24.40	8	19	09	Yq11.222	CDY2		Chromodomain protein, Y chromosome, 2	400018				
24.41	8	24	09	Yq11.221	TMSB4Y		Thymosin, beta-4, Y chromosome	400017				
24.42	8	24	09	Yq11.221	VCY, BPY1		Variably charged, Y chromosome	400012				
24.43	8	24	09	Yq11.222	XKRY		XK-related protein on Y chromosome	400015				
24.44	8	19	09	Yq11.223	EIF1AY		Eukaryotic translation initiation factor 1A, Y isoform	400014				
24.45	8	24	09	Yq11.223	PRY		PTPN13-like, Y-linked	400019				
24.46	5	28	13	Yq11.223	TTTY4		Testis-specific transcript, Y-linked, 4	400037				
24.47	5	28	13	Yq11.223	TTTY5		Testis-specific transcript, Y-linked, 5	400038				
24.48	5	28	13	Yq11.223	TTTY6		Testis-specific transcript, Y-linked, 6	400039				
24.49	5	28	13	Yq11.223	TTY17		Testis-specific transcript, Y-linked, 17	400040				
24.50	8	19	09	Yq11.23	CDY1, CDY		Chromodomain protein, Y chromosome	400016				Y(Cdy1)
24.51	11	10	17	Yq11.23	CSPG4P1Y, CSPG4LY		Chondroitin sulfate proteoglycan 4 pseudogene 1, Y-linked	400034				
24.52	5	28	13	Yq11.23	GOLGA2LY		Golgi autoantigen, golgin subfamily A, 2-like, Y-linked	400035				
24.53	5	28	13	Yq11.23	TTTY3		Testis-specific transcript, Y-linked, 3	400036				
24.54	8	25	98	Yq12	GCY, TSY, STA		Growth control, Y-chromosome influenced	475000				
24.55	3	20	08	Chr.Y	DFNY1		Deafness, Y-linked 1	400043			Deafness, Y-linked 1 (2)	
24.56	2	8	01	Chr.Y	RPY		Retinitis pigmentosa, Y-linked	400004			Retinitis pigmentosa, Y-linked (2)	
#
#
#
#
# Native OMIM data only in this file.  A version of this map integrated
# with NCBI genomic coordinates, HGNC symbols, and more is genemap2.txt
#
#
# Gene Mapping Confidence Codes :
# -------------------------------
#
# With the completion of the HGP, the Gene Mapping Confidence Codes are
# deprecated, however the column is retained so as not to break
# existing workflows.
#
#
# Mapping Method Codes :
# ----------------------
#
# With the completion of the HGP, the Mapping Method Codes are
# deprecated, however the column is retained so as not to break
# existing workflows.
#
#
# Phenotypes :
# ------------
#
# Each Phenotype is followed by its MIM number, if different from
# that of the locus, preceded by a comma
# Phenotype mapping key in parentheses follows the phenotype MIM
# number (explanation below).
# Allelic disorders are separated by a semi-colon following the
# phenotype mapping key.
#
#
# Phenotype Mapping Key - Appears in parentheses after a disorder :
# -----------------------------------------------------------------
#
# 1 - The disorder is placed on the map based on its association with
# a gene, but the underlying defect is not known.
# 2 - The disorder has been placed on the map by linkage; no mutation
# has been found.
# 3 - The molecular basis for the disorder is known; a mutation has
# been found in the gene.
# 4 - A contiguous gene deletion or duplication syndrome, multiple
# genes are deleted or duplicated causing the phenotype.
#
